Citrus Sinensis ID: 043852

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-
Protein Sequence
MPFMDAAKPKPRSSRPRLDRRNALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDNKTSFRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQEFKAAVMLDDERLVSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMKFRRPVEAVDDDEILKSFAAESDDEYFLHSPIAVGFISPLNENEENNEVRRLRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNMHS
Secondary Structure (PSIPRED)
cccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccccccccccHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHccccHHHHcccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccccccccccccccccccHHHHHHHHHccccccccccccccccccccccccccHHHcccccccccccccccccccccEEEccEEccccccEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHcccccccccEEEEEEEEccEEEEEEEEcccccHHHHHHHccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccEEEEcccccHHHHHHHHcccccccHccccHHHHHHHHHcccccccccccccccccccccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccccccEEcccccccEEEcccccccccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccccEEcccEEEEEEEEEccccEEEEEEEEEccEEEEEEEcHHHHHHccHHHHHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEEEEcccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccHccHHHHcccccccccHHcHHHHHHHHHHHHHcccccccccHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHccccHccccccccccccccccccc
Coil and Loop (DISEMBL)
mpfmdaakpkprssrprldrrnALKNiqydaslapssasssfddkssasprrirsldltdnktsfrvkgmdgEFDLICRSlgfsgpedfaiPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQEFKAAVMLDDERLVSKRGsslakrenrvgpragingdrppalsppspmkfrrpveavdddeILKSFaaesddeyflhspiavgfisplneneennevrrlretnvveesgpsisvhdhdgdddRKDLAVRLIkepvynvspngkfrRRIMSWqkgellgsgsfgtvyegytddgfFFAVKEvslqdqgtqgKQSILQLEQEILLLSRFEHenivqyfgtdkdenRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNylheqnvvhrdiKCANILvdasgsvkladfglakattmndvksckgtpfwmapevvnlknrgygltADIWSLGCTVlemltrqppyshlegMQALFrigkgepplvpnslsrDARDFILKCLqvnpndrptaaqlmehpfvkrplqksrgppsyynnmhs
Flexible Loop (DISEMBL)
mpfmdaakpkprssrprldrrNALKNIqydaslapssasssfddkssasprrirsldltdnktsfrvkgmdgeFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQEFkaavmldderlvskrgsslakrenrvgpragingdrppalsppspmkFRRPVEAVDDDEILKSFAAESDDEYFLHSPIAvgfisplneneennEVRRLRetnvveesgpsisvhdhdgddDRKDLAVRlikepvynvspngkfrRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYfgtdkdenRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLmehpfvkrplqksrgppsyynnmhs
Low Complexity Region (SEG)
MPFMDAAKPKPRSSRPRLDRRNALKNIQYdaslapssasssfddkssasPRRIRSLDLTDNKTSFRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQEFKAAVMLDDERLVSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMKFRRPVEAVDDDEILKSFAAESDDEYFLHSPIAVGFISPLneneennevrrlretnvveeSGPSISVHdhdgdddrkdLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKqsilqleqeilllsRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNMHS
Disordered region (IsUnstruct)
****************************************************************FRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDL*********************************************************************FA***DDEYFLHSPIAVGFIS****************************************LAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG***********DARDFILKCLQV************************************
Disordered Region (DISOPRED)
**************************************************************************************************************************************************************************************************************************************************************************************WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVS***************EQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM***KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV*******************
Disordered Region (DISEMBL)
****************RLDRRNALKNIQYDAS*******************RIRSLDLTDNKTSFRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQEFKAAVMLDDERLVSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMKFRRPVEAVDDDEILKSFAAESDDEYFLHSPIAVGFISPLNENEENNEVRRLRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSL********QSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNMHS
Disordered Region (DISPRO)
***************PRLDRRNALKNIQYD*************************LDLTDNKTSFRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKAR*************************************************************************KFRRPVEAVDDDEILKSFAAESDDEYFLHSPIAVGFISPL********************************************************FRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYY*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPFMDAAKPKPRSSRPRLDRRNALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDNKTSFRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQEFKAAVMLDDERLVSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMKFRRPVEAVDDDEILKSFAAESDDEYFLHSPIAVGFISPLNENEENNEVRRLRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNMHS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	551	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	yes	no	0.473	0.429	0.702	1e-106
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.479	0.139	0.612	1e-88
O22040	666	Mitogen-activated protein	no	no	0.459	0.379	0.488	3e-65
Q9FZ36	651	Mitogen-activated protein	no	no	0.455	0.385	0.477	3e-64
O22042	651	Mitogen-activated protein	no	no	0.479	0.405	0.442	4e-60
E9Q3S4	1311	Mitogen-activated protein	yes	no	0.460	0.193	0.440	2e-58
Q56UN5	1328	Mitogen-activated protein	yes	no	0.460	0.191	0.429	2e-58
Q54R82	942	Mitogen-activated protein	no	no	0.460	0.269	0.424	3e-58
Q61084	626	Mitogen-activated protein	no	no	0.459	0.404	0.429	5e-56
Q99759	626	Mitogen-activated protein	no	no	0.459	0.404	0.429	7e-56

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  385 bits (990), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 184/262 (70%), Positives = 217/262 (82%), Gaps = 1/262 (0%)

Query: 276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           I SWQKG+LLG GSFG+VYEG + DG FFAVKEVSL DQG+Q ++ I QLE EI LLS+ 
Sbjct: 330 ITSWQKGQLLGRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQL 389

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           +H+NIV+Y GT KD + L+IFLELVT+GSL  LYQ+Y L DS VS YTRQIL+GL YLH+
Sbjct: 390 QHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHD 449

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNR-GY 454
           +  +HRDIKCANILVDA+G+VKLADFGLAK +  ND+KSCKGTPFWMAPEV+N K+  GY
Sbjct: 450 KGFIHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGY 509

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G  ADIWSLGCTVLEM T Q PYS LE +QALFRIG+G  P VP++LS DAR FILKCL+
Sbjct: 510 GSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFILKCLK 569

Query: 515 VNPNDRPTAAQLMEHPFVKRPL 536
           VNP +RPTAA+L+ HPFV+RPL
Sbjct: 570 VNPEERPTAAELLNHPFVRRPL 591

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  327 bits (839), Expect = 1e-88,   Method: Compositional matrix adjust.
 Identities = 171/279 (61%), Positives = 206/279 (73%), Gaps = 15/279 (5%)

Query: 262  PVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQS 321
            P+Y  +  G F   I  WQKG+LLG GS G+VYEG + DG FFA KEVSL DQG+Q  + 
Sbjct: 1614 PIY--ASEGSF---ITCWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEW 1668

Query: 322  ILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA 381
            I Q+E  I LLS+ +H+NIV+Y GT KDE+ L+IFLELVT+GSL  LYQ+  L DS VS 
Sbjct: 1669 IQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSL 1728

Query: 382  YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF- 440
            YTRQIL+GL YLH++  +HR+IKCAN+LVDA+G+VKLADFGLAK      V S   TP+ 
Sbjct: 1729 YTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKLADFGLAK------VMSLWRTPYW 1782

Query: 441  -WMAPEVV-NLKNR-GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV 497
             WMAPEV+ N K+  GYG  ADIWSLGCTVLEMLT Q PYS LE   AL+ IG G+ P +
Sbjct: 1783 NWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKI 1842

Query: 498  PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
            P+ LS DARDFIL CL+VNP +RPTAA+L+ HPFV  PL
Sbjct: 1843 PDILSLDARDFILTCLKVNPEERPTAAELLNHPFVNMPL 1881

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  249 bits (637), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 131/268 (48%), Positives = 182/268 (67%), Gaps = 15/268 (5%)

Query: 277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQS---ILQLEQEILLL 332
           +SW+KG+L+G G+FGTVY G   D G   AVK+V +       +++   I +LE+E+ LL
Sbjct: 67  ISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLL 126

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLN 391
               H NIV+Y GT ++++ L I LE V  GS+++L +K+    +S V  YTRQ+L GL 
Sbjct: 127 KNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLE 186

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFG----LAKATTMNDVKSCKGTPFWMAPEVV 447
           YLH   ++HRDIK ANILVD  G +KLADFG    +A+  TM   KS KGTP+WMAPEV+
Sbjct: 187 YLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI 246

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYS-HLEGMQALFRIG--KGEPPLVPNSLSRD 504
                G+  +ADIWS+GCTV+EM+T + P+S   + + A+F IG  K  PP +P++LS D
Sbjct: 247 --LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPP-IPDTLSSD 303

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           A+DF+LKCLQ  PN RPTA++L++HPFV
Sbjct: 304 AKDFLLKCLQEVPNLRPTASELLKHPFV 331

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  246 bits (628), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 127/266 (47%), Positives = 178/266 (66%), Gaps = 15/266 (5%)

Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQS---ILQLEQEILLLSR 334
           W+KG+L+G G+FGTVY G   D G   AVK+V +       +++   I +LE+E+ LL  
Sbjct: 68  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLM-DSQVSAYTRQILNGLNYL 393
             H NIV+Y GT +++  L I LE V  GS+++L +K+    +S V  YT Q+L GL YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFG----LAKATTMNDVKSCKGTPFWMAPEVVNL 449
           H   ++HRDIK ANILVD  G +KLADFG    +A+  T++  KS KGTP+WMAPEV+  
Sbjct: 188 HNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVI-- 245

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYS-HLEGMQALFRIG--KGEPPLVPNSLSRDAR 506
              G+  +ADIWS+GCTV+EM+T + P+S   + + A+F IG  K  PP +P+++S DA 
Sbjct: 246 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPP-IPDNISSDAN 304

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFV 532
           DF+LKCLQ  PN RPTA++L++HPFV
Sbjct: 305 DFLLKCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  233 bits (593), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 126/285 (44%), Positives = 179/285 (62%), Gaps = 21/285 (7%)

Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEV-----SLQDQGTQGKQSILQLEQEILLL 332
           W+KGEL+G G+FG VY G   D G   A+K+V     S   + TQG   I +LE+E+ LL
Sbjct: 68  WRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGH--IRELEEEVQLL 125

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLN 391
               H NIV+Y GT ++ + L I +E V  GS+++L +K+    +  +  YT+Q+L GL 
Sbjct: 126 KNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLE 185

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT----TMNDVKSCKGTPFWMAPEVV 447
           YLH   ++HRDIK ANILVD  G ++LADFG +K      T+N  KS KGTP+WMAPEV+
Sbjct: 186 YLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI 245

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYS-HLEGMQALFRIG--KGEPPLVPNSLSRD 504
                G+  +ADIWS+GCTV+EM T +PP+S   +   A+  IG  K  PP +P  LS +
Sbjct: 246 --LQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPP-IPEDLSPE 302

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNM 549
           A+DF++KCL   P+ R +A +L++HPFV    Q+    P+Y N++
Sbjct: 303 AKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPY--PAYRNSL 345

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1

 Score =  227 bits (579), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 118/268 (44%), Positives = 168/268 (62%), Gaps = 14/268 (5%)

Query: 279  WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG-KQSILQLEQEILLLSRFEH 337
            W KGE+LG G++GTVY G T  G   AVK+V+L        ++   +L++E+ LL   +H
Sbjct: 1044 WTKGEILGRGAYGTVYCGLTSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKALKH 1103

Query: 338  ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQ 396
             NIV Y GT  +EN L IF+E V  GS++++  ++  +   V   YTRQIL G+ YLH+ 
Sbjct: 1104 VNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHDN 1163

Query: 397  NVVHRDIKCANILVDASGSVKLADFGLAK--------ATTMNDVKSCKGTPFWMAPEVVN 448
             VVHRDIK  N+++  +G +KL DFG AK         T  + +KS +GTP+WMAPEV+N
Sbjct: 1164 CVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYWMAPEVIN 1223

Query: 449  LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG--KGEPPLVPNSLSRDAR 506
                GYG  +DIWS+GCTV EM T +PP + ++ M A+F IG  +G  P +P   S  A 
Sbjct: 1224 --ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPARFSEPAA 1281

Query: 507  DFILKCLQVNPNDRPTAAQLMEHPFVKR 534
            DF+  CL  + ++RP+A QL++H F+KR
Sbjct: 1282 DFVRLCLTRDQHERPSALQLLKHSFLKR 1309

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1

 Score =  227 bits (579), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 115/268 (42%), Positives = 168/268 (62%), Gaps = 14/268 (5%)

Query: 279  WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT-QGKQSILQLEQEILLLSRFEH 337
            W KGE+LG G++GTVY G T  G   AVK+V+L        ++   +L++E+ LL   +H
Sbjct: 1061 WTKGEILGKGAYGTVYCGLTSQGQLIAVKQVALDTSNKLAAEKEYRKLQEEVDLLKALKH 1120

Query: 338  ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQ 396
             NIV Y GT   EN + IF+E V  GS++++  ++  +   V   YT+QIL G+ YLHE 
Sbjct: 1121 VNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGPLPEMVFCKYTKQILQGVAYLHEN 1180

Query: 397  NVVHRDIKCANILVDASGSVKLADFGLAK--------ATTMNDVKSCKGTPFWMAPEVVN 448
             VVHRDIK  N+++  +G +KL DFG A+         T  + +KS  GTP+WMAPEV+N
Sbjct: 1181 CVVHRDIKGNNVMLMPTGIIKLIDFGCARRLAWAGLNGTHSDMLKSMHGTPYWMAPEVIN 1240

Query: 449  LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG--KGEPPLVPNSLSRDAR 506
                GYG  +DIWS+GCTV EM T +PP + ++ M A+F IG  +G  P +P+  S +A 
Sbjct: 1241 --ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPDHFSENAA 1298

Query: 507  DFILKCLQVNPNDRPTAAQLMEHPFVKR 534
            DF+  CL  + ++RP+A QL++H F++R
Sbjct: 1299 DFVRMCLTRDQHERPSALQLLKHSFLER 1326

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  226 bits (576), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 112/264 (42%), Positives = 177/264 (67%), Gaps = 10/264 (3%)

Query: 277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGT--QGKQSILQLEQEILLLS 333
           + WQKG++LG G +G+VY G   D G  FAVK++ + D  +  + K  IL   +EI ++ 
Sbjct: 168 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMR 227

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNY 392
              H+NIV+Y GT  D++ L +FLE +  GS+++L  K+    ++ +  YT+QIL GL++
Sbjct: 228 SLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSF 287

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKGTPFWMAPEVVNLK 450
           LH  +++HRDIK ANIL+D  G VKL+DFG +K+ +  ++  KS +GTP+WMAPEV+  K
Sbjct: 288 LHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--K 345

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA-LFRIGKGEP-PLVPNSLSRDARDF 508
             G+G ++DIWSLGC ++EM T QPP+S++  + A ++ I      P +P+ +S++A DF
Sbjct: 346 QTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDF 405

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFV 532
           +  C + +P +RP A QL++HPF+
Sbjct: 406 LNLCFKRDPKERPDANQLLKHPFI 429

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1

 Score =  219 bits (558), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 115/268 (42%), Positives = 165/268 (61%), Gaps = 15/268 (5%)

Query: 277 MSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           ++W++G+LLG G+FG VY  Y  D G   A K+V       +  + +  LE EI LL   
Sbjct: 360 INWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNL 419

Query: 336 EHENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNY 392
           +HE IVQY+G   D+ E  L IF+E +  GS+ +  + Y  L +S    YTRQIL G++Y
Sbjct: 420 QHERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 479

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVV 447
           LH   +VHRDIK ANIL D++G+VKL DFG +K       +   ++S  GTP+WM+PEV+
Sbjct: 480 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 539

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLVPNSLSRDA 505
           +    GYG  AD+WSLGCTV+EMLT +PP++  E M A+F+I   +P  P +P+ +S   
Sbjct: 540 S--GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTNPQLPSHISEHG 596

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           RDF+ +   V    RP+A +L+ H F +
Sbjct: 597 RDFLRRIF-VEARQRPSAEELLTHHFAQ 623

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  218 bits (556), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 115/268 (42%), Positives = 165/268 (61%), Gaps = 15/268 (5%)

Query: 277 MSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           ++W++G+LLG G+FG VY  Y  D G   A K+V       +  + +  LE EI LL   
Sbjct: 360 INWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNL 419

Query: 336 EHENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNY 392
           +HE IVQY+G   D+ E  L IF+E +  GS+ +  + Y  L +S    YTRQIL G++Y
Sbjct: 420 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 479

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVV 447
           LH   +VHRDIK ANIL D++G+VKL DFG +K       +   ++S  GTP+WM+PEV+
Sbjct: 480 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVI 539

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLVPNSLSRDA 505
           +    GYG  AD+WSLGCTV+EMLT +PP++  E M A+F+I   +P  P +P+ +S   
Sbjct: 540 S--GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTNPQLPSHISEHG 596

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           RDF+ +   V    RP+A +L+ H F +
Sbjct: 597 RDFLRRIF-VEARQRPSAEELLTHHFAQ 623

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	551
359486016	559	PREDICTED: mitogen-activated protein kin	0.916	0.903	0.580	1e-168
298204644	719	unnamed protein product [Vitis vinifera]	0.889	0.681	0.594	1e-164
255545546	555	Mitogen-activated protein kinase kinase	0.945	0.938	0.576	1e-163
224082218	548	predicted protein [Populus trichocarpa]	0.901	0.906	0.589	1e-154
356509460	566	PREDICTED: mitogen-activated protein kin	0.940	0.915	0.544	1e-151
356518515	555	PREDICTED: mitogen-activated protein kin	0.923	0.917	0.521	1e-149
225459451	567	PREDICTED: mitogen-activated protein kin	0.938	0.911	0.544	1e-148
356557517	440	PREDICTED: mitogen-activated protein kin	0.778	0.975	0.543	1e-145
357461677	540	Mitogen-activated protein kinase kinase	0.901	0.920	0.570	1e-145
356552843	590	PREDICTED: mitogen-activated protein kin	0.936	0.874	0.530	1e-143

>gi|359486016|ref|XP_002264549.2| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  596 bits (1537), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 338/582 (58%), Positives = 401/582 (68%), Gaps = 77/582 (13%)

Query: 7   AKPKPRSSRPRLDRRNALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLT--DNKTS 64
           +K K +  +P+LDRRNA+KNI YDAS +        DD   A+  R RSLDL+   ++TS
Sbjct: 3   SKHKQKLLKPKLDRRNAIKNIDYDASTS--------DD---ATTLRTRSLDLSPISSRTS 51

Query: 65  FRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKA--------RSR------------ 104
           FR++G   EFD ICRSLG SGPEDFAIPAAAWEA+KA        RSR            
Sbjct: 52  FRIQGSAAEFDQICRSLGLSGPEDFAIPAAAWEARKALSSPNLLPRSRSDPPEKQPVAEE 111

Query: 105 FSFDNASRLQLRFDQALDLTEEQEFKAAVMLDDERLVSKRGSSLAKRENRVGPRAGINGD 164
            S +  +R+++RF   ++   E E  +   L+   L S R               GI G 
Sbjct: 112 VSREFGTRVRVRFADKIEDGNENERDSENELNCVDLNSVRSGG-----------GGIKGV 160

Query: 165 RPPALSPPSPMKFRRPVEAVDDD----EILKSFAAESD---DEYFLHSPIAV-------- 209
           RPP +  P     RRPV  VD+     ++LKSFA + D   D     S +A         
Sbjct: 161 RPPPVLAPP-PVMRRPV--VDNVSSTWDLLKSFAPQGDEPLDSLRGGSKVASSSDEEDVS 217

Query: 210 GFISPLNENEENNEVRR-------LRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEP 262
           G ++P ++ EE+ E+ R       +   N+  E   S + +D D D         +  EP
Sbjct: 218 GIVNP-SDGEEHTEIERNKVDGENVDGENIGTEESCSSTSNDEDEDSS-------MTLEP 269

Query: 263 VYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSI 322
           +Y +SPNG+F+R I SWQ+GELLGSGSFGTVYEGYTDDGFFFAVKEVSL DQG+QGKQSI
Sbjct: 270 IYGISPNGQFKRTINSWQRGELLGSGSFGTVYEGYTDDGFFFAVKEVSLLDQGSQGKQSI 329

Query: 323 LQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY 382
            QLEQEI LLS+FEHENIV+Y+GTDKD+++L+IFLELVTKGSL +LYQKY L +SQ SAY
Sbjct: 330 YQLEQEISLLSQFEHENIVRYYGTDKDDSKLYIFLELVTKGSLLSLYQKYDLRESQASAY 389

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM 442
           TRQILNGL YLHEQNVVHRDIKCANILVD +GSVKLADFGLAKAT +NDVKSCKGT FWM
Sbjct: 390 TRQILNGLKYLHEQNVVHRDIKCANILVDVNGSVKLADFGLAKATKLNDVKSCKGTVFWM 449

Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           APEVVN KN+GYGL ADIWSLGCTVLE+LTR+PPYSHLEGMQALFRIGKGEPP V NSLS
Sbjct: 450 APEVVNRKNKGYGLAADIWSLGCTVLEILTRRPPYSHLEGMQALFRIGKGEPPPVSNSLS 509

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            DAR+FILKCLQVNP+DRPTA QL++HPFVKRPL    GP S
Sbjct: 510 SDARNFILKCLQVNPSDRPTAGQLLDHPFVKRPLHTFSGPQS 551

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|298204644|emb|CBI23919.3| unnamed protein product [Vitis vinifera]

 Score =  585 bits (1509), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 332/558 (59%), Positives = 389/558 (69%), Gaps = 68/558 (12%)

Query: 19  DRRNALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLT--DNKTSFRVKGMDGEFDL 76
           DRRNA+KNI YDAS +        DD   A+  R RSLDL+   ++TSFR++G   EFD 
Sbjct: 190 DRRNAIKNIDYDASTS--------DD---ATTLRTRSLDLSPISSRTSFRIQGSAAEFDQ 238

Query: 77  ICRSLGFSGPEDFAIPAAAWEAQKA--------RSR------------FSFDNASRLQLR 116
           ICRSLG SGPEDFAIPAAAWEA+KA        RSR             S +  +R+++R
Sbjct: 239 ICRSLGLSGPEDFAIPAAAWEARKALSSPNLLPRSRSDPPEKQPVAEEVSREFGTRVRVR 298

Query: 117 FDQALDLTEEQEFKAAVMLDDERLVSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMK 176
           F   ++   E E  +   L+   L S R               GI G RPP +  P    
Sbjct: 299 FADKIEDGNENERDSENELNCVDLNSVRSGG-----------GGIKGVRPPPVLAPP-PV 346

Query: 177 FRRPVEAVDDD----EILKSFAAESDDEYFLHSPIAVGFISPLNENEENNEVRRLRETNV 232
            RRPV  VD+     ++LKSFA + D+       +  G     + +EE+  + R    NV
Sbjct: 347 MRRPV--VDNVSSTWDLLKSFAPQGDEPL---DSLRGGSKVASSSDEEDVVIER---NNV 398

Query: 233 ------VEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLG 286
                 + ES  S S   +D D+D       +  EP+Y +SPNG+F+R I SWQ+GELLG
Sbjct: 399 NGGNAGIGESQESCSSTSNDEDEDSS-----MTLEPIYGISPNGQFKRTINSWQRGELLG 453

Query: 287 SGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT 346
           SGSFGTVYEGYTDDGFFFAVKEVSL DQG+QGKQSI QLEQEI LLS+FEHENIV+Y+GT
Sbjct: 454 SGSFGTVYEGYTDDGFFFAVKEVSLLDQGSQGKQSIYQLEQEISLLSQFEHENIVRYYGT 513

Query: 347 DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           DKD+++L+IFLELVTKGSL +LYQKY L +SQ SAYTRQILNGL YLHEQNVVHRDIKCA
Sbjct: 514 DKDDSKLYIFLELVTKGSLLSLYQKYDLRESQASAYTRQILNGLKYLHEQNVVHRDIKCA 573

Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           NILVD +GSVKLADFGLAKAT +NDVKSCKGT FWMAPEVVN KN+GYGL ADIWSLGCT
Sbjct: 574 NILVDVNGSVKLADFGLAKATKLNDVKSCKGTVFWMAPEVVNRKNKGYGLAADIWSLGCT 633

Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
           VLE+LTR+PPYSHLEGMQALFRIGKGEPP V NSLS DAR+FILKCLQVNP+DRPTA QL
Sbjct: 634 VLEILTRRPPYSHLEGMQALFRIGKGEPPPVSNSLSSDARNFILKCLQVNPSDRPTAGQL 693

Query: 527 MEHPFVKRPLQKSRGPPS 544
           ++HPFVKRPL    GP S
Sbjct: 694 LDHPFVKRPLHTFSGPQS 711

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  581 bits (1498), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 326/565 (57%), Positives = 386/565 (68%), Gaps = 44/565 (7%)

Query: 9   PKPRSSRPRLDRRNALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDNKTSFRVK 68
           PK   SRPRL+RRNA K+I+YDA+ + SS  +S    S  +    RSLDL +  TSFR++
Sbjct: 3   PKNGRSRPRLERRNAAKHIEYDATSSFSSLDASSCSSSLVT----RSLDLPEG-TSFRIE 57

Query: 69  GMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQL----RFDQALDLT 124
           G DGEFD ICRS+G +GPEDF IP AAWEA K RS       SRL +    R  +A    
Sbjct: 58  GTDGEFDRICRSIGLTGPEDFEIPTAAWEAMKVRSASDLLPRSRLYVSDSPRIAEAKHKE 117

Query: 125 EEQEFK--AAVMLDDERLVSKRGSSLAKRENRVGP------RAGINGDRPPALSPPSPMK 176
           +EQE     A +LD    V    S+   +E +V P        GI G RPP L PP  M 
Sbjct: 118 QEQEKSELCARVLD---TVRTDDSTELTQEKQVQPVKLNVSGGGIKGVRPPLLKPPPSMT 174

Query: 177 FRRPVEAVDDDEILKSFAAE---------------SDDEYFLHSPIAVGFISPLNENEEN 221
                +     +IL+ FA E               SDDE  + + I  G      E++++
Sbjct: 175 LPVIDKCCSTWDILRDFAPENDRRSSMLIAEGGLSSDDEEEVAAAINKGEEEEEEEDDDD 234

Query: 222 NEVRRLRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQK 281
           N + R+RE  V+ ES    + +D D      +L        + N+SP+ +FRR I  W+K
Sbjct: 235 N-LSRIREIGVLSESCSFTTSNDDDSSSTTTEL--------MSNISPHERFRRMISDWEK 285

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           G+LLG GSFG+VYEG   DGFFFA+KEVSL DQG+QGKQSI QLEQEI LLS+FEHENIV
Sbjct: 286 GDLLGRGSFGSVYEGIAHDGFFFAIKEVSLLDQGSQGKQSIYQLEQEIALLSQFEHENIV 345

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
           +Y+GTDKD++ L+IFLELVT+GSL NLYQ+YHL DSQVSAYTRQIL+GL YLH++NVVHR
Sbjct: 346 RYYGTDKDDSNLYIFLELVTQGSLMNLYQRYHLRDSQVSAYTRQILHGLKYLHDRNVVHR 405

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIW 461
           DIKCANILVDASGSVKLADFGLAKAT +NDVKSCKGT FWMAPEVVN K  GYGL ADIW
Sbjct: 406 DIKCANILVDASGSVKLADFGLAKATKLNDVKSCKGTAFWMAPEVVNRKTHGYGLPADIW 465

Query: 462 SLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRP 521
           SLGCTVLEMLTRQ PYSHLE MQALFRIGKG PP VP+SLS DARDFIL+CLQVNPN RP
Sbjct: 466 SLGCTVLEMLTRQVPYSHLECMQALFRIGKGVPPPVPDSLSNDARDFILQCLQVNPNGRP 525

Query: 522 TAAQLMEHPFVKRPLQKSRGPPSYY 546
           TAAQL+EH FV++PL  S G  S Y
Sbjct: 526 TAAQLLEHSFVRQPLPMSSGSASPY 550

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa]

 Score =  552 bits (1422), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 319/541 (58%), Positives = 376/541 (69%), Gaps = 44/541 (8%)

Query: 22  NALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDNKTSFRVKGMDGEFDLICRSL 81
           NALK+I YDA+  PS +S      SS+S    RSLDL D +TSFR++G +GE D ICRSL
Sbjct: 31  NALKHIDYDAT--PSFSSLD---DSSSSSLFTRSLDLPD-RTSFRIEGTEGELDRICRSL 84

Query: 82  GFSGPEDFAIPAAAWEAQKARSRFSFDNASRL--------QLRFDQALDLTEEQEFK--A 131
           G SGPEDFAIPAAAWEA KARS       SRL           F   +++T +QE +   
Sbjct: 85  GLSGPEDFAIPAAAWEAMKARSASDLLRRSRLLGPDSPKAAEEFKAIVEMTNQQEERELC 144

Query: 132 AVMLDDERL--VSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMKFRRPVEAVDDDEI 189
           A +L   R+   S   ++    +NR G   GI G RPP L PP  M      +     ++
Sbjct: 145 AGVLKSVRVRDSSTELNTCHDIDNR-GVSVGIKGPRPPLLKPPPSMTLPVIDKECSTWDL 203

Query: 190 LKSFAAESDDEYFLHSPIAVGFISPLNENEE----NNEVRRLRETNVVEESGPSISVHDH 245
            + FA E+D                +N N+E    +++  R R   V++ +  S +    
Sbjct: 204 FRDFAPEND--------------GVVNNNKEFSSGDDDDGRERRPQVIDAASCSFTTS-- 247

Query: 246 DGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFA 305
                  D +     EP+ N+SPN +FRR I  W+KGELLG GSFG+VYEG +DDGFFFA
Sbjct: 248 -----NDDDSSSSTTEPMSNISPNLRFRRSITDWEKGELLGRGSFGSVYEGISDDGFFFA 302

Query: 306 VKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSL 365
           VKEVSL DQG+QGKQSI QLEQEI LLSRFEHENIVQY+GTDKDE++L+IFLELVTKGSL
Sbjct: 303 VKEVSLLDQGSQGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL 362

Query: 366 ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 425
             LYQ+Y+L DSQVSAYTRQIL+GL YLH+QNVVHRDIKCAN+LVDA+GSVKLADFGLAK
Sbjct: 363 LKLYQRYNLRDSQVSAYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADFGLAK 422

Query: 426 ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA 485
           AT  NDVKSCKGT FWMAPEVVN KN+GYGL ADIWSLGCTVLEMLTRQ PYS LE MQA
Sbjct: 423 ATKFNDVKSCKGTAFWMAPEVVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSELESMQA 482

Query: 486 LFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
           LFRIG+G PPLVP+SLS DARDFIL+CLQVNPNDRPTAA L++HPF+KRPL    G  S 
Sbjct: 483 LFRIGRGVPPLVPDSLSNDARDFILQCLQVNPNDRPTAAVLLDHPFMKRPLPTFSGSASP 542

Query: 546 Y 546
           Y
Sbjct: 543 Y 543

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356509460|ref|XP_003523467.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  542 bits (1396), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 313/575 (54%), Positives = 379/575 (65%), Gaps = 57/575 (9%)

Query: 4   MDAAKPKPRSSRPRLDRRNALK--NIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDN 61
           MD   P+    +P+L+RRNALK  + +YD   +PS      DD         RS++  D 
Sbjct: 17  MDRKNPR---RKPKLERRNALKYSSSEYDVVSSPS------DDT-----LYTRSMEFYD- 61

Query: 62  KTSFRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARS------RFSFDNASRLQL 115
           +TSFR++G++GEFD ICRSLG SGPEDFAIPAAAWEA K RS      R   DN    + 
Sbjct: 62  RTSFRIEGVEGEFDRICRSLGLSGPEDFAIPAAAWEAMKFRSSSDILPRLKLDNLDIPEE 121

Query: 116 RFDQALDLTEEQEFKAAVMLDDERLVSKRGSSLAKRENRVGPRA-GINGDRPPALSPPSP 174
             ++   + E + FK+A   ++  L    G S + R   +   + GI G RPP L PP  
Sbjct: 122 DVEEESKVNEVRMFKSA---EEGELSENHGVSDSVRVREIDESSNGIKGIRPPMLKPPPG 178

Query: 175 MKFRRPVEAVDDD-----EILKSFAAESDDEYFL-HSPIA----------VGFISPLNEN 218
            +    V+ VDD      ++L+  A +  +   L HS             VG        
Sbjct: 179 TR----VQVVDDSACSSWDLLRDLAPQGGEGLPLNHSNEEREVAEKEEGEVGTKESPKRE 234

Query: 219 EENNEVRRLRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEP-VYNVSPNGKFRRRIM 277
           EE N     R   +V     S S    + DD           +P   N+SP G+ +R I 
Sbjct: 235 EEQNVDNAARIAEIVAGLSESCSFSTSNEDDSSSSTT-----DPRSNNISPQGRIKRIIT 289

Query: 278 --SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
             SWQKGE LG GSFG+VYEG +DDGFFFAVKEVSL DQGTQGKQS+ QLEQEI LLS+F
Sbjct: 290 AGSWQKGEFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGTQGKQSVYQLEQEIALLSQF 349

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           EH+NIVQY+GT+ D+++L+IFLELVTKGSL +LYQKY L DSQVSAYTRQIL+GL YLH+
Sbjct: 350 EHDNIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRDSQVSAYTRQILHGLKYLHD 409

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           +NVVHRDIKCANILVDASGSVKLADFGLAKAT +NDVKS KGT FWMAPEVV  KN+GYG
Sbjct: 410 RNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSMKGTAFWMAPEVVKGKNKGYG 469

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
           L AD+WSLGCTVLEMLT Q PY  LE MQALFRIGKGE P +P+SLSRDA+DFIL+CLQV
Sbjct: 470 LPADMWSLGCTVLEMLTGQLPYRDLECMQALFRIGKGERPPIPDSLSRDAQDFILQCLQV 529

Query: 516 NPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNMH 550
           NPNDRPTAAQL+ H FV+RPL +S G  S + ++H
Sbjct: 530 NPNDRPTAAQLLNHSFVQRPLSQSSG--SSFPHIH 562

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356518515|ref|XP_003527924.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  533 bits (1374), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 307/589 (52%), Positives = 387/589 (65%), Gaps = 80/589 (13%)

Query: 4   MDAAKPKPRSSRPRLDRRNALK--NIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDN 61
           MD   P+    +P+L+RRNALK  + +YDA  +PS      DD         RS++  D 
Sbjct: 1   MDRKNPR---RKPKLERRNALKYSSSEYDAGSSPS------DDT-----LYTRSMEFYD- 45

Query: 62  KTSFRVKGMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQAL 121
           +TSFR++G++GEFD ICRSLG SGPEDFAIPAAAWEA K R  +S D   RL+L     L
Sbjct: 46  RTSFRIEGVEGEFDRICRSLGLSGPEDFAIPAAAWEAIKFR--YSSDILPRLKL---DNL 100

Query: 122 DLTEEQEFKAAVMLDDERLV-SKRGSSLAKRENRVG---------------PRAGINGDR 165
           D+ EE+E +  + ++++ +V S     L+++                       GI G R
Sbjct: 101 DIPEEEEGEEELKVNEDIIVNSVEEGKLSEKHGDSSSVRVRVRVRVREIDESSTGIKGTR 160

Query: 166 PPALSPPSPMKFRRPVEAVDDD-----EILKSFAAESDDEYFLHSPIAVGFISPLNENEE 220
           PP L PP   +    V+ VDD      ++L+  A + ++              PLN +E 
Sbjct: 161 PPMLKPPPGAR----VQVVDDSTCSTWDLLRDLAPQGEEGL------------PLNRSEN 204

Query: 221 NNEVRRLRETNVVEESGPSISVHDHDGDDDRKDLA-----------------VRLIKEPV 263
            +EV R  E   VE+    +   +    ++ +++A                         
Sbjct: 205 ESEVAREVERGAVEKEEGEVGTRESPKREEEENVAGLSESCSFSTSNEDDSSSSTTDPTS 264

Query: 264 YNVSPNGKFRRRIM--SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQS 321
            N+SP G+ +R I   SWQKGE LG GSFG+VYEG +DDGFFFAVKEVSL DQGTQGKQS
Sbjct: 265 NNISPQGRIKRIITAESWQKGEFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGTQGKQS 324

Query: 322 ILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA 381
           + QLEQEI LLS+FEHENIVQY+GT+ D+++L+IFLELVTKGSL +LYQKY L DSQVS+
Sbjct: 325 VYQLEQEIALLSQFEHENIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRDSQVSS 384

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFW 441
           YTRQIL+GL YLH++NVVHRDIKCANILVDASGSVKLADFGLAKAT +NDVKS KGT FW
Sbjct: 385 YTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSMKGTAFW 444

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL 501
           MAPEVV  KN+GYGL ADIWSLGCTVLEMLT Q PY  LE ++AL+RIGKGE P +P+SL
Sbjct: 445 MAPEVVKGKNKGYGLPADIWSLGCTVLEMLTGQLPYCDLESVRALYRIGKGERPRIPDSL 504

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNMH 550
           SRDA+DFIL+CLQV+PNDR TAAQL+ H FV+RPL +S G  S + ++H
Sbjct: 505 SRDAQDFILQCLQVSPNDRATAAQLLNHSFVQRPLSQSSG--SSFPHIH 551

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225459451|ref|XP_002284356.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  531 bits (1367), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 305/560 (54%), Positives = 370/560 (66%), Gaps = 43/560 (7%)

Query: 9   PKPRSSRPRLDRRNALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDNKTSFRVK 68
           PK +  +P+L+RRNAL++I YDAS + SS+S        +     +SLDL+D ++SFR+ 
Sbjct: 19  PKQKPRKPKLERRNALRHIDYDASASSSSSS-----FDDSLALHTQSLDLSD-RSSFRIH 72

Query: 69  GMDGEFDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQE 128
           G +GE D ICRSLG SGP++ +IP AAWEA K RS       +R           +E + 
Sbjct: 73  GTEGEVDEICRSLGLSGPDELSIPEAAWEAWKVRSNSDVLPRTRFNRLHSSKRKESEVKV 132

Query: 129 -----------FKAAVMLDDERLVSKRGSSLAKRENRVGPRAGINGD-----RPPALSPP 172
                      F+ +V   D   + +R  +     +R+    G  G      RPP LSPP
Sbjct: 133 DDGVVDDLADGFEDSVSCSDA--IGRRRETSELSSSRIVGGVGGCGGGIKGVRPPFLSPP 190

Query: 173 SPMKFRRPVEAVDDDEILKSFAAESDDEYFLHSPIAVG--------FISPLNENEENNEV 224
             M      +     +ILKSF  ++D      S +  G        F + L + E+ N +
Sbjct: 191 PLMSLPVISDGCSTWDILKSFGPDADGG---SSVVVEGGSSSEDDEFDAALVKGEDVNGL 247

Query: 225 RRLRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGEL 284
           R   E  ++ ES    S      DDD          EP+ N+SPNG  R    +W KG  
Sbjct: 248 RN-DEIALLSES---YSFTTTSNDDDSSSTTT----EPMSNISPNGSLRPSFTNWMKGAF 299

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           LGSGSFGTVYEG ++DG FFAVKEVSL DQG+QGKQS+ QLEQEI LLS+F+HENIVQY 
Sbjct: 300 LGSGSFGTVYEGMSEDGIFFAVKEVSLLDQGSQGKQSLYQLEQEIDLLSQFQHENIVQYH 359

Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
           GT KDE++L+IFLELVTKGSLA+LYQ+Y+L DSQ SAYTRQIL+GLNYLHE+NV+HRDIK
Sbjct: 360 GTAKDESKLYIFLELVTKGSLASLYQRYNLGDSQASAYTRQILHGLNYLHERNVIHRDIK 419

Query: 405 CANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLG 464
           CANILV A+GSVKL+DFGLAKAT +ND KSCKGTPFWMAPEVVN K +GYGL ADIWSLG
Sbjct: 420 CANILVGANGSVKLSDFGLAKATQLNDAKSCKGTPFWMAPEVVNGKGQGYGLAADIWSLG 479

Query: 465 CTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAA 524
           CTVLEMLTR+ PYSHLE MQALFRIGKGEPP VP+SLS DARDFILKCLQV P+DRPTAA
Sbjct: 480 CTVLEMLTREVPYSHLESMQALFRIGKGEPPPVPDSLSPDARDFILKCLQVIPDDRPTAA 539

Query: 525 QLMEHPFVKRPLQKSRGPPS 544
           QL+ H FVKRP   S G  S
Sbjct: 540 QLLNHQFVKRPPPTSSGSAS 559

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356557517|ref|XP_003547062.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  521 bits (1343), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 291/535 (54%), Positives = 341/535 (63%), Gaps = 106/535 (19%)

Query: 15  RPRLDRRNALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDNKTSFRVKGMDGEF 74
           +PRL+RRNA+KNI Y      + A +                    N+ SFRVKG+DGEF
Sbjct: 9   KPRLERRNAMKNIDYQLKDEDADADAD---------------AAYLNQRSFRVKGIDGEF 53

Query: 75  DLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQEFKAAVM 134
           D I RSLG SGPEDFAIPAAAWE  +A                                 
Sbjct: 54  DRILRSLGLSGPEDFAIPAAAWEEARAH-------------------------------- 81

Query: 135 LDDERLVSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMKFRRPVEAVDDDEILKSFA 194
                   K  SS+  RE       GI G RPP L PP                +  ++ 
Sbjct: 82  --------KARSSVQPRE------GGIKGVRPPVLEPPL---------------VTSAWT 112

Query: 195 AESDDEYFLHSPIAVGFISPLNENEENNEVRRLRETNVVEESGPSISVHDHDGDDDRKDL 254
           ++   E           + P +    +++V    E    E SG      DH   D     
Sbjct: 113 SQQQTER----------VPPSDSVSRDDDV--AVEAQTEEVSG---FADDHGSFD----- 152

Query: 255 AVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQ 314
                   ++N+SPNG    R  SWQKG++LG GSFGTVYEG+TDDG FFAVKEVSL D 
Sbjct: 153 --------IHNLSPNGSGYFR--SWQKGDILGKGSFGTVYEGFTDDGNFFAVKEVSLLDD 202

Query: 315 GTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL 374
           G+QGKQS+ QL+QEI LLS+F H+NIV+Y GTDKD+++L+IFLELVTKGSLA+LYQKY L
Sbjct: 203 GSQGKQSLFQLQQEISLLSQFRHDNIVRYLGTDKDDDKLYIFLELVTKGSLASLYQKYRL 262

Query: 375 MDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 434
            DSQVSAYTRQIL+GL YLH++NVVHRDIKCANILVDA+GSVKLADFGLAKAT +NDVKS
Sbjct: 263 RDSQVSAYTRQILSGLKYLHDRNVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 322

Query: 435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP 494
            KG+P+WMAPEVVNL+NRGYGL ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG+G+P
Sbjct: 323 SKGSPYWMAPEVVNLRNRGYGLAADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGRGQP 382

Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNM 549
           P VP SLS DARDFILKCLQVNPN RPTAA+L++HPFVKRPL     P S   N+
Sbjct: 383 PPVPESLSTDARDFILKCLQVNPNKRPTAARLLDHPFVKRPLLSPISPVSPSINL 437

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357461677|ref|XP_003601120.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355490168|gb|AES71371.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula]

 Score =  520 bits (1340), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 317/556 (57%), Positives = 377/556 (67%), Gaps = 59/556 (10%)

Query: 15  RPRLDRRNALKNIQYDASLAPSSASSSFDDKSSASPRRIRSLDLTDNKTSFRVKGMDGEF 74
           +P+L+RRNA K   YDA  + SS   S     +      RS++L D +TSFR++G++GEF
Sbjct: 9   KPKLERRNAQKYTDYDAGSSSSSFDDSSGSLYT------RSMELYD-RTSFRIEGVEGEF 61

Query: 75  DLICRSLGFSGPEDFAIPAAAWEAQKARSRFSFDNASRL-QLRFDQALDLTEEQEFKAAV 133
           D ICRSLG SGPEDFAIPAAAWEA K RS     N+  L  L+ D+ LDL E++      
Sbjct: 62  DRICRSLGLSGPEDFAIPAAAWEAMKIRS-----NSDGLPSLKLDE-LDLKEKK------ 109

Query: 134 MLDDERLVSKRGSSLAKRENRVGPR-----------------AGINGDRPPALSPPSPMK 176
            ++D R +  +G    K E+R   R                  GING RPP + PP  M 
Sbjct: 110 -VNDMRELENKGELNKKCEDRDMIRVRVRDEVDDSVVVVSSSGGINGIRPPMIKPPPGM- 167

Query: 177 FRRPVEAVDDD----EILKSFA--AESDDEYF-LHSPIAVGFISPLNENEENNEVRRLRE 229
            R PV  VD+     ++LK  A   E ++E F        G      E   +NE R    
Sbjct: 168 -RVPV-VVDNTCSTWDLLKDLAPVGEGEEEGFDREVEENEGEEVGREEGVVDNEARIDAI 225

Query: 230 TNVVEESGPSISVHDHDGDDDRKDLAVRLIKEP-VYNVSPNGKFRRRIM--SWQKGELLG 286
              + ES    S+     +DD    A     EP   NVSPNG+  R I   SWQKG  LG
Sbjct: 226 VAGLMES----SLFSTSNEDDSSSTAT----EPRSNNVSPNGRINRFITPGSWQKGGFLG 277

Query: 287 SGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT 346
            GSFG+VYEG +DDGFFFAVKEVSL DQG QGKQS+ QLEQEI LLSRFEH+NIVQY+GT
Sbjct: 278 GGSFGSVYEGISDDGFFFAVKEVSLLDQGEQGKQSVYQLEQEIALLSRFEHDNIVQYYGT 337

Query: 347 DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           + DE++L IF+ELVTKGSL +LYQ+Y L DSQV+AYTRQIL+GL YLH+QNVVHRDIKCA
Sbjct: 338 EMDESKLHIFIELVTKGSLRSLYQRYTLRDSQVAAYTRQILHGLKYLHDQNVVHRDIKCA 397

Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           NILV ASGSVKLADFGLAKAT +NDVKSCKGT FWMAPEVV  KN+GYGL ADIWSLGCT
Sbjct: 398 NILVHASGSVKLADFGLAKATKLNDVKSCKGTAFWMAPEVVRGKNKGYGLPADIWSLGCT 457

Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
           VLEMLT Q PYS+LE MQALFRIGKGEPPL+P+SLSRDA+DFI++CLQVNP+DR TAAQL
Sbjct: 458 VLEMLTGQIPYSNLEPMQALFRIGKGEPPLIPDSLSRDAKDFIMQCLQVNPDDRFTAAQL 517

Query: 527 MEHPFVKRPLQKSRGP 542
           + HPF++RPL +S  P
Sbjct: 518 LNHPFLQRPLSQSSSP 533

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552843|ref|XP_003544772.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  514 bits (1323), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 302/569 (53%), Positives = 367/569 (64%), Gaps = 53/569 (9%)

Query: 15  RPRLDRRNALKNIQYDA-SLAPSSASSSFDDKSSASPRRIRSLDLTDNKTSFRVKGMDGE 73
           +P+L+RRNA K+ +YDA SL  S         SS+S    RS++L D K SFR++G++GE
Sbjct: 34  QPKLERRNAAKHFEYDAGSLCSSRDEYDASTSSSSSLHCTRSMELFDRK-SFRIEGVEGE 92

Query: 74  FDLICRSLGFSGPEDFAIPAAAWEAQKARSRFSF-------------DNASRLQLRFDQA 120
           FD ICRSLG SGPEDF+IPAAAWEA K R                   +    +   ++ 
Sbjct: 93  FDQICRSLGLSGPEDFSIPAAAWEAMKLRCSSDLLPRRPKHGGEEEEFDEEPKEKEKEEV 152

Query: 121 LDLTEEQEFKAAVMLDDERLVSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMKFRRP 180
                E E +A V+  DE +V    S         G   GI G RPP L PP  ++    
Sbjct: 153 EIAVLESEDRARVL--DECVVPAESS---------GCCGGIKGFRPPMLKPPPGVR---- 197

Query: 181 VEAVDDD-----EILKSFAAE-------------SDDEYFLHSPIAVGFISPLNENEENN 222
           V  VDD      ++++ FA +             S D+   H            E E   
Sbjct: 198 VSVVDDATCSTWDLMRDFAPKGEGGGKDSYVELNSSDDEDDHEREEKEEEEEEEEEEGEV 257

Query: 223 EVRRLRETNVVEESGPSISVHDHDG-DDDRKDLAVRLIKEPVYN-VSPNGKFRRRIMS-- 278
              R+        +  +  V D  G     +D +      P  N +SPNG+ +R I +  
Sbjct: 258 GGVRVESVEEENAAAIAEIVGDFSGFSTSNEDDSSSTSTGPRSNNISPNGRIKRVITAGN 317

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           WQKGELLG GSFG+VYEG ++DGFFFAVKEVSL DQG QG+QS+ QLEQEI LLS+FEHE
Sbjct: 318 WQKGELLGRGSFGSVYEGISEDGFFFAVKEVSLLDQGNQGRQSVYQLEQEIALLSQFEHE 377

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           NIVQY GT+ D + L+IF+ELVTKGSL NLYQ+Y+L DSQVSAYTRQIL+GL YLH++N+
Sbjct: 378 NIVQYIGTEMDASNLYIFIELVTKGSLRNLYQRYNLRDSQVSAYTRQILHGLKYLHDRNI 437

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           VHRDIKCANILVDA+GSVKLADFGLAKAT  NDVKSCKGT FWMAPEVV  KN GYGL A
Sbjct: 438 VHRDIKCANILVDANGSVKLADFGLAKATKFNDVKSCKGTAFWMAPEVVKGKNTGYGLPA 497

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           DIWSLGCTVLEMLT Q PYSHLE MQALFRIG+GEPP VP+SLSRDARDFIL+CL+V+P+
Sbjct: 498 DIWSLGCTVLEMLTGQIPYSHLECMQALFRIGRGEPPHVPDSLSRDARDFILQCLKVDPD 557

Query: 519 DRPTAAQLMEHPFVKRPLQ-KSRGPPSYY 546
           +RP+AAQL+ H FV+RPL  +S G  S Y
Sbjct: 558 ERPSAAQLLNHTFVQRPLHSQSSGSASPY 586

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	551
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.490	0.444	0.648	3.1e-112
TAIR|locus:2133539	773	MAPKKK9 "mitogen-activated pro	0.475	0.338	0.615	1.9e-102
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.466	0.458	0.608	3.3e-89
TAIR|locus:2118116	1895	WRKY19 [Arabidopsis thaliana (	0.484	0.140	0.585	6.7e-76
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.479	0.433	0.474	9.9e-64
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.493	0.308	0.473	4.2e-63
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.490	0.405	0.459	7.5e-57
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.466	0.358	0.449	6.8e-56
UNIPROTKB|Q40541	690	Q40541 "Protein kinase" [Nicot	0.470	0.375	0.445	2.3e-55
ZFIN|ZDB-GENE-070910-1	620	map3k3 "mitogen-activated prot	0.455	0.404	0.421	3.3e-53

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 907 (324.3 bits), Expect = 3.1e-112, Sum P(3) = 3.1e-112
 Identities = 179/276 (64%), Positives = 213/276 (77%)

Query:   262 PVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXX 321
             P+Y   P+G     I SWQKG+LLG GSFG+VYEG + DG FFAVKEVSL DQG+Q +  
Sbjct:   321 PIY---PDGG--AIITSWQKGQLLGRGSFGSVYEGISGDGDFFAVKEVSLLDQGSQAQEC 375

Query:   322 XXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA 381
                         + +H+NIV+Y GT KD + L+IFLELVT+GSL  LYQ+Y L DS VS 
Sbjct:   376 IQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSL 435

Query:   382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFW 441
             YTRQIL+GL YLH++  +HRDIKCANILVDA+G+VKLADFGLAK +  ND+KSCKGTPFW
Sbjct:   436 YTRQILDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKSCKGTPFW 495

Query:   442 MAPEVVNLKNR-GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS 500
             MAPEV+N K+  GYG  ADIWSLGCTVLEM T Q PYS LE +QALFRIG+G  P VP++
Sbjct:   496 MAPEVINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDT 555

Query:   501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
             LS DAR FILKCL+VNP +RPTAA+L+ HPFV+RPL
Sbjct:   556 LSLDARLFILKCLKVNPEERPTAAELLNHPFVRRPL 591

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 840 (300.8 bits), Expect = 1.9e-102, Sum P(3) = 1.9e-102
 Identities = 162/263 (61%), Positives = 200/263 (76%)

Query:   278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
             SWQKG+LL  GSFG+VYE  ++DG FFAVKEVSL DQG+Q +              + EH
Sbjct:   500 SWQKGQLLRQGSFGSVYEAISEDGDFFAVKEVSLLDQGSQAQECIQQLEGEIALLSQLEH 559

Query:   338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
             +NI++Y GTDKD + L+IFLELVT+GSL  LY++Y + DS +S YT+QIL+GL YLH + 
Sbjct:   560 QNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGLKYLHHKG 619

Query:   398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLK-NRGYGL 456
              +HRDIKCA ILVDA+G+VKLADFGLAK + +ND+KS K T FWMAPEV+N K N GY  
Sbjct:   620 FIHRDIKCATILVDANGTVKLADFGLAKVSKLNDIKSRKETLFWMAPEVINRKDNDGYRS 679

Query:   457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
              ADIWSLGCTVLEM T Q PYS LE ++ALFRI +G  P VP++LS DAR FILKCL++N
Sbjct:   680 PADIWSLGCTVLEMCTGQIPYSDLEPVEALFRIRRGTLPEVPDTLSLDARHFILKCLKLN 739

Query:   517 PNDRPTAAQLMEHPFVKRPLQKS 539
             P +RPTA +L+ HPFV+RPL  S
Sbjct:   740 PEERPTATELLNHPFVRRPLPSS 762

GO:0005737 "cytoplasm" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0031347 "regulation of defense response" evidence=IMP

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 808 (289.5 bits), Expect = 3.3e-89, Sum P(3) = 3.3e-89
 Identities = 157/258 (60%), Positives = 196/258 (75%)

Query:   276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
             I SW KG+LLG GS+ +VYE  ++DG FFAVKEVSL D+G Q +              + 
Sbjct:   300 ITSWLKGQLLGRGSYASVYEAISEDGDFFAVKEVSLLDKGIQAQECIQQLEGEIALLSQL 359

Query:   336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
             +H+NIV+Y GT KD ++L+IFLELVT+GS+  LY++Y L  + VS YTRQIL GLNYLH+
Sbjct:   360 QHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERYQLSYTVVSLYTRQILAGLNYLHD 419

Query:   396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNR-GY 454
             +  VHRDIKCAN+LVDA+G+VKLADFGLA+A+  ND+ SCKGT FWMAPEV+N K+  G 
Sbjct:   420 KGFVHRDIKCANMLVDANGTVKLADFGLAEASKFNDIMSCKGTLFWMAPEVINRKDSDGN 479

Query:   455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
             G  ADIWSLGCTVLEM T Q PYS L+ +QA F+IG+G  P VP++LS DAR FIL CL+
Sbjct:   480 GSPADIWSLGCTVLEMCTGQIPYSDLKPIQAAFKIGRGTLPDVPDTLSLDARHFILTCLK 539

Query:   515 VNPNDRPTAAQLMEHPFV 532
             VNP +RPTAA+L+ HPFV
Sbjct:   540 VNPEERPTAAELLHHPFV 557

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)]

 Score = 778 (278.9 bits), Expect = 6.7e-76, P = 6.7e-76
 Identities = 165/282 (58%), Positives = 198/282 (70%)

Query:   262 PVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXX 321
             P+Y  +  G F   I  WQKG+LLG GS G+VYEG + DG FFA KEVSL DQG+Q    
Sbjct:  1614 PIY--ASEGSF---ITCWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEW 1668

Query:   322 XXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA 381
                         + +H+NIV+Y GT KDE+ L+IFLELVT+GSL  LYQ+  L DS VS 
Sbjct:  1669 IQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSL 1728

Query:   382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFW 441
             YTRQIL+GL YLH++  +HR+IKCAN+LVDA+G+VKLADFGLAK      V S   TP+W
Sbjct:  1729 YTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKLADFGLAK------VMSLWRTPYW 1782

Query:   442 --MAPEVV-NLKNR-GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV 497
               MAPEV+ N K+  GYG  ADIWSLGCTVLEMLT Q PYS LE   AL+ IG G+ P +
Sbjct:  1783 NWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKI 1842

Query:   498 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
             P+ LS DARDFIL CL+VNP +RPTAA+L+ HPFV  PL  S
Sbjct:  1843 PDILSLDARDFILTCLKVNPEERPTAAELLNHPFVNMPLPSS 1884

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=IEA;ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005622 "intracellular" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006952 "defense response" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017111 "nucleoside-triphosphatase activity" evidence=IEA

GO:0043531 "ADP binding" evidence=IEA

GO:0043565 "sequence-specific DNA binding" evidence=IEA

GO:0009941 "chloroplast envelope" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 627 (225.8 bits), Expect = 9.9e-64, Sum P(2) = 9.9e-64
 Identities = 130/274 (47%), Positives = 174/274 (63%)

Query:   264 YNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKXXX 322
             Y  SP+G       +W+KG+ LGSG+FG VY G+  + G   A+KEV +       K   
Sbjct:   204 YETSPSG-----FSTWKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECL 258

Query:   323 XXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSA 381
                        +  H NIVQY+G++  E  L ++LE V+ GS+  L + Y    +  +  
Sbjct:   259 KQLNQEINLLNQLCHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQN 318

Query:   382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTPF 440
             YTRQIL GL YLH +N VHRDIK ANILVD +G +KLADFG+AK  T  + + S KG+P+
Sbjct:   319 YTRQILAGLAYLHGRNTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPY 378

Query:   441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-EPPLVPN 499
             WMAPEVV  +N GY    DIWSLGCT+LEM T +PP+S  EG+ A+F+IG   + P +P+
Sbjct:   379 WMAPEVVMSQN-GYTHAVDIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPD 437

Query:   500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
              LS DA++FI  CLQ NP  RPTA+QL+EHPF++
Sbjct:   438 HLSNDAKNFIRLCLQRNPTVRPTASQLLEHPFLR 471

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 644 (231.8 bits), Expect = 4.2e-63, P = 4.2e-63
 Identities = 133/281 (47%), Positives = 184/281 (65%)

Query:   279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
             W+KG LLG GSFG VY G+ ++ G   A+KEV+L     + +              R  H
Sbjct:   400 WKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRH 459

Query:   338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ 396
             +NIVQY+G++  +++L+I+LE V+ GS+  L Q+Y    ++ +  YT+QIL+GL YLH +
Sbjct:   460 QNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAK 519

Query:   397 NVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
             N VHRDIK ANILVD  G VK+ADFG+AK  T  +   S KG+P+WMAPEV+   N G  
Sbjct:   520 NTVHRDIKGANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIKNSN-GSN 578

Query:   456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-EPPLVPNSLSRDARDFILKCLQ 514
             L  DIWSLGCTVLEM T +PP+S  EG+ A+F+IG   E P +P+ LS + +DF+ KCLQ
Sbjct:   579 LAVDIWSLGCTVLEMATTKPPWSQYEGVPAMFKIGNSKELPDIPDHLSEEGKDFVRKCLQ 638

Query:   515 VNPNDRPTAAQLMEHPFVKR--PLQKS--RGPPSYYNNMHS 551
              NP +RPTAAQL++H FV+   P+++    G P+   N+ S
Sbjct:   639 RNPANRPTAAQLLDHAFVRNVMPMERPIVSGEPAEAMNVAS 679

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 585 (211.0 bits), Expect = 7.5e-57, P = 7.5e-57
 Identities = 132/287 (45%), Positives = 181/287 (63%)

Query:   277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQ-GTQGKXXXXXXXXXXXXXX- 333
             +SW+KG+L+G G+FGTVY G   D G   AVK+V +     ++ K               
Sbjct:    67 ISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLL 126

Query:   334 -RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLN 391
                 H NIV+Y GT ++++ L I LE V  GS+++L +K+    +S V  YTRQ+L GL 
Sbjct:   127 KNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLE 186

Query:   392 YLHEQNVVHRDIKCANILVDASGSVKLADFG----LAKATTMNDVKSCKGTPFWMAPEVV 447
             YLH   ++HRDIK ANILVD  G +KLADFG    +A+  TM   KS KGTP+WMAPEV+
Sbjct:   187 YLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI 246

Query:   448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH-LEGMQALFRIG--KGEPPLVPNSLSRD 504
              L+  G+  +ADIWS+GCTV+EM+T + P+S   + + A+F IG  K  PP +P++LS D
Sbjct:   247 -LQT-GHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPP-IPDTLSSD 303

Query:   505 ARDFILKCLQVNPNDRPTAAQLMEHPFV--KRPLQKSRGPPSYYNNM 549
             A+DF+LKCLQ  PN RPTA++L++HPFV  K     S    S  NN+
Sbjct:   304 AKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDLGSVLNNL 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 576 (207.8 bits), Expect = 6.8e-56, P = 6.8e-56
 Identities = 121/269 (44%), Positives = 165/269 (61%)

Query:   279 WQKGELLGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
             W+KG+L+G G+FG+VY    ++ G   A+KEV L     +                  +H
Sbjct:   346 WKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQH 405

Query:   338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLH 394
              NIVQYFG++  E+R FI+LE V  GS+ N Y + H   + +S V  +TR IL+GL YLH
Sbjct:   406 PNIVQYFGSETVEDRFFIYLEYVHPGSI-NKYIRDHCGTMTESVVRNFTRHILSGLAYLH 464

Query:   395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTPFWMAPEVVNL---- 449
              +  VHRDIK AN+LVDASG VKLADFG+AK  T      S KG+P+WMAPE++      
Sbjct:   465 NKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQK 524

Query:   450 -KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
               N       DIWSLGCT++EM T +PP+S  EG  A+F++ +  PP +P S+S + +DF
Sbjct:   525 DSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMRDSPP-IPESMSPEGKDF 583

Query:   509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 537
             +  C Q NP +RPTA+ L+EH F+K  LQ
Sbjct:   584 LRLCFQRNPAERPTASMLLEHRFLKNSLQ 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)]

 Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
 Identities = 122/274 (44%), Positives = 170/274 (62%)

Query:   279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGT---QGKXXXXXXXXXXXXXXR 334
             W+KGE++G G+FG VY G   D G   A+KEVS+   G    + +               
Sbjct:    80 WRKGEMIGCGAFGRVYMGMNVDSGELLAIKEVSIAMNGASRERAQAHVRELEEEVNLLKN 139

Query:   335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYL 393
               H NIV+Y GT ++   L I LE V  GS+++L  K+    +S +  YT+Q+L GL YL
Sbjct:   140 LSHPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 199

Query:   394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKAT----TMNDVKSCKGTPFWMAPEVVNL 449
             H+  ++HRDIK ANILVD  G +KLADFG +K      TM   KS KGTP+WMAPEV+ L
Sbjct:   200 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTGAKSMKGTPYWMAPEVI-L 258

Query:   450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSH-LEGMQALFRIG--KGEPPLVPNSLSRDAR 506
             +  G+  +ADIWS+GCT++EM T +PP+S   + + ALF IG  K  PP +P  LS +++
Sbjct:   259 QT-GHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IPEHLSAESK 316

Query:   507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
             DF+LKCLQ  P+ R +A+ L++HPFV    Q++R
Sbjct:   317 DFLLKCLQKEPHLRHSASNLLQHPFVTAEHQEAR 350

GO:0005515 "protein binding" evidence=IPI

ZFIN|ZDB-GENE-070910-1 map3k3 "mitogen-activated protein kinase kinase kinase 3" [Danio rerio (taxid:7955)]

 Score = 525 (189.9 bits), Expect = 3.3e-53, Sum P(2) = 3.3e-53
 Identities = 112/266 (42%), Positives = 158/266 (59%)

Query:   277 MSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
             ++W++G+LLG G+FG VY  Y  D G   A K+V       +                  
Sbjct:   354 VTWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVHFDPASPETSKEVSALECEIQLLKNL 413

Query:   336 EHENIVQYFGTDKDENR--LFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNY 392
              HE IVQY+G  +D N   L IF+E +  GS+ +  + Y  +   V+  YTRQIL G++Y
Sbjct:   414 HHERIVQYYGCLRDHNEKTLTIFMEYMPGGSVKDQLKAYGALTENVTRKYTRQILEGMSY 473

Query:   393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVV 447
             LH   +VHRDIK ANIL D++G+VKL DFG +K       +   V+S  GTP+WM+PEV+
Sbjct:   474 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSSTGVRSVTGTPYWMSPEVI 533

Query:   448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLVPNSLSRDA 505
             +    GYG  AD+WSLGCTV+EMLT +PP++  E M A+F+I   +P  P +P+ +S   
Sbjct:   534 S--GEGYGRKADVWSLGCTVVEMLTEKPPWAEFEAMAAIFKIAT-QPTNPQLPSHISEHT 590

Query:   506 RDFILKCLQVNPNDRPTAAQLMEHPF 531
             RDF L+C+ V    RP+A +L+ HPF
Sbjct:   591 RDF-LRCIFVEAKYRPSAEELLRHPF 615

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39008	M3K1_ARATH	2, ., 7, ., 1, 1, ., 2, 5	0.7022	0.4736	0.4292	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00005840001	SubName- Full=Chromosome chr12 scaffold_159, whole genome shotgun sequence; (552 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00026919001	SubName- Full=Putative uncharacterized protein (Chromosome chr15 scaffold_40, whole genome shot [...] (375 aa)						•		•	0.800
	GSVIVG00025258001	SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (355 aa)						•		•	0.800
	GSVIVG00016645001	SubName- Full=Putative uncharacterized protein (Chromosome chr11 scaffold_13, whole genome shot [...] (354 aa)						•		•	0.800
	GSVIVG00016514001	SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (354 aa)						•		•	0.800
	GSVIVG00003414001	SubName- Full=Chromosome undetermined scaffold_143, whole genome shotgun sequence; (1088 aa)						•		•	0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	551
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-139
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-116
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-100
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-96
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-90
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-86
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-85
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-83
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-83
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-80
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-78
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-78
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-73
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-73
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-70
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-69
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-68
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-68
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-67
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-67
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-66
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-66
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-65
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-65
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-59
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-57
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-56
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-55
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-55
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-55
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-55
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-54
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-54
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-53
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-52
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-52
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-51
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-50
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-50
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-49
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-49
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-48
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-48
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-48
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-46
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-46
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-45
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-45
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-45
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-45
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-44
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-44
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-44
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-44
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-43
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-43
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-42
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-42
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-42
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-41
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-41
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-41
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-41
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-40
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-40
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-40
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-40
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-39
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-39
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-39
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-39
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-38
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-38
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-38
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-38
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-37
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-37
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-37
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-37
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-36
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-36
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-36
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-36
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-35
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-35
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-35
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-35
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-34
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-34
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-34
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-33
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-33
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-33
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-33
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-32
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-32
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-32
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-31
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-31
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-31
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-31
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-31
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-31
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-31
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-31
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-30
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-30
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-30
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-30
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-30
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-29
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-29
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-29
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-29
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-29
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-29
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-29
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-29
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-28
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-28
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-28
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-28
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-28
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-28
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-27
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-27
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-27
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-27
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-27
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-27
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-27
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-26
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-26
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-26
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-26
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-26
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-26
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-26
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-25
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-25
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-25
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-25
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-24
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-24
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-24
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-24
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-24
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-23
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-23
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-23
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-23
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-23
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-23
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-23
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-23
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-22
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-22
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-22
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-22
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-22
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-22
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-22
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-22
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-22
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-22
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-22
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-22
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-21
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-21
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-21
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-20
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-20
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-20
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-20
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-20
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-20
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-20
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-20
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-19
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-19
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-19
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-19
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-18
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-18
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-18
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-18
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-18
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-17
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-17
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-17
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-16
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-16
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-16
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-16
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-16
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-14
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-13
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-13
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-09
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-06
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  403 bits (1037), Expect = e-139
 Identities = 162/259 (62%), Positives = 200/259 (77%), Gaps = 5/259 (1%)

Query: 278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
            W+KGELLGSGSFG+VYEG   DDG FFAVKEVSL D G  G++++ QLEQEI LLS+ +
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHE 395
           H NIVQY GT+++E+ L+IFLELV  GSLA L +KY    +  +  YTRQIL GL YLH+
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGY 454
           +N VHRDIK ANILVD +G VKLADFG+AK        KS KG+P+WMAPEV+  +  GY
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG-GY 179

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILKCL 513
           GL ADIWSLGCTVLEM T +PP+S LEG+ A+F+IG+  E P +P+ LS +A+DFILKCL
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239

Query: 514 QVNPNDRPTAAQLMEHPFV 532
           Q +P+ RPTAA+L+EHPFV
Sbjct: 240 QRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  344 bits (886), Expect = e-116
 Identities = 136/265 (51%), Positives = 177/265 (66%), Gaps = 15/265 (5%)

Query: 278 SWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
            W +GELLG GSFG+VY     D G   AVK V L       ++ +  LE+EI +LS  +
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQ 57

Query: 337 HENIVQYFGTDKDE--NRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYL 393
           H NIV+Y+G+++DE  N L IFLE V+ GSL++L +K+  L +  +  YTRQIL GL YL
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPEVVNL 449
           H   +VHRDIK ANILVD+ G VKLADFG AK      T     S +GTP+WMAPEV+  
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGK-GEPPLVPNSLSRDARD 507
           +   YG  ADIWSLGCTV+EM T +PP+S L   M AL++IG  GEPP +P  LS +A+D
Sbjct: 178 E--EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235

Query: 508 FILKCLQVNPNDRPTAAQLMEHPFV 532
           F+ KCL+ +P  RPTA +L++HPF+
Sbjct: 236 FLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  304 bits (781), Expect = e-100
 Identities = 122/260 (46%), Positives = 169/260 (65%), Gaps = 15/260 (5%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           Q G+L+G G+FG VY+G   + G F A+K++SL+      ++++  + QEI LL   +H 
Sbjct: 3   QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHP 59

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQN 397
           NIV+Y G+ +  + L+I LE    GSL  + +K+    +S V+ Y  Q+L GL YLHEQ 
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRG 453
           V+HRDIK ANIL    G VKLADFG+A  T +NDV     S  GTP+WMAPEV+ +   G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEM--SG 175

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-EPPLVPNSLSRDARDFILKC 512
               +DIWSLGCTV+E+LT  PPY  L  M ALFRI +   PPL P  +S + +DF+++C
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL-PEGISPELKDFLMQC 234

Query: 513 LQVNPNDRPTAAQLMEHPFV 532
            Q +PN RPTA QL++HP++
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  293 bits (753), Expect = 2e-96
 Identities = 96/260 (36%), Positives = 144/260 (55%), Gaps = 12/260 (4%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++  E LG GSFG VY       G   A+K +  +      K+   ++ +EI +L + +H
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI----KKDRERILREIKILKKLKH 56

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQ 396
            NIV+ +   +DE++L++ +E    G L +L +K   +   +   Y RQIL+ L YLH +
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYG 455
            +VHRD+K  NIL+D  G VKLADFGLA+     +   +  GTP +MAPEV  L  +GYG
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV--LLGKGYG 174

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARDFILKC 512
              DIWSLG  + E+LT +PP+   + +  LF+      P  P     +S +A+D I K 
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 513 LQVNPNDRPTAAQLMEHPFV 532
           L  +P  R TA + ++HPF 
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  277 bits (711), Expect = 2e-90
 Identities = 109/261 (41%), Positives = 162/261 (62%), Gaps = 17/261 (6%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++  E +G G FG VY+  +   G   A+K + L+ +  + K+ I+    EI +L + +H
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIIN---EIQILKKCKH 56

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
            NIV+Y+G+   ++ L+I +E  + GSL +L +  +  L +SQ++   +++L GL YLH 
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNR 452
             ++HRDIK ANIL+ + G VKL DFGL  +  ++D K+     GTP+WMAPEV+N K  
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGL--SAQLSDTKARNTMVGTPYWMAPEVINGK-- 172

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS--LSRDARDFIL 510
            Y   ADIWSLG T +E+   +PPYS L  M+ALF+I    PP + N    S + +DF+ 
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232

Query: 511 KCLQVNPNDRPTAAQLMEHPF 531
           KCLQ NP  RPTA QL++HPF
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  267 bits (683), Expect = 5e-86
 Identities = 116/262 (44%), Positives = 165/262 (62%), Gaps = 10/262 (3%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           W++G+LLG G+FG VY  Y  D G   AVK+V       + K+ +  LE EI LL   +H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ 396
           E IVQY+G  +D+  L IF+E +  GS+ +  + Y  L ++    YTRQIL G+ YLH  
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVVNLKN 451
            +VHRDIK ANIL D++G+VKL DFG +K      ++   +KS  GTP+WM+PEV++   
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS--G 181

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-PLVPNSLSRDARDFIL 510
            GYG  AD+WS+GCTV+EMLT +PP++  E M A+F+I      P +P+ +S DAR+F+ 
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241

Query: 511 KCLQVNPNDRPTAAQLMEHPFV 532
           +    N   RP+A +L+ H FV
Sbjct: 242 RTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  265 bits (679), Expect = 2e-85
 Identities = 112/266 (42%), Positives = 164/266 (61%), Gaps = 15/266 (5%)

Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           WQ+G  +G G+FG VY     D G   AVKE+ +QD   +   +I ++  E+ +L   +H
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK---TIKEIADEMKVLELLKH 58

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQ 396
            N+V+Y+G +    +++IF+E  + G+L  L +   ++D  V   YT Q+L GL YLH  
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 397 NVVHRDIKCANILVDASGSVKLADFG----LAKATTM--NDVKSCKGTPFWMAPEVVNLK 450
            +VHRDIK ANI +D +G +KL DFG    L   TT    +V+S  GTP +MAPEV+   
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 451 NR-GYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKGEPPLVPNS--LSRDAR 506
              G+G  ADIWSLGC VLEM T + P+S L+   Q +F +G G  P +P+S  LS + +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFV 532
           DF+ +CL+ +P  RPTA++L++HPFV
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  260 bits (667), Expect = 2e-83
 Identities = 101/259 (38%), Positives = 149/259 (57%), Gaps = 10/259 (3%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
              E +G GSFG VY+          A+K + L++     +  I  ++QEI  LS+    
Sbjct: 4   TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSP 59

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
            I +Y+G+    ++L+I +E    GS  +L +   L ++ ++   R++L GL YLHE+  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYGL 456
           +HRDIK ANIL+   G VKLADFG++   T    K  +  GTPFWMAPEV+  K  GY  
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI--KQSGYDE 177

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP-NSLSRDARDFILKCLQV 515
            ADIWSLG T +E+   +PP S L  M+ LF I K  PP +  N  S+  +DF+  CL  
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237

Query: 516 NPNDRPTAAQLMEHPFVKR 534
           +P +RP+A +L++H F+K+
Sbjct: 238 DPKERPSAKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  259 bits (664), Expect = 3e-83
 Identities = 96/264 (36%), Positives = 146/264 (55%), Gaps = 14/264 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++    LGSGSFGTVY+      G   AVK +  + + ++  Q+  +   EI +L R  H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR---EIRILRRLSH 57

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQ 396
            NIV+     +D++ L++ +E    G L +   +   +   +      QIL GL YLH  
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC--KGTPFWMAPEVVNLKNRGY 454
            ++HRD+K  NIL+D +G VK+ADFGLAK    +        GTP++MAPEV+ L   GY
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL-LGGNGY 176

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSH---LEGMQALFRIGKGEPPL---VPNSLSRDARDF 508
           G   D+WSLG  + E+LT +PP+S    L+ +Q + RI            +S S +A+D 
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFV 532
           I KCL  +P+ RPTA ++++HP+ 
Sbjct: 237 IKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  252 bits (644), Expect = 3e-80
 Identities = 124/268 (46%), Positives = 168/268 (62%), Gaps = 16/268 (5%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQG---KQSILQ-LEQEILLLS 333
           W KG L+GSGSFG+VY G     G   AVK+V L          K+S+L  L +EI LL 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNY 392
             +HENIVQY G+  D + L IFLE V  GS+A L   Y    ++ V  + RQIL GLNY
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--------SCKGTPFWMAP 444
           LH + ++HRDIK ANILVD  G +K++DFG++K    N +         S +G+ FWMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD 504
           EVV  K   Y   ADIWSLGC V+EMLT + P+     +QA+F+IG+   P +P+++S +
Sbjct: 182 EVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           A DF+ K  +++ N RPTAA+L++HPF+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  247 bits (632), Expect = 2e-78
 Identities = 113/267 (42%), Positives = 165/267 (61%), Gaps = 16/267 (5%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQ--DQGTQGKQSILQLEQEILLLSRFE 336
           W KGE+LG G++GTVY G T+ G   AVK+V L   +     K+   +L++E+ LL   +
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE-YEKLQEEVDLLKSLK 60

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHE 395
           H NIVQY GT  D+N + IF+E V  GS++++  ++  L +     YT+QIL+G+ YLH 
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM--------NDVKSCKGTPFWMAPEVV 447
             VVHRDIK  N+++  +G +KL DFG A+            N +KS  GTP+WMAPEV+
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDA 505
           N    GYG  +DIWS+GCTV EM T +PP + ++ + A+F IG     +  +P+S S  A
Sbjct: 181 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
            DF+  CL  + ++RP+A QL+ H F+
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  247 bits (631), Expect = 4e-78
 Identities = 111/269 (41%), Positives = 162/269 (60%), Gaps = 16/269 (5%)

Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSL----QDQGTQGKQSILQ-LEQEILLL 332
           W KGEL+G G++G VY       G   AVK+V L      +    ++ +++ L  EI  L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ-VSAYTRQILNGLN 391
              +H NIVQY G +  E  L IFLE V  GS+ +  + Y   + Q V  +T Q+L GL 
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT---MNDVK-SCKGTPFWMAPEVV 447
           YLH + ++HRD+K  N+LVDA G  K++DFG++K +     ND   S +G+ FWMAPEV+
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG--KGEPPLVPN---SLS 502
           +  ++GY    DIWSLGC VLEM   + P+S  E + A+F++G  +  PP+ P+   +LS
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPF 531
             A DF+  C  +NP++RPTA +L++HPF
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  233 bits (597), Expect = 2e-73
 Identities = 98/257 (38%), Positives = 149/257 (57%), Gaps = 16/257 (6%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           E LG GS+G+VY+  + + G   A+K V +       ++ + ++ +EI +L + +   IV
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIV 61

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +Y+G+      L+I +E    GS++++ +     L + +++A   Q L GL YLH    +
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121

Query: 400 HRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           HRDIK  NIL++  G  KLADFG++     TM    +  GTPFWMAPEV  ++  GY   
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV--IQEIGYNNK 179

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFILKCLQV 515
           ADIWSLG T +EM   +PPYS +  M+A+F I    PP    P   S +  DF+ KCL  
Sbjct: 180 ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVK 239

Query: 516 NPNDRPTAAQLMEHPFV 532
           +P +RP+A QL++HPF+
Sbjct: 240 DPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  233 bits (597), Expect = 3e-73
 Identities = 105/257 (40%), Positives = 142/257 (55%), Gaps = 15/257 (5%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +GSG++G VY+      G   A+K + L+            ++QEI +L    H NIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAY 65

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
           FG+    ++L+I +E    GSL ++YQ     L + Q++   R+ L GL YLHE   +HR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Query: 402 DIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVV-NLKNRGYGLTA 458
           DIK ANIL+   G VKLADFG++     T+   KS  GTP+WMAPEV    +  GY    
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPPLV--PNSLSRDARDFILKCLQ 514
           DIW+LG T +E+   QPP   L  M+ALF I K    PP +      S    DFI KCL 
Sbjct: 186 DIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLT 245

Query: 515 VNPNDRPTAAQLMEHPF 531
            +P  RPTA +L++HPF
Sbjct: 246 KDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  227 bits (582), Expect = 1e-70
 Identities = 104/270 (38%), Positives = 154/270 (57%), Gaps = 30/270 (11%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
            +K   +G G+ G VY+      G   A+K++ L+      KQ+   +  EIL++   +H
Sbjct: 24  LEK---IGEGASGEVYKATDRATGKEVAIKKMRLR------KQNKELIINEILIMKDCKH 74

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
            NIV Y+ +    + L++ +E +  GSL ++  +    + + Q++   R++L GL YLH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLA--------KATTMNDVKSCKGTPFWMAPEVV 447
           QNV+HRDIK  NIL+   GSVKLADFG A        K  ++  V    GTP+WMAPEV+
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV--V----GTPYWMAPEVI 188

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPL-VPNSLSRDA 505
             K+  YG   DIWSLG   +EM   +PPY     ++ALF I  KG PPL  P   S + 
Sbjct: 189 KRKD--YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF 246

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRP 535
           +DF+ KCL  +P  RP+A +L++HPF+K+ 
Sbjct: 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  223 bits (568), Expect = 5e-69
 Identities = 119/268 (44%), Positives = 167/268 (62%), Gaps = 15/268 (5%)

Query: 277 MSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           ++W++G+LLG G+FG VY  Y  D G   A K+V    +  +  + +  LE EI LL   
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 336 EHENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNY 392
           +HE IVQY+G   D+ E  L IF+E +  GS+ +  + Y  L +S    YTRQIL G++Y
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVV 447
           LH   +VHRDIK ANIL D++G+VKL DFG +K       +   ++S  GTP+WM+PEV+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPPLVPNSLSRDA 505
           +    GYG  AD+WSLGCTV+EMLT +PP++  E M A+F+I      P L P+ +S  A
Sbjct: 182 S--GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL-PSHISEHA 238

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           RDF L C+ V    RP+A +L+ HPF +
Sbjct: 239 RDF-LGCIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  221 bits (566), Expect = 2e-68
 Identities = 107/277 (38%), Positives = 154/277 (55%), Gaps = 23/277 (8%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ---EILLLSR 334
           W+    LG G+FG VY+  + + G F A K + ++ +         +LE    EI +LS 
Sbjct: 7   WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--------ELEDFMVEIDILSE 58

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNY 392
            +H NIV  +     EN+L+I +E    G+L ++  +    L + Q+    RQ+L  LN+
Sbjct: 59  CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGL-AK-ATTMNDVKSCKGTPFWMAPEVV--- 447
           LH   V+HRD+K  NIL+   G VKLADFG+ AK  +T+    +  GTP+WMAPEVV   
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLSRDA 505
             K+  Y   ADIWSLG T++E+   +PP+  L  M+ L +I K EPP    P+  S   
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
            DF+  CL  +P+DRPTAA+L++HPFV    Q     
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSD--QSDNKA 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  220 bits (562), Expect = 5e-68
 Identities = 83/259 (32%), Positives = 149/259 (57%), Gaps = 15/259 (5%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           + +G GSFG VY      DG  + +KE+ L +   + ++  L    E+ +L +  H NI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN---EVKILKKLNHPNII 62

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHEQ 396
           +Y+ + +++ +L I +E    G L+   +K         + Q+  +  Q+   L YLH +
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
            ++HRDIK  NI + ++G VKL DFG++K   +T++  K+  GTP++++PE+   +N+ Y
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL--CQNKPY 180

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGEPPLVPNSLSRDARDFILKCL 513
              +DIWSLGC + E+ T + P+   E +  L  +I KG+ P +P+  S + R+ +   L
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239

Query: 514 QVNPNDRPTAAQLMEHPFV 532
           Q +P +RP+ AQ+++ PF+
Sbjct: 240 QKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  219 bits (558), Expect = 1e-67
 Identities = 117/265 (44%), Positives = 164/265 (61%), Gaps = 13/265 (4%)

Query: 278 SWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           +W+ G+LLG G+FG VY  Y  D G   AVK+V       +  + +  LE EI LL    
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 337 HENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS-AYTRQILNGLNYL 393
           H+ IVQY+G   D +E +L IF+E +  GS+ +  + Y  +   V+  YTRQIL G++YL
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVVN 448
           H   +VHRDIK ANIL D++G+VKL DFG +K       +   +KS  GTP+WM+PEV++
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDARD 507
               GYG  AD+WS+ CTV+EMLT +PP++  E M A+F+I  +   P++P+ +S   RD
Sbjct: 183 --GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240

Query: 508 FILKCLQVNPNDRPTAAQLMEHPFV 532
           F LK + V    RPTA  L+ HPFV
Sbjct: 241 F-LKQIFVEEKRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  215 bits (549), Expect = 8e-67
 Identities = 86/252 (34%), Positives = 129/252 (51%), Gaps = 43/252 (17%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG G FGTVY       G   A+K +  +D  +  ++    L +EI +L +  H NIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE----LLREIEILKKLNHPNIVKL 56

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHR 401
           +G  +DEN L++ +E    GSL +L ++    L + ++     QIL GL YLH   ++HR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 402 DIKCANILVDA-SGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           D+K  NIL+D+ +G VKLADFGL+K  T +   +K+  GTP +MAPEV+      Y   +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL-GKGYYSEKS 175

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           DIWSLG  + E+                                 + +D I K LQ +P 
Sbjct: 176 DIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE 203

Query: 519 DRPTAAQLMEHP 530
            RP+A +++EH 
Sbjct: 204 KRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  215 bits (549), Expect = 3e-66
 Identities = 119/266 (44%), Positives = 164/266 (61%), Gaps = 15/266 (5%)

Query: 278 SWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           +W+ G+LLG G+FG VY  Y  D G   AVK+V    +  +  + +  LE EI LL    
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 337 HENIVQYFGTDKD--ENRLFIFLELVTKGSLANLYQKYHLMDSQVS-AYTRQILNGLNYL 393
           HE IVQY+G  +D  E  L IF+E +  GS+ +  + Y  +   V+  YTRQIL G++YL
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVVN 448
           H   +VHRDIK ANIL D+ G+VKL DFG +K       +   +KS  GTP+WM+PEV++
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLVPNSLSRDAR 506
               GYG  ADIWS+GCTV+EMLT +PP++  E M A+F+I   +P  P++P  +S   R
Sbjct: 183 --GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-QPTNPVLPPHVSDHCR 239

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFV 532
           DF LK + V    RP+A +L+ H FV
Sbjct: 240 DF-LKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  214 bits (546), Expect = 9e-66
 Identities = 93/266 (34%), Positives = 154/266 (57%), Gaps = 16/266 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQ-LEQEILLLSRFE 336
           W KG+ LG+G+F + Y+      G   AVK+V+     +  ++ +++ L +EI L++R  
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS-AYTRQILNGLNYLHE 395
           H +I++  G   +++   +F+E +  GS+++L  KY      V   YT Q+L GL+YLHE
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 396 QNVVHRDIKCANILVDASGS-VKLADFGLAK--ATTMNDVKSCK----GTPFWMAPEVVN 448
             ++HRD+K AN+L+D++G  +++ADFG A   A         +    GT  +MAPEV  
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-- 179

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKG-EPPLVPNSLSRD 504
           L+   YG + D+WS+GC ++EM T +PP+    H   +  +F+I      P +P  LS  
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHP 530
            RD  L+CL++ P DRP + +L++HP
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  214 bits (547), Expect = 1e-65
 Identities = 96/263 (36%), Positives = 149/263 (56%), Gaps = 15/263 (5%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           ++ ++LG GS G VY+  +   G  +A+K++ +       KQ    L +E+  L   E  
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ----LLRELKTLRSCESP 59

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-TRQILNGLNYLHEQ- 396
            +V+ +G    E  + I LE +  GSLA+L +K   +   V AY  RQIL GL+YLH + 
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
           +++HRDIK +N+L+++ G VK+ADFG++K    T++   +  GT  +M+PE   ++   Y
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE--RIQGESY 177

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKGEPP-LVPNSLSRDARDFIL 510
              ADIWSLG T+LE    + P+         + +  I  G PP L     S + RDFI 
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237

Query: 511 KCLQVNPNDRPTAAQLMEHPFVK 533
            CLQ +P  RP+AA+L++HPF+K
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  214 bits (546), Expect = 1e-65
 Identities = 107/260 (41%), Positives = 159/260 (61%), Gaps = 17/260 (6%)

Query: 284 LLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           +LG G++G VY           A+KE+  +D      + +  L +EI L S  +H NIVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-----RYVQPLHEEIALHSYLKHRNIVQ 69

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLM---DSQVSAYTRQILNGLNYLHEQNV 398
           Y G+D +     IF+E V  GSL+ L + K+  +   +  +  YT+QIL GL YLH+  +
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 399 VHRDIKCANILVDA-SGSVKLADFGLAKATT-MNDV-KSCKGTPFWMAPEVVNLKNRGYG 455
           VHRDIK  N+LV+  SG VK++DFG +K    +N   ++  GT  +MAPEV++   RGYG
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQ-ALFRIG--KGEPPLVPNSLSRDARDFILKC 512
             ADIWSLGCT++EM T +PP+  L   Q A+F++G  K  P  +P SLS +A++FIL+C
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE-IPESLSAEAKNFILRC 248

Query: 513 LQVNPNDRPTAAQLMEHPFV 532
            + +P+ R +A  L++ PF+
Sbjct: 249 FEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  198 bits (504), Expect = 3e-59
 Identities = 99/273 (36%), Positives = 154/273 (56%), Gaps = 15/273 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +Q+ EL+G G++G VY G     G   A+K ++L          +  +++E+ LLS+   
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58

Query: 338 ---ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH 394
               NI +Y+G+     RL+I +E    GS+  L +   + +  +S   R++L  L Y+H
Sbjct: 59  SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNR 452
           +  V+HRDIK ANILV  +G+VKL DFG+A     N  K  +  GTP+WMAPEV+  + +
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI-TEGK 177

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP-NSLSRDARDFILK 511
            Y   ADIWSLG T+ EM T  PPYS ++  +A+  I K +PP +  N  S+  R+F+  
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237

Query: 512 CLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           CL   P +R +A +L++  ++K     S+ P S
Sbjct: 238 CLDEEPKERLSAEELLKSKWIK---AHSKTPVS 267

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  191 bits (487), Expect = 6e-57
 Identities = 90/274 (32%), Positives = 149/274 (54%), Gaps = 26/274 (9%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-E 336
           ++  E++G G++G VY+  +   G   A+K   + D     ++ I   ++E  +L ++  
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEI---KEEYNILRKYSN 61

Query: 337 HENIVQYFGT------DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS----AYT-RQ 385
           H NI  ++G         ++++L++ +EL   GS+ +L +       ++     AY  R+
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMA 443
            L GL YLHE  V+HRDIK  NIL+  +  VKL DFG++    +T+    +  GTP+WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 444 PEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--P 498
           PEV+      +  Y   +D+WSLG T +E+   +PP   +  M+ALF+I +  PP +  P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241

Query: 499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
            + S+   DFI +CL  N   RP   +L+EHPF+
Sbjct: 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  189 bits (480), Expect = 5e-56
 Identities = 102/264 (38%), Positives = 155/264 (58%), Gaps = 9/264 (3%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + K E +G GSFG VY+G  +      A+K + L+    + +  I  ++QEI +LS+ + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDS 61

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
             I +Y+G+     +L+I +E +  GS  +L +   L ++ ++   R+IL GL+YLH + 
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYG 455
            +HRDIK AN+L+   G VKLADFG+A   T   +K  +  GTPFWMAPEV+  K   Y 
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD 179

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
             ADIWSLG T +E+   +PP S L  M+ LF I K  PP +    S+  ++F+  CL  
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239

Query: 516 NPNDRPTAAQLMEHPFVKRPLQKS 539
           +P  RPTA +L++H F+ R  +K+
Sbjct: 240 DPRFRPTAKELLKHKFITRYTKKT 263

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  187 bits (477), Expect = 4e-55
 Identities = 93/257 (36%), Positives = 142/257 (55%), Gaps = 12/257 (4%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGK-QSILQLEQEILLLSRFEHENIVQ 342
           +G GSFG VY           A+K++S   + +  K Q I++   E+  L +  H N ++
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK---EVRFLQQLRHPNTIE 79

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
           Y G    E+  ++ +E    GS +++ +  K  L + +++A     L GL YLH    +H
Sbjct: 80  YKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG-YGLTAD 459
           RDIK  NIL+   G+VKLADFG   A+ ++   S  GTP+WMAPEV+   + G Y    D
Sbjct: 139 RDIKAGNILLTEPGTVKLADFG--SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVD 196

Query: 460 IWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSLSRDARDFILKCLQVNPN 518
           +WSLG T +E+  R+PP  ++  M AL+ I + + P L  N  S   R+F+  CLQ  P 
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQ 256

Query: 519 DRPTAAQLMEHPFVKRP 535
           DRP++ +L++H FV R 
Sbjct: 257 DRPSSEELLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  186 bits (473), Expect = 5e-55
 Identities = 101/264 (38%), Positives = 158/264 (59%), Gaps = 9/264 (3%)

Query: 279 WQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + K E +G GSFG V++G  +      A+K + L+    + +  I  ++QEI +LS+ + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDS 61

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
             + +Y+G+   + +L+I +E +  GS  +L +   L ++Q++   R+IL GL+YLH + 
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYG 455
            +HRDIK AN+L+   G VKLADFG+A   T   +K     GTPFWMAPEV+  K   Y 
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD 179

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
             ADIWSLG T +E+   +PP+S L  M+ LF I K  PP +  + S+  ++F+  CL  
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239

Query: 516 NPNDRPTAAQLMEHPFVKRPLQKS 539
            P+ RPTA +L++H F+ R  +K+
Sbjct: 240 EPSFRPTAKELLKHKFIVRFAKKT 263

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  185 bits (473), Expect = 6e-55
 Identities = 80/260 (30%), Positives = 138/260 (53%), Gaps = 16/260 (6%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG+G+ G V +      G   AVK + L       +    Q+ +E+ +L +     IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL----EINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQ-NVVH 400
           +G   +   + I +E +  GSL  + ++    + +  +      +L GL YLHE+  ++H
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RD+K +NILV++ G +KL DFG++     +  K+  GT  +MAPE   ++   Y + +DI
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE--RIQGNDYSVKSDI 182

Query: 461 WSLGCTVLEMLTRQPPY-SHLEGMQALF----RIGKGEPPLVPNS-LSRDARDFILKCLQ 514
           WSLG +++E+ T + PY    +    +F     I    PP +P+   S D +DF+  CL 
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLI 242

Query: 515 VNPNDRPTAAQLMEHPFVKR 534
            +P +RP+  +L+EHPF+K+
Sbjct: 243 KDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  185 bits (472), Expect = 7e-55
 Identities = 87/265 (32%), Positives = 142/265 (53%), Gaps = 21/265 (7%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           E++G G+   VY      +    A+K + L+   T    S+ +L +E+  +S+  H N+V
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNHPNVV 62

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANL----YQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           +Y+ +    + L++ +  ++ GSL ++    Y +  L ++ ++   +++L GL YLH   
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK------GTPFWMAPEVVNLKN 451
            +HRDIK  NIL+   GSVK+ADFG++ +      ++ K      GTP WMAPEV+  + 
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME-QV 181

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS-----LSRDAR 506
            GY   ADIWS G T +E+ T   PYS    M+ L    + +PP +         S+  R
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR 241

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPF 531
             I  CLQ +P+ RPTA +L++H F
Sbjct: 242 KMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  183 bits (468), Expect = 3e-54
 Identities = 88/268 (32%), Positives = 136/268 (50%), Gaps = 26/268 (9%)

Query: 283 ELLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           E +G GSFGTV +     DG     KE+   +   + KQ   QL  E+ +L   +H NIV
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIV 62

Query: 342 QYFG--TDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLH 394
           +Y+    D+    L+I +E    G LA L QK      ++ +  +     Q+L  L   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 395 -----EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPFWMAPEVV 447
                   V+HRD+K ANI +DA+ +VKL DFGLAK    +    K+  GTP++M+PE +
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPP---YSHLEGMQALFRIGKGEPPLVPNSLSRD 504
           N  +  Y   +DIWSLGC + E+    PP    + L+      +I +G+   +P   S +
Sbjct: 183 N--HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS---KIKEGKFRRIPYRYSSE 237

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFV 532
             + I   L V+P+ RP+  +L++ P +
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  183 bits (467), Expect = 4e-54
 Identities = 74/262 (28%), Positives = 124/262 (47%), Gaps = 18/262 (6%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFF-----AVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
           + G+ LG G+FG VY+G             AVK  +L++  ++  +   +  +E  ++ +
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK--TLKEGASE--EEREEFLEEASIMKK 57

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNY 392
             H NIV+  G       L+I  E +  G L +  +K+   L    +     QI  G+ Y
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVN 448
           L  +N VHRD+   N LV  +  VK++DFGL++    +D        K    WMAPE   
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES-- 175

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           LK+  +   +D+WS G  + E+ T  + PY  +   + L  +  G     P +   +  +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYE 235

Query: 508 FILKCLQVNPNDRPTAAQLMEH 529
            +L+C   +P DRPT ++L+E 
Sbjct: 236 LMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  182 bits (464), Expect = 7e-54
 Identities = 90/262 (34%), Positives = 130/262 (49%), Gaps = 28/262 (10%)

Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFEH 337
           LG GSFG V      D G  +A+K +         K+ I++ ++      E  +LSR  H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK--------KKKIIKRKEVEHTLTERNILSRINH 52

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQ 396
             IV+     + E +L++ LE    G L +   K      + +  Y  +I+  L YLH  
Sbjct: 53  PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRG 453
            +++RD+K  NIL+DA G +KL DFGLAK    ++        GTP ++APEV  L  +G
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEV--LLGKG 169

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKC 512
           YG   D WSLG  + EMLT +PP+   E  + ++  I K      P  LS +ARD I   
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPLRF-PEFLSPEARDLISGL 227

Query: 513 LQVNPNDRPT---AAQLMEHPF 531
           LQ +P  R     A ++  HPF
Sbjct: 228 LQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  181 bits (461), Expect = 2e-53
 Identities = 94/256 (36%), Positives = 136/256 (53%), Gaps = 13/256 (5%)

Query: 284 LLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
            LG GS+G+VY+     D  F+A+KEV L     + ++  +    EI +L+   H NI+ 
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN---EIRILASVNHPNIIS 63

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-----YTRQILNGLNYLHEQN 397
           Y     D N+L I +E    G L+    K       +          Q+L GL  LHEQ 
Sbjct: 64  YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K ANIL+ A+  VK+ D G++K    N  K+  GTP +MAPEV   K R Y   
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEV--WKGRPYSYK 181

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQAL-FRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +DIWSLGC + EM T  PP+     MQ L +++ +G+ P +P   S+D ++FI   LQV 
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVK 240

Query: 517 PNDRPTAAQLMEHPFV 532
           P  RP   +++  P V
Sbjct: 241 PKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  180 bits (457), Expect = 2e-52
 Identities = 99/266 (37%), Positives = 145/266 (54%), Gaps = 15/266 (5%)

Query: 279 WQKGELLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           W+    LG G+FG VY+    + G   A K +      T+ ++ +     EI +L+   H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNH 68

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
             IV+  G    + +L+I +E    G++  +  +    L + Q+    RQ+L  L YLH 
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGL-AKAT-TMNDVKSCKGTPFWMAPEVV---NLK 450
             ++HRD+K  N+L+   G +KLADFG+ AK   T+    S  GTP+WMAPEVV    +K
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLSRDARDF 508
           +  Y   ADIWSLG T++EM   +PP+  L  M+ L +I K EPP    P+  S + RDF
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKR 534
           +   L  +P  RP+AAQL+EHPFV  
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  178 bits (455), Expect = 2e-52
 Identities = 77/260 (29%), Positives = 128/260 (49%), Gaps = 17/260 (6%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFF----AVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
             G+ LG G+FG VY+G     G       AVK  +L++     +Q I +  +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK--TLKE-DASEQQ-IEEFLREARIMRK 57

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNY 392
            +H N+V+  G   +E  L+I +E +  G L +  +K    L  S + ++  QI  G+ Y
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTPFWMAPEVVNL 449
           L  +N +HRD+   N LV  +  VK++DFGL++          +  K    WMAPE   L
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES--L 175

Query: 450 KNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
           K   +   +D+WS G  + E+ T  + PY  +   + L  +  G     P +   +  D 
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDL 235

Query: 509 ILKCLQVNPNDRPTAAQLME 528
           +L+C   +P DRPT ++L+E
Sbjct: 236 MLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  178 bits (453), Expect = 5e-52
 Identities = 97/264 (36%), Positives = 155/264 (58%), Gaps = 9/264 (3%)

Query: 279 WQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + K E +G GSFG V++G  +      A+K + L+    + +  I  ++QEI +LS+ + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDS 61

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
             + +Y+G+     +L+I +E +  GS  +L +     + Q++   ++IL GL+YLH + 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYG 455
            +HRDIK AN+L+   G VKLADFG+A   T   +K  +  GTPFWMAPEV+  +   Y 
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--QQSAYD 179

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
             ADIWSLG T +E+   +PP S +  M+ LF I K  PP +    S+  ++FI  CL  
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239

Query: 516 NPNDRPTAAQLMEHPFVKRPLQKS 539
           +P+ RPTA +L++H F+ +  +K+
Sbjct: 240 DPSFRPTAKELLKHKFIVKNAKKT 263

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  178 bits (453), Expect = 6e-52
 Identities = 102/263 (38%), Positives = 147/263 (55%), Gaps = 13/263 (4%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           W+    LG G+FG VY+    +    A  +V      T+ ++ +     EI +L+  +H 
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVI----DTKSEEELEDYMVEIDILASCDHP 62

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSL--ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           NIV+       EN L+I +E    G++    L  +  L + Q+    +Q L  LNYLHE 
Sbjct: 63  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 397 NVVHRDIKCANILVDASGSVKLADFGL-AKAT-TMNDVKSCKGTPFWMAPEVV---NLKN 451
            ++HRD+K  NIL    G +KLADFG+ AK T T+    S  GTP+WMAPEVV     K+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFI 509
           R Y   AD+WSLG T++EM   +PP+  L  M+ L +I K EPP +  P+  S + +DF+
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242

Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            KCL+ N + R T  QL++HPFV
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (450), Expect = 1e-51
 Identities = 79/260 (30%), Positives = 127/260 (48%), Gaps = 18/260 (6%)

Query: 281 KGELLGSGSFGTVYEG-YTDDGFFF----AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
            G+ LG G+FG VY+G     G       AVK +    +    +Q I +  +E  ++ + 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKL 58

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNY 392
           +H NIV+  G   +E  L I +E +  G L +  +K     L  S + ++  QI  G+ Y
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNL 449
           L  +N +HRD+   N LV  +  VK++DFGL++    +D    KG      WMAPE   L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES--L 176

Query: 450 KNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
           K   +   +D+WS G  + E+ T  + PY  +   + L  + KG     P +   +    
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKL 236

Query: 509 ILKCLQVNPNDRPTAAQLME 528
           +L+C   +P DRPT ++L+E
Sbjct: 237 MLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  174 bits (443), Expect = 2e-50
 Identities = 104/276 (37%), Positives = 153/276 (55%), Gaps = 21/276 (7%)

Query: 268 PNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLE 326
           P  K+ R        E +G G+ GTVY       G   A+K+++LQ Q    K+ I+   
Sbjct: 17  PKKKYTRF-------EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--KELIIN-- 65

Query: 327 QEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQI 386
            EIL++   +H NIV Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ 
Sbjct: 66  -EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 124

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAP 444
           L  L +LH   V+HRDIK  NIL+   GSVKL DFG     T    K  +  GTP+WMAP
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLS 502
           EVV  K   YG   DIWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS
Sbjct: 185 EVVTRKA--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK--RPL 536
              RDF+ +CL+++   R +A +L++HPF+K  +PL
Sbjct: 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 5e-50
 Identities = 84/291 (28%), Positives = 135/291 (46%), Gaps = 50/291 (17%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQG--KQSILQLEQEILLLSRFE 336
           +K E LG G++G VY+      G   A+K++ L D   +G    ++    +EI LL   +
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTAL----REISLLKELK 56

Query: 337 HENIVQYFGTDKDENRLFI---FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
           H NIV+       E +L++   + ++  K  L           + + +   Q+L GL Y 
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYC 114

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG--TPFWMAPEVVNLKN 451
           H   ++HRD+K  NIL++  G +KLADFGLA+A  +          T ++ APE++ L +
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL-LGS 173

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI------------------- 489
           + Y    DIWS+GC   EM+T +P +   S ++  Q LF+I                   
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--Q-LFKIFQILGTPTEESWPGVTKLP 230

Query: 490 -GKGEPPLVP--------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
             K   P  P          L  +  D + K LQ NP  R +A + ++HP+
Sbjct: 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  170 bits (433), Expect = 4e-49
 Identities = 83/269 (30%), Positives = 138/269 (51%), Gaps = 28/269 (10%)

Query: 285 LGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +  G++G V+   +  T D   +A+K +   D     K  + Q+  E  +LS+ +   +V
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVV 56

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + + + + +  L++ +E +  G LA+L +    +D  V+  Y  +I+  L YLH   ++H
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMN--------DVKSCK--GTPFWMAPEVVNLK 450
           RD+K  NIL+D++G +KL DFGL+K   +         + +  +  GTP ++APEV  + 
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV--IL 174

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF---RIGKGEPPLVPNSLSRDARD 507
            +G+  T D WSLGC + E L   PP+ H E  + +F     GK E P     +S +A D
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQNILNGKIEWPEDVE-VSDEAID 232

Query: 508 FILKCLQVNPNDRPTAA---QLMEHPFVK 533
            I K L  +P  R  A    ++  HPF K
Sbjct: 233 LISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  169 bits (429), Expect = 9e-49
 Identities = 103/257 (40%), Positives = 145/257 (56%), Gaps = 16/257 (6%)

Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQ-SILQLEQEILLLSRFEHENIVQ 342
           +GSG++G VY+      G   AVK + L+     G   S++Q  QEI ++   +H NIV 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQ--QEIFMVKECKHCNIVA 70

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
           YFG+     +L+I +E    GSL ++Y     L + Q++   R+ L GL YLH +  +HR
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Query: 402 DIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNL-KNRGYGLTA 458
           DIK ANIL+  +G VKLADFG+A     T+   KS  GTP+WMAPEV  + KN GY    
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EPPLVPNSL--SRDARDFILKCLQ 514
           DIW++G T +E+   QPP   L  M+ALF + K   +PP + +    S    +F+   L 
Sbjct: 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLT 250

Query: 515 VNPNDRPTAAQLMEHPF 531
            NP  RPTA +L+ H F
Sbjct: 251 KNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  169 bits (430), Expect = 1e-48
 Identities = 95/268 (35%), Positives = 148/268 (55%), Gaps = 23/268 (8%)

Query: 285 LGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +G GS G V    +  T  G   AVK++ L+ Q     Q    L  E++++  ++H NIV
Sbjct: 27  IGEGSTGIVCIATDKST--GRQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIV 79

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
           + + +    + L++ +E +  G+L ++     + + Q++     +L  L++LH Q V+HR
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTA 458
           DIK  +IL+ + G VKL+DFG   A    +V   KS  GTP+WMAPEV++     YG   
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFC-AQVSKEVPRRKSLVGTPYWMAPEVISRLP--YGTEV 196

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS--LSRDARDFILKCLQVN 516
           DIWSLG  V+EM+  +PPY +   +QA+ RI    PP + N   +S   R F+ + L  +
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRD 256

Query: 517 PNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           P  R TAA+L+ HPF+ +      GPPS
Sbjct: 257 PAQRATAAELLNHPFLAKA-----GPPS 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  168 bits (429), Expect = 2e-48
 Identities = 84/283 (29%), Positives = 135/283 (47%), Gaps = 42/283 (14%)

Query: 282 GELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILL-LSRFEHE 338
           G+++G GSF TV     +      +A+K +  +    + K   +++E+E+L  L+   H 
Sbjct: 6   GKIIGEGSFSTVVLA-KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG--HP 62

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
            I++ + T +DE  L+  LE    G L    +KY  +D + +  Y  +IL  L YLH + 
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCK--------------- 436
           ++HRD+K  NIL+D    +K+ DFG AK          N   +                 
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 437 -GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF---RIGKG 492
            GT  +++PE++N K  G    +D+W+LGC + +MLT +PP+    G        +I K 
Sbjct: 183 VGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPFR---GSNEYLTFQKILKL 237

Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPF 531
           E    P +   DA+D I K L ++P DR        +L  HPF
Sbjct: 238 EYSF-PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  168 bits (426), Expect = 3e-48
 Identities = 98/256 (38%), Positives = 150/256 (58%), Gaps = 14/256 (5%)

Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +GSG++G VY+    + G   A+K + L+       +    ++QEI+++   +H NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           FG+    ++L+I +E    GSL ++Y     L +SQ++  +R+ L GL YLH +  +HRD
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131

Query: 403 IKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNR-GYGLTAD 459
           IK ANIL+  +G VKLADFG++     T+   KS  GTP+WMAPEV  ++ + GY    D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 460 IWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EPPLVPNSL--SRDARDFILKCLQV 515
           IW++G T +E+   QPP   L  M+ALF + K   +PP + + +  S     F+   L  
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTK 251

Query: 516 NPNDRPTAAQLMEHPF 531
           NP  RPTA +L++HPF
Sbjct: 252 NPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  167 bits (425), Expect = 3e-48
 Identities = 77/254 (30%), Positives = 135/254 (53%), Gaps = 13/254 (5%)

Query: 285 LGSGSFG--TVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           LG G+FG  T+Y   T+D      KEV+L     + ++  L    EI++LS  +H NI+ 
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQHPNIIA 63

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLY---QKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           Y+    D+N L I +E    G+L +     +     +  V  Y  QI++ ++Y+H+  ++
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123

Query: 400 HRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           HRDIK  NI +  +G +KL DFG++K   +  +  ++  GTP++M+PE+   +   Y   
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC--QGVKYNFK 181

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           +DIW+LGC + E+LT +  +     +  + +I +G    V +  S +    +   LQ +P
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDP 241

Query: 518 NDRPTAAQLMEHPF 531
             RPTA ++++ P 
Sbjct: 242 EKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  170 bits (430), Expect = 1e-47
 Identities = 91/289 (31%), Positives = 140/289 (48%), Gaps = 31/289 (10%)

Query: 278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-E 336
           S++    LG GSFG VY     D    A+K ++ + +     + + +  +EI +L+    
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESK--SKEVERFLREIQILASLNH 56

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNY 392
             NIV+ +   +DE  L++ +E V  GSL +L +K      L +S+      QIL+ L Y
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 393 LHEQNVVHRDIKCANILVDASGS-VKLADFGLAKATTMNDV--------KSCKGTPFWMA 443
           LH + ++HRDIK  NIL+D  G  VKL DFGLAK                +  GTP +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 444 PEVVNLKNRGYGLTA-DIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEPPLVP 498
           PEV+   +  Y  ++ DIWSLG T+ E+LT  PP+    +     Q L  I +   P + 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 499 NSLSRD--------ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
           + LS          A D + K L  +P +R +++  + H  +     K 
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285

Length = 384

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  162 bits (412), Expect = 4e-46
 Identities = 77/263 (29%), Positives = 126/263 (47%), Gaps = 25/263 (9%)

Query: 283 ELLGSGSFGTVYEG--YTDDGFFF--AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           + LG G+FG VY+G     DG     AVK  +L++  ++ ++      +E  ++ +  H 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVK--TLKEDASEEERK--DFLKEARVMKKLGHP 56

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQK-----YHLMDSQVS-----AYTRQILN 388
           N+V+  G   +E  L++ LE +  G L +  +K          S +S     ++  QI  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGTPF---WMAP 444
           G+ YL  +  VHRD+   N LV     VK++DFGL++    +D  +   G      WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSR 503
           E   LK+  +   +D+WS G  + E+ T    PY  L   + L  + KG     P     
Sbjct: 177 ES--LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234

Query: 504 DARDFILKCLQVNPNDRPTAAQL 526
           +  + +L C Q++P DRPT ++L
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  162 bits (412), Expect = 9e-46
 Identities = 83/280 (29%), Positives = 139/280 (49%), Gaps = 29/280 (10%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRF 335
           + LG+GSFG V    +   G ++A+K +S        K  I++L+Q      E  +L   
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILS--------KAKIVKLKQVEHVLNEKRILQSI 58

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLH 394
            H  +V  +G+ +D++ L++ +E V  G L +  +K       V+  Y  Q++  L YLH
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
             ++V+RD+K  N+L+D+ G +K+ DFG AK         C GTP ++APE+  + ++GY
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-GTPEYLAPEI--ILSKGY 175

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D W+LG  + EML   PP+     +Q   +I +G+    P+  S DA+D I   LQ
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR-FPSFFSPDAKDLIRNLLQ 234

Query: 515 VNP-----NDRPTAAQLMEHPFVK----RPLQKSRGPPSY 545
           V+      N +     +  HP+        L + +    +
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPF 274

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  162 bits (410), Expect = 1e-45
 Identities = 99/266 (37%), Positives = 152/266 (57%), Gaps = 16/266 (6%)

Query: 279 WQKGELLGSGSFGTVYEGYTDD--GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           + + E +G G+ GTV+    D   G   A+K+++LQ Q    K+ I+    EIL++   +
Sbjct: 21  YTRYEKIGQGASGTVFTA-IDVATGQEVAIKQINLQKQPK--KELIIN---EILVMKELK 74

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           + NIV +  +    + LF+ +E +  GSL ++  +  + ++Q++A  R+ L  L +LH  
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN 134

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGY 454
            V+HRDIK  N+L+   GSVKL DFG     T    K     GTP+WMAPEVV  K   Y
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AY 192

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLSRDARDFILKC 512
           G   DIWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS   RDF+ +C
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252

Query: 513 LQVNPNDRPTAAQLMEHPFVK--RPL 536
           L+++   R +A +L++HPF+K  +PL
Sbjct: 253 LEMDVEKRGSAKELLQHPFLKLAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  162 bits (411), Expect = 1e-45
 Identities = 98/258 (37%), Positives = 147/258 (56%), Gaps = 16/258 (6%)

Query: 285 LGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGK-QSILQLEQEILLLSRFEHENI 340
           +G GSFG VY     +T++    AVK++S   + T  K Q I++   E+  L + +H N 
Sbjct: 29  IGHGSFGAVYFATNSHTNE--VVAVKKMSYSGKQTNEKWQDIIK---EVKFLQQLKHPNT 83

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++Y G    E+  ++ +E    GS ++L +  K  L + +++A T   L GL YLH  N+
Sbjct: 84  IEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG-YGLT 457
           +HRDIK  NIL+   G VKLADFG   A+  +   S  GTP+WMAPEV+   + G Y   
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFG--SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSLSRDARDFILKCLQVN 516
            D+WSLG T +E+  R+PP  ++  M AL+ I + + P L  N  +   R F+  CLQ  
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKI 260

Query: 517 PNDRPTAAQLMEHPFVKR 534
           P +RP +A+L+ H FV+R
Sbjct: 261 PQERPASAELLRHDFVRR 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  161 bits (409), Expect = 2e-45
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 14/265 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + + E +G G+ GTVY       G   A+K+++LQ Q    K+ I+    EIL++   ++
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIIN---EILVMRENKN 75

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            NIV Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ L  L++LH   
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYG 455
           V+HRDIK  NIL+   GSVKL DFG     T    K  +  GTP+WMAPEVV  K   YG
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYG 193

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLSRDARDFILKCL 513
              DIWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS   RDF+ +CL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253

Query: 514 QVNPNDRPTAAQLMEHPFVK--RPL 536
           +++ + R +A +L++HPF+K  +PL
Sbjct: 254 EMDVDRRGSAKELLQHPFLKLAKPL 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  161 bits (407), Expect = 5e-45
 Identities = 99/257 (38%), Positives = 146/257 (56%), Gaps = 14/257 (5%)

Query: 285 LGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +G GSFG VY   +  T++    A+K++S    G Q  +    + +E+  L R +H N +
Sbjct: 33  IGHGSFGAVYFARDVRTNE--VVAIKKMSYS--GKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +Y G    E+  ++ +E    GS ++L +  K  L + +++A T   L GL YLH  N++
Sbjct: 89  EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG-YGLTA 458
           HRDIK  NIL+   G VKLADFG   A+  +   S  GTP+WMAPEV+   + G Y    
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG--SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSLSRDARDFILKCLQVNP 517
           D+WSLG T +E+  R+PP  ++  M AL+ I + E P L  N  S   R+F+  CLQ  P
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265

Query: 518 NDRPTAAQLMEHPFVKR 534
            DRPT+ +L++H FV R
Sbjct: 266 QDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  158 bits (401), Expect = 1e-44
 Identities = 85/258 (32%), Positives = 144/258 (55%), Gaps = 14/258 (5%)

Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           + +G GSFG +Y      D     +KE+ L     + K++    ++E++LL++ +H NIV
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIV 62

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNV 398
            +F + ++  RLFI +E    G L     +       + Q+ ++  QI  GL ++H++ +
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122

Query: 399 VHRDIKCANILVDASGSV-KLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           +HRDIK  NI +  +G V KL DFG+A+    +M    +C GTP++++PE+   +NR Y 
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC--QNRPYN 180

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVPNSLSRDARDFILKCLQ 514
              DIWSLGC + E+ T + P+      Q + +I +G   P+ PN  SRD R  I +  +
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN-FSRDLRSLISQLFK 239

Query: 515 VNPNDRPTAAQLMEHPFV 532
           V+P DRP+   +++ PF+
Sbjct: 240 VSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 2e-44
 Identities = 81/295 (27%), Positives = 135/295 (45%), Gaps = 55/295 (18%)

Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSL-QDQGTQGKQSILQLEQEILLLSRFE 336
           +QK   +G G++G VY+      G   A+K++ L  +     K ++    +EI LL    
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-----KYHLMDSQVSAYTRQILNGLN 391
           H NI++     + +  L++  E +      +LY+     +  L +S + +Y  Q+L GL 
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAPEV 446
           + H   ++HRD+K  N+L++  G +KLADFGLA++                T ++ APE+
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV---TRWYRAPEL 169

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---------------------SHLEGMQA 485
           + L ++GY    DIWS+GC   E+L+R+P +                            +
Sbjct: 170 L-LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228

Query: 486 LFR---------IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
           L R          G   P L PN  S  A D + + L  +P+ R TA Q + HP+
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  158 bits (401), Expect = 3e-44
 Identities = 94/255 (36%), Positives = 138/255 (54%), Gaps = 10/255 (3%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G GSFG VY      +    A+K++S    G Q  +    + +E+  L +  H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
            G    E+  ++ +E    GS ++L +  K  L + +++A T   L GL YLH  N++HR
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG-YGLTADI 460
           D+K  NIL+   G VKL DFG   A+ M       GTP+WMAPEV+   + G Y    D+
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV-PNSLSRDARDFILKCLQVNPND 519
           WSLG T +E+  R+PP  ++  M AL+ I + E P +     S   R+F+  CLQ  P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257

Query: 520 RPTAAQLMEHPFVKR 534
           RPT+  L++H FV R
Sbjct: 258 RPTSEVLLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  157 bits (397), Expect = 9e-44
 Identities = 98/265 (36%), Positives = 148/265 (55%), Gaps = 14/265 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + + E +G G+ GTVY       G   A+++++LQ Q    K+ I+    EIL++   ++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIIN---EILVMRENKN 76

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            NIV Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ L  L +LH   
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYG 455
           V+HRDIK  NIL+   GSVKL DFG     T    K     GTP+WMAPEVV  K   YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYG 194

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLSRDARDFILKCL 513
              DIWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS   RDF+ +CL
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254

Query: 514 QVNPNDRPTAAQLMEHPFVK--RPL 536
            ++   R +A +L++H F+K  +PL
Sbjct: 255 DMDVEKRGSAKELLQHQFLKIAKPL 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  158 bits (400), Expect = 1e-43
 Identities = 96/282 (34%), Positives = 148/282 (52%), Gaps = 31/282 (10%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +GSG+ GTVY+  +   G  +A+K +     G        Q+ +EI +L    H N+V+ 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRDVNHPNVVKC 137

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-QVSAYTRQILNGLNYLHEQNVVHRD 402
                    + + LE +  GSL       H+ D   ++   RQIL+G+ YLH +++VHRD
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRD 193

Query: 403 IKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVN--LKNRGY-GLT 457
           IK +N+L++++ +VK+ADFG+++  A TM+   S  GT  +M+PE +N  L +  Y G  
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA 253

Query: 458 ADIWSLGCTVLEM--------LTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
            DIWSLG ++LE         + RQ  ++ L  M A   I   +PP  P + SR+ R FI
Sbjct: 254 GDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCA---ICMSQPPEAPATASREFRHFI 308

Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNMHS 551
             CLQ  P  R +A QL++HPF+ R             N+H 
Sbjct: 309 SCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGG---PNLHQ 347

Length = 353

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  154 bits (391), Expect = 2e-43
 Identities = 74/255 (29%), Positives = 130/255 (50%), Gaps = 13/255 (5%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
             +G GSFG V++     D   +A+K++ L     + ++  +    E  +L++ +   I+
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID---EARVLAKLDSSYII 62

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNV 398
           +Y+ +  D+ +L I +E    G L  L +      L + QV  +  QIL GL +LH + +
Sbjct: 63  RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPFWMAPEVVNLKNRGYGL 456
           +HRDIK  N+ +DA  +VK+ D G+AK  + N     +  GTP++++PE+   +++ Y  
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC--EDKPYNE 180

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+W+LG  + E  T + P+       AL   I +G  P V    S+     I +CL  
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD-ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239

Query: 516 NPNDRPTAAQLMEHP 530
           +   RP   QL+ +P
Sbjct: 240 DYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  153 bits (388), Expect = 1e-42
 Identities = 83/258 (32%), Positives = 138/258 (53%), Gaps = 21/258 (8%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQ-GTQGKQSILQLEQEILLLSRFEHENIVQ 342
           +G G F  VY+     DG   A+K+V + +    + +Q  L+   EI LL + +H N+++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQLDHPNVIK 66

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLY-----QKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           Y  +  + N L I LEL   G L+ +      QK  + +  +  Y  Q+ + L ++H + 
Sbjct: 67  YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
           ++HRDIK AN+ + A+G VKL D GL +   + T     S  GTP++M+PE +     GY
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERI--HENGY 183

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQ--ALF-RIGKGE-PPLVPNSLSRDARDFIL 510
              +DIWSLGC + EM   Q P+ + + M   +L  +I K + PPL  +  S + RD + 
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242

Query: 511 KCLQVNPNDRPTAAQLME 528
           +C+  +P  RP  + +++
Sbjct: 243 RCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  151 bits (384), Expect = 4e-42
 Identities = 79/242 (32%), Positives = 125/242 (51%), Gaps = 10/242 (4%)

Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG G FG V           FA+K V  +     G+Q  +  E+EIL      H  IV+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN--HPFIVKL 58

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVHRD 402
           + T KD+  +++ +E    G L  + +   L D   +  Y   ++    YLH + +++RD
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118

Query: 403 IKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIW 461
           +K  N+L+D++G VKL DFG AK   +     +  GTP ++APE++   N+GY  + D W
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII--LNKGYDFSVDYW 176

Query: 462 SLGCTVLEMLTRQPPYSHLEG--MQALFRIGKGEPPLV-PNSLSRDARDFILKCLQVNPN 518
           SLG  + E+LT +PP+   +   M+    I KG   L  PN + + A+D I + L+ NP 
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236

Query: 519 DR 520
           +R
Sbjct: 237 ER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  152 bits (385), Expect = 4e-42
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 27/269 (10%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG G+ G+V +    + G  FA+K +   D     ++ IL+   E+ +    +   IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILR---ELEINKSCKSPYIVKY 64

Query: 344 FGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-----TRQILNGLNYLHEQ 396
           +G   D+  + + I +E    GSL ++Y+K      ++           +L GL+YLH +
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
            ++HRDIK +NIL+   G VKL DFG++     +   +  GT F+MAPE   ++ + Y +
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPE--RIQGKPYSI 182

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQA------LFRIGKGEPPLVPNSL------SRD 504
           T+D+WSLG T+LE+   + P+   EG         L  I     P + +        S +
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPP-EGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEE 241

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +DFI +CL+ +P  RPT   ++EHP++K
Sbjct: 242 FKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  150 bits (381), Expect = 2e-41
 Identities = 88/263 (33%), Positives = 143/263 (54%), Gaps = 17/263 (6%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG G++G+VY+  +   G   A+KE+ L+   ++  Q I++L+    +L +     IV +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIVDF 64

Query: 344 FGTDKDENRLFIFLELVTKGSLANLY---QKYHLMDSQVSAY-TRQILNGLNYLHEQ-NV 398
           +G    E  +++ +E +  GSL  LY        +   V    T  ++ GL +L E+ N+
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPE---VVNLKNRG-Y 454
           +HRD+K  N+LV+ +G VKL DFG++     +  K+  G   +MAPE            Y
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTY 184

Query: 455 GLTADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
            + +D+WSLG ++LEM   +   PP ++      L  I  G+PP +P+  S DA+DF+ K
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAK 244

Query: 512 CLQVNPNDRPTAAQLMEHPFVKR 534
           CL   PN RPT AQL+EHP++ +
Sbjct: 245 CLNKIPNRRPTYAQLLEHPWLVK 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  150 bits (380), Expect = 3e-41
 Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 53/290 (18%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQG--KQSILQLEQEILLLSRFEHENIV 341
           +G G++G VY+      G   A+K++ + +   +G    +I    +EI LL +  H NIV
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM-ENEKEGFPITAI----REIKLLQKLRHPNIV 61

Query: 342 QYFG--TDKDENRLFIFLELVT---KGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           +     T K +  +++  E +     G L +   +    +SQ+  Y +Q+L GL YLH  
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTP----FWM-APEVVNLKN 451
            ++HRDIK +NIL++  G +KLADFGLA+        S   T      W   PE++ L  
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYRPPELL-LGA 176

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI----------GKGEPPLV- 497
             YG   D+WS+GC + E+   +P +   + LE ++ +F +          G  + P   
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236

Query: 498 --------PNSL--------SRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                      L           A D + K L ++P  R +A Q ++H +
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  150 bits (379), Expect = 3e-41
 Identities = 91/254 (35%), Positives = 140/254 (55%), Gaps = 14/254 (5%)

Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G GS G V        G   AVK + L+ Q     Q    L  E++++  ++H+N+V+ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEM 83

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           + +      L++ +E +  G+L ++  +  L + Q++     +L  L YLH Q V+HRDI
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143

Query: 404 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  +IL+   G VKL+DFG   A    DV   KS  GTP+WMAPEV++     YG   DI
Sbjct: 144 KSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVIS--RTPYGTEVDI 200

Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS--LSRDARDFILKCLQVNPN 518
           WSLG  V+EM+  +PPY     +QA+ R+    PP + N+  +S   RDF+ + L   P 
Sbjct: 201 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQ 260

Query: 519 DRPTAAQLMEHPFV 532
           +R TA +L++HPF+
Sbjct: 261 ERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  149 bits (377), Expect = 3e-41
 Identities = 91/267 (34%), Positives = 145/267 (54%), Gaps = 23/267 (8%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENI 340
           EL+G+G++G VY+G +   G   A+K + +     +      +++QEI +L ++  H NI
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE------EIKQEINMLKKYSHHRNI 65

Query: 341 VQYFGTDKDEN------RLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLN 391
             Y+G    +N      +L++ +E    GS+ +L +      L +  ++   R+IL GL+
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNL 449
           +LH+  V+HRDIK  N+L+  +  VKL DFG++     T+    +  GTP+WMAPEV+  
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 450 K---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSLSRDA 505
               +  Y   +D+WSLG T +EM    PP   +  M+ALF I +   P L     S+  
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 245

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
           + FI  CL  N + RPT  QLM+HPF+
Sbjct: 246 QSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  146 bits (371), Expect = 2e-40
 Identities = 82/258 (31%), Positives = 125/258 (48%), Gaps = 21/258 (8%)

Query: 286 GSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           G G+FG V      D    FA+K ++ Q      K S+  +  E  +L    H  +V  +
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQK--CVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 345 GTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
            + +DE  +++ ++L+  G L  +L QK    + QV  +  +I+  L YLH + ++HRDI
Sbjct: 67  YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDI 126

Query: 404 KCANILVDASGSVKLADFGLA---KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  NIL+D  G V + DF +A      T+    S  GTP +MAPEV  L  +GY +  D 
Sbjct: 127 KPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEV--LCRQGYSVAVDW 182

Query: 461 WSLGCTVLEMLTRQPPY-----SHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
           WSLG T  E L  + PY     +  + ++A     +    L P + S +A D I K L+ 
Sbjct: 183 WSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ---ETADVLYPATWSTEAIDAINKLLER 239

Query: 516 NPNDR--PTAAQLMEHPF 531
           +P  R       L  HP+
Sbjct: 240 DPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  147 bits (371), Expect = 3e-40
 Identities = 102/297 (34%), Positives = 159/297 (53%), Gaps = 31/297 (10%)

Query: 255 AVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSL 311
           A++L+  P       G  R  + S+ K   +G GS G V    E +T  G   AVK++ L
Sbjct: 10  ALQLVVSP-------GDPREYLDSFIK---IGEGSTGIVCIATEKHT--GKQVAVKKMDL 57

Query: 312 QDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK 371
           + Q     Q    L  E++++  + HEN+V  + +    + L++ +E +  G+L ++   
Sbjct: 58  RKQ-----QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH 112

Query: 372 YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--M 429
             + + Q++     +L  L+YLH Q V+HRDIK  +IL+ + G +KL+DFG     +  +
Sbjct: 113 TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172

Query: 430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI 489
              KS  GTP+WMAPEV++     YG   DIWSLG  V+EM+  +PPY +   +QA+ RI
Sbjct: 173 PKRKSLVGTPYWMAPEVIS--RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230

Query: 490 GKGEPPLVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
               PP V +S  +S   R F+   L   P+ R TA +L++HPF+K       GPPS
Sbjct: 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA-----GPPS 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  146 bits (370), Expect = 4e-40
 Identities = 89/267 (33%), Positives = 143/267 (53%), Gaps = 23/267 (8%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENI 340
           E++G+G++G VY+G +   G   A+K + + +   +      +++ EI +L ++  H NI
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75

Query: 341 VQYFGT------DKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLN 391
             Y+G          +++L++ +E    GS+ +L +      L +  ++   R+IL GL 
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNL 449
           +LH   V+HRDIK  N+L+  +  VKL DFG++     T+    +  GTP+WMAPEV+  
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 450 K---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSLSRDA 505
               +  Y   +DIWSLG T +EM    PP   +  M+ALF I +  PP L     S+  
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKF 255

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
            DFI  CL  N   RP+  QL++HPF+
Sbjct: 256 IDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  145 bits (369), Expect = 8e-40
 Identities = 83/295 (28%), Positives = 134/295 (45%), Gaps = 67/295 (22%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEV-----SLQDQGTQGKQSILQLEQEILLLSRF-EH 337
           LG G+FG+VY     + G   A+K++     S ++         + L +E+  L +  EH
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--------CMNL-REVKSLRKLNEH 57

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY------HLMDSQVSAYTRQILNGLN 391
            NIV+     ++ + L+   E +      NLYQ           +S + +   QIL GL 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK------GTPFWMAPE 445
           ++H+    HRD+K  N+LV     VK+ADFGLA+     +++S         T ++ APE
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPE 168

Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQP----------------------PYSHLEGM 483
           ++ L++  Y    DIW+LGC + E+ T +P                           EG 
Sbjct: 169 IL-LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227

Query: 484 QALFRIGKGEPPLVPNSL-------SRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
           +   ++G   P   P SL       S +A D I   L+ +P  RPTA+Q ++HP+
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  145 bits (367), Expect = 1e-39
 Identities = 92/276 (33%), Positives = 149/276 (53%), Gaps = 29/276 (10%)

Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVK---EVSLQDQGTQGKQSILQLEQEILLLS 333
           +W+  E +G G++G V++     +G   AVK    +   D+  + + +IL+       LS
Sbjct: 19  TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA------LS 72

Query: 334 RFEHENIVQYFGT-----DKDENRLFIFLELVTKGSLANLYQKY----HLMDSQVSAYT- 383
             +H N+V+++G       K+ ++L++ LEL   GS+ +L + +      M+  + AY  
Sbjct: 73  --DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFW 441
            + L GL +LH    +HRD+K  NIL+   G VKL DFG++   T   ++  +  GTPFW
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 442 MAPEVVNLKNR---GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV- 497
           MAPEV+  + +    Y    D+WSLG T +E+    PP + L  M+ALF+I +  PP + 
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250

Query: 498 -PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
            P   S +  DFI KCL  +   RPT + L++H F+
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  143 bits (363), Expect = 2e-39
 Identities = 77/263 (29%), Positives = 145/263 (55%), Gaps = 17/263 (6%)

Query: 279 WQKGELLGSGSFG-TVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + K + +G GSFG  +     +DG  + +KE+++     + ++   +  +E+ +LS  +H
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKH 58

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH------LMDSQVSAYTRQILNGLN 391
            NIVQY  + ++   L+I ++    G   +LY+K +        + Q+  +  QI   L 
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALK 115

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNL 449
           ++H++ ++HRDIK  NI +   G++KL DFG+A+   +T+   ++C GTP++++PE+   
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC-- 173

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
           +NR Y   +DIW+LGC + EM T +  +        + +I +G  P V +  S D R+ +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLV 233

Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            +  + NP DRP+   ++E  F+
Sbjct: 234 SQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  144 bits (365), Expect = 2e-39
 Identities = 93/277 (33%), Positives = 142/277 (51%), Gaps = 29/277 (10%)

Query: 278 SWQKGELLGSGSFGTVYE-GYTDDGFFFAVK---EVSLQDQGTQGKQSILQLEQEILLLS 333
           +W+  E +G G++G VY+     DG   AVK    +S  D+  + + +ILQ        S
Sbjct: 23  TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ--------S 74

Query: 334 RFEHENIVQYFG----TDK-DENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYT 383
              H N+V+++G     DK    +L++ LEL   GS+  L +        L ++ +S   
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFW 441
              L GL +LH   ++HRD+K  NIL+   G VKL DFG++   T   ++  +  GTPFW
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 442 MAPEVVNLKNR---GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--L 496
           MAPEV+  + +    Y    D+WSLG T +E+    PP   +  ++ LF+I +  PP  L
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            P    R    FI +CL  +   RP+   L+EHPF+K
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  143 bits (362), Expect = 4e-39
 Identities = 76/257 (29%), Positives = 130/257 (50%), Gaps = 19/257 (7%)

Query: 288 GSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT 346
           G+FG+VY       G +FA+K +   D   + + + ++ E+ I+++   E   + + + +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYVAKLYYS 65

Query: 347 DKDENRLFIFLELVTKGSLANLYQKYHLMDSQ-VSAYTRQILNGLNYLHEQNVVHRDIKC 405
            + ++ L++ +E +  G  A+L +    +       Y  +++ G+  LH++ ++HRDIK 
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP 125

Query: 406 ANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA--DIWSL 463
            N+L+D +G +KL DFGL++    N  K   GTP ++APE +     G G     D WSL
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETIL----GVGDDKMSDWWSL 179

Query: 464 GCTVLEMLTRQPPYSHLEGMQALF-RIGKGE---PPLVPNSLSRDARDFILKCLQVNPND 519
           GC + E L   PP+ H E   A+F  I       P  V    S +A D I + L ++P  
Sbjct: 180 GCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238

Query: 520 RPTA---AQLMEHPFVK 533
           R  A    ++  HPF K
Sbjct: 239 RLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  142 bits (360), Expect = 1e-38
 Identities = 91/266 (34%), Positives = 146/266 (54%), Gaps = 19/266 (7%)

Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G GS G V        G   AVK++ L+ Q     Q    L  E++++  ++HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           + +    + L++ +E +  G+L ++     + + Q++A    +L  L+ LH Q V+HRDI
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142

Query: 404 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  +IL+   G VKL+DFG   A    +V   KS  GTP+WMAPE+++     YG   DI
Sbjct: 143 KSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKSLVGTPYWMAPELIS--RLPYGPEVDI 199

Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN--SLSRDARDFILKCLQVNPN 518
           WSLG  V+EM+  +PPY +   ++A+  I    PP + N   +S   + F+ + L  +P 
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259

Query: 519 DRPTAAQLMEHPFVKRPLQKSRGPPS 544
            R TAA+L++HPF+ +      GPPS
Sbjct: 260 QRATAAELLKHPFLAKA-----GPPS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  143 bits (362), Expect = 2e-38
 Identities = 87/267 (32%), Positives = 136/267 (50%), Gaps = 29/267 (10%)

Query: 284 LLGSGSFGTV----YEGYTDDGFFFAVK----EVSLQDQGTQGKQSILQLEQEILLLSRF 335
           +LG GSFG V     +G TD+   +AVK    +V LQD   +        E+ +L L+  
Sbjct: 2   VLGKGSFGKVLLAELKG-TDE--LYAVKVLKKDVILQDDDVE----CTMTEKRVLALAG- 53

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLH 394
           +H  + Q     + ++RLF  +E V  G L    Q+    D  +   Y  +I+ GL +LH
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKN 451
           E+ +++RD+K  N+L+D+ G +K+ADFG+ K   +  V +   C GTP ++APE+  L  
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEI--LSY 170

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
           + YG   D W+LG  + EML  Q P+   +    LF+    +    P  LS++A+  +  
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSILKS 229

Query: 512 CLQVNPNDR----PTAAQ-LMEHPFVK 533
            L  NP  R    PT  Q +  HPF +
Sbjct: 230 FLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  143 bits (362), Expect = 2e-38
 Identities = 86/299 (28%), Positives = 139/299 (46%), Gaps = 61/299 (20%)

Query: 284 LLGSGSFGTVYEGY-TDDGFFFAVKEVSL--QDQGTQGKQSILQLEQEILLLSRFEHENI 340
            +GSG++G V        G   A+K++S    D     K+ IL+   EI LL    HENI
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL-IDAKR-ILR---EIKLLRHLRHENI 61

Query: 341 VQYF-----GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLN 391
           +         + +D N ++I  EL+      +L++       L D  +  +  QIL GL 
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELM----ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----WM-APEV 446
           YLH  NV+HRD+K +NILV+++  +K+ DFGLA+    ++ +    T +    W  APE+
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP-------- 495
           + L +  Y    DIWS+GC   E+LTR+P +    +++ +  +  +  G P         
Sbjct: 178 L-LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV-LGTPSEEDLKFIT 235

Query: 496 ---------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                                L P + S +A D + K L  +P  R TA + + HP++ 
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLFPGA-SPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  140 bits (354), Expect = 9e-38
 Identities = 81/275 (29%), Positives = 142/275 (51%), Gaps = 16/275 (5%)

Query: 283 ELLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           E LG G++G V +  +   G   AVK +       + K+ ++ L+   + +   +    V
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD---ISMRSVDCPYTV 63

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-----SAYTRQILNGLNYLHEQ 396
            ++G    E  ++I +E V   SL   Y+K +     +           I+  L YLH +
Sbjct: 64  TFYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122

Query: 397 -NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVN--LKNR 452
            +V+HRD+K +N+L++ +G VKL DFG++     +  K+   G   +MAPE +N  L  +
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKGEPPLVPN-SLSRDARDFIL 510
           GY + +D+WSLG T++E+ T + PY   +   Q L ++ +   P +P    S + +DF+ 
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVN 242

Query: 511 KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
           KCL+ N  +RP   +L++HPF +  L K+    S+
Sbjct: 243 KCLKKNYKERPNYPELLQHPFFELHLSKNTDVASF 277

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  140 bits (354), Expect = 2e-37
 Identities = 85/266 (31%), Positives = 143/266 (53%), Gaps = 22/266 (8%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
             +GSG+ G VY+  +   G   AVK++       + K+ ++ L+  ++L S  +   IV
Sbjct: 21  GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD--VVLKS-HDCPYIV 77

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-TRQILNGLNYLHE-QNVV 399
           + +G    ++ +FI +EL++      L +    +   +    T  I+  L+YL E   V+
Sbjct: 78  KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI 137

Query: 400 HRDIKCANILVDASGSVKLADFGLA------KATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           HRD+K +NIL+DASG+VKL DFG++      KA T    +S  G   +MAPE ++  +  
Sbjct: 138 HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT----RS-AGCAAYMAPERIDPPDPN 192

Query: 454 --YGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKGEPPLVPN--SLSRDARDF 508
             Y + AD+WSLG +++E+ T Q PY + +   + L +I + EPP +P     S D   F
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSF 252

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKR 534
           +  CL  +   RP   +L++HPF++R
Sbjct: 253 VDLCLTKDHRKRPKYRELLQHPFIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  140 bits (354), Expect = 2e-37
 Identities = 93/294 (31%), Positives = 142/294 (48%), Gaps = 52/294 (17%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSI-LQLEQEILLLSRFE 336
           ++KG+ LG G++  VY+    + G   A+K++ L ++  + K  I     +EI LL   +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERK-EAKDGINFTALREIKLLQELK 60

Query: 337 HENI---VQYFGTDKDENRLFIF----LELVTKGSLANLYQKYHLMDSQVSAYTRQILNG 389
           H NI   +  FG   + N +F F    LE V K           L  + + +Y    L G
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDK------SIVLTPADIKSYMLMTLRG 114

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT-TMNDVKSCKG-TPFWMAPEVV 447
           L YLH   ++HRD+K  N+L+ + G +KLADFGLA++  + N   + +  T ++ APE++
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-----GEP-------- 494
               R YG+  D+WS+GC   E+L R P    L G   + ++GK     G P        
Sbjct: 175 -FGARHYGVGVDMWSVGCIFAELLLRVP---FLPGDSDIDQLGKIFEALGTPTEENWPGV 230

Query: 495 ----------PLVPNSL-------SRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                     P  P  L       S DA D + + L +NPN R TA Q +EHP+
Sbjct: 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 2e-37
 Identities = 88/295 (29%), Positives = 138/295 (46%), Gaps = 51/295 (17%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKE--VSLQDQGTQGKQSILQLEQEILLL--- 332
           +++   +G G++GTVY+    + G F A+K+  V L ++G     S L+   EI LL   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI--PLSTLR---EIALLKQL 55

Query: 333 SRFEHENIVQ-----YFGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTR 384
             FEH NIV+     +      E +L +  E V +  LA    K     L    +    R
Sbjct: 56  ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTPFWMA 443
           Q+L G+++LH   +VHRD+K  NILV + G VK+ADFGLA+  +    + S   T ++ A
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRA 174

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP---PYSHLEGMQALFRI----GKGEPP- 495
           PEV  L    Y    D+WS+GC   E+  R+P     S  + +  +F +     + E P 
Sbjct: 175 PEV--LLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232

Query: 496 -------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                               VP  +  +  D + K L  NP+ R +A + ++HP+
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVP-EICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 6e-37
 Identities = 78/285 (27%), Positives = 130/285 (45%), Gaps = 40/285 (14%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            ++G G++G V +      G   A+K+    +     K++ L+   E+ +L +  HENIV
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIV 63

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ-VSAYTRQILNGLNYLHEQNVVH 400
                 + + RL++  E V +  L  L      +    V +Y  Q+L  + Y H  N++H
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRGYGLT 457
           RDIK  NILV  SG +KL DFG A+A              T ++ APE++ + +  YG  
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL-VGDTNYGKP 182

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP------------------- 498
            D+W++GC + E+L  +P +     +  L+ I K   PL P                   
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242

Query: 499 ------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                         +S  A DF+  CL+++P +R T  +L++HP+
Sbjct: 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  136 bits (345), Expect = 2e-36
 Identities = 87/284 (30%), Positives = 137/284 (48%), Gaps = 40/284 (14%)

Query: 283 ELLGSGSFGTVYE-GYTDDGFFFAVKE-VSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            L+G GS+G V +  + + G   A+K+ +  +D     K ++    +EI +L +  HEN+
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM----REIRMLKQLRHENL 62

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ-VSAYTRQILNGLNYLHEQNVV 399
           V      + + RL++  E V    L +L +  + +D   V  Y  QIL G+ + H  N++
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 400 HRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           HRDIK  NILV  SG VKL DFG A+  A           T ++ APE++ + +  YG  
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL-VGDTKYGRA 181

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN------------------ 499
            DIW++GC V EMLT +P +     +  L+ I K    L+P                   
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241

Query: 500 ------------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                        LS    D   +CL+++P+DRP+++QL+ H F
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  136 bits (344), Expect = 3e-36
 Identities = 80/273 (29%), Positives = 121/273 (44%), Gaps = 35/273 (12%)

Query: 285 LGSGSFGTVYEGY---TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           LG G FG V         D     V   SL   G   +Q     E+EI +L   +HENIV
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EEQHRSDFEREIEILRTLDHENIV 69

Query: 342 QYFG--TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQN 397
           +Y G         L + +E +  GSL +  Q++   +   ++  ++ QI  G++YL  Q 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLKNR 452
            +HRD+   NILV++   VK++DFGLAK    +     VK    +P FW APE   L+  
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC--LRTS 187

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSH-----------------LEGMQALFRIGKGEPP 495
            +   +D+WS G T+ E+ T   P                    +  +  L + G+  P 
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
             P S   +  D +  C +  P DRP+ A L+ 
Sbjct: 248 --PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  136 bits (343), Expect = 4e-36
 Identities = 93/299 (31%), Positives = 143/299 (47%), Gaps = 61/299 (20%)

Query: 278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G  S     +EI LL    
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELN 57

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS---------QVSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASPLSGIPLPLIKSYLFQLL 110

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 166

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 167 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225

Query: 495 ----------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                                  +VP  L  D RD + + L  +PN R +A   + HPF
Sbjct: 226 PGVTSLPDYKPSFPKWARQDFSKVVPP-LDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 4e-36
 Identities = 96/303 (31%), Positives = 141/303 (46%), Gaps = 71/303 (23%)

Query: 279 WQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQS--ILQLEQEILLLSRF 335
           +QK E +G G++G VY+      G   A+K++ L +   +G  S  I    +EI LL   
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAI----REISLLKEL 55

Query: 336 EHENIVQYFGTDKDENRL---FIFLELVTKGSLANLYQKYHLMDS---------QVSAYT 383
            H NIV+       EN+L   F FL+L  K        KY  MDS          + +Y 
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLDLDLK--------KY--MDSSPLTGLDPPLIKSYL 105

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKG 437
            Q+L G+ Y H   V+HRD+K  N+L+D  G++KLADFGLA+A      T  ++V     
Sbjct: 106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---- 161

Query: 438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI-------- 489
           T ++ APE++ L +R Y    DIWS+GC   EM+ R+P +     +  LFRI        
Sbjct: 162 TLWYRAPEIL-LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD 220

Query: 490 ---------------------GKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                                 +    +VPN L  D  D + K L  +P  R +A   ++
Sbjct: 221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISAKAALQ 279

Query: 529 HPF 531
           HP+
Sbjct: 280 HPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  134 bits (338), Expect = 2e-35
 Identities = 84/272 (30%), Positives = 142/272 (52%), Gaps = 29/272 (10%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
             +G G+FGTV +  +   G   AVK +       + K+  L ++ ++++ S  +   IV
Sbjct: 10  GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR--LLMDLDVVMRSS-DCPYIV 66

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLY------QKYHLMDSQVSAYTRQILNGLNYLHE 395
           +++G    E   +I +EL+   SL   Y       K  + +  +       +  LNYL E
Sbjct: 67  KFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 396 Q-NVVHRDIKCANILVDASGSVKLADFGLAK------ATTMNDVKSCKGTPFWMAPEVVN 448
           +  ++HRD+K +NIL+D +G++KL DFG++       A T +    C+  P+ MAPE ++
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD--AGCR--PY-MAPERID 180

Query: 449 LKNR-GYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKGEPPLVPNSL----S 502
              R GY + +D+WSLG T+ E+ T + PY     +   L ++ KG+PP++ NS     S
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
               +FI  CL  + + RP   +L+EHPF+K 
Sbjct: 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  134 bits (339), Expect = 2e-35
 Identities = 84/260 (32%), Positives = 135/260 (51%), Gaps = 17/260 (6%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVK----EVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++LG GSFG V+         FFA+K    +V L D   +       +E+ +L L+ +EH
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVE----CTMVEKRVLSLA-WEH 55

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQ 396
             +   + T + +  LF  +E +  G L    Q  H  D  + + Y  +I+ GL +LH +
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGY 454
            +V+RD+K  NIL+D  G +K+ADFG+ K   + D K+C   GTP ++APE+  L  + Y
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI--LLGQKY 173

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
             + D WS G  + EML  Q P+ H    + LF+  + + P  P  L+R+A+D ++K   
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF-HGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232

Query: 515 VNPNDR-PTAAQLMEHPFVK 533
             P  R      + +HPF +
Sbjct: 233 REPERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  133 bits (336), Expect = 2e-35
 Identities = 80/256 (31%), Positives = 130/256 (50%), Gaps = 20/256 (7%)

Query: 283 ELLGSGSFGTVYE-GYTDDG-FFFAVKEVSLQD-----QGTQGKQSILQLEQEILLL-SR 334
           E LGSG+FG VY+    ++G    A+KE+++ +        +  +SI  +  E+ ++  +
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLY-----QKYHLMDSQVSAYTRQILNG 389
             H NIV+Y+ T  + +RL+I ++L+    L   +     +K    + ++     Q++  
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 390 LNYLH-EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVV 447
           L YLH E+ +VHRD+   NI++     V + DFGLAK       + S  GT  +  PE+V
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL-FRIGKGE-PPLVPNSLSRDA 505
             KN  YG  AD+W+ GC + +M T QPP+ +   M +L  +I +    PL     S D 
Sbjct: 186 --KNEPYGEKADVWAFGCILYQMCTLQPPF-YSTNMLSLATKIVEAVYEPLPEGMYSEDV 242

Query: 506 RDFILKCLQVNPNDRP 521
            D I  CL  +   RP
Sbjct: 243 TDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  132 bits (333), Expect = 9e-35
 Identities = 92/285 (32%), Positives = 144/285 (50%), Gaps = 30/285 (10%)

Query: 285 LGSGSFGTVY----EGYTDDGFFFAVKEVS----LQDQGTQGKQSILQLEQEILLLSRFE 336
           LG+G++G V+     G  D G  +A+K +     +Q   T       + E+++L   R  
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT---RTERQVLEAVR-R 63

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
              +V      + + +L + L+ V  G L  +LYQ+ H  +S+V  Y  +I+  L++LH+
Sbjct: 64  CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ 123

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDVKSCKGTPFWMAPEVVNLKNR 452
             +++RDIK  NIL+D+ G V L DFGL+K   A       S  GT  +MAPEV+   + 
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ-----ALFRIGKGEPPLVPNSLSRDARD 507
           G+    D WSLG    E+LT   P++ ++G Q        RI K +PP  P ++S +ARD
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPF-PKTMSAEARD 241

Query: 508 FILKCLQVNPNDR---PTAAQLMEHPFVKR----PLQKSRGPPSY 545
           FI K L+ +P  R     A ++  HPF +      L   R P  +
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPF 286

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  130 bits (327), Expect = 2e-34
 Identities = 77/258 (29%), Positives = 139/258 (53%), Gaps = 18/258 (6%)

Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G GS+G V    +  DG  + +K+++L++   + +++    EQE  LLS+ +H NIV Y
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVAY 64

Query: 344 FGTDKDEN-RLFIFLELVTKGSLANLYQKYH------LMDSQVSAYTRQILNGLNYLHEQ 396
             + + E+  L+I +     G   +LY K        L ++QV  +  QI   L YLHE+
Sbjct: 65  RESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDVKSCK-GTPFWMAPEVVNLKNRGY 454
           +++HRD+K  N+ +  +  +K+ D G+A+      D+ S   GTP++M+PE+    N+ Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL--FSNKPY 179

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
              +D+W+LGC V EM T +  ++  +    ++RI +G+ P +P   S +  + I   L 
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239

Query: 515 VNPNDRPTAAQLMEHPFV 532
             P  RP+   ++  P++
Sbjct: 240 KRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  130 bits (329), Expect = 2e-34
 Identities = 86/264 (32%), Positives = 138/264 (52%), Gaps = 22/264 (8%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           Q  E+LG G+ GTVY+ Y        AVK + L       KQ + +LE    +L + +  
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE----ILYKCDSP 59

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQ 396
            I+ ++G    ENR+ I  E +  GSL ++Y+K   H++     A    ++ GL YL   
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPEHVLGRIAVA----VVKGLTYLWSL 114

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
            ++HRD+K +N+LV+  G VKL DFG++     +  K+  GT  +MAPE   +    YG+
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE--RISGEQYGI 172

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEG-------MQALFRIGKGEPPLVPNSL-SRDARDF 508
            +D+WSLG + +E+   + PY  ++        +Q L  I   +PP++P    S     F
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFV 532
           I +C++  P +RP    LM+HPF+
Sbjct: 233 ITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  129 bits (326), Expect = 4e-34
 Identities = 81/250 (32%), Positives = 128/250 (51%), Gaps = 19/250 (7%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQD-QGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           +G G F  VY      DG   A+K+V + D    + +   ++   EI LL +  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIK 66

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLY-----QKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           Y+ +  ++N L I LEL   G L+ +      QK  + +  V  Y  Q+ + L ++H + 
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           V+HRDIK AN+ + A+G VKL D GL +  ++      S  GTP++M+PE ++    GY 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILK 511
             +DIWSLGC + EM   Q P+ + + M       K E    PPL  +  S + R  +  
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243

Query: 512 CLQVNPNDRP 521
           C+  +P  RP
Sbjct: 244 CINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  127 bits (322), Expect = 1e-33
 Identities = 68/255 (26%), Positives = 119/255 (46%), Gaps = 22/255 (8%)

Query: 285 LGSGSFGTVYEGY--TDDGFFFAVKEVSL----QDQGTQGKQSILQLEQEILLLSRFEHE 338
           LG G+FG+V +G      G      EV++    Q+    GK+  L+   E  ++++ +H 
Sbjct: 3   LGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHP 56

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQN 397
            IV+  G  K E  L + +EL   G L    +K   +  S +     Q+  G+ YL  ++
Sbjct: 57  CIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPF---WMAPEVVNLKNR 452
            VHRD+   N+L+      K++DFG+++A        ++     +   W APE +N    
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY--G 173

Query: 453 GYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
            +   +D+WS G T+ E  +    PY  ++G + +  +  GE    P    ++    +L 
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233

Query: 512 CLQVNPNDRPTAAQL 526
           C +  P DRPT ++L
Sbjct: 234 CWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  129 bits (326), Expect = 1e-33
 Identities = 87/282 (30%), Positives = 141/282 (50%), Gaps = 23/282 (8%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVK----EVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           +LG GSFG V          FFA+K    +V L+D   +       +E+ +L L+ +EH 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTM----VERRVLALA-WEHP 56

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQN 397
            +   F T + +  LF  +E +  G L    Q     D ++   Y  +I+ GL +LH++ 
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGY 454
           +++RD+K  N+L+D  G +K+ADFG+ K     + K+   C GTP ++APE+  LK + Y
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEI--LKGQKY 173

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
             + D WS G  + EML  Q P+ H E    LF     + P  P  +S++A+D + K  +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPF-HGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFE 232

Query: 515 VNPNDR-PTAAQLMEHPFVK----RPLQKSRGPPSYYNNMHS 551
            +P  R      + +HPF +      L+K   PP +   + S
Sbjct: 233 RDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKS 274

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  127 bits (322), Expect = 2e-33
 Identities = 84/260 (32%), Positives = 129/260 (49%), Gaps = 21/260 (8%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFF---AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           + LG GSFG V  G ++  G      AVK +   D+ +      L+   E  ++   +HE
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLK---EAAIMHSLDHE 56

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN---LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           N+++ +G       + +  EL   GSL +        H + S +  Y  QI NG+ YL  
Sbjct: 57  NLIRLYGVVLTHPLMMVT-ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLK 450
           +  +HRD+   NIL+ +   VK+ DFGL +A   N+    ++     PF W APE  +L+
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--SLR 173

Query: 451 NRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDF 508
            R +   +D+W  G T+ EM T  + P++ L G Q L +I K GE    P +  +D  + 
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233

Query: 509 ILKCLQVNPNDRPTAAQLME 528
           +L+C   NP DRPT A L E
Sbjct: 234 MLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  128 bits (325), Expect = 2e-33
 Identities = 88/314 (28%), Positives = 136/314 (43%), Gaps = 66/314 (21%)

Query: 275 RIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQS--ILQLEQEILL 331
           ++  ++    LG G+FG VY+      G   A+K++ + ++    K    I  L +EI +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE----KDGFPITAL-REIKI 60

Query: 332 LSRFEHENIVQ-----YFGTDKDENRLFIFLELVT-------KGSLANLYQKYHLMDSQV 379
           L + +H N+V          DK + +      +VT        G L N      L +SQ+
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLEN--PSVKLTESQI 117

Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----------ATT 428
             Y  Q+L G+NYLHE +++HRDIK ANIL+D  G +K+ADFGLA+              
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 429 MNDVK--SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP----------- 475
               K  +   T ++  PE++ L  R Y    DIW +GC   EM TR+P           
Sbjct: 178 GGTRKYTNLVVTRWYRPPELL-LGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 476 ---------P-------YSHLEGMQALFRIGKGEPPLVPN--SLSRDARDFILKCLQVNP 517
                    P       +  L G + +         L      L  +  D + K L ++P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 518 NDRPTAAQLMEHPF 531
             R TA+  +EHP+
Sbjct: 297 YKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  124 bits (313), Expect = 2e-32
 Identities = 80/265 (30%), Positives = 134/265 (50%), Gaps = 29/265 (10%)

Query: 285 LGSGSFGTVY---EGYTDDGFFFAV-KEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           LG GSFGTVY   +          V KE+ +   G       +Q  QE  LLS+ +H  I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV---GELNPNETVQANQEAQLLSKLDHPAI 64

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-----LMDSQVSAYTRQILNGLNYLHE 395
           V++  +  + +   I  E      L    ++       L ++QV  +  Q+L G++Y+H+
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAK--------ATTMNDVKSCKGTPFWMAPEVV 447
           + ++HRD+K  NI +  +  +K+ DFG+++        ATT        GTP++M+PE  
Sbjct: 125 RRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFT------GTPYYMSPEA- 176

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
            LK++GY   +DIWSLGC + EM      +     +  + RI +G  P +P + SR    
Sbjct: 177 -LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235

Query: 508 FILKCLQVNPNDRPTAAQLMEHPFV 532
            +   L  +P+ RP+AA+++ +PF+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  124 bits (313), Expect = 4e-32
 Identities = 93/301 (30%), Positives = 150/301 (49%), Gaps = 65/301 (21%)

Query: 278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQ-DQGTQGKQSILQLEQEILLLSRF 335
           ++++ E LG G++ TVY+G     G   A+KE+ L  ++GT    +I    +EI L+   
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-STAI----REISLMKEL 55

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS----------QVSAYTRQ 385
           +HENIV+       EN+L +  E + K       +KY  MD+           V ++T Q
Sbjct: 56  KHENIVRLHDVIHTENKLMLVFEYMDKD-----LKKY--MDTHGVRGALDPNTVKSFTYQ 108

Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTP 439
           +L G+ + HE  V+HRD+K  N+L++  G +KLADFGLA+A      T  N+V     T 
Sbjct: 109 LLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TL 164

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEP-- 494
           ++ AP+V+ L +R Y  + DIWS+GC + EM+T +P +   ++ + +  +FRI  G P  
Sbjct: 165 WYRAPDVL-LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI-MGTPTE 222

Query: 495 ----------------PLVPN--------SLSRDARDFILKCLQVNPNDRPTAAQLMEHP 530
                           P  P                D + + LQ+NP  R +A   ++HP
Sbjct: 223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282

Query: 531 F 531
           +
Sbjct: 283 W 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  125 bits (317), Expect = 6e-32
 Identities = 76/252 (30%), Positives = 120/252 (47%), Gaps = 52/252 (20%)

Query: 328 EILLLSRF-EHENIVQYFGTDKDENRLFIFL--ELVTKGSLANLYQKYHLMDSQVSAYTR 384
           EI+ L    +H NIV+     K EN   I+L  E + +  L  + +   L D        
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMY 114

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTP----- 439
           Q+L  L Y+H  NV+HRD+K +NIL+++   VKLADFGLA+  ++++++     P     
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEENPENPVLTDY 172

Query: 440 ----FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP-------------------- 475
               ++ APE++ L +  Y    D+WS+GC + EML  +P                    
Sbjct: 173 VATRWYRAPEIL-LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 476 -----------PYSH--LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPT 522
                      P++   L+ + +  R  K    L+P + S DA D + K L  NPN R T
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPR--KPLDELLPKA-SDDALDLLKKLLVFNPNKRLT 288

Query: 523 AAQLMEHPFVKR 534
           A + +EHP+V +
Sbjct: 289 AEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 8e-32
 Identities = 76/249 (30%), Positives = 122/249 (48%), Gaps = 23/249 (9%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           LG+G FG V+EG  ++    AVK +     GT   +  L   Q   ++ +  H  ++Q +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQ---IMKKLRHPKLIQLY 67

Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
                E  ++I  EL+  GSL    Q      L   Q+     Q+ +G+ YL  QN +HR
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D+   N+LV  +   K+ADFGLA+    +  ++ +G  F   W APE     NR + + +
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NR-FSIKS 185

Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG----EPPLVPNSLSRDARDFILKCL 513
           D+WS G  + E++T  + PY  +   + L ++ +G     PP  P  L     D +L C 
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKEL----YDIMLDCW 241

Query: 514 QVNPNDRPT 522
           + +P+DRPT
Sbjct: 242 KEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 1e-31
 Identities = 77/260 (29%), Positives = 126/260 (48%), Gaps = 23/260 (8%)

Query: 278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           S +    LG+G FG V+ G  +     AVK +     GT   ++ LQ   E  ++ +  H
Sbjct: 7   SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQ---EAQIMKKLRH 60

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLH 394
           + +VQ +    +E  ++I  E ++KGSL +  +      L   Q+     QI  G+ YL 
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKN 451
            +N +HRD+   NILV  +   K+ADFGLA+    ++  + +G  F   W APE  N   
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR 180

Query: 452 RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG----EPPLVPNSLSRDAR 506
             + + +D+WS G  + E++T  + PY  +   + L ++ +G     PP  P  L     
Sbjct: 181 --FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEEL----Y 234

Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +L+C   +P +RPT   L
Sbjct: 235 DLMLQCWDKDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  122 bits (308), Expect = 2e-31
 Identities = 79/250 (31%), Positives = 127/250 (50%), Gaps = 19/250 (7%)

Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSL-QDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           +G G F  VY      D    A+K+V + +    + +Q  ++   EI LL +  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLY-----QKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           Y  +  ++N L I LEL   G L+ +      QK  + +  V  Y  Q+ + + ++H + 
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           V+HRDIK AN+ + A+G VKL D GL +  ++      S  GTP++M+PE ++    GY 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILK 511
             +DIWSLGC + EM   Q P+ + + M       K E    PPL     S   R+ +  
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243

Query: 512 CLQVNPNDRP 521
           C+  +P+ RP
Sbjct: 244 CIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  122 bits (308), Expect = 2e-31
 Identities = 81/259 (31%), Positives = 124/259 (47%), Gaps = 25/259 (9%)

Query: 282 GELLGSGSFGTVYEG-YT---DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           G  +G G FG VY+G Y    ++    AVK        +  ++  LQ   E  ++ +F+H
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV-REKFLQ---EAYIMRQFDH 66

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHE 395
            +IV+  G   + N ++I +EL   G L +  Q  KY L  + +  Y+ Q+   L YL  
Sbjct: 67  PHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGT-PF-WMAPEVVNLKNR 452
           +  VHRDI   N+LV +   VKL DFGL++        K+ KG  P  WMAPE +N   R
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--R 183

Query: 453 GYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARD 507
            +   +D+W  G  + E+L     P+  ++    + RI  GE    PP  P +L      
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY----S 239

Query: 508 FILKCLQVNPNDRPTAAQL 526
            + KC   +P+ RP   +L
Sbjct: 240 LMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 2e-31
 Identities = 83/299 (27%), Positives = 132/299 (44%), Gaps = 58/299 (19%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLL 332
           +  +++G G+FG V+     D G  +A+K +         K  +++  Q      E  +L
Sbjct: 4   EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR--------KSDMIKRNQIAHVRAERDIL 55

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLN 391
           +  +   IV+ + + +DE  L++ +E +  G L NL  +     +     Y  +++  L+
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------------------------- 426
            +H+   +HRDIK  NIL+DA G +KLADFGL K                          
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 427 ------TTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL 480
                        S  GTP ++APEV  L+   YGL  D WSLG  + EML   PP+   
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEV--LRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233

Query: 481 EGMQALFRIGKGE-----PPLVPNSLSRDARDFILKCLQVNPNDRPTAA-QLMEHPFVK 533
              +   +I   +     PP  P  +S +A D I + L  +P DR  +  ++  HPF K
Sbjct: 234 TLQETYNKIINWKESLRFPPDPP--VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  122 bits (307), Expect = 2e-31
 Identities = 71/262 (27%), Positives = 133/262 (50%), Gaps = 15/262 (5%)

Query: 279 WQKGELLGSGSFGTVY--EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           ++K  ++G G+FG V+      D      +K++ ++      + +    + E  +L    
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVI-IKQIPVEQMTKDERLAA---QNECQVLKLLS 57

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYL 393
           H NI++Y+    ++  L I +E    G+LA   QK     L +  +  +  QIL  L+++
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 394 HEQNVVHRDIKCANILVDASGSV-KLADFGLAKA-TTMNDVKSCKGTPFWMAPEVVNLKN 451
           H + ++HRD+K  NIL+D    V K+ DFG++K  ++ +   +  GTP +++PE+   + 
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--EG 175

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL-FRIGKGEPPLVPNSLSRDARDFIL 510
           + Y   +DIW+LGC + E+ + +  +     + AL  +I  G    + +  S D R  IL
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234

Query: 511 KCLQVNPNDRPTAAQLMEHPFV 532
             L ++P+ RP  +Q+M  P  
Sbjct: 235 SMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  122 bits (309), Expect = 2e-31
 Identities = 90/291 (30%), Positives = 137/291 (47%), Gaps = 50/291 (17%)

Query: 281 KGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           K E +G G++G VY+G     G   A+K++ L+ +  +G  S     +EI LL   +H N
Sbjct: 4   KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAI--REISLLKELQHPN 60

Query: 340 IVQYFGTDKDENRLFIFLELVT---KGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           IV        E+RL++  E ++   K  L +L +  ++    V +Y  QIL G+ + H +
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKA-------TTMNDVKSCKGTPFWMAPEVVNL 449
            V+HRD+K  N+L+D  G +KLADFGLA+A        T   V     T ++ APEV+ L
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEVL-L 174

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP------------- 494
            +  Y    DIWS+G    EM T++P +     +  LFRI +  G P             
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234

Query: 495 --------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                           V N L  D  D + K L  +P  R +A + + HP+
Sbjct: 235 YKNTFPKWKKGSLRSAVKN-LDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  122 bits (307), Expect = 3e-31
 Identities = 86/284 (30%), Positives = 132/284 (46%), Gaps = 35/284 (12%)

Query: 272 FRRRIMSWQKGELLGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKQSILQLE 326
           F +R +  +K  +LG G FG V    Y+   D  G   AVK +  ++ G Q        +
Sbjct: 1   FHKRYL--KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSG---WK 54

Query: 327 QEILLLSRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR 384
           +EI +L    HENIV+Y G  +++    L + +E V  GSL +   K+ L  +Q+  + +
Sbjct: 55  KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQ 114

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP- 439
           QI  G+ YLH Q+ +HRD+   N+L+D    VK+ DFGLAKA         V+    +P 
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-----QPPYSHLE------GMQALFR 488
           FW A E   LK   +   +D+WS G T+ E+LT       PP    E      G   + R
Sbjct: 175 FWYAVEC--LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232

Query: 489 ----IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
               + +G     P +  ++    +  C +     RPT   L+ 
Sbjct: 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  122 bits (307), Expect = 6e-31
 Identities = 71/302 (23%), Positives = 127/302 (42%), Gaps = 59/302 (19%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           G+         + + +       AVK+++L       K+ +  L+QEI+   + +H NI+
Sbjct: 7   GKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCS---KEDLKLLQQEIITSRQLQHPNIL 62

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD---SQVSAYT-RQILNGLNYLHEQN 397
            Y  +   ++ L++   L+  GS  +L  K H  +       A+  + +LN L+Y+H + 
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIHSKG 121

Query: 398 VVHRDIKCANILVDASGSVKLADF---------GLAKAT----TMNDVKSCKGTPFWMAP 444
            +HR +K ++IL+   G V L+           G  +        + VK+      W++P
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP----WLSP 177

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--------- 495
           EV+    +GY   +DI+S+G T  E+     P+  +   Q L    +G  P         
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237

Query: 496 -----------LVPNSLSRDARD-------------FILKCLQVNPNDRPTAAQLMEHPF 531
                         +  +RD+ D             F+  CLQ +P  RP+A+QL+ H F
Sbjct: 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297

Query: 532 VK 533
            K
Sbjct: 298 FK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  120 bits (303), Expect = 1e-30
 Identities = 76/263 (28%), Positives = 135/263 (51%), Gaps = 21/263 (7%)

Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG+G+ G+V +  +   G   A K V +  + +  KQ IL+   E+ ++       IV +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-ILR---ELQIMHECRSPYIVSF 68

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-TRQILNGLNYLH-EQNVVHR 401
           +G   +EN + + +E +  GSL  +Y+K   +  ++       ++ GL YL+    ++HR
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIW 461
           DIK +NILV++ G +KL DFG++     +   +  GT  +M+PE   ++   Y + +D+W
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPE--RIQGGKYTVKSDVW 186

Query: 462 SLGCTVLEMLTRQPPYSHLEG-----------MQALFRIGKGEPPLVPNS-LSRDARDFI 509
           SLG +++E+   + P++               +  L +I +  PP +P+S    D RDF+
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFV 246

Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
             CL  +P +RPT  QL   P  
Sbjct: 247 DACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  120 bits (303), Expect = 1e-30
 Identities = 73/285 (25%), Positives = 133/285 (46%), Gaps = 46/285 (16%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQ--DQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +G G+ G V++    + G   A+K+V+L+  + G        Q  +EI  L   +H  +V
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-----NQALREIKALQACQHPYVV 62

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVV 399
           +        +   + +E +    L+ + +     L ++QV +Y R +L G+ Y+H   ++
Sbjct: 63  KLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIM 121

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRGYGL 456
           HRD+K AN+L+ A G +K+ADFGLA+  +  + +       T ++ APE++    R Y  
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL-YGARKYDP 180

Query: 457 TADIWSLGCTVLEMLTRQPPY-------------SHL--------EGMQAL-------FR 488
             D+W++GC   E+L   P +               L         G+ +L       F 
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240

Query: 489 IGKGEPP--LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
             K  P   + P++ S +A D +   L  +P+ R +AA+ + HP+
Sbjct: 241 ESKPIPLEEIFPDA-SPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  118 bits (298), Expect = 3e-30
 Identities = 79/263 (30%), Positives = 115/263 (43%), Gaps = 33/263 (12%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
              LGSG FG V+EG   +    A+K +   D   Q        ++E+  L R  H++++
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-----DFQKEVQALKRLRHKHLI 65

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLY--------QKYHLMDSQVSAYTRQILNGLNYL 393
             F        ++I  EL+ KGSL                L+D        Q+  G+ YL
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID-----MACQVAEGMAYL 120

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPF-WMAPEVVNLK 450
            EQN +HRD+   NILV      K+ADFGLA+     DV   S K  P+ W APE  +  
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAAS-- 177

Query: 451 NRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG----EPPLVPNSLSRDA 505
           +  +   +D+WS G  + EM T  Q PY  +   +   +I  G     P   P  + +  
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK-- 235

Query: 506 RDFILKCLQVNPNDRPTAAQLME 528
              +L+C    P DRP+   L E
Sbjct: 236 --IMLECWAAEPEDRPSFKALRE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  118 bits (296), Expect = 5e-30
 Identities = 73/250 (29%), Positives = 129/250 (51%), Gaps = 12/250 (4%)

Query: 284 LLGSGSFG-TVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           ++G GSFG  +   + +    +A+KE+ L    +  + S     +E +LL++ +H NIV 
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS----RKEAVLLAKMKHPNIVA 62

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQ-VSAYTRQILNGLNYLHEQNVV 399
           +  + + +  L+I +E    G L      Q+  L     +  +  Q+  G+ ++HE+ V+
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYGLT 457
           HRDIK  NI +  +G VKL DFG A+  T     +C   GTP+++ PE+   +N  Y   
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI--WENMPYNNK 180

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           +DIWSLGC + E+ T + P+        + ++ +G    +P+  S + R  I +  + NP
Sbjct: 181 SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNP 240

Query: 518 NDRPTAAQLM 527
             RP+A  ++
Sbjct: 241 RSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 9e-30
 Identities = 91/322 (28%), Positives = 136/322 (42%), Gaps = 91/322 (28%)

Query: 286 GSGSFGTVYEGYTDDGF---FFAVKE-VSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           G G++G VY+    +G     +A+K+    ++Q T   QS  +   EI LL   +HEN+V
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR---EIALLRELKHENVV 65

Query: 342 QYFGTDKDENRLFIFLELVTKG-SLA------NLYQ--KYH-------LMDSQVSAYTRQ 385
                        +FLE   K   L       +L+Q  K+H       +  S V +   Q
Sbjct: 66  SLVE---------VFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 386 ILNGLNYLHEQNVVHRDIKCANILV----DASGSVKLADFGLAKATTMNDVKSCKGTP-- 439
           ILNG++YLH   V+HRD+K ANILV       G VK+ D GLA+             P  
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 440 --FWM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP-------------PYSHLEGM 483
              W  APE++ L  R Y    DIW++GC   E+LT +P             P+   + +
Sbjct: 177 VTIWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF-QRDQL 234

Query: 484 QALFRIGKGEP-----PLV-------------------PNSLSR----------DARDFI 509
           + +F +  G P     P +                    NSL++             D +
Sbjct: 235 ERIFEV-LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLL 293

Query: 510 LKCLQVNPNDRPTAAQLMEHPF 531
            K L+ +P  R TA + +EHP+
Sbjct: 294 RKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  119 bits (300), Expect = 9e-30
 Identities = 91/303 (30%), Positives = 144/303 (47%), Gaps = 63/303 (20%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG GS G V+    +D     AVK++ L D      QS+    +EI ++ R +H+NIV+ 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 67

Query: 344 F------GTDKDE--------NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNG 389
           +      G+D  E        N ++I  E + +  LAN+ ++  L +     +  Q+L G
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVKSCKG-------TPFW 441
           L Y+H  NV+HRD+K AN+ ++    V K+ DFGLA+   ++   S KG       T ++
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR--IVDPHYSHKGYLSEGLVTKWY 184

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP--PYSH-LEGMQ-------------- 484
            +P ++ L    Y    D+W+ GC   EMLT +P    +H LE MQ              
Sbjct: 185 RSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 485 --------ALFRIGKGEP-----PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                   +  R   GEP      L+P  ++ +A DF+ + L  NP DR TA + + HP+
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPG-VNPEALDFLEQILTFNPMDRLTAEEALMHPY 302

Query: 532 VKR 534
           +  
Sbjct: 303 MSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  119 bits (299), Expect = 1e-29
 Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 34/269 (12%)

Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQL--------EQEILLLSRF 335
           +G G +G V+     D G   A+K +         K  + +L        E++IL  ++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMK--------KSLLFKLNEVRHVLTERDILTTTK- 59

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-QVSAYTRQILNGLNYLH 394
             E +V+     +D+  L++ +E V  G    L     ++       Y  ++   ++ LH
Sbjct: 60  -SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
           E   +HRD+K  N L+DASG +KL DFGL+K   +    S  G+P +MAPEV+    +GY
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKG-IVTYANSVVGSPDYMAPEVLR--GKGY 175

Query: 455 GLTADIWSLGCTVLEMLTRQPPYS---------HLEGMQALFRIGKGEPPLVPNSLSRDA 505
             T D WSLGC + E L   PP+S         +L+  +   +    + P    +LS +A
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP--RFNLSDEA 233

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
            D I K +        +   +  HPF K 
Sbjct: 234 WDLITKLINDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  118 bits (298), Expect = 1e-29
 Identities = 76/247 (30%), Positives = 122/247 (49%), Gaps = 20/247 (8%)

Query: 282 GELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSR 334
           GE LG+GSFG V    +   G ++A+K +         K+ IL+++Q      E  +L  
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIKCLK--------KREILKMKQVQHVAQEKSILME 74

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYL 393
             H  IV    + +DENR++  LE V  G L    +K     + V+  Y  +++    YL
Sbjct: 75  LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           H +++++RD+K  N+L+D  G VK+ DFG AK         C GTP ++APEV+  +++G
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-GTPEYLAPEVI--QSKG 191

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           +G   D W++G  + E +   PP+      +   +I  G     PN     ARD +   L
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLL 250

Query: 514 QVNPNDR 520
           Q +   R
Sbjct: 251 QTDHTKR 257

Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  118 bits (297), Expect = 2e-29
 Identities = 77/264 (29%), Positives = 124/264 (46%), Gaps = 21/264 (7%)

Query: 284 LLGSGSFGTVY---EGYTDDGFFFAV--KEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           +LG GSFG V       TD+ +   +  K+V +QD   +       +E+ +L L      
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVE----CTMVEKRVLALPGKPP- 61

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
            + Q     +  +RL+  +E V  G L    Q+        +  Y  +I  GL +LH + 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYG 455
           +++RD+K  N+++DA G +K+ADFG+ K        +    GTP ++APE++    + YG
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQPYG 179

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            + D W+ G  + EML  QPP+   E    LF+         P SLS++A       L  
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTK 238

Query: 516 NPNDR----PTAAQ-LMEHPFVKR 534
           +P  R    PT  + + EH F +R
Sbjct: 239 HPAKRLGCGPTGERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  118 bits (296), Expect = 2e-29
 Identities = 88/267 (32%), Positives = 131/267 (49%), Gaps = 23/267 (8%)

Query: 283 ELLGSGSFGTVYEGY---TDDGFFFAV--KEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++LG GSFG V       TD+ +   V  K+V LQD       +    E+ IL L+  +H
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMT----EKRILALAA-KH 55

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQ 396
             +       + ++RLF  +E V  G L    Q+    D   S  Y  ++   L +LH  
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGY 454
            V++RD+K  NIL+DA G  KLADFG+ K   +N V +    GTP ++APE+  L+   Y
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI--LQELEY 173

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G + D W+LG  + EM+  QPP+   +    LF     +  L P  LS++A   +   + 
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMT 232

Query: 515 VNPNDR--PTAAQ-----LMEHPFVKR 534
            NPN R    A+Q     + +HPF K 
Sbjct: 233 KNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  116 bits (293), Expect = 2e-29
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 49/293 (16%)

Query: 278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
            ++K E +G G++GTV++    +     A+K V L D       S L+   EI LL   +
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELK 57

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY------HLMDSQVSAYTRQILNGL 390
           H+NIV+ +     + +L +  E   +       +KY       +    V ++  Q+L GL
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGL 112

Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVN 448
            + H  NV+HRD+K  N+L++ +G +KLADFGLA+A  +  V+  S +    W  P  V 
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVL 171

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPP----YSHLEGMQALFRIGKGEP---------- 494
              + Y  + D+WS GC   E+     P        + ++ +FR+  G P          
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEESWPGVSK 230

Query: 495 -------PLVPN---------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                  P+ P           L+   RD +   L  NP  R +A + ++HP+
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 2e-29
 Identities = 75/253 (29%), Positives = 116/253 (45%), Gaps = 14/253 (5%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           + G  +G G FG V  G    G   AVK   L+D  T   Q+ L    E  +++   H N
Sbjct: 9   KLGATIGKGEFGDVMLG-DYRGQKVAVK--CLKDDST-AAQAFLA---EASVMTTLRHPN 61

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNGLNYLHEQ 396
           +VQ  G     N L+I  E + KGSL +  +   +  +  +Q   +   +  G+ YL E+
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           N VHRD+   N+LV      K++DFGLAK  +     S K    W APE   L+ + +  
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-QDSGKLPVKWTAPEA--LREKKFST 178

Query: 457 TADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E+ +  + PY  +     +  + KG     P     +    +  C ++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWEL 238

Query: 516 NPNDRPTAAQLME 528
           +P  RPT  QL E
Sbjct: 239 DPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  117 bits (294), Expect = 4e-29
 Identities = 85/263 (32%), Positives = 136/263 (51%), Gaps = 18/263 (6%)

Query: 284 LLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           +LG G +G V++       D G  FA+K V  +    + ++     + E  +L   +H  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           IV      +   +L++ LE ++ G L  +L ++   M+     Y  +I   L +LH+Q +
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGYG 455
           ++RD+K  NIL+DA G VKL DFGL K +      +   C GT  +MAPE+  L   G+G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEI--LMRSGHG 178

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
              D WSLG  + +MLT  PP++     + + +I KG+  L P  L+ +ARD + K L+ 
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL-PPYLTPEARDLLKKLLKR 237

Query: 516 NPNDR-----PTAAQLMEHPFVK 533
           NP+ R       AA++  HPF +
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 4e-29
 Identities = 72/241 (29%), Positives = 120/241 (49%), Gaps = 12/241 (4%)

Query: 284 LLGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
            +G+G+FG V+         ++A+K +++ +     ++  +  E+ +L      H  I++
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVL--KEVSHPFIIR 65

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVHR 401
            F T+ D+  L++ +E V  G L +  +      +     Y  +I+  L YLH + +V+R
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIW 461
           D+K  NIL+D  G +KL DFG AK         C GTP ++APEV  ++++G+    D W
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC-GTPEYLAPEV--IQSKGHNKAVDWW 182

Query: 462 SLGCTVLEMLTRQPPY--SHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPND 519
           +LG  + EML   PP+   +  G+      GK E    P  L   A+D I K L V+   
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE---FPRHLDLYAKDLIKKLLVVDRTR 239

Query: 520 R 520
           R
Sbjct: 240 R 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  116 bits (292), Expect = 6e-29
 Identities = 90/316 (28%), Positives = 135/316 (42%), Gaps = 59/316 (18%)

Query: 267 SPNGKFRRRIMSWQKGELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKQSIL 323
                F   +  ++K   +G G+FG V++     T      A+K+V L +   +G   I 
Sbjct: 2   QYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQ--IVALKKV-LMENEKEGF-PIT 57

Query: 324 QLEQEILLLSRFEHENIVQYF----GTDKDENR-------LFIFLELVTKGSLANLYQKY 372
            L +EI +L   +HEN+V             NR       +F F E    G L+N   K+
Sbjct: 58  AL-REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF 116

Query: 373 HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--N 430
            L  S++    + +LNGL Y+H   ++HRD+K ANIL+   G +KLADFGLA+A ++  N
Sbjct: 117 TL--SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174

Query: 431 DVKSCKG----TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY--------- 477
              +       T ++  PE++ L  R YG   D+W  GC + EM TR P           
Sbjct: 175 SKPNRYTNRVVTLWYRPPELL-LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233

Query: 478 ---SHLEG--------------MQALFRIGKGEPPLVPNSL-----SRDARDFILKCLQV 515
              S L G              +     + +G+   V   L        A D I K L +
Sbjct: 234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL 293

Query: 516 NPNDRPTAAQLMEHPF 531
           +P  R  A   + H F
Sbjct: 294 DPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  115 bits (289), Expect = 1e-28
 Identities = 73/287 (25%), Positives = 129/287 (44%), Gaps = 38/287 (13%)

Query: 279 WQKGELLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++K   +G GS+G V++    + G   A+K+    +     K+  L+   EI +L + +H
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKH 59

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-QVSAYTRQILNGLNYLHEQ 396
            N+V      + + +L +  E      L  L +    +    +     Q L  +N+ H+ 
Sbjct: 60  PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
           N +HRD+K  NIL+   G +KL DFG A+      +D      T ++ APE++ + +  Y
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL-VGDTQY 178

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN--------------- 499
           G   D+W++GC   E+LT QP +     +  L+ I K    L+P                
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238

Query: 500 ---------------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                          ++S  A  F+  CLQ++P +R +  +L+EHP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  115 bits (289), Expect = 1e-28
 Identities = 86/305 (28%), Positives = 127/305 (41%), Gaps = 88/305 (28%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ-----EILLLSRFE-H 337
           +G G+F  V +      G ++A+K +         K+    LEQ     EI  L R   H
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM---------KKHFKSLEQVNNLREIQALRRLSPH 57

Query: 338 ENIVQY--FGTDKDENRLFIFLELVTKGSLANLY-----QKYHLMDSQVSAYTRQILNGL 390
            NI++      D+   RL +  EL+      NLY     +K  L + +V +Y  Q+L  L
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT----PF------ 440
           +++H   + HRDIK  NIL+     +KLADFG           SC+G     P+      
Sbjct: 114 DHMHRNGIFHRDIKPENILIK-DDILKLADFG-----------SCRGIYSKPPYTEYIST 161

Query: 441 -WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP----------------------- 475
            W  APE + L +  YG   DIW++GC   E+L+  P                       
Sbjct: 162 RWYRAPECL-LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220

Query: 476 -------PYSHLEGMQALF--RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
                     H   M   F  + G G   L+PN  S +  D + K L  +P++R TA Q 
Sbjct: 221 EVLKKFRKSRH---MNYNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQA 276

Query: 527 MEHPF 531
           + HP+
Sbjct: 277 LRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 1e-28
 Identities = 85/311 (27%), Positives = 145/311 (46%), Gaps = 58/311 (18%)

Query: 264 YNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSI 322
           ++V P          +Q    +G G++G V        G   A+K++S  +  T  ++++
Sbjct: 1   FDVGPR---------YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL 51

Query: 323 LQLEQEILLLSRFEHENIVQYFGTDKDENR-----LFIFLELVTKGSLANLYQKYHLMDS 377
               +EI +L RF+HENI+      +  +      ++I  EL+ +  L  L +  HL + 
Sbjct: 52  ----REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSND 106

Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 437
            +  +  QIL GL Y+H  NV+HRD+K +N+L++ +  +K+ DFGLA+        +   
Sbjct: 107 HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 438 TPF----WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP--P---YSH-------- 479
           T +    W  APE++ L ++GY    DIWS+GC + EML+ +P  P   Y H        
Sbjct: 167 TEYVATRWYRAPEIM-LNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225

Query: 480 -----------------LEGMQAL-FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRP 521
                               +++L F+       L PN+    A D + K L  NP+ R 
Sbjct: 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNA-DPKALDLLDKMLTFNPHKRI 284

Query: 522 TAAQLMEHPFV 532
           T  + + HP++
Sbjct: 285 TVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  113 bits (285), Expect = 5e-28
 Identities = 79/292 (27%), Positives = 136/292 (46%), Gaps = 48/292 (16%)

Query: 285 LGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKQSI-LQLEQEILLLSRFEHENIVQ 342
           +G G++G VY+    D G   A+K+V L ++    K+   +   +EI +L +  H NIV 
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNE----KEGFPITAIREIKILRQLNHRNIVN 70

Query: 343 YFG--TD--------KDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLN 391
                TD        KD+   ++  E +    +  L     H  +  + ++ +Q+L GLN
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNL 449
           Y H++N +HRDIKC+NIL++  G +KLADFGLA+     + +  + K    W  P  + L
Sbjct: 131 YCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYS---HLEGMQALFRI-GKGEPPLVPNS----- 500
               YG   D+WS GC + E+ T++P +     L  ++ + R+ G   P + P+      
Sbjct: 191 GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPY 250

Query: 501 --------------------LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
                               +   A D +   L ++P+ R TA + +  P++
Sbjct: 251 FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 7e-28
 Identities = 83/296 (28%), Positives = 128/296 (43%), Gaps = 53/296 (17%)

Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           +++K + LG GS+ TVY+G +   G   A+KE+ L+ +      +I    +E  LL   +
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REASLLKDLK 61

Query: 337 HENIV---QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
           H NIV       T K    +F +L+   K  + +      +    V  +  Q+L GL Y 
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSM--HNVRLFLFQLLRGLAYC 119

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFWMAPEVV 447
           H++ V+HRD+K  N+L+   G +KLADFGLA+A      T  N+V +      W  P  V
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVT-----LWYRPPDV 174

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPY----------------------------SH 479
            L +  Y  + D+W +GC   EM T +P +                            S 
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234

Query: 480 LEGMQAL-FRIGKGEPPL-VPNSLSR--DARDFILKCLQVNPNDRPTAAQLMEHPF 531
               +   F      P +     L R     +  LK LQ  P  R +AA+ M+HP+
Sbjct: 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  113 bits (284), Expect = 9e-28
 Identities = 84/277 (30%), Positives = 147/277 (53%), Gaps = 37/277 (13%)

Query: 283 ELLGSGSFGTVY----EGYTDDGFFFAVK--------EVSLQDQGTQGKQSILQLEQEIL 330
           ++LG+G++G V+        D G  +A+K        + +   + T+ ++++L+  ++  
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 331 LLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNG 389
            L    +      F T+    +L + L+ V+ G +  +LYQ+ +  + +V  Y+ +I+  
Sbjct: 66  FLVTLHYA-----FQTEA---KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA 117

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTPFWMAPEV 446
           L +LH+  +V+RDIK  NIL+D+ G V L DFGL+K     + +   S  GT  +MAPE+
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-----MQALFRIGKGEPPLVPNSL 501
           +  K  G+G   D WSLG  + E+LT   P++ LEG      +   RI K +PP  P+ +
Sbjct: 178 IRGKG-GHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPF-PSFI 234

Query: 502 SRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK 533
             +A+D + K L+ +P  R       A+++ EHPF K
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  113 bits (284), Expect = 1e-27
 Identities = 80/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVS-LQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           E +GSG++G V     T  G   A+K++    D  T  K+++    +E+ +L  F+H+NI
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNI 66

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNYLHEQ 396
           +      +     F  + +V     ++L+   H    L +  +  +  Q+L GL Y+H  
Sbjct: 67  IAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK------GTPFWMAPEVVNLK 450
           NV+HRD+K +N+LV+    +++ DFG+A+  + +  +          T ++ APE++ L 
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL-LS 185

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQP--P---YSHLEGM----------QALFRIGK---- 491
              Y    D+WS+GC   EML R+   P   Y H   +          + L RIG     
Sbjct: 186 LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVR 245

Query: 492 ------GEPPLVPNS-----LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                      VP S      S +A D + + LQ +P +R T  Q ++HPF+ +
Sbjct: 246 KYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  113 bits (283), Expect = 1e-27
 Identities = 85/265 (32%), Positives = 129/265 (48%), Gaps = 22/265 (8%)

Query: 283 ELLGSGSFGTVYEGYT-DDGFFFAVK----EVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
            +LG GSFG V      + G  +AVK    +V LQD   +   +    E+ IL L+R  H
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NH 55

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQ 396
             + Q +   +  +RLF  +E V  G L    QK    D ++   Y  +I + L +LH++
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGY 454
            +++RD+K  N+L+D  G  KLADFG+ K    N   +    GTP ++APE+  L+   Y
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI--LQEMLY 173

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G + D W++G  + EML    P+   E    LF     +  + P  LS+DA D +   + 
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232

Query: 515 VNPNDRPTAAQL------MEHPFVK 533
            NP  R  +  L      + HPF K
Sbjct: 233 KNPTMRLGSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  111 bits (279), Expect = 2e-27
 Identities = 79/269 (29%), Positives = 131/269 (48%), Gaps = 31/269 (11%)

Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL--SRFEHENIV 341
           LG G FG V        G  +A K++  +    +  + +   E++IL    SRF    IV
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF----IV 56

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLM--------DSQVSAYTRQILNGLNYL 393
                 + ++ L + + L+  G L     KYH+         +++   Y  QI+ GL +L
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDL-----KYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           H++ +V+RD+K  N+L+D  G+V+++D GLA +      +K   GTP +MAPEV  L+  
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV--LQGE 169

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPY-SHLEGM--QALFRIGKGEPPLVPNSLSRDARDFI 509
            Y  + D ++LGCT+ EM+  + P+    E +  + L R         P+  S +A+D  
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229

Query: 510 LKCLQVNPNDR-----PTAAQLMEHPFVK 533
              LQ +P  R      +A ++ EHP  K
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 2e-27
 Identities = 77/265 (29%), Positives = 134/265 (50%), Gaps = 27/265 (10%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDG----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
           +K ++LGSG+FGTVY+G    +G       A+K +    +     ++  ++  E  +++ 
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL----REETSPKANKEILDEAYVMAS 65

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQ-VSAYTRQILNGLN 391
            +H ++V+  G      ++ +  +L+  G L + Y + H   + SQ +  +  QI  G++
Sbjct: 66  VDHPHVVRLLGICLSS-QVQLITQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKG--TPF-WMAP 444
           YL E+ +VHRD+   N+LV     VK+ DFGLAK   + DV       +G   P  WMA 
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK---LLDVDEKEYHAEGGKVPIKWMAL 180

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSR 503
           E  ++ +R Y   +D+WS G TV E++T    PY  +  ++    + KGE    P   + 
Sbjct: 181 E--SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI 238

Query: 504 DARDFILKCLQVNPNDRPTAAQLME 528
           D    ++KC  ++   RPT  +L+ 
Sbjct: 239 DVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  112 bits (281), Expect = 3e-27
 Identities = 80/306 (26%), Positives = 145/306 (47%), Gaps = 60/306 (19%)

Query: 279 WQKGELLGSGSFGTVYEGY---TDDGFFFAVKEVS-LQDQGTQGKQSILQLEQEILLLSR 334
           ++  + LG G++G V       T +    A+K+++ +  +    K+++    +E+ LL  
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRH 57

Query: 335 F-EHENIVQYFGTD----KDENRLFIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQ 385
           F  H+NI   +  D     + N L+++ EL+     A+L+Q       L D+   ++  Q
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELME----ADLHQIIRSGQPLTDAHFQSFIYQ 113

Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK------GTP 439
           IL GL Y+H  NV+HRD+K  N+LV+A   +K+ DFGLA+  + N  ++         T 
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPP-- 495
           ++ APE++ L  + Y    D+WS+GC + E+L R+P +   + +  L +I +  G P   
Sbjct: 174 WYRAPEIM-LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232

Query: 496 ---------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                                      + PN+ +  A D + K L  +P  R +  + +E
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNA-NPLALDLLEKLLAFDPTKRISVEEALE 291

Query: 529 HPFVKR 534
           HP++  
Sbjct: 292 HPYLAI 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  111 bits (279), Expect = 3e-27
 Identities = 76/265 (28%), Positives = 133/265 (50%), Gaps = 27/265 (10%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVK----EVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++LG GSFG V        G +FAVK    +V L D   +       +E+ +L L+ +E+
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVE----CTMVEKRVLALA-WEN 55

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS------QVSAYTRQILNGLN 391
             +   + T + +  LF  +E +  G L      +H+ D       + + Y  +I+ GL 
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQ 110

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNL 449
           +LH + +++RD+K  N+++D  G +K+ADFG+ K     D ++    GTP ++APE+  L
Sbjct: 111 FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI--L 168

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
           +   Y  + D WS G  + EML  Q P+ H +    LF   + + P  P  ++++++D +
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDDEDELFESIRVDTPHYPRWITKESKDIL 227

Query: 510 LKCLQVNPNDR-PTAAQLMEHPFVK 533
            K  + +P  R      +  HPF K
Sbjct: 228 EKLFERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 4e-27
 Identities = 71/253 (28%), Positives = 113/253 (44%), Gaps = 13/253 (5%)

Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           E +G G+FG VY+G        AVK           K+  LQ E EIL   +++H NIV+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL-KRKFLQ-EAEILK--QYDHPNIVK 56

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVH 400
             G    +  ++I +ELV  GSL    +K    L   ++   +     G+ YL  +N +H
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT---PF-WMAPEVVNLKNRGYGL 456
           RD+   N LV  +  +K++DFG+++           G    P  W APE +N     Y  
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR--YTS 174

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E  +    PY  +   Q   RI  G     P     +    +L+C   
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY 234

Query: 516 NPNDRPTAAQLME 528
           +P +RP+ +++  
Sbjct: 235 DPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  109 bits (273), Expect = 6e-27
 Identities = 80/250 (32%), Positives = 126/250 (50%), Gaps = 26/250 (10%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +     GT   ++ LQ  Q   ++ +  HE +VQ +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQ---VMKKLRHEKLVQLY 67

Query: 345 GTDKDENRLFIFLELVTKGSLANL----YQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               +E  ++I  E ++KGSL +       KY L   Q+     QI +G+ Y+   N VH
Sbjct: 68  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 125

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + 
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIK 183

Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQC 239

Query: 513 LQVNPNDRPT 522
            +  P +RPT
Sbjct: 240 WRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  110 bits (276), Expect = 7e-27
 Identities = 92/303 (30%), Positives = 144/303 (47%), Gaps = 66/303 (21%)

Query: 279 WQKGELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           ++K E +G G++G VY+     T++    A+K++ L +Q  +G  S     +EI LL   
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRL-EQEDEGVPSTAI--REISLLKEM 58

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQI 386
           +H NIV+       E RL++  E +      +L  K H MDS          +  Y  QI
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEYL------DLDLKKH-MDSSPDFAKNPRLIKTYLYQI 111

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKA------TTMNDVKSCKGTP 439
           L G+ Y H   V+HRD+K  N+L+D    ++KLADFGLA+A      T  ++V     T 
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TL 167

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP--- 494
           ++ APE++ L +R Y    DIWS+GC   EM+ ++P +     +  LF+I +  G P   
Sbjct: 168 WYRAPEIL-LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226

Query: 495 ------------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP 530
                                    +VP  L     D + K L+++P+ R TA   +EH 
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHE 285

Query: 531 FVK 533
           + K
Sbjct: 286 YFK 288

Length = 294

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 7e-27
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 19/272 (6%)

Query: 285 LGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G GSFG V +    D    +A+K  +++      +  +     E  +L++     IV  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALK--TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQNVVHRD 402
             + +   +L++ L  +  G L +  Q+    D S+   YT ++L  L  LH+ NV++RD
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGYGLTAD 459
           +K  NIL+D  G + L DFGL K    +D K+   C GTP ++APE+  L   GY    D
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPEL--LLGHGYTKAVD 175

Query: 460 IWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPND 519
            W+LG  + EMLT  PP+ + E +  ++R    EP   P+   RDA+D ++  L  +P  
Sbjct: 176 WWTLGVLLYEMLTGLPPF-YDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234

Query: 520 R---PTAAQLMEHPFV-----KRPLQKSRGPP 543
           R     A ++  HPF      K+ L K   PP
Sbjct: 235 RLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPP 266

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  109 bits (273), Expect = 8e-27
 Identities = 68/245 (27%), Positives = 123/245 (50%), Gaps = 15/245 (6%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           LG+G FG V+ GY ++    AVK +     GT   Q+ L+   E  L+   +H+ +V+ +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQAFLE---EANLMKTLQHDKLVRLY 67

Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
                E  ++I  E + KGSL +  +      ++  ++  ++ QI  G+ Y+  +N +HR
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ AN+LV  S   K+ADFGLA+    N+  + +G  F   W APE +N  +  + + +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 185

Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           D+WS G  + E++T  + PY  +     +  + +G       +   +  D +  C +   
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKA 245

Query: 518 NDRPT 522
            +RPT
Sbjct: 246 EERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  108 bits (270), Expect = 2e-26
 Identities = 66/247 (26%), Positives = 123/247 (49%), Gaps = 16/247 (6%)

Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           + LG+G FG V+ GY +     A+K +    QG+   ++ L    E  L+ + +H  +V+
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLA---EANLMKQLQHPRLVR 65

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++  +N +
Sbjct: 66  LYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 182

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G     P++   +  + +  C + 
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKE 242

Query: 516 NPNDRPT 522
            P +RPT
Sbjct: 243 KPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  109 bits (275), Expect = 2e-26
 Identities = 85/308 (27%), Positives = 142/308 (46%), Gaps = 56/308 (18%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQD---QGTQGKQSILQ------LEQEI 329
           QKG  LG G++G V + Y T  G   A+K+V + +     T+ +Q +          +E+
Sbjct: 12  QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 330 LLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILN 388
            +++  +HENI+       + + + + ++++    L  +   K  L +SQV     QILN
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILN 130

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT-------TMNDVKSCKGTPFW 441
           GLN LH+   +HRD+  ANI +++ G  K+ADFGLA+         T++  ++ +     
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE- 189

Query: 442 MAPEVVNLKNRG---------YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK- 491
           M  +VV L  R          Y    D+WS+GC   E+LT +P +     +  L RI + 
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249

Query: 492 -GEP------------------PLVPNSL-------SRDARDFILKCLQVNPNDRPTAAQ 525
            G P                  P  P  L       S DA D +   L++NP +R +A +
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309

Query: 526 LMEHPFVK 533
            ++H + K
Sbjct: 310 ALKHEYFK 317

Length = 335

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  109 bits (273), Expect = 3e-26
 Identities = 75/259 (28%), Positives = 116/259 (44%), Gaps = 14/259 (5%)

Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL-SRFEHENIVQ 342
           LG G FG V    Y   G  +A+K +   D   + +   L  E+ I    +   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
            F   + E+ +   +E    G L          + +   Y   ++ GL YLHE  +V+RD
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126

Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGYGLTAD 459
           +K  N+L+D  G VK+ADFGL K       ++   C GTP ++APEV  L    Y    D
Sbjct: 127 LKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEV--LTETSYTRAVD 183

Query: 460 IWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPND 519
            W LG  + EML  + P+   +  + +F     +    P  LSR+A   + + L+ NP  
Sbjct: 184 WWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242

Query: 520 R----PTAAQ-LMEHPFVK 533
           R       A+ + + PF +
Sbjct: 243 RLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  107 bits (269), Expect = 4e-26
 Identities = 85/275 (30%), Positives = 128/275 (46%), Gaps = 39/275 (14%)

Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           LG G FG V    Y+   D+ G   AVK +  +  G      I  L++EI +L    HEN
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 67

Query: 340 IVQYFG--TDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G  T+   N + + +E +  GSL       K  +   Q   Y  QI  G++YL  
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLK 450
           +  VHRD+   N+LV++   VK+ DFGL KA   +     VK    +P FW APE + ++
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL-IQ 186

Query: 451 NRGYGLTADIWSLGCTVLEMLT----RQPPYSHL-------EGMQALFRI------GKGE 493
           ++ Y + +D+WS G T+ E+LT       P +          G   + R+      GK  
Sbjct: 187 SKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           P   P +   +    + KC +  P+ R T   L+E
Sbjct: 246 P--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  107 bits (268), Expect = 4e-26
 Identities = 76/264 (28%), Positives = 114/264 (43%), Gaps = 31/264 (11%)

Query: 284 LLGSGSFGTVYEGYTDDGFF-------FAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
            LGSG+FG VYEG   D           AVK  +L+   T  ++   +  +E  L+S F 
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKK--EFLKEAHLMSNFN 57

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSL--------ANLYQKYHLMDSQVSAYTRQILN 388
           H NIV+  G        +I +EL+  G L           +    L   ++      +  
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 389 GLNYLHEQNVVHRDIKCANILV-----DASGSVKLADFGLAKATTMNDVKSCKGTPF--- 440
           G  YL + + +HRD+   N LV     DA   VK+ DFGLA+    +D    +G      
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 441 -WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVP 498
            WMAPE  +L +  +   +D+WS G  + E+LT  Q PY  L   + L  +  G     P
Sbjct: 178 RWMAPE--SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235

Query: 499 NSLSRDARDFILKCLQVNPNDRPT 522
            +        +  C   +P++RPT
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  108 bits (271), Expect = 4e-26
 Identities = 84/291 (28%), Positives = 140/291 (48%), Gaps = 48/291 (16%)

Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSIL-QLEQEILLLSRFEHENIVQ 342
           LG+G+ G V +  +   G   A K + L+      K +I  Q+ +E+ +L       IV 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEI-----KPAIRNQIIRELKVLHECNSPYIVG 63

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ-NVVH 400
           ++G    +  + I +E +  GSL  + +K   + ++ +   +  +L GL YL E+  ++H
Sbjct: 64  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + +DI
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYTVQSDI 181

Query: 461 WSLGCTVLEMLTRQ-----PPYSHLEGM---------------------------QALFR 488
           WSLG +++EM   +     P    LE M                            A+F 
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFE 241

Query: 489 ----IGKGEPPLVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
               I    PP +P+   S + +DF+ KCL+ NP +R    +L +HPF+KR
Sbjct: 242 LLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 5e-26
 Identities = 86/270 (31%), Positives = 136/270 (50%), Gaps = 34/270 (12%)

Query: 285 LGSGSFGTVYEGYTDD-GFFFAVKEVSLQD-------QGTQGKQSILQ----LEQEILLL 332
           +G G+FG VY+    D    +A+K +S ++         T G+++IL      E   ++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLN 391
            +F        F TD D   L++  + ++ G L  +L ++    + +   Y  +++  L 
Sbjct: 61  LKFS-------FQTDSD---LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE 110

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT-TMNDVKS--CKGTPFWMAPEVVN 448
           +LH+ ++V+RD+K  NIL+DA+G + L DFGL+KA  T N   +  C GT  ++APEV+ 
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVL- 168

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARD 507
           L  +GY    D WSLG  V EM     P+ + E  Q ++R I  G+     N LS + R 
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPF-YAEDTQQMYRNIAFGKVRFPKNVLSDEGRQ 227

Query: 508 FILKCLQVNPNDR----PTAAQLMEHPFVK 533
           F+   L  NP  R      A +L EHPF  
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 5e-26
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 50/277 (18%)

Query: 285 LGSGSFGTVYEGY-----TDDGFF-FAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           LG GSFG VYEG        +     A+K V+      +     ++   E  ++  F   
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE----RIEFLNEASVMKEFNCH 69

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANL------------------YQKYHLMDSQVS 380
           ++V+  G         + +EL+ KG L +                    QK+  M ++++
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 381 AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGT 438
                  +G+ YL  +  VHRD+   N +V    +VK+ DFG+ +     D   K  KG 
Sbjct: 130 -------DGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 439 -PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG--- 492
            P  WMAPE  +LK+  +   +D+WS G  + EM T  + PY  L   + L  +  G   
Sbjct: 183 LPVRWMAPE--SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240

Query: 493 -EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
             P   P+ L     + +  C Q NP  RPT  +++ 
Sbjct: 241 DLPENCPDKL----LELMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 5e-26
 Identities = 63/253 (24%), Positives = 107/253 (42%), Gaps = 14/253 (5%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + LGSG FG V+ G        A+K +       +G  S     +E  ++ +  H N+V
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIR------EGAMSEDDFIEEAKVMMKLSHPNLV 62

Query: 342 QYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQ-VSAYTRQILNGLNYLHEQNVV 399
           Q +G    +  +FI  E +  G L N L ++   + ++ +      +   + YL     +
Sbjct: 63  QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD+   N LV     VK++DFGLA+    +   S +GT F   W  PEV +     +  
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FSS 180

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E+ +  + PY      + +  +  G     P     +    +  C   
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240

Query: 516 NPNDRPTAAQLME 528
            P DRP   +L+ 
Sbjct: 241 KPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  107 bits (268), Expect = 7e-26
 Identities = 86/285 (30%), Positives = 128/285 (44%), Gaps = 42/285 (14%)

Query: 285 LGSGSFGTVYEG--YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           +G G++G V++     + G F A+K V +Q        S ++    +  L  FEH N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 343 YFG------TDKDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYL 393
            F       TD+ E +L +  E V +  L     K     +    +     Q+L GL++L
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-APEVVNLKNR 452
           H   VVHRD+K  NILV +SG +KLADFGLA+  +     +      W  APEV  L   
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV--LLQS 184

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFR-IGKGEPPLVPN--SLSRDA- 505
            Y    D+WS+GC   EM  R+P +   S ++ +  +   IG       P   +L R A 
Sbjct: 185 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244

Query: 506 -------------------RDFILKCLQVNPNDRPTAAQLMEHPF 531
                              +D +LKCL  NP  R +A   + HP+
Sbjct: 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  106 bits (265), Expect = 1e-25
 Identities = 86/285 (30%), Positives = 139/285 (48%), Gaps = 50/285 (17%)

Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH----- 337
           ++LG+G++G V          F V++VS  D G      +L+    +      EH     
Sbjct: 6   KVLGTGAYGKV----------FLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER 55

Query: 338 ---ENIVQY---------FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTR 384
              E+I Q          F TD    +L + L+ +  G L  +L Q+    + +V  Y+ 
Sbjct: 56  QVLEHIRQSPFLVTLHYAFQTD---TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG 112

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTPFW 441
           +I+  L +LH+  +++RDIK  NIL+D++G V L DFGL+K    ++V+   S  GT  +
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY-------SHLEGMQALFRIGKGEP 494
           MAP++V   + G+    D WS+G  + E+LT   P+       S  E  +   RI K EP
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RILKSEP 229

Query: 495 PLVPNSLSRDARDFILKCLQVNPNDR----PTAAQ-LMEHPFVKR 534
           P  P  +S  A+D I + L  +P  R    P+ A  + +HPF ++
Sbjct: 230 PY-PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  106 bits (265), Expect = 4e-25
 Identities = 81/293 (27%), Positives = 142/293 (48%), Gaps = 49/293 (16%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ---EILLLSR 334
           +Q    +GSG++G+V   + T  G   AVK++S      +  QSI+  ++   E+ LL  
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKH 72

Query: 335 FEHENIVQYFG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILN 388
            +HEN++          + ++ N +++   L+    L N+ +   L D  V     QIL 
Sbjct: 73  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILR 131

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVN 448
           GL Y+H  +++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ 
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM- 189

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRD 504
           L    Y  T DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249

Query: 505 ARDFIL--------------------------KCLQVNPNDRPTAAQLMEHPF 531
           AR++I                           K L ++ + R TAAQ + H +
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  104 bits (261), Expect = 6e-25
 Identities = 84/293 (28%), Positives = 139/293 (47%), Gaps = 44/293 (15%)

Query: 275 RIMSWQKGELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILL 331
           ++ ++ K + LG G++ TVY+G    TD+    A+KE+ L+ +      +I    +E+ L
Sbjct: 4   KLETYIKLDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAI----REVSL 57

Query: 332 LSRFEHENIV---QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILN 388
           L   +H NIV       T+K    +F +L+   K  L +     ++ +  V  +  Q+L 
Sbjct: 58  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLR 115

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVV 447
           GLNY H + V+HRD+K  N+L++  G +KLADFGLA+A ++     S +    W  P  +
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQP--PYSHL-EGMQALFRI-----GKGEPPLVPN 499
            L +  Y    D+W +GC   EM T +P  P S + E +  +FRI      +  P ++ N
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235

Query: 500 S---------------------LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                                 L  D  + + K LQ     R +A + M+HP+
Sbjct: 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  103 bits (258), Expect = 7e-25
 Identities = 70/245 (28%), Positives = 123/245 (50%), Gaps = 16/245 (6%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +     GT   ++ LQ  Q   ++ +  H+ +V  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQ---IMKKLRHDKLVPLY 67

Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E + KGSL +  ++    +L   Q+     QI +G+ Y+   N +HR
Sbjct: 68  AVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 184

Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           D+WS G  + E++T+ + PY  +   + L ++ +G     P        + +  C + +P
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDP 244

Query: 518 NDRPT 522
           ++RPT
Sbjct: 245 DERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 7e-25
 Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 34/265 (12%)

Query: 283 ELLGSGSFGTVYEG------YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
             LG G+FG V+ G        +D    AVK +    + T    +    E+E  LL+ F+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQ 66

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ---------------KYHLMDSQVSA 381
           HENIV+++G   + +   +  E +  G L    +                  L  SQ+  
Sbjct: 67  HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF- 440
              QI +G+ YL  Q+ VHRD+   N LV     VK+ DFG+++     D     G    
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 441 ---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLEGMQALFRIGKGEPP 495
              WM PE +    R +   +D+WS G  + E+ T  +QP Y      + +  I +G   
Sbjct: 187 PIRWMPPESI--MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECITQGRLL 243

Query: 496 LVPNSLSRDARDFILKCLQVNPNDR 520
             P +   +  D +L C + +P  R
Sbjct: 244 QRPRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (258), Expect = 7e-25
 Identities = 68/250 (27%), Positives = 112/250 (44%), Gaps = 14/250 (5%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           LGSG FG V+ G        A+K ++      +G  S     +E  ++ +  H  +VQ +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN------EGAMSEEDFIEEAKVMMKLSHPKLVQLY 65

Query: 345 GTDKDENRLFIFLELVTKGSLAN-LYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  L+I  E +  G L N L Q+   L    + +  + +  G+ YL   + +HRD
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125

Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV ++G VK++DFG+ +    ++  S  G  F   W  PEV N     Y   +D
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YSSKSD 183

Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +WS G  + E+ T  + P+      + +  I +G     P   S    + +  C    P 
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPE 243

Query: 519 DRPTAAQLME 528
            RPT A+L+ 
Sbjct: 244 GRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (258), Expect = 7e-25
 Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 16/252 (6%)

Query: 278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           S Q  + LG+G FG V+ G  +     AVK +     GT   +S L+  Q   ++ +  H
Sbjct: 7   SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQ---IMKKLRH 60

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLH 394
           + +VQ +    +E  ++I  E ++KGSL +  +      L    +     Q+  G+ Y+ 
Sbjct: 61  DKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKN 451
             N +HRD++ ANILV      K+ADFGLA+    N+  + +G  F   W APE   L  
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYG 178

Query: 452 RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
           R + + +D+WS G  + E++T+ + PY  +   + L ++ +G     P        + +L
Sbjct: 179 R-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237

Query: 511 KCLQVNPNDRPT 522
           +C + +P +RPT
Sbjct: 238 QCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (257), Expect = 9e-25
 Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 12/250 (4%)

Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           ELLG G+FG V++G   D    AVK    +D   + K   L    E  +L +++H NIV+
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLS---EARILKQYDHPNIVK 56

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVH 400
             G       ++I +ELV  G   +  +K    L   Q+  +      G+ YL  +N +H
Sbjct: 57  LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSC--KGTPF-WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  +K++DFG+++        S   K  P  W APE +N     Y   
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR--YSSE 174

Query: 458 ADIWSLGCTVLEMLTRQP-PYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+WS G  + E  +    PY  +   QA  ++ KG     P     D    + +C    
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234

Query: 517 PNDRPTAAQL 526
           P +RP  ++L
Sbjct: 235 PENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  104 bits (261), Expect = 9e-25
 Identities = 81/273 (29%), Positives = 132/273 (48%), Gaps = 42/273 (15%)

Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQ-------------LEQEI 329
           ++LG GSFG V          F V++++  D G      +L+             +E++I
Sbjct: 2   KVLGQGSFGKV----------FLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI 51

Query: 330 LLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILN 388
           L  +   H  IV+     + E +L++ L+ +  G L   L ++    +  V  Y  ++  
Sbjct: 52  L--AEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 109

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEV 446
            L++LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K  S  GT  +MAPEV
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSR 503
           VN   RG+  +AD WS G  + EMLT   P+      E M  + +   G    +P  LS 
Sbjct: 170 VN--RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG----MPQFLSP 223

Query: 504 DARDFILKCLQVNPNDRPTAA-----QLMEHPF 531
           +A+  +    + NP +R  A      ++  HPF
Sbjct: 224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  103 bits (260), Expect = 1e-24
 Identities = 86/300 (28%), Positives = 135/300 (45%), Gaps = 42/300 (14%)

Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL 332
           R +  ++K   +G G++G VY    T  G   A+K+V + D    G   I  L +EI LL
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-DNERDG-IPISSL-REITLL 60

Query: 333 SRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILN 388
               H NIV+       K  + +F+ +E   +  LA+L         +SQV     Q+L 
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLR 119

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGTPFWMAPEV 446
           GL YLHE  ++HRD+K +N+L+   G +K+ADFGLA+   +    +     T ++ APE+
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQP--------------------PYSHL-EGMQA 485
           + L    Y    D+W++GC + E+L  +P                    P   +  G   
Sbjct: 180 L-LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238

Query: 486 LFRIGKGEPPLVPNS--------LSRDARDFILKCLQVNPNDRPTAAQLMEHP-FVKRPL 536
           L  +GK   P  P +        LS      +   L  +P  R TA + +E   F ++PL
Sbjct: 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  104 bits (261), Expect = 2e-24
 Identities = 80/314 (25%), Positives = 129/314 (41%), Gaps = 95/314 (30%)

Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ-------------EI 329
             +GSG++G V                S  D  T  K +I +L +             E+
Sbjct: 21  SPVGSGAYGQV---------------CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL 65

Query: 330 LLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG-SLANLYQKY---HLMDSQVSAYTR- 384
            LL   +HEN++               L++ T   SL +    Y   HLM + ++   + 
Sbjct: 66  RLLKHMDHENVIG-------------LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC 112

Query: 385 -------------QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 431
                        QIL GL Y+H   ++HRD+K +NI V+    +K+ DFGLA+     D
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTD 169

Query: 432 VKSCK--GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI 489
            +      T ++ APE++ L    Y  T DIWS+GC + E+LT +  +   + +  L RI
Sbjct: 170 DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228

Query: 490 ----GKGEPPLVPNSLSRDARDFIL--------------------------KCLQVNPND 519
               G  +  L+    S  AR++I                           K L ++P+ 
Sbjct: 229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288

Query: 520 RPTAAQLMEHPFVK 533
           R TAA+ + HP++ 
Sbjct: 289 RITAAEALAHPYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (257), Expect = 2e-24
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 58/299 (19%)

Query: 282 GELLGSGSFGTVY-------EGYTDDGFF----------FAVKEVSLQDQGTQGKQSILQ 324
            E LG G FG V+       + +++  F            AVK   L+   +    +   
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVK--VLRPDAS--DNARED 65

Query: 325 LEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR 384
             +E+ +LSR    NI +  G    +  L + +E +  G L    QK+    S ++  ++
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 385 ------------QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 432
                       QI +G+ YL   N VHRD+   N LV  + ++K+ADFG+++    +D 
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 433 KSCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHL------ 480
              +G       WMA E V L  + +   +D+W+ G T+ E+LT  R+ PY HL      
Sbjct: 186 YRVQGRAPLPIRWMAWESV-LLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243

Query: 481 EGMQALFRIGKGE-----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           E     FR    +     PP  P    +D  + +L+C + +  DRPT  ++  H F++R
Sbjct: 244 ENAGHFFRDDGRQIYLPRPPNCP----KDIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  102 bits (254), Expect = 3e-24
 Identities = 65/245 (26%), Positives = 121/245 (49%), Gaps = 16/245 (6%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           LG+G FG V+    +     AVK +        G  S+     E  ++   +H+ +V+  
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 67

Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA---YTRQILNGLNYLHEQNVVHR 401
                E  ++I  E + KGSL +  +        +     ++ QI  G+ ++ ++N +HR
Sbjct: 68  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV AS   K+ADFGLA+    N+  + +G  F   W APE +N  +  + + +
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 184

Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           D+WS G  ++E++T  + PY  +   + +  + +G     P +   +  + +++C +  P
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244

Query: 518 NDRPT 522
            +RPT
Sbjct: 245 EERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  102 bits (257), Expect = 3e-24
 Identities = 63/249 (25%), Positives = 115/249 (46%), Gaps = 55/249 (22%)

Query: 328 EILLLSRFEHENIVQY----FGTDKDENRLFIFLELVT---KGSLANLYQKYHLMDSQVS 380
           EI +L + +H NIV       G++ D  ++++ +E V    K  +  +  K   + S+V 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETM--KQPFLQSEVK 109

Query: 381 AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA-------KATTMNDVK 433
               Q+L+G+ +LH+  ++HRD+K +N+L++  G +K+ DFGLA       K  T   V 
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168

Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFR-- 488
               T ++ APE++ L  + Y    D+WS+GC   E+LT++P +   S ++ +  +F+  
Sbjct: 169 ----TLWYRAPELL-LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223

Query: 489 ----------------IGKGEPPLVPNSLSRD----------ARDFILKCLQVNPNDRPT 522
                             K      P +  R             D + + L  +P  R +
Sbjct: 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283

Query: 523 AAQLMEHPF 531
           A   ++HP+
Sbjct: 284 AEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  102 bits (255), Expect = 4e-24
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 39/275 (14%)

Query: 283 ELLGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + LG G+FG+V    Y+   D+ G   AVK+  LQ       + +   E+EI +L   +H
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKK--LQHST---AEHLRDFEREIEILKSLQH 64

Query: 338 ENIVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY-HLMD-SQVSAYTRQILNGLNYL 393
           +NIV+Y G      R  L + +E +  GSL +  QK+   +D  ++  Y  QI  G+ YL
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVN 448
             +  VHRD+   NILV++   VK+ DFGL K    +     V+    +P FW APE  +
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE--S 182

Query: 449 LKNRGYGLTADIWSLGCTVLEMLT-----RQPPYSHLEGM-------QALFRI-----GK 491
           L    + + +D+WS G  + E+ T       PP   +  M         ++ +       
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242

Query: 492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
           G  P  P     +    + +C   +P+ RP+ ++L
Sbjct: 243 GRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  102 bits (256), Expect = 6e-24
 Identities = 80/286 (27%), Positives = 129/286 (45%), Gaps = 10/286 (3%)

Query: 252 KDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSL 311
           K+L +   K+      P  K + +   +     LG+GSFG V      +  F  V     
Sbjct: 5   KNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF 64

Query: 312 QDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK 371
           +      ++ +  +  E  +L+   H   V  +G+ KDE+ L++ LE V  G      ++
Sbjct: 65  EKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR 124

Query: 372 YHLMDSQVSA-YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 430
                + V   Y  QI+    YL   N+V+RD+K  N+L+D  G +K+ DFG AK     
Sbjct: 125 NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184

Query: 431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG 490
               C GTP ++APE+  L N G+G  AD W+LG  + E+L   PP+   E +    +I 
Sbjct: 185 TYTLC-GTPEYIAPEI--LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL 241

Query: 491 KGEPPLVPNSLSRDARDFILKCLQVN-----PNDRPTAAQLMEHPF 531
           +G     P  L  + +  + K L  +      N +  A  + EHP+
Sbjct: 242 EG-IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  102 bits (256), Expect = 6e-24
 Identities = 82/269 (30%), Positives = 121/269 (44%), Gaps = 32/269 (11%)

Query: 284 LLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           L+G G FG V    E  T D   +A+K +       Q   S  + E++IL +S       
Sbjct: 8   LVGRGHFGEVQVVREKATGD--IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNV 398
           +QY   DKD   L++ +E    G L +L  +Y     +     Y  +++  ++ +H+   
Sbjct: 66  LQYAFQDKDN--LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRG-- 453
           VHRDIK  N+L+D +G +KLADFG A   T N +   K   GTP ++APEV+   N    
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 454 --YGLTADIWSLGCTVLEMLTRQPP---------YSHLEGMQALFRIGKGEPPLVPNSLS 502
             YG+  D WSLG    EM+  + P         Y+++   Q   +      P  P  +S
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF-----PEDPK-VS 237

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPF 531
            D  D I   L     +R     L  HPF
Sbjct: 238 SDFLDLIQSLL-CGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  100 bits (251), Expect = 9e-24
 Identities = 87/280 (31%), Positives = 137/280 (48%), Gaps = 28/280 (10%)

Query: 280 QKGELLGSGSFGTVYEGY---TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           +K +LLGSG FGTV++G      D     V   ++QD+   G+Q+  ++   +L +   +
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD 67

Query: 337 HENIVQYFGTDKDENRLFIFLELVTK----GSLAN-LYQKYHLMDSQ-VSAYTRQILNGL 390
           H  IV+  G     +     L+LVT+    GSL + + Q    +D Q +  +  QI  G+
Sbjct: 68  HAYIVRLLGICPGAS-----LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTPF-WMAPEV 446
            YL E  +VHR++   NIL+ +   V++ADFG+A     +D K   S   TP  WMA E 
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
           +      Y   +D+WS G TV EM++    PY+ +   +    + KGE    P   + D 
Sbjct: 183 ILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
              ++KC  ++ N RPT  +L    F +     +R PP Y
Sbjct: 241 YMVMVKCWMIDENVRPTFKELANE-FTR----MARDPPRY 275

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =   99 bits (249), Expect = 1e-23
 Identities = 64/249 (25%), Positives = 115/249 (46%), Gaps = 14/249 (5%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           LG+G FG V  G     +  A+K +       +G  S  +  +E  ++ +  HE +VQ +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMKLSHEKLVQLY 65

Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  ++I  E ++ G L N  +++      SQ+    + +  G+ YL  +  +HRD
Sbjct: 66  GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125

Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LVD  G VK++DFGL++    ++  S  G+ F   W  PEV  L    +   +D
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LLYSKFSSKSD 183

Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +W+ G  + E+ +  + PY      + + ++ +G     P+  S      +  C      
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAE 243

Query: 519 DRPTAAQLM 527
           +RPT  QL+
Sbjct: 244 ERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  100 bits (250), Expect = 1e-23
 Identities = 91/293 (31%), Positives = 134/293 (45%), Gaps = 59/293 (20%)

Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR---FEHENI 340
           +G G++GTVY+      G F A+K V +Q     G    L   +E+ LL R   F+H NI
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQT-NEDGLP--LSTVREVALLKRLEAFDHPNI 64

Query: 341 VQYFG------TDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNY 392
           V+         TD+ E ++ +  E V +     L +     L    +    RQ L GL++
Sbjct: 65  VRLMDVCATSRTDR-ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-------TPFWMAPE 445
           LH   +VHRD+K  NILV + G VKLADFGLA+      + SC+        T ++ APE
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177

Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPL----VP 498
           V  L    Y    D+WS+GC   EM  R+P +   S  + +  +F +  G PP       
Sbjct: 178 V--LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRD 234

Query: 499 NSLSRDA--------------------RDFILKCLQVNPNDRPTAAQLMEHPF 531
            +L R A                       +L+ L  NP+ R +A + ++HPF
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  103 bits (258), Expect = 2e-23
 Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 23/268 (8%)

Query: 284 LLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-----H 337
           +LGSG+ GTV       DG  FAVK V ++      K    Q E   LL   F      H
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA-QAEVCCLLNCDFFSIVKCH 97

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR--------QILNG 389
           E+          EN L I L L    +  +L Q+          +          Q+L  
Sbjct: 98  EDFA-KKDPRNPENVLMIALVL-DYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDV-KSCKGTPFWMAPE 445
           ++++H ++++HRDIK ANIL+ ++G VKL DFG +K   AT  +DV ++  GTP+++APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
           +   + + Y   AD++SLG  + E+LT + P+      + + +   G    +P S+S + 
Sbjct: 216 I--WRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEM 273

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           ++ +   L  +P  RP++++L+  P  K
Sbjct: 274 QEIVTALLSSDPKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 99.6 bits (248), Expect = 2e-23
 Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 20/253 (7%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           GE++G G FG V +G YT  G   AVK +          Q+ L+   E  ++++  H+N+
Sbjct: 11  GEIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTA----QAFLE---ETAVMTKLHHKNL 61

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNGLNYLHEQN 397
           V+  G     N L+I +EL++KG+L N  +   +  +   Q+  ++  +  G+ YL  + 
Sbjct: 62  VRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           +VHRD+   NILV   G  K++DFGLA+  +M  V + K    W APE   LK++ +   
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEA--LKHKKFSSK 177

Query: 458 ADIWSLGCTVLEMLT--RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
           +D+WS G  + E+ +  R  PY  +   +    + KG     P     D    +  C + 
Sbjct: 178 SDVWSYGVLLWEVFSYGRA-PYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWET 236

Query: 516 NPNDRPTAAQLME 528
            P  RP+  +L E
Sbjct: 237 EPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  101 bits (252), Expect = 2e-23
 Identities = 80/266 (30%), Positives = 129/266 (48%), Gaps = 30/266 (11%)

Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K  +     E  +L    H  
Sbjct: 1   KLLGKGTFGKVILVREKAT--GKYYAMK--ILKKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA------YTRQILNGLNYL 393
           +     + +  +RL   +E    G L      +HL   +V +      Y  +I++ L YL
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALGYL 111

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLKN 451
           H  +VV+RD+K  N+++D  G +K+ DFGL K   +    +K+  GTP ++APEV  L++
Sbjct: 112 HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LED 169

Query: 452 RGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
             YG   D W LG  + EM+  R P Y+  +  + LF +   E    P +LS +A+  + 
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKLFELILMEEIRFPRTLSPEAKSLLA 227

Query: 511 KCLQVNPNDR-----PTAAQLMEHPF 531
             L+ +P  R       A ++MEH F
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  100 bits (251), Expect = 2e-23
 Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 23/277 (8%)

Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K  +     E  +L    H  
Sbjct: 1   KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 56

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH ++V
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRGYGL 456
           V+RDIK  N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV  L++  YG 
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGR 174

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ +
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 233

Query: 517 PNDR----PTAAQ-LMEHPFV-----KRPLQKSRGPP 543
           P  R    P+ A+ +MEH F      +  +QK   PP
Sbjct: 234 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 84/286 (29%), Positives = 127/286 (44%), Gaps = 43/286 (15%)

Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           E LG GS+ TVY+G +  +G   A+K +S++ +      +I    +E  LL   +H NIV
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI----REASLLKGLKHANIV 66

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNV 398
                   +  L    E +    LA  Y   H   L    V  +  Q+L GL Y+H Q++
Sbjct: 67  LLHDIIHTKETLTFVFEYM-HTDLAQ-YMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           +HRD+K  N+L+   G +KLADFGLA+A ++ +   S +    W  P  V L    Y   
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184

Query: 458 ADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRI----------GKGEPP-------- 495
            DIW  GC  +EML  QP +       E ++ ++ +          G  + P        
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244

Query: 496 --------LVPNSLSR--DARDFILKCLQVNPNDRPTAAQLMEHPF 531
                   +V   LSR   A D   + L + P DR +A   + HP+
Sbjct: 245 PCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 99.8 bits (248), Expect = 4e-23
 Identities = 76/258 (29%), Positives = 128/258 (49%), Gaps = 14/258 (5%)

Query: 283 ELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +LLG G+FG V        G ++A+K   L+ +    K  +     E  +L    H  + 
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMK--ILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 342 QYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               + + ++RL   +E V  G L  +L ++    + +   Y  +I++ L+YLH   +V+
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVY 118

Query: 401 RDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           RD+K  N+++D  G +K+ DFGL K   T    +K+  GTP ++APEV  L++  YG   
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV--LEDNDYGRAV 176

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           D W LG  + EM+  + P+ + +  + LF +   E    P +LS DA+  +   L  +PN
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN 235

Query: 519 DR-----PTAAQLMEHPF 531
            R       A ++M H F
Sbjct: 236 KRLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 97.7 bits (243), Expect = 7e-23
 Identities = 63/249 (25%), Positives = 112/249 (44%), Gaps = 14/249 (5%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
           +GSG FG V+ GY  +    A+K +       +G  S     +E  ++ +  H  +VQ +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G   + + + +  E +  G L++    Q+       +      +  G+ YL   NV+HRD
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125

Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV  +  VK++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK--YSSKSD 183

Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +WS G  + E+ +  + PY +    + +  I  G     P   S+   + +  C +  P 
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPE 243

Query: 519 DRPTAAQLM 527
           DRP+ + L+
Sbjct: 244 DRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 98.7 bits (246), Expect = 9e-23
 Identities = 78/256 (30%), Positives = 126/256 (49%), Gaps = 14/256 (5%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G GSFG V    +  DG F+AVK +  +    + +Q  +  E+ +LL    +H  +V  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL-KNVKHPFLVGL 61

Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
             + +  ++L+  L+ V  G L  +L ++    + +   Y  +I + L YLH  N+++RD
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121

Query: 403 IKCANILVDASGSVKLADFGLAK-ATTMNDVKS--CKGTPFWMAPEVVNLKNRGYGLTAD 459
           +K  NIL+D+ G V L DFGL K     +   S  C GTP ++APEV  L+ + Y  T D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEV--LRKQPYDRTVD 178

Query: 460 IWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPND 519
            W LG  + EML   PP+   +  +    I   +P  +  ++S  AR  +   LQ +   
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDTAEMYDNI-LNKPLRLKPNISVSARHLLEGLLQKDRTK 237

Query: 520 RPTAA----QLMEHPF 531
           R  A     ++  H F
Sbjct: 238 RLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 97.9 bits (244), Expect = 9e-23
 Identities = 79/281 (28%), Positives = 118/281 (41%), Gaps = 56/281 (19%)

Query: 285 LGSGSFGTVYEG----YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           LG G+FG VYEG       D     V   +L +  ++  Q       E L++S+F H+NI
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNI 71

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G   +    FI LEL+  G L +  ++      + S+ T        R +  G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK-----------ATTMNDVKSCKGT 438
           L E + +HRDI   N L+   G     K+ADFG+A+              M  +K     
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK----- 186

Query: 439 PFWMAPE-----VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPY---SHLEGMQALFRI 489
             WM PE     +   K        D+WS G  + E+ +    PY   ++ E M+ +   
Sbjct: 187 --WMPPEAFLDGIFTSK-------TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237

Query: 490 GKGEPPL-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           G+ +PP   P  + R   D    C Q  P DRP  A ++E 
Sbjct: 238 GRLDPPKGCPGPVYRIMTD----CWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 97.3 bits (242), Expect = 1e-22
 Identities = 69/247 (27%), Positives = 114/247 (46%), Gaps = 16/247 (6%)

Query: 285 LGSGSFGTVYEGY---TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           LGSG+FGTV +G           AVK +   +     K  +L+   E  ++ + ++  IV
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---EANVMQQLDNPYIV 59

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
           +  G  + E+ + + +EL   G L    QK  H+ +  ++    Q+  G+ YL E N VH
Sbjct: 60  RMIGICEAESWMLV-MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRGYG 455
           RD+   N+L+      K++DFGL+KA   ++     K+    P  W APE +N     + 
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK--FS 176

Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
             +D+WS G  + E  +  Q PY  ++G +    I  GE    P     +  D +  C  
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236

Query: 515 VNPNDRP 521
              ++RP
Sbjct: 237 YGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  100 bits (251), Expect = 1e-22
 Identities = 69/218 (31%), Positives = 113/218 (51%), Gaps = 17/218 (7%)

Query: 328 EILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----ANLYQKYHLMDSQVSAY 382
           E+  L+  +H  IV++F   K +++L + +E  + G L       L +     + +V   
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGT 438
             QI+  L+ +H + ++HRD+K ANI +  +G +KL DFG +K    + +++   S  GT
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP 495
           P+++APE+   K   Y   AD+WSLG  + E+LT   P+   S  E MQ +   GK +P 
Sbjct: 235 PYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL-YGKYDP- 290

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             P  +S   +  +   L  NP  RPT  QL+   F+K
Sbjct: 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 83/312 (26%), Positives = 131/312 (41%), Gaps = 51/312 (16%)

Query: 277 MSWQKGELLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
             ++K +LLG G  G V+       G  FA+K +  ++   + K   +  EQEIL  +  
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNY 392
           +H  +   + + + E  L + ++    G L  L Q+     L +     Y  ++L  L Y
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT----------------TMNDVK--- 433
           LH   +V+RD+K  NIL+  SG + L+DF L+K +                  +      
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 434 ------------SCKGTPFWMAPEVVNLKNRGYGLTA--DIWSLGCTVLEMLTRQPPYSH 479
                       S  GT  ++APEV+     G G  +  D W+LG  + EML    P+  
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVI----SGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234

Query: 480 LEGMQALFRIGKGEPPLVPN-SLSRDARDFILKCLQVNPNDR----PTAAQLMEHPF--- 531
               +    I K E     +  +S  ARD I K L  +P+ R      AA++ +HPF   
Sbjct: 235 SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294

Query: 532 VKRPLQKSRGPP 543
           V   L +   PP
Sbjct: 295 VNWALIRHTTPP 306

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 69/251 (27%), Positives = 112/251 (44%), Gaps = 58/251 (23%)

Query: 328 EILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR--- 384
           EI LL   +HEN++      KD       +    + +  ++Y  Y LMD+ +    R   
Sbjct: 54  EIKLLRHLDHENVIAI----KD------IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ 103

Query: 385 ------------QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND- 431
                       Q+L GL Y+H  NV+HRD+K +N+L++A+  +K+ DFGLA+ T+    
Sbjct: 104 TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163

Query: 432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG 490
            +     T ++ APE++ L    Y    D+WS+GC   E+L R+P +   + +  L  I 
Sbjct: 164 FMTEYVVTRWYRAPELL-LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT 222

Query: 491 K--GEP--------------------PLVPN-SLSR-------DARDFILKCLQVNPNDR 520
           +  G P                    P  P  S +R        A D + K L  +P+ R
Sbjct: 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282

Query: 521 PTAAQLMEHPF 531
            T  + + HP+
Sbjct: 283 ITVEEALAHPY 293

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 81/302 (26%), Positives = 137/302 (45%), Gaps = 58/302 (19%)

Query: 278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQ--DQG----TQGKQSILQLEQE-- 328
           +++K E +G G++G VY+    + G   A+K+  L+  ++G       + S+LQ+  E  
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 329 -ILLLSRFEHENIVQYFGTDKDENR-----LFIFLELVTKGSLANLYQKYH--LMDSQVS 380
            I+ L   EH         ++   +     +F +L+   K  + +  +     L    + 
Sbjct: 62  YIVRLLDVEH--------VEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 381 AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVKSCKG-- 437
           ++  Q+L G+ + H+  V+HRD+K  N+LVD    + K+AD GL +A ++  VKS     
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEI 172

Query: 438 -TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP 494
            T ++ APEV+ L +  Y    DIWS+GC   EM  +QP +     +Q L  I K  G P
Sbjct: 173 VTLWYRAPEVL-LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231

Query: 495 -----PLVPN--------------------SLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
                P V                       LS +  D + K L+ +P  R +A   + H
Sbjct: 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291

Query: 530 PF 531
           P+
Sbjct: 292 PY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 98.3 bits (245), Expect = 3e-22
 Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 50/290 (17%)

Query: 285 LGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGT--QGKQSILQLEQEILLLSRFEHENI 340
           +G G+FG V+   TD  DG     K V+L+      Q   S  ++ +E+ +L  F+H+N+
Sbjct: 8   IGYGAFGVVW-SVTDPRDG-----KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 341 VQYFGTDKDEN-----RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           +      +  +      +++  EL+       +     L    V  +  QIL GL YLH 
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---TPFWMAPEVVNLKNR 452
             ++HRDIK  N+LV+++  +K+ DFGLA+    ++ K       T ++ APE++ + +R
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL-MGSR 180

Query: 453 GYGLTADIWSLGCTVLEMLTR------QPPYSHL-------------------EGMQALF 487
            Y    DIWS+GC   E+L R      Q P   L                   EG +A  
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240

Query: 488 RIGKGEPPLVP------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
             G  +PP +P      +  + +A   + + L  +P+ R +AA  + HP+
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 96.7 bits (240), Expect = 4e-22
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 9/211 (4%)

Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           S++K E LG GS+ TVY+G +  +G   A+K + LQ++      +I    +E  LL   +
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLK 61

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLH 394
           H NIV        +  L +  E V    L     K+   L    V  +  Q+L GL+Y+H
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRG 453
           ++ ++HRD+K  N+L+  +G +KLADFGLA+A ++ +   S +    W  P  V L +  
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ 484
           Y    D+W +GC  +EM+     +  ++ +Q
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 95.7 bits (238), Expect = 5e-22
 Identities = 74/261 (28%), Positives = 123/261 (47%), Gaps = 25/261 (9%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ---EILLLSRFEHENI 340
           LG G +G VYEG         AVK +         K+  +++E+   E  ++   +H N+
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHPNL 64

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAY-TRQILNGLNYLHEQN 397
           VQ  G    E   +I  E +T G+L +  ++     +++ V  Y   QI + + YL ++N
Sbjct: 65  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGY 454
            +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKF 182

Query: 455 GLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
            + +D+W+ G  + E+ T    PY  ++  Q    + KG     P        + +  C 
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACW 242

Query: 514 QVNPNDRPTAAQL---MEHPF 531
           Q NP+DRP+ A++    E  F
Sbjct: 243 QWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 96.6 bits (240), Expect = 5e-22
 Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 7/199 (3%)

Query: 283 ELLGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G GSFG V       DG F+AVK +  +    + +Q+ +  E+ +LL +  +H  +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN-LKHPFLV 59

Query: 342 QYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               + +   +L+  L+ V  G L  +L ++   ++ +   Y  ++ + + YLH  N+++
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYGLTA 458
           RD+K  NIL+D+ G V L DFGL K     +  +    GTP ++APEV  L+   Y  T 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV--LRKEPYDRTV 177

Query: 459 DIWSLGCTVLEMLTRQPPY 477
           D W LG  + EML   PP+
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 76/274 (27%), Positives = 134/274 (48%), Gaps = 32/274 (11%)

Query: 284 LLGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           L+ +G++G VY   + +    FA+K+++ Q+   + +   + +E++IL  +  E+  +V 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVVS 65

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS-AYTRQILNGLNYLHEQNVVHR 401
            F + + +  L + +E V  G  A L +    +   ++  Y  + +  L YLH   +VHR
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMN------------------DVKSCKGTPFWMA 443
           D+K  N+L+ + G +KL DFGL+K   M+                  D + C GTP ++A
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIA 184

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR---IGKGEPPLVPNS 500
           PEV+    +GYG   D W++G  + E L    P+   +  + LF        E P    +
Sbjct: 185 PEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEGDEA 241

Query: 501 LSRDARDFILKCLQVNPNDR---PTAAQLMEHPF 531
           L  DA+D I + L+ NP +R     A ++ +H F
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 96.4 bits (240), Expect = 7e-22
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 23/203 (11%)

Query: 350 ENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANI 408
           E+RLF  +E V+ G L  ++ ++  L +     Y+ +I   LN+LHE+ +++RD+K  N+
Sbjct: 68  ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127

Query: 409 LVDASGSVKLADFGLAK-ATTMNDVKS--CKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
           L+DA G +KL D+G+ K      D  S  C GTP ++APE+  L+   YG + D W+LG 
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEI--LRGEDYGFSVDWWALGV 184

Query: 466 TVLEMLTRQPPYSHLEGMQA---------LFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
            + EM+  + P+  + GM           LF++   +   +P SLS  A   +   L  +
Sbjct: 185 LMFEMMAGRSPFD-IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKD 243

Query: 517 PNDR------PTAAQLMEHPFVK 533
           P +R           +  HPF +
Sbjct: 244 PKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 96.2 bits (239), Expect = 7e-22
 Identities = 75/264 (28%), Positives = 130/264 (49%), Gaps = 21/264 (7%)

Query: 284 LLGSGSFGTVY---EGYTDDGFFFAV--KEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           +LG GSFG V       TD+ +   +  K+V +QD   +       +E+ +L L + +  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVE----CTMVEKRVLAL-QDKPP 61

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            + Q     +  +RL+  +E V  G L  ++ Q     + Q   Y  +I  GL +LH + 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPFWMAPEVVNLKNRGYG 455
           +++RD+K  N+++D+ G +K+ADFG+ K   ++ V  ++  GTP ++APE++  +   YG
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP--YG 179

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            + D W+ G  + EML  QPP+   E    LF+         P SLS++A       +  
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTK 238

Query: 516 NPNDRPTAAQ-----LMEHPFVKR 534
           +P+ R          + EH F +R
Sbjct: 239 HPSKRLGCGPEGERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 95.5 bits (237), Expect = 7e-22
 Identities = 69/224 (30%), Positives = 118/224 (52%), Gaps = 16/224 (7%)

Query: 275 RIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           ++ ++ K + LG G++ TV++G +       A+KE+ L+ +      +I    +E+ LL 
Sbjct: 3   KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVSLLK 58

Query: 334 RFEHENIV---QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNG 389
             +H NIV       T++    +F +L+   K  L N     +LM    V  +  Q+L G
Sbjct: 59  NLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCG---NLMSMHNVKIFMFQLLRG 115

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVN 448
           L+Y H++ ++HRD+K  N+L++  G +KLADFGLA+A ++     S +    W  P  V 
Sbjct: 116 LSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQP--PYSHL-EGMQALFRI 489
           L +  Y    D+W +GC + EM T +P  P S + E +  +FR+
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 95.9 bits (238), Expect = 9e-22
 Identities = 77/261 (29%), Positives = 132/261 (50%), Gaps = 19/261 (7%)

Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K  +     E  +L    H  
Sbjct: 1   KLLGKGTFGKVILVKEKAT--GRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLH-EQN 397
           +     + +  +RL   +E    G L  +L ++    + +   Y  +I++ L+YLH E+N
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYG 455
           VV+RD+K  N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV  L++  YG
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV--LEDNDYG 174

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
              D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ 
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKK 233

Query: 516 NPNDR-----PTAAQLMEHPF 531
           +P  R       A ++M+H F
Sbjct: 234 DPKQRLGGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 82/296 (27%), Positives = 140/296 (47%), Gaps = 46/296 (15%)

Query: 275 RIMSWQKGELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILL 331
           ++ ++ K E LG G++ TV++G    T++    A+KE+ L+ +      +I    +E+ L
Sbjct: 4   KMETYIKLEKLGEGTYATVFKGRSKLTEN--LVALKEIRLEHEEGAPCTAI----REVSL 57

Query: 332 LSRFEHENIVQYFG---TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILN 388
           L   +H NIV       TDK    +F +L+   K  + +      + + ++  Y  QIL 
Sbjct: 58  LKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLY--QILR 115

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVV 447
           GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A ++     S +    W  P  V
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQP--PYSHLEG-MQALFRIGKGEP---------- 494
            L +  Y    D+W +GC   EM + +P  P S +E  +  +FR+  G P          
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL-LGTPTEETWPGISS 234

Query: 495 ---------------PLVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                          PL+ ++  L  +  + + K LQ     R +A + M+H + +
Sbjct: 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 77/265 (29%), Positives = 122/265 (46%), Gaps = 37/265 (13%)

Query: 285 LGSGSFGTVY--EGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           LG G+FG V+  E Y    T D    AVK  +L+D     ++     ++E  LL+  +HE
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 67

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH------LMD------------SQVS 380
           +IV+++G   D + L +  E +  G L N + + H      L+D            SQ+ 
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 381 AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF 440
               QI +G+ YL  Q+ VHRD+   N LV A+  VK+ DFG+++     D     G   
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 441 ----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPP 495
               WM PE  ++  R +   +D+WS G  + E+ T  + P+  L   + +  I +G   
Sbjct: 187 LPIRWMPPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 244

Query: 496 LVPNSLSRDARDFILKCLQVNPNDR 520
             P    ++  D +L C Q  P  R
Sbjct: 245 ERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 80/267 (29%), Positives = 129/267 (48%), Gaps = 25/267 (9%)

Query: 284 LLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQ-SILQLEQEILL--LSRFEHEN 339
           ++G G FG VY     D G  +A+K   L  +  + KQ   L L + I+L  +S  +   
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL------MDSQVSAYTRQILNGLNYL 393
           IV         ++L   L+L+  G L      YHL       ++++  Y  +I+ GL ++
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDL-----HYHLSQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           H + VV+RD+K ANIL+D  G V+++D GLA   +     +  GT  +MAPEV+  K   
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVA 172

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF--RIGKGEPPLVPNSLSRDARDFILK 511
           Y  +AD +SLGC + ++L    P+   +        R+       +P+S S + R  +  
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232

Query: 512 CLQVNPNDR-----PTAAQLMEHPFVK 533
            LQ + N R       A ++ EHPF +
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.0 bits (233), Expect = 3e-21
 Identities = 74/262 (28%), Positives = 120/262 (45%), Gaps = 34/262 (12%)

Query: 285 LGSGSFGTVY--EGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           LG G+FG V+  E Y      D    AVK  +L+D     ++      +E  LL+  +HE
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 67

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH---------------LMDSQVSAYT 383
           +IV+++G   + + L +  E +  G L N + + H               L  SQ+    
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF--- 440
           +QI  G+ YL  Q+ VHRD+   N LV  +  VK+ DFG+++     D     G      
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 441 -WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVP 498
            WM PE  ++  R +   +D+WSLG  + E+ T  + P+  L   + +  I +G     P
Sbjct: 187 RWMPPE--SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244

Query: 499 NSLSRDARDFILKCLQVNPNDR 520
            +  ++  D +L C Q  P+ R
Sbjct: 245 RTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 25/262 (9%)

Query: 283 ELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           +++G G FG V  G            A+K  +L+  G+  KQ +  L  E  ++ +F+H 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIK--TLKA-GSSDKQRLDFL-TEASIMGQFDHP 65

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQ 396
           NI++  G       + I  E +  GSL    ++        Q+    R I +G+ YL E 
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNR 452
           N VHRD+   NILV+++   K++DFGL++    ++     K  K    W APE +    R
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY--R 183

Query: 453 GYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG---EPPL-VPNSLSRDARD 507
            +   +D+WS G  + E+++  + PY  +     +  +  G    PP+  P++L +    
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ---- 239

Query: 508 FILKCLQVNPNDRPTAAQLMEH 529
            +L C Q + N+RPT +Q++  
Sbjct: 240 LMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 93.4 bits (232), Expect = 4e-21
 Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 25/267 (9%)

Query: 284 LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEIL--LLSRFEHENI 340
           +LG G FG V        G  +A K++  +    +  +++   E++IL  + SRF    +
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF----V 62

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLM-----DSQVSAYTRQILNGLNYLHE 395
           V      + ++ L + L L+  G L   +  Y++      + +   Y  +I  GL  LH 
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGY 454
           + +V+RD+K  NIL+D  G ++++D GLA      + ++   GT  +MAPEVV  KN  Y
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--KNERY 178

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDARDFILK 511
             + D W LGC + EM+  + P+   +     + + R  K +        S  AR    +
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238

Query: 512 CLQVNPNDR-----PTAAQLMEHPFVK 533
            L  +P  R       A ++  HPF +
Sbjct: 239 LLTKDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 94.3 bits (234), Expect = 4e-21
 Identities = 54/182 (29%), Positives = 95/182 (52%), Gaps = 11/182 (6%)

Query: 348 KDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           +  +RLF+ +E V  G L  ++ ++  L +     Y  +I   LN+LHE+ +++RD+K  
Sbjct: 66  QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125

Query: 407 NILVDASGSVKLADFGLAKATTM--NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLG 464
           N+L+DA G +KL D+G+ K      +   +  GTP ++APE+  L+   YG + D W+LG
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI--LRGEEYGFSVDWWALG 183

Query: 465 CTVLEMLTRQPPYS------HLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
             + EM+  + P+        +     LF++   +P  +P  LS  A   +   L  +P 
Sbjct: 184 VLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPK 243

Query: 519 DR 520
           +R
Sbjct: 244 ER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 94.3 bits (234), Expect = 4e-21
 Identities = 73/249 (29%), Positives = 122/249 (48%), Gaps = 22/249 (8%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEI-------LLLSR 334
           +++G GSFG V    +  +  F+AVK +         K++IL+ ++E        +LL  
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQ--------KKAILKKKEEKHIMSERNVLLKN 52

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H  +V    + +  ++L+  L+ +  G L  +L ++   ++ +   Y  +I + L YL
Sbjct: 53  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 112

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKN 451
           H  N+V+RD+K  NIL+D+ G + L DFGL K    ++  +    GTP ++APEV  L  
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV--LHK 170

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
           + Y  T D W LG  + EML   PP+      +    I      L PN ++  AR  +  
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN-ITNSARHLLEG 229

Query: 512 CLQVNPNDR 520
            LQ +   R
Sbjct: 230 LLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 94.1 bits (234), Expect = 4e-21
 Identities = 71/248 (28%), Positives = 106/248 (42%), Gaps = 54/248 (21%)

Query: 327 QEILLLSRFEHENIVQYFGTDKDENRLFIFLE------LVTK---GSLANLYQKYHLMDS 377
           +E+ LL    HENI+    +D       IF+        VT+     L  L     L   
Sbjct: 58  RELKLLKHLRHENIISL--SD-------IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQ 108

Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSC 435
            +  +  QIL GL Y+H   VVHRD+K +NIL++ +  +K+ DFGLA+     M    S 
Sbjct: 109 FIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS- 167

Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GE 493
             T ++ APE++ L  + Y +  DIWS GC   EML  +P +   + +     I    G 
Sbjct: 168 --TRYYRAPEIM-LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224

Query: 494 PPL-------------VPNSLSR---------------DARDFILKCLQVNPNDRPTAAQ 525
           PP                 SL +                A D + K L  +P  R +AA+
Sbjct: 225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284

Query: 526 LMEHPFVK 533
            + HP++ 
Sbjct: 285 ALAHPYLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 82/282 (29%), Positives = 136/282 (48%), Gaps = 18/282 (6%)

Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G GSFG V       DG  +AVK +  +    + +Q  +  E+ +LL    +H  +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL-KNVKHPFLV 59

Query: 342 QYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               + +   +L+  L+ V  G L  +L ++    + +   Y  +I + L YLH  N+V+
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119

Query: 401 RDIKCANILVDASGSVKLADFGLAK-ATTMNDVKS--CKGTPFWMAPEVVNLKNRGYGLT 457
           RD+K  NIL+D+ G V L DFGL K     +D  +  C GTP ++APEV  ++ + Y  T
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPEV--IRKQPYDNT 176

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
            D W LG  + EML   PP+   +  +    I      L P + S  A   + + L+ + 
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA-SLTAWSILEELLEKDR 235

Query: 518 NDRPTAA----QLMEHPFVKR----PLQKSRGPPSYYNNMHS 551
             R  A     ++ EHPF +      L++ + PP +  N+  
Sbjct: 236 QRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEG 277

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 97.1 bits (241), Expect = 5e-21
 Identities = 79/302 (26%), Positives = 141/302 (46%), Gaps = 41/302 (13%)

Query: 275 RIMSWQKGELLGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           R+  ++  + +G+G FG V+   +     FF  K +S +    + K    QL  E+ ++ 
Sbjct: 11  RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEVNVMR 67

Query: 334 RFEHENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-----TRQI 386
             +H+NIV+Y     +K   +L+I +E    G L+   QK + M  ++  +     TRQ+
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 387 LNGLNYLHE-------QNVVHRDIKCANILVDAS----GSV-------------KLADFG 422
           L+ L Y H        + V+HRD+K  NI +       G +             K+ DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 423 LAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE 481
           L+K   +  +  SC GTP++ +PE++  + + Y   +D+W+LGC + E+ + + P+    
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247

Query: 482 GMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
               L    K  P L     S++    I   L ++  +RP+A Q + +  +     K+ G
Sbjct: 248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII-----KNVG 302

Query: 542 PP 543
           PP
Sbjct: 303 PP 304

Length = 1021

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 83/304 (27%), Positives = 140/304 (46%), Gaps = 54/304 (17%)

Query: 279 WQKGELLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++K   LG+G+ G V++  +   G   A K + L+ +     Q I +L+    +L     
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECNS 62

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQ 396
             IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E+
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 397 N-VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           + ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y 
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYS 180

Query: 456 LTADIWSLGCTVLEMLTRQ-----PPYSHLEGM--------------------------- 483
           + +DIWS+G +++EM   +     P    LE M                           
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240

Query: 484 --------QALFR----IGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHP 530
                    A+F     I    PP +P+ +   + +DF+ KCL  NP +R    QLM H 
Sbjct: 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300

Query: 531 FVKR 534
           F+KR
Sbjct: 301 FIKR 304

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 78/274 (28%), Positives = 131/274 (47%), Gaps = 25/274 (9%)

Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEIL--LLSR 334
           ++++  +LG G FG V        G  +A K++  +    +  +S+   E++IL  + SR
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----QVSAYTRQILNG 389
           F    +V      + ++ L + L L+  G L   +  YH+ ++     +   Y  +I  G
Sbjct: 61  F----VVSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVN 448
           L  LH++ +V+RD+K  NIL+D  G ++++D GLA        +K   GT  +MAPEVV 
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV- 173

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
            KN  Y  + D W+LGC + EM+  Q P+   +     + + R+ K          S DA
Sbjct: 174 -KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDA 232

Query: 506 RDFILKCLQVNPNDR-----PTAAQLMEHPFVKR 534
           R      L  +P +R       A ++ EHP  K+
Sbjct: 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 18/179 (10%)

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTP 439
           YT QI++GL +LH++ +++RD+K  N+L+D  G+V+++D GLA       +  K   GTP
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEPP 495
            +MAPE+  L+   Y  + D ++LG T+ EM+  + P+      +E  +   RI   +  
Sbjct: 162 GFMAPEL--LQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSV 218

Query: 496 LVPNSLSRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK----RPLQKSRGPPSY 545
             P+  S  ++ F    L  +P  R          L  HP  +    R L+    PP +
Sbjct: 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPF 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 30/263 (11%)

Query: 283 ELLGSGSFGTVYEGY--TDDG--FFFAVKEVS-LQDQGTQGKQSILQLEQEILLLSRFEH 337
            ++G G FG VY G     DG     AVK ++ + D      + + Q  +E +++  F H
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-----EEVEQFLKEGIIMKDFSH 55

Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLH 394
            N++   G     E    + L  +  G L N  +   ++     +  +  Q+  G+ YL 
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D S +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE--S 173

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG----EPPLVPNSLSR 503
           L+ + +   +D+WS G  + E++TR  PPY  ++       + +G    +P   P+ L  
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY- 232

Query: 504 DARDFILKCLQVNPNDRPTAAQL 526
              + +L C    P  RPT ++L
Sbjct: 233 ---EVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 91.9 bits (228), Expect = 3e-20
 Identities = 78/273 (28%), Positives = 132/273 (48%), Gaps = 25/273 (9%)

Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI--- 340
           +GSG++GTV        G   A+K++    +  Q +    +  +E+ LL   +HEN+   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLY---RPFQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 341 VQYFGTDKDENRLFIF-LELVTKGS-LANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +  F  D   +R   F L +   G+ L  L +   L + ++     Q+L GL Y+H   +
Sbjct: 80  LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGI 139

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K  N+ V+    +K+ DFGLA+ T  +++     T ++ APEV+ L    Y  T 
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVVTRWYRAPEVI-LNWMHYTQTV 197

Query: 459 DIWSLGCTVLEMLTRQPPYS---HLEGMQALFRIGKGEPP--LVPNSLSRDARDFILKCL 513
           DIWS+GC + EMLT +P +    HL+ +  + ++  G P    V    S DA++++ K  
Sbjct: 198 DIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV-TGTPSKEFVQKLQSEDAKNYVKKLP 256

Query: 514 QVN--------PNDRPTAAQLMEHPFVKRPLQK 538
           +          PN  P A  ++E   V     +
Sbjct: 257 RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 16/230 (6%)

Query: 284 LLGSGSFGTVY---EGYTDDGFFFAV--KEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           +LG GSFG V       TD+ +   +  K+V +QD   +       +E+ +L LS  +  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVE----CTMVEKRVLALSG-KPP 61

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            + Q     +  +RL+  +E V  G L   + Q     +     Y  +I  GL +LH + 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPFWMAPEVVNLKNRGYG 455
           +++RD+K  N+++D+ G +K+ADFG+ K    + V  K+  GTP ++APE++    + YG
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII--AYQPYG 179

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
            + D W+ G  + EML  Q P+   E    LF+         P S+S++A
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEA 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 75/302 (24%), Positives = 132/302 (43%), Gaps = 57/302 (18%)

Query: 283 ELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V      D G  +A+K++   +   + + + ++ E++IL  +  ++  +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA--DNPWVV 64

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + + + +DEN L++ +E +  G +  L  K      + +  Y  + +  ++ +H+   +H
Sbjct: 65  KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH 124

Query: 401 RDIKCANILVDASGSVKLADFGLAK--------------------------ATTMNDVK- 433
           RDIK  N+L+DA G +KL+DFGL                            +  M+  + 
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184

Query: 434 -------------SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL 480
                        S  GTP ++APEV      GY    D WSLG  + EML   PP+   
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEV--FLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242

Query: 481 EGMQALFRIGKGE-----PPLVPNSLSRDARDFILKCLQVNPNDR---PTAAQLMEHPFV 532
              +   +I   +     P  VP  LS +A+D I + L      R       ++  HPF 
Sbjct: 243 NPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPFF 299

Query: 533 KR 534
           K 
Sbjct: 300 KG 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 91.8 bits (228), Expect = 5e-20
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 12/215 (5%)

Query: 271 KFRRRIMSWQKGELLGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEI 329
           K R +   +   +++G G+FG V    +      +A+K +S  +   +   +    E++I
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 330 LLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNG 389
           +  +    E IVQ     +D+  L++ +E +  G L NL   Y + +     YT +++  
Sbjct: 97  MAHA--NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLA 154

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEV 446
           L+ +H    +HRD+K  N+L+D SG +KLADFG       N +  C    GTP +++PEV
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214

Query: 447 VNLKNRG----YGLTADIWSLGCTVLEMLTRQPPY 477
             LK++G    YG   D WS+G  + EML    P+
Sbjct: 215 --LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 91.6 bits (227), Expect = 5e-20
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 12/203 (5%)

Query: 283 ELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V    +      +A+K +S  +   +   +    E++I+  +      +V
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA--NSPWVV 106

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
           Q F   +D+  L++ +E +  G L NL   Y + +     YT +++  L+ +H   ++HR
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHR 166

Query: 402 DIKCANILVDASGSVKLADFGLA---KATTMNDVKSCKGTPFWMAPEVVNLKNRG----Y 454
           D+K  N+L+D  G +KLADFG       T M    +  GTP +++PEV  LK++G    Y
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV--LKSQGGDGYY 224

Query: 455 GLTADIWSLGCTVLEMLTRQPPY 477
           G   D WS+G  + EML    P+
Sbjct: 225 GRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 90.9 bits (225), Expect = 6e-20
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 21/204 (10%)

Query: 348 KDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           + E+RLF  +E V  G L  ++ ++  L +     Y+ +I   LNYLHE+ +++RD+K  
Sbjct: 66  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125

Query: 407 NILVDASGSVKLADFGLAK-ATTMNDVKS--CKGTPFWMAPEVVNLKNRGYGLTADIWSL 463
           N+L+D+ G +KL D+G+ K      D  S  C GTP ++APE+  L+   YG + D W+L
Sbjct: 126 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI--LRGEDYGFSVDWWAL 182

Query: 464 GCTVLEMLTRQPPYSHLEGMQA--------LFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
           G  + EM+  + P+  +             LF++   +   +P SLS  A   +   L  
Sbjct: 183 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNK 242

Query: 516 NPNDR----PTA--AQLMEHPFVK 533
           +P +R    P    A +  HPF +
Sbjct: 243 DPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 90.0 bits (223), Expect = 6e-20
 Identities = 79/308 (25%), Positives = 131/308 (42%), Gaps = 62/308 (20%)

Query: 271 KFRRRIMSWQKGELLGSGSFGTVY----EGYTDDGFFFAVKEVSLQDQGTQ--------- 317
           +F R+ ++++  E LG G FG V+    EG       F  K+ SL   G Q         
Sbjct: 1   EFPRKRLTFK--EKLGEGQFGEVHLCEAEGMEK----FMDKDFSLDVSGNQPVLVAVKML 54

Query: 318 ----GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH 373
                K +     +EI ++SR +  NI++        + L +  E +  G L     ++ 
Sbjct: 55  REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE 114

Query: 374 LMDSQVSAYTR------------QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF 421
             ++   A               QI +G+ YL   N VHRD+   N LV  + ++K+ADF
Sbjct: 115 PQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADF 174

Query: 422 GLAKATTMNDVKSCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQP 475
           G+++     D    +G       WM+ E + L    +   +D+W+ G T+ E+LT  ++ 
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQ 232

Query: 476 PYSHLEGMQALFRIGK-----------GEPPLVPNSLSRDARDFILKCLQVNPNDRPT-- 522
           PYS L   Q +   G+            +P L P+SL       +L C + N  +RP+  
Sbjct: 233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLY----KLMLSCWRRNAKERPSFQ 288

Query: 523 --AAQLME 528
              A L+E
Sbjct: 289 EIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 89.6 bits (222), Expect = 8e-20
 Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)

Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEIL--LLSR 334
           ++++  +LG G FG V        G  +A K +  +    +  +S+   E++IL  + S+
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLM--------DSQVSAYTRQI 386
           F    +V      + ++ L + L ++  G L     K+H+         + +   Y  +I
Sbjct: 61  F----VVNLAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFEEERALFYAAEI 111

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPE 445
           L GL  LH +N V+RD+K  NIL+D  G ++++D GLA K      ++   GT  +MAPE
Sbjct: 112 LCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPE 171

Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEPPLVPNSL 501
           V  L N+ Y L+ D W LGC + EM+  Q P+      ++  +   R+ + E  +     
Sbjct: 172 V--LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-EVYSAKF 228

Query: 502 SRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK 533
           S +A+      L  +P  R       A ++  HPF +
Sbjct: 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 90.5 bits (225), Expect = 8e-20
 Identities = 83/310 (26%), Positives = 134/310 (43%), Gaps = 79/310 (25%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVS--LQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +GSG+ G V   Y T  G   A+K++S   Q+  T  K++     +E++L+    H+NI+
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAY----RELVLMKLVNHKNII 78

Query: 342 ---QYFGTDK---DENRLFIFLELVTKGSLANLYQKYHL-MDSQVSAY-TRQILNGLNYL 393
                F   K   +   +++ +EL+     ANL Q   + +D +  +Y   Q+L G+ +L
Sbjct: 79  GLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHL 134

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNR- 452
           H   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    R 
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---------AGTSFMMTPYVVTRYYRA 185

Query: 453 -------GYGLTADIWSLGCTVLEMLTRQ---PPYSHL---------------EGMQAL- 486
                  GY    DIWS+GC + EM+      P   H+               E M  L 
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245

Query: 487 -----------FRIGKGEPPLVPNSL------------SRDARDFILKCLQVNPNDRPTA 523
                         G     L P+ L            +  ARD + K L ++P  R + 
Sbjct: 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV 305

Query: 524 AQLMEHPFVK 533
              ++HP++ 
Sbjct: 306 DDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 90.4 bits (224), Expect = 8e-20
 Identities = 81/299 (27%), Positives = 124/299 (41%), Gaps = 68/299 (22%)

Query: 297 YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF 356
           Y   G +  V+ ++L+   T    + LQ E  +  L  F H NIV Y  T   +N L++ 
Sbjct: 21  YKPTGEYVTVRRINLE-ACTNEMVTFLQGELHVSKL--FNHPNIVPYRATFIADNELWVV 77

Query: 357 LELVTKGSLANLYQKYHLMD--SQVS-AYTRQ-ILNGLNYLHEQNVVHRDIKCANILVDA 412
              +  GS  +L    H MD  S+++ AY  Q +L  L+Y+H    VHR +K ++IL+  
Sbjct: 78  TSFMAYGSAKDLICT-HFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV 136

Query: 413 SGSVKLADFGLAKATTM----------NDVK--SCKGTPFWMAPEVVNLKNRGYGLTADI 460
            G V L+  GL    +M          +D    S K  P W++PEV+    +GY   +DI
Sbjct: 137 DGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDI 193

Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALF--------------------------------- 487
           +S+G T  E+     P+  +   Q L                                  
Sbjct: 194 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSG 253

Query: 488 ----------RIGKGEPPLVP--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                     R   GE    P   + S     F+ +CLQ NP+ RP+A+ L+ H F K+
Sbjct: 254 LGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 74/266 (27%), Positives = 131/266 (49%), Gaps = 29/266 (10%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           ++K ++LGSG+FGTVY+G +  +G       A+KE+  +    +  + IL    E  +++
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILD---EAYVMA 64

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-------HLMDSQVSAYTRQI 386
             ++ ++ +  G         I  +L+  G L +  +++       +L++  V     QI
Sbjct: 65  SVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLNWCV-----QI 118

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWM 442
             G+NYL E+ +VHRD+   N+LV     VK+ DFGLAK    ++     +  K    WM
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSL 501
           A E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KGE    P   
Sbjct: 179 ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 236

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLM 527
           + D    ++KC  ++ + RP   +L+
Sbjct: 237 TIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 56/300 (18%)

Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG+G+ G V +  +   G   A K + L+ +     Q I +L+    +L       IV +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECNSPYIVGF 68

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN-VVHR 401
           +G    +  + I +E +  GSL  + ++   +  ++    +  +L GL YL E++ ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 128

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIW 461
           D+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + +DIW
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQSDIW 186

Query: 462 SLGCTVLEM-LTRQP-PYSHLEGMQALF-----RIGKGE--------------------- 493
           S+G +++E+ + R P P    + ++A+F        +GE                     
Sbjct: 187 SMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD 246

Query: 494 ------------------PPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                             PP +PN + + D ++F+ KCL  NP +R     LM H F+KR
Sbjct: 247 SRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 57/286 (19%)

Query: 283 ELLGSGSFGTVY----EG-----------YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ 327
           E LG G FG V+    EG           +       AVK +   D     +   L+   
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR-ADVTKTARNDFLK--- 66

Query: 328 EILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA------ 381
           EI ++SR ++ NI++  G    ++ L +  E +  G L N +     ++S  +       
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLSQREIESTFTHANNIPS 125

Query: 382 --------YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 433
                      QI +G+ YL   N VHRD+   N LV    ++K+ADFG+++     D  
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 434 SCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEM--LTRQPPYSHLEGMQALF 487
             +G       WMA E + L    +   +D+W+ G T+ EM  L ++ PYS L   Q + 
Sbjct: 186 RIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243

Query: 488 RIGK-----------GEPPLVPNSLSRDARDFILKCLQVNPNDRPT 522
             G+            + PL P+ +       +++C   +  DRPT
Sbjct: 244 NTGEFFRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIKDRPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 90.5 bits (224), Expect = 2e-19
 Identities = 69/227 (30%), Positives = 114/227 (50%), Gaps = 25/227 (11%)

Query: 278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           S++ G ++G+GSFG VYE    D     A+K+V LQD   + +        E+L++    
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKNR--------ELLIMKNLN 117

Query: 337 HENIV---QYFGTD---KDENRLFIFLELVTKGSLANLYQKYHLMDSQ------VSAYTR 384
           H NI+    Y+ T+   K+E  +F+ + +       + Y K++  ++       V  Y+ 
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVK-SCKGTPFWM 442
           Q+   L Y+H + + HRD+K  N+L+D  + ++KL DFG AK         S   + F+ 
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237

Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI 489
           APE++ L    Y    D+WSLGC + EM+   P +S    +  L RI
Sbjct: 238 APELM-LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283

Length = 440

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 89.3 bits (221), Expect = 3e-19
 Identities = 87/321 (27%), Positives = 148/321 (46%), Gaps = 59/321 (18%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS--LQDQGTQGKQSILQLEQEILLLSRF 335
           +Q+ + +GSG+ G V   + T  G   AVK++S   Q+Q T  K++     +E++LL   
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAY----RELVLLKCV 77

Query: 336 EHENIVQYFGTDKDENRL--FIFLELVTKGSLANLYQKYHL-MDSQVSAYT-RQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  H+ +D +  +Y   Q+L G+ 
Sbjct: 78  NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 137

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLK 450
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+    N + +    T ++ APEV+   
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI--L 195

Query: 451 NRGYGLTADIWSLGCTVLEMLT------------------RQPPYSHLEGMQAL------ 486
             GY    DIWS+GC + E++                    Q      E M  L      
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255

Query: 487 FRIGKGEPPLV-----------PNSLSRD------ARDFILKCLQVNPNDRPTAAQLMEH 529
           +   + + P +           P+   RD      ARD + K L ++P+ R +  + + H
Sbjct: 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315

Query: 530 PFVK---RPLQKSRGPPSYYN 547
           P++     P +    PP  Y+
Sbjct: 316 PYITVWYDPAEAEAPPPQIYD 336

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 43/280 (15%)

Query: 282 GELLGSGSFGTVYEG------YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           G+ LG G+FG V +         ++    AVK   L+D  T+  + +  L  E+ ++   
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK--MLKDDATE--KDLSDLVSEMEMMKMI 72

Query: 336 -EHENIVQYFGTDKDENRLFIFLELVTKGSLANLY-------QKYHLMDSQVS------- 380
            +H+NI+   G    E  L++ +E    G+L +         +     D +         
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 381 ---AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSC 435
              ++  Q+  G+ +L  +  +HRD+   N+LV     +K+ADFGLA+     D   K+ 
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 436 KG-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP-PYS--HLEGMQALFRIG 490
            G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY    +E +  L + G
Sbjct: 193 NGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250

Query: 491 K--GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
               +P      L    RD    C    P+ RPT  QL+E
Sbjct: 251 YRMEKPQNCTQELYHLMRD----CWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 88.5 bits (219), Expect = 5e-19
 Identities = 72/277 (25%), Positives = 130/277 (46%), Gaps = 21/277 (7%)

Query: 272 FRRRIMSWQKGELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL 330
            R +   ++  +++G G+FG V    +      +A+K +S  +   +   +    E++I+
Sbjct: 38  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 331 LLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGL 390
             +      +VQ F   +D+  L++ +E +  G L NL   Y + +     YT +++  L
Sbjct: 98  AFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155

Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVV 447
           + +H    +HRD+K  N+L+D SG +KLADFG         +  C    GTP +++PEV 
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV- 214

Query: 448 NLKNRG----YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNS 500
            LK++G    YG   D WS+G  + EML    P+     +    +I   +  L     N 
Sbjct: 215 -LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273

Query: 501 LSRDARDFILKCLQVNPND----RPTAAQLMEHPFVK 533
           +S++A++ I  C  +   +    R    ++  H F K
Sbjct: 274 ISKEAKNLI--CAFLTDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 78/274 (28%), Positives = 121/274 (44%), Gaps = 35/274 (12%)

Query: 282 GELLGSGSFGTVYEGY--TDDGFF--FAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           G++LG G FG+V EG    DDG     AVK + L D  T     I +   E   +  F+H
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-DIHTY--SEIEEFLSEAACMKDFDH 60

Query: 338 ENIVQYFG---TDKDENRL---FIFLELVTKGSLAN--LY-----QKYHLMDSQVSAYTR 384
            N+++  G         ++    + L  +  G L +  LY         L    +  +  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTPF 440
            I  G+ YL  +N +HRD+   N ++    +V +ADFGL+K     D     +  K    
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG--MQALFRIGK--GEPP 495
           W+A E  +L +R Y   +D+W+ G T+ E+ TR Q PY  +E   +    R G    +P 
Sbjct: 181 WIAIE--SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
              + L     D +  C + +P DRPT  +L E 
Sbjct: 239 DCLDEL----YDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 40/278 (14%)

Query: 271 KFRRRIMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQ 324
           K R  ++ W+    LG G+FG V+           D    AVK  +L++     +Q    
Sbjct: 3   KRRDIVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD--- 53

Query: 325 LEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY----HLMD---- 376
            ++E  LL+  +H++IV+++G   +   L +  E +  G L    + +     ++     
Sbjct: 54  FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113

Query: 377 --------SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 428
                    Q+ A   QI +G+ YL   + VHRD+   N LV     VK+ DFG+++   
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173

Query: 429 MNDVKSCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLEG 482
             D     G       WM PE  ++  R +   +DIWS G  + E+ T  +QP Y  L  
Sbjct: 174 STDYYRVGGRTMLPIRWMPPE--SILYRKFTTESDIWSFGVVLWEIFTYGKQPWY-QLSN 230

Query: 483 MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
            +A+  I +G     P +   +    +  C Q  P  R
Sbjct: 231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 87.0 bits (215), Expect = 8e-19
 Identities = 87/298 (29%), Positives = 136/298 (45%), Gaps = 51/298 (17%)

Query: 268 PNGKFRRRIMSWQKGELLGSGSFGTVY--------EGYTDDGFFFAVKEVSLQDQGTQGK 319
           P  +F R  ++   G+ LG G FG V         +    +    AVK   L+D  T+  
Sbjct: 8   PRWEFSRDKLTL--GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK--MLKDDATEKD 63

Query: 320 QSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANL----------- 368
            S L  E E++ +   +H+NI+   G    +  L++ +E  +KG+L              
Sbjct: 64  LSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122

Query: 369 -YQKYHLMDSQVS-----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG 422
            Y    + D Q++     + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFG
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 182

Query: 423 LAKATTMNDVKSCKGT-----PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QP 475
           LA+   +N++   K T     P  WMAPE   L +R Y   +D+WS G  + E+ T    
Sbjct: 183 LAR--DVNNIDYYKKTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGS 238

Query: 476 PYSHLEGMQALFRIGK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           PY  +  ++ LF++ K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 239 PYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRD----CWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 87.5 bits (217), Expect = 8e-19
 Identities = 84/315 (26%), Positives = 131/315 (41%), Gaps = 72/315 (22%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           E++G GS+G V     T  G   A+K+++   +       IL+   EI LL    H +IV
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIV 62

Query: 342 QYFG-----TDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNY 392
           +        + ++   +++  EL+     ++L+Q       L       +  Q+L  L Y
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM---------A 443
           +H  NV HRD+K  NIL +A   +K+ DFGLA+    ND        FW          A
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDT---PTAIFWTDYVATRWYRA 174

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY------SHLEGMQALFRIGKGEPPLV 497
           PE+       Y    DIWS+GC   E+LT +P +        L+ +  L     G P   
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL----GTPS-- 228

Query: 498 PNSLSR----DARDFI----------------------LKCLQ----VNPNDRPTAAQLM 527
           P ++SR     AR ++                      L+ L+     +P DRPTA + +
Sbjct: 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288

Query: 528 EHPFVKRPLQKSRGP 542
             P+ K   +  R P
Sbjct: 289 ADPYFKGLAKVEREP 303

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 87.5 bits (216), Expect = 1e-18
 Identities = 88/330 (26%), Positives = 144/330 (43%), Gaps = 77/330 (23%)

Query: 279 WQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVS--LQDQGTQGKQSILQLEQEILLLS 333
           +Q  + +GSG+ G V   Y+   D     A+K++S   Q+Q T  K++     +E++L+ 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQ-THAKRAY----RELVLMK 71

Query: 334 RFEHENIVQYFGTDKDENRLFIFLE--LVTKGSLANLYQ--KYHLMDSQVSAYTRQILNG 389
              H+NI+        +  L  F +  LV +   ANL Q  +  L   ++S    Q+L G
Sbjct: 72  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 131

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNL 449
           + +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV  
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTR 182

Query: 450 KNR--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHL 480
             R        GY    DIWS+GC + EM+  +                     P    +
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242

Query: 481 EGMQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDR 520
           + +Q   R          G   P L P+SL           +  ARD + K L ++P  R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Query: 521 PTAAQLMEHPFVK---RPLQKSRGPPSYYN 547
            +  + ++HP++     P +    PP  Y+
Sbjct: 303 ISVDEALQHPYINVWYDPAEVEAPPPQIYD 332

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 69/252 (27%), Positives = 119/252 (47%), Gaps = 27/252 (10%)

Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LG G FG V      + G  +A K++  +    +  + +  LE+EIL   +     IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMD--------SQVSAYTRQILNGLNYLHE 395
               + +  L + + L+  G L     KYH+ +         +V  Y+ QI  G+ +LH 
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDL-----KYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNR 452
            ++V+RD+K  N+L+D  G+ +L+D GL  A  + D K+     GT  +MAPE+  LK  
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQRAGTNGYMAPEI--LKEE 169

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPY-SHLEGM---QALFRIGKGEPPLVPNSLSRDARDF 508
            Y    D +++GC++ EM+  + P+  H E +   +   R  + E      + + +++D 
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDI 229

Query: 509 ILKCLQVNPNDR 520
               L   P DR
Sbjct: 230 CRLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 58/302 (19%)

Query: 285 LGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G G+FG V      D    +A+K  +L+      +     ++ E  +L+  ++E +V+ 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMK--TLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVHRD 402
           + + +D++ L+  ++ +  G + +L  +  + +  ++  Y  ++   +  +H+   +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 403 IKCANILVDASGSVKLADFGL------------------AKATTMN------DVKSCK-- 436
           IK  NIL+D  G +KL DFGL                   +  +M       ++  C+  
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 437 -------------------GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY 477
                              GTP ++APEV  L   GY    D WS+G  + EML  QPP+
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEV--LLRTGYTQLCDWWSVGVILYEMLVGQPPF 244

Query: 478 SHLEGMQALFRIGKGEPPL-VPN--SLSRDARDFILKCLQVNPNDR---PTAAQLMEHPF 531
                 +   ++   E  L +P+   LSR+A D IL+ L     DR     A ++  HPF
Sbjct: 245 LADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPF 303

Query: 532 VK 533
            K
Sbjct: 304 FK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 66/255 (25%), Positives = 125/255 (49%), Gaps = 11/255 (4%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           ++ ++LGSG+FGTVY+G +  +G    +         T G ++ ++   E L+++  +H 
Sbjct: 10  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQ 396
           ++V+  G       + +  +L+  G L +   ++  ++    +  +  QI  G+ YL E+
Sbjct: 70  HLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNR 452
            +VHRD+   N+LV +   VK+ DFGLA+    ++        K    WMA E ++   R
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY--R 186

Query: 453 GYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
            +   +D+WS G T+ E++T    PY  +   +    + KGE    P   + D    ++K
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVK 246

Query: 512 CLQVNPNDRPTAAQL 526
           C  ++ + RP   +L
Sbjct: 247 CWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 26/265 (9%)

Query: 280 QKGELLGSGSFGTVYE------GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
             G+ LG+G+FG V E        +D     AVK +      ++ +++++    E+ ++S
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE-REALMS---ELKIMS 93

Query: 334 RF-EHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDS--QVSAYTRQILNG 389
               HENIV   G       + +  E    G L N L +K     +   + +++ Q+  G
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-CKGTPF----WMAP 444
           + +L  +N +HRD+   N+L+     VK+ DFGLA+   MND     KG       WMAP
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARLPVKWMAP 212

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF--RIGKGEPPLVPNSL 501
           E  ++ N  Y   +D+WS G  + E+ +    PY  +  + + F   I +G     P   
Sbjct: 213 E--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP-VDSKFYKLIKEGYRMAQPEHA 269

Query: 502 SRDARDFILKCLQVNPNDRPTAAQL 526
             +  D +  C   +P  RPT  Q+
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 14/248 (5%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           E +G G+FG V+ G    D    AVK      + T       +  QE  +L ++ H NIV
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +  G    +  ++I +ELV  G      +     L   ++         G+ YL  ++ +
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---TPF-WMAPEVVNLKNRGYG 455
           HRD+   N LV     +K++DFG+++        S  G    P  W APE +N     Y 
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR--YS 174

Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
             +D+WS G  + E  +    PY++L   Q    I +G     P          + +C +
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234

Query: 515 VNPNDRPT 522
            +P  RP+
Sbjct: 235 YDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 69/246 (28%), Positives = 114/246 (46%), Gaps = 14/246 (5%)

Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           LGSG+FG V +G Y        V    L+++  +  +  +  E EI+   + ++  IV+ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIM--HQLDNPYIVRM 60

Query: 344 FGTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
            G  + E  L + +E+ + G L      +K  +  S V     Q+  G+ YL  +N VHR
Sbjct: 61  IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRGYGL 456
           D+   N+L+      K++DFGL+KA   +D     +S    P  W APE +N   R +  
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF--RKFSS 177

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G T+ E  +  Q PY  ++G + +  I +G+    P     +    +  C   
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237

Query: 516 NPNDRP 521
              DRP
Sbjct: 238 KWEDRP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 86.6 bits (214), Expect = 3e-18
 Identities = 78/312 (25%), Positives = 140/312 (44%), Gaps = 62/312 (19%)

Query: 279 WQKGELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + K + LG G+FG V      D    +A+K +  +D   + + + ++ E++IL  +  ++
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL--AEADN 60

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQ 396
           E +V+ + + +D++ L+  ++ +  G + +L  +  +    ++  Y  ++   +  +H+ 
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLA------------------KATTMN------DV 432
             +HRDIK  NIL+D  G +KL DFGL                   +  +M+      D 
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 433 KSCK-------------------------GTPFWMAPEVVNLKNRGYGLTADIWSLGCTV 467
            +C+                         GTP ++APEV  L   GY    D WS+G  +
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV--LLRTGYTQLCDWWSVGVIL 238

Query: 468 LEMLTRQPPYSHLEGMQALFRIGKGEPPL-VP--NSLSRDARDFILKCLQVNPNDR---P 521
            EML  QPP+     ++   ++   +  L +P    LS +A D I+K L   P DR    
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKN 297

Query: 522 TAAQLMEHPFVK 533
            A ++  HPF K
Sbjct: 298 GADEIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 81/280 (28%), Positives = 127/280 (45%), Gaps = 41/280 (14%)

Query: 282 GELLGSGSFGTVY--------EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           G+ LG G FG V         +   +     AVK   L+D  T    S L  E E++ + 
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK--MLKDDATDKDLSDLVSEMEMMKMI 74

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVS- 380
             +H+NI+   G    +  L++ +E  +KG+L               +    L + Q++ 
Sbjct: 75  G-KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133

Query: 381 ------AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-- 432
                 AY  Q+  G+ YL  Q  +HRD+   N+LV     +K+ADFGLA+     D   
Sbjct: 134 KDLVSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 433 KSCKGT-PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP-PYSHLEGMQALFRI 489
           K+  G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 192 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKL 248

Query: 490 GK-GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K G     P + + +    + +C    P+ RPT  QL+E
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 348 KDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC 405
           +DEN L++ ++    G L  L  K+   L +     Y  +++  ++ +H+   VHRDIK 
Sbjct: 71  QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKP 130

Query: 406 ANILVDASGSVKLADFG-----LAKATTMNDVKSCKGTPFWMAPEVVNLKNRG---YGLT 457
            N+L+D +G ++LADFG     LA  T  ++V    GTP +++PE++     G   YG  
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--GTPDYISPEILQAMEDGKGRYGPE 188

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-----PPLVPNSLSRDARDFILK- 511
            D WSLG  + EML  + P+     ++   +I   +     PP V + +S +A+D I + 
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD-VSEEAKDLIRRL 247

Query: 512 -CLQVNPNDRPTAAQLMEHPF 531
            C       R       +HPF
Sbjct: 248 ICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 71/283 (25%), Positives = 130/283 (45%), Gaps = 41/283 (14%)

Query: 284 LLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           ++G G++G V +  + +     A+K+    ++  + K++ L+   E+ +L   + ENIV+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQENIVE 64

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHR 401
                +   +L++  E V K  L  L +  + +   +V +Y  Q++  +++ H+ ++VHR
Sbjct: 65  LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR 124

Query: 402 DIKCANILVDASGSVKLADFGLAKATTM-NDVKSCK--GTPFWMAPEVVNLKNRGYGLTA 458
           DIK  N+L+  +  +KL DFG A+  +  ++    +   T ++ +PE+  L    YG   
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL--LLGAPYGKAV 182

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--------------------- 497
           D+WS+GC + E+   QP +     +  LF I K   PL                      
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242

Query: 498 --PNSLSRDAR--------DFILKCLQVNPNDRPTAAQLMEHP 530
             P SL R           D +   L++NP DR    Q + HP
Sbjct: 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 85.7 bits (212), Expect = 4e-18
 Identities = 81/301 (26%), Positives = 132/301 (43%), Gaps = 46/301 (15%)

Query: 284 LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
            +GSG++G+V        G   A+K++S   +  Q +    +  +E+ LL   +HEN++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 343 YFG--TDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQN 397
                T       F    LV      +L QK   + L + +V     Q+L GL Y+H   
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDL-QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG 137

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K  N+ V+    +K+ DFGLA+     ++     T ++ APEV+ L    Y  T
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVI-LNWMHYNQT 195

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP--------------------- 494
            DIWS+GC + EMLT +  +   + +  L +I K  G P                     
Sbjct: 196 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLP 255

Query: 495 --------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK--RPLQKSRGPPS 544
                    L P + S  A D + K L+++ + R TA + +EHP+    R   +      
Sbjct: 256 KYPRKDFSTLFPKA-SPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP 314

Query: 545 Y 545
           Y
Sbjct: 315 Y 315

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 43/281 (15%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEV---SLQDQGTQGKQSILQLEQEI 329
           R R+      +LL  G+FG ++ G   D      +EV   +++D  ++ + ++L   QE 
Sbjct: 5   RDRVTL---SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL--QES 59

Query: 330 LLLSRFEHENI-----VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV--SAY 382
            LL    H+NI     V     +      F+    +  G+L    Q+  L ++    +  
Sbjct: 60  CLLYGLSHQNILPILHVCIEDGEPP----FVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115

Query: 383 TR-------QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 435
           T+       QI  G++YLH++ V+H+DI   N ++D    VK+ D  L++     D   C
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HC 174

Query: 436 KGT----PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHL--EGMQALF 487
            G     P  WMA E  +L N+ Y   +D+WS G  + E++T  Q PY  +    M A  
Sbjct: 175 LGDNENRPVKWMALE--SLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232

Query: 488 RIGK--GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
           + G    +P   P+ L       +  C  ++P +RP+ +QL
Sbjct: 233 KDGYRLAQPINCPDELF----AVMACCWALDPEERPSFSQL 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 86/285 (30%), Positives = 125/285 (43%), Gaps = 51/285 (17%)

Query: 282 GELLGSGSFGTVY--EGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           G+ LG G FG V   E Y       D     AVK   L+D  T    + L  E E++ L 
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATDKDLADLISEMELMKLI 74

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVS- 380
             +H+NI+   G    E  L++ +E   KG+L               +    + + Q+S 
Sbjct: 75  G-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 381 ------AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 434
                 AY  Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+   ++D+  
Sbjct: 134 KDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG--VHDIDY 189

Query: 435 CKGT-----PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHL--EGMQA 485
            K T     P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  E +  
Sbjct: 190 YKKTSNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247

Query: 486 LFRIGK--GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           L R G    +P    + L    R+    C    P  RPT  QL+E
Sbjct: 248 LLREGHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 27/264 (10%)

Query: 284 LLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
            LG G FG V+                 VK  +LQ    +  QS  +  +E+ +  +  H
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVK--ALQKTKDENLQS--EFRRELDMFRKLSH 67

Query: 338 ENIVQYFGTDKDENRLFIFLE----------LVTKGSLANLYQKYHLMDSQVSAYTRQIL 387
           +N+V+  G  ++    ++ LE          L    S     +   L   Q  A   QI 
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT--PF-WMAP 444
            G+++L     VHRD+   N LV +   VK++   L+K    ++    +    P  W+AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPL-VPNSLS 502
           E V  +   +   +D+WS G  + E+ T+ + P+  L   + L R+  G+  L VP    
Sbjct: 188 EAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCP 245

Query: 503 RDARDFILKCLQVNPNDRPTAAQL 526
                 + +C  VNP DRP+ ++L
Sbjct: 246 SRLYKLMTRCWAVNPKDRPSFSEL 269

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 15/262 (5%)

Query: 284 LLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKQ-SILQLEQEILL--LSRFEHEN 339
           ++G G FG VY     D G  +A+K   L  +  + KQ   L L + I+L  +S  +   
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           IV         ++L   L+L+  G L  +L Q     + ++  Y  +I+ GL ++H + V
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV 118

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           V+RD+K ANIL+D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +A
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGTAYDSSA 177

Query: 459 DIWSLGCTVLEMLTRQPPYSH--LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           D +SLGC + ++L    P+     +    + R+       +P+S S + +  +   LQ +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237

Query: 517 PNDR-----PTAAQLMEHPFVK 533
            + R       A ++ EH F K
Sbjct: 238 VSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 85.4 bits (211), Expect = 6e-18
 Identities = 77/307 (25%), Positives = 135/307 (43%), Gaps = 60/307 (19%)

Query: 281 KGELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           K + LG G+FG V      D    +A+K +  +D   + + + ++ E++IL  +  ++E 
Sbjct: 5   KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDIL--AEADNEW 62

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNV 398
           +V+ + + +D++ L+  ++ +  G + +L  +  +    ++  Y  ++   +  +H+   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 399 VHRDIKCANILVDASGSVKLADFGLA------------------KATTM------NDVKS 434
           +HRDIK  NIL+D  G +KL DFGL                   +  +M      +DV +
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 435 CK-------------------------GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLE 469
           C+                         GTP ++APEV  L  +GY    D WS+G  + E
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV--LLRKGYTQLCDWWSVGVILFE 240

Query: 470 MLTRQPPYSHLEGMQALFRIGKGEPPL-VPNS--LSRDARDFILK--CLQVNPNDRPTAA 524
           ML  QPP+      +   ++   E  L +P    LS +A D I K  C       R  A 
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300

Query: 525 QLMEHPF 531
            +  HPF
Sbjct: 301 DIKAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 26/268 (9%)

Query: 282 GELLGSGSFGTVYEGY--TDDGFF-FAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           G+ LG G FG+V EG    DD     AVK + +       +  +     E + +  F+H 
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI---AICTRSEMEDFLSEAVCMKEFDHP 60

Query: 339 NIVQYFGT--DKDENRLF----IFLELVTKGSLAN--LYQKY-----HLMDSQVSAYTRQ 385
           N+++  G      E+  +    + L  +  G L +  LY +      +L    +  +   
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTPFW 441
           I +G+ YL  ++ +HRD+   N +++ + +V +ADFGL+K     D     +  K    W
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNS 500
           +A E  +L +R Y   +D+WS G T+ E+ TR Q PY  +E  +    + +G     P  
Sbjct: 181 IAIE--SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238

Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
                   +  C  +NP DRP+   L  
Sbjct: 239 CLDGLYSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 18/252 (7%)

Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           + +G G FG V  G    G   AVK +   D   Q          E  ++++  H N+VQ
Sbjct: 12  QTIGKGEFGDVMLG-DYRGNKVAVKCIK-NDATAQA------FLAEASVMTQLRHSNLVQ 63

Query: 343 YFGTDKDEN-RLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNGLNYLHEQNV 398
             G   +E   L+I  E + KGSL +  +   +  L    +  ++  +   + YL   N 
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123

Query: 399 VHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           VHRD+   N+LV      K++DFGL K A++  D  + K    W APE   L+ + +   
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEA--LREKKFSTK 179

Query: 458 ADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+WS G  + E+ +  + PY  +     + R+ KG     P+       D + +C  ++
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLD 239

Query: 517 PNDRPTAAQLME 528
              RP+  QL E
Sbjct: 240 AATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 61/264 (23%), Positives = 120/264 (45%), Gaps = 23/264 (8%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V +     DG         +++  ++        E E+L      H NI+
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNII 59

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ----------VSAYTRQIL---- 387
              G  +    L++ +E    G+L +  +K  ++++            +  ++Q+L    
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 388 ---NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF-WMA 443
               G++YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    P  WMA
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
            E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     P +  
Sbjct: 180 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237

Query: 503 RDARDFILKCLQVNPNDRPTAAQL 526
            +  D + +C +  P +RP+ AQ+
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 27/267 (10%)

Query: 285 LGSGSFGTVYEGYTDDGFFFA---VKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +G+G FG V  G    G   A   VKE  L+   T  +Q  L   QE+       H N++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKE--LRASATPDEQ--LLFLQEVQPYRELNHPNVL 58

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQ------ILNGLNYLHE 395
           Q  G   +     + LE    G L N  +    M +Q++           + +GL +LH+
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTPF-WMAPEVV---- 447
            + +H D+   N  + A  SVK+ D+GLA      D    K C   P  W+APE+V    
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 448 -NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPN---SLS 502
            +L  +     ++IWSLG T+ E+ T    PY  L   Q L ++ + +   +P     L 
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238

Query: 503 RDARDF-ILKCLQVNPNDRPTAAQLME 528
              R + +++   ++P  RPTA ++ E
Sbjct: 239 YSDRWYEVMQFCWLDPETRPTAEEVHE 265

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 81/296 (27%), Positives = 131/296 (44%), Gaps = 54/296 (18%)

Query: 283 ELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V      D G  +A+K +   D   + + + ++ E++IL+ +  +   +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA--DGAWVV 64

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVH 400
           + F + +D+  L++ +E +  G +  L  K   L +     Y  + +  ++ +H+   +H
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124

Query: 401 RDIKCANILVDASGSVKLADFGLAKA-----------------------TTMNDVK---- 433
           RDIK  N+L+DA G VKL+DFGL                            MN  +    
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 434 ----------SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM 483
                     S  GTP ++APEV      GY    D WSLG  + EML   PP+   E  
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEV--FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ETP 241

Query: 484 QALFR--IGKGE----PPLVPNSLSRDARDFILK-CLQV-NPNDRPTAAQLMEHPF 531
           Q  +R  +   E    PP VP  +S  A+D IL+ C    N        ++  HPF
Sbjct: 242 QETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (206), Expect = 3e-17
 Identities = 77/306 (25%), Positives = 124/306 (40%), Gaps = 62/306 (20%)

Query: 283 ELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V      D G  +A+K  +L       K  +  ++ E  +L+  +   +V
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
             + + +D   L++ +E +  G L  +  KY      V+  Y  + +  +  +H+   +H
Sbjct: 65  SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH 124

Query: 401 RDIKCANILVDASGSVKLADFGLA-----------------------KATTMNDVK---- 433
           RDIK  NIL+D  G +KL+DFGL+                       +    N V     
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184

Query: 434 ----------------------SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEML 471
                                 S  GTP ++APE+     +GYG   D WSLG  + E L
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI--FLQQGYGQECDWWSLGAIMFECL 242

Query: 472 TRQPPYSHLEGMQALFR--IGKGEPPLVPN--SLSRDARDFILKCLQVNPN--DRPTAAQ 525
              PP+   E     +R  I   E    P+   LS +A D I + +    N   R  A +
Sbjct: 243 IGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHE 301

Query: 526 LMEHPF 531
           +  HPF
Sbjct: 302 IKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 31/270 (11%)

Query: 284 LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEIL--LLSRFEHENI 340
           +LG G FG V        G  +A K++  +    +  +++   E+ IL  + SRF    +
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF----V 62

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL-------MDSQVSA-YTRQILNGLNY 392
           V      + ++ L + L ++  G L     K+H+        D Q +  Y  ++  GL  
Sbjct: 63  VSLAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFDEQRAIFYAAELCCGLED 117

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKN 451
           L  + +V+RD+K  NIL+D  G ++++D GLA      + V+   GT  +MAPEV+N  N
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN--N 175

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQ--ALFRIGKGEPPLVPNSLSRDARDF 508
             Y  + D W LGC + EM+  Q P+    E ++   + R  K +        S DA+  
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235

Query: 509 ILKCLQVNPNDR-----PTAAQLMEHPFVK 533
               L  NP +R       AA + +HP  K
Sbjct: 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 70/238 (29%), Positives = 116/238 (48%), Gaps = 21/238 (8%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ---EILLLSRFEHENI 340
           +GSG++G+V   Y T      AVK++S      +  QS++   +   E+ LL   +HEN+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLS------RPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 341 VQYFGTDKDENRLFIFLE--LVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           +           +  F E  LVT      L N+ +   L D  V     Q+L GL Y+H 
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
             ++HRD+K +N+ V+    +++ DFGLA+    +++     T ++ APE++ L    Y 
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYVATRWYRAPEIM-LNWMHYN 194

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI----GKGEPPLVPNSLSRDARDFI 509
            T DIWS+GC + E+L  +  +   + +  L RI    G   P ++    S  AR +I
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 50/281 (17%)

Query: 285 LGSGSFGTVYEGY------TDDGFFFAVK----EVSLQDQGTQGKQSILQLEQEILLLSR 334
           +G G+FG V++         +     AVK    E S   Q           ++E  L++ 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--------ADFQREAALMAE 64

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ------------------KYHLMD 376
           F+H NIV+  G       + +  E +  G L    +                  K  L  
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 377 SQVS-----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 431
             +S        +Q+  G+ YL E+  VHRD+   N LV  +  VK+ADFGL++     D
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Query: 432 VKSCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR--QPPYSHLEGMQA 485
                        WM PE +   NR Y   +D+W+ G  + E+ +   QP Y  +   + 
Sbjct: 185 YYKASENDAIPIRWMPPESI-FYNR-YTTESDVWAYGVVLWEIFSYGMQPYYG-MAHEEV 241

Query: 486 LFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
           ++ +  G     P++   +  + +  C    P+DRP+ A +
Sbjct: 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 60/265 (22%), Positives = 119/265 (44%), Gaps = 23/265 (8%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V +     DG         +++  ++        E E+L      H NI+
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNII 71

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------------QVSAYTR 384
              G  +    L++ +E    G+L +  +K  ++++                 Q+  +  
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF-WMA 443
            +  G++YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    P  WMA
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 191

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
            E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     P +  
Sbjct: 192 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 249

Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
            +  D + +C +  P +RP+ AQ++
Sbjct: 250 DEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 69/265 (26%), Positives = 119/265 (44%), Gaps = 23/265 (8%)

Query: 282 GELLGSGSFGTVYEGY--TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           G +LG G FG+V E    ++DG F  V  V +          I +  +E   +  F+H N
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 340 IVQYFGTD---KDENRL---FIFLELVTKGSLANLY-------QKYHLMDSQVSAYTRQI 386
           +++  G     + + RL    + L  +  G L           + + L    +  +   I
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSC--KGTPFWM 442
            +G+ YL  +N +HRD+   N +++ + +V +ADFGL+K     D   + C  K    W+
Sbjct: 123 ASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSL 501
           A E  +L +  Y   +D+W+ G T+ E++TR Q PY+ +E  +    + KG     P   
Sbjct: 183 ALE--SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240

Query: 502 SRDARDFILKCLQVNPNDRPTAAQL 526
             D  + + +C    P  RP+   L
Sbjct: 241 LEDVYELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 37/278 (13%)

Query: 282 GELLGSGSFGTVYEGYT---DDGFFFAVKEVS---LQDQGTQGKQSILQLEQEILLLSRF 335
           G+ LG G FG V        D      V +V+   L+   T+   S L  E E++ +   
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG- 81

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVS--- 380
           +H+NI+   G    +  L++ +E  +KG+L               Y    + + Q+S   
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 381 ----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KS 434
               AY  Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+
Sbjct: 142 LVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 435 CKGT-PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK 491
             G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K
Sbjct: 200 TNGRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLK 256

Query: 492 -GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            G     P++ + +    +  C    P+ RPT  QL+E
Sbjct: 257 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 50/273 (18%)

Query: 283 ELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V      D G  +A+K +   D   + +   ++ E++IL+ +  +   +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA--DSLWVV 64

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVH 400
           + F + +D+  L++ +E +  G +  L  K   L + +   Y  + +  ++ +H+   +H
Sbjct: 65  KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124

Query: 401 RDIKCANILVDASGSVKLADFGLAKA-----------------------TTMNDVK---- 433
           RDIK  N+L+D+ G VKL+DFGL                            MN  +    
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 434 ----------SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM 483
                     S  GTP ++APEV      GY    D WSLG  + EML   PP+      
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEV--FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 484 QALFRIGKGE-----PPLVPNSLSRDARDFILK 511
           +   ++   +     PP VP  +S  A+D IL+
Sbjct: 243 ETYKKVMNWKETLIFPPEVP--ISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 28/277 (10%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
           +K ++LGSG+FGTVY+G +  DG       A+K V  ++   +  + IL    E  +++ 
Sbjct: 10  KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK-VLRENTSPKANKEILD---EAYVMAG 65

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTK----GSLANLYQ--KYHLMDSQVSAYTRQILN 388
                + +  G       L   ++LVT+    G L +  +  K  +    +  +  QI  
Sbjct: 66  VGSPYVCRLLGI-----CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----SCKGTPFWMAP 444
           G++YL E  +VHRD+   N+LV +   VK+ DFGLA+   +++ +      K    WMA 
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSR 503
           E  ++ +R +   +D+WS G TV E++T    PY  +   +    + KGE    P   + 
Sbjct: 181 E--SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTI 238

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
           D    ++KC  ++   RP   +L+   F +     SR
Sbjct: 239 DVYMIMVKCWMIDSECRPRFRELV-DEFSRMARDPSR 274

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 38/271 (14%)

Query: 285 LGSGSFGTVYEGYTDD------GFFFAVKEV----SLQDQGTQGKQSILQLEQEILLLSR 334
           LG GSFG VYEG   D          AVK V    SL+++        ++   E  ++  
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER--------IEFLNEASVMKG 65

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ------------VSAY 382
           F   ++V+  G         + +EL+  G L + Y +    +++            +   
Sbjct: 66  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS-YLRSLRPEAENNPGRPPPTLQEMIQM 124

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TP 439
             +I +G+ YL+ +  VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 440 F-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLV 497
             WMAPE  +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     
Sbjct: 185 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242

Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           P++      D +  C Q NP  RPT  +++ 
Sbjct: 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 66/276 (23%), Positives = 113/276 (40%), Gaps = 60/276 (21%)

Query: 325 LEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR 384
           L+ E++L   F H NI+  +      + L++    +  GS  +L + Y   +    A   
Sbjct: 46  LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF-PEGMSEALIG 104

Query: 385 QIL----NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF 440
            IL     GLNYLH+   +HR+IK ++IL+   G V L+      +   N  K+     F
Sbjct: 105 NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164

Query: 441 ---------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK 491
                    W++PE++     GY + +DI+S+G T  E+ T + P+  +   Q L +  K
Sbjct: 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK 224

Query: 492 GEP--PL--------------------------------------------VPNSLSRDA 505
           G P  PL                                               + S   
Sbjct: 225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF 284

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
           ++ +  CLQ +P  RP+A+ L+ H F K+  ++++G
Sbjct: 285 QNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQG 320

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 84/330 (25%), Positives = 139/330 (42%), Gaps = 85/330 (25%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVS--LQDQGTQGKQSILQLEQEILLLS 333
           +Q  + +GSG+ G V   Y  D       A+K++S   Q+Q T  K++     +E++L+ 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQ-THAKRAY----RELVLMK 78

Query: 334 RFEHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQ 385
              H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 134

Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPE 445
           +L G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185

Query: 446 VVNLKNR--------GYGLTADIWSLGCTVLEMLTRQ---------------------PP 476
           VV    R        GY    DIWS+GC + EM+                        P 
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245

Query: 477 YSHLEGMQALFRI---------GKGEPPLVPNSL-----------SRDARDFILKCLQVN 516
              ++ +Q   R          G     L P+ L           +  ARD + K L ++
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305

Query: 517 PNDRPTAAQLMEHPFVK---RPLQKSRGPP 543
            + R +  + ++HP++     P +    PP
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPP 335

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 16/176 (9%)

Query: 348 KDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC 405
           +DEN L++ ++    G L  L  K+   L +     Y  +++  ++ +H+ + VHRDIK 
Sbjct: 71  QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130

Query: 406 ANILVDASGSVKLADFGLAKATTMNDVKSCK-----GTPFWMAPEVVNLKNRG---YGLT 457
            N+L+D +G ++LADFG      MN   + +     GTP +++PE++     G   YG  
Sbjct: 131 DNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188

Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----PLVPNSLSRDARDFI 509
            D WSLG  + EML  + P+     ++   +I   E     P     +S +A+D I
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 61/264 (23%), Positives = 117/264 (44%), Gaps = 23/264 (8%)

Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V       DG         L++  ++        E E+L      H NI+
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLC-KLGHHPNII 66

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------------QVSAYTR 384
              G  ++   L+I +E    G+L +  +K  ++++                 Q+  +  
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF-WMA 443
            +  G+ YL E+  +HRD+   N+LV  + + K+ADFGL++   +   K+    P  WMA
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
            E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     P +  
Sbjct: 187 IESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCD 244

Query: 503 RDARDFILKCLQVNPNDRPTAAQL 526
            +  + + +C +  P +RP  AQ+
Sbjct: 245 DEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 25/217 (11%)

Query: 281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           +G  +G G++G VY+    DG     KE +L+    +G    +   +EI LL   +H N+
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQ--IEGTGISMSACREIALLRELKHPNV 60

Query: 341 V---QYFGTDKDENRLFIF------LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNG 389
           +   + F +  D     +F      L  + K   A+   K    L  S V +   QIL+G
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 390 LNYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAK-----ATTMNDVKSCKGTPF 440
           ++YLH   V+HRD+K ANILV       G VK+AD G A+        + D+     T +
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY 477
           + APE++ L  R Y    DIW++GC   E+LT +P +
Sbjct: 181 YRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 77.6 bits (192), Expect = 6e-16
 Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 19/160 (11%)

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDVKSC-KGTPFW 441
           RQ++  LN LH+ N++H DIK  N+L D A   + L D+GL K        SC  GT  +
Sbjct: 116 RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSCYDGTLDY 172

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS-------HLEGMQALFRIGKGEP 494
            +PE   +K   Y ++ D W++G    E+LT + P+         LE +  L R  K   
Sbjct: 173 FSPE--KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL--LKRQQK--K 226

Query: 495 PLVPNSLSRDARDFILKCLQVNPNDR-PTAAQLMEHPFVK 533
                ++S++A DF+   L+ N N R     ++++HPF+K
Sbjct: 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 78.2 bits (192), Expect = 9e-16
 Identities = 69/266 (25%), Positives = 128/266 (48%), Gaps = 21/266 (7%)

Query: 283 ELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +++G G+FG V      +    FA+K ++  +   + + +  + E+++L+    +    +
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVV 399
            Y    +DEN L++ ++    G L  L  K+   L +     Y  +++  ++ +H+ + V
Sbjct: 67  HY--AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 400 HRDIKCANILVDASGSVKLADFG-----LAKATTMNDVKSCKGTPFWMAPEVVNLKNRG- 453
           HRDIK  NIL+D +G ++LADFG     +   T  + V    GTP +++PE++     G 
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--GTPDYISPEILQAMEDGK 182

Query: 454 --YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI----GKGEPPLVPNSLSRDARD 507
             YG   D WSLG  + EML  + P+     ++   +I     + + P     +S DA+D
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242

Query: 508 FI--LKCLQVNPNDRPTAAQLMEHPF 531
            I  L C + +   +       +HPF
Sbjct: 243 LIRRLICSREHRLGQNGIEDFKQHPF 268

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 22/262 (8%)

Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSI---LQLEQEILLLSRFEHENIV 341
           LG GSFG VYEG    G      E  +  +      S+   ++   E  ++  F   ++V
Sbjct: 14  LGQGSFGMVYEGIAK-GVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-----------SQVSAYTRQILNGL 390
           +  G         + +EL+T+G L +  +                  ++     +I +G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMAPEV 446
            YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+PE 
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE- 191

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
            +LK+  +   +D+WS G  + E+ T  + PY  +   Q L  + +G     P++     
Sbjct: 192 -SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDML 250

Query: 506 RDFILKCLQVNPNDRPTAAQLM 527
            + +  C Q NP  RP+  +++
Sbjct: 251 FELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 31/220 (14%)

Query: 281 KGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +G  +G G++G VY+    DG     +A+K++       +G    +   +EI LL   +H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-------EGTGISMSACREIALLRELKH 57

Query: 338 ENIV---QYFGTDKDENRLFIF------LELVTKGSLANLYQK--YHLMDSQVSAYTRQI 386
            N++   + F +  D     +F      L  + K   A+   K    L    V +   QI
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAK-----ATTMNDVKSCKG 437
           L+G++YLH   V+HRD+K ANILV       G VK+AD G A+        + D+     
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY 477
           T ++ APE++ L  R Y    DIW++GC   E+LT +P +
Sbjct: 178 TFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 62/243 (25%), Positives = 107/243 (44%), Gaps = 45/243 (18%)

Query: 327 QEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ-------- 378
           +E+ +LSR +  NI++  G   DE+ L +  E +  G L      +HL D +        
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 379 ------VSAYTR------QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 426
                   +Y+       QI +G+ YL   N VHRD+   N LV  + ++K+ADFG+++ 
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187

Query: 427 TTMNDVKSCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHL 480
               D    +G       WMA E + +    +   +D+W+ G T+ E+L   ++ PY  L
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKEQPYGEL 245

Query: 481 EGMQALFRIGK-----------GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
              Q +   G+             PP  P  L     + +L+C   +  +RP+ + +  H
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY----ELMLQCWSRDCRERPSFSDI--H 299

Query: 530 PFV 532
            F+
Sbjct: 300 AFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 52/288 (18%)

Query: 280 QKGELLGSGSFGTVYE----------GYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEI 329
             G+ LG G FG V +          GYT      AVK   L++  +  +  +  L  E 
Sbjct: 3   VLGKTLGEGEFGKVVKATAFRLKGRAGYTT----VAVK--MLKENASSSE--LRDLLSEF 54

Query: 330 LLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSL------------------ANLYQK 371
            LL +  H ++++ +G    +  L + +E    GSL                   N    
Sbjct: 55  NLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSS 114

Query: 372 YHLMDSQ-------VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA 424
           Y     +       + ++  QI  G+ YL E  +VHRD+   N+LV     +K++DFGL+
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 425 KATTMND--VKSCKG-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSH 479
           +     D  VK  KG  P  WMA E  +L +  Y   +D+WS G  + E++T    PY  
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Query: 480 LEGMQALFRIGK-GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
           +   + LF + K G     P + S +  + +L C +  P+ RPT A +
Sbjct: 233 I-APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 32/265 (12%)

Query: 283 ELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           E++G+G FG V  G          F A+K  +L+   T+ ++     E  I+   +F+H 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIK--TLKSGYTEKQRRDFLSEASIM--GQFDHP 65

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQ 396
           NI+   G       + I  E +  G+L +  ++        Q+    R I  G+ YL E 
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAK-------ATTMNDVKSCKGTPFWMAPEVVNL 449
           N VHRD+   NILV+++   K++DFGL++         T       K    W APE +  
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 450 KNRGYGLTADIWSLGCTVLEMLTR-QPPY---SHLEGMQAL---FRIGKGEPPLVPNSLS 502
             R +   +D+WS G  + E+++  + PY   S+ + + A+   +R+    P   P +L 
Sbjct: 186 --RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP--PMDCPTALH 241

Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
           +     +L C Q + N RP   Q++
Sbjct: 242 Q----LMLDCWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 26/257 (10%)

Query: 281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQ----DQGTQGKQSILQLEQEILLLSRFE 336
           K +++G+G FG V+ G          KEV++       G   KQ    L  E  ++ +F 
Sbjct: 9   KQKVIGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFL-SEASIMGQFS 64

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLN 391
           H NI++  G         I  E +  G+L + Y + H  D + S+Y      R I  G+ 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDH--DGEFSSYQLVGMLRGIAAGMK 121

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL + N VHRD+   NILV+++   K++DFGL++    +D +    T     P  W APE
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPE 180

Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRD 504
            +    R +   +D+WS G  + E+++  + PY  +   + +  I  G     P      
Sbjct: 181 AIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238

Query: 505 ARDFILKCLQVNPNDRP 521
               +L+C Q +   RP
Sbjct: 239 VYQLMLQCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 28/261 (10%)

Query: 284 LLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           ++G+G FG V  G            A+K  +L+   T+ ++     E  I+   +F+H N
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIK--TLKAGYTEKQRRDFLSEASIM--GQFDHPN 66

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQN 397
           I+   G       + I  E +  GSL    +K+       Q+    R I +G+ YL +  
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPEVVNLKN 451
            VHRD+   NILV+++   K++DFGL++    +D ++   T     P  W APE +    
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTAPEAIAY-- 183

Query: 452 RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG---EPPL-VPNSLSRDAR 506
           R +   +D+WS G  + E+++  + PY  +     +  I +G     P+  P +L +   
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ--- 240

Query: 507 DFILKCLQVNPNDRPTAAQLM 527
             +L C Q + N+RP   Q++
Sbjct: 241 -LMLDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 47/142 (33%), Positives = 64/142 (45%), Gaps = 19/142 (13%)

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTPFWM 442
           +QIL GL YLH Q ++HRD+K  NI ++    V + D G A+   +        GT    
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223

Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           APEV  L    Y   ADIWS G  + EML     Y        +F     +PP  P    
Sbjct: 224 APEV--LARDKYNSKADIWSAGIVLFEMLA----YPS-----TIFE----DPPSTPEEYV 268

Query: 503 RDARDFILK---CLQVNPNDRP 521
           +     +LK    L+V+P + P
Sbjct: 269 KSCHSHLLKIISTLKVHPEEFP 290

Length = 357

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 65/259 (25%), Positives = 117/259 (45%), Gaps = 28/259 (10%)

Query: 284 LLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           +LG+G FG +  G     +      A+   +L+  G   KQ    L  E L L +F+H N
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIH--TLRA-GCSDKQRRGFL-AEALTLGQFDHSN 67

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQN 397
           IV+  G     N + I  E ++ G+L +  +K+   L+  Q+      + +G+ YL E  
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC---KGTPFWMAPEVVNLKNRGY 454
            VH+ +    +LV++    K++ F   +      + +    K    W APE +   +  +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--F 185

Query: 455 GLTADIWSLGCTVLEMLTR-QPPY---SHLEGMQAL---FRIGKGEPPLVPNSLSRDARD 507
              +D+WS G  + E+++  + PY   S  + ++A+   FR+    P   PN L +    
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA--PRNCPNLLHQ---- 239

Query: 508 FILKCLQVNPNDRPTAAQL 526
            +L C Q    +RP  +Q+
Sbjct: 240 LMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 9/169 (5%)

Query: 367 NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 426
           +LY+K   ++  +  Y+ Q+  G+ +L  +  +HRD+   NIL+  +  VK+ DFGLA+ 
Sbjct: 170 DLYKKVLTLEDLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 228

Query: 427 TTMNDVKSCKGT---PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLE 481
              +     KG    P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286

Query: 482 -GMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
              +   R+ +G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 71.4 bits (175), Expect = 5e-14
 Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 28/195 (14%)

Query: 350 ENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANI 408
           E+ +F+ L+    G L +   K+ ++ +  V  +  +++  L+ LH + +V RD+   NI
Sbjct: 57  EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116

Query: 409 LVDASGSVKLADFGLAKATTMNDVK-SCKGTP---FWMAPEVVNLKNRGYGLTA--DIWS 462
           L+D  G ++L  F        ++V+ SC G      + APEV  +       T   D WS
Sbjct: 117 LLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGISE----ETEACDWWS 167

Query: 463 LGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRP 521
           LG  + E+LT +     H  G+     +       +P  +S +AR  + + LQ NP +R 
Sbjct: 168 LGAILFELLTGKTLVECHPSGINTHTTLN------IPEWVSEEARSLLQQLLQFNPTERL 221

Query: 522 TAA-----QLMEHPF 531
            A       +  HPF
Sbjct: 222 GAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 73.4 bits (180), Expect = 1e-13
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 4/147 (2%)

Query: 288 GSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT 346
           G+FG VY G   ++   +AVK V   D   +     +Q E++ L LS+     IV  + +
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF--IVHLYYS 72

Query: 347 DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVHRDIKC 405
            +  N +++ +E +  G + +L   Y   D +++  Y  ++   L+YLH   ++HRD+K 
Sbjct: 73  LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKP 132

Query: 406 ANILVDASGSVKLADFGLAKATTMNDV 432
            N+L+   G +KL DFGL+K T   ++
Sbjct: 133 DNMLISNEGHIKLTDFGLSKVTLNREL 159

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 68.2 bits (167), Expect = 2e-13
 Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 24/184 (13%)

Query: 363 GSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLAD 420
            SLA++ +     L + ++ A   Q L  L  LH Q      +   + L+   GSV    
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKT 60

Query: 421 FGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL 480
                       +  +  P++MAPEV  ++ + Y   ADI+SLG T+ E L  + PY+  
Sbjct: 61  -----------PEQSRPDPYFMAPEV--IQGQSYTEKADIYSLGITLYEALDYELPYNEE 107

Query: 481 EGMQALF-RIGKGEPPLVPN--------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
             + A+   +  G P   P         S +R   DF+  C    P  R  A   + H  
Sbjct: 108 RELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCR 167

Query: 532 VKRP 535
               
Sbjct: 168 ALFA 171

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 50/171 (29%), Positives = 87/171 (50%), Gaps = 11/171 (6%)

Query: 366 ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK 425
             LY++   ++  +S Y+ Q+  G+ +L  +  +HRD+   NIL+  +  VK+ DFGLA+
Sbjct: 163 DELYKEPLTLEDLIS-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 221

Query: 426 ATTMNDVKSCKGT---PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHL 480
               +     KG    P  WMAPE  ++ ++ Y   +D+WS G  + E+ +    PY  +
Sbjct: 222 DIYKDPDYVRKGDARLPLKWMAPE--SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279

Query: 481 EGMQALF--RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           + +   F  R+ +G     P   + +    +L C   NP DRPT ++L+E 
Sbjct: 280 Q-IDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 10/153 (6%)

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF- 440
           ++ Q+ NG+ +L  +N VHRD+   N+L+     VK+ DFGLA+    +     KG+ F 
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 441 ---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF--RIGKGEP 494
              WMAPE  ++ N  Y   +D+WS G  + E+ T    PY  L  M   F   I +G  
Sbjct: 304 PLKWMAPE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP-MNEQFYNAIKRGYR 360

Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
              P   S +  + + KC +     RP  +QL+
Sbjct: 361 MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 64/226 (28%), Positives = 95/226 (42%), Gaps = 39/226 (17%)

Query: 283 ELLGSGSFGTVYEG--YTDDGFFFA--VKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           E LG G+FG VY+G     +    A  V   +L++      Q   +  QE  L+S  +H 
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHP 68

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR-------------- 384
           NIV   G    E    +  E +  G L     ++ + +S  S                  
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDL----HEFLVRNSPHSDVGAESGDETVKSSLDCS 124

Query: 385 -------QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKS 434
                  QI  G+ YL   + VHRD+   N LV    +VK++DFGL++     D   V+S
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 435 CKGTPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR--QPPY 477
               P  WM PE + L  + +   +DIWS G  + E+ +   QP Y
Sbjct: 185 KSLLPVRWMPPEAI-LYGK-FTTESDIWSFGVVLWEIFSYGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 12/156 (7%)

Query: 381 AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF 440
           ++T Q+  G+ +L  +N VHRD+   N+L+     VK+ DFGLA+    +     KG+ F
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 441 ----WMAPEVV--NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKG 492
               WMAPE +  NL    Y   +D+WS G  + E+ +    PY  +      + +I  G
Sbjct: 301 LPVKWMAPESIFDNL----YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356

Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P+  +++  D ++KC    P  RP+   L +
Sbjct: 357 YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.4 bits (167), Expect = 7e-13
 Identities = 69/268 (25%), Positives = 114/268 (42%), Gaps = 33/268 (12%)

Query: 285 LGSGSFGTVYEGYTDDGFFFA---VKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           +G+G FG V  G  + G+  A   VKE+    + +   Q  ++  +E       +H N++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKEL----RVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS--------QVSAYTRQILNGLNYL 393
           Q  G   +     + +E    G L    +     +         Q  A   +I  GL +L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHL 116

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTPF-WMAPEVV-- 447
           H+ N +H D+   N L+ A  +VK+ D+GL+      D          P  W+APE+V  
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 448 ---NLKNRGYGLTADIWSLGCTVLEM--LTRQPPYSHLEGMQAL-FRIGKGEPPLVPNSL 501
              NL        +++WSLG T+ E+  L  Q PY HL   Q L + + + +  L    L
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQ-PYRHLSDEQVLTYTVREQQLKLPKPRL 235

Query: 502 SRDARDFILKCLQ---VNPNDRPTAAQL 526
                D   + +Q   + P  RP+A ++
Sbjct: 236 KLPLSDRWYEVMQFCWLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 60/219 (27%), Positives = 82/219 (37%), Gaps = 18/219 (8%)

Query: 328 EILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQIL 387
           E  +L    H +I+Q  GT        + L          L  K ++    + A  R +L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA---KATTMNDVKSCKGTPFWMAP 444
             + YLHE  ++HRDIK  NI ++  G V L DFG A        N      GT    AP
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP 252

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA-----------LFRIG--K 491
           E+  L    YG   DIWS G  + EM T        +G+             + R G   
Sbjct: 253 EL--LARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310

Query: 492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP 530
            E P+   +   +    + K     P  RP    L E P
Sbjct: 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELP 349

Length = 391

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 58/272 (21%)

Query: 318 GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ------- 370
           G ++ +QLE EIL L R  HENI++     + E   +    ++T+    +LY        
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEANTY----MITQKYDFDLYSFMYDEAF 258

Query: 371 --KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 428
             K   +  Q  A  +Q+L  + Y+H++ ++HRDIK  NI ++  G + L DFG   A  
Sbjct: 259 DWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG--TAMP 316

Query: 429 MNDVKSCK-----GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ--------- 474
               +        GT    +PE+  L   GY    DIWS G  +L+ML+           
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEI--LAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374

Query: 475 ----------------------PP---YSHLEGMQALFRIGKGEPPLVPN-SLSRDARDF 508
                                 PP   + +++  + +   G   PPL+ N  L  D    
Sbjct: 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAE-IDHAGHSVPPLIRNLGLPADFEYP 433

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
           ++K L  + + RP AA+L+  P      ++  
Sbjct: 434 LVKMLTFDWHLRPGAAELLALPLFSAEEEEEI 465

Length = 501

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 8/153 (5%)

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT--- 438
           Y+ Q+  G+ +L  +  +HRD+   NIL+  +  VK+ DFGLA+    +     KG+   
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 439 PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGEPP 495
           P  WMAPE  ++ ++ Y   +D+WS G  + E+ +    PY  ++  +    R+  G   
Sbjct: 239 PLKWMAPE--SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
             P + + +    +L C Q +P +RPT + L+E
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 2e-12
 Identities = 56/236 (23%), Positives = 91/236 (38%), Gaps = 17/236 (7%)

Query: 311 LQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-NRLFIFLELVTKGSLANLY 369
           L+    + +    +  +E  L +R  H NIV    + +     LF   E V   +L  + 
Sbjct: 11  LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL 70

Query: 370 Q-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLADFGL-- 423
                L   +      Q+L+ L   H Q +VHRD+K  NI+V  +G     K+ DFG+  
Sbjct: 71  AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130

Query: 424 -------AKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPP 476
                  A   T+       GTP + APE   L+       +D+++ G   LE LT Q  
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPE--QLRGEPVTPNSDLYAWGLIFLECLTGQRV 188

Query: 477 YSHLEGMQALFRIGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                  + L++        +P  +        + K L  +P  R  +A  +   F
Sbjct: 189 VQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.6 bits (165), Expect = 4e-12
 Identities = 49/179 (27%), Positives = 74/179 (41%), Gaps = 41/179 (22%)

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTPFWM 442
           R++L  L YLH + ++HRD+K  NI +D   +  L DFG A     +     C G   W 
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG---WS 248

Query: 443 ------APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL 496
                 +PE++ L    Y    DIWS G  + EM  +      L G Q            
Sbjct: 249 GTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVT---LFGKQ------------ 291

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTA------------AQLMEHPFVKRPLQKSRGPP 543
           V +S S   R  I++C+QV+P + P              A ++  P+   P+ +  G  
Sbjct: 292 VKSS-SSQLRS-IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMH 348

Length = 392

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 64/269 (23%), Positives = 107/269 (39%), Gaps = 38/269 (14%)

Query: 283 ELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           E LG   FG VY+G+           AV   +L+D+     +   + + E ++ SR +H 
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE--EFKHEAMMRSRLQHP 68

Query: 339 NIVQYFGT-DKDENRLFIFLELVTKGSLANLYQ--------------------KYHLMDS 377
           NIV   G   K++    IF    +  S ++L++                    K  L  +
Sbjct: 69  NIVCLLGVVTKEQPLSMIF----SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 437
                  QI  G+ +L   +VVH+D+   N+LV    +VK++D GL +     D     G
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 438 TPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ-PPYSHLEGMQALFRIGKG 492
                  WM+PE +      + + +DIWS G  + E+ +    PY        +  I   
Sbjct: 185 NSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242

Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRP 521
           +    P+         +L+C    P+ RP
Sbjct: 243 QVLPCPDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 70/273 (25%), Positives = 111/273 (40%), Gaps = 46/273 (16%)

Query: 283 ELLGSGSFGTVYEGY-----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           E LG  +FG +Y+G+      D     A+K  +L+D      Q   + +QE  L++   H
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKD--INNPQQWGEFQQEASLMAELHH 66

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS----------------- 380
            NIV   G    E  + +  E + +G L     ++ +M S  S                 
Sbjct: 67  PNIVCLLGVVTQEQPVCMLFEYLNQGDL----HEFLIMRSPHSDVGCSSDEDGTVKSSLD 122

Query: 381 -----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---V 432
                    QI  G+ YL     VH+D+   NIL+     VK++D GL++     D   V
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182

Query: 433 KSCKGTPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIG 490
           +     P  WM PE +      +   +DIWS G  + E+ +    PY      + +  + 
Sbjct: 183 QPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240

Query: 491 KGEPPLVPNSLSRDARDFIL--KCLQVNPNDRP 521
           K +  L+P S     R + L  +C Q  P+ RP
Sbjct: 241 KRQ--LLPCSEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 16/101 (15%)

Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 437
           QV+A  RQ+L+ ++Y+H + ++HRDIK  N+LV+    + L DFG A        +    
Sbjct: 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF-----ARGSWS 315

Query: 438 TPFWM---------APEVVNLKNRGYGLTADIWSLGCTVLE 469
           TPF           APEV  L    Y  + DIWS G  + E
Sbjct: 316 TPFHYGIAGTVDTNAPEV--LAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 8/154 (5%)

Query: 381 AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-- 438
           +++ Q+  G+++L  +N +HRD+   NIL+      K+ DFGLA+    +     KG   
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 439 -PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR-IGKGEP 494
            P  WMAPE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I +G  
Sbjct: 278 LPVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            L P     +  D +  C   +P  RPT  Q+++
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 67/264 (25%), Positives = 119/264 (45%), Gaps = 26/264 (9%)

Query: 285 LGSGSFGTVY--EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ 342
           +G+G FG V   E YTD G    V +    +  ++ +   LQ      +L   +H NI+Q
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL---QHPNILQ 59

Query: 343 YFGTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTR---QILNGLNYLHEQN 397
             G   +     +  E    G L +    +++H  +SQ+    R   +I  G+ ++H+ N
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTPF-WMAPEVVNLKNRG 453
            +H D+   N  + +  +VK+ D+G+  +    D    +  K  P  W+APE+V   + G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 454 YGLTAD------IWSLGCTVLEML-TRQPPYSHLEGMQALFRIGKGEPPLVPN-SLSRDA 505
             +TA+      +W+LG T+ E+      PYSHL   + L  + K +   +    L    
Sbjct: 180 L-ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238

Query: 506 RDFILKCLQ---VNPNDRPTAAQL 526
            +   + LQ   ++P  R TA ++
Sbjct: 239 SERWYEVLQFCWLSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 20/157 (12%)

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKG 437
           ++ Q+  G+++L  +N +HRD+   N+L+      K+ DFGLA+   MND    VK    
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNAR 275

Query: 438 TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK---- 491
            P  WMAPE  ++ +  Y + +D+WS G  + E+ +  + PY  +      +++ K    
Sbjct: 276 LPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333

Query: 492 -GEPPLVPNSLSRDARDFILK-CLQVNPNDRPTAAQL 526
              P   P  +       I+K C  + P +RPT +Q+
Sbjct: 334 MSRPDFAPPEIYS-----IMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.9 bits (153), Expect = 3e-10
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 34/168 (20%)

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM----------NDVKS 434
           +I   + Y+H + V+HRD+K  NIL+   G V + D+G A    +          ++   
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 435 CK----------GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ 484
           C           GTP +MAPE   L       + DI++LG  + +MLT   PY   +G +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Query: 485 ALFRIGKGEPPL-------VPNSLSRDARDFILKCLQVNPNDRPTAAQ 525
             +R      P+       +P  LS+ A    +K L V+P +R ++ Q
Sbjct: 239 ISYR-DVILSPIEVAPYREIPPFLSQIA----MKALAVDPAERYSSVQ 281

Length = 932

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 27/210 (12%)

Query: 285 LGSGSFGTVYEG----YTDDGFFFAVKEVS--LQDQGTQGKQSILQLEQEILLLSRFEHE 338
           LG G+F  +Y+G     +D       +EVS  L+  G+  + S L   +   L+S+  H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS-LAFFETASLMSQLSHK 61

Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-----TRQILNGLNY 392
           ++V+ +G   +DEN   +  E V  G L +++   H   + VS +      +Q+ + L+Y
Sbjct: 62  HLVKLYGVCVRDEN--IMVEEYVKFGPL-DVF--LHREKNNVSLHWKLDVAKQLASALHY 116

Query: 393 LHEQNVVHRDIKCANILV-----DASGS--VKLADFGLAKATTMNDVKSCKGTPFWMAPE 445
           L ++ +VH ++   NILV     +      +KL+D G+    T+   +       W+APE
Sbjct: 117 LEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI--PITVLSREERVERIPWIAPE 174

Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQP 475
            +        + AD WS G T+LE+ +   
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 27/62 (43%), Positives = 32/62 (51%), Gaps = 7/62 (11%)

Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 438
           +    RQ+L GL  LH   +VHRDIK  N+LV   G VK+ DFG A       V  C G 
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA-------VDMCTGI 363

Query: 439 PF 440
            F
Sbjct: 364 NF 365

Length = 507

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 20/217 (9%)

Query: 319 KQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----RLFIFLELVTKGSLANLYQKYHL 374
           K  I   E EI  L R +  NI++ +G   D      RL + LE  T+G L         
Sbjct: 59  KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE----VLD 114

Query: 375 MDSQVSAYTR-----QILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATT 428
            +  +S  T+         GL  L++  N  ++++   + LV  +  +K+   GL K  +
Sbjct: 115 KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174

Query: 429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL---EGMQA 485
               K+      + + +++N     Y +  DI+SLG  + E+ T + P+ +L   E    
Sbjct: 175 SPPFKNVN-FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233

Query: 486 LFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPT 522
           +          +P     + +  +  C   +   RP 
Sbjct: 234 IINKNNSLK--LPLDCPLEIKCIVEACTSHDSIKRPN 268

Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 56/258 (21%), Positives = 111/258 (43%), Gaps = 27/258 (10%)

Query: 283 ELLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           E LG G+F  +++G      D       EV L+      +       +   ++S+  H++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-----LMDSQVSAYTRQILNGLNYLH 394
           +V  +G     +   +  E V  GSL    +K           +V+   +Q+   L++L 
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA---KQLAWALHFLE 117

Query: 395 EQNVVHRDIKCANILV-----DASGS---VKLADFGLAKATTMNDVKSCKGTPFWMAPEV 446
           ++ + H ++   N+L+       +G+   +KL+D G++      ++   +  P W+ PE 
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER-IP-WVPPEC 175

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQAL-FRIGKGEPPLVPNSLSRD 504
           +    +   L AD WS G T+ E+ +    P S L+  + L F   + + P  P     +
Sbjct: 176 IE-NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP-APKWT--E 231

Query: 505 ARDFILKCLQVNPNDRPT 522
             + I +C+   P+ RP+
Sbjct: 232 LANLINQCMDYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 61/217 (28%)

Query: 390 LNYLH-EQNVVHRDIKCANILVDASGS----------------VKLADFGLAKATTMNDV 432
           L+Y H E +++H D+K  NIL++ S +                V++ D G       +  
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR 302

Query: 433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY------SHLEGMQAL 486
            +   T  + +PEVV     G+  + D+WS+GC + E+ T +  Y       HL  M+  
Sbjct: 303 TAIVSTRHYRSPEVV--LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360

Query: 487 F---------RIGKGEPPLVPNS------------LSRDAR--------------DFILK 511
                     R G  E  L+ NS            L+R AR              D I  
Sbjct: 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420

Query: 512 CLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNN 548
            L  +   R  A Q+  HP+V +   + R  P+Y +N
Sbjct: 421 LLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDN 457

Length = 467

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 29/162 (17%)

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASG-------SVKLADFGLAKATTMNDVKSCK 436
           +Q+ + L+YL ++++VH ++   NIL+   G        +KL+D G+    T+   + C 
Sbjct: 112 KQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI--PITVLSRQECV 169

Query: 437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL 496
               W+APE V   ++   + AD WS G T+ E+                     GE PL
Sbjct: 170 ERIPWIAPECVE-DSKNLSIAADKWSFGTTLWEICY------------------NGEIPL 210

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
              +L+   R +  +C+ V P      A LM H     P Q+
Sbjct: 211 KDKTLAEKERFYEGQCMLVTP-SCKELADLMTHCMNYDPNQR 251

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 25/153 (16%)

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASG-------SVKLADFGLAKATTMNDVKSCK 436
           +Q+ + L+YL ++N+VH ++   NIL+   G        +KL+D G++  T ++  +  +
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERVE 182

Query: 437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEM-------LTRQPPYSHLEGMQALFRI 489
             P W+APE V   N      AD WS G T+LE+       L  + P       +   R+
Sbjct: 183 RIP-WIAPECVPGGN-SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRL 240

Query: 490 GKGEPPLVPNSLSRDARDFILKCLQVNPNDRPT 522
                   P    ++    I +CL   P  RP+
Sbjct: 241 --------PEPSCKELATLISQCLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 53/260 (20%), Positives = 92/260 (35%), Gaps = 73/260 (28%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ--------EIL 330
           W+  +L+G G FG VYE                        Q++ ++E         E L
Sbjct: 14  WKIDKLIGCGGFGCVYE-------------TQCASDHCINNQAVAKIENLENETIVMETL 60

Query: 331 L---------------LSRFEHENIVQYFGTDK-DENRL---FIFLELVTKGSLANLYQK 371
           +               +   +H  I +Y+G       R+   FI LE         L + 
Sbjct: 61  VYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLE--------KLVEN 112

Query: 372 YHLMDSQVSAY--------TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGL 423
              +  ++            + +L  L Y+HE  + H DIK  NI+VD +    + D+G+
Sbjct: 113 TKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGI 172

Query: 424 AKATTMN--DVKSCK-------GTPFWMAPEVVN---LKNRGYGLTADIWSLGCTVLEML 471
           A    ++   ++  K       GT ++   +  N   +  RG     D+ SLG  +L+  
Sbjct: 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRG-----DLESLGYCMLKWA 227

Query: 472 TRQPPYSHLEGMQALFRIGK 491
             + P+        L    K
Sbjct: 228 GIKLPWKGFGHNGNLIHAAK 247

Length = 294

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 6/98 (6%)

Query: 437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR--IGKGEP 494
           GTP ++APE+  L  + +G   D W+LG  + E LT  PP++  E  Q +F+  + +  P
Sbjct: 542 GTPDYLAPEL--LLGKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDIP 598

Query: 495 -PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
            P     LS +A++ I   L ++P  R    +L +HP 
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 21/42 (50%), Positives = 26/42 (61%), Gaps = 1/42 (2%)

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLA 424
           RQIL  L+ LH   +VHRD+K  NI+    SGS K+ D G A
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	551
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
smart00090	237	RIO RIO-like kinase.	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
KOG3087	229	consensus Serine/threonine protein kinase [General	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
COG4248	637	Uncharacterized protein with protein kinase and he	98.65
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.58
PRK09902	216	hypothetical protein; Provisional	98.53
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.41
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.3
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.29
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.11
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.09
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.86
PLN02876	822	acyl-CoA dehydrogenase	97.83
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.8
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.72
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.68
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.67
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.67
PRK10593	297	hypothetical protein; Provisional	97.66
KOG2270	520	consensus Serine/threonine protein kinase involved	97.65
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.59
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.46
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.4
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.38
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.19
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.17
PRK05231	319	homoserine kinase; Provisional	97.09
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.05
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.63
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.62
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.53
PLN02236	344	choline kinase	96.47
PLN02756	418	S-methyl-5-thioribose kinase	96.44
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.42
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.32
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.25
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.95
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.61
PRK12396	409	5-methylribose kinase; Reviewed	95.57
PTZ00384	383	choline kinase; Provisional	95.52
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.4
PRK06148	1013	hypothetical protein; Provisional	95.26
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.9
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.85
PRK11768	325	serine/threonine protein kinase; Provisional	94.7
COG2334	331	Putative homoserine kinase type II (protein kinase	94.49
PTZ00296	442	choline kinase; Provisional	93.44

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-53  Score=432.20  Aligned_cols=260  Identities=32%  Similarity=0.473  Sum_probs=222.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccc--hHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQG--KQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ..|.+.+.||+|+||.|-+|.. ++|++||||++.+.......  ........+|+.+|++|+|||||+++++|......
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            3688999999999999999987 79999999999876544322  11233456999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC---CcEEEEecCCcccccc
Q 043852          354 FIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLAKATTM  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~---g~vkL~DFGla~~~~~  429 (551)
                      ||||||+.||.|.+.+- ++.+.+.....+++||+.|+.|||++||+||||||+|||+..+   ..+||+|||+|+....
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~  331 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE  331 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence            99999999999998765 4557888888999999999999999999999999999999776   6899999999998754


Q ss_pred             C-CcccCCCCCcccChhhhhcccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHhhcCCCCCCC---CcCCH
Q 043852          430 N-DVKSCKGTPFWMAPEVVNLKNRGYGL-TADIWSLGCTVLEMLTRQPPYSHLEGMQ-ALFRIGKGEPPLVP---NSLSR  503 (551)
Q Consensus       430 ~-~~~~~~GT~~Y~APEvl~~~~~~~s~-ksDIwSLG~iLyeLltG~~Pf~~~~~~~-~~~~i~~~~~~~~~---~~~s~  503 (551)
                      . -+.+.||||.|.|||++...+..+.+ ++|||||||+||-+++|.+||.+..... ...+|.+|...+.|   ..+++
T Consensus       332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise  411 (475)
T KOG0615|consen  332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE  411 (475)
T ss_pred             ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH
Confidence            3 46788999999999998666655554 8999999999999999999997655444 56677777665544   56899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ++.+||.+||..||++|||+.++|+||||+..-
T Consensus       412 ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  412 EALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             HHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            999999999999999999999999999999443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-51  Score=439.32  Aligned_cols=261  Identities=35%  Similarity=0.629  Sum_probs=233.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..|..+++||+|+|+.||++++ .+|+.||+|+|.++....  .....++.+||+|.++|+|||||+++++|++..++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            4799999999999999999998 899999999998654332  3445678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      |+|+|..++|..++++ +.+++..++.|++||+.||.|||+++|+|||||..|+|++.+.+|||+|||||......  ..
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            9999999999999875 56999999999999999999999999999999999999999999999999999877643  34


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      .+.||||.|.|||+++  ..+++..+||||+||+||.||+|++||...+-.+.+.+|.... ...|..++.++.+||.+|
T Consensus       176 ~TlCGTPNYIAPEVl~--k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-Y~~P~~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLN--KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-YSMPSHLSAEAKDLIRKL  252 (592)
T ss_pred             ceecCCCcccChhHhc--cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-cccccccCHHHHHHHHHH
Confidence            5678999999999984  6788999999999999999999999999988888888877665 555779999999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                      |++||.+|||+.+||.|+||++.......|
T Consensus       253 L~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp  282 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLDHPFFKSGFTPARLP  282 (592)
T ss_pred             hcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence            999999999999999999996655444443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-52  Score=420.49  Aligned_cols=261  Identities=31%  Similarity=0.563  Sum_probs=235.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-eEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-RLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~  354 (551)
                      .+.+.++.||+|+.|+||++.+ .+++.+|+|+|..    ........++.+|+++++..+|||||.+||.|.... .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            3567789999999999999998 6899999999953    233455668889999999999999999999999998 599


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      |+||||.+|+|+.+++. +.+++..+..++.+|++||.|||+ .+||||||||+||||+..|.|||||||.++.......
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a  234 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA  234 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence            99999999999999886 569999999999999999999995 8999999999999999999999999999998877777


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-----hhHHHHHHhhcCCCCCCCCc-CCHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL-----EGMQALFRIGKGEPPLVPNS-LSRDAR  506 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~-~s~~l~  506 (551)
                      .+.+||..|||||.+  .+..|+.++||||||++++|+.+|+.||...     ...+.+..|..+.++..|.. +|++++
T Consensus       235 ~tfvGT~~YMsPERi--~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~  312 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERI--SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFR  312 (364)
T ss_pred             ccccccccccChhhh--cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence            888999999999987  4668999999999999999999999999763     56788889999999999987 999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCCC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP  543 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~~  543 (551)
                      +||..||++||.+|||+.|+++|||+++......+.+
T Consensus       313 ~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~  349 (364)
T KOG0581|consen  313 SFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMA  349 (364)
T ss_pred             HHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHH
Confidence            9999999999999999999999999998776655543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-51  Score=412.47  Aligned_cols=258  Identities=32%  Similarity=0.548  Sum_probs=234.2

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ....+|+++++||+|+||+||.++. ++++.||+|++.+......  ........|..||.+++||+||+++..|++...
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~--~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK--KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh--hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            3456899999999999999999987 6899999999976654433  445677899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-  430 (551)
                      +|+|+||+.||.|...+++ +.+++..+..|+.+|+.||.|||++|||||||||+|||++.+|+++|+||||++..... 
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            9999999999999998874 56899999999999999999999999999999999999999999999999999865433 


Q ss_pred             -CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 -DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                       .+.+.+||+.|||||++  ...+|+..+|+||||+++|||++|.+||.+.+......+|.++..+..+..++.++++|+
T Consensus       180 ~~t~tfcGT~eYmAPEil--~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll  257 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEIL--LGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL  257 (357)
T ss_pred             CccccccCCccccChHHH--hcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence             45667899999999997  566999999999999999999999999999999999999999988888888999999999


Q ss_pred             HHhhhcCCCCCC----CHHHHHhCcccCCc
Q 043852          510 LKCLQVNPNDRP----TAAQLMEHPFVKRP  535 (551)
Q Consensus       510 ~~cL~~DP~~RP----S~~eILehpff~~~  535 (551)
                      .++|+.||.+|.    .+.+|.+||||+..
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            999999999995    79999999999854

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-48  Score=398.79  Aligned_cols=262  Identities=31%  Similarity=0.586  Sum_probs=232.6

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      ...+++|...+.||.|+||+||+|++ .++..||||.|.++..   ++...+.+..||.+|+.++|||||.+++++.+++
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            35567899999999999999999998 6889999999976543   3456667889999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC------CcEEEEecCCc
Q 043852          352 RLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS------GSVKLADFGLA  424 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~------g~vkL~DFGla  424 (551)
                      ++|+|||||.||+|.+++++. .+++..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999999999876 79999999999999999999999999999999999999765      46999999999


Q ss_pred             cccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--CCCCCCcC
Q 043852          425 KATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--PPLVPNSL  501 (551)
Q Consensus       425 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~  501 (551)
                      +...... ..+.+|+|.|||||++  ....|+-|+|+||+|++||+|++|+.||...+..+.+.++.++.  .+.++..+
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~--~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~  240 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVI--MSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL  240 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHH--HhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence            9887554 4567899999999997  46789999999999999999999999999888888877776654  45566778


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      +....+|+...++.++..|.++.+-+.|+++.......
T Consensus       241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~  278 (429)
T KOG0595|consen  241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR  278 (429)
T ss_pred             cCchhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence            88889999999999999999999999999988665443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-49  Score=402.78  Aligned_cols=255  Identities=49%  Similarity=0.835  Sum_probs=220.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC--eE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN--RL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~  353 (551)
                      .+|..++.||+|+||.||++.+ ++|..+|||.+......     ....+.+|+.+|.+++|||||+++|......  .+
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-----~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-----TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch-----hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence            4688999999999999999987 56999999998765211     1666889999999999999999999744444  69


Q ss_pred             EEEEecccccchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEecCCcccccc-
Q 043852          354 FIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTM-  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~--l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~DFGla~~~~~-  429 (551)
                      +++|||+.+|+|.+++.+.+  +++..++.+.+||+.||.|||++||+||||||+|||++. ++.+||+|||+++.... 
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999999998765  899999999999999999999999999999999999999 79999999999986652 


Q ss_pred             ----CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCC-chhHHHHHHhhcCC-CCCCCCcCCH
Q 043852          430 ----NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH-LEGMQALFRIGKGE-PPLVPNSLSR  503 (551)
Q Consensus       430 ----~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~-~~~~~~~~~i~~~~-~~~~~~~~s~  503 (551)
                          .......||+.|||||++.. +.....++|||||||++.||+||++||.. ......+.++.... .+.+|..++.
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~  250 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD  250 (313)
T ss_pred             cccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence                23446779999999999853 22234599999999999999999999988 56666666666544 5688899999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ++++||.+|+..||++|||+.++|+|||+++...
T Consensus       251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999998776

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-49  Score=390.56  Aligned_cols=258  Identities=29%  Similarity=0.534  Sum_probs=221.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|+.+.++|+|+||.||++++ ++|+.||||++.-   ...+....+-..+||++|++++|+|+|.++.+|.....++
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E---sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh   77 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE---SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH   77 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeecc---CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence            35788999999999999999998 6899999998853   2334555566789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc-cC-C
Q 043852          355 IFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-MN-D  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~-~~-~  431 (551)
                      +|+|||+..-|.++-. -.+++...+..+++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+... .. .
T Consensus        78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            9999998855555443 2469999999999999999999999999999999999999999999999999999765 33 3


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--------------  497 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------  497 (551)
                      ++.++.|.+|+|||++ .+...|+..+|||++||++.||++|.+.|++..+.++++.|.+..-..+              
T Consensus       158 YTDYVATRWYRaPELL-vGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELL-VGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhccChhhh-cccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            5678899999999998 4668999999999999999999999999999999999887655211110              


Q ss_pred             ------C----------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          498 ------P----------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       498 ------~----------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                            +          ..++.-+.+|+..||+.||.+|++.+|+|+|+||.+...
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence                  0          245667889999999999999999999999999975543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=407.79  Aligned_cols=258  Identities=32%  Similarity=0.545  Sum_probs=224.7

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDE  350 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  350 (551)
                      .+...+|.+++.||+|+|++||+|+. .++..||||++.+.-...+.+.  ..+..|-.+|.+| .||.|++||..|+|+
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~Kv--kYV~~Ek~~l~~L~~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKV--KYVTREKEALTQLSGHPGIVKLYFTFQDE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhccc--chhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence            45567999999999999999999987 6899999999875543333333  3344566667777 899999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..+|+|+||+++|+|.+++++.+ +++...+.|+.||+.||+|||++|||||||||+|||++.+++++|+|||.|+.+..
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            99999999999999999998865 88888899999999999999999999999999999999999999999999986542


Q ss_pred             CC---------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC
Q 043852          430 ND---------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP  494 (551)
Q Consensus       430 ~~---------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~  494 (551)
                      ..               ..+.+||..|.+||++  .....++.+|||+||||||+|+.|++||.+.+....+.+|.... 
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL--~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~-  303 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELL--NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD-  303 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHh--cCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-
Confidence            21               1347799999999997  45566889999999999999999999999999998888887765 


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       495 ~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ..+++..++.+++||.++|..||.+|+|++||.+||||...
T Consensus       304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence            45578899999999999999999999999999999999754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=381.27  Aligned_cols=255  Identities=30%  Similarity=0.539  Sum_probs=231.4

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+.+|+.++.||.|+||.|.+++. .+|..||+|++.+...  ......+...+|..+|+.+.||+++++++.+.+..++
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v--VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV--VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH--HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            355899999999999999999987 5799999999875433  2244566778999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      ||||||++||.|+.++++ +++++..++.|+.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+..... +
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T  198 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-T  198 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-E
Confidence            999999999999999987 46999999999999999999999999999999999999999999999999999987766 6


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      .+.||||.|+|||++  ..++|+.++|+|+||+++|||+.|.+||...+.++.+.+|..+... +|...+.++++||.++
T Consensus       199 ~TlCGTPeYLAPEii--~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~~fs~~~kdLl~~L  275 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEII--QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-FPSYFSSDAKDLLKKL  275 (355)
T ss_pred             EEecCCccccChHHh--hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-CCcccCHHHHHHHHHH
Confidence            677899999999998  4678999999999999999999999999999999999999998754 4788999999999999


Q ss_pred             hhcCCCCC-----CCHHHHHhCcccCCc
Q 043852          513 LQVNPNDR-----PTAAQLMEHPFVKRP  535 (551)
Q Consensus       513 L~~DP~~R-----PS~~eILehpff~~~  535 (551)
                      |+.|-.+|     ....+|.+||||+..
T Consensus       276 L~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  276 LQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             HhhhhHhhhcCcCCCccccccCcccccc
Confidence            99999999     357799999999853

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=401.83  Aligned_cols=259  Identities=32%  Similarity=0.533  Sum_probs=226.6

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDEN  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  351 (551)
                      ...+.|.+++.||+|+||+|++|.+ .+|..||+|++...............+.+|+.+++.+. ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999987 68899999976554222111234556668999999999 999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-CcEEEEecCCcccc--
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKAT--  427 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGla~~~--  427 (551)
                      .+|+|||||.||+|.+++.+ +++.+..+..+++||+.|++|||++||+||||||+|||++.+ +++||+|||++...  
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            99999999999999998876 679999999999999999999999999999999999999999 99999999999877  


Q ss_pred             ccCCcccCCCCCcccChhhhhcccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcC-CHHH
Q 043852          428 TMNDVKSCKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-SRDA  505 (551)
Q Consensus       428 ~~~~~~~~~GT~~Y~APEvl~~~~~~~-s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-s~~l  505 (551)
                      ......+.+||+.|+|||++..... | +.++||||+|++||.|++|..||...+......+|.++. ..+|..+ +.++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~-Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-~~~p~~~~S~~~  251 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGT-YSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-FKIPSYLLSPEA  251 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-ccCCCCcCCHHH
Confidence            2345678889999999999853332 5 689999999999999999999999977777777776665 4556777 9999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      ++|+.+||.+||.+|+|+.+|++||||+.
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-49  Score=389.16  Aligned_cols=245  Identities=35%  Similarity=0.611  Sum_probs=218.6

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeee-eccCCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFG-TDKDEN  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~  351 (551)
                      ..+.+|+++++||.|+||+||++.. .+|..+|.|.+...   .-+......+..|+.+|++|+|||||++|+ .+.++.
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~---~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG---MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh---hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            3345899999999999999999987 79999999998743   334455667889999999999999999999 455555


Q ss_pred             e-EEEEEecccccchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHh--CC--eeecccccceEEEcCCCcEEEEec
Q 043852          352 R-LFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHE--QN--VVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       352 ~-~~lV~Ey~~ggsL~~ll~~~-----~l~~~~i~~i~~QI~~aL~yLH~--~g--IiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                      . ++||||||.+|+|..+++..     .+++..+|+++.|++.||.++|.  ..  |+||||||.||+++.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            5 89999999999999998643     48999999999999999999998  44  999999999999999999999999


Q ss_pred             CCccccccCC--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC-
Q 043852          422 GLAKATTMND--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP-  498 (551)
Q Consensus       422 Gla~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-  498 (551)
                      ||++......  ..+.+|||.||+||.+  ...+|+.++|||||||++|||+.-++||.+.+-.+...+|.++..+.+| 
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i--~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERI--HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHH--hcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence            9999775443  5678999999999997  6789999999999999999999999999999888888999999888777 


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCH
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTA  523 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~  523 (551)
                      ...|.++..||..|+.+||++||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            7789999999999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.2e-47  Score=401.17  Aligned_cols=259  Identities=29%  Similarity=0.497  Sum_probs=224.5

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +..+++|+.++.||+|+||.||+|+. .+|..||+|++.+....  ....+..+..|-.+|....+++||+||..|++..
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~--~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML--KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH--hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            34567999999999999999999987 68999999999765433  3445667778888999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc-
Q 043852          352 RLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~-  429 (551)
                      ++||||||++||++..++.+. .|++..++.|+.+++.|+.-||+.|+|||||||+|+|||..|++||+||||++.... 
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999999988754 599999999999999999999999999999999999999999999999999842110 


Q ss_pred             ---------------------CC---------------------------cccCCCCCcccChhhhhcccCCCCchhhHH
Q 043852          430 ---------------------ND---------------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIW  461 (551)
Q Consensus       430 ---------------------~~---------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIw  461 (551)
                                           .+                           ..+.+|||.|+|||++  .+.+|+..+|+|
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl--l~kgY~~~cDwW  372 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL--LGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH--hcCCCCccccHH
Confidence                                 00                           1235699999999998  567799999999


Q ss_pred             HHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC---CCCCCCcCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCcccCCc
Q 043852          462 SLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARDFILKCLQVNPNDRP---TAAQLMEHPFVKRP  535 (551)
Q Consensus       462 SLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~l~~LI~~cL~~DP~~RP---S~~eILehpff~~~  535 (551)
                      ||||||||||.|.+||.+.+..+.+.+|.+-.   ..+....++.++++||.+||. ||++|.   .++||..||||+..
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            99999999999999999999998888876643   222334688999999999999 999996   59999999999976


Q ss_pred             c
Q 043852          536 L  536 (551)
Q Consensus       536 ~  536 (551)
                      -
T Consensus       452 ~  452 (550)
T KOG0605|consen  452 D  452 (550)
T ss_pred             C
Confidence            5

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-48  Score=401.48  Aligned_cols=257  Identities=27%  Similarity=0.493  Sum_probs=222.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCC-e
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDEN-R  352 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~  352 (551)
                      +++|.+++.||.|+||.||+|+. .+|..||||.++.+...   .. ...-++|++.|++|+ |||||+|..++.+.. .
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            45799999999999999999987 68999999988644322   11 112358999999999 999999999999888 9


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc-c
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-M  429 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~-~  429 (551)
                      +|+|||||+. +|+++++..  .+++..+..|+.||++||+|+|++|++|||+||+||||..+..|||+|||||+... .
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999999966 899988753  59999999999999999999999999999999999999989999999999999764 4


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC-------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP-------------  494 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~-------------  494 (551)
                      ..++.++.|.+|+|||++ +....|+.+.|||++|||++|+++-++.|.+.+..+++++|..-  .+             
T Consensus       164 pPYTeYVSTRWYRAPEvL-Lrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVL-LRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCcchhhhcccccchHHh-hhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            567889999999999998 57778999999999999999999999999999999999887541  11             


Q ss_pred             ------CC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          495 ------PL--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       495 ------~~--------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                            +.        .-..++.++.+||.+||.+||.+|||+.|+|+||||+-....
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                  00        112378899999999999999999999999999999965533

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-47  Score=395.67  Aligned_cols=259  Identities=31%  Similarity=0.545  Sum_probs=225.4

Q ss_pred             chhhhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc
Q 043852          270 GKFRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK  348 (551)
Q Consensus       270 ~~~~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  348 (551)
                      ++..+....|+.+++||+|+||.||+|++ .+|+.||+|+|.......   .......+||.||++|+||||++|.+...
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~---~~~~t~~REI~ILr~l~HpNIikL~eivt  186 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE---GFPITAIREIKILRRLDHPNIIKLEEIVT  186 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC---cchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence            45556677899999999999999999998 799999999998765433   33455679999999999999999999876


Q ss_pred             CC--CeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          349 DE--NRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       349 ~~--~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      +.  ..+|||+|||+. +|.-++...  .+++.++..|++||+.||+|+|.+||+|||||.+|||||.+|.+||+|||||
T Consensus       187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence            65  689999999987 888877664  6999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-------
Q 043852          425 KATTMND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-------  494 (551)
Q Consensus       425 ~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-------  494 (551)
                      +......   ++..+.|.+|+|||++ ++...|+.++|+||+||||.||++|++.|.+.+..+++.+|.+-.-       
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELL-LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELL-LGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHh-cCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            9665433   6777889999999998 6778999999999999999999999999999999998888765211       


Q ss_pred             C--CCC-------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          495 P--LVP-------------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       495 ~--~~~-------------------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      +  .+|                   ..++..+.+|+..||..||.+|.|+.++|+|+||.
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            0  011                   24677888999999999999999999999999993

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-47  Score=404.01  Aligned_cols=260  Identities=30%  Similarity=0.564  Sum_probs=231.1

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..++-|+.++.||.|+.|.|.+|++ .+|+..|||+|.+.....  ......+++||.||+.+.||||+++|++|++..+
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s--~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS--SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccc--cccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            4567899999999999999999998 799999999998664322  2334467799999999999999999999999999


Q ss_pred             EEEEEecccccchHHHH-hhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-
Q 043852          353 LFIFLELVTKGSLANLY-QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll-~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-  430 (551)
                      +|+|+||+.||.|++++ .++++++..+.+|++||+.|+.|+|..+||||||||+|+|++..+++||+|||+|.....+ 
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999998865 5678999999999999999999999999999999999999999999999999999765443 


Q ss_pred             CcccCCCCCcccChhhhhcccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~-s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      -..+.||+|.|.|||++.  +..| +.++||||.|+|||.||||++||.+.+....+.++.+|.. ..|..++.++++||
T Consensus       167 lLeTSCGSPHYA~PEIV~--G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLL  243 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVS--GRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLL  243 (786)
T ss_pred             cccccCCCcccCCchhhc--CCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHH
Confidence            456788999999999984  3344 7899999999999999999999998888888888888864 45688999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      .+||..||.+|+|.++|++|||++..-..
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcCCCC
Confidence            99999999999999999999999866543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.8e-47  Score=396.37  Aligned_cols=255  Identities=33%  Similarity=0.572  Sum_probs=227.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|.+.+.||+|+||.||+|+. .+.+.||+|.+.+...   ....+..+.+|++|++.++|||||.++++|+...+++
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr---~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~   77 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR---NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLW   77 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC---chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence            35788899999999999999986 5899999999875433   3456778899999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      +|+|||.| +|..++.. +.++++.++.++.|++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+....+.  
T Consensus        78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            99999988 99988864 579999999999999999999999999999999999999999999999999999776554  


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      ..+..|||.|||||++  .+..|+..+|+|||||++|||++|++||....-.+....|.+. +...|..++..+..|+..
T Consensus       157 ltsikGtPlYmAPElv--~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-~v~~p~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELV--EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-PVKPPSTASSSFVNFLQG  233 (808)
T ss_pred             eeeccCcccccCHHHH--cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-CCCCcccccHHHHHHHHH
Confidence            4567899999999997  5789999999999999999999999999886666666666654 455566899999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +|.+||.+|.|..+++.|||.+....
T Consensus       234 LL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             HhhcChhhcccHHHHhcChHHhhhhh
Confidence            99999999999999999999886553

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-46  Score=388.90  Aligned_cols=248  Identities=34%  Similarity=0.551  Sum_probs=217.2

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-eEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-RLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV  356 (551)
                      +..+.+.||+|+||+||+|.+.....||||++.........   ...|.+|+.+|.+++|||||+++|++.+.. .++||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            44455669999999999997765555999998755433322   778999999999999999999999999887 79999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCC-eeecccccceEEEcCCC-cEEEEecCCcccccc--
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQN-VVHRDIKCANILVDASG-SVKLADFGLAKATTM--  429 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~g-IiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~--  429 (551)
                      |||+++|+|..++.+   ..++...+..|+.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+++....  
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999999965   57999999999999999999999999 99999999999999998 999999999987654  


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhh-cCCCCCCCCcCCHHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~L  508 (551)
                      .......||+.|||||++......|+.++||||||++||||+||+.||.+....+....+. ++..+.++..++..+..|
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l  278 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL  278 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence            3445578999999999984224679999999999999999999999999998877766664 677788888899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 043852          509 ILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe  528 (551)
                      |..||+.||.+||++.+|+.
T Consensus       279 ~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  279 MERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999999875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-46  Score=385.50  Aligned_cols=264  Identities=29%  Similarity=0.497  Sum_probs=225.4

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccc---------hHHHHHHHHHHHHHhcCCCCceee
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQG---------KQSILQLEQEILLLSRFEHENIVQ  342 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~---------~~~~~~~~~Ei~il~~l~HpnIv~  342 (551)
                      ++.+++|++++.||+|.||.|-+|++ .+++.||||++.+.......         ...+++..+||.||++++|+|||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            46789999999999999999999998 68999999999765432211         122567889999999999999999


Q ss_pred             eeeeccCC--CeEEEEEecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEE
Q 043852          343 YFGTDKDE--NRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA  419 (551)
Q Consensus       343 l~~~~~~~--~~~~lV~Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~  419 (551)
                      |+.+..+.  ..+|||+|||..|.+...-.... +++.++++|++.++.||+|||.+|||||||||+|+||+.+|+|||+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence            99997664  57999999999999877665555 8999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccccC-------CcccCCCCCcccChhhhhccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhh
Q 043852          420 DFGLAKATTMN-------DVKSCKGTPFWMAPEVVNLKN--RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG  490 (551)
Q Consensus       420 DFGla~~~~~~-------~~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~  490 (551)
                      |||.+......       .....+|||.|+|||++....  ...+.+.||||||++||.|+.|+.||-+....+...+|.
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv  332 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV  332 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence            99998755221       233467999999999985322  223778999999999999999999999988888888888


Q ss_pred             cCCCCCCCC-cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          491 KGEPPLVPN-SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       491 ~~~~~~~~~-~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +....+... .+...+++||.+||.+||++|++..+|..|||+.+..
T Consensus       333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            766544332 4789999999999999999999999999999998874

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=395.06  Aligned_cols=258  Identities=28%  Similarity=0.469  Sum_probs=227.8

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDE  350 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  350 (551)
                      ...+.+|..+++||+|+||+|+++.. .+++.||||++++...-.  ...++....|.+|+... +||+++.++.+|++.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~--~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ--RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec--cccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            34567999999999999999999987 578999999998665433  33445556666666655 599999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--  428 (551)
                      .++|+||||+.||++..+.+...+++..+..|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++...  
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999999997777777889999999999999999999999999999999999999999999999999998654  


Q ss_pred             cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       429 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .+.+.+.+|||.|||||++  ....|+.++|+|+|||+|||||.|+.||.+.+..+....|.... +.+|..++.++.++
T Consensus       522 g~~TsTfCGTpey~aPEil--~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~-~~yP~~ls~ea~~i  598 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVL--TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSKEAIAI  598 (694)
T ss_pred             CCccccccCChhhcChhhh--ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCCCcccHHHHHH
Confidence            3456788999999999997  67899999999999999999999999999988887777777665 56688999999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      |+++|.++|++|.-     +.+|..||||+..
T Consensus       599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            99999999999975     6889999999964

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-45  Score=358.42  Aligned_cols=253  Identities=30%  Similarity=0.496  Sum_probs=218.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|...++||+|.||.||+|++ .+|+.||||+|......   ........+||++|+.++|+||+.++++|.+.+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k---dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK---DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc---cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            3688889999999999999997 79999999999876332   2233456799999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          356 FLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      |+||++. +|+..++..  .++..++..|+.|+++||+|||++.|+||||||.|+||+.+|.+||+|||+++......  
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9999976 999998765  48889999999999999999999999999999999999999999999999999775433  


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---------------  496 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---------------  496 (551)
                      ....+-|.+|+|||++ .+...|+..+||||.|||+.||+-|.+.|.+.++.+++..|....-.+               
T Consensus       158 ~~~~V~TRWYRAPELL-fGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELL-FGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             cccceeeeeccChHHh-ccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            2223689999999998 467789999999999999999999999999999998887765421100               


Q ss_pred             ------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          497 ------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       497 ------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                                  +-..++.++.+|+.+||..||.+|+|+.|+|+|+||+.
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                        11236778899999999999999999999999999995

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-46  Score=391.64  Aligned_cols=253  Identities=36%  Similarity=0.664  Sum_probs=227.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|..-++||+|+.|.||.+.. .+++.||||.+.+..+..     ..-+.+|+.+|+..+|+|||++++.|.....+++|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            567778999999999999986 688999999998654433     23467999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~  434 (551)
                      |||++||+|-+++....+++.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++......  ...+
T Consensus       349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999998765443  3567


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~LI~~c  512 (551)
                      .+|||+|||||++  ....|++++||||||++++||+-|++||-..+....++.|.....+.+  +..+|..+++|+.+|
T Consensus       429 mVGTPYWMAPEVv--trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c  506 (550)
T KOG0578|consen  429 MVGTPYWMAPEVV--TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC  506 (550)
T ss_pred             ccCCCCccchhhh--hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence            7899999999998  567899999999999999999999999998888999888877655544  467999999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCccc
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |+.|+++|+++.+||+||||+....
T Consensus       507 L~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  507 LVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             hhcchhcCCCHHHHhcChhhhhcCC
Confidence            9999999999999999999965443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=375.27  Aligned_cols=262  Identities=32%  Similarity=0.584  Sum_probs=232.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .+.|++...||.|..++||+|+. ..++.||||++...+...    .+..+.+|++.+..++||||+.++..|..+..+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~----~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN----DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh----hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            45899999999999999999986 678999999998754433    2667889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          355 IFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +||.||.+|++.++++.   .++.+..+..+++++++||.|||++|.||||||+.||||+.+|.|||+|||.+-......
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999999875   479999999999999999999999999999999999999999999999999865332221


Q ss_pred             ------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC-------
Q 043852          432 ------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP-------  498 (551)
Q Consensus       432 ------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------  498 (551)
                            ....+||+.|||||++.....+|+.|+||||||++..||.+|..||.....++.+....++.++...       
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d  260 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD  260 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence                  1456799999999996567789999999999999999999999999999999999888888776322       


Q ss_pred             --CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          499 --NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       499 --~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                        ...+..++.+|..||++||.+|||+.++|.|+||++...+...
T Consensus       261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~  305 (516)
T KOG0582|consen  261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL  305 (516)
T ss_pred             HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence              2467789999999999999999999999999999988776654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.5e-45  Score=378.06  Aligned_cols=255  Identities=29%  Similarity=0.512  Sum_probs=221.2

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+.+|.+.+.||+|+||.||+|.+ .+|+.||||++......  .......+.+|+.++.+++||||+++++++.+...
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            3456899999999999999999987 57899999998643211  12334567899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|++||||.+++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999999988765 45888889999999999999999999999999999999999999999999999765433 


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....||+.|+|||++  .+..++.++|||||||++|+|++|..||.+.........+..+. ..++..++..+.+||.+
T Consensus       172 ~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVI--QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKG  248 (329)
T ss_pred             cceecCChhhcCHHHH--cCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHH
Confidence            2345699999999997  45567899999999999999999999998877777777776654 34566789999999999


Q ss_pred             hhhcCCCCCCC-----HHHHHhCcccCC
Q 043852          512 CLQVNPNDRPT-----AAQLMEHPFVKR  534 (551)
Q Consensus       512 cL~~DP~~RPS-----~~eILehpff~~  534 (551)
                      ||+.||.+|++     +++|+.||||+.
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            99999999997     799999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=369.56  Aligned_cols=251  Identities=29%  Similarity=0.463  Sum_probs=217.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||+|.+ .+|+.||+|++......  .......+.+|+.++++++||||+++++++.+...+|+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI--RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh--hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            688999999999999999987 47999999998643221  123345678899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccC
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC  435 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  435 (551)
                      |||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ....
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~~  158 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWTL  158 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-cccc
Confidence            999999999998865 45888999999999999999999999999999999999999999999999998765432 3345


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhc
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV  515 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~  515 (551)
                      .||+.|+|||++  ....++.++|||||||++|+|++|+.||...........+..+. ..++..++..+++||.+||+.
T Consensus       159 ~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~  235 (291)
T cd05612         159 CGTPEYLAPEVI--QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVV  235 (291)
T ss_pred             cCChhhcCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCC
Confidence            699999999997  45567999999999999999999999998877776666666654 345667899999999999999


Q ss_pred             CCCCCCC-----HHHHHhCcccCC
Q 043852          516 NPNDRPT-----AAQLMEHPFVKR  534 (551)
Q Consensus       516 DP~~RPS-----~~eILehpff~~  534 (551)
                      ||.+||+     +.++++||||+.
T Consensus       236 dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         236 DRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CHHHccCCccCCHHHHhcCccccC
Confidence            9999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-47  Score=388.55  Aligned_cols=253  Identities=41%  Similarity=0.725  Sum_probs=232.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|...++||+|+||.||+|.+ .+++.||+|++...    ..+..++.+.+|+.+|.+++++||.++|+.+..+..++++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechh----hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            577779999999999999998 68999999999864    3345677888999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcC-ChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Ccc
Q 043852          357 LELVTKGSLANLYQKYHL-MDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l-~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~  433 (551)
                      ||||.||++.++++.+++ .+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++-.....  ...
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence            999999999999998776 88888999999999999999999999999999999999999999999998655432  236


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhh
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      +.+|||+|||||+++  ..+|+.++||||||++.+||.+|.+||.....+..++.|-+..+|.+...+++.+++||..||
T Consensus       170 tfvGTPfwMAPEVI~--~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIK--QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL  247 (467)
T ss_pred             cccccccccchhhhc--cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence            778999999999984  779999999999999999999999999999999999999999999998999999999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCcc
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ++||+.|||+.++|.|+|+++..
T Consensus       248 ~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             hcCcccCcCHHHHhhhHHHHhcC
Confidence            99999999999999999999843

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=370.41  Aligned_cols=261  Identities=28%  Similarity=0.453  Sum_probs=225.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-----CC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-----EN  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~  351 (551)
                      .|..++.||+|+||.|..+.+ .+|+.||||++....   ......++..+|+++|+.++|+||+.+++++..     -.
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F---~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF---ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh---hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            456679999999999999987 689999999986432   234456778899999999999999999998765     34


Q ss_pred             eEEEEEecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--
Q 043852          352 RLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--  428 (551)
                      .+|+|+|++ +.+|..+++... +++.++..+++||++||+|+|+.+|+||||||.|+|++.++.+||||||+|+...  
T Consensus       100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence            589999999 559999999887 9999999999999999999999999999999999999999999999999999874  


Q ss_pred             --cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC------------
Q 043852          429 --MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP------------  494 (551)
Q Consensus       429 --~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~------------  494 (551)
                        ...++.++.|.+|.|||++ .....|+.+.||||+|||+.||++|++.|.+.+..+++..|..-..            
T Consensus       179 ~~~~~mTeYVaTRWYRAPEll-l~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELL-LNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             CcccchhcceeeeeecCHHHH-hccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence              4456788899999999998 6788999999999999999999999999999888776655433111            


Q ss_pred             ----------CC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCCC
Q 043852          495 ----------PL--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP  543 (551)
Q Consensus       495 ----------~~--------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~~  543 (551)
                                +.        .-+..++.+.+|+.+||..||.+|+|++|.|+|||+...+.-+..|.
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~  324 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV  324 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence                      11        11367889999999999999999999999999999998887777763

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-45  Score=353.95  Aligned_cols=256  Identities=32%  Similarity=0.527  Sum_probs=231.5

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|++++.||+|-||.||+|+. .++..+|+|++.+..  ....+...++.+|+.|-..|+||||+++|++|.+...+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            467999999999999999999987 689999999997654  33344566788999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 FIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      |+++||...|+|+..++.   ..+++...+.|+.|++.||.|+|.++||||||||+|+|+...|.+||+|||.+.....+
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            999999999999998873   34889999999999999999999999999999999999999999999999999877777


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ...+.+||..|++||.+  .+..++..+|+|++|++.||++.|.+||......+.+.+|.+.. ..+|..++..+.+||.
T Consensus       178 kR~tlcgt~dyl~pEmv--~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-~~~p~~is~~a~dlI~  254 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMV--EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-LKFPSTISGGAADLIS  254 (281)
T ss_pred             CceeeecccccCCHhhc--CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-ccCCcccChhHHHHHH
Confidence            77888999999999997  56788999999999999999999999999988777887777765 4556889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      +||.++|.+|.+..|+++|||+.+.
T Consensus       255 ~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  255 RLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999754

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2e-44  Score=373.17  Aligned_cols=247  Identities=28%  Similarity=0.471  Sum_probs=212.1

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVT  361 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  361 (551)
                      +.||+|+||.||++.+ .+|+.||||++.....  ........+.+|+.++.+++||||+++++++.....+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            4699999999999987 5899999999874322  122344567789999999999999999999999999999999999


Q ss_pred             ccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCCC
Q 043852          362 KGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGT  438 (551)
Q Consensus       362 ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~GT  438 (551)
                      +++|..++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  .......||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            9999888765 4588999999999999999999999999999999999999999999999999875322  223445699


Q ss_pred             CcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCC
Q 043852          439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN  518 (551)
Q Consensus       439 ~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~  518 (551)
                      +.|+|||++  .+..++.++|||||||++|||++|+.||...+.......+.... ..++..++..+.+||.+||+.||+
T Consensus       159 ~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         159 PEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             ccccChhhh--cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHH
Confidence            999999997  45678999999999999999999999998766655555554443 455678999999999999999999


Q ss_pred             CCC-----CHHHHHhCcccCC
Q 043852          519 DRP-----TAAQLMEHPFVKR  534 (551)
Q Consensus       519 ~RP-----S~~eILehpff~~  534 (551)
                      +||     ++.++++||||+.
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCC
Confidence            999     8999999999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-45  Score=382.53  Aligned_cols=243  Identities=29%  Similarity=0.498  Sum_probs=219.0

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      .+..++.||+|-||.||.|.++....||+|.+.....      ....|.+|+++|++|+|+|||++++++..+..+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc------ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            4556789999999999999888888999999975422      2346779999999999999999999999988999999


Q ss_pred             ecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          358 ELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       358 Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      ||+..|+|.++++.   ..+...+...++.|||.||+||+++++|||||...||||+.+..+||+|||||+....+.+..
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999999986   458889999999999999999999999999999999999999999999999999665555544


Q ss_pred             CCC---CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          435 CKG---TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       435 ~~G---T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ..|   ...|.|||++  ....|+.++||||||++||||+| |+.||.+++..+.+..+.+|...+.|..||+.+.+||.
T Consensus       361 ~~~~kfPIkWtAPEa~--~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~  438 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEAL--NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMK  438 (468)
T ss_pred             cCCCCCCceecCHHHH--hhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHH
Confidence            444   3459999998  45679999999999999999998 99999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 043852          511 KCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILe  528 (551)
                      .||+.+|++||||+.+..
T Consensus       439 ~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  439 SCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHhhCCcccCCCHHHHHH
Confidence            999999999999998764

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.6e-44  Score=361.33  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=213.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|+..+.||+|+||.||+|.+ .+|..||+|.+.......  ......+.+|+.++.+++|+||+++++++.+...++++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh--hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            377889999999999999987 689999999986543221  22334567899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-Cc
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~  432 (551)
                      |||+.+|+|..++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence            999999999877643   25888999999999999999999999999999999999999999999999998765332 23


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH---HHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ....||+.|+|||++  .+..++.++|||||||++|+|++|+.||......   +.+..........++..++..+.+|+
T Consensus       159 ~~~~g~~~y~aPE~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         159 RGRVGTVGYMAPEVI--NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             cCCCCCCCccCHhhh--cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            445689999999997  3567899999999999999999999999765432   22222223333445667899999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHhCcccCCcc
Q 043852          510 LKCLQVNPNDRPT-----AAQLMEHPFVKRPL  536 (551)
Q Consensus       510 ~~cL~~DP~~RPS-----~~eILehpff~~~~  536 (551)
                      .+||+.||.+||+     ++++++||||+..-
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            9999999999997     99999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-43  Score=361.23  Aligned_cols=251  Identities=27%  Similarity=0.449  Sum_probs=207.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +.+|++.+.||.|+||.||+|.+ .++..||+|++.......    ....+.+|+.++.+++|+||+++++++.+....|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            46899999999999999999987 578999999986543211    1234568999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      +||||+.+ +|..++...  .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            99999986 888877543  3688899999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC----------------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----------------  494 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~----------------  494 (551)
                      ......+|+.|+|||++. ....++.++|||||||++|+|++|++||.+.+..+.+..+.....                
T Consensus       159 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLL-GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cccCceecccccChHHhc-CCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            223456899999999873 345689999999999999999999999987665554433321100                


Q ss_pred             -----C--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 -----P--------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 -----~--------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                           +        .....++.++.+||.+||++||.+|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                 0        0012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.6e-44  Score=373.03  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=220.8

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEec--CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~~--~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ...+++|++.+.||+|+||.||+|.+.  ++..||+|++......  .......+.+|+.++..++||||+++++++.+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII--KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            345668999999999999999999763  3468999998643221  123345677899999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..+|+||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999999998865 4688889999999999999999999999999999999999999999999999976543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      . .....||+.|+|||++  .+..++.++|||||||++|||++|..||...+.......+..+.. .++..++..+.++|
T Consensus       184 ~-~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li  259 (340)
T PTZ00426        184 R-TYTLCGTPEYIAPEIL--LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHLM  259 (340)
T ss_pred             C-cceecCChhhcCHHHH--hCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHH
Confidence            2 3445699999999997  355678999999999999999999999998777766777666543 45677899999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          510 LKCLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       510 ~~cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      .+||+.||.+|+     +++++++||||+..
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999995     89999999999864

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.6e-44  Score=368.81  Aligned_cols=252  Identities=29%  Similarity=0.458  Sum_probs=214.4

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHH---HhcCCCCceeeeeeeccCCCeEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILL---LSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~i---l~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      |++.+.||+|+||.||+|.+ .+|+.||||++.......  ......+.+|+.+   +..++||||+++++++.+...+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA--RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            67889999999999999987 579999999987532111  1223345555544   46778999999999999999999


Q ss_pred             EEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCc
Q 043852          355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDV  432 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~  432 (551)
                      +||||+.+++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ...
T Consensus        79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999874322  223


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+.+..+....+..+.. ..+..++..+.+||.+|
T Consensus       159 ~~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~  235 (324)
T cd05589         159 STFCGTPEFLAPEVL--TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRL  235 (324)
T ss_pred             cccccCccccCHhHh--cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence            445699999999997  456789999999999999999999999998777777666665543 35677899999999999


Q ss_pred             hhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          513 LQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       513 L~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      |+.||.+||     ++.++++||||+..
T Consensus       236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         236 LRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             hhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999999     79999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-43  Score=359.04  Aligned_cols=251  Identities=26%  Similarity=0.447  Sum_probs=208.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|++ .++..||+|++......   ......+.+|+.++..++|+||+++++++.....+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            3689999999999999999988 47899999998754322   2334566789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      ||||+.++.+..+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......   
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            9999999877766543 468899999999999999999999999999999999999999999999999987653322   


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-----------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-----------------  494 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-----------------  494 (551)
                      .....||+.|+|||++  .+..++.++|||||||++|+|++|++||......+....+.....                 
T Consensus       158 ~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         158 YTEYVATRWYRSPELL--LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccCCcHHH--cCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            2345689999999997  345689999999999999999999999987665544433222100                 


Q ss_pred             ----CC----------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 ----PL----------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ----~~----------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                          +.          ....++..+.+||.+||++||.+|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                00          012367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-44  Score=367.77  Aligned_cols=265  Identities=28%  Similarity=0.447  Sum_probs=228.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +..|++++.||.|.-|+||++.. .++..+|+|++.+.....  ...+.+...|-.||..++||.++.||+.++...+.|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~--rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS--RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            44788999999999999999987 467999999997654433  444566778888999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc---
Q 043852          355 IFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT---  428 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~---  428 (551)
                      ++||||.||+|..++++.   .+++..++.|+.+++.||+|||-.|||+|||||+||||.++|+|.|+||.|+....   
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999999999865   49999999999999999999999999999999999999999999999999863100   


Q ss_pred             -------------------------------c-C-----------------------CcccCCCCCcccChhhhhcccCC
Q 043852          429 -------------------------------M-N-----------------------DVKSCKGTPFWMAPEVVNLKNRG  453 (551)
Q Consensus       429 -------------------------------~-~-----------------------~~~~~~GT~~Y~APEvl~~~~~~  453 (551)
                                                     . .                       ...+.+||-.|+|||++  .+.+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI--~G~G  311 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI--RGEG  311 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee--ecCC
Confidence                                           0 0                       01235689999999998  5667


Q ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCC-cCCHHHHHHHHHhhhcCCCCCCC----HHHHHh
Q 043852          454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN-SLSRDARDFILKCLQVNPNDRPT----AAQLME  528 (551)
Q Consensus       454 ~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~s~~l~~LI~~cL~~DP~~RPS----~~eILe  528 (551)
                      .+.++|+|+||+++|||++|..||.+.+..+.+.+|....+.+... .++..+++||+++|.+||.+|..    +++|.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            8999999999999999999999999999999999988776655433 57899999999999999999998    999999


Q ss_pred             CcccC---CccccCCCCCC
Q 043852          529 HPFVK---RPLQKSRGPPS  544 (551)
Q Consensus       529 hpff~---~~~~~~~~~~~  544 (551)
                      ||||+   +.+.+...||-
T Consensus       392 HpFF~gVnWaLir~~~PP~  410 (459)
T KOG0610|consen  392 HPFFEGVNWALIRCARPPE  410 (459)
T ss_pred             CccccCCChhheeccCCCc
Confidence            99987   45666666553

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-44  Score=359.43  Aligned_cols=256  Identities=28%  Similarity=0.480  Sum_probs=218.5

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec--cCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD--KDE  350 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~  350 (551)
                      +.++.|++++.|++|+||.||+|++ .+++.||+|+++......-.   -....+||.+|.+++|||||.+-.+.  .+-
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF---PItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF---PITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC---cchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            4567899999999999999999998 68999999999876543322   22456899999999999999987763  445


Q ss_pred             CeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      +.+|||||||+. +|..++..  .++...++..++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||||+.+.
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            679999999987 88888865  358889999999999999999999999999999999999999999999999999875


Q ss_pred             cC--CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC----------
Q 043852          429 MN--DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP----------  494 (551)
Q Consensus       429 ~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~----------  494 (551)
                      ..  .++..+-|.+|+|||++ +....|+.+.||||+|||+.||+++++.|.+....+++.+|.+-  .+          
T Consensus       229 sp~k~~T~lVVTLWYRaPELL-LG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELL-LGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             CCcccCcceEEEeeecCHHHh-cCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            43  46677789999999998 57788999999999999999999999999999988888776541  11          


Q ss_pred             -C--------C---------CCC-cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          495 -P--------L---------VPN-SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       495 -~--------~---------~~~-~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                       +        .         ++. .+++...+|+..+|..||.+|.|+.+.|+|+||..
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence             0        0         001 25688899999999999999999999999999996

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=368.06  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=215.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||+|+||.||+|.+ .+++.||||++......  .......+.+|+.++..++|+||+++++++.+...+|+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF--KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            3689999999999999999987 47899999998753221  12334567889999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      ||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus        79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~  157 (333)
T cd05600          79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANS  157 (333)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCC
Confidence            9999999999999865 4588999999999999999999999999999999999999999999999999875543 3345


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC----CCCC---CcCCHHHHH
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----PLVP---NSLSRDARD  507 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~----~~~~---~~~s~~l~~  507 (551)
                      ..||+.|+|||++.  ...++.++|||||||++|||++|..||...+..+....+.....    +...   ..++.++.+
T Consensus       158 ~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         158 VVGSPDYMAPEVLR--GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             cccCccccChhHhc--CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            66999999999973  45789999999999999999999999988766655544433211    1111   256899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ||.+||..+|.+||++.++++||||+..
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            9999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-43  Score=370.84  Aligned_cols=254  Identities=27%  Similarity=0.460  Sum_probs=211.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||+|+||+||++.+ .+++.||||++......  .......+.+|+.++.+++|+||+++++.+.+...+|+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML--EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            3689999999999999999987 57999999998643221  12334567789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      |||||.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999999999998864 568999999999999999999999999999999999999999999999999986432110   


Q ss_pred             ----------------------------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 043852          432 ----------------------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY  477 (551)
Q Consensus       432 ----------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf  477 (551)
                                                        ....+||+.|+|||++  .+..++.++|||||||++|||++|+.||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH--cCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              1234699999999997  4567899999999999999999999999


Q ss_pred             CCchhHHHHHHhhcCCC-CCCC--CcCCHHHHHHHHHhhhcCCC---CCCCHHHHHhCcccCCc
Q 043852          478 SHLEGMQALFRIGKGEP-PLVP--NSLSRDARDFILKCLQVNPN---DRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       478 ~~~~~~~~~~~i~~~~~-~~~~--~~~s~~l~~LI~~cL~~DP~---~RPS~~eILehpff~~~  535 (551)
                      .+....+...++..... ..++  ..++..+.+||.+|+. +|.   .||++++|++||||+..
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            88777776666654321 1122  2478999999998765 444   45899999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-43  Score=364.31  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=205.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----C
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----N  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~  351 (551)
                      +|++.++||+|+||.||+|.+ .+|..||||++......   ......+.+|+.++++++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc---chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            588999999999999999987 57999999988643221   22334677999999999999999999886432     3


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+|++||||. ++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            5899999995 578777754 46899999999999999999999999999999999999999999999999998754322


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhh---------------
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG---------------  490 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~---------------  490 (551)
                      .     .....||+.|+|||++......++.++|||||||++|+|++|++||.+.+....+..+.               
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1     23456999999999975334678999999999999999999999997655433221110               


Q ss_pred             ------------cCCCCC---CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          491 ------------KGEPPL---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       491 ------------~~~~~~---~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                  ...+..   ....++..+.+||.+||+.||++|||+.++++||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                        001110   01246788999999999999999999999999999986554

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=371.70  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=214.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++++.||+|+||.||+|.+ .+|..||||++......  .......+.+|+.++..++|+||+++++++.+...+|+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML--EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence            789999999999999999987 57999999999753211  123445677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----  431 (551)
                      ||||.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......    
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            999999999998765 458999999999999999999999999999999999999999999999999986432110    


Q ss_pred             ------------------------------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCC
Q 043852          432 ------------------------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP  475 (551)
Q Consensus       432 ------------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~  475 (551)
                                                          ....+||+.|+|||++  ....++.++|||||||++|||++|..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF--LQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH--cCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                1124699999999997  45678999999999999999999999


Q ss_pred             CCCCchhHHHHHHhhcCCCC-CC--CCcCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccCCc
Q 043852          476 PYSHLEGMQALFRIGKGEPP-LV--PNSLSRDARDFILKCLQVNPNDRPT---AAQLMEHPFVKRP  535 (551)
Q Consensus       476 Pf~~~~~~~~~~~i~~~~~~-~~--~~~~s~~l~~LI~~cL~~DP~~RPS---~~eILehpff~~~  535 (551)
                      ||......+....+...... ..  ...++..+.+||.+||. +|.+|++   +.++++||||+..
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99887777666666543221 11  23578999999999997 9999998   9999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=364.20  Aligned_cols=246  Identities=30%  Similarity=0.492  Sum_probs=211.2

Q ss_pred             eccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      ||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++.+++||||+++++++.+...+|+||||+.+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            79999999999987 5788999999864321  12334556778999999999999999999999999999999999999


Q ss_pred             chHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCCCCc
Q 043852          364 SLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGTPF  440 (551)
Q Consensus       364 sL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~GT~~  440 (551)
                      +|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....  .......||+.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence            99988754 4688999999999999999999999999999999999999999999999999875322  22334569999


Q ss_pred             ccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCC
Q 043852          441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR  520 (551)
Q Consensus       441 Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~R  520 (551)
                      |+|||++  .+..++.++|||||||++|+|++|+.||......+....+... ...++..++..+.+||.+||+.||.+|
T Consensus       159 y~aPE~~--~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         159 YLAPELL--LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             cCCHHHH--cCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            9999997  4567899999999999999999999999887766666665554 345567899999999999999999999


Q ss_pred             C---CHHHHHhCcccCCc
Q 043852          521 P---TAAQLMEHPFVKRP  535 (551)
Q Consensus       521 P---S~~eILehpff~~~  535 (551)
                      |   ++.+++.||||.+.
T Consensus       236 ~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         236 LGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCCCHHHHHcCCCcCCC
Confidence            7   58999999999974

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=353.28  Aligned_cols=254  Identities=29%  Similarity=0.500  Sum_probs=222.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +.|++-+.||+|.|+.||++.+ .+|+.||+|.|.......   ...+++.+|+.|...|+||||++|...+...+..||
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            3678889999999999999877 689999999987654332   256678899999999999999999999999999999


Q ss_pred             EEecccccchH-HHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC---CcEEEEecCCccccccCC
Q 043852          356 FLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMND  431 (551)
Q Consensus       356 V~Ey~~ggsL~-~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~---g~vkL~DFGla~~~~~~~  431 (551)
                      |+|++.|++|. +++++.-+++..+..+++||+.+|.|+|.+||||||+||+|+|+.+.   .-+||+|||+|.......
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            99999999995 57777788999999999999999999999999999999999999543   359999999998776332


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---CCCcCCHHHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDARD  507 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~~  507 (551)
                       ....+|||.|||||++  ....|+..+|||+.|++||.|+.|.+||.+.+....+.+|.++....   ....+++++++
T Consensus       168 ~~~G~~GtP~fmaPEvv--rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             ccccccCCCcccCHHHh--hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence             4567799999999997  56789999999999999999999999999977777788887775433   34679999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      |+++||..||.+|+|+.+.|+|||+++-
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999853

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2e-43  Score=373.39  Aligned_cols=259  Identities=27%  Similarity=0.425  Sum_probs=219.2

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+.+|++.+.||+|+||.||++.+ .++..||+|++......  .......+.+|+.+++.++||||+++++++.+...
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3456899999999999999999987 57999999998643211  12233456789999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          353 LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      +|+|||||.+|+|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999987654322 


Q ss_pred             --cccCCCCCcccChhhhhcc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-CCCCC--cCCHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLK--NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-PLVPN--SLSRD  504 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~--~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~--~~s~~  504 (551)
                        .....||+.|+|||++...  ...++.++|||||||++|||++|+.||........+..+..... ...+.  .++..
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ  277 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence              2345699999999997432  23478999999999999999999999988777666666654321 22232  57999


Q ss_pred             HHHHHHHhhhcCCCC--CCCHHHHHhCcccCC
Q 043852          505 ARDFILKCLQVNPND--RPTAAQLMEHPFVKR  534 (551)
Q Consensus       505 l~~LI~~cL~~DP~~--RPS~~eILehpff~~  534 (551)
                      +.+||.+||+.+|.+  |+|+.++++||||++
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            999999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=369.33  Aligned_cols=254  Identities=31%  Similarity=0.490  Sum_probs=216.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|.+++.||+|+||+||+|.+ .+|+.||||++......  .......+..|+.++..++|+||+++++++.+...+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI--KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh--hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            3689999999999999999987 47999999998753221  12334567789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          356 FLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      ||||+.+++|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            99999999999988764 68999999999999999999999999999999999999999999999999987544322   


Q ss_pred             ----------------------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH
Q 043852          432 ----------------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM  483 (551)
Q Consensus       432 ----------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~  483 (551)
                                                  .....||+.|+|||++  ....++.++|||||||++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL--RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHH--cCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                        2345689999999997  3457899999999999999999999999887776


Q ss_pred             HHHHHhhc--CC-CCCCCCcCCHHHHHHHHHhhhcCCCCCCC-HHHHHhCcccCCc
Q 043852          484 QALFRIGK--GE-PPLVPNSLSRDARDFILKCLQVNPNDRPT-AAQLMEHPFVKRP  535 (551)
Q Consensus       484 ~~~~~i~~--~~-~~~~~~~~s~~l~~LI~~cL~~DP~~RPS-~~eILehpff~~~  535 (551)
                      ....++..  .. .......++..+.+||.+||. ||.+||+ +.++++||||+..
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            66666554  11 112223379999999999997 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.3e-43  Score=362.75  Aligned_cols=255  Identities=28%  Similarity=0.471  Sum_probs=213.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||++++ .+|..+|+|.+....    .......+.+|+.++.+++|+||+++++++.+...+++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5899999999999999999987 578999999886432    23345578899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      ||||+.+++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++.........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  160 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  160 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccc
Confidence            9999999999998875 4588899999999999999999986 6999999999999999999999999998766555455


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-------------------------
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-------------------------  488 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~-------------------------  488 (551)
                      ...||+.|+|||++  .+..++.++|||||||++|+|++|+.||......+....                         
T Consensus       161 ~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         161 SFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cCCCCcCcCCHhHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            66799999999997  345689999999999999999999999975443322111                         


Q ss_pred             ---------------------hhcCCCCCC-CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          489 ---------------------IGKGEPPLV-PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       489 ---------------------i~~~~~~~~-~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                           +.....+.. ...++.++.+||.+||++||++|||+.+|++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                                 111111111 1246889999999999999999999999999999986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5e-43  Score=358.49  Aligned_cols=254  Identities=31%  Similarity=0.511  Sum_probs=204.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|.+ .++..||||++.......    ....+.+|+.+++.++|+||+++++++.+....|+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG----TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc----cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            5799999999999999999987 478999999986443211    12345689999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CC
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--ND  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~  431 (551)
                      ||||+.+ +|.+++.+  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ..
T Consensus        81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            9999965 66665544  3588899999999999999999999999999999999999999999999999865432  22


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHhhc--CCC------------CC
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ-ALFRIGK--GEP------------PL  496 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~-~~~~i~~--~~~------------~~  496 (551)
                      .....||+.|+|||++. ....++.++|||||||++|+|++|..||.+..... .+..+..  +.+            ..
T Consensus       160 ~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         160 YSNEVVTLWYRPPDVLL-GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             CCCCcccCCCCChHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            33456899999999873 34567899999999999999999999997754332 2221110  000            00


Q ss_pred             --------CC---------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          497 --------VP---------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       497 --------~~---------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                              .+         ...+..+.+|+.+||++||.+|||+.++++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                    00         12456789999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-43  Score=370.95  Aligned_cols=256  Identities=33%  Similarity=0.546  Sum_probs=227.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~  354 (551)
                      ..|++.+.||+|.||.||+++. .+|..+|+|.+.+......  .....+.+|+.+|+++. |||||.++++|++...+|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~--~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK--EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc--ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3699999999999999999998 4699999999976654332  24567889999999999 999999999999999999


Q ss_pred             EEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC----CcEEEEecCCcccccc-
Q 043852          355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAKATTM-  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~----g~vkL~DFGla~~~~~-  429 (551)
                      +|||+|.||.|.+.+.+..+++..+..++.||+.+++|||+.||+||||||+|+|+...    +.+|++|||++..... 
T Consensus       113 lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             EEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence            99999999999998766569999999999999999999999999999999999999643    4799999999987765 


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---CCCcCCHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDAR  506 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~  506 (551)
                      ......+||+.|+|||++  ....|+..+||||+|+++|.|++|.+||.+.+.......+..+...+   ....++..+.
T Consensus       193 ~~~~~~~Gtp~y~APEvl--~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak  270 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVL--GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK  270 (382)
T ss_pred             ceEeeecCCccccCchhh--cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence            346678899999999997  45789999999999999999999999999999888888888876533   3356899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ++|.+||..||.+|+|+.++|+|||++..-
T Consensus       271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  271 DFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             HHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            999999999999999999999999998753

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6e-43  Score=354.33  Aligned_cols=249  Identities=32%  Similarity=0.546  Sum_probs=200.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe--cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc---CCCCceeeeeeecc----
Q 043852          278 SWQKGELLGSGSFGTVYEGYT--DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR---FEHENIVQYFGTDK----  348 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~---l~HpnIv~l~~~~~----  348 (551)
                      +|++.+.||+|+||.||+|.+  .++..||+|++..........   ..+.+|+.++..   +.||||+++++++.    
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch---HHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            689999999999999999986  357889999987543322222   233455555554   57999999999864    


Q ss_pred             -CCCeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          349 -DENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       349 -~~~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                       ....++++|||+. ++|..++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence             3456899999997 488887754   34888999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC--------
Q 043852          425 KATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--------  495 (551)
Q Consensus       425 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--------  495 (551)
                      +...... .....||+.|+|||++  ....++.++|||||||++|||++|++||.+....+.+..+......        
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             EeccCCcccccccccccccChHHH--hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            7654332 3345689999999997  3557889999999999999999999999887776665554322100        


Q ss_pred             ------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          496 ------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       496 ------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                        .....++..+.+|+.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              0112467888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.5e-43  Score=365.25  Aligned_cols=248  Identities=29%  Similarity=0.472  Sum_probs=212.1

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVT  361 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  361 (551)
                      +.||+|+||.||++.+ .+|..||+|++.....  ........+.+|+.++..++||||+++++++.....+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            4699999999999987 5799999999875322  122345567789999999999999999999999999999999999


Q ss_pred             ccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccCCCC
Q 043852          362 KGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGT  438 (551)
Q Consensus       362 ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~~GT  438 (551)
                      +++|..++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ......||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            99998877654 5889999999999999999999999999999999999999999999999998753222  23345699


Q ss_pred             CcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCC
Q 043852          439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN  518 (551)
Q Consensus       439 ~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~  518 (551)
                      +.|+|||++  ....++.++|||||||++|+|++|+.||...+.......+.... ..++..++..+.+||.+||+.||.
T Consensus       159 ~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         159 PEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCcCCcccc--cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHH
Confidence            999999997  45578999999999999999999999998776666555554443 345678999999999999999999


Q ss_pred             CCC-----CHHHHHhCcccCCc
Q 043852          519 DRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       519 ~RP-----S~~eILehpff~~~  535 (551)
                      +|+     ++.++++|+||...
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCC
Confidence            998     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3e-43  Score=365.68  Aligned_cols=248  Identities=28%  Similarity=0.469  Sum_probs=211.9

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVT  361 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  361 (551)
                      +.||+|+||.||++.+ .+|..||+|++......  .......+.+|+.+++.++||||+++++++.+...+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII--AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            4699999999999987 57999999998743221  23345567889999999999999999999999999999999999


Q ss_pred             ccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCCC
Q 043852          362 KGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGT  438 (551)
Q Consensus       362 ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~GT  438 (551)
                      +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......||
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            9999887764 4588999999999999999999999999999999999999999999999999875322  223345699


Q ss_pred             CcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCC
Q 043852          439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN  518 (551)
Q Consensus       439 ~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~  518 (551)
                      +.|+|||++  ....++.++|||||||++|+|++|+.||...+.......+.... ..++..++.++.+||.+||++||.
T Consensus       159 ~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         159 PEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             cCccChhhh--cCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHH
Confidence            999999997  35578999999999999999999999998776655555554433 445678999999999999999999


Q ss_pred             CCC-----CHHHHHhCcccCCc
Q 043852          519 DRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       519 ~RP-----S~~eILehpff~~~  535 (551)
                      +|+     ++.++++||||...
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCC
Confidence            997     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.1e-43  Score=371.20  Aligned_cols=254  Identities=28%  Similarity=0.462  Sum_probs=210.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|.+++.||+|+||+||+|.+ .++..||||++......  .......+.+|+.++.+++|+||+++++++.+...+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL--NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            588999999999999999987 67899999998753221  233456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-----
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----  430 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-----  430 (551)
                      ||||.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            999999999998865 45888889999999999999999999999999999999999999999999997532100     


Q ss_pred             --------------------------------------------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHH
Q 043852          431 --------------------------------------------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT  466 (551)
Q Consensus       431 --------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~i  466 (551)
                                                                  .....+||+.|+|||++  ....++.++|||||||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH--cCCCCCCccceeehhhH
Confidence                                                        01234699999999997  45678999999999999


Q ss_pred             HHHHHcCCCCCCCchhHHHHHHhhcCC-CCCCC--CcCCHHHHHHHHHhh--hcCCCCCCCHHHHHhCcccCCc
Q 043852          467 VLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVP--NSLSRDARDFILKCL--QVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       467 LyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~LI~~cL--~~DP~~RPS~~eILehpff~~~  535 (551)
                      +|||++|..||...+..+...++.... ....+  ..++.++.+||.+|+  ..++..|+++.+|+.||||+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999998776665555554321 12222  358999999999955  4556669999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-43  Score=363.96  Aligned_cols=255  Identities=30%  Similarity=0.470  Sum_probs=210.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCe
Q 043852          278 SWQKGELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  352 (551)
                      +|++++.||+|+||.||++..    .++..||+|++..... .........+..|+.++..+ +|+||+++++++.+...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            488999999999999999875    3689999999864322 12233455677899999999 58999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-  430 (551)
                      +|++||||.+|+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            9999999999999887754 56899999999999999999999999999999999999999999999999998754322 


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch---hHH-HHHHhhcCCCCCCCCcCCHH
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQ-ALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---~~~-~~~~i~~~~~~~~~~~~s~~  504 (551)
                        ......||+.|+|||++. ....++.++|||||||++|||++|+.||....   ... ...++.. ..+.++..++..
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  237 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIR-GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGPE  237 (332)
T ss_pred             CCccccccCCccccCHHHhc-CCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHH
Confidence              223456999999999973 33457889999999999999999999996422   122 2223333 334556778999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          505 ARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      +.+||.+||+.||++||     +++++++||||+..
T Consensus       238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999999     88999999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-44  Score=362.02  Aligned_cols=252  Identities=31%  Similarity=0.509  Sum_probs=214.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      -+|...+++|.|+||.||+|+. .+++.||||++-.......         +|+.+|..+.|||||+|..+|...     
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn---------rEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN---------RELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc---------HHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            3788899999999999999987 5789999999865544433         789999999999999998876432     


Q ss_pred             CeEEEEEecccccchHHHHh-----hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-CcEEEEecCCc
Q 043852          351 NRLFIFLELVTKGSLANLYQ-----KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLA  424 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~-----~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGla  424 (551)
                      -+..+||||++. +|...++     +..++.-.+.-|..||++||.|||+.|||||||||.|+|||.+ |.+||||||.|
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            245689999977 8888877     3568888899999999999999999999999999999999976 89999999999


Q ss_pred             cccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC-------
Q 043852          425 KATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP-------  494 (551)
Q Consensus       425 ~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~-------  494 (551)
                      +....++ ..++.+|.+|+|||.+ .+...|+.+.||||.||++.||+-|++.|.+.+..+++..|.+.  .+       
T Consensus       174 K~L~~~epniSYicSRyYRaPELi-fga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELI-FGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHH-cCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            9775543 5677899999999998 57789999999999999999999999999998888777665441  10       


Q ss_pred             -------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 -------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 -------------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                                         ......++.++.+|+.++|..+|.+|.++.|++.||||+......
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence                               112345789999999999999999999999999999999776553

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.2e-43  Score=367.03  Aligned_cols=256  Identities=32%  Similarity=0.519  Sum_probs=211.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +.+|+.++.||+|+||.||+|++ .+|+.||||++....    .......+.+|+.++..++|+||+++++++.+...+|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            45788889999999999999987 578999999985321    2334557889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      +||||+.+++|...   ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            99999999998653   23456778899999999999999999999999999999999999999999998765432  23


Q ss_pred             ccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCch---hHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                      ....||..|+|||++...   +...+.++|||||||++|||++|+.||....   .......+........+..++..+.
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence            445799999999987321   2234568999999999999999999996322   1222333444445556677899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      +||.+||+.||++|||+.+|++||||.+....
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            99999999999999999999999999987644

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-43  Score=371.40  Aligned_cols=254  Identities=27%  Similarity=0.473  Sum_probs=211.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|.+++.||+|+||.||++.+ .+++.||||++.....  ........+.+|+.++.+++||||+++++++.+...+|+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            3689999999999999999987 5899999999864321  123345677889999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      |||||.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            9999999999998865 458888999999999999999999999999999999999999999999999985321100   


Q ss_pred             ----------------------------------------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHH
Q 043852          432 ----------------------------------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC  465 (551)
Q Consensus       432 ----------------------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~  465 (551)
                                                                    ....+||+.|+|||++  ....++.++|||||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGv  236 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF--LQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH--ccCCCCCceeeEecch
Confidence                                                          0124699999999997  4567899999999999


Q ss_pred             HHHHHHcCCCCCCCchhHHHHHHhhcCC-CCCCC--CcCCHHHHHHHHHhhhcCCCCC---CCHHHHHhCcccCCc
Q 043852          466 TVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVP--NSLSRDARDFILKCLQVNPNDR---PTAAQLMEHPFVKRP  535 (551)
Q Consensus       466 iLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~LI~~cL~~DP~~R---PS~~eILehpff~~~  535 (551)
                      ++|||++|.+||......+.+..+.... ....+  ..++.++.+||.+||. +|.+|   +|+.+++.||||+..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999999998877666665554322 12222  2578999999999998 67765   599999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.8e-43  Score=370.74  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=216.8

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ..++|++.+.||+|+||.||++.+ .++..||+|++......  .......+.+|+.++..++||||+++++++.+...+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            345899999999999999999987 57899999998643221  122344567899999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      |+|||||.+|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999999999988889999999999999999999999999999999999999999999999999997654322  


Q ss_pred             -cccCCCCCcccChhhhhccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-CCCC--CcCCHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKN--RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-PLVP--NSLSRDA  505 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~--~~~s~~l  505 (551)
                       .....||+.|+|||++....  ..++.++|||||||++|+|++|..||..........++..... ...+  ..++..+
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence             23556999999999984322  2378899999999999999999999988777666666654321 2223  3579999


Q ss_pred             HHHHHHhhhcCCCC--CCCHHHHHhCcccCCc
Q 043852          506 RDFILKCLQVNPND--RPTAAQLMEHPFVKRP  535 (551)
Q Consensus       506 ~~LI~~cL~~DP~~--RPS~~eILehpff~~~  535 (551)
                      ++++.+||..++.+  |+|+.++++||||+..
T Consensus       279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999999855543  8899999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-43  Score=362.97  Aligned_cols=249  Identities=32%  Similarity=0.523  Sum_probs=212.3

Q ss_pred             eEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          283 ELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      +.||+|+||.||+++.    .+++.||||++....... .......+..|+.++..++||||+++++++.+.+.+|++||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh-hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            6799999999999975    368899999987532211 12234456789999999999999999999999999999999


Q ss_pred             cccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccC
Q 043852          359 LVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSC  435 (551)
Q Consensus       359 y~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~  435 (551)
                      |+.+++|..++.+. .+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99999999888654 4778888999999999999999999999999999999999999999999998743222  23345


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhc
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV  515 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~  515 (551)
                      .||+.|+|||++  ....++.++|||||||++|||++|+.||...+....+..+..+.. .++..++..+.+||.+||++
T Consensus       161 ~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         161 CGTIEYMAPEIL--MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             CCCccccChhhc--cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHccc
Confidence            699999999997  345678999999999999999999999988877777777766543 45677899999999999999


Q ss_pred             CCCCCC-----CHHHHHhCcccCCc
Q 043852          516 NPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       516 DP~~RP-----S~~eILehpff~~~  535 (551)
                      ||++||     +++++++||||+..
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.9e-43  Score=360.46  Aligned_cols=253  Identities=27%  Similarity=0.428  Sum_probs=214.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC-ceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE-NIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~l  355 (551)
                      +|++++.||+|+||.||+|.+ .+++.||||++......  .......+..|+.++..+.|+ +|+.+++++.+...+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            488999999999999999987 47889999998753221  123345667888899988765 58889999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--cCCc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--~~~~  432 (551)
                      ||||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            9999999999988765 458889999999999999999999999999999999999999999999999986432  2223


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+....+.+..+.... ..++..++..+.+|+.+|
T Consensus       159 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         159 RTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             eeecCCccccChhhh--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHH
Confidence            445699999999997  35568899999999999999999999998877777776666554 445677999999999999


Q ss_pred             hhcCCCCCCCH-----HHHHhCcccCCc
Q 043852          513 LQVNPNDRPTA-----AQLMEHPFVKRP  535 (551)
Q Consensus       513 L~~DP~~RPS~-----~eILehpff~~~  535 (551)
                      |++||.+|++.     +++++||||+..
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999986     899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.8e-43  Score=371.08  Aligned_cols=253  Identities=28%  Similarity=0.478  Sum_probs=211.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|.+++.||+|+||.||+|.+ .+++.||+|++.....  ........+.+|+.++.+++|+||+++++.+.+...+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            588999999999999999987 5789999999864321  1233456778999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-----
Q 043852          357 LELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----  430 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-----  430 (551)
                      ||||.+|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....     
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            9999999999988654 5788889999999999999999999999999999999999999999999997522100     


Q ss_pred             --------------------------------------------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHH
Q 043852          431 --------------------------------------------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT  466 (551)
Q Consensus       431 --------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~i  466 (551)
                                                                  .....+||+.|+|||++  ....++.++|||||||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh--cCCCCCCeeeEEechHH
Confidence                                                        01234689999999997  45678999999999999


Q ss_pred             HHHHHcCCCCCCCchhHHHHHHhhcCCC---CCCCCcCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccCCc
Q 043852          467 VLEMLTRQPPYSHLEGMQALFRIGKGEP---PLVPNSLSRDARDFILKCLQVNPNDRPT---AAQLMEHPFVKRP  535 (551)
Q Consensus       467 LyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~LI~~cL~~DP~~RPS---~~eILehpff~~~  535 (551)
                      +|||++|++||...+..+...++.....   ......++.++.+||.+|+ .+|.+|++   +.++++||||+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            9999999999988777666655544221   1223468999999999987 59999987   9999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.4e-43  Score=370.41  Aligned_cols=252  Identities=28%  Similarity=0.468  Sum_probs=210.3

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++++.||+|+||.||++.+ .+++.||||++......  .......+.+|+.++..++|+||+++++.+.+...+|+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL--MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            689999999999999999987 57999999998643211  122345677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-----
Q 043852          357 LELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----  430 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-----  430 (551)
                      ||||.+|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......     
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            9999999999988664 4788888999999999999999999999999999999999999999999997422100     


Q ss_pred             ----------------------------------------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHH
Q 043852          431 ----------------------------------------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEM  470 (551)
Q Consensus       431 ----------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeL  470 (551)
                                                              .....+||+.|+|||++  ....++.++|||||||++|||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH--cCCCCCcceeeeeccceeeeh
Confidence                                                    01134699999999997  456789999999999999999


Q ss_pred             HcCCCCCCCchhHHHHHHhhcCCC---CCCCCcCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCcccCC
Q 043852          471 LTRQPPYSHLEGMQALFRIGKGEP---PLVPNSLSRDARDFILKCLQVNPNDRP---TAAQLMEHPFVKR  534 (551)
Q Consensus       471 ltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~LI~~cL~~DP~~RP---S~~eILehpff~~  534 (551)
                      ++|+.||......+....+.....   ......++..+.+||.+|+ .+|.+|+   |+.++++||||+.
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            999999988776665555443221   1122358899999999987 5999999   9999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.4e-44  Score=373.56  Aligned_cols=258  Identities=32%  Similarity=0.574  Sum_probs=233.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe-E
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR-L  353 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~  353 (551)
                      +.+|..++.+|+|+||.++++++ .++..|++|.|...........   ...+|+.+++++.|||||.+++.|.+++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~---~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR---SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH---HHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            45789999999999999999987 4788999999987765443332   56789999999999999999999999888 9


Q ss_pred             EEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 FIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|+|+||+||+|.+.+.+.   .++++.++.|+.||+.|+.|||+++|+|||||+.|||++.++.|+|+|||+|+.....
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999999988653   4889999999999999999999999999999999999999999999999999988765


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                        ...+++|||.||+||++  .+..|+.++|||||||++|||++-+++|...+....+.+|..+...+.+...+.+++.|
T Consensus       160 ~~~a~tvvGTp~YmcPEil--~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEIL--SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             hhhhheecCCCcccCHHHh--CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence              45678899999999997  57899999999999999999999999999999888999999998888999999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      |..||.++|..||++.++|.+|.++..+.+
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~P~l~~~~~~  267 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRRPHLLRYLVE  267 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhChhhhhHHHh
Confidence            999999999999999999999998865533

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.3e-43  Score=363.33  Aligned_cols=248  Identities=28%  Similarity=0.461  Sum_probs=211.3

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVT  361 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  361 (551)
                      +.||+|+||.||++.+ .+|..||+|++......  .......+.+|+.++..++|+||+++++++.+...+|+||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV--AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            4699999999999987 58999999998753221  22345567789999999999999999999999999999999999


Q ss_pred             ccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          362 KGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       362 ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      +++|..++.+ ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            9999887765 468899999999999999999997 7999999999999999999999999999875322  22334569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  ....++.++|||||||++|+|++|..||...+.......+... ...++..++..+.+||.+||+.||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         159 TPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             CcccCCHHHH--ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999997  4557899999999999999999999999877665555554443 344567799999999999999999


Q ss_pred             CCCC-----CHHHHHhCcccCCc
Q 043852          518 NDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       518 ~~RP-----S~~eILehpff~~~  535 (551)
                      .+|+     ++.++++||||+..
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCC
Confidence            9997     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9e-43  Score=360.63  Aligned_cols=248  Identities=30%  Similarity=0.485  Sum_probs=210.4

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||.||+|.+ .++..||||++......  .......+..|+.++..+ +||||+++++++.+...+|+|||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh--hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            3699999999999987 57899999998643211  122344566777777765 6999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            99999988765 4688999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  ....++.++|||||||++|+|++|+.||...+....+..+..+. ...+..++..+.+||.+||+.||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         159 TPDYIAPEIL--QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             CccccCHHHH--cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCH
Confidence            9999999997  45678899999999999999999999999887777776666554 34566789999999999999999


Q ss_pred             CCCCCH------HHHHhCcccCCc
Q 043852          518 NDRPTA------AQLMEHPFVKRP  535 (551)
Q Consensus       518 ~~RPS~------~eILehpff~~~  535 (551)
                      .+||++      .+++.||||+..
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCC
Confidence            999998      999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.5e-43  Score=361.83  Aligned_cols=248  Identities=27%  Similarity=0.495  Sum_probs=206.7

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ++||+|+||.||++.+ .++..||||++......  .......+..|+.++..+ +||||+++++++.+...+|+|||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN--DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            4699999999999987 57899999998753221  123345677889999888 6999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--cCCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--~~~~~~~~G  437 (551)
                      .+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  ........|
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            99999887754 569999999999999999999999999999999999999999999999999987432  222344569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--------hHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--------GMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      |+.|+|||++  .+..++.++|||||||++|+|++|+.||....        ......+........+|..++..+.+||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li  236 (329)
T cd05588         159 TPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL  236 (329)
T ss_pred             CccccCHHHH--cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999997  45678899999999999999999999995311        1222333333344556778999999999


Q ss_pred             HHhhhcCCCCCCC------HHHHHhCcccCC
Q 043852          510 LKCLQVNPNDRPT------AAQLMEHPFVKR  534 (551)
Q Consensus       510 ~~cL~~DP~~RPS------~~eILehpff~~  534 (551)
                      .+||+.||.+|+|      ++++++||||+.
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999999987      799999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-42  Score=342.18  Aligned_cols=254  Identities=46%  Similarity=0.839  Sum_probs=217.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +.|.+.+.||+|+||.||.+.+ .++..||+|++...............+.+|+.++.+++|+||+++++++.+....|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            3688999999999999999987 579999999987654433334456678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          356 FLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      ++||+++++|.+++.+. .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||+++......   
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999888654 57888899999999999999999999999999999999999999999999987543221   


Q ss_pred             --cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC-CCCCCCCcCCHHHHHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-EPPLVPNSLSRDARDF  508 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~~L  508 (551)
                        .....++..|+|||++.  +..++.++|||||||++|+|++|+.||...+.......+... .....+..++..+.++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVIS--GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF  239 (263)
T ss_pred             ccccCCCcCccccCcceec--cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence              12345788999999973  455889999999999999999999999877666555544332 3445667789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff  532 (551)
                      |.+||+.+|++|||+.++++|+||
T Consensus       240 i~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         240 LRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-42  Score=358.37  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=213.8

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +|.+.+.||+|+||.||+|.+ .++..||||++......  .......+..|..++..+ +|++|+.+++++.+...+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI--QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            478899999999999999987 47889999998753221  122334456677777766 58999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~  432 (551)
                      ||||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ...
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            9999999999888764 4688999999999999999999999999999999999999999999999999875432  223


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ....||+.|+|||++  ....++.++|||||||++|||++|+.||...........+.... ..++..++.++.+|+.+|
T Consensus       159 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         159 KTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             ccCCCChhhcCHHHh--cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHH
Confidence            455699999999997  35678999999999999999999999999877777766666554 345677999999999999


Q ss_pred             hhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          513 LQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       513 L~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      |++||.+|++     ..++++||||+..
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999998     4899999999753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8e-43  Score=361.51  Aligned_cols=255  Identities=28%  Similarity=0.409  Sum_probs=215.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|.+.+.||+|+||.||++.+ .+|+.||+|++.....  ........+.+|+.++..++|+||+++++++.+...+|+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            689999999999999999987 5899999999875422  1223455677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          357 LELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      |||+++++|.+++.+.  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999998764  68899999999999999999999999999999999999999999999999997654332   


Q ss_pred             cccCCCCCcccChhhhhcc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-CC--CCCcCCHH
Q 043852          432 VKSCKGTPFWMAPEVVNLK----NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-PL--VPNSLSRD  504 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~~--~~~~~s~~  504 (551)
                      .....||+.|+|||++...    ...++.++|||||||++|+|++|+.||........+.++..... ..  ....++..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence            2234689999999997421    34578999999999999999999999988777666666544321 11  22357899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      +.+||.+||+ +|.+|||++++++||||+..
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999998 99999999999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.6e-42  Score=352.30  Aligned_cols=258  Identities=27%  Similarity=0.449  Sum_probs=209.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|.+.+.||+|+||.||+|.+ .++..||+|++.......    ....+.+|+.++++++|+||+++++++......|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            46799999999999999999987 478899999986543221    1234568999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      ++|||+.+ +|..++...  .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            99999976 777766543  3788889999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-----------------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-----------------  493 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-----------------  493 (551)
                      ......+|+.|+|||++. ....++.++|||||||++|+|+||++||.+.+..+.+..+....                 
T Consensus       160 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLL-GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             ccccccccccccCCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            223345789999999873 34467899999999999999999999997765543332221100                 


Q ss_pred             -----CC-------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          494 -----PP-------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       494 -----~~-------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                           +.       .....++.++.+||.+||+.||.+|||+.++++||||+....+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence                 00       01124688999999999999999999999999999999766553

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-42  Score=364.95  Aligned_cols=253  Identities=28%  Similarity=0.490  Sum_probs=212.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||++.+ .++..||||++......  .......+..|+.++..++|+||+++++.+.+...+|+|
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML--EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh--hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            688999999999999999987 57999999998643211  223455677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----  431 (551)
                      ||||.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++......    
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            999999999998865 468899999999999999999999999999999999999999999999999986432110    


Q ss_pred             ---------------------------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 043852          432 ---------------------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS  478 (551)
Q Consensus       432 ---------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~  478 (551)
                                                       ....+||+.|+|||++  .+..++.++|||||||++|||++|+.||.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~--~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH--cCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             1234699999999997  45678999999999999999999999998


Q ss_pred             CchhHHHHHHhhcCCC-CCCC--CcCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCcccCCc
Q 043852          479 HLEGMQALFRIGKGEP-PLVP--NSLSRDARDFILKCLQVNPNDRP---TAAQLMEHPFVKRP  535 (551)
Q Consensus       479 ~~~~~~~~~~i~~~~~-~~~~--~~~s~~l~~LI~~cL~~DP~~RP---S~~eILehpff~~~  535 (551)
                      .........++..... ..++  ..++..+.+||.+|+. ||.+|+   ++.++++||||+..
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            8777766666554221 1122  2478999999999874 999998   58999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-42  Score=358.31  Aligned_cols=247  Identities=29%  Similarity=0.460  Sum_probs=209.7

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ++||+|+||.||+|.+ .+++.||||++......  .......+..|+.++..+ +||||+++++++.+...+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL--QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            3699999999999987 56889999998643221  122344566788888765 7999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  .......|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            99999887754 4688899999999999999999999999999999999999999999999999875322  22334568


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  ....++.++|||||||++|+|++|+.||...+....+..+..... ..+..++.++.+||.+||++||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         159 TPDYIAPEIL--QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             CccccCHHHH--cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCH
Confidence            9999999997  456789999999999999999999999998887777777666543 3456789999999999999999


Q ss_pred             CCCC-------CHHHHHhCcccCC
Q 043852          518 NDRP-------TAAQLMEHPFVKR  534 (551)
Q Consensus       518 ~~RP-------S~~eILehpff~~  534 (551)
                      ++|+       ++.++++||||..
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCC
Confidence            9999       9999999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3e-42  Score=356.14  Aligned_cols=248  Identities=29%  Similarity=0.502  Sum_probs=206.9

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ++||+|+||.||+|.+ .+++.||||++.......  ......+..|..++.. .+||||+++++++.....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE--DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999987 578899999987543211  1223334455555554 58999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            99999988764 4688999999999999999999999999999999999999999999999999875432  22344569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  .+..++.++|||||||++|+|++|+.||.+.+..+....+... .+.++..++.++.+||.+||+.||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         159 TPDYIAPEIL--KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             CccccCHHHH--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999997  3556899999999999999999999999887776666665543 455677899999999999999999


Q ss_pred             CCCCCH-HHHHhCcccCCc
Q 043852          518 NDRPTA-AQLMEHPFVKRP  535 (551)
Q Consensus       518 ~~RPS~-~eILehpff~~~  535 (551)
                      .+||++ .++++||||+..
T Consensus       236 ~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         236 TKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HHcCCChHHHHcCcccCCC
Confidence            999986 588999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-42  Score=365.39  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=217.1

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ...++|++.+.||+|+||.||++.+ .+++.||+|++......  .......+.+|+.++..++||||+++++++.+...
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3456899999999999999999987 57899999998643211  12234456789999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          353 LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      +|+|||||.+|+|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999997654322 


Q ss_pred             --cccCCCCCcccChhhhhccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-C--CCCCcCCHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKN--RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-P--LVPNSLSRD  504 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~--~~~~~~s~~  504 (551)
                        .....||+.|+|||++....  ..++.++|||||||++|||++|..||...+......++..... .  .....++..
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence              23456999999999985322  2378999999999999999999999988777666666654321 1  222468999


Q ss_pred             HHHHHHHhhhcCCCC--CCCHHHHHhCcccCCc
Q 043852          505 ARDFILKCLQVNPND--RPTAAQLMEHPFVKRP  535 (551)
Q Consensus       505 l~~LI~~cL~~DP~~--RPS~~eILehpff~~~  535 (551)
                      +.+||.+||..++.+  |+++++|++|+||++.
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            999999999844433  7899999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.4e-42  Score=347.89  Aligned_cols=246  Identities=26%  Similarity=0.429  Sum_probs=204.5

Q ss_pred             eccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      ||+|+||+||++.+ .+|+.||+|++......  .......+..|+.++..++|+||+++++++.....+|++|||+.+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK--KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh--hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            79999999999987 57899999998643221  2233456778999999999999999999999999999999999999


Q ss_pred             chHHHHh-----hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--cccCC
Q 043852          364 SLANLYQ-----KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCK  436 (551)
Q Consensus       364 sL~~ll~-----~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~  436 (551)
                      +|..++.     ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......  .....
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            9987763     2358899999999999999999999999999999999999999999999999987543322  23456


Q ss_pred             CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH----HHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM----QALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       437 GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ||+.|+|||++.  +..++.++|||||||++|+|++|+.||......    .....+.. ....++..++..+.+|+.+|
T Consensus       159 g~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         159 GTPGFMAPELLQ--GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-DSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             CCcCccCHHHhc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-cCCCCcccCCHHHHHHHHHH
Confidence            899999999973  557889999999999999999999999754321    22222222 23345567899999999999


Q ss_pred             hhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          513 LQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       513 L~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      |+.||++||     +++++++||||+..
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            999999999     88999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.1e-42  Score=372.81  Aligned_cols=250  Identities=29%  Similarity=0.473  Sum_probs=202.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD------  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------  349 (551)
                      .+|+++++||+|+||.||+|.+ .++..||||++.....         ...+|+.+++.++|+||+++++++..      
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            4799999999999999999987 5789999998853211         23479999999999999999887532      


Q ss_pred             --CCeEEEEEecccccchHHHHh-----hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEec
Q 043852          350 --ENRLFIFLELVTKGSLANLYQ-----KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADF  421 (551)
Q Consensus       350 --~~~~~lV~Ey~~ggsL~~ll~-----~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DF  421 (551)
                        ...+++||||+.+ +|..++.     ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence              2357799999986 5655543     24588889999999999999999999999999999999998665 6999999


Q ss_pred             CCccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--C----
Q 043852          422 GLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--P----  494 (551)
Q Consensus       422 Gla~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~----  494 (551)
                      |+++..... ......||+.|+|||++. ....|+.++|||||||++|||++|.+||.+....+.+.++....  +    
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELML-GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            999865432 334567899999999873 34568999999999999999999999998876655554443210  0    


Q ss_pred             ----------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          495 ----------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       495 ----------------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                            ..++..++.++.+||.+||++||.+|||+.++|+||||+....
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                                  1123456789999999999999999999999999999986544

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=352.15  Aligned_cols=259  Identities=35%  Similarity=0.610  Sum_probs=217.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCC--
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN-IVQYFGTDKDEN--  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~--  351 (551)
                      +..|+.+++||+|+||+||+|+. .+|+.||+|++.......   ..-....+|+.+++.++|+| |+.+++++....  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E---G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE---GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc---CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            44678888999999999999997 689999999998764421   12234569999999999999 999999988776  


Q ss_pred             ----eEEEEEecccccchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecC
Q 043852          352 ----RLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       352 ----~~~lV~Ey~~ggsL~~ll~~~-----~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                          .+++||||+.. +|..++...     +++...+..+++||+.||+|||+++|+||||||+||||+.+|.+||+|||
T Consensus        87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence                89999999966 888887653     47777899999999999999999999999999999999999999999999


Q ss_pred             Cccccc--cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC----
Q 043852          423 LAKATT--MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP----  494 (551)
Q Consensus       423 la~~~~--~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~----  494 (551)
                      +|+...  .......++|.+|+|||++ .....|+...||||+|||++||+++++.|.+....+++.+|..-  .+    
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvL-lGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVL-LGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHh-cCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            998654  3346677899999999998 56678999999999999999999999999999988888776441  11    


Q ss_pred             ------------CC--C--C-------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 ------------PL--V--P-------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 ------------~~--~--~-------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                                  .+  .  +       +..+....+++.+||+.+|.+|.|+..+|+||||+..-.+.
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence                        00  0  0       12335788999999999999999999999999999774443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.7e-42  Score=358.70  Aligned_cols=255  Identities=26%  Similarity=0.452  Sum_probs=204.5

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC--
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN--  351 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--  351 (551)
                      .+.+|++.+.||+|+||.||++.+ .+|..||||++.....   .......+.+|+.++..++|+||+++++++....  
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            456899999999999999999987 5799999999864322   2233456778999999999999999999876443  


Q ss_pred             ----eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          352 ----RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       352 ----~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                          .+|++|||+.+ +|...+. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence                57999999976 4555443 35788889999999999999999999999999999999999999999999998754


Q ss_pred             ccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--------------
Q 043852          428 TMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--------------  492 (551)
Q Consensus       428 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--------------  492 (551)
                      ... ......||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+.+....+..+...              
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             ccCccCCCCcccCCCCCchhc--cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            332 23445689999999997  4567899999999999999999999999876544332211110              


Q ss_pred             --------CCC-------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          493 --------EPP-------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       493 --------~~~-------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                              .+.                   ......+..+++||.+||+.||++|||+.++|+||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence                    000                   01122467899999999999999999999999999998544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.5e-42  Score=356.72  Aligned_cols=249  Identities=27%  Similarity=0.478  Sum_probs=207.8

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||.||+|.+ .+|..||+|++.......  ......+..|..++.. ++|+||+++++++.+...+|+|||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI--DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            4699999999999987 578999999987532211  1123345567777764 48999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--cCCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--~~~~~~~~G  437 (551)
                      .+++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...  ........|
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            99999888765 468889999999999999999999999999999999999999999999999987432  223345669


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  .+..++.++|||||||++|+|++|..||...+.......+... .+.++..++.++.+||.+||+.||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         159 TPDYIAPEIL--QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             CcCccCHHHH--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999997  4567899999999999999999999999877766555555443 345566789999999999999999


Q ss_pred             CCCCCH-HHHHhCcccCCcc
Q 043852          518 NDRPTA-AQLMEHPFVKRPL  536 (551)
Q Consensus       518 ~~RPS~-~eILehpff~~~~  536 (551)
                      .+||++ +++++||||+...
T Consensus       236 ~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         236 TRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HHcCCChHHHHcCCCcCCCC
Confidence            999997 5899999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.9e-43  Score=359.62  Aligned_cols=247  Identities=30%  Similarity=0.481  Sum_probs=211.9

Q ss_pred             eEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          283 ELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      +.||+|+||.||++.+    .+|..||+|++......   ......+.+|+.++.+++|+||+++++++.+...+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999875    36899999998753221   1233456789999999999999999999999999999999


Q ss_pred             cccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccC
Q 043852          359 LVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSC  435 (551)
Q Consensus       359 y~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~  435 (551)
                      |+.+++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            9999999988865 45889999999999999999999999999999999999999999999999998765433  23345


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhc
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV  515 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~  515 (551)
                      .||+.|+|||++  ....++.++|||||||++|+|++|+.||...+.......+.... ..++..++..+.+||.+||++
T Consensus       159 ~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         159 CGTVEYMAPEVV--NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             cCChhhcCHHHH--cCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence            699999999997  34567899999999999999999999998877777776666554 345677899999999999999


Q ss_pred             CCCCCCC-----HHHHHhCcccCCc
Q 043852          516 NPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       516 DP~~RPS-----~~eILehpff~~~  535 (551)
                      ||.+||+     ..+++.||||+..
T Consensus       236 ~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         236 NPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             CHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999     7889999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.8e-42  Score=356.43  Aligned_cols=248  Identities=29%  Similarity=0.482  Sum_probs=210.8

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||.||+|.+ .++..||||++......  .......+..|+.++..+ +|+||+++++++.+...+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL--QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999987 47889999998753211  122344566788888877 6999999999999999999999999


Q ss_pred             cccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+++|..++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....  .......|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            999998887655 689999999999999999999999999999999999999999999999999865322  22334568


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  .+..++.++|||||||++|+|++|+.||...+.......+.... ...+..++..+.+||.+||+.||
T Consensus       159 ~~~y~aPE~~--~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         159 TPDYIAPEIL--SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             CccccCHHHh--cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHccCCH
Confidence            9999999997  45678999999999999999999999998877666665555443 34567789999999999999999


Q ss_pred             CCCCCH-----HHHHhCcccCCc
Q 043852          518 NDRPTA-----AQLMEHPFVKRP  535 (551)
Q Consensus       518 ~~RPS~-----~eILehpff~~~  535 (551)
                      .+|||+     .++++||||+..
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999     999999999864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=372.67  Aligned_cols=249  Identities=32%  Similarity=0.492  Sum_probs=212.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-C-----CceeeeeeeccCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-H-----ENIVQYFGTDKDE  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~  350 (551)
                      +|.+.++||+|+||+|.+|++ .+++.||||+|+..      +....+...|+.+|..|+ |     -|||+++++|...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            799999999999999999998 68999999999643      344556678899999887 3     4899999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC--cEEEEecCCcc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG--SVKLADFGLAK  425 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g--~vkL~DFGla~  425 (551)
                      +++|||+|++.. +|+++++..   +++...++.++.||+.||.+||+.||||+||||+||||...+  .|||+|||.|.
T Consensus       261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999999955 999999865   588899999999999999999999999999999999997644  69999999998


Q ss_pred             ccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC---------
Q 043852          426 ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP---------  494 (551)
Q Consensus       426 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~---------  494 (551)
                      .....-. +++.+.+|+|||++  .+..|+.+.||||||||++||++|.+.|.+.+..+++.+|..-  .+         
T Consensus       340 ~~~q~vy-tYiQSRfYRAPEVI--LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  340 FESQRVY-TYIQSRFYRAPEVI--LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             ccCCcce-eeeeccccccchhh--ccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            7765555 78899999999997  6789999999999999999999999999998888777665331  00         


Q ss_pred             -------------C---------------------------CCC----------C-cCCHHHHHHHHHhhhcCCCCCCCH
Q 043852          495 -------------P---------------------------LVP----------N-SLSRDARDFILKCLQVNPNDRPTA  523 (551)
Q Consensus       495 -------------~---------------------------~~~----------~-~~s~~l~~LI~~cL~~DP~~RPS~  523 (551)
                                   .                           -.|          . .-...+.+||.+||.+||.+|+|+
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                         0                           001          0 122457899999999999999999


Q ss_pred             HHHHhCcccCCcc
Q 043852          524 AQLMEHPFVKRPL  536 (551)
Q Consensus       524 ~eILehpff~~~~  536 (551)
                      .|.|+||||....
T Consensus       497 ~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  497 AQALNHPFLTGTS  509 (586)
T ss_pred             HHHhcCccccccc
Confidence            9999999999444

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.8e-42  Score=374.41  Aligned_cols=264  Identities=23%  Similarity=0.344  Sum_probs=204.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC------CCceeeeeeecc
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE------HENIVQYFGTDK  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~  348 (551)
                      .++|+++++||+|+||+||+|.+ .+++.||||++.....      ....+..|+.++..+.      |.+|+++++++.
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            35799999999999999999987 5788999999863211      1223344555555554      456888888876


Q ss_pred             CC-CeEEEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCC-----------
Q 043852          349 DE-NRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASG-----------  414 (551)
Q Consensus       349 ~~-~~~~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g-----------  414 (551)
                      .. ..+|+|||++ +++|.+++. ...+++..+..++.||+.||.|||+ .|||||||||+|||++.++           
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            54 5789999998 557776664 4568999999999999999999998 5999999999999998765           


Q ss_pred             -----cEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHh
Q 043852          415 -----SVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI  489 (551)
Q Consensus       415 -----~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i  489 (551)
                           .+||+|||++.... ......+||+.|+|||++  .+..|+.++|||||||++|||++|++||.+....+.+..+
T Consensus       281 ~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~--~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVV--LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             CCCCceEEECCCCccccCc-cccccccCCccccCcHHh--hcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                 49999999875432 223456799999999997  4567899999999999999999999999876655444332


Q ss_pred             hcCCC---------------------------CCCC--------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          490 GKGEP---------------------------PLVP--------------NSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       490 ~~~~~---------------------------~~~~--------------~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .....                           ...+              ...+..+.+||.+||++||.+|||++|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            21100                           0000              012456789999999999999999999999


Q ss_pred             CcccCCccccCCCCCCCCCCC
Q 043852          529 HPFVKRPLQKSRGPPSYYNNM  549 (551)
Q Consensus       529 hpff~~~~~~~~~~~~~~~~~  549 (551)
                      ||||++.....+.-|.+.+|+
T Consensus       438 Hp~~~~~~~~~~~~~~~~~~~  458 (467)
T PTZ00284        438 HPYVLKYYPECRQHPNYPDNR  458 (467)
T ss_pred             CccccccCCccccCCCCCCcc
Confidence            999999888887777776654

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7e-42  Score=356.11  Aligned_cols=256  Identities=29%  Similarity=0.505  Sum_probs=211.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.++||+|+||.||++.+ .++..+|+|.+....    .......+.+|++++.+++|+||+++++++.+.+.+|+
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            4799999999999999999987 478899999886432    22345568899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          356 FLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      +|||+.+++|.+++.+. .+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++.........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  160 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  160 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccc
Confidence            99999999999988654 578888899999999999999975 7999999999999999999999999998765444444


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH--------------------------
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF--------------------------  487 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~--------------------------  487 (551)
                      ...||+.|+|||++  .+..++.++|||||||++|+|++|+.||......+...                          
T Consensus       161 ~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         161 SFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cCCCCccccCHHHh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            56789999999997  34568899999999999999999999997543322211                          


Q ss_pred             ------------------HhhcCCCCCCC-CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          488 ------------------RIGKGEPPLVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       488 ------------------~i~~~~~~~~~-~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                                        .+.+...+..+ ...+.++.+||.+||++||++|||+.+++.||||+....+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~  308 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE  308 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccc
Confidence                              11111111221 2367889999999999999999999999999999876543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.9e-42  Score=373.73  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=217.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cC-CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DD-GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~-g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..|.+.+.||+|+||.||+|.. .+ +..||+|.+...     .......+.+|+.++..++||||+++++++...+.+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            3599999999999999999976 34 678888876432     2233456678999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      |||||+.+|+|.+++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999887643     3578889999999999999999999999999999999999999999999999976533


Q ss_pred             CC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          430 ND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       430 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                      ..    ....+||+.|+|||++  ....++.++|||||||++|+|++|+.||......+.+..+..+.....+..++..+
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~  299 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELW--ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM  299 (478)
T ss_pred             ccccccccccCCCccccCHhHh--CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence            21    2345699999999997  45678999999999999999999999998887777777777776666677899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      .+||.+||+.||++||++.+++.|+|++.
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999863

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.8e-42  Score=355.56  Aligned_cols=248  Identities=29%  Similarity=0.516  Sum_probs=208.1

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||.||+|.+ .++..||||++.......  .........|..++.. ++||||+++++++.+...+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            4699999999999987 578899999987542211  1123344566667765 58999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            99999998875 4688899999999999999999999999999999999999999999999999875322  23344569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  .+..++.++|||||||++|+|++|..||...+..+....+.... +.++..++..+.+||.+||+.||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         159 TPDYIAPEIL--LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             CccccCHHHH--cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCH
Confidence            9999999997  35578999999999999999999999998877666665555443 34566789999999999999999


Q ss_pred             CCCCCHH-HHHhCcccCCc
Q 043852          518 NDRPTAA-QLMEHPFVKRP  535 (551)
Q Consensus       518 ~~RPS~~-eILehpff~~~  535 (551)
                      ++||++. ++++||||+..
T Consensus       236 ~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         236 ERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             hhcCCChHHHHcCcccCCC
Confidence            9999996 89999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.2e-42  Score=358.05  Aligned_cols=249  Identities=28%  Similarity=0.501  Sum_probs=205.7

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||.||++.+ .+++.||+|++......  .......+..|+.++.++ +||||+++++++.+...+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc--chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            4699999999999987 57899999998754222  223445567888888776 7999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            99999887754 4689999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc--------hhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL--------EGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~--------~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      |+.|+|||++  .+..++.++|||||||++|+|++|+.||...        .....+..........+|..++..+.+||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll  236 (329)
T cd05618         159 TPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL  236 (329)
T ss_pred             CccccCHHHH--cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            9999999997  4567889999999999999999999999521        11222233333344456778999999999


Q ss_pred             HHhhhcCCCCCCC------HHHHHhCcccCCc
Q 043852          510 LKCLQVNPNDRPT------AAQLMEHPFVKRP  535 (551)
Q Consensus       510 ~~cL~~DP~~RPS------~~eILehpff~~~  535 (551)
                      .+||+.||.+||+      ++++++||||+..
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999998      5899999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-42  Score=359.29  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=209.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      ++|++++.||+|+||.||+|.+ .++..||||++.....   .......+.+|+.++++++|+||+++++++...     
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ---SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh---hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            4799999999999999999987 5788999998864321   122344567899999999999999999887543     


Q ss_pred             -CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 -NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 -~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                       ..+|++++++ +++|..+++...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence             3578999998 77999888878899999999999999999999999999999999999999999999999999976543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC---------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP---------------  494 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~---------------  494 (551)
                       ......||+.|+|||++. ....++.++|||||||++|+|++|+.||...+..+.+.++.....               
T Consensus       171 -~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         171 -EMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             -CcCCccccccccCchHhc-CCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence             234456899999999973 335688999999999999999999999987655444433321100               


Q ss_pred             -------CCC--------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 -------PLV--------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 -------~~~--------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                             +..        ....+..+.+||.+||+.||.+|||+.++++||||.+.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence                   000        123566789999999999999999999999999999765443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=375.30  Aligned_cols=255  Identities=39%  Similarity=0.707  Sum_probs=226.4

Q ss_pred             CeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      -|.++.-||.|+||.||++.++ ++...|.|+|.     ......+..+.-||.||..+.||+||+|++.|...+.++|+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence            4788899999999999999874 66677788775     34456678899999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc--ccCCc
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~--~~~~~  432 (551)
                      .|||.||-+..++-.  ..|.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+-..  .....
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence            999999999887653  46999999999999999999999999999999999999999999999999987432  22335


Q ss_pred             ccCCCCCcccChhhhh---cccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHH
Q 043852          433 KSCKGTPFWMAPEVVN---LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARD  507 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~---~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~  507 (551)
                      .+..|||+|||||++.   .+...|++++||||||++|.||..+.+|....+.+-.+.+|.+..++++  |...+..|.+
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D  267 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD  267 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence            6788999999999973   3567899999999999999999999999999999999999999988875  5678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ++.+||.+||..||++++||+||||+..-+
T Consensus       268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  268 FLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             HHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            999999999999999999999999996543

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-42  Score=356.32  Aligned_cols=247  Identities=30%  Similarity=0.462  Sum_probs=206.5

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHH-HHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||+||+|.+ .+|+.||||++.......  ......+..|.. +++.++||||+++++.+.+...+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK--KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            4699999999999988 589999999986532211  122334444544 567899999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+++|..++++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            99999888765 4588899999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  ....++.++|||||||++|+|++|+.||...+..+....+..... ..+..++..+.+||.+||+.||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         159 TPEYLAPEVL--RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             ChhhcChhhh--cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCH
Confidence            9999999997  355789999999999999999999999988776666666655543 3455689999999999999999


Q ss_pred             CCCCCH----HHHHhCcccCC
Q 043852          518 NDRPTA----AQLMEHPFVKR  534 (551)
Q Consensus       518 ~~RPS~----~eILehpff~~  534 (551)
                      .+||++    .++++||||..
T Consensus       236 ~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         236 TKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCC
Confidence            999987    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=346.15  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=211.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|++.++||+|+||+||++.+ .++..||||++......  .......+.+|+.+++.++|+||+++++.+.+...+|++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            378899999999999999987 57899999998643221  122344567899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-c
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-V  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-~  432 (551)
                      |||+.+++|..++..   ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            999999999887643   358899999999999999999999999999999999999999999999999987653322 2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH---HHhhcCCCCCCCCcCCHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL---FRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~---~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ....||+.|+|||++  ....++.++|||||||++|+|++|+.||.+.......   ...........+..++..+.+||
T Consensus       159 ~~~~~~~~y~aPE~~--~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         159 RGRVGTVGYMAPEVV--KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccCCCCccCcHHh--cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            345689999999997  3556889999999999999999999999875543222   22222333445667899999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHhCcccCC
Q 043852          510 LKCLQVNPNDRP-----TAAQLMEHPFVKR  534 (551)
Q Consensus       510 ~~cL~~DP~~RP-----S~~eILehpff~~  534 (551)
                      .+||+.||.+||     +++++++||||..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            999999999999     8999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=359.86  Aligned_cols=248  Identities=31%  Similarity=0.476  Sum_probs=207.9

Q ss_pred             eccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC---CCCceeeeeeeccCCCeEEEEEecc
Q 043852          285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF---EHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       285 LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ||+|+||+||+|++ .+|..||||++......  .......+..|..++..+   .||||+.+++++.+...+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV--AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh--hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            79999999999987 57999999998643221  122334445566666554   6999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....  .......|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence            99999887764 4589999999999999999999999999999999999999999999999999875422  22345569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++. ....++.++|||||||++|+|++|+.||...+..+.+..+..+........++..+.+||.+||+.||
T Consensus       159 t~~y~aPE~~~-~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P  237 (330)
T cd05586         159 TTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP  237 (330)
T ss_pred             CccccCHHHHc-CCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence            99999999973 34457899999999999999999999998877777777776665555445689999999999999999


Q ss_pred             CCCC----CHHHHHhCcccCCc
Q 043852          518 NDRP----TAAQLMEHPFVKRP  535 (551)
Q Consensus       518 ~~RP----S~~eILehpff~~~  535 (551)
                      .+||    ++.++++||||+..
T Consensus       238 ~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         238 QHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HHCCCCCCCHHHHhcCccccCC
Confidence            9998    79999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-41  Score=339.12  Aligned_cols=253  Identities=47%  Similarity=0.841  Sum_probs=218.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc----chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ----GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      +|.+++.||+|+||.||+|.+ .++..||+|.+........    .......+.+|+.++.+++|+||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            478889999999999999987 5788999998865543322    22345678899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      .+++|||+.+++|..++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            9999999999999998876 457888899999999999999999999999999999999999999999999987654211


Q ss_pred             --------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCH
Q 043852          432 --------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       432 --------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  503 (551)
                              .....|+..|+|||.+  ....++.++|+|||||++|+|++|+.||........+..+.....+..+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS  238 (267)
T ss_pred             ccCCccccccccCCCcCccChhHh--ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence                    1123478899999987  345678899999999999999999999988777777777766666667778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .+.++|.+||++||.+||++.+|++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-41  Score=344.00  Aligned_cols=249  Identities=32%  Similarity=0.536  Sum_probs=198.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHh---cCCCCceeeeeeeccC----
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS---RFEHENIVQYFGTDKD----  349 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~----  349 (551)
                      +|++.+.||+|+||+||+|.+ .+|+.||+|.+...........   .+.+|+.++.   .++|+||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~---~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL---STVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCch---HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            488999999999999999987 5799999999875432221111   2334555554   4579999999998754    


Q ss_pred             -CCeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          350 -ENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                       ...++++|||+.+ +|..++.+   ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence             3458999999985 78777754   348899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--------C--
Q 043852          426 ATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--------P--  494 (551)
Q Consensus       426 ~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--------~--  494 (551)
                      ...... .....||+.|+|||++  .+..++.++|||||||++|+|++|.+||........+.++....        +  
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cccCcccCCCccccccccCchHh--hCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            654322 2345689999999997  35578999999999999999999999997766554443332210        0  


Q ss_pred             ----------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 ----------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ----------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                      ......++..+.+||.+||++||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                            00112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.2e-42  Score=360.86  Aligned_cols=253  Identities=28%  Similarity=0.493  Sum_probs=207.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-----
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-----  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----  351 (551)
                      +|++++.||+|+||.||++.+ .+|..||||++....   .......++.+|+.++..++|+||+++++++....     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            477889999999999999987 589999999875321   12234557789999999999999999999988776     


Q ss_pred             eEEEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+|+||||+.+ +|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          78 EIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            78999999975 6666554 456899999999999999999999999999999999999999999999999998754322


Q ss_pred             C---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC---------------
Q 043852          431 D---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG---------------  492 (551)
Q Consensus       431 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~---------------  492 (551)
                      .   .....+|+.|+|||++. ....++.++|||||||++|||++|+.||.+.+..+.+..+...               
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILM-GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHc-CCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            2   23345799999999973 3345789999999999999999999999877655544333210               


Q ss_pred             ----------CCC------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          493 ----------EPP------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       493 ----------~~~------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                                .++      ......+..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                      000      1223468899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.2e-42  Score=354.95  Aligned_cols=249  Identities=27%  Similarity=0.483  Sum_probs=209.0

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ++||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++.++ +|+||+.+++++.+...+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            3699999999999987 5789999999875322  1223455677888888887 6999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--cCCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--~~~~~~~~G  437 (551)
                      .+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  ........|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            99999887764 469999999999999999999999999999999999999999999999999987532  222344569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc------hhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL------EGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~------~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      |+.|+|||++  .+..++.++|||||||++|+|++|..||...      ...+.........+..++..++..+.++|.+
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~  236 (327)
T cd05617         159 TPNYIAPEIL--RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG  236 (327)
T ss_pred             CcccCCHHHH--CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999997  4567899999999999999999999999532      2233444444445556777899999999999


Q ss_pred             hhhcCCCCCCC------HHHHHhCcccCCc
Q 043852          512 CLQVNPNDRPT------AAQLMEHPFVKRP  535 (551)
Q Consensus       512 cL~~DP~~RPS------~~eILehpff~~~  535 (551)
                      ||++||.+|++      +.++++||||+..
T Consensus       237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999999997      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-41  Score=372.02  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=218.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----  351 (551)
                      .+|++.+.||+|+||+||+|.+ .+|+.||||++.....   .......+.+|+.++..++|+||++++..+....    
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            4899999999999999999987 5899999999865432   2344556789999999999999999887654322    


Q ss_pred             ----eEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecC
Q 043852          352 ----RLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       352 ----~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                          .+++||||+.+|+|.+++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                47899999999999988854     247888999999999999999999999999999999999999999999999


Q ss_pred             CccccccC----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC
Q 043852          423 LAKATTMN----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP  498 (551)
Q Consensus       423 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~  498 (551)
                      +++.....    ......||+.|+|||++  ....++.++|||||||++|||++|+.||........+..+..+.....+
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~  266 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIW--RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP  266 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHh--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            98754322    22345699999999997  3467899999999999999999999999887777777777777777778


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ..++..+.+|+.+||+.||.+||++.++++|||++...
T Consensus       267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence            88999999999999999999999999999999987543

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.6e-41  Score=356.97  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=206.0

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC---
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE---  350 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---  350 (551)
                      .+.+|++.+.||+|+||.||++.+ .++..||||++.....   .......+.+|+.+++.++|+||+++++++...   
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            356899999999999999999987 5789999998864322   223345667899999999999999999887543   


Q ss_pred             ---CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          351 ---NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       351 ---~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                         ..+|+||||+.+ +|...+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence               357999999976 56665543 5788889999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC----------
Q 043852          428 TMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL----------  496 (551)
Q Consensus       428 ~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~----------  496 (551)
                      .... .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+.+....+.++.......          
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHH--hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            4332 2345689999999997  45678999999999999999999999998776655544432211100          


Q ss_pred             -------------------------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          497 -------------------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       497 -------------------------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                                     .....+..+++||.+||+.||.+|||+.++|+||||....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence                                           0111356789999999999999999999999999997533

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=353.73  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=211.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.++..++|+||+.+++++.+...+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            3789999999999999999987 5799999999864221  112234557789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-  432 (551)
                      ||||+.+++|.+++.+  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999999999865  3588999999999999999999999999999999999999999999999999865433221 


Q ss_pred             --ccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC----CCCCCCcCCH
Q 043852          433 --KSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE----PPLVPNSLSR  503 (551)
Q Consensus       433 --~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~s~  503 (551)
                        ....||+.|+|||++...   ...++.++|||||||++|+|++|+.||......+....+....    .+.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence              224599999999998532   2357889999999999999999999998776666655554322    1222235799


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHhCcccCCc
Q 043852          504 DARDFILKCLQVNPND--RPTAAQLMEHPFVKRP  535 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~--RPS~~eILehpff~~~  535 (551)
                      .+++||.+||..++++  |+++.++++||||...
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            9999999998764443  7899999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-41  Score=334.60  Aligned_cols=254  Identities=63%  Similarity=1.072  Sum_probs=220.2

Q ss_pred             CeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|+..+.||+|+||.||+|... ++..|++|.+...............+.+|+.+++.++|+||+++++++.+...+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999874 899999999876655444556677889999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-ccc
Q 043852          357 LELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-~~~  434 (551)
                      +||+++++|.+++.+.. +++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999987654 8889999999999999999999999999999999999999999999999987654332 345


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc-CCCCCCCCcCCHHHHHHHHHhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      ..|+..|++||.+.. ...++.++|+|||||++|+|++|+.||..........++.. ...+.++..++..+.+++.+||
T Consensus       161 ~~~~~~y~~pe~~~~-~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         161 FKGSPYWMAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             cCCCcceeCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            568999999999732 22478999999999999999999999977766666555554 4455566778999999999999


Q ss_pred             hcCCCCCCCHHHHHhCccc
Q 043852          514 QVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff  532 (551)
                      +.+|.+||++.+++.|||+
T Consensus       240 ~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         240 QRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hcCcccCcCHHHHhcCCCC
Confidence            9999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.1e-42  Score=338.58  Aligned_cols=250  Identities=36%  Similarity=0.589  Sum_probs=207.1

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |++++.||+|+||+||++.+ .+++.||+|++.......   .......+|+.++.+++|+||+++++++.+....+++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE---EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH---HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc---cccchhhhhhhccccccccccccccccccccccccccc
Confidence            78899999999999999998 567799999997543322   22223345999999999999999999999999999999


Q ss_pred             ecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc--ccCCccc
Q 043852          358 ELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDVKS  434 (551)
Q Consensus       358 Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~--~~~~~~~  434 (551)
                      ||+.+++|.+++. ...++...+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||++...  .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999887 667999999999999999999999999999999999999999999999999998752  2333455


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch---hHHHHHHhhcCCCCC---CCCcCCHHHHHH
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPL---VPNSLSRDARDF  508 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---~~~~~~~i~~~~~~~---~~~~~s~~l~~L  508 (551)
                      ..+|..|+|||++. ....++.++||||||+++|+|++|..||....   ......+........   .....+..+.++
T Consensus       158 ~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQ-QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSSGGGSCHHHHT-TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence            67899999999973 35678999999999999999999999998762   222322222211110   111224899999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff  532 (551)
                      |.+||+.||++|||+.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-41  Score=351.33  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=213.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  355 (551)
                      +|+..+.||+|+||.||+|.+ .+|..||+|++......  .......+..|+.++..+. |++|+++++++.+...+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI--QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            367889999999999999987 57999999998753221  1223445667888888775 5778889999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      ||||+.+|+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....  ..
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence            9999999999988865 46899999999999999999999999999999999999999999999999998754322  23


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ....||+.|+|||++  ....++.++|||||||++|+|++|..||...........+.... ...+..++..+.+|+.+|
T Consensus       159 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         159 RTFCGTPDYIAPEII--AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             cCccCCccccCHHHH--cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHH
Confidence            345699999999997  34568999999999999999999999998877766666665544 345677899999999999


Q ss_pred             hhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          513 LQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       513 L~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      |+++|.+|++     .+++++||||+..
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            9999999997     5799999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.9e-41  Score=332.70  Aligned_cols=250  Identities=29%  Similarity=0.523  Sum_probs=218.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|.+.+.||+|+||.||+|.. .++..|++|.+......   ......+.+|+.++++++|+||+++++.+.+....|++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN---RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC---HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            478889999999999999987 57899999998653222   33456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      |||+.+++|.+++...   .++...++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++......  
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999988653   57888999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....|++.|+|||++  ....++.++|+|||||++|+|++|+.||..........++..+..+.++..++..+.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         158 ANTIVGTPYYLSPELC--EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             hhccccCccccCHHHh--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence            2234588999999997  34567899999999999999999999998887777777777777777777889999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff  532 (551)
                      ||+.+|++||++.++++|||+
T Consensus       236 ~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         236 CLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.7e-41  Score=337.46  Aligned_cols=253  Identities=44%  Similarity=0.818  Sum_probs=215.3

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCc-cchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT-QGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++++.||.|+||.||+|...+|..+|+|.+....... ........+.+|+.++++++|+||+++++++.+...+|++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            578899999999999999988889999999987543221 2233456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc------
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM------  429 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~------  429 (551)
                      |||+.+++|.+++.+ ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++.....      
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT  160 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence            999999999998876 4678899999999999999999999999999999999999999999999999864321      


Q ss_pred             --CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CCCCCCCcCCHHH
Q 043852          430 --NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EPPLVPNSLSRDA  505 (551)
Q Consensus       430 --~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~l  505 (551)
                        .......|+..|+|||++  ....++.++|||||||++|+|++|+.||...+.......+...  ..+..+..++..+
T Consensus       161 ~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         161 HSNMLKSMHGTPYWMAPEVI--NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             ccccccccCCCccccChhhh--cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence              112234588999999997  3456789999999999999999999999876665554444332  3344566789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .++|.+||+.+|.+||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2e-41  Score=354.81  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=206.2

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--  350 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  350 (551)
                      ..+.+|++.+.||+|+||.||++.+ .++..||||++.....   .......+.+|+.+++.++|+||+++++++...  
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            3456899999999999999999987 5789999998864322   233445677899999999999999999987543  


Q ss_pred             ----CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          351 ----NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       351 ----~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                          ...|++|||+.+ +|...+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          91 LEEFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             ccccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence                357999999976 56555543 578888999999999999999999999999999999999999999999999976


Q ss_pred             cccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC------------
Q 043852          427 TTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE------------  493 (551)
Q Consensus       427 ~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~------------  493 (551)
                      ..... .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+....+.+..+....            
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             CCCccccCCccccCCccCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            54332 3445689999999997  45678999999999999999999999998766544332221100            


Q ss_pred             ----------C-------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          494 ----------P-------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       494 ----------~-------------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                +                   .......+..+.+||.+||+.||.+|||+.++|+||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence                      0                   0011224567899999999999999999999999999985543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-41  Score=362.07  Aligned_cols=246  Identities=26%  Similarity=0.341  Sum_probs=198.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..+|.+++.||+|+||.||++.+ .+++.||+|....           ..+.+|+.++++++||||+++++++......+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            35799999999999999999987 6899999996421           23568999999999999999999999999999


Q ss_pred             EEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc---C
Q 043852          355 IFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM---N  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~---~  430 (551)
                      ++||++. ++|..++. +..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....   .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999996 57766654 45688999999999999999999999999999999999999999999999999864322   2


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-------HHHHHHhh-------------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-------MQALFRIG-------------  490 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-------~~~~~~i~-------------  490 (551)
                      ......||+.|+|||++  ....++.++|||||||++|||++|..||.....       ...+..+.             
T Consensus       239 ~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        239 KYYGWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccCccCCCChhhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            23345799999999997  356789999999999999999999987643210       01111110             


Q ss_pred             -------------cCC---CCCCC-----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          491 -------------KGE---PPLVP-----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       491 -------------~~~---~~~~~-----~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                                   ...   +...+     ..++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                         000   00000     1246689999999999999999999999999999864

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=353.28  Aligned_cols=255  Identities=27%  Similarity=0.511  Sum_probs=227.8

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.|-++.. ..|..||||.|++..  ...++.+..+.+||.||..|+||||+.+|.+|++.+.+.||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            688999999999999999986 789999999887554  44567788899999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-ccc
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-~~~  434 (551)
                      |||..+|.|++++.. ..|++..++.|++||+.|+.|+|+++++|||||.+|||+|.|+++||+||||+..+.... .++
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqT  211 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQT  211 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHH
Confidence            999999999999975 569999999999999999999999999999999999999999999999999997665443 577


Q ss_pred             CCCCCcccChhhhhcccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~-s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      .||+|.|.+||+++  +..| ++.+|-||||++||.|++|.+||.+.+.-..+.+|..|....  +..+.++.-||++||
T Consensus       212 FCGSPLYASPEIvN--G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  212 FCGSPLYASPEIVN--GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGLIRWML  287 (668)
T ss_pred             hcCCcccCCccccC--CCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHHHHHHH
Confidence            89999999999985  3444 788999999999999999999999998888888888875433  335678899999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCcccc
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      -.+|++|.|+.+|..|=|+.+....
T Consensus       288 mVNP~RRATieDiAsHWWvNwgy~~  312 (668)
T KOG0611|consen  288 MVNPERRATIEDIASHWWVNWGYNM  312 (668)
T ss_pred             hcCcccchhHHHHhhhheeeccccc
Confidence            9999999999999999998876543

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=339.90  Aligned_cols=256  Identities=39%  Similarity=0.699  Sum_probs=223.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||.|+||.||+|.+ .++..||+|.+....    .......+.+|+.+++.++|+||+++++.+.+...+|++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            678889999999999999987 579999999986432    123345677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~  434 (551)
                      +||+.+++|.+++....+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||+++.....  ....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999998765433  2334


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCc-CCHHHHHHHHHhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS-LSRDARDFILKCL  513 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~s~~l~~LI~~cL  513 (551)
                      ..+++.|+|||++.  ...++.++|||||||++|+|++|+.||...........+.....+..+.. ++..+.+++.+||
T Consensus       158 ~~~~~~y~~PE~~~--~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l  235 (274)
T cd06609         158 FVGTPFWMAPEVIK--QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL  235 (274)
T ss_pred             ccCCccccChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence            56888999999973  44589999999999999999999999987776666666766666666655 8999999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCccccC
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ..+|++|||++++++||||++....+
T Consensus       236 ~~~p~~Rpt~~~il~~~~~~~~~~~~  261 (274)
T cd06609         236 NKDPKERPSAKELLKHKFIKKAKKTS  261 (274)
T ss_pred             hCChhhCcCHHHHhhChhhcCCCccc
Confidence            99999999999999999999876653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-41  Score=352.41  Aligned_cols=246  Identities=27%  Similarity=0.480  Sum_probs=201.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  349 (551)
                      ++|++++.||+|+||.||+|.+      .++..||||++....    .......+.+|+.++..+ +||||+++++++..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            4799999999999999999963      245689999885321    123345678999999999 89999999998765


Q ss_pred             C-CeEEEEEecccccchHHHHhhh--------------------------------------------------------
Q 043852          350 E-NRLFIFLELVTKGSLANLYQKY--------------------------------------------------------  372 (551)
Q Consensus       350 ~-~~~~lV~Ey~~ggsL~~ll~~~--------------------------------------------------------  372 (551)
                      . ..+|++||||++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 4689999999999999888642                                                        


Q ss_pred             -------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----cccCCCCCcc
Q 043852          373 -------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFW  441 (551)
Q Consensus       373 -------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y  441 (551)
                             .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......    .....+++.|
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence                   25667888899999999999999999999999999999999999999999997543221    1233456789


Q ss_pred             cChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHH-HHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCC
Q 043852          442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQ-ALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPND  519 (551)
Q Consensus       442 ~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~  519 (551)
                      +|||++  ....++.++|||||||++|||++ |..||.+..... ....+..+.....+..++..+.+|+.+||+.||.+
T Consensus       243 ~aPE~~--~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         243 MAPESI--FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             cCcHHh--hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            999987  35578999999999999999997 999998754332 33344455555566788999999999999999999


Q ss_pred             CCCHHHHHh
Q 043852          520 RPTAAQLME  528 (551)
Q Consensus       520 RPS~~eILe  528 (551)
                      |||+.+|++
T Consensus       321 RPs~~el~~  329 (338)
T cd05102         321 RPTFSALVE  329 (338)
T ss_pred             CcCHHHHHH
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.6e-42  Score=354.44  Aligned_cols=248  Identities=29%  Similarity=0.445  Sum_probs=206.7

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHH-HHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||+||+|.+ .+|+.||+|++.......  ......+..|.. +++.++||||+++++++.....+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN--RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            4699999999999987 579999999986542211  122334445544 577899999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--cCCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--~~~~~~~~G  437 (551)
                      .+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  ........|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            99999887754 468899999999999999999999999999999999999999999999999987532  222344569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  ....++.++|||||||++|+|++|+.||...+..+....+..... ..+..++..+.++|.+||+.||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         159 TPEYLAPEVI--RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             ChhhCCHHHH--cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhccCH
Confidence            9999999997  456788999999999999999999999988777666666655443 3345689999999999999999


Q ss_pred             CCCCCH----HHHHhCcccCCc
Q 043852          518 NDRPTA----AQLMEHPFVKRP  535 (551)
Q Consensus       518 ~~RPS~----~eILehpff~~~  535 (551)
                      .+||++    .++++||||+..
T Consensus       236 ~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         236 QRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             HhcCCCCCCHHHHhcCCCcCCC
Confidence            999876    699999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.1e-41  Score=342.01  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=210.3

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |+..+.||+|+||.||++.+ .+++.||+|.+......  .......+.+|+.++.+++|+||+.+++.+.+...+|++|
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            67789999999999999987 57999999988643222  1233345668999999999999999999999999999999


Q ss_pred             ecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-Ccc
Q 043852          358 ELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVK  433 (551)
Q Consensus       358 Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~~  433 (551)
                      ||+.+++|.+++..   ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...... ...
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            99999999888753   24888999999999999999999999999999999999999999999999998654332 223


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ...||..|+|||++.  ...++.++|||||||++|+|++|+.||.....   ......+........+..++..+.+|+.
T Consensus       160 ~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05630         160 GRVGTVGYMAPEVVK--NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK  237 (285)
T ss_pred             CCCCCccccChHHHc--CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence            456899999999973  45688999999999999999999999976432   1222222222333455678999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          511 KCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       511 ~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      +||+.||++|||     +.++++||||++.
T Consensus       238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         238 MLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999999     9999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-41  Score=351.59  Aligned_cols=247  Identities=30%  Similarity=0.483  Sum_probs=205.7

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHH-HHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEI-LLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ++||+|+||.||+|++ .+|..||+|++......  .......+..|. .+++.++|+||+++++.+.+...+|+|||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL--KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999987 57899999998643221  112233444554 4678899999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+++|...+.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  .......|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            99999887754 4588899999999999999999999999999999999999999999999999875322  22334568


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  ....++.++|||||||++|||++|..||...+.......+... +..++...+..+.++|.+||+.||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         159 TPEYLAPEVL--RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             CcccCCHHHh--cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCH
Confidence            9999999997  4557889999999999999999999999887766666665554 345566789999999999999999


Q ss_pred             CCCCCH----HHHHhCcccCC
Q 043852          518 NDRPTA----AQLMEHPFVKR  534 (551)
Q Consensus       518 ~~RPS~----~eILehpff~~  534 (551)
                      .+||++    .++++|+||..
T Consensus       236 ~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         236 RRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             hhcCCCCCCHHHHhCCCCcCC
Confidence            999874    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-40  Score=330.78  Aligned_cols=250  Identities=29%  Similarity=0.556  Sum_probs=213.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-CCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-ENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l  355 (551)
                      +|++.+.||.|+||.||++.+ .+++.||+|++......   ......+.+|+.++++++|+||+++++.+.. ...+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS---RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            488999999999999999987 46889999998653322   2334567789999999999999999988764 456899


Q ss_pred             EEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          356 FLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      +|||+.+++|.+++..   ..+++.++..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......  
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            9999999999988864   24789999999999999999999999999999999999999999999999998755322  


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ......+++.|+|||++  ....++.++|||||||++|+|++|+.||...+.......+..+..+..+..++..+.+|+.
T Consensus       158 ~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         158 MASTLIGTPYYMSPELF--SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             ccccccCCcCccChhHh--cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence            22344588999999986  4557789999999999999999999999877766666666666666667788999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCccc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff  532 (551)
                      +||+.||++|||+.++++||||
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.6e-41  Score=342.73  Aligned_cols=255  Identities=29%  Similarity=0.463  Sum_probs=208.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +.+|.+.+.||.|+||.||+|.+ .++..||+|.+.......    ....+.+|+.++..++|+||+++++++.+...+|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            56899999999999999999987 478999999986543222    1234568999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      +||||+.+ +|..++.+  ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......  
T Consensus        81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            99999975 78777654  35788899999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC----------------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----------------  494 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~----------------  494 (551)
                      ......+++.|+|||++. ....++.++|||||||++|+|++|++||...+..+.+..+.....                
T Consensus       160 ~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 TYSNEVVTLWYRPPDILL-GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             cccccceeecccCcHHHh-CCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            223345789999999873 344678899999999999999999999987665444332211100                


Q ss_pred             -----CC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          495 -----PL--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       495 -----~~--------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                           +.        ....++..+.+||.+||+.||.+|||++++++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                 00        1124688899999999999999999999999999998655

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-41  Score=352.60  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=204.9

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHH-HHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEI-LLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||+||+|++ .++..||+|++.......  ......+..|. .+++.++|+||+++++++.+...+|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh--hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            4699999999999987 478899999986432211  11223333443 4578899999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKG  437 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~G  437 (551)
                      .+++|..++.+ ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            99999988865 4578888999999999999999999999999999999999999999999999875322  22345569


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |+.|+|||++  .+..++.++|||||||++|+|++|+.||......+.+..+.... ...+..++..+.+||.+||++||
T Consensus       159 t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         159 TPEYLAPEVL--HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             CccccCHHHH--cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHcccCH
Confidence            9999999997  35678899999999999999999999998877766666655443 33455789999999999999999


Q ss_pred             CCCCCHH----HHHhCcccCC
Q 043852          518 NDRPTAA----QLMEHPFVKR  534 (551)
Q Consensus       518 ~~RPS~~----eILehpff~~  534 (551)
                      .+|+++.    ++++|+||..
T Consensus       236 ~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         236 TKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             HHCCCCCCCHHHHhcCcccCC
Confidence            9999865    8999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.8e-41  Score=351.06  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=212.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||++.. .++..||+|++.....  ........+..|+.++..++|+||+++++++.+...+|+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            3789999999999999999987 5688999999864221  112233457788999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      ||||+.+|+|.+++.+  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999999875  458888999999999999999999999999999999999999999999999987543222  


Q ss_pred             -cccCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC----CCCCCcCCH
Q 043852          432 -VKSCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----PLVPNSLSR  503 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~s~  503 (551)
                       .....||+.|+|||++..   ....++.++|||||||++|||++|+.||...+..+.+.++.....    +.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence             223569999999999742   134578999999999999999999999988777777766655432    222245799


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHhCcccCCc
Q 043852          504 DARDFILKCLQVNPND--RPTAAQLMEHPFVKRP  535 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~--RPS~~eILehpff~~~  535 (551)
                      .+.+||.+||..++.+  |+++.++++||||+..
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            9999999999765544  6899999999999853

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4e-41  Score=340.36  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=202.2

Q ss_pred             eccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      ||+|+||.||++.. .+|+.||+|++........  .....+..|+.++.+++||||+++++.+.+...+|++|||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~--~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK--SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc--hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            79999999999987 5799999999864322211  12233456899999999999999999999999999999999999


Q ss_pred             chHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-cccCCCCC
Q 043852          364 SLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTP  439 (551)
Q Consensus       364 sL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~GT~  439 (551)
                      +|..++..   ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... .....||+
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            99887743   247888889999999999999999999999999999999999999999999987554322 23456899


Q ss_pred             cccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh----HHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhc
Q 043852          440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEPPLVPNSLSRDARDFILKCLQV  515 (551)
Q Consensus       440 ~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~  515 (551)
                      .|+|||++.  ...++.++|||||||++|+|++|+.||.....    .+....+...........++.++++||.+||++
T Consensus       159 ~y~aPE~~~--~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILK--EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            999999973  44589999999999999999999999965422    233333333333333456899999999999999


Q ss_pred             CCCCCCCH----HHHHhCcccCCc
Q 043852          516 NPNDRPTA----AQLMEHPFVKRP  535 (551)
Q Consensus       516 DP~~RPS~----~eILehpff~~~  535 (551)
                      ||++||++    ++++.|+||+..
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    678899999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-41  Score=341.43  Aligned_cols=257  Identities=33%  Similarity=0.574  Sum_probs=217.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++++.||+|+||.||++.+ .++..||+|.+....    .......+.+|+.++.+++|+||+++++.+.....+|++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            688899999999999999987 489999999886421    223345778999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          357 LELVTKGSLANLYQKY----HLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~----~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |||+.+++|..++...    .+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999999988764    68899999999999999999997 599999999999999999999999999987654444


Q ss_pred             cccCCCCCcccChhhhhccc----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH---HHHHhhcCCCCCCCCcCCHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKN----RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ---ALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~----~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~s~~  504 (551)
                      .....+++.|+|||++....    ..++.++|||||||++|+|++|+.||.......   .+..+..+.++..+..++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD  237 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence            44556888999999874221    245889999999999999999999997644332   23344556666667779999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      +.+||.+||+.+|++||++.++++||||......
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            9999999999999999999999999999765433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.1e-41  Score=337.53  Aligned_cols=251  Identities=31%  Similarity=0.557  Sum_probs=209.1

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.++||+|+||.||+|.+ .++..||+|.+....    .......+.+|+.++.+++||||+++++.+......+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            678889999999999999987 688999999886432    223345678899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCC
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK  436 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~  436 (551)
                      |||+.+++|..+   ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++............
T Consensus        78 ~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (279)
T cd06619          78 TEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV  154 (279)
T ss_pred             EecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence            999999998654   24678888999999999999999999999999999999999999999999999766555555567


Q ss_pred             CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-------HHHHHHhhcCCCCCC-CCcCCHHHHHH
Q 043852          437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-------MQALFRIGKGEPPLV-PNSLSRDARDF  508 (551)
Q Consensus       437 GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-------~~~~~~i~~~~~~~~-~~~~s~~l~~L  508 (551)
                      ||..|+|||++  ....++.++|+|||||++|+|++|+.||.....       ......+.....+.. ....+..+.++
T Consensus       155 ~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         155 GTNAYMAPERI--SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CChhhcCceee--cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            99999999987  345689999999999999999999999964321       122222222222222 34578899999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |.+||+.+|.+||++.++++||||+..-.
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            99999999999999999999999986643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.5e-41  Score=342.49  Aligned_cols=258  Identities=36%  Similarity=0.634  Sum_probs=218.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|++++.||+|+||.||++.+ .++..||+|.+.....     .....+.+|+.+++.++|+||+++++.+......|+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            4799999999999999999987 5899999999864322     123456789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--cc
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~  433 (551)
                      ||||+++++|.+++.+..+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.......  ..
T Consensus        94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            9999999999999988888999999999999999999999999999999999999999999999999987543322  22


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC--CCCCcCCHHHHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLSRDARDFILK  511 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~LI~~  511 (551)
                      ...+++.|+|||.+  ....++.++|+|||||++|+|++|..||...+....+..+.....+  ..+..++..+.+|+.+
T Consensus       174 ~~~~~~~y~aPE~~--~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         174 TMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             cccCCccccCHHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence            34688999999987  3456789999999999999999999999776554444333332221  2345688999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                      ||+.+|++||++.+|++||||+.....+.-
T Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (297)
T cd06656         252 CLEMDVDRRGSAKELLQHPFLKLAKPLSSL  281 (297)
T ss_pred             HccCChhhCcCHHHHhcCchhccccccccc
Confidence            999999999999999999999977766554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-40  Score=340.46  Aligned_cols=263  Identities=35%  Similarity=0.617  Sum_probs=223.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..|++.+.||.|+||.||+|.+ .+|+.||+|.+.....     .....+.+|+.+++.++|+||+++++.+.....+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence            3699999999999999999987 6899999999864322     223456789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--cc
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~  433 (551)
                      ++||+.+++|..++....+++.++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          94 VMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987543332  23


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC--CCCCCcCCHHHHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLVPNSLSRDARDFILK  511 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~LI~~  511 (551)
                      ...+++.|+|||.+  ....++.++|||||||++|+|++|+.||...+.......+.....  ...+..++..+.+||.+
T Consensus       174 ~~~~~~~y~aPE~~--~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         174 TMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CcCCCccccCcchh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence            34688999999987  345678999999999999999999999987766555554443322  22345688999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCCccccCCCCCCCC
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYY  546 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~~~~~~~~~~~~~  546 (551)
                      ||..||++|||+.+|+.||||+.....+.-....|
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~~~~~  286 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLIL  286 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhccccccCCcccc
Confidence            99999999999999999999997776655555444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.3e-41  Score=336.69  Aligned_cols=250  Identities=32%  Similarity=0.509  Sum_probs=203.8

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|.+.+.||+|+||.||+|.+ .++..||||++......   ......+.+|+.++.+++|+||+++++++.++..+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            488899999999999999987 57999999998654322   22234567899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          357 LELVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      |||+. ++|..++..    ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... 
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            99997 477777653    358889999999999999999999999999999999999999999999999987543221 


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC------------------
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG------------------  492 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~------------------  492 (551)
                       .....+++.|+|||++. ....++.++|||||||++|+|+||++||.+.........+...                  
T Consensus       157 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLL-GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             cccCCcccccccChHHhc-CCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             22345788999999873 3345788999999999999999999999876544333222110                  


Q ss_pred             ----------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          493 ----------EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       493 ----------~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                ........++.++.+||.+||+.||.+|||+.+|++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      0001123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-40  Score=340.78  Aligned_cols=256  Identities=36%  Similarity=0.630  Sum_probs=216.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|++.+.||+|+||.||+|.+ .++..||+|.+......     ....+.+|+.++..+.|+||+++++.+......|+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            4899999999999999999987 57899999988653322     23457789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--cc
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~  433 (551)
                      ||||+.+++|..++....++..++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......  ..
T Consensus        95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            9999999999999987778999999999999999999999999999999999999999999999999987543322  23


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC--CCCCcCCHHHHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLSRDARDFILK  511 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~LI~~  511 (551)
                      ...|++.|+|||.+  ....++.++|||||||++|+|++|+.||........+..+.....+  ..+..++..+.+||.+
T Consensus       175 ~~~~~~~y~aPE~~--~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         175 TMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             cccCCccccCHHHH--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence            34688999999987  3456789999999999999999999999876655444433322221  2345688999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ||.+||++|||+.+|++||||.....-+
T Consensus       253 ~l~~~p~~Rpt~~eil~~~~~~~~~~~~  280 (296)
T cd06654         253 CLDMDVEKRGSAKELLQHQFLKIAKPLS  280 (296)
T ss_pred             HCcCCcccCcCHHHHhhChhhhccCCcc
Confidence            9999999999999999999998765544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-40  Score=333.22  Aligned_cols=253  Identities=46%  Similarity=0.858  Sum_probs=212.1

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--CCeEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--ENRLF  354 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~  354 (551)
                      .|+..+.||+|+||.||++.+ .++..||+|++...............+.+|+.++.+++|+||+++++++.+  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            688899999999999999987 579999999987654433444556678899999999999999999998765  46789


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC---
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~---  430 (551)
                      +++||+.+++|.+++.. ..++...++.++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++......   
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            99999999999988865 45788889999999999999999999999999999999999999999999998754321   


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc-CCCCCCCCcCCHHHHH
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARD  507 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~  507 (551)
                        ......++..|+|||++  .+..++.++|||||||++|+|++|+.||...........+.. ...+.++..++..+.+
T Consensus       163 ~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVI--SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             CCccccCCccccccCHHHh--CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence              12234588899999997  345678999999999999999999999987766555554433 2334456678899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      ++ +||..+|++||++++|++||||+
T Consensus       241 li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.9e-41  Score=349.25  Aligned_cols=257  Identities=24%  Similarity=0.379  Sum_probs=211.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.++..++|+||+.+++++.+...+|+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3799999999999999999987 5788999999864221  122334457788999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-  432 (551)
                      ||||+.||+|..++.+  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999999999875  4588899999999999999999999999999999999999999999999999875543221 


Q ss_pred             --ccCCCCCcccChhhhhccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC----CCCCCcCCH
Q 043852          433 --KSCKGTPFWMAPEVVNLKN---RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----PLVPNSLSR  503 (551)
Q Consensus       433 --~~~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~s~  503 (551)
                        ....||+.|+|||++....   ..++.++|||||||++|+|++|+.||......+.+.++.....    +.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence              2346999999999974321   3578899999999999999999999988776666666544321    112234789


Q ss_pred             HHHHHHHHhhhcCCCC--CCCHHHHHhCcccCCc
Q 043852          504 DARDFILKCLQVNPND--RPTAAQLMEHPFVKRP  535 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~--RPS~~eILehpff~~~  535 (551)
                      .+.+||.+||..++.+  |++++++++|+||+..
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            9999999999876554  4689999999999853

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.4e-41  Score=347.10  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=203.3

Q ss_pred             eeeEeccC--CceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          281 KGELLGSG--SFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       281 ~~~~LG~G--~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      ++++||+|  +|++||++.+ .+|+.||+|++......   ......+.+|+.+++.++||||+++++++..+...|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT---NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc---HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            45789999  7899999987 68999999998643221   233456678999999999999999999999999999999


Q ss_pred             ecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC----
Q 043852          358 ELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----  430 (551)
Q Consensus       358 Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~----  430 (551)
                      ||+.+++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+......    
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999998864   34888999999999999999999999999999999999999999999999865332111    


Q ss_pred             -----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC----------
Q 043852          431 -----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP----------  495 (551)
Q Consensus       431 -----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~----------  495 (551)
                           ......++..|+|||++......++.++|||||||++|+|++|+.||..............+..+          
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 01123467789999998533356899999999999999999999999765544333222221110          


Q ss_pred             -----------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          496 -----------------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       496 -----------------------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                                         .....++..+.+||.+||+.||++|||++++++||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                               01123567899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-40  Score=329.00  Aligned_cols=250  Identities=30%  Similarity=0.576  Sum_probs=218.1

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||++.. .+|..||+|++......   ......+.+|+.++++++|+||+++++++......|++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            588999999999999999987 57899999998653222   23345678999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      |||+.+++|.+++...   .+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......  
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999999888643   47888899999999999999999999999999999999999999999999987554322  


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....|++.|+|||++  .+..++.++|+|||||++|+|++|..||......+....+..+..+..+..++..+.++|.+
T Consensus       158 ~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         158 ARTCIGTPYYLSPEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             hhhccCCccccCHHHh--CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence            2234588999999997  34567889999999999999999999998777777777777777777778899999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff  532 (551)
                      ||+.+|.+||++.+|++||||
T Consensus       236 ~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         236 LFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=337.64  Aligned_cols=255  Identities=40%  Similarity=0.707  Sum_probs=218.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||.|+||.||++.+ .++..+|+|.+...     .......+.+|+.++.+++|+||+++++.+.+...+|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            3688999999999999999987 57899999998643     23345677889999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--C
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~  431 (551)
                      +|||+.+++|..++.+  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......  .
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            9999999999998865  35899999999999999999999999999999999999999999999999987654322  1


Q ss_pred             cccCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDAR  506 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~  506 (551)
                      .....+|+.|++||++..   ....++.++|+|||||++|+|++|+.||...........+..+..+.  .+..++..+.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN  239 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence            233458999999998742   23456889999999999999999999998877766666666655433  3456889999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ++|.+||+.+|.+||++.++++||||....
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            999999999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.2e-40  Score=330.05  Aligned_cols=254  Identities=45%  Similarity=0.820  Sum_probs=212.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--CeE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--NRL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~  353 (551)
                      .+|.+.++||+|+||.||++.+ .++..||||++...............+.+|+.++.++.|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4789999999999999999987 5799999999865443333344567788999999999999999999987663  568


Q ss_pred             EEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc---
Q 043852          354 FIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM---  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~---  429 (551)
                      +++|||+++++|.+++.+. .+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++.....   
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            8999999999999988653 578888999999999999999999999999999999999999999999999875432   


Q ss_pred             --CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC-CCCCCCCcCCHHHH
Q 043852          430 --NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-EPPLVPNSLSRDAR  506 (551)
Q Consensus       430 --~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~  506 (551)
                        .......|+..|+|||++.  +..++.++|||||||++|+|++|+.||...........+... ..+..+..++..+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVIS--GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR  239 (265)
T ss_pred             cccccccCCCCccccChhhhc--CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence              1223345888999999873  456789999999999999999999999876655555444432 23445667888999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      ++|.+||. +|.+||++++|++|||+.
T Consensus       240 ~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         240 DFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            99999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-40  Score=340.61  Aligned_cols=255  Identities=30%  Similarity=0.519  Sum_probs=210.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||++.+ .++..+|+|.+....    ......++.+|+.++.+++||||+++++++.++..+|++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            689999999999999999987 578899999876421    223455678999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      |||+.+++|.+++.+ ..+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++..........
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  157 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccccccc
Confidence            999999999999865 457888899999999999999997 599999999999999999999999999987654444455


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhh------------------------
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG------------------------  490 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~------------------------  490 (551)
                      ..|++.|+|||++  .+..++.++|+|||||++|+|++|..||...+.......+.                        
T Consensus       158 ~~~~~~~~aPE~~--~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         158 FVGTRSYMSPERL--QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCCcCccChhHh--cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            6789999999987  34567899999999999999999999996544322221111                        


Q ss_pred             ------------cCCCCCCC-CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          491 ------------KGEPPLVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       491 ------------~~~~~~~~-~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                                  ....+..+ ..++.++.+|+.+||..||++|||+.+|++||||++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                        11111111 2367889999999999999999999999999999875443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-40  Score=381.75  Aligned_cols=261  Identities=28%  Similarity=0.507  Sum_probs=216.2

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--C
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--E  350 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~  350 (551)
                      ..+.+|.+++.||+|+||+||++.+ .++..||+|++.....   .......+..|+.++.+++|||||+++++|.+  .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            3456899999999999999999987 5788999999865432   22345567899999999999999999998744  4


Q ss_pred             CeEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhC-------CeeecccccceEEEcC------
Q 043852          351 NRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQ-------NVVHRDIKCANILVDA------  412 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~-------gIiHrDIKP~NILl~~------  412 (551)
                      ..+|||||||.+++|..++..     ..+++..++.|+.||+.||.|||+.       +||||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            678999999999999998864     3589999999999999999999984       4999999999999964      


Q ss_pred             -----------CCcEEEEecCCccccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Q 043852          413 -----------SGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL  480 (551)
Q Consensus       413 -----------~g~vkL~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~  480 (551)
                                 .+.+||+|||++....... ...+.||+.|+|||++......++.++||||||||||+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                       2359999999997654332 3456799999999998544456899999999999999999999999876


Q ss_pred             hhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          481 EGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       481 ~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      .....+.......+.......+..+.+||.+||+.+|.+||++.|+|.|+||+...+
T Consensus       247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            666555554444444334567899999999999999999999999999999985543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-42  Score=335.47  Aligned_cols=263  Identities=29%  Similarity=0.491  Sum_probs=228.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccc---hHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQG---KQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      ..|.-.+.||.|.-+.|..+.+ .+|..+|+|++.........   ....+.-.+|+.||+++ .||+|+.+.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4677778999999999999877 68999999998765433322   33444556899999997 5999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+++|+|+|+.|.|++++.. -.+++.....+++||+.|++|||.++|+||||||+|||++.+.+++|+|||+++.....
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence            99999999999999999975 46999999999999999999999999999999999999999999999999999877554


Q ss_pred             C-cccCCCCCcccChhhhhc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCC
Q 043852          431 D-VKSCKGTPFWMAPEVVNL----KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLS  502 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~----~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s  502 (551)
                      . ....||||+|+|||.+..    ...+|+..+|+|++|+|||-|+.|-+||-+...+-++..|..|...+-   ...++
T Consensus       177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis  256 (411)
T KOG0599|consen  177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADIS  256 (411)
T ss_pred             hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcc
Confidence            3 567889999999999742    345789999999999999999999999999888888888888765443   34688


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ...++||.+||+.||.+|.|++++|.||||.+..++.
T Consensus       257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~  293 (411)
T KOG0599|consen  257 ATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ  293 (411)
T ss_pred             ccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence            9999999999999999999999999999997766543

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=363.35  Aligned_cols=255  Identities=36%  Similarity=0.627  Sum_probs=226.7

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |.-+.-||.|+||.||.+++ .+.+.||||++...  +.....-..++..|+..|.++.|||++.+-|+|......++||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS--GKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeecccc--ccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            44457799999999999998 68999999988654  4444556778889999999999999999999999999999999


Q ss_pred             ecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccC
Q 043852          358 ELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC  435 (551)
Q Consensus       358 Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  435 (551)
                      |||-| +-.+++.  +.++.+..+..++.+.+.||.|||+.+.||||||..|||++..|.|||+|||.|...  ....+.
T Consensus       106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--~PAnsF  182 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--APANSF  182 (948)
T ss_pred             HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc--Cchhcc
Confidence            99966 7777764  568889999999999999999999999999999999999999999999999987554  345678


Q ss_pred             CCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCC-cCCHHHHHHHHHhh
Q 043852          436 KGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN-SLSRDARDFILKCL  513 (551)
Q Consensus       436 ~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~s~~l~~LI~~cL  513 (551)
                      +|||+|||||++-. ....|+-++||||||+++.||.-.++|+.+++.+..++.|..+..|.+.. ..+..|+.|+..||
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence            89999999999743 35579999999999999999999999999999999999999988877764 58999999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCcccc
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      ++-|..|||.+++|.|+|+.+..+.
T Consensus       263 qKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  263 QKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             hhCcccCCcHHHHhhcchhccCCCc
Confidence            9999999999999999999987654

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-40  Score=336.15  Aligned_cols=255  Identities=38%  Similarity=0.691  Sum_probs=221.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|+..+.||.|+||.||+|.+ .++..||+|.+....    .......+.+|+.++.++.|+||+++++++.+...+|+|
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            477788999999999999987 478999999886432    234456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--ccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~  434 (551)
                      |||+.+++|.+++....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999986554322  223


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ  514 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~  514 (551)
                      ..++..|+|||++.  ...++.++|+|||||++|||++|+.||...........+....++..+..++..+.+++.+||+
T Consensus       161 ~~~~~~y~apE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (277)
T cd06640         161 FVGTPFWMAPEVIQ--QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN  238 (277)
T ss_pred             ccCcccccCHhHhc--cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence            45788999999873  4567899999999999999999999998777666666665666666667788999999999999


Q ss_pred             cCCCCCCCHHHHHhCcccCCcccc
Q 043852          515 VNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       515 ~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      .+|++||++.+++.|+||.+...+
T Consensus       239 ~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         239 KDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             cCcccCcCHHHHHhChHhhhcchh
Confidence            999999999999999999876654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.3e-40  Score=327.02  Aligned_cols=250  Identities=34%  Similarity=0.579  Sum_probs=215.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc--CCCeEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK--DENRLF  354 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~  354 (551)
                      +|++.+.||.|+||.||++.+ .++..||+|++.....   ......++..|+.++++++|+||+++++.+.  .....|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            488899999999999999987 5789999998864322   2334556788999999999999999998764  345689


Q ss_pred             EEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHH-----hCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          355 IFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLH-----EQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH-----~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      ++|||+.+++|.+++..     ..+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.++|+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999999988864     35788899999999999999999     899999999999999999999999999998


Q ss_pred             cccccCC--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCC
Q 043852          425 KATTMND--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLS  502 (551)
Q Consensus       425 ~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  502 (551)
                      .......  .....+++.|+|||++  ....++.++|+||||+++|+|++|+.||...+.......+..+..+..+..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQL--NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS  235 (265)
T ss_pred             ccccCCcccccccccCCCccChhhh--cCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence            8665433  3345689999999997  34557899999999999999999999998877666666777777777778899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      ..+.+++.+||+.+|.+|||+.+|++|||+
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2e-40  Score=337.15  Aligned_cols=260  Identities=30%  Similarity=0.515  Sum_probs=213.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||+|.+ .+|..||||++...............+..|+.++..++|+||+++++++.+....|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999987 4789999999976544322233445667899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          357 LELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~--l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      |||+ +++|..++....  +++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++.....  ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999987654  889999999999999999999999999999999999999999999999998765432  22


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC------------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP------------------  494 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~------------------  494 (551)
                      ....+++.|+|||.+. ....++.++|||||||++|+|++|.++|........+.++.....                  
T Consensus       160 ~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T cd07841         160 THQVVTRWYRAPELLF-GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE  238 (298)
T ss_pred             cccccceeeeCHHHHh-CCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence            2334678899999873 345678999999999999999999888877665544433321100                  


Q ss_pred             ----C-----CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 ----P-----LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 ----~-----~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                          .     .....++..+.+||.+||++||.+|||+.++++|+||++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence                0     01134578899999999999999999999999999999766544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.5e-40  Score=336.18  Aligned_cols=253  Identities=30%  Similarity=0.507  Sum_probs=217.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||++.+ .+++.||+|++.....  ........+.+|+.++++++|+||+++++++.+...+|++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence            689999999999999999987 5789999999864321  1223456678999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccC
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC  435 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  435 (551)
                      |||+.+++|.+++.+ ..+++..+..++.||+.||.|||++||+|+||+|.|||++.++.++|+|||++...... ....
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~  158 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYTL  158 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCCC
Confidence            999999999998865 45889999999999999999999999999999999999999999999999998765444 3345


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhc
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV  515 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~  515 (551)
                      .+++.|+|||.+  ....++.++||||||+++|+|++|+.||...........+..+. ..++..++..+.++|.+||..
T Consensus       159 ~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~  235 (290)
T cd05580         159 CGTPEYLAPEII--LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-VRFPSFFSPDAKDLIRNLLQV  235 (290)
T ss_pred             CCCccccChhhh--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-ccCCccCCHHHHHHHHHHccC
Confidence            689999999987  34567889999999999999999999998777655555555443 445667899999999999999


Q ss_pred             CCCCCC-----CHHHHHhCcccCCcc
Q 043852          516 NPNDRP-----TAAQLMEHPFVKRPL  536 (551)
Q Consensus       516 DP~~RP-----S~~eILehpff~~~~  536 (551)
                      ||.+|+     +++++++||||+...
T Consensus       236 ~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         236 DLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             CHHHccCcccCCHHHHHcCcccccCC
Confidence            999999     999999999987543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-40  Score=332.40  Aligned_cols=246  Identities=23%  Similarity=0.435  Sum_probs=209.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .+|++.+.||+|+||.||+|.+    ..+..||+|.+....    .......+.+|+.++.+++||||+++++++.....
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            3789999999999999999975    246789999886432    12334568899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .|+||||+.+++|.+++.+.  .+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999988653  5889999999999999999999999999999999999999999999999987643222


Q ss_pred             C---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          431 D---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       431 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                      .   .....++..|+|||++  ....++.++|||||||++|||++ |..||...........+..+.....+..++..+.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAI--QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH  238 (266)
T ss_pred             chhcccCCCCceeecCHHHH--hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            1   1122356789999987  34678999999999999999875 9999988877777777777766667788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHh
Q 043852          507 DFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +++.+||+.+|.+|||+.+|++
T Consensus       239 ~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         239 QLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.6e-40  Score=333.23  Aligned_cols=252  Identities=28%  Similarity=0.510  Sum_probs=207.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|++.......   .....+.+|+.++++++|+||+++++++.....+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP---VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc---cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            3689999999999999999987 479999999886432211   122346789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--c
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~  432 (551)
                      +|||+++++|..+... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            9999999988887754 458899999999999999999999999999999999999999999999999987654332  2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC------------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP------------------  494 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~------------------  494 (551)
                      ....++..|+|||++. ....++.++|||||||++|+|++|+.||.+....+....+.....                  
T Consensus       158 ~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         158 TDYVATRWYRAPELLV-GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             cCcccccccCCHHHHh-CCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            2345788999999873 334578899999999999999999999987766554443321100                  


Q ss_pred             ---CC---------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 ---PL---------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ---~~---------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                         +.         ....++..+.+|+.+||+.||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence               00         012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=365.86  Aligned_cols=252  Identities=43%  Similarity=0.779  Sum_probs=217.5

Q ss_pred             EeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecccc
Q 043852          284 LLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTK  362 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g  362 (551)
                      +||+|+||+||-|++ .+...+|||.|..+..     ....-+..||.+.++|+|.|||+++|.+..++++-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-----r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-----REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc-----hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            799999999999998 5677899999874433     3344577899999999999999999999999999999999999


Q ss_pred             cchHHHHhh--hcC--ChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEecCCcccc-ccC-CcccC
Q 043852          363 GSLANLYQK--YHL--MDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKAT-TMN-DVKSC  435 (551)
Q Consensus       363 gsL~~ll~~--~~l--~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~DFGla~~~-~~~-~~~~~  435 (551)
                      |+|..+++.  +++  ++.++..|.+||+.||+|||++.|||||||-+||||+. .|.+||+|||-++.. ..+ .+.+.
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            999999864  355  78889999999999999999999999999999999975 799999999998864 333 34566


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHhhcC-CCCCCCCcCCHHHHHHHHHhh
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKG-EPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-~~~~~~i~~~-~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      .||..|||||++..+..+|+.++|||||||++.||.||++||..... ....+++.-. ..+.+|..++.+++.+|.+|+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            79999999999988889999999999999999999999999966544 3445554433 347788899999999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      .+||..||++.++|+.||++-.-.+.+
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~~kk~r  843 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHNNKKPR  843 (1226)
T ss_pred             CCCcccCccHHHhccCcccccCCCCCC
Confidence            999999999999999999997644433

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-40  Score=335.28  Aligned_cols=254  Identities=39%  Similarity=0.682  Sum_probs=213.7

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |++.+.||+|+||.||+|.+ .++..+++|.+...     .......+.+|+.+++.++|+||+++++.+......|++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence            67788999999999999987 46888899987532     2234556788999999999999999999999999999999


Q ss_pred             ecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Ccc
Q 043852          358 ELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK  433 (551)
Q Consensus       358 Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~  433 (551)
                      ||+.+++|..++.+  ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......  ...
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            99999999887653  46889999999999999999999999999999999999999999999999998654322  223


Q ss_pred             cCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC--CCCCcCCHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLSRDARDF  508 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~L  508 (551)
                      ...+|+.|+|||++..   ....++.++|||||||++|+|++|++||...+.......+.....+  ..+..++..+.+|
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF  241 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence            4468999999998731   2345788999999999999999999999887766666555544332  2345688999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |.+||+.||.+||++.++++||||+....
T Consensus       242 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         242 LKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            99999999999999999999999986543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.5e-40  Score=329.16  Aligned_cols=251  Identities=34%  Similarity=0.624  Sum_probs=213.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||.|+||+||+|.. .++..+|+|++......    .....+.+|+.+++.++|+||+++++.+......|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ----TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc----hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            3789999999999999999986 57889999988543221    145678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          356 FLELVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +||++.+++|.+++..    ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999999999999865    247888999999999999999999999999999999999999999999999987554322


Q ss_pred             ------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC-----Cc
Q 043852          432 ------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP-----NS  500 (551)
Q Consensus       432 ------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~  500 (551)
                            .....|+..|++||++. ....++.++|+|||||++|+|++|+.||...........+....+....     ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVME-QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK  235 (267)
T ss_pred             cccccccccccCChhhcChHHHc-cccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence                  12345889999999974 2346799999999999999999999999877766666555554433322     25


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      ++..+.+++.+||+.||++|||+.+|++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            67899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.6e-40  Score=326.49  Aligned_cols=250  Identities=29%  Similarity=0.537  Sum_probs=218.3

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|+..+.||.|+||.||.+.. .++..+++|.+......   .....++.+|+.++++++|+||+++++++.+....+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            488999999999999999886 67999999998654322   23445677999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      ||||.+++|.+++.+.   .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.......  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999999999988654   47888999999999999999999999999999999999999999999999987553332  


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....+++.|+|||++  .+..++.++|||||||++|+|++|..||......+....+..+.....+..++..+.+++.+
T Consensus       158 ~~~~~~~~~y~ape~~--~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         158 AETVVGTPYYMSPELC--QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS  235 (256)
T ss_pred             ccccCCCccccCHhhc--CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence            2345689999999986  34457889999999999999999999998877777777777777666677789999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff  532 (551)
                      ||+.+|.+|||+.++++|+|+
T Consensus       236 ~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         236 LLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.1e-40  Score=335.24  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=210.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|+..+.||+|+||+||++.+ .+++.||+|.+......  .......+.+|+.++..++|+||+.+++.+.++...|++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK--KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh--hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            367789999999999999987 57999999988643221  122334567899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-Cc
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~  432 (551)
                      |||+.+++|..++..   ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... ..
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            999999999877643   25889999999999999999999999999999999999999999999999998654322 23


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHh---hcCCCCCCCCcCCHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI---GKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ....|+..|+|||++  .+..++.++|+|||||++|+|++|..||...........+   .......++..++..+.+|+
T Consensus       159 ~~~~g~~~~~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         159 RGRVGTVGYMAPEVL--NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cCCCCCcCccChHHh--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            445689999999997  3457899999999999999999999999876543322222   11222344567889999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          510 LKCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       510 ~~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      .+||+.||++||+     +.++++|+||+..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            9999999999999     8999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-40  Score=342.16  Aligned_cols=242  Identities=30%  Similarity=0.482  Sum_probs=187.6

Q ss_pred             eeEeccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--CCeEEEE
Q 043852          282 GELLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--ENRLFIF  356 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV  356 (551)
                      +++||+|+||.||+|.+.   ++..||+|.+.....       ...+.+|+.++++++||||+++++++..  ...+|++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            468999999999999853   578899998853211       1245689999999999999999998743  5678999


Q ss_pred             EecccccchHHHHhh----------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE----cCCCcEEEEecC
Q 043852          357 LELVTKGSLANLYQK----------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV----DASGSVKLADFG  422 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~----------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl----~~~g~vkL~DFG  422 (551)
                      |||+.+ +|..++..          ..+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            999965 77766542          247888899999999999999999999999999999999    456789999999


Q ss_pred             CccccccC-----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---------HHHHHH
Q 043852          423 LAKATTMN-----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---------MQALFR  488 (551)
Q Consensus       423 la~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---------~~~~~~  488 (551)
                      +++.....     ......||+.|+|||++. ....++.++|||||||++|+|++|++||.....         ...+.+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHc-CCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99754322     233456899999999973 334689999999999999999999999964321         011111


Q ss_pred             hhc--CCC-----------------------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          489 IGK--GEP-----------------------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       489 i~~--~~~-----------------------------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      +..  +.+                                   .......+..+.+||.+||+.||.+|||++|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            100  000                                   0001123567889999999999999999999999999


Q ss_pred             c
Q 043852          532 V  532 (551)
Q Consensus       532 f  532 (551)
                      |
T Consensus       317 f  317 (317)
T cd07868         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-40  Score=333.20  Aligned_cols=251  Identities=26%  Similarity=0.462  Sum_probs=209.1

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||+|.+ .+|..||+|++......   ......+.+|+.++++++|+||+++++++.+...+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            588999999999999999987 57899999998754322   23345678999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      |||+ +++|.+++..  ..+++..++.++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++.......   
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999 9999998864  458899999999999999999999999999999999999999999999999987654432   


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC----------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP----------------  495 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~----------------  495 (551)
                      .....|+..|+|||++. ....++.++|||||||++|+|++|.++|........+.++......                
T Consensus       157 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         157 YSHQVATRWYRAPELLY-GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccccCcccccCceeee-ccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            33456899999999873 3445789999999999999999999999776655544433221000                


Q ss_pred             -------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          496 -------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       496 -------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                                   .....++..+.+||.+||+.+|++|||++++++||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                         01124578899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=338.36  Aligned_cols=254  Identities=30%  Similarity=0.471  Sum_probs=214.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||+|.. .+++.||+|.+......  .......+..|+.++..+.|+||+++++.+.+....|++
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI--KRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc--hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            689999999999999999987 46999999998754322  123456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      |||+.+++|.+++.+   ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            999999999998875   358889999999999999999999999999999999999999999999999986432211  


Q ss_pred             -----------------------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 043852          432 -----------------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG  482 (551)
Q Consensus       432 -----------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~  482 (551)
                                                   .....||..|+|||++  .+..++.++|||||||++|+|++|+.||.+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI--SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH--cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                         1123578899999997  355679999999999999999999999988776


Q ss_pred             HHHHHHhhcCCCCCC-CCcCCHHHHHHHHHhhhcCCCCCCC----HHHHHhCcccCCc
Q 043852          483 MQALFRIGKGEPPLV-PNSLSRDARDFILKCLQVNPNDRPT----AAQLMEHPFVKRP  535 (551)
Q Consensus       483 ~~~~~~i~~~~~~~~-~~~~s~~l~~LI~~cL~~DP~~RPS----~~eILehpff~~~  535 (551)
                      ...+..+........ ...++..+.++|.+||..||++|||    +++++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            666655554332221 2237899999999999999999999    9999999999864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.1e-40  Score=335.53  Aligned_cols=255  Identities=37%  Similarity=0.672  Sum_probs=214.3

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|++++.||.|+||.||+|.+ .++..+++|.+...     .......+.+|+.++..++|+||+++++.+..+..+|+|
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            588999999999999999987 56899999988632     233456678899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      |||+.+++|..++.+  ..+++..+..++.||+.+|.|||++|++|+||||+||+++.++.++|+|||++......  ..
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  167 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR  167 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence            999999999887653  45889999999999999999999999999999999999999999999999988653222  22


Q ss_pred             ccCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDARD  507 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~  507 (551)
                      ....+++.|+|||++..   ....++.++|||||||++|+|++|..||..........++.....+.  .+..++..+.+
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD  247 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence            34458899999998732   23457889999999999999999999998776665555555443332  34567889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +|.+||+.||++||++.++++||||.....
T Consensus       248 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         248 FLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             HHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            999999999999999999999999975443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-40  Score=331.87  Aligned_cols=253  Identities=32%  Similarity=0.549  Sum_probs=214.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|+..+.||+|+||.||++.+ .+++.+|+|.+.....    .....++.+|+.+++++.|+||+++++.+.....++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            577888999999999999988 4789999998865322    24455678999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      +||+.+++|.+++..  ..+++..+..++.||+.+|.|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            999999999999875  467888999999999999999999 99999999999999999999999999998755433333


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-----hhHHHHHHhhcCCCCCCCCc-CCHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL-----EGMQALFRIGKGEPPLVPNS-LSRDARD  507 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~-~s~~l~~  507 (551)
                      ...++..|+|||++.  +..++.++|||||||++|+|++|..||...     ...+....+.....+..+.. ++..+.+
T Consensus       158 ~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQ--GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHc--CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            366889999999973  457899999999999999999999999654     23334444455544454444 8999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +|.+||..||.+|||+.+++.||||++..
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            99999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.6e-40  Score=330.51  Aligned_cols=251  Identities=31%  Similarity=0.490  Sum_probs=215.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||.|+||.||+|.+ .++..||+|++.....  ........+.+|+.++++++||||+++++.+.+....|++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC--VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh--cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            488999999999999999987 4799999999875332  1223456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-Cccc
Q 043852          357 LELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~~~  434 (551)
                      +||+.+++|..++... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            9999999999988765 7899999999999999999999999999999999999999999999999998765433 2334


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh--HHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG--MQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ..|+..|+|||++.  ...++.++|+||||+++|+|++|..||.....  ...+...........+..++..+.++|.+|
T Consensus       159 ~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (258)
T cd05578         159 TSGTPGYMAPEVLC--RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL  236 (258)
T ss_pred             cCCChhhcCHHHHc--ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence            55888999999973  44588999999999999999999999987653  333333333344556677899999999999


Q ss_pred             hhcCCCCCCCH--HHHHhCccc
Q 043852          513 LQVNPNDRPTA--AQLMEHPFV  532 (551)
Q Consensus       513 L~~DP~~RPS~--~eILehpff  532 (551)
                      |+.||.+||++  .++++||||
T Consensus       237 l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         237 LERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCChhHcCCccHHHHhcCCCC
Confidence            99999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-40  Score=331.96  Aligned_cols=249  Identities=36%  Similarity=0.687  Sum_probs=205.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC------
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD------  349 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------  349 (551)
                      .|.+.+.||+|+||.||+|.. .++..||+|.+.....      ....+.+|+.++.++ +|+||+++++.+..      
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            577788999999999999987 5789999998864321      123567888889888 69999999998764      


Q ss_pred             CCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ...+|++|||+.+++|.+++...   .+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            24689999999999999988752   478888999999999999999999999999999999999999999999999875


Q ss_pred             ccc--CCcccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-CCCCCCc
Q 043852          427 TTM--NDVKSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVPNS  500 (551)
Q Consensus       427 ~~~--~~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~  500 (551)
                      ...  .......|++.|+|||++...   ...++.++|||||||++|+|++|+.||...........+.... .......
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK  240 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence            432  223345689999999997422   3457889999999999999999999997666555544443322 2333456


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      ++..+.+|+.+||+.||.+|||+.+++.||||
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            88999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=346.90  Aligned_cols=248  Identities=38%  Similarity=0.714  Sum_probs=222.6

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |.++++||+|+||.||++++ .+|+.+|||.+...       ..+.++..||.|+.+++.+++|++||.|.....++|||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            67789999999999999988 68999999988643       23557789999999999999999999999899999999


Q ss_pred             ecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CCcc
Q 043852          358 ELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVK  433 (551)
Q Consensus       358 Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~  433 (551)
                      |||..|++.++++  +..+++..+..+++.-+.||.|||...-||||||..|||++.+|..||+|||.+.....  ....
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence            9999999999875  45799999999999999999999999999999999999999999999999999865433  2345


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILK  511 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~LI~~  511 (551)
                      ++.|||+|||||+++  .-+|+.++||||||++..||..|++||.....+..++.|-...++.+  |...+.++.+++++
T Consensus       188 TVIGTPFWMAPEVI~--EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~  265 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIE--EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS  265 (502)
T ss_pred             ccccCcccccHHHHH--HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence            678999999999984  56899999999999999999999999999999998888877776665  34578999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCCc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ||-+.|++|-|+.++++|||+++.
T Consensus       266 CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HhcCCHHHHHHHHHHhhhhhhcCC
Confidence            999999999999999999999864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.9e-41  Score=336.59  Aligned_cols=253  Identities=39%  Similarity=0.703  Sum_probs=217.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|+..+.||+|+||.||+|.+ .++..||+|.+....    .......+.+|+.++++++|+||+++++.+......|+|
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            466778899999999999987 578899999875332    123445788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--ccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~  434 (551)
                      |||+.+++|.+++....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            999999999999988889999999999999999999999999999999999999999999999999987554322  223


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ  514 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~  514 (551)
                      ..|+..|+|||++.  ...++.++|+|||||++|+|++|+.||...........+..+..+..+..++..+.++|.+||+
T Consensus       161 ~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (277)
T cd06642         161 FVGTPFWMAPEVIK--QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN  238 (277)
T ss_pred             ccCcccccCHHHhC--cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            45788999999973  4567899999999999999999999998766666555565565566666788999999999999


Q ss_pred             cCCCCCCCHHHHHhCcccCCcc
Q 043852          515 VNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       515 ~DP~~RPS~~eILehpff~~~~  536 (551)
                      .+|++|||+.+++.||||+...
T Consensus       239 ~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         239 KDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             CCcccCcCHHHHHHhHHHHHHh
Confidence            9999999999999999997543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.8e-40  Score=333.29  Aligned_cols=248  Identities=25%  Similarity=0.414  Sum_probs=211.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec-CC-----ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD-DG-----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~-~g-----~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      +.+|++.+.||+|+||.||+|... .+     ..||+|.+...    ........+.+|+.++.+++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            347889999999999999999753 22     57899987532    123344567899999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhh-----------------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC
Q 043852          350 ENRLFIFLELVTKGSLANLYQK-----------------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA  412 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~-----------------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~  412 (551)
                      ....|++|||+.+++|.+++..                 ..++...+..++.||+.||.|||++|++|+||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            9999999999999999998864                 34677888999999999999999999999999999999999


Q ss_pred             CCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 043852          413 SGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALF  487 (551)
Q Consensus       413 ~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~  487 (551)
                      ++.++|+|||+++......    .....+++.|+|||.+  ....++.++|||||||++|||++ |..||.+....+...
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI--LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHh--ccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999987543222    2234467889999986  34568999999999999999998 999998877777777


Q ss_pred             HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          488 RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       488 ~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+..+.....+..++..+.+|+.+||+.||.+||++.+|+++
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777777777788899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.3e-40  Score=335.67  Aligned_cols=242  Identities=20%  Similarity=0.255  Sum_probs=204.2

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC----CCeEEEEEe
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD----ENRLFIFLE  358 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E  358 (551)
                      ..||+|++|.||+|.. +|..||||++.....  ........+.+|+.++.+++||||+++++++.+    ...++++||
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            6799999999999976 788999999865422  223345678899999999999999999998866    457899999


Q ss_pred             cccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCC
Q 043852          359 LVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK  436 (551)
Q Consensus       359 y~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~  436 (551)
                      ||.+|+|.+++.+. .+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...... ....
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~  181 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNV  181 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-cccc
Confidence            99999999988653 57888899999999999999998 499999999999999999999999999987554322 2345


Q ss_pred             CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc-CCCCCCCCcCCHHHHHHHHHhhhc
Q 043852          437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILKCLQV  515 (551)
Q Consensus       437 GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~LI~~cL~~  515 (551)
                      ||..|+|||++......++.++|||||||++|||++|+.||.+.+..+....+.. +.....+..++..+.+|+.+||+.
T Consensus       182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~  261 (283)
T PHA02988        182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH  261 (283)
T ss_pred             CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence            8899999999854346789999999999999999999999988776666555533 334445557899999999999999


Q ss_pred             CCCCCCCHHHHHh
Q 043852          516 NPNDRPTAAQLME  528 (551)
Q Consensus       516 DP~~RPS~~eILe  528 (551)
                      ||++|||+.+|++
T Consensus       262 dp~~Rps~~ell~  274 (283)
T PHA02988        262 DSIKRPNIKEILY  274 (283)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999986

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.5e-40  Score=331.79  Aligned_cols=255  Identities=39%  Similarity=0.705  Sum_probs=220.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      -|++.+.||.|+||.||+|.+ .++..||||.+....    .......+.+|+.++.+++|+||+++++.+.+....|+|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            367788999999999999987 578999999875322    123445788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--ccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~  434 (551)
                      |||+.+++|..++....++...+..++.||+.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence            999999999999988889999999999999999999999999999999999999999999999999986543322  223


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ  514 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~  514 (551)
                      ..++..|+|||.+  ....++.++|+|||||++|+|++|..||...........+.....+..+..++..+.+++.+||+
T Consensus       161 ~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (277)
T cd06641         161 FVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  238 (277)
T ss_pred             ccCCccccChhhh--ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            4578899999987  34567889999999999999999999998777666666666666666667789999999999999


Q ss_pred             cCCCCCCCHHHHHhCcccCCcccc
Q 043852          515 VNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       515 ~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      .+|.+||++.++++||||.+...+
T Consensus       239 ~~p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         239 KEPSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             CChhhCcCHHHHHhCHHHhhhhhc
Confidence            999999999999999999876544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-40  Score=333.40  Aligned_cols=250  Identities=29%  Similarity=0.487  Sum_probs=200.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||+|.+ .+|..||+|++.......   .....+.+|+.++++++|+||+++++++.+...+|++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc---cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            488899999999999999987 579999999987543221   2223566899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      +||+.+ +|..++..  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....  ..
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            999975 67666543  45899999999999999999999999999999999999999999999999998754332  22


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCC-CCchhHHHHHHhhcCC------------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGKGE------------------  493 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf-~~~~~~~~~~~i~~~~------------------  493 (551)
                      ....+++.|+|||++. ....++.++|||||||++|+|++|..|| .+.+....+..+....                  
T Consensus       157 ~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         157 SAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             CCCccccCCcChHHHh-CCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            3345789999999873 3445789999999999999999988885 3333222222221100                  


Q ss_pred             -CC---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          494 -PP---------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       494 -~~---------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                       .+         .....++..+.+||.+||+.||.+|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             00         0113478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.5e-40  Score=330.82  Aligned_cols=250  Identities=39%  Similarity=0.649  Sum_probs=206.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|++++.||+|+||.||+|.+ .++..||+|++.....     .....+.+|+.++.+++|+||+++++.+.....+|+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            3799999999999999999987 5789999999864321     223456789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      +|||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......  ..
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            9999999999988754 46888999999999999999999999999999999999999999999999998755322  12


Q ss_pred             ccCCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC-C---CCCcCCHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-L---VPNSLSRDARD  507 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-~---~~~~~s~~l~~  507 (551)
                      ....|++.|+|||.+.. ....++.++|||||||++|+|++|+.||...........+...... .   ....++..+.+
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence            34458899999998732 2345788999999999999999999999765544443333222211 1   12346889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      ||.+||+.+|++|||+++|++|+|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.2e-40  Score=331.23  Aligned_cols=250  Identities=39%  Similarity=0.688  Sum_probs=207.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|++....     ......+.+|+.++..++||||+++++.+.....+|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            3788889999999999999987 579999999986432     1223456789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      +|||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......  ..
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            9999999999998864 45889999999999999999999999999999999999999999999999998654322  22


Q ss_pred             ccCCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC--CCC--CCcCCHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLV--PNSLSRDARD  507 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~~--~~~~s~~l~~  507 (551)
                      ....||+.|+|||++.. ....++.++|+|||||++|+|++|..||.................  +..  ...++..+.+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH  243 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence            34468999999998632 234578899999999999999999999976554444433322221  111  1246789999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      +|.+||+.+|++|||+.+|++|||
T Consensus       244 li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         244 FVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=331.50  Aligned_cols=255  Identities=37%  Similarity=0.695  Sum_probs=215.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC---CCceeeeeeeccCCCeE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE---HENIVQYFGTDKDENRL  353 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~  353 (551)
                      .|+..+.||+|+||.||+|.+ .++..||+|.+.....    ......+.+|+.+++++.   |+||+++++++.+....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            467788999999999999987 6899999998864322    223456778999998886   99999999999999999


Q ss_pred             EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      |++|||+.+++|.++++...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCC-cCCHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN-SLSRDARDFIL  510 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~s~~l~~LI~  510 (551)
                      .....|+..|+|||.+. .+..++.++|+|||||++|+|++|..||...........+....++..+. .++..+.+++.
T Consensus       158 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         158 RSTFVGTPYWMAPEVIT-EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             cccccCCcceeCHHHhc-cCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence            23345889999999873 34567889999999999999999999998776655554444444444443 37889999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +||+.||++||++.+++.|+||++...
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhcccc
Confidence            999999999999999999999987553

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.4e-40  Score=335.38  Aligned_cols=246  Identities=26%  Similarity=0.412  Sum_probs=199.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-----------------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-----------------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN  339 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-----------------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn  339 (551)
                      .+|++.+.||+|+||.||+|.+.                 ++..||+|.+....    .......+.+|+.++.+++|+|
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCCC
Confidence            37889999999999999999753                 23479999886422    2334557889999999999999


Q ss_pred             eeeeeeeccCCCeEEEEEecccccchHHHHhhh--------------------cCChHHHHHHHHHHHHHHHHHHhCCee
Q 043852          340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--------------------HLMDSQVSAYTRQILNGLNYLHEQNVV  399 (551)
Q Consensus       340 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~--------------------~l~~~~i~~i~~QI~~aL~yLH~~gIi  399 (551)
                      |+++++++.+....+++|||+.+++|.+++...                    .++...+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999999999999999999999999987543                    245667889999999999999999999


Q ss_pred             ecccccceEEEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc--C
Q 043852          400 HRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--R  473 (551)
Q Consensus       400 HrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt--G  473 (551)
                      ||||||+|||++.++.+||+|||+++......    .....++..|+|||++  ....++.++|||||||++|+|++  +
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI--LMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH--hcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999999999999999987553332    1223457889999997  34568999999999999999986  6


Q ss_pred             CCCCCCchhHHHHHHhhc-------CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          474 QPPYSHLEGMQALFRIGK-------GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       474 ~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..||......+.+..+..       ......+..++..+.+||.+||+.||.+|||+.+|..
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            778877655444332211       1112234568899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.1e-40  Score=323.58  Aligned_cols=250  Identities=28%  Similarity=0.528  Sum_probs=215.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|+..+.||+|+||.||++.. .++..+|||++.....   .......+.+|+.+++.++|+||+++++.+......++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            488999999999999999987 5889999999875432   223456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCccccccCC-
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND-  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~~~-  431 (551)
                      |||+.+++|.+++...   .+++..+..++.||+.+|.|||++||+|+||+|+||+++.++ .++|+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999988653   378889999999999999999999999999999999998654 68999999987654332 


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....|+..|+|||.+.  ...++.++||||||+++|+|++|..||...+.......+.......++..++..+.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         158 AYTVVGTPCYISPELCE--GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             ccccccCCcccCchhcc--CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence            23356889999999973  4567889999999999999999999998877666666666666666777899999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff  532 (551)
                      ||+.+|.+|||+.+++.||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.5e-40  Score=324.84  Aligned_cols=252  Identities=36%  Similarity=0.625  Sum_probs=218.1

Q ss_pred             CeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|++|.||++++. +++.|++|++......    .....+.+|+.++.+++|+||+++++.+......+++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            6888999999999999999884 6999999988654321    3456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCCcc-
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~-  433 (551)
                      |||+.+++|.+++.. ..+++..++.++.||+.+|.|||+ +|++|+||+|+||+++.++.++|+|||++......... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            999999999999875 668999999999999999999999 99999999999999999999999999998765433322 


Q ss_pred             -cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc---hhHHHHHHhhcCCCCCCCCc-CCHHHHHH
Q 043852          434 -SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL---EGMQALFRIGKGEPPLVPNS-LSRDARDF  508 (551)
Q Consensus       434 -~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~-~s~~l~~L  508 (551)
                       ...++..|+|||.+  ....++.++|+||||+++|+|++|+.||...   ...+....+.....+..+.. ++..+.++
T Consensus       158 ~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         158 NTFVGTVTYMSPERI--QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             cceeecccccCHhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence             44588999999987  3457789999999999999999999999776   34455555555555566666 89999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      |.+||+.+|++|||+.++++||||+..
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.3e-40  Score=327.86  Aligned_cols=254  Identities=35%  Similarity=0.731  Sum_probs=210.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCc-cchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGT-QGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .|+.++.||+|+||.||++.+ .++..||+|++....... ........+.+|+.++++++|+||+++++++.+...+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999987 689999999987543222 223356788899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCccccccCC--
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND--  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~~~--  431 (551)
                      ||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            9999999999998865 4578899999999999999999999999999999999998776 59999999987554321  


Q ss_pred             ----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHhh-cCCCCCCCCcCCH
Q 043852          432 ----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIG-KGEPPLVPNSLSR  503 (551)
Q Consensus       432 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---~~~~~~i~-~~~~~~~~~~~s~  503 (551)
                          .....+|..|+|||++  ....++.++|+|||||++|+|++|..||.....   ......+. ....+..+..++.
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVL--RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP  238 (268)
T ss_pred             CCccccccccccceeCHhHh--ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence                1223578899999987  345678999999999999999999999964432   22222222 2233455667899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      .+.+++.+||..+|.+|||+.++++||||+
T Consensus       239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.1e-40  Score=327.67  Aligned_cols=255  Identities=42%  Similarity=0.763  Sum_probs=210.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc-----chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ-----GKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +|.+.+.||+|+||.||+|.. .+|..+|+|.+........     .......+.+|+.++..++|+||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588899999999999999987 5789999998864322211     1223456788999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+++||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999998876 45788889999999999999999999999999999999999999999999998754321


Q ss_pred             ----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-CCCC----CCcC
Q 043852          431 ----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLV----PNSL  501 (551)
Q Consensus       431 ----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~----~~~~  501 (551)
                          ......|+..|+|||++......++.++|+||||+++|+|++|..||........+..+.... ....    ...+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence                122345788999999974333357899999999999999999999997766655555443222 1222    2346


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      +..+.++|.+||+++|++|||+.+|+.||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.4e-40  Score=325.78  Aligned_cols=244  Identities=25%  Similarity=0.449  Sum_probs=210.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .+|++.+.||+|+||.||++...++..+|+|.+.....      ....+.+|+.++++++||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc------cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            36888999999999999999887778899998753211      134577899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc-
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~-  433 (551)
                      |||+++|+|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++........ 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999999998864  34788899999999999999999999999999999999999999999999998754332221 


Q ss_pred             --cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          434 --SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       434 --~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                        ...++..|+|||++  ....++.++||||||+++|+|++ |+.||......+....+..+.....+...+..+.+|+.
T Consensus       158 ~~~~~~~~~y~aPE~~--~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05114         158 SSGAKFPVKWSPPEVF--NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY  235 (256)
T ss_pred             cCCCCCchhhCChhhc--ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence              22345679999997  34568899999999999999999 99999888877777778777766667778899999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 043852          511 KCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILe  528 (551)
                      +||+.+|.+|||+.++++
T Consensus       236 ~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         236 SCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-39  Score=324.33  Aligned_cols=252  Identities=43%  Similarity=0.833  Sum_probs=212.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||+|.+ .++..|++|.+......   ......+.+|+.+++.++|+||+++++.+.+...++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            588899999999999999987 57899999998754332   34567788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc---
Q 043852          357 LELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV---  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~---  432 (551)
                      +||+.+++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........   
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            9999999999988764 478888899999999999999999999999999999999999999999999876543322   


Q ss_pred             ---ccCCCCCcccChhhhhccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHhhcCCCCCCCCc--CCHHH
Q 043852          433 ---KSCKGTPFWMAPEVVNLKN-RGYGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRIGKGEPPLVPNS--LSRDA  505 (551)
Q Consensus       433 ---~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~--~s~~l  505 (551)
                         ....+++.|+|||++.... ..++.++||||||+++|+|++|+.||.... .......+..+..+..+..  ++..+
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG  237 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence               1245788999999974332 237899999999999999999999997653 3334444444444455544  48999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .++|.+||+.+|++|||+.+++.|||+
T Consensus       238 ~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         238 KDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-39  Score=330.76  Aligned_cols=253  Identities=34%  Similarity=0.637  Sum_probs=209.2

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCC--
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDE--  350 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--  350 (551)
                      ..++|.+.+.||+|+||.||++.. .+++.+|+|++....      .....+.+|+.++.++ +|+||+++++++...  
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            345799999999999999999987 578999999885321      1233566888888888 799999999987643  


Q ss_pred             ---CeEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecC
Q 043852          351 ---NRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       351 ---~~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                         ..+|+||||+.+++|.++++.     ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence               468999999999999988752     357889999999999999999999999999999999999999999999999


Q ss_pred             CccccccCC--cccCCCCCcccChhhhhccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC
Q 043852          423 LAKATTMND--VKSCKGTPFWMAPEVVNLKN---RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV  497 (551)
Q Consensus       423 la~~~~~~~--~~~~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~  497 (551)
                      ++.......  .....|+..|+|||++....   ..++.++|||||||++|+|++|++||........+..+.....+..
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  253 (291)
T cd06639         174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL  253 (291)
T ss_pred             cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence            987543322  23346889999999874221   2368899999999999999999999988776666666655544332


Q ss_pred             --CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          498 --PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       498 --~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                        +...+..+.+||.+||+.+|++||++.+|++||||+
T Consensus       254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence              345678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.6e-40  Score=332.26  Aligned_cols=258  Identities=29%  Similarity=0.490  Sum_probs=214.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|++.+.||+|+||+||++.+ .+|..||+|++....    .......+.+|+.++..++|+||+++++.+.+...+|+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            4788999999999999999987 578999999876432    12334567899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          356 FLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      ||||+++++|..++.+. .++...+..++.||+.+|.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~  160 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD  160 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence            99999999999988764 58889999999999999999997 69999999999999999999999999998655433344


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-----------HHHHHhhcCCCCCCCC-cC
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-----------QALFRIGKGEPPLVPN-SL  501 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~-~~  501 (551)
                      ...|+..|+|||++  ....++.++|||||||++|+|++|..||......           .....+.....+.++. .+
T Consensus       161 ~~~~~~~~~aPE~~--~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         161 TFVGTSTYMSPERI--QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             ccccCcccCCHHHH--ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence            45689999999987  3457889999999999999999999999754431           2233333333333333 37


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      +..+.+|+.+||++||++|||+.++++|+||.+....+.
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~  277 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN  277 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccccc
Confidence            889999999999999999999999999999987665543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-41  Score=353.08  Aligned_cols=252  Identities=27%  Similarity=0.487  Sum_probs=208.4

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|++++.||.||-+.||++...+...||+|++...   ....+.+.-+.+||.+|.+|+ |.+||+||++...++++|||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~---~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL---EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh---hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            69999999999999999998877788888877543   233566777889999999996 89999999999999999999


Q ss_pred             EecccccchHHHHhhhcCCh--HHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc--
Q 043852          357 LELVTKGSLANLYQKYHLMD--SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~--~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~--  432 (551)
                      |||-+. +|..+++++....  .-+..|..||+.+++++|++||||.||||.|+|+ -.|.+||+|||+|.....+.+  
T Consensus       439 mE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  439 MECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             eecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccce
Confidence            998744 9999998765333  3778899999999999999999999999999999 689999999999987765543  


Q ss_pred             --ccCCCCCcccChhhhhcccCC---------CCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHhhcCCC-CCCCC
Q 043852          433 --KSCKGTPFWMAPEVVNLKNRG---------YGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRIGKGEP-PLVPN  499 (551)
Q Consensus       433 --~~~~GT~~Y~APEvl~~~~~~---------~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i~~~~~-~~~~~  499 (551)
                        .+.+||+.||+||.+......         .+.++||||||||||+|++|++||.... ....+..|..... ..+|.
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~  596 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD  596 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence              345799999999998533222         5788999999999999999999997765 3444555544422 23333


Q ss_pred             cCC-HHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          500 SLS-RDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       500 ~~s-~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      .-+ .++.++++.||..||.+|||..++|+|||++-
T Consensus       597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            323 34999999999999999999999999999985

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.7e-40  Score=332.02  Aligned_cols=259  Identities=29%  Similarity=0.529  Sum_probs=207.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHH-HHhcCCCCceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +|++.+.||+|+||.||++.+ .+|..||+|++.......    ...++..|+. .++.++|+||+++++++.....+|+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH----HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            689999999999999999987 579999999886542211    1233444555 4667789999999999999999999


Q ss_pred             EEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          356 FLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      +|||++ ++|..++..     ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999997 577776643     2588899999999999999999997 999999999999999999999999999875533


Q ss_pred             CCc-ccCCCCCcccChhhhhcc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHHhhcCCCCCCC-CcCCHH
Q 043852          430 NDV-KSCKGTPFWMAPEVVNLK--NRGYGLTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRIGKGEPPLVP-NSLSRD  504 (551)
Q Consensus       430 ~~~-~~~~GT~~Y~APEvl~~~--~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~-~~~s~~  504 (551)
                      ... ....++..|+|||++...  ...++.++|+|||||++|+|++|+.||... ...+.+..+..+..+..+ ..++..
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE  236 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence            222 224588899999987421  245788999999999999999999999653 333444444444444333 457899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                      +.++|.+||..+|.+|||+.+|++||||+....+...
T Consensus       237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~  273 (283)
T cd06617         237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTD  273 (283)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhhhcccccHH
Confidence            9999999999999999999999999999987654433

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.5e-40  Score=324.18  Aligned_cols=247  Identities=39%  Similarity=0.726  Sum_probs=210.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|... ++..|++|.+.....       ...+.+|+.++++++|+||+++++.+.+...+|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            36888999999999999999874 589999998854211       5678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      ++||+.+++|.+++..  ..+++..+..++.||+.||.|||+.+++|+||+|.||+++.++.++|+|||++.......  
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999999999998864  457899999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFI  509 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~LI  509 (551)
                      .....++..|+|||++.  +..++.++||||||+++|+|++|+.||...........+.......  .+..++..+.++|
T Consensus       156 ~~~~~~~~~y~~PE~~~--~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQ--EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV  233 (256)
T ss_pred             cccccCCccccCHHHHh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence            23345788999999973  4578899999999999999999999998766655554443332222  2345788999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCccc
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .+||+.||++|||+.++++||||
T Consensus       234 ~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.6e-40  Score=330.31  Aligned_cols=250  Identities=35%  Similarity=0.667  Sum_probs=206.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD-----  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-----  349 (551)
                      +.|++.+.||.|+||.||+|.+ .+++.+|+|++....      .....+..|+.++.++ +|+||+++++++..     
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4688889999999999999987 578999999875431      2234567888888888 69999999998753     


Q ss_pred             -CCeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          350 -ENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                       ...+|++|||+.+++|.+++..   ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence             4678999999999999998865   247788889999999999999999999999999999999999999999999987


Q ss_pred             cccc--CCcccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC-CCCC
Q 043852          426 ATTM--NDVKSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPN  499 (551)
Q Consensus       426 ~~~~--~~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~  499 (551)
                      ....  .......|++.|+|||++...   ...++.++|||||||++|+|++|..||...........+...... ....
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  249 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK  249 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence            5432  223445689999999987421   345788999999999999999999999776655555544443322 2334


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .++..+.+||.+||+.||.+|||+.+|++||||
T Consensus       250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            688999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-39  Score=324.01  Aligned_cols=246  Identities=28%  Similarity=0.516  Sum_probs=213.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||++.+ .++..||+|.+.....    ......+.+|+.++..++|+||+++++.+.+...+|++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            488899999999999999987 5799999999864322    23455677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      |||+++++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999999888754   247888999999999999999999999999999999999999999999999987553322  


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....|++.|+|||++  ....++.++|+||||+++|+|++|..||...+.......+..+.....+..++..+.+||.+
T Consensus       157 ~~~~~~~~~~~aPE~~--~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (255)
T cd08219         157 ACTYVGTPYYVPPEIW--ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ  234 (255)
T ss_pred             cccccCCccccCHHHH--ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence            2335688999999997  44568999999999999999999999998877766777777777777778899999999999


Q ss_pred             hhhcCCCCCCCHHHHHhC
Q 043852          512 CLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       512 cL~~DP~~RPS~~eILeh  529 (551)
                      ||+.||++|||+.+|+.-
T Consensus       235 ~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         235 MFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHhCCcccCCCHHHHhhc
Confidence            999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-40  Score=349.11  Aligned_cols=246  Identities=24%  Similarity=0.304  Sum_probs=199.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe---cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT---DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+|.+++.||+|+||.||++..   ..+..||+|.+...          ....+|+.++++++|+||+++++++.....+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            4799999999999999999864   24678999987532          1235799999999999999999999999999


Q ss_pred             EEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          354 FIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      |++||++.+ +|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus       162 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        162 CMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            999999964 7777664 3568999999999999999999999999999999999999999999999999987544322 


Q ss_pred             ---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHhhcC-------------
Q 043852          432 ---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKG-------------  492 (551)
Q Consensus       432 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---~~~~~~i~~~-------------  492 (551)
                         .....||+.|+|||++  ....|+.++|||||||++|||++|+.||.+...   ...+..+.+.             
T Consensus       241 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccCccCHhHh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence               2245699999999997  455789999999999999999999999965431   1111111110             


Q ss_pred             -------------CC--CCCC-----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          493 -------------EP--PLVP-----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       493 -------------~~--~~~~-----~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                                   ..  ...+     ..++.++.+||.+||..||++|||+.++|.||||++.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                         00  0011     2356788999999999999999999999999999853

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-40  Score=324.67  Aligned_cols=250  Identities=42%  Similarity=0.699  Sum_probs=210.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||.|+||.||+|.+ .++..+++|++.....     .....+.+|+.++.+++|+||+++++.+.+...+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            4799999999999999999987 5788999999874322     245677899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--C
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~  431 (551)
                      +|||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......  .
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            9999999999998865  46899999999999999999999999999999999999999999999999998754322  2


Q ss_pred             cccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC--C--CCCcCCHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--L--VPNSLSRDAR  506 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~--~~~~~s~~l~  506 (551)
                      .....++..|+|||.+... ...++.++|+|||||++|+|++|+.||...........+......  .  .....+..+.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            2345688899999987322 126788999999999999999999999877666555544443111  1  1234577899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      +|+.+||..+|.+|||+.+|+.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-41  Score=360.78  Aligned_cols=261  Identities=34%  Similarity=0.612  Sum_probs=223.5

Q ss_pred             cccCCCchhhhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceee
Q 043852          264 YNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ  342 (551)
Q Consensus       264 ~~~~p~~~~~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  342 (551)
                      ...+|.++|.+.      ..+||+|+|-+||+|.+ .+|..||.-.+..... ........+|..|+.+|+.|+|+||++
T Consensus        33 ve~~p~gRy~k~------~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-~q~~~~leR~~~Ev~lLKsL~H~NIir  105 (632)
T KOG0584|consen   33 VEKDPTGRYLKF------DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-TQSPEELERLYSEVHLLKSLKHPNIIR  105 (632)
T ss_pred             cccCCCCceeeh------hhhcccccceeeeeccccccchhhHHHHHhHHHh-hcChHHHHHHHHHHHHHccCCCCceee
Confidence            456666765432      46899999999999998 6888888766654333 344566788999999999999999999


Q ss_pred             eeeeccCCCe--EEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhC--CeeecccccceEEEcC-CCcE
Q 043852          343 YFGTDKDENR--LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ--NVVHRDIKCANILVDA-SGSV  416 (551)
Q Consensus       343 l~~~~~~~~~--~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~--gIiHrDIKP~NILl~~-~g~v  416 (551)
                      +|++|.+...  +.+|+|++..|+|..|+++. ..+...+..|++||+.||.|||++  .|||||||++||||+. .|.|
T Consensus       106 fy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V  185 (632)
T KOG0584|consen  106 FYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV  185 (632)
T ss_pred             eeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence            9999987655  88999999999999999875 477888999999999999999998  4999999999999985 5899


Q ss_pred             EEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHhhcCCCC
Q 043852          417 KLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRIGKGEPP  495 (551)
Q Consensus       417 kL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i~~~~~~  495 (551)
                      ||+|+|||+.........++|||.|||||++   ...|+..+||||||++|+||+|+..||.... ..+.+.++..|..|
T Consensus       186 KIGDLGLAtl~r~s~aksvIGTPEFMAPEmY---EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP  262 (632)
T KOG0584|consen  186 KIGDLGLATLLRKSHAKSVIGTPEFMAPEMY---EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP  262 (632)
T ss_pred             eecchhHHHHhhccccceeccCccccChHHH---hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence            9999999998888888889999999999986   3789999999999999999999999996654 56667778777665


Q ss_pred             CCC-CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          496 LVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       496 ~~~-~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      .-. .--++++++||.+||.. ...|+|+.++|+||||...
T Consensus       263 ~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  263 AALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            433 33478999999999999 9999999999999999975

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-39  Score=330.71  Aligned_cols=249  Identities=28%  Similarity=0.421  Sum_probs=201.4

Q ss_pred             EeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHH---HHHhcCCCCceeeeeeeccCCCeEEEEEec
Q 043852          284 LLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEI---LLLSRFEHENIVQYFGTDKDENRLFIFLEL  359 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey  359 (551)
                      +||+|+||.||++.+ .++..+|+|.+...........  ..+.+|.   .++....|+||+.+++.+...+..|+||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH--HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            489999999999987 5789999998865433222111  1122333   344455799999999999989999999999


Q ss_pred             ccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCCCC
Q 043852          360 VTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT  438 (551)
Q Consensus       360 ~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT  438 (551)
                      +.+++|..++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++............||
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT  158 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence            999999887754 4589999999999999999999999999999999999999999999999999875544444445689


Q ss_pred             CcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--hHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcC
Q 043852          439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--GMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN  516 (551)
Q Consensus       439 ~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~D  516 (551)
                      ..|+|||.+. .+..++.++|||||||++|+|++|..||....  ....+...........+..++..+.++|.+||+.|
T Consensus       159 ~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  237 (279)
T cd05633         159 HGYMAPEVLQ-KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD  237 (279)
T ss_pred             cCccCHHHhc-CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCC
Confidence            9999999873 34567899999999999999999999996432  22233333333344566778999999999999999


Q ss_pred             CCCCC-----CHHHHHhCcccCCc
Q 043852          517 PNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       517 P~~RP-----S~~eILehpff~~~  535 (551)
                      |.+||     |++++++||||+..
T Consensus       238 p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         238 VSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HHHhcCCCCCCHHHHHhCccccCC
Confidence            99999     69999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-39  Score=329.54  Aligned_cols=253  Identities=34%  Similarity=0.632  Sum_probs=207.1

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeec----
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTD----  347 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~----  347 (551)
                      ...++|++.+.||+|+||.||++.+ .++..+|+|++....      .....+.+|+.++..+ +|+||+++++++    
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3456899999999999999999987 578899999875321      1123566888999998 699999999986    


Q ss_pred             -cCCCeEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          348 -KDENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       348 -~~~~~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                       .....+|++|||+++++|.+++..     ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df  168 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF  168 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence             345678999999999999887642     34778889999999999999999999999999999999999999999999


Q ss_pred             CCccccccCC--cccCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC
Q 043852          422 GLAKATTMND--VKSCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL  496 (551)
Q Consensus       422 Gla~~~~~~~--~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~  496 (551)
                      |+++......  .....|++.|+|||++..   ....++.++|||||||++|+|++|+.||........+..+.....+.
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (286)
T cd06638         169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT  248 (286)
T ss_pred             CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence            9987554322  234568999999998742   13457889999999999999999999998776655555444333222


Q ss_pred             --CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          497 --VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       497 --~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                        .+..++..+.+||.+||+.||++|||+.+|++|+||
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence              344578899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-40  Score=326.41  Aligned_cols=251  Identities=34%  Similarity=0.671  Sum_probs=209.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCC---
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDE---  350 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~---  350 (551)
                      .++|++.+.||+|+||.||+|.+ .++..+++|++.....      ....+.+|+.++.++ .|+||+++++++.+.   
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP   78 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence            45899999999999999999987 4788999998864321      235678999999998 699999999998654   


Q ss_pred             ---CeEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecC
Q 043852          351 ---NRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       351 ---~~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                         ..+|++|||+.+++|.+++..     ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence               458999999999999988754     358889999999999999999999999999999999999999999999999


Q ss_pred             CccccccC--CcccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC
Q 043852          423 LAKATTMN--DVKSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV  497 (551)
Q Consensus       423 la~~~~~~--~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~  497 (551)
                      ++......  ......|++.|+|||++...   ...++.++|||||||++|+|++|+.||...........+.....+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            98654322  22345589999999987422   23568899999999999999999999987666666666665543332


Q ss_pred             C--CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          498 P--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       498 ~--~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .  ..++..+.+||.+||..||++|||+.+|++|||+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            2  2367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-41  Score=347.48  Aligned_cols=257  Identities=27%  Similarity=0.422  Sum_probs=226.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .+-|...+.||+|.|+.|-++++ -+|+.||||+|.+.+...   ..-.++.+|++.|+.++|||||+||.+...+..+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~---~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT---LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch---hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            45688889999999999999988 699999999997665443   33445678999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE-cCCCcEEEEecCCcccccc-C
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV-DASGSVKLADFGLAKATTM-N  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl-~~~g~vkL~DFGla~~~~~-~  430 (551)
                      +|+|+-.+|+|++++.+  .++.+....+|++||+.|+.|+|+..+|||||||+||.+ ..-|-|||+|||++..+.. .
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            99999999999999865  579999999999999999999999999999999999865 5679999999999976544 4


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ...+.+|+..|.|||++ ++...-.+++||||||+|||-|++|++||...++.+.+-.|.... ..+|..++.++++||.
T Consensus       174 kL~TsCGSLAYSAPEIL-LGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-YtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEIL-LGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-YTVPSHVSKECRDLIQ  251 (864)
T ss_pred             hhhcccchhhccCchhh-hcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-ccCchhhhHHHHHHHH
Confidence            46778899999999997 233333788999999999999999999999999888887776654 6778999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      .||..||.+|.|.++|..|+|++..-.
T Consensus       252 sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHhcCchhhccHHHHhccccccCCCC
Confidence            999999999999999999999996543

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.5e-40  Score=335.75  Aligned_cols=254  Identities=35%  Similarity=0.597  Sum_probs=213.7

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |.....||+|+||.||++.+ .++..||||.+...     .......+.+|+.++..++|+||+++++.+......|++|
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            34456799999999999987 57899999988532     2234456789999999999999999999999999999999


Q ss_pred             ecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccC
Q 043852          358 ELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSC  435 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~  435 (551)
                      ||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......  .....
T Consensus        99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658          99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            9999999999988778899999999999999999999999999999999999999999999999998644222  22334


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHHHHHHhh
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKCL  513 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~LI~~cL  513 (551)
                      .|+..|+|||.+  ....++.++||||||+++|||++|+.||...........+........  ...++..+.+++.+||
T Consensus       179 ~~~~~y~aPE~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         179 VGTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             ecCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence            588999999987  345678999999999999999999999987766665555544333322  2357889999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCccccC
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ..||.+|||++++++||||+..-..+
T Consensus       257 ~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         257 VREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             cCChhHCcCHHHHhhChhhhccCCcc
Confidence            99999999999999999999554444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-39  Score=325.06  Aligned_cols=247  Identities=42%  Similarity=0.751  Sum_probs=203.8

Q ss_pred             eeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEec
Q 043852          281 KGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLEL  359 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey  359 (551)
                      ....||+|+||.||+|.+ .++..||+|.+....     ......+.+|+.++..++|+||+++++++......++++||
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            346899999999999986 578889999875332     23445778999999999999999999999999999999999


Q ss_pred             ccccchHHHHhhh--cC--ChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEecCCccccccCC--c
Q 043852          360 VTKGSLANLYQKY--HL--MDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND--V  432 (551)
Q Consensus       360 ~~ggsL~~ll~~~--~l--~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~DFGla~~~~~~~--~  432 (551)
                      +.+++|.+++...  .+  +...+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++.......  .
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence            9999999988653  34  77888899999999999999999999999999999976 6799999999986543221  2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHh-hcCCCCCCCCcCCHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ-ALFRI-GKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~-~~~~i-~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ....|++.|+|||++......++.++||||||+++|+|++|..||....... ..... .....+.++..++..+.+|+.
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  246 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL  246 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence            2345889999999975444558899999999999999999999997543322 22221 223334566778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCccc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff  532 (551)
                      +||+.+|.+|||+.++++||||
T Consensus       247 ~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         247 RCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=357.31  Aligned_cols=251  Identities=28%  Similarity=0.510  Sum_probs=215.7

Q ss_pred             hhhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          272 FRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       272 ~~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      |....++..++..||+|.||+||+|.+..  .||||++.....   +...++.|.+|+..+++-+|.||+-+.|++....
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~p---t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDP---TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCC---CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            44455677888999999999999997644  489999976543   3447888999999999999999999999999888


Q ss_pred             eEEEEEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc-
Q 043852          352 RLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~-  428 (551)
                      . .||+.+|+|.+|+.++.  +.++...+.+.|++||++||.|||.++|||||||..|||+.+++.|||+||||+.... 
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            7 99999999999998874  5568888999999999999999999999999999999999999999999999986432 


Q ss_pred             ---cCCcccCCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC----CCCc
Q 043852          429 ---MNDVKSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL----VPNS  500 (551)
Q Consensus       429 ---~~~~~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~  500 (551)
                         ........|...|||||+++. ....|+..+|||||||++|||+||..||......+.++.+..|+...    +...
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence               223344457788999999863 34578999999999999999999999999878888888888885433    3346


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          501 LSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ++.++++|+..||.+++++||.+.+||.
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            8889999999999999999999999987

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=389.77  Aligned_cols=256  Identities=42%  Similarity=0.787  Sum_probs=227.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|+.+.+||.|.||.||.|.+ ++|+..|+|.+......   ......+.+|..++..++|||+|++||+-.+...++|+
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            788899999999999999987 78999999999876554   44566677999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHH-HHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-----
Q 043852          357 LELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----  430 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i-~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-----  430 (551)
                      ||||.+|+|.++++.++.-++.+ ..|..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|.....+     
T Consensus      1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            99999999999999877555544 568899999999999999999999999999999999999999999765433     


Q ss_pred             -CcccCCCCCcccChhhhhccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHhhcCCCCCCCCcCCHHHHH
Q 043852          431 -DVKSCKGTPFWMAPEVVNLKN-RGYGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRIGKGEPPLVPNSLSRDARD  507 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~s~~l~~  507 (551)
                       ..+...||+.|||||++.+.. .+..-++||||||||+.||+||+.||...+ .+...+++..|..|.+|..++.+.++
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence             245667999999999996543 567889999999999999999999997654 57888899999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ||..||..||.+|+++.||++|.|-+-..
T Consensus      1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             HHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence            99999999999999999999999977543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-39  Score=323.92  Aligned_cols=245  Identities=27%  Similarity=0.489  Sum_probs=209.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..+|+++++||+|+||.||+|...++..||+|.+....      .....+.+|+.+++.++|+||+++++.+.+....|+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            34899999999999999999988788889999875321      124567899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      +|||+.+++|.+++.+   ..++...+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999999998864   3477888899999999999999999999999999999999999999999999976543221


Q ss_pred             ---ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          433 ---KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       433 ---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                         ....++..|+|||++.  ...++.++|||||||++|+|++ |..||...........+..+........++..+.++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         159 TAREGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eccCCCccceecCCHHHhc--cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence               2223566799999873  4567889999999999999998 999998877776666666665555566789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 043852          509 ILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||+.+|++|||+.++++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-39  Score=334.01  Aligned_cols=254  Identities=28%  Similarity=0.459  Sum_probs=206.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--Ce
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--NR  352 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~  352 (551)
                      +.+|++.+.||+|+||.||+|.+ .+|..||+|++.......   .....+.+|+.++.+++|+||+++++++...  ..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            56899999999999999999987 579999999987543222   1122345799999999999999999988654  56


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|+||||+.+ +|.+++..  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            8999999975 77777664  45889999999999999999999999999999999999999999999999998765432


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC-------------
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-------------  495 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-------------  495 (551)
                        ......+++.|+|||++. ....++.++|||||||++|+|++|.+||...+..+.+..+......             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLL-GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             cCCCCcccccccccChhhhc-CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence              223334678899999873 3456789999999999999999999999887776665544331100             


Q ss_pred             --------CC--------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          496 --------LV--------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       496 --------~~--------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                              ..        ....+..+.+||.+||++||++|||+.+++.||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                    00        0125788999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-42  Score=358.13  Aligned_cols=237  Identities=31%  Similarity=0.540  Sum_probs=208.7

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      ....++.||.|+.|.||+|+. .++.||||++...            -+.+|+-|++|+|+||+.+.|+|.....+||||
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el------------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL------------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             HhhhhhhhccCcccceeeeec-cCceehhHHHhhh------------hhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence            334467899999999999965 5678999987421            125788899999999999999999999999999


Q ss_pred             ecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-ccC
Q 043852          358 ELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSC  435 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-~~~  435 (551)
                      |||..|.|..+++.. .+....+..|..+|+.||.|||.+.|||||||.-||||..+..|||+|||-++......+ -+.
T Consensus       192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence            999999999999865 588888999999999999999999999999999999999999999999999887654433 356


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-CCCCCcCCHHHHHHHHHhhh
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-PLVPNSLSRDARDFILKCLQ  514 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l~~LI~~cL~  514 (551)
                      +||..|||||++  .+...+.|+|||||||||||||||..||...+....++-+..+.. .+.|..|++.|+=||++||+
T Consensus       272 aGTVaWMAPEvI--rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  272 AGTVAWMAPEVI--RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             hhhHhhhCHHHh--hcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence            799999999998  567889999999999999999999999999888888777666543 44578899999999999999


Q ss_pred             cCCCCCCCHHHHHhC
Q 043852          515 VNPNDRPTAAQLMEH  529 (551)
Q Consensus       515 ~DP~~RPS~~eILeh  529 (551)
                      -.|.+||+|.|||.|
T Consensus       350 sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  350 SKPRNRPSFRQILLH  364 (904)
T ss_pred             cCCCCCccHHHHHHH
Confidence            999999999999998

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=338.63  Aligned_cols=260  Identities=30%  Similarity=0.518  Sum_probs=208.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      .+|++.+.||+|+||.||+|.+ .+|..||||++....    .......+.+|+.++.+++|+||+++++++...     
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            4799999999999999999987 579999999885321    123345567899999999999999999875543     


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      ...|+++||+.+ +|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            357999999975 8888888778999999999999999999999999999999999999999999999999998754322


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc--------------
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--------------  491 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~--------------  491 (551)
                      .     .....||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+....+..+..              
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            1     12346899999999863 345678999999999999999999999976544332221110              


Q ss_pred             -C----------CCCC-----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          492 -G----------EPPL-----VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       492 -~----------~~~~-----~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                       .          ....     .....+..+.+||.+||+.||++|||+.++++||||++....+..|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence             0          0000     0124577899999999999999999999999999999887654443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-39  Score=323.83  Aligned_cols=245  Identities=25%  Similarity=0.458  Sum_probs=209.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .+|.+.+.||+|+||.||++...++..+|+|.+.....      ....+.+|+.++.+++||||+++++++.+...+|++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            47899999999999999999776677799998753221      134577899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          357 LELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      |||+.+++|.+++...  .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999988653  57889999999999999999999999999999999999999999999999987554333222


Q ss_pred             ---CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          435 ---CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       435 ---~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                         ..++..|++||++.  ...++.++|||||||++|+|++ |..||...........+..+.....+...+..+.+++.
T Consensus       158 ~~~~~~~~~y~~pe~~~--~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05113         158 SVGSKFPVRWSPPEVLL--YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY  235 (256)
T ss_pred             cCCCccChhhCCHHHHh--cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence               22456799999973  4568899999999999999998 99999877776666677777666667778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 043852          511 KCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILeh  529 (551)
                      +||+.||.+|||+.+|+++
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.6e-40  Score=329.81  Aligned_cols=252  Identities=34%  Similarity=0.564  Sum_probs=207.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+......   ......+.+|+.++..++|+||+++++++.+....|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            3689999999999999999987 47899999987543221   1234456789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      +|||+.+++|..+... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......  ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            9999999999887654 35889999999999999999999999999999999999999999999999998754332  22


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC------------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP------------------  494 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~------------------  494 (551)
                      ....++..|+|||++. ....++.++|||||||++|+|++|++||......+....+.....                  
T Consensus       158 ~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         158 TDYVATRWYRAPELLV-GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             CcccceeeccCcHHhc-cccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            3455788999999873 334578899999999999999999999976555443333221000                  


Q ss_pred             ---C---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 ---P---------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ---~---------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                         +         .....++..+.+|+.+||+.+|++||++.+|++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence               0         0123568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2e-39  Score=329.24  Aligned_cols=252  Identities=34%  Similarity=0.604  Sum_probs=213.8

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |...+.||+|++|.||++.+ .++..+++|++....     ......+.+|+.++..++|+||+++++++......|+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            44457999999999999986 578999999875322     122345778999999999999999999999999999999


Q ss_pred             ecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccC
Q 043852          358 ELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSC  435 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~  435 (551)
                      ||+.+++|.+++....++...+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......  .....
T Consensus        96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999999998878899999999999999999999999999999999999999999999999987644322  12334


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHHHHHHhh
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKCL  513 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~LI~~cL  513 (551)
                      .|++.|+|||++  ....++.++|||||||++|+|++|+.||...+.......+.....+..  +..++..+.+||.+||
T Consensus       176 ~~~~~y~aPE~~--~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (285)
T cd06648         176 VGTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML  253 (285)
T ss_pred             cCCccccCHHHh--cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence            589999999997  345678999999999999999999999987766666666655543333  2347899999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCccc
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +.+|++|||+.++++||||++...
T Consensus       254 ~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         254 VRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             ccChhhCcCHHHHccCcccccCCC
Confidence            999999999999999999987664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=324.15  Aligned_cols=244  Identities=24%  Similarity=0.420  Sum_probs=208.8

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      +|++.+.||+|+||.||++.+.++..+|+|.+.....      ....+.+|+.++..++|+||+++++++......|++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            6888999999999999999887777899998753221      1235678999999999999999999999999999999


Q ss_pred             ecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccC
Q 043852          358 ELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC  435 (551)
Q Consensus       358 Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  435 (551)
                      ||+++++|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++..........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999999998864  3478889999999999999999999999999999999999999999999999876543332222


Q ss_pred             C---CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          436 K---GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       436 ~---GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .   ++..|+|||++  ....++.++||||||+++|+|++ |..||......+....+..+.....+..++..+.+++.+
T Consensus       159 ~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         159 QGTKFPVKWAPPEVF--DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             CCCCCCccccCHHHh--ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            2   33479999987  34568899999999999999998 899998877777777777666666677789999999999


Q ss_pred             hhhcCCCCCCCHHHHHhC
Q 043852          512 CLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       512 cL~~DP~~RPS~~eILeh  529 (551)
                      ||+.+|++|||+.++++.
T Consensus       237 cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=323.90  Aligned_cols=244  Identities=29%  Similarity=0.482  Sum_probs=209.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      ++|++.+.||+|+||.||+|.+.++..||+|.+.....      ....+.+|+.++.+++|+||+++++++......|++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            47899999999999999999887778899998854321      234577899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      |||+.+++|.+++...   .++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999999998653   4888999999999999999999999999999999999999999999999998766533322


Q ss_pred             cCCC---CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          434 SCKG---TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       434 ~~~G---T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ...|   +..|+|||++  ....++.++||||||+++|+|++ |+.||.+.........+........+..++..+.+++
T Consensus       160 ~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         160 AREGAKFPIKWTAPEAA--LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             ccCCCcCceeccCcccc--ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            2223   3479999986  35568999999999999999999 9999988777777777766655556677899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 043852          510 LKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||+.+|++||++.+|++
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHhhcCcccCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.5e-39  Score=323.65  Aligned_cols=244  Identities=27%  Similarity=0.462  Sum_probs=209.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|.+.+.||+|+||.||+|.. .++..||+|.+...      ......+.+|+.++..++|+||+++++++.....+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            4789999999999999999987 56889999987532      1234567889999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      +|||+.+++|.+++...   .++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999988643   478888999999999999999999999999999999999999999999999876543322


Q ss_pred             c---cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          433 K---SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       433 ~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .   ...++..|+|||.+  ....++.++|||||||++|||++ |..||.+....+....+..+.....+..++..+.++
T Consensus       160 ~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         160 TAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL  237 (263)
T ss_pred             eccCCCCCccccCCHHHh--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            2   12245679999987  45567899999999999999998 999998877666666666666667778899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 043852          509 ILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||+.||++|||+.++++
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-39  Score=328.26  Aligned_cols=246  Identities=28%  Similarity=0.464  Sum_probs=210.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      .+|.+.+.||+|+||.||+|...      ++..||||.+.....    ......+.+|+.++..+.|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS----NDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC----HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            46888899999999999999753      357899998753221    22345778999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh---------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY---------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS  415 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~---------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~  415 (551)
                      ...+++|||+.+++|.+++...               .+++..+..++.||+.||.|||++|++|+||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            9999999999999999988643               3677888999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhh
Q 043852          416 VKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIG  490 (551)
Q Consensus       416 vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~  490 (551)
                      ++|+|||+++......    .....+++.|+|||++  ....++.++|||||||++|+|++ |..||...........+.
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhh--ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9999999987543222    1233457789999997  45678999999999999999998 999998877777777777


Q ss_pred             cCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       491 ~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+.....+..++..+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            77777777789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-40  Score=345.91  Aligned_cols=244  Identities=26%  Similarity=0.353  Sum_probs=193.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..|.+++.||+|+||.||+|.+ .++..||+|+....           ....|+.++.+++|+||+++++++.+....|+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3799999999999999999987 46788999964321           12368999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-Cc
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~  432 (551)
                      ||||+.+ +|..++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus       135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            9999965 77776643  45889999999999999999999999999999999999999999999999998754322 23


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCC-CCCchh---------HHHHHHhhc---CCCCCCC-
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPP-YSHLEG---------MQALFRIGK---GEPPLVP-  498 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~P-f~~~~~---------~~~~~~i~~---~~~~~~~-  498 (551)
                      ....||+.|+|||++  ....++.++|||||||++|||+++..+ |.....         ...+..+..   ..+..++ 
T Consensus       214 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        214 LGLAGTVETNAPEVL--ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccCCeec--CCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            345699999999997  455789999999999999999985444 432111         011111111   0000000 


Q ss_pred             -----------------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          499 -----------------------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       499 -----------------------------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                                                   ..++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                         135667788999999999999999999999999986

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-39  Score=327.36  Aligned_cols=257  Identities=31%  Similarity=0.542  Sum_probs=210.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--CCeEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--ENRLF  354 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~  354 (551)
                      +|...+.||.|++|.||++.+ .++..+|+|.+.....    ......+.+|+.++..++|+||+++++++.+  ...+|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            688999999999999999987 5789999998864322    2344567899999999999999999998754  44789


Q ss_pred             EEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ++|||+++++|.+++..     ..+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999999887643     3478888999999999999999999999999999999999999999999999876544


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-----hhHHHHHHhhcCCCCCCC------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL-----EGMQALFRIGKGEPPLVP------  498 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~------  498 (551)
                      .......++..|+|||.+  ....++.++|||||||++|+|++|..||...     ...+....+.....+..+      
T Consensus       158 ~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         158 SLAGTFTGTSFYMAPERI--QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             cccccccCCccccCHHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            443445678899999987  3557899999999999999999999999755     223333333332222221      


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      ...+..+.+||.+||+.+|.+|||+.+++.||||++...+..
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~  277 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV  277 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchh
Confidence            234678999999999999999999999999999987776643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.3e-39  Score=327.25  Aligned_cols=248  Identities=24%  Similarity=0.403  Sum_probs=209.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      +.+|++.+.||+|+||.||+|..     .++..+|+|.+...    ........+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            45789999999999999999974     25678999987532    2233456778999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhh------------------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC
Q 043852          351 NRLFIFLELVTKGSLANLYQK------------------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA  412 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~------------------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~  412 (551)
                      ...|++|||+.+++|.+++..                  ..+++..+..++.||+.||.|||++||+|+||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            999999999999999998742                  23677888899999999999999999999999999999999


Q ss_pred             CCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 043852          413 SGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALF  487 (551)
Q Consensus       413 ~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~  487 (551)
                      ++.+||+|||+++......    .....++..|+|||++  .+..++.++|||||||++|||++ |..||.+........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI--MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHh--ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999997653322    2233456779999987  34568999999999999999998 999998776666666


Q ss_pred             HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          488 RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       488 ~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+........+..++..+.+++.+||+.||.+||++.+|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            666666666677899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-39  Score=332.67  Aligned_cols=261  Identities=36%  Similarity=0.635  Sum_probs=218.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..+|.+.+.||+|+||.||++.+ .++..||+|.+.....     .....+.+|+.++++++||||+++++.+......|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            35899999999999999999986 5788999998853221     22345778999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--c
Q 043852          355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V  432 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~  432 (551)
                      +|+||+.+++|..++.+..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......  .
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999876543322  2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFIL  510 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~LI~  510 (551)
                      ....|++.|++||++.  ...++.++|+|||||++|+|++|+.||...........+.....+.  .+..++..+.++|.
T Consensus       173 ~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         173 STMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccccCChhhcCchhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            3345888999999873  4567899999999999999999999998766554444333322222  23457888999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCccccCCCCC
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP  543 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~~~~~~~~~  543 (551)
                      +||..+|++||++.+++.|+||+.....++-+|
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~  283 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP  283 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence            999999999999999999999997776555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-39  Score=327.47  Aligned_cols=252  Identities=29%  Similarity=0.428  Sum_probs=203.9

Q ss_pred             EeccCCceEEEEEEe-cCCceEEEEEEecCccCccch-HHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccc
Q 043852          284 LLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGK-QSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVT  361 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  361 (551)
                      +||+|+||.||++.+ .+++.||+|.+.......... .........+.++....|+||+.+++.+.....+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999987 578999999987543222111 112222233445566789999999999999999999999999


Q ss_pred             ccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCCCCCc
Q 043852          362 KGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF  440 (551)
Q Consensus       362 ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~  440 (551)
                      |++|..++.+ ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++............|+..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence            9999887754 458999999999999999999999999999999999999999999999999987654444445679999


Q ss_pred             ccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--hHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCC
Q 043852          441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--GMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN  518 (551)
Q Consensus       441 Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~  518 (551)
                      |+|||++. .+..++.++||||+||++|+|++|+.||....  ................+..++..+.+++.+||..+|.
T Consensus       161 y~aPE~~~-~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  239 (278)
T cd05606         161 YMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN  239 (278)
T ss_pred             CcCcHHhc-CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence            99999973 34467899999999999999999999997652  2222223333334555667899999999999999999


Q ss_pred             CCC-----CHHHHHhCcccCCcc
Q 043852          519 DRP-----TAAQLMEHPFVKRPL  536 (551)
Q Consensus       519 ~RP-----S~~eILehpff~~~~  536 (551)
                      +||     ++.++++||||+...
T Consensus       240 ~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         240 RRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hccCCCCCCHHHHHhCccccCCC
Confidence            999     999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-39  Score=327.73  Aligned_cols=250  Identities=32%  Similarity=0.543  Sum_probs=204.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|+.++.||.|+||.||+|++ .+|..||||.+.......   .....+.+|+.++++++|+||+++++++.+....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc---ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            478899999999999999987 578999999886543222   2234677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--C
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~  431 (551)
                      |||+. ++|..++..   ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......  .
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99996 578777653   45788999999999999999999999999999999999999999999999998754322  2


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-----------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-----------------  494 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-----------------  494 (551)
                      .....+++.|+|||++. ....++.++|||||||++|+|+||+.||...+......++.....                 
T Consensus       157 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         157 YTHEVVTLWYRAPEILL-GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             cccccccccccCCeEEe-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            23334788999999863 334468899999999999999999999977665444433221100                 


Q ss_pred             -----------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 -----------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 -----------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                 ......++..++++|.+||+.||.+|||+++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                       00113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.7e-39  Score=317.79  Aligned_cols=250  Identities=32%  Similarity=0.632  Sum_probs=218.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|.+.+.||.|+||.||++.+ .++..|++|++......   ......+.+|+.+++.++|+|++++++.+......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC---hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            488899999999999999987 57999999998654322   34455677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          357 LELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +||+++++|.+++..     ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999998865     458899999999999999999999999999999999999999999999999987654332


Q ss_pred             --cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                        .....|++.|+|||.+  ....++.++|+||||+++|+|++|..||....................+..++..+.+++
T Consensus       158 ~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (258)
T cd08215         158 DLAKTVVGTPYYLSPELC--QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV  235 (258)
T ss_pred             ceecceeeeecccChhHh--ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence              2334588999999986  345678999999999999999999999988776666666667667777778999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCccc
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .+||+.+|++|||+.++++||||
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.2e-39  Score=338.16  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=206.6

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC---
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE---  350 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---  350 (551)
                      ...+|++.+.||+|+||.||+|.+ .+|..||||++.....   .......+.+|+.+++.++|+||+++++++...   
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            345899999999999999999987 5899999998753321   223345667899999999999999999987543   


Q ss_pred             ---CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          351 ---NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       351 ---~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                         ...|+||||+.+ +|...+... ++...+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          91 EEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence               357999999965 777776554 888999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC------------
Q 043852          428 TMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP------------  494 (551)
Q Consensus       428 ~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~------------  494 (551)
                      .... .....+|+.|+|||++  .+..++.++|||||||++|+|++|+.||...+....+..+.....            
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCCCCCCCcccccccCHHHH--hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            4332 2344588999999997  456789999999999999999999999976654433332211000            


Q ss_pred             ---------C-----C----------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 ---------P-----L----------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 ---------~-----~----------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                               +     .                .+...+..+.+||.+||+.||.+|||+.++|+||||+......
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~  321 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS  321 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence                     0     0                0113466789999999999999999999999999998655543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=321.42  Aligned_cols=253  Identities=44%  Similarity=0.819  Sum_probs=213.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--CeE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--NRL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~  353 (551)
                      .+|.+.+.||+|+||.||+|.+ .++..||+|++...............+.+|+.++++++|+||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3789999999999999999987 5799999998865433333345567888999999999999999999987653  568


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      +++|||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            899999999999988765 45888899999999999999999999999999999999999999999999998754321  


Q ss_pred             ---CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc-CCCCCCCCcCCHHHH
Q 043852          431 ---DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDAR  506 (551)
Q Consensus       431 ---~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~  506 (551)
                         ......++..|+|||++.  +..++.++|+|||||++|+|++|+.||..........++.. ...+.++..++..+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  239 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVIS--GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR  239 (264)
T ss_pred             cCccccccCCcccccCHhhhc--CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence               122345889999999873  45678999999999999999999999987766665555443 344567888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      +++.+||+ +|.+||++.+++.|||+
T Consensus       240 ~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         240 DFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-39  Score=331.92  Aligned_cols=242  Identities=29%  Similarity=0.478  Sum_probs=186.5

Q ss_pred             eeEeccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc--CCCeEEEE
Q 043852          282 GELLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK--DENRLFIF  356 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV  356 (551)
                      +.+||+|+||.||+|...   ++..||+|.+.....       ...+.+|+.++++++|+||+++++++.  ....+|++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            468999999999999853   567899998753211       224668999999999999999999874  45678999


Q ss_pred             EecccccchHHHHhh----------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE----cCCCcEEEEecC
Q 043852          357 LELVTKGSLANLYQK----------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV----DASGSVKLADFG  422 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~----------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl----~~~g~vkL~DFG  422 (551)
                      |||+.+ +|.+++..          ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            999976 66665531          137788899999999999999999999999999999999    456789999999


Q ss_pred             CccccccC-----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH---------HHHHH
Q 043852          423 LAKATTMN-----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---------QALFR  488 (551)
Q Consensus       423 la~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~---------~~~~~  488 (551)
                      +++.....     ......||+.|+|||++. ....++.++|||||||++|||+||++||......         ..+.+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhc-CCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            99755322     223456899999999873 3346799999999999999999999999643211         00000


Q ss_pred             hhc--C------------CC-----------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          489 IGK--G------------EP-----------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       489 i~~--~------------~~-----------------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      +..  +            .+                       .......+..+.+||.+||+.||.+|||++|+|+|||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            000  0            00                       0001123567889999999999999999999999999


Q ss_pred             c
Q 043852          532 V  532 (551)
Q Consensus       532 f  532 (551)
                      |
T Consensus       317 f  317 (317)
T cd07867         317 F  317 (317)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.8e-39  Score=315.10  Aligned_cols=247  Identities=42%  Similarity=0.774  Sum_probs=212.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|...+.||+|++|.||++.+ .++..+++|++.....     .....+.+|+.++.+++|+||+++++++......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            478889999999999999987 4789999999864332     3456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-cc
Q 043852          357 LELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VK  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-~~  433 (551)
                      +||+.+++|.+++...  .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            9999999999988765  68999999999999999999999999999999999999999999999999987665433 34


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCc--CCHHHHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS--LSRDARDFILK  511 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~s~~l~~LI~~  511 (551)
                      ...++..|++||.+.  ...++.++||||||+++|+|++|..||...+.......+.....+..+..  ++..+.++|.+
T Consensus       156 ~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         156 TMVGTPYWMAPEVIN--GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             ceecCCcccCHHHHc--CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            556889999999974  34578899999999999999999999987755555555444433343333  38999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcc
Q 043852          512 CLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpf  531 (551)
                      ||+.||++|||+.++++|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.9e-39  Score=320.14  Aligned_cols=250  Identities=32%  Similarity=0.620  Sum_probs=214.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|.+.+.||+|+||.||+|.. .+|..+|+|.+.......   .....+.+|+.+++.++|+||+++++.+.+....|++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            478899999999999999987 578899999986542221   2234567899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCccccccCC-
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND-  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~~~-  431 (551)
                      +||+.+++|.+++.+.   .+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||.+....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999999988653   368889999999999999999999999999999999998886 46999999987654332 


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                       ...+.|++.|+|||++  ....++.++|+||||+++|+|++|..||...+.......+..+........++..+.++|.
T Consensus       158 ~~~~~~~~~~~~ape~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 LAYTCVGTPYYLSPEIC--QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS  235 (257)
T ss_pred             cccccCCCccccCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence             2234589999999986  3456789999999999999999999999877766666666666666666778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCccc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff  532 (551)
                      +||+.+|++|||+.+++.||||
T Consensus       236 ~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         236 QLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.4e-39  Score=329.67  Aligned_cols=253  Identities=29%  Similarity=0.438  Sum_probs=211.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||++.+ .++..||+|.+.....  ........+.+|+.++..++|+||+++++.+.....+|++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            688999999999999999987 5788999998864321  1223345677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----  431 (551)
                      |||+.|++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++......    
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            999999999998865 457888899999999999999999999999999999999999999999999986321110    


Q ss_pred             -------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC--CC
Q 043852          432 -------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PL  496 (551)
Q Consensus       432 -------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~  496 (551)
                                   .....++..|+|||.+  ....++.++|+|||||++|+|++|..||.+....+....+..+..  +.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                         1123478889999986  456789999999999999999999999987766665655554432  22


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccCC
Q 043852          497 VPNSLSRDARDFILKCLQVNPNDRPT---AAQLMEHPFVKR  534 (551)
Q Consensus       497 ~~~~~s~~l~~LI~~cL~~DP~~RPS---~~eILehpff~~  534 (551)
                      ....++..+.++|.+||++||++||+   +.++++||||..
T Consensus       238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            23368899999999999999999998   799999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.7e-39  Score=322.44  Aligned_cols=246  Identities=29%  Similarity=0.481  Sum_probs=209.8

Q ss_pred             eccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      ||.|+||.||++.+ .++..||+|++.....  ........+.+|+.++..++|+||+++++.+.++..+|++|||+.++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            79999999999987 4689999999864332  12234467889999999999999999999999999999999999999


Q ss_pred             chHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-CcccCCCCCcc
Q 043852          364 SLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTPFW  441 (551)
Q Consensus       364 sL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~~~~~GT~~Y  441 (551)
                      +|.+++.+. .++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ......+++.|
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence            999988764 5788999999999999999999999999999999999999999999999998766443 22334688999


Q ss_pred             cChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--hHHHHHHhhc-CCCCCCCCcCCHHHHHHHHHhhhcCCC
Q 043852          442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--GMQALFRIGK-GEPPLVPNSLSRDARDFILKCLQVNPN  518 (551)
Q Consensus       442 ~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--~~~~~~~i~~-~~~~~~~~~~s~~l~~LI~~cL~~DP~  518 (551)
                      ++||.+  ....++.++|+||||+++|+|++|..||....  .......+.. ......+..++..+.++|.+||+.+|+
T Consensus       159 ~~PE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  236 (262)
T cd05572         159 VAPEII--LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE  236 (262)
T ss_pred             cChhHh--cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence            999986  34567899999999999999999999997766  4444554443 334555666799999999999999999


Q ss_pred             CCCC-----HHHHHhCcccCC
Q 043852          519 DRPT-----AAQLMEHPFVKR  534 (551)
Q Consensus       519 ~RPS-----~~eILehpff~~  534 (551)
                      +||+     ++++++||||+.
T Consensus       237 ~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         237 ERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             hCcCCcccCHHHHhcChhhhC
Confidence            9999     999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.4e-39  Score=318.25  Aligned_cols=250  Identities=36%  Similarity=0.594  Sum_probs=218.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||++.+ .+++.+|+|++......   ......+.+|+.+++.++|+||+++++++.+....|++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            478899999999999999987 57899999998654322   23445677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          357 LELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |||+++++|..++.+     ..+++..++.++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999988765     457888999999999999999999999999999999999999999999999997765544


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....+++.|++||.+  ....++.++|+||||+++|+|++|+.||...+.......+..+..+..+..++.++.+++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~--~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08530         158 AKTQIGTPHYMAPEVW--KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS  235 (256)
T ss_pred             cccccCCccccCHHHH--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHH
Confidence            4445688999999997  45567889999999999999999999998877766666666666666677889999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff  532 (551)
                      ||+.+|++|||+.++++||++
T Consensus       236 ~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         236 MLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-39  Score=318.92  Aligned_cols=241  Identities=30%  Similarity=0.520  Sum_probs=210.6

Q ss_pred             eEeccCCceEEEEEEec-C---CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          283 ELLGSGSFGTVYEGYTD-D---GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~-~---g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      +.||+|+||.||+|.+. .   +..|++|.+......    .....+.+|+.++..++|+||+++++++.+...++++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            46999999999999874 3   889999988643221    145678899999999999999999999999999999999


Q ss_pred             cccccchHHHHhh----------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          359 LVTKGSLANLYQK----------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       359 y~~ggsL~~ll~~----------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      |+.+++|.++++.          ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999999875          458999999999999999999999999999999999999999999999999997665


Q ss_pred             cCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCH
Q 043852          429 MND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       429 ~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  503 (551)
                      ...    .....++..|+|||.+.  ...++.++|||||||++|+|++ |..||......+....+..+.....+..++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLK--DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD  234 (262)
T ss_pred             cccccccccCCCcCccccCHHHhc--cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence            432    33445788999999873  3478999999999999999998 6999998887777777777777777788899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+.+++.+||+.+|.+|||+.+++++
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-39  Score=344.52  Aligned_cols=247  Identities=27%  Similarity=0.453  Sum_probs=202.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  349 (551)
                      .+|++++.||+|+||.||+|+.      .++..||||++.....    ......+.+|+.++..+ +||||+++++++.+
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            4799999999999999999863      3567899998853221    22345677899999999 89999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhhh---------------------------------------------------------
Q 043852          350 ENRLFIFLELVTKGSLANLYQKY---------------------------------------------------------  372 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~---------------------------------------------------------  372 (551)
                      ....|+|||||.+|+|.+++...                                                         
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            99999999999999999887532                                                         


Q ss_pred             -------------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-
Q 043852          373 -------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-  432 (551)
Q Consensus       373 -------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-  432 (551)
                                         .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                               256778889999999999999999999999999999999999999999999875543221 


Q ss_pred             ---ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHH-HHhhcCCCCCCCCcCCHHHHH
Q 043852          433 ---KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQAL-FRIGKGEPPLVPNSLSRDARD  507 (551)
Q Consensus       433 ---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~l~~  507 (551)
                         ....++..|+|||++  ....++.++|||||||++|||++ |..||........+ ..+..+.....+...+.++.+
T Consensus       271 ~~~~~~~~~~~y~aPE~~--~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  348 (375)
T cd05104         271 VVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD  348 (375)
T ss_pred             cccCCCCCCcceeChhHh--cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence               122345679999997  45578999999999999999997 89999766543333 334444444555667899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ||.+||+.||++|||+.+|++.
T Consensus       349 li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         349 IMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-39  Score=345.02  Aligned_cols=247  Identities=26%  Similarity=0.477  Sum_probs=202.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeecc
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDK  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  348 (551)
                      .++|++++.||+|+||.||+|++      .++..||||.+.....    ......+.+|+.++..+ +|+||+++++++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            44799999999999999999874      2345799998864321    22345677999999999 8999999999999


Q ss_pred             CCCeEEEEEecccccchHHHHhhh--------------------------------------------------------
Q 043852          349 DENRLFIFLELVTKGSLANLYQKY--------------------------------------------------------  372 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~--------------------------------------------------------  372 (551)
                      ....+|+|||||.+|+|.+++.+.                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999887532                                                        


Q ss_pred             ---------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc----c
Q 043852          373 ---------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----K  433 (551)
Q Consensus       373 ---------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~----~  433 (551)
                                     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......    .
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                           356778899999999999999999999999999999999999999999999875433221    1


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHh-hcCCCCCCCCcCCHHHHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRI-GKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      ...++..|+|||++  ....++.++|||||||++|+|++ |+.||...........+ ..+.....+..++.++.+++.+
T Consensus       273 ~~~~~~~y~aPE~~--~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         273 NARLPVKWMAPESI--FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             CCCCccceeCHHHh--cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHH
Confidence            22345679999997  45678999999999999999997 99999776544433333 3333444556689999999999


Q ss_pred             hhhcCCCCCCCHHHHHh
Q 043852          512 CLQVNPNDRPTAAQLME  528 (551)
Q Consensus       512 cL~~DP~~RPS~~eILe  528 (551)
                      ||+.||.+|||+.+|++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.5e-39  Score=315.01  Aligned_cols=250  Identities=54%  Similarity=0.967  Sum_probs=214.6

Q ss_pred             CeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--CeEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--NRLF  354 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~  354 (551)
                      +|.+.+.||+|++|.||+|.+. ++..+++|++......   ......+.+|+.++++++|+||+++++.+.+.  ..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            4788899999999999999874 7999999998654322   34566788999999999999999999999888  8899


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      +++||+.+++|.+++... .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            999999999999988765 68899999999999999999999999999999999999999999999999987665443  


Q ss_pred             --cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHhhc-CCCCCCCCcCCHHHHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRIGK-GEPPLVPNSLSRDARD  507 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i~~-~~~~~~~~~~s~~l~~  507 (551)
                        .....++..|++||.+  ....++.++||||||+++|+|++|..||.... .......+.. .....++..++..+.+
T Consensus       158 ~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVI--RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             ccccCCCCCccccCHhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence              3445688999999987  33457999999999999999999999997765 3333333332 3445567778999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      +|.+||+.||.+||++.+++.||||
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-39  Score=351.79  Aligned_cols=244  Identities=25%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..|.+.+.||+|+||.||++.+ .++..||||....           ..+.+|+.++++++|+|||++++++...+..|+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            3799999999999999999987 5688999995421           134589999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      +||++. ++|..++..  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||+++......  
T Consensus       238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            999996 577776654  358899999999999999999999999999999999999999999999999987543221  


Q ss_pred             --cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch-------hHHHHHHh-hcCCC--CCC--
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-------GMQALFRI-GKGEP--PLV--  497 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-------~~~~~~~i-~~~~~--~~~--  497 (551)
                        .....||+.|+|||++  .+..++.++|||||||+||||++|..++....       ....+.++ .....  ...  
T Consensus       317 ~~~~~~~GT~~Y~APE~~--~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVL--AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccCCCcCCcCHHHH--cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence              1234699999999997  45678999999999999999999876542211       01111111 11000  000  


Q ss_pred             -----------------------------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          498 -----------------------------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       498 -----------------------------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                                                   ...++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                         0134568899999999999999999999999999974

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-39  Score=325.66  Aligned_cols=251  Identities=30%  Similarity=0.507  Sum_probs=200.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++.+.||+|+||.||+|.+ .++..||||.+........    ...+.+|+.++++++|+||+++++++.+....|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA----PFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC----chhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            46899999999999999999987 4789999999875432211    123558999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      +||||+.+ +|.+++.+  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++...... 
T Consensus        80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            99999985 88887764  357889999999999999999999999999999999999999999999999986543221 


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHhhcCC----C-----------
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRIGKGE----P-----------  494 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i~~~~----~-----------  494 (551)
                       .....++..|+|||++. ....++.++|||||||++|+|++|+.||.... ..+.+..+....    .           
T Consensus       159 ~~~~~~~~~~~~aPE~~~-~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLL-GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             cccccccccccCCcHHhh-cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             22234688899999873 33457889999999999999999999996654 222221111100    0           


Q ss_pred             ------CC--------CCCcCC--HHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 ------PL--------VPNSLS--RDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ------~~--------~~~~~s--~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                            ..        ....++  ..+.+++.+||+++|.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                  00        001234  788899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.8e-39  Score=327.14  Aligned_cols=244  Identities=27%  Similarity=0.481  Sum_probs=208.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +|.+.+.||+|+||.||++..      .++..+|+|.+...     .......+.+|+.++.+++|+||+++++++....
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            788999999999999999974      23566889977532     2334556889999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh--------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEE
Q 043852          352 RLFIFLELVTKGSLANLYQKY--------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVK  417 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~--------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vk  417 (551)
                      .++++|||+.+++|.+++...              .+++..+..++.||+.||.|||++|++||||||+|||++.++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            999999999999999988643              378899999999999999999999999999999999999999999


Q ss_pred             EEecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcC
Q 043852          418 LADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG  492 (551)
Q Consensus       418 L~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~  492 (551)
                      |+|||+++.......    ....++..|+|||++  ....++.++|||||||++|+|++ |.+||...........+..+
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999875432221    223357789999987  34578999999999999999998 99999887777777777777


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       493 ~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .....+..++..+.+|+.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            766667788999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-39  Score=315.87  Aligned_cols=250  Identities=46%  Similarity=0.840  Sum_probs=218.8

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|.+.+.||+|++|.||++.+ .+++.|++|.+......   ......+.+|+.++.+++|+||+++++++.+...++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            478899999999999999987 47889999998754322   34556788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc--c
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--K  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~--~  433 (551)
                      |||+.+++|.+++.. ..+++..++.++.|++.+|.|||++||+|+||+|+||+++.++.++|+|||++........  .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            999999999998865 4688999999999999999999999999999999999999999999999999876544332  3


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhh
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      ...++..|+|||.+.  ...++.++||||||+++|+|++|..||...........+........+..++..+.+++.+||
T Consensus       158 ~~~~~~~y~~pe~~~--~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (254)
T cd06627         158 SVVGTPYWMAPEVIE--MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF  235 (254)
T ss_pred             ccccchhhcCHhhhc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence            456889999999874  344789999999999999999999999877776666666666666677789999999999999


Q ss_pred             hcCCCCCCCHHHHHhCccc
Q 043852          514 QVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff  532 (551)
                      +.+|++|||+.+++.||||
T Consensus       236 ~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         236 QKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hCChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-39  Score=329.48  Aligned_cols=252  Identities=26%  Similarity=0.482  Sum_probs=205.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--Ce
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--NR  352 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~  352 (551)
                      +++|++.+.||+|+||.||+|.+ .++..+|+|.+......   ......+.+|+.++.+++||||+++++++...  ..
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence            45788999999999999999987 47899999998754332   12233556899999999999999999988766  88


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .|++|||+.+ +|.+++...  .+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            9999999975 888877643  4889999999999999999999999999999999999999999999999998765443


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC--------------
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--------------  494 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~--------------  494 (551)
                        ......+++.|+|||.+. ....++.++|+|||||++|+|++|.+||..........++.....              
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 LKPYTQLVVTLWYRAPELLL-GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             ccccccccccccccCchhhc-CCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence              233345788999999873 333468899999999999999999999987665554433321100              


Q ss_pred             ----------------CCCCCc-CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 ----------------PLVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ----------------~~~~~~-~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                      ..++.. ++..+.+||.+||+.||++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                            111222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.2e-39  Score=326.14  Aligned_cols=253  Identities=26%  Similarity=0.435  Sum_probs=208.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+....    .......+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            347999999999999999998642      35579999875322    12233456789999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhhhc-----------CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEE
Q 043852          350 ENRLFIFLELVTKGSLANLYQKYH-----------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKL  418 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~~-----------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL  418 (551)
                      ....|++|||+.+|+|.+++.+..           +....+..++.||+.||.|||+++|+||||||+|||++.++.++|
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999999986421           345678889999999999999999999999999999999999999


Q ss_pred             EecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCC
Q 043852          419 ADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGE  493 (551)
Q Consensus       419 ~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~  493 (551)
                      +|||+++.......    ....++..|+|||.+  ....++.++|||||||++|||++ |..||.+....+....+..+.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHh--ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999875432221    122356779999987  34567899999999999999998 789998877666666666665


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh------CcccCC
Q 043852          494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME------HPFVKR  534 (551)
Q Consensus       494 ~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe------hpff~~  534 (551)
                      ....+..++..+.+++.+||+.||++|||+.++++      ||||+.
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            55566778899999999999999999999999987      777764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-39  Score=323.54  Aligned_cols=246  Identities=29%  Similarity=0.475  Sum_probs=212.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..+|++++.||.|+||.||+|.+.++..+|+|++....     ......+..|+.++..++|+||+++++++.+...+++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            34788999999999999999998779999999886432     2234467789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          356 FLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      +|||+.+++|.+++.+   ..++...+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... 
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999999865   347888999999999999999999999999999999999999999999999987553221 


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                       .....++..|++||.+  ....++.++||||||+++|+|++ |+.||......+.+..+..+.....+..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~PE~~--~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         160 LSSDKKIPYKWTAPEAA--SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             cccCCCCceEecCHHHH--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence             1223356789999987  34568899999999999999998 8999988777777777777666666778999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 043852          510 LKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||+.||.+|||+.+|++
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         238 LECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-39  Score=326.16  Aligned_cols=243  Identities=28%  Similarity=0.508  Sum_probs=203.2

Q ss_pred             eeeeEeccCCceEEEEEEec-----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          280 QKGELLGSGSFGTVYEGYTD-----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .+.+.||.|+||.||+|...     .+..|+||.+..    .........+.+|+.++.+++||||+++++++.....++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence            45789999999999999765     467899998843    222344678889999999999999999999999888899


Q ss_pred             EEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          355 IFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|||||.+|+|.+++...   .++...+..++.||+.||.|||+++++|++|++.|||++.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999998775   68899999999999999999999999999999999999999999999999987652221


Q ss_pred             ----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          432 ----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       432 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                          .....+...|+|||++.  ...++.++||||||+++|||++ |+.||......+...++..+.....+..++..+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLK--DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIY  235 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHH--HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred             ccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHH
Confidence                12234667899999974  3458999999999999999999 7899998888887888888877777888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHh
Q 043852          507 DFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ++|.+||+.||++|||+.+|++
T Consensus       236 ~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  236 SLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.6e-39  Score=326.31  Aligned_cols=251  Identities=29%  Similarity=0.484  Sum_probs=202.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCe---
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENR---  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~---  352 (551)
                      +|++.+.||+|+||.||+|.+ .+|..||||++.......   .....+.+|+.++..+. |+||+++++++.....   
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE---GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc---CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            688999999999999999987 579999999876543221   12345678999999995 6999999998876655   


Q ss_pred             --EEEEEecccccchHHHHhh------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEecCC
Q 043852          353 --LFIFLELVTKGSLANLYQK------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGL  423 (551)
Q Consensus       353 --~~lV~Ey~~ggsL~~ll~~------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~DFGl  423 (551)
                        .|++|||+.+ +|..++..      ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|||+
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence              8999999986 77776643      24788999999999999999999999999999999999998 88999999999


Q ss_pred             ccccccC--CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-------
Q 043852          424 AKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-------  494 (551)
Q Consensus       424 a~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-------  494 (551)
                      +......  ......+++.|+|||++. ....++.++||||||+++|+|++|..||.+.+....+.++.....       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLL-GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhh-CCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            8754322  223335788999999873 344578999999999999999999999987766655544322100       


Q ss_pred             ------------C--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          495 ------------P--------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       495 ------------~--------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                                  +        .....++..+.+||.+||++||.+|||+.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                        0        00134788899999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.7e-39  Score=318.92  Aligned_cols=240  Identities=25%  Similarity=0.461  Sum_probs=201.9

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVT  361 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~  361 (551)
                      +.||+|+||.||+|++ .++..||+|.+...    ........+.+|+.++++++|+||+++++++.....+|+||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            3699999999999987 57999999987532    123344567899999999999999999999999999999999999


Q ss_pred             ccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccC----
Q 043852          362 KGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC----  435 (551)
Q Consensus       362 ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~----  435 (551)
                      +++|.+++...  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...........    
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99999988653  478889999999999999999999999999999999999999999999999875432221111    


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhh
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ  514 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~  514 (551)
                      .++..|+|||.++  ...++.++|||||||++|+|++ |..||...........+........+..++..+.+|+.+||+
T Consensus       157 ~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         157 QIPVKWTAPEALN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCceeecCchhhc--CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence            1245699999873  4567899999999999999997 999998776666666666665666677889999999999999


Q ss_pred             cCCCCCCCHHHHHh
Q 043852          515 VNPNDRPTAAQLME  528 (551)
Q Consensus       515 ~DP~~RPS~~eILe  528 (551)
                      .+|++|||+.++++
T Consensus       235 ~~p~~Rps~~~~~~  248 (252)
T cd05084         235 YDPGQRPSFSTVHQ  248 (252)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.4e-39  Score=323.68  Aligned_cols=249  Identities=32%  Similarity=0.540  Sum_probs=204.1

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||.|++|.||+|.+ .+|..||||++.......    ....+.+|+.++++++|+||+++++.+.+....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG----TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc----chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            488999999999999999988 479999999987543221    233456899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          357 LELVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      |||+.+ +|.+++..    ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......  
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            999986 78777654    24889999999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC----------------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----------------  494 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~----------------  494 (551)
                      ......+|..|++||++. ....++.++|||||||++|+|++|+.||.+.+..+...++.....                
T Consensus       156 ~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLL-GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            223345788999999873 334578899999999999999999999987665544333221100                


Q ss_pred             -CC-----------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 -PL-----------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 -~~-----------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                       ..           ....++..+.+++.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence             00           112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.2e-39  Score=323.74  Aligned_cols=247  Identities=28%  Similarity=0.471  Sum_probs=198.4

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCC--CeEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDE--NRLF  354 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~  354 (551)
                      |++.+.||+|+||.||+|.+ .++..||+|++........    .....+|+.++.++. |+||+++++++.+.  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            67789999999999999987 5789999998864322111    123346888888885 99999999999887  8899


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      +||||+.+ +|.+.+..  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. +.+||+|||+++...... 
T Consensus        77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            99999975 66666654  35889999999999999999999999999999999999999 999999999987654322 


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--C---------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--P---------------  494 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~---------------  494 (551)
                      .....++..|+|||++. ....++.++|||||||++|||++|.+||...+..+....+....  +               
T Consensus       155 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         155 YTEYISTRWYRAPECLL-TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             cCCCCCCcccCChhHhh-cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            23445889999999863 34457889999999999999999999998766544433322100  0               


Q ss_pred             CC-----------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 PL-----------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ~~-----------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      ..           ....++..+.+||.+||+++|++|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00           012468899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.7e-39  Score=330.75  Aligned_cols=252  Identities=35%  Similarity=0.610  Sum_probs=212.9

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |.....||+|+||.||++.+ .++..||+|++.....     .....+.+|+.++..+.||||+++++.+......|++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            33445799999999999987 5789999999864322     12345778999999999999999999999999999999


Q ss_pred             ecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccC
Q 043852          358 ELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSC  435 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~  435 (551)
                      ||+++++|..++....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......  .....
T Consensus        98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            9999999999888878999999999999999999999999999999999999999999999999998654322  22345


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC--CCCCcCCHHHHHHHHHhh
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLSRDARDFILKCL  513 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~LI~~cL  513 (551)
                      .|+..|+|||++  ....++.++|||||||++|+|++|+.||...........+......  .....++..+.++|.+||
T Consensus       178 ~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l  255 (297)
T cd06659         178 VGTPYWMAPEVI--SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML  255 (297)
T ss_pred             ecCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence            689999999997  3456789999999999999999999999877666666555443222  223457889999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCccc
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +.+|++||++.++++||||.+...
T Consensus       256 ~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         256 TREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             cCCcccCcCHHHHhhChhhccCCC
Confidence            999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.2e-39  Score=323.17  Aligned_cols=247  Identities=24%  Similarity=0.426  Sum_probs=206.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ++|++.+.||+|+||.||+|.+.      ++..||||++....    .......+.+|+.+++.++|+||+++++++.+.
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            47999999999999999998642      35679999874321    122345678999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh-----------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEE
Q 043852          351 NRLFIFLELVTKGSLANLYQKY-----------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA  419 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~-----------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~  419 (551)
                      ...+++|||+.+++|.+++.+.           .++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            9999999999999999988642           24566788999999999999999999999999999999999999999


Q ss_pred             ecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC
Q 043852          420 DFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP  494 (551)
Q Consensus       420 DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~  494 (551)
                      |||+++.......    ....+++.|+|||++.  ...++.++|||||||++|||++ |..||.+.........+..+..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhh--cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            9999875432221    1233577899999973  4568999999999999999998 7899988777666666666666


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       495 ~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...+..++..+.+++.+||+.||++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            66677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=331.65  Aligned_cols=271  Identities=25%  Similarity=0.429  Sum_probs=230.0

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|..+++||+|.||.|-+++. .+++.||+|++++..  ...+.....-+.|-++|...+||.+..|-..|+....
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev--iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV--IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh--eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            4577999999999999999999986 589999999886543  3334455566788999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--c
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--M  429 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--~  429 (551)
                      +|+||||..||.|+..+.+ ..+++...+.|-..|+.||.|||+++||+||||.+|.|++.+|++||+||||++...  .
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            9999999999999877765 468999999999999999999999999999999999999999999999999998542  3


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ..+.+.||||.|+|||++  ....|+.++|+|.+|+++|||++|++||...+.......|.... ..+|..++++++.|+
T Consensus       323 ~t~kTFCGTPEYLAPEVl--eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-~kFPr~ls~eAktLL  399 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVL--EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-LKFPRTLSPEAKTLL  399 (516)
T ss_pred             ceeccccCChhhcCchhh--ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-ccCCccCCHHHHHHH
Confidence            456788999999999997  56789999999999999999999999998876655544444443 456889999999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHhCcccCCcc----ccCCCCCCCCCCC
Q 043852          510 LKCLQVNPNDRP-----TAAQLMEHPFVKRPL----QKSRGPPSYYNNM  549 (551)
Q Consensus       510 ~~cL~~DP~~RP-----S~~eILehpff~~~~----~~~~~~~~~~~~~  549 (551)
                      ..+|.+||.+|.     .+.+|..|+||...-    -+...+|+|--++
T Consensus       400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV  448 (516)
T KOG0690|consen  400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV  448 (516)
T ss_pred             HHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence            999999999995     489999999998543    2334455554444

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9e-39  Score=319.20  Aligned_cols=248  Identities=29%  Similarity=0.525  Sum_probs=206.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|++.+.||+|+||.||+|++ .++..||||.+.....  ........+.+|+.+++.++||||+++++++.+....++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM--MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            5799999999999999999987 5889999998864322  223445667899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          356 FLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|||+.+++|.+++..     ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999999887742     33788899999999999999999999999999999999999999999999998765432


Q ss_pred             C--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--hHHHHHHhhcCCCCCC-CCcCCHHH
Q 043852          431 D--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--GMQALFRIGKGEPPLV-PNSLSRDA  505 (551)
Q Consensus       431 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--~~~~~~~i~~~~~~~~-~~~~s~~l  505 (551)
                      .  .....|++.|+|||.+  ....++.++|+||||+++|+|++|..||....  .......+.....+.. ...++..+
T Consensus       160 ~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             hHHHhcCCCCccccChhhh--ccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            2  2234588899999987  34567889999999999999999999985432  2333344444333332 34678899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .++|.+||+.+|++||++.+|++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHH
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.9e-39  Score=326.57  Aligned_cols=255  Identities=29%  Similarity=0.503  Sum_probs=200.8

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      ...+++|++.+.||+|+||.||+|.+ .++..||||.+.......   .....+.+|+.++++++||||+++++++....
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            34566899999999999999999987 579999999986543222   12234557999999999999999999875543


Q ss_pred             --------eEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          352 --------RLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       352 --------~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                              ..|++|||+.+ +|..++...  .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence                    45999999975 777766544  5889999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCC------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc---C
Q 043852          422 GLAKATTMND------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK---G  492 (551)
Q Consensus       422 Gla~~~~~~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~---~  492 (551)
                      |++.......      .....++..|+|||++. ....++.++||||||+++|+|++|.+||...+.......+..   .
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL-GERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhc-CCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9987543322      12234678899999873 334468899999999999999999999977655433222111   0


Q ss_pred             CCCC---------------C-------------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          493 EPPL---------------V-------------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       493 ~~~~---------------~-------------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .++.               .             +...+..+.+||.+||+.||.+|||++++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            0000               0             11235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=324.18  Aligned_cols=251  Identities=30%  Similarity=0.559  Sum_probs=207.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++.+.||+|+||.||+|.+ .+++.||+|++.....   .......+.+|+.++++++|+||+++++++.+....+++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            689999999999999999987 4789999998864322   223345678999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---c
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---V  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---~  432 (551)
                      |||+.++.+..+..+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            999998777766654 458899999999999999999999999999999999999999999999999987654332   2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-------------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-------------------  493 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-------------------  493 (551)
                      ....++..|+|||++. ....++.++||||||+++|+|++|++||......+.+..+....                   
T Consensus       159 ~~~~~~~~~~~PE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         159 TDYVATRWYRAPELLV-GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             cCcccccCCcCCchhc-CCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            3456788999999974 23377899999999999999999999998765554443322100                   


Q ss_pred             ---C---------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          494 ---P---------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       494 ---~---------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                         +         ...+..++..+.+||.+||+.+|++|||+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence               0         01123358899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.8e-39  Score=330.64  Aligned_cols=246  Identities=28%  Similarity=0.477  Sum_probs=203.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCc----eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGF----FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|++.+.||+|+||.||+|.+ .++.    .||+|++...    ........+.+|+.++..++|+||+++++++... 
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            3799999999999999999976 3444    3888887532    2233445678899999999999999999998765 


Q ss_pred             eEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..++++||+.+|+|.+++...  .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            568999999999999988754  477888999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 NDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ...    ....++..|+|||++  ....++.++|||||||++|||++ |..||.+....+....+..+.....+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             CCcceeccCCccceeecChHHh--ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            221    122246679999987  45678999999999999999997 99999876655544444555555556778999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+++.+||..+|.+|||+.+++.+
T Consensus       240 ~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.6e-39  Score=322.45  Aligned_cols=247  Identities=28%  Similarity=0.458  Sum_probs=205.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ++|.+.+.||+|+||.||+|.+.      .+..||+|.+...    ........+.+|+.+++.++|+||+++++++.+.
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            47899999999999999999873      4678889976432    1123345678899999999999999999999988


Q ss_pred             CeEEEEEecccccchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC---cEEEE
Q 043852          351 NRLFIFLELVTKGSLANLYQKY--------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLA  419 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~--------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g---~vkL~  419 (551)
                      ...+++|||+.+++|.+++...        .+++..+..++.||+.||.|||+++++|+||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            8999999999999999988654        377888999999999999999999999999999999998765   59999


Q ss_pred             ecCCccccccCCcc----cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC
Q 043852          420 DFGLAKATTMNDVK----SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP  494 (551)
Q Consensus       420 DFGla~~~~~~~~~----~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~  494 (551)
                      |||+++........    ....+..|+|||++  ....++.++|||||||++|+|++ |..||...........+.....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  239 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAF--LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR  239 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHH--hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99998765322211    11234679999997  34568999999999999999996 9999988766665555555555


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       495 ~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...+..++..+.+++.+||+.+|++|||+.+|++|
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            55677889999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-39  Score=319.85  Aligned_cols=246  Identities=27%  Similarity=0.472  Sum_probs=206.7

Q ss_pred             eeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe--
Q 043852          279 WQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR--  352 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--  352 (551)
                      |++++.||+|+||.||+|...    .+..||+|.+....   ........+.+|+.+++.++|+||+++++.+.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI---HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            567889999999999999763    24789999886432   223445678899999999999999999998765443  


Q ss_pred             ----EEEEEecccccchHHHHhh-------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          353 ----LFIFLELVTKGSLANLYQK-------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       353 ----~~lV~Ey~~ggsL~~ll~~-------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                          .+++|||+.+++|..++..       ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                7999999999999888743       24788889999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCC
Q 043852          422 GLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPL  496 (551)
Q Consensus       422 Gla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  496 (551)
                      |+++.......    ....++..|+|||.+  ....++.++|||||||++|||++ |..||.+....+....+..+....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhc--ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99876543321    112346789999986  45678999999999999999998 999998888777777777777777


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       497 ~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+..++..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-39  Score=320.62  Aligned_cols=247  Identities=26%  Similarity=0.426  Sum_probs=208.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+...    ........+.+|+.++..++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            347999999999999999999753      2468999987432    122334567789999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhhh-----------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEE
Q 043852          350 ENRLFIFLELVTKGSLANLYQKY-----------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKL  418 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~-----------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL  418 (551)
                      ....|++|||+.+++|.+++...           .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            99999999999999999988542           2566788999999999999999999999999999999999999999


Q ss_pred             EecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCC
Q 043852          419 ADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGE  493 (551)
Q Consensus       419 ~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~  493 (551)
                      +|||+++......    .....+|..|+|||.+  ....++.++|||||||++|||++ |..||...........+..+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHH--hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            9999987554332    1233467889999987  34568899999999999999998 999998877666666666666


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       494 ~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ....+..++..+.+|+.+||+.+|++|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            66677788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.8e-39  Score=323.68  Aligned_cols=246  Identities=28%  Similarity=0.463  Sum_probs=203.7

Q ss_pred             eccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      ||+|+||+||++.+ .+|..||+|.+......  .......+..|+.++.+++|+||+++++.+.....+|+||||+.++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK--KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh--hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            69999999999986 57899999998653221  1223445568999999999999999999999999999999999999


Q ss_pred             chHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-CcccCCCCC
Q 043852          364 SLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTP  439 (551)
Q Consensus       364 sL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~~~~~GT~  439 (551)
                      +|.+++.+.   .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence            999887643   4888999999999999999999999999999999999999999999999998754322 233455788


Q ss_pred             cccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcC
Q 043852          440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN  516 (551)
Q Consensus       440 ~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~D  516 (551)
                      .|+|||++.  +..++.++|||||||++|+|++|+.||.....   ...+...........+..++..+.++|.+||+.|
T Consensus       159 ~y~~PE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         159 GYMAPEVLQ--GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CcCCHHHhc--CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            999999973  44588999999999999999999999976543   2222222223344556678999999999999999


Q ss_pred             CCCCC-----CHHHHHhCcccCC
Q 043852          517 PNDRP-----TAAQLMEHPFVKR  534 (551)
Q Consensus       517 P~~RP-----S~~eILehpff~~  534 (551)
                      |.+||     ++.++++||||+.
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhc
Confidence            99999     8899999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6e-39  Score=321.48  Aligned_cols=251  Identities=31%  Similarity=0.546  Sum_probs=213.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~  354 (551)
                      ++|.+.+.||+|+||.||++.. .+|..||+|++......  .......+.+|+.++.++. |+||+++++++.+....+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            3789999999999999999987 58999999988653221  2233456778999999998 999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      ++|||+.+++|.+++.+. .++...++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999999999988766 68999999999999999999999999999999999999999999999999987543322  


Q ss_pred             --------------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc
Q 043852          432 --------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK  491 (551)
Q Consensus       432 --------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~  491 (551)
                                          .....++..|+|||++  ....++.++|+||||+++++|++|..||...........+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL--NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHh--CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                                1223478899999986  345678999999999999999999999987765555544443


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCH----HHHHhCccc
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPFV  532 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~----~eILehpff  532 (551)
                      . ....+..++..+.+||.+||+.+|++|||+    .+++.||||
T Consensus       237 ~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 L-EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             c-CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            2 334566789999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-39  Score=323.35  Aligned_cols=249  Identities=33%  Similarity=0.559  Sum_probs=204.1

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |++.+.||.|++|.||+|.+ .+|..||+|++.......   .....+.+|+.+++.++|+||+++++++.+....|++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE---GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc---cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            56788999999999999987 589999999987543221   22335668999999999999999999999999999999


Q ss_pred             ecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          358 ELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      ||+. ++|.+++...   .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            9995 5888887654   4889999999999999999999999999999999999999999999999998754322  22


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--------------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--------------------  492 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--------------------  492 (551)
                      ....+++.|+|||++. ....++.++||||||+++|+|++|++||...+......++...                    
T Consensus       157 ~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         157 THEVVTLWYRAPEILL-GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             CccccccCCCCCceee-cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            2334688999999863 3345788999999999999999999999876655444332211                    


Q ss_pred             --------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          493 --------EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       493 --------~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                              ........++..+.++|.+||+.||.+|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                    0011124567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-38  Score=321.79  Aligned_cols=245  Identities=30%  Similarity=0.473  Sum_probs=203.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCce----EEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFF----FAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~----vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|++.+.||+|+||.||+|.+ .++..    +++|.+..    .........+..|+.++.++.|+||+++++++.. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            4788999999999999999986 35554    56665532    2223445677888889999999999999998754 4


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..++++||+.+|+|.+++..  ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57889999999999999864  3578899999999999999999999999999999999999999999999999975432


Q ss_pred             CC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 ND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ..    .....++..|++||++  ....++.++|||||||++|||++ |..||.+.........+.++.....+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESI--LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             CCcccccCCCCCcccccCHHHh--ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence            22    2233467789999987  34568999999999999999998 99999887665555555666666666778899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+++.+||..||.+|||+.++++
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999987

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.1e-39  Score=317.97  Aligned_cols=245  Identities=32%  Similarity=0.543  Sum_probs=207.8

Q ss_pred             eccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      ||.|+||.||++.+. +|+.+++|++.....  ........+.+|+.++.+++|+||+++++.+......|++|||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh--hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            689999999999884 699999998864322  12345667889999999999999999999999999999999999999


Q ss_pred             chHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC----------Cc
Q 043852          364 SLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----------DV  432 (551)
Q Consensus       364 sL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~----------~~  432 (551)
                      +|.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......          ..
T Consensus        79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence            99998876 46889999999999999999999999999999999999999999999999998754333          22


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCc--CCHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS--LSRDARDFIL  510 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~s~~l~~LI~  510 (551)
                      ....++..|++||++.  ...++.++||||||+++|+|++|..||...........+..+.. ..+..  ++..+.+++.
T Consensus       159 ~~~~~~~~~~~Pe~~~--~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~  235 (265)
T cd05579         159 KRIVGTPDYIAPEVIL--GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLIS  235 (265)
T ss_pred             cCcccCccccCHHHhc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHH
Confidence            3345788999999973  44578899999999999999999999987776666655555332 22333  4899999999


Q ss_pred             HhhhcCCCCCCCH---HHHHhCcccCC
Q 043852          511 KCLQVNPNDRPTA---AQLMEHPFVKR  534 (551)
Q Consensus       511 ~cL~~DP~~RPS~---~eILehpff~~  534 (551)
                      +||+.+|.+|||+   .++++||||+.
T Consensus       236 ~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHhcCCHhhcCCCccHHHHhcCccccC
Confidence            9999999999999   99999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.5e-39  Score=324.83  Aligned_cols=247  Identities=23%  Similarity=0.379  Sum_probs=209.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      .+|.+.+.||+|+||.||+|...      .+..||||++....    .......+.+|+.++..++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            36778899999999999999753      35789999886432    123345677899999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhh-----------------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC
Q 043852          351 NRLFIFLELVTKGSLANLYQK-----------------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS  413 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-----------------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~  413 (551)
                      ...++++||+.+++|.+++..                 ..++...+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            999999999999999988742                 236777889999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 043852          414 GSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFR  488 (551)
Q Consensus       414 g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~  488 (551)
                      +.+||+|||+++......    .....+++.|+|||.+  ....++.++|||||||++|||++ |..||.+....+....
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHH--hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999987543322    1233457789999987  34568899999999999999998 8899988877777777


Q ss_pred             hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       489 i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +..+.....+..++..+.+|+.+||+.+|.+||++++|+..
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            77777777778899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-38  Score=318.33  Aligned_cols=243  Identities=26%  Similarity=0.482  Sum_probs=207.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .+|+++++||+|+||.||+|...++..||+|.+.....      ....+.+|+.++++++|+||+++++++. ....|++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            47999999999999999999888889999998853221      2346778999999999999999999874 4568999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-  432 (551)
                      |||+.+++|.+++..   ..++...+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999999998754   3478888999999999999999999999999999999999999999999999876542222 


Q ss_pred             --ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          433 --KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       433 --~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                        ....++..|+|||++  ....++.++||||||+++|+|++ |++||.+.........+..+.....+..++..+.+++
T Consensus       159 ~~~~~~~~~~y~~pe~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         159 AREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             cccCCcccccccCHHHh--ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence              223356789999987  34567889999999999999998 9999988777766666666666666777899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 043852          510 LKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||+.+|++|||+++++.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         237 RLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHccCChhhCCCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.9e-39  Score=319.10  Aligned_cols=244  Identities=27%  Similarity=0.469  Sum_probs=207.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .++|++.+.||+|+||.||+|...++..+|+|.+......      ...+.+|+.++++++|+||+++++++.. ...|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS------PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC------HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            3478999999999999999998778888999988643221      2357799999999999999999998754 56799


Q ss_pred             EEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      +|||+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999988642   478889999999999999999999999999999999999999999999999876543322


Q ss_pred             c---cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          433 K---SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       433 ~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .   ...++..|+|||++  ....++.++||||||+++|+|++ |.+||...+..+....+..+.....+..++..+.+|
T Consensus       158 ~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         158 TARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             ccccCCCCCccccChHHH--hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            1   22345679999986  34567899999999999999999 999998877777777777666666677889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 043852          509 ILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||+++|++|||++++.+
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.8e-39  Score=325.84  Aligned_cols=247  Identities=24%  Similarity=0.465  Sum_probs=205.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CCc--eEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DGF--FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g~--~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  352 (551)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.+...    ........+.+|+.++.++ +||||+++++++.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            47899999999999999999863 443  4678776421    1223345678899999999 79999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc
Q 043852          353 LFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS  415 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~  415 (551)
                      +|++|||+++++|.+++.+.                 .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            99999999999999988643                 3677889999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccccCCccc-CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCC
Q 043852          416 VKLADFGLAKATTMNDVKS-CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGE  493 (551)
Q Consensus       416 vkL~DFGla~~~~~~~~~~-~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~  493 (551)
                      +||+|||++.......... ...+..|+|||++  ....++.++|||||||++|||++ |..||......+....+..+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhh--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            9999999986432211111 2234569999986  45568899999999999999997 999998877777777776666


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       494 ~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ....+..++..+.+|+.+||+.+|.+|||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            666677899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-38  Score=324.06  Aligned_cols=254  Identities=31%  Similarity=0.505  Sum_probs=205.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|.+......   ......+.+|+.++++++|+||+++++++.+....|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            5799999999999999999987 47899999988643221   1233456789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEecCCccccccC-
Q 043852          356 FLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~DFGla~~~~~~-  430 (551)
                      ||||+.+ +|..++...   .+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++...... 
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999965 676666432   2567788899999999999999999999999999999985 557999999998754322 


Q ss_pred             -CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--C-------------
Q 043852          431 -DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--P-------------  494 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~-------------  494 (551)
                       ......+++.|+|||++. ....++.++|||||||++|+|+||.+||...+..+.+.++....  +             
T Consensus       158 ~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILL-GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccccCceeecccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             223345788999999873 34467899999999999999999999998776655554432110  0             


Q ss_pred             ------C-------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          495 ------P-------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       495 ------~-------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                            .       .....++..+.+++.+||+.+|++||++.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                  0       0123468889999999999999999999999999999864

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=319.01  Aligned_cols=247  Identities=26%  Similarity=0.454  Sum_probs=209.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ++|++.+.||+|+||.||+|...    +...||||.+....    .......+.+|+.++.+++|+||+++++.+.+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            36889999999999999999863    24579999875322    23345567889999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc-
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-  429 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~-  429 (551)
                      .+++|||+.+++|.+++..  ..++...+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++.... 
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999998865  3588999999999999999999999999999999999999999999999999986642 


Q ss_pred             -CCcc--cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          430 -NDVK--SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       430 -~~~~--~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                       ....  ...++..|+|||.+  ....++.++||||||+++|+|++ |..||...........+..+.....+..++..+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL  237 (266)
T ss_pred             ccceeccCCCCCccccChhhh--ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence             1111  22345789999987  34568899999999999999998 999998777777777777666656667789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+|+.+||+.+|++||++.+|+++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         238 YQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-38  Score=323.49  Aligned_cols=245  Identities=28%  Similarity=0.462  Sum_probs=208.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      .+|.+.+.||+|+||.||+|..      .++..+++|.+..     ........+.+|+.++.+++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            4789999999999999999974      2455688887642     2223345678999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC
Q 043852          351 NRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS  413 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~  413 (551)
                      ...++||||+.+++|.+++...                 .+++..++.++.||+.||.|||++||+|+||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            9999999999999999988643                 26788899999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 043852          414 GSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFR  488 (551)
Q Consensus       414 g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~  488 (551)
                      +.++|+|||+++......    .....++..|+|||.+  ....++.++|||||||++|+|+| |+.||........+..
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999987543322    2234467889999987  45678899999999999999998 9999987777777777


Q ss_pred             hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       489 i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +..+.....+..++..+.+|+.+||+.||++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            7777766667778999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=316.25  Aligned_cols=244  Identities=29%  Similarity=0.486  Sum_probs=210.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      ++|.+.+.||+|+||.||++.+.++..+|||.+.....      ....+.+|+.++++++|+||+++++++.+....+++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            47999999999999999999887788899998864322      234677899999999999999999999988999999


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      |||+.+++|.+++...   .++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++........
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            9999999999988653   4788999999999999999999999999999999999999999999999998765432211


Q ss_pred             ---cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          434 ---SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       434 ---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                         ...++..|+|||.+  .+..++.++|||||||++|+|++ |+.||.+......+..+..+.....+..++..+.+++
T Consensus       160 ~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         160 AREGAKFPIKWTAPEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhccCCCccccCHHHh--ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence               22245679999987  35568899999999999999998 9999988877777777777666666677899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 043852          510 LKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||+.+|++||+++++++
T Consensus       238 ~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         238 LQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHcccCcccCCCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.4e-39  Score=324.29  Aligned_cols=245  Identities=26%  Similarity=0.456  Sum_probs=205.2

Q ss_pred             CeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +|++.+.||+|+||.||+|...      ....+++|.+....    .......+.+|+.++..+.||||+++++.+....
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            4778899999999999999752      23568888775321    1233567889999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-------------------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccc
Q 043852          352 RLFIFLELVTKGSLANLYQKY-------------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA  406 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-------------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~  406 (551)
                      ..+++|||+.+++|.+++...                         .++...++.++.||+.||.|||++||+||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999999999887542                         3677888999999999999999999999999999


Q ss_pred             eEEEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCch
Q 043852          407 NILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLE  481 (551)
Q Consensus       407 NILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~  481 (551)
                      |||++.++.++|+|||+++......    .....++..|+|||++  ....++.++|||||||++|+|++ |..||.+..
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH--ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999987543222    1223356789999986  45568999999999999999998 999998877


Q ss_pred             hHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          482 GMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       482 ~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .......+..+.....+..++..+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            66666666666566667788999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-38  Score=316.87  Aligned_cols=239  Identities=28%  Similarity=0.454  Sum_probs=202.5

Q ss_pred             EeccCCceEEEEEEe---cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          284 LLGSGSFGTVYEGYT---DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      .||+|+||.||+|..   .++..+|+|++....   ........+.+|+.++..+.|+||+++++++.. ...+++|||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecC
Confidence            589999999999964   467899999875332   223455678899999999999999999998754 4678999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-----cc
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KS  434 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-----~~  434 (551)
                      .+++|.+++.+ ..+++..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||+++.......     ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            99999998865 4588999999999999999999999999999999999999999999999999876543221     12


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      ..++..|+|||++  ....++.++|||||||++|||++ |+.||...........+.++.....+..++.++.+||.+||
T Consensus       158 ~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~  235 (257)
T cd05116         158 GKWPVKWYAPECM--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW  235 (257)
T ss_pred             CCCCccccCHhHh--ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence            2245789999987  34567889999999999999997 99999887777777777777777778889999999999999


Q ss_pred             hcCCCCCCCHHHHHh
Q 043852          514 QVNPNDRPTAAQLME  528 (551)
Q Consensus       514 ~~DP~~RPS~~eILe  528 (551)
                      +.||++||++++|.+
T Consensus       236 ~~~p~~Rp~~~~i~~  250 (257)
T cd05116         236 TYGVDERPGFAVVEL  250 (257)
T ss_pred             ccCchhCcCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=348.37  Aligned_cols=254  Identities=28%  Similarity=0.531  Sum_probs=219.3

Q ss_pred             hhhhcccCeeeeeEeccCCceEEEEEEec--CC--ce-EEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeee
Q 043852          271 KFRRRIMSWQKGELLGSGSFGTVYEGYTD--DG--FF-FAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFG  345 (551)
Q Consensus       271 ~~~~~~~~y~~~~~LG~G~fG~VY~~~~~--~g--~~-vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  345 (551)
                      .|.....+....++||+|+||.||+|...  ++  .. ||||....  ........++++.+|++++++++|||||++||
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            34444456677799999999999999763  22  23 89997753  22344677889999999999999999999999


Q ss_pred             eccCCCeEEEEEecccccchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCC
Q 043852          346 TDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       346 ~~~~~~~~~lV~Ey~~ggsL~~ll~~~~--l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                      ++.+...+|+|||+|.||+|.+++++.+  ++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+|||+
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            9999999999999999999999999875  88999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCc-c-cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHh-hcCCCCCCCC
Q 043852          424 AKATTMNDV-K-SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRI-GKGEPPLVPN  499 (551)
Q Consensus       424 a~~~~~~~~-~-~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i-~~~~~~~~~~  499 (551)
                      ++....... . .+.-...|+|||.++  ...|+.++|||||||++||+++ |..||.+....+...+| ..+.+...+.
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~--~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~  386 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLN--TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS  386 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhc--cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence            876542221 1 223456799999984  3489999999999999999998 89999999999999999 7788888888


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..+..+..++.+||..||++|||+.++.+
T Consensus       387 ~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  387 KTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            99999999999999999999999999876

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-38  Score=326.33  Aligned_cols=248  Identities=26%  Similarity=0.447  Sum_probs=206.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec--------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD--------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGT  346 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  346 (551)
                      ..+|.+++.||+|+||.||++.+.        ++..+|+|.+....    ......++.+|+.++..+ +|+||++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            458999999999999999999752        23579999875321    123345677899999999 79999999999


Q ss_pred             ccCCCeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEE
Q 043852          347 DKDENRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL  409 (551)
Q Consensus       347 ~~~~~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NIL  409 (551)
                      +......|++|||+.+++|.+++...                 .++...+..++.||+.||.|||++|++|+||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            99999999999999999999988642                 3677889999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHH
Q 043852          410 VDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQ  484 (551)
Q Consensus       410 l~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~  484 (551)
                      ++.++.++|+|||+++......    .....+++.|+|||++  .+..++.++|||||||++|+|++ |..||......+
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh--ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999987543221    1112245689999987  34568999999999999999998 899998766655


Q ss_pred             HHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          485 ALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       485 ~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ....+..+.....+..++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            555555565556677889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-38  Score=326.63  Aligned_cols=254  Identities=35%  Similarity=0.618  Sum_probs=212.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|...+.||+|+||+||+|.. .+|+.||+|++.....  ........+.+|+.++..++|+||+++++++.+....|+|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc--CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            588889999999999999987 5799999998864322  2233455678999999999999999999999999999999


Q ss_pred             EecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          357 LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      |||+.+ +|.+++.  ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......  ..
T Consensus        94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~~  170 (307)
T cd06607          94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NS  170 (307)
T ss_pred             HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--CC
Confidence            999975 6655553  346889999999999999999999999999999999999999999999999998654322  34


Q ss_pred             CCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC-CCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV-PNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~l~~LI~~c  512 (551)
                      ..+++.|+|||++.. ....++.++||||||+++|+|++|+.||...+.......+.....+.. +..++..+.++|.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  250 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence            568889999998632 234578899999999999999999999988777666665554443333 345788999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCcc
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~  536 (551)
                      |+.||++||++.+|+.||||....
T Consensus       251 l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         251 LQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             hcCChhhCcCHHHHhcChhhcccC
Confidence            999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-39  Score=327.13  Aligned_cols=251  Identities=30%  Similarity=0.476  Sum_probs=197.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-c--CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--Ce
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-D--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--NR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~--~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~  352 (551)
                      +|.+.+.||+|+||.||+|.+ .  ++..||+|.+.....  ........+.+|+.++.+++||||+++++++.+.  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            478899999999999999987 3  589999999875331  1122234566899999999999999999999888  88


Q ss_pred             EEEEEecccccchHHHHhh------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC----CCcEEEEecC
Q 043852          353 LFIFLELVTKGSLANLYQK------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA----SGSVKLADFG  422 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~----~g~vkL~DFG  422 (551)
                      +|+||||+.+ +|..++..      ..+++..++.++.||+.||.|||+.+|+||||||+|||++.    ++.+||+|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999999976 56555432      25788899999999999999999999999999999999999    8999999999


Q ss_pred             CccccccCC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH---------HHHH
Q 043852          423 LAKATTMND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ---------ALFR  488 (551)
Q Consensus       423 la~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~---------~~~~  488 (551)
                      ++.......     .....+|+.|+|||++. ....++.++|||||||++|+|++|++||.......         .+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            987543221     23446789999999873 34567899999999999999999999996543221         0000


Q ss_pred             hh-------------------------cCCCCCCC-----------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          489 IG-------------------------KGEPPLVP-----------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       489 i~-------------------------~~~~~~~~-----------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      +.                         .......+           ...+..+.+++.+||+.||++|||+.++++||||
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00                         00000111           1466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9e-39  Score=327.60  Aligned_cols=249  Identities=24%  Similarity=0.459  Sum_probs=204.3

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCce--EEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCC
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFF--FAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDE  350 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~--vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  350 (551)
                      .+++|++.+.||+|+||.||+|.+ .++..  +|+|.+..    .........+.+|+.++.++ +|+||+++++++.+.
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            356899999999999999999986 45544  46665432    11233455778899999999 899999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC
Q 043852          351 NRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS  413 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~  413 (551)
                      ..+|++|||+++++|.+++.+.                 .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            9999999999999999988643                 36788899999999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhc
Q 043852          414 GSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGK  491 (551)
Q Consensus       414 g~vkL~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~  491 (551)
                      +.++|+|||++....... .....++..|+|||++  ....++.++|||||||++|+|+| |..||......+....+..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHH--hccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            999999999986432111 1112245679999987  34567899999999999999998 9999987766666655555


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.....+..++..+.+|+.+||+.+|++||++.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            54444556688999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.7e-39  Score=323.56  Aligned_cols=256  Identities=39%  Similarity=0.701  Sum_probs=216.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..|...+.||+|+||.||+|.+. ++..|++|++.....      ....+.+|+.++.+++|+||+++++.+......|+
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            36788899999999999999874 789999999864322      34567789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--C
Q 043852          356 FLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~  431 (551)
                      ++||+.+++|.+++...  .++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......  .
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            99999999999999876  6899999999999999999999999999999999999999999999999987644322  1


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFI  509 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~LI  509 (551)
                      .....++..|++||++  ....++.++|+||||+++|+|++|+.||...........+.....+..  +..++..+.+||
T Consensus       173 ~~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         173 RNSVVGTPYWMAPEVI--KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             hccccCCcccCCHhHh--cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence            2234478899999987  345678999999999999999999999987766555555444333322  233789999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      .+||+.+|.+|||+.+|++|+||++....+.
T Consensus       251 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  281 (286)
T cd06614         251 NKCLVKDPEKRPSAEELLQHPFLKKACPKEE  281 (286)
T ss_pred             HHHhccChhhCcCHHHHhhChHhhccCchHh
Confidence            9999999999999999999999998655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-38  Score=316.47  Aligned_cols=243  Identities=26%  Similarity=0.461  Sum_probs=205.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      ++|.+...||+|+||.||++.+..+..+|+|.+.....      ....+.+|+.+++.+.|+||+++++++.. ...|++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            46899999999999999999877767899998753221      22456789999999999999999998754 567899


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-  432 (551)
                      |||+.+++|.+++...   .++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999988653   367888999999999999999999999999999999999999999999999876543322 


Q ss_pred             --ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          433 --KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       433 --~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                        ....++..|+|||.+  ....++.++||||||+++|+|++ |..||.+.........+..+.....+..++..+.+++
T Consensus       159 ~~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05069         159 ARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM  236 (260)
T ss_pred             ccCCCccchhhCCHHHh--ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence              123356779999986  34568999999999999999999 9999988777777777766655666677899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 043852          510 LKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||++||++||++++|++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999987

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-38  Score=323.16  Aligned_cols=249  Identities=26%  Similarity=0.467  Sum_probs=209.5

Q ss_pred             cccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeec
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTD  347 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  347 (551)
                      ...+|++.+.||+|+||.||++...      ....+|+|.+....    .......+.+|+.++.++ +|+||+++++++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3458999999999999999999753      23689999875321    223445678999999999 799999999999


Q ss_pred             cCCCeEEEEEecccccchHHHHhh-----------------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE
Q 043852          348 KDENRLFIFLELVTKGSLANLYQK-----------------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV  410 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~-----------------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl  410 (551)
                      .....++++|||+.+++|..+++.                 ..+++..+..++.||+.||.|||++||+|+||||+|||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~  165 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV  165 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence            999999999999999999998853                 247788899999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 043852          411 DASGSVKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQA  485 (551)
Q Consensus       411 ~~~g~vkL~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~  485 (551)
                      +.++.+||+|||+++.......    ....++..|+|||++  ....++.++|||||||++|+|++ |..||......+.
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh--ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            9999999999999876543221    122245679999986  45678899999999999999997 9999988777666


Q ss_pred             HHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          486 LFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       486 ~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...+..+.....+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66666666666677889999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2e-38  Score=321.69  Aligned_cols=251  Identities=31%  Similarity=0.497  Sum_probs=198.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|.+.+.||+|+||.||+|.+ .+|..||+|++.......    ....+.+|+.++..++|+||+++++++.+....|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            35899999999999999999987 578999999986442211    1224568999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      ++|||+. ++|..++..  ..+.+..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++.....  
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9999996 566555433  34778888999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-HHHHHhhc------------------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGK------------------  491 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-~~~~~i~~------------------  491 (551)
                      ......+++.|+|||++. ....++.++|||||||++|+|++|..||...... +.+..+..                  
T Consensus       159 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLL-GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCccccccccCCceee-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            223345789999999863 3345788999999999999999999999765432 22221110                  


Q ss_pred             CCCCCC----C---------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          492 GEPPLV----P---------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       492 ~~~~~~----~---------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      ......    +         ...+..+.+++.+||..||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            000000    0         0135688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-38  Score=317.99  Aligned_cols=243  Identities=29%  Similarity=0.463  Sum_probs=205.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      ++|++.++||+|+||.||+|.+.++..||+|.+.....      ....+.+|+.++..++|+||+++++.+.. ...|++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence            46999999999999999999876666799998864221      12357789999999999999999998754 557999


Q ss_pred             EecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-
Q 043852          357 LELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-  432 (551)
                      |||+.+++|.+++.+   ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999999999875   3478889999999999999999999999999999999999999999999999875543322 


Q ss_pred             --ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          433 --KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       433 --~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                        ....++..|+|||++  ....++.++|||||||++|+|++ |..||...........+..+.....+..++..+.+|+
T Consensus       159 ~~~~~~~~~~y~~PE~~--~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (262)
T cd05071         159 ARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  236 (262)
T ss_pred             cccCCcccceecCHhHh--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence              123356779999986  35568999999999999999999 8999988777666666666655555667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 043852          510 LKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||++||.+||++.++++
T Consensus       237 ~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         237 CQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-38  Score=317.89  Aligned_cols=252  Identities=29%  Similarity=0.532  Sum_probs=211.1

Q ss_pred             CeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|.+.+.||+|+||.||++.+. .+..+++|++..............++..|+.++..++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4888999999999999999873 455666666544332222223344566889999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          357 LELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |||+.+++|..++..     ..+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCceeecCCCc
Confidence            999999999987753     3588899999999999999999999999999999999996 4679999999987553322


Q ss_pred             --cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                        .....|++.|+|||.+  ....++.++|+||||+++|+|++|..||...........+..+..+..+..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (260)
T cd08222         160 DLATTFTGTPYYMSPEAL--KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM  237 (260)
T ss_pred             ccccCCCCCcCccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHH
Confidence              2234578899999986  345678899999999999999999999987777777777777777777778899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCccc
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .+||+.+|++||++.++++||||
T Consensus       238 ~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         238 QSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=315.49  Aligned_cols=262  Identities=31%  Similarity=0.529  Sum_probs=219.5

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDE  350 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  350 (551)
                      ...+++.+.+..||.|+.|+|+++.. .+|...|||.+..    +.++...++++..+.++...+ +|+||+.+|+|..+
T Consensus        88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r----t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR----TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecc----cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            34455777788999999999999987 5799999999865    344556667777777666554 89999999999999


Q ss_pred             CeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      ..++|.||.+.. .+..++++  .++++..+-++...++.||.||.+ +||+|||+||+|||+|..|++||||||++...
T Consensus       164 ~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  164 TDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             chHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence            999999999854 66776654  468888888999999999999986 48999999999999999999999999999766


Q ss_pred             ccCCc-ccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHHhhcCCCCCCCC--cCC
Q 043852          428 TMNDV-KSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRIGKGEPPLVPN--SLS  502 (551)
Q Consensus       428 ~~~~~-~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~--~~s  502 (551)
                      ..... ....|-+.|||||.+... ...|+.++||||||++|+||.||+.||.+. .+.+.+-++.+..++.++.  ..+
T Consensus       243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS  322 (391)
T KOG0983|consen  243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS  322 (391)
T ss_pred             ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence            54433 344588999999998644 457899999999999999999999999874 5677888888877776664  379


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ..+++|+..||.+|+.+||...++|+|||++.....+
T Consensus       323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             HHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence            9999999999999999999999999999988765544

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=316.73  Aligned_cols=247  Identities=28%  Similarity=0.471  Sum_probs=202.1

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHH-HHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +.||+|+||.||+|.+ .+|+.||+|++.......  ......+..|.. +....+|+||+++++++.....+|++|||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA--KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH--HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            5699999999999987 578999999886432211  122223334443 345568999999999999999999999999


Q ss_pred             cccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCCCCC
Q 043852          361 TKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTP  439 (551)
Q Consensus       361 ~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~  439 (551)
                      .+++|..+++. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....  .....+++
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~  157 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTP  157 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCc
Confidence            99999999875 4588999999999999999999999999999999999999999999999999875433  22345888


Q ss_pred             cccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC---CCCCCcCCHHHHHHHHHhhhcC
Q 043852          440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP---PLVPNSLSRDARDFILKCLQVN  516 (551)
Q Consensus       440 ~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~l~~LI~~cL~~D  516 (551)
                      .|++||.+.  +..++.++||||||+++|+|++|..||...+.......+..+..   ......++..+.+++.+||+.+
T Consensus       158 ~y~~pe~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         158 DYLAPETIL--GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CccChhhhc--CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            999999973  34578999999999999999999999987776666555544332   2233468999999999999999


Q ss_pred             CCCCC---CHHHHHhCcccCCc
Q 043852          517 PNDRP---TAAQLMEHPFVKRP  535 (551)
Q Consensus       517 P~~RP---S~~eILehpff~~~  535 (551)
                      |++||   +++|++.||||+..
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcC
Confidence            99999   55899999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=320.05  Aligned_cols=249  Identities=29%  Similarity=0.536  Sum_probs=204.4

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--CeEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--NRLFI  355 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l  355 (551)
                      |++.+.||+|+||.||+|.+ .+|+.+|+|++....   ........+.+|+.++..++|+||+++++++.+.  ...++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            67889999999999999987 468999999997553   1122334567899999999999999999999887  88999


Q ss_pred             EEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          356 FLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      +|||+.+ +|..++...  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9999975 888877654  68899999999999999999999999999999999999999999999999987654432  


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC---------------
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP---------------  495 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~---------------  495 (551)
                       .....++..|+|||.+. ....++.++||||||+++|+|++|+.||...+....+..+......               
T Consensus       157 ~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 DYTNRVITLWYRPPELLL-GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cccccccccccCCceeeE-ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence             23345688899999763 3346789999999999999999999999876655444433221100               


Q ss_pred             ---------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          496 ---------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       496 ---------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                     .....++..+.+++.+||+.+|.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                           0011138889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.6e-38  Score=313.99  Aligned_cols=245  Identities=24%  Similarity=0.444  Sum_probs=208.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.....      ....+.+|+.++.++.|+||+++++++......+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            37889999999999999999877788999998753222      123577899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc-
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~-  433 (551)
                      |||+.+++|.+++..  ..+++..+..++.||+.+|.|||+.+++|+||||+||+++.++.++|+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            999999999998864  34788899999999999999999999999999999999999999999999998755433222 


Q ss_pred             --cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          434 --SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       434 --~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                        ...++..|+|||++.  ...++.++||||||+++|||++ |..||...........+..+.....+...+..+.+|+.
T Consensus       158 ~~~~~~~~~~~aPe~~~--~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         158 STGTKFPVKWSSPEVFS--FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ  235 (256)
T ss_pred             cCCCccchhhcCHhHhc--cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence              222456799999873  4568899999999999999998 99999877766666666666555556678999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 043852          511 KCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILeh  529 (551)
                      +||+.+|++|||+.+++++
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHcccChhhCCCHHHHHHh
Confidence            9999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-38  Score=331.31  Aligned_cols=252  Identities=30%  Similarity=0.500  Sum_probs=204.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      .+|.+.+.||.|+||.||+|.+ .+|..||+|++.....     .....+.+|+.++++++|+||+++++++...     
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            4799999999999999999987 5799999999865432     2345677899999999999999999776543     


Q ss_pred             ---------CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEe
Q 043852          351 ---------NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLAD  420 (551)
Q Consensus       351 ---------~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~D  420 (551)
                               ...|++|||+. ++|..++....+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                     35799999997 48888887778999999999999999999999999999999999999974 55789999


Q ss_pred             cCCccccccCC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-
Q 043852          421 FGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-  494 (551)
Q Consensus       421 FGla~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-  494 (551)
                      ||+++......     .....++..|+|||++. ....++.++|||||||++|+|++|+.||...........+....+ 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHh-CccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99987543211     12235788999999863 345678999999999999999999999977665444433322111 


Q ss_pred             -----------------------C-----CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          495 -----------------------P-----LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       495 -----------------------~-----~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                                             .     .....++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                   0     0113477889999999999999999999999999999843

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=356.19  Aligned_cols=244  Identities=26%  Similarity=0.471  Sum_probs=204.0

Q ss_pred             CeeeeeEeccCCceEEEEEEecCC-ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeee-ccC-----
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDG-FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGT-DKD-----  349 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g-~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~-----  349 (551)
                      ++++.+.|-+|||+.||+|.+..+ ..||+|++...     ++..+..+.+||.+|++|. |+|||.+++. ...     
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            678899999999999999998554 99999988642     4667778889999999997 9999999993 221     


Q ss_pred             -CCeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEcCCCcEEEEecCC
Q 043852          350 -ENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                       .-.++|+||||.||.|-+++.+   .+|++..+++|++|+++|+.+||...  |||||||-+||||..+|++||||||.
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence             2357899999999999988864   35999999999999999999999997  99999999999999999999999999


Q ss_pred             ccccccCCcc-----------cCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc
Q 043852          424 AKATTMNDVK-----------SCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK  491 (551)
Q Consensus       424 a~~~~~~~~~-----------~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~  491 (551)
                      ++........           ....|+.|+|||++... +...+.|+|||+|||+||-|++...||++...    ..|.+
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln  268 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN  268 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe
Confidence            8754333211           12269999999998643 45689999999999999999999999987432    24455


Q ss_pred             CCCCCCC-CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 043852          492 GEPPLVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  530 (551)
Q Consensus       492 ~~~~~~~-~~~s~~l~~LI~~cL~~DP~~RPS~~eILehp  530 (551)
                      +.....+ ..++..+.+||..||+.||++||++.|++++-
T Consensus       269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            5443333 57899999999999999999999999999863

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-38  Score=313.99  Aligned_cols=243  Identities=28%  Similarity=0.478  Sum_probs=208.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..+|++.+.||.|+||.||+|.. .|+.||+|.+.....      ...++.+|+.++..++|+||+++++++.+....|+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            34788999999999999999965 478899998864321      45678899999999999999999999998999999


Q ss_pred             EEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      +|||+.+++|.++++..   .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            99999999999988654   488999999999999999999999999999999999999999999999999876633222


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                       ...++..|+|||.+  ....++.++||||||+++|+|++ |..||...........+..+.....+..++..+.++|.+
T Consensus       158 -~~~~~~~~~ape~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         158 -SGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             -cCCCcccccCchhh--cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence             33345679999987  34567889999999999999997 999998776666665666555555667789999999999


Q ss_pred             hhhcCCCCCCCHHHHHh
Q 043852          512 CLQVNPNDRPTAAQLME  528 (551)
Q Consensus       512 cL~~DP~~RPS~~eILe  528 (551)
                      ||+.+|++|||+.++++
T Consensus       235 ~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         235 CWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-38  Score=331.99  Aligned_cols=260  Identities=28%  Similarity=0.457  Sum_probs=214.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe---
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR---  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---  352 (551)
                      ++|++.+.||+|+||.||+|.+ .++..||||++....   ........+.+|+.+++++.|+||+++++++.....   
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4799999999999999999987 578999999875432   122334556789999999999999999988766554   


Q ss_pred             ---EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          353 ---LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       353 ---~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                         +|+++||+ +++|.+++....+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence               89999999 56999999888899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC-------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-------------  496 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~-------------  496 (551)
                      . .....++..|+|||++. ....++.++|||||||++|+|++|+.||........+..+.......             
T Consensus       171 ~-~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         171 E-MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             c-ccCCcccccccCHHHHh-CCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence            3 34456889999999873 33467899999999999999999999998776655554433321100             


Q ss_pred             -----------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          497 -----------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       497 -----------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                                       ....++..+.+||.+||+.||++|||+.+|++||||++.......+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~  311 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEP  311 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccc
Confidence                             0123588999999999999999999999999999999776655443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.1e-39  Score=323.40  Aligned_cols=256  Identities=30%  Similarity=0.533  Sum_probs=204.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  355 (551)
                      +|...+.||+|+||.||++.+ .++..+|+|.+......    .....+.+|+.++.++. |+||+++++++......++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            456678899999999999987 57899999988643221    34456778999999996 9999999999999999999


Q ss_pred             EEecccccchHHHHh------hhcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          356 FLELVTKGSLANLYQ------KYHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~------~~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      +|||+.. +|..+..      ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999865 5444321      24588899999999999999999975 99999999999999999999999999987543


Q ss_pred             cC-CcccCCCCCcccChhhhhccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHhhcCCCCCCC----CcC
Q 043852          429 MN-DVKSCKGTPFWMAPEVVNLKN-RGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKGEPPLVP----NSL  501 (551)
Q Consensus       429 ~~-~~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~----~~~  501 (551)
                      .. ......|++.|+|||++.... ..++.++|||||||++|+|++|+.||..... .+.+.++..+..+..+    ..+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            22 223345889999999974221 3689999999999999999999999976542 2333343333332222    247


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      +..+.+||.+||++||++|||+.+|+.||||+....+
T Consensus       240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            8999999999999999999999999999999875543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.5e-38  Score=316.89  Aligned_cols=245  Identities=26%  Similarity=0.453  Sum_probs=201.6

Q ss_pred             eeeeEeccCCceEEEEEEec-CCc--eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC------
Q 043852          280 QKGELLGSGSFGTVYEGYTD-DGF--FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE------  350 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~-~g~--~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------  350 (551)
                      .+++.||+|+||.||+|.+. ++.  .+|+|.+....   ........+.+|+.++..++|+||+++++.+...      
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            46788999999999999874 333  68999875432   2234456778899999999999999999875321      


Q ss_pred             CeEEEEEecccccchHHHHhh-------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCC
Q 043852          351 NRLFIFLELVTKGSLANLYQK-------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                      ...+++|||+.+|+|..++..       ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCc
Confidence            246899999999999887632       2377888999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCC
Q 043852          424 AKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVP  498 (551)
Q Consensus       424 a~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  498 (551)
                      ++.......    ....+++.|++||++  ....++.++|||||||++|+|++ |+.||...........+..+.....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP  236 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHc--cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            876543221    222356789999986  45678999999999999999999 89999887777766777776665566


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ..++..+.++|.+||+.||++|||+.+|+++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            7789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-38  Score=315.13  Aligned_cols=242  Identities=26%  Similarity=0.468  Sum_probs=205.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec-cCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD-KDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~  354 (551)
                      ..+|++.+.||+|+||.||++.. .|..+|+|.+...       .....+.+|+.++++++|+||+++++++ .+....|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            34799999999999999999964 5778999987432       1234677899999999999999999875 4566789


Q ss_pred             EEEecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          355 IFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      ++|||+.+++|.+++++..   +++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999999999886532   6788899999999999999999999999999999999999999999999987543322


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                       ....++..|+|||++  ....++.++|||||||++|+|++ |+.||......+....+.++.....+..++..+.+++.
T Consensus       157 -~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         157 -DTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             -CCCccceeecCHHHH--ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence             233456689999987  34568899999999999999997 99999877666666667667666677789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHh
Q 043852          511 KCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILe  528 (551)
                      +||+.+|++|||+.++++
T Consensus       234 ~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         234 QCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-39  Score=358.55  Aligned_cols=244  Identities=28%  Similarity=0.494  Sum_probs=217.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +....+.||+|+||+||+|+-      .+...||||.++..    ...+..++|++|+.++..++|||||+|+|+|.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----AENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            556678999999999999963      34668999987632    22446778999999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh---------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcE
Q 043852          352 RLFIFLELVTKGSLANLYQKY---------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV  416 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~---------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~v  416 (551)
                      .+|||+|||..|+|.+++...               .|+..+.+.++.||+.||.||-++.+|||||.+.|+||.++-.|
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence            999999999999999998531               27778899999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCCcccCCC----CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhc
Q 043852          417 KLADFGLAKATTMNDVKSCKG----TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGK  491 (551)
Q Consensus       417 kL~DFGla~~~~~~~~~~~~G----T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~  491 (551)
                      ||+||||++.....+++...|    ..+||+||.+  ....|+.++||||+||+|||+++ |+.||.+....+.+..|..
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI--ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI--LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHh--hcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            999999999776666555443    3579999998  67789999999999999999997 9999999999999999999


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  527 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eIL  527 (551)
                      +..-..|..|+.++++||..||+.+|.+||++.+|-
T Consensus       721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            999899999999999999999999999999999984

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.8e-38  Score=313.15  Aligned_cols=248  Identities=30%  Similarity=0.566  Sum_probs=207.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|... +|..||+|.+......  .......+.+|+.++++++|+||+++++.+.+....++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM--DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            57999999999999999999884 8999999988643322  22335578899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          356 FLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|||+.+++|..++..     ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999988753     34788899999999999999999999999999999999999999999999998754332


Q ss_pred             C--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--hHHHHHHhhcCCCCCCCC-cCCHHH
Q 043852          431 D--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--GMQALFRIGKGEPPLVPN-SLSRDA  505 (551)
Q Consensus       431 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~-~~s~~l  505 (551)
                      .  .....+++.|+|||.+  ....++.++|||||||++|+|++|+.||....  .......+..+..+..+. .++..+
T Consensus       160 ~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             CcccceecCCccccCHHHh--ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence            2  2334588899999987  35568899999999999999999999995433  223333444444444444 688899


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .++|.+||+.+|++|||+.+|++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-38  Score=317.85  Aligned_cols=248  Identities=30%  Similarity=0.549  Sum_probs=205.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|.+.+.||+|+||.||++.. .++..+|||.+.....  ........+.+|+.+++.++|+||+++++++.+....++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            4788899999999999999986 5899999998764332  223345678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          356 FLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|||+.+++|.+++..     ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999988753     34788999999999999999999999999999999999999999999999998755432


Q ss_pred             C--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh--HHHHHHhhcCCCCC-CCCcCCHHH
Q 043852          431 D--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG--MQALFRIGKGEPPL-VPNSLSRDA  505 (551)
Q Consensus       431 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~--~~~~~~i~~~~~~~-~~~~~s~~l  505 (551)
                      .  .....|+..|+|||++  ....++.++|+||||+++|+|++|..||.....  ......+.....+. .+..++..+
T Consensus       160 ~~~~~~~~~~~~~~ape~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             CcccccccCCcCccCHHHh--cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence            2  2334688999999997  345678999999999999999999999965432  23333333333332 334588999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+++.+||+.||++|||+.+|++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2e-38  Score=339.16  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=204.9

Q ss_pred             hhhhcccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeee
Q 043852          271 KFRRRIMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQY  343 (551)
Q Consensus       271 ~~~~~~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l  343 (551)
                      ++.....+|+++++||+|+||.||+|.+.      .+..||||++....    .......+.+|+.++.++. ||||+++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~~l~~l~~HpnIv~l  106 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----RSSEKQALMSELKIMTHLGPHLNIVNL  106 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            34444558999999999999999999752      24579999885432    2233456889999999996 9999999


Q ss_pred             eeeccCCCeEEEEEecccccchHHHHhhh---------------------------------------------------
Q 043852          344 FGTDKDENRLFIFLELVTKGSLANLYQKY---------------------------------------------------  372 (551)
Q Consensus       344 ~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~---------------------------------------------------  372 (551)
                      ++++.+...+|||||||.+|+|.+++.+.                                                   
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence            99999999999999999999998877532                                                   


Q ss_pred             ----------------------------------------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccc
Q 043852          373 ----------------------------------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA  406 (551)
Q Consensus       373 ----------------------------------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~  406 (551)
                                                                    .+++..+..++.||+.||.|||+++|+|+||||+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~  266 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR  266 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence                                                          2566777889999999999999999999999999


Q ss_pred             eEEEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCch
Q 043852          407 NILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLE  481 (551)
Q Consensus       407 NILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~  481 (551)
                      |||++.++.+||+|||+++......    .....+++.|+|||++  .+..++.++|||||||++|+|++ |..||....
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI--FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            9999999999999999987543322    1223467789999987  35568999999999999999997 999997654


Q ss_pred             hHH-HHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          482 GMQ-ALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       482 ~~~-~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ... ....+..+.....+..++..+.+++.+||+.||++|||+.+|.+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333 33344455455566778999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-38  Score=320.41  Aligned_cols=244  Identities=26%  Similarity=0.449  Sum_probs=207.8

Q ss_pred             CeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +|...+.||+|+||.||++..      .++..+|+|.+...     .......+.+|+.++..++|+||+++++++.+..
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            678889999999999999863      24668888876532     2334557889999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc
Q 043852          352 RLFIFLELVTKGSLANLYQKY----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS  415 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~  415 (551)
                      ..+++|||+.+++|.+++...                .+++..+..++.||+.||.|||++|++|+||||+|||++.++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            999999999999999988643                3678889999999999999999999999999999999999999


Q ss_pred             EEEEecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhh
Q 043852          416 VKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIG  490 (551)
Q Consensus       416 vkL~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~  490 (551)
                      ++|+|||++........    ....+++.|+|||++  ....++.++|||||||++|+|++ |.+||...........+.
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHh--ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            99999999875433221    222356789999987  34568999999999999999998 999998877777777777


Q ss_pred             cCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       491 ~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+.....+..++..+.+||.+||+.||++||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            77666677789999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4e-38  Score=317.59  Aligned_cols=245  Identities=27%  Similarity=0.461  Sum_probs=204.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCc----eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGF----FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|++.+.||+|+||+||+|.+ .+|.    .||+|++...    ........+.+|+.++..++|+||+++++++... 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            4799999999999999999985 4554    4788987532    2233455678899999999999999999988754 


Q ss_pred             eEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..++++||+++|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            578999999999999988653  578999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 NDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ...    ....+++.|+|||.+  ....++.++|||||||++|||++ |..||...........+..+.....+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESI--LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             ccceeecCCCccchhhCCHHHh--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence            221    122346789999987  45578999999999999999998 99999876665555555566555666778999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+++.+||+.||++||++.++++
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.3e-38  Score=311.28  Aligned_cols=240  Identities=28%  Similarity=0.491  Sum_probs=203.7

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecccc
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTK  362 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g  362 (551)
                      ++||+|+||.||+|...++..+|+|.+....    .......+.+|+.++.+++|+||+++++++......+++|||+.+
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            3699999999999987788999999875322    123344678899999999999999999999999999999999999


Q ss_pred             cchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc---ccCCC
Q 043852          363 GSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKG  437 (551)
Q Consensus       363 gsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~G  437 (551)
                      ++|..++...  .+.+..+..++.||+.+|.|||++|++|+||||+||+++.++.++|+|||++........   ....+
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9999987643  478889999999999999999999999999999999999999999999999865432211   11234


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN  516 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~D  516 (551)
                      +..|+|||+++  ...++.++||||||+++|+|++ |..||...........+..+.....+..++..+.+++.+||+.+
T Consensus       157 ~~~y~aPE~~~--~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         157 PIKWTAPEALN--YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             cccccCHHHhc--cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            56799999973  4567889999999999999998 99999887777666677766666667778999999999999999


Q ss_pred             CCCCCCHHHHHh
Q 043852          517 PNDRPTAAQLME  528 (551)
Q Consensus       517 P~~RPS~~eILe  528 (551)
                      |++|||+.++++
T Consensus       235 p~~Rp~~~~l~~  246 (250)
T cd05085         235 PENRPKFSELQK  246 (250)
T ss_pred             cccCCCHHHHHH
Confidence            999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-38  Score=331.17  Aligned_cols=260  Identities=28%  Similarity=0.443  Sum_probs=209.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|++.....   .......+.+|+.++.+++|+||+++++++...     
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            5899999999999999999986 5899999998864321   122345677899999999999999999887532     


Q ss_pred             -CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 -NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 -~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                       ..+|++++++ +++|.++++...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence             3468888887 77999888877899999999999999999999999999999999999999999999999999875432


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC---------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP---------------  494 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~---------------  494 (551)
                       ......+|+.|+|||++. ....++.++|||||||++|+|++|+.||...........+.....               
T Consensus       173 -~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         173 -EMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             -cccccccCCCccCHHHHh-CccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence             233456889999999873 334678899999999999999999999976554433322211100               


Q ss_pred             -------CC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          495 -------PL--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       495 -------~~--------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                             +.        .....+..+.+||.+||+.||.+|||+.+++.||||++.......+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~  313 (345)
T cd07877         251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  313 (345)
T ss_pred             HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence                   00        0113578899999999999999999999999999999777655443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.6e-38  Score=318.45  Aligned_cols=244  Identities=25%  Similarity=0.424  Sum_probs=196.9

Q ss_pred             ccCeeeeeEe--ccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELL--GSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~L--G~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~  351 (551)
                      .+.|.+.+.+  |+|+||.||++.. .++..+|+|.+.......          .|+..... .+|+||+++++.+....
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            3456665655  9999999999987 578999999886432111          01111111 26999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~  429 (551)
                      .+|+||||+++++|.+++... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||+++....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            999999999999999998765 789999999999999999999999999999999999999988 999999999875543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH----HHHHHhhcCCCCCCCCcCCHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM----QALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                      .  ....++..|+|||++  ....++.++|||||||++|+|++|..||......    ..+.... ......+..++..+
T Consensus       163 ~--~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (267)
T PHA03390        163 P--SCYDGTLDYFSPEKI--KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA  237 (267)
T ss_pred             C--ccCCCCCcccChhhh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence            2  234588999999997  3456789999999999999999999999754322    2222222 23334455789999


Q ss_pred             HHHHHHhhhcCCCCCCC-HHHHHhCcccCC
Q 043852          506 RDFILKCLQVNPNDRPT-AAQLMEHPFVKR  534 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS-~~eILehpff~~  534 (551)
                      .+||.+||+++|.+||+ ++++++||||+.
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999996 699999999974

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-38  Score=328.58  Aligned_cols=259  Identities=29%  Similarity=0.468  Sum_probs=206.5

Q ss_pred             Cee-eeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccch---------HHHHHHHHHHHHHhcCCCCceeeeeee
Q 043852          278 SWQ-KGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGK---------QSILQLEQEILLLSRFEHENIVQYFGT  346 (551)
Q Consensus       278 ~y~-~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~~~  346 (551)
                      +|. +.+.||.|+||+||+|.+ .+++.||||++..........         .....+.+|+.++.+++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            555 357799999999999987 579999999986543322110         012246789999999999999999999


Q ss_pred             ccCCCeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          347 DKDENRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       347 ~~~~~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      +......|++|||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         89 YVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             EecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence            9999999999999974 78777754 468899999999999999999999999999999999999999999999999987


Q ss_pred             cccc----------------CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHh
Q 043852          426 ATTM----------------NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI  489 (551)
Q Consensus       426 ~~~~----------------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i  489 (551)
                      ....                .......+++.|+|||++. ....++.++|||||||++|+|++|++||...+....+..+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM-GAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcc-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            5441                1122234688899999874 3345789999999999999999999999877765554433


Q ss_pred             hcCC----CC-----------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          490 GKGE----PP-----------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       490 ~~~~----~~-----------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      ....    ..                       .....++..+.++|.+||+.+|++|||+++++.||||+..-..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            2210    00                       0112457889999999999999999999999999999965443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-38  Score=329.76  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=210.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----  351 (551)
                      ++|++++.||+|+||.||++.+ .+|..||||++....   ........+.+|+.+++.++|+||+++++++....    
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            4799999999999999999986 589999999885432   22333446778999999999999999999886543    


Q ss_pred             --eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 --RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 --~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                        .+++||||+ +++|..++....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence              468999999 77999888877899999999999999999999999999999999999999999999999999875533


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC---------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP---------------  494 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~---------------  494 (551)
                      . .....+++.|+|||++. ....++.++|+|||||++|+|++|..||...........+.+...               
T Consensus       171 ~-~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         171 E-MTGYVVTRWYRAPEVIL-NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             C-ccccccCCcccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence            2 23445789999999873 334578999999999999999999999987655443333221110               


Q ss_pred             ---------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 ---------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 ---------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                                     ......++..+.++|.+||+.||.+|||+.+++.||||+......
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence                           011235778899999999999999999999999999999765443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.6e-38  Score=319.72  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=209.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCe
Q 043852          278 SWQKGELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  352 (551)
                      .|++.+.||+|+||.||++..    .+|..||+|++..... .........+.+|+.++.++ +|+||+.+++++.....
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            378899999999999999976    3789999999864322 11223345667899999999 58999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|++|||+.+++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            9999999999999988764 458888999999999999999999999999999999999999999999999987654322


Q ss_pred             ---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh----HHHHHHhhcCCCCCCCCcCCHH
Q 043852          432 ---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       432 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                         .....|+..|+|||.+......++.++||||||+++|+|++|..||.....    ......+... .+..+..++..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  238 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEMSAL  238 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCCccCCHH
Confidence               224558899999999743334578899999999999999999999964321    2222222222 33456678999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHhCcccCCcc
Q 043852          505 ARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRPL  536 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RP-----S~~eILehpff~~~~  536 (551)
                      +.+|+.+||+.||.+||     ++.++++||||++.-
T Consensus       239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            99999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-38  Score=322.02  Aligned_cols=254  Identities=29%  Similarity=0.541  Sum_probs=204.4

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  351 (551)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|++.......   .....+.+|+.++..++||||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE---GFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc---CchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            3456899999999999999999987 478999999987543222   22335668999999999999999999876654 


Q ss_pred             ---------eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEe
Q 043852          352 ---------RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLAD  420 (551)
Q Consensus       352 ---------~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~D  420 (551)
                               .+|+++||+.+ +|..++..  ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                     78999999987 56565553  3588999999999999999999999999999999999999999999999


Q ss_pred             cCCccccccCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC---CC
Q 043852          421 FGLAKATTMND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG---EP  494 (551)
Q Consensus       421 FGla~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~---~~  494 (551)
                      ||++.......   .....++..|+|||++. ....++.++|||||||++|+|++|++||...+....+..+...   ..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLL-GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99987554322   12234578899999873 3345688999999999999999999999876655544333221   10


Q ss_pred             C--------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 P--------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ~--------------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      +                          .....++..+.+++.+||+.||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0                          0112468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=313.47  Aligned_cols=239  Identities=26%  Similarity=0.482  Sum_probs=201.0

Q ss_pred             eEeccCCceEEEEEEe-cC---CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          283 ELLGSGSFGTVYEGYT-DD---GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~---g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      ++||+|+||.||+|.. ..   +..+|+|.+......    .....+.+|+.+++.+.|+||+++++++. ...++++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            4699999999999975 22   378999987643221    34556789999999999999999999876 456799999


Q ss_pred             cccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc----
Q 043852          359 LVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----  433 (551)
Q Consensus       359 y~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~----  433 (551)
                      |+.+++|.+++.+.. +++..+..++.||+.+|.|||.++++|+||||+|||++.++.++|+|||+++........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            999999999887654 889999999999999999999999999999999999999999999999998755333211    


Q ss_pred             -cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          434 -SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       434 -~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                       ...++..|+|||.+  ....++.++|||||||++|+|++ |.+||......+....+........+..++..+.++|.+
T Consensus       156 ~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05060         156 TAGRWPLKWYAPECI--NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS  233 (257)
T ss_pred             cCccccccccCHHHh--cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence             11134579999987  44568999999999999999998 999998877776666666666667777899999999999


Q ss_pred             hhhcCCCCCCCHHHHHh
Q 043852          512 CLQVNPNDRPTAAQLME  528 (551)
Q Consensus       512 cL~~DP~~RPS~~eILe  528 (551)
                      ||+.+|.+||++.++++
T Consensus       234 cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         234 CWKYRPEDRPTFSELES  250 (257)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2e-38  Score=323.88  Aligned_cols=251  Identities=33%  Similarity=0.587  Sum_probs=212.0

Q ss_pred             eeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          282 GELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ...||+|+||.||++.. .++..||||++....     ......+.+|+.+++.++|+||+++++.+......|++|||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            36799999999999987 589999999875321     233456789999999999999999999999999999999999


Q ss_pred             cccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccCCCC
Q 043852          361 TKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGT  438 (551)
Q Consensus       361 ~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~~GT  438 (551)
                      ++++|.+++....+++..+..++.||+.+|+|||++|++|+||+|+||+++.++.++|+|||++......  ......|+
T Consensus       100 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         100 EGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            9999999888778899999999999999999999999999999999999999999999999987654322  22335588


Q ss_pred             CcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHHHHHHHHHhhhcC
Q 043852          439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFILKCLQVN  516 (551)
Q Consensus       439 ~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~LI~~cL~~D  516 (551)
                      +.|++||.+  ....++.++|+||||+++|+|++|+.||...........+....+..  ....++..+.+++.+||+.+
T Consensus       180 ~~y~~pE~~--~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         180 PYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             ccccCHHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            999999986  34567889999999999999999999998766655544444333322  23457899999999999999


Q ss_pred             CCCCCCHHHHHhCcccCCccccC
Q 043852          517 PNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       517 P~~RPS~~eILehpff~~~~~~~  539 (551)
                      |.+||++.+++.||||......+
T Consensus       258 P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         258 PAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             cccCcCHHHHhcChHHhccCCCc
Confidence            99999999999999999766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=322.45  Aligned_cols=256  Identities=30%  Similarity=0.509  Sum_probs=212.0

Q ss_pred             eeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEEEEec
Q 043852          282 GELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFIFLEL  359 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey  359 (551)
                      .++||+|+|+.|--+.. .+|..||||+|.+. .+    ....++.+|+.++.+.+ |+||+.|+.+|+++..+|+|||.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~g----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PG----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC-Cc----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            36899999999999887 79999999999754 22    23446678999999885 99999999999999999999999


Q ss_pred             ccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc---EEEEecCCccccccC-----
Q 043852          360 VTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMN-----  430 (551)
Q Consensus       360 ~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~---vkL~DFGla~~~~~~-----  430 (551)
                      +.||+|...+++ ..+++..+..+++.|+.||.|||.+||.||||||+|||....+.   ||||||.|..-...+     
T Consensus       158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            999999876654 56999999999999999999999999999999999999976654   899999987533222     


Q ss_pred             ----CcccCCCCCcccChhhhh---cccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh--------------HHH-HHH
Q 043852          431 ----DVKSCKGTPFWMAPEVVN---LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG--------------MQA-LFR  488 (551)
Q Consensus       431 ----~~~~~~GT~~Y~APEvl~---~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~--------------~~~-~~~  488 (551)
                          +..+.+|+..|||||++.   .....|+.++|.||||+|||.||+|.+||.+.-.              .+. ...
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence                234556889999999974   2345689999999999999999999999964322              222 345


Q ss_pred             hhcCCCCCCC---CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          489 IGKGEPPLVP---NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       489 i~~~~~~~~~---~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                      |..|...+..   ..+|.++.+||..+|..|+.+|.++.++++|||+++..++...|
T Consensus       318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp  374 (463)
T KOG0607|consen  318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP  374 (463)
T ss_pred             HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence            6666544433   35899999999999999999999999999999999988876543

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.7e-38  Score=322.34  Aligned_cols=249  Identities=27%  Similarity=0.470  Sum_probs=207.9

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe--------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeee
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFG  345 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~--------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~  345 (551)
                      ...+|.+++.||+|+||.||+++.        .++..+|+|.+...    ........+.+|+.++..+ +|+||+++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            345899999999999999999963        13457899977532    1223456788999999999 7999999999


Q ss_pred             eccCCCeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceE
Q 043852          346 TDKDENRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANI  408 (551)
Q Consensus       346 ~~~~~~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NI  408 (551)
                      ++......|++|||+.+++|.+++.+.                 .++...+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999999999988642                 356677889999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH
Q 043852          409 LVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGM  483 (551)
Q Consensus       409 Ll~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~  483 (551)
                      |++.++.+||+|||+++......    .....+++.|+|||++  .+..++.++||||||+++|+|++ |..||......
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh--ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999987653322    1223356789999987  34568999999999999999998 88999887776


Q ss_pred             HHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          484 QALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       484 ~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +....+..+.....+..++..+.+|+.+||+.+|.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            7666666666666667889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.8e-38  Score=322.92  Aligned_cols=246  Identities=27%  Similarity=0.471  Sum_probs=206.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEec--------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeec
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD--------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTD  347 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  347 (551)
                      .+|.+++.||+|+||.||++...        .+..+|+|.+....    .......+.+|+.++.++ .|+||+++++++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            47899999999999999999641        35578999875321    223455678899999999 599999999999


Q ss_pred             cCCCeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE
Q 043852          348 KDENRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV  410 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl  410 (551)
                      .+...+|++|||+.+++|.+++...                 .++...+..++.||+.||.|||++||+|+||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999988642                 36778889999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 043852          411 DASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQA  485 (551)
Q Consensus       411 ~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~  485 (551)
                      +.++.+||+|||+++......    .....++..|+|||++  ....++.++|||||||++|+|++ |..||......+.
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHH--ccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999997553221    1112244679999987  34568899999999999999998 8999988777666


Q ss_pred             HHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          486 LFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       486 ~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ...+..+.....+..++..+.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            6666666655667788999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-38  Score=329.86  Aligned_cols=261  Identities=26%  Similarity=0.440  Sum_probs=207.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      .+|.+.+.||+|+||+||++.+ .++..||||.+.....   .......+.+|+.++..++|+||+++++++...     
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            3799999999999999999987 5799999998864322   122334566899999999999999999987544     


Q ss_pred             CeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ...|+++||+. ++|.+++.. ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            35899999996 578777754 4689999999999999999999999999999999999999999999999999876543


Q ss_pred             C--CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc----------------
Q 043852          430 N--DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK----------------  491 (551)
Q Consensus       430 ~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~----------------  491 (551)
                      .  ......++..|+|||.+. ....++.++|||||||++|+|++|++||.+.+.......+..                
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLL-NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CcccccccccccCccChHHHh-cCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            2  123445788999999873 234578999999999999999999999976543222211110                


Q ss_pred             -----------CCC---CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          492 -----------GEP---PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       492 -----------~~~---~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                                 ...   ......++..+.+||.+||+.+|++|||+.++++||||......+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~  304 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEP  304 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCc
Confidence                       000   011235788999999999999999999999999999998765555443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.4e-38  Score=313.83  Aligned_cols=238  Identities=28%  Similarity=0.464  Sum_probs=200.9

Q ss_pred             EeccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          284 LLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      .||+|+||.||+|...   ++..+|+|++...    ........+.+|+.++++++|+||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            3899999999999752   4567999987532    12334456889999999999999999999875 45689999999


Q ss_pred             cccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc-----c
Q 043852          361 TKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----K  433 (551)
Q Consensus       361 ~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~-----~  433 (551)
                      ++++|.+++..  ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++........     .
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999998853  4688999999999999999999999999999999999999999999999999875432211     1


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ...++..|+|||++.  ...++.++|||||||++|+|++ |..||...........+..+.....+..++.++.++|.+|
T Consensus       157 ~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05115         157 AGKWPLKWYAPECIN--FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC  234 (257)
T ss_pred             CCCCCcccCCHHHHc--cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence            122357899999873  4567899999999999999996 9999988887777777777777777888999999999999


Q ss_pred             hhcCCCCCCCHHHHHh
Q 043852          513 LQVNPNDRPTAAQLME  528 (551)
Q Consensus       513 L~~DP~~RPS~~eILe  528 (551)
                      |..+|++||++.+|++
T Consensus       235 ~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         235 WIYKWEDRPNFAKVEE  250 (257)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=365.94  Aligned_cols=271  Identities=27%  Similarity=0.375  Sum_probs=225.6

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..-.+|.++++||+|+||.|.++++ .+++.||+|++.+-....  ...-..|..|-.+|..-+.+-|+.++..|++..+
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3345899999999999999999987 689999999986521111  1123356677778888889999999999999999


Q ss_pred             EEEEEecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|+||||++||+|..++.++. +++.-++.|+..|+.||..||+.|+|||||||+||||+..|++||+|||.+-....+.
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            999999999999999999887 9999999999999999999999999999999999999999999999999886554332


Q ss_pred             ---cccCCCCCcccChhhhhccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-CCCCC--CcCC
Q 043852          432 ---VKSCKGTPFWMAPEVVNLKN---RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVP--NSLS  502 (551)
Q Consensus       432 ---~~~~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~s  502 (551)
                         ....+|||.|.+||+++..+   ..|+..+|+||||+++|||++|..||....-.+.+-+|.+.. ...+|  ..+|
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence               23457999999999986433   458999999999999999999999999988888888876652 11222  4589


Q ss_pred             HHHHHHHHHhhhcCCCCCCC---HHHHHhCcccCCcc-ccCCCCCCCCC
Q 043852          503 RDARDFILKCLQVNPNDRPT---AAQLMEHPFVKRPL-QKSRGPPSYYN  547 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS---~~eILehpff~~~~-~~~~~~~~~~~  547 (551)
                      ..+++||.+++. +|+.|..   ++++..||||.+.- ..-+...+||.
T Consensus       310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~v  357 (1317)
T KOG0612|consen  310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVV  357 (1317)
T ss_pred             HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCC
Confidence            999999999996 7999998   99999999998654 33344444444

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=317.57  Aligned_cols=249  Identities=30%  Similarity=0.537  Sum_probs=205.8

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |.+.+.||+|++|.||++.+ .+++.+++|++......   ......+.+|+.++++++|+||+++++++.+....|++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            56778999999999999987 57999999988644322   133456778999999999999999999999999999999


Q ss_pred             ecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--cc
Q 043852          358 ELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK  433 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~  433 (551)
                      ||+.+ +|..++...  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......  ..
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            99976 777776553  68899999999999999999999999999999999999999999999999987654432  23


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC------------------
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP------------------  495 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~------------------  495 (551)
                      ...++..|+|||.+. ....++.++|+||||+++|+|++|+.||...+..+.+.++......                  
T Consensus       157 ~~~~~~~~~~PE~~~-~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         157 HYVVTRWYRAPELLL-GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             CccCcccccCcHHHh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            345788899999974 3346899999999999999999999999877765554443221000                  


Q ss_pred             -----------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          496 -----------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       496 -----------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                 .....++..+.++|.+||++||.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                       0112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.3e-38  Score=316.55  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=206.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEecC-----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-C
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDD-----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-E  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~-----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~  350 (551)
                      ++|++.+.||+|+||.||+|.+..     +..+++|.+..    .........+.+|+.++.+++|+||+++++++.. .
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            378999999999999999998754     78899998752    2233445677899999999999999999998655 5


Q ss_pred             CeEEEEEecccccchHHHHhh---------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          351 NRLFIFLELVTKGSLANLYQK---------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~---------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                      ...+++++|+.+++|.+++..         ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            678999999999999998865         34788899999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCC
Q 043852          422 GLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPL  496 (551)
Q Consensus       422 Gla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  496 (551)
                      |+++.......    ....++..|+|||++  ....++.++|||||||++|+|++ |+.||......+....+..+....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESL--VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHH--hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            99975543321    123356679999987  45568999999999999999998 999998777666666666665555


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       497 ~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+..++..+.+++.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            56678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.9e-38  Score=314.92  Aligned_cols=246  Identities=25%  Similarity=0.449  Sum_probs=206.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-C---CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-D---GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~---g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.+....    .......+.+|+.++.+++||||+++++++.+...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            37889999999999999999763 2   3378999875321    12345578899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .|++|||+++++|.+++.+.  .++...+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999988754  4788899999999999999999999999999999999999999999999998765432


Q ss_pred             Cc-----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          431 DV-----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       431 ~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ..     ....++..|++||++  ....++.++|+|||||++|++++ |..||......+....+..+.....+..++..
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA  237 (267)
T ss_pred             cceeeecCCCccceeecCHhHh--ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHH
Confidence            21     111235679999997  34568999999999999999886 99999877766666666666555556678999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+++.+||+.+|.+||++.++++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         238 LHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHcccCchhCCCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-38  Score=328.73  Aligned_cols=262  Identities=26%  Similarity=0.460  Sum_probs=208.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc----CCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK----DEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~  351 (551)
                      .+|++.+.||+|+||.||+|.+ .+|..||+|++......   ......+.+|+.++..++|+||+++++++.    ...
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV---PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc---ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            4789999999999999999987 57999999998643221   223456678999999999999999998765    345


Q ss_pred             eEEEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+|+||||+. ++|..++. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            7899999996 57888775 345899999999999999999999999999999999999999999999999998754322


Q ss_pred             C------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc-------------
Q 043852          431 D------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-------------  491 (551)
Q Consensus       431 ~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~-------------  491 (551)
                      .      .....|+..|+|||++. ....++.++|||||||++|+|++|++||...+....+..+..             
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             CcCCCcccccccccccccChHHhc-CCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            1      12346889999999873 334578999999999999999999999977654332221111             


Q ss_pred             ------------CCCCCC-----CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCCC
Q 043852          492 ------------GEPPLV-----PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP  543 (551)
Q Consensus       492 ------------~~~~~~-----~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~~  543 (551)
                                  ......     ...++..+.++|.+||+.+|.+|||+.+++.||||++.......+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~  308 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT  308 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence                        000111     1346889999999999999999999999999999987666555543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-38  Score=327.93  Aligned_cols=261  Identities=30%  Similarity=0.475  Sum_probs=213.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-----
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-----  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----  351 (551)
                      +|++.+.||.|+||.||+|++ .++..||||.+.....   .......+.+|+.+++.++|+||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            488899999999999999987 4699999998864321   1234456778999999999999999999987765     


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+|++|||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++......
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            78999999985 78777765 36889999999999999999999999999999999999999999999999999865443


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---------
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---------  496 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---------  496 (551)
                      .     .....+|+.|+|||++.. ...++.++|+|||||++|+|++|.+||...+..+.+..+.......         
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLS-SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             ccccccccccccccCcCCceeeec-ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            2     334568899999999742 2278999999999999999999999998776655444332211000         


Q ss_pred             ---------------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCCC
Q 043852          497 ---------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP  543 (551)
Q Consensus       497 ---------------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~~  543 (551)
                                           ....++..+.+||.+||+++|.+|||+.+++.||||++....+..++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~  303 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV  303 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCC
Confidence                                 11236788999999999999999999999999999998776655543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.7e-39  Score=363.99  Aligned_cols=254  Identities=32%  Similarity=0.549  Sum_probs=209.1

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--  349 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  349 (551)
                      -+.+.+|+.+++||+||||.||++++ -+|..||||+|....    ......++.+|+.++.+|+|||||++|..|.+  
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST  550 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence            35678999999999999999999998 499999999997653    34456678899999999999999999822100  


Q ss_pred             --------------------------------------------------------------------------------
Q 043852          350 --------------------------------------------------------------------------------  349 (551)
Q Consensus       350 --------------------------------------------------------------------------------  349 (551)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------C--------CeEEEEEecccccchHHHHhhhcCC--hHHHHHHHHHHHHHH
Q 043852          350 -----------------------------E--------NRLFIFLELVTKGSLANLYQKYHLM--DSQVSAYTRQILNGL  390 (551)
Q Consensus       350 -----------------------------~--------~~~~lV~Ey~~ggsL~~ll~~~~l~--~~~i~~i~~QI~~aL  390 (551)
                                                   .        ..+||.||||+..+|.+++..+.+.  ...+|.+++||+.||
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence                                         0        1368999999999999999887764  678899999999999


Q ss_pred             HHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--------------------cCCcccCCCCCcccChhhhhcc
Q 043852          391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--------------------MNDVKSCKGTPFWMAPEVVNLK  450 (551)
Q Consensus       391 ~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--------------------~~~~~~~~GT~~Y~APEvl~~~  450 (551)
                      .|+|++|||||||||.||+++.++.|||+|||+|+...                    ....+..+||..|+|||++...
T Consensus       711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99999999999999999999999999999999997511                    0113456799999999998533


Q ss_pred             c-CCCCchhhHHHHHHHHHHHHcCCCCC-CCchhHHHHHHhhcCCCCCC---CCcCCHHHHHHHHHhhhcCCCCCCCHHH
Q 043852          451 N-RGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGKGEPPLV---PNSLSRDARDFILKCLQVNPNDRPTAAQ  525 (551)
Q Consensus       451 ~-~~~s~ksDIwSLG~iLyeLltG~~Pf-~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~LI~~cL~~DP~~RPS~~e  525 (551)
                      . ..|+.|+||||||+||+||+.   || ..++....+..+.++..+..   ...--..-..+|.+||+.||.+|||+.|
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence            2 269999999999999999985   46 45666677777777766655   2223345568999999999999999999


Q ss_pred             HHhCcccC
Q 043852          526 LMEHPFVK  533 (551)
Q Consensus       526 ILehpff~  533 (551)
                      +|++.||.
T Consensus       868 LL~s~llp  875 (1351)
T KOG1035|consen  868 LLNSELLP  875 (1351)
T ss_pred             HhhccCCC
Confidence            99999987

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.3e-38  Score=318.13  Aligned_cols=246  Identities=24%  Similarity=0.436  Sum_probs=207.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ++|++.+.||+|+||.||++.+.      ++..||+|.+....    .......+.+|+.++.++.|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            37889999999999999999753      57789999875321    223445688999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh-----------------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccce
Q 043852          351 NRLFIFLELVTKGSLANLYQKY-----------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN  407 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~-----------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~N  407 (551)
                      ...|++|||+.+++|.+++...                       .+++..++.++.||+.||.|||+++++|+||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            9999999999999999988642                       35677889999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchh
Q 043852          408 ILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEG  482 (551)
Q Consensus       408 ILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~  482 (551)
                      ||++.++.++|+|||++.......    .....++..|+|||.+  ....++.++|||||||++|+|++ |..||.+...
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH--hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999986543221    1222346679999986  34578999999999999999997 8889987777


Q ss_pred             HHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          483 MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       483 ~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+....+..+.....+..++..+.+||.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            7777677766665566778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.8e-38  Score=329.94  Aligned_cols=264  Identities=29%  Similarity=0.454  Sum_probs=210.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC--CC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD--EN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~  351 (551)
                      ..+|++.+.||+|+||.||+|.+ .+|..+|+|++......   ......+.+|+.++.++ +|+||+++++++..  ..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc---chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            35789999999999999999987 47899999988543211   12234566899999999 99999999998754  34


Q ss_pred             eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          352 RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      ..|+||||+.+ +|..++....+.+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          83 DIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             eEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            68999999975 89888877778888889999999999999999999999999999999999999999999987543221


Q ss_pred             -------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-----------
Q 043852          432 -------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-----------  493 (551)
Q Consensus       432 -------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-----------  493 (551)
                             .....||+.|+|||++. ....++.++|||||||++|+|++|++||..........++....           
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILL-GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             ccccCcchhcccccccccCceeee-ccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence                   22345889999999863 34567889999999999999999999997655444333221110           


Q ss_pred             -------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCCCC
Q 043852          494 -------------------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS  544 (551)
Q Consensus       494 -------------------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~~~  544 (551)
                                         .......++..+.+||.+||+.||.+|||+.++++||||++....+..+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~  310 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVL  310 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCC
Confidence                               001112378899999999999999999999999999999987665555433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.8e-38  Score=311.89  Aligned_cols=244  Identities=26%  Similarity=0.477  Sum_probs=207.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .++|++.+.||+|+||.||++....+..+|+|.+...      ......+.+|+.++++++|+||+++++.+.+ ...|+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            4589999999999999999998777788999987532      2234567889999999999999999999887 77899


Q ss_pred             EEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      +|||+.+++|.+++.+.   .++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999999988653   367788899999999999999999999999999999999999999999999875533222


Q ss_pred             c---cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          433 K---SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       433 ~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .   ...++..|+|||++.  ...++.++|+|||||++|+|++ |..||...+.......+..+.....+...+..+.++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         158 TAREGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             ccccCCcccccccCHhHhc--cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence            1   223456799999973  4567889999999999999998 999998877766666666666656667789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 043852          509 ILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||+++|++||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-38  Score=317.26  Aligned_cols=245  Identities=30%  Similarity=0.482  Sum_probs=197.5

Q ss_pred             Ce-eeeeEeccCCceEEEEEEe-----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--
Q 043852          278 SW-QKGELLGSGSFGTVYEGYT-----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--  349 (551)
Q Consensus       278 ~y-~~~~~LG~G~fG~VY~~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  349 (551)
                      +| ++.+.||+|+||+||++..     .++..||+|.+....    .......+.+|+.++.+++|+||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            44 8889999999999987642     468899999886432    12334567789999999999999999998654  


Q ss_pred             CCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ...+|++|||+.+++|.+++....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++....
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            34689999999999999999888899999999999999999999999999999999999999999999999999875543


Q ss_pred             CCc-----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-H--------------HHHHh
Q 043852          430 NDV-----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-Q--------------ALFRI  489 (551)
Q Consensus       430 ~~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-~--------------~~~~i  489 (551)
                      ...     ....++..|+|||++  ....++.++|||||||++|+|++|..||...... .              ....+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHh--cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            221     122356679999987  3456789999999999999999999998543211 0              01111


Q ss_pred             hcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          490 GKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       490 ~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..+.....+..++..+.+++.+||+.+|++|||+++|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222233345678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-38  Score=328.82  Aligned_cols=254  Identities=26%  Similarity=0.478  Sum_probs=202.1

Q ss_pred             eEeccC--CceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEec
Q 043852          283 ELLGSG--SFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLEL  359 (551)
Q Consensus       283 ~~LG~G--~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey  359 (551)
                      ..||+|  +||+||++++ .+|+.||+|++.....   .....+.+.+|+.+++.++|+||+++++++......|++|||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            356666  9999999987 5899999998864322   223456788999999999999999999999999999999999


Q ss_pred             ccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-----
Q 043852          360 VTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----  431 (551)
Q Consensus       360 ~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-----  431 (551)
                      +.+++|.+++.+.   .+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+.......     
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999999988753   47888899999999999999999999999999999999999999999998543221110     


Q ss_pred             ----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-------------
Q 043852          432 ----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-------------  494 (551)
Q Consensus       432 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-------------  494 (551)
                          .....++..|+|||++......++.++|||||||++|+|++|++||.................             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                011224567999999853335678999999999999999999999987655444333222111             


Q ss_pred             ---------------------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 ---------------------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 ---------------------------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                                                       ......++..+.+||.+||+.||++|||+.++++||||++...+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~  318 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT  318 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence                                             001123567899999999999999999999999999998766543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=361.62  Aligned_cols=245  Identities=31%  Similarity=0.538  Sum_probs=215.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe--cCCc----eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT--DDGF----FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~--~~g~----~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      ..+....||+|+||.||.|..  ..|.    .||||.+..    ....+...+|.+|..+|++++|||||+++|++.+..
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~----~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR----LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc----cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            466788999999999999975  3343    488887753    334567889999999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCC
Q 043852          352 RLFIFLELVTKGSLANLYQKY--------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~--------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                      ..+|++|||.||+|..++++.        .++..++..++.||++|++||+++++|||||...|+|++....|||+|||+
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999999865        478889999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcccCCCC----CcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCC
Q 043852          424 AKATTMNDVKSCKGT----PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVP  498 (551)
Q Consensus       424 a~~~~~~~~~~~~GT----~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  498 (551)
                      |+.+...+++...|-    ..|||||.+  ....|+.++||||||++|||++| |..||.+....+.+.....+-....|
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl--~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESL--KDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHH--hhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            996555544433332    469999997  45789999999999999999998 99999999999998866666678888


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..|+..+.+||.+||+.+|++||++..|++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            999999999999999999999999999987

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8e-38  Score=309.19  Aligned_cols=243  Identities=31%  Similarity=0.543  Sum_probs=209.1

Q ss_pred             eeeeEeccCCceEEEEEEec-C----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          280 QKGELLGSGSFGTVYEGYTD-D----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~-~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ++.+.||.|+||.||++.+. .    +..+|+|++....    .......+..|+.++..++|+||+++++++.+....|
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC----ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            46788999999999999874 3    3889999885332    1224567889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          355 IFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      ++|||+.+++|.+++....   +++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999999886533   8999999999999999999999999999999999999999999999999987654332


Q ss_pred             cc---cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHH
Q 043852          432 VK---SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD  507 (551)
Q Consensus       432 ~~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  507 (551)
                      ..   ...+++.|+|||.+  ....++.++|||||||++|+|++ |.+||...........+........+..++..+.+
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYK  235 (258)
T ss_pred             ccccccCCCcccccChHHh--ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence            21   12367889999987  45678999999999999999998 89999887777777777777777777789999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHh
Q 043852          508 FILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ++.+||+.||++|||+.++++
T Consensus       236 ~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      236 LMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.1e-38  Score=320.32  Aligned_cols=252  Identities=31%  Similarity=0.536  Sum_probs=199.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-----
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-----  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----  349 (551)
                      +++|.+.++||+|+||.||+|.+ .++..+|||++........   ....+.+|+.+++.++|+||+++++.+.+     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            56899999999999999999987 5789999999865432221   12345689999999999999999987643     


Q ss_pred             ---CCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          350 ---ENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       350 ---~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                         ...+|++|||+.+ +|...+..  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence               3357999999976 56555543  35899999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC-------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc
Q 043852          425 KATTMND-------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK  491 (551)
Q Consensus       425 ~~~~~~~-------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~  491 (551)
                      .......             .....+++.|+|||++. ....++.++|||||||++|+|++|++||.+.+.......+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhh-CCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            7543221             12234688899999873 344578999999999999999999999987666544433221


Q ss_pred             CCCC----------------------CC-------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          492 GEPP----------------------LV-------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       492 ~~~~----------------------~~-------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      ....                      ..       ...++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            1000                      00       02345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.2e-38  Score=322.82  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=201.9

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      |.+++.+|.|+++.||++. .++..||||++....   ........+.+|+.+++.++|+||+++++++.+...+|++||
T Consensus         4 ~~i~~~~~~~~~v~~~~~~-~~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             hhhhHhhcCCceEEEEEec-CCCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence            3445566666776666664 379999999987542   223456678899999999999999999999999999999999


Q ss_pred             cccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----
Q 043852          359 LVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  431 (551)
Q Consensus       359 y~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----  431 (551)
                      |+.+++|.+++.+   ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+.......    
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999999998875   357888999999999999999999999999999999999999999999999886442211    


Q ss_pred             -----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC-----------
Q 043852          432 -----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-----------  495 (551)
Q Consensus       432 -----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-----------  495 (551)
                           .....++..|+|||++......++.++|||||||++|+|++|..||..............+..+           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence                 1223467789999998543356889999999999999999999999876554433222111100           


Q ss_pred             ----------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          496 ----------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       496 ----------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                            .....++.++.+|+.+||+.||++|||+.++++||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                  00112346788999999999999999999999999999765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=334.42  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=218.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +.|..-.+||+|+||.||-++. .+|+.||+|.+.++....  .....-.++|-.||.+++.++||.+-..|++.+.+|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk--r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK--RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH--hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3577778999999999999986 689999999886554332  2233345688899999999999999999999999999


Q ss_pred             EEecccccchHHHHh-hh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQ-KY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~-~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      ||..|.||+|...+- -+  ++++..+..|+.+|+.||++||+.+||+|||||+|||+|..|+++|+|+|||..+.....
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            999999999976553 33  699999999999999999999999999999999999999999999999999988766554


Q ss_pred             -ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch---hHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          433 -KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       433 -~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                       ...+||.+|||||+++  +..|+...|+|||||+||||+.|+.||....   ..+.+.+.....+..++...|+++++|
T Consensus       343 ~~~rvGT~GYMAPEvl~--ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQ--NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             cccccCcccccCHHHHc--CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence             4458999999999984  4459999999999999999999999996433   344455555566677789999999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      ...+|++||.+|.     .++++.+||||+..
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            9999999999996     47799999999863

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-37  Score=310.94  Aligned_cols=245  Identities=25%  Similarity=0.447  Sum_probs=205.4

Q ss_pred             CeeeeeEeccCCceEEEEEEec-CCc---eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-DGF---FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-~g~---~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      +|+..+.||+|+||.||+|... ++.   .+|+|.+....    .......+.+|+.++.+++|+||+++++++.+....
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            6788899999999999999863 333   78999875321    123345678999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          354 FIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |++|||+.+++|..++.+  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999998865  357888999999999999999999999999999999999999999999999987543222


Q ss_pred             cc-----cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          432 VK-----SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       432 ~~-----~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                      ..     ....+..|+|||++.  ...++.++|||||||++|||++ |..||...........+..+.....+..++..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  239 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIA--YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV  239 (268)
T ss_pred             ccceeccCCCcCceecCHHHhh--cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            11     112345799999873  4567899999999999999997 999998777666666666665555566789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+++.+||+.+|++||++.+|++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.8e-38  Score=319.72  Aligned_cols=264  Identities=30%  Similarity=0.520  Sum_probs=209.3

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      ..+++|++.+.||+|+||.||+|.+. ++..||||.+.....    ......+..|+.++.+. .|+||+++++++.+..
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            34568999999999999999999885 599999999864322    12233455666655555 4999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ..|++|||+.+ +|..++..  ..+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++.++|+|||++....
T Consensus        88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99999999854 77776654  357888889999999999999997 599999999999999999999999999987543


Q ss_pred             cCC-cccCCCCCcccChhhhhccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHhhcCCCCCCC--CcCC
Q 043852          429 MND-VKSCKGTPFWMAPEVVNLKN--RGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKGEPPLVP--NSLS  502 (551)
Q Consensus       429 ~~~-~~~~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-~~~~~~i~~~~~~~~~--~~~s  502 (551)
                      ... .....++..|+|||.+....  ..++.++||||||+++|+|++|+.||..... .+.+.++.....+..+  ..++
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T cd06618         167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS  246 (296)
T ss_pred             CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence            222 22334788999999974332  3478899999999999999999999976433 3444444444333333  2478


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                      ..+.+|+.+||+.||++||++.+++.||||+....+...+
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~  286 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV  286 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHHHH
Confidence            9999999999999999999999999999999877665543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-37  Score=320.13  Aligned_cols=253  Identities=36%  Similarity=0.631  Sum_probs=210.3

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |...+.||+|+||+||+|++ .+|..|++|++.....  ........+.+|+.++..++|+||+++++++.+....|++|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            55667899999999999987 5789999999865432  22344557788999999999999999999999999999999


Q ss_pred             ecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccC
Q 043852          358 ELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC  435 (551)
Q Consensus       358 Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  435 (551)
                      ||+.+ +|.+++..  ..+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++....  .....
T Consensus       101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--~~~~~  177 (313)
T cd06633         101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--PANSF  177 (313)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--CCCCc
Confidence            99965 66666543  458888999999999999999999999999999999999999999999999986432  22345


Q ss_pred             CCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC-CCCcCCHHHHHHHHHhh
Q 043852          436 KGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPNSLSRDARDFILKCL  513 (551)
Q Consensus       436 ~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~LI~~cL  513 (551)
                      .|+..|+|||++.. ....++.++|||||||++|+|++|..||...+.......+.....+. ....++..+.+|+.+||
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  257 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL  257 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHc
Confidence            68899999998732 23457889999999999999999999998877666666655444333 33457888999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCcc
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +.+|.+||++.+++.||||+...
T Consensus       258 ~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         258 QKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             cCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-38  Score=308.20  Aligned_cols=243  Identities=35%  Similarity=0.570  Sum_probs=209.2

Q ss_pred             eccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      ||+|+||.||++.+ .++..+|+|++.....  ........+..|+.++++++|+||+++++.+......|++|||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            79999999999987 4689999998865432  22334567789999999999999999999999999999999999999


Q ss_pred             chHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccCCCCCc
Q 043852          364 SLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPF  440 (551)
Q Consensus       364 sL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~~GT~~  440 (551)
                      +|.+++... .+++..+..++.||+.||.|||+.+++|+||+|.||+++.++.++|+|||++......  ......++..
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence            999988765 6889999999999999999999999999999999999999999999999998765443  2344568889


Q ss_pred             ccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCC
Q 043852          441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR  520 (551)
Q Consensus       441 Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~R  520 (551)
                      |++||.+.  ...++.++|+||||+++|+|++|..||...+.......+.. .....+..++..+.+++.+||..||++|
T Consensus       159 ~~~Pe~~~--~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         159 YLAPEVLL--GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             ccChHHhC--CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            99999873  44578899999999999999999999987766555555554 3355677789999999999999999999


Q ss_pred             CCH---HHHHhCccc
Q 043852          521 PTA---AQLMEHPFV  532 (551)
Q Consensus       521 PS~---~eILehpff  532 (551)
                      |++   .++++||||
T Consensus       236 ~~~~~~~~l~~~~~f  250 (250)
T cd05123         236 LGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCcccHHHHHhCCCC
Confidence            999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.3e-38  Score=310.14  Aligned_cols=239  Identities=34%  Similarity=0.582  Sum_probs=199.5

Q ss_pred             eEeccCCceEEEEEEec--CC--ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          283 ELLGSGSFGTVYEGYTD--DG--FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~--~g--~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      +.||+|+||.||+|.+.  ++  ..||||.+......    .....+.+|+.++.+++|+||+++++.+.+ ..++++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            36899999999999863  23  36899988643322    556678899999999999999999999888 88999999


Q ss_pred             cccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----
Q 043852          359 LVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  431 (551)
Q Consensus       359 y~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----  431 (551)
                      |+.+++|.+++...   .+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++......    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999999988654   47889999999999999999999999999999999999999999999999987654321    


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhc-CCCCCCCCcCCHHHHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDF  508 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l~~L  508 (551)
                       .....++..|+|||++  ....++.++|||||||++|+|++ |..||......+....+.. ......+..++..+.++
T Consensus       156 ~~~~~~~~~~y~~pE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (257)
T cd05040         156 MEEHLKVPFAWCAPESL--RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV  233 (257)
T ss_pred             cccCCCCCceecCHHHh--cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence             1123467789999986  34568899999999999999998 9999987766665555442 33334456688999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 043852          509 ILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||+.+|.+|||+.++++
T Consensus       234 i~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         234 MLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=307.84  Aligned_cols=240  Identities=27%  Similarity=0.471  Sum_probs=202.9

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecccc
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTK  362 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g  362 (551)
                      ++||+|+||.||++.+..++.||+|.+......    .....+.+|+.+++++.|+||+++++++.+....+++|||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            369999999999998766999999987643221    3455788999999999999999999999999999999999999


Q ss_pred             cchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc----cCC
Q 043852          363 GSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----SCK  436 (551)
Q Consensus       363 gsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~----~~~  436 (551)
                      ++|.+++.+.  .++...+..++.|++.+|.|||+++++|+||||+|||++.++.++|+|||++.........    ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9999988653  4788889999999999999999999999999999999999999999999998754322111    122


Q ss_pred             CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhc
Q 043852          437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV  515 (551)
Q Consensus       437 GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~  515 (551)
                      ++..|+|||.+  ....++.++|+|||||++|+|++ |..||...........+........+..++..+.+++.+||+.
T Consensus       157 ~~~~y~~PE~~--~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         157 IPIKWTAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             ceeccCChHhh--ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhcc
Confidence            35679999987  34568899999999999999998 8999987776666666665555556677899999999999999


Q ss_pred             CCCCCCCHHHHHh
Q 043852          516 NPNDRPTAAQLME  528 (551)
Q Consensus       516 DP~~RPS~~eILe  528 (551)
                      +|.+|||+.++++
T Consensus       235 ~p~~Rp~~~ell~  247 (251)
T cd05041         235 DPENRPSFSEIYN  247 (251)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.7e-38  Score=328.95  Aligned_cols=246  Identities=27%  Similarity=0.475  Sum_probs=200.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC-
Q 043852          278 SWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD-  349 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-  349 (551)
                      +|++++.||+|+||.||+|..      .+++.||+|++....    .......+.+|+.++.++ +|+||+++++++.. 
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            688999999999999999963      235789999885321    123345677899999999 79999999998754 


Q ss_pred             CCeEEEEEecccccchHHHHhh----------------------------------------------------------
Q 043852          350 ENRLFIFLELVTKGSLANLYQK----------------------------------------------------------  371 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~----------------------------------------------------------  371 (551)
                      ...++++|||+.+++|.+++..                                                          
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            4678999999999999988742                                                          


Q ss_pred             ----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----cccCCCCCcccC
Q 043852          372 ----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMA  443 (551)
Q Consensus       372 ----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~A  443 (551)
                          ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......    .....++..|+|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                246788899999999999999999999999999999999999999999999997653222    223345678999


Q ss_pred             hhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHH-HHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCC
Q 043852          444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQAL-FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRP  521 (551)
Q Consensus       444 PEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RP  521 (551)
                      ||++  ....++.++|||||||++|||++ |..||.+....+.+ ..+..+.....+..++..+.+++.+||+.+|++||
T Consensus       244 PE~~--~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         244 PESI--FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             cHHh--cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            9987  45678999999999999999997 99999764433332 33444445555677889999999999999999999


Q ss_pred             CHHHHHhC
Q 043852          522 TAAQLMEH  529 (551)
Q Consensus       522 S~~eILeh  529 (551)
                      ++.+|++|
T Consensus       322 s~~ell~~  329 (337)
T cd05054         322 TFSELVEI  329 (337)
T ss_pred             CHHHHHHH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-37  Score=311.34  Aligned_cols=246  Identities=26%  Similarity=0.459  Sum_probs=205.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CC---ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DG---FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g---~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..|++.+.||+|+||.||+|... ++   ..||||.+...    ........+..|+.++++++||||+++++++.+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            46889999999999999999863 33   36999987532    123345678899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      ++++|||+.+++|..++..  ..++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999999998864  34788899999999999999999999999999999999999999999999998654322


Q ss_pred             Cc----c-cCC--CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCC
Q 043852          431 DV----K-SCK--GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS  502 (551)
Q Consensus       431 ~~----~-~~~--GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  502 (551)
                      ..    . ...  .+..|+|||.+  ....++.++|||||||++|||++ |..||...........+........+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  237 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCP  237 (269)
T ss_pred             ccccccccccCCCcceeecCHhHh--ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCC
Confidence            11    1 111  23579999997  35578999999999999999886 999998777666666666555555566789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..+.+++.+||+.+|.+||++.+|+.
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         238 TALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-37  Score=323.58  Aligned_cols=247  Identities=27%  Similarity=0.469  Sum_probs=206.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEec--------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeec
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD--------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTD  347 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  347 (551)
                      .+|++++.||+|+||.||++.+.        .+..||+|.+...    ........+.+|+.++.++ +|+||+++++++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            37999999999999999999742        1236899977532    1223456788999999999 799999999999


Q ss_pred             cCCCeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE
Q 043852          348 KDENRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV  410 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl  410 (551)
                      .....+|++|||+.+++|.+++.+.                 .++...+..++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            9999999999999999999988642                 25667788899999999999999999999999999999


Q ss_pred             cCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 043852          411 DASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQA  485 (551)
Q Consensus       411 ~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~  485 (551)
                      +.++.+||+|||+++......    .....++..|+|||++  ....++.++|||||||++|||++ |..||.+.+....
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh--ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999987543321    1122245679999987  45678899999999999999998 8999988777666


Q ss_pred             HHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          486 LFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       486 ~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...+........+..++..+.+|+.+||+.+|.+|||+.+|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            66666666666677789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-37  Score=315.42  Aligned_cols=257  Identities=31%  Similarity=0.468  Sum_probs=207.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCe
Q 043852          278 SWQKGELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  352 (551)
                      +|++.+.||+|+||.||+++.    .++..||||++..... .........+.+|+.++.++ +|+||+++++.+.....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            478899999999999999874    3678899999864322 12223445677899999999 59999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|+||||+.+++|..++.. ..+++..+..++.|++.+|.|||+.|++|+||||.||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            9999999999999888764 458889999999999999999999999999999999999999999999999987543322


Q ss_pred             ---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh----HHHHHHhhcCCCCCCCCcCCHH
Q 043852          432 ---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       432 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                         .....|+..|++||.+......++.++||||||+++|+|++|..||.....    ......+... ....+..++..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  238 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKTMSAE  238 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCCCcccCHH
Confidence               123458899999999743333478899999999999999999999953221    1222222222 24456678999


Q ss_pred             HHHHHHHhhhcCCCCCCC---HHHHHhCcccCCcc
Q 043852          505 ARDFILKCLQVNPNDRPT---AAQLMEHPFVKRPL  536 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS---~~eILehpff~~~~  536 (551)
                      +.++|.+||+.||++|||   +.++|+||||+..-
T Consensus       239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             HHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            999999999999999998   56789999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.8e-37  Score=320.01  Aligned_cols=257  Identities=36%  Similarity=0.619  Sum_probs=213.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|...+.||+|+||.||++++ .++..+|+|++......  .......+.+|+.++++++|+|++++++++.+....|++
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            367788999999999999987 57899999988644222  234456788999999999999999999999999999999


Q ss_pred             EecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          357 LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      |||+.+ +|.+++.  ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....  ...
T Consensus       104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~~  180 (317)
T cd06635         104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--ANS  180 (317)
T ss_pred             EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--ccc
Confidence            999976 6666653  34588899999999999999999999999999999999999999999999999865432  234


Q ss_pred             CCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-CCCCCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-PLVPNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~l~~LI~~c  512 (551)
                      ..|++.|+|||++.. ....++.++|||||||++|+|++|+.||........+..+..... ......++..+.+|+.+|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            468899999998632 234578899999999999999999999987776666666655443 333456788999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      |+.+|.+||++.++++|+|+.....+.
T Consensus       261 l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         261 LQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             ccCCcccCcCHHHHHhChhhhccCccc
Confidence            999999999999999999997655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-37  Score=312.84  Aligned_cols=240  Identities=25%  Similarity=0.485  Sum_probs=197.5

Q ss_pred             eEeccCCceEEEEEEe-cCCc--eEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEEEe
Q 043852          283 ELLGSGSFGTVYEGYT-DDGF--FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~--~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      +.||+|+||.||+|.. .++.  .+++|.+...    ........+.+|+.++.++ +||||+++++++.....+|++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3689999999999987 3444  4677766421    1223345677899999999 79999999999999999999999


Q ss_pred             cccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          359 LVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       359 y~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                      |+.+++|.+++...                 .++...+..++.||+.||+|||++|++|+||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            99999999988643                 3678889999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCc-ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCC
Q 043852          422 GLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPN  499 (551)
Q Consensus       422 Gla~~~~~~~~-~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  499 (551)
                      |++........ .....+..|+|||++  ....++.++|||||||++|+|++ |..||...+.......+..+.....+.
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHH--ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            99853321111 112235679999987  45568999999999999999997 999998776666666666655555666


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .++..+.+|+.+||+.||.+|||+.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            78899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-37  Score=316.39  Aligned_cols=246  Identities=29%  Similarity=0.433  Sum_probs=202.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-----------------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-----------------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN  339 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-----------------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn  339 (551)
                      .+|++++.||+|+||.||++.+.                 .+..||+|.+....    .......+.+|+.++.+++|+|
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----SDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhcCCCC
Confidence            47899999999999999998753                 12458899876432    1244567889999999999999


Q ss_pred             eeeeeeeccCCCeEEEEEecccccchHHHHhhh------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccce
Q 043852          340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKY------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN  407 (551)
Q Consensus       340 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~N  407 (551)
                      |+++++++......+++|||+.+++|..++.+.            .+++..++.++.||+.||.|||++||+|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            999999999999999999999999999988654            37888999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc--CCCCCCCch
Q 043852          408 ILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLE  481 (551)
Q Consensus       408 ILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt--G~~Pf~~~~  481 (551)
                      |+++.++.++|+|||+++......    .....+++.|+|||++.  ...++.++|||||||++|+|++  +..||....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL--LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh--cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999987543332    22334677899999873  4568999999999999999998  788887766


Q ss_pred             hHHHHHHhhcC-------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          482 GMQALFRIGKG-------EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       482 ~~~~~~~i~~~-------~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..+.+..+...       .....+..++.++.+|+.+||+.||.+|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            65555444322       112234457899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-38  Score=347.43  Aligned_cols=259  Identities=26%  Similarity=0.353  Sum_probs=192.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec--CCceEEEEEEecC------------ccCccchHHHHHHHHHHHHHhcCCCCcee
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQ------------DQGTQGKQSILQLEQEILLLSRFEHENIV  341 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~--~g~~vAVK~i~~~------------~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  341 (551)
                      +.+|++++.||+|+||+||++...  .+...++|.+...            ............+.+|+.++.+++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998642  3333333321110            00111223455678999999999999999


Q ss_pred             eeeeeccCCCeEEEEEecccccchHHHHhhhc------CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc
Q 043852          342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS  415 (551)
Q Consensus       342 ~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~  415 (551)
                      ++++++.+....|++++++.+ +|..++....      .....+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999965 5655553322      335567889999999999999999999999999999999999


Q ss_pred             EEEEecCCccccccCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCC-CCCc--hhHHHHHHh
Q 043852          416 VKLADFGLAKATTMND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPP-YSHL--EGMQALFRI  489 (551)
Q Consensus       416 vkL~DFGla~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~P-f~~~--~~~~~~~~i  489 (551)
                      +||+|||+++......   .....||+.|+|||++  .+..++.++|||||||++|||++|..+ |...  .....+.++
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL--AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            9999999997654322   2235699999999997  456789999999999999999998754 4321  122222221


Q ss_pred             hcCC----------------------CC----CC-----CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          490 GKGE----------------------PP----LV-----PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       490 ~~~~----------------------~~----~~-----~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ....                      ..    .+     ...++..+.++|.+||+.||.+|||+.|+|.||||.....
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~  462 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE  462 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence            1100                      00    00     1135677888999999999999999999999999986543

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-37  Score=318.68  Aligned_cols=247  Identities=27%  Similarity=0.473  Sum_probs=203.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeecc
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDK  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  348 (551)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+.....    ......+.+|+.+++++ +|+||+++++.+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            34799999999999999999864      2456799998753221    23345678999999999 7999999999999


Q ss_pred             CCCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          349 DENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      .....|++|||+.+++|.++++..   .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||+++
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999999988653   27889999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH-hhcCCCCCCCC
Q 043852          426 ATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFR-IGKGEPPLVPN  499 (551)
Q Consensus       426 ~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~-i~~~~~~~~~~  499 (551)
                      .......    ....++..|+|||.+  ....++.++|||||||++|+|++ |..||..........+ +..+.....+.
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhh--ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            5533221    123356789999987  34567899999999999999998 9999977655443333 33344444556


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..+..+.+|+.+||+++|++|||+.+|++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            68899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-37  Score=311.24  Aligned_cols=246  Identities=28%  Similarity=0.474  Sum_probs=206.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEecC----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDD----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .+|.+.++||+|+||.||+|.+.+    ...+|||.+....    .......+.+|+.+++++.|+||+++++++.+ ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            368899999999999999997632    3468888775322    13345577899999999999999999998875 45


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .|++|||+.+++|.+++.+.  .++...+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            78999999999999998754  4788999999999999999999999999999999999999999999999998755433


Q ss_pred             Ccc---cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          431 DVK---SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       431 ~~~---~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                      ...   ...++..|+|||.+  ....++.++|||||||++|+|++ |..||......+....+.++.....+..++..+.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  238 (270)
T ss_pred             cceecCCCCccccccChhhh--ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence            211   12234679999986  34568899999999999999986 9999988877777777777777777788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ++|.+||..+|.+|||+.+++..
T Consensus       239 ~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         239 SLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999998863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-37  Score=309.67  Aligned_cols=241  Identities=29%  Similarity=0.544  Sum_probs=203.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +.+|++.+.||+|+||.||++. .++..||+|.+....       ....+.+|+.++..++|+||+++++++.... .|+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~   75 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYI   75 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc-cCCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEE
Confidence            4579999999999999999985 477889999875321       1245778999999999999999999987654 799


Q ss_pred             EEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      +|||+.+++|.+++...   .++...+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-~  154 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-V  154 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-C
Confidence            99999999999988653   3788889999999999999999999999999999999999999999999998654322 2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....+..|+|||.+  ....++.++|+|||||++|+|++ |.+||......+....+..+.....+..++..+.+++.+
T Consensus       155 ~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         155 DNSKLPVKWTAPEAL--KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             CCCCCCceecCHHHh--ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence            223345679999987  34568899999999999999997 999998877666666666666555667789999999999


Q ss_pred             hhhcCCCCCCCHHHHHh
Q 043852          512 CLQVNPNDRPTAAQLME  528 (551)
Q Consensus       512 cL~~DP~~RPS~~eILe  528 (551)
                      ||+.+|++||++++|++
T Consensus       233 ~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         233 CWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.4e-37  Score=310.00  Aligned_cols=240  Identities=27%  Similarity=0.439  Sum_probs=190.8

Q ss_pred             EeccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          284 LLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      .||+|+||.||+|...   ....+|+|.+...    ........+.+|+.+++.++|+||+++++.+.+...+|++|||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            5999999999999653   3346777765422    22334456778999999999999999999999999999999999


Q ss_pred             cccchHHHHhhhc------CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          361 TKGSLANLYQKYH------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       361 ~ggsL~~ll~~~~------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      .+|+|.+++....      ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999999886532      3466778999999999999999999999999999999999999999999986532221   


Q ss_pred             -cccCCCCCcccChhhhhcc-----cCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC-----CCCCC
Q 043852          432 -VKSCKGTPFWMAPEVVNLK-----NRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP-----PLVPN  499 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~  499 (551)
                       .....++..|+|||++...     ...++.++|||||||++|||++ |..||......+.+..+.....     +..+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence             1223356779999997432     3456889999999999999998 8889987766655544333221     22344


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .++..+.+++..|| .||++|||+++|++
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            67889999999999 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-37  Score=324.50  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=204.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      .+|.+.+.||+|+||.||+|.+ .+|..||||++......   ......+.+|+.++..++|+||+++++++...     
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS---EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc---ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            4799999999999999999987 57999999988643221   22234567899999999999999999987654     


Q ss_pred             -CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 -NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 -~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                       ..+|+++||+.. +|..+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             CceEEEEeccccc-CHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence             346999999964 6666543 3688899999999999999999999999999999999999999999999999875432


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC---------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP---------------  494 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~---------------  494 (551)
                       ......+|+.|+|||++. ....++.++|||||||++|||++|+.||.+.+....+..+.....               
T Consensus       170 -~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         170 -EMTGYVVTRWYRAPEVIL-NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             -CCCCceeeecccChhhhc-CccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence             223345788999999873 334578899999999999999999999987665544433322100               


Q ss_pred             -------CCC--------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          495 -------PLV--------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       495 -------~~~--------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                             +..        ...++..+.+||.+||+.||.+||++.+++.||||+.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                   000        12467789999999999999999999999999999977654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-37  Score=321.84  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=211.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-CCeE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-ENRL  353 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~  353 (551)
                      .++|++.+.||.|+||.||++.+ .++..||||++......   ......+.+|+.++..++||||+++++++.. ....
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST---PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc---cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            35799999999999999999987 58999999988643221   2234456789999999999999999998865 5678


Q ss_pred             EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      |++|||+ +++|..+++...++...+..++.||+.||.|||++||+|+||+|.|||++.++.++|+|||++..... ...
T Consensus        86 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-~~~  163 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-QMT  163 (328)
T ss_pred             EEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-CcC
Confidence            9999999 56899888877888888999999999999999999999999999999999999999999999875432 223


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc----------------------
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK----------------------  491 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~----------------------  491 (551)
                      ...+++.|+|||++. ....++.++|||||||++|+|++|+.||...........+.+                      
T Consensus       164 ~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd07856         164 GYVSTRYYRAPEIML-TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV  242 (328)
T ss_pred             CCcccccccCceeee-ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence            445788999999863 335689999999999999999999999976554222111100                      


Q ss_pred             -----CCCCC---CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          492 -----GEPPL---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       492 -----~~~~~---~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                           .....   ....++..+.++|.+||+.+|++|||+.+++.||||++.......+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~  301 (328)
T cd07856         243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP  301 (328)
T ss_pred             hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence                 00000   1134788999999999999999999999999999998777665553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-37  Score=354.59  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=201.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|+++++||+|+||.||+|.+ .+|..||||++....  ........++.+|+.++.+++||||+++++++.+.+..|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly   78 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY   78 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence            46899999999999999999987 579999999986432  222344567889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecC
Q 043852          355 IFLELVTKGSLANLYQKY------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                      ++|||++|++|.+++...            .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999999887531            24456678899999999999999999999999999999999999999999


Q ss_pred             CccccccC--------------------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 043852          423 LAKATTMN--------------------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG  482 (551)
Q Consensus       423 la~~~~~~--------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~  482 (551)
                      +++.....                    ......||+.|+|||++  .+..++.++|||||||++|||+||..||.....
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l--~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh--cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            99754111                    01124699999999987  456789999999999999999999999977554


Q ss_pred             HHHHHHhhcCCCCC--CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          483 MQALFRIGKGEPPL--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       483 ~~~~~~i~~~~~~~--~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...........+..  ....++..+.+++.+||+.||++|++..+.+.+
T Consensus       237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43332221111111  123678999999999999999999876655543

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.3e-37  Score=315.35  Aligned_cols=245  Identities=26%  Similarity=0.415  Sum_probs=197.5

Q ss_pred             CeeeeeEeccCCceEEEEEEec-----------------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-----------------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI  340 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-----------------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI  340 (551)
                      +|++.+.||+|+||.||++.+.                 ++..+|+|.+....    .......+.+|+.++..++|+||
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCc
Confidence            6899999999999999998532                 34578999875321    23345578899999999999999


Q ss_pred             eeeeeeccCCCeEEEEEecccccchHHHHhhhc------------CChHHHHHHHHHHHHHHHHHHhCCeeecccccceE
Q 043852          341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYH------------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANI  408 (551)
Q Consensus       341 v~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~------------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NI  408 (551)
                      +++++++.+....+++|||+.+++|.+++.+..            +++..+..++.||+.||.|||+.||+|+||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999886532            45567999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc--CCCCCCCchh
Q 043852          409 LVDASGSVKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLEG  482 (551)
Q Consensus       409 Ll~~~g~vkL~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt--G~~Pf~~~~~  482 (551)
                      |++.++.++|+|||+++.......    ....++..|++||+.  ....++.++|||||||++|||++  |..||.....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI--LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH--hcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999999999999999875433221    122345789999986  34568999999999999999998  7889976655


Q ss_pred             HHHHHHhh-------cCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          483 MQALFRIG-------KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       483 ~~~~~~i~-------~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+.+....       .......+..++..+.+|+.+||+.||.+|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            44333221       11122334568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=311.32  Aligned_cols=248  Identities=31%  Similarity=0.520  Sum_probs=198.5

Q ss_pred             eeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC---CCCceeeeeeeccCCCe--
Q 043852          279 WQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF---EHENIVQYFGTDKDENR--  352 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~--  352 (551)
                      |++.+.||+|+||.||+|++. ++..||+|++.......   .....+.+|+.++.++   .|+||+++++++.+...  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE---GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc---hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            678899999999999999884 68999999987543321   1223344666665554   69999999999887776  


Q ss_pred             ---EEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          353 ---LFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       353 ---~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                         ++++|||+.+ +|.+++...   .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence               9999999975 787777542   488999999999999999999999999999999999999999999999999876


Q ss_pred             cccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-----------
Q 043852          427 TTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-----------  494 (551)
Q Consensus       427 ~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-----------  494 (551)
                      ..... .....++..|+|||++  ....++.++|+|||||++|+|++|.+||......+.+.++.....           
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVL--LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             ccCCcccccccccccccChHHh--ccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            54332 2334578899999997  345678899999999999999999999987766555444322100           


Q ss_pred             ---------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          495 ---------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       495 ---------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                     ......++..+.++|.+||+.||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                           00011345778899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=316.33  Aligned_cols=246  Identities=26%  Similarity=0.397  Sum_probs=198.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEecC---------------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCcee
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDD---------------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV  341 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~---------------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv  341 (551)
                      .+|++.+.||+|+||.||++.+..               ...||+|.+....    .......+.+|+.++.+++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            378999999999999999986532               2358999875321    223445688999999999999999


Q ss_pred             eeeeeccCCCeEEEEEecccccchHHHHhhh-------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceE
Q 043852          342 QYFGTDKDENRLFIFLELVTKGSLANLYQKY-------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANI  408 (551)
Q Consensus       342 ~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~-------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NI  408 (551)
                      ++++++......+++|||+.+++|.+++...             .+++..+..++.||+.||.|||++|++|+||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9999999999999999999999999988543             256778889999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc--CCCCCCCchh
Q 043852          409 LVDASGSVKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLEG  482 (551)
Q Consensus       409 Ll~~~g~vkL~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt--G~~Pf~~~~~  482 (551)
                      +++.++.+||+|||++........    ....++..|+|||++  ....++.++|||||||++|+|++  +..||.....
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI--LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh--ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999875433221    222346789999986  34568999999999999999988  6778876655


Q ss_pred             HHHHHHhh-------cCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          483 MQALFRIG-------KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       483 ~~~~~~i~-------~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+.+..+.       .......+..++..+.+|+.+||+.||++|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            44433321       11122334567899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=335.31  Aligned_cols=249  Identities=32%  Similarity=0.491  Sum_probs=215.5

Q ss_pred             eeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          282 GELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      .++||.|-||+||-|++ ++|+.||||+|.+..-..++.   .++.+|+.||.+++||.||.+.-.|++...+++|||.+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe---sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl  645 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE---SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL  645 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchH---HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence            47999999999999998 799999999998765544433   57789999999999999999999999999999999999


Q ss_pred             cccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC---cEEEEecCCccccccCC-ccc
Q 043852          361 TKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKATTMND-VKS  434 (551)
Q Consensus       361 ~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g---~vkL~DFGla~~~~~~~-~~~  434 (551)
                      .|..|.-++.  ++.+++.....++.||+.||.|||.+||+|+||||+|||+....   ++||||||+|+...... ..+
T Consensus       646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs  725 (888)
T KOG4236|consen  646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS  725 (888)
T ss_pred             cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence            8877776664  56799998899999999999999999999999999999997653   79999999999887765 457


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-HHHHHhhcCCCCCCCCcCCHHHHHHHHHhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKGEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      .+|||.|+|||++  .+++|+...||||+|+|+|--++|.-||...++. +++.....-.++.....++..+.+||..+|
T Consensus       726 VVGTPAYLaPEVL--rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL  803 (888)
T KOG4236|consen  726 VVGTPAYLAPEVL--RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL  803 (888)
T ss_pred             hcCCccccCHHHH--hhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence            7899999999997  5778999999999999999999999999765543 333333333455555679999999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCc
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~  535 (551)
                      +..-.+|.|..+.|.|||+|..
T Consensus       804 qVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  804 QVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHhcchHhhccchhhhcc
Confidence            9999999999999999999864

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-37  Score=321.36  Aligned_cols=257  Identities=28%  Similarity=0.464  Sum_probs=201.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cC--CceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeecc----C
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DD--GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDK----D  349 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~--g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~----~  349 (551)
                      +|.+.+.||+|+||.||++.+ .+  +..||+|++.....   .......+.+|+.++.++ +|+||+++++.+.    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            478899999999999999987 34  88999998863221   122344667899999998 5999999998643    2


Q ss_pred             CCeEEEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ...+|++++|+. ++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            345789999986 47877664 4568899999999999999999999999999999999999999999999999987543


Q ss_pred             cCC------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc-----------
Q 043852          429 MND------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-----------  491 (551)
Q Consensus       429 ~~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~-----------  491 (551)
                      ...      .....||+.|+|||++. ....++.++|||||||++|+|++|++||........+..+..           
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             cccccccccccCcccCccccCcHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            221      22346899999999863 335678999999999999999999999976543322221111           


Q ss_pred             ----------------CCC---CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          492 ----------------GEP---PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       492 ----------------~~~---~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                                      ...   ......++..+.+|+.+||+.||.+|||+.+++.||||+......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~  302 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPD  302 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcc
Confidence                            000   011224678999999999999999999999999999998665443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=312.87  Aligned_cols=249  Identities=32%  Similarity=0.534  Sum_probs=204.8

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |+..+.||+|+||.||+|+. .+++.||+|++.....   .......+..|+.++++++|+||+++++++.+...++++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            56778999999999999987 4699999999875431   1223345668999999999999999999999999999999


Q ss_pred             ecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--cc
Q 043852          358 ELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK  433 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~  433 (551)
                      ||+.+ +|.+++.+.  .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            99985 899988765  68999999999999999999999999999999999999999999999999987654322  22


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--------------------
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--------------------  493 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--------------------  493 (551)
                      ...++..|+|||++. ....++.++|||||||++|+|++|.+||........+.++....                    
T Consensus       157 ~~~~~~~~~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         157 HEVVTLWYRAPEILL-GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             ccccCcCcCChHHhc-CCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            334677899999974 33467899999999999999999999998766555444332110                    


Q ss_pred             CC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          494 PP--------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       494 ~~--------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      .+        .....++..+.++|.+||..||++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            00        0012347789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.8e-37  Score=306.65  Aligned_cols=240  Identities=27%  Similarity=0.495  Sum_probs=197.2

Q ss_pred             eEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc-CCCeEEEEE
Q 043852          283 ELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK-DENRLFIFL  357 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~  357 (551)
                      +.||+|+||.||+|.+.    .+..+|+|.+...    ........+.+|+.+++.++||||+++++++. .+...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            36899999999999752    3457999976421    12334567788999999999999999999764 456689999


Q ss_pred             ecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----
Q 043852          358 ELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----  431 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----  431 (551)
                      ||+.+++|.+++.+.  .+....+..++.||+.||.|||+.+++|+||||+|||++.++.+||+|||+++......    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999998653  35667788899999999999999999999999999999999999999999987543211    


Q ss_pred             --cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                        .....++..|+|||.+  ....++.++|||||||++|||++ |.+||......+....+..+.....+..++..+.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         157 HNHTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             cccccCcCCccccChhHh--ccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence              1233467789999987  34578999999999999999999 567787777666666666666666667789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 043852          509 ILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||+.+|++||++.+|++
T Consensus       235 i~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-37  Score=313.29  Aligned_cols=246  Identities=30%  Similarity=0.484  Sum_probs=198.3

Q ss_pred             CeeeeeEeccCCceEEEEEEe-----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  350 (551)
                      -|++++.||+|+||.||++..     .++..||+|.+....    .......+.+|+.+++.+.|+||+++++++.+.  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            367889999999999999873     468899999875332    233455788999999999999999999988765  


Q ss_pred             CeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ...+++|||+++++|.+++.+.  .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++...
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            5689999999999999988653  47889999999999999999999999999999999999999999999999987554


Q ss_pred             cCC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch---------------hHHHHHH
Q 043852          429 MND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---------------GMQALFR  488 (551)
Q Consensus       429 ~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---------------~~~~~~~  488 (551)
                      ...     .....++..|+|||++  .+..++.++|||||||++|+|+++..|+....               .......
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHh--ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            322     1234467789999986  34568899999999999999999876542210               0111222


Q ss_pred             hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       489 i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +..+.....+..++..+.+|+.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            33344444566789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=316.20  Aligned_cols=250  Identities=30%  Similarity=0.450  Sum_probs=206.7

Q ss_pred             eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC----CCeEEEE
Q 043852          283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD----ENRLFIF  356 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~~lV  356 (551)
                      ++||-|-.|.|..+.+ .+++.||+|++.-.          .+.++|+.+.-.. .|+|||.++++|.+    ...+.+|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC----------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            5799999999999987 68999999987421          1344677665444 59999999998764    4568899


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CCcEEEEecCCccccc-c
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATT-M  429 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g~vkL~DFGla~~~~-~  429 (551)
                      ||.++||.|+..++..   .+++.++..+++||+.|+.|||+.+|.||||||+|+|...   |..+||+|||+|+... .
T Consensus       138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            9999999999988754   3899999999999999999999999999999999999975   4579999999999765 4


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh----HHHHHHhhcCCCCCCC---CcCC
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEPPLVP---NSLS  502 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~---~~~s  502 (551)
                      ....+-+.||+|.|||++  ....|+..+|+||+|+++|.|++|.+||.....    ..+..+|..+...+..   ..+|
T Consensus       218 ~~L~TPc~TPyYvaPevl--g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS  295 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS  295 (400)
T ss_pred             ccccCCcccccccCHHHh--CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence            556777899999999997  566799999999999999999999999965543    2344566666544332   4589


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCCCC
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS  544 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~~~  544 (551)
                      +.++++|+.+|..+|.+|.|++++++|||+.+...-...|.+
T Consensus       296 e~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  296 EAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             HHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence            999999999999999999999999999999876554444443

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=313.12  Aligned_cols=248  Identities=29%  Similarity=0.505  Sum_probs=201.5

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV  356 (551)
                      |++.+.||+|+||.||+|+. .++..|+||.+......    .......+|+..+.++. |+||+++++++.+....|++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            67789999999999999987 46889999987643221    11223446888999999 99999999999999999999


Q ss_pred             EecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-Cc
Q 043852          357 LELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~  432 (551)
                      |||+ +++|.+++...   .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||+++..... ..
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 77888877543   5789999999999999999999999999999999999999999999999998765432 23


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC-----------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-----------------  495 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  495 (551)
                      ....++..|+|||++. ....++.++|+||||+++|+|++|++||..........++......                 
T Consensus       156 ~~~~~~~~~~aPE~~~-~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         156 TDYVSTRWYRAPEILL-RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             CCCCCcccccCceeee-cCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            3456889999999873 3445789999999999999999999999776554444332211000                 


Q ss_pred             ------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          496 ------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       496 ------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                                  ......+..+.+||.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                        0011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.3e-37  Score=307.76  Aligned_cols=250  Identities=30%  Similarity=0.553  Sum_probs=206.8

Q ss_pred             CeeeeeEeccCCceEEEEEEec--CCceEEEEEEecCccC-----ccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccC
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQG-----TQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKD  349 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~--~g~~vAVK~i~~~~~~-----~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~  349 (551)
                      .|++.+.||+|+||.||+|.+.  ++..+|+|.+......     ........++.+|+.++.+ ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            3778899999999999999874  4789999988644321     1233455667788887765 799999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCC
Q 043852          350 ENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                      ....+++|||+.+++|.+++..     ..+++..++.++.||+.+|.|||+ .+++|+||+|.||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999887642     358888999999999999999996 7899999999999999999999999999


Q ss_pred             ccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC-CcC
Q 043852          424 AKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP-NSL  501 (551)
Q Consensus       424 a~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~  501 (551)
                      +...... ......|+..|++||++.  ...++.++||||||+++|+|++|+.||...........+........+ ..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~--~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVK--NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY  238 (269)
T ss_pred             eeecccccccccccCcccCcChhhhc--CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence            8765443 234456889999999973  456799999999999999999999999776665555555554433333 367


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +..+.++|.+||+.||++||++.++.++
T Consensus       239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         239 SEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            8999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=329.17  Aligned_cols=252  Identities=29%  Similarity=0.486  Sum_probs=199.7

Q ss_pred             chhhhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          270 GKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       270 ~~~~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      ..+....+.|....+||+|+||.||+|...+|..||||++......    . ..+|.+|+.++.+++|||+|+|+|+|.+
T Consensus        68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~----~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e  142 (361)
T KOG1187|consen   68 DELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ----G-EREFLNEVEILSRLRHPNLVKLLGYCLE  142 (361)
T ss_pred             HHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc----c-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence            3455666788888999999999999999888899999976532211    1 4459999999999999999999999999


Q ss_pred             CC-eEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCC---eeecccccceEEEcCCCcEEEEecC
Q 043852          350 EN-RLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQN---VVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       350 ~~-~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~g---IiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                      .+ ..+||+||+.+|+|.+++...   .+++....+|+.++++||+|||...   |||||||++|||+|.+.+.||+|||
T Consensus       143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG  222 (361)
T KOG1187|consen  143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG  222 (361)
T ss_pred             CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence            88 599999999999999988643   6799999999999999999999854   9999999999999999999999999


Q ss_pred             Ccccccc-CCc-ccC-CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch-----hHHHH--HHhhcC
Q 043852          423 LAKATTM-NDV-KSC-KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-----GMQAL--FRIGKG  492 (551)
Q Consensus       423 la~~~~~-~~~-~~~-~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-----~~~~~--~~i~~~  492 (551)
                      +|+.... ... ... .||.+|++||++.  ....+.++||||||++|+||+||+.+.....     ....+  ..+..+
T Consensus       223 La~~~~~~~~~~~~~~~gt~gY~~PEy~~--~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  223 LAKLGPEGDTSVSTTVMGTFGYLAPEYAS--TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             CcccCCccccceeeecCCCCccCChhhhc--cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            9976553 222 222 7999999999974  3567999999999999999999998775321     11121  112222


Q ss_pred             CC-----CCCC-CcCC--H---HHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          493 EP-----PLVP-NSLS--R---DARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       493 ~~-----~~~~-~~~s--~---~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..     +.+. ...+  .   .+..+..+|++.+|..||++.||++
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11     1111 1222  2   2557788999999999999999865

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=322.51  Aligned_cols=259  Identities=27%  Similarity=0.422  Sum_probs=217.8

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDE  350 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  350 (551)
                      +..+.+|..+.+||+|+||.|.++..+ +.+.||||++++...-..  ...+--..|-++|... +-|.++.++.+|++.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd--DDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD--DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec--CcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            345668999999999999999999764 688999999875533221  1122223455566554 467899999999999


Q ss_pred             CeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc-
Q 043852          351 NRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~-  428 (551)
                      +.+|+||||+.||+|...++. +.+.+..+..|+.+|+.||-+||++|||+||||.+|||++.+|++||+|||+++.-. 
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999999999887776 458899999999999999999999999999999999999999999999999998543 


Q ss_pred             -cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHH
Q 043852          429 -MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD  507 (551)
Q Consensus       429 -~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  507 (551)
                       ...+.+.+|||.|+|||++  ....|+.++|+||+|++||||+.|++||.+.+..+....|... -..+|..+|.++.+
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi--~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-nvsyPKslSkEAv~  579 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-NVSYPKSLSKEAVA  579 (683)
T ss_pred             CCcceeeecCCCcccccceE--EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-cCcCcccccHHHHH
Confidence             3446678899999999997  6789999999999999999999999999997766666555543 46678999999999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHHhCcccCCcc
Q 043852          508 FILKCLQVNPNDRPT-----AAQLMEHPFVKRPL  536 (551)
Q Consensus       508 LI~~cL~~DP~~RPS-----~~eILehpff~~~~  536 (551)
                      +....|.+.|.+|..     -++|.+||||++.-
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            999999999999964     46799999999753

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-37  Score=308.85  Aligned_cols=245  Identities=29%  Similarity=0.486  Sum_probs=206.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CCc----eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DGF----FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g~----~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|++++.||+|+||.||+|.+. +|.    .+|+|.+....    .......+.+|+.++.+++|+||+++++++.. .
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            37899999999999999999863 343    58888764322    23455678899999999999999999999877 7


Q ss_pred             eEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..+++|||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            889999999999999988653  588999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 NDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ...    ....++..|+|||.+  ....++.++|+|||||++|||++ |..||......+....+..+.....+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             cccceecCCCcccccccCHHHh--hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            221    112235679999986  35678899999999999999998 99999887766666666666666667778999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+++.+||..||.+||++.++++
T Consensus       240 ~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         240 VYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.3e-37  Score=308.87  Aligned_cols=244  Identities=27%  Similarity=0.468  Sum_probs=195.1

Q ss_pred             CeeeeeEeccCCceEEEEEEe-----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc--CC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK--DE  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~  350 (551)
                      +|++.+.||+|+||.||++..     .++..||+|.+...     .......+.+|+.++.+++|+||+++++++.  +.
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            688899999999999999863     36889999987532     2334567889999999999999999998754  34


Q ss_pred             CeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ..++++|||+.+++|.+++.+.  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            5689999999999999988653  47889999999999999999999999999999999999999999999999987654


Q ss_pred             cCCc-----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH----------------HHHH
Q 043852          429 MNDV-----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM----------------QALF  487 (551)
Q Consensus       429 ~~~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~----------------~~~~  487 (551)
                      ....     ....++..|+|||++  .+..++.++|||||||++|||++|..++......                ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHh--ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            3221     111234469999987  3456899999999999999999987765332211                0011


Q ss_pred             HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          488 RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       488 ~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+........+..++..+.+|+.+||+.+|++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            12223333445678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-37  Score=323.40  Aligned_cols=247  Identities=27%  Similarity=0.471  Sum_probs=199.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  349 (551)
                      ++|++++.||+|+||.||+|.+      .+++.||||.+....    .......+.+|+.++.++ +|+||+++++++..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            4789999999999999999963      357899999986432    122345677899999999 68999999997754


Q ss_pred             -CCeEEEEEecccccchHHHHhhh--------------------------------------------------------
Q 043852          350 -ENRLFIFLELVTKGSLANLYQKY--------------------------------------------------------  372 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~~--------------------------------------------------------  372 (551)
                       ...++++||||.+|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             45689999999999999887532                                                        


Q ss_pred             ------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----cccCC
Q 043852          373 ------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCK  436 (551)
Q Consensus       373 ------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----~~~~~  436 (551)
                                  .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......    .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                        25667778899999999999999999999999999999999999999999987543221    12233


Q ss_pred             CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH-HHHHHhhcCCCCCCCCcCCHHHHHHHHHhhh
Q 043852          437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGM-QALFRIGKGEPPLVPNSLSRDARDFILKCLQ  514 (551)
Q Consensus       437 GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~  514 (551)
                      ++..|+|||++  ....++.++|||||||++|+|++ |..||...... .....+..+.....+..++..+.+++.+||+
T Consensus       243 ~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         243 LPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCcceECcHHh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            56779999987  35578999999999999999996 99999765433 2333444555555566688999999999999


Q ss_pred             cCCCCCCCHHHHHhC
Q 043852          515 VNPNDRPTAAQLMEH  529 (551)
Q Consensus       515 ~DP~~RPS~~eILeh  529 (551)
                      .||++|||+.+|++|
T Consensus       321 ~~p~~Rps~~eil~~  335 (343)
T cd05103         321 GEPSQRPTFSELVEH  335 (343)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.8e-37  Score=314.56  Aligned_cols=246  Identities=27%  Similarity=0.490  Sum_probs=200.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCc----eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGF----FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      ++|+..+.||+|+||.||+|.+ .+|.    .+|+|.+...    ........+.+|+.++..++|+||+++++++... 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            4788899999999999999986 3554    4677766422    2233344678899999999999999999988654 


Q ss_pred             eEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..++++||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            467999999999999988654  478889999999999999999999999999999999999999999999999975432


Q ss_pred             CC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 ND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ..    .....++..|+|||++  .+..++.++|||||||++|||++ |..||.+.........+..+.....+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECI--HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             cccccccCCCccccccCCHHHh--ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            21    1223356789999987  45678999999999999999997 99999876555444444555545556678899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+++.+||..+|++||++.++++.
T Consensus       240 ~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.7e-37  Score=316.36  Aligned_cols=255  Identities=35%  Similarity=0.609  Sum_probs=210.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|...+.||+|+||.||+|++ .++..+|+|.+......  ......++.+|+.+++.++|+|++++++++......++|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            467778999999999999987 57889999988643222  223455677899999999999999999999999999999


Q ss_pred             EecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          357 LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      |||+.+ +|.+++.  ...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~  170 (308)
T cd06634          94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NX  170 (308)
T ss_pred             EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--cc
Confidence            999974 7766553  335788899999999999999999999999999999999999999999999998654332  33


Q ss_pred             CCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC-CCCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~LI~~c  512 (551)
                      ..+++.|+|||++.. ....++.++|||||||++|+|++|..||...........+..+..+. ....++..+.+||.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            458899999998732 23457889999999999999999999998776665555555444333 3456889999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCccc
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |+.+|++||++.++++|||+.....
T Consensus       251 l~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         251 LQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             hhCCcccCCCHHHHhhCccccccCC
Confidence            9999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.5e-37  Score=329.62  Aligned_cols=250  Identities=28%  Similarity=0.441  Sum_probs=204.2

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeee
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGT  346 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~  346 (551)
                      ....+|.+++.||+|+||.||+|++.      .+..||||++.....    ......+.+|+.++.++. |+||++++++
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR----SSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC----hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            33457888999999999999999742      456899999864321    222346779999999997 9999999999


Q ss_pred             ccCCCeEEEEEecccccchHHHHhhh------------------------------------------------------
Q 043852          347 DKDENRLFIFLELVTKGSLANLYQKY------------------------------------------------------  372 (551)
Q Consensus       347 ~~~~~~~~lV~Ey~~ggsL~~ll~~~------------------------------------------------------  372 (551)
                      +.....+++|||||.+|+|.+++.+.                                                      
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            99999999999999999999988542                                                      


Q ss_pred             ---------------------------------------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccce
Q 043852          373 ---------------------------------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN  407 (551)
Q Consensus       373 ---------------------------------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~N  407 (551)
                                                                   .++...+..++.||+.||.|||+.+|+||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         14455678899999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchh
Q 043852          408 ILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEG  482 (551)
Q Consensus       408 ILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~  482 (551)
                      ||++.++.++|+|||+++......    .....+++.|+|||++  ....++.++|||||||++|||++ |..||.....
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI--FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh--cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999987543221    1223467889999987  34567899999999999999998 8999977554


Q ss_pred             HHHHH-HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          483 MQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       483 ~~~~~-~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+... .+..+.....+..++..+.+|+.+||+.+|.+||++.+|++.
T Consensus       348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44433 344455555667789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-37  Score=308.96  Aligned_cols=237  Identities=23%  Similarity=0.403  Sum_probs=188.8

Q ss_pred             eEeccCCceEEEEEEecC-------------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          283 ELLGSGSFGTVYEGYTDD-------------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~-------------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      +.||+|+||.||+|+..+             ...+++|++...     .......+.+|+.++..++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            368999999999997421             235777875432     22334567788999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc-------EEEEe
Q 043852          350 ENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS-------VKLAD  420 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~-------vkL~D  420 (551)
                      ....+++|||+.+++|..++.+  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.       ++++|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            8899999999999999888764  35888999999999999999999999999999999999987664       89999


Q ss_pred             cCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHH-cCCCCCCCchhHHHHHHhhcCCCCCCCC
Q 043852          421 FGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEML-TRQPPYSHLEGMQALFRIGKGEPPLVPN  499 (551)
Q Consensus       421 FGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLl-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~  499 (551)
                      ||++.....  .....++..|+|||++. ....++.++|||||||++|+|+ +|..||......+.. ........ ...
T Consensus       156 ~g~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~-~~~  230 (262)
T cd05077         156 PGIPITVLS--RQECVERIPWIAPECVE-DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM-LVT  230 (262)
T ss_pred             CCCCccccC--cccccccccccChhhhc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc-CCC
Confidence            999865432  23456788999999873 3466899999999999999998 588898765443332 22222221 223


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ..+.++.+||.+||+.||.+||++.+|+++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=306.90  Aligned_cols=248  Identities=27%  Similarity=0.424  Sum_probs=200.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      ++|.+.+.||+|+|+-||+++. .++..||+|+|....     ...++...+|+...++++||||++++++...+     
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            3899999999999999999986 689999999997543     45567788999999999999999999876443     


Q ss_pred             CeEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEcCCCcEEEEecCC
Q 043852          351 NRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                      ...||++.|...|+|.+.++.     ..+++.++..|+.+|++||++||+..  ++||||||.|||+...+.++|.|||.
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence            358999999999999887753     24889999999999999999999998  99999999999999999999999999


Q ss_pred             ccccccC-----------CcccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH--HHHHHh
Q 043852          424 AKATTMN-----------DVKSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM--QALFRI  489 (551)
Q Consensus       424 a~~~~~~-----------~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~--~~~~~i  489 (551)
                      ++.....           +.....+|.-|+|||.++.. +...+.++|||||||+||+|+.|..||......  .....+
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv  255 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV  255 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence            8643321           12234478999999998644 345799999999999999999999999532210  000111


Q ss_pred             hcCCC-CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          490 GKGEP-PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       490 ~~~~~-~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .++.. .+....++..+.+||++||+.||.+||++.+++.+
T Consensus       256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            22111 11123489999999999999999999999999864

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.2e-37  Score=308.36  Aligned_cols=239  Identities=31%  Similarity=0.509  Sum_probs=199.6

Q ss_pred             EeccCCceEEEEEEecC-------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          284 LLGSGSFGTVYEGYTDD-------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~~-------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .||+|+||.||+|+..+       +..+|||.+....    .......+.+|+.+++.++|+||+++++++.+....+++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            69999999999997532       3679999875321    122345677899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-----cEEEEecCC
Q 043852          357 LELVTKGSLANLYQK--------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-----SVKLADFGL  423 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-----~vkL~DFGl  423 (551)
                      |||+.+++|.+++..        ..++...+..++.||+.||.|||+.+++|+||||+||+++.++     .++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999998854        2367788899999999999999999999999999999999877     899999999


Q ss_pred             ccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCC
Q 043852          424 AKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVP  498 (551)
Q Consensus       424 a~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  498 (551)
                      +........    ....++..|+|||++  ....++.++|||||||++|+|++ |..||......+....+..+.....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESL--LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP  235 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHH--ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc
Confidence            875433221    122356789999987  34567999999999999999998 99999877777666666666555666


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..++..+.+||.+||..+|.+||++.+|++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            778999999999999999999999999976

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.3e-37  Score=307.11  Aligned_cols=247  Identities=25%  Similarity=0.451  Sum_probs=204.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      .+|++...||+|+||.||+|+..      +...+++|.+....    .......+.+|+.++.+++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK----DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc----chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            47889999999999999999853      34678888764321    223455688999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh----------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEe
Q 043852          351 NRLFIFLELVTKGSLANLYQKY----------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLAD  420 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~----------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~D  420 (551)
                      ...|++|||+.+++|.+++...          .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999999988643          378999999999999999999999999999999999999999999999


Q ss_pred             cCCccccccCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC-C
Q 043852          421 FGLAKATTMND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP-P  495 (551)
Q Consensus       421 FGla~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~-~  495 (551)
                      ||++.......   .....++..|+|||.+.  ...++.++||||||+++|+|++ |..||...........+..+.. .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ--EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            99986443222   22334677899999873  4457889999999999999998 8889987666666655554433 2


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       496 ~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ..+..++..+.+++.+||+.+|.+|||+.+++..
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            2345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-36  Score=305.21  Aligned_cols=241  Identities=25%  Similarity=0.406  Sum_probs=190.1

Q ss_pred             eEeccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEec
Q 043852          283 ELLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLEL  359 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey  359 (551)
                      +.||+|+||.||+|...   ++..+|+|.+.....    ......+.+|+.++..++|+||+++++++.+...+++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            35899999999999753   456789998754321    23344678899999999999999999999999999999999


Q ss_pred             ccccchHHHHhhh------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          360 VTKGSLANLYQKY------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       360 ~~ggsL~~ll~~~------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      +.+|+|.+++...      ..+...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++......  
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            9999999988642      24456777899999999999999999999999999999999999999999986543222  


Q ss_pred             --cccCCCCCcccChhhhhccc-----CCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCC-----CCCCC
Q 043852          432 --VKSCKGTPFWMAPEVVNLKN-----RGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGE-----PPLVP  498 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~-----~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~-----~~~~~  498 (551)
                        .....++..|+|||++....     ..++.++|||||||++|||++ |..||......+.........     .+...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence              12234678899999974221     245789999999999999996 999997766555443322221     12222


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ...+..+.+++.+|| .+|++|||+++|+.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            346788999999999 58999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.6e-37  Score=304.11  Aligned_cols=235  Identities=23%  Similarity=0.396  Sum_probs=187.0

Q ss_pred             eEeccCCceEEEEEEec-CC----------ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          283 ELLGSGSFGTVYEGYTD-DG----------FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~-~g----------~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +.||+|+||.||+|.+. ++          ..+++|.+....      .....+.+|+.++++++|+||+++++++.. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH------RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch------hhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            46999999999999874 33          246677654221      114567789999999999999999999887 7


Q ss_pred             eEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-------cEEEEecC
Q 043852          352 RLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-------SVKLADFG  422 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-------~vkL~DFG  422 (551)
                      ..++||||+.+++|..++...  .++...+..++.||+.||.|||++||+|+||||+|||++.++       .++|+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            789999999999999988754  478888999999999999999999999999999999999887       79999999


Q ss_pred             CccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcC
Q 043852          423 LAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSL  501 (551)
Q Consensus       423 la~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  501 (551)
                      ++.....  .....++..|+|||++......++.++|||||||++|+|++ |..||.................  .+...
T Consensus       154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~  229 (259)
T cd05037         154 IPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--LPMPD  229 (259)
T ss_pred             ccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC--CCCCC
Confidence            9876543  22345677899999974333478999999999999999999 5888866543332222222211  12223


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ...+.++|.+||+.+|.+|||+.+|++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHH
Confidence            478999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-37  Score=309.38  Aligned_cols=237  Identities=21%  Similarity=0.364  Sum_probs=190.0

Q ss_pred             eEeccCCceEEEEEEec-CC-------ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          283 ELLGSGSFGTVYEGYTD-DG-------FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~-~g-------~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +.||.|+||.||+|.+. .+       ..+|+|.+..     ........+..|+.+++.+.|+||+++++++......+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            36999999999999763 22       2377776532     22334456778999999999999999999999988999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc--------EEEEecCCc
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS--------VKLADFGLA  424 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~--------vkL~DFGla  424 (551)
                      +||||+.+|+|..++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.        ++|+|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999998654  4788888999999999999999999999999999999987764        699999988


Q ss_pred             cccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHhhcCCCCCCCCcCCH
Q 043852          425 KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       425 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  503 (551)
                      .....  .....++..|+|||++. ....++.++|||||||++|+|++| .+||...+.........  ....++...+.
T Consensus       156 ~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  230 (258)
T cd05078         156 ITVLP--KEILLERIPWVPPECIE-NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--DRHQLPAPKWT  230 (258)
T ss_pred             cccCC--chhccccCCccCchhcc-CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH--ccccCCCCCcH
Confidence            65432  22345788999999973 334578899999999999999998 56766555443332222  22344556778


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ++.+|+.+||+.||++|||+++|++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-38  Score=288.95  Aligned_cols=253  Identities=30%  Similarity=0.523  Sum_probs=212.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|...++||+|+||+||++++ ++++.||+|.++......--..   ...+||.+++.++|.|||+++++...+..+-+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvps---salreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcH---HHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            577789999999999999987 6899999999987654433232   345899999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      +|||.. .|..+...  +.+..+.+..++.|+++||.|+|++++.||||||.|.||+.+|.+||+|||+++.....  .+
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            999966 77777653  45788889999999999999999999999999999999999999999999999977543  34


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcC--CC---------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG--EP---------------  494 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~--~~---------------  494 (551)
                      ...+-|.+|.+|.++. ..+-|+...|+||.||++.|+.. |.+.|++.+-.+++.+|...  .+               
T Consensus       159 saevvtlwyrppdvlf-gakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eceeeeeeccCcceee-eeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            5556799999999983 55678999999999999999985 89999998888877776441  11               


Q ss_pred             --CCCC---------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          495 --PLVP---------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       495 --~~~~---------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                        +.++         +.++..-++|+.++|..+|.+|++++..++||||...
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence              1111         1344557899999999999999999999999999753

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.6e-37  Score=308.89  Aligned_cols=236  Identities=22%  Similarity=0.350  Sum_probs=187.5

Q ss_pred             EeccCCceEEEEEEec-------------------------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC
Q 043852          284 LLGSGSFGTVYEGYTD-------------------------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE  338 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~-------------------------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp  338 (551)
                      +||+|+||.||+|...                         ....+|+|++...     .......+.+|+.++..++|+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----HRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----HHHHHHHHHHHHHHHhcCCCC
Confidence            6999999999998631                         1135778876421     123345677889999999999


Q ss_pred             ceeeeeeeccCCCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC--
Q 043852          339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG--  414 (551)
Q Consensus       339 nIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g--  414 (551)
                      ||+++++++.+....++||||+.+++|..++.+  ..+++..+..++.||+.||.|||++||+||||||+|||++..+  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999988854  4578889999999999999999999999999999999997644  


Q ss_pred             -----cEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHH-cCCCCCCCchhHHHHHH
Q 043852          415 -----SVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEML-TRQPPYSHLEGMQALFR  488 (551)
Q Consensus       415 -----~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLl-tG~~Pf~~~~~~~~~~~  488 (551)
                           .++|+|||++......  ....++..|+|||++. ....++.++|||||||++|||+ +|+.||......+....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVP-GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cCccceeeecCCccccccccc--cccccCCcccCchhhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence                 4899999987543222  2335788899999873 3356899999999999999995 79999977654433222


Q ss_pred             hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       489 i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ....  ...+...+..+.++|.+||+.+|++|||+.+|+++
T Consensus       234 ~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            2221  12233456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=332.21  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=223.2

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ...+.|.+.+.||.|.|+.|.++++ .++..||||.+.+....   ......+.+|+++|+.++|||||+++.+......
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln---~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN---PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC---hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            4456899999999999999999988 68999999988654332   3334457899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|+||||+.+|.+++++.+. .+.+..+..++.|++.+++|||+++|||||||.+|||++.+.++||+|||++.++....
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence            99999999999999988765 47778888999999999999999999999999999999999999999999998876543


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                       ..+.+|++.|.|||++++.. ..++.+|+||+|++||.|+.|.+||.+.+-.+...+...+. .-++-.++-+..+||+
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLr  287 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLR  287 (596)
T ss_pred             cccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccccccchheeee-ecccceeechhHHHHH
Confidence             56788999999999986443 45889999999999999999999999866554444444333 2345568889999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      ++|-++|.+|++.++|+.|.|....+..
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999998765554

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.2e-37  Score=307.03  Aligned_cols=245  Identities=31%  Similarity=0.506  Sum_probs=200.0

Q ss_pred             CeeeeeEeccCCceEEEEEEec-----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--C
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--E  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~  350 (551)
                      .|++.+.||+|+||.||++...     ++..+|||.+......    .....+.+|+.+++.+.|+||+++++++..  .
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            5778899999999999999742     4789999988643222    345678899999999999999999998877  5


Q ss_pred             CeEEEEEecccccchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~--l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ...+++|||+.+++|.+++....  ++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            67899999999999999987655  8899999999999999999999999999999999999999999999999987654


Q ss_pred             cCCc-----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH--------------H-HHHH
Q 043852          429 MNDV-----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM--------------Q-ALFR  488 (551)
Q Consensus       429 ~~~~-----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~--------------~-~~~~  488 (551)
                      ....     ....++..|++||.+  ....++.++|||||||++|||++|..||......              . ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHH--ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            2211     112345669999987  3456788999999999999999999998543211              1 1122


Q ss_pred             hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       489 i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +........+..++..+.+|+.+||+.+|.+|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2333334445678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-36  Score=343.32  Aligned_cols=148  Identities=28%  Similarity=0.499  Sum_probs=132.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|.++++||+|+||.||+|.+ .++..||||++.....  ........+..|+.++..++|+||+++++++.....+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            56899999999999999999987 4799999999865332  22344567889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      |||||+.+++|..++... .+++..++.++.||+.||.|||.+||+||||||+||||+.++.+||+|||+++
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999988754 47888899999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2e-36  Score=304.13  Aligned_cols=240  Identities=22%  Similarity=0.335  Sum_probs=188.3

Q ss_pred             EeccCCceEEEEEEecCCc---eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          284 LLGSGSFGTVYEGYTDDGF---FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~~g~---~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      .||+|+||.||++...++.   .+++|.+...    ........+.+|+.++..++||||+++++.+.+....|++|||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            5999999999999754333   3455554322    11234567889999999999999999999999999999999999


Q ss_pred             cccchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC----C
Q 043852          361 TKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----D  431 (551)
Q Consensus       361 ~ggsL~~ll~~~-----~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~----~  431 (551)
                      .+++|..++.+.     .+....+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++......    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999988653     2455667889999999999999999999999999999999999999999997643221    1


Q ss_pred             cccCCCCCcccChhhhhcc-----cCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC-----CCCCCc
Q 043852          432 VKSCKGTPFWMAPEVVNLK-----NRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP-----PLVPNS  500 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~  500 (551)
                      .....++..|+|||++...     ...++.++|||||||++|||++ |..||......+.+..+.+...     +..+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            2334578899999987321     2245789999999999999996 6778877666655554433321     233445


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          501 LSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ++..+.+++.+|| .+|++||++++|++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7889999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.4e-36  Score=302.67  Aligned_cols=246  Identities=25%  Similarity=0.443  Sum_probs=200.0

Q ss_pred             eeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC---
Q 043852          279 WQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN---  351 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---  351 (551)
                      |.+.+.||+|+||.||+|...    ++..+|||++....   .......++.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI---FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc---CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            567789999999999999752    47899999886432   22334566789999999999999999999875432   


Q ss_pred             ---eEEEEEecccccchHHHHhh-------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          352 ---RLFIFLELVTKGSLANLYQK-------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       352 ---~~~lV~Ey~~ggsL~~ll~~-------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                         ..+++++|+.+++|..++..       ..++...+..++.||+.||+|||++||+|+||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               34788999999999877632       13678889999999999999999999999999999999999999999999


Q ss_pred             CCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCC
Q 043852          422 GLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPL  496 (551)
Q Consensus       422 Gla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  496 (551)
                      |+++......    .....+++.|++||.+  ....++.++|||||||++|+|++ |.+||...+.......+..+....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHH--hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9987553322    1222356789999986  35567889999999999999998 899998777666555565555555


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       497 ~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+..++..+.+++.+||+.+|++|||+.+++.+
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            556788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=326.14  Aligned_cols=262  Identities=27%  Similarity=0.473  Sum_probs=227.8

Q ss_pred             ccCCccccCCCc-hhhhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC
Q 043852          259 IKEPVYNVSPNG-KFRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE  336 (551)
Q Consensus       259 ~~~~~~~~~p~~-~~~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~  336 (551)
                      .+..+|.++|+- +|...-.+..+..+||-|-||.||.|.+ +-...||||.++      ...-.+.+|+.|+.+|+.++
T Consensus       248 nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeik  321 (1157)
T KOG4278|consen  248 NKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIK  321 (1157)
T ss_pred             CCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhc
Confidence            344566777754 3333334677778999999999999987 467789999884      23345778999999999999


Q ss_pred             CCceeeeeeeccCCCeEEEEEecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC
Q 043852          337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS  413 (551)
Q Consensus       337 HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~  413 (551)
                      |||+|+|+|+|..+..+|||+|||..|+|.+++++..   ++.-.++.++.||..||+||..+++|||||...|+||..+
T Consensus       322 HpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn  401 (1157)
T KOG4278|consen  322 HPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN  401 (1157)
T ss_pred             CccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc
Confidence            9999999999999999999999999999999998653   4445566788999999999999999999999999999999


Q ss_pred             CcEEEEecCCccccccCCcccCCCC---CcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHh
Q 043852          414 GSVKLADFGLAKATTMNDVKSCKGT---PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRI  489 (551)
Q Consensus       414 g~vkL~DFGla~~~~~~~~~~~~GT---~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i  489 (551)
                      ..||++||||++.+....++...|.   .-|.|||-+  ....++.++|||+||++|||+.| |..||.+.+..+.+..+
T Consensus       402 hiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsL--AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL  479 (1157)
T KOG4278|consen  402 HIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL  479 (1157)
T ss_pred             ceEEeeccchhhhhcCCceecccCccCcccccCcccc--cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH
Confidence            9999999999998877776666654   459999986  66788999999999999999996 89999999999999999


Q ss_pred             hcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          490 GKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       490 ~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .++....-|..|++.+.+||+.||++.|..||++++|-+
T Consensus       480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            999999999999999999999999999999999999843

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-37  Score=329.42  Aligned_cols=254  Identities=28%  Similarity=0.450  Sum_probs=209.5

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      -|.+++.||-|+||.|.++.. ++...||+|.+.+.+...  .........|-.||..-..+-||+||..|.+.+.+|+|
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~--rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM--RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh--hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            488999999999999999875 678899999998765443  33444566778889999999999999999999999999


Q ss_pred             EecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc------
Q 043852          357 LELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM------  429 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~------  429 (551)
                      |+|++||++..++-+.+ +.+..++.|+.++..|++++|..|+|||||||+|||||.+|++||+||||++-+.-      
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            99999999998776554 66777888999999999999999999999999999999999999999999852110      


Q ss_pred             ---CC-----------------------------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHH
Q 043852          430 ---ND-----------------------------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEML  471 (551)
Q Consensus       430 ---~~-----------------------------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLl  471 (551)
                         +.                                   ..+.+||+.|+|||++  ...+|+..+|+||.|+|||||+
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl--~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL--ARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh--cccCccccchhhHhhHHHHHHh
Confidence               00                                   1235699999999997  6778999999999999999999


Q ss_pred             cCCCCCCCchhHHHHHHhhc---CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccCCcc
Q 043852          472 TRQPPYSHLEGMQALFRIGK---GEPPLVPNSLSRDARDFILKCLQVNPNDRPT---AAQLMEHPFVKRPL  536 (551)
Q Consensus       472 tG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS---~~eILehpff~~~~  536 (551)
                      .|++||-..+..+.-.++.+   ......-..++.++.+||.++.. +++.|..   +.+|..||||+.+-
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence            99999977766655444332   22223345689999999998764 6888864   77899999999753

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-36  Score=299.83  Aligned_cols=227  Identities=24%  Similarity=0.330  Sum_probs=186.7

Q ss_pred             CCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecccccchH
Q 043852          288 GSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLA  366 (551)
Q Consensus       288 G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~  366 (551)
                      |.||.||++.+ .+++.||+|.+....          ...+|...+....||||+++++++.+...+|++|||+.+++|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            89999999988 589999999986432          1223444455567999999999999999999999999999998


Q ss_pred             HHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCCCCCcccChh
Q 043852          367 NLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPE  445 (551)
Q Consensus       367 ~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APE  445 (551)
                      +++.+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....++..|+|||
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE  152 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPE  152 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCc
Confidence            88754 46889999999999999999999999999999999999999999999999987654432 22334677899999


Q ss_pred             hhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCH--
Q 043852          446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTA--  523 (551)
Q Consensus       446 vl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~--  523 (551)
                      .+  ....++.++|+||+||++|+|++|..||......     +.......++..++..+++||.+||+.||.+||++  
T Consensus       153 ~~--~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         153 VG--GISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             cc--CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            86  3456788999999999999999999887543211     11111223456789999999999999999999985  


Q ss_pred             ---HHHHhCccc
Q 043852          524 ---AQLMEHPFV  532 (551)
Q Consensus       524 ---~eILehpff  532 (551)
                         +++++||||
T Consensus       226 ~~~~~~~~h~~~  237 (237)
T cd05576         226 AGVEDIKSHPFF  237 (237)
T ss_pred             cchHHHHcCCCC
Confidence               999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.8e-36  Score=305.21  Aligned_cols=247  Identities=21%  Similarity=0.339  Sum_probs=184.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-C---CceEEEEEEecCccCccchHH------HHHHHHHHHHHhcCCCCceeeeeee
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-D---GFFFAVKEVSLQDQGTQGKQS------ILQLEQEILLLSRFEHENIVQYFGT  346 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~---g~~vAVK~i~~~~~~~~~~~~------~~~~~~Ei~il~~l~HpnIv~l~~~  346 (551)
                      .+|++.++||+|+||+||+|... +   +..+|+|+.............      ......+...+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            37999999999999999999864 3   456677754332221111110      1112233445667789999999987


Q ss_pred             ccCCC----eEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          347 DKDEN----RLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       347 ~~~~~----~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                      +....    ..+++++++.. ++.+++... ..++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF  170 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY  170 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence            55432    44778888754 565655543 3677888999999999999999999999999999999999999999999


Q ss_pred             CCccccccC---------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-H-------
Q 043852          422 GLAKATTMN---------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-Q-------  484 (551)
Q Consensus       422 Gla~~~~~~---------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-~-------  484 (551)
                      |+++.....         ......||+.|+|||+.  .+..++.++|||||||++|||++|+.||.+.... .       
T Consensus       171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~--~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH--NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             CCceeeccCCcccccccccccccCCCccccCHHHh--CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            999754321         11234699999999986  4567899999999999999999999999776321 1       


Q ss_pred             -HHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          485 -ALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       485 -~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                       .+.++..+..  ....++..+.+++..||+.+|++||++++|++
T Consensus       249 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 DFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             1222332221  23457899999999999999999999999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-37  Score=329.07  Aligned_cols=242  Identities=30%  Similarity=0.431  Sum_probs=203.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHH-HhcCCCCceeeeeeeccCCCeE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILL-LSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ..+|.....||.|+|+.|-.+.+ .+++.+++|++.......         .+|+.+ +..-+|+||+++.+.+.+..+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~---------~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN---------QDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccccc---------ccccchhhhhcCCCcceeecceecCCcee
Confidence            45788888999999999999877 689999999997652222         145533 3334799999999999999999


Q ss_pred             EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE-cCCCcEEEEecCCccccccCCc
Q 043852          354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV-DASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl-~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      |+|||++.|+.+.+-+...+.....+..|++||+.++.|||++|++||||||+|||+ +..|+++|+|||.++..... .
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~  470 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-C  470 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-h
Confidence            999999999988777666555557778899999999999999999999999999999 58999999999999776544 2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-HHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .+-+-|..|.|||++  ...+|+.++||||||++||+||+|+.||...... +...++..+.   +...+|..+++||.+
T Consensus       471 ~tp~~t~~y~APEvl--~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~---~s~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVL--AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK---FSECVSDEAKDLLQQ  545 (612)
T ss_pred             cccchhhcccChhhh--ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc---cccccCHHHHHHHHH
Confidence            233468889999997  4789999999999999999999999999766555 4444554443   337899999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff  532 (551)
                      ||+.||.+|+++.+++.||||
T Consensus       546 LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hccCChhhCcChhhhccCcch
Confidence            999999999999999999999

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-37  Score=306.47  Aligned_cols=255  Identities=31%  Similarity=0.521  Sum_probs=201.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-c--C--CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-D--D--GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~--~--g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-  349 (551)
                      +..|+..+.||+|+||.||++.. +  +  +..||||.+.-.....   .......+|+.+++.++|+||+.|..++.. 
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t---GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT---GISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC---CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            34799999999999999999953 2  2  3479999886443322   222345589999999999999999999877 


Q ss_pred             CCeEEEEEecccccchHHHHh------hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC----CcEEEE
Q 043852          350 ENRLFIFLELVTKGSLANLYQ------KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS----GSVKLA  419 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~------~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~----g~vkL~  419 (551)
                      +..+++++||.+. +|..+++      ...++...+..++.||+.|+.|||++=|+||||||.||||..+    |.|||+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            7889999999987 7777664      2348888999999999999999999999999999999999877    899999


Q ss_pred             ecCCccccccC-----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---------HHH
Q 043852          420 DFGLAKATTMN-----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---------MQA  485 (551)
Q Consensus       420 DFGla~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---------~~~  485 (551)
                      |||+++.....     ....++-|.+|+|||++ ++...|+.+.|||++|||+.||+|-++.|.+.+.         .++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL-LGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELL-LGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHh-cccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999865432     23445679999999998 5778899999999999999999999998865432         122


Q ss_pred             HHHhhc--CCCCC--------CC--------------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          486 LFRIGK--GEPPL--------VP--------------------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       486 ~~~i~~--~~~~~--------~~--------------------------~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+|.+  |.+..        .|                          ..-++...+|+.+||+.||-+|.|+.|.|+|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            223222  11100        00                          1134458899999999999999999999999


Q ss_pred             cccCCc
Q 043852          530 PFVKRP  535 (551)
Q Consensus       530 pff~~~  535 (551)
                      +||...
T Consensus       338 ~yF~~d  343 (438)
T KOG0666|consen  338 PYFTED  343 (438)
T ss_pred             cccccC
Confidence            999854

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=324.06  Aligned_cols=245  Identities=29%  Similarity=0.504  Sum_probs=210.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe---cCC--ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT---DDG--FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~---~~g--~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +.....++||+|-||.||+|..   ..|  --||||+.+....    ...-+.|..|..+|++++||||++++|++.+. 
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t----~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT----PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC----hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            3556678999999999999974   133  3577887653222    23356788999999999999999999998765 


Q ss_pred             eEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      .++||||+++.|.|..+++..  .++...+..|+.||+.+|.|||+.++|||||...||||.+..+|||+||||++....
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            589999999999999999754  588888999999999999999999999999999999999999999999999987766


Q ss_pred             CCccc-CCC--CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          430 NDVKS-CKG--TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       430 ~~~~~-~~G--T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                      ..+.. ..|  ..-|||||.+  ....++.++|||-||+++||++. |..||.+..+.+.+.++.+|...+.|+.|++.+
T Consensus       544 ~~yYkaS~~kLPIKWmaPESI--NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L  621 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESI--NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL  621 (974)
T ss_pred             cchhhccccccceeecCcccc--chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence            55432 222  3459999987  45678999999999999999985 999999999999999999999999999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..|+.+||..||.+||.+.+|..
T Consensus       622 YslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHHhccCcccCCcHHHHHH
Confidence            99999999999999999988753

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=326.14  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=225.3

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecC-CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~-g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+.+++++..||-|+||.|=++..++ ...+|+|.+++...  ......+.+..|-+||.+.+.++||++|..|.+..++
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI--VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI--VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc--cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            34577888899999999999887643 33589998765432  3334556777899999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-C
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-D  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~  431 (551)
                      |++||-|-||.|..++.+ +.+.+.....++..++.|++|||++|||+|||||+|.|++.+|.+||.|||+|+....+ .
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            999999999999998875 45888899999999999999999999999999999999999999999999999987554 4


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-CCCCCCcCCHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVPNSLSRDARDFIL  510 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~LI~  510 (551)
                      +.+.+|||.|.|||++  .+++++.++|.||||+++|||++|.+||.+.+.+..+..|.+|. ...+|..++..+.+||+
T Consensus       576 TwTFcGTpEYVAPEII--LnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik  653 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEII--LNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIK  653 (732)
T ss_pred             eeeecCCcccccchhh--hccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence            6678899999999997  67788999999999999999999999999999999999888875 34567889999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHhCcccCC
Q 043852          511 KCLQVNPNDRPT-----AAQLMEHPFVKR  534 (551)
Q Consensus       511 ~cL~~DP~~RPS-----~~eILehpff~~  534 (551)
                      ++...+|.+|..     ..+|..|-||..
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            999999999976     899999999864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=315.76  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=201.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC--C----ceeeeeeecc
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH--E----NIVQYFGTDK  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~  348 (551)
                      .++|.+.++||+|+||.|.++++ .++..+|||+++......      +...-|+.+|.++.+  |    -+|.+.++|.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr------eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR------EAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh------hHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            35899999999999999999987 568999999986433222      233467888888842  2    3788889999


Q ss_pred             CCCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-------------
Q 043852          349 DENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-------------  412 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-------------  412 (551)
                      ..+++|||+|.+ |-++.++++.+   +++..+++.+.+||+.+++|||+.+++|.||||+|||+..             
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            999999999999 66999999875   4788999999999999999999999999999999999832             


Q ss_pred             -------CCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 043852          413 -------SGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA  485 (551)
Q Consensus       413 -------~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~  485 (551)
                             +..|+|+|||.|+...... ...+.|..|.|||++  .+.+|+..+||||+||||+||+||...|...++.+.
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEVi--LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVI--LGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchhe--eccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                   2358999999987665444 556789999999997  678999999999999999999999999987776554


Q ss_pred             HH---HhhcCCCC-----------------CCCC-------------------------cCCHHHHHHHHHhhhcCCCCC
Q 043852          486 LF---RIGKGEPP-----------------LVPN-------------------------SLSRDARDFILKCLQVNPNDR  520 (551)
Q Consensus       486 ~~---~i~~~~~~-----------------~~~~-------------------------~~s~~l~~LI~~cL~~DP~~R  520 (551)
                      +.   +|....+.                 ..++                         .....+.+||.+||..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            32   22211110                 0000                         011247799999999999999


Q ss_pred             CCHHHHHhCcccCCcc
Q 043852          521 PTAAQLMEHPFVKRPL  536 (551)
Q Consensus       521 PS~~eILehpff~~~~  536 (551)
                      +|+.|+|.||||.+..
T Consensus       398 iTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  398 ITLREALSHPFFARLT  413 (415)
T ss_pred             ccHHHHhcCHHhhcCC
Confidence            9999999999999764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=329.08  Aligned_cols=249  Identities=30%  Similarity=0.490  Sum_probs=216.4

Q ss_pred             eeeeeEeccCCceEEEEEEec--CC--ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          279 WQKGELLGSGSFGTVYEGYTD--DG--FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~--~g--~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ....++||+|.||.|+.|.+.  +|  ..||||.+.......    ....|++|+.+|.+|+|+|+++|||+..+ ..+.
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~----~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA----IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch----hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            344588999999999999763  34  468999886544332    56789999999999999999999999887 6789


Q ss_pred             EEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          355 IFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      ||||+++.|+|.+.+.+   ..|....+..|+.||+.||.||..+++|||||...|+|+-....|||+||||.+....++
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999998876   247778888999999999999999999999999999999999999999999999877655


Q ss_pred             cc-cCC----CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          432 VK-SCK----GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       432 ~~-~~~----GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                      .. ...    -...|+|||.+  ....|+.++|||++|+++|||+| |..||.+....+++.+|..+.....|+.|++++
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsL--rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI  344 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESL--RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI  344 (1039)
T ss_pred             cceEecCCCcCcccccCHhHh--ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence            32 221    23569999997  46689999999999999999997 899999999999999999999999999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      ++++..||..+|..||||..|.+.-+++.
T Consensus       345 Y~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  345 YQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            99999999999999999999987655443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=328.05  Aligned_cols=256  Identities=25%  Similarity=0.455  Sum_probs=224.2

Q ss_pred             CeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ...+.++||.|.||.||+|..+    ....||||.++..    .......+|+.|+.||.++.||||++|.|+......+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            4667889999999999999863    4568999998643    3345566899999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          354 FIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +||+|||++|+|+.++++  +.+...++..+++.|+.||+||-+.|+|||||...||||+.+-.+|++||||++....+.
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            999999999999999975  458888999999999999999999999999999999999999999999999999765443


Q ss_pred             ---cccCCC--CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          432 ---VKSCKG--TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       432 ---~~~~~G--T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                         +.+..|  ...|.|||.+  ....++.++||||+|++|||.++ |..||=++.+.+.+..|..+...+.|..|+..+
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAI--a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL  863 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL  863 (996)
T ss_pred             CccccccCCccceeecChhHh--hhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence               222223  3579999998  56789999999999999999985 999999999999999999999999999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC--cccCCccccC
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEH--PFVKRPLQKS  539 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILeh--pff~~~~~~~  539 (551)
                      .+||..||++|-.+||.|.||+.+  ..++++.+-.
T Consensus       864 ~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk  899 (996)
T KOG0196|consen  864 YQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK  899 (996)
T ss_pred             HHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence            999999999999999999999864  6666665443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=8.8e-35  Score=282.42  Aligned_cols=238  Identities=38%  Similarity=0.683  Sum_probs=200.9

Q ss_pred             CceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecccccchHH
Q 043852          289 SFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN  367 (551)
Q Consensus       289 ~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~  367 (551)
                      +||.||+|... +|+.+|+|++........    ...+.+|+..+.+++|+||+++++.+......++++||+.+++|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            58999999884 689999999865432211    5678899999999999999999999999899999999999999999


Q ss_pred             HHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-CcccCCCCCcccChh
Q 043852          368 LYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTPFWMAPE  445 (551)
Q Consensus       368 ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~~~~~GT~~Y~APE  445 (551)
                      ++.... ++...++.++.|++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+...... ......++..|++||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            887655 888999999999999999999999999999999999999999999999998766543 344556889999999


Q ss_pred             hhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCC-chhHHHHHHhhcCCCCCCCCc--CCHHHHHHHHHhhhcCCCCCCC
Q 043852          446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH-LEGMQALFRIGKGEPPLVPNS--LSRDARDFILKCLQVNPNDRPT  522 (551)
Q Consensus       446 vl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~--~s~~l~~LI~~cL~~DP~~RPS  522 (551)
                      .+.  ...++.++||||||+++|+|++|..||.. .........+...........  ++..+.+++.+||..+|++||+
T Consensus       157 ~~~--~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      157 VLL--GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            873  55678899999999999999999999977 333333444444433332222  8899999999999999999999


Q ss_pred             HHHHHhCccc
Q 043852          523 AAQLMEHPFV  532 (551)
Q Consensus       523 ~~eILehpff  532 (551)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=326.00  Aligned_cols=252  Identities=33%  Similarity=0.663  Sum_probs=218.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeecc-----
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDK-----  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-----  348 (551)
                      ...|++.+.||.|.+|.||+++. ++++..|+|+.......      ...++.|..+|+.. +|||++.+|++|.     
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            34789999999999999999987 68899999987543322      23455677777776 5999999999874     


Q ss_pred             CCCeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          349 DENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      .+++++||||||.||+.-+++++   ..+.+..+..+++.++.||.+||.+.++|||||-.|||++.+|.|||+|||++.
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence            35789999999999999999875   358888999999999999999999999999999999999999999999999986


Q ss_pred             cc--ccCCcccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--C
Q 043852          426 AT--TMNDVKSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--P  498 (551)
Q Consensus       426 ~~--~~~~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~  498 (551)
                      ..  ......+++|||+|||||++...   ...|+.++|+||||+|..||--|.+|+.++..+..++.|-.+.++..  +
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp  251 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP  251 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence            43  33456678899999999998433   34578899999999999999999999999999999999988877765  4


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      ...+.++.++|..||.+|-++||+..++|+|||++
T Consensus       252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             hhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            56899999999999999999999999999999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-37  Score=298.56  Aligned_cols=253  Identities=29%  Similarity=0.521  Sum_probs=207.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD------  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------  349 (551)
                      ..|....+||+|.||.||+++. ++|+.||+|++.......-   .-....+|+++|..++|+|++.++..|..      
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG---fpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC---CcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            3677788999999999999987 6788899998765433222   22345689999999999999999987643      


Q ss_pred             --CCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          350 --ENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       350 --~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                        ...+|+||.+|+. +|.-++..  ..++..++.+++.++..||.|+|+..|+|||+|+.|+||+.+|.+||+|||+++
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence              3458999999977 78777754  358889999999999999999999999999999999999999999999999997


Q ss_pred             ccccCC------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC----CC-
Q 043852          426 ATTMND------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG----EP-  494 (551)
Q Consensus       426 ~~~~~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~----~~-  494 (551)
                      ......      ++..+.|.+|++||.+ .+...|+++.|||..|||+.||.|+.+.|.+.+..+++..|..-    .+ 
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEll-LG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELL-LGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHh-hcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            655433      3344569999999998 57789999999999999999999999999988887776554221    00 


Q ss_pred             ----------------CCCCC-------------cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          495 ----------------PLVPN-------------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       495 ----------------~~~~~-------------~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                                      ++.+.             .-++++.+|+.++|..||.+|+++.++++|.||..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence                            11111             12457889999999999999999999999999874

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=295.45  Aligned_cols=274  Identities=25%  Similarity=0.454  Sum_probs=225.8

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKDE  350 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~  350 (551)
                      ...+.+|..+.+||+|+|++|.++.. ++.+.||+|++++......  ..+.-...|-.+..+ -+||.+|-++.+|++.
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd--edidwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc--ccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            34567999999999999999999987 6899999999876533322  222233344444444 3699999999999999


Q ss_pred             CeEEEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc-
Q 043852          351 NRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~-  428 (551)
                      ..+++|.||++||+|...++ ..++++++++.|...|+.||.|||+.|||+||||.+|+|++..|++||+|+|+++..- 
T Consensus       324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            99999999999999976554 5679999999999999999999999999999999999999999999999999998542 


Q ss_pred             c-CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCC-------CchhHHHHHHhhcCCCCCCCCc
Q 043852          429 M-NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS-------HLEGMQALFRIGKGEPPLVPNS  500 (551)
Q Consensus       429 ~-~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~-------~~~~~~~~~~i~~~~~~~~~~~  500 (551)
                      . ..+.+.+|||.|.|||++  .+..|...+|+|+||++++||+.|+.||.       ..+..+.++++.-....-+|..
T Consensus       404 ~gd~tstfcgtpnyiapeil--rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs  481 (593)
T KOG0695|consen  404 PGDTTSTFCGTPNYIAPEIL--RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS  481 (593)
T ss_pred             CCcccccccCCCcccchhhh--cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence            2 335677899999999997  56788999999999999999999999994       3345566777777777888999


Q ss_pred             CCHHHHHHHHHhhhcCCCCCC------CHHHHHhCcccCCc----cccCCCCCCCCCCCC
Q 043852          501 LSRDARDFILKCLQVNPNDRP------TAAQLMEHPFVKRP----LQKSRGPPSYYNNMH  550 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RP------S~~eILehpff~~~----~~~~~~~~~~~~~~~  550 (551)
                      ++-.+..+++.-|++||.+|.      .+.++..|+||+..    +.+..-.|+|.-++.
T Consensus       482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~  541 (593)
T KOG0695|consen  482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQIT  541 (593)
T ss_pred             eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccc
Confidence            999999999999999999994      48999999999843    344444555555544

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=294.69  Aligned_cols=255  Identities=31%  Similarity=0.504  Sum_probs=209.7

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHH-HHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .+-+..||.|+||+|++..+ .+|+..|||.|+....    ....++++.|.. +++.-++||||++||....++-.+|.
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC  141 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC  141 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence            33456799999999999887 6899999999986443    344556667765 45556799999999999889999999


Q ss_pred             EecccccchHHHHh------hhcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          357 LELVTKGSLANLYQ------KYHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~------~~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ||++.- +|..+++      +..++++.+-.+..-.+.||.||.. .+|||||+||+|||++..|.|||||||++.....
T Consensus       142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            999954 7776653      4568888888888899999999985 4899999999999999999999999999865433


Q ss_pred             CC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHhhcCCCCCCCC-----cCC
Q 043852          430 ND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRIGKGEPPLVPN-----SLS  502 (551)
Q Consensus       430 ~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~-----~~s  502 (551)
                      .- .+.-.|-..|||||.+.....+|+.++||||||++|||+.||+.||..-+ -.+++..+..+.++.+..     ..+
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS  300 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence            22 22334667899999997667789999999999999999999999997654 456777777777665432     378


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      ..+..+|.-||.+|-..||++.+++.+||++.....
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence            899999999999999999999999999999876544

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=311.62  Aligned_cols=245  Identities=28%  Similarity=0.441  Sum_probs=208.2

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      ...++++||+|-||.|.++....+..||||.++..    .++..-..|.+||++|.+++||||++++|+|..++.+++|+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~----a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD----ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcc----cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            45678999999999999998888899999988643    23334568899999999999999999999999999999999


Q ss_pred             ecccccchHHHHhhhcC---ChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          358 ELVTKGSLANLYQKYHL---MDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~l---~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      ||+++|+|..++.+...   .......++.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.....+...
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            99999999999987632   345566799999999999999999999999999999999999999999998665555554


Q ss_pred             CCC----CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc--CCCCCCCchhHHHHHHhhcC-------CCCCCCCcC
Q 043852          435 CKG----TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLEGMQALFRIGKG-------EPPLVPNSL  501 (551)
Q Consensus       435 ~~G----T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt--G~~Pf~~~~~~~~~~~i~~~-------~~~~~~~~~  501 (551)
                      ..|    ...|||+|.+  .-..++.++|+|+||++|||+++  .+.||...++.+.......-       .....|..|
T Consensus       695 vqgr~vlpiRwmawEsi--llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c  772 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESI--LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC  772 (807)
T ss_pred             eecceeeeeeehhHHHH--HhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence            443    4679999997  44578999999999999999874  88999988887766543321       123456779


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +..+.+||.+||..|-++|||+++|-.
T Consensus       773 p~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  773 PQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            999999999999999999999999854

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3e-36  Score=314.55  Aligned_cols=248  Identities=29%  Similarity=0.444  Sum_probs=210.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC------CceeeeeeeccCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH------ENIVQYFGTDKDE  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~  350 (551)
                      +|.+....|+|-|++|..|.+ ..|..||||+|.      .+..+.+.=+.|+.||++|+.      .|+++|+..|...
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR------nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR------NNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEee------cchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            799999999999999999987 468899999995      345556666789999999953      4899999999999


Q ss_pred             CeEEEEEecccccchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-CcEEEEecCCcc
Q 043852          351 NRLFIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAK  425 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~----l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGla~  425 (551)
                      .++|||||.+.- +|.+++++++    |....+..|+.||+.||..|...||+|.||||.||||+.. ..+||||||.|.
T Consensus       507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            999999999954 8999998764    7788999999999999999999999999999999999875 468999999999


Q ss_pred             ccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH--hhcCCCCC-------
Q 043852          426 ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR--IGKGEPPL-------  496 (551)
Q Consensus       426 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~--i~~~~~~~-------  496 (551)
                      ....++.+.+..+.+|.|||++  .+..|+...|+||+||+||||+||+..|++.+.-+++..  -.+|..+.       
T Consensus       586 ~~~eneitPYLVSRFYRaPEIi--LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq  663 (752)
T KOG0670|consen  586 FASENEITPYLVSRFYRAPEII--LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ  663 (752)
T ss_pred             ccccccccHHHHHHhccCccee--ecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence            9999998888889999999997  678899999999999999999999999998776555432  11111100       


Q ss_pred             --------------------------------CC-----------CcC-------CHHHHHHHHHhhhcCCCCCCCHHHH
Q 043852          497 --------------------------------VP-----------NSL-------SRDARDFILKCLQVNPNDRPTAAQL  526 (551)
Q Consensus       497 --------------------------------~~-----------~~~-------s~~l~~LI~~cL~~DP~~RPS~~eI  526 (551)
                                                      .|           +.+       -..+++|+.+||..||++|.|..|.
T Consensus       664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA  743 (752)
T KOG0670|consen  664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA  743 (752)
T ss_pred             hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence                                            00           011       1348899999999999999999999


Q ss_pred             HhCcccCC
Q 043852          527 MEHPFVKR  534 (551)
Q Consensus       527 Lehpff~~  534 (551)
                      |.||||+.
T Consensus       744 L~HpFi~~  751 (752)
T KOG0670|consen  744 LKHPFITE  751 (752)
T ss_pred             hcCCcccC
Confidence            99999975

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=320.80  Aligned_cols=239  Identities=31%  Similarity=0.539  Sum_probs=192.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-----
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-----  351 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----  351 (551)
                      -|...+.||+|+||.||+|++ .+|..||||++....    ........-+|+++|++++|+|||+++++-.+..     
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            577789999999999999996 699999999987533    2233445668999999999999999999866544     


Q ss_pred             -eEEEEEecccccchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc--CCC--cEEEEecC
Q 043852          352 -RLFIFLELVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD--ASG--SVKLADFG  422 (551)
Q Consensus       352 -~~~lV~Ey~~ggsL~~ll~~----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~--~~g--~vkL~DFG  422 (551)
                       .-.++||||.||+|...+++    ++|++..++.++..+..||.|||++||+||||||.||++-  .+|  ..||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             45899999999999999964    5899999999999999999999999999999999999983  234  48999999


Q ss_pred             CccccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh----HHHHHHhhcCCC---
Q 043852          423 LAKATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEP---  494 (551)
Q Consensus       423 la~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~----~~~~~~i~~~~~---  494 (551)
                      .|+....+. ..+..||+.|++||++. ....|+..+|.|||||++|+..||..||.....    .+..+.+....+   
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E-~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYE-RQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHh-hccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            999886554 67788999999999973 357889999999999999999999999943322    223333322211   


Q ss_pred             -----------------CCCCCcCCHH----HHHHHHHhhhcCCCCCC
Q 043852          495 -----------------PLVPNSLSRD----ARDFILKCLQVNPNDRP  521 (551)
Q Consensus       495 -----------------~~~~~~~s~~----l~~LI~~cL~~DP~~RP  521 (551)
                                       -+++..++..    +...+..+|..+|.+|.
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                             1123444443    45678889999999998

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.7e-34  Score=321.04  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=174.6

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cC----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeee---
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DD----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT---  346 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~---  346 (551)
                      ..++|.+.+.||+|+||.||+|.+ .+    +..||||++.....     .  .....+  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~--e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----V--EIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----h--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            456899999999999999999987 45    78999998753211     0  001111  1111122222222221   


Q ss_pred             ---ccCCCeEEEEEecccccchHHHHhhhcC---------------------ChHHHHHHHHHHHHHHHHHHhCCeeecc
Q 043852          347 ---DKDENRLFIFLELVTKGSLANLYQKYHL---------------------MDSQVSAYTRQILNGLNYLHEQNVVHRD  402 (551)
Q Consensus       347 ---~~~~~~~~lV~Ey~~ggsL~~ll~~~~l---------------------~~~~i~~i~~QI~~aL~yLH~~gIiHrD  402 (551)
                         ..+...+++||||+.+++|.+++....+                     ....+..++.||+.||.|||++||+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2456679999999999999988864321                     1234567999999999999999999999


Q ss_pred             cccceEEEcC-CCcEEEEecCCccccccC---CcccCCCCCcccChhhhhccc--------------------CCCCchh
Q 043852          403 IKCANILVDA-SGSVKLADFGLAKATTMN---DVKSCKGTPFWMAPEVVNLKN--------------------RGYGLTA  458 (551)
Q Consensus       403 IKP~NILl~~-~g~vkL~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~--------------------~~~s~ks  458 (551)
                      |||+|||++. ++.+||+|||+++.....   ......+|+.|+|||.+....                    ..++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 579999999999754322   234567899999999753211                    1244567


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCchhHHHHHHh-hcCC----------CCC----------CCCcCCHHHHHHHHHhhhcCC
Q 043852          459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRI-GKGE----------PPL----------VPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       459 DIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i-~~~~----------~~~----------~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |||||||+||||+++..++..  ....+.++ ....          ...          ..........+||.+||++||
T Consensus       361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999999997766532  21111111 1000          000          001123345689999999999


Q ss_pred             CCCCCHHHHHhCcccCCcccc
Q 043852          518 NDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       518 ~~RPS~~eILehpff~~~~~~  538 (551)
                      .+|||+.++|+||||++....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCcc
Confidence            999999999999999875443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=301.55  Aligned_cols=263  Identities=25%  Similarity=0.426  Sum_probs=213.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc--chHHHHHHHHHHHHHhcCCCCceeeeeeecc-CCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ--GKQSILQLEQEILLLSRFEHENIVQYFGTDK-DENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~  352 (551)
                      ++|-.+.+||+|+|+.||++.+ ....+||||+-........  .....+...+|..|.+.|.||-||++|+++. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            3688899999999999999987 5688899997654433322  2334566779999999999999999999875 5567


Q ss_pred             EEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhC--CeeecccccceEEEc---CCCcEEEEecCCccc
Q 043852          353 LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ--NVVHRDIKCANILVD---ASGSVKLADFGLAKA  426 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~--gIiHrDIKP~NILl~---~~g~vkL~DFGla~~  426 (551)
                      +|-|+|||+|.+|..+++.. .+++..++.|+.||+.||.||.+.  .|||-||||.|||+-   ..|.+||+||||++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            89999999999999988765 478999999999999999999976  599999999999994   457899999999987


Q ss_pred             cccCCc---------ccCCCCCcccChhhhhcc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH---HhhcC
Q 043852          427 TTMNDV---------KSCKGTPFWMAPEVVNLK--NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF---RIGKG  492 (551)
Q Consensus       427 ~~~~~~---------~~~~GT~~Y~APEvl~~~--~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~---~i~~~  492 (551)
                      ......         ....||.+|++||++-..  .-..+.++||||+|+|+|..++|+.||.+....+.+.   .|.+.
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            654432         234589999999997433  3356889999999999999999999998765544332   34444


Q ss_pred             CCCCCC--CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          493 EPPLVP--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       493 ~~~~~~--~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ....+|  +.++.++.+||++||.+--+.|....++..||||.--..++
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs  751 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRS  751 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhc
Confidence            333333  45899999999999999999999999999999998544444

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=315.33  Aligned_cols=249  Identities=30%  Similarity=0.520  Sum_probs=211.6

Q ss_pred             CeeeeeEeccCCceEEEEEEec----C----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeecc
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD----D----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDK  348 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~----~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~  348 (551)
                      ...+.+.||+|+||+|++|...    .    ...||||.+....    .......+..|+.+|..+. |+||+.++|++.
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~----~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA----SSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEeccccc----CcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            3455669999999999998631    1    4578898775322    2245667889999999985 999999999999


Q ss_pred             CCCeEEEEEecccccchHHHHhhhc-----------------CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc
Q 043852          349 DENRLFIFLELVTKGSLANLYQKYH-----------------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD  411 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~~-----------------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~  411 (551)
                      ..+.+++|+|||..|+|..+++..+                 ++..+++.++.||+.||+||++.+++||||...||||.
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence            9999999999999999999998777                 88899999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccccCCcccCC---CC--CcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCch-hHH
Q 043852          412 ASGSVKLADFGLAKATTMNDVKSCK---GT--PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLE-GMQ  484 (551)
Q Consensus       412 ~~g~vkL~DFGla~~~~~~~~~~~~---GT--~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~-~~~  484 (551)
                      .+..+||+|||+++...........   ||  ..|||||.+  ....|+.++||||+|++|||++| |..||.+.. ..+
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl--~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL--FDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh--ccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            9999999999999865554443322   22  349999998  34789999999999999999998 999999865 455


Q ss_pred             HHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          485 ALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       485 ~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      .+..+..|.....|..|+.++.++|+.||+.+|++||++.++.+  +|..
T Consensus       531 l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~  578 (609)
T KOG0200|consen  531 LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK  578 (609)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence            56678999999999999999999999999999999999999887  4444

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.9e-34  Score=275.86  Aligned_cols=255  Identities=24%  Similarity=0.449  Sum_probs=209.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCC--C
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDE--N  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~  351 (551)
                      +.+|++.+++|+|.|+.||.|.. .+++.++||+++.        ...+.+.+|++||..|. ||||+.++++..+.  .
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            45899999999999999999987 6888999998853        23446789999999997 99999999998765  4


Q ss_pred             eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-CcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGla~~~~~~  430 (551)
                      ...+|+||+.+.+...+...  ++.-.+..++.||+.||.|+|+.||.|||+||.|++|+.. ..++|+|+|||.+....
T Consensus       109 tpaLiFE~v~n~Dfk~ly~t--l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLYPT--LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             CchhHhhhhccccHHHHhhh--hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            57899999999888887765  7788899999999999999999999999999999999865 46999999999887654


Q ss_pred             C-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCC-CCchhHHHHHHhhcCC-------------C-
Q 043852          431 D-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGKGE-------------P-  494 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf-~~~~~~~~~~~i~~~~-------------~-  494 (551)
                      . ....+.+..|--||++ .....|+.+.|+|||||+|..|+..+.|| .+.+..+++.+|.+-.             . 
T Consensus       187 ~eYnVRVASRyfKGPELL-Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             ceeeeeeehhhcCCchhe-eechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            4 4555678889999998 46678899999999999999999998887 4445555554443210             0 


Q ss_pred             ------------------CCCC----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          495 ------------------PLVP----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       495 ------------------~~~~----~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                                        .+++    ...++++.+|+.++|..|-++|+|+.+.+.||||.........
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~  334 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS  334 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence                              0111    1256899999999999999999999999999999866654443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=284.37  Aligned_cols=249  Identities=26%  Similarity=0.434  Sum_probs=208.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----  351 (551)
                      .+|..++.+|.|+- .|..+.+ -.+..||+|++..+.   .+.....+..+|..++..+.|+||++++.+|.-..    
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf---~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF---QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc---ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            37888999999999 6777765 579999999887662   33455667789999999999999999999886544    


Q ss_pred             --eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 --RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 --~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                        .+|+||||+.. +|...+. ..+.=..+..++.|++.|++|||+.||+||||||+||++..++.+||+|||+++....
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence              47999999966 7777666 4566678899999999999999999999999999999999999999999999987665


Q ss_pred             C-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC--------------
Q 043852          430 N-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--------------  494 (551)
Q Consensus       430 ~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~--------------  494 (551)
                      . ..+.++.|..|.|||++  .+.+|...+||||+||++.||++|+..|.+.+..+++.++.....              
T Consensus       171 ~~~mtpyVvtRyyrapevi--l~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             ccccCchhheeeccCchhe--eccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            5 56778899999999997  455699999999999999999999999999888877766543210              


Q ss_pred             ----------------CCCC-----------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          495 ----------------PLVP-----------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       495 ----------------~~~~-----------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                                      ..+|           ..-+..+++|+.+||-.||++|.|++++|.||||+
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                            0001           12235688999999999999999999999999997

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=300.94  Aligned_cols=260  Identities=23%  Similarity=0.335  Sum_probs=183.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-----------------cCCceEEEEEEecCccCccc---------hHHHHHHHHHH
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-----------------DDGFFFAVKEVSLQDQGTQG---------KQSILQLEQEI  329 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-----------------~~g~~vAVK~i~~~~~~~~~---------~~~~~~~~~Ei  329 (551)
                      .++|.+.++||+|+||.||+|..                 ..+..||||.+.........         .........|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            34799999999999999999863                 24567999998643221100         00111233466


Q ss_pred             HHHhcCCCCce-----eeeeeeccC--------CCeEEEEEecccccchHHHHhhh------------------------
Q 043852          330 LLLSRFEHENI-----VQYFGTDKD--------ENRLFIFLELVTKGSLANLYQKY------------------------  372 (551)
Q Consensus       330 ~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~ggsL~~ll~~~------------------------  372 (551)
                      .++.+++|.++     +++++++..        .+..++||||+.+++|.+++...                        
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766554     566666542        35689999999999998887531                        


Q ss_pred             -cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-cc--cCCCCCcccChhhhh
Q 043852          373 -HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VK--SCKGTPFWMAPEVVN  448 (551)
Q Consensus       373 -~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-~~--~~~GT~~Y~APEvl~  448 (551)
                       .++...+..++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++....... ..  ...+|+.|+|||++.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence             12345677899999999999999999999999999999999999999999986543221 11  123588999999873


Q ss_pred             cccC--------------------CCCchhhHHHHHHHHHHHHcCCC-CCCCchhHHH----------HHHhhcCCC--C
Q 043852          449 LKNR--------------------GYGLTADIWSLGCTVLEMLTRQP-PYSHLEGMQA----------LFRIGKGEP--P  495 (551)
Q Consensus       449 ~~~~--------------------~~s~ksDIwSLG~iLyeLltG~~-Pf~~~~~~~~----------~~~i~~~~~--~  495 (551)
                      ....                    ....+.||||+||++|+|++|.. ||........          .++......  .
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~  463 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF  463 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence            2110                    11234799999999999999876 6654221111          111111111  1


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCC---CCCCCHHHHHhCcccCCc
Q 043852          496 LVPNSLSRDARDFILKCLQVNP---NDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       496 ~~~~~~s~~l~~LI~~cL~~DP---~~RPS~~eILehpff~~~  535 (551)
                      .....++...++|+.+||.++|   .+|+|++|+|+||||...
T Consensus       464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            1234578999999999999876   689999999999999754

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=306.65  Aligned_cols=244  Identities=30%  Similarity=0.506  Sum_probs=209.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCc----eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGF----FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .....++||+|+||+||+|.+ ..|+    +||||++...    ...+....+..|+.+|.++.|||+++|++++.... 
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~----t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF----TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc----CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            345568999999999999987 3344    5777776532    33344567889999999999999999999988665 


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +.||++|+++|+|.++++.  ..+.....+.|..||++||.|||.++++||||...||||..-.++||.|||+++.....
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            8899999999999999874  46888899999999999999999999999999999999999999999999999876543


Q ss_pred             C--cccC--CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          431 D--VKSC--KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       431 ~--~~~~--~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                      .  +...  .-.+-|||-|.+  ....|+.++|||||||++||++| |..||.+....+.-..+.++.....|+.|+-++
T Consensus       852 ~~ey~~~~gK~pikwmale~i--~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDV  929 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESI--RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDV  929 (1177)
T ss_pred             cccccccccccCcHHHHHHHh--hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHH
Confidence            3  2222  234569999987  45689999999999999999998 999999999888888889999988999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..++.+||..|+..||+|.++.+
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999999865

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=308.02  Aligned_cols=240  Identities=35%  Similarity=0.508  Sum_probs=188.5

Q ss_pred             eeeeEeccCCceEE-EEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEEE
Q 043852          280 QKGELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       280 ~~~~~LG~G~fG~V-Y~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      .-.+++|.|+-|+| |+|. -.|+.||||.+..        .......+||.+|..- .|||||++|+...+..+.||..
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~--------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGV-YEGREVAVKRLLE--------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             ccHHHcccCCCCcEEEEEe-eCCceehHHHHhh--------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            33467899999975 7884 4778999998742        2233456899988887 4999999999999999999999


Q ss_pred             ecccccchHHHHhhhc-----CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CC--cEEEEecCCcccc
Q 043852          358 ELVTKGSLANLYQKYH-----LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SG--SVKLADFGLAKAT  427 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~-----l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g--~vkL~DFGla~~~  427 (551)
                      |+|.. +|.+++....     ......+..+.|++.||++||+.+||||||||.||||..   ++  .++|+|||+++..
T Consensus       583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99966 9999987631     111345788999999999999999999999999999976   33  6899999999876


Q ss_pred             ccCC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHhhcCCCCCCC--C
Q 043852          428 TMND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVP--N  499 (551)
Q Consensus       428 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~--~  499 (551)
                      ..+.     ...+.||-+|+|||+++..  .-+.++|||||||++|+.++| .+||...-..+.  .|.++......  .
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~  737 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEP  737 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeecc
Confidence            5432     3456699999999998533  336689999999999999985 999976544443  34444332221  1


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      ....++.+||.+|++++|..||++.+||.||||=
T Consensus       738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence            1122899999999999999999999999999984

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=324.72  Aligned_cols=237  Identities=21%  Similarity=0.365  Sum_probs=185.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..|...+.||+|+||.||+|.+ .++..||||++......         ...|+.++++++|||||++++++.+....|+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            3566778999999999999987 68999999988532211         1245788999999999999999999999999


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHH---hCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH---EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH---~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      ||||+++|+|.++++.  +++..+..++.||+.||.|||   +.+|+||||||+||+++.++..++. ||.......  .
T Consensus       761 v~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--~  835 (968)
T PLN00113        761 IHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--D  835 (968)
T ss_pred             EEeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--C
Confidence            9999999999999964  788889999999999999999   6699999999999999998888775 665543321  2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch----hHHHHHHhhc-CC------CCCC----
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE----GMQALFRIGK-GE------PPLV----  497 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~----~~~~~~~i~~-~~------~~~~----  497 (551)
                      ....+|+.|+|||++  ....++.++|||||||++|||+||+.||....    ....+.+... ..      .+..    
T Consensus       836 ~~~~~t~~y~aPE~~--~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        836 TKCFISSAYVAPETR--ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             CCccccccccCcccc--cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence            234688999999987  45678999999999999999999999984321    1111111100 00      0000    


Q ss_pred             --CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          498 --PNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       498 --~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                        +.....++.+++.+||+.||++|||+.++++.
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              11122356789999999999999999999984

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-33  Score=275.57  Aligned_cols=250  Identities=29%  Similarity=0.497  Sum_probs=201.2

Q ss_pred             eeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-----eEEE
Q 043852          282 GELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-----RLFI  355 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~l  355 (551)
                      .+.||-|+||.||.+++ ++|+.+|+|++....   .+-..-+++.+|+++|.-++|.|++..++...-..     .+|+
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            36799999999999988 789999999875432   22345567889999999999999999988765443     3577


Q ss_pred             EEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          356 FLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      ++|++.. +|..++- -..++..++.-+++||++||+|||+.+|.||||||.|.|+++|..+||||||+++.....+   
T Consensus       135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h  213 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN  213 (449)
T ss_pred             HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence            8888855 6766654 3568999999999999999999999999999999999999999999999999998765543   


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc--------------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--------------------  491 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~--------------------  491 (551)
                      ++..+-|-+|.|||++ .+...|+.+.||||+|||+.||+..+..|......+++..|..                    
T Consensus       214 MTqEVVTQYYRAPEiL-MGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  214 MTHEVVTQYYRAPELL-MGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hHHHHHHHHhccHHHh-hcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            3334568899999998 4667899999999999999999999999987777665544322                    


Q ss_pred             ---CC--CCCCC--------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          492 ---GE--PPLVP--------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       492 ---~~--~~~~~--------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                         +.  ++..+        ..-..+...++.++|.+||.+|.+.++.+.|+++.+..
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence               11  11111        12334677899999999999999999999999987654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-31  Score=274.08  Aligned_cols=127  Identities=28%  Similarity=0.412  Sum_probs=106.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC--------CCceeeeeeec
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE--------HENIVQYFGTD  347 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~  347 (551)
                      ++|.+.++||-|.|++||++++ .+..+||+|+++....      .-+....||++|+++.        ..+||+|++.|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh------YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH------YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH------HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            4799999999999999999988 6888999999864322      2334568899998873        34799999988


Q ss_pred             cC----CCeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEE
Q 043852          348 KD----ENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILV  410 (551)
Q Consensus       348 ~~----~~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl  410 (551)
                      ..    +.++|||+|++ |.+|..++++   .+++...+..|++||+.||.|||.. ||||.||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            64    56899999999 5577777765   3699999999999999999999965 99999999999999

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=276.05  Aligned_cols=237  Identities=30%  Similarity=0.443  Sum_probs=182.2

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHH--HHhcCCCCceeeeeeeccCCC----e
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL--LLSRFEHENIVQYFGTDKDEN----R  352 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~--il~~l~HpnIv~l~~~~~~~~----~  352 (551)
                      .+..++||+|.||.||+|.. +++.||||++...        ....+..|-.  -+-.++|+||+++++......    .
T Consensus       212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~--------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ--------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             hhhHHHhhcCccceeehhhc-cCceeEEEecCHH--------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            45568899999999999965 4589999998632        2223444444  444678999999999876555    8


Q ss_pred             EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC---------CeeecccccceEEEcCCCcEEEEecCC
Q 043852          353 LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ---------NVVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~---------gIiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                      ++||++|.+.|+|.++++.+-+++....+++..|++||+|||+.         .|+|||||..||||..+++..|+||||
T Consensus       283 ywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999999999999999999999999999999999963         599999999999999999999999999


Q ss_pred             ccccccC----CcccCCCCCcccChhhhhcccCCCC-----chhhHHHHHHHHHHHHcC------------CCCCC----
Q 043852          424 AKATTMN----DVKSCKGTPFWMAPEVVNLKNRGYG-----LTADIWSLGCTVLEMLTR------------QPPYS----  478 (551)
Q Consensus       424 a~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~s-----~ksDIwSLG~iLyeLltG------------~~Pf~----  478 (551)
                      |......    +....+||.+|||||++.+ ...+.     .+.||||+|.|||||++.            ++||.    
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEg-ainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEG-AINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhh-hcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            9765432    3445679999999999842 22232     468999999999999984            23442    


Q ss_pred             ---CchhHHHHHHhhcCCCCCCCCc-----CCHHHHHHHHHhhhcCCCCCCCHHHH
Q 043852          479 ---HLEGMQALFRIGKGEPPLVPNS-----LSRDARDFILKCLQVNPNDRPTAAQL  526 (551)
Q Consensus       479 ---~~~~~~~~~~i~~~~~~~~~~~-----~s~~l~~LI~~cL~~DP~~RPS~~eI  526 (551)
                         ..+.++.+.-..+. .|.++..     --.-+++.+..||+.||+.|.|+.=+
T Consensus       442 ~hPt~e~mq~~VV~kK~-RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQ-RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCCCHHHHHHHHHhhcc-CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence               12223333222333 3333322     23568899999999999999996543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.6e-30  Score=241.60  Aligned_cols=209  Identities=41%  Similarity=0.696  Sum_probs=183.3

Q ss_pred             eccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      ||+|.+|.||++... +++.+++|++.......    ....+.+|+.++..+.|++|+++++++......+++||++.++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            689999999999874 59999999986443221    3456889999999999999999999999989999999999999


Q ss_pred             chHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEecCCccccccCC--cccCCCC
Q 043852          364 SLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMND--VKSCKGT  438 (551)
Q Consensus       364 sL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~DFGla~~~~~~~--~~~~~GT  438 (551)
                      +|..++...  .++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+.......  .....++
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999875  6889999999999999999999999999999999999998 8999999999987665443  4445578


Q ss_pred             CcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCC
Q 043852          439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN  518 (551)
Q Consensus       439 ~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~  518 (551)
                      ..|++||.+.. ...++.+.|+|+||+++++|                                ..+.+++.+|++.+|.
T Consensus       157 ~~~~~pe~~~~-~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~  203 (215)
T cd00180         157 PAYMAPEVLLG-KGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE  203 (215)
T ss_pred             CCccChhHhcc-cCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcc
Confidence            89999998732 23678999999999999999                                6788999999999999


Q ss_pred             CCCCHHHHHhCc
Q 043852          519 DRPTAAQLMEHP  530 (551)
Q Consensus       519 ~RPS~~eILehp  530 (551)
                      +||++.+++.|+
T Consensus       204 ~R~~~~~l~~~~  215 (215)
T cd00180         204 KRPSAKEILEHL  215 (215)
T ss_pred             cCcCHHHHhhCC
Confidence            999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=292.28  Aligned_cols=257  Identities=40%  Similarity=0.652  Sum_probs=220.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|..+..+|.|+||.||++++ .+++..|+|+|+.....     .+.-+.+||-+++..+|+|||.+++.+......+|
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-----d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-----cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            3788999999999999999998 68999999999764322     23345589999999999999999999999999999


Q ss_pred             EEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc--ccCCc
Q 043852          356 FLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~--~~~~~  432 (551)
                      .||||.||+|.+++. .+.+++.++...++..++||+|||++|=+|||||-.|||++..|.+||+|||.+-.+  .....
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence            999999999999876 467999999999999999999999999999999999999999999999999997543  23446


Q ss_pred             ccCCCCCcccChhhhh-cccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC--CC--CCcCCHHHHH
Q 043852          433 KSCKGTPFWMAPEVVN-LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LV--PNSLSRDARD  507 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~-~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~--~~~~s~~l~~  507 (551)
                      ++..|||+|||||+.- ....+|+..+|||++|++..||---++|......+..++.+-+....  ..  +...+..|.+
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~  249 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN  249 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence            6788999999999953 23568999999999999999999888888777888887766553322  21  2346888999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      |++.+|.++|.+|||++.+|.|||+.+.+..
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~~l~~  280 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQTLSR  280 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeeccchhh
Confidence            9999999999999999999999999887543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=250.14  Aligned_cols=214  Identities=29%  Similarity=0.506  Sum_probs=174.7

Q ss_pred             eeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccCCCeEEEEE
Q 043852          280 QKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      ..+..||+|+||.|-+.++ .+|...|+|.+.....    .+..+++++|+.+..+ ..+|++|.+||...+...++|.|
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            3456799999999988887 6999999999875432    3445567788876554 47999999999999999999999


Q ss_pred             ecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          358 ELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       358 Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |.+.. +|..+.++     ..+++.-+-+++..++.||.|||++ .+||||+||+||||+.+|+||+||||++......-
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            99965 88776643     3478888889999999999999976 89999999999999999999999999987655443


Q ss_pred             ccc-CCCCCcccChhhhhc--ccCCCCchhhHHHHHHHHHHHHcCCCCCC-CchhHHHHHHhhcCCCCCCC
Q 043852          432 VKS-CKGTPFWMAPEVVNL--KNRGYGLTADIWSLGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVP  498 (551)
Q Consensus       432 ~~~-~~GT~~Y~APEvl~~--~~~~~s~ksDIwSLG~iLyeLltG~~Pf~-~~~~~~~~~~i~~~~~~~~~  498 (551)
                      ..+ ..|-..|||||.++.  .+.+|+.++||||||+++.||.+++.||. ..+..+++.++.....+.+|
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence            333 346677999999853  34589999999999999999999999995 45677888887776655544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-30  Score=265.54  Aligned_cols=243  Identities=28%  Similarity=0.428  Sum_probs=184.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc--CCCCceeeeeeeccCC----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR--FEHENIVQYFGTDKDE----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~----  350 (551)
                      .+.++.+.||+|.||.||+|. ..|+.||||++...+..        ...+|..|...  |+|+||+.+++....+    
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~-wrGe~VAVKiF~srdE~--------SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGR-WRGEDVAVKIFSSRDER--------SWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             heeEEEEEecCccccceeecc-ccCCceEEEEecccchh--------hhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            367889999999999999994 57889999999754332        22345555444  6899999999875433    


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC--------CeeecccccceEEEcCCCcEEEEecC
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ--------NVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~--------gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                      .+++||++|.+.|+|++++++..++.+.+.+++..++.||+|||..        .|.|||||..||||..+|..-|+|+|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            3689999999999999999999999999999999999999999953        49999999999999999999999999


Q ss_pred             CccccccC------CcccCCCCCcccChhhhhcc----cCCCCchhhHHHHHHHHHHHHc----------CCCCCCCch-
Q 043852          423 LAKATTMN------DVKSCKGTPFWMAPEVVNLK----NRGYGLTADIWSLGCTVLEMLT----------RQPPYSHLE-  481 (551)
Q Consensus       423 la~~~~~~------~~~~~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLG~iLyeLlt----------G~~Pf~~~~-  481 (551)
                      ||......      .....+||..|||||++...    ....-..+||||||.++||+.-          -++||.+.. 
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            99654322      13456799999999997411    1112345899999999999975          267874432 


Q ss_pred             ---hHHHHHHh--hcCCCCCCCCcCC-----HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          482 ---GMQALFRI--GKGEPPLVPNSLS-----RDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       482 ---~~~~~~~i--~~~~~~~~~~~~s-----~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                         ..+...++  .+...|.+|+...     ..+..||+.||..+|.-|.|+-.|..
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence               23333332  1122344444321     24668999999999999999766643

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5.6e-29  Score=240.17  Aligned_cols=214  Identities=38%  Similarity=0.604  Sum_probs=180.5

Q ss_pred             eeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      |.+.+.||+|++|.||++... +++.+|+|.+......    .....+.+|+..+.+++|+|++++++.+......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            567789999999999999884 5899999998654322    24567889999999999999999999999889999999


Q ss_pred             ecccccchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC---Cc
Q 043852          358 ELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---DV  432 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~--l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~---~~  432 (551)
                      ||+.+++|.+++....  +++..+..++.|++.+|.+||+++++|+||+|.||+++.++.++|+|||++......   ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999999987654  788999999999999999999999999999999999999999999999998765443   22


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCC-chhH-HHHHHhhcCCCCCC
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH-LEGM-QALFRIGKGEPPLV  497 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~-~~~~-~~~~~i~~~~~~~~  497 (551)
                      ....++..|++||.+. ....++.++|+|+||+++|+|++|+.||.. .+.. .....+..+.+...
T Consensus       157 ~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (225)
T smart00221      157 KTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW  222 (225)
T ss_pred             cceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence            3455788899999874 556778899999999999999999999977 4444 55556666654443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=273.99  Aligned_cols=205  Identities=26%  Similarity=0.434  Sum_probs=173.9

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchH---HHHHHHHHHHHHhcCC---CCceeeeeee
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQ---SILQLEQEILLLSRFE---HENIVQYFGT  346 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~---~~~~~~~Ei~il~~l~---HpnIv~l~~~  346 (551)
                      +.+.+|..++.||+|+||.|++|++ .+...|+||.|.+.+.....-.   .+-.+-.||+||..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            4456899999999999999999998 4677899998875432221110   0112347999999997   9999999999


Q ss_pred             ccCCCeEEEEEeccc-ccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          347 DKDENRLFIFLELVT-KGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       347 ~~~~~~~~lV~Ey~~-ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      |++++++||+||-.. |.+|++++.. ..+++..+..+++|++.|+++||++||||||||-+|+.++.+|.+||+|||.+
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            999999999999864 4588998875 46999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 043852          425 KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH  479 (551)
Q Consensus       425 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~  479 (551)
                      ...........+||..|.|||++. +....+..-|||+||++||-+++...||.+
T Consensus       718 a~~ksgpfd~f~gtv~~aapevl~-g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKSGPFDVFVGTVDYAAPEVLG-GEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcCCCcceeeeeccccchhhhC-CCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            888888888899999999999983 333447778999999999999999888864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=256.42  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=208.2

Q ss_pred             CeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-C
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-E  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~  350 (551)
                      +++...++-+|+||.||.|++.      +.+.+.+|+++.    ....-....+..|..++..+.|||+..+.+++.+ .
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            5667778999999999999653      344566676542    2233456677889999999999999999998654 4


Q ss_pred             CeEEEEEecccccchHHHHhhh---------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          351 NRLFIFLELVTKGSLANLYQKY---------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~---------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                      ...+.++.+..-|+|..+++..         .++..++..++.|++.|+.|||+.|+||.||...|++|+..-+|||+|=
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence            5678888999999999998722         2556677889999999999999999999999999999999999999999


Q ss_pred             CCccccccCCcccCC----CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCC
Q 043852          422 GLAKATTMNDVKSCK----GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPL  496 (551)
Q Consensus       422 Gla~~~~~~~~~~~~----GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~  496 (551)
                      .+++.....+++...    ....||+||.+  .+..|+.++|+||||++||||+| |+.||...+..++...+.+|....
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal--~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla  518 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEAL--QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA  518 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHH--hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence            999977766554221    23459999997  46689999999999999999998 999999999999999999999999


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       497 ~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .|.+|++++..+|..||..+|++||+++|+...
T Consensus       519 QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~c  551 (563)
T KOG1024|consen  519 QPFNCPDELFTVMACCWALLPEERPSFSQLVIC  551 (563)
T ss_pred             CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence            999999999999999999999999999998753

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.2e-29  Score=261.23  Aligned_cols=250  Identities=29%  Similarity=0.474  Sum_probs=195.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-c---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-D---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  351 (551)
                      +.|..+++||+|+|++||++.+ .   ...+||+|.+......       .++..|+.+|..+. +.||+++.+++..++
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-------~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-------SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-------hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4688899999999999999976 3   5789999998654322       24678999999985 899999999999999


Q ss_pred             eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEecCCccc----
Q 043852          352 RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKA----  426 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~DFGla~~----  426 (551)
                      .+.+||||++...-.+++..  ++...+..|++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||||..    
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             eeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            99999999999998888876  556889999999999999999999999999999999975 57799999999851    


Q ss_pred             -------------ccc-C----------------C------------cccCCCCCcccChhhhhcccCCCCchhhHHHHH
Q 043852          427 -------------TTM-N----------------D------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLG  464 (551)
Q Consensus       427 -------------~~~-~----------------~------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG  464 (551)
                                   ... .                .            .....||++|.|||++. ....-+.++||||.|
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~-k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF-RCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh-hccCcCCccceeecc
Confidence                         000 0                0            01234999999999984 445568899999999


Q ss_pred             HHHHHHHcCCCCCCCc-hhHHHHHHh--------------hcCC--------C-----------C---------------
Q 043852          465 CTVLEMLTRQPPYSHL-EGMQALFRI--------------GKGE--------P-----------P---------------  495 (551)
Q Consensus       465 ~iLyeLltG~~Pf~~~-~~~~~~~~i--------------~~~~--------~-----------~---------------  495 (551)
                      +|++-++++..||... ++...+..+              ..+.        .           .               
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            9999999999998321 111111000              0000        0           0               


Q ss_pred             --CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          496 --LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       496 --~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                        ......+..+.+|+.+||..||.+|.|+++.|.||||....
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence              00012345788999999999999999999999999998443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=6.6e-29  Score=287.17  Aligned_cols=193  Identities=16%  Similarity=0.246  Sum_probs=142.7

Q ss_pred             Cceeeeeeec-------cCCCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceE
Q 043852          338 ENIVQYFGTD-------KDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANI  408 (551)
Q Consensus       338 pnIv~l~~~~-------~~~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NI  408 (551)
                      .||+++++++       .....++++|||+ +++|.+++..  ..+++..+..+++||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4777777766       2334577888887 5599999964  3488999999999999999999999999999999999


Q ss_pred             EEcCC-------------------CcEEEEecCCccccccC------------------CcccCCCCCcccChhhhhccc
Q 043852          409 LVDAS-------------------GSVKLADFGLAKATTMN------------------DVKSCKGTPFWMAPEVVNLKN  451 (551)
Q Consensus       409 Ll~~~-------------------g~vkL~DFGla~~~~~~------------------~~~~~~GT~~Y~APEvl~~~~  451 (551)
                      ||+..                   +.+||+|||+++.....                  ......||+.|||||++  ..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~--~~  189 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED--NG  189 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh--cc
Confidence            99654                   44566666665432100                  00113578999999997  45


Q ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       452 ~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      ..|+.++|||||||+||||++|.+|+.....  ....+.....+...........+++.+||+++|.+|||+.+|++|||
T Consensus       190 ~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        190 SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence            6789999999999999999999988764322  11111111111111122455678999999999999999999999999


Q ss_pred             cCCc
Q 043852          532 VKRP  535 (551)
Q Consensus       532 f~~~  535 (551)
                      |...
T Consensus       268 ~~~~  271 (793)
T PLN00181        268 INEP  271 (793)
T ss_pred             hhhh
Confidence            9865

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-28  Score=235.89  Aligned_cols=256  Identities=22%  Similarity=0.316  Sum_probs=198.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeee-ccCCCeE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGT-DKDENRL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~-~~~~~~~  353 (551)
                      +.|.+.+.||+|.||.+.++.+ .++..+++|.+....      ..+.+|.+|..---.| .|.||+.-|++ |+..+.+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch------hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            4789999999999999999998 478889999886432      2356788887654444 48999998764 7788899


Q ss_pred             EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-C-CcEEEEecCCccccccCC
Q 043852          354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-S-GSVKLADFGLAKATTMND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~-g~vkL~DFGla~~~~~~~  431 (551)
                      ++++||++.|+|..-+...++.+.....++.|++.||.|+|++++||||||.+||||-. + -.|||||||+.+..+.. 
T Consensus        98 vF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-  176 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-  176 (378)
T ss_pred             EEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence            99999999999999998899999999999999999999999999999999999999943 3 36999999987543321 


Q ss_pred             cccCCCCCcccChhhhhccc-C--CCCchhhHHHHHHHHHHHHcCCCCCCCchh----HHHHHHhhcCCCCCCC---CcC
Q 043852          432 VKSCKGTPFWMAPEVVNLKN-R--GYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEPPLVP---NSL  501 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~-~--~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~----~~~~~~i~~~~~~~~~---~~~  501 (551)
                      .....-+..|.+||++.... .  ...+.+|+|.||+++|..+||.+||.....    .-.+.+..++..+..|   +.+
T Consensus       177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence            12222456789999864221 1  247889999999999999999999963221    2222233333333333   457


Q ss_pred             CHHHHHHHHHhhhcCCCCC---CCHHHHHhCcccCCccccC
Q 043852          502 SRDARDFILKCLQVNPNDR---PTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~R---PS~~eILehpff~~~~~~~  539 (551)
                      +..+..+.++-|..+++.|   .+++......|....+...
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~  297 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTV  297 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccc
Confidence            8899999999999999999   7888888888876554433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=6.1e-27  Score=220.24  Aligned_cols=159  Identities=31%  Similarity=0.407  Sum_probs=127.1

Q ss_pred             cchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCCCCCc
Q 043852          363 GSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF  440 (551)
Q Consensus       363 gsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~  440 (551)
                      |+|.+++..  .++++..++.++.||+.||.|||+++      ||+|||++.++.+++  ||++.......   ..||+.
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~~g~~~   69 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---SRVDPY   69 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---CCCccc
Confidence            688888874  35999999999999999999999998      999999999999999  99987654322   358999


Q ss_pred             ccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHhhcCCCCC------CCCcCCH--HHHHHHHH
Q 043852          441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ-ALFRIGKGEPPL------VPNSLSR--DARDFILK  511 (551)
Q Consensus       441 Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~-~~~~i~~~~~~~------~~~~~s~--~l~~LI~~  511 (551)
                      |+|||++  .+..++.++|||||||++|||++|+.||....... .+..+.......      .+..++.  .+.++|.+
T Consensus        70 y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  147 (176)
T smart00750       70 FMAPEVI--QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV  147 (176)
T ss_pred             ccChHHh--cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence            9999997  45678999999999999999999999997654322 222222222211      1122333  68999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCC
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~  534 (551)
                      ||+.||.+|||+.++++|+|+..
T Consensus       148 cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      148 CASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999763

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=9.4e-25  Score=216.44  Aligned_cols=258  Identities=35%  Similarity=0.501  Sum_probs=206.6

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC-ceeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE-NIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~  357 (551)
                      |.+.+.||.|+||.||++.+.  ..+++|.+........  .....+.+|+.++..+.|+ +|+++++.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            678899999999999999776  7889998865433322  3466778999999999988 7999999997777789999


Q ss_pred             ecccccchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCccccccC--
Q 043852          358 ELVTKGSLANLYQKY----HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN--  430 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~----~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~~--  430 (551)
                      +++.++++..++...    .+....+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||++......  
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999999777665    588899999999999999999999999999999999999988 7999999998744332  


Q ss_pred             ------CcccCCCCCcccChhhhhccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchh----HHHHHHhhcCCCC-CCC
Q 043852          431 ------DVKSCKGTPFWMAPEVVNLKN-RGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEPP-LVP  498 (551)
Q Consensus       431 ------~~~~~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~----~~~~~~i~~~~~~-~~~  498 (551)
                            ......||..|++||.+.... ..+....|+|++|++++++++|..||.....    ......+.....+ ...
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  235567999999999974321 5778999999999999999999999876653    3333333333322 111


Q ss_pred             ---CcC----CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          499 ---NSL----SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       499 ---~~~----s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                         ...    ...+.+++..|+..+|..|.+..+...++|.........
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~  286 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES  286 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccc
Confidence               111    257899999999999999999999999877665554443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.7e-24  Score=222.60  Aligned_cols=244  Identities=24%  Similarity=0.284  Sum_probs=188.7

Q ss_pred             CeeeeeEeccCCceEEEEEEecC--CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC----CCceeeeeeec-cCC
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDD--GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE----HENIVQYFGTD-KDE  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~--g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~----HpnIv~l~~~~-~~~  350 (551)
                      +|.+.+.||+|+||.||+|.+..  ...+|+|+..........     .+..|+.++..+.    ..++..+++.+ ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-----~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-----VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-----cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            79999999999999999998744  358899987653222111     3446667777765    36899999998 578


Q ss_pred             CeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-----CcEEEEecC
Q 043852          351 NRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-----GSVKLADFG  422 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-----g~vkL~DFG  422 (551)
                      .+.||||+++ |.+|.++...   ..++..++..++.|++.+|++||+.|++||||||.|+++...     ..+.|+|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            8899999999 7799998754   358999999999999999999999999999999999999765     369999999


Q ss_pred             Ccc--ccccCC----------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH---HH
Q 043852          423 LAK--ATTMND----------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA---LF  487 (551)
Q Consensus       423 la~--~~~~~~----------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~---~~  487 (551)
                      +++  ......          .....||..|+++.+  +.+...+.+.|+||+++++.+|+.|.+||........   ..
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~--H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINV--HLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHH--hCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            998  321111          123449999999998  4677789999999999999999999999977654322   22


Q ss_pred             HhhcCCCCC-CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          488 RIGKGEPPL-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       488 ~i~~~~~~~-~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +........ .....+..+.++...+-..+...+|....+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            222222111 234456788888888888999999999888764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.1e-24  Score=207.29  Aligned_cols=241  Identities=21%  Similarity=0.283  Sum_probs=189.7

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC-CceeeeeeeccCCCe
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH-ENIVQYFGTDKDENR  352 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~  352 (551)
                      ..++|.++++||.|+||.+|+|.. .+|+.||||+-+......       ++..|.++...|++ ..|..+..++.+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-------qL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-------QLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-------chhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            456899999999999999999987 789999999865433322       45577788888764 788889999999999


Q ss_pred             EEEEEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc---CCCcEEEEecCCcccc
Q 043852          353 LFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKAT  427 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~---~~g~vkL~DFGla~~~  427 (551)
                      ..+||+++ |.+|.++++  ...++..+++-++-||+.-++|+|.+++|||||||+|+|+.   ....+.|+|||||+..
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999999 779999876  34688889999999999999999999999999999999995   3457999999999854


Q ss_pred             ccC---------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH---HHHHHhhcCCCC
Q 043852          428 TMN---------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPP  495 (551)
Q Consensus       428 ~~~---------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~---~~~~~i~~~~~~  495 (551)
                      ...         ......||..|.+-...  .+...+.+.|+-|+|.+|.++.-|.+||.+....   +...+|..-...
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh--~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAH--LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhh--hhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            322         23455699999887653  3445588899999999999999999999877543   333333332222


Q ss_pred             C----CCCcCCHHHHHHHHHhhhcCCCCCCCHHH
Q 043852          496 L----VPNSLSRDARDFILKCLQVNPNDRPTAAQ  525 (551)
Q Consensus       496 ~----~~~~~s~~l~~LI~~cL~~DP~~RPS~~e  525 (551)
                      .    .....|.++.-.+..|-..--++-|....
T Consensus       243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y  276 (341)
T KOG1163|consen  243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY  276 (341)
T ss_pred             CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence            2    23467888888888887777777777443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2e-25  Score=248.74  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=194.3

Q ss_pred             eeeEeccCCceEEEEEEe-cCCceEEEEEEecCc-cCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          281 KGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQD-QGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~-~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      ...++|.|++|.|+.+.. .....++.|.++... ...........+..|..+-..+.|+|++..+....+...++-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            457899999998887765 455556666554220 112222223336678888888999999888887777666666699


Q ss_pred             cccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC------C
Q 043852          359 LVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN------D  431 (551)
Q Consensus       359 y~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~------~  431 (551)
                      ||++ +|+.++... .+....+..++.||+.|++|||+.||.|||||++|+++..+|.+||+|||.+......      .
T Consensus       402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~  480 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHE  480 (601)
T ss_pred             cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhh
Confidence            9999 999999876 7888999999999999999999999999999999999999999999999998654322      2


Q ss_pred             cccCCCCCcccChhhhhcccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHH-HHhhc-------CCCCCCCCcCC
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL-FRIGK-------GEPPLVPNSLS  502 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~-s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~-~~i~~-------~~~~~~~~~~s  502 (551)
                      ....+|+..|+|||++  .+..| ....||||.|++++.|++|+.||......+.. .....       ..+..+...++
T Consensus       481 ~~g~~gS~pY~apE~~--~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  481 SSGIVGSDPYLAPEVL--TGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hcCcccCCcCcCcccc--cccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence            3455689999999997  44555 44589999999999999999999544333221 11111       11122234578


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ...+.+|.+||++||.+|.|+++|++.+||+..--
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            88999999999999999999999999999997643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.4e-24  Score=226.66  Aligned_cols=165  Identities=19%  Similarity=0.166  Sum_probs=128.5

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEec--CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceee-eeeeccCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ-YFGTDKDE  350 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~--~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~  350 (551)
                      ....+|.+.+.||+|+||+||+|.+.  ++..+|||++...............+.+|+.+|.+++|+||+. ++..    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            44568999999999999999999863  6788899987532111112334556889999999999999985 5543    


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeeccc-ccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI-KCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDI-KP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ...|+|||||.|++|... ..  .   ....++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+++....
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~--~---~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP--H---GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc--c---chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            357999999999999632 11  1   12468899999999999999999999 99999999999999999999985433


Q ss_pred             CC----------cccCCCCCcccChhhhh
Q 043852          430 ND----------VKSCKGTPFWMAPEVVN  448 (551)
Q Consensus       430 ~~----------~~~~~GT~~Y~APEvl~  448 (551)
                      ..          .....+++.|+|||.+.
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            22          23445788899999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-23  Score=210.07  Aligned_cols=238  Identities=21%  Similarity=0.336  Sum_probs=189.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  355 (551)
                      .|.++++||+|+||.++.|.+ -+++.||||.-..+....       ++..|.+..+.|. .++|...|.+..++.+..|
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP-------QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP-------QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcc-------hHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            689999999999999999987 699999999765443332       4556666666664 6899999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-----CcEEEEecCCccccc
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-----GSVKLADFGLAKATT  428 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-----g~vkL~DFGla~~~~  428 (551)
                      |+|++ |.+|++++.-  ..++..++..++.||+.-++|+|++.+|+|||||+|+||...     ..|.|+|||+|+...
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99999 7799998874  358999999999999999999999999999999999999654     359999999998654


Q ss_pred             cCC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch---hHHHHHHhhcCCCCC
Q 043852          429 MND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPL  496 (551)
Q Consensus       429 ~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---~~~~~~~i~~~~~~~  496 (551)
                      ...         .++..||..||+-..  +.+..-+.+.|+-|||.+++++|-|.+||.+..   .-+.+.+|......+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINT--HlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINT--HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             CccccccCccccccccccceeeeEeec--cccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            332         345669999999775  567778999999999999999999999997654   345556665544433


Q ss_pred             C----CCcCCHHHHHHHHHhhhcCCCCCCCHHH
Q 043852          497 V----PNSLSRDARDFILKCLQVNPNDRPTAAQ  525 (551)
Q Consensus       497 ~----~~~~s~~l~~LI~~cL~~DP~~RPS~~e  525 (551)
                      .    ...++.++...+...-..+-.+-|..+-
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy  291 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY  291 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence            2    2346777777776666666666666443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.8e-25  Score=239.01  Aligned_cols=239  Identities=28%  Similarity=0.464  Sum_probs=200.4

Q ss_pred             EeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEEEEe
Q 043852          284 LLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      .+|+|+||.|+++..    +.|.-||+|+.++.........   ....|..++...+ ||.+|++...++.+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            379999999998643    5688999999876654443333   3345667777777 9999999999999999999999


Q ss_pred             cccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCCC
Q 043852          359 LVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG  437 (551)
Q Consensus       359 y~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~G  437 (551)
                      +..||.|...+.+. .+.+.....+...++.+++++|+.+|+|+|+|++||+++.+|++++.|||+++........  +|
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cg  155 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CG  155 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--cc
Confidence            99999998776654 4667778889999999999999999999999999999999999999999999876544444  89


Q ss_pred             CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCC
Q 043852          438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP  517 (551)
Q Consensus       438 T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP  517 (551)
                      |..|||||+++    ++..+.|.||||+++++|+||..||..    +...+|.+.. ...|..++..+++++.+++..+|
T Consensus       156 t~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  156 TYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             chhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCH
Confidence            99999999984    568899999999999999999999988    4444444433 44577889999999999999999


Q ss_pred             CCCCC-----HHHHHhCcccCCcc
Q 043852          518 NDRPT-----AAQLMEHPFVKRPL  536 (551)
Q Consensus       518 ~~RPS-----~~eILehpff~~~~  536 (551)
                      .+|.-     ..++++|+||+...
T Consensus       227 ~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  227 ENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             HHHhccCcchhHHHhccchheeee
Confidence            99964     57899999998654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=4.2e-23  Score=231.62  Aligned_cols=244  Identities=22%  Similarity=0.288  Sum_probs=183.5

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      ++...+-||.+.|=+|.+|+++.|. |+||++.+......-. ..++...|++ ...++|||++.+.-+-..+...|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~-~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLR-PFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCch-HHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6777899999999999999998887 8899987765443333 3334445555 66678999999998888888889999


Q ss_pred             ecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc----
Q 043852          358 ELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----  432 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~----  432 (551)
                      +|+.. +|++.+...+ +..-+...|+.||+.||.-+|..||+|||||.+||||+.-+.+.|+||..-+.......    
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99966 8888776555 55556677889999999999999999999999999999999999999987764432221    


Q ss_pred             -c----cCCCCCcccChhhhhccc--------CC-CCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCC-
Q 043852          433 -K----SCKGTPFWMAPEVVNLKN--------RG-YGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPL-  496 (551)
Q Consensus       433 -~----~~~GT~~Y~APEvl~~~~--------~~-~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~-  496 (551)
                       .    +...--.|.|||-+....        .. .+++.||||+||+++||++ |+++|.-    .++.....+.... 
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDP  255 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCH
Confidence             1    111223599999874211        11 5789999999999999997 7888852    2222222221100 


Q ss_pred             ---CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          497 ---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       497 ---~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                         ....-+..++.||..|++.||.+|.++++.|+.
T Consensus       256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence               011124578999999999999999999999986

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=5.8e-22  Score=201.19  Aligned_cols=234  Identities=24%  Similarity=0.297  Sum_probs=152.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC----------Cceeeeeee
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH----------ENIVQYFGT  346 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H----------pnIv~l~~~  346 (551)
                      .+..+..||.|+++.||.+++ .+|+.+|||++....  ......++++.+|......+.+          -.++..++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            567789999999999999998 689999999988766  3444567777777766555433          112221111


Q ss_pred             c------------cCCC-----eEEEEEecccccchHHHHh---hhc-----CChHHHHHHHHHHHHHHHHHHhCCeeec
Q 043852          347 D------------KDEN-----RLFIFLELVTKGSLANLYQ---KYH-----LMDSQVSAYTRQILNGLNYLHEQNVVHR  401 (551)
Q Consensus       347 ~------------~~~~-----~~~lV~Ey~~ggsL~~ll~---~~~-----l~~~~i~~i~~QI~~aL~yLH~~gIiHr  401 (551)
                      .            .+..     ..+++|+-+.+ +|..++.   ...     +.......+..|+++.+++||..|++|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            1            1111     23667777744 7776653   221     2223334566899999999999999999


Q ss_pred             ccccceEEEcCCCcEEEEecCCccccccCCcccCCCCCcccChhhhhcc------cCCCCchhhHHHHHHHHHHHHcCCC
Q 043852          402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLK------NRGYGLTADIWSLGCTVLEMLTRQP  475 (551)
Q Consensus       402 DIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~------~~~~s~ksDIwSLG~iLyeLltG~~  475 (551)
                      ||+|+|+|++.+|.++|+||+.....+..... ...+..|.+||.....      ...++.+.|.|+||+++|.|.+|..
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999999876554433222 3456789999986432      2357999999999999999999999


Q ss_pred             CCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCC
Q 043852          476 PYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR  520 (551)
Q Consensus       476 Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~R  520 (551)
                      ||.............    .... .+++.++.||..+|+.||.+|
T Consensus       249 Pf~~~~~~~~~~~~f----~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEWDF----SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGGGG----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccccc----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            997654322111111    1122 688999999999999999987

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=7.3e-22  Score=190.47  Aligned_cols=143  Identities=17%  Similarity=0.158  Sum_probs=110.4

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccch---------------------HHHHHHHHHHHHHhcCCCCce
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGK---------------------QSILQLEQEILLLSRFEHENI  340 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~---------------------~~~~~~~~Ei~il~~l~HpnI  340 (551)
                      .++||+|+||.||+|.+.+|+.||||++..........                     ........|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999988789999999997543211110                     011233469999999987776


Q ss_pred             eeeeeeccCCCeEEEEEecccccchHHH-HhhhcCChHHHHHHHHHHHHHHHHH-HhCCeeecccccceEEEcCCCcEEE
Q 043852          341 VQYFGTDKDENRLFIFLELVTKGSLANL-YQKYHLMDSQVSAYTRQILNGLNYL-HEQNVVHRDIKCANILVDASGSVKL  418 (551)
Q Consensus       341 v~l~~~~~~~~~~~lV~Ey~~ggsL~~l-l~~~~l~~~~i~~i~~QI~~aL~yL-H~~gIiHrDIKP~NILl~~~g~vkL  418 (551)
                      .........  ..+|||||+.|+++... +....++...+..++.||+.+|.|| |+.||+||||||+|||++ ++.++|
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L  158 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI  158 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence            443332222  23899999999877554 4556788899999999999999999 799999999999999998 588999


Q ss_pred             EecCCcccc
Q 043852          419 ADFGLAKAT  427 (551)
Q Consensus       419 ~DFGla~~~  427 (551)
                      +|||+|...
T Consensus       159 iDFG~a~~~  167 (190)
T cd05147         159 IDVSQSVEH  167 (190)
T ss_pred             EEccccccC
Confidence            999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=6.3e-22  Score=195.37  Aligned_cols=172  Identities=17%  Similarity=0.199  Sum_probs=132.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHH------HHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQ------LEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ++|...++||.|+||.||+... ++..+|||++.......  ......      +.+|+..+.++.|++|..+.+++...
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            4799999999999999999644 67789999986543322  222223      67999999999999999988875533


Q ss_pred             --------CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecC
Q 043852          351 --------NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       351 --------~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                              ...+|+|||++|.+|.++..   +++    ....+|+.+|..||+.|++||||||+||+++.+| ++|+|||
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence                    35789999999999987732   222    3466999999999999999999999999999888 9999999


Q ss_pred             CccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHH
Q 043852          423 LAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEML  471 (551)
Q Consensus       423 la~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLl  471 (551)
                      ..+........           ..+ .....|+.++|+|+||+++..+.
T Consensus       180 ~~~~~~e~~a~-----------d~~-vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRKAK-----------DRI-DLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CcccccchhhH-----------HHH-HHHhHhcccccccceeEeehHHH
Confidence            87544222111           112 13445678999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4.1e-21  Score=184.87  Aligned_cols=144  Identities=19%  Similarity=0.186  Sum_probs=113.0

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccc---------------------hHHHHHHHHHHHHHhcCCCCce
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG---------------------KQSILQLEQEILLLSRFEHENI  340 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~---------------------~~~~~~~~~Ei~il~~l~HpnI  340 (551)
                      .+.||+|+||+||+|.+.+|+.||||++.........                     ......+..|+..+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999998778999999998765321110                     1112334678999999999887


Q ss_pred             eeeeeeccCCCeEEEEEecccccchH-HHHhhhcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEE
Q 043852          341 VQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKL  418 (551)
Q Consensus       341 v~l~~~~~~~~~~~lV~Ey~~ggsL~-~ll~~~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL  418 (551)
                      .....+....  .||||||+.|+++. ..+....++...+..++.|++.+|.+||+ +||+||||||+|||++ ++.++|
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l  158 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI  158 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence            4443333222  48999999988553 34566678888999999999999999999 9999999999999998 899999


Q ss_pred             EecCCccccc
Q 043852          419 ADFGLAKATT  428 (551)
Q Consensus       419 ~DFGla~~~~  428 (551)
                      +|||+++...
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05145         159 IDVSQAVELD  168 (190)
T ss_pred             EEcccceecC
Confidence            9999986553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.2e-20  Score=183.33  Aligned_cols=188  Identities=20%  Similarity=0.144  Sum_probs=140.7

Q ss_pred             eeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEEEEe
Q 043852          280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      .+...|++|+||+||.+. ..+..++.+.+........ ......+.+|+++|.++. |++|++++++    ...|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~-~~~~k~~~~~l~~~~~~~~-~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVR-GGERKFVRRDLSAAPWWLR-GVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEee-cCCceeeecccccchhhhh-hHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            356789999999999874 4777777776643322111 111224779999999995 4789999886    33699999


Q ss_pred             cccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeeccc-ccceEEEcCCCcEEEEecCCccccccCCc-----
Q 043852          359 LVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI-KCANILVDASGSVKLADFGLAKATTMNDV-----  432 (551)
Q Consensus       359 y~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDI-KP~NILl~~~g~vkL~DFGla~~~~~~~~-----  432 (551)
                      |+.|.+|.......      ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++........     
T Consensus        79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence            99999986544221      2457889999999999999999999 79999999999999999999975443221     


Q ss_pred             ----------ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 043852          433 ----------KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH  479 (551)
Q Consensus       433 ----------~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~  479 (551)
                                .....++.|++|+.-......--.+.++++.|+-+|.++|+..++-+
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                      01125788999987543333334678999999999999999888643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.6e-21  Score=196.99  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=179.1

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEecC-C-----------------------------------ceEEEEEEecCccCcc
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTDD-G-----------------------------------FFFAVKEVSLQDQGTQ  317 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~~-g-----------------------------------~~vAVK~i~~~~~~~~  317 (551)
                      -.+++|.++..||+|.-..||.+...+ |                                   ...|||.+..-.....
T Consensus       154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~  233 (598)
T KOG4158|consen  154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG  233 (598)
T ss_pred             cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence            356789999999999999999875311 1                                   1244554433333333


Q ss_pred             chHHHHHHHHHHH------HH--------hc--------CCCCceeeeeeeccC--------------------------
Q 043852          318 GKQSILQLEQEIL------LL--------SR--------FEHENIVQYFGTDKD--------------------------  349 (551)
Q Consensus       318 ~~~~~~~~~~Ei~------il--------~~--------l~HpnIv~l~~~~~~--------------------------  349 (551)
                      ....+..+.+|.-      ++        +.        -+|||||++.+.|.+                          
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence            3333333333321      11        01        259999999987654                          


Q ss_pred             -CCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc--CCC--cEEEEecCCc
Q 043852          350 -ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD--ASG--SVKLADFGLA  424 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~--~~g--~vkL~DFGla  424 (551)
                       ...+|+||..... +|..++-....+.....-++.|+++|+.|||++||.|||+|.+||||.  .++  .+.|+|||++
T Consensus       314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence             2357999998865 899998877788888889999999999999999999999999999994  333  5899999987


Q ss_pred             cccccC--------CcccCCCCCcccChhhhhcccCCC----CchhhHHHHHHHHHHHHcCCCCCCCchhHHH-HHHhhc
Q 043852          425 KATTMN--------DVKSCKGTPFWMAPEVVNLKNRGY----GLTADIWSLGCTVLEMLTRQPPYSHLEGMQA-LFRIGK  491 (551)
Q Consensus       425 ~~~~~~--------~~~~~~GT~~Y~APEvl~~~~~~~----s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~-~~~i~~  491 (551)
                      -.....        ..-...|....||||+.+......    -.++|.|+.|.+.||+++...||.....+.. ......
T Consensus       393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe  472 (598)
T KOG4158|consen  393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE  472 (598)
T ss_pred             eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence            543321        122344788899999975333221    3478999999999999999999976433321 112334


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCH
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTA  523 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~  523 (551)
                      ...+..+..++..+++|+..+|+.||.+|++.
T Consensus       473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             hhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence            45677788999999999999999999999883

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=3.1e-21  Score=216.74  Aligned_cols=214  Identities=30%  Similarity=0.477  Sum_probs=161.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|..+++|..|+||.||.+++ .+.+.+|+| +.+..       .+  +++   ++.....|.+|               
T Consensus        84 df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------li--lRn---ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   84 DFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------LI--LRN---ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------hh--hhc---cccccCCccee---------------
Confidence            789999999999999999988 467888885 32111       00  001   22222334333               


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-----
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----  430 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-----  430 (551)
                            |+=..+++. +.++.        +++.+++|||+.||+|||+||+|.+|+.-|++|++|||+++.....     
T Consensus       136 ------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             ------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                  333333433 22333        2388999999999999999999999999999999999998642211     


Q ss_pred             ------------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--
Q 043852          431 ------------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--  496 (551)
Q Consensus       431 ------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--  496 (551)
                                  ..+..+|||.|.|||++  ...+|+..+|+|+||+|+||++-|..||.+.+..+.+..+......+  
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi--lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhh--hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence                        12345799999999997  56789999999999999999999999999988877776655543322  


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCC---CCHHHHHhCcccCCc
Q 043852          497 VPNSLSRDARDFILKCLQVNPNDR---PTAAQLMEHPFVKRP  535 (551)
Q Consensus       497 ~~~~~s~~l~~LI~~cL~~DP~~R---PS~~eILehpff~~~  535 (551)
                      -...++.+++++|.++|+.+|..|   ..+-++.+|+||+..
T Consensus       280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            245688999999999999999999   467889999999843

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2e-20  Score=183.54  Aligned_cols=243  Identities=21%  Similarity=0.363  Sum_probs=188.0

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      +.....+|.+..-|..|+|++..+. +++|++.....   .......|..|.-.|+-+.||||+.+++.|.....+.++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~---t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGND-IVAKILNVREV---TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhc---chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            4455667889999999999775544 45576654322   2223345667777888899999999999999999999999


Q ss_pred             ecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          358 ELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      .|++.|+|+.++....   ....++.+++.+|++|+.|||+..  |.---|....++|+.+-+.+|. .+-.++....  
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe--  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE--  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeec--
Confidence            9999999999987542   566789999999999999999874  4444688899999988776653 2212222111  


Q ss_pred             ccCCCCCcccChhhhhcccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHh-hcCCCCCCCCcCCHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI-GKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~-s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ....-.|.||+||.++.+.... -.++|+|||.+++|||.|...||.....++-=.+| ..|....+|+.++..+..|+.
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~  423 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMN  423 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHH
Confidence            1122368899999987554433 45689999999999999999999888877654443 457778899999999999999


Q ss_pred             HhhhcCCCCCCCHHHHH
Q 043852          511 KCLQVNPNDRPTAAQLM  527 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eIL  527 (551)
                      -|++.||.+||.+.+|+
T Consensus       424 icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  424 ICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHhcCCCCcCCCcceeh
Confidence            99999999999998865

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=2.1e-19  Score=175.98  Aligned_cols=133  Identities=20%  Similarity=0.306  Sum_probs=104.9

Q ss_pred             eeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-----CCCceeeeeeeccCCC---
Q 043852          281 KGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-----EHENIVQYFGTDKDEN---  351 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---  351 (551)
                      -.++||+|+||.||.  + .++.. +||++.....     .....+.+|+.++..+     .||||+++++++.++.   
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            347899999999996  5 34444 7998865322     1234678999999999     5799999999998863   


Q ss_pred             eEE-EEEec--ccccchHHHHhhhcCChHHHHHHHHHHHHHH-HHHHhCCeeecccccceEEEcCC----CcEEEEecCC
Q 043852          352 RLF-IFLEL--VTKGSLANLYQKYHLMDSQVSAYTRQILNGL-NYLHEQNVVHRDIKCANILVDAS----GSVKLADFGL  423 (551)
Q Consensus       352 ~~~-lV~Ey--~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL-~yLH~~gIiHrDIKP~NILl~~~----g~vkL~DFGl  423 (551)
                      .++ +|+||  +.+++|.+++++..+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            434 78999  558999999987666555  36678888777 99999999999999999999743    3799999553

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=1.2e-18  Score=199.18  Aligned_cols=240  Identities=23%  Similarity=0.294  Sum_probs=171.6

Q ss_pred             cCCCchhhhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC---CCceee
Q 043852          266 VSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE---HENIVQ  342 (551)
Q Consensus       266 ~~p~~~~~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~  342 (551)
                      +.+...+...-+.|.+.+.||+|+||+||.|.+.+|+.||+|+-.........  .-      .+++.+|+   -+.|+.
T Consensus       687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY--I~------~q~~~RLk~~~~~~~~~  758 (974)
T KOG1166|consen  687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY--IC------LQVMERLKPQMLPSIMH  758 (974)
T ss_pred             cCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee--eh------HHHHHhhchhhhcchHH
Confidence            33444444445689999999999999999999877999999986544333211  11      12333333   235666


Q ss_pred             eeeeccCCCeEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-------CC
Q 043852          343 YFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-------SG  414 (551)
Q Consensus       343 l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-------~g  414 (551)
                      ++..+.-.+..+||+||.+.|+|.++++.. .+++..+..++.||+..+++||..+|||+||||+|+||..       +-
T Consensus       759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             HHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence            666666667779999999999999999854 4777788899999999999999999999999999999943       23


Q ss_pred             cEEEEecCCccccc---cC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhh
Q 043852          415 SVKLADFGLAKATT---MN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG  490 (551)
Q Consensus       415 ~vkL~DFGla~~~~---~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~  490 (551)
                      .++|+|||.+--+.   .. .....++|-.+-++|+.  .+..|+..+|.|.|+-|++-||.|+..       +    ..
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~--~grpWtYq~DyfGlAa~~h~mLFG~y~-------q----~~  905 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR--EGRPWTYQIDYFGLAATVHVMLFGKYM-------E----VK  905 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHh--cCCCCchhhhhHHHHHHHHHHHHHHHH-------H----hc
Confidence            69999999875322   12 34456688899999986  678999999999999999999998643       1    22


Q ss_pred             cCCCCCC----CCcCCHHH-HHHHHHhhhcCCCCCCCHHHH
Q 043852          491 KGEPPLV----PNSLSRDA-RDFILKCLQVNPNDRPTAAQL  526 (551)
Q Consensus       491 ~~~~~~~----~~~~s~~l-~~LI~~cL~~DP~~RPS~~eI  526 (551)
                      ++.....    +.....++ .+++..+|+.|-..=|...+|
T Consensus       906 ~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l  946 (974)
T KOG1166|consen  906 NGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL  946 (974)
T ss_pred             CCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence            2222111    22222333 467788888444443554444

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=1.1e-18  Score=174.17  Aligned_cols=145  Identities=21%  Similarity=0.200  Sum_probs=112.7

Q ss_pred             CeeeeeEeccCCceEEEEEE--ecCCceEEEEEEecCccCccc-------------------hHHHHHHHHHHHHHhcCC
Q 043852          278 SWQKGELLGSGSFGTVYEGY--TDDGFFFAVKEVSLQDQGTQG-------------------KQSILQLEQEILLLSRFE  336 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~--~~~g~~vAVK~i~~~~~~~~~-------------------~~~~~~~~~Ei~il~~l~  336 (551)
                      -|.+.+.||+|+||.||+|.  ..+|..||||++.........                   ......+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998  368999999998754321100                   112234678999999997


Q ss_pred             CC--ceeeeeeeccCCCeEEEEEecccccchHHHH-hhhcCChHHHHHHHHHHHHHHHHHHhCC-eeecccccceEEEcC
Q 043852          337 HE--NIVQYFGTDKDENRLFIFLELVTKGSLANLY-QKYHLMDSQVSAYTRQILNGLNYLHEQN-VVHRDIKCANILVDA  412 (551)
Q Consensus       337 Hp--nIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll-~~~~l~~~~i~~i~~QI~~aL~yLH~~g-IiHrDIKP~NILl~~  412 (551)
                      +.  .+.++++.    ...++||||+.|++|..+. ....+....+..++.||+.+|.+||++| |+|+||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            53  34455543    2348999999998886654 4445666677899999999999999999 99999999999998 


Q ss_pred             CCcEEEEecCCcccc
Q 043852          413 SGSVKLADFGLAKAT  427 (551)
Q Consensus       413 ~g~vkL~DFGla~~~  427 (551)
                      ++.++|+|||++...
T Consensus       184 ~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCCEEEEEChhhhcc
Confidence            889999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3.3e-18  Score=166.03  Aligned_cols=139  Identities=20%  Similarity=0.272  Sum_probs=113.2

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCc---cchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEec
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT---QGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLEL  359 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey  359 (551)
                      +.||+|++|.||+|.. .|..+++|+........   ........+.+|+.++..+.|++|.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999976 67789999765322211   1122334677899999999999887766666666778999999


Q ss_pred             ccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          360 VTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       360 ~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ++|++|.+++.....   ....++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998865332   7789999999999999999999999999999998 88999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=5.7e-18  Score=162.98  Aligned_cols=135  Identities=24%  Similarity=0.294  Sum_probs=107.1

Q ss_pred             EeccCCceEEEEEEecCCceEEEEEEecCccCc---cchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecc
Q 043852          284 LLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT---QGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      +||+|+||.||+|. .+|..+++|+........   .......++.+|+.++..+.|+++.....++.+....+++|||+
T Consensus         1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            48999999999997 467789999865332111   12233466788999999998887554444444556678999999


Q ss_pred             cccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          361 TKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       361 ~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      +|++|.+++.....      .++.||+.+|.+||+.|++|+|++|.||+++ ++.++|+|||++..
T Consensus        80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988765321      8899999999999999999999999999998 89999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=6.3e-18  Score=163.36  Aligned_cols=141  Identities=21%  Similarity=0.219  Sum_probs=109.8

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccc-----------------hHHHHHHHHHHHHHhcCCCC--c
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG-----------------KQSILQLEQEILLLSRFEHE--N  339 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~-----------------~~~~~~~~~Ei~il~~l~Hp--n  339 (551)
                      |.+.+.||+|+||.||++...+|..||||++.........                 .........|+.++..+.|.  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            6778899999999999998878999999997653211000                 01122356788888888877  4


Q ss_pred             eeeeeeeccCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEE
Q 043852          340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA  419 (551)
Q Consensus       340 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~  419 (551)
                      ++..++.    ...+++|||+.|++|..+...     .....++.+|+.++.++|+.||+|+||||+||+++.++.++|+
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~li  167 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYII  167 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEE
Confidence            4444442    345899999999998776431     3456789999999999999999999999999999999999999


Q ss_pred             ecCCccccc
Q 043852          420 DFGLAKATT  428 (551)
Q Consensus       420 DFGla~~~~  428 (551)
                      |||++....
T Consensus       168 Dfg~~~~~~  176 (198)
T cd05144         168 DWPQMVSTD  176 (198)
T ss_pred             ECCccccCC
Confidence            999985443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.73  E-value=1e-17  Score=180.33  Aligned_cols=197  Identities=26%  Similarity=0.513  Sum_probs=153.2

Q ss_pred             HhcCCCCceeeeeeeccCCCeEEEEEecccccchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHhCCe-eecccccceE
Q 043852          332 LSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNV-VHRDIKCANI  408 (551)
Q Consensus       332 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~--l~~~~i~~i~~QI~~aL~yLH~~gI-iHrDIKP~NI  408 (551)
                      |+.+.|.|+.+++|.+.++..+++|.+||..|+|.+.+....  ++.--...+++.|+.||.|||...| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            356789999999999999999999999999999999987654  4444556788999999999998866 9999999999


Q ss_pred             EEcCCCcEEEEecCCcccccc----CCcccCCCCCcccChhhhhcc--cC---CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 043852          409 LVDASGSVKLADFGLAKATTM----NDVKSCKGTPFWMAPEVVNLK--NR---GYGLTADIWSLGCTVLEMLTRQPPYSH  479 (551)
Q Consensus       409 Ll~~~g~vkL~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~--~~---~~s~ksDIwSLG~iLyeLltG~~Pf~~  479 (551)
                      +++....+||+|||+......    .......-..-|.|||.+...  ..   ..+.+.||||+|++++|+++.+.||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999765532    111111123459999998532  11   147789999999999999999999964


Q ss_pred             c----hhHHHHHHhhc-CCCCCCCC-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          480 L----EGMQALFRIGK-GEPPLVPN-----SLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       480 ~----~~~~~~~~i~~-~~~~~~~~-----~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .    ...+.+.++.+ +..+..|.     .+.+.+..++..||..+|.+||++++|-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    22345556665 33323222     34557889999999999999999999865

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=2.4e-17  Score=183.06  Aligned_cols=139  Identities=21%  Similarity=0.239  Sum_probs=110.6

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCc---cchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT---QGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      |...+.||+|+||.||+|..... .+++|+........   ........+.+|+.++..++|++|+..+.++.+....++
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            45578999999999999976443 34445432221111   112334568899999999999999887777666677899


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ||||++|++|.+++.       ....++.||+.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       414 v~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        414 VMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999998875       356789999999999999999999999999999 688999999999854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=2.3e-18  Score=182.73  Aligned_cols=243  Identities=22%  Similarity=0.328  Sum_probs=166.3

Q ss_pred             CeeeeeEeccCCceEEEEEEecC----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeee-------e
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDD----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFG-------T  346 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-------~  346 (551)
                      .+.+.+-.+..+++.++......    .+.++-+....     ..........+++-.+....|.+..-+.+       .
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~-----d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~  319 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV-----DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES  319 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhc-----cchhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence            45556777888888877654321    33444333221     11122223334444444444433333332       1


Q ss_pred             cc-----CCCeEEEEEecccccchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEE
Q 043852          347 DK-----DENRLFIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVK  417 (551)
Q Consensus       347 ~~-----~~~~~~lV~Ey~~ggsL~~ll~~~~----l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vk  417 (551)
                      +.     ...++||.|++|...+|.+++.+..    .+...+..++.|++.+++|   +|.+|+|+||.||+...++.+|
T Consensus       320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence            11     1235899999999999999997432    5556788999999999999   9999999999999999999999


Q ss_pred             EEecCCccccccCC--------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 043852          418 LADFGLAKATTMND--------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFR  488 (551)
Q Consensus       418 L~DFGla~~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~  488 (551)
                      |.|||+.+......        ....+||..||+||.+  .+..|+.++|||+||++|+||++ -...|   +....+.-
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi--~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d  471 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQI--RGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTD  471 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHH--hhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhh
Confidence            99999986544332        2345699999999997  56789999999999999999997 23332   33334444


Q ss_pred             hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       489 i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      +..+..++....=.+.-..|+.+||.+.|.+||++.+.--|.|.+
T Consensus       472 ~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  472 IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            455544422222223456899999999999999888888887764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=8.6e-19  Score=195.71  Aligned_cols=253  Identities=30%  Similarity=0.422  Sum_probs=201.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe--cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT--DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLF  354 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~  354 (551)
                      .|...+-||+|+|+.|-....  .....+|+|.+....   ......++...|..+-..+. |.|++.+++...+....+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            567777899999999988765  355666777665443   22334445556777777777 999999999999999999


Q ss_pred             EEEecccccchHHHH-hhh--cCChHHHHHHHHHHHHHHHHHH-hCCeeecccccceEEEcCCC-cEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLY-QKY--HLMDSQVSAYTRQILNGLNYLH-EQNVVHRDIKCANILVDASG-SVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll-~~~--~l~~~~i~~i~~QI~~aL~yLH-~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~  429 (551)
                      ++++|..|+++...+ ...  ..+......++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|+....
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999998877 432  5677888999999999999999 99999999999999999999 999999999986654


Q ss_pred             -CC----cccCCC-CCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH--hhc--CCCCCCCC
Q 043852          430 -ND----VKSCKG-TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR--IGK--GEPPLVPN  499 (551)
Q Consensus       430 -~~----~~~~~G-T~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~--i~~--~~~~~~~~  499 (551)
                       +.    ....+| ++.|+|||... ......+..|+||+|+++..+++|..||.........+.  +..  ........
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~-~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLS-GKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             cCCcceeeecccCCCCCCCCccccc-chhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence             22    234457 99999999873 223457889999999999999999999965443322211  111  11233456


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      .++....+++.+++..+|.+|.+..++..++|+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            78899999999999999999999999999999987

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=1.9e-16  Score=150.71  Aligned_cols=140  Identities=24%  Similarity=0.304  Sum_probs=98.5

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHH-------------------HHHHHHHHHHhcCCCCc--e
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSI-------------------LQLEQEILLLSRFEHEN--I  340 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~-------------------~~~~~Ei~il~~l~Hpn--I  340 (551)
                      ++.||+|+||+||+|.+.+|..||||++.............                   .....|...+..+.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988889999999986533221111100                   11134555555554432  4


Q ss_pred             eeeeeeccCCCeEEEEEecccccchHH-HHhhhcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEE
Q 043852          341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKL  418 (551)
Q Consensus       341 v~l~~~~~~~~~~~lV~Ey~~ggsL~~-ll~~~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL  418 (551)
                      .+.+++.    ..+++|||+.++.+.. .+...... ..+..++.|++.++.++|. .||+|+||||+||+++ ++.++|
T Consensus        82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~l  155 (187)
T cd05119          82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYI  155 (187)
T ss_pred             CceEecC----CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEE
Confidence            4444432    3589999999954321 12221111 6678899999999999999 9999999999999999 999999


Q ss_pred             EecCCcccc
Q 043852          419 ADFGLAKAT  427 (551)
Q Consensus       419 ~DFGla~~~  427 (551)
                      +|||.+...
T Consensus       156 iDfg~a~~~  164 (187)
T cd05119         156 IDVPQAVEI  164 (187)
T ss_pred             EECcccccc
Confidence            999988544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=6.9e-16  Score=154.16  Aligned_cols=139  Identities=19%  Similarity=0.204  Sum_probs=104.8

Q ss_pred             eEec-cCCceEEEEEEecCCceEEEEEEecCcc--------CccchHHHHHHHHHHHHHhcCCCCce--eeeeeeccCC-
Q 043852          283 ELLG-SGSFGTVYEGYTDDGFFFAVKEVSLQDQ--------GTQGKQSILQLEQEILLLSRFEHENI--VQYFGTDKDE-  350 (551)
Q Consensus       283 ~~LG-~G~fG~VY~~~~~~g~~vAVK~i~~~~~--------~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~-  350 (551)
                      ..|| .|+.|+||.+.. .+..++||.+.....        .........++.+|+.++..+.|++|  +..++..... 
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4677 888888888855 467889998753211        01112234567789999999998875  6666653322 


Q ss_pred             Ce---EEEEEecccc-cchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          351 NR---LFIFLELVTK-GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       351 ~~---~~lV~Ey~~g-gsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ..   .++|||+++| .+|.+++....+++.    .+.||+.+|.+||++||+|+||||.|||++.++.++|+|||.+..
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            22   3599999997 689888877655554    367899999999999999999999999999999999999998744

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=2.1e-15  Score=135.78  Aligned_cols=131  Identities=20%  Similarity=0.274  Sum_probs=108.9

Q ss_pred             eeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC--CceeeeeeeccCCCeEEEEEe
Q 043852          281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH--ENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E  358 (551)
                      +++.||+|.++.||++...+ ..+++|.+.....       ...+.+|+.++..+.|  .++++++.+....+..+++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            35789999999999997644 7899998753321       3456788888988876  588999998888888999999


Q ss_pred             cccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC---CeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          359 LVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ---NVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       359 y~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~---gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      |+.++.+..+      +......++.+++.+|.+||..   +++|+||+|.||+++..+.++|+|||++.
T Consensus        74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            9999877654      4456677899999999999985   79999999999999998999999999863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=3.7e-15  Score=160.94  Aligned_cols=252  Identities=27%  Similarity=0.282  Sum_probs=190.4

Q ss_pred             CeeeeeEecc--CCceEEEEEEe---cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCC
Q 043852          278 SWQKGELLGS--GSFGTVYEGYT---DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDEN  351 (551)
Q Consensus       278 ~y~~~~~LG~--G~fG~VY~~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  351 (551)
                      .+.+.+.+|.  |.+|.||.+..   .++..+|+|.-............   =.+|+.-..+++ |+|.++.+..+...+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~---k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKR---KLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccccc---ccchhhcccccCccccccccCcccccCC
Confidence            3556678999  99999999864   47889999974433322221111   124554444553 899999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-h-cCChHHHHHHHHHHHH----HHHHHHhCCeeecccccceEEEcCC-CcEEEEecCCc
Q 043852          352 RLFIFLELVTKGSLANLYQK-Y-HLMDSQVSAYTRQILN----GLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLA  424 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~-~l~~~~i~~i~~QI~~----aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGla  424 (551)
                      ..|+-+|+|. .+|..+... . .+++..++..+.+...    ||.++|..+++|-|+||.||++..+ ...+++|||+.
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            9999999996 566665543 3 3788899999999999    9999999999999999999999999 88999999998


Q ss_pred             cccccCCcc-------cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc--hhHHHHHHhhcCCCC
Q 043852          425 KATTMNDVK-------SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL--EGMQALFRIGKGEPP  495 (551)
Q Consensus       425 ~~~~~~~~~-------~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~--~~~~~~~~i~~~~~~  495 (551)
                      ..+......       ...|...|++||+.   ..-++...|+|+||.++.+-.++..++...  ..+..+.+..  .+.
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~---~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~  345 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL---NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPL  345 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhh---ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cch
Confidence            766554422       11467789999986   356688999999999999999988776543  3333332222  222


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       496 ~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      .+....+..+...+.+|++.+|-.|++++.++.|+++...+--
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~  388 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFV  388 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhh
Confidence            2334567777889999999999999999999999998855533

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=1.6e-13  Score=148.68  Aligned_cols=143  Identities=19%  Similarity=0.181  Sum_probs=98.3

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCccc-------------------------h----------HHHHHHHH
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG-------------------------K----------QSILQLEQ  327 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~-------------------------~----------~~~~~~~~  327 (551)
                      +.||.|++|+||+|+..+|+.||||+..........                         .          ....++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            679999999999999889999999997532110000                         0          00112445


Q ss_pred             HHHHHhcCC-----CCce--eeeeeeccCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHH-HHHHHHhCCee
Q 043852          328 EILLLSRFE-----HENI--VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILN-GLNYLHEQNVV  399 (551)
Q Consensus       328 Ei~il~~l~-----HpnI--v~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~-aL~yLH~~gIi  399 (551)
                      |+..+.++.     +++|  .+++..+  ....+|+|||++|++|.++........ ....++.+++. .+..+|..|++
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence            555555442     3333  2333222  334689999999999988765321111 23456666665 47889999999


Q ss_pred             ecccccceEEEcCCCcEEEEecCCccccc
Q 043852          400 HRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       400 HrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      |+|+||.||+++.+|.++|+|||++....
T Consensus       280 H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       280 HADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999986554

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=6.2e-14  Score=151.54  Aligned_cols=254  Identities=23%  Similarity=0.232  Sum_probs=189.0

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe--cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT--DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDE  350 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  350 (551)
                      ....+|..+..||.|.|+.||++..  .++..|++|.+........   ....-..|+.+...+ .|.+++.++..|...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~---~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA---SDIFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH---hhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            4456899999999999999998753  5788999998754433221   222223555555555 488999999888888


Q ss_pred             CeEEEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-CcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGla~~~~  428 (551)
                      ...|+-.|||.++++..... ..-+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+.+...
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence            88889999999998865442 2346778889999999999999999999999999999999876 788999999986533


Q ss_pred             cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       429 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .........+..|-..|++ .....+..+.|+||||..+.+..++.+.-..   ...+..+..+..+..+... ..+..+
T Consensus       419 ~~~~~~~~~~r~~p~~~~~-~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~-~~~q~~  493 (524)
T KOG0601|consen  419 FSSGVFHHIDRLYPIAEIL-LEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLK-LQLQVL  493 (524)
T ss_pred             eecccccccccccccchhh-ccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchH-Hhhhhh
Confidence            2222222233334124544 3566788999999999999999998765433   3344455556555444434 888999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ...++.+++..||.+.++..|.=|.+.
T Consensus       494 ~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  494 LKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             hhhhcCCccccchhhhhhcccchhhhh
Confidence            999999999999999999888766543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.41  E-value=6.3e-14  Score=158.50  Aligned_cols=261  Identities=23%  Similarity=0.302  Sum_probs=201.9

Q ss_pred             hhhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          272 FRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       272 ~~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ++..+..+.+.+-+-.|+++.++.+.- -.|..+++|+......-.  .........+-.++....+|.++.....+...
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~--~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR--TNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhc--cccccccCCccCccccCCCCceecccCCCCCC
Confidence            556677899999999999999998854 356677777654332211  11122223333444444567777766666677


Q ss_pred             CeEEEEEecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc-
Q 043852          351 NRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~-  428 (551)
                      ...+++++|..+++|...+...+ .+.+....++..+..+++|||...+.|+|++|.|+|+..+|+.++.|||...... 
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            88999999999999988887655 7777778899999999999999999999999999999999999999998432100 


Q ss_pred             ------c--------------------------CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCC
Q 043852          429 ------M--------------------------NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPP  476 (551)
Q Consensus       429 ------~--------------------------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~P  476 (551)
                            .                          .......||+.|.+||..  .+......+|+|++|++++|.++|.+|
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~--lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL--LGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccc--ccccCCCcchhhhhhhhhhhhhcCCCC
Confidence                  0                          001234589999999986  556678889999999999999999999


Q ss_pred             CCCchhHHHHHHhhcCCCCC--CCCcCCHHHHHHHHHhhhcCCCCCCCHH---HHHhCcccCCcc
Q 043852          477 YSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFILKCLQVNPNDRPTAA---QLMEHPFVKRPL  536 (551)
Q Consensus       477 f~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~LI~~cL~~DP~~RPS~~---eILehpff~~~~  536 (551)
                      |......+....|.++..+.  -+...+..+++++..++..+|.+|..+.   ++-.|+||+..-
T Consensus      1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            99988888887777765544  3456899999999999999999998877   899999998543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.6e-13  Score=137.06  Aligned_cols=198  Identities=24%  Similarity=0.400  Sum_probs=142.8

Q ss_pred             HHhcCCCCceeeeeeeccCCC-----eEEEEEecccccchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHhC--Ce
Q 043852          331 LLSRFEHENIVQYFGTDKDEN-----RLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHEQ--NV  398 (551)
Q Consensus       331 il~~l~HpnIv~l~~~~~~~~-----~~~lV~Ey~~ggsL~~ll~~~-----~l~~~~i~~i~~QI~~aL~yLH~~--gI  398 (551)
                      .|-++-|.|||+++.++.+..     ...+++||+..|+|..++++.     .+......+|+-||+.||.|||+.  -|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            345567999999998876544     478999999999999998753     377788889999999999999987  59


Q ss_pred             eecccccceEEEcCCCcEEEEecCCcccc------ccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc
Q 043852          399 VHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT  472 (551)
Q Consensus       399 iHrDIKP~NILl~~~g~vkL~DFGla~~~------~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt  472 (551)
                      +|+++.+.-|++..+|-+|+.--......      .........+-++|.+||.  +.-...+-++|||++|+..++|..
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s--g~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES--GTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc--CcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999999987422211100      0011122336788999996  445566788999999999999988


Q ss_pred             CCCCCCCchh----HHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          473 RQPPYSHLEG----MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       473 G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +..--...+.    .+.+.+...+    ..   ...-++++.+|++..|+.||++..++-||.+-..+.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~----le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIG----LE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             heeccCCCcceeehhhhhhhheee----cc---CccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence            7665322221    1111111111    11   122346799999999999999999999998765543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=3.2e-13  Score=148.77  Aligned_cols=143  Identities=17%  Similarity=0.190  Sum_probs=92.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecC-CceEEEEEEecCccCc-------------------------cch----HHH---
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGT-------------------------QGK----QSI---  322 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~-g~~vAVK~i~~~~~~~-------------------------~~~----~~~---  322 (551)
                      +..|.. +.||.|++|+||+|+..+ |+.||||++.......                         .-.    ...   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            445665 789999999999999865 9999999997432100                         000    111   


Q ss_pred             ---HHHHHHHHHHhcCC----CCce---eeeeeeccCCCeEEEEEecccccchHHH--Hhhhc-----CChHHHHHHHHH
Q 043852          323 ---LQLEQEILLLSRFE----HENI---VQYFGTDKDENRLFIFLELVTKGSLANL--YQKYH-----LMDSQVSAYTRQ  385 (551)
Q Consensus       323 ---~~~~~Ei~il~~l~----HpnI---v~l~~~~~~~~~~~lV~Ey~~ggsL~~l--l~~~~-----l~~~~i~~i~~Q  385 (551)
                         .++.+|+..+.++.    +.+.   .++|.-+  ....+|+||||.|+.+.++  +...+     +.+..+..++.|
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~--st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY--CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc--CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence               12334443333332    2222   2222221  2345799999999999764  33333     333334445555


Q ss_pred             HHHHHHHHHhCCeeecccccceEEEcCCC----cEEEEecCCccccc
Q 043852          386 ILNGLNYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATT  428 (551)
Q Consensus       386 I~~aL~yLH~~gIiHrDIKP~NILl~~~g----~vkL~DFGla~~~~  428 (551)
                      |+       ..|++|+|+||.||+++.+|    .++++|||++....
T Consensus       276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            54       58999999999999999888    99999999986543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.37  E-value=5.9e-12  Score=121.90  Aligned_cols=141  Identities=17%  Similarity=0.167  Sum_probs=101.8

Q ss_pred             eeEeccCCceEEEEEEecC-------CceEEEEEEecCccCc---------------------cchHHHHHHHHHHHHHh
Q 043852          282 GELLGSGSFGTVYEGYTDD-------GFFFAVKEVSLQDQGT---------------------QGKQSILQLEQEILLLS  333 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~-------g~~vAVK~i~~~~~~~---------------------~~~~~~~~~~~Ei~il~  333 (551)
                      ...||.|--+.||.|...+       +..+|||+.+.....-                     .........++|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997642       4799999976322100                     01112223348888888


Q ss_pred             cCCC--CceeeeeeeccCCCeEEEEEecccccchH-HHHhhhcCChHHHHHHHHHHHHHHHHH-HhCCeeecccccceEE
Q 043852          334 RFEH--ENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYL-HEQNVVHRDIKCANIL  409 (551)
Q Consensus       334 ~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~-~ll~~~~l~~~~i~~i~~QI~~aL~yL-H~~gIiHrDIKP~NIL  409 (551)
                      ++..  -++...+++    ...+|||||+.++.+. ..++...++...+..+..|++.+|..| |+.||+|+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8854  355666654    3458999999875442 234444455666778889999999999 8999999999999999


Q ss_pred             EcCCCcEEEEecCCcccc
Q 043852          410 VDASGSVKLADFGLAKAT  427 (551)
Q Consensus       410 l~~~g~vkL~DFGla~~~  427 (551)
                      +. ++.++|+|||.+...
T Consensus       158 ~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EE-CCcEEEEECCCceeC
Confidence            96 578999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=3.5e-12  Score=119.04  Aligned_cols=126  Identities=18%  Similarity=0.168  Sum_probs=93.0

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEEEEEecc
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ++.|+.|.++.||++.. .+..|++|.......      ....+..|+.++..+.+.++ .+++.....  ..++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEec
Confidence            46789999999999865 477899997643211      11234578888887765444 445554432  347999999


Q ss_pred             cccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCe-----eecccccceEEEcCCCcEEEEecCCc
Q 043852          361 TKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV-----VHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       361 ~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gI-----iHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      +|.++...    .   .....++.+++.+|..||..++     +|+|++|.||+++ ++.++|+|||.+
T Consensus        74 ~G~~l~~~----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          74 EGSELLTE----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             CCCccccc----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence            99887643    1   1123467899999999999885     9999999999998 778999999976

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.31  E-value=5.4e-11  Score=130.32  Aligned_cols=162  Identities=25%  Similarity=0.370  Sum_probs=120.7

Q ss_pred             cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecccccchHHHHhhhcCChHH
Q 043852          299 DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ  378 (551)
Q Consensus       299 ~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~  378 (551)
                      .++.++.|.+......     .......+-++-|+.++||||+++++.+...+.+|||+|-+..  |..++++  +....
T Consensus        35 ~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--l~~~~  105 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--LGKEE  105 (690)
T ss_pred             ccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--hHHHH
Confidence            4677788777654322     2233445677889999999999999999999999999999854  4445554  23566


Q ss_pred             HHHHHHHHHHHHHHHH-hCCeeecccccceEEEcCCCcEEEEecCCccccccCC--cccCCCCCcccChhhhhcccCCCC
Q 043852          379 VSAYTRQILNGLNYLH-EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRGYG  455 (551)
Q Consensus       379 i~~i~~QI~~aL~yLH-~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s  455 (551)
                      +..-+.||+.||.||| +.+++|++|.-..|+|+..|..||++|-++.......  .....---.|..|+.+.  ..  .
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~--~s--~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID--PS--E  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC--cc--c
Confidence            7778899999999998 6789999999999999999999999998865332211  11111222367777542  11  2


Q ss_pred             chhhHHHHHHHHHHHHcC
Q 043852          456 LTADIWSLGCTVLEMLTR  473 (551)
Q Consensus       456 ~ksDIwSLG~iLyeLltG  473 (551)
                      ...|.|-|||++++++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            457999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=2.8e-11  Score=114.60  Aligned_cols=136  Identities=21%  Similarity=0.298  Sum_probs=100.7

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCcc----chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQ----GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      ..+++|+-+.+|.+.. -|..+++|. ..++....    .+-...+..+|++++.++.--.|.-.+-++.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4688999999999844 344455564 33333222    23345566789999998876555444444456666789999


Q ss_pred             cccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          359 LVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       359 y~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      |++|..|.+++...      ...+++.+-.-+.-||..||+|+||.++||++.. +.+.++||||+...
T Consensus        80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~-~~i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG-GRIYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC-CcEEEEECCccccc
Confidence            99999999888765      2567888888899999999999999999999954 44999999998643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.24  E-value=9.9e-11  Score=110.59  Aligned_cols=146  Identities=23%  Similarity=0.266  Sum_probs=107.4

Q ss_pred             eeeEeccCCceEEEEEEecCCceEEEEEEecCccCc---cchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT---QGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      .+.+|-||+-+.|+++ ...|+.+.||.-..+.-.+   +.+....+..+|+++|.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~-~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRG-SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeee-ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678999999999999 4577888888644332222   23445567789999999976555543333445555567999


Q ss_pred             ecccc-cchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC---cEEEEecCCcccc
Q 043852          358 ELVTK-GSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKAT  427 (551)
Q Consensus       358 Ey~~g-gsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g---~vkL~DFGla~~~  427 (551)
                      ||+.| .++.+++...   .........++++|-..+.-||.++|||+||.++||++..+|   .+.|+|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99988 4677776543   233334478999999999999999999999999999997765   3689999998544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=1.5e-10  Score=112.25  Aligned_cols=138  Identities=20%  Similarity=0.229  Sum_probs=100.9

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC--ceeeeeeeccCC---CeEEEEE
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE--NIVQYFGTDKDE---NRLFIFL  357 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~---~~~~lV~  357 (551)
                      +.||.|.++.||++...+|..|++|........    .....+..|+.++..+.+.  ++.+++.+....   +..+++|
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            578999999999997766788999986543221    1233567888888888763  456677766553   3678999


Q ss_pred             ecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 043852          358 ELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE------------------------------------------  395 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~------------------------------------------  395 (551)
                      ||++|.++...+....++..+...++.+++.+|.+||+                                          
T Consensus        80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99999888665432345555666666777777776663                                          


Q ss_pred             --------------CCeeecccccceEEEcC--CCcEEEEecCCc
Q 043852          396 --------------QNVVHRDIKCANILVDA--SGSVKLADFGLA  424 (551)
Q Consensus       396 --------------~gIiHrDIKP~NILl~~--~g~vkL~DFGla  424 (551)
                                    ..++|+|+++.||+++.  ++.+.|+||+.+
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~  204 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELA  204 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence                          24799999999999988  567899999976

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=1.5e-09  Score=104.55  Aligned_cols=130  Identities=25%  Similarity=0.280  Sum_probs=87.6

Q ss_pred             EEEEEEecCCceEEEEEEecCcc---------------------CccchHHHHHHHHHHHHHhcCCCC--ceeeeeeecc
Q 043852          292 TVYEGYTDDGFFFAVKEVSLQDQ---------------------GTQGKQSILQLEQEILLLSRFEHE--NIVQYFGTDK  348 (551)
Q Consensus       292 ~VY~~~~~~g~~vAVK~i~~~~~---------------------~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~  348 (551)
                      .||.|...+|..+|||.......                     ............+|.+.|.++..-  ++.+.+.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999888899999998764311                     011223355677899999999866  466677553 


Q ss_pred             CCCeEEEEEeccc--ccchHHHHhhhcCChHHHHHHHHHHHHHHHH-HHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          349 DENRLFIFLELVT--KGSLANLYQKYHLMDSQVSAYTRQILNGLNY-LHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       349 ~~~~~~lV~Ey~~--ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~y-LH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                         ..+|||||+.  |..+..+.. ..++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             ---CCEEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence               2479999999  666655443 233355677888888885555 579999999999999999766 99999999875


Q ss_pred             cc
Q 043852          426 AT  427 (551)
Q Consensus       426 ~~  427 (551)
                      ..
T Consensus       155 ~~  156 (188)
T PF01163_consen  155 DS  156 (188)
T ss_dssp             ET
T ss_pred             ec
Confidence            44

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.07  E-value=5.5e-09  Score=111.72  Aligned_cols=210  Identities=16%  Similarity=0.227  Sum_probs=150.6

Q ss_pred             CceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC----CCeEEEEEecccc-
Q 043852          289 SFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD----ENRLFIFLELVTK-  362 (551)
Q Consensus       289 ~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~g-  362 (551)
                      .-.+.|++.. .+|..|++|++.-......++.     -.-+.+++++.|.|||++..++..    +..+++|++|.++ 
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~-----t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKD-----TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccc-----hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            3446799987 6899999999843322222222     134677999999999999988763    4468999999876 


Q ss_pred             cchHHHHh----------------hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          363 GSLANLYQ----------------KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       363 gsL~~ll~----------------~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ++|.++.-                ..+.++..+|.|+.||+.||.++|+.|+.-+-|.+.+||++.+..++|.-.|....
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence            47766541                12467789999999999999999999999999999999998888899987777644


Q ss_pred             cccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCC-CCCchhHHH-HHHhhcCCCCCCCCcCCHH
Q 043852          427 TTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPP-YSHLEGMQA-LFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       427 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~s~~  504 (551)
                      ...+.          .  +.++     --.+-|.=.||.+++.|.||..- +......+. +..        +....+.+
T Consensus       443 l~~d~----------~--~~le-----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--------I~~~yS~D  497 (655)
T KOG3741|consen  443 LQEDP----------T--EPLE-----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--------ITTTYSTD  497 (655)
T ss_pred             ecCCC----------C--cchh-----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------hhhhhhHH
Confidence            43332          1  1111     13456888999999999999554 211111111 222        23457889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ++++|..+...+++. -+.++++.|
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999999999988886 677777654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=1.6e-08  Score=102.89  Aligned_cols=141  Identities=13%  Similarity=0.090  Sum_probs=92.1

Q ss_pred             EeccCCceEEEEEEecCCceEEEEEEecCccCccch------HHHHHHHHHHHHHhcCCCCce--eeeeeeccC-----C
Q 043852          284 LLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGK------QSILQLEQEILLLSRFEHENI--VQYFGTDKD-----E  350 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~------~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~  350 (551)
                      .+-......|+++ .-+|+.|.||...........+      .....+.+|...+.++...+|  +.+++++..     .
T Consensus        29 ~v~~~~~rrvvr~-~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRF-ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEE-EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            3333444446665 3466788888653221100000      011125577777766643332  233333321     2


Q ss_pred             CeEEEEEeccccc-chHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-------CCcEEEE
Q 043852          351 NRLFIFLELVTKG-SLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-------SGSVKLA  419 (551)
Q Consensus       351 ~~~~lV~Ey~~gg-sL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-------~g~vkL~  419 (551)
                      ...+||||++++. +|.+++..   ..........++.+|+..+.-||..||+|+|+++.|||++.       +..+.|+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            3578999999886 78888763   23455667789999999999999999999999999999975       4679999


Q ss_pred             ecCCcc
Q 043852          420 DFGLAK  425 (551)
Q Consensus       420 DFGla~  425 (551)
                      ||+.+.
T Consensus       188 Dl~r~~  193 (268)
T PRK15123        188 DLHRAQ  193 (268)
T ss_pred             ECCccc
Confidence            999774

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.1e-08  Score=100.46  Aligned_cols=139  Identities=25%  Similarity=0.248  Sum_probs=103.8

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCcc-----------------CccchHHHHHHHHHHHHHhcCCCC--c
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQ-----------------GTQGKQSILQLEQEILLLSRFEHE--N  339 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~-----------------~~~~~~~~~~~~~Ei~il~~l~Hp--n  339 (551)
                      +.++..||.|--+.||.|.+..|.++|||.=+....                 ............+|..+|..|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345688999999999999999999999996432210                 001122345567899999998765  6


Q ss_pred             eeeeeeeccCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEE
Q 043852          340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA  419 (551)
Q Consensus       340 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~  419 (551)
                      |.+.+++.    ...+||||++|-.|...-    +..+....++..|+.-+..+-..||||+|+.+-||+++.+|.+.++
T Consensus       173 VP~P~~~n----RHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI  244 (304)
T COG0478         173 VPKPIAWN----RHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI  244 (304)
T ss_pred             CCCccccc----cceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence            67766653    457999999997775533    2345556667777777776668999999999999999999999999


Q ss_pred             ecCCcc
Q 043852          420 DFGLAK  425 (551)
Q Consensus       420 DFGla~  425 (551)
                      ||--+.
T Consensus       245 DwPQ~v  250 (304)
T COG0478         245 DWPQAV  250 (304)
T ss_pred             eCcccc
Confidence            998653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.81  E-value=2.2e-09  Score=118.32  Aligned_cols=153  Identities=24%  Similarity=0.343  Sum_probs=114.3

Q ss_pred             HHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCccccccCC------cc-----cCCCCCcccChhhhhccc
Q 043852          384 RQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMND------VK-----SCKGTPFWMAPEVVNLKN  451 (551)
Q Consensus       384 ~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~------~~-----~~~GT~~Y~APEvl~~~~  451 (551)
                      .+.+.||.|+|.. ++||+.|.|++|.++.+|..||+.|+.+.......      +.     .......|.|||++  ..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~--~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL--LG  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh--cc
Confidence            3445999999965 89999999999999999999999999875333211      11     12245679999997  34


Q ss_pred             CCCCchhhHHHHHHHHHHHH-cCCCCCCCchhHHHHH---HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 043852          452 RGYGLTADIWSLGCTVLEML-TRQPPYSHLEGMQALF---RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  527 (551)
Q Consensus       452 ~~~s~ksDIwSLG~iLyeLl-tG~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eIL  527 (551)
                      ...+.++|+|||||++|.++ .|+..+..........   .........+...++.++++=+.+++..++..||++..++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            66789999999999999999 6776665432221111   1111122233467899999999999999999999999999


Q ss_pred             hCcccCCcccc
Q 043852          528 EHPFVKRPLQK  538 (551)
Q Consensus       528 ehpff~~~~~~  538 (551)
                      ..+||.....+
T Consensus       264 ~~~ff~D~~~~  274 (700)
T KOG2137|consen  264 SIPFFSDPGLK  274 (700)
T ss_pred             cccccCCchhh
Confidence            99999876544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=6.5e-08  Score=94.48  Aligned_cols=103  Identities=22%  Similarity=0.310  Sum_probs=77.1

Q ss_pred             HHHHHHHHHhcCCCCc--eeeeeeeccC----CCeEEEEEeccccc-chHHHHhhh-cCChHHHHHHHHHHHHHHHHHHh
Q 043852          324 QLEQEILLLSRFEHEN--IVQYFGTDKD----ENRLFIFLELVTKG-SLANLYQKY-HLMDSQVSAYTRQILNGLNYLHE  395 (551)
Q Consensus       324 ~~~~Ei~il~~l~Hpn--Iv~l~~~~~~----~~~~~lV~Ey~~gg-sL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~  395 (551)
                      +..+|...+..+...+  ++..+++...    ....+||+|++++. +|.+++... .++......++.+++..+.-||.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            4556666666554322  2333333322    13458999999884 788888762 35566778899999999999999


Q ss_pred             CCeeecccccceEEEcCCC---cEEEEecCCccc
Q 043852          396 QNVVHRDIKCANILVDASG---SVKLADFGLAKA  426 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~g---~vkL~DFGla~~  426 (551)
                      +||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999887   899999997643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.65  E-value=4.6e-07  Score=95.16  Aligned_cols=235  Identities=17%  Similarity=0.196  Sum_probs=147.7

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeee------ccCCC-eEE
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT------DKDEN-RLF  354 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~------~~~~~-~~~  354 (551)
                      +.-||+|+-+.+|-.-.-.+ . +.|+..........     +...  .+-+.-.||-+-.-+.+      .-+.+ .+.
T Consensus        16 gr~LgqGgea~ly~l~e~~d-~-VAKIYh~Pppa~~a-----qk~a--~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD-Q-VAKIYHAPPPAAQA-----QKVA--ELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CccccCCccceeeecchhhc-h-hheeecCCCchHHH-----HHHH--HhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            45699999999997533222 2 34766544332211     1111  12223345543331111      12223 377


Q ss_pred             EEEeccccc-chHHHHh------hhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          355 IFLELVTKG-SLANLYQ------KYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       355 lV~Ey~~gg-sL~~ll~------~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ++|..+.|. .+..++.      .++ ..+.-+....+.|+.+...||..|.+-+|+.++|+||..++.|.|+|=..-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            888888775 3334442      111 45667788899999999999999999999999999999999999998664333


Q ss_pred             cccCCc-ccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcC-CCCCCCchh-------HH-HHH------
Q 043852          427 TTMNDV-KSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG-------MQ-ALF------  487 (551)
Q Consensus       427 ~~~~~~-~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~-------~~-~~~------  487 (551)
                      ...... ...+|.+.|.+||.-+..   +..-+...|.|.||+++++|+.| ++||.+...       .+ .+.      
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            322222 233589999999985422   23346778999999999999875 999965432       11 110      


Q ss_pred             --HhhcCCC---CCCC-CcCCHHHHHHHHHhhhc--CCCCCCCHHH
Q 043852          488 --RIGKGEP---PLVP-NSLSRDARDFILKCLQV--NPNDRPTAAQ  525 (551)
Q Consensus       488 --~i~~~~~---~~~~-~~~s~~l~~LI~~cL~~--DP~~RPS~~e  525 (551)
                        +-..+..   ..+| ..++..+..|..+|+..  ++.-|||++.
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence              0111111   1111 34788999999999975  3557999764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=8.8e-08  Score=105.39  Aligned_cols=144  Identities=19%  Similarity=0.177  Sum_probs=92.8

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCcc-------------------------c----------hHHHHHHHH
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQ-------------------------G----------KQSILQLEQ  327 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~-------------------------~----------~~~~~~~~~  327 (551)
                      +-|+.++-|+||+|+..+|+.||||+.+.......                         -          -....++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999999863221100                         0          011222334


Q ss_pred             HHHHHhcCC-----CCceeeeeeeccCCCeEEEEEecccccchHHH--HhhhcCChHHHHHHHHHHHHHHHHHHhCCeee
Q 043852          328 EILLLSRFE-----HENIVQYFGTDKDENRLFIFLELVTKGSLANL--YQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH  400 (551)
Q Consensus       328 Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~l--l~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiH  400 (551)
                      |...+.++.     .++|.--.-++.-.+.-.|+|||+.|-.+.++  ++..+++...+.....++.  +..+-..|++|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffH  288 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFH  288 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccc
Confidence            444444432     33332222222223445899999999999877  4555565444443333332  22233379999


Q ss_pred             cccccceEEEcCCCcEEEEecCCccccc
Q 043852          401 RDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       401 rDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      .|.+|.||+++.+|.+.+.|||+.....
T Consensus       289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         289 ADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cCCCccceEEecCCcEEEEcCcceecCC
Confidence            9999999999999999999999975443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.58  E-value=5.6e-07  Score=88.40  Aligned_cols=138  Identities=12%  Similarity=0.165  Sum_probs=88.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHH------HHHHHHHhcC---CCCceeeeeee-
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQL------EQEILLLSRF---EHENIVQYFGT-  346 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~------~~Ei~il~~l---~HpnIv~l~~~-  346 (551)
                      ++|...+++-......|.+. .-+|..+++|........  ....+..|      .+.+..+..+   ....+..++.+ 
T Consensus        31 ~~~~~~kv~k~~~r~~ValI-ei~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALI-EIDGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             CCceEEEeecCCCccEEEEE-EECCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            36888888888888888776 346788999987543321  12222211      2233323332   22223332222 


Q ss_pred             ----ccCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecC
Q 043852          347 ----DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       347 ----~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                          +.-....+++|||++|..|.++..   +.+    .+...|..++.-||+.|++|+|++|.|++++ ++.++++||+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-~~~i~iID~~  179 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-NNGIRIIDTQ  179 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE-CCcEEEEECc
Confidence                222345678999999988866542   222    3456677889999999999999999999997 5559999998


Q ss_pred             Ccc
Q 043852          423 LAK  425 (551)
Q Consensus       423 la~  425 (551)
                      ..+
T Consensus       180 ~k~  182 (229)
T PF06176_consen  180 GKR  182 (229)
T ss_pred             ccc
Confidence            643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.53  E-value=6.5e-07  Score=87.50  Aligned_cols=139  Identities=16%  Similarity=0.130  Sum_probs=95.9

Q ss_pred             ccCCceEEEEEEecCCceEEEEEEecCccCccc-hHHHHHHHHHHHHHhcCCCCc--eeeeeee--ccC--CCeEEEEEe
Q 043852          286 GSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG-KQSILQLEQEILLLSRFEHEN--IVQYFGT--DKD--ENRLFIFLE  358 (551)
Q Consensus       286 G~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~--~~~--~~~~~lV~E  358 (551)
                      |+||-+-|+.... .|..|-+|.-.......-. ..-...|.+|+..+.++...+  +.+....  ...  ...-+||+|
T Consensus        27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            4688888988643 4446777865311111111 112345778888888875433  3333311  111  224689999


Q ss_pred             cccc-cchHHHHhhhcC---ChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc--EEEEecCCcc
Q 043852          359 LVTK-GSLANLYQKYHL---MDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAK  425 (551)
Q Consensus       359 y~~g-gsL~~ll~~~~l---~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~--vkL~DFGla~  425 (551)
                      -+.| .+|.+++....+   +......++.+|+..+.-||+.|+.|+|+-+.|||++.+|.  +.++||.-++
T Consensus       106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            7765 588888876544   55666789999999999999999999999999999987777  9999998654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.51  E-value=1.2e-06  Score=87.07  Aligned_cols=141  Identities=20%  Similarity=0.203  Sum_probs=96.5

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccc-------------------hHHHHHHHHHHHHHhcCCC--Cce
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG-------------------KQSILQLEQEILLLSRFEH--ENI  340 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~-------------------~~~~~~~~~Ei~il~~l~H--pnI  340 (551)
                      ...|..|--+.||+|...++..+|||++.........                   .....-..+|..-|.++..  -.+
T Consensus        53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3478899999999998888999999998643221110                   1112223455555555532  233


Q ss_pred             eeeeeeccCCCeEEEEEecccccch-HHHHhhhcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEE
Q 043852          341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKL  418 (551)
Q Consensus       341 v~l~~~~~~~~~~~lV~Ey~~ggsL-~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL  418 (551)
                      .+.+++.    ...|+|||+....+ .=.++..++.......+..++++.+.-|-. .++||+||+.-|||+. ++.+.|
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            4444433    24799999976421 113334445555677888899999888877 8999999999999997 899999


Q ss_pred             EecCCcccc
Q 043852          419 ADFGLAKAT  427 (551)
Q Consensus       419 ~DFGla~~~  427 (551)
                      +|||-|...
T Consensus       208 ID~~QaV~~  216 (268)
T COG1718         208 IDVSQAVTI  216 (268)
T ss_pred             EECcccccc
Confidence            999977544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.41  E-value=3.1e-06  Score=82.14  Aligned_cols=135  Identities=21%  Similarity=0.301  Sum_probs=77.9

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC--ceeeeeeec---cCCCeEEEE
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE--NIVQYFGTD---KDENRLFIF  356 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~---~~~~~~~lV  356 (551)
                      ++.|+.|..+.||++...+ ..+++|.....       .....+.+|..++..+...  .+.+++...   ......+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence            4689999999999997766 58899976421       2344556777777666432  245555532   233457999


Q ss_pred             EecccccchHH---------H-------Hh---hh-----cCChHH---------HHHH------------HHHHHH-HH
Q 043852          357 LELVTKGSLAN---------L-------YQ---KY-----HLMDSQ---------VSAY------------TRQILN-GL  390 (551)
Q Consensus       357 ~Ey~~ggsL~~---------l-------l~---~~-----~l~~~~---------i~~i------------~~QI~~-aL  390 (551)
                      |++++|..+..         +       +.   ..     ++....         ....            ...+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            99999987766         1       11   00     000000         0000            111222 23


Q ss_pred             HHHH-------hCCeeecccccceEEEc-CCCcEEEEecCCc
Q 043852          391 NYLH-------EQNVVHRDIKCANILVD-ASGSVKLADFGLA  424 (551)
Q Consensus       391 ~yLH-------~~gIiHrDIKP~NILl~-~~g~vkL~DFGla  424 (551)
                      ..++       ...++|+|+.|.|||++ .++.+.|+||+.+
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence            3333       24599999999999999 6677789999865

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=1e-06  Score=96.96  Aligned_cols=144  Identities=17%  Similarity=0.141  Sum_probs=95.2

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCcc--------------------------------chHHHHHHHHHHH
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQ--------------------------------GKQSILQLEQEIL  330 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~--------------------------------~~~~~~~~~~Ei~  330 (551)
                      +.||.-+.|+||+|+.++|+.||||+-+..-....                                .-....+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            57999999999999999999999998653221110                                0001112333433


Q ss_pred             HHhc----CCCCc------eeeeeeeccCCCeEEEEEecccccchHH--HHhhhcCChHHHHHHHHHHHHHHHHHHhCCe
Q 043852          331 LLSR----FEHEN------IVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV  398 (551)
Q Consensus       331 il~~----l~Hpn------Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~--ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gI  398 (551)
                      ...+    +.|-+      |.++|..+.  ..-.|+||||.|..+.+  .+.+.+++...+...+.+...-+-+  ..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcCC
Confidence            2222    23444      445554433  33579999999988765  4567778777666655555443333  3589


Q ss_pred             eecccccceEEEcC----CCcEEEEecCCccccccC
Q 043852          399 VHRDIKCANILVDA----SGSVKLADFGLAKATTMN  430 (551)
Q Consensus       399 iHrDIKP~NILl~~----~g~vkL~DFGla~~~~~~  430 (551)
                      +|+|-+|.||+++.    ++.+.+.|||+.......
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            99999999999984    568999999998655433

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.30  E-value=5.2e-06  Score=82.38  Aligned_cols=131  Identities=14%  Similarity=0.147  Sum_probs=79.8

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc--eeeeeeeccCCCeEEEEEecc
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN--IVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      ..||+|..+.||+.   .|..+++|......       ....+.+|.+++..+..-+  +.+.+++..+.....++||++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            56899999999984   24567788764211       1223467888888775433  466777777777788999999


Q ss_pred             cccc-hHHHH------------------h---hh---cCChHHH-HHHHHH----------HHH-HHHHHH----hCCee
Q 043852          361 TKGS-LANLY------------------Q---KY---HLMDSQV-SAYTRQ----------ILN-GLNYLH----EQNVV  399 (551)
Q Consensus       361 ~ggs-L~~ll------------------~---~~---~l~~~~i-~~i~~Q----------I~~-aL~yLH----~~gIi  399 (551)
                      .|.. +...+                  .   ..   ....... ..+..+          +.. ...+|.    ...++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            9963 21111                  0   00   0010000 011111          111 122222    12479


Q ss_pred             ecccccceEEEcCCCcEEEEecCCc
Q 043852          400 HRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       400 HrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      |+|+.|.||+++.++ +.|+||+.+
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhc
Confidence            999999999998888 999999976

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.29  E-value=3.3e-06  Score=98.12  Aligned_cols=209  Identities=25%  Similarity=0.342  Sum_probs=148.2

Q ss_pred             chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe----EEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHH
Q 043852          318 GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR----LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNY  392 (551)
Q Consensus       318 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~y  392 (551)
                      .+..+...+.|+..+.++.|+|++.++.+......    +.+..++|.+-++...++.. ..+...++.+..++..||.|
T Consensus       222 ~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  222 GKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             hHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHH
Confidence            34556666778888999999999999988654432    33556789888888877654 57888899999999999999


Q ss_pred             HHhCCeeecccccc---eEEEcCCCcEEEE--ecCCccccccCCc-ccCCCCCcccChhhhhcccCCCCchhhHHHHHHH
Q 043852          393 LHEQNVVHRDIKCA---NILVDASGSVKLA--DFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT  466 (551)
Q Consensus       393 LH~~gIiHrDIKP~---NILl~~~g~vkL~--DFGla~~~~~~~~-~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~i  466 (551)
                      +|+....|.-+...   +..++..+.+.+.  ||+.++....... .....+..|.++|.............|+|++|..
T Consensus       302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence            99997766666555   4445566777777  8988776554432 2333456688888764333334445799999999


Q ss_pred             HHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       467 LyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +..+..|..+-.......          ...+........+++.+|+.-++++|+++.+++.|+|.+-+-
T Consensus       382 ~~~~~~~~~i~~~~~~~~----------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAVPV----------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             HhhhhhcCcccccccchh----------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            999988765532111111          111122222677889999999999999999999999987443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.11  E-value=3.1e-05  Score=75.35  Aligned_cols=133  Identities=19%  Similarity=0.275  Sum_probs=94.7

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCcc-----------chHHHHHHHHHHHHHhcCC------CCceeeeee
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQ-----------GKQSILQLEQEILLLSRFE------HENIVQYFG  345 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~-----------~~~~~~~~~~Ei~il~~l~------HpnIv~l~~  345 (551)
                      ..||+|+.-.||.  +.+....+||+.........           ......+..+|+.-...+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            5799999999998  45566678998865540000           0112344555665555444      789999999


Q ss_pred             eccCCCeEEEEEecccc------cchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC----c
Q 043852          346 TDKDENRLFIFLELVTK------GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG----S  415 (551)
Q Consensus       346 ~~~~~~~~~lV~Ey~~g------gsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g----~  415 (551)
                      +.++..-..+|+|.+..      .+|.++++...++.    .+...+-.-..||-+++|+.+||+|.||++....    .
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~  160 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFR  160 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceE
Confidence            99999889999998754      36788887777766    3444445556788889999999999999996432    4


Q ss_pred             EEEEec
Q 043852          416 VKLADF  421 (551)
Q Consensus       416 vkL~DF  421 (551)
                      +.|+|-
T Consensus       161 lvlIDG  166 (199)
T PF10707_consen  161 LVLIDG  166 (199)
T ss_pred             EEEEeC
Confidence            777774

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.09  E-value=5.3e-07  Score=98.92  Aligned_cols=242  Identities=25%  Similarity=0.258  Sum_probs=164.9

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCCeEEEEE
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN-IVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~  357 (551)
                      +..-.-+++|+++.+|+.+..-.+....+.+...          +...-++.+|.+++||| .+..++.+..+.+.++.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            3344568899999999986533333335655422          23446788999999999 788888888888999999


Q ss_pred             eccccc-chHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-Ccc
Q 043852          358 ELVTKG-SLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVK  433 (551)
Q Consensus       358 Ey~~gg-sL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-~~~  433 (551)
                      ++|.++ +......  ...+..-+.....+.-+++++|||+.-=+|+|    ||+. .++..++.||+........ ...
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~~~~  388 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRTMKPR  388 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc-cccccccccccCCcccCcccccc
Confidence            999988 3322211  11233344556777788999999988668998    7777 4588999999987654333 344


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-CCCCCC--cCCHHHH-HHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVPN--SLSRDAR-DFI  509 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~--~~s~~l~-~LI  509 (551)
                      ...+|+.|+|||+.  ....+....|.|++|.--.+|--|.+|-..  .......+..+. .+....  ..+..+. ++.
T Consensus       389 t~~~~~~~~~pev~--~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~  464 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVI--QENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP  464 (829)
T ss_pred             cCCCCCCCCCchhh--cccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCc
Confidence            56699999999986  455778889999999877777777777543  122222222221 000000  0111122 477


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ..|+..-|..|+.....+-|.+|.+.-.+.
T Consensus       465 ~~~~~g~P~~pkv~mgacfsKvfngCpl~i  494 (829)
T KOG0576|consen  465 APCLNGLPPTPKVHMGACFSKVFNGCPLRI  494 (829)
T ss_pred             ccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence            789999999999999999999998765443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=3.6e-05  Score=76.57  Aligned_cols=74  Identities=18%  Similarity=0.138  Sum_probs=47.8

Q ss_pred             eccCCc-eEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEEEEecccc
Q 043852          285 LGSGSF-GTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFIFLELVTK  362 (551)
Q Consensus       285 LG~G~f-G~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~g  362 (551)
                      |-.|.. ..||+.... +..+.||......        ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            444545 788998543 4678888664221        123456777766663 23456677776666677899999999


Q ss_pred             cchHH
Q 043852          363 GSLAN  367 (551)
Q Consensus       363 gsL~~  367 (551)
                      .+|..
T Consensus        77 ~~l~~   81 (244)
T cd05150          77 VPAAA   81 (244)
T ss_pred             ccHhH
Confidence            87753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.86  E-value=8.3e-05  Score=70.63  Aligned_cols=128  Identities=20%  Similarity=0.184  Sum_probs=88.4

Q ss_pred             eeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEEEEEe
Q 043852          280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E  358 (551)
                      ...+.|++|++|.||+|.+ .|..+|+|+-.....       ...++.|+++|..+...++ .++|.+..+    ++.||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~-------r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP-------RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCCcc-------hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            3457899999999999965 455788887653322       2356789999998887766 446655443    35599


Q ss_pred             cccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccc-cceEEEcCCCcEEEEecCCcc
Q 043852          359 LVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK-CANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       359 y~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIK-P~NILl~~~g~vkL~DFGla~  425 (551)
                      |+.|-.|..+....  .    .+-+..++..-.-|-..||-|+.|. |..++|-.++.+.|+||..|+
T Consensus        93 ~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          93 YIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            99998887765432  1    2233445555556677899999995 444444456699999999875

>PLN02876 acyl-CoA dehydrogenase

Probab=97.83  E-value=0.00016  Score=84.96  Aligned_cols=79  Identities=15%  Similarity=0.199  Sum_probs=54.2

Q ss_pred             eeEeccCCceEEEEEEecCC---ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCce--eeeeeeccCC---Ce
Q 043852          282 GELLGSGSFGTVYEGYTDDG---FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENI--VQYFGTDKDE---NR  352 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g---~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~  352 (551)
                      +..|+.|.+..+|+....++   ..+++|+.......    .....+.+|+.+++.+. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~----~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL----QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC----ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            57789999999999865443   46777765322111    11235678999998885 6654  7777777654   45


Q ss_pred             EEEEEecccccc
Q 043852          353 LFIFLELVTKGS  364 (551)
Q Consensus       353 ~~lV~Ey~~ggs  364 (551)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            789999998864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.80  E-value=9.9e-05  Score=73.24  Aligned_cols=28  Identities=29%  Similarity=0.381  Sum_probs=24.3

Q ss_pred             CeeecccccceEEEcCCCcEEEEecCCc
Q 043852          397 NVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       397 gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      +++|+|+.+.|||++.++..-|+||+.+
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            5899999999999986655679999976

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.72  E-value=0.00035  Score=68.01  Aligned_cols=130  Identities=25%  Similarity=0.260  Sum_probs=88.0

Q ss_pred             cCeeeeeEeccCCc-eEEEEEEecCCceEEEEEEec---CccCcc---c----------hHHHHHHHHHHHHHhcCC---
Q 043852          277 MSWQKGELLGSGSF-GTVYEGYTDDGFFFAVKEVSL---QDQGTQ---G----------KQSILQLEQEILLLSRFE---  336 (551)
Q Consensus       277 ~~y~~~~~LG~G~f-G~VY~~~~~~g~~vAVK~i~~---~~~~~~---~----------~~~~~~~~~Ei~il~~l~---  336 (551)
                      .+++.++.||.|.- |.||++. -+|..||+|.+..   ......   .          .....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~-I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE-IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE-ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            47889999999999 9999995 4677999999322   111000   0          012334667777666664   


Q ss_pred             CCce--eeeeeeccCC------------------CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC
Q 043852          337 HENI--VQYFGTDKDE------------------NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ  396 (551)
Q Consensus       337 HpnI--v~l~~~~~~~------------------~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~  396 (551)
                      +.++  |+.+|+..-.                  ....||.||+....        .+    ...=+.+|..-|..+|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~----~~~~~~~~~~dl~~~~k~  183 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PL----QIRDIPQMLRDLKILHKL  183 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------cc----chhHHHHHHHHHHHHHHC
Confidence            4455  8888874211                  12456777766533        11    223466788889999999


Q ss_pred             CeeecccccceEEEcCCCcEEEEecCCc
Q 043852          397 NVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       397 gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      ||+-+|+++.|..     .-+|+|||.+
T Consensus       184 gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  184 GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CeeeccCcccccc-----CCEEEecccC
Confidence            9999999999985     3478999853

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.68  E-value=0.00014  Score=70.19  Aligned_cols=95  Identities=27%  Similarity=0.242  Sum_probs=78.2

Q ss_pred             HHHHHHhcCCC-CceeeeeeeccCCCeEEEEEecccccchHH----HHhhhcCChHHHHHHHHHHHHHHHHHHh---CCe
Q 043852          327 QEILLLSRFEH-ENIVQYFGTDKDENRLFIFLELVTKGSLAN----LYQKYHLMDSQVSAYTRQILNGLNYLHE---QNV  398 (551)
Q Consensus       327 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~----ll~~~~l~~~~i~~i~~QI~~aL~yLH~---~gI  398 (551)
                      .|..++..+++ +++++++|+|-+    +++.||...+++..    +.+-...++..+.+++.|++..+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57778888876 699999999843    67999998776642    2233346788899999999999999997   458


Q ss_pred             eecccccceEEEcCCCcEEEEecCCcc
Q 043852          399 VHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       399 iHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      .-.|++++|+-++.+|.+|++|...+.
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcc
Confidence            899999999999999999999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.67  E-value=3.7e-05  Score=79.17  Aligned_cols=137  Identities=18%  Similarity=0.224  Sum_probs=96.1

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCcc-----------------CccchHHHHHHHHHHHHHhcCCC--Cc
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQ-----------------GTQGKQSILQLEQEILLLSRFEH--EN  339 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~-----------------~~~~~~~~~~~~~Ei~il~~l~H--pn  339 (551)
                      +.+++.||-|--+-||.+-+..|..+++|.=+....                 ............+|...|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            556889999999999999888899999986432111                 11111122234467777776653  22


Q ss_pred             eeeeeeeccCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEE
Q 043852          340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA  419 (551)
Q Consensus       340 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~  419 (551)
                      +.+.+++    ...++|||++.|-.|....+-     ..+..+...+..-+--|..+|+||+|..--||+|+.++.++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vI  244 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVI  244 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEe
Confidence            3444443    446899999999777554321     2244566666777778889999999999999999999999999


Q ss_pred             ecCCc
Q 043852          420 DFGLA  424 (551)
Q Consensus       420 DFGla  424 (551)
                      ||--+
T Consensus       245 DFPQm  249 (465)
T KOG2268|consen  245 DFPQM  249 (465)
T ss_pred             echHh
Confidence            99754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.67  E-value=2.2e-05  Score=93.23  Aligned_cols=204  Identities=14%  Similarity=0.009  Sum_probs=137.5

Q ss_pred             HHHHHHhcCCCCceeeeeeecc--CCCeEEEEEecccccchHHHHhhhc----CChHHHHHHHHHH-HHHHHHHHhCC--
Q 043852          327 QEILLLSRFEHENIVQYFGTDK--DENRLFIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQI-LNGLNYLHEQN--  397 (551)
Q Consensus       327 ~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~Ey~~ggsL~~ll~~~~----l~~~~i~~i~~QI-~~aL~yLH~~g--  397 (551)
                      .|...++...|+++...+.-..  +...-|..++||.+|.+...+-++.    .-.+.......|+ +.+..-.|+..  
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            3444455568998877665433  2345689999999999999886542    1122233333444 66677766541  


Q ss_pred             ---eeecccccceEEEcCCCcEEEEecCCcccccc--CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc
Q 043852          398 ---VVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT  472 (551)
Q Consensus       398 ---IiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt  472 (551)
                         .+|+++|+-|.+|..+-.++++++|+.+....  ...+...+++.|+.|++.+  ...++.++|+|..|+.+|++..
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N--~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN--EIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH--HHhhhhHHHHHHHHHHHHHHhc
Confidence               69999999999999999999999999983221  2245566889999999864  4567888999999999999999


Q ss_pred             CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          473 RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       473 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      |..+|........-..+.++..-.++...+.++..+...+|-..-..||.-..++.-+.|
T Consensus      1436 ~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1436 GNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             ccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            988875433322222333333333444445555555555666666778887777766543

>PRK10593 hypothetical protein; Provisional

Probab=97.66  E-value=0.00061  Score=70.45  Aligned_cols=77  Identities=14%  Similarity=0.113  Sum_probs=51.6

Q ss_pred             eeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC---CceeeeeeeccC---CCeEE
Q 043852          281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH---ENIVQYFGTDKD---ENRLF  354 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~  354 (551)
                      ..+.||.|..+.||.....++ .+++|..+....       ...+..|...|+.+..   -.+.++++++.+   .+..+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~-------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFST-------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEeccccc-------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            356799999999999865555 466676431001       1245577777776642   356777776643   36689


Q ss_pred             EEEecccccch
Q 043852          355 IFLELVTKGSL  365 (551)
Q Consensus       355 lV~Ey~~ggsL  365 (551)
                      ||||++.|.++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999998754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.65  E-value=0.00029  Score=73.75  Aligned_cols=143  Identities=19%  Similarity=0.180  Sum_probs=99.6

Q ss_pred             eeeEeccCCceEEEEEEecCCceEEEEEEecCcc---------------------CccchHHHHHHHHHHHHHhcCCCCc
Q 043852          281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQ---------------------GTQGKQSILQLEQEILLLSRFEHEN  339 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~---------------------~~~~~~~~~~~~~Ei~il~~l~Hpn  339 (551)
                      +-.+|..|--+.||.+...+|..+|||++...-.                     .+..+-.....+.|++-|.+++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            3468999999999999888999999998752210                     1111222334467777787776544


Q ss_pred             eeeeeeeccCCCeEEEEEecccccch-HHHHhhhcCChHHHHHHHHHHHHHHHHHH-hCCeeecccccceEEEcCCCcEE
Q 043852          340 IVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLH-EQNVVHRDIKCANILVDASGSVK  417 (551)
Q Consensus       340 Iv~l~~~~~~~~~~~lV~Ey~~ggsL-~~ll~~~~l~~~~i~~i~~QI~~aL~yLH-~~gIiHrDIKP~NILl~~~g~vk  417 (551)
                      |.-.--+..  ....|||+|+....- .-.++...++...+..+-.|++.-|.-|- ..++||.||.=-|+|+ .+|.++
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ly  304 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLY  304 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEE
Confidence            322111111  123799999965322 23455667777788888888888877775 5689999999999999 789999


Q ss_pred             EEecCCccc
Q 043852          418 LADFGLAKA  426 (551)
Q Consensus       418 L~DFGla~~  426 (551)
                      |+|.+-+..
T Consensus       305 iIDVSQSVE  313 (520)
T KOG2270|consen  305 IIDVSQSVE  313 (520)
T ss_pred             EEEcccccc
Confidence            999997643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.59  E-value=0.00044  Score=68.22  Aligned_cols=74  Identities=11%  Similarity=0.111  Sum_probs=46.3

Q ss_pred             eeEeccCCceEEEEEEecC--CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCCeEEEEEe
Q 043852          282 GELLGSGSFGTVYEGYTDD--GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN-IVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~--g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~E  358 (551)
                      ++.|..|-...+|++...+  +..|++|+......      ......+|+.++..+...+ .++++..+. .   .++||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEE
Confidence            4678889999999986553  67888896542211      1112336777777764333 344544433 2   38999


Q ss_pred             cccccch
Q 043852          359 LVTKGSL  365 (551)
Q Consensus       359 y~~ggsL  365 (551)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.46  E-value=0.0021  Score=69.14  Aligned_cols=81  Identities=14%  Similarity=0.123  Sum_probs=53.1

Q ss_pred             eeEeccCCceEEEEEEecCC-ceEEEEEEecCcc--CccchHHHHHHHHHHHHHhcC---CCCceeeeeeeccCCCeEEE
Q 043852          282 GELLGSGSFGTVYEGYTDDG-FFFAVKEVSLQDQ--GTQGKQSILQLEQEILLLSRF---EHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g-~~vAVK~i~~~~~--~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+.||.|.+..||++...+| +.++||.-.....  +........+...|...|..+   ...++++++.+..  ...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            36799999999999987666 5899997431111  111122344555666666664   2346778887744  44689


Q ss_pred             EEecccccc
Q 043852          356 FLELVTKGS  364 (551)
Q Consensus       356 V~Ey~~ggs  364 (551)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.40  E-value=0.001  Score=68.73  Aligned_cols=137  Identities=16%  Similarity=0.163  Sum_probs=77.7

Q ss_pred             eeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC--ceeeeeeec------cCCC
Q 043852          280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE--NIVQYFGTD------KDEN  351 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~------~~~~  351 (551)
                      ...+.++.|....+|+....+| .+++|......    ..   ..+..|+.++..|...  .+++++...      ...+
T Consensus        25 ~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~----~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g   96 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV----KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG   96 (307)
T ss_pred             eeccccCCccccceEEEEeCCC-cEEEEEecCCC----CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence            3456778888889999866555 57788764311    11   1233445555554321  234444321      2245


Q ss_pred             eEEEEEecccccchH-----HH------H---hh--hcCCh-------HHHH-H---------------HHHHHHHHHHH
Q 043852          352 RLFIFLELVTKGSLA-----NL------Y---QK--YHLMD-------SQVS-A---------------YTRQILNGLNY  392 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~-----~l------l---~~--~~l~~-------~~i~-~---------------i~~QI~~aL~y  392 (551)
                      ..+++++|++|..+.     .+      +   ..  .+++.       ...+ .               ....+...+.+
T Consensus        97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~  176 (307)
T TIGR00938        97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY  176 (307)
T ss_pred             eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence            678999999885431     11      1   00  01100       0000 0               01123344555


Q ss_pred             HHh-------CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          393 LHE-------QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       393 LH~-------~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      +..       .++||+|+++.||+++.++.+.|+||+.+
T Consensus       177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence            542       58999999999999998887789999975

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.38  E-value=0.00041  Score=69.70  Aligned_cols=130  Identities=18%  Similarity=0.233  Sum_probs=73.6

Q ss_pred             eccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEEEEEeccccc
Q 043852          285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLFIFLELVTKG  363 (551)
Q Consensus       285 LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~~gg  363 (551)
                      +..|-...+|+.. .++..+++|.........     .....+|..+++.+...++ .+++....    -++||||++|.
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKAL-----GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccc-----cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            5678888899885 456678888643211110     0123567777777754333 34444432    26899999986


Q ss_pred             chHH--------------HHhh---hc-----CCh-HHHHHHHHHH---------HHHHHHHHh--------CCeeeccc
Q 043852          364 SLAN--------------LYQK---YH-----LMD-SQVSAYTRQI---------LNGLNYLHE--------QNVVHRDI  403 (551)
Q Consensus       364 sL~~--------------ll~~---~~-----l~~-~~i~~i~~QI---------~~aL~yLH~--------~gIiHrDI  403 (551)
                      .+..              .+.+   ..     +.. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            6531              1111   01     111 1222222222         111222221        25899999


Q ss_pred             ccceEEEcCCCcEEEEecCCcc
Q 043852          404 KCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       404 KP~NILl~~~g~vkL~DFGla~  425 (551)
                      .|.||+++.++ +.|+||..+.
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccC
Confidence            99999998877 7899999763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.19  E-value=0.0016  Score=66.92  Aligned_cols=75  Identities=15%  Similarity=0.219  Sum_probs=45.2

Q ss_pred             eeEeccCCceEEEEEEecC-------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeE
Q 043852          282 GELLGSGSFGTVYEGYTDD-------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRL  353 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~-------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~  353 (551)
                      ++.|..|-.-.||+....+       +..|++|+......      ......+|..++..+...++ .++++.+..    
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----   72 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE------LLIDRERELVVFARLSERNLGPKLYGIFPN----   72 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc------ceechHHHHHHHHHHHhCCCCCceEEEeCC----
Confidence            3556777777899986544       57888998543211      11234467666666643333 445555532    


Q ss_pred             EEEEecccccchH
Q 043852          354 FIFLELVTKGSLA  366 (551)
Q Consensus       354 ~lV~Ey~~ggsL~  366 (551)
                      .+|+||++|..+.
T Consensus        73 ~~v~e~i~G~~l~   85 (302)
T cd05156          73 GRIEEFIPSRTLT   85 (302)
T ss_pred             CchhheeCCCcCC
Confidence            3688998887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.17  E-value=0.003  Score=64.55  Aligned_cols=135  Identities=16%  Similarity=0.147  Sum_probs=78.9

Q ss_pred             eeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc--eeeeeeec------cCCCe
Q 043852          281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN--IVQYFGTD------KDENR  352 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~------~~~~~  352 (551)
                      ..+.|..|....+|+....++ .+++|+...  .   .   ...+..|+.++..+.+.+  +++++...      ...+.
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~   88 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDSG-RYVLTLFEK--V---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK   88 (296)
T ss_pred             heecccCccccceEEEEeCCC-cEEEEEcCC--C---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence            356788888889999865444 688887642  1   1   123445666666664322  44444321      22345


Q ss_pred             EEEEEecccccchHH----H-------Hh---h--hcCChH-------HHH-------------HHHHHHHHHHHHHHh-
Q 043852          353 LFIFLELVTKGSLAN----L-------YQ---K--YHLMDS-------QVS-------------AYTRQILNGLNYLHE-  395 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~----l-------l~---~--~~l~~~-------~i~-------------~i~~QI~~aL~yLH~-  395 (551)
                      .++++++++|..+..    .       +.   .  ..+...       ...             .....+..++.++.+ 
T Consensus        89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  168 (296)
T cd05153          89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF  168 (296)
T ss_pred             eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence            689999999876421    1       00   0  001000       000             011122334444443 


Q ss_pred             ------CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 ------QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 ------~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                            .++||+|+.|.||+++.++.+.|+||+.+
T Consensus       169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence                  47999999999999988777789999965

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.09  E-value=0.0043  Score=64.27  Aligned_cols=29  Identities=28%  Similarity=0.441  Sum_probs=25.1

Q ss_pred             CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      .++||+|+.|.||+++.+...-|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~  215 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFA  215 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccc
Confidence            37999999999999986655689999976

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.05  E-value=0.0012  Score=71.73  Aligned_cols=160  Identities=22%  Similarity=0.330  Sum_probs=106.3

Q ss_pred             HHHHHHHHHhcCCCCceeeeeeeccCC-CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecc
Q 043852          324 QLEQEILLLSRFEHENIVQYFGTDKDE-NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD  402 (551)
Q Consensus       324 ~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrD  402 (551)
                      ++.....+++.+.|+|...++++-... ....+|||++ +.+|++++..+.+......              .+++.|- 
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~~-   91 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLHL-   91 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------cccccee-
Confidence            456778889999999999999876543 3478899999 5599998876553322211              1222221 


Q ss_pred             cccceEEEcCCCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 043852          403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG  482 (551)
Q Consensus       403 IKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~  482 (551)
                                 +.++.+| -++             |. |  |-.       ..+++|||++|.++.++.-|...+.....
T Consensus        92 -----------~~~~~td-~~~-------------t~-~--~~~-------~~pKsdVwsl~~i~~el~L~~~l~~~~~~  136 (725)
T KOG1093|consen   92 -----------NIIYITD-HFL-------------TK-Y--PSP-------IGPKSDVWSLGFIILELYLGISLEAELTE  136 (725)
T ss_pred             -----------hhhhccc-ccc-------------cc-C--CCC-------CCcchhhhhHHHHHHHHHHhhHHHHHHHH
Confidence                       1223333 000             00 0  111       12599999999999999999888877666


Q ss_pred             HHHHHHhhcCCCCCC-----------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          483 MQALFRIGKGEPPLV-----------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       483 ~~~~~~i~~~~~~~~-----------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      .+....+.+......           -..++..+.++..+|+-..|..||...++.+++-|..
T Consensus       137 s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e  199 (725)
T KOG1093|consen  137 SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE  199 (725)
T ss_pred             HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence            665554444322211           1246778889999999999999999999998877653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.63  E-value=0.018  Score=60.01  Aligned_cols=141  Identities=14%  Similarity=0.177  Sum_probs=79.1

Q ss_pred             eeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC--ceeeeeeeccCCC--eEEEE
Q 043852          281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE--NIVQYFGTDKDEN--RLFIF  356 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~--~~~lV  356 (551)
                      +++.+..|.--.+|.... +++.+++. ...   ............+|..+++.+.--  -+...++.|.++.  ..|+|
T Consensus        29 ~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~---~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          29 IVEEISGGWSNDTFRLGD-TGQKYVLR-KPP---RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             eeeeccCCcccceEEEec-CCceEEEe-cCC---ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            334443333333444423 37778777 221   112233444556777777776432  2345566666655  67999


Q ss_pred             EecccccchHHH------------------Hhh---------------hcCChHHHHHHHHH--------------HHHH
Q 043852          357 LELVTKGSLANL------------------YQK---------------YHLMDSQVSAYTRQ--------------ILNG  389 (551)
Q Consensus       357 ~Ey~~ggsL~~l------------------l~~---------------~~l~~~~i~~i~~Q--------------I~~a  389 (551)
                      |+|++|..+...                  +..               ......++..+..+              +..-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999998432111                  100               00011122222222              2233


Q ss_pred             HHHHHhC--------CeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          390 LNYLHEQ--------NVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       390 L~yLH~~--------gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ..+|+.+        .++|+|+.+.||+++.++-+-|+||+++..
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            4555533        489999999999999988899999998854

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.62  E-value=0.013  Score=60.07  Aligned_cols=28  Identities=32%  Similarity=0.479  Sum_probs=24.0

Q ss_pred             CeeecccccceEEEcCCCc-EEEEecCCc
Q 043852          397 NVVHRDIKCANILVDASGS-VKLADFGLA  424 (551)
Q Consensus       397 gIiHrDIKP~NILl~~~g~-vkL~DFGla  424 (551)
                      .++|+|++|.|||++.++. .-|+||+.+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a  214 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEA  214 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence            4899999999999987555 569999976

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.53  E-value=0.014  Score=61.85  Aligned_cols=78  Identities=18%  Similarity=0.170  Sum_probs=48.4

Q ss_pred             EeccCCceEEEEEEecCC-ceEEEEEEecCcc--CccchHHHHHHHHHHHHHhcCC--CC-ceeeeeeeccCCCeEEEEE
Q 043852          284 LLGSGSFGTVYEGYTDDG-FFFAVKEVSLQDQ--GTQGKQSILQLEQEILLLSRFE--HE-NIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~~g-~~vAVK~i~~~~~--~~~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lV~  357 (551)
                      .||.|....||++.+.+| .-++||.-.....  +........+..-|...|....  .| .++++|.+.  .....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence            479999999999987543 5788886432111  1223344445556666665543  23 566677653  44456999


Q ss_pred             eccccc
Q 043852          358 ELVTKG  363 (551)
Q Consensus       358 Ey~~gg  363 (551)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=96.47  E-value=0.014  Score=61.59  Aligned_cols=135  Identities=15%  Similarity=0.208  Sum_probs=77.2

Q ss_pred             eeeEeccCCceEEEEEEec-----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEE
Q 043852          281 KGELLGSGSFGTVYEGYTD-----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLF  354 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~  354 (551)
                      .+..|-.|-.-.+|++...     .+..|++|+......      ....-.+|..++..+...++ .++++.+..+    
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~------~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----  109 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE------LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----  109 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC------eeechHHHHHHHHHHHHcCCCCceEEEECCc----
Confidence            3456666888899998642     236788886643211      11122467777777654444 3456665433    


Q ss_pred             EEEecccccchHHH--------------Hhh---hc-------CChHHHHHHHHHH-----------------HHHHHHH
Q 043852          355 IFLELVTKGSLANL--------------YQK---YH-------LMDSQVSAYTRQI-----------------LNGLNYL  393 (551)
Q Consensus       355 lV~Ey~~ggsL~~l--------------l~~---~~-------l~~~~i~~i~~QI-----------------~~aL~yL  393 (551)
                      .|.+|+.+.+|...              +.+   ..       .....+..|..++                 ...+..|
T Consensus       110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L  189 (344)
T PLN02236        110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL  189 (344)
T ss_pred             eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence            57899877665311              110   01       1112333333222                 1111122


Q ss_pred             ----H----hCCeeecccccceEEEcC-CCcEEEEecCCcc
Q 043852          394 ----H----EQNVVHRDIKCANILVDA-SGSVKLADFGLAK  425 (551)
Q Consensus       394 ----H----~~gIiHrDIKP~NILl~~-~g~vkL~DFGla~  425 (551)
                          .    ...++|+|+++.|||++. ++.+.|+||..+.
T Consensus       190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                1    225899999999999976 4789999998763

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.44  E-value=0.045  Score=59.00  Aligned_cols=78  Identities=14%  Similarity=0.120  Sum_probs=49.0

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCcc--CccchHHHHHHHHHHHHHhcCC---CCceeeeeeeccCCCeEEEE
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQ--GTQGKQSILQLEQEILLLSRFE---HENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~--~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .+.||.|.--.||+..+. +..|+||.-.....  .........+...|...|..+.   ..+++++|.++.+.  .+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            577999999999998764 45688887541111  1111112333334455555443   35788899887744  5788


Q ss_pred             Eecccc
Q 043852          357 LELVTK  362 (551)
Q Consensus       357 ~Ey~~g  362 (551)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.42  E-value=0.016  Score=60.74  Aligned_cols=133  Identities=11%  Similarity=0.223  Sum_probs=74.9

Q ss_pred             eeEeccCCceEEEEEEecC----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEEEE
Q 043852          282 GELLGSGSFGTVYEGYTDD----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLFIF  356 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV  356 (551)
                      ++.|..|=.-.+|++...+    +..|++|+......      ....-.+|..+++.+..-++ .++++++.. +   +|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~------~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i   88 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD------YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MI   88 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC------eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---Ee
Confidence            4556568888889885432    23788886643211      12223467777777765555 455655532 2   58


Q ss_pred             EecccccchHH--------------HHhh---hcC-------ChHHHHHHHHHH----------------------HHHH
Q 043852          357 LELVTKGSLAN--------------LYQK---YHL-------MDSQVSAYTRQI----------------------LNGL  390 (551)
Q Consensus       357 ~Ey~~ggsL~~--------------ll~~---~~l-------~~~~i~~i~~QI----------------------~~aL  390 (551)
                      .+|+.|..|..              .+++   ..+       ....+..|..++                      ..-+
T Consensus        89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  168 (330)
T PLN02421         89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI  168 (330)
T ss_pred             ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence            89987765521              1111   111       112233333222                      1112


Q ss_pred             HHH---H-hC----CeeecccccceEEEcC-CCcEEEEecCCc
Q 043852          391 NYL---H-EQ----NVVHRDIKCANILVDA-SGSVKLADFGLA  424 (551)
Q Consensus       391 ~yL---H-~~----gIiHrDIKP~NILl~~-~g~vkL~DFGla  424 (551)
                      ..+   . ..    -++|.|+.+.|||++. ++.++|+||..|
T Consensus       169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence            121   1 11    2799999999999975 578999999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.32  E-value=0.073  Score=54.61  Aligned_cols=28  Identities=29%  Similarity=0.487  Sum_probs=24.9

Q ss_pred             CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      .++||+|+.+.||+++. +.+.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            47999999999999987 77899999965

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.25  E-value=0.063  Score=55.56  Aligned_cols=28  Identities=21%  Similarity=0.313  Sum_probs=26.3

Q ss_pred             CeeecccccceEEEcCCCcEEEEecCCc
Q 043852          397 NVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       397 gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      ++||+|+.+.|||++.++.+.|+||..+
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~  224 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKA  224 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence            7999999999999999999999999865

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.95  E-value=0.042  Score=56.69  Aligned_cols=75  Identities=20%  Similarity=0.210  Sum_probs=43.5

Q ss_pred             eeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC---CCCceeeeeeeccCCCeEEEE
Q 043852          280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF---EHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +..+.|+.|....+|... .++..|.||+-.....        ..+..|..-|+.|   ..-.+++.+++....+..||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~--------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGR--------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGC--------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecChhhH--------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            345778999999999985 6777899997652111        1344565555555   445677888877666667999


Q ss_pred             Eeccccc
Q 043852          357 LELVTKG  363 (551)
Q Consensus       357 ~Ey~~gg  363 (551)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.61  E-value=0.052  Score=53.75  Aligned_cols=150  Identities=17%  Similarity=0.159  Sum_probs=90.8

Q ss_pred             CCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEecccccchHH
Q 043852          288 GSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN  367 (551)
Q Consensus       288 G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~  367 (551)
                      |+-++...+..+=|. ..+|++.......    ....+..+..++.+++  .|+++..-  +...+.+++|+|-....  
T Consensus        73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~----~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCI----NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--  141 (308)
T ss_pred             CCceEEEEeccccch-hhhhhccCCCccc----chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--
Confidence            445555555443343 3455554222111    2234567888888876  68888843  56678899999955321  


Q ss_pred             HHhhhcCChHHHHHHHHHHHHHHHHHHh--CCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCCCCCcccChh
Q 043852          368 LYQKYHLMDSQVSAYTRQILNGLNYLHE--QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPE  445 (551)
Q Consensus       368 ll~~~~l~~~~i~~i~~QI~~aL~yLH~--~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APE  445 (551)
                               . ...++.-=+.+|.-.|+  .+.+|+|..|+|||-+..|.+||.|=+..-.          .+..|.--|
T Consensus       142 ---------~-~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~----------~~V~~vN~~  201 (308)
T PF07387_consen  142 ---------N-FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE----------NQVNMVNIE  201 (308)
T ss_pred             ---------c-hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh----------heeeEEeee
Confidence                     1 11222222456777884  4799999999999999999999999885421          112232211


Q ss_pred             hhhcccCCCCchhhHHHHHHHHHHHHcC
Q 043852          446 VVNLKNRGYGLTADIWSLGCTVLEMLTR  473 (551)
Q Consensus       446 vl~~~~~~~s~ksDIwSLG~iLyeLltG  473 (551)
                           ....++++.+-+|-.-++++...
T Consensus       202 -----Y~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  202 -----YESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             -----ccccChHHHHHHHHHHHHHHHHH
Confidence                 23446677777776666666653

The function of this family is unknown.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.57  E-value=0.054  Score=58.16  Aligned_cols=79  Identities=15%  Similarity=0.114  Sum_probs=51.5

Q ss_pred             eeEeccCCceEEEEEEec-CCceEEEEEEecC-ccCccchHHHHHHHHHHHHHhcCC---CCceeeeeeeccCCCeEEEE
Q 043852          282 GELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQ-DQGTQGKQSILQLEQEILLLSRFE---HENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~-~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .+.||.|.-..||++.+. ++.-++||.-... ..+........+..-|...|+...   -.+++++|.+.  .....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence            577999999999999864 3567888864221 122333455566666777666543   23566777653  4445788


Q ss_pred             Eecccc
Q 043852          357 LELVTK  362 (551)
Q Consensus       357 ~Ey~~g  362 (551)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998865

>PTZ00384 choline kinase; Provisional

Probab=95.52  E-value=0.07  Score=57.26  Aligned_cols=80  Identities=16%  Similarity=0.231  Sum_probs=46.3

Q ss_pred             eeeEeccCCceEEEEEEecC--CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEEEEE
Q 043852          281 KGELLGSGSFGTVYEGYTDD--GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLFIFL  357 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~--g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~  357 (551)
                      ..+.|..|-...+|++...+  +..+.+|.+.....+. .......-.+|+.+++.+...++ .++++.+..    +++.
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            34567678899999986432  2333333221111111 11112233468888888876555 556776643    5999


Q ss_pred             ecccccch
Q 043852          358 ELVTKGSL  365 (551)
Q Consensus       358 Ey~~ggsL  365 (551)
                      ||++|..|
T Consensus       129 efIeGr~l  136 (383)
T PTZ00384        129 EWVEGNTM  136 (383)
T ss_pred             EEeccccC
Confidence            99998765

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.40  E-value=0.093  Score=53.63  Aligned_cols=76  Identities=14%  Similarity=0.202  Sum_probs=44.5

Q ss_pred             ccCCceEEEEEEec-----C----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-------------CCceeee
Q 043852          286 GSGSFGTVYEGYTD-----D----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-------------HENIVQY  343 (551)
Q Consensus       286 G~G~fG~VY~~~~~-----~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-------------HpnIv~l  343 (551)
                      |.|-.|.+|++...     +    ...++||.................+.+|+.+...+-             ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            67888888876431     1    235777775422222222233455677777666541             1345777


Q ss_pred             eeeccCCCeEEEEEeccc
Q 043852          344 FGTDKDENRLFIFLELVT  361 (551)
Q Consensus       344 ~~~~~~~~~~~lV~Ey~~  361 (551)
                      +....+....+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            777766666788988653

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK06148 hypothetical protein; Provisional

Probab=95.26  E-value=0.18  Score=60.74  Aligned_cols=30  Identities=47%  Similarity=0.630  Sum_probs=25.6

Q ss_pred             CCeeecccccceEEEcCCC--cEE-EEecCCcc
Q 043852          396 QNVVHRDIKCANILVDASG--SVK-LADFGLAK  425 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~g--~vk-L~DFGla~  425 (551)
                      .++||+|+.+.|||++.++  .+. |+|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999998775  555 99999764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.90  E-value=0.059  Score=56.93  Aligned_cols=75  Identities=20%  Similarity=0.331  Sum_probs=56.9

Q ss_pred             CCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          349 DENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      +..+.|++|++. |++|.-+-   ....+++..++.+.+..+.-|..+ .+-|||+.-.||||+ +|+|-|+||-+++..
T Consensus       297 e~~y~yl~~kdh-gt~is~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISIIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             CceEEEEEEecC-Cceeeeee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            345667888887 44543321   134567888888888888777754 689999999999998 999999999999844


Q ss_pred             c
Q 043852          428 T  428 (551)
Q Consensus       428 ~  428 (551)
                      .
T Consensus       372 ~  372 (488)
T COG5072         372 Y  372 (488)
T ss_pred             c
Confidence            3

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.85  E-value=0.13  Score=51.19  Aligned_cols=73  Identities=15%  Similarity=0.222  Sum_probs=48.0

Q ss_pred             eccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC---CCCceeeeeeeccCCCeEEEEEeccc
Q 043852          285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF---EHENIVQYFGTDKDENRLFIFLELVT  361 (551)
Q Consensus       285 LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~  361 (551)
                      +--|..-..|.. ......|.||+-.        ......|..|+.-|..|   +.-.+.+.+.+.....+.|+||||++
T Consensus        24 v~gG~inea~~v-~dg~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          24 VSGGDINEAWRL-RDGTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             cCCccccceeEe-ecCCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            444444444554 3456778888532        23334455666544444   55678889999999999999999998


Q ss_pred             ccchH
Q 043852          362 KGSLA  366 (551)
Q Consensus       362 ggsL~  366 (551)
                      -+.+.
T Consensus        95 ~~~~d   99 (286)
T COG3001          95 TGPLD   99 (286)
T ss_pred             CCCCC
Confidence            86664

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.70  E-value=0.32  Score=50.88  Aligned_cols=27  Identities=26%  Similarity=0.220  Sum_probs=23.2

Q ss_pred             CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      .++||+|+.+.|||++ + .+.|+||+.+
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~  222 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDA  222 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCC
Confidence            4689999999999995 4 6789999965

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.49  E-value=0.29  Score=51.46  Aligned_cols=132  Identities=19%  Similarity=0.227  Sum_probs=75.9

Q ss_pred             EeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc------eeeeee----eccCCCeE
Q 043852          284 LLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN------IVQYFG----TDKDENRL  353 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~----~~~~~~~~  353 (551)
                      .|.+ .--.||+..+.+|.. ++|+.... ..      ..++..|+..+..+.-.+      +..+-|    ......+.
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~------~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~  103 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WT------RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP  103 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CC------HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence            4545 556789987777766 88876543 11      223445555565553222      122222    11122377


Q ss_pred             EEEEecccccchHH-H----H--------------hhhc---------CChH----HH---------HHHHHHHHHHHHH
Q 043852          354 FIFLELVTKGSLAN-L----Y--------------QKYH---------LMDS----QV---------SAYTRQILNGLNY  392 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~-l----l--------------~~~~---------l~~~----~i---------~~i~~QI~~aL~y  392 (551)
                      +-+++|++|..+.. .    +              +..+         ..+.    ..         .....++...+..
T Consensus       104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~  183 (331)
T COG2334         104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR  183 (331)
T ss_pred             EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence            88999999987761 1    0              0111         0110    00         0123445555555


Q ss_pred             HHhC--------C--eeecccccceEEEcCCCc-EEEEecCCc
Q 043852          393 LHEQ--------N--VVHRDIKCANILVDASGS-VKLADFGLA  424 (551)
Q Consensus       393 LH~~--------g--IiHrDIKP~NILl~~~g~-vkL~DFGla  424 (551)
                      +.+.        +  +||+|+.|.||+++.+.. +-++||+-+
T Consensus       184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence            5542        3  999999999999998875 899999965

>PTZ00296 choline kinase; Provisional

Probab=93.44  E-value=0.5  Score=51.74  Aligned_cols=75  Identities=12%  Similarity=0.006  Sum_probs=43.7

Q ss_pred             eeeEeccCCceEEEEEEecC---------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCC
Q 043852          281 KGELLGSGSFGTVYEGYTDD---------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDE  350 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~---------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~  350 (551)
                      .++.|..|-.-.+|++...+         ++.|.+++.-....      .+..-..|..++..+...+| .++++.+. +
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te------~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD------ELYNPISEFEVYKTMSKYRIAPQLLNTFS-G  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc------ceeCHHHHHHHHHHHHHCCCCCceEEEeC-C
Confidence            55778788888889886431         45677776532211      11123356666666654444 34555553 2


Q ss_pred             CeEEEEEecccccch
Q 043852          351 NRLFIFLELVTKGSL  365 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL  365 (551)
                         +.|.||++|..|
T Consensus       182 ---g~I~efi~g~~l  193 (442)
T PTZ00296        182 ---GRIEEWLYGDPL  193 (442)
T ss_pred             ---CEEEEeeCCccC
Confidence               467899987644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	551
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-43
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-43
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-43
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-43
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-43
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-43
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-42
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-42
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-42
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-42
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-42
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-41
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-40
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-40
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-40
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-37
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-37
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-36
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-36
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-36
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-36
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-36
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-35
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-34
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-33
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-33
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-33
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-33
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-33
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-33
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-33
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-33
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-32
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-30
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-30
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-29
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-28
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-28
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-28
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-28
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-28
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-28
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-28
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-28
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-28
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-28
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-28
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-28
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-28
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-28
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-28
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-28
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-28
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-28
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-28
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-28
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-28
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-28
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-28
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-28
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-28
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-28
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-27
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-27
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-27
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-27
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-27
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-27
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-27
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-27
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-27
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-27
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-27
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-26
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-26
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-26
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-26
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-26
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-25
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-25
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-25
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-25
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-25
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-25
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-25
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-25
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-24
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-24
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-24
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-24
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-24
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-24
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-24
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-24
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-24
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-24
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-24
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-24
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-24
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-24
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-24
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-24
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-24
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-24
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-24
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-24
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-24
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-24
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-24
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-24
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-24
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-24
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-24
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-24
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-24
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-24
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-24
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-24
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-24
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-24
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-23
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-23
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-23
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-23
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-23
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-23
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-23
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-23
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-23
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-23
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-23
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-22
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-22
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-22
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-22
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-22
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-22
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-22
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-22
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-22
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-22
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-22
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-22
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-22
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-22
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-22
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-22
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-22
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-22
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-22
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-22
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-22
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-22
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-22
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-22
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-22
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-22
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-22
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-22
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-22
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-22
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-22
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-22
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-22
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-22
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-22
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-22
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-22
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-22
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-22
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-22
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-22
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-22
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-22
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-22
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-22
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-22
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-22
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-21
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-21
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-21
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-21
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-21
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-21
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-21
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-21
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-21
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-21
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-21
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-21
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-21
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-21
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-21
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-21
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-21
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-21
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-21
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-21
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-21
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-21
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-21
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-21
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-21
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-21
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-21
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-21
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-21
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-21
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-21
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-21
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-21
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-20
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-20
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-20
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-20
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-20
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-20
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-20
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-20
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-20
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-20
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-20
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-20
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-20
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-20
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-20
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-20
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-20
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-20
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-20
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-20
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-20
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-20
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-20
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-20
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-20
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-20
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-20
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-20
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-20
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-20
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-20
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-20
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-20
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-20
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-20
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-20
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-20
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-20
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-20
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-20
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-20
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-20
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-20
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-20
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-20
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-20
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-20
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-20
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-20
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-20
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-20
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-20
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-20
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-20
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-20
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-20
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-20
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-20
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-20
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-20
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-20
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-20
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-20
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-20
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-20
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-20
3soa_A	444	Full-Length Human Camkii Length = 444		4e-20
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-20
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-20
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-20
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-20
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-20
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-20
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-20
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-20
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-20
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-20
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-20
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-20
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-20
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-20
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-20
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-20
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-19
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-19
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-19
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-19
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-19
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-19
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-19
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-19
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-19
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-19
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-19
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-19
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-19
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-19
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-19
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-19
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-19
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-19
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-19
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-19
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-19
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-19
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-19
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-19
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-19
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-19
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-19
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-19
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-19
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-19
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-19
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-19
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-19
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-19
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-19
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-19
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-19
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-19
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-19
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-19
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-19
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-19
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-19
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-19
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-19
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-19
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-19
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-19
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-19
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-19
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-19
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-19
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-19
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-19
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-19
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-19
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-19
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-19
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-19
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-19
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-19
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-19
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-19
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-19
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-19
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-18
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-18
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-18
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-18
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-18
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-18
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-18
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-18
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-18
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-18
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-18
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-18
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-18
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-18
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-18
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-18
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-18
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-18
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-18
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-18
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-18
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-18
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-18
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-18
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-18
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-18
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-18
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-18
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-18
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-18
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-18
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-18
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-18
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-18
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-18
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-18
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-18
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-18
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-18
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-18
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-18
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-18
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-18
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-18
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-18
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-18
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-18
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-18
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-18
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-18
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-18
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-18
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-18
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-18
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-18
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-18
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-18
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-18
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-18
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-18
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-18
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-18
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-18
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-18
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-18
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-18
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-17
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-17
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-17
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-17
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-17
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-17
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-17
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-17
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-17
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-17
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-17
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-17
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-17
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-16
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-16
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-16
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-16
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-16
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-16
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-16
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-16
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-16
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-16
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-16
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-16
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-15
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-15
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-15
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-15
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-14
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-14
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-14
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-14
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-14
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-14
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-14
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		6e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-14
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-14
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		8e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-13
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-13
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-13
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-13
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-13
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-13
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-13
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-13
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-13
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-13
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-13
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-13

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  172 bits (436), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 95/262 (36%), Positives = 148/262 (56%), Gaps = 9/262 (3%)
Query: 281 KGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           K E +G GSFG V++G  +      A+K + L++   + +               +    
Sbjct: 26  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---- 81
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           + +Y+G+   + +L+I +E +  GS  +L +   L ++Q++   R+IL GL+YLH +  +
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYGLT 457
           HRDIK AN+L+   G VKLADFG+A   T   +K     GTPFWMAPEV+  K   Y   
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAYDSK 199
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           ADIWSLG T +E+   +PP+S L  M+ LF I K  PP +  + S+  ++F+  CL   P
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 518 NDRPTAAQLMEHPFVKRPLQKS 539
           + RPTA +L++H F+ R  +K+
Sbjct: 260 SFRPTAKELLKHKFILRNAKKT 281

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  172 bits (436), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 95/262 (36%), Positives = 149/262 (56%), Gaps = 9/262 (3%)
Query: 281 KGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           K E +G GSFG V++G  +      A+K + L++   + +               +    
Sbjct: 11  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---- 66
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           + +Y+G+   + +L+I +E +  GS  +L +   L ++Q++   R+IL GL+YLH +  +
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 126
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYGLT 457
           HRDIK AN+L+   G VKLADFG+A   T   +K  +  GTPFWMAPEV+  K   Y   
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSK 184
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           ADIWSLG T +E+   +PP+S L  M+ LF I K  PP +  + S+  ++F+  CL   P
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 518 NDRPTAAQLMEHPFVKRPLQKS 539
           + RPTA +L++H F+ R  +K+
Sbjct: 245 SFRPTAKELLKHKFILRNAKKT 266

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  172 bits (436), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 150/264 (56%), Gaps = 9/264 (3%)
Query: 279 WQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           + K E +G GSFG V++G  +      A+K + L++   + +               +  
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY-- 86
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
             + +Y+G+   + +L+I +E +  GS  +L +   L ++Q++   R+IL GL+YLH + 
Sbjct: 87  --VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYG 455
            +HRDIK AN+L+   G VKLADFG+A   T   +K  +  GTPFWMAPEV+  K   Y 
Sbjct: 145 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD 202
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
             ADIWSLG T +E+   +PP+S L  M+ LF I K  PP +  + S+  ++F+  CL  
Sbjct: 203 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 262
Query: 516 NPNDRPTAAQLMEHPFVKRPLQKS 539
            P+ RPTA +L++H F+ R  +K+
Sbjct: 263 EPSFRPTAKELLKHKFILRNAKKT 286

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  172 bits (435), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 143/263 (54%), Gaps = 13/263 (4%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           W+    LG G+FG VY+    +    A  +V      T+ +                +H 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDHP 94
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQ 396
           NIV+       EN L+I +E    G++  +  +    L +SQ+    +Q L+ LNYLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 397 NVVHRDIKCANILVDASGSVKLADFGL-AKAT-TMNDVKSCKGTPFWMAPEVVNL---KN 451
            ++HRD+K  NIL    G +KLADFG+ AK T T+    S  GTP+WMAPEVV     K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFI 509
           R Y   AD+WSLG T++EM   +PP+  L  M+ L +I K EPP +  P+  S + +DF+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            KCL+ N + R T +QL++HPFV
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  172 bits (435), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 95/262 (36%), Positives = 148/262 (56%), Gaps = 9/262 (3%)
Query: 281 KGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           K E +G GSFG V++G  +      A+K + L++   + +               +    
Sbjct: 11  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY---- 66
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           + +Y+G+   + +L+I +E +  GS  +L +   L ++Q++   R+IL GL+YLH +  +
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 126
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYGLT 457
           HRDIK AN+L+   G VKLADFG+A   T   +K     GTPFWMAPEV+  K   Y   
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAYDSK 184
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           ADIWSLG T +E+   +PP+S L  M+ LF I K  PP +  + S+  ++F+  CL   P
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 518 NDRPTAAQLMEHPFVKRPLQKS 539
           + RPTA +L++H F+ R  +K+
Sbjct: 245 SFRPTAKELLKHKFILRNAKKT 266

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  171 bits (433), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 141/263 (53%), Gaps = 13/263 (4%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           W+    LG G+FG VY+    +    A  +V      T+ +                +H 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDHP 94
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQ 396
           NIV+       EN L+I +E    G++  +  +    L +SQ+    +Q L+ LNYLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKGTPFWMAPEVVNL---KN 451
            ++HRD+K  NIL    G +KLADFG++   T  +    S  GTP+WMAPEVV     K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFI 509
           R Y   AD+WSLG T++EM   +PP+  L  M+ L +I K EPP +  P+  S + +DF+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            KCL+ N + R T +QL++HPFV
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 94/263 (35%), Positives = 140/263 (53%), Gaps = 13/263 (4%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           W+    LG G+FG VY+    +    A  +V      T+ +                +H 
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDHP 94
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQ 396
           NIV+       EN L+I +E    G++  +  +    L +SQ+    +Q L+ LNYLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKGTPFWMAPEVVNL---KN 451
            ++HRD+K  NIL    G +KLADFG++   T  +       GTP+WMAPEVV     K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFI 509
           R Y   AD+WSLG T++EM   +PP+  L  M+ L +I K EPP +  P+  S + +DF+
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            KCL+ N + R T +QL++HPFV
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  169 bits (428), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 142/258 (55%), Gaps = 9/258 (3%)
Query: 285 LGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GSFG VY+G  +      A+K + L++   + +               +    I +Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY----ITRY 82
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           FG+     +L+I +E +  GS  +L +   L ++ ++   R+IL GL+YLH +  +HRDI
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 142
Query: 404 KCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYGLTADIW 461
           K AN+L+   G VKLADFG+A   T   +K     GTPFWMAPEV+  K   Y   ADIW
Sbjct: 143 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI--KQSAYDFKADIW 200
Query: 462 SLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRP 521
           SLG T +E+   +PP S L  M+ LF I K  PP +    S+  ++F+  CL  +P  RP
Sbjct: 201 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRP 260
Query: 522 TAAQLMEHPFVKRPLQKS 539
           TA +L++H F+ R  +K+
Sbjct: 261 TAKELLKHKFITRYTKKT 278

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 141/264 (53%), Gaps = 15/264 (5%)
Query: 279 WQKGELLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           W+    LG G+FG VY+    + G   A K +      T+ +                +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 75
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
             IV+  G    + +L+I +E    G++  +  +    L + Q+    RQ+L  LN+LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDVKSCKGTPFWMAPEVV---NLK 450
           + ++HRD+K  N+L+   G ++LADFG++     T+    S  GTP+WMAPEVV    +K
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLSRDARDF 508
           +  Y   ADIWSLG T++EM   +PP+  L  M+ L +I K +PP  L P+  S + RDF
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255
Query: 509 ILKCLQVNPNDRPTAAQLMEHPFV 532
           +   L  NP  RP+AAQL+EHPFV
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFV 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  169 bits (427), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 141/264 (53%), Gaps = 15/264 (5%)
Query: 279 WQKGELLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           W+    LG G+FG VY+    + G   A K +      T+ +                +H
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 67
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
             IV+  G    + +L+I +E    G++  +  +    L + Q+    RQ+L  LN+LH 
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDVKSCKGTPFWMAPEVV---NLK 450
           + ++HRD+K  N+L+   G ++LADFG++     T+    S  GTP+WMAPEVV    +K
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLSRDARDF 508
           +  Y   ADIWSLG T++EM   +PP+  L  M+ L +I K +PP  L P+  S + RDF
Sbjct: 188 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 247
Query: 509 ILKCLQVNPNDRPTAAQLMEHPFV 532
           +   L  NP  RP+AAQL+EHPFV
Sbjct: 248 LKIALDKNPETRPSAAQLLEHPFV 271

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/270 (37%), Positives = 154/270 (57%), Gaps = 15/270 (5%)
Query: 284 LLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           +LG G++G VY G    +    A+KE+  +D                      +H+NIVQ
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPLHEEIALHKHLKHKNIVQ 83
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQ--VSAYTRQILNGLNYLHEQNV 398
           Y G+  +   + IF+E V  GSL+ L +     L D++  +  YT+QIL GL YLH+  +
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 399 VHRDIKCANILVDA-SGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           VHRDIK  N+L++  SG +K++DFG +K  A      ++  GT  +MAPE+++   RGYG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRIGKGE-PPLVPNSLSRDARDFILKCL 513
             ADIWSLGCT++EM T +PP+  L E   A+F++G  +  P +P S+S +A+ FILKC 
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263
Query: 514 QVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
           + +P+ R  A  L+   F+K   +K +  P
Sbjct: 264 EPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 92/258 (35%), Positives = 140/258 (54%), Gaps = 16/258 (6%)
Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LG GS+G+VY+  + + G   A+K+V ++    +                + +  ++V
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-------IIKEISIMQQCDSPHVV 87
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +Y+G+      L+I +E    GS++++ +     L + +++   +  L GL YLH    +
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           HRDIK  NIL++  G  KLADFG+A   T  M       GTPFWMAPEV+  +  GY   
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI--QEIGYNCV 205
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKCLQV 515
           ADIWSLG T +EM   +PPY+ +  M+A+F I    PP    P   S +  DF+ +CL  
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265
Query: 516 NPNDRPTAAQLMEHPFVK 533
           +P  R TA QL++HPFV+
Sbjct: 266 SPEQRATATQLLQHPFVR 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/260 (38%), Positives = 150/260 (57%), Gaps = 15/260 (5%)
Query: 284 LLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           +LG G++G VY G    +    A+KE+  +D                      +H+NIVQ
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPLHEEIALHKHLKHKNIVQ 69
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQ--VSAYTRQILNGLNYLHEQNV 398
           Y G+  +   + IF+E V  GSL+ L +     L D++  +  YT+QIL GL YLH+  +
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 399 VHRDIKCANILVDA-SGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           VHRDIK  N+L++  SG +K++DFG +K  A      ++  GT  +MAPE+++   RGYG
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRIGKGE-PPLVPNSLSRDARDFILKCL 513
             ADIWSLGCT++EM T +PP+  L E   A+F++G  +  P +P S+S +A+ FILKC 
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 249
Query: 514 QVNPNDRPTAAQLMEHPFVK 533
           + +P+ R  A  L+   F+K
Sbjct: 250 EPDPDKRACANDLLVDEFLK 269

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  161 bits (408), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 90/262 (34%), Positives = 146/262 (55%), Gaps = 9/262 (3%)
Query: 281 KGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           K E +G GSFG V++G  +      A+K + L++   + +               +    
Sbjct: 27  KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY---- 82
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           + +Y+G+    ++L+I +E +  GS  +L +     + Q++   ++IL GL+YLH +  +
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 142
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYGLT 457
           HRDIK AN+L+   G VKLADFG+A   T   +K  +  GTPFWMAPEV+  +   Y   
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--QQSAYDSK 200
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           ADIWSLG T +E+   +PP S +  M+ LF I K  PP +    ++  ++FI  CL  +P
Sbjct: 201 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDP 260
Query: 518 NDRPTAAQLMEHPFVKRPLQKS 539
           + RPTA +L++H F+ +  +K+
Sbjct: 261 SFRPTAKELLKHKFIVKNSKKT 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GSFG VY      +    A+K++S    G Q                +  H N +QY
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
            G    E+  ++ +E    GS ++L +  K  L + +++A T   L GL YLH  N++HR
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG-YGLTADI 460
           D+K  NIL+   G VKL DFG   A+ M       GTP+WMAPEV+   + G Y    D+
Sbjct: 179 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVPNSLSRDARDFILKCLQVNPND 519
           WSLG T +E+  R+PP  ++  M AL+ I + E P L     S   R+F+  CLQ  P D
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 296
Query: 520 RPTAAQLMEHPFVKR 534
           RPT+  L++H FV R
Sbjct: 297 RPTSEVLLKHRFVLR 311

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GSFG VY      +    A+K++S    G Q                +  H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
            G    E+  ++ +E    GS ++L +  K  L + +++A T   L GL YLH  N++HR
Sbjct: 81  RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG-YGLTADI 460
           D+K  NIL+   G VKL DFG   A+ M       GTP+WMAPEV+   + G Y    D+
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVPNSLSRDARDFILKCLQVNPND 519
           WSLG T +E+  R+PP  ++  M AL+ I + E P L     S   R+F+  CLQ  P D
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 257
Query: 520 RPTAAQLMEHPFVKR 534
           RPT+  L++H FV R
Sbjct: 258 RPTSEVLLKHRFVLR 272

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 139/261 (53%), Gaps = 14/261 (5%)
Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E +G G+ GTVY       G   A+++++LQ Q  +                  ++ NIV
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKNPNIV 80
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
            Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ L  L +LH   V+HR
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYGLTAD 459
           DIK  NIL+   GSVKL DFG     T    K     GTP+WMAPEVV  K   YG   D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK--AYGPKVD 198
Query: 460 IWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLSRDARDFILKCLQVNP 517
           IWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS   RDF+ +CL+++ 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 258
Query: 518 NDRPTAAQLMEHPFVK--RPL 536
             R +A +L++H F+K  +PL
Sbjct: 259 EKRGSAKELLQHQFLKIAKPL 279

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 141/265 (53%), Gaps = 14/265 (5%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           + + E +G G+ GTVY       G   A+++++LQ Q  +                  ++
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKN 77
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            NIV Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ L  L +LH   
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYG 455
           V+HRDIK  NIL+   GSVKL DFG     T    K     GTP+WMAPEVV  K   YG
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK--AYG 195
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLSRDARDFILKCL 513
              DIWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS   RDF+ +CL
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 255
Query: 514 QVNPNDRPTAAQLMEHPFVK--RPL 536
           +++   R +A +L++H F+K  +PL
Sbjct: 256 EMDVEKRGSAKELIQHQFLKIAKPL 280

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 141/265 (53%), Gaps = 14/265 (5%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           + + E +G G+ GTVY       G   A+++++LQ Q  +                  ++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKN 76
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            NIV Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ L  L +LH   
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYG 455
           V+HRDIK  NIL+   GSVKL DFG     T    K  +  GTP+WMAPEVV  K   YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYG 194
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLSRDARDFILKCL 513
              DIWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS   RDF+ +CL
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 514 QVNPNDRPTAAQLMEHPFVK--RPL 536
            ++   R +A +L++H F+K  +PL
Sbjct: 255 DMDVEKRGSAKELLQHQFLKIAKPL 279

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 141/265 (53%), Gaps = 14/265 (5%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           + + E +G G+ GTVY       G   A+++++LQ Q  +                  ++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKN 76
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            NIV Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ L  L +LH   
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYG 455
           V+HRDIK  NIL+   GSVKL DFG     T    K  +  GTP+WMAPEVV  K   YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRK--AYG 194
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLSRDARDFILKCL 513
              DIWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS   RDF+ +CL
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 514 QVNPNDRPTAAQLMEHPFVK--RPL 536
            ++   R +A +L++H F+K  +PL
Sbjct: 255 DMDVEKRGSAKELLQHQFLKIAKPL 279

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 92/265 (34%), Positives = 142/265 (53%), Gaps = 14/265 (5%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           + + E +G G+ GTVY       G   A+++++LQ Q  +                  ++
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKN 77
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            NIV Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ L  L +LH   
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYG 455
           V+HR+IK  NIL+   GSVKL DFG     T    K  +  GTP+WMAPEVV  K   YG
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYG 195
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLV-PNSLSRDARDFILKCL 513
              DIWSLG   +EM+  +PPY +   ++AL+ I   G P L  P  LS   RDF+ +CL
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 255
Query: 514 QVNPNDRPTAAQLMEHPFVK--RPL 536
           +++   R +A +L++H F+K  +PL
Sbjct: 256 EMDVEKRGSAKELIQHQFLKIAKPL 280

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 135/267 (50%), Gaps = 21/267 (7%)
Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           EL+G+G++G VY+G +   G   A+K + +      G                  H NI 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEINMLKKYSHHRNIA 84
Query: 342 QYFGTDKDEN------RLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNY 392
            Y+G    +N      +L++ +E    GS+ +L +      L +  ++   R+IL GL++
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDVKSCKGTPFWMAPEVVNLK 450
           LH+  V+HRDIK  N+L+  +  VKL DFG++     T+    +  GTP+WMAPEV+   
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 451 ---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSLSRDAR 506
              +  Y   +D+WSLG T +EM    PP   +  M+ALF I +   P L     S+  +
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 264
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
            FI  CL  N + RP   QLM+HPF++
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 76/203 (37%), Positives = 117/203 (57%), Gaps = 8/203 (3%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH 394
           ++H N+V+ + +      L++ +E +  G+L ++  +  L + Q++     +L  L YLH
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKN 451
            Q V+HRDIK  +IL+   G VKL+DFG   A    DV   K   GTP+WMAPEV++   
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKXLVGTPYWMAPEVIS--R 215
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS--LSRDARDFI 509
             Y    DIWSLG  V+EM+  +PPY     +QA+ R+    PP + NS  +S   RDF+
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275
Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            + L  +P +R TA +L++HPF+
Sbjct: 276 ERMLVRDPQERATAQELLDHPFL 298

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GS G V        G   AVK++ L+ Q  +                 ++HEN+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEM 213
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           + +    + L++ +E +  G+L ++     + + Q++A    +L  L+ LH Q V+HRDI
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 273
Query: 404 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  +IL+   G VKL+DFG   A    +V   K   GTP+WMAPE+++     YG   DI
Sbjct: 274 KSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDI 330
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN--SLSRDARDFILKCLQVNPN 518
           WSLG  V+EM+  +PPY +   ++A+  I    PP + N   +S   + F+ + L  +P 
Sbjct: 331 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPA 390
Query: 519 DRPTAAQLMEHPFVKRPLQKSRGPPS 544
            R TAA+L++HPF+ +      GPP+
Sbjct: 391 QRATAAELLKHPFLAK-----AGPPA 411

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 78/215 (36%), Positives = 120/215 (55%), Gaps = 13/215 (6%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH 394
           + H+N+V  + +    + L++ +E +  G+L ++     + + Q++     +L  L+YLH
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH 158
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKN 451
            Q V+HRDIK  +IL+ + G +KL+DFG   A    +V   K   GTP+WMAPEV++   
Sbjct: 159 NQGVIHRDIKSDSILLTSDGRIKLSDFGFC-AQVSKEVPKRKXLVGTPYWMAPEVIS--R 215
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP--NSLSRDARDFI 509
             YG   DIWSLG  V+EM+  +PPY +   +QA+ RI    PP V   + +S   R F+
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFL 275
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
              L   P+ R TA +L+ HPF+K       GPPS
Sbjct: 276 DLMLVREPSQRATAQELLGHPFLKLA-----GPPS 305

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GS G V        G   AVK++ L+ Q  +                 ++HEN+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEM 91
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           + +    + L++ +E +  G+L ++     + + Q++A    +L  L+ LH Q V+HRDI
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 151
Query: 404 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  +IL+   G VKL+DFG   A    +V   K   GTP+WMAPE+++     YG   DI
Sbjct: 152 KSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDI 208
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN--SLSRDARDFILKCLQVNPN 518
           WSLG  V+EM+  +PPY +   ++A+  I    PP + N   +S   + F+ + L  +P 
Sbjct: 209 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPA 268
Query: 519 DRPTAAQLMEHPFVKRPLQKSRGPPS 544
            R TAA+L++HPF+ +      GPP+
Sbjct: 269 QRATAAELLKHPFLAKA-----GPPA 289

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GS G V        G   AVK++ L+ Q  +                 ++HEN+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEM 93
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           + +    + L++ +E +  G+L ++     + + Q++A    +L  L+ LH Q V+HRDI
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 153
Query: 404 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  +IL+   G VKL+DFG   A    +V   K   GTP+WMAPE+++     YG   DI
Sbjct: 154 KSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDI 210
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN--SLSRDARDFILKCLQVNPN 518
           WSLG  V+EM+  +PPY +   ++A+  I    PP + N   +S   + F+ + L  +P 
Sbjct: 211 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPA 270
Query: 519 DRPTAAQLMEHPFVKRPLQKSRGPPS 544
            R TAA+L++HPF+ +      GPP+
Sbjct: 271 QRATAAELLKHPFLAKA-----GPPA 291

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GS G V        G   AVK++ L+ Q  +                 ++HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEM 82
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           + +    + L++ +E +  G+L ++     + + Q++A    +L  L+ LH Q V+HRDI
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 142
Query: 404 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  +IL+   G VKL+DFG   A    +V   K   GTP+WMAPE+++     YG   DI
Sbjct: 143 KSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDI 199
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN--SLSRDARDFILKCLQVNPN 518
           WSLG  V+EM+  +PPY +   ++A+  I    PP + N   +S   + F+ + L  +P 
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPA 259
Query: 519 DRPTAAQLMEHPFVKRPLQKSRGPPS 544
            R TAA+L++HPF+ +      GPP+
Sbjct: 260 QRATAAELLKHPFLAKA-----GPPA 280

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GS G V        G   AVK++ L+ Q  +                 ++HEN+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEM 136
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           + +    + L++ +E +  G+L ++     + + Q++A    +L  L+ LH Q V+HRDI
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 196
Query: 404 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  +IL+   G VKL+DFG   A    +V   K   GTP+WMAPE+++     YG   DI
Sbjct: 197 KSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDI 253
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN--SLSRDARDFILKCLQVNPN 518
           WSLG  V+EM+  +PPY +   ++A+  I    PP + N   +S   + F+ + L  +P 
Sbjct: 254 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPA 313
Query: 519 DRPTAAQLMEHPFVKRPLQKSRGPPS 544
            R TAA+L++HPF+ +      GPP+
Sbjct: 314 QRATAAELLKHPFLAKA-----GPPA 334

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  139 bits (349), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GS G V        G   AVK++ L+ Q  +                 ++HEN+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEM 86
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDI 403
           + +    + L++ +E +  G+L ++     + + Q++A    +L  L+ LH Q V+HRDI
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 146
Query: 404 KCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           K  +IL+   G VKL+DFG   A    +V   K   GTP+WMAPE+++     YG   DI
Sbjct: 147 KSDSILLTHDGRVKLSDFGFC-AQVSKEVPRRKXLVGTPYWMAPELIS--RLPYGPEVDI 203
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN--SLSRDARDFILKCLQVNPN 518
           WSLG  V+EM+  +PPY +   ++A+  I    PP + N   +S   + F+ + L  +P 
Sbjct: 204 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPA 263
Query: 519 DRPTAAQLMEHPFVKRPLQKSRGPPS 544
            R TAA+L++HPF+ +      GPP+
Sbjct: 264 QRATAAELLKHPFLAKA-----GPPA 284

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 143/282 (50%), Gaps = 31/282 (10%)
Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E++GSG+   V   Y        A+K ++L+   T                 +  H NIV
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHHPNIV 76
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQ--------KYHLMD-SQVSAYTRQILNGLNY 392
            Y+ +   ++ L++ ++L++ GS+ ++ +        K  ++D S ++   R++L GL Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK--AT----TMNDV-KSCKGTPFWMAPE 445
           LH+   +HRD+K  NIL+   GSV++ADFG++   AT    T N V K+  GTP WMAPE
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLS--- 502
           V+  + RGY   ADIWS G T +E+ T   PY     M+ L    + +PP +   +    
Sbjct: 197 VME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKE 255
Query: 503 ------RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
                 +  R  I  CLQ +P  RPTAA+L+ H F ++   K
Sbjct: 256 MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 142/278 (51%), Gaps = 31/278 (11%)
Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E++GSG+   V   Y        A+K ++L+   T                 +  H NIV
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHHPNIV 71
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQ--------KYHLMD-SQVSAYTRQILNGLNY 392
            Y+ +   ++ L++ ++L++ GS+ ++ +        K  ++D S ++   R++L GL Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK--AT----TMNDV-KSCKGTPFWMAPE 445
           LH+   +HRD+K  NIL+   GSV++ADFG++   AT    T N V K+  GTP WMAPE
Sbjct: 132 LHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 191
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL---- 501
           V+  + RGY   ADIWS G T +E+ T   PY     M+ L    + +PP +   +    
Sbjct: 192 VME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKE 250
Query: 502 -----SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                 +  R  I  CLQ +P  RPTAA+L+ H F ++
Sbjct: 251 MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 135/264 (51%), Gaps = 11/264 (4%)
Query: 285 LGSGSFG-TVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GSFG  +    T+DG  + +KE+++    ++ +                +H NIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLA---NMKHPNIVQY 88
Query: 344 FGTDKDENRLFIFLELVTKGSL---ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
             + ++   L+I ++    G L    N  +     + Q+  +  QI   L ++H++ ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 401 RDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           RDIK  NI +   G+V+L DFG+A+   +T+   ++C GTP++++PE+   +N+ Y   +
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--ENKPYNNKS 206
Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           DIW+LGC + E+ T +  +        + +I  G  P V    S D R  + +  + NP 
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPR 266
Query: 519 DRPTAAQLMEHPFVKRPLQKSRGP 542
           DRP+   ++E  F+ + ++K   P
Sbjct: 267 DRPSVNSILEKGFIAKRIEKFLSP 290

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 139/283 (49%), Gaps = 18/283 (6%)
Query: 261 EPVYNVS-PNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVK----EVSLQDQ 314
           EP  N   P+ + + +I  ++  ++LG GSFG V+   +     FFA+K    +V L D 
Sbjct: 1   EPELNKERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 60
Query: 315 GTQGKXXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL 374
             +                 +EH  +   F T + +  LF  +E +  G L    Q  H 
Sbjct: 61  DVECTMVEKRVLSLA-----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK 115
Query: 375 MD-SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 433
            D S+ + Y  +I+ GL +LH + +V+RD+K  NIL+D  G +K+ADFG+ K   + D K
Sbjct: 116 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 175
Query: 434 SCK--GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK 491
           + +  GTP ++APE+  L  + Y  + D WS G  + EML  Q P+ H +  + LF   +
Sbjct: 176 TNEFCGTPDYIAPEI--LLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIR 232
Query: 492 GEPPLVPNSLSRDARDFILKCLQVNPNDR-PTAAQLMEHPFVK 533
            + P  P  L ++A+D ++K     P  R      + +HP  +
Sbjct: 233 MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 275

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 135/276 (48%), Gaps = 19/276 (6%)
Query: 268 PNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVK----EVSLQDQGTQGKXXX 322
           P+ + + +I  +   ++LG GSFG V+   +     FFA+K    +V L D   +     
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 323 XXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSA 381
                       +EH  +   F T + +  LF  +E +  G L    Q  H  D S+ + 
Sbjct: 68  KRVLSLA-----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 122
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGT 438
           Y  +I+ GL +LH + +V+RD+K  NIL+D  G +K+ADFG+ K   + D K+   C GT
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-GT 181
Query: 439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP 498
           P ++APE+  L  + Y  + D WS G  + EML  Q P+ H +  + LF   + + P  P
Sbjct: 182 PDYIAPEI--LLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYP 238
Query: 499 NSLSRDARDFILKCLQVNPNDR-PTAAQLMEHPFVK 533
             L ++A+D ++K     P  R      + +HP  +
Sbjct: 239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 138/266 (51%), Gaps = 12/266 (4%)
Query: 275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           +I  ++ G LLG GSF  VY   +   G   A+K +  +     G               
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--MVQRVQNEVKIHC 66
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLM---DSQVSAYTRQILNGL 390
           + +H +I++ +   +D N +++ LE+   G + N Y K  +    +++   +  QI+ G+
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVN 448
            YLH   ++HRD+  +N+L+  + ++K+ADFGLA    M   K  +  GTP +++PE+  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
                +GL +D+WSLGC    +L  +PP+        L ++   +  + P+ LS +A+D 
Sbjct: 186 --RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM-PSFLSIEAKDL 242
Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKR 534
           I + L+ NP DR + + +++HPF+ R
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE   +G +    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 253
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE   +G +    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 253
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 249
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 97
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 98  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 215
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 274
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 275 PMLREVLEHPWI 286

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 127/264 (48%), Gaps = 5/264 (1%)
Query: 270 GKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXX 329
           GK +  +  ++ G  LG G FG VY        F    +V  + Q  +            
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREV 59
Query: 330 XXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILN 388
                  H NI++ +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVN 448
            L+Y H + V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++ 
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI- 178
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
            + R +    D+WSLG    E L  +PP+      +   RI + E    P+ ++  ARD 
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDL 236
Query: 509 ILKCLQVNPNDRPTAAQLMEHPFV 532
           I + L+ NP+ RP   +++EHP++
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 127/264 (48%), Gaps = 5/264 (1%)
Query: 270 GKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXX 329
           GK +  +  ++ G  LG G FG VY        F    +V  + Q  +            
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREV 59
Query: 330 XXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILN 388
                  H NI++ +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVN 448
            L+Y H + V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++ 
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMI- 178
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
            + R +    D+WSLG    E L  +PP+      +   RI + E    P+ ++  ARD 
Sbjct: 179 -EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDL 236
Query: 509 ILKCLQVNPNDRPTAAQLMEHPFV 532
           I + L+ NP+ RP   +++EHP++
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 88
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 89  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 148
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 206
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 207 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 265
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 266 PMLREVLEHPWI 277

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 91/270 (33%), Positives = 133/270 (49%), Gaps = 18/270 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E +G+GSFGTV+      G   AVK +  QD   +                R  H NIV 
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAE---RVNEFLREVAIMKRLRHPNIVL 98
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKY----HLMDSQVSAYTRQILNGLNYLHEQN- 397
           + G       L I  E +++GSL  L  K      L + +  +    +  G+NYLH +N 
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 398 -VVHRDIKCANILVDASGSVKLADFGLA--KATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
            +VHR++K  N+LVD   +VK+ DFGL+  KA+T    KS  GTP WMAPEV  L++   
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV--LRDEPS 216
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDARDFILKCL 513
              +D++S G  + E+ T Q P+ +L   Q +  +G K +   +P +L+      I  C 
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 514 QVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
              P  RP+ A +M+   + RPL KS  PP
Sbjct: 277 TNEPWKRPSFATIMD---LLRPLIKSAVPP 303

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY     +  F    +V  + Q  +                   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 72  RLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIH 131
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+          RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 248
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 70
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 71  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 130
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 188
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 189 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 247
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 248 PMLREVLEHPWI 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 249
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 251
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 248
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 248
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 253
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 5/266 (1%)
Query: 268 PNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
           P G  +  +  ++ G  LG G FG VY        F    +V  + Q  +          
Sbjct: 2   PLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRR 60
Query: 328 XXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQI 386
                    H NI++ +G   D  R+++ LE    G++    QK    D Q +A Y  ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEV 446
            N L+Y H + V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE+
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEM 180
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +  + R +    D+WSLG    E L  +PP+      +   RI + E    P+ ++  AR
Sbjct: 181 I--EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGAR 237
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFV 532
           D I + L+ NP+ RP   +++EHP++
Sbjct: 238 DLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 97
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 98  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMI--EGRMHDEKVDL 215
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 274
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 275 PMLREVLEHPWI 286

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 6/198 (3%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHE 395
           H+++V + G  +D + +F+ LEL  + SL  L+++   L + +   Y RQI+ G  YLH 
Sbjct: 80  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 139
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRG 453
             V+HRD+K  N+ ++    VK+ DFGLA     +    K+  GTP ++APEV  L  +G
Sbjct: 140 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV--LSKKG 197
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           +    D+WS+GC +  +L  +PP+      +   RI K E   +P  ++  A   I K L
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKML 256
Query: 514 QVNPNDRPTAAQLMEHPF 531
           Q +P  RPT  +L+   F
Sbjct: 257 QTDPTARPTINELLNDEF 274

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 75
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 135
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 136 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 193
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 194 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 252
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 253 PMLREVLEHPWI 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 251
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 251
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 6/198 (3%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHE 395
           H+++V + G  +D + +F+ LEL  + SL  L+++   L + +   Y RQI+ G  YLH 
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRG 453
             V+HRD+K  N+ ++    VK+ DFGLA     +    K+  GTP ++APEV  L  +G
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV--LSKKG 193
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           +    D+WS+GC +  +L  +PP+      +   RI K E   +P  ++  A   I K L
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKML 252
Query: 514 QVNPNDRPTAAQLMEHPF 531
           Q +P  RPT  +L+   F
Sbjct: 253 QTDPTARPTINELLNDEF 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 6/198 (3%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHE 395
           H+++V + G  +D + +F+ LEL  + SL  L+++   L + +   Y RQI+ G  YLH 
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRG 453
             V+HRD+K  N+ ++    VK+ DFGLA     +    K+  GTP ++APEV  L  +G
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV--LSKKG 193
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           +    D+WS+GC +  +L  +PP+      +   RI K E   +P  ++  A   I K L
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKML 252
Query: 514 QVNPNDRPTAAQLMEHPF 531
           Q +P  RPT  +L+   F
Sbjct: 253 QTDPTARPTINELLNDEF 270

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 73
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDL 191
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 250
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 251 PMLREVLEHPWI 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 248
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE +  + R +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXI--EGRXHDEKVDL 194
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 253
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 254 PXLREVLEHPWI 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 190
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 249
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 250 PMLREVLEHPWI 261

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 251
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 194
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 253
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 254 PMLREVLEHPWI 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 248
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE++  + R +    D+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDL 189
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 248
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 249 PMLREVLEHPWI 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 68
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 69  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 128
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 186
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 187 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 245
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 246 PMLREVLEHPWI 257

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 122/253 (48%), Gaps = 5/253 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQ-LEKAGVEHQLRREVEIQSHLRHPNIL 75
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 193
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L   PP+      +   RI + E    P+ ++  ARD I + L+ N + R
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF-PDFVTEGARDLISRLLKHNASQR 252
Query: 521 PTAAQLMEHPFVK 533
            T A+++EHP++K
Sbjct: 253 LTLAEVLEHPWIK 265

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 6/198 (3%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHE 395
           H+++V + G  +D + +F+ LEL  + SL  L+++   L + +   Y RQI+ G  YLH 
Sbjct: 98  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 157
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRG 453
             V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV  L  +G
Sbjct: 158 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV--LSKKG 215
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           +    D+WS+GC +  +L  +PP+      +   RI K E   +P  ++  A   I K L
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKML 274
Query: 514 QVNPNDRPTAAQLMEHPF 531
           Q +P  RPT  +L+   F
Sbjct: 275 QTDPTARPTINELLNDEF 292

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 6/198 (3%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHE 395
           H+++V + G  +D + +F+ LEL  + SL  L+++   L + +   Y RQI+ G  YLH 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRG 453
             V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV  L  +G
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV--LSKKG 217
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           +    D+WS+GC +  +L  +PP+      +   RI K E   +P  ++  A   I K L
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKML 276
Query: 514 QVNPNDRPTAAQLMEHPF 531
           Q +P  RPT  +L+   F
Sbjct: 277 QTDPTARPTINELLNDEF 294

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 122/253 (48%), Gaps = 5/253 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQ-LEKAGVEHQLRREVEIQSHLRHPNIL 75
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI--EGRMHDEKVDL 193
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L   PP+      +   RI + E    P+ ++  ARD I + L+ N + R
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF-PDFVTEGARDLISRLLKHNASQR 252
Query: 521 PTAAQLMEHPFVK 533
            T A+++EHP++K
Sbjct: 253 LTLAEVLEHPWIK 265

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 6/198 (3%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHE 395
           H+++V + G  +D + +F+ LEL  + SL  L+++   L + +   Y RQI+ G  YLH 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRG 453
             V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV  L  +G
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV--LSKKG 191
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           +    D+WS+GC +  +L  +PP+      +   RI K E   +P  ++  A   I K L
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-IPKHINPVAASLIQKML 250
Query: 514 QVNPNDRPTAAQLMEHPF 531
           Q +P  RPT  +L+   F
Sbjct: 251 QTDPTARPTINELLNDEF 268

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+A+FG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 192
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 251
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 252 PMLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 122/252 (48%), Gaps = 5/252 (1%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  +                   H NI+
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNIL 73
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +G   D  R+++ LE    G++    QK    D Q +A Y  ++ N L+Y H + V+H
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RDIK  N+L+ ++G +K+A+FG +     +   +  GT  ++ PE++  + R +    D+
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDL 191
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ NP+ R
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHNPSQR 250
Query: 521 PTAAQLMEHPFV 532
           P   +++EHP++
Sbjct: 251 PMLREVLEHPWI 262

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 131/270 (48%), Gaps = 18/270 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E +G+GSFGTV+      G   AVK +  QD   +                R  H NIV 
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAE---RVNEFLREVAIMKRLRHPNIVL 98
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKY----HLMDSQVSAYTRQILNGLNYLHEQN- 397
           + G       L I  E +++GSL  L  K      L + +  +    +  G+NYLH +N 
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 398 -VVHRDIKCANILVDASGSVKLADFGLA--KATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
            +VHRD+K  N+LVD   +VK+ DFGL+  KA+     K   GTP WMAPEV  L++   
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEV--LRDEPS 216
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDARDFILKCL 513
              +D++S G  + E+ T Q P+ +L   Q +  +G K +   +P +L+      I  C 
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 514 QVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
              P  RP+ A +M+   + RPL KS  PP
Sbjct: 277 TNEPWKRPSFATIMD---LLRPLIKSAVPP 303

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 126/270 (46%), Gaps = 26/270 (9%)
Query: 264 YNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXX 322
           YN   N +  ++I         G G F  VY      DG   A+K+V + D         
Sbjct: 28  YNTLANFRIEKKI---------GRGQFSEVYRAACLLDGVPVALKKVQIFD--LMDAKAR 76
Query: 323 XXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLY-----QKYHLMDS 377
                      +  H N+++Y+ +  ++N L I LEL   G L+ +      QK  + + 
Sbjct: 77  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSC 435
            V  Y  Q+ + L ++H + V+HRDIK AN+ + A+G VKL D GL +  ++      S 
Sbjct: 137 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-- 493
            GTP++M+PE ++    GY   +DIWSLGC + EM   Q P+ + + M       K E  
Sbjct: 197 VGTPYYMSPERIH--ENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQC 253
Query: 494 --PPLVPNSLSRDARDFILKCLQVNPNDRP 521
             PPL  +  S + R  +  C+  +P  RP
Sbjct: 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRP 283

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 132/277 (47%), Gaps = 13/277 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEV--SLQDQGTQGKXXXXXXXXXXX 330
           R +  + +G  LG G F   YE    D    FA K V  S+  +  Q +           
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 331 XXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNG 389
                ++ ++V + G  +D++ +++ LE+  + SL  L+++   + + +   + RQ + G
Sbjct: 99  ----LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVV 447
           + YLH   V+HRD+K  N+ ++    VK+ DFGLA     +    K+  GTP ++APEV 
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEV- 213
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
            L  +G+    DIWSLGC +  +L  +PP+      +   RI K E   VP  ++  A  
Sbjct: 214 -LCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-VPRHINPVASA 271
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            I + L  +P  RP+ A+L+   F        R P S
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTS 308

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 13/277 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEV--SLQDQGTQGKXXXXXXXXXXX 330
           R +  + +G  LG G F   YE    D    FA K V  S+  +  Q +           
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 331 XXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNG 389
                ++ ++V + G  +D++ +++ LE+  + SL  L+++   + + +   + RQ + G
Sbjct: 99  ----LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVV 447
           + YLH   V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV 
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEV- 213
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
            L  +G+    DIWSLGC +  +L  +PP+      +   RI K E   VP  ++  A  
Sbjct: 214 -LCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-VPRHINPVASA 271
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            I + L  +P  RP+ A+L+   F        R P S
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTS 308

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 13/277 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEV--SLQDQGTQGKXXXXXXXXXXX 330
           R +  + +G  LG G F   YE    D    FA K V  S+  +  Q +           
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 331 XXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNG 389
                ++ ++V + G  +D++ +++ LE+  + SL  L+++   + + +   + RQ + G
Sbjct: 99  ----LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVV 447
           + YLH   V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV 
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEV- 213
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
            L  +G+    DIWSLGC +  +L  +PP+      +   RI K E   VP  ++  A  
Sbjct: 214 -LCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-VPRHINPVASA 271
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            I + L  +P  RP+ A+L+   F        R P S
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTS 308

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 13/277 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEV--SLQDQGTQGKXXXXXXXXXXX 330
           R +  + +G  LG G F   YE    D    FA K V  S+  +  Q +           
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 331 XXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNG 389
                ++ ++V + G  +D++ +++ LE+  + SL  L+++   + + +   + RQ + G
Sbjct: 83  ----LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 138
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVV 447
           + YLH   V+HRD+K  N+ ++    VK+ DFGLA     +    K   GTP ++APEV 
Sbjct: 139 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEV- 197
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
            L  +G+    DIWSLGC +  +L  +PP+      +   RI K E   VP  ++  A  
Sbjct: 198 -LCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-VPRHINPVASA 255
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            I + L  +P  RP+ A+L+   F        R P S
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLPTS 292

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 120/257 (46%), Gaps = 13/257 (5%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           G  LG G FG VY        F    +V  + Q  + +                 H NI+
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-LEKEGVEHQLRREIEIQSHLRHPNIL 78
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVH 400
           + +    D  R+++ LE   +G L    QK+   D Q SA +  ++ + L+Y HE+ V+H
Sbjct: 79  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH 138
Query: 401 RDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTAD 459
           RDIK  N+L+   G +K+ADFG +  A ++     C GT  ++ PE++  + + +    D
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEMI--EGKTHDEKVD 195
Query: 460 IWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +W  G    E L   PP+   SH E  + +  +    PP     LS  ++D I K L+ +
Sbjct: 196 LWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF----LSDGSKDLISKLLRYH 251
Query: 517 PNDRPTAAQLMEHPFVK 533
           P  R     +MEHP+VK
Sbjct: 252 PPQRLPLKGVMEHPWVK 268

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 119/254 (46%), Gaps = 13/254 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG VY        F    +V  + Q  + +                 H NI++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQ-LEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVHRDI 403
               D  R+++ LE   +G L    QK+   D Q SA +  ++ + L+Y HE+ V+HRDI
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 404 KCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
           K  N+L+   G +K+ADFG +  A ++     C GT  ++ PE++  + + +    D+W 
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEMI--EGKTHDEKVDLWC 197
Query: 463 LGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPND 519
            G    E L   PP+   SH E  + +  +    PP     LS  ++D I K L+ +P  
Sbjct: 198 AGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF----LSDGSKDLISKLLRYHPPQ 253
Query: 520 RPTAAQLMEHPFVK 533
           R     +MEHP+VK
Sbjct: 254 RLPLKGVMEHPWVK 267

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 141/300 (47%), Gaps = 65/300 (21%)
Query: 283 ELLGSGSFGTVYEGYTDD-GFFFAVKEVSL-QDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E LG+G++ TVY+G     G + A+KEV L  ++GT                   +HENI
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS-----TAIREISLMKELKHENI 65
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ-------------VSAYTRQIL 387
           V+ +     EN+L +  E      + N  +KY  MDS+             V  +  Q+L
Sbjct: 66  VRLYDVIHTENKLTLVFEF-----MDNDLKKY--MDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPE 445
            GL + HE  ++HRD+K  N+L++  G +KL DFGLA+A    +N   S   T ++ AP+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEP-------- 494
           V+ + +R Y  + DIWS GC + EM+T +P +   +  E ++ +F I  G P        
Sbjct: 179 VL-MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI-MGTPNESLWPSV 236
Query: 495 -------PLVPNSLSRDAR----------------DFILKCLQVNPNDRPTAAQLMEHPF 531
                  P +     RD R                DF+   LQ+NP+ R +A Q + HP+
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 284 LLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +LG GSFG V +    D        V + ++ +                 + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 344 FGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           F   +D +  +I  EL T G L + + ++    +   +   +Q+ +G+ Y+H+ N+VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 403 IKCANILVDAS---GSVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG-YGLT 457
           +K  NIL+++      +K+ DFGL+     N  +K   GT +++APEV+    RG Y   
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----RGTYDEK 202
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPN--SLSRDARDFILKCLQ 514
            D+WS G  +  +L+  PP+        L R+  G+    +P   ++S DA+D I K L 
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 515 VNPNDRPTAAQLMEHPFVKR 534
            +P+ R TA Q +EHP++++
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 284 LLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +LG GSFG V +    D        V + ++ +                 + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 344 FGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           F   +D +  +I  EL T G L + + ++    +   +   +Q+ +G+ Y+H+ N+VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 403 IKCANILVDAS---GSVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG-YGLT 457
           +K  NIL+++      +K+ DFGL+     N  +K   GT +++APEV+    RG Y   
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----RGTYDEK 202
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPN--SLSRDARDFILKCLQ 514
            D+WS G  +  +L+  PP+        L R+  G+    +P   ++S DA+D I K L 
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 515 VNPNDRPTAAQLMEHPFVKR 534
            +P+ R TA Q +EHP++++
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 284 LLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +LG GSFG V +    D        V + ++ +                 + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 344 FGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           F   +D +  +I  EL T G L + + ++    +   +   +Q+ +G+ Y+H+ N+VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 403 IKCANILVDAS---GSVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG-YGLT 457
           +K  NIL+++      +K+ DFGL+     N  +K   GT +++APEV+    RG Y   
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----RGTYDEK 202
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPN--SLSRDARDFILKCLQ 514
            D+WS G  +  +L+  PP+        L R+  G+    +P   ++S DA+D I K L 
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 515 VNPNDRPTAAQLMEHPFVKR 534
            +P+ R TA Q +EHP++++
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 111/207 (53%), Gaps = 9/207 (4%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H +I+    + +  + +F+  +L+ KG L + L +K  L + +  +  R +L  +++LH 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLK---- 450
            N+VHRD+K  NIL+D +  ++L+DFG +      + ++   GTP ++APE++       
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARD 507
           + GYG   D+W+ G  +  +L   PP+ H   +  L  I +G+        +  S   +D
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKR 534
            I + LQV+P  R TA Q ++HPF +R
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 112/202 (55%), Gaps = 9/202 (4%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + 
Sbjct: 145 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 202
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFR----IGKGEPPLVPNSL-SRDARDFILKC 512
           +DIWS+G +++EM   + P     G  A+F     I    PP +P+ + S + +DF+ KC
Sbjct: 203 SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 262
Query: 513 LQVNPNDRPTAAQLMEHPFVKR 534
           L  NP +R    QLM H F+KR
Sbjct: 263 LIKNPAERADLKQLMVHAFIKR 284

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 121/284 (42%), Gaps = 38/284 (13%)
Query: 284 LLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           L+G GS+G V +    D G   A+K+    D     K              +  HEN+V 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD---KMVKKIAMREIKLLKQLRHENLVN 88
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQNVVHR 401
                K + R ++  E V    L +L    + +D QV   Y  QI+NG+ + H  N++HR
Sbjct: 89  LLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR 148
Query: 402 DIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTAD 459
           DIK  NILV  SG VKL DFG A+  A           T ++ APE++ + +  YG   D
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL-VGDVKYGKAVD 207
Query: 460 IWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN-------------------- 499
           +W++GC V EM   +P +     +  L+ I      L+P                     
Sbjct: 208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267
Query: 500 ----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                      LS    D   KCL ++P+ RP  A+L+ H F +
Sbjct: 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 122/259 (47%), Gaps = 15/259 (5%)
Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LG+G+F  V        G  FAVK   +  +  +GK              + +HENIV
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVK--CIPKKALKGKESSIENEIAVLR--KIKHENIV 83
Query: 342 QYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
                 +  N L++ ++LV+ G L + + +K    +   S   RQ+L+ + YLH   +VH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 401 RDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGL 456
           RD+K  N+L    D    + ++DFGL+K     DV S   GTP ++APEV  L  + Y  
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEV--LAQKPYSK 201
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDARDFILKCL 513
             D WS+G     +L   PP+      +   +I K E        + +S  A+DFI   +
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLM 261
Query: 514 QVNPNDRPTAAQLMEHPFV 532
           + +PN R T  Q   HP++
Sbjct: 262 EKDPNKRYTCEQAARHPWI 280

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 127/257 (49%), Gaps = 15/257 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +G GSF TVY+G  D      V    LQD+    K                +H NIV+++
Sbjct: 34  IGRGSFKTVYKGL-DTETTVEVAWCELQDRKLT-KSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 345 ----GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN-- 397
                T K +  + +  EL T G+L    +++ +   +V  ++ RQIL GL +LH +   
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 398 VVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           ++HRD+KC NI +   +GSVK+ D GLA     +  K+  GTP + APE    K   Y  
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEK---YDE 208
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGEPPLVPNSLSR-DARDFILKCLQ 514
           + D+++ G   LE  T + PYS  +    ++ R+  G  P   + ++  + ++ I  C++
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 515 VNPNDRPTAAQLMEHPF 531
            N ++R +   L+ H F
Sbjct: 269 QNKDERYSIKDLLNHAF 285

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 141/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL++ H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 114 QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 169
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 170 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 289 DVTKPVPHLR 298

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 137/304 (45%), Gaps = 50/304 (16%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 63
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD---SQVSAYTRQILNGLNYL 393
           H NIV+       EN+L++  E ++   L +      L       + +Y  Q+L GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFWMAPEVV 447
           H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++ APE++
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 178
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----------- 494
            L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P           
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 495 ----PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF---VKRPL 536
               P  P             L  D R  + + L  +PN R +A   + HPF   V +P+
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297
Query: 537 QKSR 540
              R
Sbjct: 298 PHLR 301

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 133/262 (50%), Gaps = 17/262 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG+ G V++  +   G   AVK++       + K                +   IVQ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS---HDCPYIVQC 89
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQN-VV 399
           FGT      +FI +EL+  G+ A   +K     + +  +   T  I+  L YL E++ V+
Sbjct: 90  FGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-CKGTPFWMAPEVVNLKNRG---YG 455
           HRD+K +NIL+D  G +KL DFG++     +  K    G   +MAPE ++  +     Y 
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKGEPPLVPNSL--SRDARDFILKC 512
           + AD+WSLG +++E+ T Q PY + +   + L ++ + EPPL+P  +  S D + F+  C
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDC 267
Query: 513 LQVNPNDRPTAAQLMEHPFVKR 534
           L  +   RP   +L+EH F+KR
Sbjct: 268 LTKDHRKRPKYNKLLEHSFIKR 289

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 67
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 120
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V +     ++
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL----WY 176
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 177 RAPEIL-LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 235
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 236 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 296 DVTKPVPHLR 305

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 137/306 (44%), Gaps = 54/306 (17%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPE 445
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP--------- 494
           ++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P         
Sbjct: 174 IL-LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 232
Query: 495 ------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF---VKR 534
                 P  P             L  D R  + + L  +PN R +A   + HPF   V +
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292
Query: 535 PLQKSR 540
           P+   R
Sbjct: 293 PVPHLR 298

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 63
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E ++        +K+  MD+          + +Y  Q+L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMD-----LKKF--MDASALTGIPLPLIKSYLFQLL 116
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 173 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 231
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 232 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 292 DVTKPVPHLR 301

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 64
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 117
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 173
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 174 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 232
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 233 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 293 DVTKPVPHLR 302

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 170 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 289 DVTKPVPHLR 298

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 61
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E ++        +K+  MD+          + +Y  Q+L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMD-----LKKF--MDASALTGIPLPLIKSYLFQLL 114
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 170
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 171 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 229
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 230 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 290 DVTKPVPHLR 299

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 137/304 (45%), Gaps = 50/304 (16%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD---SQVSAYTRQILNGLNYL 393
           H NIV+       EN+L++  E + +  L +      L       + +Y  Q+L GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFWMAPEVV 447
           H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++ APE++
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 175
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----------- 494
            L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P           
Sbjct: 176 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 495 ----PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF---VKRPL 536
               P  P             L  D R  + + L  +PN R +A   + HPF   V +P+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294
Query: 537 QKSR 540
              R
Sbjct: 295 PHLR 298

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 62
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 115
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 116 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 171
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 172 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 230
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 231 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 291 DVTKPVPHLR 300

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 137/304 (45%), Gaps = 50/304 (16%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 62
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD---SQVSAYTRQILNGLNYL 393
           H NIV+       EN+L++  E ++   L +      L       + +Y  Q+L GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFWMAPEVV 447
           H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++ APE++
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 177
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----------- 494
            L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P           
Sbjct: 178 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 495 ----PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF---VKRPL 536
               P  P             L  D R  + + L  +PN R +A   + HPF   V +P+
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296
Query: 537 QKSR 540
              R
Sbjct: 297 PHLR 300

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 62
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 115
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 171
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 172 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 230
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 231 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 291 DVTKPVPHLR 300

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 61
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 114
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 170
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 171 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 229
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 230 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 290 DVTKPVPHLR 299

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 170 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 289 DVTKPVPHLR 298

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 63
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E V +       +K+  MD+          + +Y  Q+L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 116
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 173 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 231
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 232 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 292 DVTKPVPHLR 301

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 169
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 170 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 289 DVTKPVPHLR 298

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 59
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 112
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 168
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 169 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 288 DVTKPVPHLR 297

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 61
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 114
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 170
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 171 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 229
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 230 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 290 DVTKPVPHLR 299

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 59
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 112
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 168
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 169 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 288 DVTKPVPHLR 297

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 64
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 117
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 173
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 174 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 232
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 233 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 293 DVTKPVPHLR 302

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 63
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 116
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 173 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 231
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 232 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 292 DVTKPVPHLR 301

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 67
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 120
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 176
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 177 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 235
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 236 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 296 DVTKPVPHLR 305

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 63
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 116
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 173 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 231
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 232 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 292 DVTKPVPHLR 301

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 62
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 115
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 171
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 172 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 230
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 231 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 291 DVTKPVPHLR 300

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 61
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 114
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 170
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 171 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 229
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 230 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 290 DVTKPVPHLR 299

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 59
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 112
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 168
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 169 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 288 DVTKPVPHLR 297

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 140/310 (45%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 169
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 170 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 289 DVTKPVPHLR 298

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 136/300 (45%), Gaps = 59/300 (19%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 170 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                     P  P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 127/283 (44%), Gaps = 17/283 (6%)
Query: 266 VSPNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVK----EVSLQDQGTQGKX 320
           +  N   R  I +++   +LG GSFG V      + G  +AVK    +V LQD   +   
Sbjct: 12  IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71
Query: 321 XXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQV 379
                           H  + Q F   +  +RLF  +E V  G L    QK    D ++ 
Sbjct: 72  TEKRILSLAR-----NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA 126
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--G 437
             Y  +I++ L +LH++ +++RD+K  N+L+D  G  KLADFG+ K    N V +    G
Sbjct: 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG 186
Query: 438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV 497
           TP ++APE+  L+   YG   D W++G  + EML    P+   E    LF     +  + 
Sbjct: 187 TPDYIAPEI--LQEMLYGPAVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILNDEVVY 243
Query: 498 PNSLSRDARDFILKCLQVNPNDR-PTAAQLMEHPFVKRPLQKS 539
           P  L  DA   +   +  NP  R  +  Q  EH  ++ P  K 
Sbjct: 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 136/304 (44%), Gaps = 50/304 (16%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 63
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD---SQVSAYTRQILNGLNYL 393
           H NIV+       EN+L++  E + +  L        L       + +Y  Q+L GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFWMAPEVV 447
           H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++ APE++
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 178
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----------- 494
            L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P           
Sbjct: 179 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 495 ----PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF---VKRPL 536
               P  P             L  D R  + + L  +PN R +A   + HPF   V +P+
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297
Query: 537 QKSR 540
              R
Sbjct: 298 PHLR 301

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 136/300 (45%), Gaps = 59/300 (19%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 170 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                     P  P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 136/304 (44%), Gaps = 50/304 (16%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 59
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD---SQVSAYTRQILNGLNYL 393
           H NIV+       EN+L++  E V +  L        L       + +Y  Q+L GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFWMAPEVV 447
           H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++ APE++
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----------- 494
            L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P           
Sbjct: 175 -LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 495 ----PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF---VKRPL 536
               P  P             L  D R  + + L  +PN R +A   + HPF   V +P+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
Query: 537 QKSR 540
              R
Sbjct: 294 PHLR 297

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 136/300 (45%), Gaps = 59/300 (19%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 59
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 112
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 168
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 169 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                     P  P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 136/300 (45%), Gaps = 59/300 (19%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+K++ L D  T+G                  
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEG--VPSTAIREISLLKELN 61
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 114
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 170
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 171 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 229
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                     P  P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 230 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G+GS+G   +     DG     KE+   D G+  +                +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 344 FG--TDKDENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQ 396
           +    D+    L+I +E    G LA++  K      +L +  V     Q+   L   H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 397 N-----VVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNL 449
           +     V+HRD+K AN+ +D   +VKL DFGLA+    ++   K   GTP++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMN- 189
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
               Y   +DIWSLGC + E+    PP++     +   +I +G+   +P   S +  + I
Sbjct: 190 -RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            + L +    RP+  +++E+P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 57/293 (19%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQ--DQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E +G G++G VY+   + G  FA+K++ L+  D+G                    +H NI
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS-----TTIREISILKELKHSNI 62
Query: 341 VQYFGTDKDENRLFIFLEL----------VTKGSLANLYQKYHLMDSQVSAYTRQILNGL 390
           V+ +     + RL +  E           V +G L ++  K  L+         Q+LNG+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL---------QLLNGI 113
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG--TPFWMAPEVVN 448
            Y H++ V+HRD+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+ 
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL- 172
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI-----GKGEPPLV--- 497
           + ++ Y  T DIWS+GC   EM+   P +   S  + +  +FRI      K  P +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 498 ---PN--------------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
              PN               L     D + K L+++PN R TA Q +EH + K
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 57/293 (19%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQ--DQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E +G G++G VY+   + G  FA+K++ L+  D+G                    +H NI
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS-----TTIREISILKELKHSNI 62
Query: 341 VQYFGTDKDENRLFIFLEL----------VTKGSLANLYQKYHLMDSQVSAYTRQILNGL 390
           V+ +     + RL +  E           V +G L ++  K  L+         Q+LNG+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL---------QLLNGI 113
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG--TPFWMAPEVVN 448
            Y H++ V+HRD+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+ 
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL- 172
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI-----GKGEPPLV--- 497
           + ++ Y  T DIWS+GC   EM+   P +   S  + +  +FRI      K  P +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 498 ---PN--------------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
              PN               L     D + K L+++PN R TA Q +EH + K
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 57/293 (19%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQ--DQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E +G G++G VY+   + G  FA+K++ L+  D+G                    +H NI
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS-----TTIREISILKELKHSNI 62
Query: 341 VQYFGTDKDENRLFIFLEL----------VTKGSLANLYQKYHLMDSQVSAYTRQILNGL 390
           V+ +     + RL +  E           V +G L ++  K  L+         Q+LNG+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL---------QLLNGI 113
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG--TPFWMAPEVVN 448
            Y H++ V+HRD+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+ 
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL- 172
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI-----GKGEPPLV--- 497
           + ++ Y  T DIWS+GC   EM+   P +   S  + +  +FRI      K  P +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 498 ---PN--------------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
              PN               L     D + K L+++PN R TA Q +EH + K
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 110/198 (55%), Gaps = 5/198 (2%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++            GT  +M+PE   L+   Y + 
Sbjct: 129 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPE--RLQGTHYSVQ 186
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-SRDARDFILKCLQVN 516
           +DIWS+G +++EM   + P   +   + L  I    PP +P+++ S + +DF+ KCL  N
Sbjct: 187 SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKN 246
Query: 517 PNDRPTAAQLMEHPFVKR 534
           P +R    QLM H F+KR
Sbjct: 247 PAERADLKQLMVHAFIKR 264

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 44/301 (14%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSL--QDQGTQGKXXXXXXX 326
           N  F+  +  +QK E +G G++G VY+     G   A+K + L  +D+G           
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS-----TAI 67
Query: 327 XXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQ 385
                     H NIV        E  L +  E + K     L + K  L DSQ+  Y  Q
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---TPFWM 442
           +L G+ + H+  ++HRD+K  N+L+++ G++KLADFGLA+A  +  V+S      T ++ 
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYR 186
Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--------------------- 481
           AP+V+ + ++ Y  + DIWS+GC   EM+T +P +  +                      
Sbjct: 187 APDVL-MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 482 -------GMQALFRIGKGEP--PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
                    Q  F++ + +P   ++P    ++  D +   L  +PN R +A   M HP+ 
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304
Query: 533 K 533
           K
Sbjct: 305 K 305

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G+GS+G   +     DG     KE+   D G+  +                +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 344 FG--TDKDENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQ 396
           +    D+    L+I +E    G LA++  K      +L +  V     Q+   L   H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 397 N-----VVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNL 449
           +     V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GTP++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN- 189
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
               Y   +DIWSLGC + E+    PP++     +   +I +G+   +P   S +  + I
Sbjct: 190 -RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            + L +    RP+  +++E+P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 285 LGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G+GS+G   +     DG     KE+   D G+  +                +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKEL---DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 344 FG--TDKDENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQ 396
           +    D+    L+I +E    G LA++  K      +L +  V     Q+   L   H +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 397 N-----VVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNL 449
           +     V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GTP++M+PE +N 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN- 189
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
               Y   +DIWSLGC + E+    PP++     +   +I +G+   +P   S +  + I
Sbjct: 190 -RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 248
Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
            + L +    RP+  +++E+P +
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 138/301 (45%), Gaps = 44/301 (14%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSL--QDQGTQGKXXXXXXX 326
           N  F+  +  +QK E +G G++G VY+     G   A+K + L  +D+G           
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS-----TAI 67
Query: 327 XXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQ 385
                     H NIV        E  L +  E + K     L + K  L DSQ+  Y  Q
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---TPFWM 442
           +L G+ + H+  ++HRD+K  N+L+++ G++KLADFGLA+A  +  V+S      T ++ 
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYR 186
Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--------------------- 481
           AP+V+ + ++ Y  + DIWS+GC   EM+T +P +  +                      
Sbjct: 187 APDVL-MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 482 -------GMQALFRIGKGEP--PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
                    Q  F++ + +P   ++P    ++  D +   L  +PN R +A   M HP+ 
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304
Query: 533 K 533
           K
Sbjct: 305 K 305

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           R +I  +  G+ LG G+FG V  G +   G   AVK   L  Q  +              
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK--ILNRQKIRSLDVVGKIKREIQN 64
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGL 390
              F H +I++ +         F+ +E V+ G L +   K+  + + +     +QIL+ +
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNL 449
           +Y H   VVHRD+K  N+L+DA  + K+ADFGL+   +  + +++  G+P + APEV++ 
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS- 183
Query: 450 KNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
             R Y G   DIWS G  +  +L    P+   E +  LF+  +G    +P  L+R     
Sbjct: 184 -GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVATL 241
Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
           ++  LQV+P  R T   + EH + K+ L      PSY
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQDL------PSY 272

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 131/264 (49%), Gaps = 36/264 (13%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSGSFGTVY+G +  D    AVK + + D   +                +  H NI+ +
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPE---QFQAFRNEVAVLRKTRHVNILLF 97
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLHEQN 397
            G    +N     L +VT+    ++LY+  H+ +++   +      RQ   G++YLH +N
Sbjct: 98  MGYMTKDN-----LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN 152
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK-NR 452
           ++HRD+K  NI +    +VK+ DFGLA   +       V+   G+  WMAPEV+ ++ N 
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL------VPNSLSR 503
            +   +D++S G  + E++T + PYSH+    Q +F +G+G   P L       P ++ R
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKR 272
Query: 504 DARDFILKCLQVNPNDRPTAAQLM 527
              D    C++    +RP   Q++
Sbjct: 273 LVAD----CVKKVKEERPLFPQIL 292

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 139/310 (44%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+ ++ L D  T+G                  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEG--VPSTAIREISLLKELN 60
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 113
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 169
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 170 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 228
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 229 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 289 DVTKPVPHLR 298

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 139/310 (44%), Gaps = 62/310 (20%)
Query: 278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           ++QK E +G G++G VY+      G   A+ ++ L D  T+G                  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEG--VPSTAIREISLLKELN 59
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ---------VSAYTRQIL 387
           H NIV+       EN+L++  E + +       +K+  MD+          + +Y  Q+L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKKF--MDASALTGIPLPLIKSYLFQLL 112
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSCKGTPFW 441
            GL + H   V+HRD+K  N+L++  G++KLADFGLA+A      T  ++V     T ++
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWY 168
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP----- 494
            APE++ L  + Y    DIWSLGC   EM+TR+  +     +  LFRI +  G P     
Sbjct: 169 RAPEIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 495 ----------PLVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF-- 531
                     P  P             L  D R  + + L  +PN R +A   + HPF  
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
Query: 532 -VKRPLQKSR 540
            V +P+   R
Sbjct: 288 DVTKPVPHLR 297

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 79  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 137
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTI 195
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 255
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 256 RPEDRPT 262

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 17/278 (6%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           R +I  +  G+ LG G+FG V  G +   G   AVK   L  Q  +              
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK--ILNRQKIRSLDVVGKIKREIQN 64
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGL 390
              F H +I++ +         F+ +E V+ G L +   K+  + + +     +QIL+ +
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPFWMAPEVVN 448
           +Y H   VVHRD+K  N+L+DA  + K+ADFGL+   +  +    SC G+P + APEV++
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC-GSPNYAAPEVIS 183
Query: 449 LKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
              R Y G   DIWS G  +  +L    P+   E +  LF+  +G    +P  L+R    
Sbjct: 184 --GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVAT 240
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
            ++  LQV+P  R T   + EH + K+ L      PSY
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL------PSY 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 81
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 82  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 140
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTI 198
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 199 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 258
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 259 RPEDRPT 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 80
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 81  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 139
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTI 197
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 198 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 257
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 258 RPEDRPT 264

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 82
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 83  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 141
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 199
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 200 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 259
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 260 RPEDRPT 266

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 134/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 40  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 93
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 94  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 148
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ ++
Sbjct: 149 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 268
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 269 MKRLMAECLKKKRDERPLFPQIL 291

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 73  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTI 189
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 250 RPEDRPT 256

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 77
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 78  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 136
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 194
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 195 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 254
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 255 RPEDRPT 261

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 79  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 137
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 195
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 255
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 256 RPEDRPT 262

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 74
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 75  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 133
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTI 191
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 192 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 251
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 252 RPEDRPT 258

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 135/263 (51%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 94
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 95  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 149
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLA----KATTMNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+ ++
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 269
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 270 MKRLMAECLKKKRDERPLFPQIL 292

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 74  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 132
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTI 190
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 191 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 250
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 251 RPEDRPT 257

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 134/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 94
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 95  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 149
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ ++
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 269
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 270 MKRLMAECLKKKRDERPLFPQIL 292

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 134/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 15  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 68
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 69  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 123
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ ++
Sbjct: 124 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 243
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 244 MKRLMAECLKKKRDERPLFPQIL 266

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 135/263 (51%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 33  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 86
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 87  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 141
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLA----KATTMNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+ ++
Sbjct: 142 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 261
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 262 MKRLMAECLKKKRDERPLFPQIL 284

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 73  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT--FTI 189
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 250 RPEDRPT 256

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 67
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 68  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 126
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 184
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 185 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 244
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 245 RPEDRPT 251

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 73  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 189
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 250 RPEDRPT 256

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 134/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 71
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 72  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 126
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ ++
Sbjct: 127 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 246
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 247 MKRLMAECLKKKRDERPLFPQIL 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 134/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 66
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 67  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ ++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 242 MKRLMAECLKKKRDERPLFPQIL 264

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 135/263 (51%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 66
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 67  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLA----KATTMNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+ ++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 242 MKRLMAECLKKKRDERPLFPQIL 264

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 9/207 (4%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NI+Q   T +     F+  +L+ KG L + L +K  L + +     R +L  +  LH+
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVV----NLK 450
            N+VHRD+K  NIL+D   ++KL DFG + +      ++S  GTP ++APE++    N  
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDN 202
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARD 507
           + GYG   D+WS G  +  +L   PP+ H + M  L  I  G         +  S   +D
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKR 534
            + + L V P  R TA + + HPF ++
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 134/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 71
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 72  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 126
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ ++
Sbjct: 127 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 246
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 247 MKRLMAECLKKKRDERPLFPQIL 269

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 134/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 66
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAY-----TRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H+++++          RQ   G++YLH
Sbjct: 67  LLFMGYSTAPQ-----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ ++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           ++  Y   +D+++ G  + E++T Q PYS++    Q +F +G+G   P L  V ++  + 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP   Q++
Sbjct: 242 MKRLMAECLKKKRDERPLFPQIL 264

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 77/212 (36%), Positives = 113/212 (53%), Gaps = 19/212 (8%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYL 393
           +H NI+       D   +++  EL+  G L +  L QK+   + + SA    I   + YL
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYL 132
Query: 394 HEQNVVHRDIKCANIL-VDASG---SVKLADFGLAKATTMND---VKSCKGTPFWMAPEV 446
           H Q VVHRD+K +NIL VD SG   S+++ DFG AK     +   +  C    F +APEV
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF-VAPEV 191
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKGEPPLVP---NS 500
             L+ +GY    DIWSLG  +  MLT   P+++       + L RIG G+  L     NS
Sbjct: 192 --LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +S  A+D + K L V+P+ R TAA ++ HP++
Sbjct: 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 132/274 (48%), Gaps = 12/274 (4%)
Query: 275 RIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXX 330
            I ++Q  + LG GSFG V   Y T  G   A+K ++   L     QG+           
Sbjct: 2   HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL- 60
Query: 331 XXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGL 390
                 H +I++ +   K ++ + + +E         + Q+  + + +   + +QI++ +
Sbjct: 61  ----LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 116
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNL 449
            Y H   +VHRD+K  N+L+D   +VK+ADFGL+   T  N +K+  G+P + APEV++ 
Sbjct: 117 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG 176
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
           K    G   D+WS G  +  ML R+ P+   E +  LF+        +P  LS  A   I
Sbjct: 177 KLYA-GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLI 234
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
            + L VNP +R +  ++M+  + K  L +   PP
Sbjct: 235 KRMLIVNPLNRISIHEIMQDDWFKVDLPEYLLPP 268

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 132/274 (48%), Gaps = 12/274 (4%)
Query: 275 RIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXX 330
            I ++Q  + LG GSFG V   Y T  G   A+K ++   L     QG+           
Sbjct: 6   HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL- 64
Query: 331 XXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGL 390
                 H +I++ +   K ++ + + +E         + Q+  + + +   + +QI++ +
Sbjct: 65  ----LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNL 449
            Y H   +VHRD+K  N+L+D   +VK+ADFGL+   T  N +K+  G+P + APEV++ 
Sbjct: 121 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG 180
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
           K    G   D+WS G  +  ML R+ P+   E +  LF+        +P  LS  A   I
Sbjct: 181 KLYA-GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLI 238
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
            + L VNP +R +  ++M+  + K  L +   PP
Sbjct: 239 KRMLIVNPLNRISIHEIMQDDWFKVDLPEYLLPP 272

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 124/284 (43%), Gaps = 19/284 (6%)
Query: 283 ELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E LG GSFG V  G  D   G   +V    L+                       +H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++ +G       + +  EL   GSL +  +K+  H +   +S Y  Q+  G+ YL  +  
Sbjct: 78  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 136
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRG 453
           +HRD+   N+L+     VK+ DFGL +A   ND    ++  +  PF W APE  +LK R 
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE--SLKTRT 194
Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILK 511
           +   +D W  G T+ EM T  Q P+  L G Q L +I K GE    P    +D  + +++
Sbjct: 195 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 254
Query: 512 CLQVNPNDRPTAAQLME-----HPFVKRPLQKSRGPPSYYNNMH 550
           C    P DRPT   L +      P   R LQ    P   +  M+
Sbjct: 255 CWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEEPDKLHIQMN 298

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 118/264 (44%), Gaps = 14/264 (5%)
Query: 283 ELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E LG GSFG V  G  D   G   +V    L+                       +H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++ +G       + +  EL   GSL +  +K+  H +   +S Y  Q+  G+ YL  +  
Sbjct: 84  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRG 453
           +HRD+   N+L+     VK+ DFGL +A   ND    ++  +  PF W APE  +LK R 
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE--SLKTRT 200
Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILK 511
           +   +D W  G T+ EM T  Q P+  L G Q L +I K GE    P    +D  + +++
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 260
Query: 512 CLQVNPNDRPTAAQLMEHPFVKRP 535
           C    P DRPT   L +     +P
Sbjct: 261 CWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 110/208 (52%), Gaps = 8/208 (3%)
Query: 334 RFEHENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLN 391
           + +H N+V+      D +E+ L++  ELV +G +  +     L + Q   Y + ++ G+ 
Sbjct: 92  KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIE 151
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNL 449
           YLH Q ++HRDIK +N+LV   G +K+ADFG++     +D  + +  GTP +MAPE ++ 
Sbjct: 152 YLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSE 211
Query: 450 KNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS--LSRDAR 506
             + + G   D+W++G T+   +  Q P+   E +  L    K +    P+   ++ D +
Sbjct: 212 TRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLK 270
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           D I + L  NP  R    ++  HP+V R
Sbjct: 271 DLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 120/249 (48%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I +E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 80  AVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAA-LYGR-FTIKS 196
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 252
Query: 514 QVNPNDRPT 522
           + +P +RPT
Sbjct: 253 RKDPEERPT 261

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 118/264 (44%), Gaps = 14/264 (5%)
Query: 283 ELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E LG GSFG V  G  D   G   +V    L+                       +H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++ +G       + +  EL   GSL +  +K+  H +   +S Y  Q+  G+ YL  +  
Sbjct: 84  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRG 453
           +HRD+   N+L+     VK+ DFGL +A   ND    ++  +  PF W APE  +LK R 
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE--SLKTRT 200
Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILK 511
           +   +D W  G T+ EM T  Q P+  L G Q L +I K GE    P    +D  + +++
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 260
Query: 512 CLQVNPNDRPTAAQLMEHPFVKRP 535
           C    P DRPT   L +     +P
Sbjct: 261 CWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 129/269 (47%), Gaps = 15/269 (5%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           +Q+ + LGSG++G V      D      + + +  + +                   +H 
Sbjct: 39  YQRVKKLGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           NI++ +   +D+   ++ +E    G L + +  +    +   +   +Q+L+G+ YLH+ N
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 398 VVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           +VHRD+K  N+L+++      +K+ DFGL+        +K   GT +++APEV+  K   
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--- 213
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG----EPPLVPNSLSRDARDFI 509
           Y    D+WS+G  +  +L   PP+      + L ++ KG    + P   N +S  A+D I
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN-VSEGAKDLI 272
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
            + LQ +   R +A Q +EHP++K    K
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSK 301

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 115/255 (45%), Gaps = 14/255 (5%)
Query: 283 ELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E LG GSFG V  G  D   G   +V    L+                       +H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++ +G       + +  EL   GSL +  +K+  H +   +S Y  Q+  G+ YL  +  
Sbjct: 74  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRG 453
           +HRD+   N+L+     VK+ DFGL +A   ND    ++  +  PF W APE  +LK R 
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE--SLKTRT 190
Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILK 511
           +   +D W  G T+ EM T  Q P+  L G Q L +I K GE    P    +D  + +++
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 250
Query: 512 CLQVNPNDRPTAAQL 526
           C    P DRPT   L
Sbjct: 251 CWAHKPEDRPTFVAL 265

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 9/207 (4%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NI+Q   T +     F+  +L+ KG L + L +K  L + +     R +L  +  LH+
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVV----NLK 450
            N+VHRD+K  NIL+D   ++KL DFG + +      ++   GTP ++APE++    N  
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARD 507
           + GYG   D+WS G  +  +L   PP+ H + M  L  I  G         +  S   +D
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKR 534
            + + L V P  R TA + + HPF ++
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 119/247 (48%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G FG V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 68
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 69  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 127
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HR+++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE +N     + +
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 185
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 186 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 245
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 246 RPEDRPT 252

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 120/249 (48%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I +E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 80  AVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 196
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 252
Query: 514 QVNPNDRPT 522
           + +P +RPT
Sbjct: 253 RKDPEERPT 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 115/255 (45%), Gaps = 14/255 (5%)
Query: 283 ELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E LG GSFG V  G  D   G   +V    L+                       +H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++ +G       + +  EL   GSL +  +K+  H +   +S Y  Q+  G+ YL  +  
Sbjct: 74  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRG 453
           +HRD+   N+L+     VK+ DFGL +A   ND    ++  +  PF W APE  +LK R 
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE--SLKTRT 190
Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILK 511
           +   +D W  G T+ EM T  Q P+  L G Q L +I K GE    P    +D  + +++
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 250
Query: 512 CLQVNPNDRPTAAQL 526
           C    P DRPT   L
Sbjct: 251 CWAHKPEDRPTFVAL 265

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 127/263 (48%), Gaps = 25/263 (9%)
Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEV----SLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E+LGSG+F  V+       G  FA+K +    + +D   + +              + +H
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK---------KIKH 65
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           ENIV      +     ++ ++LV+ G L + + ++    +   S   +Q+L+ + YLHE 
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 397 NVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
            +VHRD+K  N+L    + +  + + DFGL+K      + +  GTP ++APEV  L  + 
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV--LAQKP 183
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG----EPPLVPNSLSRDARDFI 509
           Y    D WS+G     +L   PP+      +   +I +G    E P   + +S  A+DFI
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW-DDISESAKDFI 242
Query: 510 LKCLQVNPNDRPTAAQLMEHPFV 532
              L+ +PN+R T  + + HP++
Sbjct: 243 CHLLEKDPNERYTCEKALSHPWI 265

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 9/207 (4%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NI+Q   T +     F+  +L+ KG L + L +K  L + +     R +L  +  LH+
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVV----NLK 450
            N+VHRD+K  NIL+D   ++KL DFG + +      ++   GTP ++APE++    N  
Sbjct: 130 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 189
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARD 507
           + GYG   D+WS G  +  +L   PP+ H + M  L  I  G         +  S   +D
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 249
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKR 534
            + + L V P  R TA + + HPF ++
Sbjct: 250 LVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 115/255 (45%), Gaps = 14/255 (5%)
Query: 283 ELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E LG GSFG V  G  D   G   +V    L+                       +H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++ +G       + +  EL   GSL +  +K+  H +   +S Y  Q+  G+ YL  +  
Sbjct: 74  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRG 453
           +HRD+   N+L+     VK+ DFGL +A   ND    ++  +  PF W APE  +LK R 
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE--SLKTRT 190
Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILK 511
           +   +D W  G T+ EM T  Q P+  L G Q L +I K GE    P    +D  + +++
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 250
Query: 512 CLQVNPNDRPTAAQL 526
           C    P DRPT   L
Sbjct: 251 CWAHKPEDRPTFVAL 265

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 115/255 (45%), Gaps = 14/255 (5%)
Query: 283 ELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           E LG GSFG V  G  D   G   +V    L+                       +H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++ +G       + +  EL   GSL +  +K+  H +   +S Y  Q+  G+ YL  +  
Sbjct: 78  IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 136
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRG 453
           +HRD+   N+L+     VK+ DFGL +A   ND    ++  +  PF W APE  +LK R 
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE--SLKTRT 194
Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDARDFILK 511
           +   +D W  G T+ EM T  Q P+  L G Q L +I K GE    P    +D  + +++
Sbjct: 195 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 254
Query: 512 CLQVNPNDRPTAAQL 526
           C    P DRPT   L
Sbjct: 255 CWAHKPEDRPTFVAL 269

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 117/212 (55%), Gaps = 14/212 (6%)
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHE 395
           V ++G    E  ++I +EL+   SL   Y++       + +  +      I+  L +LH 
Sbjct: 113 VTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 396 Q-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC-KGTPFWMAPEVVN--LKN 451
           + +V+HRD+K +N+L++A G VK+ DFG++     +  K+   G   +MAPE +N  L  
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGKGEPPLVP-NSLSRDARDFI 509
           +GY + +DIWSLG T++E+   + PY S     Q L ++ +   P +P +  S +  DF 
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
            +CL+ N  +RPT  +LM+HPF    L +S+G
Sbjct: 292 SQCLKKNSKERPTYPELMQHPFFT--LHESKG 321

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 130/266 (48%), Gaps = 13/266 (4%)
Query: 279 WQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FE 336
           ++ GE LGSG F  V +      G  +A K +  +   +  +              R   
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NI+      +++  + + LELV+ G L + L +K  L + + + + +QIL+G++YLH 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
           + + H D+K  NI L+D +     +KL DFG+A K    N+ K+  GTP ++APE+VN +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD---ARD 507
               GL AD+WS+G     +L+   P+      + L  I            S     A+D
Sbjct: 187 --PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVK 533
           FI + L  +P  R T AQ +EH ++K
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 134/284 (47%), Gaps = 13/284 (4%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           R +I  +  G+ LG G+FG V  G  +  G   AVK   L  Q  +              
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK--ILNRQKIRSLDVVGKIRREIQN 69
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGL 390
              F H +I++ +      + +F+ +E V+ G L +   K   +D + S    +QIL+G+
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPFWMAPEVVN 448
           +Y H   VVHRD+K  N+L+DA  + K+ADFGL+   +  +    SC G+P + APEV++
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC-GSPNYAAPEVIS 188
Query: 449 LKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
              R Y G   DIWS G  +  +L    P+   + +  LF+         P  L+     
Sbjct: 189 --GRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLNPSVIS 245
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP--PSYYNNM 549
            +   LQV+P  R T   + EH + K+ L K   P  PSY + M
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTM 289

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 112/211 (53%), Gaps = 21/211 (9%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 458 ADIWSLGCTVLEMLT-------------RQPPYSHLEGMQALFRIGKGEPPLVPNSL-SR 503
           +DIWS+G +++EM                +PP +  E    L  I    PP +P+ + S 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFE---LLDYIVNEPPPKLPSGVFSL 240
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           + +DF+ KCL  NP +R    QLM H F+KR
Sbjct: 241 EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 119/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 80  AVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 196
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 252
Query: 514 QVNPNDRPT 522
           + +P +RPT
Sbjct: 253 RKDPEERPT 261

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 11/262 (4%)
Query: 276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           I  ++ G  LG G FG VY        F    +V  + Q  + +                
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ-IEKEGVEHQLRREIEIQAHL 80
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLH 394
            H NI++ +    D  R+++ LE   +G L    QK    D Q +A    ++ + L Y H
Sbjct: 81  HHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
            + V+HRDIK  N+L+   G +K+ADFG +        K+  GT  ++ PE++  + R +
Sbjct: 141 GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMI--EGRMH 198
Query: 455 GLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
               D+W +G    E+L   PP+   SH E  + + ++    P  VP      A+D I K
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTG----AQDLISK 254
Query: 512 CLQVNPNDRPTAAQLMEHPFVK 533
            L+ NP++R   AQ+  HP+V+
Sbjct: 255 LLRHNPSERLPLAQVSAHPWVR 276

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 285 LGSGSFGTVYEG--YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           +G G++G V++     + G F A+K V +Q                      FEH N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 343 YFG------TDKDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYL 393
            F       TD+ E +L +  E V +  L     K     +    +     Q+L GL++L
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNR 452
           H   VVHRD+K  NILV +SG +KLADFGLA+  +    + S   T ++ APEV  L   
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV--LLQS 194
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI----------------------- 489
            Y    D+WS+GC   EM  R+P +     +  L +I                       
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 254
Query: 490 -GKGEPPL--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             K   P+      +    +D +LKCL  NP  R +A   + HP+ +
Sbjct: 255 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 285 LGSGSFGTVYEG--YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           +G G++G V++     + G F A+K V +Q                      FEH N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 343 YFG------TDKDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYL 393
            F       TD+ E +L +  E V +  L     K     +    +     Q+L GL++L
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNR 452
           H   VVHRD+K  NILV +SG +KLADFGLA+  +    + S   T ++ APEV  L   
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV--LLQS 194
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI----------------------- 489
            Y    D+WS+GC   EM  R+P +     +  L +I                       
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 254
Query: 490 -GKGEPPL--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             K   P+      +    +D +LKCL  NP  R +A   + HP+ +
Sbjct: 255 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 285 LGSGSFGTVYEG--YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           +G G++G V++     + G F A+K V +Q                      FEH N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 343 YFG------TDKDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYL 393
            F       TD+ E +L +  E V +  L     K     +    +     Q+L GL++L
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNR 452
           H   VVHRD+K  NILV +SG +KLADFGLA+  +    + S   T ++ APEV  L   
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV--LLQS 194
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI----------------------- 489
            Y    D+WS+GC   EM  R+P +     +  L +I                       
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 254
Query: 490 -GKGEPPL--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             K   P+      +    +D +LKCL  NP  R +A   + HP+ +
Sbjct: 255 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 119/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 70
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 71  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 129
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 187
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 243
Query: 514 QVNPNDRPT 522
           + +P +RPT
Sbjct: 244 RKDPEERPT 252

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 120/250 (48%), Gaps = 26/250 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               +E  ++I  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VH
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIK 195
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQC 251
Query: 513 LQVNPNDRPT 522
            + +P +RPT
Sbjct: 252 WRKDPEERPT 261

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 119/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 68
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 69  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 127
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 185
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 241
Query: 514 QVNPNDRPT 522
           + +P +RPT
Sbjct: 242 RKDPEERPT 250

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 90
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM-LNSKG 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 269 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 327

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 91
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM-LNSKG 209
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 269
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 270 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 328

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 120/250 (48%), Gaps = 26/250 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKIRHEKLVQLY 79
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               +E  ++I  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VH
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + 
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIK 195
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQC 251
Query: 513 LQVNPNDRPT 522
            + +P +RPT
Sbjct: 252 WRKDPEERPT 261

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 118/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 329 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 445
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 501
Query: 514 QVNPNDRPT 522
           +  P +RPT
Sbjct: 502 RKEPEERPT 510

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 86
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 204
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYL 264
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 265 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 323

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 135/265 (50%), Gaps = 22/265 (8%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEV-SLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           +G G++G+V +  +   G   AVK + S  D+  Q +               +    IVQ
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY----IVQ 85
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK-YHLMDSQV-----SAYTRQILNGLNYLHEQ 396
           ++G    E   +I +EL++  S    Y+  Y ++D  +        T   +  LN+L E 
Sbjct: 86  FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 397 -NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-CKGTPFWMAPEVVN--LKNR 452
             ++HRDIK +NIL+D SG++KL DFG++     +  K+   G   +MAPE ++     +
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKGEPPLVPNSLSRDAR----D 507
           GY + +D+WSLG T+ E+ T + PY     +   L ++ KG+PP + NS  R+      +
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFIN 264
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFV 532
           F+  CL  + + RP   +L++HPF+
Sbjct: 265 FVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 88
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 206
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 266
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 267 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 325

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 86
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 204
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 265 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 323

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILL----RFRHENIIGI 90
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 269 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 327

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 90
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 269 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 327

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/224 (35%), Positives = 117/224 (52%), Gaps = 22/224 (9%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYL 393
           +H NI+       D   +++  EL+  G L +  L QK+   + + S     I   + YL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 394 HEQNVVHRDIKCANIL-VDASGS---VKLADFGLAKATTMND---VKSCKGTPFWMAPEV 446
           H Q VVHRD+K +NIL VD SG+   +++ DFG AK     +   +  C    F +APEV
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF-VAPEV 196
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKGEPPLVP---NS 500
             LK +GY    DIWSLG  +  ML    P+++       + L RIG G+  L     N+
Sbjct: 197 --LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           +S  A+D + K L V+P+ R TA Q+++HP+V    QK + P S
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVT---QKDKLPQS 295

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 86
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 204
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 265 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 323

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 94
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 212
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 213 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 272
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 273 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 331

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 86
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 204
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 265 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 323

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/224 (35%), Positives = 117/224 (52%), Gaps = 22/224 (9%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYL 393
           +H NI+       D   +++  EL+  G L +  L QK+   + + S     I   + YL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 394 HEQNVVHRDIKCANIL-VDASGS---VKLADFGLAKATTMND---VKSCKGTPFWMAPEV 446
           H Q VVHRD+K +NIL VD SG+   +++ DFG AK     +   +  C    F +APEV
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF-VAPEV 196
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKGEPPLVP---NS 500
             LK +GY    DIWSLG  +  ML    P+++       + L RIG G+  L     N+
Sbjct: 197 --LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           +S  A+D + K L V+P+ R TA Q+++HP+V    QK + P S
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVT---QKDKLPQS 295

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 116/212 (54%), Gaps = 14/212 (6%)
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHE 395
           V ++G    E  ++I +EL+   SL   Y++       + +  +      I+  L +LH 
Sbjct: 69  VTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 396 Q-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC-KGTPFWMAPEVVN--LKN 451
           + +V+HRD+K +N+L++A G VK+ DFG++     +  K    G   +MAPE +N  L  
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGKGEPPLVP-NSLSRDARDFI 509
           +GY + +DIWSLG T++E+   + PY S     Q L ++ +   P +P +  S +  DF 
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
            +CL+ N  +RPT  +LM+HPF    L +S+G
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFT--LHESKG 277

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 91
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 209
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 269
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 270 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 328

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 92
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 210
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 211 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 270
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 271 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 329

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 83
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 201
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 202 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 261
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 262 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 320

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 90
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 269 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 327

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 119/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I +E ++KG L +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 80  AVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 196
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 252
Query: 514 QVNPNDRPT 522
           + +P +RPT
Sbjct: 253 RKDPEERPT 261

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 84
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 202
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYL 262
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 263 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 321

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 118/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 72
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 73  AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 131
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 189
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 245
Query: 514 QVNPNDRPT 522
           +  P +RPT
Sbjct: 246 RKEPEERPT 254

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 84
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 202
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 262
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 263 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 321

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 106
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 224
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 284
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 285 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 343

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 86
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 146 LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 204
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYL 264
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 265 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 323

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 129/267 (48%), Gaps = 12/267 (4%)
Query: 275 RIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXX 330
            I ++Q  + LG GSFG V   Y T  G   A+K ++   L     QG+           
Sbjct: 12  HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL- 70
Query: 331 XXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGL 390
                 H +I++ +   K ++ + + +E         + Q+  + + +   + +QI++ +
Sbjct: 71  ----LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 126
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNL 449
            Y H   +VHRD+K  N+L+D   +VK+ADFGL+   T  N +K+  G+P + APEV++ 
Sbjct: 127 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG 186
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
           K    G   D+WS G  +  ML R+ P+   E +  LF+        +P  LS  A   I
Sbjct: 187 KLYA-GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLI 244
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPL 536
            + L VNP +R +  ++M+  + K  L
Sbjct: 245 KRMLIVNPLNRISIHEIMQDDWFKVDL 271

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 118/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 76
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E + KGSL +  +     +L   Q+   + QI +G+ Y+   N VHR
Sbjct: 77  AVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 193
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 249
Query: 514 QVNPNDRPT 522
           +  P +RPT
Sbjct: 250 RKEPEERPT 258

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 129/267 (48%), Gaps = 12/267 (4%)
Query: 275 RIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXX 330
            I ++Q  + LG GSFG V   Y T  G   A+K ++   L     QG+           
Sbjct: 11  HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL- 69
Query: 331 XXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGL 390
                 H +I++ +   K ++ + + +E         + Q+  + + +   + +QI++ +
Sbjct: 70  ----LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV 125
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNL 449
            Y H   +VHRD+K  N+L+D   +VK+ADFGL+   T  N +K+  G+P + APEV++ 
Sbjct: 126 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG 185
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
           K    G   D+WS G  +  ML R+ P+   E +  LF+        +P  LS  A   I
Sbjct: 186 KLYA-GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLI 243
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPL 536
            + L VNP +R +  ++M+  + K  L
Sbjct: 244 KRMLIVNPLNRISIHEIMQDDWFKVDL 270

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 134/285 (47%), Gaps = 45/285 (15%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   Y    G   AVK++S   +  Q                  +HEN++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 115
Query: 344 F-----GTDKDE-NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                  T  +E N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 116 LDVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 174
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y +T
Sbjct: 175 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNMT 232
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFRIGKGEPP--LVPNSLSRDARDFI--- 509
            DIWS+GC + E+LT +   P   H+  +Q + R+  G PP  ++    S +AR++I   
Sbjct: 233 VDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRL-TGTPPASVISRMPSHEARNYINSL 291
Query: 510 -----------------------LKCLQVNPNDRPTAAQLMEHPF 531
                                   K L ++ + R TA++ + HP+
Sbjct: 292 PQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPY 336

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 118/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 76
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E + KGSL +  +     +L   Q+   + QI +G+ Y+   N VHR
Sbjct: 77  AVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAA-LYGR-FTIKS 193
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 249
Query: 514 QVNPNDRPT 522
           +  P +RPT
Sbjct: 250 RKEPEERPT 258

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 90
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 269 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 327

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 129/278 (46%), Gaps = 18/278 (6%)
Query: 283 ELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LGSG+FG V+       G  F  K ++     T                 +  H  ++
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLI 111
Query: 342 QYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
                 +D+  + + LE ++ G L +    + Y + +++V  Y RQ   GL ++HE ++V
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 171
Query: 400 HRDIKCANILVDA--SGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGYGL 456
           H DIK  NI+ +   + SVK+ DFGLA     ++ VK    T  + APE+V+      G 
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGF 229
Query: 457 TADIWSLGCTVLEMLTRQPPYS---HLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
             D+W++G     +L+   P++    LE +Q + R          +S+S +A+DFI   L
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289
Query: 514 QVNPNDRPTAAQLMEHPFVK--RPLQKSRGPPSYYNNM 549
           Q  P  R T    +EHP++K       SR P S YN +
Sbjct: 290 QKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI 327

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 133/271 (49%), Gaps = 22/271 (8%)
Query: 283 ELLGSGSFGTVY-----EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           ++LG+G++G V+      G+ D G  +A+K +       + K                + 
Sbjct: 60  KVLGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
             +V      + E +L + L+ +  G L  +L Q+    + +V  Y  +I+  L +LH+ 
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRG 453
            +++RDIK  NIL+D++G V L DFGL+K    ++ +      GT  +MAP++V   + G
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALF--RIGKGEPPLVPNSLSRDARDF 508
           +    D WSLG  + E+LT   P++ ++G    QA    RI K EPP  P  +S  A+D 
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRILKSEPP-YPQEMSALAKDL 296
Query: 509 ILKCLQVNPNDR-----PTAAQLMEHPFVKR 534
           I + L  +P  R       A ++ EH F ++
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               +E  ++I  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VH
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIK 361
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQC 417
Query: 513 LQVNPNDRPT 522
            +  P +RPT
Sbjct: 418 WRKEPEERPT 427

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               +E  ++I  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VH
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+  ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + 
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIK 195
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQC 251
Query: 513 LQVNPNDRPT 522
            + +P +RPT
Sbjct: 252 WRKDPEERPT 261

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               +E  ++I  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VH
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIK 361
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQC 417
Query: 513 LQVNPNDRPT 522
            +  P +RPT
Sbjct: 418 WRKEPEERPT 427

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A++++S  +  T  +              RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 90
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 269 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 327

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/212 (35%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYL 393
           +H NI+       D   +++  EL   G L +  L QK+   + + SA    I   + YL
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVLFTITKTVEYL 132
Query: 394 HEQNVVHRDIKCANIL-VDASG---SVKLADFGLAKATTMND---VKSCKGTPFWMAPEV 446
           H Q VVHRD+K +NIL VD SG   S+++ DFG AK     +      C    F +APEV
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANF-VAPEV 191
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKGEPPLVP---NS 500
             L+ +GY    DIWSLG  +   LT   P+++       + L RIG G+  L     NS
Sbjct: 192 --LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +S  A+D + K L V+P+ R TAA ++ HP++
Sbjct: 250 VSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E ++KG L +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIKS 196
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 252
Query: 514 QVNPNDRPT 522
           + +P +RPT
Sbjct: 253 RKDPEERPT 261

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 47/299 (15%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +              RF HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL----RFRHENIIGI 106
Query: 344 FGTDK----DENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
               +    ++ +    +  +    L  L +  HL +  +  +  QIL GL Y+H  NV+
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVL 166
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRGY 454
           HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++GY
Sbjct: 167 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKGY 225
Query: 455 GLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI---------------------- 489
             + DIWS+GC + EML+ +P +    +L+ +  +  I                      
Sbjct: 226 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 285
Query: 490 ---GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
               K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++++    S  P
Sbjct: 286 SLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 343

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 279 WQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FE 336
           ++ GE LGSG F  V +      G  +A K +  +   +  +              R   
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NI+      +++  + + LELV+ G L + L +K  L + + + + +QIL+G++YLH 
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
           + + H D+K  NI L+D +     +KL DFG+A K    N+ K+  GTP ++APE+VN +
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 193
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD---ARD 507
               GL AD+WS+G     +L+   P+      + L  I            S     A+D
Sbjct: 194 --PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 251
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVK 533
           FI + L  +P  R   AQ +EH ++K
Sbjct: 252 FIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 117/249 (46%), Gaps = 24/249 (9%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 69
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  + I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N VHR
Sbjct: 70  AVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 128
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAA-LYGR-FTIKS 186
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKCL 513
           D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C 
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCW 242
Query: 514 QVNPNDRPT 522
           +  P +RPT
Sbjct: 243 RKEPEERPT 251

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +   + + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               +E  ++I  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VH
Sbjct: 246 AVVSEEP-IYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE   L  R + + 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIK 361
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQC 417
Query: 513 LQVNPNDRPT 522
            +  P +RPT
Sbjct: 418 WRKEPEERPT 427

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FE 336
           ++ GE LGSG F  V +      G  +A K +  +   +  +              R   
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NI+      +++  + + LELV+ G L + L +K  L + + + + +QIL+G++YLH 
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
           + + H D+K  NI L+D +     +KL DFG+A K    N+ K+  GTP ++APE+VN +
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 207
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD---ARD 507
               GL AD+WS+G     +L+   P+      + L  I            S     A+D
Sbjct: 208 --PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 265
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVK 533
           FI + L  +P  R   AQ +EH ++K
Sbjct: 266 FIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 139/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +               F HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLA----FRHENIIGI 88
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 206
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---------SHLEGM-----QALFRIG--------- 490
           Y  + DIWS+GC + EML+ +P +         +H+ G+     Q     G         
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYL 266
Query: 491 -----KGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++ +    S  P
Sbjct: 267 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEP 325

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 119/250 (47%), Gaps = 26/250 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G FG V+ G  +     A+K +        G               +  HE +VQ +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK------PGNMSPEAFLQEAQVMKKLRHEKLVQLY 246
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
               +E  ++I  E ++KGSL +  +    KY L   Q+     QI +G+ Y+   N VH
Sbjct: 247 AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 304
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD++ ANILV  +   K+ADFGL +    N+  + +G  F   W APE   L  R + + 
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAA-LYGR-FTIK 362
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + +C
Sbjct: 363 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQC 418
Query: 513 LQVNPNDRPT 522
            + +P +RPT
Sbjct: 419 WRKDPEERPT 428

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 117/247 (47%), Gaps = 16/247 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E LG+G  G V+ GY +     AVK +       QG               + +H+ +V+
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+N +
Sbjct: 73  LYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD++ ANILV  + S K+ADFGLA+     +  + +G  F   W APE +N     + +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT--FTI 189
Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C + 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249
Query: 516 NPNDRPT 522
            P DRPT
Sbjct: 250 RPEDRPT 256

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 19/270 (7%)
Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           ++  E++G G+F  V      + G  FAVK V +    +                   +H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNY 392
            +IV+   T   +  L++  E +    L     K     +   ++  S Y RQIL  L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 393 LHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVV 447
            H+ N++HRD+K  N+L+   + S  VKL DFG+A     + + +    GTP +MAPEVV
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSR 503
             K   YG   D+W  G  +  +L+   P+   +  + LF  I KG+  + P   + +S 
Sbjct: 206 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSHISE 261
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            A+D + + L ++P +R T  + + HP++K
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +   + + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++G V   Y + +    A+K++S  +  T  +               F HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLA----FRHENIIGI 88
Query: 344 FG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+ +  L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +      +     T ++ APE++ L ++G
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 206
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--------------------- 489
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I                     
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 266
Query: 490 ----GKGEPP---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
                K + P   L PN+ S+ A D + K L  NP+ R    Q + HP++ +    S  P
Sbjct: 267 LSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEP 325

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 192 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 248
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 119/245 (48%), Gaps = 13/245 (5%)
Query: 283 ELLGSGSFGTVY----EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           ++LG GSFG V+        D G  +A+K +    + T                    H 
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK---KATLKVRDRVRTKMERDILADVNHP 90
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            +V+     + E +L++ L+ +  G L   L ++    +  V  Y  ++  GL++LH   
Sbjct: 91  FVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLG 150
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGYG 455
           +++RD+K  NIL+D  G +KL DFGL+K    ++ K  S  GT  +MAPEVVN   +G+ 
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN--RQGHS 208
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +AD WS G  + EMLT   P+   +  + +  I K +  + P  LS +A+  +    + 
Sbjct: 209 HSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGM-PQFLSTEAQSLLRALFKR 267
Query: 516 NPNDR 520
           NP +R
Sbjct: 268 NPANR 272

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           R  H NI++     +    + + LELVT G L + + +K +  +   +   +QIL  + Y
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 393 LHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVN 448
           LHE  +VHRD+K  N+L         +K+ADFGL+K      + K+  GTP + APE+  
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI-- 221
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGEPPLVP---NSLSRD 504
           L+   YG   D+WS+G     +L    P+    G Q +F RI   E   +    + +S +
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           A+D + K + ++P  R T  Q ++HP+V
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 192 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 248
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 16/245 (6%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V+    +     AVK +        G                 +H+ +V+  
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 76
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDS---QVSAYTRQILNGLNYLHEQNVVHR 401
                E  ++I  E + KGSL +  +          ++  ++ QI  G+ ++ ++N +HR
Sbjct: 77  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV AS   K+ADFGLA+    N+  + +G  F   W APE +N  +  + + +
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 193
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           D+WS G  ++E++T  + PY  +   + +  + +G     P +   +  + +++C +  P
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 253
Query: 518 NDRPT 522
            +RPT
Sbjct: 254 EERPT 258

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 115/246 (46%), Gaps = 17/246 (6%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V+ GY ++    AVK +        G                 +H+ +V+ +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK------PGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHR 401
                E  ++I  E + KGSL +  +      ++  ++  ++ QI  G+ Y+  +N +HR
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ AN+LV  S   K+ADFGLA+    N+  + +G  F   W APE +N     + + +
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG--CFTIKS 192
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG-EPPLVPNSLSRDARDFILKCLQVN 516
           D+WS G  + E++T  + PY        +  + +G   P V N    +  D +  C +  
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENC-PDELYDIMKMCWKEK 251
Query: 517 PNDRPT 522
             +RPT
Sbjct: 252 AEERPT 257

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 9   RERI---ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQE 61
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  K+ L  + +  Y  Q+
Sbjct: 62  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 120
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV A+  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKW 178
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 179 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 236
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 237 CPPTLY----SLMTKCWAYDPSRRPRFTEL 262

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 11  RERI---ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFLQE 63
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+
Sbjct: 64  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 122
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKW 180
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 181 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 238
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 239 CPPTLY----SLMTKCWAYDPSRRPRFTEL 264

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 6   RERI---ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFLQE 58
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+
Sbjct: 59  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKW 175
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 176 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 234 CPPTLY----SLMTKCWAYDPSRRPRFTEL 259

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 37  RERI---ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFLQE 89
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+
Sbjct: 90  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 148
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKW 206
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 207 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 264
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 265 CPPTL----YSLMTKCWAYDPSRRPRFTEL 290

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 9   RERI---ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQE 61
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+
Sbjct: 62  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 120
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKW 178
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 179 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 236
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 237 CPPTLY----SLMTKCWAYDPSRRPRFTEL 262

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 12  RERI---ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFLQE 64
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+
Sbjct: 65  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 123
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 124 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKW 181
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 182 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 239
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 240 CPPTLY----SLMTKCWAYDPSRRPRFTEL 265

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 389 RERI---ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQE 441
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  K+ L  + +  Y  Q+
Sbjct: 442 ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV A+  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKW 558
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 559 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 617 CPPTLY----SLMTKCWAYDPSRRPRFTEL 642

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 9   RERI---ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFLQE 61
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+
Sbjct: 62  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 120
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKW 178
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 179 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 236
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 237 CPPTLY----SLMTKCWAYDPSRRPRFTEL 262

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 14  RERI---ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFLQE 66
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  KY L  + +  Y  Q+
Sbjct: 67  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKW 183
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 184 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 241
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 242 CPPTLY----SLMTKCWAYDPSRRPRFTEL 267

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 285 LGSGSFGTV----YEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G FG V    Y+   D  G   AVK +   D G Q +                 HE+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADCGPQHRSGWKQEIDILRT---LYHEH 77
Query: 340 IVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           I++Y G   D+ E  L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH Q+
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQH 137
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLKNR 452
            +HR++   N+L+D    VK+ DFGLAKA         V+    +P FW APE   LK  
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--LKEY 195
Query: 453 GYGLTADIWSLGCTVLEMLT-----RQPPYSHLE------GMQALFRIG----KGEPPLV 497
            +   +D+WS G T+ E+LT     + PP   LE      G   + R+     +GE    
Sbjct: 196 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 255
Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
           P+    +    +  C +   + RPT   L+  P +K   +K R
Sbjct: 256 PDKCPCEVYHLMKNCWETEASFRPTFENLI--PILKTVHEKYR 296

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 132/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 82
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSA-----YTRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H  +++          RQ   G++YLH
Sbjct: 83  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLA----KATTMNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+ ++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           +   Y   +D+++ G  + E++T Q PYS++    Q +  +G+G   P L  V ++  + 
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP+  +++
Sbjct: 258 MKRLMAECLKKKRDERPSFPRIL 280

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 131/263 (49%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 17  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 70
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSA-----YTRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H  +++          RQ   G++YLH
Sbjct: 71  LLFMGYSTKPQ-----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 125
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ ++
Sbjct: 126 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           +   Y   +D+++ G  + E++T Q PYS++    Q +  +G+G   P L  V ++  + 
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 245
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP+  +++
Sbjct: 246 MKRLMAECLKKKRDERPSFPRIL 268

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 16/245 (6%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V+    +     AVK +        G                 +H+ +V+  
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDS---QVSAYTRQILNGLNYLHEQNVVHR 401
                E  ++I  E + KGSL +  +          ++  ++ QI  G+ ++ ++N +HR
Sbjct: 250 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV AS   K+ADFGLA+    N+  + +G  F   W APE +N  +  + + +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 366
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           D+WS G  ++E++T  + PY  +   + +  + +G     P +   +  + +++C +  P
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 426
Query: 518 NDRPT 522
            +RPT
Sbjct: 427 EERPT 431

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 129/284 (45%), Gaps = 35/284 (12%)
Query: 285 LGSGSFGTV----YEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G FG V    Y+   D  G   AVK +   D G Q +                 HE+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRT---LYHEH 94
Query: 340 IVQYFGTDKDEN--RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           I++Y G  +D     L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH Q+
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLKNR 452
            +HRD+   N+L+D    VK+ DFGLAKA         V+    +P FW APE   LK  
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC--LKEY 212
Query: 453 GYGLTADIWSLGCTVLEMLT-----RQPPYSHLE------GMQALFRIG----KGEPPLV 497
            +   +D+WS G T+ E+LT     + PP   LE      G   + R+     +GE    
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272
Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
           P+    +    +  C +   + RPT   L+  P +K   +K +G
Sbjct: 273 PDKCPAEVYHLMKNCWETEASFRPTFENLI--PILKTVHEKYQG 314

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 285 LGSGSFGTV----YEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G FG V    Y+   D  G   AVK +   D G Q +                 HE+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADCGPQHRSGWKQEIDILRT---LYHEH 77
Query: 340 IVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           I++Y G   D+ E  L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH Q+
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 137
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLKNR 452
            +HR++   N+L+D    VK+ DFGLAKA         V+    +P FW APE   LK  
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--LKEY 195
Query: 453 GYGLTADIWSLGCTVLEMLT-----RQPPYSHLE------GMQALFRIG----KGEPPLV 497
            +   +D+WS G T+ E+LT     + PP   LE      G   + R+     +GE    
Sbjct: 196 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 255
Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
           P+    +    +  C +   + RPT   L+  P +K   +K R
Sbjct: 256 PDKCPCEVYHLMKNCWETEASFRPTFENLI--PILKTVHEKYR 296

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 126/262 (48%), Gaps = 13/262 (4%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           GE LGSG F  V +      G  +A K +   Q + ++                +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++      ++   + + LELV+ G L + L QK  L + + +++ +QIL+G+NYLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 399 VHRDIKCANI-LVDASG---SVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG 453
            H D+K  NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN +   
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--P 194
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  A+DFI 
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 511 KCLQVNPNDRPTAAQLMEHPFV 532
           K L      R T  + + HP++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 126/262 (48%), Gaps = 13/262 (4%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           GE LGSG F  V +      G  +A K +   Q + ++                +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++      ++   + + LELV+ G L + L QK  L + + +++ +QIL+G+NYLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 399 VHRDIKCANI-LVDASG---SVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG 453
            H D+K  NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN +   
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--P 194
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  A+DFI 
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 511 KCLQVNPNDRPTAAQLMEHPFV 532
           K L      R T  + + HP++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWI 276

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 128/265 (48%), Gaps = 18/265 (6%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSL-QDQGTQGKXXXXXXXXXXXXXXRFEH 337
           +Q+ + LGSG++G V      D    A + + + +                     + +H
Sbjct: 23  YQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLAN---LYQKYHLMDSQVSAYTRQILNGLNYLH 394
            NI++ +   +D+   ++ +E+   G L +   L QK+  +D+ V    +Q+L+G  YLH
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLSGTTYLH 138
Query: 395 EQNVVHRDIKCANILVDASGS---VKLADFGL-AKATTMNDVKSCKGTPFWMAPEVVNLK 450
           + N+VHRD+K  N+L+++      +K+ DFGL A       +K   GT +++APEV+  K
Sbjct: 139 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK 198
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARD 507
              Y    D+WS G  +  +L   PP+      + L R+ KG+    P     +S +A+ 
Sbjct: 199 ---YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQ 255
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFV 532
            +   L   P+ R +A + + HP++
Sbjct: 256 LVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 126/262 (48%), Gaps = 13/262 (4%)
Query: 282 GELLGSGSFGTVYEGYTDD-GFFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           GE LGSG F  V +      G  +A K +   Q + ++                +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           I+      ++   + + LELV+ G L + L QK  L + + +++ +QIL+G+NYLH + +
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 399 VHRDIKCANI-LVDASG---SVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG 453
            H D+K  NI L+D +     +KL DFGLA       + K+  GTP ++APE+VN +   
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--P 194
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  A+DFI 
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 511 KCLQVNPNDRPTAAQLMEHPFV 532
           K L      R T  + + HP++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWI 276

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 119/256 (46%), Gaps = 27/256 (10%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQD-----------QGTQGKXXXXXXXXXXXX 331
           ++LG GSFG V          F VK++S  D           + T               
Sbjct: 30  KVLGQGSFGKV----------FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGL 390
                H  IV+     + E +L++ L+ +  G L   L ++    +  V  Y  ++   L
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVN 448
           ++LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K  S  GT  +MAPEVVN
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
              RG+  +AD WS G  + EMLT   P+   +  + +  I K +  + P  LS +A+  
Sbjct: 200 --RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-PQFLSPEAQSL 256
Query: 509 ILKCLQVNPNDRPTAA 524
           +    + NP +R  A 
Sbjct: 257 LRMLFKRNPANRLGAG 272

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 132/263 (50%), Gaps = 28/263 (10%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q                +  H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNI 82
Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSA-----YTRQILNGLNYLH 394
           + + G           L +VT+    ++LY   H  +++          RQ   G++YLH
Sbjct: 83  LLFMGYSTAPQ-----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLA----KATTMNDVKSCKGTPFWMAPEVVNLK 450
            ++++HRD+K  NI +    +VK+ DFGLA    + +  +  +   G+  WMAPEV+ ++
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 451 NRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKG--EPPL--VPNSLSRD 504
           +   Y   +D+++ G  + E++T Q PYS++    Q +  +G+G   P L  V ++  + 
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
            +  + +CL+   ++RP+  +++
Sbjct: 258 MKRLMAECLKKKRDERPSFPRIL 280

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 23/277 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 14  KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH ++V
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 129
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGL 456
           V+RDIK  N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV  L++  YG 
Sbjct: 130 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGR 187
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ +
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 246
Query: 517 PNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           P  R       A ++MEH F      +  +QK   PP
Sbjct: 247 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 283

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 124/262 (47%), Gaps = 13/262 (4%)
Query: 282 GELLGSGSFGTVYEGYTDD-GFFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           GE LGSG F  V +      G  +A K +   Q + ++                +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++      ++   + + LELV+ G L + L QK  L + + +++ +QIL+G+NYLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 399 VHRDIKCANILVDASG----SVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG 453
            H D+K  NI++         +KL DFGLA       + K+  GTP ++APE+VN +   
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--P 194
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  A+DFI 
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 511 KCLQVNPNDRPTAAQLMEHPFV 532
           K L      R T  + + HP++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 124/262 (47%), Gaps = 13/262 (4%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSL-QDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           GE LGSG F  V +      G  +A K +   Q + ++                +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++      ++   + + LELV+ G L + L QK  L + + +++ +QIL+G+NYLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 399 VHRDIKCANILVDASG----SVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG 453
            H D+K  NI++         +KL DFGLA       + K+  GTP ++APE+VN +   
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--P 194
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  A+DFI 
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 511 KCLQVNPNDRPTAAQLMEHPFV 532
           K L      R T  + + HP++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 124/262 (47%), Gaps = 13/262 (4%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           GE LGSG F  V +      G  +A K +   Q + ++                +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++      ++   + + LELV+ G L + L QK  L + + +++ +QIL+G+NYLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 399 VHRDIKCANILVDASG----SVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRG 453
            H D+K  NI++         +KL DFGLA       + K+  GTP ++APE+VN +   
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--P 194
Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  A+DFI 
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 511 KCLQVNPNDRPTAAQLMEHPFV 532
           K L      R T  + + HP++
Sbjct: 255 KLLVKETRKRLTIQEALRHPWI 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 110/207 (53%), Gaps = 11/207 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NIV+   +  +E   ++  +LVT G L  ++  + +  ++  S   +QIL  + + 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 394 HEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVN 448
           H+  VVHRD+K  N+L+ +     +VKLADFGLA              GTP +++PEV  
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV-- 195
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDA 505
           L+   YG   D+W+ G  +  +L   PP+   +  +   +I  G    P    ++++ +A
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 255
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +D I K L +NP+ R TAA+ ++HP++
Sbjct: 256 KDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 23/277 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 11  KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH ++V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGL 456
           V+RDIK  N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV  L++  YG 
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGR 184
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 517 PNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           P  R       A ++MEH F      +  +QK   PP
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 23/277 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 11  KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH ++V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGL 456
           V+RDIK  N+++D  G +K+ DFGL K    +   +K+  GTP ++APEV  L++  YG 
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGR 184
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 517 PNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           P  R       A ++MEH F      +  +QK   PP
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 9   RERI---ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQE 61
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  K+ L  + +  Y  Q+
Sbjct: 62  ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 120
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTXXKASKGKLPIKW 178
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 179 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 236
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 237 CPPTLY----SLMTKCWAYDPSRRPRFTEL 262

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 119/256 (46%), Gaps = 27/256 (10%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQD-----------QGTQGKXXXXXXXXXXXX 331
           ++LG GSFG V          F VK++S  D           + T               
Sbjct: 31  KVLGQGSFGKV----------FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGL 390
                H  IV+     + E +L++ L+ +  G L   L ++    +  V  Y  ++   L
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVN 448
           ++LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K  S  GT  +MAPEVVN
Sbjct: 141 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
              RG+  +AD WS G  + EMLT   P+   +  + +  I K +  + P  LS +A+  
Sbjct: 201 --RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-PQFLSPEAQSL 257
Query: 509 ILKCLQVNPNDRPTAA 524
           +    + NP +R  A 
Sbjct: 258 LRMLFKRNPANRLGAG 273

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 119/256 (46%), Gaps = 27/256 (10%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQD-----------QGTQGKXXXXXXXXXXXX 331
           ++LG GSFG V          F VK++S  D           + T               
Sbjct: 30  KVLGQGSFGKV----------FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGL 390
                H  IV+     + E +L++ L+ +  G L   L ++    +  V  Y  ++   L
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVN 448
           ++LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K  S  GT  +MAPEVVN
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
              RG+  +AD WS G  + EMLT   P+   +  + +  I K +  + P  LS +A+  
Sbjct: 200 --RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-PQFLSPEAQSL 256
Query: 509 ILKCLQVNPNDRPTAA 524
           +    + NP +R  A 
Sbjct: 257 LRMLFKRNPANRLGAG 272

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 43/276 (15%)
Query: 282 GELLGSGSFG-TVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           GE+LG G FG  +   + + G    +KE+   D+ TQ                  EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC-----LEHPNV 69
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-----SAYTRQILNGLNYLHE 395
           +++ G    + RL    E +  G+L  + +    MDSQ       ++ + I +G+ YLH 
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCK-----------GTP 439
            N++HRD+   N LV  + +V +ADFGLA+      T    ++S K           G P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR------QPPYSHLEGMQALFRIGKGE 493
           +WMAPE++N   R Y    D++S G  + E++ R        P +   G+     + +  
Sbjct: 187 YWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           PP  P S         ++C  ++P  RP+  +L EH
Sbjct: 245 PPNCPPSFF----PITVRCCDLDPEKRPSFVKL-EH 275

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 56/296 (18%)
Query: 278 SWQKGELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR 334
           ++ K + LG G++ TVY+G    TD+    A+KE+ L+ +    +               
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDN--LVALKEIRLEHE----EGAPCTAIREVSLLKD 56
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTK---------GSLANLYQKYHLMDSQVSAYTRQ 385
            +H NIV        E  L +  E + K         G++ N++         V  +  Q
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN--------VKLFLFQ 108
Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAP 444
           +L GL Y H Q V+HRD+K  N+L++  G +KLADFGLA+A ++       +    W  P
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI-----GKGEPPL 496
             + L +  Y    D+W +GC   EM T +P +   +  E +  +FRI      +  P +
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 497 VPNS---------------------LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
           + N                      L  D  D + K LQ    +R +A   M+HPF
Sbjct: 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 121/251 (48%), Gaps = 27/251 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V+ GY ++    AVK +        G                 +H+ +V+ +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK------PGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHR 401
                E  ++I  E + KGSL +  +      ++  ++  ++ QI  G+ Y+  +N +HR
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ AN+LV  S   K+ADFGLA+    N+  + +G  F   W APE +N     + + +
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG--CFTIKS 191
Query: 459 DIWSLGCTVLEMLTR-QPPY---SHLEGMQAL---FRIGKGEPPLVPNSLSRDARDFILK 511
           ++WS G  + E++T  + PY   ++ + M AL   +R+ + E    P+ L     D +  
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMEN--CPDEL----YDIMKM 245
Query: 512 CLQVNPNDRPT 522
           C +    +RPT
Sbjct: 246 CWKEKAEERPT 256

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 110/207 (53%), Gaps = 11/207 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NIV+   +  +E   ++  +LVT G L  ++  + +  ++  S    QIL  +N++
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHI 146
Query: 394 HEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVN 448
           H+ ++VHRD+K  N+L+ +     +VKLADFGLA              GTP +++PEV  
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV-- 204
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDA 505
           L+   YG   DIW+ G  +  +L   PP+   +  +   +I  G    P    ++++ +A
Sbjct: 205 LRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEA 264
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
           ++ I + L +NP  R TA Q ++HP+V
Sbjct: 265 KNLINQMLTINPAKRITADQALKHPWV 291

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN---LYQKYHLMDSQVSAYTRQILNGL 390
           + +H NI++ +   +D+   ++ +E+   G L +   L QK+  +D+ V    +Q+L+G 
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLSGT 117
Query: 391 NYLHEQNVVHRDIKCANILVDASGS---VKLADFGL-AKATTMNDVKSCKGTPFWMAPEV 446
            YLH+ N+VHRD+K  N+L+++      +K+ DFGL A       +K   GT +++APEV
Sbjct: 118 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV 177
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSR 503
           +  K   Y    D+WS G  +  +L   PP+      + L R+ KG+    P     +S 
Sbjct: 178 LRKK---YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSD 234
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +A+  +   L   P+ R +A + + HP++
Sbjct: 235 EAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 23/277 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 16  KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH ++V
Sbjct: 72  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 131
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGL 456
           V+RDIK  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV  L++  YG 
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV--LEDNDYGR 189
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ +
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 248
Query: 517 PNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           P  R       A ++MEH F      +  +QK   PP
Sbjct: 249 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 285

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 105/194 (54%), Gaps = 4/194 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLM-DSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + +    +  M + +  A  RQI++ + Y H+
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T  N + +  G+P + APE+   K    
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD- 183
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L 
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKKFLI 242
Query: 515 VNPNDRPTAAQLME 528
           +NP+ R T  Q+M+
Sbjct: 243 LNPSKRGTLEQIMK 256

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 146 IIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 203
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 514 QV 515
           Q+
Sbjct: 264 QM 265

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 23/277 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 11  KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH ++V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGL 456
           V+RDIK  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV  L++  YG 
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV--LEDNDYGR 184
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 517 PNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           P  R       A ++MEH F      +  +QK   PP
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXX 328
           R RI   + G  +G G FG V++G      +     A+K      +              
Sbjct: 389 RERI---ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFLQE 441
Query: 329 XXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQI 386
                +F+H +IV+  G    EN ++I +EL T G L +  Q  K+ L  + +  Y  Q+
Sbjct: 442 ALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGT-PF-W 441
              L YL  +  VHRDI   N+LV ++  VKL DFGL++   M D    K+ KG  P  W
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKW 558
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           MAPE +N   R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP 
Sbjct: 559 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P +L       + KC   +P+ RP   +L
Sbjct: 617 CPPTLY----SLMTKCWAYDPSRRPRFTEL 642

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 105/194 (54%), Gaps = 4/194 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + + L     + + +  A  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T  N + +  G+P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD- 190
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKKFLI 249
Query: 515 VNPNDRPTAAQLME 528
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 105/194 (54%), Gaps = 4/194 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + + L     + + +  A  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T  N + +  G+P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD- 190
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKKFLI 249
Query: 515 VNPNDRPTAAQLME 528
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 23/277 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 11  KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH ++V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGL 456
           V+RDIK  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV  L++  YG 
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV--LEDNDYGR 184
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 517 PNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           P  R       A ++MEH F      +  +QK   PP
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 23/277 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 11  KLLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH ++V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGL 456
           V+RDIK  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV  L++  YG 
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV--LEDNDYGR 184
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   L+ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 517 PNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           P  R       A ++MEH F      +  +QK   PP
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 112/208 (53%), Gaps = 13/208 (6%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NIV+   +  +E   ++  +LVT G L  ++  + +  ++  S   +QIL  +N+ 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 394 HEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSC---KGTPFWMAPEVV 447
           H   +VHRD+K  N+L+ +     +VKLADFGLA      D ++     GTP +++PEV 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV- 177
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRD 504
            L+   YG   D+W+ G  +  +L   PP+   +  +   +I  G    P    ++++ +
Sbjct: 178 -LRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           A+D I K L +NP  R TA++ ++HP++
Sbjct: 237 AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 145/321 (45%), Gaps = 58/321 (18%)
Query: 256 VRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQ 314
           V ++K   ++V P          + + + +G G++G V   Y        A+K++S  + 
Sbjct: 31  VEMVKGQPFDVGPR---------YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEH 81
Query: 315 GTQGKXXXXXXXXXXXXXXRFEHENIVQ----YFGTDKDENRLFIFLELVTKGSLANLYQ 370
            T  +              RF HEN++        +  +  R    ++ + +  L  L +
Sbjct: 82  QTYCQRTLREIQILL----RFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLK 137
Query: 371 KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-ATTM 429
              L +  +  +  QIL GL Y+H  NV+HRD+K +N+L++ +  +K+ DFGLA+ A   
Sbjct: 138 SQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPE 197
Query: 430 ND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEG 482
           +D    +     T ++ APE++ L ++GY  + DIWS+GC + EML+ +P +    +L+ 
Sbjct: 198 HDHTGFLTEXVATRWYRAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 256
Query: 483 MQALFRIGKGEPP-----------------------------LVPNSLSRDARDFILKCL 513
           +  +  I  G P                              L P S S+ A D + + L
Sbjct: 257 LNHILGI-LGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSK-ALDLLDRML 314
Query: 514 QVNPNDRPTAAQLMEHPFVKR 534
             NPN R T  + + HP++++
Sbjct: 315 TFNPNKRITVEEALAHPYLEQ 335

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 105/194 (54%), Gaps = 4/194 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + + L     + + +  A  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T  N + +  G+P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD- 190
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKKFLI 249
Query: 515 VNPNDRPTAAQLME 528
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 19/259 (7%)
Query: 285 LGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG+GSFG V+   +  +G ++A+K   L+ +                      H  I++ 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMK--VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVHRD 402
           +GT +D  ++F+ ++ +  G L +L +K     + V+  Y  ++   L YLH +++++RD
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 131
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
           +K  NIL+D +G +K+ DFG AK         C GTP ++APEVV+ K   Y  + D WS
Sbjct: 132 LKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-GTPDYIAPEVVSTK--PYNKSIDWWS 188
Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARDFILKCLQVNPND 519
            G  + EML    P+     M+   +I   E   PP      + D +D + + +  + + 
Sbjct: 189 FGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FNEDVKDLLSRLITRDLSQ 244
Query: 520 RPTAAQ-----LMEHPFVK 533
           R    Q     +  HP+ K
Sbjct: 245 RLGNLQNGTEDVKNHPWFK 263

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNAMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 122/279 (43%), Gaps = 19/279 (6%)
Query: 283 ELLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LG+G+FG V+       G  FA K V      T  +                 H  +V
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTMSVLRHPTLV 111
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVV 399
                 +D+N + +  E ++ G L       H  + + +   Y RQ+  GL ++HE N V
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 400 HRDIKCANILVDA--SGSVKLADFGL-AKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           H D+K  NI+     S  +KL DFGL A       VK   GT  + APEV   K  GY  
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY-- 229
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS---LSRDARDFILKCL 513
             D+WS+G     +L+   P+      + L  +   +  +  ++   +S D +DFI K L
Sbjct: 230 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 289
Query: 514 QVNPNDRPTAAQLMEHPFV---KRPLQKSRGPPSYYNNM 549
             +PN R T  Q +EHP++     P + S+ P S Y  +
Sbjct: 290 LADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 328

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 211
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 515 V 515
           +
Sbjct: 272 M 272

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 211
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 515 V 515
           +
Sbjct: 272 M 272

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 152 IIHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 209
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 514 QV 515
           Q+
Sbjct: 270 QM 271

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 122/279 (43%), Gaps = 19/279 (6%)
Query: 283 ELLGSGSFGTVYE-GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LG+G+FG V+       G  FA K V      T  +                 H  +V
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVV 399
                 +D+N + +  E ++ G L       H  + + +   Y RQ+  GL ++HE N V
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 400 HRDIKCANILVDA--SGSVKLADFGL-AKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           H D+K  NI+     S  +KL DFGL A       VK   GT  + APEV   K  GY  
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY-- 335
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS---LSRDARDFILKCL 513
             D+WS+G     +L+   P+      + L  +   +  +  ++   +S D +DFI K L
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395
Query: 514 QVNPNDRPTAAQLMEHPFV---KRPLQKSRGPPSYYNNM 549
             +PN R T  Q +EHP++     P + S+ P S Y  +
Sbjct: 396 LADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 434

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 148 IIHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 205
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 514 QV 515
           Q+
Sbjct: 266 QM 267

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 211
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 515 V 515
           +
Sbjct: 272 M 272

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q+       + + +   R I   + +LH  N+ HRD+K  N+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 410 V---DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
               +    +KL DFG AK TT N +++   TP+++APEV  L    Y  + D+WSLG  
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGVI 199
Query: 467 VLEMLTRQPP-YSHL-----EGMQALFRIGK-GEPPLVPNSLSRDARDFILKCLQVNPND 519
           +  +L   PP YS+       GM+   R+G+ G P    + +S DA+  I   L+ +P +
Sbjct: 200 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 520 RPTAAQLMEHPFVKRPLQKSRGP 542
           R T  Q M HP++ + +   + P
Sbjct: 260 RLTITQFMNHPWINQSMVVPQTP 282

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 112/208 (53%), Gaps = 13/208 (6%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NIV+   +  +E   ++  +LVT G L  ++  + +  ++  S   +QIL  +N+ 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 394 HEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSC---KGTPFWMAPEVV 447
           H   +VHRD+K  N+L+ +     +VKLADFGLA      D ++     GTP +++PEV 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV- 177
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRD 504
            L+   YG   D+W+ G  +  +L   PP+   +  +   +I  G    P    ++++ +
Sbjct: 178 -LRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           A+D I K L +NP  R TA++ ++HP++
Sbjct: 237 AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 209
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 515 V 515
           +
Sbjct: 270 M 270

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 104/194 (53%), Gaps = 4/194 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + + L     + + +  A  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T  N +    G+P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD- 190
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKKFLI 249
Query: 515 VNPNDRPTAAQLME 528
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 129/267 (48%), Gaps = 15/267 (5%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQ-DQGTQGKXXXXXXXXXXXXXXRFE 336
           +  GE LGSG F  V +      G  +A K +  +  + ++                  +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + +  ELV  G L + L +K  L + + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 396 QNVVHRDIKCANI-LVDASG---SVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI L+D +     +K+ DFGLA K    N+ K+  GTP ++APE+VN +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG----KGEPPLVPNSLSRDAR 506
               GL AD+WS+G     +L+   P+      + L  +     + E     N+ S  A+
Sbjct: 193 --PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAK 249
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 104/194 (53%), Gaps = 4/194 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + + L     + + +  A  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T  N + +  G P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD- 190
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKKFLI 249
Query: 515 VNPNDRPTAAQLME 528
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q+       + + +   R I   + +LH  N+ HRD+K  N+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 410 V---DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
               +    +KL DFG AK TT N +++   TP+++APEV  L    Y  + D+WSLG  
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGVI 218
Query: 467 VLEMLTRQPP-YSHL-----EGMQALFRIGK-GEPPLVPNSLSRDARDFILKCLQVNPND 519
           +  +L   PP YS+       GM+   R+G+ G P    + +S DA+  I   L+ +P +
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 520 RPTAAQLMEHPFVKRPLQKSRGP 542
           R T  Q M HP++ + +   + P
Sbjct: 279 RLTITQFMNHPWINQSMVVPQTP 301

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---KPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 215
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 514 QV 515
           Q+
Sbjct: 276 QM 277

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGXVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 18/264 (6%)
Query: 284 LLGSGSFGTVYE----GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LG G +G V++       + G  FA+K V  +    +                  +H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           IV      +   +L++ LE ++ G L   L ++   M+     Y  +I   L +LH++ +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGYG 455
           ++RD+K  NI+++  G VKL DFGL K +  +   +   C GT  +MAPE+  L   G+ 
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC-GTIEYMAPEI--LMRSGHN 199
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
              D WSLG  + +MLT  PP++     + + +I K +  L P  L+++ARD + K L+ 
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL-PPYLTQEARDLLKKLLKR 258
Query: 516 NPNDR-----PTAAQLMEHPFVKR 534
           N   R       A ++  HPF + 
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFFRH 282

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 169
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 227
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 228 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 287
Query: 515 V 515
           +
Sbjct: 288 M 288

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 157 IIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 214
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 274
Query: 514 QV 515
           Q+
Sbjct: 275 QM 276

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H  +V      + E+RLF  +E V  G L  ++ ++  L +     Y+ +I   LNYLHE
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGTPFWMAPEVVNLKNRG 453
           + +++RD+K  N+L+D+ G +KL D+G+ K      +   +  GTP ++APE+  L+   
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI--LRGED 229
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHL--------EGMQALFRIGKGEPPLVPNSLSRDA 505
           YG + D W+LG  + EM+  + P+  +             LF++   +   +P SLS  A
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289
Query: 506 RDFILKCLQVNPNDRPTA------AQLMEHPFVK 533
              +   L  +P +R         A +  HPF +
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 224
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 284
Query: 515 V 515
           +
Sbjct: 285 M 285

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 211
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 212 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 515 V 515
           +
Sbjct: 272 M 272

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 209
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 515 V 515
           +
Sbjct: 270 M 270

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 210
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 515 V 515
           +
Sbjct: 271 M 271

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 143
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 201
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 261
Query: 515 V 515
           +
Sbjct: 262 M 262

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 210
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 270
Query: 515 V 515
           +
Sbjct: 271 M 271

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 18/264 (6%)
Query: 284 LLGSGSFGTVYE----GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LG G +G V++       + G  FA+K V  +    +                  +H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           IV      +   +L++ LE ++ G L   L ++   M+     Y  +I   L +LH++ +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGYG 455
           ++RD+K  NI+++  G VKL DFGL K +  +   +   C GT  +MAPE+  L   G+ 
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEI--LMRSGHN 199
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
              D WSLG  + +MLT  PP++     + + +I K +  L P  L+++ARD + K L+ 
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL-PPYLTQEARDLLKKLLKR 258
Query: 516 NPNDR-----PTAAQLMEHPFVKR 534
           N   R       A ++  HPF + 
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFFRH 282

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 206
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 515 V 515
           +
Sbjct: 267 M 267

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 215
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 514 QV 515
           Q+
Sbjct: 276 QM 277

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 98
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 215
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 514 QV 515
           Q+
Sbjct: 276 QM 277

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 203
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 514 QV 515
           Q+
Sbjct: 264 QM 265

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 203
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 514 QV 515
           Q+
Sbjct: 264 QM 265

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 148
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 206
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 207 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 266
Query: 515 V 515
           +
Sbjct: 267 M 267

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 223
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 283
Query: 515 V 515
           +
Sbjct: 284 M 284

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 208
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 514 QV 515
           Q+
Sbjct: 269 QM 270

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 91
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 151
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 209
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 210 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 269
Query: 515 V 515
           +
Sbjct: 270 M 270

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 85
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 86  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 145
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 203
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 204 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 263
Query: 515 V 515
           +
Sbjct: 264 M 264

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 97
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 157 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 214
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 274
Query: 514 QV 515
           Q+
Sbjct: 275 QM 276

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 200
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 515 V 515
           +
Sbjct: 261 M 261

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 110/207 (53%), Gaps = 11/207 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NIV+   +  +E   ++  +LVT G L  ++  + +  ++  S   +QIL  + + 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 394 HEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVN 448
           H+  VVHR++K  N+L+ +     +VKLADFGLA              GTP +++PEV  
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV-- 184
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDA 505
           L+   YG   D+W+ G  +  +L   PP+   +  +   +I  G    P    ++++ +A
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +D I K L +NP+ R TAA+ ++HP++
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 203
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 514 QV 515
           Q+
Sbjct: 264 QM 265

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 119/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGL + T  +++     T ++ APE++ L    Y  T
Sbjct: 146 IIHRDLKPSNLAVNEDSELKILDFGLCRHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 203
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 514 QV 515
           Q+
Sbjct: 264 QM 265

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 83
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 84  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 143
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 201
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 202 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 261
Query: 515 V 515
           +
Sbjct: 262 M 262

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 84
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 85  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 144
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 202
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 203 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 262
Query: 515 V 515
           +
Sbjct: 263 M 263

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 88
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 205
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 514 QV 515
           Q+
Sbjct: 266 QM 267

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 109
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGYVATRWYRAPEIM-LNWMHYNQT 226
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 286
Query: 514 QV 515
           Q+
Sbjct: 287 QM 288

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + +H NIV      +    L++ ++LV+ G L + + +K    +   S    Q+L+ + Y
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 393 LHEQNVVHRDIKCANIL---VDASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVN 448
           LH+  +VHRD+K  N+L   +D    + ++DFGL+K      V S   GTP ++APEV  
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-- 189
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDA 505
           L  + Y    D WS+G     +L   PP+      +   +I K E        + +S  A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +DFI   ++ +P  R T  Q ++HP++
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + +H NIV      +    L++ ++LV+ G L + + +K    +   S    Q+L+ + Y
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 393 LHEQNVVHRDIKCANIL---VDASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVN 448
           LH+  +VHRD+K  N+L   +D    + ++DFGL+K      V S   GTP ++APEV  
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-- 189
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDA 505
           L  + Y    D WS+G     +L   PP+      +   +I K E        + +S  A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +DFI   ++ +P  R T  Q ++HP++
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGXVATRWYRAPEIM-LNWMHYNQTV 224
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 284
Query: 515 V 515
           +
Sbjct: 285 M 285

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + +H NIV      +    L++ ++LV+ G L + + +K    +   S    Q+L+ + Y
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 393 LHEQNVVHRDIKCANIL---VDASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVN 448
           LH+  +VHRD+K  N+L   +D    + ++DFGL+K      V S   GTP ++APEV  
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-- 189
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDA 505
           L  + Y    D WS+G     +L   PP+      +   +I K E        + +S  A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +DFI   ++ +P  R T  Q ++HP++
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 351 NRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           +RL+  +E V  G L  ++ Q     + Q   Y  +I  GL +LH++ +++RD+K  N++
Sbjct: 93  DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVM 152
Query: 410 VDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           +D+ G +K+ADFG+ K   M+ V +   C GTP ++APE++  +   YG + D W+ G  
Sbjct: 153 LDSEGHIKIADFGMCKEHMMDGVTTREFC-GTPDYIAPEIIAYQP--YGKSVDWWAYGVL 209
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAA-- 524
           + EML  QPP+   E    LF+         P SLS++A       +  +P  R      
Sbjct: 210 LYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPAKRLGCGPE 268
Query: 525 ---QLMEHPFVKR 534
               + EH F +R
Sbjct: 269 GERDVREHAFFRR 281

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 92
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 152
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 210
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 211 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 270
Query: 515 V 515
           +
Sbjct: 271 M 271

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + +H NIV      +    L++ ++LV+ G L + + +K    +   S    Q+L+ + Y
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 393 LHEQNVVHRDIKCANIL---VDASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVN 448
           LH+  +VHRD+K  N+L   +D    + ++DFGL+K      V S   GTP ++APEV  
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-- 189
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDA 505
           L  + Y    D WS+G     +L   PP+      +   +I K E        + +S  A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +DFI   ++ +P  R T  Q ++HP++
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 106
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 107 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 166
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 224
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 225 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 284
Query: 515 V 515
           +
Sbjct: 285 M 285

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H  +V      + E+RLF  +E V  G L  ++ ++  L +     Y+ +I   LNYLHE
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGTPFWMAPEVVNLKNRG 453
           + +++RD+K  N+L+D+ G +KL D+G+ K      +      GTP ++APE+  L+   
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI--LRGED 182
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHL--------EGMQALFRIGKGEPPLVPNSLSRDA 505
           YG + D W+LG  + EM+  + P+  +             LF++   +   +P SLS  A
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 242
Query: 506 RDFILKCLQVNPNDRPTA------AQLMEHPFVK 533
              +   L  +P +R         A +  HPF +
Sbjct: 243 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 105
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 106 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 165
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 223
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 224 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 283
Query: 515 V 515
           +
Sbjct: 284 M 284

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 96
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 156
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 214
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 215 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 274
Query: 515 V 515
           +
Sbjct: 275 M 275

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 200
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 515 V 515
           +
Sbjct: 261 M 261

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H  +V      + E+RLF  +E V  G L  ++ ++  L +     Y+ +I   LNYLHE
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM--NDVKSCKGTPFWMAPEVVNLKNRG 453
           + +++RD+K  N+L+D+ G +KL D+G+ K      +      GTP ++APE+  L+   
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI--LRGED 186
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHL--------EGMQALFRIGKGEPPLVPNSLSRDA 505
           YG + D W+LG  + EM+  + P+  +             LF++   +   +P SLS  A
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 246
Query: 506 RDFILKCLQVNPNDRPTA------AQLMEHPFVK 533
              +   L  +P +R         A +  HPF +
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 113/245 (46%), Gaps = 16/245 (6%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V+ G  +     A+K +        G               + +H+ +VQ +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK------PGTMSPESFLEEAQIMKKLKHDKLVQLY 70
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHR 401
               +E  ++I  E + KGSL +  +      L    +     Q+  G+ Y+   N +HR
Sbjct: 71  AVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D++ ANILV      K+ADFGLA+    N+  + +G  F   W APE   L  R + + +
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAA-LYGR-FTIKS 187
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           D+WS G  + E++T+ + PY  +   + L ++ +G     P        + ++ C + +P
Sbjct: 188 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDP 247
Query: 518 NDRPT 522
            +RPT
Sbjct: 248 EERPT 252

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 13/208 (6%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NIV+   +  +E   ++  +LVT G L  ++  + +  ++  S   +QIL  + + 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 394 HEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSC---KGTPFWMAPEVV 447
           H+  VVHRD+K  N+L+ +     +VKLADFGLA      D ++     GTP +++PEV 
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV- 177
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRD 504
            L+   YG   DIW+ G  +  +L   PP+   +  +   +I  G    P    ++++ +
Sbjct: 178 -LRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           A++ I + L +NP  R TA + ++HP+V
Sbjct: 237 AKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +K+ADFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LGSG FG V  G     +  AVK +       +G               +  H  +V+++
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK------EGSMSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHR 401
           G    E  ++I  E ++ G L N Y + H   L  SQ+      +  G+ +L     +HR
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTA 458
           D+   N LVD    VK++DFG+ +    +   S  GT F   W APEV +     Y   +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YSSKS 186
Query: 459 DIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNP 517
           D+W+ G  + E+ +  + PY      + + ++ +G     P+  S      +  C    P
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELP 246
Query: 518 NDRPTAAQLM 527
             RPT  QL+
Sbjct: 247 EKRPTFQQLL 256

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIM-LNWMHYNQTV 200
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 515 V 515
           +
Sbjct: 261 M 261

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DFGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 200
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQ 260
Query: 515 V 515
           +
Sbjct: 261 M 261

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 123/278 (44%), Gaps = 17/278 (6%)
Query: 260 KEPVYNVSPN-GKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQ 317
           K  VY VSPN  K+            LG G +G VYEG +       AVK +       +
Sbjct: 241 KPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------E 294
Query: 318 GKXXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL--M 375
                             +H N+VQ  G    E   +I  E +T G+L +  ++ +   +
Sbjct: 295 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 354
Query: 376 DSQVSAY-TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS 434
           ++ V  Y   QI + + YL ++N +HR++   N LV  +  VK+ADFGL++  T +   +
Sbjct: 355 NAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 414
Query: 435 CKGTPF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIG 490
             G  F   W APE  +L    + + +D+W+ G  + E+ T    PY  ++  Q    + 
Sbjct: 415 HAGAKFPIKWTAPE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 472
Query: 491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           K      P        + +  C Q NP+DRP+ A++ +
Sbjct: 473 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 510

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 16/286 (5%)
Query: 255 AVRLIKEPVYNVS-PNGKFRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQ 312
           A   ++ P Y+ S P   F++   S+Q+   LG GS+G V++  + +DG  +AVK     
Sbjct: 37  ASETLQSPGYDPSRPESFFQQ---SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP 93
Query: 313 DQGTQGKXXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY 372
            +G + +                +H   V+     ++   L++  EL    SL    + +
Sbjct: 94  FRGPKDRARKLAEVGSHEKVG--QHPCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAW 150
Query: 373 --HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG-LAKATTM 429
              L ++QV  Y R  L  L +LH Q +VH D+K ANI +   G  KL DFG L +  T 
Sbjct: 151 GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210
Query: 430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI 489
              +  +G P +MAPE++      YG  AD++SLG T+LE+          EG Q L R 
Sbjct: 211 GAGEVQEGDPRYMAPELL---QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-RQ 266
Query: 490 GKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 535
           G   PP     LS + R  ++  L+ +P  R TA  L+  P +++P
Sbjct: 267 GY-LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ D+GLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H  +V      + E+RLF  +E V  G L  ++ ++  L +     Y+ +I   LNYLHE
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKS--CKGTPFWMAPEVVNLKNR 452
           + +++RD+K  N+L+D+ G +KL D+G+ K      D  S  C GTP ++APE+  L+  
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEI--LRGE 196
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHL--------EGMQALFRIGKGEPPLVPNSLSRD 504
            YG + D W+LG  + EM+  + P+  +             LF++   +   +P S+S  
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVK 256
Query: 505 ARDFILKCLQVNPNDRPTA------AQLMEHPFVK 533
           A   +   L  +P +R         A +  HPF +
Sbjct: 257 AASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           + R   ++K + LG G F TVY+    +     A+K++ L  +                 
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 332 XXRFEHENIVQY---FGTDKDENRLFIFLE-----LVTKGSLANLYQKYHLMDSQVSAYT 383
                H NI+     FG   + + +F F+E     ++   SL        L  S + AY 
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYM 118
Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDVKSCKGTPFWM 442
              L GL YLH+  ++HRD+K  N+L+D +G +KLADFGLAK+  + N     +    W 
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWY 178
Query: 443 -APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP 475
            APE++    R YG+  D+W++GC + E+L R P
Sbjct: 179 RAPELL-FGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHE 395
           V ++G    E  ++I  EL    SL   Y++       + +  +      I+  L +LH 
Sbjct: 96  VTFYGALFREGDVWICXEL-XDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 154
Query: 396 Q-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC-KGTPFWMAPEVVN--LKN 451
           + +V+HRD+K +N+L++A G VK  DFG++     +  K    G   + APE +N  L  
Sbjct: 155 KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQ 214
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGKGEPPLVP-NSLSRDARDFI 509
           +GY + +DIWSLG T +E+   + PY S     Q L ++ +   P +P +  S +  DF 
Sbjct: 215 KGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 274
Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
            +CL+ N  +RPT  +L +HPF    L +S+G
Sbjct: 275 SQCLKKNSKERPTYPELXQHPFFT--LHESKG 304

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 20/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G FG VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 72
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I  E +T G+L +  ++ +    +VSA        QI + + YL ++N 
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE--SLAYNKFS 188
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 515 VNPNDRPTAAQL 526
            NP+DRP+ A++
Sbjct: 249 WNPSDRPSFAEI 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 21/280 (7%)
Query: 260 KEPVYNVSPN-GKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQ 317
           K  +Y VSPN  K+            LG G +G VYEG +       AVK +       +
Sbjct: 202 KPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------E 255
Query: 318 GKXXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS 377
                             +H N+VQ  G    E   +I  E +T G+L +  ++ +    
Sbjct: 256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQ 313
Query: 378 QVSAYT-----RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 432
           +VSA        QI + + YL ++N +HR++   N LV  +  VK+ADFGL++  T +  
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373
Query: 433 KSCKGTPF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR 488
            +  G  F   W APE  +L    + + +D+W+ G  + E+ T    PY  ++  Q    
Sbjct: 374 TAHAGAKFPIKWTAPE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 431
Query: 489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           + K      P        + +  C Q NP+DRP+ A++ +
Sbjct: 432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 47/240 (19%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + 
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 245
Query: 458 ADIWSLGCTVLEMLTRQ-----PPYSHLEGM----------------------------- 483
           +DIWS+G +++EM   +     P    LE M                             
Sbjct: 246 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 305
Query: 484 ----QALFR----IGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                A+F     I    PP +P+++ S + +DF+ KCL  NP +R    QLM H F+KR
Sbjct: 306 SRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 365

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 20/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 72
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I +E +T G+L +  ++ +    +VSA        QI + + YL ++N 
Sbjct: 73  LGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE--SLAYNKFS 188
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 515 VNPNDRPTAAQL 526
            NP+DRP+ A++
Sbjct: 249 WNPSDRPSFAEI 260

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ LE    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +K+ADFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 75
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I +E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 76  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE--SLAYNKFSIK 193
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 253
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 254 PSDRPSFAEI 263

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 20/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I +E +T G+L +  ++ +    +VSA        QI + + YL ++N 
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 190
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 515 VNPNDRPTAAQL 526
            NP+DRP+ A++
Sbjct: 251 WNPSDRPSFAEI 262

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   E +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADEPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 20/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I +E +T G+L +  ++ +    +VSA        QI + + YL ++N 
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 190
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 515 VNPNDRPTAAQL 526
            NP+DRP+ A++
Sbjct: 251 WNPSDRPSFAEI 262

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 19/270 (7%)
Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           ++  E++G G F  V      + G  FAVK V +    +                   +H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNY 392
            +IV+   T   +  L++  E +    L     K     +   ++  S Y RQIL  L Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 393 LHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVV 447
            H+ N++HRD+K   +L+   + S  VKL  FG+A     + + +    GTP +MAPEVV
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSR 503
             K   YG   D+W  G  +  +L+   P+   +  + LF  I KG+  + P   + +S 
Sbjct: 208 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSHISE 263
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            A+D + + L ++P +R T  + + HP++K
Sbjct: 264 SAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 19/273 (6%)
Query: 271 KFRRRIMSWQKGELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
           K R  +  ++  +LLG G+FG V    E  T  G ++A+K   L+ +    K        
Sbjct: 145 KHRVTMNEFEYLKLLGKGTFGKVILVKEKAT--GRYYAMK--ILKKEVIVAKDEVAHTLT 200
Query: 328 XXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQI 386
                    H  +     + +  +RL   +E    G L  +L ++    + +   Y  +I
Sbjct: 201 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 260
Query: 387 LNGLNYLH-EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMA 443
           ++ L+YLH E+NVV+RD+K  N+++D  G +K+ DFGL K    +   +K+  GTP ++A
Sbjct: 261 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 320
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSR 503
           PEV  L++  YG   D W LG  + EM+  + P+ + +  + LF +   E    P +L  
Sbjct: 321 PEV--LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGP 377
Query: 504 DARDFILKCLQVNPNDR-----PTAAQLMEHPF 531
           +A+  +   L+ +P  R       A ++M+H F
Sbjct: 378 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 410

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 112/242 (46%), Gaps = 8/242 (3%)
Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GSFG V      D    +A+K   +  Q    +                EH  +V  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMK--YMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           + + +DE  +F+ ++L+  G L  +L Q  H  +  V  +  +++  L+YL  Q ++HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 403 IKCANILVDASGSVKLADFGLAKAT-TMNDVKSCKGTPFWMAPEVV-NLKNRGYGLTADI 460
           +K  NIL+D  G V + DF +A        + +  GT  +MAPE+  + K  GY    D 
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200
Query: 461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKCLQVNPN 518
           WSLG T  E+L  + PY       +   +   E  +V  P++ S++    + K L+ NP+
Sbjct: 201 WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPD 260
Query: 519 DR 520
            R
Sbjct: 261 QR 262

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NI++ F   +D+   ++  E    G L   +  ++   +   +   +QIL+G+ YL
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYL 162
Query: 394 HEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNL 449
           H+ N+VHRDIK  NIL++   S   +K+ DFGL+   + +  ++   GT +++APEV+  
Sbjct: 163 HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK 222
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN---SLSRDAR 506
           K   Y    D+WS G  +  +L   PP+        + ++ KG+     N   ++S +A+
Sbjct: 223 K---YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           + I   L  + N R TA + +   ++K+
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I +E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 80  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 197
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 257
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 258 PSDRPSFAEI 267

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 113/238 (47%), Gaps = 8/238 (3%)
Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG+GSFG V    + + G  FA+K +  Q      +               F     ++Y
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
             + KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
           +K  N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWA 223
Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           LG  + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 113/238 (47%), Gaps = 8/238 (3%)
Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG+GSFG V    + + G  FA+K +  Q      +               F     ++Y
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
             + KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
           +K  N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWA 223
Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           LG  + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 113/259 (43%), Gaps = 16/259 (6%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E++G G FG VY  +   G   AVK  +  D                      +H NI+ 
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV--- 399
             G    E  L + +E    G L  +     +    +  +  QI  G+NYLH++ +V   
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 400 HRDIKCANILV-------DASGSV-KLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           HRD+K +NIL+       D S  + K+ DFGLA+        S  G   WMAPEV+    
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM 190
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPNSLSRDARDFIL 510
              G  +D+WS G  + E+LT + P+  ++G+   + +   +  L +P++        + 
Sbjct: 191 FSKG--SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLME 248
Query: 511 KCLQVNPNDRPTAAQLMEH 529
            C   +P+ RP+   +++ 
Sbjct: 249 DCWNPDPHSRPSFTNILDQ 267

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 113/238 (47%), Gaps = 8/238 (3%)
Query: 285 LGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG+GSFG V    + + G  FA+K +  Q      +               F     ++Y
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
             + KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
           +K  N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWA 223
Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           LG  + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 47/240 (19%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + 
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 210
Query: 458 ADIWSLGCTVLEMLTRQ-----PPYSHLEGM----------------------------- 483
           +DIWS+G +++EM   +     P    LE M                             
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 484 ----QALFR----IGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                A+F     I    PP +P+ + S + +DF+ KCL  NP +R    QLM H F+KR
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 19/273 (6%)
Query: 271 KFRRRIMSWQKGELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
           K R  +  ++  +LLG G+FG V    E  T  G ++A+K   L+ +    K        
Sbjct: 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKAT--GRYYAMK--ILKKEVIVAKDEVAHTLT 197
Query: 328 XXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQI 386
                    H  +     + +  +RL   +E    G L  +L ++    + +   Y  +I
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 387 LNGLNYLH-EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMA 443
           ++ L+YLH E+NVV+RD+K  N+++D  G +K+ DFGL K    +   +K+  GTP ++A
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSR 503
           PEV  L++  YG   D W LG  + EM+  + P+ + +  + LF +   E    P +L  
Sbjct: 318 PEV--LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGP 374
Query: 504 DARDFILKCLQVNPNDR-----PTAAQLMEHPF 531
           +A+  +   L+ +P  R       A ++M+H F
Sbjct: 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LG G+F  V    +   G  FA K ++ +    +                + +H NIV
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIV 91
Query: 342 QYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
           +   + ++E+  ++  +LVT G L  ++  +    ++  S   +QIL  + Y H   +VH
Sbjct: 92  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 151
Query: 401 RDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRGY 454
           R++K  N+L+ +     +VKLADFGL  A  +ND ++     GTP +++PEV  LK   Y
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEV--LKKDPY 207
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARDFILK 511
               DIW+ G  +  +L   PP+   +  +   +I  G    P    ++++ +A+  I  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 512 CLQVNPNDRPTAAQLMEHPFV 532
            L VNP  R TA Q ++ P++
Sbjct: 268 MLTVNPKKRITADQALKVPWI 288

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 272 FRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXX 330
           F   +  ++K   +G G+FG V++  +   G   A+K+V ++++    +           
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIK 69
Query: 331 XXXRFEHENIVQYFGTDKDE----NR-------LFIFLELVTKGSLANLYQKYHLMDSQV 379
                +HEN+V      + +    NR       +F F E    G L+N+  K+ L  S++
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEI 127
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----DVKS 434
               + +LNGL Y+H   ++HRD+K AN+L+   G +KLADFGLA+A ++      +   
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP 475
            +    W  P  + L  R YG   D+W  GC + EM TR P
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 19/270 (7%)
Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           ++  E++G G F  V      + G  FAVK V +    +                   +H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNY 392
            +IV+   T   +  L++  E +    L     K     +   ++  S Y RQIL  L Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 393 LHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVV 447
            H+ N++HRD+K   +L+   + S  VKL  FG+A     + + +    GTP +MAPEVV
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSR 503
             K   YG   D+W  G  +  +L+   P+   +  + LF  I KG+  + P   + +S 
Sbjct: 206 --KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSHISE 261
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            A+D + + L ++P +R T  + + HP++K
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 272 FRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXX 330
           F   +  ++K   +G G+FG V++  +   G   A+K+V ++++    +           
Sbjct: 12  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIK 68
Query: 331 XXXRFEHENIVQYFGTDKDE----NR-------LFIFLELVTKGSLANLYQKYHLMDSQV 379
                +HEN+V      + +    NR       +F F E    G L+N+  K+ L  S++
Sbjct: 69  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEI 126
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----DVKS 434
               + +LNGL Y+H   ++HRD+K AN+L+   G +KLADFGLA+A ++      +   
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP 475
            +    W  P  + L  R YG   D+W  GC + EM TR P
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E +  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +K+ADFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 91/174 (52%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E +  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +K+ADFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 54/300 (18%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           +R +++   +++G+GSFG V++    +    A+K+V LQD+  + +              
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKNRELQIMRI------- 88
Query: 334 RFEHENIVQ---YF---GTDKDENRLFIFLELVTKG------SLANLYQKYHLMDSQVSA 381
             +H N+V    +F   G  KDE  L + LE V +         A L Q   ++   +  
Sbjct: 89  -VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML--LIKL 145
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDVK-SCKGTP 439
           Y  Q+L  L Y+H   + HRDIK  N+L+D  SG +KL DFG AK     +   S   + 
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR 205
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK-------- 491
           ++ APE++      Y    DIWS GC + E++  QP +    G+  L  I K        
Sbjct: 206 YYRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264
Query: 492 ------------GEPPLVPNSLSR--------DARDFILKCLQVNPNDRPTAAQLMEHPF 531
                         P + P+  S+        DA D I + L+  P+ R TA + + HPF
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 20/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 72
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I  E +T G+L +  ++ +    +VSA        QI + + YL ++N 
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE--SLAYNKFS 188
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 515 VNPNDRPTAAQL 526
            NP+DRP+ A++
Sbjct: 249 WNPSDRPSFAEI 260

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LG G+F  V    +   G  FA K ++ +    +                + +H NIV
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIV 67
Query: 342 QYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
           +   + ++E+  ++  +LVT G L  ++  +    ++  S   +QIL  + Y H   +VH
Sbjct: 68  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 127
Query: 401 RDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRGY 454
           R++K  N+L+ +     +VKLADFGL  A  +ND ++     GTP +++PEV  LK   Y
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEV--LKKDPY 183
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARDFILK 511
               DIW+ G  +  +L   PP+   +  +   +I  G    P    ++++ +A+  I  
Sbjct: 184 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 243
Query: 512 CLQVNPNDRPTAAQLMEHPFV 532
            L VNP  R TA Q ++ P++
Sbjct: 244 MLTVNPKKRITADQALKVPWI 264

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 47/240 (19%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 458 ADIWSLGCTVLEMLTRQ-----PPYSHLEGM----------------------------- 483
           +DIWS+G +++EM   +     P    LE M                             
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 484 ----QALFR----IGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                A+F     I    PP +P+ + S + +DF+ KCL  NP +R    QLM H F+KR
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 47/240 (19%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 458 ADIWSLGCTVLEMLTRQ-----PPYSHLEGM----------------------------- 483
           +DIWS+G +++EM   +     P    LE M                             
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 484 ----QALFR----IGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                A+F     I    PP +P+ + S + +DF+ KCL  NP +R    QLM H F+KR
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 106/198 (53%), Gaps = 4/198 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + + L     + + +  +  RQI++ + Y H+
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T+   + +  G+P + APE+   K    
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD- 188
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + + L 
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKRFLV 247
Query: 515 VNPNDRPTAAQLMEHPFV 532
           +NP  R T  Q+M+  ++
Sbjct: 248 LNPIKRGTLEQIMKDRWI 265

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 47/240 (19%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 458 ADIWSLGCTVLEMLTRQ-----PPYSHLEGM----------------------------- 483
           +DIWS+G +++EM   +     P    LE M                             
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 484 ----QALFR----IGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                A+F     I    PP +P+ + S + +DF+ KCL  NP +R    QLM H F+KR
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 47/240 (19%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 458 ADIWSLGCTVLEMLTRQ-----PPYSHLEGM----------------------------- 483
           +DIWS+G +++EM   +     P    LE M                             
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 484 ----QALFR----IGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                A+F     I    PP +P+ + S + +DF+ KCL  NP +R    QLM H F+KR
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LG G+F  V    +   G  FA K ++ +    +                + +H NIV
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIV 68
Query: 342 QYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
           +   + ++E+  ++  +LVT G L  ++  +    ++  S   +QIL  + Y H   +VH
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 401 RDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRGY 454
           R++K  N+L+ +     +VKLADFGL  A  +ND ++     GTP +++PEV  LK   Y
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEV--LKKDPY 184
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARDFILK 511
               DIW+ G  +  +L   PP+   +  +   +I  G    P    ++++ +A+  I  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 512 CLQVNPNDRPTAAQLMEHPFV 532
            L VNP  R TA Q ++ P++
Sbjct: 245 MLTVNPKKRITADQALKVPWI 265

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 20/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I  E +T G+L +  ++ +    +VSA        QI + + YL ++N 
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 137
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 195
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 515 VNPNDRPTAAQL 526
            NP+DRP+ A++
Sbjct: 256 WNPSDRPSFAEI 267

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 132 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 248
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 249 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 272 FRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXX 330
           F   +  ++K   +G G+FG V++  +   G   A+K+V ++++    +           
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIK 69
Query: 331 XXXRFEHENIVQYFGTDKDE----NR-------LFIFLELVTKGSLANLYQKYHLMDSQV 379
                +HEN+V      + +    NR       +F F E    G L+N+  K+ L  S++
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL--SEI 127
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----DVKS 434
               + +LNGL Y+H   ++HRD+K AN+L+   G +KLADFGLA+A ++      +   
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP 475
            +    W  P  + L  R YG   D+W  GC + EM TR P
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           E LG G+F  V    +   G  FA K ++ +    +                + +H NIV
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIV 68
Query: 342 QYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
           +   + ++E+  ++  +LVT G L  ++  +    ++  S   +QIL  + Y H   +VH
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 401 RDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRGY 454
           R++K  N+L+ +     +VKLADFGL  A  +ND ++     GTP +++PEV  LK   Y
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEV--LKKDPY 184
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARDFILK 511
               DIW+ G  +  +L   PP+   +  +   +I  G    P    ++++ +A+  I  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 512 CLQVNPNDRPTAAQLMEHPFV 532
            L VNP  R TA Q ++ P++
Sbjct: 245 MLTVNPKKRITADQALKVPWI 265

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 106 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 165
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 166 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 222
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 223 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 272 FRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXX 330
           F   +  ++K   +G G+FG V++  +   G   A+K+V ++++    +           
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIK 69
Query: 331 XXXRFEHENIVQYFGTDKDE----NR-------LFIFLELVTKGSLANLYQKYHLMDSQV 379
                +HEN+V      + +    NR       +F F E    G L+N+  K+ L  S++
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEI 127
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-----DVKS 434
               + +LNGL Y+H   ++HRD+K AN+L+   G +KLADFGLA+A ++      +   
Sbjct: 128 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP 475
            +    W  P  + L  R YG   D+W  GC + EM TR P
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 116/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+  FGLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 20/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I  E +T G+L +  ++ +    +VSA        QI + + YL ++N 
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 190
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 515 VNPNDRPTAAQL 526
            NP+DRP+ A++
Sbjct: 251 WNPSDRPSFAEI 262

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 24/278 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 16  KLLGKGTFGKVILVKEKAT--GRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLH-EQN 397
           +     + +  +RL   +E    G L  +L ++    + +   Y  +I++ L+YLH E+N
Sbjct: 72  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 131
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYG 455
           VV+RD+K  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV  L++  YG
Sbjct: 132 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV--LEDNDYG 189
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
              D W LG  + EM+  + P+ + +  + LF +   E    P +L  +A+  +   L+ 
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK 248
Query: 516 NPNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           +P  R       A ++M+H F      +   +K   PP
Sbjct: 249 DPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 286

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 20/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I  E +T G+L +  ++ +    +VSA        QI + + YL ++N 
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 190
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 515 VNPNDRPTAAQL 526
            NP+DRP+ A++
Sbjct: 251 WNPSDRPSFAEI 262

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 349 DENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           D    +I LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 408 ILVDASGS---VKLADFGLAKATTMNDV-KSCKGTPFWMAPEV-VNLKNRGYGLTADIWS 462
           +L+ +      +K+ DFG +K      + ++  GTP ++APEV V++   GY    D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 463 LGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVPN---SLSRDARDFILKCLQVNPN 518
           LG  +   L+  PP+S H   +    +I  G+   +P     +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 519 DRPTAAQLMEHPFVK 533
            R T  + + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 349 DENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           D    +I LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 91  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 150
Query: 408 ILVDASGS---VKLADFGLAKATTMNDV-KSCKGTPFWMAPEV-VNLKNRGYGLTADIWS 462
           +L+ +      +K+ DFG +K      + ++  GTP ++APEV V++   GY    D WS
Sbjct: 151 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 210
Query: 463 LGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVPN---SLSRDARDFILKCLQVNPN 518
           LG  +   L+  PP+S H   +    +I  G+   +P     +S  A D + K L V+P 
Sbjct: 211 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 270
Query: 519 DRPTAAQLMEHPFVK 533
            R T  + + HP+++
Sbjct: 271 ARFTTEEALRHPWLQ 285

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 349 DENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           D    +I LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 84  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 143
Query: 408 ILVDASGS---VKLADFGLAKATTMNDV-KSCKGTPFWMAPEV-VNLKNRGYGLTADIWS 462
           +L+ +      +K+ DFG +K      + ++  GTP ++APEV V++   GY    D WS
Sbjct: 144 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 203
Query: 463 LGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVPN---SLSRDARDFILKCLQVNPN 518
           LG  +   L+  PP+S H   +    +I  G+   +P     +S  A D + K L V+P 
Sbjct: 204 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 263
Query: 519 DRPTAAQLMEHPFVK 533
            R T  + + HP+++
Sbjct: 264 ARFTTEEALRHPWLQ 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 349 DENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           D    +I LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 408 ILVDASGS---VKLADFGLAKATTMNDV-KSCKGTPFWMAPEV-VNLKNRGYGLTADIWS 462
           +L+ +      +K+ DFG +K      + ++  GTP ++APEV V++   GY    D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 463 LGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVPN---SLSRDARDFILKCLQVNPN 518
           LG  +   L+  PP+S H   +    +I  G+   +P     +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 519 DRPTAAQLMEHPFVK 533
            R T  + + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 337 HENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH 394
           HE+IV+Y G   D+ E  + + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNL 449
            Q+ +HR +   N+L+D    VK+ DFGLAKA         V+    +P FW APE   L
Sbjct: 130 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--L 187
Query: 450 KNRGYGLTADIWSLGCTVLEMLT----RQPPYS-------HLEGMQALFRIG----KGEP 494
           K   +   +D+WS G T+ E+LT     Q P++       H +G   + R+     +GE 
Sbjct: 188 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 247
Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
              P+    +    +  C +   + RPT   L+
Sbjct: 248 LPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 98  KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 157
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 158 NLLIDEQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 214
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 215 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE--SLAYNKFSIK 197
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 257
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 258 PSDRPSFAEI 267

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 20/242 (8%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V+    +     AVK +        G                 +H+ +V+  
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 243
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDS---QVSAYTRQILNGLNYLHEQNVVHR 401
                E  ++I  E + KGSL +  +          ++  ++ QI  G+ ++ ++N +HR
Sbjct: 244 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 302
Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIW 461
           D++ ANILV AS   K+ADFGLA+      +K       W APE +N  +  + + +D+W
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFPIK-------WTAPEAINFGS--FTIKSDVW 353
Query: 462 SLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           S G  ++E++T  + PY  +   + +  + +G     P +   +  + +++C +  P +R
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 413
Query: 521 PT 522
           PT
Sbjct: 414 PT 415

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 116/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ D GLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 349 DENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           D    +I LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 408 ILVDASGS---VKLADFGLAKATTMNDV-KSCKGTPFWMAPEV-VNLKNRGYGLTADIWS 462
           +L+ +      +K+ DFG +K      + ++  GTP ++APEV V++   GY    D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 463 LGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVPN---SLSRDARDFILKCLQVNPN 518
           LG  +   L+  PP+S H   +    +I  G+   +P     +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 519 DRPTAAQLMEHPFVK 533
            R T  + + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 132 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGATWTLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 248
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 249 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 24/278 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 15  KLLGKGTFGKVILVKEKAT--GRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPF 70
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLH-EQN 397
           +     + +  +RL   +E    G L  +L ++    + +   Y  +I++ L+YLH E+N
Sbjct: 71  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 130
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYG 455
           VV+RD+K  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV  L++  YG
Sbjct: 131 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV--LEDNDYG 188
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
              D W LG  + EM+  + P+ + +  + LF +   E    P +L  +A+  +   L+ 
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK 247
Query: 516 NPNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           +P  R       A ++M+H F      +   +K   PP
Sbjct: 248 DPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 285

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 197
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 257
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 258 PSDRPSFAEI 267

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 24/278 (8%)
Query: 283 ELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LLG G+FG V    E  T  G ++A+K   L+ +    K                 H  
Sbjct: 14  KLLGKGTFGKVILVKEKAT--GRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLH-EQN 397
           +     + +  +RL   +E    G L  +L ++    + +   Y  +I++ L+YLH E+N
Sbjct: 70  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 129
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYG 455
           VV+RD+K  N+++D  G +K+ DFGL K    +   +K   GTP ++APEV  L++  YG
Sbjct: 130 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV--LEDNDYG 187
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
              D W LG  + EM+  + P+ + +  + LF +   E    P +L  +A+  +   L+ 
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK 246
Query: 516 NPNDR-----PTAAQLMEHPFV-----KRPLQKSRGPP 543
           +P  R       A ++M+H F      +   +K   PP
Sbjct: 247 DPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 284

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 79
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 197
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 198 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 257
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 258 PSDRPSFAEI 267

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 349 DENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           D    +I LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 210 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269
Query: 408 ILVDASGS---VKLADFGLAKATTMNDV-KSCKGTPFWMAPEV-VNLKNRGYGLTADIWS 462
           +L+ +      +K+ DFG +K      + ++  GTP ++APEV V++   GY    D WS
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 463 LGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVPN---SLSRDARDFILKCLQVNPN 518
           LG  +   L+  PP+S H   +    +I  G+   +P     +S  A D + K L V+P 
Sbjct: 330 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389
Query: 519 DRPTAAQLMEHPFVK 533
            R T  + + HP+++
Sbjct: 390 ARFTTEEALRHPWLQ 404

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 196
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 256
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 257 PSDRPSFAEI 266

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 123/277 (44%), Gaps = 9/277 (3%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           + I  +  G+LLG GS+G V E    +       ++  + +  +                
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 334 RFEHENIVQYFGT--DKDENRLFIFLELVTKG--SLANLYQKYHLMDSQVSAYTRQILNG 389
           R  H+N++Q      ++++ ++++ +E    G   + +   +      Q   Y  Q+++G
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDVKSCKGTPFWMAPE 445
           L YLH Q +VH+DIK  N+L+   G++K++  G+A+A       +  ++ +G+P +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
           + N  +   G   DIWS G T+  + T   P+      +    IGKG    +P       
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA-IPGDCGPPL 240
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
            D +   L+  P  R +  Q+ +H + ++    +  P
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP 277

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 337 HENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH 394
           HE+IV+Y G   D+ E  + + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNL 449
            Q+ +HR +   N+L+D    VK+ DFGLAKA         V+    +P FW APE   L
Sbjct: 129 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--L 186
Query: 450 KNRGYGLTADIWSLGCTVLEMLT----RQPPYS-------HLEGMQALFRIG----KGEP 494
           K   +   +D+WS G T+ E+LT     Q P++       H +G   + R+     +GE 
Sbjct: 187 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 246
Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
              P+    +    +  C +   + RPT   L+
Sbjct: 247 LPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 104 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 163
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 220
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 221 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 76
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 194
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 254
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 255 PSDRPSFAEI 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 76
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 194
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 254
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 255 PSDRPSFAEI 264

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 192
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 252
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 253 PSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 192
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 252
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 253 PSDRPSFAEI 262

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 125/297 (42%), Gaps = 47/297 (15%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++GTVY+      G F A+K V + +                     FEH N+V+ 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
                   TD++     +F E V +     L +     L    +    RQ L GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVF-EHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-APEVVNLKNRGY 454
             +VHRD+K  NILV + G+VKLADFGLA+  +     +      W  APEV  L    Y
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV--LLQSTY 188
Query: 455 GLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP---------------- 495
               D+WS+GC   EM  R+P +   S  + +  +F +  G PP                
Sbjct: 189 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRDVSLPRGAFP 247
Query: 496 ---------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
                    +VP  +       +L+ L  NP+ R +A + ++H +    L K  G P
Sbjct: 248 PRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSY----LHKDEGNP 299

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 349 DENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           D    +I LEL+  G L + +     L ++    Y  Q+L  + YLHE  ++HRD+K  N
Sbjct: 224 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 283
Query: 408 ILVDASGS---VKLADFGLAKATTMNDV-KSCKGTPFWMAPEV-VNLKNRGYGLTADIWS 462
           +L+ +      +K+ DFG +K      + ++  GTP ++APEV V++   GY    D WS
Sbjct: 284 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 343
Query: 463 LGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVPN---SLSRDARDFILKCLQVNPN 518
           LG  +   L+  PP+S H   +    +I  G+   +P     +S  A D + K L V+P 
Sbjct: 344 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 403
Query: 519 DRPTAAQLMEHPFVK 533
            R T  + + HP+++
Sbjct: 404 ARFTTEEALRHPWLQ 418

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 105/198 (53%), Gaps = 4/198 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + + L     + + +  +  RQI++ + Y H+
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T+   + +  G P + APE+   K    
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD- 191
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + + L 
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKRFLV 250
Query: 515 VNPNDRPTAAQLMEHPFV 532
           +NP  R T  Q+M+  ++
Sbjct: 251 LNPIKRGTLEQIMKDRWI 268

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 116/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ D GLA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 76
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE--SLAYNKFSIK 194
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 254
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 255 PSDRPSFAEI 264

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 215
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E   G Q  FR            +S + 
Sbjct: 216 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR----------QRVSXEC 264
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 265 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 75
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 76  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE--SLAYNKFSIK 193
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 253
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 254 PSDRPSFAEI 263

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 214
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E   G Q  FR            +S + 
Sbjct: 215 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR----------QRVSSEC 263
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 264 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+++D  G +K+ DFGLAK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLMIDQQGYIKVTDFGLAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 16/250 (6%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VYEG +       AVK +       +                  +H N+VQ 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 87
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAY-TRQILNGLNYLHEQNVVH 400
            G    E   +I  E +T G+L +  ++ +   +++ V  Y   QI + + YL ++N +H
Sbjct: 88  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLT 457
           RD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + + 
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNKFSIK 205
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C Q N
Sbjct: 206 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 265
Query: 517 PNDRPTAAQL 526
           P+DRP+ A++
Sbjct: 266 PSDRPSFAEI 275

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 132 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 248
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 249 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 120/271 (44%), Gaps = 27/271 (9%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE +   +     + ++  L +    ++  Q+L  + +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 186
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 187 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 235
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           +  I  CL + P+DRPT  ++  HP+++  L
Sbjct: 236 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 266

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 214
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E   G Q  FR            +S + 
Sbjct: 215 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR----------QRVSXEC 263
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 264 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 12/184 (6%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +VQ F   +D+  L++ +E +  G L NL   Y + +     YT +++  L+ +H    +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRG--- 453
           HRD+K  N+L+D SG +KLADFG         +  C    GTP +++PEV  LK++G   
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV--LKSQGGDG 248
Query: 454 -YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDARDFI 509
            YG   D WS+G  + EML    P+     +    +I   +  L     N +S++A++ I
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308
Query: 510 LKCL 513
              L
Sbjct: 309 CAFL 312

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 116/241 (48%), Gaps = 15/241 (6%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FGTDKDENRLFIF--LELVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F  + LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 146
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           +HRD+K +N+ V+    +K+ DF LA+ T  +++     T ++ APE++ L    Y  T 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQTV 204
Query: 459 DIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQ 514
           DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    Q
Sbjct: 205 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 264
Query: 515 V 515
           +
Sbjct: 265 M 265

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +VQ F   +D+  L++ +E +  G L NL   Y + +     YT +++  L+ +H   ++
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 196
Query: 400 HRDIKCANILVDASGSVKLADFGLA---KATTMNDVKSCKGTPFWMAPEVVNLKNRG--- 453
           HRD+K  N+L+D  G +KLADFG       T M    +  GTP +++PEV  LK++G   
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV--LKSQGGDG 254
Query: 454 -YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDARDFI 509
            YG   D WS+G  + EML    P+     +    +I   +  L       +S+ A++ I
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLI 314
Query: 510 LKCLQVNPN--DRPTAAQLMEHPFVK 533
              L        R    ++ +HPF K
Sbjct: 315 CAFLTDREVRLGRNGVEEIKQHPFFK 340

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 119/242 (49%), Gaps = 17/242 (7%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   +  Q                  +HEN++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 86
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
                   + ++ N +++   L+    L N+ +   L D  V     QIL GL Y+H  +
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +N+ V+    +K+ D GLA+ T  +++     T ++ APE++ L    Y  T
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDGGLARHTD-DEMTGYVATRWYRAPEIM-LNWMHYNQT 203
Query: 458 ADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCL 513
            DIWS+GC + E+LT +   P   H++ ++ + R +G     L+    S  AR++I    
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 514 QV 515
           Q+
Sbjct: 264 QM 265

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 215
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E   G Q  FR            +S + 
Sbjct: 216 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR----------QRVSSEC 264
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 265 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+++D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLIIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--ISKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 214
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E   G Q  FR            +S + 
Sbjct: 215 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR----------QRVSSEC 263
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 264 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 215
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E   G Q  FR            +S + 
Sbjct: 216 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR----------QRVSXEC 264
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 265 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 12/184 (6%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +VQ F   +D+  L++ +E +  G L NL   Y + +     YT +++  L+ +H    +
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRG--- 453
           HRD+K  N+L+D SG +KLADFG         +  C    GTP +++PEV  LK++G   
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV--LKSQGGDG 253
Query: 454 -YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDARDFI 509
            YG   D WS+G  + EML    P+     +    +I   +  L     N +S++A++ I
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313
Query: 510 LKCL 513
              L
Sbjct: 314 CAFL 317

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 104 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 163
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 220
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 221 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 99  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 215
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E   G Q  FR            +S + 
Sbjct: 216 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR----------QRVSSEC 264
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 265 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 118/255 (46%), Gaps = 10/255 (3%)
Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGT-QGKXXX 322
           N+ P+     +   +   +++G GSFG V    +  +  F+AVK   LQ +   + K   
Sbjct: 26  NLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVK--VLQKKAILKKKEEK 83
Query: 323 XXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSA 381
                        +H  +V    + +  ++L+  L+ +  G L  +L ++   ++ +   
Sbjct: 84  HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF 143
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTP 439
           Y  +I + L YLH  N+V+RD+K  NIL+D+ G + L DFGL K    ++  +    GTP
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP 203
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN 499
            ++APEV  L  + Y  T D W LG  + EML   PP+      +    I      L PN
Sbjct: 204 EYLAPEV--LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261
Query: 500 SLSRDARDFILKCLQ 514
            ++  AR  +   LQ
Sbjct: 262 -ITNSARHLLEGLLQ 275

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 5/170 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVD 276

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 97  KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 156
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 157 NLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 213
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 214 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 12/184 (6%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +VQ F   +D+  L++ +E +  G L NL   Y + +     YT +++  L+ +H    +
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKNRG--- 453
           HRD+K  N+L+D SG +KLADFG         +  C    GTP +++PEV  LK++G   
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV--LKSQGGDG 253
Query: 454 -YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDARDFI 509
            YG   D WS+G  + EML    P+     +    +I   +  L     N +S++A++ I
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 313
Query: 510 LKCL 513
              L
Sbjct: 314 CAFL 317

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 124/297 (41%), Gaps = 47/297 (15%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++GTVY+      G F A+K V + +                     FEH N+V+ 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
                   TD++     +F E V +     L +     L    +    RQ L GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVF-EHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-APEVVNLKNRGY 454
             +VHRD+K  NILV + G+VKLADFGLA+  +            W  APEV  L    Y
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV--LLQSTY 188
Query: 455 GLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP---------------- 495
               D+WS+GC   EM  R+P +   S  + +  +F +  G PP                
Sbjct: 189 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRDVSLPRGAFP 247
Query: 496 ---------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
                    +VP  +       +L+ L  NP+ R +A + ++H +    L K  G P
Sbjct: 248 PRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSY----LHKDEGNP 299

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 128/300 (42%), Gaps = 50/300 (16%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR---FEHENI 340
           +G G++GTVY+      G F A+K V + + G  G               R   FEH N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 341 VQYFG------TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNY 392
           V+         TD++     +F E V +     L +     L    +    RQ L GL++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVF-EHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-APEVVNLKN 451
           LH   +VHRD+K  NILV + G+VKLADFGLA+  +     +      W  APEV  L  
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEV--LLQ 193
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP------------- 495
             Y    D+WS+GC   EM  R+P +   S  + +  +F +  G PP             
Sbjct: 194 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRDVSLPRG 252
Query: 496 ------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
                       +VP  +       +L+ L  NP+ R +A + ++H +    L K  G P
Sbjct: 253 AFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSY----LHKDEGNP 307

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 50/284 (17%)
Query: 277 MSWQKGELLGSGSFGT-VYEGYTD-----------DGFFFAVKEVSLQDQGTQGKXXXXX 324
           +S+   ++LG G+ GT VY G  D           + F FA +EV L  +          
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD-------- 75
Query: 325 XXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYT 383
                      EH N+++YF T+KD    +I +EL        + QK +  +  +     
Sbjct: 76  -----------EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLL 124
Query: 384 RQILNGLNYLHEQNVVHRDIKCANILV---DASGSVK--LADFGLAKAT-----TMNDVK 433
           +Q  +GL +LH  N+VHRD+K  NIL+   +A G +K  ++DFGL K       + +   
Sbjct: 125 QQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 434 SCKGTPFWMAPEVVN---LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
              GT  W+APE+++    +N  Y  T DI+S GC    +++    P+      QA   +
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTY--TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
Query: 490 GKGEPPLVPNSLSRD--ARDFILKCLQVNPNDRPTAAQLMEHPF 531
           G      +      D  AR+ I K + ++P  RP+A  +++HPF
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + +M    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYQMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 119/271 (43%), Gaps = 27/271 (9%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 182
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E   G Q  FR            +S + 
Sbjct: 183 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR----------QRVSSEC 231
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           +  I  CL + P+DRPT  ++  HP+++  L
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 112/238 (47%), Gaps = 8/238 (3%)
Query: 285 LGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG+GSFG V    + + G  +A+K +  Q      +               F     +++
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
             + KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD
Sbjct: 110 --SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
           +K  N+++D  G +K+ DFG AK         C GTP ++APE++   ++GY    D W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWA 224
Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           LG  + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 135/301 (44%), Gaps = 63/301 (20%)
Query: 285 LGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G  G V+    +D     A+K++ L D  +                 R +H+NIV+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-----VKHALREIKIIRRLDHDNIVKV 73
Query: 344 F--------------GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNG 389
           F              G+  + N ++I  E + +  LAN+ ++  L++     +  Q+L G
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVKSCKG-------TPFW 441
           L Y+H  NV+HRD+K AN+ ++    V K+ DFGLA+   M+   S KG       T ++
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHLSEGLVTKWY 190
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS---HLEGMQALF----------- 487
            +P ++ L    Y    D+W+ GC   EMLT +  ++    LE MQ +            
Sbjct: 191 RSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 488 -----------RIGKGEP-----PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                      R    EP      L+P  +SR+A DF+ + L  +P DR TA + + HP+
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLP-GISREAVDFLEQILTFSPMDRLTAEEALSHPY 308
Query: 532 V 532
           +
Sbjct: 309 M 309

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 131/289 (45%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQ +  + +        
Sbjct: 12  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMR-- 68
Query: 328 XXXXXXRFEHENIVQ--YFGTDKDENRLFIFLELVTKGSLANLYQ--------KYHLMDS 377
                 + +H NIV+  YF     E +  ++L LV     A +Y+        K  L   
Sbjct: 69  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 183 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 237
Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTA-AQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN    A  Q+  HP+ K  + + R PP
Sbjct: 238 ----VLGTPTREQI---REMNPNYTEFAFPQIKAHPWTK--VFRPRTPP 277

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 134/287 (46%), Gaps = 29/287 (10%)
Query: 267 SPNGKFRRRIMSWQKG-----------ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQ 314
           +P   F  RI++ ++G           E+LG G FG V++   T  G   A K +     
Sbjct: 68  APPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK---- 123
Query: 315 GTQGKXXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKY 372
            T+G               + +H N++Q +   + +N + + +E V  G L +  + + Y
Sbjct: 124 -TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY 182
Query: 373 HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATT- 428
           +L +     + +QI  G+ ++H+  ++H D+K  NIL    DA   +K+ DFGLA+    
Sbjct: 183 NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKP 241
Query: 429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR 488
              +K   GTP ++APEVVN     +    D+WS+G     +L+   P+      + L  
Sbjct: 242 REKLKVNFGTPEFLAPEVVNYDFVSF--PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299
Query: 489 IGKGEPPLVPNS---LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           I      L       +S +A++FI K L    + R +A++ ++HP++
Sbjct: 300 ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 124/297 (41%), Gaps = 47/297 (15%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G G++GTVY+      G F A+K V + +                     FEH N+V+ 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 344 FG------TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
                   TD++     +F E V +     L +     L    +    RQ L GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVF-EHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-APEVVNLKNRGY 454
             +VHRD+K  NILV + G+VKLADFGLA+  +            W  APEV  L    Y
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV--LLQSTY 188
Query: 455 GLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP---------------- 495
               D+WS+GC   EM  R+P +   S  + +  +F +  G PP                
Sbjct: 189 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRDVSLPRGAFP 247
Query: 496 ---------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
                    +VP  +       +L+ L  NP+ R +A + ++H +    L K  G P
Sbjct: 248 PRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSY----LHKDEGNP 299

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+++D  G +K+ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 201
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 202 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 250
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 251 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 221
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 222 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 270
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 201
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 202 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSXEC 250
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 251 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/346 (23%), Positives = 144/346 (41%), Gaps = 70/346 (20%)
Query: 260 KEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQG 318
           K  VYN+S +         +Q   LLG G++G V    +   G   A+K++   D+    
Sbjct: 3   KRIVYNISSD---------FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK---- 49
Query: 319 KXXXXXXXXXXXXXXRFEHENIVQYFGTDKDE-----NRLFIFLELVTKGSLANLYQKYH 373
                           F+HENI+  F   + +     N ++I  EL+ +  L  +     
Sbjct: 50  PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQM 108
Query: 374 LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 433
           L D  +  +  Q L  +  LH  NV+HRD+K +N+L++++  +K+ DFGLA+    +   
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 434 SCK------------GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE 481
           + +             T ++ APEV+ L +  Y    D+WS GC + E+  R+P +   +
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
Query: 482 GMQALFRIGK--GEP---------------------PLVPNS--------LSRDARDFIL 510
               L  I    G P                     P+ P +        ++    D + 
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 511 KCLQVNPNDRPTAAQLMEHPFVKR---PLQKSRG---PPSYYNNMH 550
           + L  +P  R TA + +EHP+++    P  +  G   PPS++   H
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDH 333

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 202
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 203 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSXEC 251
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 252 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/346 (23%), Positives = 144/346 (41%), Gaps = 70/346 (20%)
Query: 260 KEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQG 318
           K  VYN+S +         +Q   LLG G++G V    +   G   A+K++   D+    
Sbjct: 3   KRIVYNISSD---------FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK---- 49
Query: 319 KXXXXXXXXXXXXXXRFEHENIVQYFGTDKDE-----NRLFIFLELVTKGSLANLYQKYH 373
                           F+HENI+  F   + +     N ++I  EL+ +  L  +     
Sbjct: 50  PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQM 108
Query: 374 LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 433
           L D  +  +  Q L  +  LH  NV+HRD+K +N+L++++  +K+ DFGLA+    +   
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 434 SCK------------GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE 481
           + +             T ++ APEV+ L +  Y    D+WS GC + E+  R+P +   +
Sbjct: 169 NSEPTGQQSGMTEYVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
Query: 482 GMQALFRIGK--GEP---------------------PLVPNS--------LSRDARDFIL 510
               L  I    G P                     P+ P +        ++    D + 
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 511 KCLQVNPNDRPTAAQLMEHPFVKR---PLQKSRG---PPSYYNNMH 550
           + L  +P  R TA + +EHP+++    P  +  G   PPS++   H
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDH 333

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 112/238 (47%), Gaps = 8/238 (3%)
Query: 285 LGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG+GSFG V    + + G  +A+K +  Q      +               F     +++
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
             + KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD
Sbjct: 110 --SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
           +K  N+++D  G +K+ DFG AK         C GTP ++APE++   ++GY    D W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWA 224
Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           LG  + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 27/271 (9%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 187
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 188 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 236
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           +  I  CL + P+DRPT  ++  HP+++  L
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+++D  G +K+ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 228
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 229 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/346 (23%), Positives = 144/346 (41%), Gaps = 70/346 (20%)
Query: 260 KEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQG 318
           K  VYN+S +         +Q   LLG G++G V    +   G   A+K++   D+    
Sbjct: 3   KRIVYNISSD---------FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK---- 49
Query: 319 KXXXXXXXXXXXXXXRFEHENIVQYFGTDKDE-----NRLFIFLELVTKGSLANLYQKYH 373
                           F+HENI+  F   + +     N ++I  EL+ +  L  +     
Sbjct: 50  PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQM 108
Query: 374 LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK 433
           L D  +  +  Q L  +  LH  NV+HRD+K +N+L++++  +K+ DFGLA+    +   
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 434 SCK------------GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE 481
           + +             T ++ APEV+ L +  Y    D+WS GC + E+  R+P +   +
Sbjct: 169 NSEPTGQQSGMTEXVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
Query: 482 GMQALFRIGK--GEP---------------------PLVPNS--------LSRDARDFIL 510
               L  I    G P                     P+ P +        ++    D + 
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 511 KCLQVNPNDRPTAAQLMEHPFVKR---PLQKSRG---PPSYYNNMH 550
           + L  +P  R TA + +EHP+++    P  +  G   PPS++   H
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDH 333

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 112/238 (47%), Gaps = 8/238 (3%)
Query: 285 LGSGSFGTVY-EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG+GSFG V    + + G  +A+K +  Q      +               F     +++
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
             + KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD
Sbjct: 110 --SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
           +K  N+++D  G +K+ DFG AK         C GTP ++APE++   ++GY    D W+
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWA 224
Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           LG  + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 225 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 202
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 203 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 251
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 252 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 27/271 (9%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 187
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 188 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 236
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           +  I  CL + P+DRPT  ++  HP+++  L
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 267

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+++D  G +K+ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 229
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 230 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSXEC 278
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 279 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 99/192 (51%), Gaps = 4/192 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++  E  + G + + L       + +  A  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+DA  ++K+ADFG +   T  N + +  G P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD- 190
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P   S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYXSTDCENLLKKFLI 249
Query: 515 VNPNDRPTAAQL 526
           +NP+ R T  Q+
Sbjct: 250 LNPSKRGTLEQI 261

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 27/271 (9%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 186
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 187 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 235
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           +  I  CL + P+DRPT  ++  HP+++  L
Sbjct: 236 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 266

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+++D  G +++ DFGLAK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLMIDQQGYIQVTDFGLAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 234
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 235 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSXEC 283
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 284 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 311

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 214
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 215 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 263
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 264 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP  +APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEALAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-----LMDSQVSAYTRQILNG 389
            +H NI++ F   +D + ++I +E    G L             L +  V+   +Q++N 
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 390 LNYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMNDVKS-CKGTPFWMAPE 445
           L Y H Q+VVH+D+K  NIL   +     +K+ DFGLA+    ++  +   GT  +MAPE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY--SHLEGMQALFRIGKGEPPLVPNSLSR 503
           V     R      DIWS G  +  +LT   P+  + LE +Q      +    +    L+ 
Sbjct: 197 VF---KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
            A D + + L  +P  RP+AAQ++ H + K+
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 27/271 (9%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 182
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 183 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSXEC 231
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           +  I  CL + P+DRPT  ++  HP+++  L
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 187
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 188 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 236
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 367 RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 425
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 426 QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 484
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 485 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 545 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 602
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 603 DLMNLCWTYDVENRPGFAAV 622

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 24  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 80
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 81  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 194
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 195 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 249
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 250 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 289

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V  G     +  A+K +       +G                  HE +VQ +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  +FI  E +  G L N  +  ++     Q+    + +   + YL  +  +HRD
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 130
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV+  G VK++DFGL++    ++  S +G+ F   W  PEV  L    +   +D
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEV--LMYSKFSSKSD 188
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           IW+ G  + E+ +  + PY      +    I +G     P+  S      +  C     +
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 248
Query: 519 DRPTAAQLM 527
           +RPT   L+
Sbjct: 249 ERPTFKILL 257

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 368 RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 426
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 427 QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 485
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 486 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 546 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 603
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 604 DLMNLCWTYDVENRPGFAAV 623

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 31  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 87
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 88  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 142 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 201
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 202 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 256
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 257 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 296

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 20  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 76
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 77  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 131 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 190
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 191 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 245
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 246 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 285

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK         C GTP ++AP ++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPAII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 229
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 230 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 278
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 279 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 11/213 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NI++ + T +D   +++ +EL T G L   +  K    +S  +   + +L+ + Y 
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 394 HEQNVVHRDIKCAN--ILVDASGS-VKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNL 449
           H+ NV HRD+K  N   L D+  S +KL DFGLA       +   K GTP++++P+V+  
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-- 180
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDAR 506
               YG   D WS G  +  +L   PP+S     + + +I +G    P     ++S  A 
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAE 239
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
             I + L  +P  R T+ Q +EH + ++ L  S
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 118/268 (44%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 209
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 210 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSXEC 258
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P+DRPT  ++  HP+++
Sbjct: 259 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 286

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 46  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 102
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 103 ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 216
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 217 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 271
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 272 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 311

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 11/213 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H NI++ + T +D   +++ +EL T G L   +  K    +S  +   + +L+ + Y 
Sbjct: 80  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 139
Query: 394 HEQNVVHRDIKCAN--ILVDASGS-VKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNL 449
           H+ NV HRD+K  N   L D+  S +KL DFGLA       +   K GTP++++P+V+  
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-- 197
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDAR 506
               YG   D WS G  +  +L   PP+S     + + +I +G    P     ++S  A 
Sbjct: 198 -EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAE 256
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
             I + L  +P  R T+ Q +EH + ++ L  S
Sbjct: 257 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 289

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 12  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 68
Query: 328 XXXXXXRFEHENIVQ--YFGTDKDENRLFIFLELVTKGSLANLYQ--------KYHLMDS 377
                 + +H NIV+  YF     E +  ++L LV       +Y+        K  L   
Sbjct: 69  ------KLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 183 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 237
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 238 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 277

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 46  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 102
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 103 ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 217 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 271
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 272 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 311

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 117/268 (43%), Gaps = 27/268 (10%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 202
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 203 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSXEC 251
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           +  I  CL + P DRPT  ++  HP+++
Sbjct: 252 QHLIRWCLALRPXDRPTFEEIQNHPWMQ 279

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 25  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 81
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 82  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 136 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 195
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 196 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 250
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 251 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 290

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 24  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 80
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 81  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 194
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 195 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 249
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 250 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 289

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 13  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 69
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 70  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 124 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 183
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 184 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 238
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 239 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 278

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 40  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 96
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 97  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 150
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 151 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 210
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 211 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 265
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 266 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 305

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK           GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-GRTWXLXGTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLN 391
           +  H+NIV     D++++  ++ +E +   +L+   + +    +D+ ++ +T QIL+G+ 
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN-FTNQILDGIK 125
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTPFWMAPEVVN 448
           + H+  +VHRDIK  NIL+D++ ++K+ DFG+AKA   T++       GT  + +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--Q 183
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA--- 505
            K        DI+S+G  + EML  +PP++    +    +  +   P V   + +D    
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 506 -RDFILKCLQVNPNDRPTAAQLME 528
             + IL+  + +  +R    Q M+
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMK 267

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 48  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 104
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 105 ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 158
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 159 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 218
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 219 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 273
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 274 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 313

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 12  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 68
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 69  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 183 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 237
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 238 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 277

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 12  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 68
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 69  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 183 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 237
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 238 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 277

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 27/271 (9%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 182
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 183 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 231
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           +  I  CL + P+DRPT  ++  HP+++  L
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E V  G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+L+D  G +++ DFG AK           GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-GRTWXLAGTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 119/271 (43%), Gaps = 27/271 (9%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKXXXXXXXXXXXXXXR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G                   
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 335 FEHENIVQYFGTDKDENRLFIFLELV--TKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE     +     + ++  L +    ++  Q+L  + +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTMNDVKSCKGTPFWMAPEVVN 448
            H   V+HRDIK  NIL+D + G +KL DFG   L K T   D     GT  +  PE + 
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIR 185
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDA 505
             +R +G +A +WSLG  + +M+    P+ H E +   Q  FR            +S + 
Sbjct: 186 Y-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------QRVSSEC 234
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           +  I  CL + P+DRPT  ++  HP+++  L
Sbjct: 235 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 265

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 115/258 (44%), Gaps = 25/258 (9%)
Query: 284 LLGSGSFGTVYEG-YTD---DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LG G FG VYEG YT+   +    AVK    +D     K                +H +
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMK---NLDHPH 86
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQN 397
           IV+  G  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + YL   N
Sbjct: 87  IVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 145
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGY 454
            VHRDI   NILV +   VKL DFGL++     D      T     WM+PE +N   R +
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--RRF 203
Query: 455 GLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
              +D+W     + E+L+  + P+  LE    +  + KG+    P L P  L       +
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT----LM 259
Query: 510 LKCLQVNPNDRPTAAQLM 527
            +C   +P+DRP   +L+
Sbjct: 260 TRCWDYDPSDRPRFTELV 277

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 50  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 106
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 107 ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 160
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 161 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 220
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 221 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 275
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 276 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 315

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 33/274 (12%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E++G G+FG V +        +  K+V+++    + +              R  H NIV+
Sbjct: 15  EVVGRGAFGVVCKAK------WRAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVK 66
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKY----HLMDSQVSAYTRQILNGLNYLHE--- 395
            +G     N + + +E    GSL N+        +   +   ++  Q   G+ YLH    
Sbjct: 67  LYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 396 QNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
           + ++HRD+K  N+L+ A G+V K+ DFG A       + + KG+  WMAPEV    N  Y
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTHMTNNKGSAAWMAPEVFEGSN--Y 181
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEG--MQALFRIGKG-EPPLVPNSLSRDARDFILK 511
               D++S G  + E++TR+ P+  + G   + ++ +  G  PPL+ N L +     + +
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN-LPKPIESLMTR 240
Query: 512 CLQVNPNDRPTA---AQLMEH-----PFVKRPLQ 537
           C   +P+ RP+     ++M H     P    PLQ
Sbjct: 241 CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 274

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 115/258 (44%), Gaps = 25/258 (9%)
Query: 284 LLGSGSFGTVYEG-YTD---DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LG G FG VYEG YT+   +    AVK    +D     K                +H +
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMK---NLDHPH 70
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQN 397
           IV+  G  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + YL   N
Sbjct: 71  IVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 129
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGY 454
            VHRDI   NILV +   VKL DFGL++     D      T     WM+PE +N   R +
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--RRF 187
Query: 455 GLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
              +D+W     + E+L+  + P+  LE    +  + KG+    P L P  L       +
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT----LM 243
Query: 510 LKCLQVNPNDRPTAAQLM 527
            +C   +P+DRP   +L+
Sbjct: 244 TRCWDYDPSDRPRFTELV 261

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQ +  + +        
Sbjct: 12  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMR-- 68
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 69  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 183 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 237
Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTA-AQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN    A  Q+  HP+ K  + + R PP
Sbjct: 238 ----VLGTPTREQI---REMNPNYTEFAFPQIKAHPWTK--VFRPRTPP 277

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 17  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 73
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 74  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 128 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 187
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 188 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 242
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 243 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 282

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 12  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 68
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 69  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 183 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 237
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 238 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 277

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 16  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 72
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 73  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 127 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 186
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 187 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 241
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 242 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 281

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 133/289 (46%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQD+  + +        
Sbjct: 91  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNRELQIMR-- 147
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 148 ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 201
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 202 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 261
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 262 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 316
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 317 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 356

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 115/258 (44%), Gaps = 25/258 (9%)
Query: 284 LLGSGSFGTVYEG-YTD---DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           +LG G FG VYEG YT+   +    AVK    +D     K                +H +
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMK---NLDHPH 74
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQN 397
           IV+  G  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + YL   N
Sbjct: 75  IVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGY 454
            VHRDI   NILV +   VKL DFGL++     D      T     WM+PE +N   R +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--RRF 191
Query: 455 GLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
              +D+W     + E+L+  + P+  LE    +  + KG+    P L P  L       +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT----LM 247
Query: 510 LKCLQVNPNDRPTAAQLM 527
            +C   +P+DRP   +L+
Sbjct: 248 TRCWDYDPSDRPRFTELV 265

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 33/274 (12%)
Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           E++G G+FG V +        +  K+V+++    + +              R  H NIV+
Sbjct: 14  EVVGRGAFGVVCKAK------WRAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVK 65
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKY----HLMDSQVSAYTRQILNGLNYLHE--- 395
            +G     N + + +E    GSL N+        +   +   ++  Q   G+ YLH    
Sbjct: 66  LYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 396 QNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
           + ++HRD+K  N+L+ A G+V K+ DFG A       + + KG+  WMAPEV    N  Y
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTHMTNNKGSAAWMAPEVFEGSN--Y 180
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEG--MQALFRIGKG-EPPLVPNSLSRDARDFILK 511
               D++S G  + E++TR+ P+  + G   + ++ +  G  PPL+ N L +     + +
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN-LPKPIESLMTR 239
Query: 512 CLQVNPNDRPTA---AQLMEH-----PFVKRPLQ 537
           C   +P+ RP+     ++M H     P    PLQ
Sbjct: 240 CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 23  RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 81
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 82  QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 140
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 141 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 201 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 258
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 259 DLMNLCWTYDVENRPGFAAV 278

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 25  RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 83
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 84  QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 142
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 143 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 203 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 260
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 261 DLMNLCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 25  RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 83
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 84  QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 142
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 143 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 203 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 260
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 261 DLMNLCWTYDVENRPGFAAV 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 348 KDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA 406
           KD + L++ +E    G + ++L +     +     Y  QI+    YLH  ++++RD+K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           N+++D  G +++ DFG AK         C GTP ++APE++   ++GY    D W+LG  
Sbjct: 171 NLMIDQQGYIQVTDFGFAKRVKGRTWXLC-GTPEYLAPEII--LSKGYNKAVDWWALGVL 227
Query: 467 VLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
           + EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 38/298 (12%)
Query: 260 KEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQ 314
           K+P   V P   F +R +  ++   LG G FG V    Y+   D+ G   AVK +  +  
Sbjct: 7   KKPATEVDPT-HFEKRFL--KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63
Query: 315 GTQGKXXXXXXXXXXXXXXRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLY--Q 370
           G                     HENIV+Y G  T+   N + + +E +  GSL       
Sbjct: 64  GNH----IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 119
Query: 371 KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 430
           K  +   Q   Y  QI  G++YL  +  VHRD+   N+LV++   VK+ DFGL KA   +
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179
Query: 431 D----VKSCKGTP-FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR------------ 473
                VK  + +P FW APE   L    + + +D+WS G T+ E+LT             
Sbjct: 180 KEXXTVKDDRDSPVFWYAPEC--LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL 237
Query: 474 ---QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
               P +  +   + +  + +G+    P +   +    + KC +  P++R +   L+E
Sbjct: 238 KMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 130/263 (49%), Gaps = 15/263 (5%)
Query: 281 KGE-LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           KG+ +LG GSFG V        G   AVK +S   +  + K              + +H 
Sbjct: 35  KGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           NI++ +   +D+   ++  E+ T G L + +  +    +   +   RQ+L+G+ Y+H+  
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 398 VVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           +VHRD+K  N+L+++     ++++ DFGL+        +K   GT +++APEV+   +  
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL---HGT 209
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPN--SLSRDARDFIL 510
           Y    D+WS G  +  +L+  PP++       L ++ KG+    +P    +S  A+D I 
Sbjct: 210 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 269
Query: 511 KCLQVNPNDRPTAAQLMEHPFVK 533
           K L   P+ R +A   ++H +++
Sbjct: 270 KMLTYVPSMRISARDALDHEWIQ 292

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 24/278 (8%)
Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           +K ++LGSG FGTV++G +  +G    +       +   G+                +H 
Sbjct: 34  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 93
Query: 339 NIVQYFGTDKDENRLFIFLELVTK----GSLANLYQKYH--LMDSQVSAYTRQILNGLNY 392
           +IV+  G     +     L+LVT+    GSL +  +++   L    +  +  QI  G+ Y
Sbjct: 94  HIVRLLGLCPGSS-----LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTPF-WMAPEVVN 448
           L E  +VHR++   N+L+ +   V++ADFG+A     +D   + S   TP  WMA E ++
Sbjct: 149 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 449 LKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
                Y   +D+WS G TV E++T    PY+ L   +    + KGE    P   + D   
Sbjct: 209 FGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM 266
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
            ++KC  ++ N RPT  +L    F +     +R PP Y
Sbjct: 267 VMVKCWMIDENIRPTFKELANE-FTRM----ARDPPRY 299

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 132/265 (49%), Gaps = 19/265 (7%)
Query: 281 KGE-LLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           KG+ +LG GSFG V    +  T  G   AVK +S   +  + K              + +
Sbjct: 29  KGQRVLGKGSFGEVILCKDKIT--GQECAVKVIS--KRQVKQKTDKESLLREVQLLKQLD 84
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NI++ +   +D+   ++  E+ T G L + +  +    +   +   RQ+L+G+ Y+H+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 396 QNVVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDVKSCKGTPFWMAPEVVNLKN 451
             +VHRD+K  N+L+++     ++++ DFGL+        +K   GT +++APEV+   +
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL---H 201
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPN--SLSRDARDF 508
             Y    D+WS G  +  +L+  PP++       L ++ KG+    +P    +S  A+D 
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVK 533
           I K L   P+ R +A   ++H +++
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQ 286

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 40/288 (13%)
Query: 279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           ++K   +G GS+G V++    D G   A+K+     +                   + +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQLKH 61
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANL--YQKYHLMDSQVSAYTRQILNGLNYLHE 395
            N+V      + + RL +  E      L  L  YQ+  + +  V + T Q L  +N+ H+
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHK 120
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSCKGTPFWMAPEVVNLKNRG 453
            N +HRD+K  NIL+     +KL DFG A+  T   +       T ++ +PE++ + +  
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL-VGDTQ 179
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN-------------- 499
           YG   D+W++GC   E+L+  P +     +  L+ I K    L+P               
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 500 ----------------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                           ++S  A   +  CL ++P +R T  QL+ HP+
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V  G     +  A+K +       +G                  HE +VQ +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  +FI  E +  G L N  +  ++     Q+    + +   + YL  +  +HRD
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV  L    +   +D
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMYSKFSSKSD 183
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           IW+ G  + E+ +  + PY      +    I +G     P+  S      +  C     +
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 243
Query: 519 DRPTAAQLM 527
           +RPT   L+
Sbjct: 244 ERPTFKILL 252

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V  G     +  A+K +       +G                  HE +VQ +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLVQLY 69
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  +FI  E +  G L N  +  ++     Q+    + +   + YL  +  +HRD
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 129
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV  L    +   +D
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMYSKFSSKSD 187
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           IW+ G  + E+ +  + PY      +    I +G     P+  S      +  C     +
Sbjct: 188 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 247
Query: 519 DRPTAAQLM 527
           +RPT   L+
Sbjct: 248 ERPTFKILL 256

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 9   RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 67
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 68  QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 126
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 127 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 187 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 244
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 245 DLMNLCWTYDVENRPGFAAV 264

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 130/263 (49%), Gaps = 15/263 (5%)
Query: 281 KGE-LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           KG+ +LG GSFG V        G   AVK +S   +  + K              + +H 
Sbjct: 52  KGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           NI++ +   +D+   ++  E+ T G L + +  +    +   +   RQ+L+G+ Y+H+  
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 398 VVHRDIKCANILVDAS---GSVKLADFGLAKA-TTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           +VHRD+K  N+L+++     ++++ DFGL+        +K   GT +++APEV+   +  
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL---HGT 226
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPN--SLSRDARDFIL 510
           Y    D+WS G  +  +L+  PP++       L ++ KG+    +P    +S  A+D I 
Sbjct: 227 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 286
Query: 511 KCLQVNPNDRPTAAQLMEHPFVK 533
           K L   P+ R +A   ++H +++
Sbjct: 287 KMLTYVPSMRISARDALDHEWIQ 309

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 15  RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 73
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 74  QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 193 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 250
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 251 DLMNLCWTYDVENRPGFAAV 270

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V  G     +  A+K +       +G                  HE +VQ +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  +FI  E +  G L N  +  ++     Q+    + +   + YL  +  +HRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV  L    +   +D
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMYSKFSSKSD 203
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           IW+ G  + E+ +  + PY      +    I +G     P+  S      +  C     +
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 519 DRPTAAQLM 527
           +RPT   L+
Sbjct: 264 ERPTFKILL 272

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 127/259 (49%), Gaps = 14/259 (5%)
Query: 284 LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           +LG GSFG V        G   AVK +S   +  + K              + +H NI++
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLLREVQLLKQLDHPNIMK 114
Query: 343 YFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
            +   +D+   ++  E+ T G L + +  +    +   +   RQ+L+G+ Y+H+  +VHR
Sbjct: 115 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR 174
Query: 402 DIKCANILVDAS---GSVKLADFGLAKA-TTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           D+K  N+L+++     ++++ DFGL+        +K   GT +++APEV+   +  Y   
Sbjct: 175 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL---HGTYDEK 231
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPN--SLSRDARDFILKCLQ 514
            D+WS G  +  +L+  PP++       L ++ KG+    +P    +S  A+D I K L 
Sbjct: 232 CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLT 291
Query: 515 VNPNDRPTAAQLMEHPFVK 533
             P+ R +A   ++H +++
Sbjct: 292 YVPSMRISARDALDHEWIQ 310

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 24/278 (8%)
Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           +K ++LGSG FGTV++G +  +G    +       +   G+                +H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 339 NIVQYFGTDKDENRLFIFLELVTK----GSLANLYQKYH--LMDSQVSAYTRQILNGLNY 392
           +IV+  G     +     L+LVT+    GSL +  +++   L    +  +  QI  G+ Y
Sbjct: 76  HIVRLLGLCPGSS-----LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTPF-WMAPEVVN 448
           L E  +VHR++   N+L+ +   V++ADFG+A     +D   + S   TP  WMA E ++
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 449 LKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
                Y   +D+WS G TV E++T    PY+ L   +    + KGE    P   + D   
Sbjct: 191 FGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM 248
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
            ++KC  ++ N RPT  +L    F +     +R PP Y
Sbjct: 249 VMVKCWMIDENIRPTFKELANE-FTRM----ARDPPRY 281

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 9   RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 67
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 68  QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 126
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 127 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 187 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 244
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 245 DLMNLCWTYDVENRPGFAAV 264

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 43/288 (14%)
Query: 283 ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           ELLG G++  V    +  +G  +AVK +  Q   ++ +              +    NI+
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNK----NIL 74
Query: 342 QYFGTDKDENRLFIFLELVTKGS-LANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
           +     +D+ R ++  E +  GS LA++ ++ H  + + S   R +   L++LH + + H
Sbjct: 75  ELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAH 134
Query: 401 RDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSCK-----------GTPFWMAPEV 446
           RD+K  NIL ++      VK+ DF L     +N+  SC            G+  +MAPEV
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNN--SCTPITTPELTTPCGSAEYMAPEV 192
Query: 447 VNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA------LFRI-------- 489
           V +   +   Y    D+WSLG  +  ML+  PP+    G         + R+        
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 252
Query: 490 ---GKGE-PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
              GK E P      +S +A+D I K L  +   R +AAQ+++HP+V+
Sbjct: 253 IQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V  G     +  A+K +       +G                  HE +VQ +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  +FI  E +  G L N  +  ++     Q+    + +   + YL  +  +HRD
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 130
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV  L    +   +D
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMYSKFSSKSD 188
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           IW+ G  + E+ +  + PY      +    I +G     P+  S      +  C     +
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 248
Query: 519 DRPTAAQLM 527
           +RPT   L+
Sbjct: 249 ERPTFKILL 257

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 3   RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 61
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 62  QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 120
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 121 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 181 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 238
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 239 DLMNLCWTYDVENRPGFAAV 258

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 11/260 (4%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           R++++ +  EL GSG+FGTV +GY           V +                      
Sbjct: 5   RKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNY 392
           + ++  IV+  G  + E+ + + +E+   G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 64  QLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVV 447
           L E N VHRD+   N+L+      K++DFGL+KA   ++     ++    P  W APE +
Sbjct: 123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           N     +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  
Sbjct: 183 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240
Query: 507 DFILKCLQVNPNDRPTAAQL 526
           D +  C   +  +RP  A +
Sbjct: 241 DLMNLCWTYDVENRPGFAAV 260

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 111/225 (49%), Gaps = 28/225 (12%)
Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXX 324
           NV+ N  F  R +S   G  +G G FG VY+GY ++      K  ++ D  T+       
Sbjct: 22  NVTNN--FDERPISV-GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE--ELKQQ 76
Query: 325 XXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ--VSAY 382
                    + +HEN+V+  G   D + L +    +  GSL +   +   +D    +S +
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD---RLSCLDGTPPLSWH 133
Query: 383 TRQIL-----NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMND 431
            R  +     NG+N+LHE + +HRDIK ANIL+D + + K++DFGLA+A      T M  
Sbjct: 134 MRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMX- 192
Query: 432 VKSCKGTPFWMAPEVVNLKNRGYGL-TADIWSLGCTVLEMLTRQP 475
                GT  +MAPE +    RG     +DI+S G  +LE++T  P
Sbjct: 193 -SRIVGTTAYMAPEAL----RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 111/225 (49%), Gaps = 28/225 (12%)
Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXX 324
           NV+ N  F  R +S   G  +G G FG VY+GY ++      K  ++ D  T+       
Sbjct: 22  NVTNN--FDERPISV-GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE--ELKQQ 76
Query: 325 XXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ--VSAY 382
                    + +HEN+V+  G   D + L +    +  GSL +   +   +D    +S +
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD---RLSCLDGTPPLSWH 133
Query: 383 TRQIL-----NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMND 431
            R  +     NG+N+LHE + +HRDIK ANIL+D + + K++DFGLA+A      T M  
Sbjct: 134 MRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMX- 192
Query: 432 VKSCKGTPFWMAPEVVNLKNRGYGL-TADIWSLGCTVLEMLTRQP 475
                GT  +MAPE +    RG     +DI+S G  +LE++T  P
Sbjct: 193 -XRIVGTTAYMAPEAL----RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V  G     +  A+K +       +G                  HE +VQ +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  +FI  E +  G L N  +  ++     Q+    + +   + YL  +  +HRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV  L    +   +D
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEV--LMYSKFSSKSD 203
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           IW+ G  + E+ +  + PY      +    I +G     P+  S      +  C     +
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 519 DRPTAAQLM 527
           +RPT   L+
Sbjct: 264 ERPTFKILL 272

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG+G FG V  G     +  A+K +       +G                  HE +VQ +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLVQLY 76
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G    +  +FI  E +  G L N  +  ++     Q+    + +   + YL  +  +HRD
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 136
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV  L    +   +D
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMYSKFSSKSD 194
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           IW+ G  + E+ +  + PY      +    I +G     P+  S      +  C     +
Sbjct: 195 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 254
Query: 519 DRPTAAQLM 527
           +RPT   L+
Sbjct: 255 ERPTFKILL 263

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 121/283 (42%), Gaps = 31/283 (10%)
Query: 274 RRIMSWQKGEL-LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           R  + W   +L LG GSFG V+       GF  AVK+V L+                   
Sbjct: 89  REEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLE----------VFRAEELMA 138
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLM-DSQVSAYTRQILNGL 390
                   IV  +G  ++   + IF+EL+  GSL  L ++   + + +   Y  Q L GL
Sbjct: 139 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGL 198
Query: 391 NYLHEQNVVHRDIKCANILVDASGS-VKLADF---------GLAKATTMNDVKSCKGTPF 440
            YLH + ++H D+K  N+L+ + GS   L DF         GL K+    D     GT  
Sbjct: 199 EYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY--IPGTET 256
Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VP 498
            MAPEVV    R      D+WS  C +L ML    P++         +I    PP+  +P
Sbjct: 257 HMAPEVV--LGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP 314
Query: 499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
            S +      I + L+  P  R +AA+L     V R LQ+  G
Sbjct: 315 PSCAPLTAQAIQEGLRKEPIHRVSAAELGGK--VNRALQQVGG 355

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 115/265 (43%), Gaps = 37/265 (13%)
Query: 285 LGSGSFGTVY--EGY----TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           LG G+FG V+  E Y    T D    AVK  +L+D     +                +HE
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREAELLT---NLQHE 77
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH------LMD------------SQVS 380
           +IV+++G   D + L +  E +  G L N + + H      L+D            SQ+ 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 381 AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF 440
               QI +G+ YL  Q+ VHRD+   N LV A+  VK+ DFG+++     D     G   
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 441 ----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPP 495
               WM PE  ++  R +   +D+WS G  + E+ T  + P+  L   + +  I +G   
Sbjct: 197 LPIRWMPPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 254
Query: 496 LVPNSLSRDARDFILKCLQVNPNDR 520
             P    ++  D +L C Q  P  R
Sbjct: 255 ERPRVCPKEVYDVMLGCWQREPQQR 279

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 132/289 (45%), Gaps = 37/289 (12%)
Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
            G  R + +S+   +++G+GSFG VY+    D G   A+K+V LQ +  + +        
Sbjct: 12  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFKNRELQIMR-- 68
Query: 328 XXXXXXRFEHENIVQ--YF----GTDKDENRLFIFLELV--TKGSLANLYQ--KYHLMDS 377
                 + +H NIV+  YF    G  KDE  L + L+ V  T   +A  Y   K  L   
Sbjct: 69  ------KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMNDVK-SC 435
            V  Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S 
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
             + ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K    
Sbjct: 183 ICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK---- 237
Query: 496 LVPNSLSRDARDFILKCLQVNPN-DRPTAAQLMEHPFVKRPLQKSRGPP 543
                L    R+ I    ++NPN       Q+  HP+ K  + + R PP
Sbjct: 238 ----VLGTPTREQI---REMNPNYTEFKFPQIKAHPWTK--VFRPRTPP 277

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 13/278 (4%)
Query: 273 RRRIMSWQKGELLGSGSFGTV-YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           +R I  +   E LG GSFG V    +       A+K +S Q                   
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLN 391
             R  H +I++ +        + + +E         + +K  + + +   + +QI+  + 
Sbjct: 65  LLR--HPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLK 450
           Y H   +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+P + APEV+N K
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
               G   D+WS G  +  ML  + P+   E +  LF+       ++P+ LS  A+  I 
Sbjct: 183 LYA-GPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240
Query: 511 KCLQVNPNDRPTAAQLMEHPFVK-------RPLQKSRG 541
           + +  +P  R T  ++   P+         RP+++ +G
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQG 278

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 112/223 (50%), Gaps = 24/223 (10%)
Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXX 324
           NV+ N  F  R +S   G  +G G FG VY+GY ++      K  ++ D  T+       
Sbjct: 16  NVTNN--FDERPISV-GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE--ELKQQ 70
Query: 325 XXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ--VSAY 382
                    + +HEN+V+  G   D + L +    +  GSL +   +   +D    +S +
Sbjct: 71  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD---RLSCLDGTPPLSWH 127
Query: 383 TRQIL-----NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSC 435
            R  +     NG+N+LHE + +HRDIK ANIL+D + + K++DFGLA+A+      V   
Sbjct: 128 MRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXX 187
Query: 436 K--GTPFWMAPEVVNLKNRG-YGLTADIWSLGCTVLEMLTRQP 475
           +  GT  +MAPE +    RG     +DI+S G  +LE++T  P
Sbjct: 188 RIVGTTAYMAPEAL----RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 39/290 (13%)
Query: 276 IMSWQKGELLGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR 334
           +  ++K E +G G++GTV++    +     A+K V L D     +               
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKE 57
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNY 392
            +H+NIV+       + +L +  E   +  L   +   +  L    V ++  Q+L GL +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKN 451
            H +NV+HRD+K  N+L++ +G +KLADFGLA+A  +     S +    W  P  V    
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEP------------- 494
           + Y  + D+WS GC   E+     P        + ++ +FR+  G P             
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRL-LGTPTEEQWPSMTKLPD 235
Query: 495 ----PLVPNS---------LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
               P+ P +         L+   RD +   L+ NP  R +A + ++HP+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG FG V+ GY  +    A+K +       +G               +  H  +VQ +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G   ++  + +  E +  G L++    Q+       +      +  G+ YL E +V+HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 186
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +WS G  + E+ +  + PY +    + +  I  G     P   S      +  C +  P 
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 246
Query: 519 DRPTAAQLM 527
           DRP  ++L+
Sbjct: 247 DRPAFSRLL 255

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 120/281 (42%), Gaps = 27/281 (9%)
Query: 274 RRIMSWQKGEL-LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           R  + W   +L LG GSFG V+       GF  AVK+V L+                   
Sbjct: 70  REEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLE----------VFRAEELMA 119
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLM-DSQVSAYTRQILNGL 390
                   IV  +G  ++   + IF+EL+  GSL  L ++   + + +   Y  Q L GL
Sbjct: 120 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGL 179
Query: 391 NYLHEQNVVHRDIKCANILVDASGS-VKLADFGLAKATTMNDVKS-------CKGTPFWM 442
            YLH + ++H D+K  N+L+ + GS   L DFG A     + +           GT   M
Sbjct: 180 EYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHM 239
Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNS 500
           APEVV    R      D+WS  C +L ML    P++         +I    PP+  +P S
Sbjct: 240 APEVV--LGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPS 297
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
            +      I + L+  P  R +AA+L     V R LQ+  G
Sbjct: 298 CAPLTAQAIQEGLRKEPIHRVSAAELGGK--VNRALQQVGG 336

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 353 LFIFLELVTKGSLANLYQKYHLM-----DSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           L + L L+  G L   +  YH+      +++   Y  +I  GL  LH + +V+RD+K  N
Sbjct: 259 LCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316
Query: 408 ILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           IL+D  G ++++D GLA        +K   GT  +MAPEVV  KN  Y  + D W+LGC 
Sbjct: 317 ILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWALGCL 374
Query: 467 VLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR--- 520
           + EM+  Q P+   +     + + R+ K  P       S  AR    + L  +P +R   
Sbjct: 375 LYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGC 434
Query: 521 --PTAAQLMEHPFVKR 534
              +A ++ EHP  K+
Sbjct: 435 RGGSAREVKEHPLFKK 450

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 273 RRRIMSWQKGELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXX 329
           ++R   ++ G++LG GSF TV    E  T   +   +    L+ +    +          
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRER 61
Query: 330 XXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILN 388
               R +H   V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++
Sbjct: 62  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 121
Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAP 444
            L YLH + ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++P
Sbjct: 122 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD 504
           E+  L  +    ++D+W+LGC + +++   PP+          +I K E    P      
Sbjct: 182 EL--LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPK 238
Query: 505 ARDFILKCLQVNPNDRPTAAQ------LMEHPF 531
           ARD + K L ++   R    +      L  HPF
Sbjct: 239 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 271

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 273 RRRIMSWQKGELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXX 329
           ++R   ++ G++LG GSF TV    E  T   +   +    L+ +    +          
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRER 60
Query: 330 XXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILN 388
               R +H   V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++
Sbjct: 61  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 120
Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAP 444
            L YLH + ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++P
Sbjct: 121 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD 504
           E+  L  +    ++D+W+LGC + +++   PP+          +I K E    P      
Sbjct: 181 EL--LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPK 237
Query: 505 ARDFILKCLQVNPNDRPTAAQ------LMEHPF 531
           ARD + K L ++   R    +      L  HPF
Sbjct: 238 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 270

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 131/267 (49%), Gaps = 23/267 (8%)
Query: 281 KGE-LLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFE 336
           KG+ +LG GSFG V    +  T  G   AVK +S   +  + K              + +
Sbjct: 29  KGQRVLGKGSFGEVILCKDKIT--GQECAVKVIS--KRQVKQKTDKESLLREVQLLKQLD 84
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NI + +   +D+   ++  E+ T G L + +  +    +   +   RQ+L+G+ Y H+
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 396 QNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNL 449
             +VHRD+K  N+L+++     ++++ DFGL  +T     K  K   GT +++APEV+  
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGL--STHFEASKKXKDKIGTAYYIAPEVL-- 200
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPN--SLSRDAR 506
            +  Y    D+WS G  +  +L+  PP++       L ++ KG+    +P    +S  A+
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           D I K L   P+ R +A   ++H +++
Sbjct: 260 DLIRKXLTYVPSXRISARDALDHEWIQ 286

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 131/275 (47%), Gaps = 26/275 (9%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG GSF    +  +      FAVK +S + +    K                 H NIV+ 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG-------HPNIVKL 71
Query: 344 FGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
                D+   F+ +EL+  G L   + +K H  +++ S   R++++ ++++H+  VVHRD
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 403 IKCANILVDASG---SVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRGYGLT 457
           +K  N+L         +K+ DFG A+    ++  +K+   T  + APE++N    GY  +
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN--QNGYDES 189
Query: 458 ADIWSLGCTVLEMLTRQPPY-SH------LEGMQALFRIGKGEPPL---VPNSLSRDARD 507
            D+WSLG  +  ML+ Q P+ SH         ++ + +I KG+         ++S++A+D
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
            I   L V+PN R   + L  + +++   Q S  P
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 116/264 (43%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +         S  GT  +++PE+  L  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL--LTEKS 210
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 269
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 337 HENIVQYFG--TDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNY 392
           HENIV+Y G  T+   N + + +E +  GSL       K  +   Q   Y  QI  G++Y
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 129
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVV 447
           L  +  VHRD+   N+LV++   VK+ DFGL KA   +     VK  + +P FW APE  
Sbjct: 130 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC- 188
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR---------------QPPYSHLEGMQALFRIGKG 492
            L    + + +D+WS G T+ E+LT                 P +  +   + +  + +G
Sbjct: 189 -LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 247
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           +    P +   +    + KC +  P++R +   L+E
Sbjct: 248 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 346 TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT---------RQILNGLNYLH-E 395
           T+ DE  ++I  E +   S+    + + ++D   + +          + +LN  +Y+H E
Sbjct: 113 TNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           +N+ HRD+K +NIL+D +G VKL+DFG ++      +K  +GT  +M PE  + ++   G
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG 230
Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALF---RIGKGEPPL---------------- 496
              DIWSLG  +  M     P+S    +  LF   R    E PL                
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
             N LS +  DF+   L+ NP +R T+   ++H ++
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 335 FEHENIVQYFGTDKDENRL----FIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNG 389
             H  IV  + T + E       +I +E V   +L ++      M  + +          
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAP 444
           LN+ H+  ++HRD+K ANI++ A+ +VK+ DFG+A+A      ++    +  GT  +++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 445 EVVNLKNRGYGLTA--DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS-- 500
           E    + RG  + A  D++SLGC + E+LT +PP++    +   ++  + E P+ P++  
Sbjct: 189 E----QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARH 243
Query: 501 --LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             LS D    +LK L  NP +R   A  M    V+
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 353 LFIFLELVTKGSLANLYQKYHLM-----DSQVSAYTRQILNGLNYLHEQNVVHRDIKCAN 407
           L + L L+  G L   +  YH+      +++   Y  +I  GL  LH + +V+RD+K  N
Sbjct: 259 LCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316
Query: 408 ILVDASGSVKLADFGLA-KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           IL+D  G ++++D GLA        +K   GT  +MAPEVV  KN  Y  + D W+LGC 
Sbjct: 317 ILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWALGCL 374
Query: 467 VLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR--- 520
           + EM+  Q P+   +     + + R+ K  P       S  AR    + L  +P +R   
Sbjct: 375 LYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGC 434
Query: 521 --PTAAQLMEHPFVKR 534
              +A ++ EHP  K+
Sbjct: 435 RGGSAREVKEHPLFKK 450

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 335 FEHENIVQYFGTDKDENRL----FIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNG 389
             H  IV  + T + E       +I +E V   +L ++      M  + +          
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAP 444
           LN+ H+  ++HRD+K ANIL+ A+ +VK+ DFG+A+A      ++    +  GT  +++P
Sbjct: 129 LNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP 188
Query: 445 EVVNLKNRGYGLTA--DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS-- 500
           E    + RG  + A  D++SLGC + E+LT +PP++    +   ++  + E P+ P++  
Sbjct: 189 E----QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARH 243
Query: 501 --LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             LS D    +LK L  NP +R   A  M    V+
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 273 RRRIMSWQKGELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXX 329
           ++R   ++ G++LG GSF TV    E  T   +   +    L+ +    +          
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRER 59
Query: 330 XXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILN 388
               R +H   V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAP 444
            L YLH + ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD 504
           E+  L  +    ++D+W+LGC + +++   PP+          +I K E    P      
Sbjct: 180 EL--LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPK 236
Query: 505 ARDFILKCLQVNPNDRPTAAQ------LMEHPF 531
           ARD + K L ++   R    +      L  HPF
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 273 RRRIMSWQKGELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXX 329
           ++R   ++ G++LG GSF TV    E  T   +   +    L+ +    +          
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRER 58
Query: 330 XXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILN 388
               R +H   V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++
Sbjct: 59  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 118
Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAP 444
            L YLH + ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++P
Sbjct: 119 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD 504
           E+  L  +    ++D+W+LGC + +++   PP+          +I K E    P      
Sbjct: 179 EL--LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPK 235
Query: 505 ARDFILKCLQVNPNDRPTAAQ------LMEHPF 531
           ARD + K L ++   R    +      L  HPF
Sbjct: 236 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 268

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 116/244 (47%), Gaps = 51/244 (20%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQV-SAYTRQILNGLNYLHEQN- 397
           IV ++G    +  + I +E +  GSL  + ++   +  ++    +  +L GL YL E++ 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLT 457
           ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +MAPE   L+   Y + 
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPE--RLQGTHYSVQ 193
Query: 458 ADIWSLGCTVLEM-LTRQP-PYSHLEGMQALFR--IGKGE-------------------- 493
           +DIWS+G +++E+ + R P P    + ++A+F   +  GE                    
Sbjct: 194 SDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 253
Query: 494 ----------------------PPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHP 530
                                 PP +PN + + D ++F+ KCL  NP +R     L  H 
Sbjct: 254 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHT 313
Query: 531 FVKR 534
           F+KR
Sbjct: 314 FIKR 317

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG FG V+ GY  +    A+K +       +G               +  H  +VQ +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G   ++  + +  E +  G L++    Q+       +      +  G+ YL E  V+HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 186
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +WS G  + E+ +  + PY +    + +  I  G     P   S      +  C +  P 
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 246
Query: 519 DRPTAAQLM 527
           DRP  ++L+
Sbjct: 247 DRPAFSRLL 255

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 21/266 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +         S  GT  +++PE+  L  + 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL--LTEKS 211
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 270
Query: 514 QVNPNDRPTAAQ------LMEHPFVK 533
            ++   R    +      L  HPF +
Sbjct: 271 VLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG FG V+ GY  +    A+K +       +G               +  H  +VQ +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK------EGSMSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G   ++  + +  E +  G L++    Q+       +      +  G+ YL E  V+HRD
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 148
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 206
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +WS G  + E+ +  + PY +    + +  I  G     P   S      +  C +  P 
Sbjct: 207 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 266
Query: 519 DRPTAAQLM 527
           DRP  ++L+
Sbjct: 267 DRPAFSRLL 275

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG FG V+ GY  +    A+K +       +G               +  H  +VQ +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G   ++  + +  E +  G L++    Q+       +      +  G+ YL E  V+HRD
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 184
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +WS G  + E+ +  + PY +    + +  I  G     P   S      +  C +  P 
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 244
Query: 519 DRPTAAQLM 527
           DRP  ++L+
Sbjct: 245 DRPAFSRLL 253

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG FG V+ GY  +    A+K +       +G               +  H  +VQ +
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G   ++  + +  E +  G L++    Q+       +      +  G+ YL E  V+HRD
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 189
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +WS G  + E+ +  + PY +    + +  I  G     P   S      +  C +  P 
Sbjct: 190 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 249
Query: 519 DRPTAAQLM 527
           DRP  ++L+
Sbjct: 250 DRPAFSRLL 258

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 335 FEHENIVQYFGTDKDENRL----FIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNG 389
             H  IV  + T + E       +I +E V   +L ++      M   +           
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAP 444
           LN+ H+  ++HRD+K ANI++ A+ +VK+ DFG+A+A      ++    +  GT  +++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 445 EVVNLKNRGYGLTA--DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS-- 500
           E    + RG  + A  D++SLGC + E+LT +PP++    +   ++  + E P+ P++  
Sbjct: 189 E----QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARH 243
Query: 501 --LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             LS D    +LK L  NP +R   A  M    V+
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 335 FEHENIVQYFGTDKDENRL----FIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNG 389
             H  IV  + T + E       +I +E V   +L ++      M  + +          
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAP 444
           LN+ H+  ++HRD+K ANI++ A+ +VK+ DFG+A+A      ++    +  GT  +++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 445 EVVNLKNRGYGLTA--DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS-- 500
           E    + RG  + A  D++SLGC + E+LT +PP++    +   ++  + E P+ P++  
Sbjct: 189 E----QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARH 243
Query: 501 --LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             LS D    +LK L  NP +R   A  M    V+
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           +R  M +++ EL+GSG FG V++  +  DG  + +K V   ++  +              
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE---------REVKA 57
Query: 332 XXRFEHENIVQYFG-----------TDKDENR-----LFIFLELVTKGSLANLYQKY--H 373
             + +H NIV Y G           + K+ +R     LFI +E   KG+L    +K    
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 374 LMDSQVS-AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 432
            +D  ++     QI  G++Y+H + +++RD+K +NI +  +  VK+ DFGL   +  ND 
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDG 176
Query: 433 K--SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG 490
           K    KGT  +M+PE ++  ++ YG   D+++LG  + E+L                R G
Sbjct: 177 KRXRSKGTLRYMSPEQIS--SQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
Query: 491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
                ++ +   +  +  + K L   P DRP  ++++
Sbjct: 235 -----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 114/262 (43%), Gaps = 34/262 (12%)
Query: 285 LGSGSFGTVY--EGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           LG G+FG V+  E Y      D    AVK  +L+D     +                +HE
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKDFHREAELLT---NLQHE 75
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH---------------LMDSQVSAYT 383
           +IV+++G   + + L +  E +  G L N + + H               L  SQ+    
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF--- 440
           +QI  G+ YL  Q+ VHRD+   N LV  +  VK+ DFG+++     D     G      
Sbjct: 135 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 441 -WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVP 498
            WM PE  ++  R +   +D+WSLG  + E+ T  + P+  L   + +  I +G     P
Sbjct: 195 RWMPPE--SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 252
Query: 499 NSLSRDARDFILKCLQVNPNDR 520
            +  ++  + +L C Q  P+ R
Sbjct: 253 RTCPQEVYELMLGCWQREPHMR 274

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 14/249 (5%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG FG V+ GY  +    A+K +       +G               +  H  +VQ +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G   ++  + +  E +  G L++    Q+       +      +  G+ YL E  V+HRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 403 IKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGLTAD 459
           +   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV +     Y   +D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSSKSD 187
Query: 460 IWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +WS G  + E+ +  + PY +    + +  I  G     P   S      +  C +  P 
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPE 247
Query: 519 DRPTAAQLM 527
           DRP  ++L+
Sbjct: 248 DRPAFSRLL 256

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 11/191 (5%)
Query: 351 NRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           +RL+  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++RD+K  N++
Sbjct: 94  DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 153
Query: 410 VDASGSVKLADFGLAKATTMNDV--KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTV 467
           +D+ G +K+ADFG+ K    + V  K   GTP ++APE++  +   YG + D W+ G  +
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 211
Query: 468 LEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAA--- 524
            EML  Q P+   E    LF+         P S+S++A       +  +P  R       
Sbjct: 212 YEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEG 270
Query: 525 --QLMEHPFVK 533
              + EH F +
Sbjct: 271 ERDIKEHAFFR 281

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 21/266 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +  A+K   L+ +    +              R +H 
Sbjct: 34  GKILGEGSFSTVVLARELATSREY--AIK--ILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK     +      S  GT  +++PE+  L  + 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL--LTEKS 207
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 266
Query: 514 QVNPNDRPTAAQ------LMEHPFVK 533
            ++   R    +      L  HPF +
Sbjct: 267 VLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 39/290 (13%)
Query: 276 IMSWQKGELLGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR 334
           +  ++K E +G G++GTV++    +     A+K V L D     +               
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKE 57
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNY 392
            +H+NIV+       + +L +  E   +  L   +   +  L    V ++  Q+L GL +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKN 451
            H +NV+HRD+K  N+L++ +G +KLA+FGLA+A  +     S +    W  P  V    
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEP------------- 494
           + Y  + D+WS GC   E+     P        + ++ +FR+  G P             
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEEQWPSMTKLPD 235
Query: 495 ----PLVPNS---------LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
               P+ P +         L+   RD +   L+ NP  R +A + ++HP+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 212
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 213 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 272
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 273 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 301

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 211
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 212 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 271
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 272 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 300

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 206
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 207 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 266
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 267 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 295

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 221
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 222 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 281
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 282 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 310

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 207
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 208 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 267
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 268 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 296

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 207
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 208 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 267
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 268 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 296

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 251
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 312 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 340

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 213
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 214 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 273
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 274 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 302

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 205
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 206 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 265
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 266 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 294

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D+WSLG 
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 257
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 258 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 317
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 318 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 346

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 335 FEHENIVQYFGTDKDENRL----FIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNG 389
             H  IV  + T + E       +I +E V   +L ++      M   +           
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 145
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAP 444
           LN+ H+  ++HRD+K ANI++ A+ +VK+ DFG+A+A      ++    +  GT  +++P
Sbjct: 146 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 205
Query: 445 EVVNLKNRGYGLTA--DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS-- 500
           E    + RG  + A  D++SLGC + E+LT +PP++    +   ++  + E P+ P++  
Sbjct: 206 E----QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARH 260
Query: 501 --LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             LS D    +LK L  NP +R   A  M    V+
Sbjct: 261 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 295

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 11/191 (5%)
Query: 351 NRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           +RL+  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++RD+K  N++
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 410 VDASGSVKLADFGLAKATTMNDV--KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTV 467
           +D+ G +K+ADFG+ K    + V  K   GTP ++APE++  +   YG + D W+ G  +
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 532
Query: 468 LEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAA--- 524
            EML  Q P+   E    LF+         P S+S++A       +  +P  R       
Sbjct: 533 YEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEG 591
Query: 525 --QLMEHPFVK 533
              + EH F +
Sbjct: 592 ERDIKEHAFFR 602

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK     +      +  GT  +++PE+  L  + 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL--LTEKS 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 267
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 268 VLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 210
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 269
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 267
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 268 VLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G+FG V              +    AVK   L+D  T+ K              
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 96
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTF 156
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXK 214
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 215 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 208
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 267
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 268 VLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 21/266 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 211
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 270
Query: 514 QVNPNDRPTAAQ------LMEHPFVK 533
            ++   R    +      L  HPF +
Sbjct: 271 VLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 210
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 269
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 210
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF-PEKFFPKARDLVEKLL 269
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 21/266 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 40  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 213
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P +    ARD + K L
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PAAFFPKARDLVEKLL 272
Query: 514 QVNPNDRPTAAQ------LMEHPFVK 533
            ++   R    +      L  HPF +
Sbjct: 273 VLDATKRLGCEEMEGYGPLKAHPFFE 298

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 210
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 269
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I +E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N +     TP+++APEV  L    Y  + D+WSLG 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 205
Query: 466 TVLEMLTRQPPYSHLE------GMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPN 518
            +  +L   PP+          GM+   R+G+ E P    S +S + +  I   L+  P 
Sbjct: 206 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 265
Query: 519 DRPTAAQLMEHPFV-------KRPLQKSR 540
            R T  + M HP++       + PL  SR
Sbjct: 266 QRMTITEFMNHPWIMQSTKVPQTPLHTSR 294

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G+FG V              +    AVK   L+D  T+ K              
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 96
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXK 214
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 215 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 119/264 (45%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +  A+K   L+ +    +              R +H 
Sbjct: 19  GKILGEGSFSTVVLARELATSREY--AIK--ILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 192
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 251
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 252 VLDATKRLGCEEMEGYGPLKAHPF 275

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G+FG V              +    AVK   L+D  T+ K              
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 96
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK 214
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 215 NTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 210
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF-PEKFFPKARDLVEKLL 269
Query: 514 QVNPNDRPTAAQ------LMEHPF 531
            ++   R    +      L  HPF
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPF 293

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G+FG V              +    AVK   L+D  T+ K              
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 96
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 97  IGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK 214
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 215 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV++         L I +E  + G L   +       + +   + +Q+++G++Y H 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 396 QNVVHRDIKCANILVDASGS--VKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNR 452
             V HRD+K  N L+D S +  +K+ADFG +KA+ ++   KS  GTP ++APEV+ LK  
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVL-LKKE 192
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLE-------GMQALFRIGKGEPPLVPNSLSRDA 505
             G  AD+WS G T+  ML    P+   E        +  +  +    P  V   +S + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV--HISPEC 250
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           R  I +    +P  R +  ++  H +  + L
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKNL 281

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 36/275 (13%)
Query: 284 LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQ--GTQGKXXXXXXXXXXXXXXRF----- 335
           +LG G+FG V +     D  ++A+K++   ++   T                 R+     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR---QILNGLNY 392
           E  N V+     K ++ LFI +E    G+L +L    +L + Q   Y R   QIL  L+Y
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-NQQRDEYWRLFRQILEALSY 131
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT----------------TMNDVKSCK 436
           +H Q ++HRD+K  NI +D S +VK+ DFGLAK                  + +++ S  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS----HLEGMQALFRIGKG 492
           GT  ++A EV++     Y    D++SLG    EM+    P+S     +  ++ L  +   
Sbjct: 192 GTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIE 247
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
            PP   ++  +  +  I   +  +PN RP A  L+
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 121/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G FG V              +    AVK   L+D  T+ K              
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 142
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK 260
Query: 437 GT-----PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T     P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 261 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 317
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 318 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 357

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 112/249 (44%), Gaps = 20/249 (8%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G+FG+V +G            + +  QGT+ K              + ++  IV+  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G  + E  L + +E+   G L      ++  +  S V+    Q+  G+ YL E+N VHRD
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 403 IKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRGYGLT 457
           +   N+L+      K++DFGL+KA   +D     +S    P  W APE +N   R +   
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSR 193
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILKC 512
           +D+WS G T+ E L+  Q PY  ++G + +  I +G+    PP  P  L     D    C
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSD----C 249
Query: 513 LQVNPNDRP 521
                 DRP
Sbjct: 250 WIYKWEDRP 258

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 335 FEHENIVQYFGTDKDENRL----FIFLELVTKGSLANLYQKYHLMDSQVS-AYTRQILNG 389
             H  IV  + T + E       +I +E V   +L ++      M  + +          
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAP 444
           LN+ H+  ++HRD+K ANI++ A+ +VK+ DFG+A+A      ++    +  GT  +++P
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 445 EVVNLKNRGYGLTA--DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS-- 500
           E    + RG  + A  D++SLGC + E+LT +PP++        ++  + E P+ P++  
Sbjct: 189 E----QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR-EDPIPPSARH 243
Query: 501 --LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             LS D    +LK L  NP +R   A  M    V+
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAKA-TTMND---- 431
           +S   RQI + L+YLH Q + HRDIK  N L   + S  +KL DFGL+K    +N+    
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG 490
            + +  GTP+++APEV+N  N  YG   D WS G  +  +L    P+  +     + ++ 
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289
Query: 491 KGEPPLVP---NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
             +        N LS  ARD +   L  N ++R  A + ++HP++ +
Sbjct: 290 NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLA-KATTMNDVKSCKGTP 439
           +QIL G+ YLH+ N+VH D+K  NIL+ +    G +K+ DFG++ K     +++   GTP
Sbjct: 138 KQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP- 498
            ++APE++N          D+W++G     +LT   P+   +  +    I +        
Sbjct: 198 EYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255
Query: 499 --NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
             +S+S+ A DFI   L  NP  RPTA   + H ++++
Sbjct: 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNY 392
           R +H   V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVN 448
           LH + ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL-- 203
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
           L  +    ++D+W+LGC + +++   PP+          +I K E    P      ARD 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDL 262
Query: 509 ILKCLQVNPNDRPTAAQ------LMEHPF 531
           + K L ++   R    +      L  HPF
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G+FG V              +    AVK   L+D  T+ K              
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 96
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 97  IGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK 214
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 215 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 120/266 (45%), Gaps = 21/266 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +  A+K   L+ +    +              R +H 
Sbjct: 34  GKILGEGSFSTVVLARELATSREY--AIK--ILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ + T +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 207
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 266
Query: 514 QVNPNDRPTAAQ------LMEHPFVK 533
            ++   R    +      L  HPF +
Sbjct: 267 VLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 124/271 (45%), Gaps = 13/271 (4%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXX 323
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G    +    ++ +         
Sbjct: 37  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK 96
Query: 324 XXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSA 381
                       ++ ++ +  G         I  +L+  G L +  +++  ++    +  
Sbjct: 97  EILDEAYVMASVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLN 155
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKG 437
           +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +  K 
Sbjct: 156 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 438 TPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPL 496
              WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KGE   
Sbjct: 216 PIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 273
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
            P   + D    ++KC  ++ + RP   +L+
Sbjct: 274 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 104/194 (53%), Gaps = 4/194 (2%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV+ F   + E  L++ +E  + G + + L     + + +  A  RQI++ + Y H+
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGY 454
           + +VHRD+K  N+L+D   ++K+ADFG +   T+ N + +  G+P + APE+   K    
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD- 191
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D+WSLG  +  +++   P+      +   R+ +G+   +P  +S D  + + K L 
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-IPFYMSTDCENLLKKLLV 250
Query: 515 VNPNDRPTAAQLME 528
           +NP  R +  Q+M+
Sbjct: 251 LNPIKRGSLEQIMK 264

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 120/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G FG V              +    AVK   L+D  T+ K              
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 83
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 84  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 143
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 144 KDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLAR--DINNIDYYK 201
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 202 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 258
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 259 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 298

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 120/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G FG V              +    AVK   L+D  T+ K              
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 85
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 86  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 145
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 146 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK 203
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 204 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 260
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 261 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 300

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 120/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G FG V              +    AVK   L+D  T+ K              
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 88
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 89  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 148
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 149 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK 206
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 207 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 263
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 264 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 303

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 110/223 (49%), Gaps = 24/223 (10%)
Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXX 324
           NV+ N  F  R +S   G   G G FG VY+GY ++      K  ++ D  T+       
Sbjct: 13  NVTNN--FDERPISV-GGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE--ELKQQ 67
Query: 325 XXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ--VSAY 382
                    + +HEN+V+  G   D + L +       GSL +   +   +D    +S +
Sbjct: 68  FDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLD---RLSCLDGTPPLSWH 124
Query: 383 TRQIL-----NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MNDVKSC 435
            R  +     NG+N+LHE + +HRDIK ANIL+D + + K++DFGLA+A+      V   
Sbjct: 125 XRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXS 184
Query: 436 K--GTPFWMAPEVVNLKNRG-YGLTADIWSLGCTVLEMLTRQP 475
           +  GT  + APE +    RG     +DI+S G  +LE++T  P
Sbjct: 185 RIVGTTAYXAPEAL----RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 110/245 (44%), Gaps = 12/245 (4%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           LG G+FG+V +G            + +  QGT+ K              + ++  IV+  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 345 GTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRD 402
           G  + E  L + +E+   G L      ++  +  S V+    Q+  G+ YL E+N VHR+
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 403 IKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPF-WMAPEVVNLKNRGYGLT 457
           +   N+L+      K++DFGL+KA   +D     +S    P  W APE +N   R +   
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSR 519
Query: 458 ADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           +D+WS G T+ E L+  Q PY  ++G + +  I +G+    P     +    +  C    
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 579
Query: 517 PNDRP 521
             DRP
Sbjct: 580 WEDRP 584

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 194
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 195 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 254
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 255 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 286

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G+FG V              +    AVK   L+D  T+ K              
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 96
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +E  +KG+L                  N   +  +  
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +++ADFGLA+   +N++   K
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLAR--DINNIDYYK 214
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 215 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 136/319 (42%), Gaps = 55/319 (17%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           +Q+ + +GSG+ G V   + T  G   AVK++S   +  Q +                 H
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLKCVNH 82
Query: 338 ENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQKYHL-MDSQVSAYT-RQILNGLNYL 393
           +NI+        +  L  F  + LV +   ANL Q  H+ +D +  +Y   Q+L G+ +L
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 142
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-CKGTPFWMAPEVVNLKNR 452
           H   ++HRD+K +NI+V +  ++K+ DFGLA+    N + +    T ++ APEV+     
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI--LGM 200
Query: 453 GYGLTADIWSLGCTVLEML---------------------TRQPPYSHLEGMQALFRIGK 491
           GY    DIWS+GC + E++                        P    +  +Q   R   
Sbjct: 201 GYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 260
Query: 492 GEPP--------------LVPNSLSRD------ARDFILKCLQVNPNDRPTAAQLMEHPF 531
              P              + P+   RD      ARD + K L ++P+ R +  + + HP+
Sbjct: 261 ENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 320
Query: 532 VK---RPLQKSRGPPSYYN 547
           +     P +    PP  Y+
Sbjct: 321 ITVWYDPAEAEAPPPQIYD 339

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 106/260 (40%), Gaps = 63/260 (24%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAYTRQ-ILNGLN 391
           F H NIV Y  T   +N L++    +  GS  +L   + +  M+    AY  Q +L  L+
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM----------NDV--KSCKGTP 439
           Y+H    VHR +K ++IL+   G V L+  GL    +M          +D    S K  P
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--- 496
            W++PEV+    +GY   +DI+S+G T  E+     P+  +   Q L     G  P    
Sbjct: 201 -WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 497 ----------------VPNSLSRDA--------------------------RDFILKCLQ 514
                           V NS   D+                            F+ +CLQ
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 515 VNPNDRPTAAQLMEHPFVKR 534
            NP+ RP+A+ L+ H F K+
Sbjct: 320 RNPDARPSASTLLNHSFFKQ 339

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 59
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 60  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 117
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 178 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 7   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 63
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 64  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 121
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 122 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 182 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 239
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 240 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK+  LQ  G   +                  + 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKA---LHSDF 69
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+ YL  
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLK 450
           +  VHRD+   NILV++   VK+ADFGLAK   ++     V+    +P FW APE  +L 
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE--SLS 187
Query: 451 NRGYGLTADIWSLGCTVLEMLTR-----QPPYSHLEGM------QALFR----IGKGEPP 495
           +  +   +D+WS G  + E+ T       P    L  M       AL R    + +G+  
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL 247
Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
             P +   +  + +  C   +P DRP+ + L
Sbjct: 248 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 4   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 60
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 61  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 118
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 119 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 179 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 236
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 237 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 50/306 (16%)
Query: 284 LLGSGSFGTVYEGYTDDGFFFAVKEV--SLQDQGTQGKXXXXXXXXXXXXXXR----FEH 337
            + SGS+G V  G   +G   A+K V  ++ D  T                 R    F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 338 ENI-----VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS--QVSAYTRQILNGL 390
            NI     +     +   ++L++  EL+ +  LA +     ++ S   +  +   IL GL
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-APEVVNL 449
           + LHE  VVHRD+   NIL+  +  + + DF LA+  T +  K+   T  W  APE+V +
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-M 206
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPPL----------- 496
           + +G+    D+WS GC + EM  R+  +        L +I +  G P +           
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 497 ---VPNSLSR---------------DARDFILKCLQVNPNDRPTAAQLMEHPFVKR---P 535
              + NSLS                 A D I K L+ NP  R +  Q + HP+ +    P
Sbjct: 267 RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326
Query: 536 LQKSRG 541
           L  + G
Sbjct: 327 LDLTEG 332

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 188
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 189 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 248
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 249 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 189
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 190 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 249
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 250 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 117/273 (42%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL    QK+   +   ++  YT QI  G+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 193
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 254 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 193
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 254 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 5   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 61
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 62  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 119
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 120 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 180 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 237
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 238 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 106/260 (40%), Gaps = 63/260 (24%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL--MDSQVSAYTRQ-ILNGLN 391
           F H NIV Y  T   +N L++    +  GS  +L   + +  M+    AY  Q +L  L+
Sbjct: 67  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 126
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM----------NDV--KSCKGTP 439
           Y+H    VHR +K ++IL+   G V L+  GL    +M          +D    S K  P
Sbjct: 127 YIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLP 184
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--- 496
            W++PEV+    +GY   +DI+S+G T  E+     P+  +   Q L     G  P    
Sbjct: 185 -WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 243
Query: 497 ----------------VPNSLSRDA--------------------------RDFILKCLQ 514
                           V NS   D+                            F+ +CLQ
Sbjct: 244 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 303
Query: 515 VNPNDRPTAAQLMEHPFVKR 534
            NP+ RP+A+ L+ H F K+
Sbjct: 304 RNPDARPSASTLLNHSFFKQ 323

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 190
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 251 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 62
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 63  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 120
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 121 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 181 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 238
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 239 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 4   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 60
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 61  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGXLLDYVREHKDNIGSQ 118
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 119 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 179 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 236
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 237 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 21/266 (7%)
Query: 282 GELLGSGSFGTVY---EGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G++LG GSF TV    E  T   +   +    L+ +    +              R +H 
Sbjct: 42  GKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQN 397
             V+ +   +D+ +L+  L     G L    +K    D   +  YT +I++ L YLH + 
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS----CKGTPFWMAPEVVNLKNRG 453
           ++HRD+K  NIL++    +++ DFG AK  +    ++      GT  +++PE+  L  + 
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL--LTEKS 215
Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              ++D+W+LGC + +++   PP+          +I K E    P      ARD + K L
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKARDLVEKLL 274
Query: 514 QVNPNDRPTAAQ------LMEHPFVK 533
            ++   R    +      L  HPF +
Sbjct: 275 VLDATKRLGCEEMEGYGPLKAHPFFE 300

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 196
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 197 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 256
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 257 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 288

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 197
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 198 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 257
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 258 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 289

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 195
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 196 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 255
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 256 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 287

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 190
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 251 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 38/222 (17%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMDSQ 378
           +H+NI+   G    +  L++ +E  +KG+L                  N   +  +    
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 438
           + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K T
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKT 216
Query: 439 PF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK 491
                   WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K
Sbjct: 217 TNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLK 273
Query: 492 -----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                 +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 274 EGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 221
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 282 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE--SLT 190
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 251 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 125/295 (42%), Gaps = 66/295 (22%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V        G   A+K++S   +  Q +                +HEN++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIG- 87
Query: 344 FGTDKDENRLFIFLELVT-KGSLANLYQKYHLM----------------DSQVSAYTRQI 386
                        L++ T   SL N Y  Y +M                + ++     Q+
Sbjct: 88  ------------LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEV 446
           L GL Y+H   VVHRD+K  N+ V+    +K+ DFGLA+     ++     T ++ APEV
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVVTRWYRAPEV 194
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS---HLEGMQALFRI-------------- 489
           + L    Y  T DIWS+GC + EMLT +  +    +L+ +  + ++              
Sbjct: 195 I-LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 490 --GKGEPPLVPNSLSRD-----------ARDFILKCLQVNPNDRPTAAQLMEHPF 531
              K     +P +  +D           A D + K L+++ + R TAAQ + HPF
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 50/306 (16%)
Query: 284 LLGSGSFGTVYEGYTDDGFFFAVKEV--SLQDQGTQGKXXXXXXXXXXXXXXR----FEH 337
            + SGS+G V  G   +G   A+K V  ++ D  T                 R    F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 338 ENI-----VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS--QVSAYTRQILNGL 390
            NI     +     +   ++L++  EL+ +  LA +     ++ S   +  +   IL GL
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-APEVVNL 449
           + LHE  VVHRD+   NIL+  +  + + DF LA+  T +  K+   T  W  APE+V +
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-M 206
Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPPL----------- 496
           + +G+    D+WS GC + EM  R+  +        L +I +  G P +           
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 497 ---VPNSLSR---------------DARDFILKCLQVNPNDRPTAAQLMEHPFVKR---P 535
              + NSLS                 A D I K L+ NP  R +  Q + HP+ +    P
Sbjct: 267 RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326
Query: 536 LQKSRG 541
           L  + G
Sbjct: 327 LDLTEG 332

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 137/319 (42%), Gaps = 55/319 (17%)
Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           +Q+ + +GSG+ G V   + T  G   AVK++S   +  Q +                 H
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLKCVNH 80
Query: 338 ENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQKYHL-MDSQVSAYT-RQILNGLNYL 393
           +NI+        +  L  F  + LV +   ANL Q  H+ +D +  +Y   Q+L G+ +L
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 140
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-CKGTPFWMAPEVVNLKNR 452
           H   ++HRD+K +NI+V +  ++K+ DFGLA+  + N + +    T ++ APEV+     
Sbjct: 141 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI--LGM 198
Query: 453 GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEGMQALFRIGK 491
           GY    DIWS+GC + E++                        P    +  +Q   R   
Sbjct: 199 GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 258
Query: 492 GEPP--------------LVPNSLSRD------ARDFILKCLQVNPNDRPTAAQLMEHPF 531
              P              + P+   RD      ARD + K L ++P+ R +  + + HP+
Sbjct: 259 ENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 318
Query: 532 VK---RPLQKSRGPPSYYN 547
           +     P +    PP  Y+
Sbjct: 319 ITVWYDPAEAEAPPPQIYD 337

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 123/295 (41%), Gaps = 66/295 (22%)
Query: 285 LGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +GSG++G+V        G   A+K++S   +  Q +                +HEN++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIG- 105
Query: 344 FGTDKDENRLFIFLELVT-KGSLANLYQKYHLM----------------DSQVSAYTRQI 386
                        L++ T   SL N Y  Y +M                + ++     Q+
Sbjct: 106 ------------LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQM 153
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEV 446
           L GL Y+H   VVHRD+K  N+ V+    +K+ DFGLA+     ++     T ++ APEV
Sbjct: 154 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVVTRWYRAPEV 212
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEP---------- 494
           + L    Y  T DIWS+GC + EMLT +  +   + +  L +I K  G P          
Sbjct: 213 I-LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271
Query: 495 ----------PLVPNS--------LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                     P  P           S  A D + K L+++ + R TAAQ + HPF
Sbjct: 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 208
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 269 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 121/260 (46%), Gaps = 11/260 (4%)
Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQD-QGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           ++G G FG VY     D G  +A+K +  +  +  QG+                +   IV
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 342 QYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
                    ++L   L+L+  G L  +L Q     ++ +  Y  +I+ GL ++H + VV+
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 314
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RD+K ANIL+D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD 
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADW 373
Query: 461 WSLGCTVLEMLTRQPPYSH--LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +SLGC + ++L    P+     +    + R+       +P+S S + R  +   LQ + N
Sbjct: 374 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 433
Query: 519 DR-----PTAAQLMEHPFVK 533
            R       A ++ E PF +
Sbjct: 434 RRLGCLGRGAQEVKESPFFR 453

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 121/260 (46%), Gaps = 11/260 (4%)
Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQD-QGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           ++G G FG VY     D G  +A+K +  +  +  QG+                +   IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 342 QYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
                    ++L   L+L+  G L  +L Q     ++ +  Y  +I+ GL ++H + VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RD+K ANIL+D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADW 374
Query: 461 WSLGCTVLEMLTRQPPYSH--LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +SLGC + ++L    P+     +    + R+       +P+S S + R  +   LQ + N
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 519 DR-----PTAAQLMEHPFVK 533
            R       A ++ E PF +
Sbjct: 435 RRLGCLGRGAQEVKESPFFR 454

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKXV 80
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK 140
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVVTRYY 191
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 312 VDDALQHPYINVWYDPAEVEAPPPQIYD 339

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 208
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 269 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 52/290 (17%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           +R  M +++ EL+GSG FG V++  +  DG  + ++ V   ++  +              
Sbjct: 8   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE---------REVKA 58
Query: 332 XXRFEHENIVQYFGT------------------------DKDENR-----LFIFLELVTK 362
             + +H NIV Y G                          K+ +R     LFI +E   K
Sbjct: 59  LAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 363 GSLANLYQKY--HLMDSQVS-AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA 419
           G+L    +K     +D  ++     QI  G++Y+H + ++HRD+K +NI +  +  VK+ 
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 420 DFGLAKATTMNDVKSC--KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY 477
           DFGL   +  ND K    KGT  +M+PE ++  ++ YG   D+++LG  + E+L      
Sbjct: 179 DFGLV-TSLKNDGKRTRSKGTLRYMSPEQIS--SQDYGKEVDLYALGLILAELLHVCDTA 235
Query: 478 SHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
                     R G     ++ +   +  +  + K L   P DRP  ++++
Sbjct: 236 FETSKFFTDLRDG-----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK+  LQ  G   +                  + 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKA---LHSDF 73
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+ YL  
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLK 450
           +  VHRD+   NILV++   VK+ADFGLAK   ++     V+    +P FW APE  +L 
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--SLS 191
Query: 451 NRGYGLTADIWSLGCTVLEMLTR-----QPPYSHLEGMQ------ALFR----IGKGEPP 495
           +  +   +D+WS G  + E+ T       P    L  M       AL R    + +G+  
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL 251
Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
             P +   +  + +  C   +P DRP+ + L
Sbjct: 252 PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 11/255 (4%)
Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           ++ ++LGSG+FGTVY+G +  +G    +         T G                 +H 
Sbjct: 41  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 100
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQ 396
           ++V+  G       + +  +L+  G L     ++  ++    +  +  QI  G+ YL E+
Sbjct: 101 HLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 159
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNR 452
            +VHRD+   N+LV +   VK+ DFGLA+    ++        K    WMA E ++   R
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY--R 217
Query: 453 GYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
            +   +D+WS G T+ E++T    PY  +   +    + KGE    P   + D    ++K
Sbjct: 218 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVK 277
Query: 512 CLQVNPNDRPTAAQL 526
           C  ++ + RP   +L
Sbjct: 278 CWMIDADSRPKFKEL 292

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 16/176 (9%)
Query: 348 KDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC 405
           +DEN L++ ++    G L  L  K+   L +     Y  +++  ++ +H+ + VHRDIK 
Sbjct: 160 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKP 219
Query: 406 ANILVDASGSVKLADFGLAKATTMNDVKSCK-----GTPFWMAPEVVNLKNRG---YGLT 457
            N+L+D +G ++LADFG      MND  + +     GTP +++PE++     G   YG  
Sbjct: 220 DNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 277
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----PLVPNSLSRDARDFI 509
            D WSLG  + EML  + P+     ++   +I   E     P     +S +A+D I
Sbjct: 278 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLI 333

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 16/176 (9%)
Query: 348 KDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC 405
           +DEN L++ ++    G L  L  K+   L +     Y  +++  ++ +H+ + VHRDIK 
Sbjct: 144 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKP 203
Query: 406 ANILVDASGSVKLADFGLAKATTMNDVKSCK-----GTPFWMAPEVVNLKNRG---YGLT 457
            N+L+D +G ++LADFG      MND  + +     GTP +++PE++     G   YG  
Sbjct: 204 DNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 261
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----PLVPNSLSRDARDFI 509
            D WSLG  + EML  + P+     ++   +I   E     P     +S +A+D I
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLI 317

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 19/237 (8%)
Query: 285 LGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           +GSG++G+V   Y  D       AVK++S   +  Q                  +HEN++
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLS---RPFQSLIHARRTYRELRLLKHLKHENVI 90
Query: 342 QYFGTDKDENRLFIFLE--LVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
                      +  F E  LVT      L N+ +   L D  V     Q+L GL Y+H  
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
            ++HRD+K +N+ V+    +++ DFGLA+     ++     T ++ APE++ L    Y  
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIM-LNWMHYNQ 208
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI----GKGEPPLVPNSLSRDARDFI 509
           T DIWS+GC + E+L  +  +   + +  L RI    G   P ++    S  AR +I
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK+  LQ  G   +                  + 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKA---LHSDF 72
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+ YL  
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLK 450
           +  VHRD+   NILV++   VK+ADFGLAK   ++     V+    +P FW APE  +L 
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--SLS 190
Query: 451 NRGYGLTADIWSLGCTVLEMLT 472
           +  +   +D+WS G  + E+ T
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 82/145 (56%), Gaps = 9/145 (6%)
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS--CKGTP 439
           YT QI++GL +LH++N+++RD+K  N+L+D  G+V+++D GLA        K+    GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEPP 495
            +MAPE+  L    Y  + D ++LG T+ EM+  + P+      +E  +   R+ + +  
Sbjct: 354 GFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAV 410
Query: 496 LVPNSLSRDARDFILKCLQVNPNDR 520
             P+  S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 82/145 (56%), Gaps = 9/145 (6%)
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS--CKGTP 439
           YT QI++GL +LH++N+++RD+K  N+L+D  G+V+++D GLA        K+    GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEPP 495
            +MAPE+  L    Y  + D ++LG T+ EM+  + P+      +E  +   R+ + +  
Sbjct: 354 GFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAV 410
Query: 496 LVPNSLSRDARDFILKCLQVNPNDR 520
             P+  S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 82/145 (56%), Gaps = 9/145 (6%)
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS--CKGTP 439
           YT QI++GL +LH++N+++RD+K  N+L+D  G+V+++D GLA        K+    GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEPP 495
            +MAPE+  L    Y  + D ++LG T+ EM+  + P+      +E  +   R+ + +  
Sbjct: 354 GFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAV 410
Query: 496 LVPNSLSRDARDFILKCLQVNPNDR 520
             P+  S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 121/260 (46%), Gaps = 11/260 (4%)
Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQD-QGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           ++G G FG VY     D G  +A+K +  +  +  QG+                +   IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 342 QYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
                    ++L   L+L+  G L  +L Q     ++ +  Y  +I+ GL ++H + VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RD+K ANIL+D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADW 374
Query: 461 WSLGCTVLEMLTRQPPYSH--LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +SLGC + ++L    P+     +    + R+       +P+S S + R  +   LQ + N
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 519 DR-----PTAAQLMEHPFVK 533
            R       A ++ E PF +
Sbjct: 435 RRLGCLGRGAQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 121/260 (46%), Gaps = 11/260 (4%)
Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQD-QGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           ++G G FG VY     D G  +A+K +  +  +  QG+                +   IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 342 QYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
                    ++L   L+L+  G L  +L Q     ++ +  Y  +I+ GL ++H + VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
           RD+K ANIL+D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y  +AD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADW 374
Query: 461 WSLGCTVLEMLTRQPPYSH--LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           +SLGC + ++L    P+     +    + R+       +P+S S + R  +   LQ + N
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 434
Query: 519 DR-----PTAAQLMEHPFVK 533
            R       A ++ E PF +
Sbjct: 435 RRLGCLGRGAQEVKESPFFR 454

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 120/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G+FG V              +    AVK   L+D  T+ K              
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 96
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +   +KG+L                  N   +  +  
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK 214
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 215 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
             H NIV++         L I +E  + G L   +       + +   + +Q+L+G++Y 
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 394 HEQNVVHRDIKCANILVDASGS--VKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLK 450
           H   + HRD+K  N L+D S +  +K+ DFG +K++ ++   KS  GTP ++APEV+ L+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LR 191
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
               G  AD+WS G T+  ML    P+   E           EP        RD R  I 
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-----------EP--------RDYRKTIQ 232
Query: 511 KCLQVN---PND---RPTAAQLMEHPFVKRPLQKSRGP 542
           + L V    P+D    P    L+   FV  P  +   P
Sbjct: 233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIP 270

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 59
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 60  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 117
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 178 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 11/255 (4%)
Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           ++ ++LGSG+FGTVY+G +  +G    +         T G                 +H 
Sbjct: 18  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 77
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQ 396
           ++V+  G       + +  +L+  G L     ++  ++    +  +  QI  G+ YL E+
Sbjct: 78  HLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 136
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNR 452
            +VHRD+   N+LV +   VK+ DFGLA+    ++        K    WMA E ++   R
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY--R 194
Query: 453 GYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
            +   +D+WS G T+ E++T    PY  +   +    + KGE    P   + D    ++K
Sbjct: 195 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVK 254
Query: 512 CLQVNPNDRPTAAQL 526
           C  ++ + RP   +L
Sbjct: 255 CWMIDADSRPKFKEL 269

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK 140
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVVTRYY 191
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 312 VDDALQHPYINVWYDPAEVEAPPPQIYD 339

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 82/145 (56%), Gaps = 9/145 (6%)
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS--CKGTP 439
           YT QI++GL +LH++N+++RD+K  N+L+D  G+V+++D GLA        K+    GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGEPP 495
            +MAPE+  L    Y  + D ++LG T+ EM+  + P+      +E  +   R+ + +  
Sbjct: 354 GFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAV 410
Query: 496 LVPNSLSRDARDFILKCLQVNPNDR 520
             P+  S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 59
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 60  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGXLLDYVREHKDNIGSQ 117
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 178 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 21/167 (12%)
Query: 374 LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFG---LAKATTM 429
           L +    ++  Q+L  + + H   V+HRDIK  NIL+D + G +KL DFG   L K T  
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QAL 486
            D     GT  +  PE +   +R +G +A +WSLG  + +M+    P+ H E +   Q  
Sbjct: 214 TDF---DGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 269
Query: 487 FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 270 FR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 9   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 65
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 66  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 123
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 124 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 183
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 184 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 241
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 242 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 10  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 66
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 67  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 124
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 125 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 185 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 242
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 243 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK+  LQ  G   +                  + 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKA---LHSDF 85
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+ YL  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP-FWMAPEVVNLK 450
           +  VHRD+   NILV++   VK+ADFGLAK   ++     V+    +P FW APE  +L 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--SLS 203
Query: 451 NRGYGLTADIWSLGCTVLEMLT 472
           +  +   +D+WS G  + E+ T
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 285 LGSGSFGTVYEGYTDDG-----FFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LGSG+FG V+     +        F  KE  L+D   +                R EH N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIE-DPKLGKVTLEIAILSRVEHAN 90
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLY---QKYHLMDSQVSAYT-RQILNGLNYLHE 395
           I++    D  EN+ F  L +   GS  +L+    ++  +D  +++Y  RQ+++ + YL  
Sbjct: 91  IIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGY 454
           ++++HRDIK  NI++    ++KL DFG A       +  +  GT  + APEV+ + N   
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL-MGNPYR 207
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           G   ++WSLG T+  ++  + P+  L E ++A        PP +   +S++    +   L
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH-----PPYL---VSKELMSLVSGLL 259
Query: 514 QVNPNDRPTAAQLMEHPFVKRPL 536
           Q  P  R T  +L+  P+V +P+
Sbjct: 260 QPVPERRTTLEKLVTDPWVTQPV 282

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 89
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAK------ATTMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE--S 207
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 267
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 268 VMLKCWHPKAEMRPSFSELV 287

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 62
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 63  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 120
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 121 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 181 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 238
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 239 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 62
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 63  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 120
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 121 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 181 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 238
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 239 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 5   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 61
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 62  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 119
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 120 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 180 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 237
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 238 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQ--DQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           LG G++G VY+   T      A+K + L+  ++G  G                 +H NI+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG-----TAIREVSLLKELQHRNII 96
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS-----AYTRQILNGLNYLHEQ 396
           +        +RL +  E        N  +KY   +  VS     ++  Q++NG+N+ H +
Sbjct: 97  ELKSVIHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 397 NVVHRDIKCANILVDASGS-----VKLADFGLAKATTMNDVK-SCKGTPFWMAPEVVNLK 450
             +HRD+K  N+L+  S +     +K+ DFGLA+A  +   + + +    W  P  + L 
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI 489
           +R Y  + DIWS+ C   EML + P +     +  LF+I
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
             H NIV++         L I +E  + G L   +       + +   + +Q+++G++Y 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 394 HEQNVVHRDIKCANILVDASGS--VKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLK 450
           H   V HRD+K  N L+D S +  +K+ DFG +K++ ++   KS  GTP ++APEV+ LK
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LK 190
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-------GMQALFRIGKGEPPLVPNSLSR 503
               G  AD+WS G T+  ML    P+   E        +  +  +    P  V   +S 
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV--HISP 248
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           + R  I +    +P  R +  ++  H +  + L
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 281

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 27  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 81
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 82  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 192
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 313 VDDALQHPYINVWYDPAEVEAPPPQIYD 340

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 191
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 312 VDDALQHPYINVWYDPAEVEAPPPQIYD 339

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 19/237 (8%)
Query: 285 LGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           +GSG++G+V   Y  D       AVK++S   +  Q                  +HEN++
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLS---RPFQSLIHARRTYRELRLLKHLKHENVI 90
Query: 342 QYFGTDKDENRLFIFLE--LVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
                      +  F E  LVT      L N+ +   L D  V     Q+L GL Y+H  
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
            ++HRD+K +N+ V+    +++ DFGLA+     ++     T ++ APE++ L    Y  
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIM-LNWMHYNQ 208
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI----GKGEPPLVPNSLSRDARDFI 509
           T DIWS+GC + E+L  +  +   + +  L RI    G   P ++    S  AR +I
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 191
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 312 VDDALQHPYINVWYDPAEVEAPPPQIYD 339

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 36/275 (13%)
Query: 284 LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQ--GTQGKXXXXXXXXXXXXXXRF----- 335
           +LG G+FG V +     D  ++A+K++   ++   T                 R+     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR---QILNGLNY 392
           E  N V+     K ++ LFI +E     +L +L    +L + Q   Y R   QIL  L+Y
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENL-NQQRDEYWRLFRQILEALSY 131
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT----------------TMNDVKSCK 436
           +H Q ++HRD+K  NI +D S +VK+ DFGLAK                  + +++ S  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS----HLEGMQALFRIGKG 492
           GT  ++A EV++     Y    D++SLG    EM+    P+S     +  ++ L  +   
Sbjct: 192 GTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIE 247
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
            PP   ++  +  +  I   +  +PN RP A  L+
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 28  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 84
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 85  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 142
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 143 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 202
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 203 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 260
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 261 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLAN------------LYQKYHLMDSQVSA-- 381
           +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S+  
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
                 Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 197 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 253
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 254 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 120/284 (42%), Gaps = 49/284 (17%)
Query: 282 GELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           G+ LG G+FG V              +    AVK   L+D  T+ K              
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE-KDLSDLVSEMEMMKM 96
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMD 376
             +H+NI+   G    +  L++ +   +KG+L                  N   +  +  
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
             + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+   +N++   K
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK 214
Query: 437 GTPF------WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRI 489
            T        WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++
Sbjct: 215 KTTNGRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 271
Query: 490 GK-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            K      +P    N L    RD    C    P+ RPT  QL+E
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVE 311

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 25  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 79
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 80  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 139
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 140 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 190
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 251 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 310
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 311 VDDALQHPYINVWYDPAEVEAPPPQIYD 338

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 19/237 (8%)
Query: 285 LGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           +GSG++G+V   Y  D       AVK++S   +  Q                  +HEN++
Sbjct: 28  VGSGAYGSVCSAY--DARLRQKVAVKKLS---RPFQSLIHARRTYRELRLLKHLKHENVI 82
Query: 342 QYFGTDKDENRLFIFLE--LVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
                      +  F E  LVT      L N+ +   L D  V     Q+L GL Y+H  
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
            ++HRD+K +N+ V+    +++ DFGLA+     ++     T ++ APE++ L    Y  
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLARQAD-EEMTGYVATRWYRAPEIM-LNWMHYNQ 200
Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI----GKGEPPLVPNSLSRDARDFI 509
           T DIWS+GC + E+L  +  +   + +  L RI    G   P ++    S  AR +I
Sbjct: 201 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 257

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 27  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 81
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 82  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 192
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 313 VDDALQHPYINVWYDPAEVEAPPPQIYD 340

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 64  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 118
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 229
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 350 VDDALQHPYINVWYDPAEVEAPPPQIYD 377

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H NIV++         L I +E  + G L   +       + +   + +Q+++G++Y H 
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 396 QNVVHRDIKCANILVDASGS--VKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNR 452
             V HRD+K  N L+D S +  +K+ DFG +K++ ++   KS  GTP ++APEV+ LK  
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LKKE 191
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLE-------GMQALFRIGKGEPPLVPNSLSRDA 505
             G  AD+WS G T+  ML    P+   E        +  +  +    P  V   +S + 
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV--HISPEC 249
Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           R  I +    +P  R +  ++  H +  + L
Sbjct: 250 RHLISRIFVADPAKRISIPEIRNHEWFLKNL 280

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 19  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 73
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK 133
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVVTRYY 184
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 305 VDDALQHPYINVWYDPAEVEAPPPQIYD 332

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 122/260 (46%), Gaps = 19/260 (7%)
Query: 280 QKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR 334
           +K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K               
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMAS- 67
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNY 392
            ++ ++ +  G         I  +L+  G L +  +++  ++    +  +  QI  G+NY
Sbjct: 68  VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVN 448
           L ++ +VHRD+   N+LV     VK+ DFGLAK     +     +  K    WMA E  +
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--S 184
Query: 449 LKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           + +R Y   +D+WS G TV E++T    PY  +   +    + KGE    P   + D   
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            ++KC  ++ + RP   +L+
Sbjct: 245 IMVKCWMIDADSRPKFRELI 264

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 109/251 (43%), Gaps = 20/251 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG G +G VY G +       AVK +       +                  +H N+VQ 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 93
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLNYLHEQNV 398
            G    E   +I  E +  G+L +  ++ +    +V+A        QI + + YL ++N 
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRECN--REEVTAVVLLYMATQISSAMEYLEKKNF 151
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE  +L    + 
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE--SLAYNTFS 209
Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+W+ G  + E+ T    PY  ++  Q    + KG     P        + +  C +
Sbjct: 210 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWK 269
Query: 515 VNPNDRPTAAQ 525
            +P DRP+ A+
Sbjct: 270 WSPADRPSFAE 280

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVSA-- 381
           +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S+  
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
                 Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 141 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 201 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 257
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 258 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVSA-- 381
           +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S+  
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
                 Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 212 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVSA-- 381
           +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S+  
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
                 Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 145 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 205 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 261
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 262 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVSA-- 381
           +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S+  
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
                 Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 144 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 204 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 260
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 261 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 20  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 74
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 75  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 135 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 185
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 306 VDDALQHPYINVWYDPAEVEAPPPQIYD 333

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 19  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 73
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 184
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 305 VDDALQHPYINVWYDPAEVEAPPPQIYD 332

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVSA-- 381
           +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S+  
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
                 Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 212 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 109
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 169
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 227
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 287
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 288 VMLKCWHPKAEMRPSFSELV 307

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 108
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 168
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 226
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 286
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 287 VMLKCWHPKAEMRPSFSELV 306

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 117/273 (42%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  Q +   +   ++  YT QI  G+ YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HRD+   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE--SLT 193
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 254 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 82
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 142
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 200
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 260
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 261 VMLKCWHPKAEMRPSFSELV 280

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGS-LANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N+++     ++E+R ++  E +  GS L++++++ H  + + S   + + + L++LH 
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 396 QNVVHRDIKCANILVDASGS---VKLADFGLAKATTMN---------DVKSCKGTPFWMA 443
           + + HRD+K  NIL +       VK+ DFGL     +N         ++ +  G+  +MA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 444 PEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---- 496
           PEVV     +   Y    D+WSLG  +  +L+  PP+    G    +  G+  P      
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 497 ----------VPNS----LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                      P+     +S  A+D I K L  +   R +AAQ+++HP+V+
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-----------------KYHLMDSQ 378
           +H+NI+   G    +  L++ +E  +KG+L    Q                 +  L    
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
           + +   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 212 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 122/260 (46%), Gaps = 19/260 (7%)
Query: 280 QKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR 334
           +K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K               
Sbjct: 15  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMAS- 70
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNY 392
            ++ ++ +  G         I  +L+  G L +  +++  ++    +  +  QI  G+NY
Sbjct: 71  VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVN 448
           L ++ +VHRD+   N+LV     VK+ DFGLAK     +     +  K    WMA E  +
Sbjct: 130 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--S 187
Query: 449 LKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           + +R Y   +D+WS G TV E++T    PY  +   +    + KGE    P   + D   
Sbjct: 188 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 247
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            ++KC  ++ + RP   +L+
Sbjct: 248 IMVKCWMIDADSRPKFRELI 267

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 285 LGSGSFGTV----YEGYTDD-GFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           LG G+FG+V    Y+   D+ G   AVK++         +                +H+N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 340 IVQYFGTDKDENR--LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
           IV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+ YL  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMN----DVKSCKGTP-FWMAPEVVNLK 450
           +  +HR++   NILV+    VK+ DFGL K    +     VK    +P FW APE  +L 
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE--SLT 191
Query: 451 NRGYGLTADIWSLGCTVLEMLT-----RQPPYSHL-------EGMQALFRI-----GKGE 493
              + + +D+WS G  + E+ T     + PP   +       +G   +F +       G 
Sbjct: 192 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 251
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
            P  P+    +    + +C   N N RP+   L
Sbjct: 252 LPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 283

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 20  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 74
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 75  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 135 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 185
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 306 VDDALQHPYINVWYDPAEVEAPPPQIYD 333

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLAN------------LYQKYHLMDSQVSA-- 381
           +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S+  
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
                 Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 212 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 87
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 147
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 205
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 266 VMLKCWHPKAEMRPSFSELV 285

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/328 (25%), Positives = 132/328 (40%), Gaps = 73/328 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 64  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 118
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVVTRYY 229
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 523 AAQLMEHPFVK---RPLQKSRGPPSYYN 547
               ++HP++     P +    PP  Y+
Sbjct: 350 VDDALQHPYINVWYDPAEVEAPPPQIYD 377

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 7   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 63
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 64  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 121
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFG AK     +     +
Sbjct: 122 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 182 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 239
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 240 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 90
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 208
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 268
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 269 VMLKCWHPKAEMRPSFSELV 288

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 88
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 148
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 206
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 266
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 267 VMLKCWHPKAEMRPSFSELV 286

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 85
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 203
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 263
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 264 VMLKCWHPKAEMRPSFSELV 283

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 111/236 (47%), Gaps = 25/236 (10%)
Query: 337 HENIV---QYFGTDK--DENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLN 391
           HEN++     F  D+  D+   F  +       L  L +   L + ++     Q+L GL 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 142
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           Y+H   ++HRD+K  N+ V+    +K+ DFGLA+    +++     T ++ APEV+ L  
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMXGXVVTRWYRAPEVI-LNW 200
Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYS---HLEGMQALFRIGKGEPP--LVPNSLSRDAR 506
             Y  T DIWS+GC + EM+T +  +    HL+ ++ + ++  G PP   V    S +A+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV-TGTPPAEFVQRLQSDEAK 259
Query: 507 DFILKCLQVNPND--------RPTAAQLMEHPFVKRPLQKSRGPPS----YYNNMH 550
           +++    ++   D         P A  L+E   V    Q+     +    Y+ ++H
Sbjct: 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++L SG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 10  APNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 66
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 67  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 124
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 125 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 185 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 242
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 243 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 107/261 (40%), Gaps = 20/261 (7%)
Query: 285 LGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FEHENIVQ 342
           LG GSFG VYEG   D     A   V+++                     + F   ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------QVSAYTRQILNGLN 391
             G         + +EL+  G L +  +                  ++     +I +G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----WMAPEVV 447
           YL+ +  VHRD+   N +V    +VK+ DFG+ +     D     G       WMAPE  
Sbjct: 145 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE-- 202
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     P++      
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 262
Query: 507 DFILKCLQVNPNDRPTAAQLM 527
           D +  C Q NPN RPT  +++
Sbjct: 263 DLMRMCWQFNPNMRPTFLEIV 283

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVSA-- 381
           +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S+  
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCK 436
                 Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D   K+  
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 437 G-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-G 492
           G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +  ++ LF++ K G
Sbjct: 253 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 309
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 310 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 89
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 207
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 267
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 268 VMLKCWHPKAEMRPSFSELV 287

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 19/279 (6%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVV 447
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+    +    GT  ++APE+ 
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL- 177
Query: 448 NLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
            LK R +     D+WS G  +  ML  + P+         +   K +   +      D+ 
Sbjct: 178 -LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSA 236
Query: 507 DFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
              L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 237 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 90
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ YL 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT------TMNDVKSCKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+        ++++    K    WMA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 208
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 268
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 269 VMLKCWHPKAEMRPSFSELV 288

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 13  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 69
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 70  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 127
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 128 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 187
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 188 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 245
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    + KC  ++ + RP   +L+
Sbjct: 246 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 5   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 61
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 62  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 119
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFG AK     +     +
Sbjct: 120 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 180 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 237
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 238 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 121/289 (41%), Gaps = 25/289 (8%)
Query: 254 LAVRLIKEPVY--NVSPNGKFRRRIMSWQKGEL-----LGSGSFGTVYEGYTDDGFFFAV 306
           L  RLIK  V    V+   +F R   +    EL     +G G FG V  G    G   AV
Sbjct: 163 LCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG-DYRGNKVAV 221
Query: 307 KEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYFGTDKDE-NRLFIFLELVTKGSL 365
           K +   D   Q                +  H N+VQ  G   +E   L+I  E + KGSL
Sbjct: 222 KCIK-NDATAQA------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 366 ANLYQ---KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG 422
            +  +   +  L    +  ++  +   + YL   N VHRD+   N+LV      K++DFG
Sbjct: 275 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334
Query: 423 LAK-ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHL 480
           L K A++  D  + K    W APE   L+ + +   +D+WS G  + E+ +  + PY  +
Sbjct: 335 LTKEASSTQD--TGKLPVKWTAPEA--LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390
Query: 481 EGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
                + R+ KG     P+       D +  C  ++   RPT  QL E 
Sbjct: 391 PLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQ 439

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 62
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 63  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 120
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 121 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 181 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 238
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    + KC  ++ + RP   +L+
Sbjct: 239 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 12/218 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYL 393
             HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ YL
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEVVN 448
           H   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+  
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL-- 178
Query: 449 LKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           LK R +     D+WS G  +  ML  + P+         +   K +   +      D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 508 FIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
             L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L + +E    G+L+                  +LY+ +  ++  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 152 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 211 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 30/275 (10%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA-----------------NLYQKYHLMDSQVS 380
           N+V   G   K    L + +E    G+L+                 +LY+ +  ++  + 
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI- 151
Query: 381 AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG--- 437
            Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG   
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 438 TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGEP 494
            P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G  
Sbjct: 212 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
              P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 270 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 12/218 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYL 393
             HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ YL
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEVVN 448
           H   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+  
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL-- 177
Query: 449 LKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           LK R +     D+WS G  +  ML  + P+         +   K +   +      D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 508 FIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
             L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 238 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA----------------NLYQKYHLMDSQVSA 381
           N+V   G   K    L + +E    G+L+                +LY+ +  ++  +  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX- 152
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---T 438
           Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG    
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 439 PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGEPP 495
           P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G   
Sbjct: 213 PLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
             P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 271 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L + +E    G+L+                  +LY+ +  ++  +
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 143 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 202 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 260 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA--------------NLYQKYHLMDSQVSAYT 383
           N+V   G   K    L + +E    G+L+              +LY+ +  ++  +  Y+
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI-CYS 150
Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---TPF 440
            Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG    P 
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 441 -WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGEPPLV 497
            WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G     
Sbjct: 211 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 269 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 19/279 (6%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEIXIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVV 447
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+    +    GT  ++APE+ 
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL- 177
Query: 448 NLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
            LK R +     D+WS G  +  ML  + P+         +   K +   +      D+ 
Sbjct: 178 -LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 507 DFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
              L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 237 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 21/280 (7%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 177
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
             LK R +     D+WS G  +  ML  + P+         +   K +   +      D+
Sbjct: 178 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
Query: 506 RDFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
               L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 236 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 21/280 (7%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEIXIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 177
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
             LK R +     D+WS G  +  ML  + P+         +   K +   +      D+
Sbjct: 178 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
Query: 506 RDFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
               L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 236 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 19/279 (6%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVV 447
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+    +    GT  ++APE+ 
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL- 177
Query: 448 NLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
            LK R +     D+WS G  +  ML  + P+         +   K +   +      D+ 
Sbjct: 178 -LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 236
Query: 507 DFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
              L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 237 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 21/280 (7%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 57
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 176
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
             LK R +     D+WS G  +  ML  + P+         +   K +   +      D+
Sbjct: 177 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 506 RDFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
               L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 274

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L + +E    G+L+                  +LY+ +  ++  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 152 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 211 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 12/218 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYL 393
             HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ YL
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEVVN 448
           H   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+  
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL-- 178
Query: 449 LKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           LK R +     D+WS G  +  ML  + P+         +   K +   +      D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 508 FIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
             L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 12/218 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYL 393
             HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ YL
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEVVN 448
           H   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+  
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL-- 178
Query: 449 LKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           LK R +     D+WS G  +  ML  + P+         +   K +   +      D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 508 FIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
             L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 12/218 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYL 393
             HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ YL
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEVVN 448
           H   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+  
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL-- 178
Query: 449 LKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           LK R +     D+WS G  +  ML  + P+         +   K +   +      D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 508 FIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
             L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 12/218 (5%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYL 393
             HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ YL
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEVVN 448
           H   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+  
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL-- 177
Query: 449 LKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           LK R +     D+WS G  +  ML  + P+         +   K +   +      D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 508 FIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
             L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 238 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 19/279 (6%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEIXIN 59
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVV 447
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+    +    GT  ++APE+ 
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL- 178
Query: 448 NLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
            LK R +     D+WS G  +  ML  + P+         +   K +   +      D+ 
Sbjct: 179 -LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237
Query: 507 DFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
              L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 59
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 60  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 117
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 178 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    + KC  ++ + RP   +L+
Sbjct: 236 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++L SG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 3   APNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 59
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 60  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 117
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 178 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA--------------NLYQKYHLMDSQVSAYT 383
           N+V   G   K    L + +E    G+L+              +LY+ +  ++  +  Y+
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX-YS 150
Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---TPF 440
            Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG    P 
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 441 -WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGEPPLV 497
            WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G     
Sbjct: 211 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 269 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 70/310 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKXV 80
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIK 140
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVVTRYY 191
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 523 AAQLMEHPFV 532
               ++HP++
Sbjct: 312 VDDALQHPYI 321

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 149
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ +L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT---TMNDVKSCKGTPF---WMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+       + V +  G      WMA E  +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE--S 267
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 328 VMLKCWHPKAEMRPSFSELV 347

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 21/280 (7%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 59
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 178
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
             LK R +     D+WS G  +  ML  + P+         +   K +   +      D+
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
Query: 506 RDFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
               L  K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 90
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ +L 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT---TMNDVKSCKGTPF---WMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+       + V +  G      WMA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE--S 208
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 268
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 269 VMLKCWHPKAEMRPSFSELV 288

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L + +E    G+L+                  +LY+ +  ++  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 152 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 211 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L + +E    G+L+                  +LY+ +  ++  +
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 154 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 213 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 270
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 271 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 30/258 (11%)
Query: 284 LLGSGSFGTVYEG-YTDDG---FFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           ++G G FG VY G Y D        A+K +S   +  Q +                 H N
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG----LNHPN 83
Query: 340 IVQYFGTDKDENRL-FIFLELVTKGSLANLY---QKYHLMDSQVSAYTRQILNGLNYLHE 395
           ++   G       L  + L  +  G L       Q+   +   +S +  Q+  G+ YL E
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS-FGLQVARGMEYLAE 142
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF------WMAPEVVNL 449
           Q  VHRD+   N ++D S +VK+ADFGLA+     +  S +          W A E  +L
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE--SL 200
Query: 450 KNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG----EPPLVPNSLSRD 504
           +   +   +D+WS G  + E+LTR  PPY H++       + +G    +P   P+SL + 
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ- 259
Query: 505 ARDFILKCLQVNPNDRPT 522
               + +C + +P  RPT
Sbjct: 260 ---VMQQCWEADPAVRPT 274

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L +  E    G+L+                  +LY+ +  ++  +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 143 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 202 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 260 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++L SG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 10  APNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 66
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 67  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 124
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +     +
Sbjct: 125 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 185 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 242
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 243 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 88
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ +L 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 148
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT---TMNDVKSCKGTPF---WMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+       + V +  G      WMA E  +
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE--S 206
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 266
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 267 VMLKCWHPKAEMRPSFSELV 286

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 353 LFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           L I  E +  G L +  Q        + + S   + I   + YLH  N+ HRD+K  N+L
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 410 VDA---SGSVKLADFGLAKATT-MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGC 465
             +   +  +KL DFG AK TT  N + +   TP+++APEV  L    Y  + D WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDXWSLGV 251
Query: 466 TVLEMLTRQPPYSHLEGM------QALFRIGKGE-PPLVPNSLSRDARDFILKCLQVNPN 518
               +L   PP+    G+      +   R G+ E P    + +S + +  I   L+  P 
Sbjct: 252 IXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPT 311
Query: 519 DRPTAAQLMEHPFVKR-------PLQKSR 540
            R T  +   HP++ +       PL  SR
Sbjct: 312 QRXTITEFXNHPWIXQSTKVPQTPLHTSR 340

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 59
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 60  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 117
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFG AK     +     +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 177
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 178 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 95
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ +L 
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 155
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT---TMNDVKSCKGTPF---WMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+       + V +  G      WMA E  +
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE--S 213
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 273
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 274 VMLKCWHPKAEMRPSFSELV 293

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 10  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 66
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 67  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 124
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFG AK     +     +
Sbjct: 125 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 184
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 185 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 242
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    ++KC  ++ + RP   +L+
Sbjct: 243 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 70/310 (22%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLS---RPFQNQTHAKRAYRELVLMKXV 80
Query: 336 EHENIVQYFGTDKDENRLFIF--LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLN 391
            H+NI+        +  L  F  + LV +   ANL Q  +  L   ++S    Q+L G+ 
Sbjct: 81  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
           +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV    
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVVTRYY 191
Query: 452 R--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYSHLEG 482
           R        GY    DIWS+GC + EM+  +                     P    ++ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 483 MQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPNDRPT 522
           +Q   R          G   P L P+SL           +  ARD + K L ++P  R +
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 523 AAQLMEHPFV 532
               ++HP++
Sbjct: 312 VDDALQHPYI 321

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 5   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 61
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I ++L+  G L +  +++  ++   
Sbjct: 62  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-MQLMPFGCLLDYVREHKDNIGSQ 119
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFG AK     +     +
Sbjct: 120 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 180 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 237
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    + KC  ++ + RP   +L+
Sbjct: 238 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L + +E    G+L+                  +LY+ +  ++  +
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 189 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 248 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 305
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 306 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 21/275 (7%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 177
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
             LK R +     D+WS G  +  ML  + P+         +   K +   +      D+
Sbjct: 178 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
Query: 506 RDFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
               L  K L  NP+ R T   + +  +  +PL+K
Sbjct: 236 APLALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 90
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ +L 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT---TMNDVKSCKGTPF---WMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+       + V +  G      WMA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE--S 208
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 268
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 269 VMLKCWHPKAEMRPSFSELV 288

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 348 KDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC 405
           +D+N L++ ++    G L  L  K+   L +     Y  +++  ++ +H+ + VHRDIK 
Sbjct: 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203
Query: 406 ANILVDASGSVKLADFG-----LAKATTMNDVKSCKGTPFWMAPEVVNLKNRG---YGLT 457
            NIL+D +G ++LADFG     +   T  + V    GTP +++PE++     G   YG  
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--GTPDYISPEILQAMEGGKGRYGPE 261
Query: 458 ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----PLVPNSLSRDARDFI--LK 511
            D WSLG  + EML  + P+     ++   +I   +     P     +S +A+D I  L 
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI 321
Query: 512 CLQVNPNDRPTAAQLMEHPF 531
           C + +   +       +HPF
Sbjct: 322 CSREHRLGQNGIEDFKKHPF 341

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 21/275 (7%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 59
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 60  AMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 178
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
             LK R +     D+WS G  +  ML  + P+         +   K +   +      D+
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
Query: 506 RDFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
               L  K L  NP+ R T   + +  +  +PL+K
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 91
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ +L 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATT---MNDVKSCKGTPF---WMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+       + V +  G      WMA E  +
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE--S 209
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 269
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 270 VMLKCWHPKAEMRPSFSELV 289

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 283 ELLGSGSFGTVYEG--YTDDG--FFFAVKEVS-LQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           E++G G FG VY G    +DG     AVK ++ + D G   +               F H
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSH 91
Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ +L 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKAT---TMNDVKSCKGTPF---WMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+       + V +  G      WMA E  +
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE--S 209
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 269
Query: 508 FILKCLQVNPNDRPTAAQLM 527
            +LKC       RP+ ++L+
Sbjct: 270 VMLKCWHPKAEMRPSFSELV 289

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 21/275 (7%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 177
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
             LK R +     D+WS G  +  ML  + P+         +   K +   +      D+
Sbjct: 178 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
Query: 506 RDFIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
               L  K L  NP+ R T   + +  +  +PL+K
Sbjct: 236 APLALLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 114/264 (43%), Gaps = 23/264 (8%)
Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIV 341
           GEL+G G FG VY G      +     + L D     +              +  HEN+V
Sbjct: 38  GELIGKGRFGQVYHGR-----WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
            + G       L I   L    +L ++ +  K  L  ++     ++I+ G+ YLH + ++
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTM-------NDVKSCKGTPFWMAPEVVNL--- 449
           H+D+K  N+  D +G V + DFGL   + +       + ++   G    +APE++     
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 450 ----KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-EPPLVPNSLSRD 504
                   +   +D+++LG    E+  R+ P+        ++++G G +P L    + ++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE 271
Query: 505 ARDFILKCLQVNPNDRPTAAQLME 528
             D +L C      +RPT  +LM+
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMD 295

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 120/295 (40%), Gaps = 46/295 (15%)
Query: 280 QKGELLGSGSFGTVYE------GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           Q G+ LG+G+FG V E      G  D     AVK +       + +              
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG- 107
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANL------------YQKYHLMDSQVSA 381
             +HENIV   G       + +  E    G L N             Y   H  + Q+S+
Sbjct: 108 --QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 382 -----YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----V 432
                ++ Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    V
Sbjct: 166 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIV 224
Query: 433 KSCKGTPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ-PPYSHLEGMQALFRIG 490
           K     P  WMAPE  ++ +  Y + +D+WS G  + E+ +    PY  +      +++ 
Sbjct: 225 KGNARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 282
Query: 491 K-----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
           K      +P   P    ++    +  C  + P  RPT  Q+    F++   Q+ R
Sbjct: 283 KDGYQMAQPAFAP----KNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQEDR 331

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
             H NIV++         L I +E  + G L   +       + +   + +Q+++G++Y 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 394 HEQNVVHRDIKCANILVDASGS--VKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLK 450
           H   V HRD+K  N L+D S +  +K+  FG +K++ ++   KS  GTP ++APEV+ LK
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LK 190
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-------GMQALFRIGKGEPPLVPNSLSR 503
               G  AD+WS G T+  ML    P+   E        +  +  +    P  V   +S 
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV--HISP 248
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           + R  I +    +P  R +  ++  H +  + L
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 281

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 106/261 (40%), Gaps = 20/261 (7%)
Query: 285 LGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FEHENIVQ 342
           LG GSFG VYEG   D     A   V+++                     + F   ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------QVSAYTRQILNGLN 391
             G         + +EL+  G L +  +                  ++     +I +G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----WMAPEVV 447
           YL+ +  VHRD+   N +V    +VK+ DFG+ +     D     G       WMAPE  
Sbjct: 145 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE-- 202
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     P++      
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 262
Query: 507 DFILKCLQVNPNDRPTAAQLM 527
           D +  C Q NP  RPT  +++
Sbjct: 263 DLMRMCWQFNPKMRPTFLEIV 283

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L +  E    G+L+                  +LY+ +  ++  +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 143 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 202 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 260 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 106/261 (40%), Gaps = 20/261 (7%)
Query: 285 LGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FEHENIVQ 342
           LG GSFG VYEG   D     A   V+++                     + F   ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------QVSAYTRQILNGLN 391
             G         + +EL+  G L +  +                  ++     +I +G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----WMAPEVV 447
           YL+ +  VHRD+   N +V    +VK+ DFG+ +     D     G       WMAPE  
Sbjct: 142 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE-- 199
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     P++      
Sbjct: 200 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 259
Query: 507 DFILKCLQVNPNDRPTAAQLM 527
           D +  C Q NP  RPT  +++
Sbjct: 260 DLMRMCWQFNPKMRPTFLEIV 280

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 121/293 (41%), Gaps = 44/293 (15%)
Query: 280 QKGELLGSGSFGTVYE------GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           Q G+ LG+G+FG V E      G  D     AVK +       + +              
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG- 107
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK----------YHLMDSQVSA-- 381
             +HENIV   G       + +  E    G L N  ++          + + +S +S   
Sbjct: 108 --QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKS 434
              ++ Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    VK 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKG 224
Query: 435 CKGTPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ-PPYSHLEGMQALFRIGK- 491
               P  WMAPE  ++ +  Y + +D+WS G  + E+ +    PY  +      +++ K 
Sbjct: 225 NARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 492 ----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
                +P   P    ++    +  C  + P  RPT  Q+    F++   Q+ R
Sbjct: 283 GYQMAQPAFAP----KNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQEDR 329

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 31/276 (11%)
Query: 282 GELLGSGSFGTVYEG---YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           G+ LG G+FG V E      D         V +  +G                     H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 339 NIVQYFG-TDKDENRLFIFLELVTKGSLA------------------NLYQKYHLMDSQV 379
           N+V   G   K    L +  E    G+L+                  +LY+ +  ++  +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG-- 437
             Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +     KG  
Sbjct: 143 -CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 438 -TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALF-RIGKGE 493
             P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++  +    R+ +G 
Sbjct: 202 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 260 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 122
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 183 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 242
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 243 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 300
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 301 VYR----IMTQCWQHQPEDRPNFAIILE 324

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGS-LANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N+++     ++E+R ++  E +  GS L++++++ H  + + S   + + + L++LH 
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 396 QNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDVKSCKGTP---------FWMA 443
           + + HRD+K  NIL +       VK+ DF L     +N   S   TP          +MA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 444 PEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---- 496
           PEVV     +   Y    D+WSLG  +  +L+  PP+    G    +  G+  P      
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 497 ----------VPNS----LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                      P+     +S  A+D I K L  +   R +AAQ+++HP+V+
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 177
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSH 479
             LK R +     D+WS G  +  ML  + P+  
Sbjct: 178 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 96
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 217 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 274
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 275 VYR----IMTQCWQHQPEDRPNFAIILE 298

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 59
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 178
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSH 479
             LK R +     D+WS G  +  ML  + P+  
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 23/221 (10%)
Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXX 331
           R+ +  +Q   + G G+FGTV  G     G   A+K+V +QD   + +            
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAV-- 75
Query: 332 XXRFEHENIVQ---YFGTDKDENRLFIFLELVTK---GSLANLYQKYHLMDSQ-----VS 380
                H NIVQ   YF T  + +R  I+L +V +    +L    + Y+          + 
Sbjct: 76  ---LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 381 AYTRQILNGLNYLH--EQNVVHRDIKCANILV-DASGSVKLADFGLAKATTMNDVK-SCK 436
            +  Q++  +  LH    NV HRDIK  N+LV +A G++KL DFG AK  + ++   +  
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY 477
            + ++ APE++   N+ Y    DIWS+GC   EM+  +P +
Sbjct: 193 CSRYYRAPELI-FGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C   P+ +APE+
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY-VAPEL 177
Query: 447 VNLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSH 479
             LK R +     D+WS G  +  ML  + P+  
Sbjct: 178 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 20/261 (7%)
Query: 285 LGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FEHENIVQ 342
           LG GSFG VYEG   D     A   V+++                     + F   ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------QVSAYTRQILNGLN 391
             G         + +EL+  G L +  +                  ++     +I +G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMAPEVV 447
           YL+ +  VHR++   N +V    +VK+ DFG+ +     D   K  KG  P  WMAPE  
Sbjct: 145 YLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-- 202
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     P++      
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 262
Query: 507 DFILKCLQVNPNDRPTAAQLM 527
           D +  C Q NPN RPT  +++
Sbjct: 263 DLMRMCWQFNPNMRPTFLEIV 283

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 57/249 (22%)
Query: 335 FEHENIVQY---------FGTDKDENRLFIFLELVTKGSLANLYQKYH----LMDSQVSA 381
           F+H+NI+           +G  K    +++ L+L+     ++L+Q  H    L    V  
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKS---VYVVLDLME----SDLHQIIHSSQPLTLEHVRY 162
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK------SC 435
           +  Q+L GL Y+H   V+HRD+K +N+LV+ +  +K+ DFG+A+    +  +        
Sbjct: 163 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFRIGKG 492
             T ++ APE++ L    Y    D+WS+GC   EML R+   P  +++  +Q +  +   
Sbjct: 223 VATRWYRAPELM-LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281
Query: 493 EPPLVPNSLS---------------------------RDARDFILKCLQVNPNDRPTAAQ 525
             P V  ++                            R A   + + L+  P+ R +AA 
Sbjct: 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341
Query: 526 LMEHPFVKR 534
            + HPF+ +
Sbjct: 342 ALRHPFLAK 350

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 276 IMSWQKGELLGSGSFGTV---YEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           +  W   + LG G++G V       T++    AVK V ++    +               
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDMK----RAVDCPENIKKEICIN 58
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L +  +    + +     +  Q++ G+ 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVV 447
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+    +    GT  ++APE+ 
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL- 177
Query: 448 NLKNRGYGLT-ADIWSLGCTVLEMLTRQPPYSH 479
            LK R +     D+WS G  +  ML  + P+  
Sbjct: 178 -LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 57/249 (22%)
Query: 335 FEHENIVQY---------FGTDKDENRLFIFLELVTKGSLANLYQKYH----LMDSQVSA 381
           F+H+NI+           +G  K    +++ L+L+     ++L+Q  H    L    V  
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKS---VYVVLDLME----SDLHQIIHSSQPLTLEHVRY 163
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK------SC 435
           +  Q+L GL Y+H   V+HRD+K +N+LV+ +  +K+ DFG+A+    +  +        
Sbjct: 164 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFRIGKG 492
             T ++ APE++ L    Y    D+WS+GC   EML R+   P  +++  +Q +  +   
Sbjct: 224 VATRWYRAPELM-LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 282
Query: 493 EPPLVPNSLS---------------------------RDARDFILKCLQVNPNDRPTAAQ 525
             P V  ++                            R A   + + L+  P+ R +AA 
Sbjct: 283 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 342
Query: 526 LMEHPFVKR 534
            + HPF+ +
Sbjct: 343 ALRHPFLAK 351

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 112/263 (42%), Gaps = 28/263 (10%)
Query: 283 ELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           E++G+G FG V  G            A+K +    +G   +              +FEH 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHP 77
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQ 396
           NI++  G   +   + I  E +  G+L +  +         Q+    R I +G+ YL E 
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF-------WMAPEVVNL 449
           + VHRD+   NILV+++   K++DFGL++    N     + +         W APE +  
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 450 KNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG----EPPLVPNSLSRD 504
             R +   +D WS G  + E+++  + PY  +     +  I +      PP  P SL + 
Sbjct: 198 --RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQ- 254
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
               +L C Q + N RP   Q++
Sbjct: 255 ---LMLDCWQKDRNARPRFPQVV 274

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------------QV 379
           H NI+   G  +    L++ +E    G+L +  +K  ++++                 Q+
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTP 439
             +   +  G++YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    P
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 440 F-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLV 497
             WMA E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G     
Sbjct: 195 VRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 252
Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           P +   +  D + +C +  P +RP+ AQ++
Sbjct: 253 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------------Q 378
            H NI+   G  +    L++ +E    G+L +  +K  ++++                 Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 438
           +  +   +  G++YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 439 PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPL 496
           P  WMA E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G    
Sbjct: 204 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 261
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
            P +   +  D + +C +  P +RP+ AQ++
Sbjct: 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 87
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 148 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 207
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 208 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 265
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 266 VYR----IMTQCWQHQPEDRPNFAIILE 289

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 44/293 (15%)
Query: 280 QKGELLGSGSFGTVYE------GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           Q G+ LG+G+FG V E      G  D     AVK +       + +              
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG- 107
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK----------YHLMDSQVSA-- 381
             +HENIV   G       + +  E    G L N  ++          + + +S  S   
Sbjct: 108 --QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 382 ---YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKS 434
              ++ Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    VK 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKG 224
Query: 435 CKGTPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ-PPYSHLEGMQALFRIGK- 491
               P  WMAPE  ++ +  Y + +D+WS G  + E+ +    PY  +      +++ K 
Sbjct: 225 NARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 492 ----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
                +P   P    ++    +  C  + P  RPT  Q+    F++   Q+ R
Sbjct: 283 GYQMAQPAFAP----KNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQEDR 329

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 95
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 216 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 273
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 274 VYR----IMTQCWQHQPEDRPNFAIILE 297

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEG-YTDDG----FFFAVKEVSLQDQGTQGK 319
           +PN    R +    ++K ++LGSG+FGTVY+G +  +G       A+KE+    + T  K
Sbjct: 5   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPK 61
Query: 320 XXXXXXXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDS 377
                           ++ ++ +  G         I  +L+  G L +  +++  ++   
Sbjct: 62  ANKEILDEAYVMAS-VDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQ 119
Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VK 433
            +  +  QI  G+NYL ++ +VHRD+   N+LV     VK+ DFG AK     +     +
Sbjct: 120 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG 492
             K    WMA E  ++ +R Y   +D+WS G TV E++T    PY  +   +    + KG
Sbjct: 180 GGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 237
Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           E    P   + D    + KC  ++ + RP   +L+
Sbjct: 238 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 112
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 173 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 232
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 233 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 290
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 291 VYR----IMTQCWQHQPEDRPNFAIILE 314

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 20/261 (7%)
Query: 285 LGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FEHENIVQ 342
           LG GSFG VYEG   D     A   V+++                     + F   ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------QVSAYTRQILNGLN 391
             G         + +EL+  G L +  +                  ++     +I +G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMAPEVV 447
           YL+ +  VHR++   N +V    +VK+ DFG+ +     D   K  KG  P  WMAPE  
Sbjct: 146 YLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-- 203
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     P++      
Sbjct: 204 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 263
Query: 507 DFILKCLQVNPNDRPTAAQLM 527
           D +  C Q NPN RPT  +++
Sbjct: 264 DLMRMCWQFNPNMRPTFLEIV 284

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 102
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 163 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 222
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 223 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 280
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 281 VYR----IMTQCWQHQPEDRPNFAIILE 304

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 109/261 (41%), Gaps = 20/261 (7%)
Query: 285 LGSGSFGTVYEGYTDDGFFF-AVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FEHENIVQ 342
           LG GSFG VYEG   D     A   V+++                     + F   ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------QVSAYTRQILNGLN 391
             G         + +EL+  G L +  +                  ++     +I +G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMAPEVV 447
           YL+ +  VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WMAPE  
Sbjct: 145 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-- 202
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     P++      
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 262
Query: 507 DFILKCLQVNPNDRPTAAQLM 527
           D +  C Q NP  RPT  +++
Sbjct: 263 DLMRMCWQFNPKMRPTFLEIV 283

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 119/263 (45%), Gaps = 28/263 (10%)
Query: 283 ELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           +++G+G FG V  G+         F A+K  +L+   T+ +              +F+H 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIK--TLKSGYTEKQRRDFLSEASIMG--QFDHP 94
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQ 396
           N++   G       + I  E +  GSL +  ++        Q+    R I  G+ YL + 
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTPF---WMAPEVVNL 449
           N VHRD+   NILV+++   K++DFGL++     T+     S  G      W APE +  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 212
Query: 450 KNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG---EPPL-VPNSLSRD 504
           + R +   +D+WS G  + E+++  + PY  +     +  I +     PP+  P++L + 
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ- 271
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
               +L C Q + N RP   Q++
Sbjct: 272 ---LMLDCWQKDRNHRPKFGQIV 291

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +     +              +F H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VYSEQDELDFLMEALIISKFNHQNI 110
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 231 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 288
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 289 VYR----IMTQCWQHQPEDRPNFAIILE 312

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 96
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 217 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 274
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 275 VYR----IMTQCWQHQPEDRPNFAIILE 298

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGLA+    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 113
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDV---KSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+            C   P  WM PE
Sbjct: 174 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 233
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 234 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 291
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 292 VYR----IMTQCWQHQPEDRPNFAIILE 315

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 111/265 (41%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 18  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D     G       WM+
Sbjct: 134 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 194 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 251
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 252 DMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 109/261 (41%), Gaps = 20/261 (7%)
Query: 285 LGSGSFGTVYEGYTDDGFFF-AVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FEHENIVQ 342
           LG GSFG VYEG   D     A   V+++                     + F   ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------QVSAYTRQILNGLN 391
             G         + +EL+  G L +  +                  ++     +I +G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMAPEVV 447
           YL+ +  VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WMAPE  
Sbjct: 144 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE-- 201
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     P++      
Sbjct: 202 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 261
Query: 507 DFILKCLQVNPNDRPTAAQLM 527
           D +  C Q NP  RPT  +++
Sbjct: 262 DLMRMCWQFNPKMRPTFLEIV 282

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 95
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI +EL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 216 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 273
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 274 VYR----IMTQCWQHQPEDRPNFAIILE 297

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 128/314 (40%), Gaps = 78/314 (24%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M PEVV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMEPEVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYS 478
               R        GY    DIWS+GC + EM+  +                     P  +
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPA 247
Query: 479 HLEGMQALFR---------IGKGEPPLVPNSL-----------SRDARDFILKCLQVNPN 518
            ++ +Q   R          G     L P+ L           +  ARD + K L ++ +
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 519 DRPTAAQLMEHPFV 532
            R +  + ++HP++
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
             H NIV++         L I +E  + G L   +       + +   + +Q+++G++Y 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 394 HEQNVVHRDIKCANILVDASGS--VKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLK 450
           H   V HRD+K  N L+D S +  +K+  FG +K++ ++   K   GTP ++APEV+ LK
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVL-LK 190
Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-------GMQALFRIGKGEPPLVPNSLSR 503
               G  AD+WS G T+  ML    P+   E        +  +  +    P  V   +S 
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYV--HISP 248
Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           + R  I +    +P  R +  ++  H +  + L
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 281

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 37/212 (17%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M PEVV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPEVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML 471
               R        GY    DIWS+GC + EM+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQN 397
           I Q     +DEN L++ +E    G L  L  K+   +       Y  +I+  ++ +H   
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 398 VVHRDIKCANILVDASGSVKLADFG-LAKATTMNDVKS--CKGTPFWMAPEVVNLKNRGY 454
            VHRDIK  NIL+D  G ++LADFG   K      V+S    GTP +++PE++     G 
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 455 GLT-----ADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP----PLVPNSLSRDA 505
           G        D W+LG    EM   Q P+      +   +I   +     PLV   +  +A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 506 RDFI--LKCLQVNPNDRPTAAQLMEHPF 531
           RDFI  L C       R  A     HPF
Sbjct: 303 RDFIQRLLCPPETRLGRGGAGDFRTHPF 330

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 111/265 (41%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 27  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D     G       WM+
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 203 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 260
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 261 DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 136
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDV---KSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+            C   P  WM PE
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 257 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 314
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 315 VYR----IMTQCWQHQPEDRPNFAIILE 338

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 113/234 (48%), Gaps = 40/234 (17%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS--------AYTRQIL 387
           +H N+++Y+ ++  +  L+I LEL    +L +L +  ++ D  +         +  RQI 
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASG-------------SVKLADFGLAK------ATT 428
           +G+ +LH   ++HRD+K  NILV  S               + ++DFGL K      ++ 
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 429 MNDVKSCKGTPFWMAPEVVNLKN-----RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG 482
             ++ +  GT  W APE++   N     R    + DI+S+GC    +L++ + P+     
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 483 -----MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                ++ +F + + +  L   SL  +A D I + +  +P  RPTA +++ HP 
Sbjct: 246 RESNIIRGIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 367 NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 426
           +LY+ +  ++  +  Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 191 DLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 249
Query: 427 TTMNDVKSCKG---TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLE 481
              +     KG    P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++
Sbjct: 250 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 307
Query: 482 GMQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
             +    R+ +G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 308 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 367 NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 426
           +LY+ +  ++  +  Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 184 DLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 427 TTMNDVKSCKG---TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLE 481
              +     KG    P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 482 GMQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
             +    R+ +G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 367 NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 426
           +LY+ +  ++  +  Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 189 DLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 247
Query: 427 TTMNDVKSCKG---TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLE 481
              +     KG    P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++
Sbjct: 248 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 305
Query: 482 GMQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
             +    R+ +G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 306 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +F H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 110
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI +EL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 231 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 288
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 289 VYR----IMTQCWQHQPEDRPNFAIILE 312

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 367 NLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA 426
           +LY+ +  ++  +  Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+ 
Sbjct: 182 DLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 240
Query: 427 TTMNDVKSCKG---TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLE 481
              +     KG    P  WMAPE +   +R Y + +D+WS G  + E+ +    PY  ++
Sbjct: 241 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 298
Query: 482 GMQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
             +    R+ +G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 299 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG    V++   +    +A+K V+L++   Q                +   + I++ +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
             +  +  +++ +E       + L +K  +   +  +Y + +L  ++ +H+  +VH D+K
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 405 CANILVDASGSVKLADFGLA---KATTMNDVKSCK-GTPFWMAPEVVN--LKNRGYG--- 455
            AN L+   G +KL DFG+A   +  T + VK  + GT  +M PE +     +R  G   
Sbjct: 183 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 241
Query: 456 ----LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-------SRD 504
                 +D+WSLGC +  M   + P+      Q + +I K    + PN          +D
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 32/282 (11%)
Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVS---------LQDQGTQGKXXXXXXXXXXXX 331
           G LLG G FGTV+ G+   D    A+K +          L D  T               
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 332 XXRFEHENIVQYFGTDKDENRLFIFLE--LVTKGSLANLYQKYHLMDSQVSAYTRQILNG 389
                H  +++     + +    + LE  L  +     + +K  L +     +  Q++  
Sbjct: 96  G----HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 390 LNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVN 448
           + + H + VVHRDIK  NIL+D   G  KL DFG              GT  +  PE ++
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS 211
Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSH-LEGMQALFRIGKGEPPLVPNSLSRDARD 507
            +++ + L A +WSLG  + +M+    P+    E ++A            P  +S D   
Sbjct: 212 -RHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF--------PAHVSPDCCA 262
Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKR-----PLQKSRGPPS 544
            I +CL   P+ RP+  +++  P+++      PL  S+G P+
Sbjct: 263 LIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPA 304

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 280 QKGELLGSGSFGTVYE------GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           Q G+ LG+G+FG V E      G  D     AVK +       + +              
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG- 99
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-----------SQVSAY 382
             +HENIV   G       + +  E    G L N  ++    D             +  +
Sbjct: 100 --QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGT 438
           + Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    VK     
Sbjct: 158 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARL 216
Query: 439 PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ-PPYSHLEGMQALFRIGK----- 491
           P  WMAPE  ++ +  Y + +D+WS G  + E+ +    PY  +      +++ K     
Sbjct: 217 PVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 274
Query: 492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
            +P   P    ++    +  C  + P  RPT  Q+    F++   Q+ R
Sbjct: 275 AQPAFAP----KNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQEDR 317

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 280 QKGELLGSGSFGTVYE------GYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXX 333
           Q G+ LG+G+FG V E      G  D     AVK +       + +              
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG- 107
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-----------SQVSAY 382
             +HENIV   G       + +  E    G L N  ++    D             +  +
Sbjct: 108 --QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGT 438
           + Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+   MND    VK     
Sbjct: 166 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-DIMNDSNYIVKGNARL 224
Query: 439 PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ-PPYSHLEGMQALFRIGK----- 491
           P  WMAPE  ++ +  Y + +D+WS G  + E+ +    PY  +      +++ K     
Sbjct: 225 PVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 282
Query: 492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
            +P   P    ++    +  C  + P  RPT  Q+    F++   Q+ R
Sbjct: 283 AQPAFAP----KNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQEDR 325

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG    V++   +    +A+K V+L++   Q                +   + I++ +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
             +  +  +++ +E       + L +K  +   +  +Y + +L  ++ +H+  +VH D+K
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 405 CANILVDASGSVKLADFGLAKAT---TMNDVKSCK-GTPFWMAPEVVN--LKNRGYG--- 455
            AN L+   G +KL DFG+A      T + VK  + GT  +M PE +     +R  G   
Sbjct: 183 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 241
Query: 456 ----LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-------SRD 504
                 +D+WSLGC +  M   + P+      Q + +I K    + PN          +D
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 111/263 (42%), Gaps = 28/263 (10%)
Query: 283 ELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           E++G+G FG V  G            A+K +    +G   +              +FEH 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHP 75
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQ 396
           NI++  G   +   + I  E +  G+L +  +         Q+    R I +G+ YL E 
Sbjct: 76  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF-------WMAPEVVNL 449
           + VHRD+   NILV+++   K++DFGL++    N       +         W APE +  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 450 KNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG----EPPLVPNSLSRD 504
             R +   +D WS G  + E+++  + PY  +     +  I +      PP  P SL + 
Sbjct: 196 --RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQ- 252
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
               +L C Q + N RP   Q++
Sbjct: 253 ---LMLDCWQKDRNARPRFPQVV 272

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 112/259 (43%), Gaps = 21/259 (8%)
Query: 283 ELLGSGSFGTVYEGY--TDDGFFFAVKEVSLQDQGTQG---KXXXXXXXXXXXXXXRFEH 337
           +++G+G FG VY+G   T  G     KEV +  +  +    +              +F H
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSG----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
            NI++  G       + I  E +  G+L    ++        Q+    R I  G+ YL  
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPEVVNL 449
            N VHRD+   NILV+++   K++DFGL++    +D ++   T     P  W APE ++ 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 450 KNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF 508
             R +   +D+WS G  + E++T  + PY  L   + +  I  G     P          
Sbjct: 225 --RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 282
Query: 509 ILKCLQVNPNDRPTAAQLM 527
           +++C Q     RP  A ++
Sbjct: 283 MMQCWQQERARRPKFADIV 301

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 24  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 140 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 199
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 200 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 257
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 258 DMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 33  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSA---------YTRQIL 387
           ++V+  G         + +EL+T+G L +  +     + ++ V A            +I 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 209 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 266
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 267 DMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 100 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 159
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 160 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 218
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 219 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 276
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 277 LYQ----LMLDCWQKDRNNRPKFEQIV 299

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 133 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 191
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 192 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 249
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 250 LYQ----LMLDCWQKDRNNRPKFEQIV 272

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 133 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 191
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 192 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 249
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 250 LYQ----LMLDCWQKDRNNRPKFEQIV 272

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 33  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 209 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 266
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 267 DMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 27  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 202
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 203 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 260
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 261 DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +  H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKLNHQNI 96
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 217 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 274
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 275 VYR----IMTQCWQHQPEDRPNFAIILE 298

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 90  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 149
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL++    +D ++   T     P  W +PE
Sbjct: 150 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTRGGKIPIRWTSPE 208
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 209 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 266
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 267 LYQ----LMLDCWQKDRNNRPKFEQIV 289

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           LG GSFG V+       GF  AVK+V L+                           IV  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE----------VFRVEELVACAGLSSPRIVPL 129
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLM-DSQVSAYTRQILNGLNYLHEQNVVHRD 402
           +G  ++   + IF+EL+  GSL  L ++   + + +   Y  Q L GL YLH + ++H D
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 189
Query: 403 IKCANILVDASGS-VKLADF---------GLAKATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           +K  N+L+ + GS   L DF         GL K+    D     GT   MAPEVV    +
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVV--MGK 245
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSH 479
                 DIWS  C +L ML    P++ 
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ 
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL +   VHRD+   NIL++++   K++DFGL +    +D ++   T     P  W +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPE 220
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  + +G    PP+  P +
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA 278
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q + N+RP   Q++
Sbjct: 279 LYQ----LMLDCWQKDRNNRPKFEQIV 301

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 26  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 202 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 259
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 260 DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 26  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 202 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 259
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 260 DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 55  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 171 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 230
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 231 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 288
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 289 DMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 20  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 136 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 196 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 253
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 254 DMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------------Q 378
            H NI+   G  +    L++ +E    G+L +  +K  ++++                 Q
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 438
           +  +   +  G++YL ++  +HR++   NILV  +   K+ADFGL++   +   K+    
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 200
Query: 439 PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPL 496
           P  WMA E +N     Y   +D+WS G  + E+++    PY  +   +   ++ +G    
Sbjct: 201 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 258
Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
            P +   +  D + +C +  P +RP+ AQ++
Sbjct: 259 KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG    V++   +    +A+K V+L++   Q                +   + I++ +
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 75
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
             +  +  +++ +E       + L +K  +   +  +Y + +L  ++ +H+  +VH D+K
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 135
Query: 405 CANILVDASGSVKLADFGLAKAT---TMNDVKSCK-GTPFWMAPEVVN--LKNRGYG--- 455
            AN L+   G +KL DFG+A      T + VK  + GT  +M PE +     +R  G   
Sbjct: 136 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 194
Query: 456 ----LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-------SRD 504
                 +D+WSLGC +  M   + P+      Q + +I K    + PN          +D
Sbjct: 195 SKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKD 249
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 250 LQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 78/314 (24%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M PEVV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMEPEVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYS 478
               R        GY    D+WS+GC + EM+  +                     P   
Sbjct: 188 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 479 HLEGMQALFRI---------GKGEPPLVPNSL-----------SRDARDFILKCLQVNPN 518
            ++ +Q   R          G     L P+ L           +  ARD + K L ++ +
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 519 DRPTAAQLMEHPFV 532
            R +  + ++HP++
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 23  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSA---------YTRQIL 387
           ++V+  G         + +EL+T+G L +  +     + ++ V A            +I 
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 139 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 198
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 199 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 256
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 257 DMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 109/261 (41%), Gaps = 20/261 (7%)
Query: 285 LGSGSFGTVYEGYTDDGF-FFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXR-FEHENIVQ 342
           LG GSFG VYEG   D     A   V+++                     + F   ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 343 YFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------QVSAYTRQILNGLN 391
             G         + +EL+  G L +  +                  ++     +I +G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT--TMNDVKSCKG-TPF-WMAPEVV 447
           YL+ +  VHRD+   N +V    +VK+ DFG+ +    T    K  KG  P  WMAPE  
Sbjct: 145 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPE-- 202
Query: 448 NLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +LK+  +  ++D+WS G  + E+ +  + PY  L   Q L  +  G     P++      
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 262
Query: 507 DFILKCLQVNPNDRPTAAQLM 527
           D +  C Q NP  RPT  +++
Sbjct: 263 DLMRMCWQFNPKMRPTFLEIV 283

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 110/230 (47%), Gaps = 36/230 (15%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS--------AYTRQIL 387
           +H N+++Y+ ++  +  L+I LEL    +L +L +  ++ D  +         +  RQI 
Sbjct: 85  DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASG-------------SVKLADFGLAKATTMN---- 430
           +G+ +LH   ++HRD+K  NILV  S               + ++DFGL K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 431 --DVKSCKGTPFWMAPEVVNLKN-RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG---- 482
             ++ +  GT  W APE++     R    + DI+S+GC    +L++ + P+         
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 483 -MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
            ++ +F + + +  L   SL  +A D I + +  +P  RPTA +++ HP 
Sbjct: 264 IIRGIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG    V++   +    +A+K V+L++   Q                +   + I++ +
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 94
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
             +  +  +++ +E       + L +K  +   +  +Y + +L  ++ +H+  +VH D+K
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 154
Query: 405 CANILVDASGSVKLADFGLAKAT---TMNDVKSCK-GTPFWMAPEVVN--LKNRGYG--- 455
            AN L+   G +KL DFG+A      T + VK  + GT  +M PE +     +R  G   
Sbjct: 155 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 213
Query: 456 ----LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-------SRD 504
                 +D+WSLGC +  M   + P+      Q + +I K    + PN          +D
Sbjct: 214 SKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKD 268
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 269 LQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG    V++   +    +A+K V+L++   Q                +   + I++ +
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 78
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
             +  +  +++ +E       + L +K  +   +  +Y + +L  ++ +H+  +VH D+K
Sbjct: 79  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 138
Query: 405 CANILVDASGSVKLADFGLAKAT---TMNDVKSCK-GTPFWMAPEVVN--LKNRGYG--- 455
            AN L+   G +KL DFG+A      T + VK  + GT  +M PE +     +R  G   
Sbjct: 139 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 197
Query: 456 ----LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-------SRD 504
                 +D+WSLGC +  M   + P+      Q + +I K    + PN          +D
Sbjct: 198 SKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKD 252
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 253 LQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 23/265 (8%)
Query: 282 GELLGSGSFGTVYEGYT--DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHEN 339
           G +LG G FG+V E     +DG F  V  V +                       F+H +
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVA-VKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 340 IVQYFGTD---KDENRL---FIFLELVTKGSLANLY-------QKYHLMDSQVSAYTRQI 386
           + +  G     + + RL    + L  +  G L             ++L    +  +   I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSC--KGTPFWM 442
             G+ YL  +N +HRD+   N ++    +V +ADFGL++     D   + C  K    W+
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSL 501
           A E  +L +  Y + +D+W+ G T+ E++TR Q PY+ +E  +    +  G     P   
Sbjct: 207 ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPEC 264
Query: 502 SRDARDFILKCLQVNPNDRPTAAQL 526
             +  D + +C   +P  RP+   L
Sbjct: 265 MEEVYDLMYQCWSADPKQRPSFTCL 289

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 110/230 (47%), Gaps = 36/230 (15%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS--------AYTRQIL 387
           +H N+++Y+ ++  +  L+I LEL    +L +L +  ++ D  +         +  RQI 
Sbjct: 85  DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASG-------------SVKLADFGLAKATTMN---- 430
           +G+ +LH   ++HRD+K  NILV  S               + ++DFGL K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 431 --DVKSCKGTPFWMAPEVVNLKN-RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG---- 482
             ++ +  GT  W APE++     R    + DI+S+GC    +L++ + P+         
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 483 -MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
            ++ +F + + +  L   SL  +A D I + +  +P  RPTA +++ HP 
Sbjct: 264 IIRGIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG    V++   +    +A+K V+L++   Q                +   + I++ +
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 74
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
             +  +  +++ +E       + L +K  +   +  +Y + +L  ++ +H+  +VH D+K
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 134
Query: 405 CANILVDASGSVKLADFGLAKAT---TMNDVKSCK-GTPFWMAPEVVN--LKNRGYG--- 455
            AN L+   G +KL DFG+A      T + VK  + GT  +M PE +     +R  G   
Sbjct: 135 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 193
Query: 456 ----LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-------SRD 504
                 +D+WSLGC +  M   + P+      Q + +I K    + PN          +D
Sbjct: 194 SKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKD 248
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 249 LQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 43/228 (18%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
                      DF+ K L+ +   R TA + MEHP+   P+ K +  P
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY-PVVKEQSQP 334

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 285 LGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           LG G+FG VYEG      +D     V   +L +  ++                +  H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKLNHQNI 110
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNGLNY 392
           V+  G        FI LEL+  G L +  ++     SQ S+          R I  G  Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 393 LHEQNVVHRDIKCANILVDASGS---VKLADFGLAK---ATTMNDVKSCKGTPF-WMAPE 445
           L E + +HRDI   N L+   G     K+ DFG+A+     +      C   P  WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR----QPPYSHLEGMQALFRIGKGEPPL-VPNS 500
                   +    D WS G  + E+ +      P  S+ E ++ +   G+ +PP   P  
Sbjct: 231 A--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 288
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLME 528
           + R     + +C Q  P DRP  A ++E
Sbjct: 289 VYR----IMTQCWQHQPEDRPNFAIILE 312

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GSFG V+       GF  AVK+V L+                           IV  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE----------VFRVEELVACAGLSSPRIVPL 115
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLM-DSQVSAYTRQILNGLNYLHEQNVVHRD 402
           +G  ++   + IF+EL+  GSL  L ++   + + +   Y  Q L GL YLH + ++H D
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 403 IKCANILVDASGS-VKLADF---------GLAKATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           +K  N+L+ + GS   L DF         GL K+    D     GT   MAPEVV    +
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVV--MGK 231
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSH 479
                 DIWS  C +L ML    P++ 
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 337 HENIVQYFGT---DKDENRL----FIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQ 385
           H NIVQ+       K+E+      F+ L  + KG L    +K      L    V     Q
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 386 ILNGLNYLHEQN--VVHRDIKCANILVDASGSVKLADFGLAKATT--------------M 429
               + ++H Q   ++HRD+K  N+L+   G++KL DFG A   +              +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 430 NDVKSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR 488
            +  +   TP +  PE+++L  N   G   DIW+LGC +  +  RQ P+       A  R
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLR 260
Query: 489 IGKGEPPLVPNSLSRDA-RDFILKCLQVNPNDRPTAAQLMEH 529
           I  G+  + P+          I   LQVNP +R + A+++  
Sbjct: 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 111/234 (47%), Gaps = 40/234 (17%)
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS--------AYTRQIL 387
           +H N+++Y+ ++  +  L+I LEL    +L +L +  ++ D  +         +  RQI 
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASG-------------SVKLADFGLAKATTMN---- 430
           +G+ +LH   ++HRD+K  NILV  S               + ++DFGL K         
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 431 --DVKSCKGTPFWMAPEVVNLKN-----RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG 482
             ++ +  GT  W APE++   N     R    + DI+S+GC    +L++ + P+     
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 483 -----MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                ++ +F + + +  L   SL  +A D I + +  +P  RPTA +++ HP 
Sbjct: 246 RESNIIRGIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQY 343
           +G GSFG V+       GF  AVK+V L+                           IV  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE----------VFRVEELVACAGLSSPRIVPL 131
Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLM-DSQVSAYTRQILNGLNYLHEQNVVHRD 402
           +G  ++   + IF+EL+  GSL  L ++   + + +   Y  Q L GL YLH + ++H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 191
Query: 403 IKCANILVDASGS-VKLADF---------GLAKATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           +K  N+L+ + GS   L DF         GL K+    D     GT   MAPEVV    +
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVV--MGK 247
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYS 478
                 DIWS  C +L ML    P++
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHPWT 273

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+L+D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 106/260 (40%), Gaps = 24/260 (9%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           GE +G G+FG V+ G    D    AVK      + T                 ++ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           V+  G    +  ++I +ELV  G        +   L    +         G+ YL  +  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG----TPF-WMAPEVVNLKNRG 453
           +HRD+   N LV     +K++DFG+++    + V +  G     P  W APE +N     
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTAPEALNYGR-- 291
Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDF 508
           Y   +D+WS G  + E  +    PY +L   Q    + KG     P L P+++ R     
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR----L 347
Query: 509 ILKCLQVNPNDRPTAAQLME 528
           + +C    P  RP+ + + +
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQ 367

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 104/259 (40%), Gaps = 22/259 (8%)
Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENI 340
           GE +G G+FG V+ G    D    AVK      + T                 ++ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSC----RETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           V+  G    +  ++I +ELV  G        +   L    +         G+ YL  +  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG---TPF-WMAPEVVNLKNRGY 454
           +HRD+   N LV     +K++DFG+++        +  G    P  W APE +N     Y
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR--Y 292
Query: 455 GLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
              +D+WS G  + E  +    PY +L   Q    + KG     P L P+++ R     +
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR----LM 348
Query: 510 LKCLQVNPNDRPTAAQLME 528
            +C    P  RP+ + + +
Sbjct: 349 EQCWAYEPGQRPSFSTIYQ 367

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H N+V   G       + I +E +  G+L    +K+       Q+    R I  G+ 
Sbjct: 100 QFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMR 159
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCKGTPF---WMAPEV 446
           YL +   VHRD+   NILV+++   K++DFGL++    +   V +  G      W APE 
Sbjct: 160 YLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA 505
           +  + R +   +D+WS G  + E+++  + PY  +     +  I +G     P       
Sbjct: 220 I--QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGL 277
Query: 506 RDFILKCLQVNPNDRPTAAQLM 527
              +L C Q    +RP   Q++
Sbjct: 278 HQLMLDCWQKERAERPKFEQIV 299

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 113/265 (42%), Gaps = 28/265 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKE-----VSLQDQGTQGKXXXXXXXXXXXXXXR-FEHE 338
           LG GSFG VYEG         VK+     V+++                     + F   
Sbjct: 20  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMD----------SQVSAYTRQIL 387
           ++V+  G         + +EL+T+G L +  +     M+          S++     +I 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKG-TPF-WMA 443
           +G+ YL+    VHRD+   N  V    +VK+ DFG+ +     D   K  KG  P  WM+
Sbjct: 136 DGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
           PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P++  
Sbjct: 196 PE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 253
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
               + +  C Q NP  RP+  +++
Sbjct: 254 DMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKVV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLSQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML 471
               R        GY    DIWS+GC + EM+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 27/269 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG    V++   +    +A+K V+L++   Q                +   + I++ +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
             +  +  +++ +E       + L +K  +   +  +Y + +L  ++ +H+  +VH D+K
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 405 CANILVDASGSVKLADFGLAKAT---TMNDVKSCK-GTPFWMAPEVVN--LKNRGYG--- 455
            AN L+   G +KL DFG+A      T + VK  + G   +M PE +     +R  G   
Sbjct: 183 PANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241
Query: 456 ----LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-------SRD 504
                 +D+WSLGC +  M   + P+      Q + +I K    + PN          +D
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/269 (22%), Positives = 119/269 (44%), Gaps = 27/269 (10%)
Query: 285 LGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQYF 344
           +GSG    V++   +    +A+K V+L++   Q                +   + I++ +
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 94
Query: 345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK 404
             +  +  +++ +E       + L +K  +   +  +Y + +L  ++ +H+  +VH D+K
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 154
Query: 405 CANILVDASGSVKLADFGLAKATTMNDVKSCK----GTPFWMAPEVVN--LKNRGYG--- 455
            AN L+   G +KL DFG+A     +     K    GT  +M PE +     +R  G   
Sbjct: 155 PANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 213
Query: 456 ----LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSL-------SRD 504
                 +D+WSLGC +  M   + P+      Q + +I K    + PN          +D
Sbjct: 214 SKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDIPEKD 268
Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 269 LQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 334 RFEHENIVQYFGTDKDE-NRLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNG 389
           +  H N+VQ  G   +E   L+I  E + KGSL +  +   +  L    +  ++  +   
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTPFWMAPEVVN 448
           + YL   N VHRD+   N+LV      K++DFGL K A++  D  + K    W APE   
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEA-- 185
Query: 449 LKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E+ +  + PY  +     + R+ KG     P+       +
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245
Query: 508 FILKCLQVNPNDRPTAAQLMEH 529
            +  C  ++   RP+  QL E 
Sbjct: 246 VMKNCWHLDAAMRPSFLQLREQ 267

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVS----LQDQGTQGKXXXXXXXXXXXXXX 333
           W   ++LG G+   V+ G +   G  FA+K  +    L+    Q +              
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK-------- 62
Query: 334 RFEHENIVQYFGTDKDEN--RLFIFLELVTKGSLANLYQK----YHLMDSQVSAYTRQIL 387
           +  H+NIV+ F  +++       + +E    GSL  + ++    Y L +S+     R ++
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 388 NGLNYLHEQNVVHRDIKCANIL----VDASGSVKLADFGLAKATTMND-VKSCKGTPFWM 442
            G+N+L E  +VHR+IK  NI+     D     KL DFG A+    ++   S  GT  ++
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 443 APEVVNL------KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKG 492
            P++           + YG T D+WS+G T     T   P+   EG     + +++I  G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 493 EP 494
           +P
Sbjct: 243 KP 244

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 109 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 166
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 167 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 225
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLSQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML 471
               R        GY    DIWS+GC + EM+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 110 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 226
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 78/314 (24%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKVV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLSQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML---TRQPPYSHLEGMQALF-RIGKGEP- 494
               R        GY    DIWS+GC + EM+      P   H++    +  ++G   P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPE 247
Query: 495 -------------------------PLVPNSL-----------SRDARDFILKCLQVNPN 518
                                     L P+ L           +  ARD + K L ++ +
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 519 DRPTAAQLMEHPFV 532
            R +  + ++HP++
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 116/266 (43%), Gaps = 26/266 (9%)
Query: 282 GELLGSGSFGTVYEG--YTDDG--FFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           G++LG G FG+V EG    +DG     AVK + L D  +Q +               F H
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL-DNSSQREIEEFLSEAACMKD--FSH 95
Query: 338 ENIVQYFGTDKDEN-----RLFIFLELVTKGSLAN--LYQKY-----HLMDSQVSAYTRQ 385
            N+++  G   + +     +  + L  +  G L    LY +      H+    +  +   
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTPFW 441
           I  G+ YL  +N +HRD+   N ++    +V +ADFGL+K     D     +  K    W
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNS 500
           +A E  +L +R Y   +D+W+ G T+ E+ TR   PY  ++  +    +  G     P  
Sbjct: 216 IAIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED 273
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQL 526
              +  + +  C + +P DRPT + L
Sbjct: 274 CLDELYEIMYSCWRTDPLDRPTFSVL 299

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 110 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 226
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 48/281 (17%)
Query: 284 LLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHENIVQ 342
           +LG G+FG V +     D  ++A+K++    + T+ K                 H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLAS--LNHQYVVR 66
Query: 343 YFGT-------------DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR---QI 386
           Y+                K ++ LFI  E     +L +L    +L + Q   Y R   QI
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENL-NQQRDEYWRLFRQI 125
Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT----------------TMN 430
           L  L+Y+H Q ++HR++K  NI +D S +VK+ DFGLAK                  + +
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS----HLEGMQAL 486
           ++ S  GT  ++A EV++     Y    D +SLG    E +    P+S     +  ++ L
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGH-YNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKKL 241
Query: 487 FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
             +    PP   ++  +  +  I   +  +PN RP A  L+
Sbjct: 242 RSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 334 RFEHENIVQYFGTDKDE-NRLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNG 389
           +  H N+VQ  G   +E   L+I  E + KGSL +  +   +  L    +  ++  +   
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTPFWMAPEVVN 448
           + YL   N VHRD+   N+LV      K++DFGL K A++  D  + K    W APE   
Sbjct: 115 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEA-- 170
Query: 449 LKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E+ +  + PY  +     + R+ KG     P+       +
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 230
Query: 508 FILKCLQVNPNDRPTAAQLMEH 529
            +  C  ++   RP+  QL E 
Sbjct: 231 VMKNCWHLDAAMRPSFLQLREQ 252

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 10/202 (4%)
Query: 334 RFEHENIVQYFGTDKDE-NRLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNG 389
           +  H N+VQ  G   +E   L+I  E + KGSL +  +   +  L    +  ++  +   
Sbjct: 61  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 120
Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-ATTMNDVKSCKGTPFWMAPEVVN 448
           + YL   N VHRD+   N+LV      K++DFGL K A++  D  + K    W APE   
Sbjct: 121 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEA-- 176
Query: 449 LKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+   +   +D+WS G  + E+ +  + PY  +     + R+ KG     P+       +
Sbjct: 177 LREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 236
Query: 508 FILKCLQVNPNDRPTAAQLMEH 529
            +  C  ++   RP+  QL E 
Sbjct: 237 VMKNCWHLDAAMRPSFLQLREQ 258

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 40/278 (14%)
Query: 271 KFRRRIMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKXXXXX 324
           K R  ++ W+    LG G+FG V+           D    AVK  +L++     +     
Sbjct: 16  KRRDIVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQR 69
Query: 325 XXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS------- 377
                      +H++IV++FG   +   L +  E +  G L N + + H  D+       
Sbjct: 70  EAELLTM---LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGE 125
Query: 378 ----------QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 427
                     Q+ A   Q+  G+ YL   + VHRD+   N LV     VK+ DFG+++  
Sbjct: 126 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 185
Query: 428 TMNDVKSCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG 482
              D     G       WM PE  ++  R +   +D+WS G  + E+ T  + P+  L  
Sbjct: 186 YSTDYYRVGGRTMLPIRWMPPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 243
Query: 483 MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
            +A+  I +G     P +   +    +  C Q  P  R
Sbjct: 244 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 116 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 173
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 174 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 232
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 233 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 292
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 293 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 40/278 (14%)
Query: 271 KFRRRIMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKXXXXX 324
           K R  ++ W+    LG G+FG V+           D    AVK  +L++     +     
Sbjct: 10  KRRDIVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQDFQR 63
Query: 325 XXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS------- 377
                      +H++IV++FG   +   L +  E +  G L N + + H  D+       
Sbjct: 64  EAELLTM---LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGE 119
Query: 378 ----------QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 427
                     Q+ A   Q+  G+ YL   + VHRD+   N LV     VK+ DFG+++  
Sbjct: 120 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 179
Query: 428 TMNDVKSCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG 482
              D     G       WM PE  ++  R +   +D+WS G  + E+ T  + P+  L  
Sbjct: 180 YSTDYYRVGGRTMLPIRWMPPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 237
Query: 483 MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
            +A+  I +G     P +   +    +  C Q  P  R
Sbjct: 238 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 28/263 (10%)
Query: 283 ELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRFEHE 338
           +++G+G FG V  G+         F A+K  +L+   T+ +              +F+H 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIK--TLKSGYTEKQRRDFLSEASIMG--QFDHP 68
Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQ 396
           N++   G       + I  E +  GSL +  ++        Q+    R I  G+ YL + 
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTPF---WMAPEVVNL 449
           N VHR +   NILV+++   K++DFGL++     T+     S  G      W APE +  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 186
Query: 450 KNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNSLSRD 504
           + R +   +D+WS G  + E+++  + PY  +     +  I +     PP+  P++L + 
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ- 245
Query: 505 ARDFILKCLQVNPNDRPTAAQLM 527
               +L C Q + N RP   Q++
Sbjct: 246 ---LMLDCWQKDRNHRPKFGQIV 265

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 106/252 (42%), Gaps = 18/252 (7%)
Query: 285 LGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQG--TQGKXXXXXXXXXXXXXXRFEHENIV 341
           +G G FG V++G    D    A+K + L D    T+                   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 342 QYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSA-YTRQILNGLNYLHEQN-- 397
           + +G   +  R+   +E V  G L + L  K H +   V       I  G+ Y+  QN  
Sbjct: 87  KLYGLMHNPPRMV--MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 398 VVHRDIKCANILV-----DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           +VHRD++  NI +     +A    K+ADFGL++  +++ V    G   WMAPE +  +  
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI---GKGEPPLVPNSLSRDARDFI 509
            Y   AD +S    +  +LT + P+      +  F      +G  P +P       R+ I
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVI 263
Query: 510 LKCLQVNPNDRP 521
             C   +P  RP
Sbjct: 264 ELCWSGDPKKRP 275

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
           +  E V       LYQ   L D  +  Y  +IL  L+Y H   ++HRD+K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 415 -SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT 472
             ++L D+GLA+        + +  + ++  PE++ +  + Y  + D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 473 RQPPYSH-LEGMQALFRIGK----------------GEPPLVPNSLSRDAR--------- 506
           R+ P+ H  +    L RI K                   P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 507 -----------DFILKCLQVNPNDRPTAAQLMEHPF 531
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML 471
               R        GY    DIWS+GC + EM+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 29/265 (10%)
Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVK-EVSLQDQGTQGKXXXXXXXXXXXXXXRFEH 337
           +K ++LGSG+FGTVY+G +  DG    +   + +  + T  K                + 
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI----------LDE 69
Query: 338 ENIVQYFGTDKDENRLFIFL----ELVTK----GSLANLYQ--KYHLMDSQVSAYTRQIL 387
             ++   G+      L I L    +LVT+    G L +  +  +  L    +  +  QI 
Sbjct: 70  AYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIA 129
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----SCKGTPFWMA 443
            G++YL +  +VHRD+   N+LV +   VK+ DFGLA+   +++ +      K    WMA
Sbjct: 130 KGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189
Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS 502
            E  ++  R +   +D+WS G TV E++T    PY  +   +    + KGE    P   +
Sbjct: 190 LE--SILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICT 247
Query: 503 RDARDFILKCLQVNPNDRPTAAQLM 527
            D    ++KC  ++   RP   +L+
Sbjct: 248 IDVYMIMVKCWMIDSECRPRFRELV 272

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 28  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 82
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 83  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 138
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 139 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMVPFVV 189
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML 471
               R        GY    DIWS+GC + EM+
Sbjct: 190 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML 471
               R        GY    DIWS+GC + EM+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 80
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLSQVIQMELDHERMSYLLYQML 136
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML 471
               R        GY    DIWS+GC + EM+
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 27  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 81
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 137
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVV 188
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEML 471
               R        GY    DIWS+GC + EM+
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 40/278 (14%)
Query: 271 KFRRRIMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKXXXXX 324
           K R  ++ W+    LG G+FG V+           D    AVK +    +  +       
Sbjct: 39  KRRDIVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR-----QD 89
Query: 325 XXXXXXXXXRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS------- 377
                      +H++IV++FG   +   L +  E +  G L N + + H  D+       
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGE 148
Query: 378 ----------QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT 427
                     Q+ A   Q+  G+ YL   + VHRD+   N LV     VK+ DFG+++  
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 208
Query: 428 TMNDVKSCKGTPF----WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEG 482
              D     G       WM PE  ++  R +   +D+WS G  + E+ T  + P+  L  
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
Query: 483 MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR 520
            +A+  I +G     P +   +    +  C Q  P  R
Sbjct: 267 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI+   G       + I  E +  GSL    +K        Q+    R I +G+ 
Sbjct: 86  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL + + VHRD+   NILV+++   K++DFG+++    +D ++   T     P  W APE
Sbjct: 146 YLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTRGGKIPIRWTAPE 204
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG---EPPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  I +G    PP+  P +
Sbjct: 205 AIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA 262
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q   +DRP   Q++
Sbjct: 263 LHQ----LMLDCWQKERSDRPKFGQIV 285

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/340 (24%), Positives = 134/340 (39%), Gaps = 85/340 (25%)
Query: 270 GKFRRRIM-SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXX 327
           G+  R ++  ++  + LG G++G V++      G   AVK++   D              
Sbjct: 1   GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF--DAFQNSTDAQRTFRE 58
Query: 328 XXXXXXRFEHENIVQYFGT-----DKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSA 381
                    HENIV          D+D   +F ++E      + AN+ +  H    Q   
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH---KQYVV 115
Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------------TTM 429
           Y  Q++  + YLH   ++HRD+K +NIL++A   VK+ADFGL+++             ++
Sbjct: 116 Y--QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 430 ND-----------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS 478
           N+           +     T ++ APE++ L +  Y    D+WSLGC + E+L  +P + 
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEIL-LGSTKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 479 HLEGMQALFRI-------------------------GKGEPPLVPNSLSRD--------- 504
               M  L RI                            E   +  S  RD         
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 505 ------------ARDFILKCLQVNPNDRPTAAQLMEHPFV 532
                       A D + K LQ NPN R +A   ++HPFV
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 45/247 (18%)
Query: 339 NIVQYFGTDKD--ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           NI++   T KD       +  E +       LYQ   L D  +  Y  ++L  L+Y H +
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQI--LTDFDIRFYMYELLKALDYCHSK 151
Query: 397 NVVHRDIKCANILVD-ASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGY 454
            ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE++ +  + Y
Sbjct: 152 GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL-VDYQMY 210
Query: 455 GLTADIWSLGCTVLEMLTRQPPYSH-LEGMQALFRIGK--GEPPLVP------------- 498
             + D+WSLGC +  M+ R+ P+ H  +    L RI K  G   L               
Sbjct: 211 DYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHF 270
Query: 499 ---------------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 537
                                + +S +A D + K L+ +   R TA + MEHP+   P+ 
Sbjct: 271 NDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF-YPVV 329
Query: 538 KSRGPPS 544
           K +  PS
Sbjct: 330 KEQSQPS 336

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 126/314 (40%), Gaps = 78/314 (24%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 31  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 85
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 86  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 141
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 142 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVV 192
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYS 478
               R        GY    D+WS+GC + EM+  +                     P   
Sbjct: 193 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPE 252
Query: 479 HLEGMQALFRI---------GKGEPPLVPNSL-----------SRDARDFILKCLQVNPN 518
            ++ +Q   R          G     L P+ L           +  ARD + K L ++ +
Sbjct: 253 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 312
Query: 519 DRPTAAQLMEHPFV 532
            R +  + ++HP++
Sbjct: 313 KRISVDEALQHPYI 326

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 127/283 (44%), Gaps = 31/283 (10%)
Query: 274 RRIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXX 332
           R    + + E +GSG FG+V++     DG  +A+K       G+  +             
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 333 XRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLM----DSQVSAYTRQIL 387
              +H ++V+YF    +++ + I  E    GSLA+ + + Y +M    ++++     Q+ 
Sbjct: 64  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 388 NGLNYLHEQNVVHRDIKCANILVD-----------------ASGSVKLADFGLAKATTMN 430
            GL Y+H  ++VH DIK +NI +                  AS  V      L   T ++
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 181
Query: 431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP-PYSHLEGMQALFRI 489
             +  +G   ++A EV+  +N  +   ADI++L  TV+     +P P +   G Q    I
Sbjct: 182 SPQVEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVXAAGAEPLPRN---GDQ-WHEI 236
Query: 490 GKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
            +G  P +P  LS++  + +   +  +P  RP+A  L++H  +
Sbjct: 237 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 126/314 (40%), Gaps = 78/314 (24%)
Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---FAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           +Q  + +GSG+ G V   Y  D       A+K++S   +  Q +                
Sbjct: 20  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLS---RPFQNQTHAKRAYRELVLMKCV 74
Query: 336 EHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQIL 387
            H+NI+        +  L      +I +EL+     ANL Q  +  L   ++S    Q+L
Sbjct: 75  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML 130
Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVV 447
            G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+           GT F M P VV
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPYVV 181
Query: 448 NLKNR--------GYGLTADIWSLGCTVLEMLTRQ---------------------PPYS 478
               R        GY    D+WS+GC + EM+  +                     P   
Sbjct: 182 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPE 241
Query: 479 HLEGMQALFRI---------GKGEPPLVPNSL-----------SRDARDFILKCLQVNPN 518
            ++ +Q   R          G     L P+ L           +  ARD + K L ++ +
Sbjct: 242 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 301
Query: 519 DRPTAAQLMEHPFV 532
            R +  + ++HP++
Sbjct: 302 KRISVDEALQHPYI 315

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI+   G       + I  E +  GSL    +K        Q+    R I +G+ 
Sbjct: 65  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL + + VHRD+   NILV+++   K++DFG+++    +D ++   T     P  W APE
Sbjct: 125 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTRGGKIPIRWTAPE 183
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  I +G    PP+  P +
Sbjct: 184 AIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA 241
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q   +DRP   Q++
Sbjct: 242 LHQ----LMLDCWQKERSDRPKFGQIV 264

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH----------------------- 373
           H ++++ +G    +  L + +E    GSL    ++                         
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 374 --LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 431
             L    + ++  QI  G+ YL E ++VHRD+   NILV     +K++DFGL++     D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 432 --VKSCKG-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP-PYSHLEGMQAL 486
             VK  +G  P  WMA E  +L +  Y   +D+WS G  + E++T    PY  +   +  
Sbjct: 205 SXVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 487 FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL---MEHPFVKR 534
             +  G     P++ S +    +L+C +  P+ RP  A +   +E   VKR
Sbjct: 263 NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +F+H NI+   G       + I  E +  GSL    +K        Q+    R I +G+ 
Sbjct: 71  QFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPE 445
           YL + + VHRD+   NILV+++   K++DFG+++    +D ++   T     P  W APE
Sbjct: 131 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE-DDPEAAYTTRGGKIPIRWTAPE 189
Query: 446 VVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE---PPL-VPNS 500
            +    R +   +D+WS G  + E+++  + PY  +     +  I +G    PP+  P +
Sbjct: 190 AIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIA 247
Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLM 527
           L +     +L C Q   +DRP   Q++
Sbjct: 248 LHQ----LMLDCWQKERSDRPKFGQIV 270

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 109/278 (39%), Gaps = 36/278 (12%)
Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           G+ LG+G+FG V E        +D     AVK +      T+ +                
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--- 107
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVS------------- 380
            H NIV   G         +  E    G L N  ++     + S+ S             
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 381 ----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
               +++ Q+  G+ +L  +N +HRD+   NIL+      K+ DFGLA+    +     K
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 437 GTP----FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR-IG 490
           G       WMAPE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I 
Sbjct: 228 GNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           +G   L P     +  D +  C   +P  RPT  Q+++
Sbjct: 286 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 109/278 (39%), Gaps = 36/278 (12%)
Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           G+ LG+G+FG V E        +D     AVK +      T+ +                
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--- 100
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVS------------- 380
            H NIV   G         +  E    G L N  ++     + S+ S             
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 381 ----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
               +++ Q+  G+ +L  +N +HRD+   NIL+      K+ DFGLA+    +     K
Sbjct: 161 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 437 GTP----FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR-IG 490
           G       WMAPE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I 
Sbjct: 221 GNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278
Query: 491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           +G   L P     +  D +  C   +P  RPT  Q+++
Sbjct: 279 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVS----LQDQGTQGKXXXXXXXXXXXXXX 333
           W   ++LG G+   V+ G +   G  FA+K  +    L+    Q +              
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK-------- 62
Query: 334 RFEHENIVQYFGTDKDEN--RLFIFLELVTKGSLANLYQK----YHLMDSQVSAYTRQIL 387
           +  H+NIV+ F  +++       + +E    GSL  + ++    Y L +S+     R ++
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 388 NGLNYLHEQNVVHRDIKCANIL----VDASGSVKLADFGLAKATTMND-VKSCKGTPFWM 442
            G+N+L E  +VHR+IK  NI+     D     KL DFG A+    ++      GT  ++
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYL 182
Query: 443 APEVVNL------KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKG 492
            P++           + YG T D+WS+G T     T   P+   EG     + +++I  G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 493 EP 494
           +P
Sbjct: 243 KP 244

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 109/278 (39%), Gaps = 36/278 (12%)
Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKXXXXXXXXXXXXXXRF 335
           G+ LG+G+FG V E        +D     AVK +      T+ +                
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--- 107
Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVS------------- 380
            H NIV   G         +  E    G L N  ++     + S+ S             
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 381 ----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
               +++ Q+  G+ +L  +N +HRD+   NIL+      K+ DFGLA+    +     K
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 437 GTP----FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR-IG 490
           G       WMAPE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I 
Sbjct: 228 GNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           +G   L P     +  D +  C   +P  RPT  Q+++
Sbjct: 286 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH----------------------- 373
           H ++++ +G    +  L + +E    GSL    ++                         
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 374 --LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND 431
             L    + ++  QI  G+ YL E  +VHRD+   NILV     +K++DFGL++     D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 432 --VKSCKG-TPF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP-PYSHLEGMQAL 486
             VK  +G  P  WMA E  +L +  Y   +D+WS G  + E++T    PY  +   +  
Sbjct: 205 SXVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 487 FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL---MEHPFVKR 534
             +  G     P++ S +    +L+C +  P+ RP  A +   +E   VKR
Sbjct: 263 NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/106 (39%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAKATT-----M 429
           V +   QIL+G++YLH   V+HRD+K ANILV       G VK+AD G A+        +
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP 475
            D+     T ++ APE++ L  R Y    DIW++GC   E+LT +P
Sbjct: 190 ADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEP 234
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	551
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-143
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-125
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-125
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-107
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-104
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-99
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-96
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-93
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-92
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-90
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-90
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-89
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-88
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-88
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-88
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-86
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-84
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-83
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-82
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-81
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-80
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-78
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-77
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-76
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-74
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-73
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-72
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-72
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-70
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-70
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-67
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-67
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-66
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-64
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-62
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-62
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-60
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-60
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-59
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-59
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-58
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-57
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-57
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-57
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-57
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-56
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-56
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-56
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-56
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-56
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-56
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-56
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-56
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-07
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-55
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-55
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-55
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-55
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-54
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-54
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-54
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-54
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-53
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-53
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-53
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-52
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-52
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-52
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-52
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-52
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-52
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-51
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-51
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-51
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-51
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-51
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-50
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-50
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-50
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-50
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-49
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-49
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-49
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-49
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-49
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-49
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-48
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-48
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-48
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-47
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-47
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-47
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-46
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-46
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-46
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-45
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-45
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-45
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-45
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-45
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-45
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-45
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-44
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-44
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-44
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-44
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-44
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-43
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-43
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-43
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-43
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-43
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-43
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-43
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-43
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-43
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-43
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-43
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-43
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-42
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-42
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-42
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-42
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-42
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-42
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-42
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-41
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-41
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-41
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-40
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-40
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-39
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-39
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-39
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-38
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-38
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-37
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-37
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-36
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-36
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-36
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-36
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-36
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-34
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-34
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-34
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-33
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-31
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-31
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-30
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-30
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-30
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-29
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-28
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-26
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-24
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-23
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  414 bits (1066), Expect = e-143
 Identities = 104/287 (36%), Positives = 160/287 (55%), Gaps = 15/287 (5%)

Query: 267 SPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQL 325
           S   ++           +LG G++G VY G    +    A+KE+  +D      +    L
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPL 66

Query: 326 EQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH----LMDSQVSA 381
            +EI L    +H+NIVQY G+  +   + IF+E V  GSL+ L +         +  +  
Sbjct: 67  HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAK--ATTMNDVKSCKGT 438
           YT+QIL GL YLH+  +VHRDIK  N+L++  SG +K++DFG +K  A      ++  GT
Sbjct: 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186

Query: 439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRIGKGE-PPL 496
             +MAPE+++   RGYG  ADIWSLGCT++EM T +PP+  L E   A+F++G  +  P 
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE 246

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
           +P S+S +A+ FILKC + +P+ R  A  L+   F+K   +K +  P
Sbjct: 247 IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  368 bits (948), Expect = e-125
 Identities = 79/296 (26%), Positives = 146/296 (49%), Gaps = 23/296 (7%)

Query: 250 DRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKE 308
           +++   +  ++     +S +G+F       +    +G GSF TVY+G  T+     A  E
Sbjct: 5   NQQQDDIEELETKAVGMSNDGRF------LKFDIEIGRGSFKTVYKGLDTETTVEVAWCE 58

Query: 309 VSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFG----TDKDENRLFIFLELVTKGS 364
           +  +      K    + ++E  +L   +H NIV+++     T K +  + +  EL+T G+
Sbjct: 59  LQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115

Query: 365 LANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDA-SGSVKLAD 420
           L    +++ +M    + ++ RQIL GL +LH +   ++HRD+KC NI +   +GSVK+ D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175

Query: 421 FGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL 480
            GLA     +  K+  GTP +MAPE+       Y  + D+++ G  +LEM T + PYS  
Sbjct: 176 LGLATLKRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSEC 232

Query: 481 EGMQALFRIG--KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           +    ++R      +P         + ++ I  C++ N ++R +   L+ H F + 
Sbjct: 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  370 bits (952), Expect = e-125
 Identities = 78/331 (23%), Positives = 126/331 (38%), Gaps = 30/331 (9%)

Query: 225 RRLRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGEL 284
                          +     + +D+   L    +K        + ++R  +        
Sbjct: 12  SLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLK------PVDYEYREEVHWMTHQPR 65

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G GSFG V+       GF  AVK+V L+              +E++  +      IV  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPL 115

Query: 344 FGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQNVVHRD 402
           +G  ++   + IF+EL+  GSL  L ++   +   +   Y  Q L GL YLH + ++H D
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175

Query: 403 IKCANILVDASGS-VKLADFGLAK-------ATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
           +K  N+L+ + GS   L DFG A          ++       GT   MAPEVV    +  
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPC 233

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFILKC 512
               DIWS  C +L ML    P++         +I    PP+  +P S +      I + 
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293

Query: 513 LQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
           L+  P  R +A +L                P
Sbjct: 294 LRKEPVHRASAMELRRKVGKALQEVGGLKSP 324

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  321 bits (826), Expect = e-107
 Identities = 65/298 (21%), Positives = 132/298 (44%), Gaps = 36/298 (12%)

Query: 266 VSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQ 324
           +    ++      + + E +GSG FG+V++     DG  +A+K       G+  +Q+ L+
Sbjct: 3   MGMKSRYTTE---FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR 59

Query: 325 LEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQV 379
             +        +H ++V+YF    +++ + I  E    GSLA+   +      +  ++++
Sbjct: 60  --EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS-------------------VKLAD 420
                Q+  GL Y+H  ++VH DIK +NI +  +                      K+ D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 421 FGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL 480
            G    T ++  +  +G   ++A EV+  +N  +   ADI++L  TV+     +P   + 
Sbjct: 178 LGHV--TRISSPQVEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVCAAGAEPLPRNG 234

Query: 481 EGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
           +       I +G  P +P  LS++  + +   +  +P  RP+A  L++H  +    +K
Sbjct: 235 DQWH---EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  314 bits (806), Expect = e-104
 Identities = 83/283 (29%), Positives = 131/283 (46%), Gaps = 14/283 (4%)

Query: 257 RLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQG 315
             ++ P Y+  P+        S+Q+   LG GS+G V++    +DG  +AVK      +G
Sbjct: 39  ETLQSPGYD--PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG 96

Query: 316 TQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--H 373
            + +   L   +        +H   V+     ++   L++  EL    SL    + +   
Sbjct: 97  PKDRARKLA--EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGAS 153

Query: 374 LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDV 432
           L ++QV  Y R  L  L +LH Q +VH D+K ANI +   G  KL DFGL     T    
Sbjct: 154 LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213

Query: 433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG 492
           +  +G P +MAPE++      YG  AD++SLG T+LE+          EG Q L +    
Sbjct: 214 EVQEGDPRYMAPELL---QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--GY 268

Query: 493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 535
            PP     LS + R  ++  L+ +P  R TA  L+  P +++P
Sbjct: 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  306 bits (785), Expect = 1e-99
 Identities = 64/298 (21%), Positives = 129/298 (43%), Gaps = 23/298 (7%)

Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQ 324
           + S N     +   +   + +GSG    V++   +    +A+K V+L++      Q++  
Sbjct: 44  SSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD---NQTLDS 100

Query: 325 LEQEILLLSRFEH--ENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSA 381
              EI  L++ +   + I++ +  +  +  +++ +E      L + L +K  +   +  +
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKS 159

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDVKSCKG 437
           Y + +L  ++ +H+  +VH D+K AN L+   G +KL DFG+A      TT     S  G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 438 TPFWMAPEVVNLKN---------RGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALF 487
              +M PE +   +               +D+WSLGC +  M   + P+  +   +  L 
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 488 RIGK-GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            I         P+   +D +D +  CL+ +P  R +  +L+ HP+V+           
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  297 bits (762), Expect = 5e-97
 Identities = 65/297 (21%), Positives = 130/297 (43%), Gaps = 29/297 (9%)

Query: 266 VSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQL 325
           +S  G+       +   + +GSG    V++   +    +A+K V+L++      Q++   
Sbjct: 4   ISVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD---NQTLDSY 54

Query: 326 EQEILLLSRFEH--ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAY 382
             EI  L++ +   + I++ +  +  +  +++ +E      L +  +K   +D  +  +Y
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 113

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDVKSCKGT 438
            + +L  ++ +H+  +VH D+K AN L+   G +KL DFG+A      TT     S  GT
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 439 PFWMAPEVVNLKN---------RGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFR 488
             +M PE +   +               +D+WSLGC +  M   + P+  +   +  L  
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232

Query: 489 IGK-GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           I         P+   +D +D +  CL+ +P  R +  +L+ HP+V+           
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  294 bits (754), Expect = 4e-96
 Identities = 63/280 (22%), Positives = 126/280 (45%), Gaps = 23/280 (8%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH- 337
           +   + +GSG    V++   +    +A+K V+L++      Q++     EI  L++ +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD---NQTLDSYRNEIAYLNKLQQH 86

Query: 338 -ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHE 395
            + I++ +  +  +  +++ +E      L +  +K   +D  +  +Y + +L  ++ +H+
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKA----TTMNDVKSCKGTPFWMAPEVVNLKN 451
             +VH D+K AN L+   G +KL DFG+A      TT     S  GT  +M PE +   +
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 452 ---------RGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGK-GEPPLVPNS 500
                          +D+WSLGC +  M   + P+  +   +  L  I         P+ 
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
             +D +D +  CL+ +P  R +  +L+ HP+V+       
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  293 bits (753), Expect = 6e-96
 Identities = 79/273 (28%), Positives = 133/273 (48%), Gaps = 15/273 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++  + +G G F  VY      DG   A+K+V + D      ++     +EI LL +  H
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA--KARADCIKEIDLLKQLNH 91

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNY 392
            N+++Y+ +  ++N L I LEL   G L+ + + +      + +  V  Y  Q+ + L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLK 450
           +H + V+HRDIK AN+ + A+G VKL D GL +   +      S  GTP++M+PE +   
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--H 209

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALF-RIGKGE-PPLVPNSLSRDARD 507
             GY   +DIWSLGC + EM   Q P+      + +L  +I + + PPL  +  S + R 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269

Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
            +  C+  +P  RP    + +          S 
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  286 bits (735), Expect = 8e-93
 Identities = 74/275 (26%), Positives = 141/275 (51%), Gaps = 11/275 (4%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
            + + +G GSFG       T+DG  + +KE+++    ++ ++   +   E+ +L+  +H 
Sbjct: 27  VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANMKHP 83

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHE 395
           NIVQY  + ++   L+I ++    G L             + Q+  +  QI   L ++H+
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           + ++HRDIK  NI +   G+V+L DFG+A+   +T+   ++C GTP++++PE+   +N+ 
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI--CENKP 201

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
           Y   +DIW+LGC + E+ T +  +        + +I  G  P V    S D R  + +  
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261

Query: 514 QVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNN 548
           + NP DRP+   ++E  F+ + ++K   P      
Sbjct: 262 KRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEE 296

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  283 bits (727), Expect = 3e-92
 Identities = 100/265 (37%), Positives = 155/265 (58%), Gaps = 9/265 (3%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + K E +G GSFG V++G         A+K + L ++     + I   +QEI +LS+ + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDI---QQEITVLSQCDS 79

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
             + +Y+G+   + +L+I +E +  GS  +L +   L ++Q++   R+IL GL+YLH + 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 139

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
            +HRDIK AN+L+   G VKLADFG+A     T     +  GTPFWMAPEV+  K   Y 
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD 197

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
             ADIWSLG T +E+   +PP+S L  M+ LF I K  PP +  + S+  ++F+  CL  
Sbjct: 198 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 257

Query: 516 NPNDRPTAAQLMEHPFVKRPLQKSR 540
            P+ RPTA +L++H F+ R  +K+ 
Sbjct: 258 EPSFRPTAKELLKHKFILRNAKKTS 282

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  279 bits (716), Expect = 1e-90
 Identities = 96/277 (34%), Positives = 145/277 (52%), Gaps = 27/277 (9%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           W+    LG G+FG VY+    + G   A K +  + +     + +     EI +L+  +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-----EELEDYIVEIEILATCDH 75

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
             IV+  G    + +L+I +E    G++  +  +    L + Q+    RQ+L  LN+LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 396 QNVVHRDIKCANILVDASGSVKLADFG--------LAKATTMNDVKSCKGTPFWMAPEVV 447
           + ++HRD+K  N+L+   G ++LADFG        L K  +        GTP+WMAPEVV
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF------IGTPYWMAPEVV 189

Query: 448 ---NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLS 502
               +K+  Y   ADIWSLG T++EM   +PP+  L  M+ L +I K +PP  L P+  S
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
            + RDF+   L  NP  RP+AAQL+EHPFV       
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  279 bits (716), Expect = 4e-90
 Identities = 92/270 (34%), Positives = 140/270 (51%), Gaps = 18/270 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +     +G GSFG VY      +    A+K++S   +  Q  +    + +E+  L +  H
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRH 113

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
            N +QY G    E+  ++ +E    GS ++L + +   L + +++A T   L GL YLH 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 396 QNVVHRDIKCANILVDASGSVKLADFG----LAKATTMNDVKSCKGTPFWMAPEVV-NLK 450
            N++HRD+K  NIL+   G VKL DFG    +A A +        GTP+WMAPEV+  + 
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF------VGTPYWMAPEVILAMD 226

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSLSRDARDFI 509
              Y    D+WSLG T +E+  R+PP  ++  M AL+ I + E P L     S   R+F+
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286

Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
             CLQ  P DRPT+  L++H FV R    +
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  276 bits (707), Expect = 2e-89
 Identities = 91/261 (34%), Positives = 145/261 (55%), Gaps = 12/261 (4%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + + E +G G+ GTVY       G   A+++++LQ Q    K+ I+    EIL++   ++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIIN---EILVMRENKN 76

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            NIV Y  +    + L++ +E +  GSL ++  +  + + Q++A  R+ L  L +LH   
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           V+HRDIK  NIL+   GSVKL DFG         +   +  GTP+WMAPEVV    + YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYG 194

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKCL 513
              DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+ +CL
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254

Query: 514 QVNPNDRPTAAQLMEHPFVKR 534
           +++   R +A +L++H F+K 
Sbjct: 255 EMDVEKRGSAKELLQHQFLKI 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  275 bits (704), Expect = 1e-88
 Identities = 95/268 (35%), Positives = 150/268 (55%), Gaps = 16/268 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +   E LG GS+G+VY+    + G   A+K+V ++         + ++ +EI ++ + + 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDS 83

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
            ++V+Y+G+      L+I +E    GS++++ +  +  L + +++   +  L GL YLH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
              +HRDIK  NIL++  G  KLADFG+A     TM    +  GTPFWMAPEV+  +  G
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI--QEIG 201

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILK 511
           Y   ADIWSLG T +EM   +PPY+ +  M+A+F I    PP    P   S +  DF+ +
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261

Query: 512 CLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
           CL  +P  R TA QL++HPFV+     S
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVS 289

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  275 bits (704), Expect = 2e-88
 Identities = 89/273 (32%), Positives = 145/273 (53%), Gaps = 23/273 (8%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-E 336
           ++  EL+G+G++G VY+G     G   A+K + +            +++QEI +L ++  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSH 79

Query: 337 HENIVQYFG------TDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQIL 387
           H NI  Y+G          +++L++ +E    GS+ +L +      L +  ++   R+IL
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPE 445
            GL++LH+  V+HRDIK  N+L+  +  VKL DFG++     T+    +  GTP+WMAPE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 446 VV---NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSL 501
           V+      +  Y   +D+WSLG T +EM    PP   +  M+ALF I +   P L     
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           S+  + FI  CL  N + RP   QLM+HPF++ 
Sbjct: 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  273 bits (699), Expect = 7e-88
 Identities = 85/266 (31%), Positives = 139/266 (52%), Gaps = 12/266 (4%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
                 +G GS G V        G   AVK + L+ Q  Q ++ +     E++++  ++H
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFN---EVVIMRDYQH 101

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            N+V+ + +      L++ +E +  G+L ++  +  L + Q++     +L  L YLH Q 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           V+HRDIK  +IL+   G VKL+DFG     +  +   KS  GTP+WMAPEV+      Y 
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI--SRSLYA 219

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKCL 513
              DIWSLG  V+EM+  +PPY     +QA+ R+    PP +   + +S   RDF+ + L
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279

Query: 514 QVNPNDRPTAAQLMEHPFVKRPLQKS 539
             +P +R TA +L++HPF+ +     
Sbjct: 280 VRDPQERATAQELLDHPFLLQTGLPE 305

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  267 bits (684), Expect = 7e-86
 Identities = 88/282 (31%), Positives = 146/282 (51%), Gaps = 31/282 (10%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++  E++GSG+   V   Y        A+K ++L ++       +L+   EI  +S+  H
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-EKCQTSMDELLK---EIQAMSQCHH 72

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH---------LMDSQVSAYTRQILN 388
            NIV Y+ +   ++ L++ ++L++ GS+ ++ +            L +S ++   R++L 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCK-----GTPFW 441
           GL YLH+   +HRD+K  NIL+   GSV++ADFG++   AT  +  ++       GTP W
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP------ 495
           MAPEV+  + RGY   ADIWS G T +E+ T   PY     M+ L    + +PP      
Sbjct: 193 MAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251

Query: 496 ---LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
               +     +  R  I  CLQ +P  RPTAA+L+ H F ++
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  267 bits (683), Expect = 4e-84
 Identities = 72/279 (25%), Positives = 125/279 (44%), Gaps = 26/279 (9%)

Query: 277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF- 335
           +S+   ++LG G+ GT+      D    AVK +          +     ++E+ LL    
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL--------PECFSFADREVQLLRESD 75

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--RQILNGLNYL 393
           EH N+++YF T+KD    +I +EL    +L    ++       +   T  +Q  +GL +L
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 394 HEQNVVHRDIKCANILVDASGS-----VKLADFGLAK-----ATTMNDVKSCKGTPFWMA 443
           H  N+VHRD+K  NIL+    +       ++DFGL K       + +      GT  W+A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 444 PEVVNLK-NRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG--EPPLVPN 499
           PE+++         T DI+S GC    +++    P+      QA   +G    +      
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254

Query: 500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
                AR+ I K + ++P  RP+A  +++HPF     ++
Sbjct: 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  259 bits (663), Expect = 5e-83
 Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 37/280 (13%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           ++ EL+GSG FG V++     DG  + +K V   ++         + E+E+  L++ +H 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHV 64

Query: 339 NIVQYFG----------------TDKDENRLFIFLELVTKGSLANLYQKY---HLMDSQV 379
           NIV Y G                +      LFI +E   KG+L    +K     L     
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDVKSCKGT 438
                QI  G++Y+H + +++RD+K +NI +  +  VK+ DFGL  +          KGT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP 498
             +M+PE   + ++ YG   D+++LG  + E+L            +           ++ 
Sbjct: 185 LRYMSPEQ--ISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDLRDGIIS 237

Query: 499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
           +   +  +  + K L   P DRP  ++++    V +   +
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  258 bits (661), Expect = 1e-82
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 22/276 (7%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           +    +G+GS+G   +     DG     KE+         KQ ++    E+ LL   +H 
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS---EVNLLRELKHP 65

Query: 339 NIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLN 391
           NIV+Y+    D+    L+I +E    G LA++  K      +L +  V     Q+   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 392 YLHEQN-----VVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAP 444
             H ++     V+HRD+K AN+ +D   +VKL DFGLA+      +  K+  GTP++M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGEPPLVPNSLSR 503
           E   +    Y   +DIWSLGC + E+    PP++     + L  +I +G+   +P   S 
Sbjct: 186 EQ--MNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRYSD 242

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
           +  + I + L +    RP+  +++E+P +       
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  257 bits (658), Expect = 7e-81
 Identities = 65/316 (20%), Positives = 118/316 (37%), Gaps = 63/316 (19%)

Query: 279 WQKGELLGSG--SFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           ++   ++G G     TV        G +  V+ ++L+    +    +     E+ +   F
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG---ELHVSKLF 83

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNY 392
            H NIV Y  T   +N L++    +  GS  +L   +    + +  ++   + +L  L+Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLA--------KATTMNDVKSCK-GTPFWMA 443
           +H    VHR +K ++IL+   G V L+             +   ++D          W++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-------- 495
           PEV+    +GY   +DI+S+G T  E+     P+  +   Q L     G  P        
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263

Query: 496 -------------------------------------LVPNSLSRDARDFILKCLQVNPN 518
                                                    + S     F+ +CLQ NP+
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323

Query: 519 DRPTAAQLMEHPFVKR 534
            RP+A+ L+ H F K+
Sbjct: 324 ARPSASTLLNHSFFKQ 339

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  251 bits (644), Expect = 7e-80
 Identities = 74/301 (24%), Positives = 135/301 (44%), Gaps = 44/301 (14%)

Query: 274 RRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL 332
           R    +++  +LG G+FG V +     D  ++A+K++         ++ +  +  E++LL
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------EEKLSTILSEVMLL 56

Query: 333 SRFEHENIVQYFGTDKDENR-------------LFIFLELVTKGSLANLYQKYHLMDSQV 379
           +   H+ +V+Y+    +                LFI +E    G+L +L    +L   + 
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 380 SA--YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK------------ 425
                 RQIL  L+Y+H Q ++HRD+K  NI +D S +VK+ DFGLAK            
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 426 ----ATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE 481
                 + +++ S  GT  ++A EV++     Y    D++SLG    EM+   P  + +E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY--PFSTGME 233

Query: 482 GMQALFRIGKGE---PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
            +  L ++       PP   ++  +  +  I   +  +PN RP A  L+   ++    Q 
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

Query: 539 S 539
            
Sbjct: 294 E 294

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  246 bits (630), Expect = 9e-78
 Identities = 66/286 (23%), Positives = 117/286 (40%), Gaps = 39/286 (13%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           +  + LG G FG V+E     D   +A+K + L ++    ++    + +E+  L++ EH 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK----VMREVKALAKLEHP 63

Query: 339 NIVQYFGTDKDENR------------LFIFLELVTKGSLANLYQK----YHLMDSQVSAY 382
            IV+YF    ++N             L+I ++L  K +L +             S     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA--------------TT 428
             QI   + +LH + ++HRD+K +NI       VK+ DFGL  A                
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR 488
                   GT  +M+PE   +    Y    DI+SLG  + E+L   P  + +E ++ L  
Sbjct: 184 YARHTGQVGTKLYMSPEQ--IHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239

Query: 489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           +   + P +           +   L  +P +RP A  ++E+   + 
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  246 bits (631), Expect = 1e-77
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 36/294 (12%)

Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSIL 323
            +SP   +       +    +G G++G+V +      G   AVK +      T  ++   
Sbjct: 10  KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS----TVDEKEQK 65

Query: 324 QLEQEI-LLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD------ 376
           QL  ++ +++   +   IVQ++G    E   +I +EL++  S    Y+  + +       
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPE 124

Query: 377 SQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFG--------LAKAT 427
             +   T   +  LN+L E   ++HRDIK +NIL+D SG++KL DFG        +AK  
Sbjct: 125 EILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184

Query: 428 TMNDVKSCKGTPFWMAPEVVN--LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-Q 484
                    G   +MAPE ++     +GY + +D+WSLG T+ E+ T + PY     +  
Sbjct: 185 DA-------GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237

Query: 485 ALFRIGKGEPPLVPNSL----SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
            L ++ KG+PP + NS     S    +F+  CL  + + RP   +L++HPF+  
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  241 bits (617), Expect = 5e-76
 Identities = 79/276 (28%), Positives = 131/276 (47%), Gaps = 32/276 (11%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEI-LLLSRFE 336
            +    LG G++G V +  +   G   AVK +      T   Q   +L  ++ + +   +
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDISMRTVD 64

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-----SQVSAYTRQILNGLN 391
               V ++G    E  ++I +EL+   SL   Y++            +      I+  L 
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 392 YLHEQ-NVVHRDIKCANILVDASGSVKLADFG--------LAKATTMNDVKSCKGTPFWM 442
           +LH + +V+HRD+K +N+L++A G VK+ DFG        +AK     D     G   +M
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DA----GCKPYM 176

Query: 443 APEVVN--LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKGEPP-LVP 498
           APE +N  L  +GY + +DIWSLG T++E+   + PY       Q L ++ +   P L  
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236

Query: 499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           +  S +  DF  +CL+ N  +RPT  +LM+HPF   
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  236 bits (605), Expect = 8e-74
 Identities = 80/270 (29%), Positives = 135/270 (50%), Gaps = 29/270 (10%)

Query: 283 ELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEI-LLLSRFEHENI 340
             +GSG+ G V++  +   G   AVK++      +  K+   ++  ++ ++L   +   I
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRR----SGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-TRQILNGLNYLHEQ-NV 398
           VQ FGT      +FI +EL+   +     +    +  ++    T  I+  L YL E+  V
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146

Query: 399 VHRDIKCANILVDASGSVKLADFG--------LAKATTMNDVKSCKGTPFWMAPEVVN-- 448
           +HRD+K +NIL+D  G +KL DFG         AK  +        G   +MAPE ++  
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-------GCAAYMAPERIDPP 199

Query: 449 -LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKGEPPLVPNSL--SRD 504
                 Y + AD+WSLG +++E+ T Q PY + +   + L ++ + EPPL+P  +  S D
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
            + F+  CL  +   RP   +L+EH F+KR
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  230 bits (589), Expect = 5e-72
 Identities = 77/284 (27%), Positives = 142/284 (50%), Gaps = 21/284 (7%)

Query: 270 GKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKQSILQL 325
                +I  ++ G LLG GSF  VY       G   A+K +    +   G        ++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-----RV 58

Query: 326 EQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYT 383
           + E+ +  + +H +I++ +   +D N +++ LE+   G +    +       +++   + 
Sbjct: 59  QNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTPF 440
            QI+ G+ YLH   ++HRD+  +N+L+  + ++K+ADFGLA    M   K    C GTP 
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPN 177

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS 500
           +++PE+       +GL +D+WSLGC    +L  +PP+        L ++   +  + P+ 
Sbjct: 178 YISPEIAT--RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM-PSF 234

Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR---PLQKSRG 541
           LS +A+D I + L+ NP DR + + +++HPF+ R      K  G
Sbjct: 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  230 bits (590), Expect = 5e-72
 Identities = 86/283 (30%), Positives = 135/283 (47%), Gaps = 21/283 (7%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKQSILQLEQE 328
            R    + +G  LG G F   +E    D    FA K V    L     + K     +  E
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-----MSME 65

Query: 329 ILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQIL 387
           I +     H+++V + G  +D + +F+ LEL  + SL  L+++   L + +   Y RQI+
Sbjct: 66  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----SCKGTPFWMA 443
            G  YLH   V+HRD+K  N+ ++    VK+ DFGLA      D +     C GTP ++A
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLC-GTPNYIA 183

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGEPPLVPNSLS 502
           PEV  L  +G+    D+WS+GC +  +L  +PP+     ++  + RI K E  + P  ++
Sbjct: 184 PEV--LSKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEYSI-PKHIN 239

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
             A   I K LQ +P  RPT  +L+   F       +R P + 
Sbjct: 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  227 bits (582), Expect = 2e-70
 Identities = 89/320 (27%), Positives = 143/320 (44%), Gaps = 21/320 (6%)

Query: 237 GPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG 296
           GP+ +     G              P   +       R    + +G  LG G F   +E 
Sbjct: 1   GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI 60

Query: 297 Y-TDDGFFFAVKEVS---LQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR 352
              D    FA K V    L     + K     +  EI +     H+++V + G  +D + 
Sbjct: 61  SDADTKEVFAGKIVPKSLLLKPHQREK-----MSMEISIHRSLAHQHVVGFHGFFEDNDF 115

Query: 353 LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD 411
           +F+ LEL  + SL  L+++   L + +   Y RQI+ G  YLH   V+HRD+K  N+ ++
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175

Query: 412 ASGSVKLADFGLAKATTMNDVK----SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTV 467
               VK+ DFGLA      D +     C GTP ++APEV++   +G+    D+WS+GC +
Sbjct: 176 EDLEVKIGDFGLA-TKVEYDGERKKVLC-GTPNYIAPEVLS--KKGHSFEVDVWSIGCIM 231

Query: 468 LEMLTRQPPYSHLEGMQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQL 526
             +L  +PP+     ++  + RI K E  + P  ++  A   I K LQ +P  RPT  +L
Sbjct: 232 YTLLVGKPPF-ETSCLKETYLRIKKNEYSI-PKHINPVAASLIQKMLQTDPTARPTINEL 289

Query: 527 MEHPFVKRPLQKSRGPPSYY 546
           +   F       +R P +  
Sbjct: 290 LNDEFFTSGYIPARLPITCL 309

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  227 bits (581), Expect = 6e-70
 Identities = 80/302 (26%), Positives = 135/302 (44%), Gaps = 52/302 (17%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++K   LG+G+ G V++  +   G   A K + L            Q+ +E+ +L     
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 90

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-TRQILNGLNYLHEQ 396
             IV ++G    +  + I +E +  GSL  + +K   +  Q+    +  ++ GL YL E+
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 397 -NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
             ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y 
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER--LQGTHYS 208

Query: 456 LTADIWSLGCTVLEMLTRQPPY-------------------------------------- 477
           + +DIWS+G +++EM   + P                                       
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268

Query: 478 SHLEGMQALF----RIGKGEPPLVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
                  A+F     I    PP +P+ + S + +DF+ KCL  NP +R    QLM H F+
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

Query: 533 KR 534
           KR
Sbjct: 329 KR 330

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  218 bits (557), Expect = 3e-67
 Identities = 82/273 (30%), Positives = 136/273 (49%), Gaps = 7/273 (2%)

Query: 269 NGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ 327
           + K +  +  ++ G  LG G FG VY        F  A+K V  + Q  +      QL +
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGV-EHQLRR 58

Query: 328 EILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQI 386
           E+ + S   H NI++ +G   D  R+++ LE    G++    QK    D Q +A Y  ++
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEV 446
            N L+Y H + V+HRDIK  N+L+ ++G +K+ADFG +     +      GT  ++ PE+
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 178

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
           +    R +    D+WSLG    E L  +PP+      +   RI + E    P+ ++  AR
Sbjct: 179 IE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGAR 235

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
           D I + L+ NP+ RP   +++EHP++     K 
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  218 bits (558), Expect = 5e-67
 Identities = 61/280 (21%), Positives = 109/280 (38%), Gaps = 29/280 (10%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
              + LG G F  V       DG F+A+K +   +     +Q   + ++E  +   F H 
Sbjct: 32  LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHP 86

Query: 339 NIVQYFG----TDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNG 389
           NI++           ++  ++ L    +G+L N  ++       L + Q+      I  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA-----------KATTMNDVKSCKGT 438
           L  +H +   HRD+K  NIL+   G   L D G             +A T+ D  + + T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 439 PFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPY--SHLEGMQALFRIGKGEPP 495
             + APE+ +++ +       D+WSLGC +  M+  + PY     +G      +      
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 535
                 S      +   + V+P+ RP    L+      +P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  219 bits (560), Expect = 6e-66
 Identities = 75/298 (25%), Positives = 129/298 (43%), Gaps = 47/298 (15%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EH 337
               ++LG GS GTV    +  G   AVK +                  EI LL+   +H
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--------IDFCDIALMEIKLLTESDDH 68

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT--------RQILNG 389
            N+++Y+ ++  +  L+I LEL    +L +L +  ++ D  +            RQI +G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 390 LNYLHEQNVVHRDIKCANILVDASGS-------------VKLADFGLAK------ATTMN 430
           + +LH   ++HRD+K  NILV  S               + ++DFGL K      ++   
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 431 DVKSCKGTPFWMAPEVVN-----LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQ 484
           ++ +  GT  W APE++         R    + DI+S+GC    +L++ + P+      +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 485 ALFRIGK----GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
           +    G         L   SL  +A D I + +  +P  RPTA +++ HP      +K
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  211 bits (540), Expect = 1e-64
 Identities = 81/265 (30%), Positives = 126/265 (47%), Gaps = 9/265 (3%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           G  LG G FG VY      + F  A+K V  + Q  +      QL +EI + S   H NI
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALK-VLFKSQLEKEGV-EHQLRREIEIQSHLRHPNI 76

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVV 399
           ++ +    D  R+++ LE   +G L    QK+   D Q SA +  ++ + L+Y HE+ V+
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 136

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTPFWMAPEVVNLKNRGYGLTA 458
           HRDIK  N+L+   G +K+ADFG +        +  C GT  ++ PE++    + +    
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-GTLDYLPPEMIE--GKTHDEKV 193

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN 518
           D+W  G    E L   PP+      +   RI   +    P  LS  ++D I K L+ +P 
Sbjct: 194 DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-FPPFLSDGSKDLISKLLRYHPP 252

Query: 519 DRPTAAQLMEHPFVKRPLQKSRGPP 543
            R     +MEHP+VK   ++   P 
Sbjct: 253 QRLPLKGVMEHPWVKANSRRVLPPV 277

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  211 bits (540), Expect = 5e-64
 Identities = 66/302 (21%), Positives = 124/302 (41%), Gaps = 42/302 (13%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVS------------LQDQGTQGKQ 320
            + I  ++    L  G F  +      D  F+A+K+                +     K 
Sbjct: 27  DKYINDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85

Query: 321 SILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVS 380
                + E+ +++  ++E  +   G   + + ++I  E +   S+    + + ++D   +
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 381 A---------YTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMN 430
                       + +LN  +Y+H + N+ HRD+K +NIL+D +G VKL+DFG ++     
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205

Query: 431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RI 489
            +K  +GT  +M PE  + ++   G   DIWSLG  +  M     P+S    +  LF  I
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265

Query: 490 GKGE------------------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                                      N LS +  DF+   L+ NP +R T+   ++H +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325

Query: 532 VK 533
           + 
Sbjct: 326 LA 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  206 bits (527), Expect = 1e-62
 Identities = 92/278 (33%), Positives = 142/278 (51%), Gaps = 20/278 (7%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            E +G+GSFGTV+      G   AVK +  QD   +      +  +E+ ++ R  H NIV
Sbjct: 42  KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVN---EFLREVAIMKRLRHPNIV 97

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANL----YQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
            + G       L I  E +++GSL  L      +  L + +  +    +  G+NYLH +N
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 398 --VVHRDIKCANILVDASGSVKLADFGLA--KATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
             +VHR++K  N+LVD   +VK+ DFGL+  KA+T    KS  GTP WMAPEV  L++  
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV--LRDEP 215

Query: 454 YGLTADIWSLGCTVL-EMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDARDFILK 511
               +D++S G  +L E+ T Q P+ +L   Q +  +G K +   +P +L+      I  
Sbjct: 216 SNEKSDVYSFG-VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274

Query: 512 CLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNM 549
           C    P  RP+ A +M+     RPL KS  PP   +++
Sbjct: 275 CWTNEPWKRPSFATIMDL---LRPLIKSAVPPPNRSDL 309

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  205 bits (524), Expect = 2e-62
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 16/260 (6%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            E++G G FG VY  +   G   AVK  +  D      Q+I  + QE  L +  +H NI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN---V 398
              G    E  L + +E    G L  +     +    +  +  QI  G+NYLH++    +
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 399 VHRDIKCANILVDASGS--------VKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLK 450
           +HRD+K +NIL+             +K+ DFGLA+        S  G   WMAPEV  ++
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV--IR 187

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDARDFI 509
              +   +D+WS G  + E+LT + P+  ++G+   + +        +P++        +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLM 247

Query: 510 LKCLQVNPNDRPTAAQLMEH 529
             C   +P+ RP+   +++ 
Sbjct: 248 EDCWNPDPHSRPSFTNILDQ 267

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  208 bits (531), Expect = 7e-62
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 21/269 (7%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKQSILQLEQEILLLSRFEH 337
            + LGSG+ G V   +        A++ +S         +     L +E EI +L +  H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
             I++       E+  +I LEL+  G L + +     L ++    Y  Q+L  + YLHE 
Sbjct: 200 PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258

Query: 397 NVVHRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPEVV-N 448
            ++HRD+K  N+L+   +    +K+ DFG +K     + M  +  C GTP ++APEV+ +
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--C-GTPTYLAPEVLVS 315

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGE---PPLVPNSLSRD 504
           +   GY    D WSLG  +   L+  PP+S      +L  +I  G+    P V   +S  
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
           A D + K L V+P  R T  + + HP+++
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  201 bits (513), Expect = 3e-60
 Identities = 65/298 (21%), Positives = 113/298 (37%), Gaps = 50/298 (16%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           W   ++LG G+   V+ G     G  FA+K  +         + +    +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI----SFLRPVDVQMREFEVLKKLNH 66

Query: 338 ENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLN 391
           +NIV+ F    +       + +E    GSL  + ++    Y L +S+     R ++ G+N
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 392 YLHEQNVVHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEV 446
           +L E  +VHR+IK  NI+     D     KL DFG A+    ++   S  GT  ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 447 V------NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEP-- 494
                      + YG T D+WS+G T     T   P+   EG     + +++I  G+P  
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 495 ----------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP 530
                                   +   L       +   L+ +        Q     
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  199 bits (508), Expect = 4e-60
 Identities = 67/263 (25%), Positives = 116/263 (44%), Gaps = 18/263 (6%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQS--ILQLEQEILLLSRFEHE 338
            + +G G FG V++G    D    A+K + L D   + +      + ++E+ ++S   H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMD-SQVSAYTRQILNGLNYLHEQ 396
           NIV+ +G   +     + +E V  G L + L  K H +  S        I  G+ Y+  Q
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141

Query: 397 N--VVHRDIKCANILVDASG-----SVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNL 449
           N  +VHRD++  NI + +         K+ADFGL++ +  + V    G   WMAPE +  
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-HSVSGLLGNFQWMAPETIGA 200

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG---KGEPPLVPNSLSRDAR 506
           +   Y   AD +S    +  +LT + P+      +  F      +G  P +P       R
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLR 260

Query: 507 DFILKCLQVNPNDRPTAAQLMEH 529
           + I  C   +P  RP  + +++ 
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKE 283

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  201 bits (512), Expect = 6e-60
 Identities = 72/312 (23%), Positives = 119/312 (38%), Gaps = 55/312 (17%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
              +G GS+G V            A+K ++         + + +++ E+ L+ +  H NI
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 341 VQYFGTDKDENRLFIFLELVTKGSL----------------------------------- 365
            + +   +DE  + + +EL   G L                                   
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 366 ------ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV--DASGSVK 417
                       +   +  +S   RQI + L+YLH Q + HRDIK  N L   + S  +K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210

Query: 418 LADFGLAKATTMNDVKSCK------GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEML 471
           L DFGL+K     +           GTP+++APEV+N  N  YG   D WS G  +  +L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 472 TRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILKCLQVNPNDRPTAAQLM 527
               P+            +   +        N LS  ARD +   L  N ++R  A + +
Sbjct: 271 MGAVPFPG-VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329

Query: 528 EHPFVKRPLQKS 539
           +HP++ +   K 
Sbjct: 330 QHPWISQFSDKI 341

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  199 bits (507), Expect = 1e-59
 Identities = 80/299 (26%), Positives = 141/299 (47%), Gaps = 34/299 (11%)

Query: 267 SPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS--------------- 310
           S +     ++  +   + +G GS+G V   Y  +D  ++A+K +S               
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 311 ------LQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFG--TDKDENRLFIFLELVTK 362
                       Q +  I Q+ QEI +L + +H N+V+      D +E+ L++  ELV +
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 363 GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG 422
           G +  +     L + Q   Y + ++ G+ YLH Q ++HRDIK +N+LV   G +K+ADFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 423 LAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYS 478
           ++     +D     +  GTP +MAPE ++   + + G   D+W++G T+   +  Q P+ 
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 479 HLEGMQALFR-IGKGEPPLVPN--SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
             E +  L   I        P+   ++ D +D I + L  NP  R    ++  HP+V R
Sbjct: 242 D-ERIMCLHSKIKSQALEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  201 bits (513), Expect = 1e-59
 Identities = 48/324 (14%), Positives = 95/324 (29%), Gaps = 50/324 (15%)

Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSIL 323
                 +   R  +  +G +LG        E    + G  F V      ++        +
Sbjct: 61  PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120

Query: 324 QLEQEIL-----------------------LLSRFEHENIVQYFGTDKDENRLFIFLEL- 359
           + E   L                       L+   + + +++    ++D   L  F    
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180

Query: 360 VTKGSLANLY--------QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD 411
             + +L                L+       T Q++  L  LH   +VH  ++  +I++D
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 240

Query: 412 ASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVN---------LKNRGYGLTADIWS 462
             G V L  F                +  +  PE+            +      + D W+
Sbjct: 241 QRGGVFLTGFEHLVR--DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPT 522
           LG  +  +     P +    +     I +        ++ +  R  +   L+    DR  
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLL 353

Query: 523 AAQLMEHPFVKR-PLQKSRGPPSY 545
             Q ME P  ++   + S   P Y
Sbjct: 354 PLQAMETPEYEQLRTELSAALPLY 377

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  198 bits (505), Expect = 3e-59
 Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 17/267 (6%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKQSILQLEQEILLLSRFEH 337
            + LGSG+ G V   +        A+K +S         +     L +E EI +L +  H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
             I++       E+  +I LEL+  G L + +     L ++    Y  Q+L  + YLHE 
Sbjct: 75  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133

Query: 397 NVVHRDIKCANILVDASG---SVKLADFGLAKATTMNDV--KSCKGTPFWMAPEV-VNLK 450
            ++HRD+K  N+L+ +      +K+ DFG +K      +    C GTP ++APEV V++ 
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVG 192

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGE---PPLVPNSLSRDAR 506
             GY    D WSLG  +   L+  PP+S      +L   I  G+    P V   +S  A 
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           D + K L V+P  R T  + + HP+++
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQ 279

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  196 bits (500), Expect = 2e-58
 Identities = 61/266 (22%), Positives = 122/266 (45%), Gaps = 25/266 (9%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           GEL+G G FG VY G +  +    A++ + ++       +     ++E++   +  HEN+
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLK---AFKREVMAYRQTRHENV 91

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANL--YQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           V + G       L I   L    +L ++    K  L  ++     ++I+ G+ YLH + +
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTM-------NDVKSCKGTPFWMAPEVVNLKN 451
           +H+D+K  N+  D +G V + DFGL   + +       + ++   G    +APE++   +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 452 RG-------YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVPNSLSR 503
                    +   +D+++LG    E+  R+ P+        ++++G G  P L    + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEH 529
           +  D +L C      +RPT  +LM+ 
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDM 296

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  197 bits (503), Expect = 2e-58
 Identities = 38/307 (12%), Positives = 80/307 (26%), Gaps = 49/307 (15%)

Query: 272 FRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL 330
             +     +  E L  G    V+     +    FA+K  ++  + +  +  + +L +   
Sbjct: 57  LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS--RSELERLHEATF 114

Query: 331 LLSRFEHENIVQYFGT--------------------------DKDENRLFIFLELVTKGS 364
             +R   E+  +                              D       + +       
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVD 173

Query: 365 LANLY--------QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV 416
           L  L+         +       +   T Q++     L  + +VH      N+ +   G +
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL 233

Query: 417 KLADFGLAKATTMNDVKSCKGTPFWM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP 475
            L D        +         P      E +N     +    + W LG ++  +     
Sbjct: 234 MLGDVSALWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291

Query: 476 PYSHLEGMQA-------LFRIGKGEPPL-VPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
           P+  +            L   G           L    +  I + L  +   R    + M
Sbjct: 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351

Query: 528 EHPFVKR 534
           E P   +
Sbjct: 352 ETPEFLQ 358

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  195 bits (497), Expect = 3e-58
 Identities = 73/265 (27%), Positives = 133/265 (50%), Gaps = 28/265 (10%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           G+ +GSGSFGTVY+G +  D    AVK +++     Q  Q     + E+ +L +  H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ---AFKNEVGVLRKTRHVNI 82

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR-----QILNGLNYLHE 395
           + + G       L I  +     SL   Y   H  +++           Q   G++YLH 
Sbjct: 83  LLFMGYSTAPQ-LAIVTQWCEGSSL---YHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTM----NDVKSCKGTPFWMAPEVVNLKN 451
           ++++HRD+K  NI +    +VK+ DFGLA   +     +  +   G+  WMAPEV+ +++
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 452 RG-YGLTADIWSLGCTVL-EMLTRQPPYSHLEGM-QALFRIGKG----EPPLVPNSLSRD 504
              Y   +D+++ G  VL E++T Q PYS++    Q +  +G+G    +   V ++  + 
Sbjct: 199 SNPYSFQSDVYAFG-IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEH 529
            +  + +CL+   ++RP+  +++  
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILAE 282

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  193 bits (492), Expect = 2e-57
 Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 23/272 (8%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSI----LQLEQEILLLSR-F 335
            E+LG G    V    +      +AVK + +   G+   + +        +E+ +L +  
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLH 394
            H NI+Q   T +     F+  +L+ KG L + L +K  L + +     R +L  +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPEV---- 446
           + N+VHRD+K  NIL+D   ++KL DFG +        + +V  C GTP ++APE+    
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--C-GTPSYLAPEIIECS 198

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLS 502
           +N  + GYG   D+WS G  +  +L   PP+ H      + R I  G         +  S
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYS 257

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
              +D + + L V P  R TA + + HPF ++
Sbjct: 258 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  197 bits (503), Expect = 4e-57
 Identities = 68/272 (25%), Positives = 130/272 (47%), Gaps = 16/272 (5%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
             +LG GSFG V        G   AVK   +  +  + K     L +E+ LL + +H NI
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVK--VISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           ++ +   +D+   ++  E+ T G L + +  +    +   +   RQ+L+G+ Y+H+  +V
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 148

Query: 400 HRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYG 455
           HRD+K  N+L+       ++++ DFGL+     +   K   GT +++APEV++     Y 
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH---GTYD 205

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILK 511
              D+WS G  +  +L+  PP+ +      + + + KG+          +S  A+D I K
Sbjct: 206 EKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264

Query: 512 CLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
            L   P+ R +A   ++H +++   ++     
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVD 296

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  191 bits (487), Expect = 5e-57
 Identities = 49/260 (18%), Positives = 103/260 (39%), Gaps = 22/260 (8%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
              L     G +++G    G    VK + ++D  T+  +      +E   L  F H N++
Sbjct: 15  LTKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSR---DFNEECPRLRIFSHPNVL 70

Query: 342 QYFG--TDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQ 396
              G           +    +  GSL N+  +   + +  SQ   +   +  G+ +LH  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 397 N--VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGY 454
              +    +   ++++D   + +++   +  +            P W+APE   L+ +  
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---PGRMYAPAWVAPEA--LQKKPE 185

Query: 455 GLT---ADIWSLGCTVL-EMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDARDFI 509
                 AD+WS    +L E++TR+ P++ L  M+   ++  +G  P +P  +S      +
Sbjct: 186 DTNRRSADMWSFA-VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLM 244

Query: 510 LKCLQVNPNDRPTAAQLMEH 529
             C+  +P  RP    ++  
Sbjct: 245 KICMNEDPAKRPKFDMIVPI 264

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  194 bits (495), Expect = 8e-57
 Identities = 65/297 (21%), Positives = 113/297 (38%), Gaps = 50/297 (16%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           W   ++LG G+   V+ G     G  FA+K  +         + +    +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI----SFLRPVDVQMREFEVLKKLNH 66

Query: 338 ENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLN 391
           +NIV+ F    +       + +E    GSL  + ++    Y L +S+     R ++ G+N
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 392 YLHEQNVVHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEV 446
           +L E  +VHR+IK  NI+     D     KL DFG A+    ++   S  GT  ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 447 V------NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEPP- 495
                      + YG T D+WS+G T     T   P+   EG     + +++I  G+P  
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 496 -----------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
                                   +   L       +   L+ +        Q    
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  196 bits (501), Expect = 9e-57
 Identities = 71/273 (26%), Positives = 130/273 (47%), Gaps = 17/273 (6%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            + LGSG++G V            A+K +      T       +L +E+ +L   +H NI
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS---KLLEEVAVLKLLDHPNI 98

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           ++ +   +D+   ++ +E    G L + +  +    +   +   +Q+L+G+ YLH+ N+V
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158

Query: 400 HRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYG 455
           HRD+K  N+L+   +    +K+ DFGL+         K   GT +++APEV+    + Y 
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---KKYD 215

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILK 511
              D+WS+G  +  +L   PP+   +  Q + R + KG+         ++S  A+D I +
Sbjct: 216 EKCDVWSIGVILFILLAGYPPF-GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274

Query: 512 CLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            LQ +   R +A Q +EHP++K    K      
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  191 bits (488), Expect = 9e-57
 Identities = 68/271 (25%), Positives = 115/271 (42%), Gaps = 34/271 (12%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           GE+LG G FG   +  + + G    +KE  L     + +++ L+   E+ ++   EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLK---EVKVMRCLEHPNV 69

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTR-----QILNGLNYLHE 395
           +++ G    + RL    E +  G+L  + +    MDSQ     R      I +G+ YLH 
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLA----------------KATTMNDVKSCKGTP 439
            N++HRD+   N LV  + +V +ADFGLA                K        +  G P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG--KGEPPLV 497
           +WMAPE+  +  R Y    D++S G  + E++ R             F +          
Sbjct: 187 YWMAPEM--INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           P +         ++C  ++P  RP+  +L  
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  190 bits (486), Expect = 1e-56
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 21/265 (7%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
              LGSG+FG V+       G    +K ++      + +  + Q+E EI +L   +H NI
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINK----DRSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 341 VQYFGTDKDENRLFIFLELVTKGSL-----ANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           ++ F   +D + ++I +E    G L     +   +   L +  V+   +Q++N L Y H 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142

Query: 396 QNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKN 451
           Q+VVH+D+K  NIL         +K+ DFGLA+    ++   +  GT  +MAPEV     
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF---K 199

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEP--PLVPNSLSRDARDF 508
           R      DIWS G  +  +LT   P+     ++ + +     EP   +    L+  A D 
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVK 533
           + + L  +P  RP+AAQ++ H + K
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWFK 283

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  192 bits (491), Expect = 1e-56
 Identities = 75/271 (27%), Positives = 124/271 (45%), Gaps = 27/271 (9%)

Query: 282 GELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
            E++G G F  V     +   G  FAVK V +    +    S   L++E  +    +H +
Sbjct: 29  CEVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDS----QVSAYTRQILNGLNYLH 394
           IV+   T   +  L++  E +    L   + ++            S Y RQIL  L Y H
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 395 EQNVVHRDIKCANILV---DASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEV 446
           + N++HRD+K   +L+   + S  VKL  FG+A                 GTP +MAPEV
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--V-GTPHFMAPEV 204

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLS 502
             +K   YG   D+W  G  +  +L+   P+   +  + LF  I KG+  + P   + +S
Sbjct: 205 --VKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSHIS 260

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
             A+D + + L ++P +R T  + + HP++K
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  191 bits (487), Expect = 1e-56
 Identities = 67/260 (25%), Positives = 123/260 (47%), Gaps = 27/260 (10%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            E++G G+FG V +         A+K++  + +             E+  LSR  H NIV
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-------RKAFIVELRQLSRVNHPNIV 64

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLNYLHEQN 397
           + +G   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH   
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 398 ---VVHRDIKCANILVDASGSV-KLADFGLAK--ATTMNDVKSCKGTPFWMAPEVVNLKN 451
              ++HRD+K  N+L+ A G+V K+ DFG A    T M    + KG+  WMAPEV   + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWMAPEV--FEG 177

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEG--MQALFRIGKGEPPLVPNSLSRDARDFI 509
             Y    D++S G  + E++TR+ P+  + G   + ++ +  G  P +  +L +     +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237

Query: 510 LKCLQVNPNDRPTAAQLMEH 529
            +C   +P+ RP+  ++++ 
Sbjct: 238 TRCWSKDPSQRPSMEEIVKI 257

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  193 bits (491), Expect = 1e-56
 Identities = 74/271 (27%), Positives = 135/271 (49%), Gaps = 22/271 (8%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVS---LQDQGTQGKQSILQLEQEILLLSR-FE 336
            +++G G    V    +   G  FAVK +     +    Q ++      +E  +L +   
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H +I+    + +  + +F+  +L+ KG L + L +K  L + +  +  R +L  +++LH 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPEV----V 447
            N+VHRD+K  NIL+D +  ++L+DFG +        + ++  C GTP ++APE+    +
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--C-GTPGYLAPEILKCSM 275

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSR 503
           +  + GYG   D+W+ G  +  +L   PP+ H      + R I +G+        +  S 
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRSS 334

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
             +D I + LQV+P  R TA Q ++HPF +R
Sbjct: 335 TVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  190 bits (486), Expect = 2e-56
 Identities = 77/261 (29%), Positives = 127/261 (48%), Gaps = 17/261 (6%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            E+LGSG+F  V+       G  FA+K +               LE EI +L + +HENI
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-----KSPAFRDSSLENEIAVLKKIKHENI 68

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           V      +     ++ ++LV+ G L + + ++    +   S   +Q+L+ + YLHE  +V
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 400 HRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           HRD+K  N+L    + +  + + DFGL+K      + +  GTP ++APEV  L  + Y  
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV--LAQKPYSK 186

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILKC 512
             D WS+G     +L   PP+   E    LF  I +G         + +S  A+DFI   
Sbjct: 187 AVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL 245

Query: 513 LQVNPNDRPTAAQLMEHPFVK 533
           L+ +PN+R T  + + HP++ 
Sbjct: 246 LEKDPNERYTCEKALSHPWID 266

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  195 bits (498), Expect = 3e-56
 Identities = 69/281 (24%), Positives = 130/281 (46%), Gaps = 22/281 (7%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVS--------LQDQGTQGKQSILQLEQEILLL 332
              LGSG++G V      +     A+K +           D     ++   ++  EI LL
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLN 391
              +H NI++ F   +D+   ++  E    G L   +  ++   +   +   +QIL+G+ 
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160

Query: 392 YLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVV 447
           YLH+ N+VHRDIK  NIL+   ++  ++K+ DFGL+   + +   +   GT +++APEV+
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSR 503
               + Y    D+WS G  +  +L   PP+   +  Q + + + KG+         ++S 
Sbjct: 221 ---KKKYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYYFDFNDWKNISD 276

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           +A++ I   L  + N R TA + +   ++K+          
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQ 317

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  195 bits (497), Expect = 3e-56
 Identities = 74/273 (27%), Positives = 136/273 (49%), Gaps = 17/273 (6%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
             +LG GSFG V +         +AVK ++      +       + +E+ LL + +H NI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS---TILREVELLKKLDHPNI 83

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           ++ F   +D +  +I  EL T G L + + ++    +   +   +Q+ +G+ Y+H+ N+V
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143

Query: 400 HRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYG 455
           HRD+K  NIL+   +    +K+ DFGL+     N   K   GT +++APEV+      Y 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL---RGTYD 200

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILK 511
              D+WS G  +  +L+  PP+ + +    + + +  G+         ++S DA+D I K
Sbjct: 201 EKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 512 CLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            L  +P+ R TA Q +EHP++++   ++     
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  188 bits (480), Expect = 7e-56
 Identities = 76/266 (28%), Positives = 125/266 (46%), Gaps = 24/266 (9%)

Query: 282 GELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
            E LG G+F  V         G  FA K ++ +    +  Q    LE+E  +  + +H N
Sbjct: 11  KEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPN 66

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           IV+   + ++E+  ++  +LVT G L   +  +    ++  S   +QIL  + Y H   +
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126

Query: 399 VHRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPEVVNLKN 451
           VHR++K  N+L+       +VKLADFGLA     +   +      GTP +++PEV  LK 
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--A-GTPGYLSPEV--LKK 181

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARD 507
             Y    DIW+ G  +  +L   PP+   E    L+  I  G         ++++ +A+ 
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240

Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVK 533
            I   L VNP  R TA Q ++ P++ 
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWIC 266

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  190 bits (483), Expect = 7e-56
 Identities = 49/264 (18%), Positives = 98/264 (37%), Gaps = 22/264 (8%)

Query: 288 GSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD 347
            ++         +       +    D        +     +I  +  F  +N V      
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 348 KDENRLFIFLELVTKGSLANLYQKYHLMD----SQVSAYTRQILNGLNYLHEQNVVHRDI 403
             +  L+I ++L  K +L +   +   ++            QI   + +LH + ++HRD+
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190

Query: 404 KCANILVDASGSVKLADFGLAK--------ATTMNDVKSCK------GTPFWMAPEVVNL 449
           K +NI       VK+ DFGL           T +  + +        GT  +M+PE   +
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ--I 248

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
               Y    DI+SLG  + E+L      + +E ++ +  +   + PL+           +
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMV 306

Query: 510 LKCLQVNPNDRPTAAQLMEHPFVK 533
              L  +P +RP A  ++E+   +
Sbjct: 307 QDMLSPSPTERPEATDIIENAIFE 330

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 19/74 (25%), Positives = 39/74 (52%), Gaps = 6/74 (8%)

Query: 275 RIMS-WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL 332
           R ++ ++  + +G G FG V+E     D   +A+K + L ++    +    ++ +E+  L
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKAL 58

Query: 333 SRFEHENIVQYFGT 346
           ++ EH  IV+YF  
Sbjct: 59  AKLEHPGIVRYFNA 72

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  188 bits (480), Expect = 2e-55
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 30/281 (10%)

Query: 281 KGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHE 338
           K + LG GSF    +         FAVK +S        K+     ++EI  L     H 
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQKEITALKLCEGHP 66

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           NIV+      D+   F+ +EL+  G L   + +K H  +++ S   R++++ ++++H+  
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126

Query: 398 VVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVK---SCKGTPFWMAPEVVNLKN 451
           VVHRD+K  N+L    + +  +K+ DFG A+    ++      C  T  + APE+  L  
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPEL--LNQ 183

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPP-YSHLEGM-----QALF-RIGKGEPPLVP---NSL 501
            GY  + D+WSLG  +  ML+ Q P  SH   +       +  +I KG+         ++
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
           S++A+D I   L V+PN R   + L  + +++   Q S  P
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  188 bits (480), Expect = 3e-55
 Identities = 82/269 (30%), Positives = 128/269 (47%), Gaps = 28/269 (10%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHEN 339
            E +G GS+              FAVK +          +S     +EI +L R+ +H N
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID---------KSKRDPTEEIEILLRYGQHPN 77

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           I+       D   +++  EL+  G L + + ++    + + SA    I   + YLH Q V
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 399 VHRDIKCANILV----DASGSVKLADFGLAKATTMNDVK---SCKGTPFWMAPEVVNLKN 451
           VHRD+K +NIL         S+++ DFG AK     +      C  T  ++APEV  L+ 
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEV--LER 194

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM--QALF-RIGKGEPPLVP---NSLSRDA 505
           +GY    DIWSLG  +  MLT   P+++      + +  RIG G+  L     NS+S  A
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254

Query: 506 RDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           +D + K L V+P+ R TAA ++ HP++  
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVH 283

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  188 bits (478), Expect = 4e-55
 Identities = 69/294 (23%), Positives = 118/294 (40%), Gaps = 40/294 (13%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEH 337
           +   +L  G F  VYE      G  +A+K +   +     ++    + QE+  + +   H
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGH 85

Query: 338 ENIVQYFG-------TDKDENRLFIFLELVTKGSLA----NLYQKYHLMDSQVSAYTRQI 386
            NIVQ+                 F+ L  + KG L      +  +  L    V     Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 387 LNGLNYLHEQN--VVHRDIKCANILVDASGSVKLADFGLA--------------KATTMN 430
              + ++H Q   ++HRD+K  N+L+   G++KL DFG A              +   + 
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 431 DVKSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI 489
           +  +   TP +  PE+++L  N   G   DIW+LGC +  +  RQ P+   E   A  RI
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF---ED-GAKLRI 261

Query: 490 GKGEPPLVPN-SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
             G+  + P+ +        I   LQVNP +R + A+++         +     
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  185 bits (473), Expect = 6e-55
 Identities = 75/265 (28%), Positives = 134/265 (50%), Gaps = 23/265 (8%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
             +LG GSFG V +         +AVK ++      +   +   + +E+ LL + +H NI
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST---ILREVELLKKLDHPNI 83

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           ++ F   +D +  +I  EL T G L + + ++    +   +   +Q+ +G+ Y+H+ N+V
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143

Query: 400 HRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           HRD+K  NIL+   +    +K+ DFGL+      T M D     GT +++APEV+     
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--I-GTAYYIAPEVL---RG 197

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDF 508
            Y    D+WS G  +  +L+  PP+   +    + + +  G+         ++S DA+D 
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVK 533
           I K L  +P+ R TA Q +EHP+++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQ 281

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  185 bits (471), Expect = 1e-54
 Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 17/280 (6%)

Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL 332
             +  W   + LG G++G V            AVK V ++    +       +++EI + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPENIKKEICIN 59

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLN 391
               HEN+V+++G  ++ N  ++FLE  + G L + +     + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEV 446
           YLH   + HRDIK  N+L+D   ++K++DFGLA     N+      K C GT  ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 447 VNLKNRGY-GLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGKGEPPLVP-NSLSR 503
             LK R +     D+WS G  +  ML  + P+    +  Q      + +  L P   +  
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
                + K L  NP+ R T   + +  +  +PL+K    P
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  183 bits (468), Expect = 3e-54
 Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 25/271 (9%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
              +G GS+G V            A K++          + + + +QEI ++   +H NI
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-----KYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           ++ + T +D   +++ +EL T G L   +  K    +S  +   + +L+ + Y H+ NV 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 400 HRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           HRD+K  N L         +KL DFGLA        M       GTP++++P+V+     
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--V-GTPYYVSPQVL---EG 182

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDF 508
            YG   D WS G  +  +L   PP+        +   I +G          ++S  A   
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
           I + L  +P  R T+ Q +EH + ++ L  S
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  183 bits (467), Expect = 5e-54
 Identities = 79/273 (28%), Positives = 137/273 (50%), Gaps = 21/273 (7%)

Query: 282 GELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQD-QGTQGKQSILQLEQEILLLSRFEHE 338
           GE LGSG F  V +       G  +A K +  +    ++   S  ++E+E+ +L    H 
Sbjct: 10  GEELGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           NI+      +++  + + LELV+ G L + L +K  L + + + + +QIL+G++YLH + 
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 128

Query: 398 VVHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNR 452
           + H D+K  NI++      +  +KL DFG+A      +  K+  GTP ++APE+  +   
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI--VNYE 186

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKG-----EPPLVPNSLSRDAR 506
             GL AD+WS+G     +L+   P+   E  Q     I        E     ++ S  A+
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYF--SNTSELAK 243

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
           DFI + L  +P  R T AQ +EH ++K   +++
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  185 bits (473), Expect = 6e-54
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 22/265 (8%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            E LG G+F  V        G  FA K ++ +    +  Q    LE+E  +  + +H NI
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNI 90

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           V+   + ++E+  ++  +LVT G L   +  +    ++  S   +QIL  + Y H   +V
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150

Query: 400 HRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           HR++K  N+L+       +VKLADFGLA     +   +      GTP +++PEV  LK  
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--A-GTPGYLSPEV--LKKD 205

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDF 508
            Y    DIW+ G  +  +L   PP+   E    L+  I  G         ++++ +A+  
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVK 533
           I   L VNP  R TA Q ++ P++ 
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWIC 289

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  185 bits (472), Expect = 6e-54
 Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 19/262 (7%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
              LG G+   VY          +A+K +               +  EI +L R  H NI
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNI 110

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           ++     +    + + LELVT G L + + +K +  +   +   +QIL  + YLHE  +V
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 400 HRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYG 455
           HRD+K  N+L         +K+ADFGL+K      + K+  GTP + APE+  L+   YG
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI--LRGCAYG 228

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILK 511
              D+WS+G     +L    P+    G Q +FR I   E   +    + +S +A+D + K
Sbjct: 229 PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288

Query: 512 CLQVNPNDRPTAAQLMEHPFVK 533
            + ++P  R T  Q ++HP+V 
Sbjct: 289 LIVLDPKKRLTTFQALQHPWVT 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (462), Expect = 4e-53
 Identities = 76/293 (25%), Positives = 116/293 (39%), Gaps = 52/293 (17%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
              E +G G +G V+ G +  G   AVK  S +D     ++S  + E E+       HEN
Sbjct: 11  TLLECVGKGRYGEVWRG-SWQGENVAVKIFSSRD-----EKSWFR-ETELYNTVMLRHEN 63

Query: 340 IVQYFGTDKDEN----RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           I+ +  +D        +L++       GSL +  Q   L           I +GL +LH 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 396 Q--------NVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDV--KSCKGTPFW 441
           +         + HRD+K  NILV  +G   +AD GLA     +T   DV      GT  +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 442 MAPEV----VNLKNRGYGLTADIWSLGCTVL-EMLTR----------QPPYSHLEGMQAL 486
           MAPEV    + +         DIW+ G  VL E+  R          +PP+  +      
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 487 FR------IGKGEPPLVPNSLSRDA-----RDFILKCLQVNPNDRPTAAQLME 528
           F           + P +PN    D         + +C   NP+ R TA ++ +
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  181 bits (462), Expect = 7e-53
 Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 17/280 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           W   + LG G++G V            AVK V +     +       +++EI +     H
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 64

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           EN+V+++G  ++ N  ++FLE  + G L + +     + +     +  Q++ G+ YLH  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEVVNLKN 451
            + HRDIK  N+L+D   ++K++DFGLA     N+      K C GT  ++APE+  LK 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL--LKR 181

Query: 452 RGY-GLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGKGEPPLVP-NSLSRDARDF 508
           R +     D+WS G  +  ML  + P+    +  Q      + +  L P   +       
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNN 548
           + K L  NP+ R T   + +  +  +PL+K    P   + 
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  184 bits (470), Expect = 8e-53
 Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 25/267 (9%)

Query: 282 GELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
            E LG G+F  V         G  +A   ++ +    +  Q    LE+E  +    +H N
Sbjct: 16  FEELGKGAFSVVRRC-VKVLAGQEYAAMIINTKKLSARDHQK---LEREARICRLLKHPN 71

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           IV+   +  +E   ++  +LVT G L   +  + +  ++  S   +QIL  + + H+  V
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131

Query: 399 VHRDIKCANILV---DASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVVNLK 450
           VHR++K  N+L+       +VKLADFGLA                 GTP +++PEV  L+
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF--A-GTPGYLSPEV--LR 186

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDAR 506
              YG   D+W+ G  +  +L   PP+   E    L++ I  G         ++++ +A+
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           D I K L +NP+ R TAA+ ++HP++ 
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWIS 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  181 bits (461), Expect = 1e-52
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 19/277 (6%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQD-QGTQGKQSILQLEQEILLLSRFEHEN 339
           GE LGSG F  V +      G  +A K +  +  + ++   S  ++E+E+ +L +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           ++      ++   + + LELV+ G L + L QK  L + + +++ +QIL+G+NYLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 399 VHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRG 453
            H D+K  NI++         +KL DFGLA         K+  GTP ++APE+  +    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI--VNYEP 194

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKG-----EPPLVPNSLSRDARD 507
            GL AD+WS+G     +L+   P+   +  Q     I        E     +  S  A+D
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFF--SHTSELAKD 251

Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           FI K L      R T  + + HP++     +      
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  181 bits (462), Expect = 1e-52
 Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 29/278 (10%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           ++LG G  G V E +    G   A+K +              + E +    +     +IV
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQAS-GGPHIV 85

Query: 342 QYFGT----DKDENRLFIFLELVTKGSLAN-LYQKYHLMDS--QVSAYTRQILNGLNYLH 394
                       +  L I +E +  G L + + ++     +  + +   R I   + +LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 395 EQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
             N+ HRD+K  N+L    +    +KL DFG AK TT N +++   TP+++APEV  L  
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV--LGP 203

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALF-RIGKGEPPLVP---NSLSRD 504
             Y  + D+WSLG  +  +L   PP+   +       +  RI  G+        + +S D
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
           A+  I   L+ +P +R T  Q M HP++ + +   + P
Sbjct: 264 AKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  180 bits (458), Expect = 2e-52
 Identities = 72/286 (25%), Positives = 129/286 (45%), Gaps = 31/286 (10%)

Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSIL 323
              P    ++R   ++ G++LG GSF TV           +A+K +         K+ I+
Sbjct: 18  AQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--------KRHII 69

Query: 324 QLEQ------EILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS 377
           +  +      E  ++SR +H   V+ + T +D+ +L+  L     G L    +K    D 
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE 129

Query: 378 QVSA-YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-- 434
             +  YT +I++ L YLH + ++HRD+K  NIL++    +++ DFG AK  +    ++  
Sbjct: 130 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189

Query: 435 ---CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK 491
                GT  +++PE+  L  +    ++D+W+LGC + +++   PP+          +I K
Sbjct: 190 NSFV-GTAQYVSPEL--LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246

Query: 492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPT------AAQLMEHPF 531
            E    P      ARD + K L ++   R           L  HPF
Sbjct: 247 LEYDF-PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  181 bits (461), Expect = 3e-52
 Identities = 80/266 (30%), Positives = 130/266 (48%), Gaps = 19/266 (7%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVS-LQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           GE LGSG F  V +      G  +A K +   Q + ++      ++E+E+ +L +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           I+      ++   + + LELV+ G L + L QK  L + + +++ +QIL+G+NYLH + +
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 399 VHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRG 453
            H D+K  NI++         +KL DFGLA         K+  GTP ++APE+VN +   
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE--P 194

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKG-----EPPLVPNSLSRDARD 507
            GL AD+WS+G     +L+   P+   +  Q     I        E     +  S  A+D
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFF--SQTSELAKD 251

Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVK 533
           FI K L      R T  + + HP++ 
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWIT 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  179 bits (457), Expect = 4e-52
 Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 19/267 (7%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            E LG G FG V+    T     +  K V ++          + +++EI +L+   H NI
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNI 63

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           +    + +    L +  E ++   +        + L + ++ +Y  Q+   L +LH  N+
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 399 VHRDIKCANILV--DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYG 455
            H DI+  NI+     S ++K+ +FG A+     D  +     P + APEV   ++    
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV--HQHDVVS 181

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILK 511
              D+WSLG  V  +L+   P+   E  Q +   I   E          +S +A DF+ +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 512 CLQVNPNDRPTAAQLMEHPFVKRPLQK 538
            L      R TA++ ++HP++K+ +++
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIER 267

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  178 bits (454), Expect = 6e-52
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 17/283 (6%)

Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL 332
           + I  +  G+LLG GS+G V E   ++     AVK +  + +  +       +++EI LL
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLL 60

Query: 333 SRFEHENIVQYFG--TDKDENRLFIFLELVTKGS--LANLYQKYHLMDSQVSAYTRQILN 388
            R  H+N++Q      ++++ ++++ +E    G   + +   +      Q   Y  Q+++
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID 120

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-----SCKGTPFWMA 443
           GL YLH Q +VH+DIK  N+L+   G++K++  G+A+A            S  G+P +  
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQP 179

Query: 444 PEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVPNSL 501
           PE+ N     + G   DIWS G T+  + T   P+   + +  LF  IGKG   + P   
Sbjct: 180 PEIAN-GLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYAI-PGDC 236

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
                D +   L+  P  R +  Q+ +H + ++    +  P  
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVP 279

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  178 bits (455), Expect = 8e-52
 Identities = 74/267 (27%), Positives = 131/267 (49%), Gaps = 21/267 (7%)

Query: 282 GELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQD-QGTQGKQSILQLEQEILLLSRFEHE 338
           GE LGSG F  V +   +   G  +A K +  +  + ++   S   +E+E+ +L   +H 
Sbjct: 16  GEELGSGQFAVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           N++      +++  + + LELV  G L + L +K  L + + + + +QILNG+ YLH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134

Query: 398 VVHRDIKCANILV----DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNR 452
           + H D+K  NI++         +K+ DFGLA      +  K+  GTP ++APE+  +   
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI--VNYE 192

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKG-----EPPLVPNSLSRDAR 506
             GL AD+WS+G     +L+   P+   +  Q     +        +     ++ S  A+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYF--SNTSALAK 249

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  179 bits (455), Expect = 1e-51
 Identities = 74/294 (25%), Positives = 113/294 (38%), Gaps = 54/294 (18%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           Q  + +G G +G V+ G +   G   AVK     +     + S  + E EI       HE
Sbjct: 40  QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-----EASWFR-ETEIYQTVLMRHE 91

Query: 339 NIVQYFGTDKDENRLFIFLELVT----KGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH 394
           NI+ +   D      +  L L+T     GSL +  +   L    +       ++GL +LH
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLH 151

Query: 395 EQN--------VVHRDIKCANILVDASGSVKLADFGLA------KATTMNDVKSCKGTPF 440
            +         + HRD+K  NILV  +G+  +AD GLA               +  GT  
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 441 WMAPEV----VNLKNRGYGLTADIWSLGCTVL-EMLTR----------QPPYSHLEGMQA 485
           +M PEV    +N  +    + AD++S G  +L E+  R          Q PY  L     
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGL-ILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270

Query: 486 LFRI------GKGEPPLVPNSLSRDA-----RDFILKCLQVNPNDRPTAAQLME 528
            +         K   P  PN  S D         + +C   NP  R TA ++ +
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  179 bits (457), Expect = 2e-51
 Identities = 79/324 (24%), Positives = 141/324 (43%), Gaps = 27/324 (8%)

Query: 229 ETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSG 288
                +  GP I+ +D   +D  K    + ++         G        +   E LGSG
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVE------VKQGSVYDY---YDILEELGSG 62

Query: 289 SFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD 347
           +FG V+       G  F  K ++     T        ++ EI ++++  H  ++      
Sbjct: 63  AFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 348 KDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC 405
           +D+  + + LE ++ G L +    + Y + +++V  Y RQ   GL ++HE ++VH DIK 
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 177

Query: 406 ANILV--DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNRGYGLTADIWS 462
            NI+     + SVK+ DFGLA     +++ K    T  + APE+V+      G   D+W+
Sbjct: 178 ENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWA 235

Query: 463 LGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILKCLQVNPN 518
           +G     +L+   P+   E      + + + +        +S+S +A+DFI   LQ  P 
Sbjct: 236 IGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 294

Query: 519 DRPTAAQLMEHPFVKRPLQKSRGP 542
            R T    +EHP++K         
Sbjct: 295 KRLTVHDALEHPWLKGDHSNLTSR 318

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  178 bits (453), Expect = 2e-51
 Identities = 77/292 (26%), Positives = 117/292 (40%), Gaps = 50/292 (17%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
              E +G G FG V+ G    G   AVK  S ++     ++S  + E EI       HEN
Sbjct: 45  VLQESIGKGRFGEVWRG-KWRGEEVAVKIFSSRE-----ERSWFR-EAEIYQTVMLRHEN 97

Query: 340 IVQYFGTDKDENRLFIFLELVT----KGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           I+ +   D  +N  +  L LV+     GSL +   +Y +    +        +GL +LH 
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 396 Q--------NVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSC--KGTPFW 441
           +         + HRD+K  NILV  +G+  +AD GLA     AT   D+      GT  +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 442 MAPEV----VNLKNRGYGLTADIWSLGCTVLEMLTR----------QPPYSHLEGMQALF 487
           MAPEV    +N+K+      ADI+++G    E+  R          Q PY  L       
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 488 R------IGKGEPPLVPNSLSRDA-----RDFILKCLQVNPNDRPTAAQLME 528
                    +   P +PN              + +C   N   R TA ++ +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  175 bits (446), Expect = 4e-51
 Identities = 86/288 (29%), Positives = 138/288 (47%), Gaps = 27/288 (9%)

Query: 268 PNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKQSIL 323
                R +I  +  G+ LG G+FG V  G     G   AVK ++   ++     GK    
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK---- 57

Query: 324 QLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAY 382
            +++EI  L  F H +I++ +         F+ +E V+ G L + + +   + + +    
Sbjct: 58  -IKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL 116

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTP 439
            +QIL+ ++Y H   VVHRD+K  N+L+DA  + K+ADFGL+     +      SC G+P
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSP 174

Query: 440 FWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLV 497
            + APEV++   R Y G   DIWS G  +  +L    P+   E +  LF+ I  G   + 
Sbjct: 175 NYAAPEVIS--GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYI- 230

Query: 498 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSY 545
           P  L+R     ++  LQV+P  R T   + EH + K      +  PSY
Sbjct: 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK------QDLPSY 272

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  179 bits (455), Expect = 6e-51
 Identities = 46/305 (15%), Positives = 89/305 (29%), Gaps = 44/305 (14%)

Query: 281 KGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR----- 334
           +G +LG        E    + G  F V      ++        ++ E   L L R     
Sbjct: 82  RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141

Query: 335 ---------------FEHENIVQYFGTDKDENRLFIFLELV----TKGSLANLYQ----- 370
                           +     +      DE  +++          + +L    +     
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201

Query: 371 ---KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK-- 425
                 L+       T Q++  L  LH   +VH  ++  +I++D  G V L  F      
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 426 -ATTMNDVKSCKGTPFWMAPEVVNLKNRG---YGLTADIWSLGCTVLEMLTRQPPYSHLE 481
            A+ ++ +      P   A  ++              D W+LG  +  +     P +   
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321

Query: 482 GMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG 541
            +     I +         + +  R  +   L+    DR    Q ME P  ++   +   
Sbjct: 322 ALGGSEWIFRSCKN-----IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSA 376

Query: 542 PPSYY 546
               Y
Sbjct: 377 ALPLY 381

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  176 bits (448), Expect = 8e-51
 Identities = 69/288 (23%), Positives = 141/288 (48%), Gaps = 18/288 (6%)

Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSIL 323
           +++     +  I +++  + +G G+F  V        G   A+K +   D+      S+ 
Sbjct: 3   SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII---DKTQLNPTSLQ 59

Query: 324 QLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAY 382
           +L +E+ ++    H NIV+ F   + E  L++ +E  + G + + L     + + +  + 
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK----SCKGT 438
            RQI++ + Y H++ +VHRD+K  N+L+DA  ++K+ADFG   +            C G 
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF--SNEFTVGGKLDAFC-GA 176

Query: 439 PFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGEPPL 496
           P + APE+   + + Y G   D+WSLG  +  +++   P+   + ++ L  R+ +G+   
Sbjct: 177 PPYAAPEL--FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR- 232

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           +P  +S D  + + + L +NP  R T  Q+M+  ++    ++    P 
Sbjct: 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPF 280

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  181 bits (461), Expect = 2e-50
 Identities = 76/262 (29%), Positives = 117/262 (44%), Gaps = 18/262 (6%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            E LG+G+FG V+       G  FA K V      T  +     + +EI  +S   H  +
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTMSVLRHPTL 216

Query: 341 VQYFGTDKDENRLFIFLELVTKGSL--ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           V      +D+N + +  E ++ G L      +   + + +   Y RQ+  GL ++HE N 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 399 VHRDIKCANILV--DASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGYG 455
           VH D+K  NI+     S  +KL DFGL         VK   GT  + APEV     +  G
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE--GKPVG 334

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDFILK 511
              D+WS+G     +L+   P+   E      R +   +  +     + +S D +DFI K
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393

Query: 512 CLQVNPNDRPTAAQLMEHPFVK 533
            L  +PN R T  Q +EHP++ 
Sbjct: 394 LLLADPNTRMTIHQALEHPWLT 415

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  174 bits (443), Expect = 3e-50
 Identities = 69/289 (23%), Positives = 129/289 (44%), Gaps = 41/289 (14%)

Query: 281 KGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HE 338
           + ++LG G+   V           +AVK +       Q      ++ +E+ +L + + H 
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIE-----KQPGHIRSRVFREVEMLYQCQGHR 71

Query: 339 NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           N+++     ++E+R ++  E +  GS+ + ++++ H  + + S   + + + L++LH + 
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 398 VVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCK---------GTPFWMAPE 445
           + HRD+K  NIL    +    VK+ DF L     +N   S           G+  +MAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 446 VVN---LKNRGYGLTADIWSLGCTVLEMLTRQPP--------------YSHLEGMQALF- 487
           VV     +   Y    D+WSLG  +  +L+  PP               +       LF 
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251

Query: 488 RIGKGEPPLVP---NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            I +G+          +S  A+D I K L  +   R +AAQ+++HP+V+
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  174 bits (444), Expect = 3e-50
 Identities = 70/284 (24%), Positives = 128/284 (45%), Gaps = 35/284 (12%)

Query: 281 KGELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH- 337
             + LG G F  V +       G  +A K +  + +G   +  I     EI +L   +  
Sbjct: 33  TSKELGRGKFAVVRQC-ISKSTGQEYAAKFLKKRRRGQDCRAEI---LHEIAVLELAKSC 88

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSL-----ANLYQKYHLMDSQVSAYTRQILNGLNY 392
             ++      ++ + + + LE    G +       L +   + ++ V    +QIL G+ Y
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--MVSENDVIRLIKQILEGVYY 146

Query: 393 LHEQNVVHRDIKCANILV---DASGSVKLADFGLAK----ATTMNDVKSCKGTPFWMAPE 445
           LH+ N+VH D+K  NIL+      G +K+ DFG+++    A  + ++    GTP ++APE
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI--M-GTPEYLAPE 203

Query: 446 VVNLKNRGYGLTADIWSLGCTVLE--MLTRQPPYSHLEGMQALFR-IGKGEPPLVP---N 499
           ++N          D+W++G  ++   +LT   P+   E  Q  +  I +          +
Sbjct: 204 ILNYD--PITTATDMWNIG--IIAYMLLTHTSPFVG-EDNQETYLNISQVNVDYSEETFS 258

Query: 500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
           S+S+ A DFI   L  NP  RPTA   + H ++++   ++   P
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  175 bits (446), Expect = 5e-50
 Identities = 72/272 (26%), Positives = 134/272 (49%), Gaps = 22/272 (8%)

Query: 281 KGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           K E+LG G FG V++   T  G   A K +      T+G +   +++ EI ++++ +H N
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEVKNEISVMNQLDHAN 147

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           ++Q +   + +N + + +E V  G L +  + + Y+L +     + +QI  G+ ++H+  
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207

Query: 398 VVHRDIKCANILV--DASGSVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNRGY 454
           ++H D+K  NIL     +  +K+ DFGLA+     +      GTP ++APEVVN      
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD--FV 265

Query: 455 GLTADIWSLGCTVLE--MLTRQPPYSHLEGMQALFR-IGKGEPPLVP---NSLSRDARDF 508
               D+WS+G  V+   +L+   P+   +        I      L       +S +A++F
Sbjct: 266 SFPTDMWSVG--VIAYMLLSGLSPF-LGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR 540
           I K L    + R +A++ ++HP++      SR
Sbjct: 323 ISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  180 bits (458), Expect = 1e-49
 Identities = 57/279 (20%), Positives = 99/279 (35%), Gaps = 21/279 (7%)

Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL 332
           +    W+  E LG+G FG V      D G   A+K+   +       ++  +   EI ++
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIM 66

Query: 333 SRFEHENIVQYFGTDKDENRL------FIFLELVTKGSLANLYQK----YHLMDSQVSAY 382
            +  H N+V          +L       + +E    G L     +      L +  +   
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMNDV-KSCKGT 438
              I + L YLHE  ++HRD+K  NI++         K+ D G AK     ++     GT
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

Query: 439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP 498
             ++APE+  L+ + Y +T D WS G    E +T   P+             + +     
Sbjct: 187 LQYLAPEL--LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244

Query: 499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 537
                         +   PN            +++  L 
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM 283

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  172 bits (437), Expect = 2e-49
 Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 20/291 (6%)

Query: 265 NVSPNGKFRRRIMS-WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGK 319
              P GK R    + ++ G LLG G FGTV+ G+   D    A+K +    +        
Sbjct: 18  TPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSD 77

Query: 320 QSILQLEQEILLLSR--FEHENIVQYFGTDKDENRLFIFLELVTKGS--LANLYQKYHLM 375
                LE  +L        H  +++     + +    + LE           + +K  L 
Sbjct: 78  SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137

Query: 376 DSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVKS 434
           +     +  Q++  + + H + VVHRDIK  NIL+D   G  KL DFG            
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197

Query: 435 CKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE 493
             GT  +  PE   +    Y  L A +WSLG  + +M+    P+   +       I + E
Sbjct: 198 FDGTRVYSPPEW--ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE 249

Query: 494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
               P  +S D    I +CL   P+ RP+  +++  P+++ P +     PS
Sbjct: 250 LH-FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPS 299

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  172 bits (437), Expect = 2e-49
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 17/293 (5%)

Query: 265 NVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSIL 323
            ++P  +       +Q G LLGSG FG+VY G    D    A+K V        G+    
Sbjct: 31  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 90

Query: 324 -QLEQEILLLSRFEHE--NIVQYFGTDKDENRLFIFLELVT-KGSLAN-LYQKYHLMDSQ 378
            ++  E++LL +       +++     +  +   + LE       L + + ++  L +  
Sbjct: 91  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150

Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVKSCKG 437
             ++  Q+L  + + H   V+HRDIK  NIL+D   G +KL DFG              G
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG 210

Query: 438 TPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL 496
           T  +  PE   ++   Y G +A +WSLG  + +M+    P+ H E       I +G+   
Sbjct: 211 TRVYSPPEW--IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF- 261

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNM 549
               +S + +  I  CL + P+DRPT  ++  HP+++  L        + +++
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 314

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  171 bits (435), Expect = 5e-49
 Identities = 80/298 (26%), Positives = 119/298 (39%), Gaps = 62/298 (20%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           Q  E+   G FG V++       + AVK   +QD     KQS    E E+  L   +HEN
Sbjct: 27  QLLEVKARGRFGCVWKA-QLLNEYVAVKIFPIQD-----KQSWQN-EYEVYSLPGMKHEN 79

Query: 340 IVQYFGTDKDENRLFIFLELVT----KGSLANLYQKYHLMDSQVSAYTR-----QILNGL 390
           I+Q+ G +K    + + L L+T    KGSL        L  + VS          +  GL
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSL-----SDFLKANVVSWNELCHIAETMARGL 134

Query: 391 NYLHEQ----------NVVHRDIKCANILVDASGSVKLADFGLAK----ATTMNDVKSCK 436
            YLHE            + HRDIK  N+L+  + +  +ADFGLA       +  D     
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194

Query: 437 GTPFWMAPEVVN---LKNRGYGLTADIWSLGCTVLEMLTRQPPYSH-------------- 479
           GT  +MAPEV+       R   L  D++++G  + E+ +R                    
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254

Query: 480 ----LEGMQALFRIGKGEPPLVPNSLSRDA-----RDFILKCLQVNPNDRPTAAQLME 528
               LE MQ +    K  P L  +   + A      + I +C   +   R +A  + E
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVL-RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  171 bits (436), Expect = 5e-49
 Identities = 74/288 (25%), Positives = 129/288 (44%), Gaps = 22/288 (7%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKQSILQLEQE 328
           +R I  +   E LG GSFG V            A+K +S   L+      +     +E+E
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-----VERE 59

Query: 329 ILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQIL 387
           I  L    H +I++ +        + + +E    G L + + +K  + + +   + +QI+
Sbjct: 60  ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII 118

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTPFWMAP 444
             + Y H   +VHRD+K  N+L+D + +VK+ADFGL+     +      SC G+P + AP
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAP 176

Query: 445 EVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVPNSLS 502
           EV  +  + Y G   D+WS G  +  ML  + P+   E +  LF+ +      + P+ LS
Sbjct: 177 EV--INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVM-PDFLS 232

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNNMH 550
             A+  I + +  +P  R T  ++   P+    L     P       +
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  172 bits (438), Expect = 1e-48
 Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 30/271 (11%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            ++LG G  G V + +       FA+K +              + E E+   +  +  +I
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRAS-QCPHI 117

Query: 341 VQYFGTDKD----ENRLFIFLELVTKGSL-ANLYQKYHLMDS--QVSAYTRQILNGLNYL 393
           V+     ++       L I +E +  G L + +  +     +  + S   + I   + YL
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177

Query: 394 HEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNL 449
           H  N+ HRD+K  N+L      +  +KL DFG AK TT ++   +   TP+++APEV  L
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--L 235

Query: 450 KNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALF-RIGKGEPPLVP---NSLS 502
               Y  + D+WSLG  +  +L   PP+     L     +  RI  G+        + +S
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            + +  I   L+  P  R T  + M HP++ 
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  170 bits (434), Expect = 3e-48
 Identities = 68/262 (25%), Positives = 120/262 (45%), Gaps = 23/262 (8%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFE 336
            +G GSFG V      D    +A+K ++        KQ  ++  +      E+ ++   E
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLE 73

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H  +V  + + +DE  +F+ ++L+  G L   L Q  H  +  V  +  +++  L+YL  
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS--CKGTPFWMAPEVVNLKN-R 452
           Q ++HRD+K  NIL+D  G V + DF +A         +    GT  +MAPE+ + +   
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEMFSSRKGA 192

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPY--SHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
           GY    D WSLG T  E+L  + PY        + +    +      P++ S++    + 
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLK 252

Query: 511 KCLQVNPNDR-PTAAQLMEHPF 531
           K L+ NP+ R    + +   P+
Sbjct: 253 KLLEPNPDQRFSQLSDVQNFPY 274

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  169 bits (430), Expect = 3e-48
 Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 23/266 (8%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVS---LQDQGTQGKQSILQLEQEILLLSRFEH 337
              LGSG+FG V+     +      VK +    + +        + ++  EI +LSR EH
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGS--LANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
            NI++     +++    + +E    G    A + +   L +   S   RQ+++ + YL  
Sbjct: 89  ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTPFWMAPEVVNLKNR 452
           ++++HRDIK  NI++    ++KL DFG A A           C GT  + APEV  L   
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFC-GTIEYCAPEV--LMGN 204

Query: 453 GY-GLTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            Y G   ++WSLG T+  ++  + P+  L E ++A            P  +S++    + 
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP--------PYLVSKELMSLVS 256

Query: 511 KCLQVNPNDRPTAAQLMEHPFVKRPL 536
             LQ  P  R T  +L+  P+V +P+
Sbjct: 257 GLLQPVPERRTTLEKLVTDPWVTQPV 282

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  170 bits (432), Expect = 3e-47
 Identities = 86/287 (29%), Positives = 137/287 (47%), Gaps = 21/287 (7%)

Query: 267 SPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKQSI 322
                 R +I  +  G+ LG G+FG V  G     G   AVK ++   ++     GK   
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK--- 62

Query: 323 LQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSA 381
             + +EI  L  F H +I++ +      + +F+ +E V+ G L + + +   L + +   
Sbjct: 63  --IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR 120

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGT 438
             +QIL+G++Y H   VVHRD+K  N+L+DA  + K+ADFGL+     +      SC G+
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GS 178

Query: 439 PFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPL 496
           P + APEV++   R Y G   DIWS G  +  +L    P+   + +  LF+ I  G    
Sbjct: 179 PNYAAPEVIS--GRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYT 235

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
            P  L+      +   LQV+P  R T   + EH + K+ L K   P 
Sbjct: 236 -PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPE 281

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  167 bits (424), Expect = 4e-47
 Identities = 72/308 (23%), Positives = 138/308 (44%), Gaps = 25/308 (8%)

Query: 237 GPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG 296
           G + +       +  K+   +  ++ +       +   ++  + + + LG+GSFG V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 297 -YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFEHENIVQYFGTDKD 349
            + + G  +A+K +         KQ +++L+Q      E  +L       +V+   + KD
Sbjct: 61  KHKESGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112

Query: 350 ENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQNVVHRDIKCANI 408
            + L++ +E V  G + +  ++        +  Y  QI+    YLH  ++++RD+K  N+
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172

Query: 409 LVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVL 468
           L+D  G +++ DFG AK         C GTP  +APE+  + ++GY    D W+LG  + 
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEI--ILSKGYNKAVDWWALGVLIY 229

Query: 469 EMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR-----PTA 523
           EM    PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R        
Sbjct: 230 EMAAGYPPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV 288

Query: 524 AQLMEHPF 531
             +  H +
Sbjct: 289 NDIKNHKW 296

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  166 bits (421), Expect = 6e-47
 Identities = 73/326 (22%), Positives = 124/326 (38%), Gaps = 64/326 (19%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            EL+G G +G VY+G + D    AVK  S  +     +Q+ +  E+ I  +   EH+NI 
Sbjct: 18  LELIGRGRYGAVYKG-SLDERPVAVKVFSFAN-----RQNFIN-EKNIYRVPLMEHDNIA 70

Query: 342 QYFGTDK-----DENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           ++   D+           + +E    GSL      +             +  GL YLH +
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130

Query: 397 ---------NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK----------G 437
                     + HRD+   N+LV   G+  ++DFGL+   T N +              G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 438 TPFWMAPEV----VNLKN-RGYGLTADIWSLGCTVLEMLTR---QPPYSHLEGMQALFR- 488
           T  +MAPEV    VNL++        D+++LG    E+  R     P   +   Q  F+ 
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250

Query: 489 ---------------IGKGEPPLVPNSLSRDA------RDFILKCLQVNPNDRPTAA--- 524
                            + + P  P +   ++      ++ I  C   +   R TA    
Sbjct: 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310

Query: 525 QLMEHPFVKRPLQKSRGPPSYYNNMH 550
           + M    +     KS  P +++++ H
Sbjct: 311 ERMAELMMIWERNKSVSPTAHHHHHH 336

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  164 bits (417), Expect = 2e-46
 Identities = 74/266 (27%), Positives = 132/266 (49%), Gaps = 35/266 (13%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFE 336
            LG+GSFG V+      +G ++A+K +         K+ +++L+Q      E L+LS   
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVT 64

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHE 395
           H  I++ +GT +D  ++F+ ++ +  G L +L +K     + V+  Y  ++   L YLH 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVVNLK 450
           +++++RD+K  NIL+D +G +K+ DFG AK       T+     C GTP ++APEV  + 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----C-GTPDYIAPEV--VS 176

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            + Y  + D WS G  + EML    P+     M+   +I   E    P   + D +D + 
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-PPFFNEDVKDLLS 235

Query: 511 KCLQVNPNDR-----PTAAQLMEHPF 531
           + +  + + R          +  HP+
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPW 261

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  164 bits (417), Expect = 3e-46
 Identities = 84/303 (27%), Positives = 125/303 (41%), Gaps = 61/303 (20%)

Query: 275 RIMS-WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL 332
           + M  ++   L+G GS+G V +    D G   A+K+    D     K+  ++   EI LL
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLL 78

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-----KYHLMDSQVSAYTRQIL 387
            +  HEN+V      K + R ++  E V       +          L    V  Y  QI+
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQII 134

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF------- 440
           NG+ + H  N++HRDIK  NILV  SG VKL DFG A+        +  G  +       
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART------LAAPGEVYDDEVATR 188

Query: 441 WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP---------------------PYS 478
           W  APE++ + +  YG   D+W++GC V EM   +P                        
Sbjct: 189 WYRAPELL-VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247

Query: 479 HLEGMQAL-----FRIGKGEPP-----LVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           H E           R+ + +         P  LS    D   KCL ++P+ RP  A+L+ 
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLH 306

Query: 529 HPF 531
           H F
Sbjct: 307 HDF 309

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  162 bits (413), Expect = 6e-46
 Identities = 71/325 (21%), Positives = 131/325 (40%), Gaps = 64/325 (19%)

Query: 276 IMS-WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           +M  ++K   +G GS+G V++    D G   A+K+    +     K+  L+   EI +L 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLK 57

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQ-----KYHLMDSQVSAYTRQILN 388
           + +H N+V      + + RL +  E         +       +  + +  V + T Q L 
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQ 113

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF-------W 441
            +N+ H+ N +HRD+K  NIL+     +KL DFG A+        +     +       W
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL------LTGPSDYYDDEVATRW 167

Query: 442 M-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---------------------SH 479
             +PE++ + +  YG   D+W++GC   E+L+  P +                      H
Sbjct: 168 YRSPELL-VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226

Query: 480 LEGMQAL-----FRIGKGEPP-----LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
            +           +I   E         PN +S  A   +  CL ++P +R T  QL+ H
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTCEQLLHH 285

Query: 530 PF---VKRPLQKSRGPPSYYNNMHS 551
           P+   ++     ++       N++ 
Sbjct: 286 PYFENIREIEDLAKEHDKPAENLYF 310

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  163 bits (415), Expect = 2e-45
 Identities = 85/317 (26%), Positives = 133/317 (41%), Gaps = 72/317 (22%)

Query: 266 VSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQL 325
            S      +R +++   +++G+GSFG V++    +    A+K+V LQD+  + +      
Sbjct: 29  ASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFKNR------ 81

Query: 326 EQEILLLSRFEHENIVQ---YF---GTDKDENRLFIFLELVTKGSLANLYQ--------K 371
             E+ ++   +H N+V    +F   G  KDE  L + LE V +     +Y+        K
Sbjct: 82  --ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLK 135

Query: 372 YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMN 430
             +    +  Y  Q+L  L Y+H   + HRDIK  N+L+D  SG +KL DFG AK     
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-- 193

Query: 431 DVKSCKGTPF-------WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG 482
                 G P        +  APE++      Y    DIWS GC + E++  QP +    G
Sbjct: 194 -----AGEPNVSYICSRYYRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

Query: 483 MQALFRIGK--GEPP--------------------------LVPNSLSRDARDFILKCLQ 514
           +  L  I K  G P                           +       DA D I + L+
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307

Query: 515 VNPNDRPTAAQLMEHPF 531
             P+ R TA + + HPF
Sbjct: 308 YTPSARLTAIEALCHPF 324

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  161 bits (410), Expect = 2e-45
 Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 36/269 (13%)

Query: 284 LLGSGSFGTVY----EGYTDDGFFFAVKEVSLQDQGTQGKQSILQ-------LEQEILLL 332
           +LG GSFG V+       +D    +A+K +         K ++         +E++IL+ 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVE 82

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLN 391
               H  IV+     + E +L++ L+ +  G L   L ++    +  V  Y  ++   L+
Sbjct: 83  VN--HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVN 448
           +LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+   C GT  +MAPEV  
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEV-- 197

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARD 507
           +  RG+  +AD WS G  + EMLT   P+   +  +     I K +  + P  LS +A+ 
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGM-PQFLSPEAQS 255

Query: 508 FILKCLQVNPNDR-----PTAAQLMEHPF 531
            +    + NP +R         ++  H F
Sbjct: 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  162 bits (412), Expect = 2e-45
 Identities = 53/307 (17%), Positives = 97/307 (31%), Gaps = 41/307 (13%)

Query: 260 KEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDD------GFFFAVKEVSLQD 313
           +  +  + P  +F+          LLG G+F  VYE    D         F +K     +
Sbjct: 48  QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107

Query: 314 QGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH 373
                        Q +  L        ++++     +N   +  EL + G+L N    Y 
Sbjct: 108 -----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162

Query: 374 ------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV-----------DASGSV 416
                 +    V ++  ++L  +  +H+  ++H DIK  N ++           D S  +
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222

Query: 417 KLADFGLAKATTMND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEML 471
            L D G +    +          C  T  +   E+  L N+ +    D + +  TV  ML
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEM--LSNKPWNYQIDYFGVAATVYCML 279

Query: 472 TRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                    EG +          P +         +F    L +       +  L+    
Sbjct: 280 FGTYMKVKNEGGECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKL 334

Query: 532 VKRPLQK 538
            K   Q 
Sbjct: 335 KKVFQQH 341

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  161 bits (410), Expect = 4e-45
 Identities = 70/300 (23%), Positives = 126/300 (42%), Gaps = 27/300 (9%)

Query: 260 KEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQG 318
           + PV     +         +   + +GSG+FG              AVK +         
Sbjct: 3   RAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE-------- 54

Query: 319 KQSIL--QLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLM 375
           + + +   +++EI+      H NIV++         L I +E  + G L   +       
Sbjct: 55  RGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS 114

Query: 376 DSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS--GSVKLADFGLAKATTMNDV- 432
           + +   + +Q+L+G++Y H   + HRD+K  N L+D S    +K+ DFG +K++ ++   
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174

Query: 433 KSCKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPY--SHLEGM--QALF 487
           KS  GTP ++APEV  L  + Y G  AD+WS G T+  ML    P+          + + 
Sbjct: 175 KSTVGTPAYIAPEV--LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232

Query: 488 RIGKGE---PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
           RI   +   P  +   +S +    I +    +P  R +  ++  H +  + L       S
Sbjct: 233 RILSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNES 290

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  161 bits (409), Expect = 6e-45
 Identities = 81/274 (29%), Positives = 132/274 (48%), Gaps = 36/274 (13%)

Query: 284 LLGSGSFGTVY----EGYTDDGFFFAVKEVSLQDQGTQGKQSILQ---------LEQEIL 330
           +LG+G++G V+        D G  +A+K +         K +I+Q          E+++L
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK--------KATIVQKAKTTEHTRTERQVL 112

Query: 331 LLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNG 389
              R +   +V      + E +L + L+ +  G L   L Q+    + +V  Y  +I+  
Sbjct: 113 EHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEV 446
           L +LH+  +++RDIK  NIL+D++G V L DFGL+K    ++ +      GT  +MAP++
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPP-YSHLEG--MQALFR-IGKGEPPLVPNSLS 502
           V   + G+    D WSLG  + E+LT   P     E      + R I K EPP  P  +S
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY-PQEMS 290

Query: 503 RDARDFILKCLQVNPNDR----PT-AAQLMEHPF 531
             A+D I + L  +P  R    P  A ++ EH F
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  162 bits (412), Expect = 9e-45
 Identities = 87/353 (24%), Positives = 139/353 (39%), Gaps = 64/353 (18%)

Query: 226 RLRETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELL 285
           R R T+  E   P             +D     +   V          + + S+   +++
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEV-SYTDTKVI 62

Query: 286 GSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ-- 342
           G+GSFG VY+    D G   A+K+V LQD+  + +        E+ ++ + +H NIV+  
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKNR--------ELQIMRKLDHCNIVRLR 113

Query: 343 -YF---GTDKDENRLFIFLELVTKGSLANLYQ--------KYHLMDSQVSAYTRQILNGL 390
            +F   G  KDE  L + L+ V +     +Y+        K  L    V  Y  Q+   L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 391 NYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEV 446
            Y+H   + HRDIK  N+L+D  +  +KL DFG AK     +      C  + ++ APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPEL 227

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPP--------- 495
           +      Y  + D+WS GC + E+L  QP +    G+  L  I K  G P          
Sbjct: 228 I-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286

Query: 496 -----------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                            +       +A     + L+  P  R T  +   H F
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  160 bits (406), Expect = 9e-45
 Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 34/269 (12%)

Query: 284 LLGSGSFGTVY----EGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-------LL 332
           +LG G +G V+        + G  FA+K +         K  I++  ++         +L
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--------KAMIVRNAKDTAHTKAERNIL 75

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLN 391
              +H  IV      +   +L++ LE ++ G L   L ++   M+     Y  +I   L 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVN 448
           +LH++ +++RD+K  NI+++  G VKL DFGL K +  +   +   C GT  +MAPE+  
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEI-- 192

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEPPLVPNSLSRDARD 507
           L   G+    D WSLG  + +MLT  PP++  E  +     I K +  L P  L+++ARD
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNL-PPYLTQEARD 250

Query: 508 FILKCLQVNPNDR----PT-AAQLMEHPF 531
            + K L+ N   R    P  A ++  HPF
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  158 bits (401), Expect = 3e-44
 Identities = 85/306 (27%), Positives = 137/306 (44%), Gaps = 64/306 (20%)

Query: 272 FRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG--KQSILQLEQEI 329
           F+  +  +QK E +G G++G VY+     G   A+K + L D   +G    +I    +EI
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL-DAEDEGIPSTAI----REI 70

Query: 330 LLLSRFEHENIVQYFGTDKDENRLFI---FLELVTKGSLANLYQKYHLMDSQVSAYTRQI 386
            LL    H NIV        E  L +   F+E   K  L     K  L DSQ+  Y  Q+
Sbjct: 71  SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQL 128

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF------ 440
           L G+ + H+  ++HRD+K  N+L+++ G++KLADFGLA+A          G P       
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA---------FGIPVRSYTHE 179

Query: 441 ----WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI--- 489
               W  AP+V+ + ++ Y  + DIWS+GC   EM+T +P +   +  + +  +F I   
Sbjct: 180 VVTLWYRAPDVL-MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238

Query: 490 ---------------GKGEPP---------LVPNSLSRDARDFILKCLQVNPNDRPTAAQ 525
                           +             ++P    ++  D +   L  +PN R +A  
Sbjct: 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARD 297

Query: 526 LMEHPF 531
            M HP+
Sbjct: 298 AMNHPY 303

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  165 bits (420), Expect = 3e-44
 Identities = 76/266 (28%), Positives = 125/266 (46%), Gaps = 27/266 (10%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQE--------IL-LLS 333
           ++G G FG VY     D G  +A+K +         K+ I   + E        +L L+S
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLD--------KKRIKMKQGETLALNERIMLSLVS 247

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNY 392
             +   IV         ++L   L+L+  G L  +L Q     ++ +  Y  +I+ GL +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNR 452
           +H + VV+RD+K ANIL+D  G V+++D GLA   +     +  GT  +MAPEV+  K  
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGV 366

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGM--QALFRIGKGEPPLVPNSLSRDARDFIL 510
            Y  +AD +SLGC + ++L    P+   +      + R+       +P+S S + R  + 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426

Query: 511 KCLQVNPNDR-----PTAAQLMEHPF 531
             LQ + N R       A ++ E PF
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPF 452

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  156 bits (398), Expect = 4e-44
 Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 63/298 (21%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG--KQSILQLEQEILLLSRFE 336
           +   E +G G++G VY+   + G  FA+K++ L ++  +G    +I    +EI +L   +
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL-EKEDEGIPSTTI----REISILKELK 58

Query: 337 HENIVQYFGTDKDENRLFI---FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
           H NIV+ +     + RL +    L+   K  L     +  L      ++  Q+LNG+ Y 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYC 116

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----------WM- 442
           H++ V+HRD+K  N+L++  G +K+ADFGLA+A          G P           W  
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARA---------FGIPVRKYTHEIVTLWYR 167

Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP--------------------P------ 476
           AP+V+ + ++ Y  T DIWS+GC   EM+   P                    P      
Sbjct: 168 APDVL-MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 477 -YSHLEGMQALFRIGKGEP--PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
             + L      F + +  P    +   L     D + K L+++PN R TA Q +EH +
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKG-LDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  158 bits (401), Expect = 5e-44
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 39/285 (13%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ 327
            R +   +    LG G+FG+V          + G   AVK   LQ  G   ++   +   
Sbjct: 22  ERHL---KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQR--- 73

Query: 328 EILLLSRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYT 383
           EI +L     + IV+Y G         L + +E +  G L +  Q++   L  S++  Y+
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP 439
            QI  G+ YL  +  VHRD+   NILV++   VK+ADFGLAK   ++     V+    +P
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 440 -FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPL- 496
            FW APE   L +  +   +D+WS G  + E+ T      S       +    +  P L 
Sbjct: 194 IFWYAPES--LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

Query: 497 -VPNSLSRDAR------------DFILKCLQVNPNDRPTAAQLME 528
            +   L    R            + +  C   +P DRP+ + L  
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  158 bits (401), Expect = 5e-44
 Identities = 70/268 (26%), Positives = 129/268 (48%), Gaps = 31/268 (11%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFF----AVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
           +K ++LGSG+FGTVY+G +  +G       A+K   L++  +   ++  ++  E  +++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSP--KANKEILDEAYVMAS 73

Query: 335 FEHENIVQYFG--TDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGL 390
            ++ ++ +  G       + + +  +L+  G L +     K ++    +  +  QI  G+
Sbjct: 74  VDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130

Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKG-TPF-WMAPEV 446
           NYL ++ +VHRD+   N+LV     VK+ DFGLAK     +    +  G  P  WMA E 
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSL 501
           +   +R Y   +D+WS G TV E++T    PY  +   +    + KGE    PP+    +
Sbjct: 191 IL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLMEH 529
                  + KC  ++ + RP   +L+  
Sbjct: 249 Y----MIMRKCWMIDADSRPKFRELIIE 272

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  156 bits (397), Expect = 9e-44
 Identities = 59/279 (21%), Positives = 103/279 (36%), Gaps = 49/279 (17%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            ++LG G  G V + +       FA+K +              + E E+   +  +  +I
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRAS-QCPHI 73

Query: 341 VQYFG----TDKDENRLFIFLELVTKGSLAN-LYQKYHLMDS--QVSAYTRQILNGLNYL 393
           V+              L I +E +  G L + +  +     +  + S   + I   + YL
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 394 HEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLK 450
           H  N+ HRD+K  N+L      +  +KL DFG                    A E     
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------AKETT--- 171

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALF-RIGKGEPPLVP---NSLSR 503
              Y  + D+WSLG  +  +L   PP+     L     +  RI  G+        + +S 
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
           + +  I   L+  P  R T  + M HP++ +  +  + P
Sbjct: 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  156 bits (397), Expect = 1e-43
 Identities = 79/287 (27%), Positives = 121/287 (42%), Gaps = 44/287 (15%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGYTDD-----GFFFAVKEVSLQDQGTQGKQSILQLEQ 327
           +R +   +K   LG G FG V     D      G   AVK  +L+     G Q     +Q
Sbjct: 30  KRYL---KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKA--DAGPQHRSGWKQ 82

Query: 328 EILLLSRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQ 385
           EI +L    HE+I++Y G   D     L + +E V  GSL +   ++ +  +Q+  + +Q
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ 142

Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTP-----F 440
           I  G+ YLH Q+ +HRD+   N+L+D    VK+ DFGLAKA                  F
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT---------------RQPPYSHLEGMQA 485
           W APE   LK   +   +D+WS G T+ E+LT                      +  ++ 
Sbjct: 203 WYAPEC--LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260

Query: 486 LFRIGKGE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
              + +GE    P   P  +       +  C +   + RPT   L+ 
Sbjct: 261 TELLERGERLPRPDKCPAEV----YHLMKNCWETEASFRPTFENLIP 303

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  156 bits (398), Expect = 2e-43
 Identities = 76/264 (28%), Positives = 128/264 (48%), Gaps = 28/264 (10%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFE 336
           LLG G+FG V        G ++A+K +         K+ I+  ++      E  +L    
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILR--------KEVIIAKDEVAHTVTESRVLQNTR 63

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
           H  +       +  +RL   +E    G L  +L ++    + +   Y  +I++ L YLH 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNR 452
           ++VV+RDIK  N+++D  G +K+ DFGL K    +       C GTP ++APEV  L++ 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEV--LEDN 180

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC 512
            YG   D W LG  + EM+  + P+ + +  + LF +   E    P +LS +A+  +   
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239

Query: 513 LQVNPNDR----PTAAQ-LMEHPF 531
           L+ +P  R    P+ A+ +MEH F
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRF 263

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  156 bits (397), Expect = 3e-43
 Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 39/275 (14%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQ--------LEQEILLLSR 334
           ++G GS+  V           +A+K V         K+ +           E+ +   + 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK--------KELVNDDEDIDWVQTEKHVFEQAS 67

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
             H  +V      + E+RLF  +E V  G L  ++ ++  L +     Y+ +I   LNYL
Sbjct: 68  -NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLK 450
           HE+ +++RD+K  N+L+D+ G +KL D+G+ K        +   C GTP ++APE+  L+
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI--LR 183

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA--------LFRIGKGEPPLVPNSLS 502
              YG + D W+LG  + EM+  + P+  +             LF++   +   +P SLS
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243

Query: 503 RDARDFILKCLQVNPNDR------PTAAQLMEHPF 531
             A   +   L  +P +R         A +  HPF
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  157 bits (398), Expect = 3e-43
 Identities = 80/317 (25%), Positives = 133/317 (41%), Gaps = 58/317 (18%)

Query: 266 VSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQ 324
            + + + R+ +  +Q   + G G+FGTV  G     G   A+K+V +QD     +   LQ
Sbjct: 12  AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRF--RNRELQ 68

Query: 325 LEQEILLLSRFEHENIVQ---YFGTDKDENRLFIFLELVTKGSLANLYQ--------KYH 373
               +  L+   H NIVQ   YF T  + +R  I+L +V +     L++        +  
Sbjct: 69  ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA 125

Query: 374 LMDSQVSAYTRQILNGLNYLHEQ--NVVHRDIKCANILVD-ASGSVKLADFGLAKATTMN 430
                +  +  Q++  +  LH    NV HRDIK  N+LV+ A G++KL DFG AK  + +
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185

Query: 431 DVKS---CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF 487
           +      C  + ++ APE++   N+ Y    DIWS+GC   EM+  +P +        L 
Sbjct: 186 EPNVAYIC--SRYYRAPELI-FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 488 RIGK--GEP-----------------------------PLVPNSLSRDARDFILKCLQVN 516
            I +  G P                                    +++A D +   LQ  
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 517 PNDRPTAAQLMEHPFVK 533
           P +R    + + HP+  
Sbjct: 303 PEERMKPYEALCHPYFD 319

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  160 bits (407), Expect = 3e-43
 Identities = 72/300 (24%), Positives = 134/300 (44%), Gaps = 48/300 (16%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFE 336
           +LG G FG V+       G  +A K+++        K+ + + +       E  +L++  
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--------KKRLKKRKGYQGAMVEKKILAKVH 243

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA----------YTRQI 386
              IV      + +  L + + ++  G +     +YH+ +               YT QI
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMA 443
           ++GL +LH++N+++RD+K  N+L+D  G+V+++D GLA        K+     GTP +MA
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPP-YSHLEGMQA--LFRIGKGEPPLVPNS 500
           PE+  L    Y  + D ++LG T+ EM+  + P  +  E ++   L +    +    P+ 
Sbjct: 358 PEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

Query: 501 LSRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK----RPLQKSRGPPSYYNNMHS 551
            S  ++DF    LQ +P  R      +   L  HP  +    R L+     P +  +  +
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRT 475

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  156 bits (397), Expect = 3e-43
 Identities = 81/267 (30%), Positives = 125/267 (46%), Gaps = 32/267 (11%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQ--------LEQEILLLSR 334
           +LG GSFG V      + G  +AVK +         K  ILQ         E+ IL L+R
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK--------KDVILQDDDVECTMTEKRILSLAR 81

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
             H  + Q F   +  +RLF  +E V  G L  ++ +     +++   Y  +I++ L +L
Sbjct: 82  -NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLK 450
           H++ +++RD+K  N+L+D  G  KLADFG+ K    N V +   C GTP ++APE+  L+
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEI--LQ 197

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
              YG   D W++G  + EML    P+   E    LF     +  + P  L  DA   + 
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATGILK 256

Query: 511 KCLQVNPNDR----PTAA--QLMEHPF 531
             +  NP  R           ++ HPF
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPF 283

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  155 bits (394), Expect = 4e-43
 Identities = 92/330 (27%), Positives = 146/330 (44%), Gaps = 75/330 (22%)

Query: 278 SWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSL-QDQG---TQGKQSILQLEQEILLL 332
            +++ E LG+G++ TVY+G     G + A+KEV L  ++G   T    +I    +EI L+
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST----AI----REISLM 57

Query: 333 SRFEHENIVQYFGTDKDENRLFI---FLELVTKG---SLANLYQKYHLMDSQVSAYTRQI 386
              +HENIV+ +     EN+L +   F++   K    S         L  + V  +  Q+
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF------ 440
           L GL + HE  ++HRD+K  N+L++  G +KL DFGLA+A          G P       
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA---------FGIPVNTFSSE 168

Query: 441 ----WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP-------------------- 475
               W  AP+V+ + +R Y  + DIWS GC + EM+T +P                    
Sbjct: 169 VVTLWYRAPDVL-MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227

Query: 476 P-------YSHLEGMQALFRIGKGEP------PLVPNSLSRDARDFILKCLQVNPNDRPT 522
           P        + L       +            P     L  +  DF+   LQ+NP+ R +
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287

Query: 523 AAQLMEHP-FVKRPLQKS-RGPPSYYNNMH 550
           A Q + HP F +     S  G  S++++ H
Sbjct: 288 AKQALHHPWFAEYYHHASMGGSRSHHHHHH 317

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  155 bits (395), Expect = 4e-43
 Identities = 80/262 (30%), Positives = 131/262 (50%), Gaps = 27/262 (10%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQ--------LEQEILLLSR 334
           +LG GSFG V+   +     FFA+K +         K  +L         +E+ +L L+ 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALK--------KDVVLMDDDVECTMVEKRVLSLAW 75

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            EH  +   F T + +  LF  +E +  G L  ++   +    S+ + Y  +I+ GL +L
Sbjct: 76  -EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLK 450
           H + +V+RD+K  NIL+D  G +K+ADFG+ K   + D K+   C GTP ++APE+  L 
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI--LL 191

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            + Y  + D WS G  + EML  Q P+ H +  + LF   + + P  P  L ++A+D ++
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 250

Query: 511 KCLQVNPNDRPTAAQ-LMEHPF 531
           K     P  R      + +HP 
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPL 272

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  156 bits (397), Expect = 5e-43
 Identities = 75/265 (28%), Positives = 128/265 (48%), Gaps = 30/265 (11%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQ--------LEQEILLLSR 334
           ++G GSFG V    +  +  F+AVK   LQ      K++IL+         E+ +LL + 
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVK--VLQ------KKAILKKKEEKHIMSERNVLLKNV 96

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +H  +V    + +  ++L+  L+ +  G L  +L ++   ++ +   Y  +I + L YL
Sbjct: 97  -KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 155

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLK 450
           H  N+V+RD+K  NIL+D+ G + L DFGL K    ++  +   C GTP ++APEV  L 
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEV--LH 212

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            + Y  T D W LG  + EML   PP+        ++     +P  +  +++  AR  + 
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKPNITNSARHLLE 271

Query: 511 KCLQVNPNDR----PTAAQLMEHPF 531
             LQ +   R        ++  H F
Sbjct: 272 GLLQKDRTKRLGAKDDFMEIKSHVF 296

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  155 bits (394), Expect = 5e-43
 Identities = 73/313 (23%), Positives = 126/313 (40%), Gaps = 65/313 (20%)

Query: 268 PNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQG--KQSILQ 324
                   I  +++   LG G++G VY+   T      A+K + L +   +G    +I  
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAI-- 81

Query: 325 LEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYT 383
             +E+ LL   +H NI++        +RL +  E      L     K   +    + ++ 
Sbjct: 82  --REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFL 138

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDAS-----GSVKLADFGLAKATTMNDVKSCKGT 438
            Q++NG+N+ H +  +HRD+K  N+L+  S       +K+ DFGLA+A          G 
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---------FGI 189

Query: 439 PF----------WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP------------ 475
           P           W   PE++ L +R Y  + DIWS+ C   EML + P            
Sbjct: 190 PIRQFTHEIITLWYRPPEIL-LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248

Query: 476 --------P-------YSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFILKCLQVNPN 518
                   P        + L   +  F   +G+     +   L  +  D +   L+++P 
Sbjct: 249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV 308

Query: 519 DRPTAAQLMEHPF 531
            R +A   +EHP+
Sbjct: 309 KRISAKNALEHPY 321

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  154 bits (391), Expect = 7e-43
 Identities = 81/314 (25%), Positives = 124/314 (39%), Gaps = 76/314 (24%)

Query: 274 RRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSI----LQLEQE 328
                ++    +G G++GTVY+      G F A+K V +   G  G   +    ++   E
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR---E 61

Query: 329 ILLL---SRFEHENIVQ-----YFGTDKDENRLFI---FLELVTKGSLANLYQKYHLMDS 377
           + LL     FEH N+V+            E ++ +    ++   +  L        L   
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAE 120

Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKG 437
            +    RQ L GL++LH   +VHRD+K  NILV + G+VKLADFGLA+            
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---------YS 171

Query: 438 TPFWMAPEVVNLKNRG--------YGLTADIWSLGCTVLEMLTRQPPYSHL-----EGMQ 484
               + P VV L  R         Y    D+WS+GC   EM  R+P    L     E  Q
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP----LFCGNSEADQ 227

Query: 485 ALFRIGK--GEP-------------------------PLVPNSLSRDARDFILKCLQVNP 517
            L +I    G P                          +VP  +       +L+ L  NP
Sbjct: 228 -LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNP 285

Query: 518 NDRPTAAQLMEHPF 531
           + R +A + ++H +
Sbjct: 286 HKRISAFRALQHSY 299

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  153 bits (390), Expect = 7e-43
 Identities = 71/291 (24%), Positives = 113/291 (38%), Gaps = 48/291 (16%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ 327
            R +   +  + LG G+FG+V          + G   AVK   LQ    +  +   +   
Sbjct: 9   ERHL---KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFER--- 60

Query: 328 EILLLSRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYT 383
           EI +L   +H+NIV+Y G         L + +E +  GSL +  QK+   +   ++  YT
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTP---- 439
            QI  G+ YL  +  +HRD+   NILV+    VK+ DFGL K    +        P    
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 440 -FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR----------------QPPYSHLEG 482
            FW APE   L    + + +D+WS G  + E+ T                       +  
Sbjct: 181 IFWYAPES--LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 483 MQALFRIGKGE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
              +  +        P   P+ +       + +C   N N RP+   L   
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEI----YMIMTECWNNNVNQRPSFRDLALR 285

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  160 bits (406), Expect = 8e-43
 Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 39/272 (14%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFE 336
           +LG G FG V        G  +A K++         K+ I + +       E  +L +  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--------KKRIKKRKGEAMALNEKQILEKVN 242

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHL--------MDSQVSAYTRQILN 388
              +V      + ++ L + L L+  G L     K+H+         +++   Y  +I  
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDL-----KFHIYHMGQAGFPEARAVFYAAEICC 297

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVV 447
           GL  LH + +V+RD+K  NIL+D  G ++++D GLA        +K   GT  +MAPEV 
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV- 356

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPPLVPNSLSRD 504
            +KN  Y  + D W+LGC + EM+  Q P+         + + R+ K  P       S  
Sbjct: 357 -VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415

Query: 505 ARDFILKCLQVNPNDR-----PTAAQLMEHPF 531
           AR    + L  +P +R      +A ++ EHP 
Sbjct: 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  153 bits (389), Expect = 1e-42
 Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 69/302 (22%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQG--KQSILQLEQEILLLSRF 335
           ++K E +G G++GTV++    +     A+K V L D   +G    ++    +EI LL   
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSAL----REICLLKEL 58

Query: 336 EHENIVQYFGTDKDENRLFI---FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNY 392
           +H+NIV+       + +L +   F +   K    +      L    V ++  Q+L GL +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGF 116

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----------WM 442
            H +NV+HRD+K  N+L++ +G +KLA+FGLA+A          G P           W 
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARA---------FGIPVRCYSAEVVTLWY 167

Query: 443 -APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGK--GEP-- 494
             P+V+    + Y  + D+WS GC   E+     P     G      L RI +  G P  
Sbjct: 168 RPPDVL-FGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTE 224

Query: 495 -------------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
                                     +VP  L+   RD +   L+ NP  R +A + ++H
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISAEEALQH 283

Query: 530 PF 531
           P+
Sbjct: 284 PY 285

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  154 bits (391), Expect = 3e-42
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 31/266 (11%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQ--------LEQEILLLSR 334
           +LG GSFG V           +AVK +         K  ++Q        +E+ +L L  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRVLALPG 78

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +   + Q     +  +RL+  +E V  G L  ++ Q     +     Y  +I  GL +L
Sbjct: 79  -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLK 450
             + +++RD+K  N+++D+ G +K+ADFG+ K    + V +   C GTP ++APE+  + 
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI--IA 194

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            + YG + D W+ G  + EML  Q P+   E    LF+         P S+S++A     
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253

Query: 511 KCLQVNPNDR----PTAAQ-LMEHPF 531
             +  +P  R    P   + + EH F
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAF 279

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  153 bits (388), Expect = 3e-42
 Identities = 73/303 (24%), Positives = 117/303 (38%), Gaps = 50/303 (16%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ 327
            R +   +  + LG G+FG+V          + G   AVK   LQ    +  +   +   
Sbjct: 40  ERHL---KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFER--- 91

Query: 328 EILLLSRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYT 383
           EI +L   +H+NIV+Y G         L + +E +  GSL +  QK+   +   ++  YT
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTP---- 439
            QI  G+ YL  +  +HRD+   NILV+    VK+ DFGL K    +        P    
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 440 -FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR----------------QPPYSHLEG 482
            FW APE   L    + + +D+WS G  + E+ T                       +  
Sbjct: 212 IFWYAPES--LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269

Query: 483 MQALFRIGKGE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
              +  +        P   P+ +       + +C   N N RP+   L     V +   +
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEI----YMIMTECWNNNVNQRPSFRDL--ALRVDQIRDQ 323

Query: 539 SRG 541
             G
Sbjct: 324 MAG 326

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  153 bits (388), Expect = 3e-42
 Identities = 84/335 (25%), Positives = 128/335 (38%), Gaps = 79/335 (23%)

Query: 274 RRIMSWQKGELLGSGSFGTVYEG--YTDDGFFFAVKEVSLQDQGTQG--KQSILQLEQEI 329
           R    ++    +G G++G V++     + G F A+K V +   G +G    +I    +E+
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTI----REV 62

Query: 330 LLL---SRFEHENIVQ-----YFGTDKDENRLFI---FLELVTKGSLANLYQKYHLMDSQ 378
            +L     FEH N+V+            E +L +    ++      L  +  +  +    
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTET 121

Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT 438
           +     Q+L GL++LH   VVHRD+K  NILV +SG +KLADFGLA+             
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---------YSF 172

Query: 439 PFWMAPEVVNLKNRG--------YGLTADIWSLGCTVLEMLTRQPPYSHL-----EGMQA 485
              +   VV L  R         Y    D+WS+GC   EM  R+P    L     +  Q 
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP----LFRGSSDVDQ- 227

Query: 486 LFRIGK--GEP-------------------------PLVPNSLSRDARDFILKCLQVNPN 518
           L +I    G P                           V + +    +D +LKCL  NP 
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPA 286

Query: 519 DRPTAAQLMEHP-FVKRPLQKSRGPPSY--YNNMH 550
            R +A   + HP F      K           N  
Sbjct: 287 KRISAYSALSHPYFQDLERCKENLDSHLPPSQNTS 321

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  155 bits (393), Expect = 3e-42
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 39/275 (14%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQ--------LEQEILLLSR 334
           ++G GS+  V           +A++ V         K+ +           E+ +   + 
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVK--------KELVNDDEDIDWVQTEKHVFEQAS 110

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
             H  +V      + E+RLF  +E V  G L  ++ ++  L +     Y+ +I   LNYL
Sbjct: 111 -NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLK 450
           HE+ +++RD+K  N+L+D+ G +KL D+G+ K        +   C GTP ++APE+  L+
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI--LR 226

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA--------LFRIGKGEPPLVPNSLS 502
              YG + D W+LG  + EM+  + P+  +             LF++   +   +P SLS
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286

Query: 503 RDARDFILKCLQVNPNDR------PTAAQLMEHPF 531
             A   +   L  +P +R         A +  HPF
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  154 bits (392), Expect = 3e-42
 Identities = 66/260 (25%), Positives = 107/260 (41%), Gaps = 24/260 (9%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           GE +G G+FG V+ G    D    AVK    +      K   LQ   E  +L ++ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQ---EARILKQYSHPNI 174

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLY---QKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           V+  G    +  ++I +ELV  G     +   +   L    +         G+ YL  + 
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----WMAPEVVNLKNRG 453
            +HRD+   N LV     +K++DFG+++        +  G       W APE   L    
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA--LNYGR 291

Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDF 508
           Y   +D+WS G  + E  +    PY +L   Q    + KG     P L P+++       
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV----FRL 347

Query: 509 ILKCLQVNPNDRPTAAQLME 528
           + +C    P  RP+ + + +
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQ 367

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  151 bits (383), Expect = 4e-42
 Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 22/257 (8%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + LGSG FG V  G     +  AVK +    +G+  +    Q   E   + +  H  +V
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQ---EAQTMMKLSHPKLV 66

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +++G    E  ++I  E ++ G L N  + +   L  SQ+      +  G+ +L     +
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD+   N LVD    VK++DFG+ +    +   S  GT F   W APEV       Y  
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV--FHYFKYSS 184

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILK 511
            +D+W+ G  + E+ +  + PY      + + ++ +G     P L  +++       +  
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI----YQIMYS 240

Query: 512 CLQVNPNDRPTAAQLME 528
           C    P  RPT  QL+ 
Sbjct: 241 CWHELPEKRPTFQQLLS 257

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  153 bits (388), Expect = 5e-42
 Identities = 83/345 (24%), Positives = 138/345 (40%), Gaps = 76/345 (22%)

Query: 267 SPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQG--KQSIL 323
           S    F   +  ++K   +G G+FG V++      G   A+K+V + +   +G    ++ 
Sbjct: 7   SVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITAL- 64

Query: 324 QLEQEILLLSRFEHENIVQ--------YFGTDKDENRLFI---FLELVTKGSLANLYQKY 372
              +EI +L   +HEN+V             ++ +  +++   F E    G L+N     
Sbjct: 65  ---REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLV 119

Query: 373 HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV 432
               S++    + +LNGL Y+H   ++HRD+K AN+L+   G +KLADFGLA+A   +  
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA--FSLA 177

Query: 433 KSCKGTPF-------WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL---- 480
           K+ +   +       W   PE++ L  R YG   D+W  GC + EM TR P    +    
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSP----IMQGN 232

Query: 481 -EGMQALFRIGK--GEP-----------PLV---------PNSL---------SRDARDF 508
            E  Q L  I +  G              L             +            A D 
Sbjct: 233 TEQHQ-LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 291

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVK---RPLQKSRGPPSYYNNMH 550
           I K L ++P  R  +   + H F      P        ++  +M 
Sbjct: 292 IDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMF 336

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  152 bits (386), Expect = 6e-42
 Identities = 82/299 (27%), Positives = 125/299 (41%), Gaps = 62/299 (20%)

Query: 278 SWQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           ++ K + LG G++ TVY+G         A+KE+ L+ +      +I    +E+ LL   +
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK 58

Query: 337 HENIVQYFGTDKDENRLFI---FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
           H NIV        E  L +   +L+   K  L +      +    V  +  Q+L GL Y 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----------WM- 442
           H Q V+HRD+K  N+L++  G +KLADFGLA+A         K  P           W  
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARA---------KSIPTKTYDNEVVTLWYR 167

Query: 443 APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRI---------- 489
            P+++ L +  Y    D+W +GC   EM T +P +   +  E +  +FRI          
Sbjct: 168 PPDIL-LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 490 --------GKGEPP---------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                        P           P  L  D  D + K LQ    +R +A   M+HPF
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPR-LDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  151 bits (384), Expect = 6e-42
 Identities = 83/290 (28%), Positives = 131/290 (45%), Gaps = 46/290 (15%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ 327
           +R +   ++   LG G FG V          + G   AVK  SL+     G   I  L++
Sbjct: 20  KRFL---KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKP--ESGGNHIADLKK 72

Query: 328 EILLLSRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYT 383
           EI +L    HENIV+Y G  T+   N + + +E +  GSL     K    +   Q   Y 
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132

Query: 384 RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTP 439
            QI  G++YL  +  VHRD+   N+LV++   VK+ DFGL KA   +     VK  + +P
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 440 -FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR---------------QPPYSHLEGM 483
            FW APE   L    + + +D+WS G T+ E+LT                 P +  +   
Sbjct: 193 VFWYAPEC--LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250

Query: 484 QALFRIGKGE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           + +  + +G+    PP  P+ +       + KC +  P++R +   L+E 
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDEV----YQLMRKCWEFQPSNRTSFQNLIEG 296

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  150 bits (382), Expect = 9e-42
 Identities = 76/281 (27%), Positives = 118/281 (41%), Gaps = 28/281 (9%)

Query: 267 SPNGKFRRRI--MSWQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQ 320
            P       I     +  E LG GSFG V  G     +      AVK   L+       +
Sbjct: 6   GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLSQPE 63

Query: 321 SILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQ 378
           ++    +E+  +   +H N+++ +G       + +  EL   GSL +     + H +   
Sbjct: 64  AMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGT 122

Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCK 436
           +S Y  Q+  G+ YL  +  +HRD+   N+L+     VK+ DFGL +A   ND      +
Sbjct: 123 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

Query: 437 GTPF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK- 491
                  W APE +    R +   +D W  G T+ EM T  Q P+  L G Q L +I K 
Sbjct: 183 HRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240

Query: 492 GE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           GE    P   P  +     + +++C    P DRPT   L +
Sbjct: 241 GERLPRPEDCPQDI----YNVMVQCWAHKPEDRPTFVALRD 277

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  151 bits (383), Expect = 1e-41
 Identities = 72/266 (27%), Positives = 124/266 (46%), Gaps = 27/266 (10%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFF----AVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
           +K ++LGSG FGTV++G +  +G        +K +     G Q  Q++      +L +  
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTD---HMLAIGS 71

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNY 392
            +H +IV+  G       L +  + +  GSL +     +  L    +  +  QI  G+ Y
Sbjct: 72  LDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKG-TPF-WMAPEVVN 448
           L E  +VHR++   N+L+ +   V++ADFG+A     +D  +   +  TP  WMA E ++
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSR 503
                Y   +D+WS G TV E++T    PY+ L   +    + KGE    P +    +  
Sbjct: 191 --FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY- 247

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEH 529
                ++KC  ++ N RPT  +L   
Sbjct: 248 ---MVMVKCWMIDENIRPTFKELANE 270

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  151 bits (384), Expect = 2e-41
 Identities = 82/306 (26%), Positives = 132/306 (43%), Gaps = 64/306 (20%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSL--QDQGTQG--KQSILQLEQ 327
           + R   ++K + LG G F TVY+    +     A+K++ L  + +   G  + ++    +
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----R 61

Query: 328 EILLLSRFEHENIVQYFGTDKDENRLFI---FLELVTKGSLANLYQKYHLMDSQVSAYTR 384
           EI LL    H NI+        ++ + +   F+E   +  + +      L  S + AY  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---- 440
             L GL YLH+  ++HRD+K  N+L+D +G +KLADFGLAK+          G+P     
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS---------FGSPNRAYT 170

Query: 441 ------WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLE--------- 481
                 W  APE++    R YG+  D+W++GC + E+L R P     S L+         
Sbjct: 171 HQVVTRWYRAPELL-FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229

Query: 482 ---------GMQAL-----FRIGKGEP--PLVPNSLSRDARDFILKCLQVNPNDRPTAAQ 525
                     M +L     F+   G P   +       D  D I      NP  R TA Q
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQ 288

Query: 526 LMEHPF 531
            ++  +
Sbjct: 289 ALKMKY 294

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  153 bits (388), Expect = 2e-41
 Identities = 74/327 (22%), Positives = 139/327 (42%), Gaps = 35/327 (10%)

Query: 242 VHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRR-RIMSWQKGELLGSGSFGTVYE-GYTD 299
           V+D D    RK+  +        +     +  R +   ++  +++G G+FG V    +  
Sbjct: 33  VYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS 92

Query: 300 DGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFEHENIVQYFGTDKDENRL 353
               +A+K +S        K  +++         E  +++      +VQ F   +D+  L
Sbjct: 93  TRKVYAMKLLS--------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144

Query: 354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS 413
           ++ +E +  G L NL   Y + +     YT +++  L+ +H    +HRD+K  N+L+D S
Sbjct: 145 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204

Query: 414 GSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLK--NRGYGLTADIWSLGCTVL 468
           G +KLADFG         +  C    GTP +++PEV+  +  +  YG   D WS+G  + 
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264

Query: 469 EMLTRQPPYSHLEGMQALF-RIGKGEPPLV---PNSLSRDARDFILKCLQVNPNDR---P 521
           EML    P+   + +   + +I   +  L     N +S++A++ I      +   R    
Sbjct: 265 EMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI-CAFLTDREVRLGRN 322

Query: 522 TAAQLMEHPFVK-----RPLQKSRGPP 543
              ++  H F K         +    P
Sbjct: 323 GVEEIKRHLFFKNDQWAWETLRDTVAP 349

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  150 bits (380), Expect = 2e-41
 Identities = 71/262 (27%), Positives = 117/262 (44%), Gaps = 24/262 (9%)

Query: 281 KGELLGSGSFGTVYEG-YTDDGFFF--AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           + + LGSG+FGTV +G Y         AVK   L++          +L  E  ++ + ++
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVK--ILKN-EANDPALKDELLAEANVMQQLDN 77

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
             IV+  G  + E    + +E+   G L   L Q  H+ D  +     Q+  G+ YL E 
Sbjct: 78  PYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPF---WMAPEVVNLKN 451
           N VHRD+   N+L+      K++DFGL+KA   ++   K+     +   W APE +N   
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN--Y 194

Query: 452 RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDAR 506
             +   +D+WS G  + E  +  Q PY  ++G +    + KGE    P   P  +     
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM----Y 250

Query: 507 DFILKCLQVNPNDRPTAAQLME 528
           D +  C   +  +RP  A +  
Sbjct: 251 DLMNLCWTYDVENRPGFAAVEL 272

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  148 bits (377), Expect = 2e-41
 Identities = 60/257 (23%), Positives = 114/257 (44%), Gaps = 22/257 (8%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + +GSG FG V+ GY  +    A+K  ++++ G   ++  ++   E  ++ +  H  +V
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIK--TIRE-GAMSEEDFIE---EAEVMMKLSHPKLV 66

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           Q +G   ++  + +  E +  G L++  +          +      +  G+ YL E  V+
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD+   N LV  +  +K++DFG+ +    +   S  GT F   W +PEV       Y  
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV--FSFSRYSS 184

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILK 511
            +D+WS G  + E+ +  + PY +    + +  I  G     P L    +       +  
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV----YQIMNH 240

Query: 512 CLQVNPNDRPTAAQLME 528
           C +  P DRP  ++L+ 
Sbjct: 241 CWRERPEDRPAFSRLLR 257

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (378), Expect = 9e-41
 Identities = 70/266 (26%), Positives = 129/266 (48%), Gaps = 27/266 (10%)

Query: 280 QKGELLGSGSFGTVYEG-YTDDGFFF----AVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
           +K ++LGSG+FGTVY+G +  +G       A+K   L++  +   ++  ++  E  +++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSP--KANKEILDEAYVMAS 73

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNY 392
            ++ ++ +  G       + +  +L+  G L +     K ++    +  +  QI  G+NY
Sbjct: 74  VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKG-TPF-WMAPEVVN 448
           L ++ +VHRD+   N+LV     VK+ DFGLAK     +    +  G  P  WMA E + 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSR 503
             +R Y   +D+WS G TV E++T    PY  +   +    + KGE    PP+    +  
Sbjct: 193 --HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY- 249

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEH 529
                ++KC  ++ + RP   +L+  
Sbjct: 250 ---MIMVKCWMIDADSRPKFRELIIE 272

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  155 bits (393), Expect = 9e-41
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 31/266 (11%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQ--------LEQEILLLSR 334
           +LG GSFG V           +AVK +         K  ++Q        +E+ +L L  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRVLALPG 399

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYL 393
            +   + Q     +  +RL+  +E V  G L  ++ Q     +     Y  +I  GL +L
Sbjct: 400 -KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLK 450
             + +++RD+K  N+++D+ G +K+ADFG+ K    + V +   C GTP ++APE+  + 
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI--IA 515

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
            + YG + D W+ G  + EML  Q P+   E    LF+         P S+S++A     
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574

Query: 511 KCLQVNPNDR-----PTAAQLMEHPF 531
             +  +P  R          + EH F
Sbjct: 575 GLMTKHPGKRLGCGPEGERDIKEHAF 600

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  152 bits (385), Expect = 1e-40
 Identities = 77/258 (29%), Positives = 125/258 (48%), Gaps = 24/258 (9%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
              LG G FG V+ G  +     A+K +     GT   ++ LQ   E  ++ +  HE +V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLV 242

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNV 398
           Q +    +E  ++I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N 
Sbjct: 243 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           VHRD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE        + 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT 359

Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFIL 510
           + +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + 
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMC 415

Query: 511 KCLQVNPNDRPTAAQLME 528
           +C +  P +RPT   L  
Sbjct: 416 QCWRKEPEERPTFEYLQA 433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  147 bits (374), Expect = 1e-40
 Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 22/258 (8%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + LG+G FG V  G     +  A+K +    +G+  +   ++   E  ++    HE +V
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIE---EAKVMMNLSHEKLV 82

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           Q +G    +  +FI  E +  G L N  ++  +     Q+    + +   + YL  +  +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYGL 456
           HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV  L    +  
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMYSKFSS 200

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFILK 511
            +DIW+ G  + E+ +  + PY      +    I +G     P L    +       +  
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV----YTIMYS 256

Query: 512 CLQVNPNDRPTAAQLMEH 529
           C     ++RPT   L+ +
Sbjct: 257 CWHEKADERPTFKILLSN 274

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  151 bits (384), Expect = 1e-40
 Identities = 75/283 (26%), Positives = 134/283 (47%), Gaps = 33/283 (11%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFE 336
           LLG G+FG V        G ++A+K +         K+ I+  ++      E  +L    
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILK--------KEVIVAKDEVAHTLTENRVLQNSR 206

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSL-ANLYQKYHLMDSQVSAYTRQILNGLNYLH- 394
           H  +     + +  +RL   +E    G L  +L ++    + +   Y  +I++ L+YLH 
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKN 451
           E+NVV+RD+K  N+++D  G +K+ DFGL K    +       C GTP ++APEV  L++
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV--LED 323

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
             YG   D W LG  + EM+  + P+ + +  + LF +   E    P +L  +A+  +  
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382

Query: 512 CLQVNPNDR----PT-AAQLMEHPFVK----RPLQKSRGPPSY 545
            L+ +P  R       A ++M+H F      + + + +  P +
Sbjct: 383 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPF 425

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  146 bits (371), Expect = 3e-40
 Identities = 76/261 (29%), Positives = 119/261 (45%), Gaps = 25/261 (9%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFF---AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
             +LG G FG VYEG YT+        AVK    +D     K+  +    E +++   +H
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMS---EAVIMKNLDH 72

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
            +IV+  G  ++E   +I +EL   G L +  ++    L    +  Y+ QI   + YL  
Sbjct: 73  PHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNR 452
            N VHRDI   NILV +   VKL DFGL++     D      T     WM+PE   +  R
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES--INFR 189

Query: 453 GYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARD 507
            +   +D+W     + E+L+  + P+  LE    +  + KG+    P L P  L      
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL----YT 245

Query: 508 FILKCLQVNPNDRPTAAQLME 528
            + +C   +P+DRP   +L+ 
Sbjct: 246 LMTRCWDYDPSDRPRFTELVC 266

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  146 bits (370), Expect = 4e-40
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 26/259 (10%)

Query: 285 LGSGSFGTVYEGY---TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           LG G+FG+V +G           A+K   L+  GT+   +  ++ +E  ++ + ++  IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQ-GTEKADTE-EMMREAQIMHQLDNPYIV 73

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +  G  + E  L + +E+   G L          +  S V+    Q+  G+ YL E+N V
Sbjct: 74  RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPF---WMAPEVVNLKNRGY 454
           HRD+   N+L+      K++DFGL+KA   +D    +     +   W APE +N   R +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKF 190

Query: 455 GLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
              +D+WS G T+ E L+  Q PY  ++G + +  I +G+    PP  P  L       +
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL----YALM 246

Query: 510 LKCLQVNPNDRPTAAQLME 528
             C      DRP    + +
Sbjct: 247 SDCWIYKWEDRPDFLTVEQ 265

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  149 bits (379), Expect = 6e-40
 Identities = 65/270 (24%), Positives = 120/270 (44%), Gaps = 31/270 (11%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFE 336
           ++G G+FG V      +    FA+K ++        K  +L+  +      E  +L   +
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILN--------KWEMLKRAETACFREERDVLVNGD 132

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLH 394
            + I       +D+N L++ ++    G L  L  K+   L +     Y  +++  ++ +H
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLK- 450
           + + VHRDIK  NIL+D +G ++LADFG       +         GTP +++PE++    
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252

Query: 451 --NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGEP----PLVPNSLSR 503
                YG   D WSLG  + EML  + P+ + E +   + +I   +     P     +S 
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQVTDVSE 311

Query: 504 DARDFILKCLQVNPN--DRPTAAQLMEHPF 531
           +A+D I + +    +   +       +HPF
Sbjct: 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPF 341

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  145 bits (367), Expect = 1e-39
 Identities = 78/263 (29%), Positives = 117/263 (44%), Gaps = 29/263 (11%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFF---AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           G  +G G FG V++G Y          A+K        T        L QE L + +F+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFL-QEALTMRQFDH 75

Query: 338 ENIVQYFG--TDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYL 393
            +IV+  G  T   EN ++I +EL T G L +    +KY L  + +  Y  Q+   L YL
Sbjct: 76  PHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLK 450
             +  VHRDI   N+LV ++  VKL DFGL++    +             WMAPE   + 
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES--IN 190

Query: 451 NRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDA 505
            R +   +D+W  G  + E+L     P+  ++    + RI  GE    PP  P +L    
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL---- 246

Query: 506 RDFILKCLQVNPNDRPTAAQLME 528
              + KC   +P+ RP   +L  
Sbjct: 247 YSLMTKCWAYDPSRRPRFTELKA 269

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  146 bits (370), Expect = 1e-39
 Identities = 68/295 (23%), Positives = 119/295 (40%), Gaps = 38/295 (12%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFF---AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           G +LG G FG+V E     +   F   AVK +            I +  +E   +  F+H
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK---ADIIASSDIEEFLREAACMKEFDH 84

Query: 338 ENIVQYFG--TDKD----ENRLFIFLELVTKGSLAN-------LYQKYHLMDSQVSAYTR 384
            ++ +  G               + L  +  G L             ++L    +  +  
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGT-PF- 440
            I  G+ YL  +N +HRD+   N ++    +V +ADFGL++     D   + C    P  
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PP 495
           W+A E  +L +  Y + +D+W+ G T+ E++TR Q PY+ +E  +    +  G     PP
Sbjct: 205 WLALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP 262

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQL---MEHPFVKRPLQKSRGPPSYYN 547
                +     D + +C   +P  RP+   L   +E+      +  +   P Y N
Sbjct: 263 ECMEEV----YDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYIN 313

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  145 bits (367), Expect = 1e-39
 Identities = 64/257 (24%), Positives = 125/257 (48%), Gaps = 17/257 (6%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
            + LG G   TVY    T      A+K  ++     + ++++ + E+E+   S+  H+NI
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIK--AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQNVV 399
           V     D++++  ++ +E +   +L+   + +  +       +T QIL+G+ + H+  +V
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIV 133

Query: 400 HRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           HRDIK  NIL+D++ ++K+ DFG+AKA   T++       GT  + +PE      +G   
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA----KGEAT 189

Query: 457 TA--DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN----SLSRDARDFIL 510
               DI+S+G  + EML  +PP++    +    +  +   P V       + +   + IL
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVIL 249

Query: 511 KCLQVNPNDRPTAAQLM 527
           +  + +  +R    Q M
Sbjct: 250 RATEKDKANRYKTIQEM 266

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  144 bits (366), Expect = 1e-39
 Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 24/260 (9%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
              LG G +G VYEG +       AVK +    + T   +  L+   E  ++   +H N+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLK---EAAVMKEIKHPNL 71

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANL---YQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           VQ  G    E   +I  E +T G+L +      +  +    +     QI + + YL ++N
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGY 454
            +HRD+   N LV  +  VK+ADFGL++  T +   +  G  F   W APE   L    +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES--LAYNKF 189

Query: 455 GLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
            + +D+W+ G  + E+ T    PY  ++  Q    + K      P   P  +     + +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELM 245

Query: 510 LKCLQVNPNDRPTAAQLMEH 529
             C Q NP+DRP+ A++ + 
Sbjct: 246 RACWQWNPSDRPSFAEIHQA 265

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  147 bits (374), Expect = 1e-39
 Identities = 73/273 (26%), Positives = 114/273 (41%), Gaps = 35/273 (12%)

Query: 284 LLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQ------EILLLSRFE 336
           ++G G+F  V        G  +A+K ++        K  +L+  +      E  +L   +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMN--------KWDMLKRGEVSCFREERDVLVNGD 119

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLH 394
              I Q     +DEN L++ +E    G L  L  K+   +       Y  +I+  ++ +H
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWMAPEVVNLKN 451
               VHRDIK  NIL+D  G ++LADFG       +         GTP +++PE++    
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239

Query: 452 RG-----YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEP----PLVPNSL 501
            G     YG   D W+LG    EM   Q P+ + +     +  I   +     PLV   +
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEGV 298

Query: 502 SRDARDFILKCLQVNPNDR---PTAAQLMEHPF 531
             +ARDFI + L   P  R     A     HPF
Sbjct: 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  150 bits (379), Expect = 2e-39
 Identities = 77/258 (29%), Positives = 125/258 (48%), Gaps = 24/258 (9%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
              LG G FG V+ G  +     A+K +     GT   ++ LQ   E  ++ +  HE +V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQ---EAQVMKKLRHEKLV 325

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNV 398
           Q +    +E  ++I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N 
Sbjct: 326 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGYG 455
           VHRD++ ANILV  +   K+ADFGLA+    N+  + +G  F   W APE        + 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT 442

Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFIL 510
           + +D+WS G  + E+ T+ + PY  +   + L ++ +G     PP  P SL     D + 
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMC 498

Query: 511 KCLQVNPNDRPTAAQLME 528
           +C +  P +RPT   L  
Sbjct: 499 QCWRKEPEERPTFEYLQA 516

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  146 bits (371), Expect = 3e-39
 Identities = 74/334 (22%), Positives = 128/334 (38%), Gaps = 95/334 (28%)

Query: 278 SWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
            +  G+ LG+GSFG V E +  + G  FA+K+V    +            +E+ ++   +
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---------RELDIMKVLD 58

Query: 337 HENIVQ---YFGTD-----------------------------------KDENRLFIFLE 358
           H NI++   YF T                                         L + +E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 359 LVTKGSLANLYQ--------KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV 410
            V       L++           +  + +S Y  Q+   + ++H   + HRDIK  N+LV
Sbjct: 119 YVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174

Query: 411 DA-SGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCT 466
           ++   ++KL DFG AK    ++      C  + F+ APE++ L    Y  + D+WS+GC 
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELM-LGATEYTPSIDLWSIGCV 231

Query: 467 VLEMLTRQPPYSHLEGMQALFRIGK--GEPP--------------------------LVP 498
             E++  +P +S    +  L RI +  G P                           ++P
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291

Query: 499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
                 A D + + L+  P+ R    + M HPF 
Sbjct: 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  144 bits (366), Expect = 3e-39
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 26/263 (9%)

Query: 282 GELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
            +++GSG  G V  G            A+K  +L+  G   +Q       E  ++ +F+H
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--ALKA-GYTERQRR-DFLSEASIMGQFDH 109

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
            NI++  G         I  E +  GSL    + +       Q+    R +  G+ YL +
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPF---WMAPEVVNLK 450
              VHRD+   N+LVD++   K++DFGL++    +     +  G      W APE +   
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA-- 227

Query: 451 NRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDA 505
            R +   +D+WS G  + E+L   + PY ++     +  + +G     P   P++L    
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHAL---- 283

Query: 506 RDFILKCLQVNPNDRPTAAQLME 528
              +L C   +   RP  +Q++ 
Sbjct: 284 HQLMLDCWHKDRAQRPRFSQIVS 306

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  143 bits (364), Expect = 5e-39
 Identities = 61/256 (23%), Positives = 104/256 (40%), Gaps = 17/256 (6%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
             L+G G  G VYE   T      A+K   + +  +       ++++E     R +  ++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALK--LMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQNVV 399
           V      + + +L++ + L+    LA + ++   +   +  A  RQI + L+  H     
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT 156

Query: 400 HRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           HRD+K  NILV A     L DFG+A A     +  + +  GT ++MAPE           
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF----SESHA 212

Query: 457 TA--DIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN---SLSRDARDFILK 511
           T   DI++L C + E LT  PPY   + +  +        P        +       I +
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIAR 271

Query: 512 CLQVNPNDRPTAAQLM 527
            +  NP DR      +
Sbjct: 272 GMAKNPEDRYVTCGDL 287

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  142 bits (361), Expect = 6e-39
 Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 28/261 (10%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            E LG+G FG V+ GY +     AVK +    QG+    + L    E  L+ + +H+ +V
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLA---EANLMKQLQHQRLV 71

Query: 342 QYFG--TDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQ 396
           + +   T   +  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+
Sbjct: 72  RLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRG 453
           N +HRD++ ANILV  + S K+ADFGLA+    N+  + +G  F   W APE   +    
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA--INYGT 186

Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDF 508
           + + +D+WS G  + E++T  + PY  +   + +  + +G     P   P  L       
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL----YQL 242

Query: 509 ILKCLQVNPNDRPTAAQLMEH 529
           +  C +  P DRPT   L   
Sbjct: 243 MRLCWKERPEDRPTFDYLRSV 263

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  143 bits (363), Expect = 1e-38
 Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 27/264 (10%)

Query: 282 GELLGSGSFGTVYEGY-----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
            +++G+G FG VY+G             A+K +     G   KQ +  L  E  ++ +F 
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFL-GEAGIMGQFS 104

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLH 394
           H NI++  G       + I  E +  G+L    ++        Q+    R I  G+ YL 
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPF---WMAPEVVNL 449
             N VHRD+   NILV+++   K++DFGL++    +     +  G      W APE ++ 
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS- 223

Query: 450 KNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRD 504
             R +   +D+WS G  + E++T  + PY  L   + +  I  G     P   P+++   
Sbjct: 224 -YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI--- 279

Query: 505 ARDFILKCLQVNPNDRPTAAQLME 528
               +++C Q     RP  A ++ 
Sbjct: 280 -YQLMMQCWQQERARRPKFADIVS 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  143 bits (362), Expect = 1e-38
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 54/275 (19%)

Query: 284 LLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           L+G G FG VY+G   DG   A+K      + +QG +   + E EI  LS   H ++V  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALK--RRTPESSQGIE---EFETEIETLSFCRHPHLVSL 100

Query: 344 FG-TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-----TR-QIL----NGLNY 392
            G  D+    + I+ + +  G+L       HL  S +         R +I      GL+Y
Sbjct: 101 IGFCDERNEMILIY-KYMENGNLKR-----HLYGSDLPTMSMSWEQRLEICIGAARGLHY 154

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-------VKSCKGTPFWMAPE 445
           LH + ++HRD+K  NIL+D +   K+ DFG++K  T  D       V   KGT  ++ PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV---KGTLGYIDPE 211

Query: 446 VVNLKNRGYGLT--ADIWSLGCTVLEMLTRQPP--YSHLEGMQ-----ALFRIGKGE--- 493
                 +G  LT  +D++S G  + E+L  +     S    M      A+     G+   
Sbjct: 212 YF---IKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267

Query: 494 ---PPLVPNSLSRDARDFI---LKCLQVNPNDRPT 522
              P L         R F    +KCL ++  DRP+
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  141 bits (358), Expect = 4e-38
 Identities = 74/306 (24%), Positives = 126/306 (41%), Gaps = 65/306 (21%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           + LG G  G V+     D     A+K++ L D     K ++    +EI ++ R +H+NIV
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL----REIKIIRRLDHDNIV 71

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS----------------QVSAYTRQ 385
           + F          +  ++ +   L ++Y     M++                ++  Y  Q
Sbjct: 72  KVFEILGPSGSQ-LTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY--Q 128

Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMNDVKSCKGTPF---- 440
           +L GL Y+H  NV+HRD+K AN+ ++     +K+ DFGLA+    +       +      
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 441 WM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP- 495
           W  +P ++ L    Y    D+W+ GC   EMLT +  +     LE MQ +          
Sbjct: 189 WYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES-IPVVHE 246

Query: 496 ---------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                                      L+P   SR+A DF+ + L  +P DR TA + + 
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI-SREAVDFLEQILTFSPMDRLTAEEALS 305

Query: 529 HPFVKR 534
           HP++  
Sbjct: 306 HPYMSI 311

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  147 bits (371), Expect = 5e-38
 Identities = 68/259 (26%), Positives = 120/259 (46%), Gaps = 26/259 (10%)

Query: 285 LGSGSFGTVYEG-YTDDGFFF--AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           LG G+FG+V +G Y         A+K   L+    +      ++ +E  ++ + ++  IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEK--ADTEEMMREAQIMHQLDNPYIV 399

Query: 342 QYFGTDKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +  G  + E  L + +E+   G L    + ++  +  S V+    Q+  G+ YL E+N V
Sbjct: 400 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGTPF---WMAPEVVNLKNRGY 454
           HR++   N+L+      K++DFGL+KA   +D    +     +   W APE +N   R +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKF 516

Query: 455 GLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
              +D+WS G T+ E L+  Q PY  ++G + +  I +G+    PP  P  L       +
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY----ALM 572

Query: 510 LKCLQVNPNDRPTAAQLME 528
             C      DRP    + +
Sbjct: 573 SDCWIYKWEDRPDFLTVEQ 591

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (365), Expect = 9e-38
 Identities = 68/260 (26%), Positives = 117/260 (45%), Gaps = 24/260 (9%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
              LG G +G VYEG +       AVK +    + T   +  L+   E  ++   +H N+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLK---EAAVMKEIKHPNL 278

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANL---YQKYHLMDSQVSAYTRQILNGLNYLHEQN 397
           VQ  G    E   +I  E +T G+L +      +  +    +     QI + + YL ++N
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGY 454
            +HR++   N LV  +  VK+ADFGL++  T +   +  G  F   W APE +      +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F 396

Query: 455 GLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
            + +D+W+ G  + E+ T    PY  ++  Q    + K      P   P  +     + +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----ELM 452

Query: 510 LKCLQVNPNDRPTAAQLMEH 529
             C Q NP+DRP+ A++ + 
Sbjct: 453 RACWQWNPSDRPSFAEIHQA 472

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  142 bits (359), Expect = 1e-37
 Identities = 65/263 (24%), Positives = 119/263 (45%), Gaps = 26/263 (9%)

Query: 282 GELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
            +++G+G FG V  G     +      A+K  +L+  G   KQ       E  ++ +F+H
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIK--TLKV-GYTEKQRR-DFLGEASIMGQFDH 105

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
            NI++  G       + I  E +  GSL +  +K+       Q+    R I +G+ YL +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPF---WMAPEVVNLK 450
              VHRD+   NIL++++   K++DFGL +    +     + +G      W +PE +   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY- 224

Query: 451 NRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDA 505
            R +   +D+WS G  + E+++  + PY  +     +  + +G     P   P +L    
Sbjct: 225 -RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL---- 279

Query: 506 RDFILKCLQVNPNDRPTAAQLME 528
              +L C Q + N+RP   Q++ 
Sbjct: 280 YQLMLDCWQKDRNNRPKFEQIVS 302

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  139 bits (352), Expect = 2e-37
 Identities = 53/273 (19%), Positives = 102/273 (37%), Gaps = 43/273 (15%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFF-------AVKEVSLQDQGTQGKQSILQLEQEILLLS 333
            E LG G+F  +++G   + G +         +K   L        +S  +      ++S
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK--VLDKAHRNYSESFFE---AASMMS 67

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLN 391
           +  H+++V  +G     +   +  E V  GSL    +K    +         +Q+   ++
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 392 YLHEQNVVHRDIKCANILVDASGS--------VKLADFGLAKATTMND-----VKSCKGT 438
           +L E  ++H ++   NIL+             +KL+D G++      D     +      
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP----- 182

Query: 439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE--PP 495
             W+ PE +    +   L  D WS G T+ E+ +    P S L+  + L         P 
Sbjct: 183 --WVPPECI-ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                L     + I  C+   P+ RP+   ++ 
Sbjct: 240 PKAAEL----ANLINNCMDYEPDHRPSFRAIIR 268

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  139 bits (353), Expect = 2e-37
 Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 34/273 (12%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFF---AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           G++LG G FG+V EG    +       AVK  +++   +  ++ I +   E   +  F H
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVK--TMKLDNSSQRE-IEEFLSEAACMKDFSH 95

Query: 338 ENIVQYFG--TDKD---ENRLFIFLELVTKGSLAN-------LYQKYHLMDSQVSAYTRQ 385
            N+++  G   +       +  + L  +  G L              H+    +  +   
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 386 ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--KSCKGT-PF-W 441
           I  G+ YL  +N +HRD+   N ++    +V +ADFGL+K     D   +      P  W
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPL 496
           +A E  +L +R Y   +D+W+ G T+ E+ TR   PY  ++  +    +  G     P  
Sbjct: 216 IAIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED 273

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
             + L     + +  C + +P DRPT + L   
Sbjct: 274 CLDEL----YEIMYSCWRTDPLDRPTFSVLRLQ 302

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  138 bits (351), Expect = 2e-37
 Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 28/268 (10%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFF----AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
               ++G G FG VY G   D        A+K  SL        Q +    +E LL+   
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITEM--QQVEAFLREGLLMRGL 79

Query: 336 EHENIVQYFGT-DKDENRLFIFLELVTKGSLAN--LYQKYHLMDSQVSAYTRQILNGLNY 392
            H N++   G     E    + L  +  G L       + +     + ++  Q+  G+ Y
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---VKSCKGTPF---WMAPEV 446
           L EQ  VHRD+   N ++D S +VK+ADFGLA+     +   V+  +       W A E 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE- 198

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSL 501
            +L+   +   +D+WS G  + E+LTR  PPY H++       + +G     P   P+SL
Sbjct: 199 -SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLMEH 529
                  + +C + +P  RPT   L+  
Sbjct: 258 ----YQVMQQCWEADPAVRPTFRVLVGE 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (366), Expect = 4e-37
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 25/261 (9%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFF---AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           G  +G G FG V++G Y          A+K           ++  LQ   E L + +F+H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQ---EALTMRQFDH 450

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
            +IV+  G   +   ++I +EL T G L +  Q     L  + +  Y  Q+   L YL  
Sbjct: 451 PHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNR 452
           +  VHRDI   N+LV ++  VKL DFGL++    +             WMAPE   +  R
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES--INFR 567

Query: 453 GYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARD 507
            +   +D+W  G  + E+L     P+  ++    + RI  GE    PP  P +L      
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL----YS 623

Query: 508 FILKCLQVNPNDRPTAAQLME 528
            + KC   +P+ RP   +L  
Sbjct: 624 LMTKCWAYDPSRRPRFTELKA 644

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  138 bits (349), Expect = 6e-37
 Identities = 80/287 (27%), Positives = 133/287 (46%), Gaps = 56/287 (19%)

Query: 272 FRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQD--QGTQGKQSILQLEQEI 329
           F  R +S   G  +G G FG VY+GY ++    AVK+++        + KQ   Q +QEI
Sbjct: 27  FDERPIS-VGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQ---QFDQEI 81

Query: 330 LLLSRFEHENIVQYFG--TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA----YT 383
            ++++ +HEN+V+  G  +D  ++   ++   +  GSL +      L     +     + 
Sbjct: 82  KVMAKCQHENLVELLGFSSD-GDDLCLVY-VYMPNGSLLD-----RLSCLDGTPPLSWHM 134

Query: 384 RQ-----ILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND------- 431
           R        NG+N+LHE + +HRDIK ANIL+D + + K++DFGLA+A+           
Sbjct: 135 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194

Query: 432 VKSCKGTPFWMAPEVVNLKNRGYGLT--ADIWSLGCTVLEMLT-------RQPPYSHLEG 482
           +    GT  +MAPE +    RG  +T  +DI+S G  +LE++T        + P   L+ 
Sbjct: 195 I---VGTTAYMAPEAL----RGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246

Query: 483 MQALFRIGKGEPPLVPNSL----SRDARDFI---LKCLQVNPNDRPT 522
            + +    K     +   +    S           +CL    N RP 
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  137 bits (348), Expect = 7e-37
 Identities = 69/266 (25%), Positives = 114/266 (42%), Gaps = 28/266 (10%)

Query: 282 GELLGSGSFGTVYEGYTDDG----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
            E++G G FG VY G   D        AVK  SL          + Q   E +++  F H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDI--GEVSQFLTEGIIMKDFSH 85

Query: 338 ENIVQYFGT-DKDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N  +   ++     +  +  Q+  G+ YL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF------WMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+     +  S            WMA E  +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE--S 203

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSR 503
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G     P   P+ L  
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL-- 261

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEH 529
              + +LKC       RP+ ++L+  
Sbjct: 262 --YEVMLKCWHPKAEMRPSFSELVSR 285

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  136 bits (346), Expect = 7e-37
 Identities = 66/260 (25%), Positives = 114/260 (43%), Gaps = 30/260 (11%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + +G G FG V  G    G   AVK   +++  T   Q+ L    E  ++++  H N+V
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDAT--AQAFLA---EASVMTQLRHSNLV 77

Query: 342 QYFGT-DKDENRLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNGLNYLHEQN 397
           Q  G   +++  L+I  E + KGSL +  +   +  L    +  ++  +   + YL   N
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRGY 454
            VHRD+   N+LV      K++DFGL K        +         W APE   L+ + +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA--LREKKF 191

Query: 455 GLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFI 509
              +D+WS G  + E+ +  + PY  +     + R+ KG     P   P ++     + +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV----YEVM 247

Query: 510 LKCLQVNPNDRPTAAQLMEH 529
             C  ++   RP+  QL E 
Sbjct: 248 KNCWHLDAAMRPSFLQLREQ 267

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  140 bits (354), Expect = 8e-37
 Identities = 78/330 (23%), Positives = 124/330 (37%), Gaps = 79/330 (23%)

Query: 273 RRRIMSWQK--GELLGSGSFGTVYEGYTDD---GFFFAVKEVSLQDQGTQGKQSILQLEQ 327
           R R+    +  G  +G G++G VY+    D      +A+K++          +       
Sbjct: 15  RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------- 67

Query: 328 EILLLSRFEHENIVQYFG--TDKDENRLFI---FLE------LVTKGSLANLYQKYHLMD 376
           EI LL   +H N++          + ++++   + E      +    +     +   L  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127

Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAKATTMNDV 432
             V +   QIL+G++YLH   V+HRD+K ANILV       G VK+AD G A+       
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 433 KSCKGTP----FWM-APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP---------PYS 478
                 P    FW  APE++ L  R Y    DIW++GC   E+LT +P           S
Sbjct: 188 PLADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246

Query: 479 HLEGMQALFRIGK--GEP---------------PLVPN--------------------SL 501
           +      L RI    G P                L+ +                      
Sbjct: 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
              A   + K L ++P  R T+ Q M+ P+
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (356), Expect = 1e-36
 Identities = 67/260 (25%), Positives = 127/260 (48%), Gaps = 28/260 (10%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + LG+G FG V+    +     AVK +     G+   ++ L    E  ++   +H+ +V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLA---EANVMKTLQHDKLV 246

Query: 342 QYFG--TDKDENRLFIFLELVTKGSLANL---YQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           +     T   +  ++I  E + KGSL +     +       ++  ++ QI  G+ ++ ++
Sbjct: 247 KLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNRG 453
           N +HRD++ ANILV AS   K+ADFGLA+    N+  + +G  F   W APE +N  +  
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-- 361

Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDF 508
           + + +D+WS G  ++E++T  + PY  +   + +  + +G     P   P  L     + 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL----YNI 417

Query: 509 ILKCLQVNPNDRPTAAQLME 528
           +++C +  P +RPT   +  
Sbjct: 418 MMRCWKNRPEERPTFEYIQS 437

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  138 bits (350), Expect = 1e-36
 Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 65/305 (21%)

Query: 283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLE------QEILLLSRFE 336
             + SGS+G V  G   +G   A+K V       +    +          +EI LL+ F 
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 337 HENI-----VQYFGTDKDENRLFIFLELVTKGSLANLYQ-----KYHLMDSQVSAYTRQI 386
           H NI     +     +   ++L++  EL+      +L Q     +  +    +  +   I
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQYFMYHI 143

Query: 387 LNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM---- 442
           L GL+ LHE  VVHRD+   NIL+  +  + + DF LA+  T +  K    T +      
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK----THYVTHRWY 199

Query: 443 -APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP--- 495
            APE+V ++ +G+    D+WS GC + EM  R+  +   +    +  +  +  G P    
Sbjct: 200 RAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV-VGTPKIED 257

Query: 496 ---------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
                                      +VP +    A D I K L+ NP  R +  Q + 
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQALR 316

Query: 529 HPFVK 533
           HP+ +
Sbjct: 317 HPYFE 321

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (346), Expect = 2e-36
 Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 38/293 (12%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
              LG GSFG VYEG              A+K  ++ +  +   +  ++   E  ++  F
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASM--RERIEFLNEASVMKEF 85

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSL-----------ANLYQKYHLMDSQVSAYTR 384
              ++V+  G         + +EL+T+G L           AN         S++     
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGT-PF- 440
           +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D   K  KG  P  
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PP 495
           WM+PE  +LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P 
Sbjct: 206 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYNN 548
             P+ L     + +  C Q NP  RP+  +++    +K  ++      S+Y +
Sbjct: 264 NCPDML----FELMRMCWQYNPKMRPSFLEIISS--IKEEMEPGFREVSFYYS 310

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  137 bits (346), Expect = 4e-36
 Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 50/289 (17%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +GSG++G+V        G   A+K++S   Q     +   +   E+LLL   +HEN++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR---ELLLLKHMQHENVIGL 88

Query: 344 FGTDKDENRLFIFLE--LVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
                  + L  F +  LV      +L +       + ++     Q+L GL Y+H   VV
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVV 148

Query: 400 HRDIKCANILVDASGSVKLADFGLAKAT--TMND-VKSCKGTPFWMAPEVVNLKNRGYGL 456
           HRD+K  N+ V+    +K+ DFGLA+     M   V     T ++ APEV+ L    Y  
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV----VTRWYRAPEVI-LSWMHYNQ 203

Query: 457 TADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP------------------ 495
           T DIWS+GC + EMLT +  +    +L+ +  + ++  G P                   
Sbjct: 204 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV-TGVPGTEFVQKLNDKAAKSYIQS 262

Query: 496 -----------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                      L P + S  A D + K L+++ + R TAAQ + HPF +
Sbjct: 263 LPQTPRKDFTQLFPRA-SPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  137 bits (346), Expect = 5e-36
 Identities = 70/306 (22%), Positives = 125/306 (40%), Gaps = 60/306 (19%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +Q  + +GSG+ G V   Y        A+K++S   Q     +   +   E++L+    H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR---ELVLMKCVNH 83

Query: 338 ENIVQYFGTDKDENRLFIFLE--LVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYL 393
           +NI+        +  L  F +  +V +   ANL Q  +  L   ++S    Q+L G+ +L
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-----APEVVN 448
           H   ++HRD+K +NI+V +  ++K+ DFGLA+    + +     TP+ +     APEV  
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYRAPEV-- 197

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQP--------------------------------- 475
           +   GY    DIWS+GC + EM+                                     
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257

Query: 476 -------PYSHLEGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 527
                  P       + LF  +            +  ARD + K L ++ + R +  + +
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317

Query: 528 EHPFVK 533
           +HP++ 
Sbjct: 318 QHPYIN 323

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  136 bits (345), Expect = 8e-36
 Identities = 81/292 (27%), Positives = 140/292 (47%), Gaps = 51/292 (17%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +G G++G V   Y   +    A+K++S  +  T  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90

Query: 344 F-----GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                  T +    ++I  +L+    L  L +  HL +  +  +  QIL GL Y+H  NV
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF----WM-APEVVNLKNRG 453
           +HRD+K +N+L++ +  +K+ DFGLA+    +   +   T +    W  APE++ L ++G
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-LNSKG 208

Query: 454 YGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP--------------- 495
           Y  + DIWS+GC + EML+ +P +    +L+ +  +  I  G P                
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI-LGSPSQEDLNCIINLKARNY 267

Query: 496 --------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                         L PN+    A D + K L  NP+ R    Q + HP+++
Sbjct: 268 LLSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (344), Expect = 9e-36
 Identities = 83/403 (20%), Positives = 145/403 (35%), Gaps = 56/403 (13%)

Query: 169 LSPPSPMKFRRPVEAVDDDEILKSFAAESDDEYFLHSPIAVGFISPLNENEENNEVRRLR 228
           +SP  PM             +             L    + G     +  E +  + +  
Sbjct: 1   MSPIDPMGHHHHHHGRRRASVAAGI---------LVPRGSPGLDGICSIEELSTSLYKKA 51

Query: 229 ETNVVEESGPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSG 288
            +  +   G +    D    +     AV+ +                 +     E++G G
Sbjct: 52  GSENLYFQGANTVHIDLSALNPELVQAVQHVVIG-----------PSSLIVHFNEVIGRG 100

Query: 289 SFGTVYEGYTDDG----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYF 344
            FG VY G   D        AVK  SL          + Q   E +++  F H N++   
Sbjct: 101 HFGCVYHGTLLDNDGKKIHCAVK--SLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 345 GT-DKDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHR 401
           G   + E    + L  +  G L N  +   ++     +  +  Q+  G+ +L  +  VHR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216

Query: 402 DIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT-----PF-WMAPEVVNLKNRGYG 455
           D+   N ++D   +VK+ADFGLA+     +  S         P  WMA E  +L+ + + 
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE--SLQTQKFT 274

Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARDFIL 510
             +D+WS G  + E++TR  PPY  +        + +G     P   P+ L     + +L
Sbjct: 275 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL----YEVML 330

Query: 511 KCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG------PPSYYN 547
           KC       RP+ ++L+    +        G        +Y N
Sbjct: 331 KCWHPKAEMRPSFSELVSR--ISAIFSTFIGEHYVHVNATYVN 371

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  135 bits (343), Expect = 1e-35
 Identities = 72/302 (23%), Positives = 130/302 (43%), Gaps = 59/302 (19%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            LLG G++G V        G   A+K++   D+     +++    +EI +L  F+HENI+
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENII 72

Query: 342 QYF-----GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
             F      + ++ N ++I  EL+    L  +     L D  +  +  Q L  +  LH  
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK---GTPFWM---------AP 444
           NV+HRD+K +N+L++++  +K+ DFGLA+    +   + +        +         AP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191

Query: 445 EVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP------ 495
           EV+ L +  Y    D+WS GC + E+  R+P +    +   +  +F I  G P       
Sbjct: 192 EVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI-IGTPHSDNDLR 249

Query: 496 ------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                                   + P   +    D + + L  +P  R TA + +EHP+
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRV-NPKGIDLLQRMLVFDPAKRITAKEALEHPY 308

Query: 532 VK 533
           ++
Sbjct: 309 LQ 310

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  133 bits (336), Expect = 3e-35
 Identities = 74/283 (26%), Positives = 118/283 (41%), Gaps = 51/283 (18%)

Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVK---EVSLQDQGTQGKQSILQLEQEILLL 332
              LG G+FG V+         T D    AVK   + +L  +           ++E  LL
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--------KDFQREAELL 71

Query: 333 SRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLM 375
           +  +HE+IV+++G   D + L +  E +  G L                      K  L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 376 DSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KS 434
            SQ+     QI +G+ YL  Q+ VHRD+   N LV A+  VK+ DFG+++     D  + 
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191

Query: 435 CKGTPF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLEGMQALFRI 489
              T     WM PE   +  R +   +D+WS G  + E+ T  +Q P+  L   + +  I
Sbjct: 192 GGHTMLPIRWMPPES--IMYRKFTTESDVWSFGVILWEIFTYGKQ-PWFQLSNTEVIECI 248

Query: 490 GKG----EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
            +G     P + P  +     D +L C Q  P  R    ++ +
Sbjct: 249 TQGRVLERPRVCPKEV----YDVMLGCWQREPQQRLNIKEIYK 287

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  133 bits (337), Expect = 3e-35
 Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 22/262 (8%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
           GE+LG G    V+      D    AVK   L+    +     L+  +E    +   H  I
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVK--VLRADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 341 VQYF--GTDKDENRLFIFL--ELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHE 395
           V  +  G  +       ++  E V   +L ++      M   +           LN+ H+
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 134

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAPEVVNLK 450
             ++HRD+K ANI++ A+ +VK+ DFG+A+A      ++    +  GT  +++PE     
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA--- 191

Query: 451 NRGYGLTA--DIWSLGCTVLEMLTRQPPYSHLEGMQ-ALFRIGKGEPPL--VPNSLSRDA 505
            RG  + A  D++SLGC + E+LT +PP++    +  A   + +   P       LS D 
Sbjct: 192 -RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 250

Query: 506 RDFILKCLQVNPNDRPTAAQLM 527
              +LK L  NP +R   A  M
Sbjct: 251 DAVVLKALAKNPENRYQTAAEM 272

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (337), Expect = 4e-35
 Identities = 78/297 (26%), Positives = 110/297 (37%), Gaps = 44/297 (14%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
              LG G+FG VYEG              AVK  +L +  ++  Q  L    E L++S+F
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSE--QDELDFLMEALIISKF 90

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLAN--------LYQKYHLMDSQVSAYTRQIL 387
            H+NIV+  G        FI +EL+  G L +          Q   L    +    R I 
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMND--VKSCKGT-PF- 440
            G  YL E + +HRDI   N L+   G     K+ DFG+A+         K      P  
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG----EPP 495
           WM PE        +    D WS G  + E+ +    PY      + L  +  G     P 
Sbjct: 211 WMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 268

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH--------PFVKRPLQKSRGPPS 544
             P  +       + +C Q  P DRP  A ++E           +   L    GP  
Sbjct: 269 NCPGPV----YRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLV 321

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  133 bits (336), Expect = 1e-34
 Identities = 78/292 (26%), Positives = 109/292 (37%), Gaps = 42/292 (14%)

Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
              LG G+FG VYEG              AVK  +L +  ++  Q  L    E L++S+F
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSE--QDELDFLMEALIISKF 131

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSL--------ANLYQKYHLMDSQVSAYTRQIL 387
            H+NIV+  G        FI LEL+  G L            Q   L    +    R I 
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMND--VKSCKGT-PF- 440
            G  YL E + +HRDI   N L+   G     K+ DFG+A+         K      P  
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG----EPP 495
           WM PE        +    D WS G  + E+ +    PY      + L  +  G     P 
Sbjct: 252 WMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 309

Query: 496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYN 547
             P  +       + +C Q  P DRP  A ++E       ++     P   N
Sbjct: 310 NCPGPV----YRIMTQCWQHQPEDRPNFAIILER------IEYCTQDPDVIN 351

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  137 bits (346), Expect = 1e-34
 Identities = 63/258 (24%), Positives = 105/258 (40%), Gaps = 35/258 (13%)

Query: 282 GELLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
              +  G  G +Y    D   +G    +K   L   G    Q++   E++ L  +   H 
Sbjct: 85  KGCIAHGGLGWIYLA-LDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFL--AEVVHP 139

Query: 339 NIVQ-Y-FGTDKDEN---RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
           +IVQ + F    D +     +I +E V   SL     +  L  ++  AY  +IL  L+YL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYL 198

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           H   +V+ D+K  NI++     +KL D G              GTP + APE+V    R 
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRIN--SFGYLYGTPGFQAPEIV----RT 251

Query: 454 YGLT--ADIWSLGCTVLEMLTRQPPYS--HLEGMQALFRIGKGEPPLVPNSLSRDARDFI 509
            G T   DI+++G T+  +    P  +  +++G+         E   V           +
Sbjct: 252 -GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------EDDPVL-KTYDSYGRLL 301

Query: 510 LKCLQVNPNDRPTAAQLM 527
            + +  +P  R T A+ M
Sbjct: 302 RRAIDPDPRQRFTTAEEM 319

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  132 bits (333), Expect = 2e-34
 Identities = 76/302 (25%), Positives = 120/302 (39%), Gaps = 66/302 (21%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-E 336
           +Q    LG G +  V+E     +     VK +         K+ I +   EI +L     
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKR---EIKILENLRG 89

Query: 337 HENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH 394
             NI+       D       +  E V       LYQ   L D  +  Y  +IL  L+Y H
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 147

Query: 395 EQNVVHRDIKCANILVDAS-GSVKLADFGLAK----ATTMND-VKSCKGTPFWMAPEVVN 448
              ++HRD+K  N+++D     ++L D+GLA+        N  V     + ++  PE++ 
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV----ASRYFKGPELL- 202

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGK--GEPPL------- 496
           +  + Y  + D+WSLGC +  M+ R+ P+ H  G      L RI K  G   L       
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKY 260

Query: 497 -----------------------VPNS----LSRDARDFILKCLQVNPNDRPTAAQLMEH 529
                                  V +     +S +A DF+ K L+ +   R TA + MEH
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320

Query: 530 PF 531
           P+
Sbjct: 321 PY 322

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  132 bits (335), Expect = 2e-34
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 51/290 (17%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +GSG++G+V   + T  G   AVK++S   Q     +   +   E+ LL   +HEN++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---ELRLLKHMKHENVIGL 93

Query: 344 FGTDKDENRLFIFLE--LVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                    L  F +  LVT      L N+ +   L D  V     QIL GL Y+H  ++
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 153

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATT--MND-VKSCKGTPFWMAPEVVNLKNRGYG 455
           +HRD+K +N+ V+    +K+ DFGLA+ T   M   V     T ++ APE++ L    Y 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIM-LNWMHYN 208

Query: 456 LTADIWSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP----------------- 495
            T DIWS+GC + E+LT +  +    H++ ++ + R+  G P                  
Sbjct: 209 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKKISSESARNYIQ 267

Query: 496 ------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                       +   + +  A D + K L ++ + R TAAQ + H +  
Sbjct: 268 SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (339), Expect = 2e-34
 Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 34/261 (13%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + +G G FG V  G    G   AVK   +++  T   Q+ L    E  ++++  H N+V
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATA--QAFLA---EASVMTQLRHSNLV 249

Query: 342 QYFG--TDKDENRLFIFLELVTKGSLANLY----QKYHLMDSQVSAYTRQILNGLNYLHE 395
           Q  G    +++  L+I  E + KGSL + Y     +  L    +  ++  +   + YL  
Sbjct: 250 QLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF---WMAPEVVNLKNR 452
            N VHRD+   N+LV      K++DFGL K        +         W APE   L+ +
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA--LREK 361

Query: 453 GYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE----PPLVPNSLSRDARD 507
            +   +D+WS G  + E+ +  + PY  +     + R+ KG     P   P ++     D
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY----D 417

Query: 508 FILKCLQVNPNDRPTAAQLME 528
            +  C  ++   RPT  QL E
Sbjct: 418 VMKNCWHLDAATRPTFLQLRE 438

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  132 bits (334), Expect = 2e-34
 Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 49/289 (16%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +GSG++G V        G   A+K++    Q     +   +   E+ LL    HEN++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMRHENVIGL 89

Query: 344 FGTDKDENRLFIFLE--LVTK---GSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
                 +  L  F +  LV       L  L +   L + ++     Q+L GL Y+H   +
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 149

Query: 399 VHRDIKCANILVDASGSVKLADFGLAK--ATTMND-VKSCKGTPFWMAPEVVNLKNRGYG 455
           +HRD+K  N+ V+    +K+ DFGLA+   + M   V     T ++ APEV+ L    Y 
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----VTRWYRAPEVI-LNWMRYT 204

Query: 456 LTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPP------------------ 495
            T DIWS+GC + EM+T +  +   + +  L  I K  G PP                  
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264

Query: 496 -----------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                      ++ N+ S  A + + K L ++   R TA + + HP+ +
Sbjct: 265 LPELEKKDFASILTNA-SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  130 bits (329), Expect = 6e-34
 Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 51/297 (17%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
              LG G+FG V+     +          AVK  +L++     +Q     ++E  LL+  
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQ---DFQREAELLTML 100

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSL----------------ANLYQKYHLMDSQV 379
           +H++IV++FG   +   L +  E +  G L                        L   Q+
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 380 SAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGT 438
            A   Q+  G+ YL   + VHRD+   N LV     VK+ DFG+++     D  +    T
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 439 PF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLEGMQALFRIGKG- 492
                WM PE   +  R +   +D+WS G  + E+ T  +Q P+  L   +A+  I +G 
Sbjct: 221 MLPIRWMPPES--ILYRKFTTESDVWSFGVVLWEIFTYGKQ-PWYQLSNTEAIDCITQGR 277

Query: 493 ---EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK-SRGPPSY 545
               P   P  +       +  C Q  P  R +   +         LQ  ++ PP Y
Sbjct: 278 ELERPRACPPEV----YAIMRGCWQREPQQRHSIKDVHAR------LQALAQAPPVY 324

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (323), Expect = 2e-33
 Identities = 64/281 (22%), Positives = 104/281 (37%), Gaps = 44/281 (15%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
            E LG   FG VY+G+             A+K  +L+D+         +   E +L +R 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TLKDKAE--GPLREEFRHEAMLRARL 69

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLMDSQ 378
           +H N+V   G    +  L +     + G L                  +   K  L    
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 379 VSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKG 437
                 QI  G+ YL   +VVH+D+   N+LV    +VK++D GL +     D  K    
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 438 TPF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--RQPPYSHLEGMQALFRIGKG 492
           +     WMAPE   +    + + +DIWS G  + E+ +   Q PY        +  I   
Sbjct: 190 SLLPIRWMAPE--AIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-PYCGYSNQDVVEMIRNR 246

Query: 493 E----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           +    P   P  +       +++C    P+ RP    +   
Sbjct: 247 QVLPCPDDCPAWV----YALMIECWNEFPSRRPRFKDIHSR 283

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  131 bits (332), Expect = 2e-33
 Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 60/300 (20%)

Query: 285 LGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +GSG+ G V   Y        A+K++S   Q     +   +   E++L+    H+NI+  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR---ELVLMKCVNHKNIISL 126

Query: 344 FGTDKDENRLFIFLE--LVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
                 +  L  F +  LV +   ANL Q  +  L   ++S    Q+L G+ +LH   ++
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGII 186

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM-----APEVVNLKNRGY 454
           HRD+K +NI+V +  ++K+ DFGLA+    + +     TP+ +     APEV  +   GY
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPEV--ILGMGY 240

Query: 455 GLTADIWSLGCTVLEMLTRQP--------------------------------------- 475
               DIWS+GC + EM+  +                                        
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300

Query: 476 -PYSHLEGMQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
            P         LF               +  ARD + K L ++P  R +    ++HP++ 
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  127 bits (321), Expect = 5e-33
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 50/288 (17%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           G+ LG G FG V +               AVK   L++  +     +  L  E  +L + 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASP--SELRDLLSEFNVLKQV 83

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSL-------------------------ANLYQ 370
            H ++++ +G    +  L + +E    GSL                          +   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 371 KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 430
           +  L    + ++  QI  G+ YL E  +VHRD+   NILV     +K++DFGL++     
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 431 D--VKSCKGT-PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQA 485
           D  VK  +G  P  WMA E  +L +  Y   +D+WS G  + E++T    PY  +   + 
Sbjct: 204 DSYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261

Query: 486 LFRIGKGE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
              +  G     P      +       +L+C +  P+ RP  A + + 
Sbjct: 262 FNLLKTGHRMERPDNCSEEM----YRLMLQCWKQEPDKRPVFADISKD 305

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  127 bits (320), Expect = 1e-32
 Identities = 76/283 (26%), Positives = 121/283 (42%), Gaps = 45/283 (15%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF--------AVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           G+ LG G+FG V                   AVK   L+D  T+  + +  L  E+ ++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 95

Query: 334 RF-EHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLM 375
              +H+NI+   G    +  L++ +E  +KG+L                  N   +  + 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 376 DSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK 433
              + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+     D   K
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215

Query: 434 SCKGT-PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIG 490
           +  G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +   +    + 
Sbjct: 216 TTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

Query: 491 KG----EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           +G    +P    N L       +  C    P+ RPT  QL+E 
Sbjct: 274 EGHRMDKPANCTNEL----YMMMRDCWHAVPSQRPTFKQLVED 312

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  126 bits (318), Expect = 2e-32
 Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 50/288 (17%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
              +G G+FG V++        +      AVK   L+++ +         ++E  L++ F
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASA--DMQADFQREAALMAEF 107

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSL-------------------------ANLYQ 370
           ++ NIV+  G       + +  E +  G L                          +   
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 371 KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 430
              L  ++     RQ+  G+ YL E+  VHRD+   N LV  +  VK+ADFGL++     
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 431 D--VKSCKGT-PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQA 485
           D          P  WM PE  ++    Y   +D+W+ G  + E+ +    PY  +   + 
Sbjct: 228 DYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285

Query: 486 LFRIGKGE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           ++ +  G     P   P  L     + +  C    P DRP+   +   
Sbjct: 286 IYYVRDGNILACPENCPLEL----YNLMRLCWSKLPADRPSFCSIHRI 329

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (317), Expect = 6e-32
 Identities = 76/283 (26%), Positives = 119/283 (42%), Gaps = 45/283 (15%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF--------AVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           G+ LG G FG V                   AVK   L+D  T+  + +  L  E+ ++ 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 141

Query: 334 RF-EHENIVQYFGTDKDENRLFIFLELVTKGSL-----------------ANLYQKYHLM 375
              +H+NI+   G    +  L++ +E  +KG+L                  N   +  + 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 376 DSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VK 433
              + + T Q+  G+ YL  Q  +HRD+   N+LV  +  +K+ADFGLA+     D   K
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 434 SCKGT-PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIG 490
           +  G  P  WMAPE   L +R Y   +D+WS G  + E+ T    PY  +   +    + 
Sbjct: 262 TTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319

Query: 491 KGE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           +G     P    N L       +  C    P+ RPT  QL+E 
Sbjct: 320 EGHRMDKPANCTNEL----YMMMRDCWHAVPSQRPTFKQLVED 358

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  123 bits (312), Expect = 9e-32
 Identities = 70/284 (24%), Positives = 113/284 (39%), Gaps = 47/284 (16%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           G+ LG G+FG V E               AVK   L++  T        L  E+ +L   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATH--SEHRALMSELKILIHI 87

Query: 336 -EHENIVQYFG--TDKDENRLFIFLELVTKGSL------------ANLYQKYHLMDSQVS 380
             H N+V   G  T      L + +E    G+L                    L    ++
Sbjct: 88  GHHLNVVNLLGACTKPGG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 381 -----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV--K 433
                 Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +    +
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 434 SCKGT-PF-WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR-I 489
                 P  WMAPE   + +R Y + +D+WS G  + E+ +    PY  ++  +   R +
Sbjct: 207 KGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

Query: 490 GKGE----PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
            +G     P      +       +L C    P+ RPT ++L+EH
Sbjct: 265 KEGTRMRAPDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEH 304

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (315), Expect = 1e-31
 Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 45/283 (15%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF--------AVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           G+ LG G+FG V                   AVK   L+   T+  + +  L  E+ ++ 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATE--KDLSDLISEMEMMK 129

Query: 334 RF-EHENIVQYFGTDKDENRLFIFLELVTKGSL------------ANLYQKYHLMDSQVS 380
              +H+NI+   G    +  L++ +E  +KG+L               Y   H  + Q+S
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 381 -----AYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KS 434
                +   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D  K 
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 435 CKGTPF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIG 490
                    WMAPE   L +R Y   +D+WS G  + E+ T    PY  +   +    + 
Sbjct: 250 TTNGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307

Query: 491 KG----EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           +G    +P    N L       +  C    P+ RPT  QL+E 
Sbjct: 308 EGHRMDKPSNCTNEL----YMMMRDCWHAVPSQRPTFKQLVED 346

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  124 bits (313), Expect = 2e-31
 Identities = 72/327 (22%), Positives = 121/327 (37%), Gaps = 84/327 (25%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENI 340
           + LG G++G V++      G   AVK++    Q +   Q   +   EI++L+    HENI
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR---EIMILTELSGHENI 71

Query: 341 VQYFGTDKDENR--LFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHE 395
           V      + +N   +++  + +      +L+       L          Q++  + YLH 
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLA--------------KATTMNDVKSCKGTPFW 441
             ++HRD+K +NIL++A   VK+ADFGL+               +   N        P  
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187

Query: 442 M---------APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP----------------- 475
                     APE++ L +  Y    D+WSLGC + E+L  +P                 
Sbjct: 188 TDYVATRWYRAPEIL-LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246

Query: 476 ----------------------------PYSHLEGMQALFRIGKGEPPLVPNSL-SRDAR 506
                                                   +       + P +  + +A 
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVK 533
           D + K LQ NPN R +A   ++HPFV 
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVS 333

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  122 bits (309), Expect = 2e-31
 Identities = 67/284 (23%), Positives = 103/284 (36%), Gaps = 46/284 (16%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           G+ LG+G+FG V E               AVK   L+            L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHL--TEREALMSELKVLSYL 83

Query: 336 -EHENIVQYFGTDKDENRLFIFLELVTKGSL-----------ANLYQKYHLMDSQVSAYT 383
             H NIV   G         +  E    G L                   +M+    A  
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 384 --------RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KS 434
                    Q+  G+ +L  +N +HRD+   NIL+      K+ DFGLA+    +     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 435 CKGTPF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR-I 489
                    WMAPE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I
Sbjct: 204 KGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 490 GKG----EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
            +G     P   P  +     D +  C   +P  RPT  Q+++ 
Sbjct: 262 KEGFRMLSPEHAPAEM----YDIMKTCWDADPLKRPTFKQIVQL 301

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  123 bits (311), Expect = 1e-30
 Identities = 69/357 (19%), Positives = 123/357 (34%), Gaps = 110/357 (30%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSL-QDQGTQGKQSILQLEQEILLLSRFE 336
           ++   L+G+GS+G V E Y   +    A+K++    +     K+ +    +EI +L+R  
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLN 110

Query: 337 HENIVQ-----YFGTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQIL 387
           H+++V+          +  + L++ LE+      ++  +      +L +  +      +L
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNLL 166

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM----- 442
            G+ Y+H   ++HRD+K AN LV+   SVK+ DFGLA+     +  + +           
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 443 ------------------------APEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS 478
                                   APE++ L    Y    D+WS+GC   E+L       
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIGCIFAELLNMIKENV 285

Query: 479 HLEGM-QALFR----------------------------------IGKGEPPLVPNSLSR 503
                   LF                                   +G      +      
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345

Query: 504 DARDFIL--------------------------KCLQVNPNDRPTAAQLMEHPFVKR 534
           DA+ +I                           + L  NPN R T  + + HPF K 
Sbjct: 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  122 bits (308), Expect = 2e-30
 Identities = 75/345 (21%), Positives = 124/345 (35%), Gaps = 102/345 (29%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            L+G GS+G VY  Y  +     A+K+V+   +     + IL+   EI +L+R + + I+
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR---EITILNRLKSDYII 88

Query: 342 QYFGTDKDENR-----LFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNY 392
           + +     ++      L+I LE+      ++L +       L +  +      +L G N+
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWM---------- 442
           +HE  ++HRD+K AN L++   SVK+ DFGLA+        +                  
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204

Query: 443 --------------APEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALF 487
                         APE++ L    Y  + DIWS GC   E+L   Q   +       LF
Sbjct: 205 KKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263

Query: 488 RIGKGEPPLVPNSL--------------------------------SRDARDFIL----- 510
             G    PL P+                                    +   +I      
Sbjct: 264 P-GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR 322

Query: 511 ---------------------KCLQVNPNDRPTAAQLMEHPFVKR 534
                                  L+ NPN R T  Q ++HP++K 
Sbjct: 323 KPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  119 bits (302), Expect = 3e-30
 Identities = 81/287 (28%), Positives = 119/287 (41%), Gaps = 67/287 (23%)

Query: 284 LLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQY 343
           +LG G FG VY+G   DG   AVK   L+++ TQG +   Q + E+ ++S   H N+++ 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 92

Query: 344 FG--TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAY-----TRQ-----ILNGLN 391
            G      E RL ++   +  GS+A       L +   S        RQ        GL 
Sbjct: 93  RGFCMTPTE-RLLVY-PYMANGSVA-----SCLRERPESQPPLDWPKRQRIALGSARGLA 145

Query: 392 YLHEQ---NVVHRDIKCANILVDASGSVKLADFGLAKATTMND------VKSCKGTPFWM 442
           YLH+     ++HRD+K ANIL+D      + DFGLAK     D      V   +GT   +
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV---RGTIGHI 202

Query: 443 APEVVNLKNRGYGLT------ADIWSLGCTVLEMLTRQPP--YSHLEGMQA--------- 485
           APE        Y  T       D++  G  +LE++T Q     + L              
Sbjct: 203 APE--------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 486 LFRIGKGE----PPLVPNSLSRDARDFI---LKCLQVNPNDRPTAAQ 525
           L +  K E      L  N    +    I   L C Q +P +RP  ++
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  119 bits (300), Expect = 6e-30
 Identities = 66/291 (22%), Positives = 108/291 (37%), Gaps = 49/291 (16%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLE 326
           R  +   Q G+ LG+G+FG V E               AVK   L+            L 
Sbjct: 45  RNNL---QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHA--DEKEALM 97

Query: 327 QEILLLSRF-EHENIVQYFGTDKDENRLFIFLELVTKGSLAN-------LYQKYHLMDSQ 378
            E+ ++S   +HENIV   G       + +  E    G L N       + +        
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 379 VSAYT--------RQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 430
            S  +         Q+  G+ +L  +N +HRD+   N+L+      K+ DFGLA+    +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

Query: 431 DV-KSCKGTPF---WMAPEVVNLKNRGYGLTADIWSLGCTVL--EMLT--RQPPYSHLEG 482
                         WMAPE  ++ +  Y + +D+WS G  +L  E+ +    P    L  
Sbjct: 218 SNYIVKGNARLPVKWMAPE--SIFDCVYTVQSDVWSYG--ILLWEIFSLGLNPYPGILVN 273

Query: 483 MQALFRIGKG----EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
            +    +  G    +P   P ++       +  C  + P  RPT  Q+   
Sbjct: 274 SKFYKLVKDGYQMAQPAFAPKNI----YSIMQACWALEPTHRPTFQQICSF 320

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  117 bits (296), Expect = 8e-30
 Identities = 33/270 (12%), Positives = 64/270 (23%), Gaps = 39/270 (14%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
               G       ++   T      A+  V  Q           +     L LSR +   +
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ--ETLSRTLRLSRIDKPGV 93

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
            +            +  E +  GSL  +               + +    +  H   V  
Sbjct: 94  ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADI 460
                + + V   G V LA                        P+             DI
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDAN---------------PQ------------DDI 185

Query: 461 WSLGCTVLEMLTRQPPY---SHLEGMQALFRIGKGEPP----LVPNSLSRDARDFILKCL 513
             +G ++  +L  + P        G+    R   G+P     +    +         + +
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR-DIPFQISAVAARSV 244

Query: 514 QVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
           Q +   R  +  L           ++    
Sbjct: 245 QGDGGIRSASTLLNLMQQATAVADRTEVLG 274

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  117 bits (294), Expect = 5e-29
 Identities = 62/289 (21%), Positives = 103/289 (35%), Gaps = 51/289 (17%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF------AVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           G++LGSG+FG V                 AVK   L+++          L  E+ ++++ 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADS--SEREALMSELKMMTQL 105

Query: 336 -EHENIVQYFGTDKDENRLFIFLELVTKGSL------------------------ANLYQ 370
             HENIV   G       +++  E    G L                             
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 371 KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 430
              L    +  +  Q+  G+ +L  ++ VHRD+   N+LV     VK+ DFGLA+    +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 431 DV-KSCKGTPF---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQA 485
                         WMAPE  +L    Y + +D+WS G  + E+ +    PY  +     
Sbjct: 226 SNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283

Query: 486 LFR-IGKG----EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
            ++ I  G    +P      +       +  C   +   RP+   L   
Sbjct: 284 FYKLIQNGFKMDQPFYATEEI----YIIMQSCWAFDSRKRPSFPNLTSF 328

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (291), Expect = 9e-29
 Identities = 59/275 (21%), Positives = 118/275 (42%), Gaps = 37/275 (13%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFF---AVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EH 337
            +++G G+FG V +            A+K   +++  ++          E+ +L +   H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASK--DDHRDFAGELEVLCKLGHH 85

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSL------------ANLYQKYHLMDSQVSA---- 381
            NI+   G  +    L++ +E    G+L               +   +   S +S+    
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 382 -YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPF 440
            +   +  G++YL ++  +HRD+   NILV  +   K+ADFGL++   +   K+    P 
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205

Query: 441 -WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG----EP 494
            WMA E   L    Y   +D+WS G  + E+++    PY  +   +   ++ +G    +P
Sbjct: 206 RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 263

Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
               + +     D + +C +  P +RP+ AQ++  
Sbjct: 264 LNCDDEV----YDLMRQCWREKPYERPSFAQILVS 294

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  114 bits (288), Expect = 4e-28
 Identities = 70/344 (20%), Positives = 120/344 (34%), Gaps = 103/344 (29%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVK--------------EVSL---------QDQGTQG 318
             LG G F TV+      +    A+K              E+ L           + + G
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 319 KQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSL-----ANLYQKYH 373
              IL+L      L  F H+          +   + +  E++   +L        ++   
Sbjct: 85  ANHILKL------LDHFNHKG--------PNGVHVVMVFEVL-GENLLALIKKYEHRGIP 129

Query: 374 LMDSQVSAYTRQILNGLNYLH-EQNVVHRDIKCANILVDAS------GSVKLADFGLAKA 426
           L    V   ++Q+L GL+Y+H    ++H DIK  N+L++          +K+AD G A  
Sbjct: 130 L--IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-C 186

Query: 427 TTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQP----------- 475
                  +   T  + +PEV+ L    +G  ADIWS  C + E++T              
Sbjct: 187 WYDEHYTNSIQTREYRSPEVL-LGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244

Query: 476 -PYSHLEGMQALF-------------------------RIGKGEPPLVPNSLSR------ 503
               H+  +  L                           I K +   + + L+       
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304

Query: 504 -DAR---DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
            +A+   DF+   LQ++P  R  A  L+ HP++K  L       
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  109 bits (274), Expect = 6e-26
 Identities = 73/339 (21%), Positives = 118/339 (34%), Gaps = 94/339 (27%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEV----SLQDQGTQGKQSILQLEQEIL-LLSRFE 336
           +++G GSFG V + Y        A+K V        Q           E  IL  L + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--------AEEIRILEHLRKQD 154

Query: 337 HE---NIVQYFGTDKDENRLFIFLELVTKGSLANLY--------QKYHLMDSQVSAYTRQ 385
            +   N++         N + +  EL++     NLY        Q + L    V  +   
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM----NLYELIKKNKFQGFSL--PLVRKFAHS 208

Query: 386 ILNGLNYLHEQNVVHRDIKCANILV--DASGSVKLADFGLAKATTMNDVKSCKGTPFWMA 443
           IL  L+ LH+  ++H D+K  NIL+       +K+ DFG +       V +   + F+ A
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTYIQSRFYRA 267

Query: 444 PEVVNLKNRGYGLTADIWSLGCTV---------------LEMLTR------QPP------ 476
           PEV  +    YG+  D+WSLGC +                + L         P       
Sbjct: 268 PEV--ILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325

Query: 477 ------YSHLEGMQALFRIGKGEPPLVPNSLSRDAR------------------------ 506
                 +   +G      +       V  +  R  R                        
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385

Query: 507 -DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPS 544
            DF+ +CL+ +P  R T  Q + HP+++R L K      
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEK 424

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  107 bits (268), Expect = 1e-25
 Identities = 76/348 (21%), Positives = 117/348 (33%), Gaps = 103/348 (29%)

Query: 283 ELLGSGSFGTVYEGY--TDDGFFFAVKEV----SLQDQGTQGKQSILQLEQEIL-LLSRF 335
             LG G+FG V E           A+K +      ++          +LE  +L  +   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--------RLEINVLKKIKEK 76

Query: 336 EHEN---IVQYFGTDKDENRLFIFLELVTKGSL-----ANLYQKYHLMDSQVSAYTRQIL 387
           + EN    V           + I  EL+ K +       N +Q Y L    V     Q+ 
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPL--PHVRHMAYQLC 133

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASG-------------------SVKLADFGLAKATT 428
           + L +LHE  + H D+K  NIL   S                    S+++ADFG   AT 
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATF 191

Query: 429 MND-VKSCKGTPFWMAPEVV-NLKNRGYGLTADIWSLGCTVLEMLTRQP------PYSHL 480
            ++   +   T  +  PEV+  L   G+    D+WS+GC + E               HL
Sbjct: 192 DHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248

Query: 481 EGMQALFRIGKGEPP-----------------LVPNSLSRDAR----------------- 506
             M+ +     G  P                 LV +  S D R                 
Sbjct: 249 VMMEKIL----GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304

Query: 507 -------DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYN 547
                  D + + L+ +P  R T A+ + HPF      + R   +  N
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  106 bits (268), Expect = 1e-25
 Identities = 69/332 (20%), Positives = 112/332 (33%), Gaps = 95/332 (28%)

Query: 283 ELLGSGSFGTVYEGY--TDDGFFFAVKEV----SLQDQGTQGKQSILQLEQEIL-LLSRF 335
           + LG G+FG V E       G   AVK V       +          + E ++L  L+  
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--------RSEIQVLEHLNTT 71

Query: 336 EHEN---IVQYFGTDKDENRLFIFLELVTKGSL-----ANLYQKYHLMDSQVSAYTRQIL 387
           +  +    VQ     +    + I  EL+   S       N +  + L    +     QI 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRL--DHIRKMAYQIC 128

Query: 388 NGLNYLHEQNVVHRDIKCANILVDASG-------------------SVKLADFGLAKATT 428
             +N+LH   + H D+K  NIL   S                     +K+ DFG   AT 
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG--SATY 186

Query: 429 MNDVKSC-KGTPFWMAPEVV-NLKNRGYGLTADIWSLGCTVLEMLTRQP------PYSHL 480
            ++  S    T  + APEV+  L   G+    D+WS+GC ++E               HL
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243

Query: 481 EGMQAL-----------------FRIGKGEPP-------------------LVPNSLSRD 504
             M+ +                 F   + +                     ++   +  +
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303

Query: 505 A-RDFILKCLQVNPNDRPTAAQLMEHPFVKRP 535
              D I K L+ +P  R T  + ++HPF    
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  103 bits (259), Expect = 3e-24
 Identities = 80/376 (21%), Positives = 133/376 (35%), Gaps = 118/376 (31%)

Query: 245 HDGDDDRKDLAVRLIKEPVYNVSPNGKFRRR--IMSWQKGELLGSGSFGTVYEGY-TDDG 301
             GDD+             ++            ++       +G G+FG V      D+ 
Sbjct: 16  FQGDDEIVH----------FSWKKGMLLNNAFLVI-----RKMGDGTFGRVLLCQHIDNK 60

Query: 302 FFFAVKEV----SLQDQGTQGKQSILQLEQEIL-LLSRFEHE--NIVQYFGTDKDENRLF 354
            ++AVK V                  ++E +IL  +   +    NIV+Y G     + + 
Sbjct: 61  KYYAVKVVRNIKKYTRSA--------KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112

Query: 355 IFLELVTKGSL-----ANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL 409
           +  E +   SL      N Y  +H+    +  Y  +IL  LNYL + ++ H D+K  NIL
Sbjct: 113 LIFEPLGP-SLYEIITRNNYNGFHI--EDIKLYCIEILKALNYLRKMSLTHTDLKPENIL 169

Query: 410 VDASG-------------------------SVKLADFGLAKATTMNDVKSC-KGTPFWMA 443
           +D                             +KL DFG   AT  +D       T  + A
Sbjct: 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG--CATFKSDYHGSIINTRQYRA 227

Query: 444 PEVV-NLKNRGYGLTADIWSLGCTVLEMLTRQP------PYSHLEGMQALF--------- 487
           PEV+ NL   G+ +++D+WS GC + E+ T            HL  M+++          
Sbjct: 228 PEVILNL---GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284

Query: 488 ---------------------------RIGKGEPPLVPNSLSRDAR---DFILKCLQVNP 517
                                         K     +P           DF+   LQ++P
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344

Query: 518 NDRPTAAQLMEHPFVK 533
             RP+ A+L++H F++
Sbjct: 345 TLRPSPAELLKHKFLE 360

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  100 bits (252), Expect = 3e-23
 Identities = 76/379 (20%), Positives = 136/379 (35%), Gaps = 110/379 (29%)

Query: 238 PSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY 297
               V++   DDD  D          Y V    K+  R   ++   L+G GSFG V + Y
Sbjct: 28  KERKVYNDGYDDDNYD----------YIVKNGEKWMDR---YEIDSLIGKGSFGQVVKAY 74

Query: 298 -TDDGFFFAVKEV----SLQDQGTQGKQSILQLEQEIL-LLSRFEHEN---IVQYFGTDK 348
              +  + A+K +    +  +Q         Q+E  +L L+++ + E    IV       
Sbjct: 75  DRVEQEWVAIKIIKNKKAFLNQA--------QIEVRLLELMNKHDTEMKYYIVHLKRHFM 126

Query: 349 DENRLFIFLELVTKGSLANLYQ-----KYH-LMDSQVSAYTRQILNGLNYLH--EQNVVH 400
             N L +  E+++     NLY       +  +  +    + +Q+   L +L   E +++H
Sbjct: 127 FRNHLCLVFEMLSY----NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIH 182

Query: 401 RDIKCANILV--DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
            D+K  NIL+      ++K+ DFG +       +     + F+ +PEV  L    Y L  
Sbjct: 183 CDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQYIQSRFYRSPEV--LLGMPYDLAI 239

Query: 459 DIWSLGCTV---------------LEMLTR------QPPYSHLE---------------- 481
           D+WSLGC +               ++ + +       PP   L+                
Sbjct: 240 DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGT 299

Query: 482 ----------------GMQALFRIGKGEPPLVPNSLSRDA----------RDFILKCLQV 515
                           G + L  I   E        + ++          +D IL+ L  
Sbjct: 300 WNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359

Query: 516 NPNDRPTAAQLMEHPFVKR 534
           +P  R      ++H F K+
Sbjct: 360 DPKTRIQPYYALQHSFFKK 378

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 16/158 (10%)

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV-KSCKGTPF 440
           Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +           
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257

Query: 441 ---WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR-IGKG--- 492
              WMAPE   + +R Y + +D+WS G  + E+ +    PY  ++  +   R + +G   
Sbjct: 258 PLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315

Query: 493 -EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
             P      +       +L C    P+ RPT ++L+EH
Sbjct: 316 RAPDYTTPEM----YQTMLDCWHGEPSQRPTFSELVEH 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 34/162 (20%), Positives = 58/162 (35%), Gaps = 15/162 (9%)

Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           G+ LG G+FG V E        T      AVK   L++  T        L  E+ +L   
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATH--SEHRALMSELKILIHI 82

Query: 336 -EHENIVQYFGT-DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
             H N+V   G   K    L + +E    G+L+   +              +   G +Y+
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC 435
                +  D+K     + +S S   + F   K+ +  + +  
Sbjct: 143 ---GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 81.5 bits (201), Expect = 9e-17
 Identities = 52/252 (20%), Positives = 77/252 (30%), Gaps = 100/252 (39%)

Query: 377 SQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDAS---------------------- 413
             V    +Q+L GL+YLH +  ++H DIK  NIL+  +                      
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205

Query: 414 ---------------------------GSVKLADFGLAKATTMNDVKSCKGTPFWMAPEV 446
                                        VK+AD G A             T  + + EV
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-KHFTEDIQTRQYRSLEV 264

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS------------HLEGMQALFR------ 488
           + + + GY   ADIWS  C   E+ T    +             H+  +  L        
Sbjct: 265 L-IGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322

Query: 489 IGKGE---------------PPLVPNSLSRDAR--------------DFILKCLQVNPND 519
           I  G+                 L P  L                   DF+L  L++ P  
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382

Query: 520 RPTAAQLMEHPF 531
           R TAA+ + HP+
Sbjct: 383 RATAAECLRHPW 394

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 55/235 (23%), Positives = 100/235 (42%), Gaps = 35/235 (14%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFE 336
           ++ G  +GSGSFG +Y G     G     +EV+++ +  + K   L +E +I  ++    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHIESKIYKMMQGGV 65

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLN 391
               +++ G + D N   + +EL+   SL +L+        + S  T      Q+++ + 
Sbjct: 66  GIPTIRWCGAEGDYN--VMVMELLGP-SLEDLFNF---CSRKFSLKTVLLLADQMISRIE 119

Query: 392 YLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN---------DVKSCKGTP 439
           Y+H +N +HRD+K  N L+        V + DFGLAK              + K+  GT 
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGK 491
            + +  +            D+ SLG  ++       P+  L+     Q   RI +
Sbjct: 180 RYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 33/235 (14%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++ G  +G GSFG ++EG    +      ++V+++ +  +     L+ E     L     
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNN-----QQVAIKFEPRRSDAPQLRDEYRTYKL-LAGC 65

Query: 338 ENI--VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQ--VSAYTRQILNGLNYL 393
             I  V YFG +   N   + ++L+   SL +L        S   V+   +Q+L  +  +
Sbjct: 66  TGIPNVYYFGQEGLHN--VLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122

Query: 394 HEQNVVHRDIKCANILVDASGS-----VKLADFGLAK----ATT-----MNDVKSCKGTP 439
           HE+++V+RDIK  N L+    S     + + DFG+ K      T       + K+  GT 
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGK 491
            +M+  +     R      D+ +LG   +  L    P+  L+     Q   RIG+
Sbjct: 183 RYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 47/208 (22%), Positives = 76/208 (36%), Gaps = 36/208 (17%)

Query: 243 HDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIM--SWQKGELLGSGSFGTVYEGY-TD 299
           H H    D     +     P     P GK    +    W  G+ +GSG FG +Y  + T+
Sbjct: 5   HHHSSGVDLGTENLYFQSMPF----PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTN 60

Query: 300 DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ----------------- 342
                A   V ++ Q          L  E+    R   ++ ++                 
Sbjct: 61  KPEKDARHVVKVEYQENG------PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114

Query: 343 YFGTDKDENRLFIFL--ELVTKGSLANLYQKYHLMDSQ-VSAYTRQILNGLNYLHEQNVV 399
             G  + + R + F+  E +    L  +  +        V     ++L+ L Y+HE   V
Sbjct: 115 GSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYV 173

Query: 400 HRDIKCANILVDASGS--VKLADFGLAK 425
           H DIK AN+L+       V LAD+GL+ 
Sbjct: 174 HGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 55/239 (23%), Positives = 98/239 (41%), Gaps = 41/239 (17%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++ G+ +G G+FG +  G       + A+K   ++ +  Q       L  E     +   
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-------LHLEYRFYKQLGS 63

Query: 338 -ENI--VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNG 389
            + I  V YFG     N   + LEL+   SL +L+      D   S  T      Q+++ 
Sbjct: 64  GDGIPQVYYFGPCGKYN--AMVLELLGP-SLEDLFDL---CDRTFSLKTVLMIAIQLISR 117

Query: 390 LNYLHEQNVVHRDIKCANILVDASGS-----VKLADFGLAK----ATT-----MNDVKSC 435
           + Y+H +N+++RD+K  N L+   G+     + + DF LAK      T       + KS 
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177

Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGK 491
            GT  +M+  +     +      D+ +LG   +  L    P+  L+     +   +IG 
Sbjct: 178 TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 35/170 (20%), Positives = 57/170 (33%), Gaps = 27/170 (15%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           W+ G  +G G FG +Y    +           +             L  E+    R    
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE---PSDNGPLFTELKFYQRAAKP 93

Query: 339 NIVQ-----------------YFGTDKDENRLFIFL--ELVTKGSLANLYQK--YHLMDS 377
             +Q                   G      + + F+  +      L  +Y+         
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRK 152

Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAK 425
            V   + +IL+ L Y+HE   VH DIK +N+L++      V L D+GLA 
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 72.7 bits (178), Expect = 8e-14
 Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 35/235 (14%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFE 336
           ++ G  +GSGSFG +Y G           +EV+++ +  + K   L  E +I  +L    
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTKHPQLLYESKIYRILQGGT 63

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYT-----RQILNGLN 391
               V++FG + D N   + ++L+   SL +L+        ++S  T      Q++N + 
Sbjct: 64  GIPNVRWFGVEGDYN--VLVMDLLGP-SLEDLFNF---CSRKLSLKTVLMLADQMINRVE 117

Query: 392 YLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMN---------DVKSCKGTP 439
           ++H ++ +HRDIK  N L+        V + DFGLAK              + K+  GT 
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGK 491
            + +  V            D+ SLG  ++  L    P+  L+     Q   +I +
Sbjct: 178 RYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 36/171 (21%), Positives = 60/171 (35%), Gaps = 29/171 (16%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFF---------FAVKEVSLQDQGT------QGKQSIL 323
           W+        + G +YE                 F++K  +   +        Q     L
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 324 QLEQEILLLSRFEHENI--VQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA 381
           Q+ +   L        I     FG  +D+ R F+ L  + + SL +           +S 
Sbjct: 104 QVNKWKKL-YSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGR-SLQSALDVSP--KHVLSE 158

Query: 382 YT-----RQILNGLNYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAK 425
            +      ++L+ L +LHE   VH ++   NI VD      V LA +G A 
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.8 bits (162), Expect = 4e-12
 Identities = 29/191 (15%), Positives = 58/191 (30%), Gaps = 44/191 (23%)

Query: 279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQ---GTQGKQSILQLEQEILLLSRF 335
            Q+ E +G G FG V++    D    A+K ++++         +++  ++  EI++    
Sbjct: 22  LQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80

Query: 336 E---------HENIVQYFG------------------------------TDKDENRLFIF 356
                      E  +                                      +++LFI 
Sbjct: 81  SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140

Query: 357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGS 415
           LE    G      +      +   +   Q+   L          HRD+   N+L+  +  
Sbjct: 141 LEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL 200

Query: 416 VKLADFGLAKA 426
            KL      K+
Sbjct: 201 KKLHYTLNGKS 211

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 1e-07
 Identities = 55/356 (15%), Positives = 104/356 (29%), Gaps = 133/356 (37%)

Query: 277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           M ++ GE      +  +   + D    F V     +D        +  + + IL  S+ E
Sbjct: 7   MDFETGEH--QYQYKDILSVFEDA---F-VDNFDCKD--------VQDMPKSIL--SKEE 50

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK---------YHLMDSQVSAYTRQ-I 386
            ++I+     D     L +F  L++K     + QK         Y  + S +    RQ  
Sbjct: 51  IDHIIM--SKDAVSGTLRLFWTLLSKQE--EMVQKFVEEVLRINYKFLMSPIKTEQRQPS 106

Query: 387 LNGLNYLHEQNVVHRD-----------------IKCA--------NILVDASGSVKLADF 421
           +    Y+ +++ ++ D                 ++ A        N+L+D  G   +   
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID--G---VLGS 161

Query: 422 G---LAKATTMNDVKSCKGTP---FWM------APEVV--NLKNRGYGLTA--------- 458
           G   +A        K         FW+      +PE V   L+   Y +           
Sbjct: 162 GKTWVA-LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS 220

Query: 459 -------------------------------DIWS--------LGCTVLEMLTRQPPYSH 479
                                          ++ +        L C +L + TR      
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL-LTTRFK---- 275

Query: 480 LEGMQALFRIGKGEPPLVPNSLS---RDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
            +    L         L  +S++    + +  +LK L   P D P       +P  
Sbjct: 276 -QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT-NPRR 329

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 4e-06
 Identities = 66/430 (15%), Positives = 124/430 (28%), Gaps = 121/430 (28%)

Query: 26  NIQYDASLAPSSASSSFDDKSS---ASPRRIRSLDLTDNKTSFRVKGMDGE----FDLIC 78
             + D S        S   +      S      L +  N     V+  + +    F+L C
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN-----VQ--NAKAWNAFNLSC 266

Query: 79  RSL---GFSGPEDFAIPAAAWEAQKARSRFSFDNASRLQLRFDQALDLTEEQEFKAAVML 135
           + L    F    DF   A            +        L   + LD    Q+    V+ 
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL-LLKYLD-CRPQDLPREVLT 324

Query: 136 DDERLVSKRGSSLAKRENRVGPRAGINGDRPPALSPPSPMKFRRPVEAVDDDEILKSFAA 195
            + R +S    S+            +N D+   L+          +  ++  E  K F  
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCDK---LT----TIIESSLNVLEPAEYRKMFDR 377

Query: 196 ES---DDEYFLHSPIAVGFISPLNENEENNEVRR----LRETNVVEESGP--SISVHDHD 246
            S         H P  +  +S +  +   ++V      L + ++VE+     +IS+    
Sbjct: 378 LSVFPPS---AHIPTIL--LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 247 GD-----DDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYTDDG 301
            +     ++   L   ++    YN        +   S                     D 
Sbjct: 433 LELKVKLENEYALHRSIVDH--YN------IPKTFDSDDLIPP-------------YLDQ 471

Query: 302 FFFAVKEVSLQDQGTQGKQSI------LQLEQEILLLSRFEHENIVQYFGTDKDENRLFI 355
           +F+                 I      ++  + + L           +   D      F 
Sbjct: 472 YFY---------------SHIGHHLKNIEHPERMTLFRMV-------FL--D------FR 501

Query: 356 FLE---------LVTKGSLANLYQ---KY--HLMDSQVSAYTRQILNGLNYL--HEQNVV 399
           FLE             GS+ N  Q    Y  ++ D+    Y R +   L++L   E+N++
Sbjct: 502 FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND-PKYERLVNAILDFLPKIEENLI 560

Query: 400 HRDIKCANIL 409
               K  ++L
Sbjct: 561 CS--KYTDLL 568

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	551
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.03
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.44
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.21
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.11
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.74
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.71
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.56
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.48
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.41
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.39
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.35
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.16
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.11
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.9
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.87
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.85
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.85
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.55
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.86
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.82
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.83

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-59  Score=489.06  Aligned_cols=260  Identities=27%  Similarity=0.546  Sum_probs=228.1

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      +.+++|++++.||+|+||+||+|++ .+|+.||||++.....   .......+.+|+.+|++++|||||++++++.+.+.
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM---SSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC---CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            4467999999999999999999998 6899999999976533   23446678899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          353 LFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      +|||||||.||+|.+++...   .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999999999998643   368889999999999999999999999999999999999999999999999987643


Q ss_pred             CC--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHH
Q 043852          430 ND--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD  507 (551)
Q Consensus       430 ~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  507 (551)
                      ..  ....+||+.|||||++  .+..|+.++|||||||+||||+||++||.+.+..+.+.++..+..+..+..++.++.+
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l--~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~  255 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEIC--ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             CcccccccCCCccccCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence            32  3456799999999998  4568999999999999999999999999999988999999998888888899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      ||.+||++||.+|||++|+|+||||++...+
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~  286 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIEK  286 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTTGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcCCCc
Confidence            9999999999999999999999999876544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2e-58  Score=481.85  Aligned_cols=254  Identities=33%  Similarity=0.578  Sum_probs=227.9

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|++++.||+|+||+||+|++ .+|+.||||++.......     ...+.+|+.+|++++|||||++++++.+.+.+|||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            699999999999999999998 589999999997543322     23467899999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~  434 (551)
                      ||||.||+|.+++.+.++++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....  ...+
T Consensus       150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999866433  3456


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~LI~~c  512 (551)
                      .+||+.|||||++  ....|+.++|||||||++|||++|++||.+.+..+.+..+....++..  +..++.++.+||.+|
T Consensus       230 ~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          230 LVGTPYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred             cccCcCcCCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence            7899999999997  456799999999999999999999999999888888888877654443  346899999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      |++||.+|||++|+|+||||++....
T Consensus       308 L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          308 LVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             cCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            99999999999999999999876543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3e-58  Score=473.92  Aligned_cols=256  Identities=27%  Similarity=0.454  Sum_probs=227.7

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ..++|++++.||+|+||+||+|++ .+|+.||||++.+.....  ......+.+|+.+|++++|||||++++++.+...+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            456899999999999999999998 689999999997543211  22355788999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      |||||||.||+|.+++++ ..+++..+..|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999998876 46999999999999999999999999999999999999999999999999999865422  


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                        ...+.+||+.|||||++  .+..|+.++|||||||++|+|+||++||.+.+..+.+.+|.++.. .+|..++.++++|
T Consensus       188 ~~~~~~~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dl  264 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDL  264 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHH--HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHH
T ss_pred             cccccCcccCcccCCHHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHH
Confidence              24567899999999998  456789999999999999999999999999888888888887764 4577899999999


Q ss_pred             HHHhhhcCCCCCCCHHH------HHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTAAQ------LMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~e------ILehpff~~~  535 (551)
                      |.+||++||.+|||++|      |++||||+..
T Consensus       265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            99999999999999887      6899999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9e-58  Score=463.20  Aligned_cols=258  Identities=28%  Similarity=0.452  Sum_probs=209.6

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|++++.||+|+||+||+|++ .+|+.||||++.......  ......+.+|+.++++++|||||++++++.+...
T Consensus        10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   87 (275)
T 3hyh_A           10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK--SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE   87 (275)
T ss_dssp             ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            4578999999999999999999987 589999999997543322  2334568899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-
Q 043852          353 LFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-  430 (551)
                      +||||||| +|+|.+++. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            99999999 568877765 457999999999999999999999999999999999999999999999999999865433 


Q ss_pred             CcccCCCCCcccChhhhhcccCC-CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~-~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ...+.+||+.|||||++.  +.. ++.++|||||||++|+|+||+.||.+.+.......+.++.. .++..++.++++||
T Consensus       167 ~~~~~~GT~~Y~APE~~~--~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  243 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-TLPKFLSPGAAGLI  243 (275)
T ss_dssp             --------CTTSCHHHHS--SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHH
T ss_pred             ccCCeeECcccCChhhhc--CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHH
Confidence            345678999999999983  344 46899999999999999999999998877777777776654 45778999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      .+||++||++|||++|+++||||+..++
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~~~p  271 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKVDLP  271 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred             HHHccCChhHCcCHHHHHcCcccccCCC
Confidence            9999999999999999999999987654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-57  Score=483.17  Aligned_cols=254  Identities=33%  Similarity=0.571  Sum_probs=228.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..|++++.||+|+||.||+|++ .+|+.||||++.......     ...+.+|+.+|++++|||||++++++.+.+.+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            3699999999999999999998 589999999997653322     2346799999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Ccc
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~  433 (551)
                      |||||.||+|.++++..++++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....  ...
T Consensus       226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999865433  345


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHHHHHHHHH
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFILK  511 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~LI~~  511 (551)
                      ..+||+.|||||++  ....|+.++|||||||++|||++|++||.+.+..+.+..+.....+.  .+..++.++++||.+
T Consensus       306 ~~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          306 SLVGTPYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             CCEECTTTCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred             ccccCcCcCCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence            67899999999997  45679999999999999999999999999988888888887765443  345789999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ||++||.+|||++|||+||||++...
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            99999999999999999999987543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-56  Score=458.09  Aligned_cols=250  Identities=29%  Similarity=0.535  Sum_probs=215.2

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC----CCeE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD----ENRL  353 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~  353 (551)
                      |++.+.||+|+||+||+|.+ .++..||||++.....   .......+.+|+.++++++|||||++++++.+    ...+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            36678899999999999987 5799999999975432   23445678899999999999999999998754    4568


Q ss_pred             EEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEcC-CCcEEEEecCCcccccc
Q 043852          354 FIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDA-SGSVKLADFGLAKATTM  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~~-~g~vkL~DFGla~~~~~  429 (551)
                      |||||||.||+|.+++++. .+++..+..|+.||+.||.|||++|  |+||||||+||||+. +|.+||+|||+|+....
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999999998764 6899999999999999999999998  999999999999974 79999999999987666


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH-HHhhcCCC-CCCCCcCCHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL-FRIGKGEP-PLVPNSLSRDARD  507 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~-~~i~~~~~-~~~~~~~s~~l~~  507 (551)
                      ....+.+||+.|||||+++   ..|+.++|||||||+||||+||+.||.+......+ ..+..+.. ..++..+++++.+
T Consensus       185 ~~~~~~~GTp~YmAPE~~~---~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             CccCCcccCccccCHHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence            6667788999999999873   36899999999999999999999999776554444 44554433 3345668899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      ||.+||++||.+|||++|+|+||||++
T Consensus       262 li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.2e-57  Score=463.72  Aligned_cols=253  Identities=29%  Similarity=0.443  Sum_probs=218.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .+|++++.||+|+||+||+|++    .+++.||||++.........   ..++.+|+.++.+++|||||++++++.+.+.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            4799999999999999999975    25789999999754332222   2256789999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--  429 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--  429 (551)
                      +|||||||.||+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....  
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999999998876 4699999999999999999999999999999999999999999999999999986533  


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ....+.+||+.|||||++  .+..|+.++|||||||++|||+||++||.+.+..+.+.++.++.. .+|..+|+++.+||
T Consensus       181 ~~~~~~~GT~~YmAPE~~--~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  257 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLL  257 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHH--HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred             ccccccccCcccCCHHHh--ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHH
Confidence            334567899999999997  456899999999999999999999999999888888888887764 45778999999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          510 LKCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       510 ~~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      .+||++||++|||     ++||++||||+..
T Consensus       258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999998     5899999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.1e-56  Score=462.08  Aligned_cols=250  Identities=30%  Similarity=0.459  Sum_probs=217.7

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+..|++.++||+|+||.||+|++ .+|+.||||++.....          ..+|+.++.+++|||||++++++.+...+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~  125 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWV  125 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            355799999999999999999998 6899999999975422          13699999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCccccccCC
Q 043852          354 FIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~~~  431 (551)
                      |||||||+||+|.+++++. .+++..+..|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+......
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999999998764 699999999999999999999999999999999999999988 69999999998654322


Q ss_pred             -------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC--CCCCcCC
Q 043852          432 -------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP--LVPNSLS  502 (551)
Q Consensus       432 -------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s  502 (551)
                             ....+||+.|||||++  .+..|+.++|||||||+||||+||++||.+......+.++....++  .++..++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~--~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s  283 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA  283 (336)
T ss_dssp             --------CCCCCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred             cccceecCCccccCccccCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence                   2335799999999998  4567999999999999999999999999887766666677666543  3567899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHH-------------HhCcccCCcc
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQL-------------MEHPFVKRPL  536 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eI-------------Lehpff~~~~  536 (551)
                      ..+.+||.+||++||.+|||+.||             ++|||+....
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            999999999999999999999998             5799987654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-54  Score=443.98  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=202.8

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-  351 (551)
                      +.+++|++++.||+|+||+||+|++ .+|+.||||++....    .......+.+|+.+|++++|||||++++++.+.+ 
T Consensus         2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A            2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred             CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence            3466899999999999999999987 589999999997543    2344567889999999999999999999886543 


Q ss_pred             -----------eEEEEEecccccchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcE
Q 043852          352 -----------RLFIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV  416 (551)
Q Consensus       352 -----------~~~lV~Ey~~ggsL~~ll~~~~----l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~v  416 (551)
                                 ++|||||||.+|+|.+++....    .....++.++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence                       4799999999999999997643    3345578899999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCC--------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 043852          417 KLADFGLAKATTMND--------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG  482 (551)
Q Consensus       417 kL~DFGla~~~~~~~--------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~  482 (551)
                      ||+|||+|+......              ....+||+.|||||++  .+..|+.++|||||||++|||++   ||.....
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~--~~~~y~~~~DiwSlGvilyell~---Pf~~~~~  232 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI--HGNSYSHKVDIFSLGLILFELLY---PFSTQME  232 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHH--TTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHH--cCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence            999999998654321              2345799999999998  45689999999999999999996   7865432


Q ss_pred             -HHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          483 -MQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       483 -~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                       ...+..+.....+......++.+.+||.+||++||.+|||+.||++||||+..
T Consensus       233 ~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence             33444555554444344567778899999999999999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-54  Score=442.43  Aligned_cols=251  Identities=26%  Similarity=0.455  Sum_probs=220.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ++|.+.+.||+|+||+||+|++.      ++..||||++...     ......+|.+|+.+|.+++|||||++++++.+.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            37899999999999999999752      5788999998632     234566789999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh--------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcE
Q 043852          351 NRLFIFLELVTKGSLANLYQKY--------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV  416 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~--------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~v  416 (551)
                      +.+|||||||++|+|.+++.+.              .+++..+..++.||+.||.|||+++|+||||||+||||+.++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence            9999999999999999998653              48899999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhc
Q 043852          417 KLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGK  491 (551)
Q Consensus       417 kL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~  491 (551)
                      ||+|||+|+......    .....||+.|||||++  ....|+.++|||||||+||||+| |+.||.+.+..+.+..+..
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~--~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHH--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998654332    2234589999999998  45679999999999999999998 8999999998888999999


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +..+..|..++.++.+||.+||+.||++|||+.+|+  +|+++..
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~  288 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA  288 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence            988888999999999999999999999999999995  4776543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=443.99  Aligned_cols=246  Identities=26%  Similarity=0.430  Sum_probs=213.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      .+|.+.+.||+|+||+||+|+..      ++..||||++...     ......+|.+|+.+|.+++|||||++++++.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            47889999999999999999753      5889999998532     344566789999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC
Q 043852          351 NRLFIFLELVTKGSLANLYQKY----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG  414 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g  414 (551)
                      ..+|||||||++|+|.+++.+.                .+++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            9999999999999999998642                488899999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHh
Q 043852          415 SVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRI  489 (551)
Q Consensus       415 ~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i  489 (551)
                      .+||+|||+++......    .....||+.|||||++  ....|+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~--~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHH--TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhh--cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999998654332    2345699999999997  45679999999999999999999 89999999988888889


Q ss_pred             hcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          490 GKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       490 ~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ..+.....|..+++++.+||.+||+.||++|||+.+|+++
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8888888899999999999999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-53  Score=454.40  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=216.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc------CC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK------DE  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------~~  350 (551)
                      +|++++.||+|+||+||+|++ .+|+.||||++.....   ......++.+|+.+|+.++|||||++++++.      +.
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            799999999999999999998 6899999999864322   2344567789999999999999999999865      34


Q ss_pred             CeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..+|||||||. |+|.+++.+ ..+++..+..|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            67899999996 568777754 5699999999999999999999999999999999999999999999999999985432


Q ss_pred             ------CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--CC------
Q 043852          430 ------NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--PP------  495 (551)
Q Consensus       430 ------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~------  495 (551)
                            ....+.+||+.|||||++. ....|+.++||||||||+|||++|++||.+.+..+.+..|....  ++      
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~-~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHT-TCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             CccccccccccceeChHhcCHHHhc-CCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence                  2345678999999999973 34567999999999999999999999999988877776654321  10      


Q ss_pred             ---------------C-------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          496 ---------------L-------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       496 ---------------~-------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                                     .       ....++.++.+||.+||++||.+|||++|+|+||||++....
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence                           0       013478999999999999999999999999999999976543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-53  Score=439.25  Aligned_cols=248  Identities=23%  Similarity=0.401  Sum_probs=218.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      +.++++++.||+|+||+||+|..      .++..||||++.....    ......|.+|+.++.+++|||||+++|++.+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            34788899999999999999974      3578999999854321    2334578899999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhh-----------------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC
Q 043852          350 ENRLFIFLELVTKGSLANLYQK-----------------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA  412 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~-----------------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~  412 (551)
                      ...+|||||||++|+|.+++..                 ..+++..+..++.||+.||.|||+++||||||||+||||+.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            9999999999999999999853                 24888999999999999999999999999999999999999


Q ss_pred             CCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 043852          413 SGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALF  487 (551)
Q Consensus       413 ~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~  487 (551)
                      ++.+||+|||+++......    .....||+.|||||++.  ...|+.++|||||||+||||+| |..||.+.+..+...
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh--CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999998653322    34457999999999983  5679999999999999999998 899999999888888


Q ss_pred             HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          488 RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       488 ~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+..+.....|..++..+.+||.+||+.||.+|||+.+|+++
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            898888888899999999999999999999999999999874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4e-53  Score=435.54  Aligned_cols=248  Identities=28%  Similarity=0.508  Sum_probs=205.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..++++++.||+|+||+||+|++.+  .||||+++...   ........|.+|+.++++++|||||++++++.+ +.+||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVD---PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            3578899999999999999997643  58999886432   234556789999999999999999999998765 56899


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC---
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~---  430 (551)
                      |||||++|+|.+++..  ..+++..+..++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.....   
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999998854  46999999999999999999999999999999999999999999999999999865322   


Q ss_pred             -CcccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-hhcCCC----CCCCCcCCH
Q 043852          431 -DVKSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR-IGKGEP----PLVPNSLSR  503 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~-i~~~~~----~~~~~~~s~  503 (551)
                       .....+||+.|||||++... ...|+.++|||||||+||||+||+.||.+.+....+.. +..+..    +..+..++.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK  268 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence             23456799999999998533 34689999999999999999999999988765544443 333322    234567999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+.+||.+||+.||++|||+.+|+++
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999998654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-52  Score=469.18  Aligned_cols=259  Identities=28%  Similarity=0.412  Sum_probs=223.2

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccC-ccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQG-TQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .+++|+++++||+|+||+||+|++ .+|+.||||++.+.... ............++.++..++|||||+++++|.+...
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            467999999999999999999998 68999999999754322 1223334444556788889999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|||||||.||+|..++.+. .+++..+..|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            99999999999999988764 69999999999999999999999999999999999999999999999999999877777


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch---hHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      ..+.+||+.|||||++. .+..|+.++|||||||+||||++|.+||.+..   .......+.. ....+|..++.++++|
T Consensus       347 ~~t~~GTp~YmAPEvl~-~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~~~~p~~~S~~a~dL  424 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAVELPDSFSPELRSL  424 (689)
T ss_dssp             CCSCCSCGGGCCHHHHS-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CCCCCCTTSCHHHHHH
T ss_pred             CCCccCCcCccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CCCCCCccCCHHHHHH
Confidence            77889999999999983 34579999999999999999999999997543   2233333433 3455678899999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      |.+||++||.+|++     +++|++||||+..
T Consensus       425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            99999999999998     7999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.7e-52  Score=438.71  Aligned_cols=249  Identities=26%  Similarity=0.382  Sum_probs=205.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      +.|++++.||+|+||+||+|+++    +++.||||.+....       ...++.+|+.+|..+ +|||||++++++.+.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            47999999999999999999763    57899999885422       123567899999988 6999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-CcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGla~~~~~~  430 (551)
                      ++|||||||+||+|.++++  .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus        94 ~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            9999999999999999985  48999999999999999999999999999999999999876 89999999999744321


Q ss_pred             ------------------------------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCC-
Q 043852          431 ------------------------------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH-  479 (551)
Q Consensus       431 ------------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~-  479 (551)
                                                    .....+||+.|+|||++. ....|+.++||||+||++|||++|+.||.. 
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT-KCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence                                          123457999999999983 445689999999999999999999999943 


Q ss_pred             chhHHHHHHhhcC-------------------------------------C----------------CCCCCCcCCHHHH
Q 043852          480 LEGMQALFRIGKG-------------------------------------E----------------PPLVPNSLSRDAR  506 (551)
Q Consensus       480 ~~~~~~~~~i~~~-------------------------------------~----------------~~~~~~~~s~~l~  506 (551)
                      .+..+++.+|...                                     .                .......+++++.
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            3344443332110                                     0                0011235789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      +||.+||++||.+|||++|+|+||||+..
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999853

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-51  Score=457.06  Aligned_cols=255  Identities=29%  Similarity=0.440  Sum_probs=226.3

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|++++.||+|+||.||+|.+ .+|+.||||++....     ......+.+|+.+|+.++|||||++++++.+...+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            457899999999999999999988 689999999986532     23345678999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC--CcEEEEecCCcccccc
Q 043852          354 FIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS--GSVKLADFGLAKATTM  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~--g~vkL~DFGla~~~~~  429 (551)
                      |||||||.||+|.+++.+  ..+++..+..|++||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+....
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999999998853  469999999999999999999999999999999999999854  8999999999987654


Q ss_pred             CC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHH
Q 043852          430 ND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDA  505 (551)
Q Consensus       430 ~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l  505 (551)
                      .. ....+||+.|||||++  .+..|+.++|||||||+||||++|.+||.+.+..+.+..+........   ...++.++
T Consensus       310 ~~~~~~~~GT~~y~APEv~--~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             CCceeeeEECccccCHHHh--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            33 4566899999999998  456799999999999999999999999999998888888877654332   35689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .+||.+||++||.+|||+.|+|+||||+...
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            9999999999999999999999999998654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.8e-51  Score=429.72  Aligned_cols=248  Identities=27%  Similarity=0.456  Sum_probs=212.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC-Cceeeeeeecc
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH-ENIVQYFGTDK  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~  348 (551)
                      .++|++++.||+|+||+||+|.+.      .++.||||.+....    .......+.+|+.+|.++.| ||||+++++|.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            458999999999999999999753      23579999885322    23345678899999999965 89999999886


Q ss_pred             C-CCeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE
Q 043852          349 D-ENRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV  410 (551)
Q Consensus       349 ~-~~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl  410 (551)
                      + ...+|||||||++|+|.+++++.                 .+++..+..|+.||+.||.|||+++||||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            5 46789999999999999998642                 37889999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH-H
Q 043852          411 DASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGM-Q  484 (551)
Q Consensus       411 ~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~-~  484 (551)
                      +.++.+||+|||+|+......    ....+||+.|||||++  ....|+.++|||||||+||||+| |+.||.+.... .
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l--~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH--hcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999998654332    2345689999999998  45689999999999999999998 99999886543 4


Q ss_pred             HHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          485 ALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       485 ~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ....+..+..+..|..+++++.+||.+||+.||.+|||+.+|++|
T Consensus       297 ~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            445566777788888999999999999999999999999999997

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.1e-48  Score=400.87  Aligned_cols=260  Identities=25%  Similarity=0.440  Sum_probs=227.5

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|++++.||+|+||.||+|.+ .+|+.||||++.....   .......+.+|+.+++.++||||+++++++.+...
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            3467899999999999999999988 6899999999975432   23456678899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-  430 (551)
                      +|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999999998754 56999999999999999999999999999999999999999999999999999765433 


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      .....+||+.|+|||++. .....+.++|||||||++|+|++|+.||.+.+..+...++..+.. ..|..++..+.+||.
T Consensus       169 ~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~  246 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLK  246 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHH-TCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred             ccccccCCcceeCccccc-CCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHH
Confidence            345667999999999984 222335899999999999999999999999887777777776654 456679999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      +||+.||.+|||++++++||||+.....
T Consensus       247 ~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          247 RFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             HHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             HHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence            9999999999999999999999976543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.2e-49  Score=404.68  Aligned_cols=245  Identities=27%  Similarity=0.380  Sum_probs=193.5

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----eE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----RL  353 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~  353 (551)
                      +|.+.+.||+|+||+||+|++ +|+.||||++...      .......+.|+..+.+++|||||++++++.+..    .+
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            688999999999999999976 6899999998532      112223456777778899999999999987543    68


Q ss_pred             EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC--------CeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ--------NVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~--------gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      |||||||++|+|.+++++.++++..+..++.|++.||.|||++        +|+||||||+||||+.++.+||+|||+++
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999999999999999999999999999999987        99999999999999999999999999997


Q ss_pred             ccccCC------cccCCCCCcccChhhhhcc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCch--------------
Q 043852          426 ATTMND------VKSCKGTPFWMAPEVVNLK----NRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--------------  481 (551)
Q Consensus       426 ~~~~~~------~~~~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--------------  481 (551)
                      ......      ....+||+.|||||++...    ...|+.++|||||||+||||+||.+||....              
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            654322      2235699999999998422    1136789999999999999999977653211              


Q ss_pred             hHHHHHH-h-hcCCCCCCCCc-----CCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          482 GMQALFR-I-GKGEPPLVPNS-----LSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       482 ~~~~~~~-i-~~~~~~~~~~~-----~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ..+.+.+ + .....+.+|..     ++..+.+|+.+||+.||.+|||+.+|++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            1222222 2 22333444432     33578899999999999999999999873

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.2e-48  Score=395.91  Aligned_cols=256  Identities=35%  Similarity=0.612  Sum_probs=223.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..+|++.+.||+|+||+||+|.+ .+|+.||||++.......     ...+.+|+.++.+++||||+++++++.+...+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence            34799999999999999999987 689999999987543322     345678999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--c
Q 043852          355 IFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--V  432 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~  432 (551)
                      +|||||.+++|.+++.+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .
T Consensus        94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             EEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999987654332  3


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC--CCCCCcCCHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLVPNSLSRDARDFIL  510 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~LI~  510 (551)
                      ....||+.|+|||++  .+..++.++|||||||++|+|++|..||...........+.....  ...+..++..+.+||.
T Consensus       174 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          174 STMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CCCCSCGGGCCHHHH--HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred             CCccCCcCccChhhh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence            455799999999997  456789999999999999999999999988777666655543332  3345678999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      +||+.||.+|||+.++++||||+...+.
T Consensus       252 ~~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHccCChhHCcCHHHHhhChhhcccCcc
Confidence            9999999999999999999999965543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2e-47  Score=397.54  Aligned_cols=255  Identities=28%  Similarity=0.451  Sum_probs=222.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||+||+|.+ .+|+.||||++......  .......+.+|+.++..++||||+++++++.+...+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII--AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            56899999999999999999987 57999999999753211  1223456778999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CC
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--ND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~  431 (551)
                      +|||||.||+|..++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            999999999999888654 589999999999999999999999999999999999999999999999999975432  23


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      ....+||+.|+|||++  .+..++.++|||||||++|||++|+.||.+.+.......+.... ..++..++..+.+||.+
T Consensus       162 ~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             BCCCEECGGGCCGGGG--SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             ccccccChhhCChhhh--cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence            4556799999999997  45678999999999999999999999998877777666666554 34567899999999999


Q ss_pred             hhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          512 CLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       512 cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      ||+.||.+||     ++.+|++||||+..
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999999     99999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=401.73  Aligned_cols=257  Identities=29%  Similarity=0.451  Sum_probs=219.4

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      ..+++|+++++||+|+||.||+|++ .+|+.||||++......  .......+.+|+.++..+ +||||+++++++.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc--chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            3466999999999999999999987 57999999999753211  122345677899999987 6999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc-
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~-  429 (551)
                      .+|+|||||.||+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999998865 4699999999999999999999999999999999999999999999999999975432 


Q ss_pred             -CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          430 -NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       430 -~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                       ......+||+.|+|||++.  ...|+.++|||||||++|||++|..||.+.+..+.+.++..+.. .++..++..+.+|
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~l  254 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQ--EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGI  254 (353)
T ss_dssp             --------CCGGGCCHHHHH--HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHH
T ss_pred             CccccccCCCcCeEChhhcC--CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHH
Confidence             2344567999999999974  45689999999999999999999999999888888888777654 4467799999999


Q ss_pred             HHHhhhcCCCCCCCH------HHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTA------AQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~------~eILehpff~~~  535 (551)
                      |.+||++||.+||++      .+|++||||+..
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999999998      999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=388.78  Aligned_cols=260  Identities=30%  Similarity=0.525  Sum_probs=214.7

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc---------------------chHHHHHHHHHHHHH
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ---------------------GKQSILQLEQEILLL  332 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~---------------------~~~~~~~~~~Ei~il  332 (551)
                      .+++|++.+.||+|+||.||+|.+ .+|..||||++........                     .......+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            356899999999999999999987 5799999999975432111                     112245678999999


Q ss_pred             hcCCCCceeeeeeeccC--CCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE
Q 043852          333 SRFEHENIVQYFGTDKD--ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV  410 (551)
Q Consensus       333 ~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl  410 (551)
                      ++++||||+++++++.+  ...+|+||||+.+++|.+++....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            99999999999999876  5689999999999999988877789999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCCccccccCC--cccCCCCCcccChhhhhcccCC-CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 043852          411 DASGSVKLADFGLAKATTMND--VKSCKGTPFWMAPEVVNLKNRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF  487 (551)
Q Consensus       411 ~~~g~vkL~DFGla~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~-~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~  487 (551)
                      +.++.+||+|||+++......  .....||+.|+|||++...... ++.++|||||||++|+|++|+.||..........
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~  250 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS  250 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence            999999999999997654332  3445799999999997422221 4789999999999999999999998877666655


Q ss_pred             HhhcCCCCC-CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          488 RIGKGEPPL-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       488 ~i~~~~~~~-~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      .+....... ....++..+.+||.+||+.||.+|||+.+|++||||++
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            555543332 23468999999999999999999999999999999964

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.1e-47  Score=398.13  Aligned_cols=257  Identities=29%  Similarity=0.462  Sum_probs=223.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc-chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ-GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +.|++++.||+|+||.||+|.+ .+|..||+|++........ .......+.+|+.++.+++||||+++++++.+...+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            4799999999999999999988 5799999999976543221 1123456789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC----cEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g----~vkL~DFGla~~~~~  429 (551)
                      +|||||.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++....
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            99999999999998865 4689999999999999999999999999999999999998877    799999999986544


Q ss_pred             C-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHH
Q 043852          430 N-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDA  505 (551)
Q Consensus       430 ~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l  505 (551)
                      . ......||+.|+|||++  ....++.++|||||||++|+|++|.+||.+.+..+.+..+..+.....   ...++..+
T Consensus       172 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  249 (361)
T 2yab_A          172 GVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA  249 (361)
T ss_dssp             TCCCCCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred             CCccccCCCCccEECchHH--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence            3 34556799999999997  456789999999999999999999999998888888777776654432   25689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      .+||.+||.+||.+|||+.++++||||+..
T Consensus       250 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          250 KDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999999853

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.5e-47  Score=389.52  Aligned_cols=258  Identities=30%  Similarity=0.510  Sum_probs=211.9

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .+++|++++.||+|+||+||+|.+.+|+.||||++.....   .......+.+|+.++.+++||||+++++++.+...+|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            3568999999999999999999988899999999865422   2223456779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--C
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--N  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~  430 (551)
                      +|||||.+ +|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .
T Consensus        96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            99999986 67666654  3489999999999999999999999999999999999999999999999999976542  2


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc---CCCC-C----------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK---GEPP-L----------  496 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~---~~~~-~----------  496 (551)
                      ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+....+.+..+..   ...+ .          
T Consensus       175 ~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLM-GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             ---CCCCCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             cccCCcccCCcCCHHHhc-CCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            334456899999999973 345689999999999999999999999987665554444322   1100 0          


Q ss_pred             ---------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          497 ---------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       497 ---------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                     ....++.++.+||.+||++||.+|||++++++||||+..-+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                           11346789999999999999999999999999999997543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-47  Score=391.17  Aligned_cols=255  Identities=28%  Similarity=0.482  Sum_probs=224.2

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+.+|++++.||+|+||.||+|++ .+|+.||+|++......  .......+.+|+.++..++||||+++++++.+...+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV--RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            356899999999999999999988 58999999998753211  112345677899999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      |+|||||.||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-~~  160 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VT  160 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CB
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-cc
Confidence            999999999999998875 4689999999999999999999999999999999999999999999999999976543 33


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ...+||+.|+|||++  ....++.++|||||||++|||++|..||...+......++..... .++..++..+.+||.+|
T Consensus       161 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~l  237 (318)
T 1fot_A          161 YTLCGTPDYIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRL  237 (318)
T ss_dssp             CCCCSCTTTCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHH
T ss_pred             ccccCCccccCHhHh--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHH
Confidence            456799999999997  456789999999999999999999999998888877777777654 45677999999999999


Q ss_pred             hhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          513 LQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       513 L~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      |+.||.+||     ++++|++||||+..
T Consensus       238 L~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          238 ITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             hccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            999999999     99999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.4e-47  Score=381.88  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=211.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||+||+|.+ .+|+.||||++......   ......+.+|+.++.+++||||+++++++.+...+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence            35899999999999999999988 57999999999765432   234456779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CC
Q 043852          355 IFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--ND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~  431 (551)
                      +|||||.++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ..
T Consensus        78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9999998755544444 35699999999999999999999999999999999999999999999999999976542  23


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCC-CCCchhHHHHHHhhcC--C---------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPP-YSHLEGMQALFRIGKG--E---------------  493 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~P-f~~~~~~~~~~~i~~~--~---------------  493 (551)
                      .....||+.|+|||++. ....++.++|||||||++|+|++|..| |.+.+..+.+..+...  .               
T Consensus       158 ~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCSCCSCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             ccCCccccCCcChHHHc-CCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            34556899999999973 334589999999999999999987777 5555555444443221  0               


Q ss_pred             -----------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          494 -----------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       494 -----------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                 .......++..+.+||.+||+.||.+|||++++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                       0111235789999999999999999999999999999999654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-46  Score=391.71  Aligned_cols=255  Identities=27%  Similarity=0.472  Sum_probs=217.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRL  353 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  353 (551)
                      +.+|++++.||+|+||.||+|++ .+++.||||++......  .......+.+|+.++.++ +||||+++++++.+...+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            56899999999999999999987 57999999999754322  234556678899999887 899999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--cC
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--MN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--~~  430 (551)
                      |+|||||.+|+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...  ..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            999999999999998875 469999999999999999999999999999999999999999999999999997532  23


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc---------hhHHHHHHhhcCCCCCCCCcC
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL---------EGMQALFRIGKGEPPLVPNSL  501 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~  501 (551)
                      .....+||+.|+|||++  .+..++.++|||||||++|||++|+.||...         ........+... ...++..+
T Consensus       166 ~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~  242 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSL  242 (345)
T ss_dssp             CBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTS
T ss_pred             cccccCCCccccCcccc--CCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCC
Confidence            34556799999999997  4567899999999999999999999999642         112223334333 34567789


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCH------HHHHhCcccCCc
Q 043852          502 SRDARDFILKCLQVNPNDRPTA------AQLMEHPFVKRP  535 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~------~eILehpff~~~  535 (551)
                      +..+.+||.+||+.||.+||++      .+|++||||+..
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            9999999999999999999995      899999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.7e-47  Score=382.99  Aligned_cols=255  Identities=31%  Similarity=0.535  Sum_probs=211.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +++|++++.||+|+||+||+|.+.+|+.||+|++.......   .....+.+|+.++++++||||+++++++.+...+|+
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE---GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG---CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc---ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence            35899999999999999999998889999999986543222   223456789999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CC
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--ND  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~  431 (551)
                      ||||+.+ +|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ..
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9999986 88887764  5689999999999999999999999999999999999999999999999999876532  22


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC---------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP---------------  494 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~---------------  494 (551)
                      .....||+.|+|||++. ....++.++|||||||++|+|++|+.||.+....+.+.++...  .+               
T Consensus       157 ~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLM-GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             -----CCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cccccccccccCchhee-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            34456899999999973 3446899999999999999999999999887766665544321  00               


Q ss_pred             -----------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          495 -----------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       495 -----------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                                 ......++..+.+||.+||+.||.+|||++++++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                       01123578999999999999999999999999999999853

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.3e-47  Score=403.19  Aligned_cols=257  Identities=27%  Similarity=0.484  Sum_probs=215.6

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCe
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENR  352 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  352 (551)
                      .+.+|+++++||+|+||.||+|++ .+++.||||++.......  ......+..|..++.++ +||||+++++++.+...
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~--~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            356899999999999999999987 578999999997543322  22334566888888776 89999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--c
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--M  429 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--~  429 (551)
                      +|+|||||.||+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...  .
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999999999988865 469999999999999999999999999999999999999999999999999998532  2


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--------hHHHHHHhhcCCCCCCCCcC
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--------GMQALFRIGKGEPPLVPNSL  501 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~~  501 (551)
                      ......+||+.|+|||++  .+..|+.++|||||||++|||++|++||....        ....+..........+|..+
T Consensus       208 ~~~~~~~gt~~Y~aPE~l--~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  285 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  285 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred             CccccccCCcccCCchhh--cCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence            335567799999999997  45678999999999999999999999996321        12223333333345567789


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCH------HHHHhCcccCCc
Q 043852          502 SRDARDFILKCLQVNPNDRPTA------AQLMEHPFVKRP  535 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~------~eILehpff~~~  535 (551)
                      +..+.+||.+||++||.+||++      ++|++||||+..
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999999984      899999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.2e-47  Score=390.23  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=216.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||.||+|.+ .+++.||||++......    .....+.+|+.+++.++||||+++++++.+....|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc----chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            56899999999999999999988 48999999998654322    22345778999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC---
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~---  430 (551)
                      +|||||.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....   
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999999988754 6999999999999999999999999999999999999999999999999999754322   


Q ss_pred             -CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH-HHHhh-cCCCCCCCCcCCHHHHH
Q 043852          431 -DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA-LFRIG-KGEPPLVPNSLSRDARD  507 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~-~~~i~-~~~~~~~~~~~s~~l~~  507 (551)
                       ......||+.|+|||++. ....++.++|||||||++|+|++|+.||........ ..... ..........++..+.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHH-CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             cccCCCccCcCccCcHHhc-cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence             234567999999999974 233347899999999999999999999976554322 22222 22222233568999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                      ||.+||+.||.+|||+.|+++||||++...+...
T Consensus       241 li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~  274 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK  274 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCCCC
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhccccccccc
Confidence            9999999999999999999999999987765543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-47  Score=391.93  Aligned_cols=255  Identities=24%  Similarity=0.394  Sum_probs=222.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|.+++.||+|+||.||+|.+ .++..||+|.+...      ......+.+|+.++..++||||+++++++.+...+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence            45899999999999999999987 57999999998632      123446779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC--CCcEEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~--~g~vkL~DFGla~~~~~~  430 (551)
                      +|||||.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.....
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999999998754  5899999999999999999999999999999999999987  789999999999866433


Q ss_pred             C-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---CcCCHHHH
Q 043852          431 D-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDAR  506 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l~  506 (551)
                      . .....||+.|+|||++.  ...++.++|||||||++|+|++|..||.+....+.+..+..+......   ..++..+.
T Consensus       158 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHT--TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CccccccCChhhcCcHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            2 34456999999999973  456799999999999999999999999988887777777766554432   46899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      +||.+||+.||.+|||+.++|+||||++....
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  267 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCccc
Confidence            99999999999999999999999999876543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.7e-47  Score=396.29  Aligned_cols=256  Identities=29%  Similarity=0.478  Sum_probs=215.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +.|++.+.||+|+||.||+|.+ .+|+.||||++...............+.+|+.++..++||||+++++++.+...+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3699999999999999999987 589999999987543222212234567899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc---EEEEecCCcccc
Q 043852          356 FLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKAT  427 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~-----~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~---vkL~DFGla~~~  427 (551)
                      |||||.+++|.+++.+.     .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998776543     3889999999999999999999999999999999999987654   999999999766


Q ss_pred             ccCC--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---CcCC
Q 043852          428 TMND--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLS  502 (551)
Q Consensus       428 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s  502 (551)
                      ....  .....||+.|+|||++  ....++.++|||||||++|+|++|..||.+.. ......+..+.....+   ..++
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s  260 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVV--KREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS  260 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             cCCCeeecCCcCCcCccCHHHH--cCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence            4433  3445799999999997  35578999999999999999999999998754 3444455555433322   4689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            999999999999999999999999999999863

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-47  Score=392.38  Aligned_cols=268  Identities=26%  Similarity=0.445  Sum_probs=222.7

Q ss_pred             hhhhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          271 KFRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       271 ~~~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      ......++|++++.||+|+||.||+|.+ .++..||+|++...............+.+|+.++.+++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3334456899999999999999999987 688999999987543222233455678899999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhh-----------------------------------------hcCChHHHHHHHHHHHH
Q 043852          350 ENRLFIFLELVTKGSLANLYQK-----------------------------------------YHLMDSQVSAYTRQILN  388 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~-----------------------------------------~~l~~~~i~~i~~QI~~  388 (551)
                      ...+|+|||||.+++|.+++..                                         ..+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999998851                                         12456778899999999


Q ss_pred             HHHHHHhCCeeecccccceEEEcCCC--cEEEEecCCccccccC------CcccCCCCCcccChhhhhcccCCCCchhhH
Q 043852          389 GLNYLHEQNVVHRDIKCANILVDASG--SVKLADFGLAKATTMN------DVKSCKGTPFWMAPEVVNLKNRGYGLTADI  460 (551)
Q Consensus       389 aL~yLH~~gIiHrDIKP~NILl~~~g--~vkL~DFGla~~~~~~------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDI  460 (551)
                      ||.|||++||+||||||+|||++.++  .+||+|||+++.....      ......||+.|+|||++......++.++||
T Consensus       180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            99999999999999999999998776  8999999999754321      123456999999999985445678999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          461 WSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       461 wSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |||||++|+|++|+.||.+....+....+.........   ..++..+.+||.+||+.||.+|||+.++++||||++...
T Consensus       260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            99999999999999999988888777777665543332   247999999999999999999999999999999987654


Q ss_pred             c
Q 043852          538 K  538 (551)
Q Consensus       538 ~  538 (551)
                      +
T Consensus       340 ~  340 (345)
T 3hko_A          340 K  340 (345)
T ss_dssp             C
T ss_pred             h
Confidence            4

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.2e-47  Score=405.66  Aligned_cols=260  Identities=25%  Similarity=0.389  Sum_probs=222.3

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ...++|+++++||+|+||+||+|++ .+++.||+|++.......  ......+.+|+.++..++||||+++++++.+...
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3456899999999999999999988 579999999986532111  0112236689999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          353 LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      +|+|||||.||+|.+++++..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            9999999999999999998899999999999999999999999999999999999999999999999999997654432 


Q ss_pred             --cccCCCCCcccChhhhhcccC--CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC---CCCCCCcCCHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNR--GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRD  504 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~--~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~  504 (551)
                        ....+||+.|+|||++.....  .|+.++|||||||++|||++|++||.+.+......++....   ..+....++..
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence              345679999999999853221  17899999999999999999999999888877777776532   22223468999


Q ss_pred             HHHHHHHhhhcCCCC--CCCHHHHHhCcccCCc
Q 043852          505 ARDFILKCLQVNPND--RPTAAQLMEHPFVKRP  535 (551)
Q Consensus       505 l~~LI~~cL~~DP~~--RPS~~eILehpff~~~  535 (551)
                      +.+||.+||+.+|.+  ||++++|++||||+..
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            999999999999988  9999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3e-47  Score=397.58  Aligned_cols=257  Identities=29%  Similarity=0.491  Sum_probs=222.6

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      ..+++|++++.||+|+||.||+|++ .+|+.||||++.......  ......+..|..++..+ +||||+++++++.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh--hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            4567999999999999999999988 579999999997532111  12234566788888876 8999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--  428 (551)
                      .+|+|||||.||+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...  
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999998875 568999999999999999999999999999999999999999999999999997543  


Q ss_pred             cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       429 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .......+||+.|+|||++  .+..++.++|||||||++|||++|..||.+.+..+....+....+ .++..++..+.+|
T Consensus       172 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l  248 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEIL--LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDL  248 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHH
T ss_pred             CCcccCCCCCcccCChhhh--cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccCHHHHHH
Confidence            2334566799999999997  456789999999999999999999999998888777777766653 4567799999999


Q ss_pred             HHHhhhcCCCCCCCHH-HHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTAA-QLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~-eILehpff~~~  535 (551)
                      |.+||+.||.+||++. +|++||||+..
T Consensus       249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          249 LVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            9999999999999998 99999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.2e-47  Score=394.66  Aligned_cols=255  Identities=26%  Similarity=0.432  Sum_probs=225.2

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|++++.||+|+||.||+|++ .+|+.||||++......  .......+.+|+.++..++||||+++++++.+...+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc--cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            456899999999999999999987 57999999998653221  112345677999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      |+|||||.||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~  195 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-T  195 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-B
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-c
Confidence            999999999999998875 46899999999999999999999999999999999999999999999999999865433 3


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ...+||+.|+|||++  .+..++.++|||||||++|+|++|..||.+.+..+...++..+.. .++..++..+.+||.+|
T Consensus       196 ~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~l  272 (350)
T 1rdq_E          196 WTLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             CCCEECGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHH
T ss_pred             ccccCCccccCHHHh--cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHH
Confidence            456799999999997  456789999999999999999999999998888888877777654 45678999999999999


Q ss_pred             hhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          513 LQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       513 L~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      |+.||.+||+     +++|++||||+..
T Consensus       273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          273 LQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            9999999998     9999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-47  Score=398.88  Aligned_cols=261  Identities=27%  Similarity=0.424  Sum_probs=210.1

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCC--
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDE--  350 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--  350 (551)
                      .+.+|++++.||+|+||.||+|.+ .+|+.||||++...   .........+.+|+.++..+. |+||+++++++...  
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc---ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            356899999999999999999987 68999999998543   223445567789999999997 99999999998643  


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc-
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~-  429 (551)
                      ..+|+|||||.+ +|..++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus        84 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           84 RDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             SCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             CEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            478999999975 899999888899999999999999999999999999999999999999999999999999975421 


Q ss_pred             ----------------------CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 043852          430 ----------------------NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF  487 (551)
Q Consensus       430 ----------------------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~  487 (551)
                                            ......+||+.|+|||++. ....|+.++|||||||++|||++|++||.+.+....+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhc-CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                                  1123457999999999973 34678999999999999999999999999888777666


Q ss_pred             HhhcCCCC----------------------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCC
Q 043852          488 RIGKGEPP----------------------------------------------LVPNSLSRDARDFILKCLQVNPNDRP  521 (551)
Q Consensus       488 ~i~~~~~~----------------------------------------------~~~~~~s~~l~~LI~~cL~~DP~~RP  521 (551)
                      ++......                                              .....++..+.+||.+||+.||.+||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence            55321100                                              01126789999999999999999999


Q ss_pred             CHHHHHhCcccCCccccCC
Q 043852          522 TAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       522 S~~eILehpff~~~~~~~~  540 (551)
                      |++++|+||||+.......
T Consensus       322 t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          322 SANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             CHHHHTTSTTTTTTCCGGG
T ss_pred             CHHHHhCCHHHHHhcCCcc
Confidence            9999999999987654443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=387.23  Aligned_cols=258  Identities=29%  Similarity=0.484  Sum_probs=222.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccc-hHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQG-KQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +.|.+++.||+|+||.||+|.+ .+|..||+|++......... ......+.+|+.++.+++||||+++++++.+...+|
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3699999999999999999988 57999999999765433221 123456789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC----cEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g----~vkL~DFGla~~~~~  429 (551)
                      +|||||.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            99999999999998865 4589999999999999999999999999999999999998887    899999999986643


Q ss_pred             -CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHH
Q 043852          430 -NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDA  505 (551)
Q Consensus       430 -~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l  505 (551)
                       .......||+.|+|||++  ....++.++|||||||++|+|++|..||.+....+.+..+........   ...++..+
T Consensus       171 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA  248 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCccccccCCcCcCCceee--cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence             334556799999999997  456789999999999999999999999988877777666655443332   24689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .+||.+||+.||.+|||+.++++||||+...
T Consensus       249 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-46  Score=393.65  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=222.5

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      ..+.+|++++.||+|+||.||+|.+ .+|+.||||++......  .......+..|..++..+ +||||+++++++.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            3466999999999999999999988 46899999998753221  112345667899999887 7999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--  428 (551)
                      .+|+|||||.||+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...  
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999998875 569999999999999999999999999999999999999999999999999998543  


Q ss_pred             cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       429 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .......+||+.|+|||++  ....++.++|||||||++|||++|+.||.+.+..+....+..... .++..++..+.+|
T Consensus       175 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l  251 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAI  251 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHH--TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHH
T ss_pred             CcccccccCCccccChhhh--cCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHH
Confidence            2234566799999999997  456789999999999999999999999998888777777776654 4567899999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      |.+||++||.+||+     +++|++||||+..
T Consensus       252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            99999999999994     7999999999853

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-46  Score=385.49  Aligned_cols=260  Identities=32%  Similarity=0.540  Sum_probs=202.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..+|++++.||+|+||.||+|.+ .+|..||||++.......    ....+.+|+.++++++||||+++++++.+...+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            35799999999999999999987 579999999997543221    2235668999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          355 IFLELVTKGSLANLYQKY-------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      +||||+.+ +|.+++...       .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            99999985 888887643       4888999999999999999999999999999999999999999999999999765


Q ss_pred             cc--CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC---------
Q 043852          428 TM--NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP---------  494 (551)
Q Consensus       428 ~~--~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~---------  494 (551)
                      ..  .......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+....+.+..+...  .+         
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLM-GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcccCCCCcccccccCchHhh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            43  2334557899999999973 3346899999999999999999999999887776665544321  00         


Q ss_pred             ----------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          495 ----------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       495 ----------------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                                            +.....++..+.+||.+||+.||.+|||+.++++||||++.......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence                                  00122578899999999999999999999999999999987765443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2e-46  Score=393.18  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=220.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||+|+||.||+|.+ .+|..||+|++.....   .......+.+|+.++.+++||||+++++++.+...+|+
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            4799999999999999999987 5799999999975433   23445678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC---cEEEEecCCccccccCC
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKATTMND  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g---~vkL~DFGla~~~~~~~  431 (551)
                      |||||.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++.......
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            9999999999887754 4589999999999999999999999999999999999998654   59999999997664332


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---CcCCHHHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARD  507 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l~~  507 (551)
                       .....||+.|+|||++  ....++.++|||||||++|+|++|.+||.+.+.......+..+......   ..++..+.+
T Consensus       186 ~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  263 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  263 (362)
T ss_dssp             SCCCSCSCTTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred             ccccCCCCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence             3456799999999997  4557899999999999999999999999988877777777666543322   468999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ||.+||++||.+|||+.++|+||||+..
T Consensus       264 li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          264 LIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-46  Score=377.11  Aligned_cols=261  Identities=29%  Similarity=0.516  Sum_probs=221.9

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|++++.||+|+||.||+|.+ .++..||||++......  .......+.+|+.++.+++||||+++++++.+....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc--hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            467899999999999999999987 57889999998643211  122345678999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      ++||||+.+++|.+++.+ ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~  164 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  164 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence            999999999999988865 4689999999999999999999999999999999999999999999999999876655555


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ....||+.|+|||++  .+..++.++|||||||++|+|++|..||...........+.... ...+..++..+.+||.+|
T Consensus       165 ~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  241 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRL  241 (279)
T ss_dssp             ---CCCCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred             cccCCCCCccCHhHh--ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHH
Confidence            666799999999997  45677899999999999999999999999887777766665544 345677999999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      |+.||.+|||+.+|++||||+....+..
T Consensus       242 l~~~p~~Rps~~e~l~h~~~~~~~~~~~  269 (279)
T 3fdn_A          242 LKHNPSQRPMLREVLEHPWITANSSKPS  269 (279)
T ss_dssp             CCSSGGGSCCHHHHHHCHHHHHHCSSCC
T ss_pred             hccChhhCCCHHHHhhCccccCCccCcc
Confidence            9999999999999999999987665443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-46  Score=383.45  Aligned_cols=252  Identities=34%  Similarity=0.595  Sum_probs=221.0

Q ss_pred             CeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|...+.||+|+||.||+|.+. +|+.||||++.....     .....+.+|+.++.+++|+||+++++++......|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            3777789999999999999884 899999999875432     2234577999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~  434 (551)
                      |||+.+++|.+++.+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  ....
T Consensus       121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            99999999999999888999999999999999999999999999999999999999999999999998765432  2345


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~LI~~c  512 (551)
                      ..||+.|+|||++  ....++.++|||||||++|+|++|+.||......+....+.....+..  ...++..+.+||.+|
T Consensus       201 ~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          201 LVGTPYWMAPEVI--SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             ccCCccccCHhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            6799999999997  455789999999999999999999999988877777777666554433  346899999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCcc
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~  536 (551)
                      |+.||.+|||+.++++||||++..
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999998643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.3e-46  Score=385.15  Aligned_cols=256  Identities=28%  Similarity=0.454  Sum_probs=213.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .++|++++.||+|+||.||++.+    .+|+.||||++...... ........+.+|+.++.+++||||+++++++.+..
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            45899999999999999999986    47999999998654321 12233445678999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+|+|||||.+++|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            999999999999999988754 5889999999999999999999999999999999999999999999999998754322


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                        ......||+.|+|||++  ....++.++|||||||++|+|++|+.||.+.+....+.++..... ..+..++..+.+|
T Consensus       175 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~l  251 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEIL--MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARDL  251 (327)
T ss_dssp             ----CTTSSCCTTSCHHHH--TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHH
T ss_pred             CccccccCCCcCccCHhhC--cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHH
Confidence              23456799999999997  456789999999999999999999999998887777777766543 4566799999999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      |.+||+.||.+||     ++.++++||||+..
T Consensus       252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            9999999999999     89999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.5e-46  Score=393.08  Aligned_cols=261  Identities=25%  Similarity=0.425  Sum_probs=216.0

Q ss_pred             hcccCeeeeeEeccC--CceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          274 RRIMSWQKGELLGSG--SFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G--~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ...++|+++++||+|  +||.||+|.+ .+|+.||||++.....   .......+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            345689999999999  9999999998 4899999999975432   234566788999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      ..+|+|||||.+++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999999998865   46899999999999999999999999999999999999999999999999987543


Q ss_pred             cc---------CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC---
Q 043852          428 TM---------NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP---  495 (551)
Q Consensus       428 ~~---------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~---  495 (551)
                      ..         .......||+.|+|||++......++.++|||||||++|+|++|+.||.+......+..+..+..+   
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            21         112234689999999998533367899999999999999999999999876655554443332211   


Q ss_pred             ------------------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          496 ------------------------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       496 ------------------------------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                                                                ..+..++..+.+||.+||+.||.+|||+.++|+||||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                      13345788999999999999999999999999999999


Q ss_pred             Cccc
Q 043852          534 RPLQ  537 (551)
Q Consensus       534 ~~~~  537 (551)
                      +...
T Consensus       339 ~~~~  342 (389)
T 3gni_B          339 QIKR  342 (389)
T ss_dssp             GC--
T ss_pred             HHhh
Confidence            7654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=379.14  Aligned_cols=258  Identities=26%  Similarity=0.454  Sum_probs=212.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||.||+|.+ .+|..||||++....   ........+.+|+.++.+++||||+++++++.+....+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            46899999999999999999988 579999999886432   23344566789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--C
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~  431 (551)
                      +|||||.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999999999988764 45899999999999999999999999999999999999999999999999999765422  2


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC-------------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-------------------  492 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~-------------------  492 (551)
                      .....||+.|+|||++. ....++.++|||||||++|+|++|..||.+....+....+...                   
T Consensus       159 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 YDDEVATRWYRSPELLV-GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             -------GGGCCHHHHH-TCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             cCCCcCCccccChHHHh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            34456899999999973 3457899999999999999999999999887766555443221                   


Q ss_pred             -CCCCC----------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          493 -EPPLV----------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       493 -~~~~~----------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                       .....          ...++..+.+||.+||+.||.+|||++++++||||++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence             00000          1357889999999999999999999999999999997643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=402.26  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=220.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|++++.||+|+||.||+|.+ .+|..||+|++.....   .......+.+|+.+++.++||||+++++++.+...+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            35799999999999999999987 6899999999875432   2334567889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc---CCCcEEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~---~~g~vkL~DFGla~~~~~~  430 (551)
                      +|||||.||+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            99999999999887754 5689999999999999999999999999999999999998   4678999999999765433


Q ss_pred             C--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---CcCCHHH
Q 043852          431 D--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDA  505 (551)
Q Consensus       431 ~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l  505 (551)
                      .  .....||+.|+|||++  ....|+.++|||||||++|+|++|.+||.+.+....+..+..+......   ..++..+
T Consensus       167 ~~~~~~~~gt~~Y~APE~l--~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVL--RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CceeecccCCcccCCHHHh--cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            2  3456799999999997  4557899999999999999999999999988887777777766543332   4689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      .+||.+||+.||.+|||+.++|+||||+..
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999999999753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=396.74  Aligned_cols=259  Identities=25%  Similarity=0.464  Sum_probs=219.9

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|++++.||+|+||.||+|.+ .+++.||+|++......  .......+.+|+.++..++||||+++++++.+...+
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV--ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc--cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356899999999999999999987 57999999998653211  122345678999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc-CC
Q 043852          354 FIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM-ND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~-~~  431 (551)
                      |+|||||.||+|..+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ..
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            9999999999999988764 689999999999999999999999999999999999999999999999999986543 33


Q ss_pred             cccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCch--hHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--GMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      ....+||+.|+|||++... +..|+.++|||||||++|+|++|+.||....  ....+...........+..++..+.+|
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~l  250 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL  250 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHH
Confidence            4567799999999998432 3468999999999999999999999996432  222222222334455677899999999


Q ss_pred             HHHhhhcCCCCCCC-HHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPT-AAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS-~~eILehpff~~~  535 (551)
                      |.+||+.||.+||+ +++|++||||+..
T Consensus       251 i~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            99999999999998 9999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.1e-46  Score=392.33  Aligned_cols=257  Identities=27%  Similarity=0.427  Sum_probs=215.4

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHH-HhcCCCCceeeeeeeccCCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILL-LSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~  351 (551)
                      ..+++|++++.||+|+||.||+|++ .++..||||++.......  ......+..|..+ ++.++||||+++++++.+..
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            4456899999999999999999988 578999999997653322  2233445566665 57789999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--  428 (551)
                      .+|+|||||.||+|..++++ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...  
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999998875 458899999999999999999999999999999999999999999999999998533  


Q ss_pred             cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       429 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .......+||+.|+|||++  .+..++.++|||||||++|||++|..||.+.+..+....+..... .++..++..+.+|
T Consensus       193 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l  269 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVL--HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHL  269 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CCCSSSCHHHHHH
T ss_pred             CCccccccCCccccCHHHh--CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHH
Confidence            2234566799999999997  456789999999999999999999999998888877777776643 4466799999999


Q ss_pred             HHHhhhcCCCCCCCH----HHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTA----AQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~----~eILehpff~~~  535 (551)
                      |.+||++||.+||++    .+|++||||+..
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999986    699999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.6e-47  Score=395.52  Aligned_cols=261  Identities=27%  Similarity=0.428  Sum_probs=217.9

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|.+++.||+|+||.||+|.+ .+|+.||||++.......  ......+.+|+.+++.++||||+++++++.+...
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK--SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc--hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4577999999999999999999987 689999999986432111  1123467799999999999999999999999999


Q ss_pred             EEEEEecccccchHHHH-hhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-
Q 043852          353 LFIFLELVTKGSLANLY-QKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll-~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-  430 (551)
                      +|+||||+ +|+|.+++ ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999999 56777665 4567999999999999999999999999999999999999999999999999999765433 


Q ss_pred             CcccCCCCCcccChhhhhcccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGY-GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~-s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      .....+||+.|+|||++.  +..+ +.++|||||||++|+|++|..||...........+.. .....+..++..+.+||
T Consensus       163 ~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li  239 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVIN--GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS-CVYVMPDFLSPGAQSLI  239 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSC--CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS-SCCCCCTTSCHHHHHHH
T ss_pred             ccccccCCcCcCCHHHHc--CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCcccCCHHHHHHH
Confidence            245567999999999973  3333 7899999999999999999999976544333322222 23445677999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      .+||+.||.+|||+++|++||||+...+...
T Consensus       240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  270 (336)
T 3h4j_B          240 RRMIVADPMQRITIQEIRRDPWFNVNLPDYL  270 (336)
T ss_dssp             HTTSCSSGGGSCCHHHHTTCHHHHTTCCGGG
T ss_pred             HHHcCCChhHCcCHHHHHhChhhccCCcccc
Confidence            9999999999999999999999997665443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=381.82  Aligned_cols=258  Identities=31%  Similarity=0.532  Sum_probs=207.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC---CCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF---EHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~  351 (551)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++...............+.+|+.+++.+   +||||+++++++.+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            35899999999999999999987 6899999999975543222222222344566665555   5999999999987654


Q ss_pred             -----eEEEEEecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCC
Q 043852          352 -----RLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       352 -----~~~lV~Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                           .++++|||+.+ +|.+++....   +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence                 58999999975 9988887643   89999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--CC--C--
Q 043852          424 AKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--PP--L--  496 (551)
Q Consensus       424 a~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~--~--  496 (551)
                      ++..... ......||+.|+|||++  ....++.++|||||||++|+|++|++||.+......+.++....  ++  .  
T Consensus       167 a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          167 ARIYSYQMALTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             TTTSTTCCCSGGGGCCCSSCCHHHH--HTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccCCCcccCCccccccccCchHH--cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            9765433 33456799999999997  35678999999999999999999999998887776665553311  00  0  


Q ss_pred             --------------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          497 --------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       497 --------------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                          ....++..+.+||.+||++||.+|||+.++|+||||++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                                1135789999999999999999999999999999999753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.3e-46  Score=382.40  Aligned_cols=252  Identities=24%  Similarity=0.429  Sum_probs=206.8

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC--
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN--  351 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--  351 (551)
                      .+++|++++.||+|+||.||+|++ .+|..||||++....    .......+.+|+.++.+++||||+++++++.+..  
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence            456899999999999999999998 489999999997543    2234567889999999999999999999875432  


Q ss_pred             -------------------------------------------------------eEEEEEecccccchHHHHhhhc---
Q 043852          352 -------------------------------------------------------RLFIFLELVTKGSLANLYQKYH---  373 (551)
Q Consensus       352 -------------------------------------------------------~~~lV~Ey~~ggsL~~ll~~~~---  373 (551)
                                                                             .+|++||||.+++|.++++...   
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  159 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE  159 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence                                                                   3899999999999999987643   


Q ss_pred             -CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--------------cccCCCC
Q 043852          374 -LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--------------VKSCKGT  438 (551)
Q Consensus       374 -l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--------------~~~~~GT  438 (551)
                       .....++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......              .....||
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence             4445688999999999999999999999999999999999999999999997654331              2335699


Q ss_pred             CcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCC
Q 043852          439 PFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPN  518 (551)
Q Consensus       439 ~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~  518 (551)
                      +.|+|||++  .+..++.++|||||||++|+|++|..|+..  .......+.....+......+..+.+||.+||+.||.
T Consensus       240 ~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          240 KLYMSPEQI--HGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             GGGSCHHHH--HCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             cCccChHHh--cCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCC
Confidence            999999997  456789999999999999999998777532  2233334444443333445678899999999999999


Q ss_pred             CCCCHHHHHhCcccCC
Q 043852          519 DRPTAAQLMEHPFVKR  534 (551)
Q Consensus       519 ~RPS~~eILehpff~~  534 (551)
                      +|||+.++++||||++
T Consensus       316 ~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          316 ERPEATDIIENAIFEN  331 (332)
T ss_dssp             GSCCHHHHHHSTTCCC
T ss_pred             cCCCHHHHhhchhhhc
Confidence            9999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-45  Score=368.72  Aligned_cols=259  Identities=28%  Similarity=0.451  Sum_probs=222.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|++.+.||+|+||.||+|.+ .+|..||+|++.....   .......+.+|+.++.+++||||+++++++.+....|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   81 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence            35899999999999999999987 5799999999875432   2344567889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc---EEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~---vkL~DFGla~~~~~~  430 (551)
                      ++|||+.+++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999999999877654 45899999999999999999999999999999999999987655   999999999765433


Q ss_pred             C-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---CCCcCCHHHH
Q 043852          431 D-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDAR  506 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~  506 (551)
                      . .....||+.|+|||++  ....++.++|||||||++|+|++|..||...........+..+....   ....++..+.
T Consensus       162 ~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             ccccCCCCCcCCcCchhh--cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence            3 3456799999999997  45578999999999999999999999998887777776665554322   2246899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      +||.+||+.||.+|||+.++++||||++.....
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence            999999999999999999999999998765443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.4e-46  Score=371.90  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=221.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|.+ .++..+|+|++......     ....+.+|+.++.+++||||+++++++.+....|+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            4799999999999999999987 56889999998754322     24467799999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE---cCCCcEEEEecCCccccccC-
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl---~~~g~vkL~DFGla~~~~~~-  430 (551)
                      ||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||+   +.++.++|+|||++...... 
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9999999999887764 458999999999999999999999999999999999999   78899999999999765433 


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---CcCCHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARD  507 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l~~  507 (551)
                      ......||+.|+|||++.   ..++.++|||||||++|+|++|+.||......+....+..+......   ..++..+.+
T Consensus       164 ~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHT---TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             chhccCCCCCccChHHhc---ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence            334566999999999873   34899999999999999999999999988888877777776554433   268999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ||.+||+.||.+|||+.++++||||++.+..+
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence            99999999999999999999999998766543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.2e-46  Score=400.51  Aligned_cols=256  Identities=27%  Similarity=0.448  Sum_probs=214.3

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|+++++||+|+||.||+|.+ .+|..||||++......  .......+.+|+.++..++||||+++++++.+...+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV--AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh--hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            456899999999999999999987 58999999998743211  123345667899999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCcccccc--
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTM--  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--  429 (551)
                      |+|||||.+++|..++.+ ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++....  
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            999999999999988865 458999999999999999999998 9999999999999999999999999999975432  


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ......+||+.|+|||++  .+..++.++|||||||++|||++|+.||.+.+.......+..... .++..++..+.+||
T Consensus       304 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li  380 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLL  380 (446)
T ss_dssp             ---CCSSSCGGGCCHHHH--HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred             cccccccCCccccCHhhc--CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHH
Confidence            234556799999999997  456789999999999999999999999988877777766665543 45677999999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          510 LKCLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       510 ~~cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      .+||++||.+||     |++++++||||+..
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999     99999999999865

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.2e-46  Score=372.75  Aligned_cols=258  Identities=29%  Similarity=0.489  Sum_probs=224.3

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|++++.||+|+||.||+|.+ .++..||||++.......  ......+.+|+.++..++|+||+++++++.+...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK--EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch--HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            356899999999999999999987 478899999986432111  12235678999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      |++|||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            999999999999998865 4689999999999999999999999999999999999999999999999999876655555


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ....||+.|+|||++  .+..++.++|||||||++|+|++|..||...........+..... ..+..++..+.+||.+|
T Consensus       170 ~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~  246 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMI--EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISKL  246 (284)
T ss_dssp             CCCCSCGGGCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHHH
T ss_pred             ccccCCCCcCCHHHh--ccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-CCCCcCCHHHHHHHHHH
Confidence            566799999999997  355679999999999999999999999988777776666665543 45677899999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCccc
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |+.||.+|||+.++++||||+....
T Consensus       247 l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          247 LRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             SCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             hhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            9999999999999999999986554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=391.30  Aligned_cols=255  Identities=28%  Similarity=0.470  Sum_probs=221.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .+.|++++.||+|+||.||+|.+ .+|..||+|++....     ......+.+|+.++.+++||||+++++++.+...+|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence            46899999999999999999987 579999999986432     223446789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC--CCcEEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~--~g~vkL~DFGla~~~~~~  430 (551)
                      +|||||.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.....
T Consensus       125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999999988653  5899999999999999999999999999999999999974  467999999999866443


Q ss_pred             C-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---CCCcCCHHHH
Q 043852          431 D-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDAR  506 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~  506 (551)
                      . .....||+.|+|||++  ....++.++|||||||++|+|++|..||.+....+.+..+.......   ....++..+.
T Consensus       205 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIV--DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             SCEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             cceeeeccCCCccCchhc--cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            2 3345699999999997  45678999999999999999999999999888777777766654332   2356899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +||.+||+.||.+|||+.++++||||+....
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            9999999999999999999999999987543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=388.23  Aligned_cols=257  Identities=25%  Similarity=0.439  Sum_probs=212.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----  351 (551)
                      .+|++++.||+|+||.||+|.+ .+|+.||||++....   ........+.+|+.+++.++||||+++++++....    
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            4799999999999999999988 689999999885432   23445667889999999999999999999987653    


Q ss_pred             --eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 --RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 --~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                        .+|+||||+ +++|.++++...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence              469999999 78999999888899999999999999999999999999999999999999999999999999986543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC-------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP-------------  494 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~-------------  494 (551)
                       ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+..+.+..+...  .+             
T Consensus       181 -~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          181 -EMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             -SCCSSCSCGGGCCTHHHH-TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             -ccCcCcCCCCcCCHHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence             345567999999999973 3357899999999999999999999999988776665544321  10             


Q ss_pred             ---------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 ---------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 ---------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                                     ......++..+.+||.+||+.||.+|||++++|+||||+......
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence                           112245789999999999999999999999999999999766544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-45  Score=386.98  Aligned_cols=254  Identities=26%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|++++.||+|+||.||++++ .+++.||||++......      ...+.+|+.+++.++||||+++++++.+...+|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            45899999999999999999988 58999999998653322      135678999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc--EEEEecCCcccccc-C
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS--VKLADFGLAKATTM-N  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~--vkL~DFGla~~~~~-~  430 (551)
                      +|||||.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... .
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            99999999999988864 56999999999999999999999999999999999999987765  99999999874332 2


Q ss_pred             CcccCCCCCcccChhhhhcccCCCC-chhhHHHHHHHHHHHHcCCCCCCCchh----HHHHHHhhcCCCC-CCCCcCCHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYG-LTADIWSLGCTVLEMLTRQPPYSHLEG----MQALFRIGKGEPP-LVPNSLSRD  504 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s-~ksDIwSLG~iLyeLltG~~Pf~~~~~----~~~~~~i~~~~~~-~~~~~~s~~  504 (551)
                      ......||+.|+|||++.  +..++ .++|||||||++|+|++|+.||.+...    ...+..+...... .....++..
T Consensus       173 ~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  250 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLL--RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE  250 (361)
T ss_dssp             --------CTTSCHHHHH--CSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred             CCCCCcCCCCcCChhhhc--CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence            334567999999999973  34454 448999999999999999999976443    2333333333222 223368999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +.+||.+||+.||.+|||+.++++||||.+.+.
T Consensus       251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            999999999999999999999999999976654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-45  Score=370.53  Aligned_cols=251  Identities=30%  Similarity=0.474  Sum_probs=210.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|.+.+.||+|+||.||++.+ .++..+|+|++......    .....+.+|+.++.+++||||+++++++.+...+|+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            4799999999999999999987 57999999998754322    224567899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE---cCCCcEEEEecCCcccc
Q 043852          356 FLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKAT  427 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl---~~~g~vkL~DFGla~~~  427 (551)
                      ||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999999887743     458999999999999999999999999999999999999   45678999999999765


Q ss_pred             ccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHH
Q 043852          428 TMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRD  504 (551)
Q Consensus       428 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~  504 (551)
                      ... ......||+.|+|||++.   ..++.++|||||||++|+|++|..||.+.........+.......  ....++..
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             ---------CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             CCcccCcCcccccCcCChHHhc---cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence            433 234566999999999873   468999999999999999999999998877666655554443322  22347899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      +.+||.+||+.||.+|||+.++++||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.2e-46  Score=401.97  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=219.8

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ..++|+++++||+|+||+||+|++ .+++.||||++.......  ......+.+|+.++..++||||+++++++.+...+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--RAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            346899999999999999999988 578999999986432111  11122367899999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          354 FIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |+|||||.||+|.+++.+  ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999976  569999999999999999999999999999999999999999999999999997654332


Q ss_pred             ---cccCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC----CCCCCCCcC
Q 043852          432 ---VKSCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG----EPPLVPNSL  501 (551)
Q Consensus       432 ---~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~  501 (551)
                         ....+||+.|+|||++..   ....|+.++|||||||++|||++|+.||.+.+..+.+.++...    ..+.....+
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  309 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV  309 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence               234579999999999842   1456899999999999999999999999988877777766542    223333568


Q ss_pred             CHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccCCc
Q 043852          502 SRDARDFILKCLQVNPND--RPTAAQLMEHPFVKRP  535 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~--RPS~~eILehpff~~~  535 (551)
                      +..+.+||.+||..+|++  |+++++|++||||+..
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            999999999999988888  9999999999999853

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=397.89  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=218.1

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ..++|+++++||+|+||+||+|++ .+|+.||||++......  .......+.+|+.++..++|+||+++++++.+...+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML--KRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            356899999999999999999988 58999999998643211  112233467899999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          354 FIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |+|||||.||+|.+++.+.  .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            9999999999999999764  58999999999999999999999999999999999999999999999999997654432


Q ss_pred             ---cccCCCCCcccChhhhhcc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC----CCCCCCC
Q 043852          432 ---VKSCKGTPFWMAPEVVNLK-----NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG----EPPLVPN  499 (551)
Q Consensus       432 ---~~~~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~----~~~~~~~  499 (551)
                         ....+||+.|+|||++...     ...|+.++|||||||++|||++|+.||.+.+..+.+.++...    ..+..+.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence               2345799999999998532     346899999999999999999999999988877777666542    2233346


Q ss_pred             cCCHHHHHHHHHhhhcCCCCC---CCHHHHHhCcccCCc
Q 043852          500 SLSRDARDFILKCLQVNPNDR---PTAAQLMEHPFVKRP  535 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~R---PS~~eILehpff~~~  535 (551)
                      .++.++++||.+||. +|.+|   |++++|++||||+..
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            799999999999999 99998   599999999999754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-45  Score=367.40  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=212.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRL  353 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  353 (551)
                      .++|++++.||+|+||.||+|.+ .++..||||++......   ......+.+|+.++..+ +||||+++++++.+...+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            45899999999999999999988 48999999998754332   23455677899999998 899999999999999999


Q ss_pred             EEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC---------------
Q 043852          354 FIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS---------------  413 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~---------------  413 (551)
                      |+||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.+               
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999998875     348999999999999999999999999999999999999844               


Q ss_pred             ----CcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHh
Q 043852          414 ----GSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI  489 (551)
Q Consensus       414 ----g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i  489 (551)
                          ..+||+|||++......  ....||+.|+|||++. ....++.++|||||||++|+|++|.+++.....   ...+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHT-TCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH
T ss_pred             cCCceEEEEcccccccccCCc--cccCCCccccChhHhc-CCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH
Confidence                47999999998765433  3345999999999984 334567899999999999999999988765543   3445


Q ss_pred             hcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          490 GKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       490 ~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ..+..+..+..++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            55666777888999999999999999999999999999999998654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=383.11  Aligned_cols=260  Identities=29%  Similarity=0.462  Sum_probs=209.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||.||+|.+ .++..||||++.......    ....+.+|+.++.+++||||+++++++.+...+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   76 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc----cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence            46899999999999999999988 489999999986433211    1112347899999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      +||||+.+ +|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           77 LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             EEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            99999985 887777643  4888999999999999999999999999999999999999999999999998755422  


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--C--CC----------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--P--PL----------  496 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~--~~----------  496 (551)
                      ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+....+.+..+....  +  ..          
T Consensus       156 ~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILL-GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -------CGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccccCcccccChhhhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            234456899999999973 34578999999999999999999999998877766655543311  0  00          


Q ss_pred             ---------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          497 ---------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       497 ---------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                                     ....++..+.+||.+||+.||.+|||++++|+||||+....+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  294 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK  294 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence                           012478899999999999999999999999999999977655443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-45  Score=373.87  Aligned_cols=255  Identities=39%  Similarity=0.704  Sum_probs=228.1

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|++++.||+|+||.||+|.+ .++..||||++......    .....+.+|+.++.++.|+||+++++++.+...+|+|
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            699999999999999999987 57999999998754322    2355778999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--ccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~  434 (551)
                      |||+.+++|.+++....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......  ...
T Consensus        99 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A           99 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             EECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            999999999999998889999999999999999999999999999999999999999999999999997654332  344


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ  514 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~  514 (551)
                      ..||+.|+|||++  ....++.++|||||||++|+|++|+.||...........+.....+..+..++..+.+||.+||+
T Consensus       179 ~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  256 (303)
T 3a7i_A          179 FVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  256 (303)
T ss_dssp             CCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCC
T ss_pred             cCCCcCccCHHHH--hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcC
Confidence            5689999999997  45578899999999999999999999999888877777777777777888899999999999999


Q ss_pred             cCCCCCCCHHHHHhCcccCCcccc
Q 043852          515 VNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       515 ~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      .||.+|||+.++++||||.+...+
T Consensus       257 ~dp~~Rps~~~ll~~~~~~~~~~~  280 (303)
T 3a7i_A          257 KEPSFRPTAKELLKHKFILRNAKK  280 (303)
T ss_dssp             SSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred             CChhhCcCHHHHhhChhhhcCCCc
Confidence            999999999999999999765443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-45  Score=401.93  Aligned_cols=263  Identities=30%  Similarity=0.454  Sum_probs=226.9

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|.+++.||+|+||.||+|.+ .+|+.||||++......  .......+.+|+.+++.++||||+++++++.+...
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR--SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH--HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3467899999999999999999988 58999999998643211  11234567899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|+|||||.+++|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999999998865 468999999999999999999999999999999999999999999999999998664432


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                       ....+||+.|+|||++. ....++.++|||||||++|+|++|+.||..........++..+.. ..+..++..+.+||.
T Consensus       171 ~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~  248 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLK  248 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHT-TCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHHHHHH
T ss_pred             cccccCCCcCeEChhhcc-CCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHHHHHH
Confidence             44567999999999974 222347899999999999999999999998777777777766643 456779999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      +||+.||.+|||+.+|++||||++.+....
T Consensus       249 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  278 (476)
T 2y94_A          249 HMLQVDPMKRATIKDIREHEWFKQDLPKYL  278 (476)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHTTCCTTT
T ss_pred             HHcCCCchhCcCHHHHHhCHHhhhcCcccc
Confidence            999999999999999999999998665433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=383.06  Aligned_cols=261  Identities=29%  Similarity=0.462  Sum_probs=209.7

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ...++|++++.||+|+||.||+|.+ .+|+.||||++...............+.+|+.++.+++||||+++++++.+...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3456899999999999999999988 579999999986543322222223467799999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +++||||+.+ +|..++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999999987 788877654  4889999999999999999999999999999999999999999999999999765332


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC--CC--------
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP--PL--------  496 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~--~~--------  496 (551)
                        ......||+.|+|||++. ....++.++|||||||++|+|++|.+||.+....+.+.++...  .+  ..        
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLF-GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHT-TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             cccCCcccccccccCchHhh-CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence              234567999999999973 3456899999999999999999999999988877766655431  10  00        


Q ss_pred             ---------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          497 ---------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       497 ---------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                     ....++..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                           0134678999999999999999999999999999998643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.8e-45  Score=375.99  Aligned_cols=258  Identities=29%  Similarity=0.458  Sum_probs=222.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccc-hHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQG-KQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +.|++++.||+|+||.||+|.+ .+|..||||++......... ......+.+|+.++.+++||||+++++++.+...+|
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            4799999999999999999987 57999999999765433211 123456789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC----cEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g----~vkL~DFGla~~~~~  429 (551)
                      +||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            99999999999998875 4588999999999999999999999999999999999999888    799999999976543


Q ss_pred             C-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHH
Q 043852          430 N-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDA  505 (551)
Q Consensus       430 ~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l  505 (551)
                      . ......||+.|+|||++  ....++.++|||||||++|+|++|..||.+....+.+..+........   ...++..+
T Consensus       172 ~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (321)
T 2a2a_A          172 GVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA  249 (321)
T ss_dssp             TCCCCCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred             cccccccCCCCCccCcccc--cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHH
Confidence            3 23455699999999997  456789999999999999999999999998887777777666544332   25689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .+||.+||+.||.+|||+.++++||||+...
T Consensus       250 ~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          250 KDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999998643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.5e-45  Score=382.37  Aligned_cols=259  Identities=29%  Similarity=0.505  Sum_probs=217.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      .+|++++.||+|+||.||+|.+ .++..||||++...    ........+.+|+.++.+++||||+++++++...     
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence            3799999999999999999987 58899999998632    2234456788999999999999999999988654     


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      ..+|++|||+.+ +|.++++...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          103 KDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             CCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             ceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            468999999975 9999998888999999999999999999999999999999999999999999999999999765432


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC---------
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP---------  494 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~---------  494 (551)
                      .     .....||+.|+|||++. ....++.++|||||||++|+|++|+.||.+....+.+..+...  .+         
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHH-TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccccccccccccCCCCCHHhc-CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            2     23457999999999873 4456899999999999999999999999887665555443221  00         


Q ss_pred             --------------CC-----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          495 --------------PL-----VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       495 --------------~~-----~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                                    ..     ....++..+.+||.+||++||.+|||+.++|+||||++....+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~  326 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE  326 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccc
Confidence                          00     114578999999999999999999999999999999987655433

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.8e-46  Score=404.06  Aligned_cols=255  Identities=26%  Similarity=0.441  Sum_probs=207.0

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC---
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE---  350 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---  350 (551)
                      .+++|++++.||+|+||+||+|.+ .+|+.||||++...   ........++.+|+.+++.++||||+++++++...   
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence            356899999999999999999987 57999999999753   22344566788999999999999999999998654   


Q ss_pred             ---CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          351 ---NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       351 ---~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                         ..+|+||||+.++ |...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       137 ~~~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          137 EEFQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             TTCCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             ccCCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence               4579999999875 5555543 4889999999999999999999999999999999999999999999999999866


Q ss_pred             ccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC----------
Q 043852          428 TMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL----------  496 (551)
Q Consensus       428 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~----------  496 (551)
                      ... .....+||+.|+|||++  .+..|+.++|||||||++|||++|++||.+.+..+.+.++.......          
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          215 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             --CCCC----CCCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             CCCcccCCCcccccccCHHHH--cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            543 34556799999999998  34578999999999999999999999999888777666554311100          


Q ss_pred             --------------------CCCc-----------CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          497 --------------------VPNS-----------LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       497 --------------------~~~~-----------~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                          ++..           .+..+.+||.+||++||.+|||++|+|+||||+...
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                                0000           156789999999999999999999999999998644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2e-45  Score=382.28  Aligned_cols=248  Identities=29%  Similarity=0.437  Sum_probs=209.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-----CCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-----HENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~~  349 (551)
                      .++|+++++||+|+||+||+|.+ .++..||||++..      .......+..|+.++..+.     |+||+++++++..
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            35899999999999999999988 6899999999852      2233445677899999886     9999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC--------------
Q 043852          350 ENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA--------------  412 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~--------------  412 (551)
                      ...+|+||||+ +++|.+++....   +++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            99999999999 889999887654   889999999999999999999999999999999999975              


Q ss_pred             -----------CCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch
Q 043852          413 -----------SGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE  481 (551)
Q Consensus       413 -----------~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~  481 (551)
                                 ++.+||+|||+++.... ......||+.|+|||++  .+..++.++|||||||++|+|++|+.||....
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVI--LNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHH--cCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                       78999999999975443 23456799999999997  45678999999999999999999999998877


Q ss_pred             hHHHHHHhhcCCCCCC---------------------------------------------CCcCCHHHHHHHHHhhhcC
Q 043852          482 GMQALFRIGKGEPPLV---------------------------------------------PNSLSRDARDFILKCLQVN  516 (551)
Q Consensus       482 ~~~~~~~i~~~~~~~~---------------------------------------------~~~~s~~l~~LI~~cL~~D  516 (551)
                      ..+.+..+.....+..                                             ....+..+.+||.+||+.|
T Consensus       264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            6665554433211110                                             0112477889999999999


Q ss_pred             CCCCCCHHHHHhCcccC
Q 043852          517 PNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       517 P~~RPS~~eILehpff~  533 (551)
                      |.+|||+.++|+||||+
T Consensus       344 P~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          344 PTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGGSCCHHHHTTSGGGC
T ss_pred             hhhCCCHHHHhcCcccC
Confidence            99999999999999996

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-45  Score=366.90  Aligned_cols=260  Identities=25%  Similarity=0.423  Sum_probs=216.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||.||+|.+ .+++.||||++.....    ......+.+|+.++..++||||+++++++.+....|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence            46899999999999999999987 4799999999875432    223456789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC---
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~---  430 (551)
                      +||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......   
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            99999999999998875 46899999999999999999999999999999999999999999999999998754322   


Q ss_pred             -CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-HHHHHhhcCC-CCCCCCcCCHHHHH
Q 043852          431 -DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKGE-PPLVPNSLSRDARD  507 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~~s~~l~~  507 (551)
                       ......||+.|+|||++. ....++.++|||||||++|+|++|..||...... ..+..+.... .......++..+.+
T Consensus       162 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  240 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGT-CSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             hcccCCccccCccChHHHh-cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence             234556899999999973 2223478999999999999999999999765443 2222222222 12223468999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      ||.+||+.||.+|||+.+|++||||++...+..
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  273 (276)
T 2yex_A          241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGA  273 (276)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC---
T ss_pred             HHHHHCCCCchhCCCHHHHhcCccccChhhccC
Confidence            999999999999999999999999998876654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.8e-46  Score=370.92  Aligned_cols=259  Identities=28%  Similarity=0.559  Sum_probs=198.1

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|++++.||+|+||.||+|.+ .+|+.||||++......  .......+.+|+.++.+++||||+++++++.+...
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY   85 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh--hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence            4567899999999999999999987 68999999998643211  11234567899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .|++|||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999999999876  45899999999999999999999999999999999999999999999999998765422


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                        ......||+.|+|||++  ....++.++|||||||++|+|++|+.||........+..+.... ...+..++..+.+|
T Consensus       166 ~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  242 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIA--TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDL  242 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-CCCCTTSCHHHHHH
T ss_pred             CCcceeccCCCCcCCcchh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-cCCccccCHHHHHH
Confidence              23345689999999987  34567899999999999999999999998766555554444332 33466789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |.+||+.||.+|||+.++++||||++...
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            99999999999999999999999987553

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-45  Score=395.72  Aligned_cols=258  Identities=28%  Similarity=0.481  Sum_probs=196.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-----C
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-----E  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~  350 (551)
                      ++|++++.||+|+||+||+|.+ .+|+.||||++...   ........++.+|+.++..++|+||+++++++..     .
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECST---TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh---hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            5799999999999999999987 58999999998543   2234456678899999999999999999999843     3


Q ss_pred             CeEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..+|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            57999999985 5888887654 599999999999999999999999999999999999999999999999999976532


Q ss_pred             C-----------------------------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc--------
Q 043852          430 N-----------------------------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT--------  472 (551)
Q Consensus       430 ~-----------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt--------  472 (551)
                      .                             .....+||+.|+|||++ .....|+.++||||||||||||++        
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHH-TTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHh-hCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            1                             23345689999999986 345679999999999999999998        


Q ss_pred             ---CCCCCCCchh--------------------HHHHHHhhc--CCC----------------------------CCCCC
Q 043852          473 ---RQPPYSHLEG--------------------MQALFRIGK--GEP----------------------------PLVPN  499 (551)
Q Consensus       473 ---G~~Pf~~~~~--------------------~~~~~~i~~--~~~----------------------------~~~~~  499 (551)
                         |+++|.+...                    .+.+..+..  +.+                            .....
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               7777765431                    111111110  000                            00123


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      .++..+.+||.+||.+||.+|||++++|+||||+......
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            4689999999999999999999999999999999875443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=386.72  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=212.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|...+.||+|+||.||+|.+ .+|..||+|++....     ......+.+|+.++.+++||||+++++++.+...+|+|
T Consensus        90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             EEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            345578899999999999987 579999999987432     23455788999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE--cCCCcEEEEecCCccccccCC-
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV--DASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl--~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      ||||.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++...... 
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            999999999887754  358999999999999999999999999999999999999  567899999999998654332 


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDARDF  508 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~L  508 (551)
                      .....||+.|+|||++  ....++.++|||||||++|+|++|..||.+....+.+..+........   ...++..+.+|
T Consensus       245 ~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVV--NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             CCCCCSSCTTCCHHHH--TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred             cccccCCCcEeChhhc--cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence            3445699999999997  455789999999999999999999999998888877777766544332   24689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      |.+||+.||.+|||+.++++||||+..
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999865

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=376.60  Aligned_cols=249  Identities=32%  Similarity=0.462  Sum_probs=203.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ++|+++++||+|+||+||+|.+ .+|..||||++......   .........|+..+.+ ..|+||+++++++.+...+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG---PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC---hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            4799999999999999999988 48999999987543222   2233344455554444 48999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      +||||| +++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999999 56888777653  48999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-CCCCCCcCCHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-PPLVPNSLSRDARDFIL  510 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~l~~LI~  510 (551)
                      .....||+.|+|||++.   ..++.++|||||||++|||++|..+|........+   ..+. ++..+..++..+.+||.
T Consensus       213 ~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQ---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL---RQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             --CCCCCGGGCCGGGGG---TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH---TTTCCCHHHHTTSCHHHHHHHH
T ss_pred             CcccCCCccccCHhHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---hccCCCcccccCCCHHHHHHHH
Confidence            33456999999999874   26899999999999999999998777654443332   2222 22234568999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          511 KCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      +||++||++|||+.++++||||+++
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~p  311 (311)
T 3p1a_A          287 MMLEPDPKLRATAEALLALPVLRQP  311 (311)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred             HHcCCChhhCcCHHHHHhCccccCC
Confidence            9999999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.5e-46  Score=382.22  Aligned_cols=257  Identities=25%  Similarity=0.450  Sum_probs=206.3

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|++++.||+|+||+||+|.+ .+|+.||||++.....   .......+.+|+.++.+++||||+++++++.+...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            3456899999999999999999987 5899999999864422   22334456789999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc-----CCCcEEEEecCCccc
Q 043852          353 LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD-----ASGSVKLADFGLAKA  426 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~-----~~g~vkL~DFGla~~  426 (551)
                      +|+|||||.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++.
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999999986 888887654 689999999999999999999999999999999999994     445699999999976


Q ss_pred             ccc--CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--------
Q 043852          427 TTM--NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--------  496 (551)
Q Consensus       427 ~~~--~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--------  496 (551)
                      ...  .......||+.|+|||++. ....++.++|||||||++|+|++|..||......+.+..+.......        
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILL-GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HC-----------CCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCcccccCCCcCCccccCHHHhc-CCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            532  2234456899999999973 33458999999999999999999999998887777666553321000        


Q ss_pred             ---------C------------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          497 ---------V------------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       497 ---------~------------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                               .            +..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                     0            01278999999999999999999999999999999965

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-45  Score=367.61  Aligned_cols=258  Identities=29%  Similarity=0.511  Sum_probs=223.4

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec--cCCC
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD--KDEN  351 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~  351 (551)
                      .+++|++++.||+|+||.||++.+ .+|+.||+|++.....   .......+.+|+.++.+++||||+++++++  ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            456899999999999999999988 5899999999875432   234456788999999999999999999977  4467


Q ss_pred             eEEEEEecccccchHHHHhhhc-----CChHHHHHHHHHHHHHHHHHHhCC-----eeecccccceEEEcCCCcEEEEec
Q 043852          352 RLFIFLELVTKGSLANLYQKYH-----LMDSQVSAYTRQILNGLNYLHEQN-----VVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~~-----l~~~~i~~i~~QI~~aL~yLH~~g-----IiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                      .+|+||||+.+++|.+++....     +++..++.++.||+.||.|||++|     |+|+||||+|||++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            8999999999999999887532     899999999999999999999999     999999999999999999999999


Q ss_pred             CCccccccCC--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCC
Q 043852          422 GLAKATTMND--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPN  499 (551)
Q Consensus       422 Gla~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  499 (551)
                      |+++......  .....||+.|+|||++.  ...++.++|||||||++|+|++|+.||......+....+..+.....+.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  238 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHH--CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             chheeeccccccccccCCCccccChHHhc--cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence            9987654332  12345899999999973  4578999999999999999999999999888777777788887777888


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      .++..+.+||.+||+.||.+|||+.+|++|+|+.++.+
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            89999999999999999999999999999999998764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-44  Score=388.36  Aligned_cols=259  Identities=30%  Similarity=0.486  Sum_probs=208.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++....   .......++.+|+.++.+++|+||+++++++...     
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            4899999999999999999987 578999999986432   2344566788999999999999999999998766     


Q ss_pred             CeEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..+|+||||+.+ +|.++++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            579999999975 998888764 489999999999999999999999999999999999999999999999999986533


Q ss_pred             C------------------------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-----------CC
Q 043852          430 N------------------------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-----------RQ  474 (551)
Q Consensus       430 ~------------------------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-----------G~  474 (551)
                      .                        .....+||+.|+|||++ .....|+.++|||||||++|||++           |.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHH-TTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHH-hcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            2                        13566799999999986 245678999999999999999998           44


Q ss_pred             CCCCCch-----------------hHHHHHHhhc-----------------------CCCCCC-------CCcCCHHHHH
Q 043852          475 PPYSHLE-----------------GMQALFRIGK-----------------------GEPPLV-------PNSLSRDARD  507 (551)
Q Consensus       475 ~Pf~~~~-----------------~~~~~~~i~~-----------------------~~~~~~-------~~~~s~~l~~  507 (551)
                      ++|.+..                 ..+++..+..                       ..+...       ...++..+.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            4554432                 1111111110                       011111       1358999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      ||.+||+.||.+|||++++|+||||+.......
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  373 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKKL  373 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence            999999999999999999999999998765543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.9e-45  Score=367.16  Aligned_cols=252  Identities=29%  Similarity=0.539  Sum_probs=214.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC----CCe
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD----ENR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~  352 (551)
                      .|.+.+.||+|+||.||+|.+ .++..||+|++.....   .......+.+|+.++.+++||||+++++++..    ...
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            588999999999999999987 5788999999875432   23445678899999999999999999997654    467


Q ss_pred             EEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEc-CCCcEEEEecCCccccc
Q 043852          353 LFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVD-ASGSVKLADFGLAKATT  428 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~-~~g~vkL~DFGla~~~~  428 (551)
                      +|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++|  |+|+||||+|||++ .++.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            8999999999999999876 56889999999999999999999999  99999999999997 78999999999997666


Q ss_pred             cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH-HhhcCC-CCCCCCcCCHHHH
Q 043852          429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGE-PPLVPNSLSRDAR  506 (551)
Q Consensus       429 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~-~i~~~~-~~~~~~~~s~~l~  506 (551)
                      ........||+.|+|||++.   ..++.++|||||||++|+|++|+.||.......... .+..+. +...+..++..+.
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  260 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  260 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             ccccccccCCcCcCCHHHHh---ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence            55566677999999999873   458999999999999999999999998755544443 343332 2334456789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      +||.+||+.||.+|||+.++++||||+..
T Consensus       261 ~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.7e-45  Score=366.88  Aligned_cols=265  Identities=28%  Similarity=0.457  Sum_probs=224.3

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc----chHHHHHHHHHHHHHhcCC-CCceeeeeeec
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ----GKQSILQLEQEILLLSRFE-HENIVQYFGTD  347 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~----~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~  347 (551)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||||++........    .......+.+|+.++.++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3456899999999999999999988 5799999999976542221    1234556789999999995 99999999999


Q ss_pred             cCCCeEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          348 KDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      .+....|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            9999999999999999999988754 689999999999999999999999999999999999999999999999999876


Q ss_pred             cccC-CcccCCCCCcccChhhhhc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---
Q 043852          427 TTMN-DVKSCKGTPFWMAPEVVNL----KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---  498 (551)
Q Consensus       427 ~~~~-~~~~~~GT~~Y~APEvl~~----~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---  498 (551)
                      .... ......||+.|+|||++..    ....++.++|||||||++|+|++|..||...........+..+......   
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  253 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence            5433 3345568999999999742    2346789999999999999999999999888777776666655433322   


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      ..++..+.+||.+||+.||.+|||+.++++||||++...+
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            4689999999999999999999999999999999977644

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-45  Score=371.13  Aligned_cols=262  Identities=29%  Similarity=0.482  Sum_probs=204.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|++++.||+|+||.||+|.+ .+|+.||||++.....   .......+..+..+++.++||||+++++++.+....|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            45899999999999999999987 6899999999864321   2223333445556688899999999999999999999


Q ss_pred             EEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          355 IFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      +||||+.+ +|.+++..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999986 77766543     4689999999999999999999998 99999999999999999999999999997654


Q ss_pred             cCC-cccCCCCCcccChhhhh--cccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHH-hhcCCCCCCCCcCCH
Q 043852          429 MND-VKSCKGTPFWMAPEVVN--LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFR-IGKGEPPLVPNSLSR  503 (551)
Q Consensus       429 ~~~-~~~~~GT~~Y~APEvl~--~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-~~~~~~~~-i~~~~~~~~~~~~s~  503 (551)
                      ... .....||+.|+|||++.  .....++.++|||||||++|+|++|..||... .....+.. +....+......++.
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA  241 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred             ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCH
Confidence            333 23346999999999963  13456899999999999999999999999753 33333333 333444444567899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                      .+.+||.+||+.||.+|||+.++++||||+........
T Consensus       242 ~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~~  279 (290)
T 3fme_A          242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTD  279 (290)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCC
T ss_pred             HHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccccC
Confidence            99999999999999999999999999999876555433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.3e-45  Score=381.71  Aligned_cols=261  Identities=27%  Similarity=0.497  Sum_probs=222.8

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc---chHHHHHHHHHHHHHhcC-CCCceeeeeeecc
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ---GKQSILQLEQEILLLSRF-EHENIVQYFGTDK  348 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  348 (551)
                      ...++|.+.+.||+|+||.||+|.+ .+|+.||||++........   .......+.+|+.++.++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            3345799999999999999999988 4899999999875532211   123345678999999998 7999999999999


Q ss_pred             CCCeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          349 DENRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      .....|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+|||++.+|.++|+|||++...
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            99999999999999999998875 46899999999999999999999999999999999999999999999999998765


Q ss_pred             ccC-CcccCCCCCcccChhhhhcc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---C
Q 043852          428 TMN-DVKSCKGTPFWMAPEVVNLK----NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---N  499 (551)
Q Consensus       428 ~~~-~~~~~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~  499 (551)
                      ... ......||+.|+|||++...    ...++.++|||||||++|+|++|..||........+..+..+......   .
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  330 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD  330 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            433 34456799999999997432    235789999999999999999999999887777777666665543321   4


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      .++..+.+||.+||+.||.+|||+.++++||||++
T Consensus       331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            68899999999999999999999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=378.30  Aligned_cols=254  Identities=24%  Similarity=0.462  Sum_probs=209.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC--CceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH--ENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~  354 (551)
                      .+|++++.||+|+||.||++.+.++..||||++....   ........+.+|+.++.++.|  +||+++++++.+...+|
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc---cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            3799999999999999999998889999999987543   234456678899999999986  99999999999999999


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      +||| +.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......  
T Consensus        86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            9999 4577999888754 588999999999999999999999999999999999996 7889999999997654332  


Q ss_pred             --cccCCCCCcccChhhhhc---------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHhh-cCCCCCCC
Q 043852          432 --VKSCKGTPFWMAPEVVNL---------KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIG-KGEPPLVP  498 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~---------~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-~~~~~~i~-~~~~~~~~  498 (551)
                        .....||+.|+|||++..         ....++.++|||||||++|+|++|+.||..... ...+..+. .......+
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  243 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence              234569999999999743         125689999999999999999999999976433 33333333 33444566


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ...+..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            7788999999999999999999999999999999743

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4e-45  Score=371.23  Aligned_cols=254  Identities=29%  Similarity=0.473  Sum_probs=219.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|.+.+.||+|+||.||++.+ .+|+.||+|++.....     .....+.+|+.++.+++||||+++++++.+...+|+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            4799999999999999999987 5899999999874322     123457799999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE---cCCCcEEEEecCCccccccCC
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl---~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||+   +.++.++|+|||+++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            9999999999888764 468999999999999999999999999999999999999   778899999999987655444


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC---CCCCcCCHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP---LVPNSLSRDARDF  508 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~l~~L  508 (551)
                      .....||+.|+|||++  ....++.++|||||||++|+|++|..||...........+..+...   .....++..+.+|
T Consensus       164 ~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  241 (304)
T 2jam_A          164 MSTACGTPGYVAPEVL--AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF  241 (304)
T ss_dssp             THHHHSCCCBCCTTTB--SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred             cccccCCCCccChHHh--ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence            4455699999999997  4567899999999999999999999999887777776666665433   2345789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |.+||+.||.+|||+.++++||||+....
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          242 ICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             HHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence            99999999999999999999999986543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-45  Score=379.97  Aligned_cols=254  Identities=29%  Similarity=0.461  Sum_probs=197.4

Q ss_pred             Ceeee---eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCe
Q 043852          278 SWQKG---ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENR  352 (551)
Q Consensus       278 ~y~~~---~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~  352 (551)
                      +|++.   +.||+|+||.||+|.+ .+|+.||||++...        ....+.+|+.++..+. ||||+++++++.+...
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            45553   7899999999999988 57999999998632        2345668999999997 9999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC---cEEEEecCCccccc
Q 043852          353 LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKATT  428 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g---~vkL~DFGla~~~~  428 (551)
                      .|+|||||.+++|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            99999999999999988754 589999999999999999999999999999999999998766   89999999997553


Q ss_pred             cC--CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-------HHHHHHhhcCCCCCCC-
Q 043852          429 MN--DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-------MQALFRIGKGEPPLVP-  498 (551)
Q Consensus       429 ~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~-  498 (551)
                      ..  ......||+.|+|||++  ....++.++|||||||++|+|++|..||.....       .+...++..+...... 
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          161 PDNQPLKTPCFTLHYAAPELL--NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             CCCCcccccCCCcCccCHHHh--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            32  23455689999999997  456789999999999999999999999976432       3455566665544332 


Q ss_pred             --CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          499 --NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       499 --~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                        ..++..+.+||.+||+.||.+|||+.++++||||+.....+..
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~  283 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN  283 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCS
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCC
Confidence              3589999999999999999999999999999999976655443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.7e-45  Score=366.65  Aligned_cols=259  Identities=31%  Similarity=0.524  Sum_probs=224.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..+|.+++.||+|+||.||++.+ .+++.||+|++......  .......+.+|+.+++.+.|+||+++++++.+....|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            35899999999999999999988 57899999998754322  2344567889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--C
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~  431 (551)
                      ++|||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......  .
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            99999999999998875 46899999999999999999999999999999999999999999999999999765422  2


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....||+.|+|||++  ....++.++|||||||++|+|++|+.||......+....+.... ...+..++..+.+||.+
T Consensus       172 ~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~  248 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVL--SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQK  248 (294)
T ss_dssp             BCCCCSCCSSCCHHHH--TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHH
T ss_pred             cccccCCCCcCCcchh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHH
Confidence            3445689999999997  35567999999999999999999999998877776666665554 34567899999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      ||+.||.+|||+.++++||||+......
T Consensus       249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          249 MLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HcccChhhCcCHHHHhhChheecCCcCC
Confidence            9999999999999999999998665443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.7e-45  Score=376.05  Aligned_cols=258  Identities=31%  Similarity=0.529  Sum_probs=224.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|.+++.||+|+||.||++.+ .+++.||+|++......  .......+.+|+.++..++|+||+++++++.+...+|+
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4799999999999999999988 57899999998754322  23455678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      ||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            9999999999998875 46899999999999999999999999999999999999999999999999999765422  23


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ....||+.|+|||++  ....++.++|||||||++|+|++|+.||......+.+..+.... ...+..++..+.+||.+|
T Consensus       199 ~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          199 KVLCGTPNYIAPEVL--SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKM  275 (335)
T ss_dssp             CCCCSCCSSCCHHHH--HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred             cccCCCccccCHHHh--ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHH
Confidence            445699999999997  35567999999999999999999999998877766666666554 345677999999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      |+.||.+|||+.++++||||+......
T Consensus       276 l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          276 LQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             ccCChhHCcCHHHHhcCccccCCCccc
Confidence            999999999999999999998765443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.3e-45  Score=379.24  Aligned_cols=254  Identities=36%  Similarity=0.626  Sum_probs=219.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|..++.||+|+||.||+|.+ .+|..||||++.....  ........+.+|+.++.+++||||+++++++.+....|+|
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            589999999999999999987 6899999999875432  2234556788999999999999999999999999999999


Q ss_pred             EecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCccc
Q 043852          357 LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  434 (551)
                      ||||.| +|.+++.  +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus       133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~~~  209 (348)
T 1u5q_A          133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS  209 (348)
T ss_dssp             EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCC
T ss_pred             EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--CCc
Confidence            999985 7777664  34689999999999999999999999999999999999999999999999999876543  345


Q ss_pred             CCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC-CCCCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP-LVPNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~LI~~c  512 (551)
                      ..||+.|+|||++.. ....++.++|||||||++|||++|+.||........+..+..+..+ ..+..++..+.+||.+|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            679999999999742 2456899999999999999999999999888777777666655443 34567899999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCcc
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~  536 (551)
                      |+.||.+|||+.++++||||.+..
T Consensus       290 l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             cccChhhCcCHHHHhhChhhhccC
Confidence            999999999999999999997654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.5e-45  Score=382.10  Aligned_cols=249  Identities=32%  Similarity=0.487  Sum_probs=209.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRL  353 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  353 (551)
                      .++|++++.||+|+||.||+|.+ .+|+.||||++......         ..+|+.++.++ +||||+++++++.+...+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            34799999999999999999988 57999999999754321         23577777777 799999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC----CcEEEEecCCccccc
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS----GSVKLADFGLAKATT  428 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~----g~vkL~DFGla~~~~  428 (551)
                      |+|||||.||+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++...
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            999999999999988765 458999999999999999999999999999999999998543    359999999998654


Q ss_pred             cC--CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc---hhHHHHHHhhcCCCCC---CCCc
Q 043852          429 MN--DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL---EGMQALFRIGKGEPPL---VPNS  500 (551)
Q Consensus       429 ~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~---~~~~~~~~i~~~~~~~---~~~~  500 (551)
                      ..  .....+||+.|+|||++.  ...|+.++|||||||++|+|++|..||...   ...+.+..+..+....   .+..
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLE--RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHH--HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CCCCceeccCCCccccCHHHhc--CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            32  234567999999999974  345789999999999999999999999753   3445555666555433   2356


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            89999999999999999999999999999999753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-45  Score=363.72  Aligned_cols=248  Identities=23%  Similarity=0.401  Sum_probs=219.5

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ....+|++.+.||+|+||.||+|.+.++..||+|++......      ...+.+|+.++.+++||||+++++++.+...+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            334589999999999999999999888889999998643221      24578999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          354 FIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |+||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999999998653  48899999999999999999999999999999999999999999999999997554322


Q ss_pred             ---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHH
Q 043852          432 ---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD  507 (551)
Q Consensus       432 ---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  507 (551)
                         .....+|+.|+|||++  ....++.++|||||||++|+|++ |..||......+....+..+.....+..++..+.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ  238 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             cccccCcccccccCCHHHh--cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence               2334577889999997  45578999999999999999999 99999998888888888888777778889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      |+.+||+.||.+|||+.++++|
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=380.91  Aligned_cols=254  Identities=29%  Similarity=0.417  Sum_probs=202.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .+.|++.+.||+|+||.||+|.+ .+++.||||++....       ....+.+|+.++.+++||||+++++++.+...+|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            34799999999999999999988 478899999986432       1235678999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CCcEEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g~vkL~DFGla~~~~~~  430 (551)
                      +||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.....
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999999988654 5889999999999999999999999999999999999975   889999999999765433


Q ss_pred             C-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHhhcCCCCC---CCCcCCHHH
Q 043852          431 D-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ-ALFRIGKGEPPL---VPNSLSRDA  505 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~-~~~~i~~~~~~~---~~~~~s~~l  505 (551)
                      . .....||+.|+|||++  .+..++.++|||||||++|+|++|..||....... .+..+.......   ....++..+
T Consensus       205 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEIL--RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             --------CGGGSCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cccccccCCCCccCHHHh--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence            2 3456699999999997  35578999999999999999999999997665544 444454443322   235689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      .+||.+||+.||++|||+.++++||||+.....
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            999999999999999999999999999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.9e-45  Score=373.46  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=205.0

Q ss_pred             cCeeee-eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeE
Q 043852          277 MSWQKG-ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRL  353 (551)
Q Consensus       277 ~~y~~~-~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  353 (551)
                      ..|++. +.||+|+||.||+|.+ .+++.||||++.....     .....+.+|+.++.++ +||||+++++++.+...+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            468885 7899999999999987 5899999999865422     1234677899999884 799999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc---EEEEecCCcccccc
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKATTM  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~---vkL~DFGla~~~~~  429 (551)
                      |+|||||.+++|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999999998865 45899999999999999999999999999999999999988776   99999999875432


Q ss_pred             C---------CcccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---------------
Q 043852          430 N---------DVKSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---------------  482 (551)
Q Consensus       430 ~---------~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---------------  482 (551)
                      .         ......||+.|+|||++...   ...++.++|||||||++|+|++|+.||.+...               
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            1         12234599999999997421   13478899999999999999999999976431               


Q ss_pred             HHHHHHhhcCCCCCCC---CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          483 MQALFRIGKGEPPLVP---NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       483 ~~~~~~i~~~~~~~~~---~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                      ......+..+......   ..++..+.+||.+||+.||.+|||+.++++||||+.......-
T Consensus       247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~  308 (316)
T 2ac3_A          247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL  308 (316)
T ss_dssp             HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--------
T ss_pred             HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccC
Confidence            2233344444332221   3589999999999999999999999999999999976554433

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.9e-45  Score=381.86  Aligned_cols=249  Identities=27%  Similarity=0.465  Sum_probs=217.6

Q ss_pred             cccCeeeeeEeccCCceEEEEEEec--------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeee
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTD--------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFG  345 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~  345 (551)
                      ...+|++++.||+|+||.||+|.+.        ++..||||++...    ........+.+|+.++..+ +||||+++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            3468999999999999999999752        4567999988543    2344566788999999999 8999999999


Q ss_pred             eccCCCeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceE
Q 043852          346 TDKDENRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANI  408 (551)
Q Consensus       346 ~~~~~~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NI  408 (551)
                      ++.+...+|+||||+.+|+|.+++...                 .++...++.++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            999999999999999999999998754                 367889999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH
Q 043852          409 LVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGM  483 (551)
Q Consensus       409 Ll~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~  483 (551)
                      |++.++.+||+|||+++......    .....+|+.|+|||++  .+..++.++|||||||++|||++ |..||.+....
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH--HTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh--cCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999997554322    2334578899999997  45678999999999999999999 99999988777


Q ss_pred             HHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          484 QALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       484 ~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +....+..+.....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7777777777777888999999999999999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.5e-45  Score=379.97  Aligned_cols=255  Identities=29%  Similarity=0.486  Sum_probs=215.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||+|+||.||+|.+ .++..||+|++....    .......+.+|+.++.+++||||+++++++.+...+|+
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            4899999999999999999988 489999999987532    34455678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          356 FLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      ||||+.+++|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.........
T Consensus       109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  188 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  188 (360)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred             EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence            99999999999988764 688999999999999999999996 9999999999999999999999999999765544455


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH---------------------------
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL---------------------------  486 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~---------------------------  486 (551)
                      ...||+.|+|||++  .+..++.++|||||||++|+|++|+.||......+..                           
T Consensus       189 ~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          189 SFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             --CCCCTTCCHHHH--TTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             CCCCCCCeECHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            66799999999997  4567899999999999999999999999765433221                           


Q ss_pred             ---------------HHhhcCCCCCC-CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          487 ---------------FRIGKGEPPLV-PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       487 ---------------~~i~~~~~~~~-~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                     ..+.....+.. ...++..+.+||.+||+.||.+|||++++++||||++...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence                           12222222222 3457999999999999999999999999999999986543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.2e-45  Score=397.00  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=220.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc--------chHHHHHHHHHHHHHhcCCCCceeeeeee
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ--------GKQSILQLEQEILLLSRFEHENIVQYFGT  346 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  346 (551)
                      .++|.+++.||+|+||+||+|.+ .++..||||++........        .......+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            35799999999999999999988 5789999999975432211        11234567899999999999999999999


Q ss_pred             ccCCCeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC---cEEEEecC
Q 043852          347 DKDENRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLADFG  422 (551)
Q Consensus       347 ~~~~~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g---~vkL~DFG  422 (551)
                      +.+...+|+|||||.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            9999999999999999999887754 5699999999999999999999999999999999999998776   69999999


Q ss_pred             CccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---
Q 043852          423 LAKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---  498 (551)
Q Consensus       423 la~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---  498 (551)
                      +++..... ......||+.|+|||++.   ..++.++|||||||++|+|++|.+||.+....+.+..+..+......   
T Consensus       195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (504)
T 3q5i_A          195 LSSFFSKDYKLRDRLGTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW  271 (504)
T ss_dssp             TCEECCTTSCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred             CCEEcCCCCccccccCCcCCCCHHHhc---cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence            99865433 345567999999999973   46899999999999999999999999998888888888777644322   


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ..++..+.+||.+||++||.+|||+.++|+||||++...
T Consensus       272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            568999999999999999999999999999999986544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.7e-45  Score=364.46  Aligned_cols=260  Identities=29%  Similarity=0.473  Sum_probs=214.7

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|++++.||+|+||.||+|.+ .+|+.||||++......  .......+.+|+.+++.++||||+++++++.+...+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR--SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc--chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            456899999999999999999988 48999999998643211  122345678999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      |+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            999999999999998865 468899999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      .....||+.|+|||++. .....+.++||||||+++|+|++|+.||...........+..+. ...+..++..+.+||.+
T Consensus       167 ~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  244 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMH  244 (276)
T ss_dssp             ----------CCTGGGT-TSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             eecccCCccccCHHHHc-CCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHH
Confidence            33456899999999973 22233689999999999999999999998877666666665554 34567789999999999


Q ss_pred             hhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          512 CLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       512 cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      ||+.||.+|||+.++++||||++.++.
T Consensus       245 ~l~~~p~~Rps~~~~l~h~~~~~~~~~  271 (276)
T 2h6d_A          245 MLQVDPLKRATIKDIREHEWFKQDLPS  271 (276)
T ss_dssp             HTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred             HccCChhhCCCHHHHHhChhhccCchh
Confidence            999999999999999999999977654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=369.27  Aligned_cols=264  Identities=26%  Similarity=0.455  Sum_probs=217.4

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec--cCCC
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD--KDEN  351 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~  351 (551)
                      .+++|++++.||+|+||.||++.+ .++..||+|++....... .......+.+|+.++.+++|+||+++++++  .+..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            356899999999999999999987 578999999986532211 123356788999999999999999999987  4556


Q ss_pred             eEEEEEecccccchHHHHh---hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          352 RLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~---~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      .+|+||||+.++ |.+++.   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            899999999987 555554   3468899999999999999999999999999999999999999999999999997653


Q ss_pred             cC----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          429 MN----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       429 ~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ..    ......||+.|+|||++......++.++|||||||++|+|++|..||...........+..+.. ..+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~  239 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-AIPGDCGPP  239 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCCSSSCHH
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-CCCCccCHH
Confidence            21    2234568999999999853333457899999999999999999999998777777666666543 456779999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                      +.+||.+||+.||.+|||+.++++||||++.......
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~  276 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEA  276 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CC
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCC
Confidence            9999999999999999999999999999977665443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9e-45  Score=395.31  Aligned_cols=255  Identities=28%  Similarity=0.504  Sum_probs=216.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||+|+||+||+|.+ .++..||||++........   ....+.+|+.+++.++||||+++++++.+...+|+
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            4799999999999999999988 5899999999975433222   23457799999999999999999999999999999


Q ss_pred             EEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC---CcEEEEecCCccccccC-
Q 043852          356 FLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMN-  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~---g~vkL~DFGla~~~~~~-  430 (551)
                      |||||.+|+|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||++...... 
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            999999999988765 4578999999999999999999999999999999999999764   45999999999765433 


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---CcCCHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDARD  507 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l~~  507 (551)
                      ......||+.|+|||++.   ..|+.++|||||||++|+|++|.+||.+....+.+..+..+......   ..++..+.+
T Consensus       194 ~~~~~~gt~~y~aPE~l~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLR---KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             cccccCCCcCeeCHHHHc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence            345567999999999973   46899999999999999999999999998888888877776554332   468999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ||.+||++||.+|||+.++|+||||++...
T Consensus       271 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  300 (494)
T 3lij_A          271 LIKQMLQFDSQRRISAQQALEHPWIKEMCS  300 (494)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred             HHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence            999999999999999999999999987543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.8e-45  Score=396.42  Aligned_cols=256  Identities=30%  Similarity=0.512  Sum_probs=220.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++........   ....+.+|+.++++++||||+++++++.+...+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch---HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            45799999999999999999988 5899999999975432222   2356779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc---CCCcEEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~---~~g~vkL~DFGla~~~~~~  430 (551)
                      +|||||.+++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999999999988765 45689999999999999999999999999999999999995   4567999999999765433


Q ss_pred             -CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHHH
Q 043852          431 -DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDAR  506 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~  506 (551)
                       ......||+.|+|||++.   ..|+.++|||||||++|+|++|.+||.+....+.+..+..+.....   ...++..+.
T Consensus       178 ~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  254 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (486)
T ss_dssp             ----CCTTGGGGCCGGGGG---SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred             CccCCCcCCCCCCCHHHhC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence             344567999999999973   3589999999999999999999999999888888887777654332   246899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +||.+||++||.+|||+.++|+||||++...
T Consensus       255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            9999999999999999999999999986543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.5e-45  Score=364.73  Aligned_cols=261  Identities=29%  Similarity=0.473  Sum_probs=220.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccc-hHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQG-KQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ++|++++.||+|+||.||+|.+. +|+.||+|++......... ......+.+|+.++.+++||||+++++++.+....|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            37999999999999999999884 7999999999765433221 123456789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC----cEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g----~vkL~DFGla~~~~~  429 (551)
                      +||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++    .+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            99999999999998865 4689999999999999999999999999999999999998877    899999999976543


Q ss_pred             C-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHH
Q 043852          430 N-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDA  505 (551)
Q Consensus       430 ~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l  505 (551)
                      . ......||+.|+|||++  ....++.++|||||||++|+|++|..||......+.+..+........   ...++..+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA  242 (283)
T ss_dssp             -------CCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred             CCcccccCCCcCccCccee--cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence            2 23445699999999997  455789999999999999999999999998877777666655543322   24688999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      .+||.+||+.||.+|||+.++++||||+....+.
T Consensus       243 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             HHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            9999999999999999999999999999766544

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1e-44  Score=384.09  Aligned_cols=254  Identities=29%  Similarity=0.427  Sum_probs=208.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD------  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------  349 (551)
                      ..+|.++++||+|+||.||+|.+..+..+|+|++.......         .+|+.+++.++||||+++++++..      
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~---------~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK---------NRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC---------CHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH---------HHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            34799999999999999999998666679999886443222         269999999999999999998843      


Q ss_pred             CCeEEEEEecccccchHHHHh----hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc-CCCcEEEEecCCc
Q 043852          350 ENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLA  424 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~----~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~-~~g~vkL~DFGla  424 (551)
                      ...+|+|||||.++.+..+..    ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus       110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            334889999998865544432    34688999999999999999999999999999999999998 7999999999999


Q ss_pred             cccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--C--------
Q 043852          425 KATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--E--------  493 (551)
Q Consensus       425 ~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~--------  493 (551)
                      +..... ......||+.|+|||++. ....++.++|||||||++|||++|++||.+....+.+..+.+.  .        
T Consensus       190 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          190 KILIAGEPNVSYICSRYYRAPELIF-GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             EECCTTCCCCSSCSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccccCCCCCcccccCcCccCHHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            865333 344567899999999973 3456899999999999999999999999988776666554331  0        


Q ss_pred             ---------CC---------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          494 ---------PP---------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       494 ---------~~---------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                               .+         ..+..++..+.+||.+||++||.+|||+.++++||||+......
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence                     00         02234789999999999999999999999999999999765544

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-44  Score=371.03  Aligned_cols=254  Identities=33%  Similarity=0.540  Sum_probs=210.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..+|++.+.||+|+||+||+|.+ +|..||||++.....   .......+.+|+.++.+++||||+++++++.+...+++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            45899999999999999999965 688899999864422   34456678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          356 FLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~----l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ||||+.+++|.+++.+..    +++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999999999987543    899999999999999999999999  99999999999999999999999999975433


Q ss_pred             C--CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhh-cCCCCCCCCcCCHHHH
Q 043852          430 N--DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDAR  506 (551)
Q Consensus       430 ~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~  506 (551)
                      .  ......||+.|+|||++  .+..++.++|||||||++|+|++|+.||......+....+. .......+..++..+.
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  269 (309)
T 3p86_A          192 TFLSSKSAAGTPEWMAPEVL--RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA  269 (309)
T ss_dssp             ----------CCTTSCHHHH--TTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             cccccccCCCCccccChhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence            2  23455699999999997  45668999999999999999999999999887776666553 4445566788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHh--CcccCCc
Q 043852          507 DFILKCLQVNPNDRPTAAQLME--HPFVKRP  535 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILe--hpff~~~  535 (551)
                      +||.+||+.||.+|||+++|++  .++++..
T Consensus       270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            9999999999999999999998  4555543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.5e-45  Score=382.32  Aligned_cols=250  Identities=27%  Similarity=0.466  Sum_probs=207.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc------
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK------  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------  348 (551)
                      ..+|++++.||+|+||.||+|.+ .+|+.||||++.......         .+|+.+++.++|+||+++++++.      
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---------~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---------NRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC---------CHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH---------HHHHHHHHHcCCCCccchhheeeecCccc
Confidence            35899999999999999999987 689999999986543222         27999999999999999999873      


Q ss_pred             --------------------------------CCCeEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHH
Q 043852          349 --------------------------------DENRLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLN  391 (551)
Q Consensus       349 --------------------------------~~~~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~  391 (551)
                                                      +..++++|||||.+ +|.+.+..     ..+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                            34458999999985 77666543     46899999999999999999


Q ss_pred             HHHhCCeeecccccceEEEc-CCCcEEEEecCCccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHH
Q 043852          392 YLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLE  469 (551)
Q Consensus       392 yLH~~gIiHrDIKP~NILl~-~~g~vkL~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLye  469 (551)
                      |||++||+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++. ....++.++|||||||++|+
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML-GATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT-TCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc-CCCCCCcchhhhhHHHHHHH
Confidence            99999999999999999997 6889999999999865433 344567899999999973 34568999999999999999


Q ss_pred             HHcCCCCCCCchhHHHHHHhhcC--CC--------------------------CCCCCcCCHHHHHHHHHhhhcCCCCCC
Q 043852          470 MLTRQPPYSHLEGMQALFRIGKG--EP--------------------------PLVPNSLSRDARDFILKCLQVNPNDRP  521 (551)
Q Consensus       470 LltG~~Pf~~~~~~~~~~~i~~~--~~--------------------------~~~~~~~s~~l~~LI~~cL~~DP~~RP  521 (551)
                      |++|++||.+....+.+..+.+.  .+                          ...+..++..+.+||.+||+.||.+||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999988777766655321  00                          013445889999999999999999999


Q ss_pred             CHHHHHhCcccCCcc
Q 043852          522 TAAQLMEHPFVKRPL  536 (551)
Q Consensus       522 S~~eILehpff~~~~  536 (551)
                      |+.++++||||+...
T Consensus       315 t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          315 NPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CHHHHHTSGGGHHHH
T ss_pred             CHHHHhcCHHHHHHH
Confidence            999999999998643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-45  Score=378.43  Aligned_cols=258  Identities=32%  Similarity=0.524  Sum_probs=213.8

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|++++.||+|+||.||+|.+ .+|+.||||++....   ........+.+|+.++.+++||||+++++++.+...
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            4567999999999999999999988 579999999986442   233445567799999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC-
Q 043852          353 LFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~-  430 (551)
                      +|+||||+.+++|..+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999999999988765 456899999999999999999999999999999999999999999999999999754332 


Q ss_pred             -CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC----------------
Q 043852          431 -DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE----------------  493 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~----------------  493 (551)
                       ......||+.|+|||++. ....++.++|||||||++|+|++|+.||......+.+..+....                
T Consensus       179 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLV-GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             -----CCCCCTTCCHHHHT-TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             cccCCCcCCccccCccccc-CCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             234556999999999973 33468999999999999999999999998877666554432110                


Q ss_pred             -----CCC---------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          494 -----PPL---------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       494 -----~~~---------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                           .+.         ....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                 000         012578999999999999999999999999999999853

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.3e-45  Score=376.70  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=209.5

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC----
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD----  349 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----  349 (551)
                      .+++|++++.||+|+||.||+|.+ .+|+.||||++........   ....+.+|+.++..++||||+++++++.+    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS---SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            356899999999999999999988 6899999998865543222   23356689999999999999999998876    


Q ss_pred             ----CCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCC
Q 043852          350 ----ENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       350 ----~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                          .+.+|+|||||.+ +|...+..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence                4568999999987 66655543  4689999999999999999999999999999999999999999999999999


Q ss_pred             cccccc------CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC---CC
Q 043852          424 AKATTM------NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG---EP  494 (551)
Q Consensus       424 a~~~~~------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~---~~  494 (551)
                      ++....      .......||+.|+|||++. ....++.++|||||||++|+|++|.+||.+......+..+...   ..
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLL-GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhc-CCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            975432      2234456899999999873 3456899999999999999999999999987776665544331   11


Q ss_pred             CCCCCc----------------------------CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          495 PLVPNS----------------------------LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       495 ~~~~~~----------------------------~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      +.....                            .+..+.+||.+||+.||.+|||++++|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            111111                            26789999999999999999999999999999854

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.2e-45  Score=384.86  Aligned_cols=257  Identities=29%  Similarity=0.452  Sum_probs=199.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      ++|++++.||+|+||.||+|.+ .+|..||||++....   ........+.+|+.+++.++||||+++++++...     
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            5899999999999999999987 689999999886432   2334556778999999999999999999988654     


Q ss_pred             -CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 -NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 -~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                       ..+|++|||+ +++|.++++...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence             5679999999 67999999888899999999999999999999999999999999999999999999999999976543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC-------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP-------------  494 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~-------------  494 (551)
                      . .....||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+..+.+..+.+.  .+             
T Consensus       185 ~-~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          185 E-MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             -------CCCTTCCHHHHT-TCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             c-CCCcCcCcCccChHHHc-CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            2 44567999999999973 3357899999999999999999999999988776665544321  00             


Q ss_pred             -------CC--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          495 -------PL--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       495 -------~~--------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                             +.        ....++..+.+||.+||+.||.+|||+.++|+||||+......
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence                   00        0124688999999999999999999999999999999766544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.7e-45  Score=405.36  Aligned_cols=256  Identities=27%  Similarity=0.451  Sum_probs=218.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|.+.++||+|+||.||+|.+ .+|+.||||++.......  ......+.+|+.++.+++||||+++++++.+...+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            45799999999999999999988 589999999997532211  122445778999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          355 IFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|||||.||+|..++...   .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            999999999999988653   38999999999999999999999999999999999999999999999999998664433


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHhhcCCCCCCCCcCCHHHHH
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGKGEPPLVPNSLSRDARD  507 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~l~~  507 (551)
                       ....+||+.|+|||++.  +..|+.++|||||||++|||++|+.||.....   ...+.......+..++..++..+.+
T Consensus       341 ~~~~~~GT~~Y~APEvl~--~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~d  418 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVK--NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS  418 (576)
T ss_dssp             CEECCCSCGGGCCHHHHT--TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccccCCCccccCHHHHc--CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHH
Confidence             34567999999999973  45689999999999999999999999976532   2333333333445567789999999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          508 FILKCLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       508 LI~~cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      ||.+||++||.+||     ++++|++||||+..
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999999     89999999999963

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=363.83  Aligned_cols=260  Identities=38%  Similarity=0.637  Sum_probs=210.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+|....+||+|+||.||+|.+ .++..||||++....     ......+.+|+.++..++||||+++++++.+...+++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            3455567999999999999987 578999999986432     2234567899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-CCcEEEEecCCccccccC
Q 043852          356 FLELVTKGSLANLYQKY----HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-SGSVKLADFGLAKATTMN  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~----~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-~g~vkL~DFGla~~~~~~  430 (551)
                      ||||+.+++|.+++...    .+++..+..++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            99999999999998754    3567888999999999999999999999999999999987 899999999999765432


Q ss_pred             --CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH--HHHHhhcCCCCCCCCcCCHHHH
Q 043852          431 --DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ--ALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       431 --~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                        ......||+.|+|||++......++.++|||||||++|+|++|+.||.......  ..........+..+..++..+.
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK  256 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHH
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHH
Confidence              233456899999999985444458999999999999999999999996543222  2222233444566778999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                      +||.+||+.||++|||+.++++||||+....+...
T Consensus       257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~  291 (295)
T 2clq_A          257 AFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT  291 (295)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHTSGGGCC-------
T ss_pred             HHHHHHccCChhhCCCHHHHhcChhhhhccccCCC
Confidence            99999999999999999999999999977655443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.8e-45  Score=368.47  Aligned_cols=256  Identities=37%  Similarity=0.680  Sum_probs=215.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +.|++++.||+|+||.||+|.+ .+|..||+|++....     ......+.+|+.++..++||||+++++++.+...+|+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            4799999999999999999988 479999999986432     2234567899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--CC
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--ND  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~~  431 (551)
                      ||||+.+++|..++..  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....  ..
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK  173 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence            9999999999998764  4689999999999999999999999999999999999999999999999998753221  12


Q ss_pred             cccCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDAR  506 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~  506 (551)
                      .....||+.|+|||++..   ....++.++|||||||++|+|++|..||...........+.....+.  .+..++..+.
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  253 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR  253 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence            334568999999999732   34568899999999999999999999999887777766666555433  3457899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +||.+||+.||.+|||+.++++||||+....
T Consensus       254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          254 DFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            9999999999999999999999999997653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.9e-45  Score=397.48  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=222.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|.+ .+|+.||||++.......  ......+.+|+.++.+++||||+++++++.+...+|+
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4799999999999999999988 589999999997543322  2234567899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE---cCCCcEEEEecCCccccccC-
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTMN-  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl---~~~g~vkL~DFGla~~~~~~-  430 (551)
                      |||||.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..... 
T Consensus       104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            9999999999887754 568999999999999999999999999999999999999   46789999999999765433 


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDARD  507 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~~  507 (551)
                      ......||+.|+|||++.   ..|+.++|||||||++|+|++|.+||.+....+.+..+..+.....   ...++..+.+
T Consensus       184 ~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLH---GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHH---TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             ccccCCCCccccCceeec---CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            334567999999999974   2689999999999999999999999999888888888877654432   2468999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ||.+||++||.+|||+.++|+||||+....
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            999999999999999999999999986554

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=379.55  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=213.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc---chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ---GKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .++|++++.||+|+||.||+|.+ .+|..||||++........   .......+.+|+.++.+++||||+++++++.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            45899999999999999999987 6899999999976542221   1112234567999999999999999999999999


Q ss_pred             eEEEEEeccccc-chHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKG-SLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~gg-sL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      .+++||||+.+| +|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999999999776 999988765 689999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          430 ND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       430 ~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .. .....||+.|+|||++. ....++.++|||||||++|+|++|..||......      . ......+..++..+.+|
T Consensus       183 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-~~~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          183 GKLFYTFCGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V-EAAIHPPYLVSKELMSL  254 (335)
T ss_dssp             TCCBCEECSCGGGCCHHHHT-TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T-TTCCCCSSCCCHHHHHH
T ss_pred             CCceeccCCCccccChhhhc-CCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H-hhccCCCcccCHHHHHH
Confidence            33 34566999999999973 2223488999999999999999999999764331      1 12233455689999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |.+||++||.+|||+.++++||||++...
T Consensus       255 i~~~L~~dP~~Rps~~ell~hp~~~~~~~  283 (335)
T 3dls_A          255 VSGLLQPVPERRTTLEKLVTDPWVTQPVN  283 (335)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred             HHHHccCChhhCcCHHHHhcCccccCCcc
Confidence            99999999999999999999999987653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.5e-44  Score=372.14  Aligned_cols=257  Identities=28%  Similarity=0.498  Sum_probs=213.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE-----  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  350 (551)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++...    ........+.+|+.++.+++||||+++++++...     
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            5899999999999999999987 57999999998532    2234456678999999999999999999987654     


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      ...|++|||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           87 NEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             CCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             ceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            678999999974 8999998888999999999999999999999999999999999999999999999999999754322


Q ss_pred             C------------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc--CCCC-
Q 043852          431 D------------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPP-  495 (551)
Q Consensus       431 ~------------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~--~~~~-  495 (551)
                      .            .....||+.|+|||++. ....++.++|||||||++|+|++|..||.+......+..+..  +.+. 
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHH-SCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             cccccCccccccchhhccccccccCCeeec-cCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            1            22346899999999873 446789999999999999999999999988776554433321  0000 


Q ss_pred             ----------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          496 ----------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       496 ----------------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                                                  .....++..+.+||.+||+.||.+|||+.++++||||+......
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence                                        01136789999999999999999999999999999999765443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.9e-45  Score=385.69  Aligned_cols=250  Identities=27%  Similarity=0.434  Sum_probs=201.1

Q ss_pred             cccCeeee-eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHH-hcCCCCceeeeeeeccC--
Q 043852          275 RIMSWQKG-ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL-SRFEHENIVQYFGTDKD--  349 (551)
Q Consensus       275 ~~~~y~~~-~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~--  349 (551)
                      .+++|.+. ++||+|+||+||++.+ .+|+.||||++...          ..+.+|+.++ +..+||||+++++++..  
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            34578877 7899999999999988 57999999998521          1345777776 45689999999998764  


Q ss_pred             --CCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CCcEEEEec
Q 043852          350 --ENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SGSVKLADF  421 (551)
Q Consensus       350 --~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g~vkL~DF  421 (551)
                        ...+|||||||.||+|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              66789999999999999998754   4899999999999999999999999999999999999987   789999999


Q ss_pred             CCccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH----HHHHhhcCCCC-
Q 043852          422 GLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ----ALFRIGKGEPP-  495 (551)
Q Consensus       422 Gla~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~----~~~~i~~~~~~-  495 (551)
                      |+++..... .....+||+.|+|||++  ....|+.++|||||||++|+|++|..||.......    ....+..+... 
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGS--CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ccccccCCCCccccCCCCCCccCHhhc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            999865432 34456789999999997  45678999999999999999999999997654321    22233333222 


Q ss_pred             --CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          496 --LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       496 --~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                        .....++..+.+||.+||+.||.+|||+.+|++||||++..
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence              22256899999999999999999999999999999998654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-44  Score=382.47  Aligned_cols=253  Identities=23%  Similarity=0.457  Sum_probs=210.3

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC--CCceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE--HENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~l  355 (551)
                      .|.+++.||+|+||.||+|.+.++..||||++.....   .......+.+|+.++.++.  |+||+++++++.....+|+
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            6999999999999999999887799999999975432   3445667889999999996  5999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      ||| +.+++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......   
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            999 567899998865 4578889999999999999999999999999999999994 6899999999998654332   


Q ss_pred             -cccCCCCCcccChhhhhcc---------cCCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHhhcC-CCCCCCC
Q 043852          432 -VKSCKGTPFWMAPEVVNLK---------NRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRIGKG-EPPLVPN  499 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i~~~-~~~~~~~  499 (551)
                       ....+||+.|+|||++...         ...++.++|||||||++|+|++|+.||.... ....+..+... .....+.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  291 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  291 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence             2355799999999998431         2368999999999999999999999997653 33444444443 2334566


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ..+..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            678999999999999999999999999999999754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-44  Score=359.42  Aligned_cols=247  Identities=25%  Similarity=0.426  Sum_probs=218.9

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..++|++++.||+|+||.||+|.+.++..||+|++......      ...+.+|+.++.+++||||+++++++.+...+|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            34589999999999999999998888889999998643221      245779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      +||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            999999999999988754  489999999999999999999999999999999999999999999999999976544432


Q ss_pred             ---ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          433 ---KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       433 ---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                         ....+|+.|+|||++.  ...++.++|||||||++|+|++ |..||...........+..+.....+..++..+.+|
T Consensus       160 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFH--YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHH--HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             hcccCCCcCcccCCHHHHh--ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence               2334667899999973  4567899999999999999999 999999888888888888888788888899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhC
Q 043852          509 ILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILeh  529 (551)
                      |.+||+.||.+|||+.+++++
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=382.80  Aligned_cols=259  Identities=28%  Similarity=0.433  Sum_probs=212.5

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD  349 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  349 (551)
                      .+++|++++.||+|+||.||+|.+    .+|..||||++....... .......+.+|+.++..+ +|+||+++++++.+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-hhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            456899999999999999999987    378999999986432111 111122455788889988 69999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ...+|+|||||.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            9999999999999999998865 468999999999999999999999999999999999999999999999999997543


Q ss_pred             cC---CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch----hHHHHHHhhcCCCCCCCCcC
Q 043852          429 MN---DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE----GMQALFRIGKGEPPLVPNSL  501 (551)
Q Consensus       429 ~~---~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~  501 (551)
                      ..   ......||+.|+|||++......++.++|||||||++|+|++|+.||....    .......+... .+..+..+
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  289 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEM  289 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCCCTTS
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCCCCccc
Confidence            22   233456999999999985434567899999999999999999999996432    22222333333 34556789


Q ss_pred             CHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          502 SRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      +..+.+||.+||+.||.+||     |+.++++||||+..
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            99999999999999999999     99999999999865

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6e-45  Score=382.17  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=205.1

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC--
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN--  351 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--  351 (551)
                      .+++|++++.||+|+||.||+|.+ .+|..||||++....   ........+.+|+.+++.++||||+++++++....  
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence            356899999999999999999987 579999999987532   22345567789999999999999999999987654  


Q ss_pred             ----eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          352 ----RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       352 ----~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                          .+|+|||||.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          100 EEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence                78999999976 6777765 46889999999999999999999999999999999999999999999999999765


Q ss_pred             ccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC--------
Q 043852          428 TMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP--------  498 (551)
Q Consensus       428 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~--------  498 (551)
                      ... ......||+.|+|||++  .+..++.++|||||||++|+|++|..||.+.+..+.+..+........+        
T Consensus       178 ~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          178 GTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             ------------CTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             ccccccCCceecCCccCHHHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            433 23456799999999997  3467899999999999999999999999988877776665543211100        


Q ss_pred             ---------------------------C------cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          499 ---------------------------N------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       499 ---------------------------~------~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                                 .      ..+..+.+||.+||+.||.+|||++++|+||||+....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                                       0      11567899999999999999999999999999986443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=366.41  Aligned_cols=251  Identities=37%  Similarity=0.712  Sum_probs=214.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..|++++.||+|+||.||+|.+ .+|..||||++.....       ...+.+|+.++..++||||+++++++.+...+|+
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            4799999999999999999987 4799999999875321       2357789999999999999999999999999999


Q ss_pred             EEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--C
Q 043852          356 FLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~  431 (551)
                      ||||+.+++|.+++.  ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......  .
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999999886  346899999999999999999999999999999999999999999999999999765432  2


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC--CCCcCCHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL--VPNSLSRDARDFI  509 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~l~~LI  509 (551)
                      .....||+.|+|||++  ....++.++|||||||++|+|++|..||...........+.......  .+..++..+.+||
T Consensus       182 ~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  259 (314)
T 3com_A          182 RNTVIGTPFWMAPEVI--QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV  259 (314)
T ss_dssp             BCCCCSCGGGCCHHHH--SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cCccCCCCCccChhhc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence            3445689999999997  45568999999999999999999999998877776666655544333  2456899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .+||+.||.+|||+.++++||||+...
T Consensus       260 ~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          260 KQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999998654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=367.61  Aligned_cols=253  Identities=28%  Similarity=0.488  Sum_probs=207.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec--------
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD--------  347 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--------  347 (551)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++...     .......+.+|+.++++++||||+++++++        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            4899999999999999999988 46999999998643     234566788999999999999999999876        


Q ss_pred             ------cCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc-CCCcEEEEe
Q 043852          348 ------KDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD-ASGSVKLAD  420 (551)
Q Consensus       348 ------~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~-~~g~vkL~D  420 (551)
                            .+...+|+||||+. ++|.+++....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  34567899999998 5999999888899999999999999999999999999999999999997 567999999


Q ss_pred             cCCccccccC-----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC
Q 043852          421 FGLAKATTMN-----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP  495 (551)
Q Consensus       421 FGla~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~  495 (551)
                      ||+++.....     ......+|+.|+|||++. ....++.++|||||||++|+|++|+.||.+.........+....+.
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHH-CTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhc-CcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999765321     223445799999999873 3457899999999999999999999999887776655544332211


Q ss_pred             -----------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          496 -----------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       496 -----------------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                                   .....++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence                                         01245899999999999999999999999999999998543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-44  Score=408.84  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=224.0

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      ..+.+|+++++||+|+||.||+|.+ .+++.||||++......  .......+..|..++..+ +|+||+.+++++.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH--HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            4567999999999999999999987 57899999998753211  112344567888889887 7999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc--
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT--  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~--  428 (551)
                      .+||||||+.||+|..++++ ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...  
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999999998876 569999999999999999999999999999999999999999999999999998533  


Q ss_pred             cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       429 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      .......+||+.|+|||++  ....|+.++|||||||+||||++|++||.+.+..+.+..|..... .++..++.++.+|
T Consensus       496 ~~~~~~~~GT~~Y~APE~l--~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l  572 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAI  572 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHH--TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCTTSCHHHHHH
T ss_pred             CcccccccCCCcccCHhhh--cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHH
Confidence            2334566799999999997  456789999999999999999999999999888888888877654 4567899999999


Q ss_pred             HHHhhhcCCCCCCCH-----HHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTA-----AQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~-----~eILehpff~~~  535 (551)
                      |.+||++||.+||++     ++|++||||+..
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999997     999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-44  Score=399.91  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=217.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..+|.+.++||+|+||+||+|++ .+|+.||||++......  .......+.+|+.++.+++||||+++++++.+...+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK--KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh--hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            45899999999999999999988 57999999999653221  1123456778999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-----~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      +|||||.||+|..++...     .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999988643     488999999999999999999999999999999999999999999999999986544


Q ss_pred             CC--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch----hHHHHHHhhcCCCCCCCCcCCH
Q 043852          430 ND--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE----GMQALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       430 ~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~s~  503 (551)
                      ..  ....+||+.|+|||++  .+..|+.++|||||||++|||++|+.||....    .......+... ...++..++.
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l--~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~  418 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELL--LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AVTYPDKFSP  418 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CCCCCTTSCH
T ss_pred             CCcccccccCCccccChhhh--cCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-ccCCCcccCH
Confidence            33  3345799999999997  45678999999999999999999999997642    23334444443 3445678999


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          504 DARDFILKCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      .+.+||.+||++||.+||+     +++|++||||+..
T Consensus       419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            9999999999999999996     5899999999973

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.4e-45  Score=372.90  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC---
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN---  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---  351 (551)
                      .++|++++.||+|+||.||+|.+ .+++.||||++.....  ........+.+|+.++.+++||||+++++++....   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            35899999999999999999987 6899999999865332  23455667889999999999999999999876554   


Q ss_pred             -eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 -RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 -~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                       ..|+|||||.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence             34999999999999998875 4589999999999999999999999999999999999999999999999999975533


Q ss_pred             C-----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcC
Q 043852          430 N-----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSL  501 (551)
Q Consensus       430 ~-----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~  501 (551)
                      .     ......||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+.........+........   ...+
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             -------------CCTTCCHHHH--HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             cccccccccccCcCcccCCHHHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            2     22345689999999997  455789999999999999999999999998877766665555443321   3458


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +..+.+||.+||+.||.+||++.+++.|+|++...
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            99999999999999999999999999999987543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-44  Score=384.63  Aligned_cols=251  Identities=28%  Similarity=0.430  Sum_probs=205.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD------  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------  349 (551)
                      .+|++++.||+|+||.||+|++ .+|+.||||++......         ..+|+.+++.++|+||+++++++..      
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---------HHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            3799999999999999999988 57999999998643221         2369999999999999999988732      


Q ss_pred             CCeEEEEEecccccchHHHHh-----hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-CcEEEEecCC
Q 043852          350 ENRLFIFLELVTKGSLANLYQ-----KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGL  423 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~-----~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGl  423 (551)
                      ..++++||||+.+ +|..++.     ...+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence            3357899999987 5555443     3468899999999999999999999999999999999999965 5689999999


Q ss_pred             ccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--C-------
Q 043852          424 AKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--E-------  493 (551)
Q Consensus       424 a~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~-------  493 (551)
                      ++..... ......||+.|+|||++. ....|+.++|||||||++|||++|++||.+....+.+..+.+.  .       
T Consensus       204 a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          204 AKQLVRGEPNVSYICSRYYRAPELIF-GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CEECCTTCCCCSCCSCTTSCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hhhcccCCCceeeeeCCCcCCHHHHc-CCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865433 344567999999999973 3447899999999999999999999999988776665554321  0       


Q ss_pred             ----------CCC---------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          494 ----------PPL---------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       494 ----------~~~---------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                                .+.         ++..++.++.+||.+||++||.+|||+.++++||||+.....
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence                      000         224578999999999999999999999999999999866543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-44  Score=361.10  Aligned_cols=251  Identities=23%  Similarity=0.418  Sum_probs=218.4

Q ss_pred             hhhhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          271 KFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       271 ~~~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      .+.....+|++++.||+|+||.||++.+.++..||||++......      ...+.+|+.++.+++|+||+++++++.+.
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            334445689999999999999999998888889999998643221      24577999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ..+|+||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            999999999999999999875  568999999999999999999999999999999999999999999999999997554


Q ss_pred             cCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          429 MND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       429 ~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ...   .....+|+.|+|||++.  ...++.++|||||||++|+|++ |+.||...........+..+.....+..++..
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK  249 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccCCccCcccCCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHH
Confidence            322   23344678899999974  4568999999999999999998 99999998888888888888777788889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+||.+||+.||.+|||+.++++|
T Consensus       250 l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          250 VYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.7e-44  Score=368.56  Aligned_cols=250  Identities=28%  Similarity=0.461  Sum_probs=207.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccC--CCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKD--ENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~  352 (551)
                      ++|++++.||+|+||.||+|.+ .+++.||||++....        ...+.+|+.++.++. |+||+++++++.+  ...
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            4899999999999999999987 689999999985321        245779999999997 9999999999887  677


Q ss_pred             EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCccccccC-
Q 043852          353 LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMN-  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~~-  430 (551)
                      .+++|||+.+++|..+++.  +++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... 
T Consensus       108 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eEEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            8999999999999998864  88899999999999999999999999999999999999777 8999999999765433 


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHHh-------------hcCCC--
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRI-------------GKGEP--  494 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-~~~~~~~~i-------------~~~~~--  494 (551)
                      ......||+.|+|||++. ....++.++|||||||++|+|++|..||... ...+.+..+             .....  
T Consensus       186 ~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             ccccccccccccChhhhc-CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            344567999999999973 3367899999999999999999999999432 222222211             11110  


Q ss_pred             ---------------------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          495 ---------------------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       495 ---------------------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                           ...+..++..+.+||.+||++||.+|||++++|+||||+....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                                 1112237999999999999999999999999999999997654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.8e-44  Score=370.19  Aligned_cols=255  Identities=25%  Similarity=0.435  Sum_probs=214.6

Q ss_pred             cCeeee-eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeE
Q 043852          277 MSWQKG-ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRL  353 (551)
Q Consensus       277 ~~y~~~-~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  353 (551)
                      +.|.+. +.||+|+||.||+|.+ .+|+.||||++.......   .....+.+|+.++..+. ||||+++++++.+...+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE---ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            367777 8999999999999988 579999999987543322   22446778999999985 69999999999999999


Q ss_pred             EEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CCcEEEEecCCcccc
Q 043852          354 FIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKAT  427 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g~vkL~DFGla~~~  427 (551)
                      |+|||||.+++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            999999999999998754   46899999999999999999999999999999999999987   789999999999865


Q ss_pred             ccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC---CCCCCcCCH
Q 043852          428 TMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP---PLVPNSLSR  503 (551)
Q Consensus       428 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~s~  503 (551)
                      ... ......||+.|+|||++  ....++.++|||||||++|+|++|+.||......+....+.....   ......++.
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          185 GHACELREIMGTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             ---------CCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             CCccccccccCCcCccCCeee--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence            433 23456799999999997  456789999999999999999999999988877766665554432   333456899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .+.+||.+||+.||.+|||++++|+||||++.-
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            999999999999999999999999999998653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.4e-44  Score=362.64  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=212.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++.+++||||+++++++.+...+|+
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            4799999999999999999987 5899999999865433  334556788899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          356 FLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      ||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            99999999999988764 58999999999999999999999999999999999999999999999999997654332   


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC----CCCcCCHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL----VPNSLSRDARD  507 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~s~~l~~  507 (551)
                      .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+........+......+.    .+..++..+.+
T Consensus       169 ~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQA--KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             ------CCSSCCHHHH--HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred             cCccccCccccCHhHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence            3345699999999997  45678999999999999999999999999887766655555444332    24568999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      +|.+||++||.+||+..+.+.+.|..
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHhcCCHhHccccHHHHHHHHHH
Confidence            99999999999999666666666654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.1e-44  Score=386.18  Aligned_cols=255  Identities=28%  Similarity=0.441  Sum_probs=206.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC------CCCceeeeeeecc
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF------EHENIVQYFGTDK  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~  348 (551)
                      ..+|++++.||+|+||+||+|.+ .+++.||||++...      ......+.+|+.++..+      .|+||+++++++.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            34799999999999999999987 57999999998532      23334566777777766      6779999999999


Q ss_pred             CCCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc--EEEEecCC
Q 043852          349 DENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS--VKLADFGL  423 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~--vkL~DFGl  423 (551)
                      ....+|++|||+. ++|.+++...   ++++..+..++.||+.||.|||++||+||||||+||||+.++.  +||+|||+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999996 5888887654   3889999999999999999999999999999999999999887  99999999


Q ss_pred             ccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--CC------
Q 043852          424 AKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--PP------  495 (551)
Q Consensus       424 a~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~------  495 (551)
                      +..... ......||+.|+|||++  .+..++.++|||||||++|||++|.+||.+.+..+.+..+....  ++      
T Consensus       249 a~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          249 SCYEHQ-RVYTYIQSRFYRAPEVI--LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             CEETTC-CCCSSCSCGGGCCHHHH--HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ceecCC-cccccCCCCCccChHHH--hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence            965443 34456799999999997  35578999999999999999999999998877766554433210  00      


Q ss_pred             --------------------------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHH
Q 043852          496 --------------------------------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQ  525 (551)
Q Consensus       496 --------------------------------------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~e  525 (551)
                                                                        ..+...+..+.+||.+||++||.+|||++|
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence                                                              011234788999999999999999999999


Q ss_pred             HHhCcccCCccccCC
Q 043852          526 LMEHPFVKRPLQKSR  540 (551)
Q Consensus       526 ILehpff~~~~~~~~  540 (551)
                      +|+||||++.+.+..
T Consensus       406 ~L~Hpw~~~~~~~~~  420 (429)
T 3kvw_A          406 ALRHPWLRRRLPKPP  420 (429)
T ss_dssp             HHTSTTTC-------
T ss_pred             HhCChhhccCCCCCC
Confidence            999999998776543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4e-45  Score=368.93  Aligned_cols=259  Identities=34%  Similarity=0.618  Sum_probs=196.9

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ..++|++.+.||+|+||.||+|.+ .++..||||++.....    ......+.+|+.++.+++||||+++++++......
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC----QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc----chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            345899999999999999999987 5789999998754321    22345677999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh---------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          354 FIFLELVTKGSLANLYQK---------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~---------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      |+||||+.+++|.+++..         ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999998863         34889999999999999999999999999999999999999999999999998


Q ss_pred             cccccC-------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC-
Q 043852          425 KATTMN-------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-  496 (551)
Q Consensus       425 ~~~~~~-------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~-  496 (551)
                      ......       ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.................+. 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHH-HHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhc-cccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            654322       123456899999999974 22467999999999999999999999998776655554444433322 


Q ss_pred             --------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          497 --------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       497 --------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                              ....++..+.+||.+||+.||.+|||+.++++||||++...+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence                    224678999999999999999999999999999999876543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.1e-45  Score=375.16  Aligned_cols=260  Identities=25%  Similarity=0.407  Sum_probs=220.3

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccc------------hHHHHHHHHHHHHHhcCCCCceee
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQG------------KQSILQLEQEILLLSRFEHENIVQ  342 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~------------~~~~~~~~~Ei~il~~l~HpnIv~  342 (551)
                      .+++|++++.||+|+||.||+|.+ +|..||||++.........            ......+.+|+.++.+++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            356999999999999999999988 9999999999754322111            112257889999999999999999


Q ss_pred             eeeeccCCCeEEEEEecccccchHHH------Hhh---hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcC
Q 043852          343 YFGTDKDENRLFIFLELVTKGSLANL------YQK---YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDA  412 (551)
Q Consensus       343 l~~~~~~~~~~~lV~Ey~~ggsL~~l------l~~---~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~  412 (551)
                      +++++.+...+|+||||+.+++|.++      +..   ..+++..++.++.||+.||.|||+ +||+|+||||+|||++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999987      543   468899999999999999999999 99999999999999999


Q ss_pred             CCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHhh
Q 043852          413 SGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL-TADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIG  490 (551)
Q Consensus       413 ~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~-ksDIwSLG~iLyeLltG~~Pf~~~~~-~~~~~~i~  490 (551)
                      ++.+||+|||++............||+.|+|||++. ....++. ++|||||||++|+|++|..||..... .+....+.
T Consensus       188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGS-SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred             CCcEEEeccccccccccccccCCCCCcCccCchhhc-CCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence            999999999999876555556677999999999973 2224555 99999999999999999999987766 55555565


Q ss_pred             cCCCCCCC------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          491 KGEPPLVP------------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       491 ~~~~~~~~------------------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .+......                  ..++..+.+||.+||+.||.+|||+.++++||||+..-
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            55433221                  56899999999999999999999999999999998643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=367.72  Aligned_cols=254  Identities=34%  Similarity=0.658  Sum_probs=210.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC----
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD----  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----  349 (551)
                      .++|++++.||+|+||.||+|.+ .+|+.||||++......      ...+.+|+.++.++ +||||+++++++..    
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST------THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc------HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            45899999999999999999987 58999999998643221      23567899999998 79999999999866    


Q ss_pred             --CCeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          350 --ENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       350 --~~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                        ...+|+||||+.+++|.+++..   ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              5678999999999999999875   45889999999999999999999999999999999999999999999999998


Q ss_pred             cccccC--CcccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC-CCCC
Q 043852          425 KATTMN--DVKSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP-PLVP  498 (551)
Q Consensus       425 ~~~~~~--~~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~-~~~~  498 (551)
                      ......  ......||+.|+|||++...   ...++.++|||||||++|+|++|..||...........+..... ...+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence            765322  23345699999999997421   45688999999999999999999999988777766666555433 3345


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ..++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            6789999999999999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=369.05  Aligned_cols=247  Identities=23%  Similarity=0.408  Sum_probs=215.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      ..+|.+.+.||+|+||.||+|.+.    .+..||||++...    ........+.+|+.++.+++||||+++++++.+..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG----YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            358999999999999999999873    3445999998632    22344567889999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      .+|+||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999999999864  3689999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCH
Q 043852          430 ND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       430 ~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  503 (551)
                      ..     .....+|+.|+|||++  ....++.++|||||||++|+|++ |..||......+....+..+.....+..++.
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH  281 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CccceeeccCCCCcccccCHhHh--cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence            32     1223467889999997  34568999999999999999999 9999999888888888888877778888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+.+||.+||+.||.+|||+.+|++
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=378.84  Aligned_cols=251  Identities=28%  Similarity=0.434  Sum_probs=218.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      .+|++++.||+|+||.||+|..      .++..||||++...    ........+.+|+.++.+++||||+++++++.+.
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4799999999999999999983      35778999988532    2334455788999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC---cEEEE
Q 043852          351 NRLFIFLELVTKGSLANLYQKY--------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLA  419 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~--------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g---~vkL~  419 (551)
                      ...|+|||||.+|+|.+++...        .++...++.++.||+.||.|||++||+||||||+|||++.+|   .+||+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999998764        388889999999999999999999999999999999999655   59999


Q ss_pred             ecCCcccccc----CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC
Q 043852          420 DFGLAKATTM----NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP  494 (551)
Q Consensus       420 DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~  494 (551)
                      |||+++....    .......||+.|+|||++  ....++.++|||||||++|||++ |..||......+....+..+..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999974322    222334579999999997  35678999999999999999998 9999999888888888888887


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       495 ~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      ...+..++..+.+||.+||+.||.+|||+.+|+++.++-
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            778888999999999999999999999999999987643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=9.5e-45  Score=387.58  Aligned_cols=260  Identities=28%  Similarity=0.452  Sum_probs=204.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc---chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ---GKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .++|.+.+.||+|+||.||+|.+ .+++.||||++........   .......+.+|+.++.+++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            45899999999999999999987 5789999999976532211   12223357799999999999999999999754 4


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC---cEEEEecCCcccc
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG---SVKLADFGLAKAT  427 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g---~vkL~DFGla~~~  427 (551)
                      .+|+|||||.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            57999999999999887754 4689999999999999999999999999999999999997654   5999999999876


Q ss_pred             ccCC-cccCCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-HHHHHhhcCCCCCCC---CcC
Q 043852          428 TMND-VKSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKGEPPLVP---NSL  501 (551)
Q Consensus       428 ~~~~-~~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-~~~~~i~~~~~~~~~---~~~  501 (551)
                      .... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||...... .....+..+.....+   ..+
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  372 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  372 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence            4432 345679999999999742 2456889999999999999999999999764432 222333444333322   468


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +..+.+||.+||+.||.+|||++++|+||||+...
T Consensus       373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            99999999999999999999999999999998643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-44  Score=357.41  Aligned_cols=250  Identities=27%  Similarity=0.507  Sum_probs=204.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +.+|++.+.||+|+||.||+|.+ .|..||||++...... ........+.+|+.++..++||||+++++++.+....|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            45899999999999999999976 5889999987643222 223345678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCC---eeecccccceEEEcC--------CCcEEEEecCCc
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN---VVHRDIKCANILVDA--------SGSVKLADFGLA  424 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~g---IiHrDIKP~NILl~~--------~g~vkL~DFGla  424 (551)
                      ||||+.+++|.+++....+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||++
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            999999999999998888999999999999999999999999   999999999999986        778999999999


Q ss_pred             cccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC-CCCCCCCcCCH
Q 043852          425 KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-EPPLVPNSLSR  503 (551)
Q Consensus       425 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~  503 (551)
                      +...........||+.|+|||++  ....++.++|||||||++|+|++|+.||.+.........+... .....+..++.
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (271)
T 3dtc_A          164 REWHRTTKMSAAGAYAWMAPEVI--RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE  241 (271)
T ss_dssp             ------------CCGGGSCHHHH--HHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cccccccccCCCCccceeCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCH
Confidence            86655555566799999999997  3557899999999999999999999999987776666555443 34456678999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+.+||.+||+.||.+|||+.+++++
T Consensus       242 ~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          242 PFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999999999974

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.2e-44  Score=363.71  Aligned_cols=248  Identities=25%  Similarity=0.450  Sum_probs=216.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      ..+|.+++.||+|+||.||+|.+      .++..||||++...    ........+.+|+.++.+++||||+++++++.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            45899999999999999999975      24578999988532    234456678899999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhhh-------------------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQKY-------------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK  404 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~-------------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIK  404 (551)
                      ...+|+||||+.+++|.+++...                         .+++..++.++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            99999999999999999998753                         27888999999999999999999999999999


Q ss_pred             cceEEEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 043852          405 CANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSH  479 (551)
Q Consensus       405 P~NILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~  479 (551)
                      |+|||++.++.+||+|||+++......    .....+|+.|+|||++.  +..++.++|||||||++|+|++ |..||.+
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc--CCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999997554322    23345788899999973  4568999999999999999999 9999988


Q ss_pred             chhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          480 LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       480 ~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .........+..+.....+..++..+.+||.+||+.||.+|||+.+|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            87777777777777777788899999999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-44  Score=375.05  Aligned_cols=252  Identities=26%  Similarity=0.443  Sum_probs=220.4

Q ss_pred             hhhcccCeeeeeEeccCCceEEEEEEec--------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceee
Q 043852          272 FRRRIMSWQKGELLGSGSFGTVYEGYTD--------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQ  342 (551)
Q Consensus       272 ~~~~~~~y~~~~~LG~G~fG~VY~~~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~  342 (551)
                      +....++|.+++.||+|+||.||+|.+.        .+..||||++...    ........+.+|+.++.++ +||||++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            3344568999999999999999999752        3357999998643    2344566788999999999 8999999


Q ss_pred             eeeeccCCCeEEEEEecccccchHHHHhhhc-----------------CChHHHHHHHHHHHHHHHHHHhCCeeeccccc
Q 043852          343 YFGTDKDENRLFIFLELVTKGSLANLYQKYH-----------------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC  405 (551)
Q Consensus       343 l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~-----------------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP  405 (551)
                      +++++.+...+|+|||||.+++|.+++....                 +++..++.++.||+.||.|||++||+||||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999987643                 88999999999999999999999999999999


Q ss_pred             ceEEEcCCCcEEEEecCCccccccC----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 043852          406 ANILVDASGSVKLADFGLAKATTMN----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHL  480 (551)
Q Consensus       406 ~NILl~~~g~vkL~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~  480 (551)
                      +|||++.++.+||+|||+++.....    ......+|+.|+|||++  .+..++.++|||||||++|+|++ |..||...
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh--cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999765432    23334578899999997  45678999999999999999999 99999988


Q ss_pred             hhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          481 EGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       481 ~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...+....+..+.....+..++..+.+||.+||+.||.+|||+.+|+++
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8888887888887777888899999999999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.3e-44  Score=371.25  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=207.3

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCc------cchHHHHHHHHHHHHHhcCCCCceeeeeeec-
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT------QGKQSILQLEQEILLLSRFEHENIVQYFGTD-  347 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-  347 (551)
                      ..++|++++.||+|+||.||+|.+.+|..||||++.......      ........+.+|+.++.+++||||+++++++ 
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            345899999999999999999998889999999986543221      1233456788999999999999999999987 


Q ss_pred             ----cCCCeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEec
Q 043852          348 ----KDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       348 ----~~~~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                          .....+|+||||+.+ +|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence                344578999999985 777666543  5899999999999999999999999999999999999999999999999


Q ss_pred             CCccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--------
Q 043852          422 GLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--------  492 (551)
Q Consensus       422 Gla~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--------  492 (551)
                      |+++..... ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+......+..+...        
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TC---------------CGGGCCHHHHT-TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CcccccccccccceecccceecCcHHhc-CCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            999754332 234456899999999973 3356899999999999999999999999887766555443220        


Q ss_pred             ---------------CCC--------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          493 ---------------EPP--------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       493 ---------------~~~--------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                     ...        .....++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                           000        012356889999999999999999999999999999997643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.4e-44  Score=367.14  Aligned_cols=256  Identities=24%  Similarity=0.426  Sum_probs=202.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CCc---eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DGF---FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g~---~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ++|++++.||+|+||.||+|.+. ++.   .||||++.....   .......+.+|+.++++++||||+++++++.+...
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            47999999999999999999874 332   799998864322   22345678899999999999999999999877665


Q ss_pred             E------EEEEecccccchHHHHhhh-------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEE
Q 043852          353 L------FIFLELVTKGSLANLYQKY-------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA  419 (551)
Q Consensus       353 ~------~lV~Ey~~ggsL~~ll~~~-------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~  419 (551)
                      .      +++|||+.+++|.+++...       .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence            4      9999999999999988643       48889999999999999999999999999999999999999999999


Q ss_pred             ecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC
Q 043852          420 DFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP  494 (551)
Q Consensus       420 DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~  494 (551)
                      |||+++......    .....+|+.|+|||++  .+..++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             eccccccccccccccccccccCcccccCchhh--cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            999997654322    2234467889999997  45578999999999999999999 9999998888888888887777


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCC-------HHHHHhCcccCCccc
Q 043852          495 PLVPNSLSRDARDFILKCLQVNPNDRPT-------AAQLMEHPFVKRPLQ  537 (551)
Q Consensus       495 ~~~~~~~s~~l~~LI~~cL~~DP~~RPS-------~~eILehpff~~~~~  537 (551)
                      ...+..++..+.+||.+||+.||.+|||       +++++.|+|+....+
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            7778889999999999999999999999       888999999876443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.4e-44  Score=368.89  Aligned_cols=259  Identities=28%  Similarity=0.457  Sum_probs=207.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccC---ccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQG---TQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .++|.+.+.||+|+||.||+|.+ .++..||||++......   .........+.+|+.++.+++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            35799999999999999999987 57899999998654321   111223445779999999999999999999987665


Q ss_pred             eEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc---EEEEecCCcccc
Q 043852          352 RLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS---VKLADFGLAKAT  427 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~---vkL~DFGla~~~  427 (551)
                       +|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999987764 46889999999999999999999999999999999999987664   999999999765


Q ss_pred             ccCC-cccCCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-HHHHHhhcCCCCCC---CCcC
Q 043852          428 TMND-VKSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM-QALFRIGKGEPPLV---PNSL  501 (551)
Q Consensus       428 ~~~~-~~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~-~~~~~i~~~~~~~~---~~~~  501 (551)
                      .... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||...... .....+..+.....   ...+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  247 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred             ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence            4332 234458999999999742 3456899999999999999999999999764432 22223333333222   2468


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      +..+.+||.+||+.||.+|||+.++++||||+..
T Consensus       248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            9999999999999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-43  Score=362.73  Aligned_cols=256  Identities=31%  Similarity=0.522  Sum_probs=209.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe--cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc---CCCCceeeeeeecc--
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT--DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR---FEHENIVQYFGTDK--  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~---l~HpnIv~l~~~~~--  348 (551)
                      .++|++++.||+|+||.||+|.+  .+|..||||++...........   .+.+|+.+++.   +.||||+++++++.  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL---STIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBC---THHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCc---hhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            35899999999999999999987  4688999999875443222122   23355555554   48999999999886  


Q ss_pred             ---CCCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecC
Q 043852          349 ---DENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       349 ---~~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                         ....+++||||+. ++|.+++...   .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence               6678999999998 5998888653   38999999999999999999999999999999999999999999999999


Q ss_pred             CccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--------
Q 043852          423 LAKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--------  493 (551)
Q Consensus       423 la~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--------  493 (551)
                      +++..... ......||+.|+|||++  ....++.++|||||||++|+|++|+.||.+......+..+....        
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             ccccccCCCCccccccccceeCHHHH--hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            99765432 23456689999999997  34568999999999999999999999998877766665543210        


Q ss_pred             ------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          494 ------------------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       494 ------------------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                        .......++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                              01123468899999999999999999999999999999986543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=368.59  Aligned_cols=251  Identities=25%  Similarity=0.435  Sum_probs=206.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC--eE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN--RL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~  353 (551)
                      ++|+++++||+|+||+||+|.+ .+|+.||||++......    .....+.+|+.++.+++||||+++++++....  .+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            3799999999999999999988 56999999998643221    22445678999999999999999999887654  78


Q ss_pred             EEEEecccccchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE----cCCCcEEEEecCCcc
Q 043852          354 FIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV----DASGSVKLADFGLAK  425 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~----l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl----~~~g~vkL~DFGla~  425 (551)
                      |+|||||.+++|.+++....    +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999999987543    8999999999999999999999999999999999999    778889999999998


Q ss_pred             ccccC-CcccCCCCCcccChhhhhcc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCch----hHHHHHHhhcCCC
Q 043852          426 ATTMN-DVKSCKGTPFWMAPEVVNLK------NRGYGLTADIWSLGCTVLEMLTRQPPYSHLE----GMQALFRIGKGEP  494 (551)
Q Consensus       426 ~~~~~-~~~~~~GT~~Y~APEvl~~~------~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~----~~~~~~~i~~~~~  494 (551)
                      ..... ......||+.|+|||++...      ...++.++|||||||++|||++|+.||....    ..+.+.++..+.+
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            65433 33456699999999997421      4678999999999999999999999996322    2344444444332


Q ss_pred             CC------------------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          495 PL------------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       495 ~~------------------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      ..                        ....++..+.+||.+||+.||++|||++|+|+||-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            11                        11234567889999999999999999999999974

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.5e-45  Score=384.50  Aligned_cols=250  Identities=19%  Similarity=0.231  Sum_probs=198.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHH---HHHhcCCCCceeeee-------e
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEI---LLLSRFEHENIVQYF-------G  345 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei---~il~~l~HpnIv~l~-------~  345 (551)
                      .+|++++.||+|+||+||+|.+ .+|+.||||++.......  ......+.+|+   .++.+++||||++++       +
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            4799999999999999999987 679999999997543222  23456778899   556666899999998       4


Q ss_pred             eccCCC-----------------eEEEEEecccccchHHHHhhh-cCCh-------HHHHHHHHHHHHHHHHHHhCCeee
Q 043852          346 TDKDEN-----------------RLFIFLELVTKGSLANLYQKY-HLMD-------SQVSAYTRQILNGLNYLHEQNVVH  400 (551)
Q Consensus       346 ~~~~~~-----------------~~~lV~Ey~~ggsL~~ll~~~-~l~~-------~~i~~i~~QI~~aL~yLH~~gIiH  400 (551)
                      ++.+.+                 ..|++|||| +|+|.+++.+. .+++       ..++.++.||+.||.|||++||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            444332                 378999999 57999988753 3544       777889999999999999999999


Q ss_pred             cccccceEEEcCCCcEEEEecCCccccccCCcccCCCCCcccChhhhhcc---------cCCCCchhhHHHHHHHHHHHH
Q 043852          401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLK---------NRGYGLTADIWSLGCTVLEML  471 (551)
Q Consensus       401 rDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLG~iLyeLl  471 (551)
                      |||||+|||++.++.+||+|||+++.... ......| +.|+|||++...         ...++.++|||||||++|||+
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            99999999999999999999999975433 3344567 999999998432         026899999999999999999


Q ss_pred             cCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          472 TRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       472 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +|+.||...........+...     ...++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus       308 tg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          308 CADLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HSSCCC------CCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HCCCCCcccccccchhhhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            999999765544333333222     256899999999999999999999999999999998654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.8e-44  Score=374.16  Aligned_cols=253  Identities=29%  Similarity=0.468  Sum_probs=209.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE--
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL--  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~--  353 (551)
                      ++|.+.+.||+|+||.||+|.+ .+|+.||||++....   ........+.+|+.+++.++||||+++++++......  
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            5899999999999999999987 579999999986432   2344566788999999999999999999998877654  


Q ss_pred             ----EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          354 ----FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       354 ----~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                          |+||||+.+ +|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       119 ~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          119 FYDFYLVMPFMQT-DLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CCCCEEEEECCCE-EHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             ceeEEEEEccccc-cHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence                999999974 88777743 589999999999999999999999999999999999999999999999999975543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--C-------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--P-------------  494 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~-------------  494 (551)
                       ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+..+.+..+....  +             
T Consensus       197 -~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          197 -EMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             ----CTTCCCTTSCHHHHS-CCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             -CcCCcccCccccCHHHhc-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence             234567899999999973 33678999999999999999999999998877666555443210  0             


Q ss_pred             --------C-------CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          495 --------P-------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       495 --------~-------~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                              .       .....++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                    0       01235789999999999999999999999999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.3e-44  Score=372.31  Aligned_cols=263  Identities=26%  Similarity=0.349  Sum_probs=200.7

Q ss_pred             hhhhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          271 KFRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       271 ~~~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      .....+++|++.+.||+|+||.||+|.+ .+|..||||++.......      ..+.+++..+..++||||+++++++..
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC------CHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc------HHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            3456678999999999999999999988 579999999986533222      134567778888899999999998754


Q ss_pred             CC-------eEEEEEecccccchHHHH----hhhcCChHHHHHHHHHHHHHHHHHH--hCCeeecccccceEEEcC-CCc
Q 043852          350 EN-------RLFIFLELVTKGSLANLY----QKYHLMDSQVSAYTRQILNGLNYLH--EQNVVHRDIKCANILVDA-SGS  415 (551)
Q Consensus       350 ~~-------~~~lV~Ey~~ggsL~~ll----~~~~l~~~~i~~i~~QI~~aL~yLH--~~gIiHrDIKP~NILl~~-~g~  415 (551)
                      ..       .+++||||+.++.+..+.    ....+++..+..++.||+.||.|||  ++||+||||||+|||++. ++.
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred             cccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence            32       388999999875443332    2345888899999999999999999  999999999999999996 899


Q ss_pred             EEEEecCCccccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC-
Q 043852          416 VKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-  493 (551)
Q Consensus       416 vkL~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~-  493 (551)
                      +||+|||+++...... .....||+.|+|||++. ....++.++|||||||++|+|++|+.||.+......+..+.... 
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF-GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEEeeCCCceecCCCCCcccccCCcceeCHHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            9999999998654333 34556899999999973 34458999999999999999999999998877766655543210 


Q ss_pred             ------------------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          494 ------------------------------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       494 ------------------------------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                                                    .......++..+.+||.+||+.||.+|||+.++|+||||+.......
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence                                          01112235788999999999999999999999999999997765443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-44  Score=368.28  Aligned_cols=247  Identities=23%  Similarity=0.407  Sum_probs=216.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      .++|++++.||+|+||.||+|.+.      ++..||||++....    .......+.+|+.++.+++||||+++++++.+
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            458999999999999999999874      34889999886322    23455678899999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhh-------------------------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQK-------------------------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIK  404 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~-------------------------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIK  404 (551)
                      ...+|+||||+.+++|.+++..                         ..+++..++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            9999999999999999999875                         458889999999999999999999999999999


Q ss_pred             cceEEEcCCCcEEEEecCCccccccC----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 043852          405 CANILVDASGSVKLADFGLAKATTMN----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSH  479 (551)
Q Consensus       405 P~NILl~~~g~vkL~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~  479 (551)
                      |+|||++.++.+||+|||+++.....    ......+|+.|+|||++.  ...++.++|||||||++|+|++ |..||.+
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc--cCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999998754322    223445789999999974  4568999999999999999999 9999998


Q ss_pred             chhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          480 LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       480 ~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ....+....+..+.....+..++..+.+||.+||+.||.+|||+.++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            8888888888888877788899999999999999999999999999987

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.5e-44  Score=377.38  Aligned_cols=249  Identities=24%  Similarity=0.435  Sum_probs=217.0

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ...++|.+++.||+|+||.||+|.+. ++..||||++...    ........+.+|+.++++++||||+++++++.+...
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT----SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            34468999999999999999999884 8999999987532    123344567899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|+|||||.+|+|.+++...  .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999999998754  4899999999999999999999999999999999999999999999999999754433


Q ss_pred             Cccc----CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          431 DVKS----CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       431 ~~~~----~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                      ....    ..+++.|+|||++.  ...++.++|||||||++|||++ |..||......+....+..+.....+..++..+
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  344 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALN--YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV  344 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            2221    22467799999974  4568999999999999999998 999999988887777777877777788899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||.+||+.||.+|||+.+|++
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.9e-44  Score=353.42  Aligned_cols=246  Identities=23%  Similarity=0.402  Sum_probs=217.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ..+|++.+.||+|+||.||+|.+.++..||+|++......      ...+.+|+.++.+++||||+++++++.+...+|+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            4589999999999999999998888889999998643321      2467799999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC---
Q 043852          356 FLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~---  430 (551)
                      +|||+.+++|.+++...  .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......   
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            99999999999998764  4889999999999999999999999999999999999999999999999998755322   


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      ......+|+.|+|||++  ....++.++|||||||++|+|++ |..||...........+..+.....+..++..+.+|+
T Consensus       161 ~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             STTSTTCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             ccccccccccccChhhh--cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence            12334578889999997  34578999999999999999999 8999998888877878888777777888999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhC
Q 043852          510 LKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+||+.||.+|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-43  Score=357.17  Aligned_cols=252  Identities=29%  Similarity=0.513  Sum_probs=203.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-----
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-----  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----  349 (551)
                      .++|++++.||+|+||.||+|.+ .+|..||||++..      .......+.+|+.++.+++||||+++++++.+     
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            35799999999999999999987 5899999999853      23445678899999999999999999987643     


Q ss_pred             --------CCeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEE
Q 043852          350 --------ENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA  419 (551)
Q Consensus       350 --------~~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~  419 (551)
                              ...+|+||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence                    46789999999999999999753  46778899999999999999999999999999999999999999999


Q ss_pred             ecCCcccccc----------------CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-hh
Q 043852          420 DFGLAKATTM----------------NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL-EG  482 (551)
Q Consensus       420 DFGla~~~~~----------------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-~~  482 (551)
                      |||++.....                .......||+.|+|||++. ....++.++|||||||++|+|++   ||... ..
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~  234 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER  234 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHT-SCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCccccc-CCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence            9999875432                1223456899999999974 33468999999999999999998   55433 33


Q ss_pred             HHHHHHhhcC---CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          483 MQALFRIGKG---EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       483 ~~~~~~i~~~---~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      ......+...   .+...+..++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred             HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence            3333344332   233345567888999999999999999999999999999986543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=366.57  Aligned_cols=254  Identities=28%  Similarity=0.451  Sum_probs=209.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe---
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR---  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---  352 (551)
                      .+|.+.+.||+|+||.||+|.+ .+|+.||||++....   ........+.+|+.++..++||||+++++++.....   
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            5799999999999999999987 579999999986432   233455678899999999999999999999887654   


Q ss_pred             ---EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          353 ---LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       353 ---~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                         +|++|||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          101 FYDFYLVMPFMQT-DLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCCEEEEECCSE-EGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             ceeEEEEeccccC-CHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence               4999999974 88877654 589999999999999999999999999999999999999999999999999976543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC-----------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-----------------  492 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~-----------------  492 (551)
                      . .....||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+..+.+..+.+.                 
T Consensus       179 ~-~~~~~~t~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          179 E-MTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             ------CCSBCCSCHHHHS-CCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             C-ccccccCcCcCCHHHHh-CcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence            2 34457899999999973 3357899999999999999999999999887665554443220                 


Q ss_pred             -------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          493 -------------EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       493 -------------~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                   ........++..+.+||.+||+.||.+|||++++++||||+....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                         011223467999999999999999999999999999999986543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.4e-44  Score=370.53  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=210.8

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGT  346 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  346 (551)
                      ...++|++++.||+|+||.||+|.+      .+++.||||++...    ........+.+|+.++.++ +||||++++++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc----CCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            3345899999999999999999973      35689999998642    2234456788999999999 78999999999


Q ss_pred             ccCCC-eEEEEEecccccchHHHHhhhc----------------------------------------------------
Q 043852          347 DKDEN-RLFIFLELVTKGSLANLYQKYH----------------------------------------------------  373 (551)
Q Consensus       347 ~~~~~-~~~lV~Ey~~ggsL~~ll~~~~----------------------------------------------------  373 (551)
                      +.+.. .+++|||||.+|+|.+++....                                                    
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            87754 4899999999999999986532                                                    


Q ss_pred             ---------------CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC----ccc
Q 043852          374 ---------------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKS  434 (551)
Q Consensus       374 ---------------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~----~~~  434 (551)
                                     +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......    ...
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                           8888999999999999999999999999999999999999999999999997553322    234


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH-HHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGM-QALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ..||+.|+|||++.  ...++.++|||||||++|+|++ |..||.+.... .....+..+.....+..++..+.+||.+|
T Consensus       255 ~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          255 ARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  332 (359)
T ss_dssp             CEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cCCCceeEChhhhc--CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            45788999999974  5678999999999999999998 99999876543 33444555666667788999999999999


Q ss_pred             hhcCCCCCCCHHHHHhC
Q 043852          513 LQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       513 L~~DP~~RPS~~eILeh  529 (551)
                      |+.||.+|||+.+|++|
T Consensus       333 l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHH
Confidence            99999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=365.58  Aligned_cols=246  Identities=25%  Similarity=0.468  Sum_probs=207.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|+++++||+|+||+||+|.+ .++..||+|++..     ........+.+|+.++.+++||||+++++++.+....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            45899999999999999999988 5799999998843     23455667889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      +||||+.+++|.++++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999976  5688999999999999999999999999999999999999999999999999975433221


Q ss_pred             ----------------ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH------HHHHhh
Q 043852          433 ----------------KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ------ALFRIG  490 (551)
Q Consensus       433 ----------------~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~------~~~~i~  490 (551)
                                      ....||+.|+|||++  .+..++.++|||||||++|+|++|..||.......      ......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccCCCcceeCHHHh--cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence                            145699999999997  45678999999999999999999999986432110      000111


Q ss_pred             cCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       491 ~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                          ...+..++..+.+||.+||+.||++|||+.++++  |+++
T Consensus       242 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~  279 (310)
T 3s95_A          242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET  279 (310)
T ss_dssp             ----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             ----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence                1234668889999999999999999999999987  5543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.6e-44  Score=377.76  Aligned_cols=250  Identities=29%  Similarity=0.463  Sum_probs=188.2

Q ss_pred             Ceee-eeEeccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec--cCCC
Q 043852          278 SWQK-GELLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD--KDEN  351 (551)
Q Consensus       278 ~y~~-~~~LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~  351 (551)
                      .|.+ +++||+|+||+||+|.+.   ++..||||++.....       ...+.+|+.++.+++||||+++++++  ....
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            4665 568999999999999853   688999998853321       12466899999999999999999998  5578


Q ss_pred             eEEEEEecccccchHHHHhhh----------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE----cCCCcEE
Q 043852          352 RLFIFLELVTKGSLANLYQKY----------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV----DASGSVK  417 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~----------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl----~~~g~vk  417 (551)
                      .+|+||||+.+ +|.+++...          .+++..++.++.||+.||.|||++||+||||||+||||    +.++.+|
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            89999999976 676665422          38899999999999999999999999999999999999    6778999


Q ss_pred             EEecCCcccccc-----CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---------H
Q 043852          418 LADFGLAKATTM-----NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---------M  483 (551)
Q Consensus       418 L~DFGla~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---------~  483 (551)
                      |+|||+++....     .......||+.|+|||++. ....++.++|||||||++|+|++|.+||.+...         .
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHT-TCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhc-CCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999976543     2234567999999999973 334589999999999999999999999965432         1


Q ss_pred             HHHHHhhc--CCCCC-----------------------------------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 043852          484 QALFRIGK--GEPPL-----------------------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQL  526 (551)
Q Consensus       484 ~~~~~i~~--~~~~~-----------------------------------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eI  526 (551)
                      +.+.++..  +.+..                                   .....+..+.+||.+||++||.+|||++++
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            22222211  11100                                   001126788999999999999999999999


Q ss_pred             HhCcccCCcc
Q 043852          527 MEHPFVKRPL  536 (551)
Q Consensus       527 Lehpff~~~~  536 (551)
                      |+||||+...
T Consensus       332 L~hp~f~~~~  341 (405)
T 3rgf_A          332 MQDPYFLEDP  341 (405)
T ss_dssp             HTSGGGTSSS
T ss_pred             hcChhhccCC
Confidence            9999998643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.5e-44  Score=375.62  Aligned_cols=249  Identities=27%  Similarity=0.377  Sum_probs=200.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC--------CCceeeeeeec
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE--------HENIVQYFGTD  347 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~  347 (551)
                      ++|+++++||+|+||+||+|++ .+++.||||++...      ......+.+|+.++..+.        |+||+++++++
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            5899999999999999999987 67999999998532      334556778999998885        78899999998


Q ss_pred             c----CCCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCC------
Q 043852          348 K----DENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASG------  414 (551)
Q Consensus       348 ~----~~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g------  414 (551)
                      .    +...+|+||||+.++.+..+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++      
T Consensus       111 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             EEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             eecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence            7    66789999999955444444443  3589999999999999999999998 999999999999998775      


Q ss_pred             -------------------------------------------cEEEEecCCccccccCCcccCCCCCcccChhhhhccc
Q 043852          415 -------------------------------------------SVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN  451 (551)
Q Consensus       415 -------------------------------------------~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~  451 (551)
                                                                 .+||+|||++...... .....||+.|+|||++  .+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~--~~  267 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVL--IG  267 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHH--HT
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhh--cC
Confidence                                                       7999999999765433 4456799999999997  35


Q ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCch------hHHHHHHhhc--CCC-----------------------------
Q 043852          452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLE------GMQALFRIGK--GEP-----------------------------  494 (551)
Q Consensus       452 ~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~------~~~~~~~i~~--~~~-----------------------------  494 (551)
                      ..++.++|||||||++|+|++|+.||....      ....+..+..  +..                             
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            568999999999999999999999996543      1222221111  000                             


Q ss_pred             ----------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          495 ----------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       495 ----------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                                ...+..++..+.+||.+||+.||.+|||++++|+||||+.
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                      0112234567889999999999999999999999999973

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-43  Score=363.25  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=206.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe--cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC------ceeeeeeecc
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT--DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE------NIVQYFGTDK  348 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~~~~~  348 (551)
                      ++|++++.||+|+||.||+|.+  .++..||||++...      ......+.+|+.++..++|+      +|+++++++.
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            4899999999999999999986  37899999998532      23345677888888887665      4999999999


Q ss_pred             CCCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-------------
Q 043852          349 DENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-------------  412 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-------------  412 (551)
                      +...+|+||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.             
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999999 78998888754   4788999999999999999999999999999999999987             


Q ss_pred             ------CCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 043852          413 ------SGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL  486 (551)
Q Consensus       413 ------~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~  486 (551)
                            ++.+||+|||+++.... ......||+.|+|||++  .+..++.++|||||||++|+|++|..||...+..+..
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVI--LALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHH--TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             ccccccCCCceEeeCcccccCcc-ccccccCCccccChHHh--hCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                  66899999999976443 23456799999999997  4567899999999999999999999999877665544


Q ss_pred             HHhhcCCCC-------------------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCH
Q 043852          487 FRIGKGEPP-------------------------------------------LVPNSLSRDARDFILKCLQVNPNDRPTA  523 (551)
Q Consensus       487 ~~i~~~~~~-------------------------------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~  523 (551)
                      ..+.....+                                           ......+..+.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            332211000                                           0112235778999999999999999999


Q ss_pred             HHHHhCcccCCcc
Q 043852          524 AQLMEHPFVKRPL  536 (551)
Q Consensus       524 ~eILehpff~~~~  536 (551)
                      .++++||||+...
T Consensus       324 ~ell~hp~f~~~~  336 (339)
T 1z57_A          324 REALKHPFFDLLK  336 (339)
T ss_dssp             HHHTTSGGGGGGG
T ss_pred             HHHhcCHHHHHHh
Confidence            9999999998654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-43  Score=356.56  Aligned_cols=248  Identities=29%  Similarity=0.475  Sum_probs=204.7

Q ss_pred             cccCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ..++|++++.||+|+||.||+|.+.    .+..||+|++...    ........+.+|+.++.+++||||+++++++. .
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            3458999999999999999999863    3557999976532    22345567889999999999999999999985 4


Q ss_pred             CeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ...|+||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            5689999999999999998754  58899999999999999999999999999999999999999999999999997654


Q ss_pred             cCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          429 MND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       429 ~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ...   .....+|+.|+|||++.  ...++.++|||||||++|+|++ |..||.+....+....+..+.....+..++..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT  245 (281)
T ss_dssp             -----------CCGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             cccccccccCCCcccccChhhcc--cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            332   22344678999999973  5578999999999999999996 99999888777777788887777788889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       246 l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-43  Score=356.87  Aligned_cols=255  Identities=30%  Similarity=0.514  Sum_probs=217.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|++++.||+|+||.||+|.+ .+++.||||++.......   .....+.+|+.++.+++||||+++++++.+...+|
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            45899999999999999999988 489999999987543322   23456779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC---CcEEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS---GSVKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~---g~vkL~DFGla~~~~~~  430 (551)
                      ++|||+.+++|.+++. ...+++..++.++.||+.||.|||++||+|+||||+||+++.+   +.+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            9999999999988765 4568999999999999999999999999999999999999764   46999999998765433


Q ss_pred             C-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHHH
Q 043852          431 D-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDAR  506 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~  506 (551)
                      . .....||+.|+|||++.   ..++.++|||||||++|+|++|..||......+....+..+.....   ...++..+.
T Consensus       178 ~~~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHT---TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             CccccccCcccccChHHhc---CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            2 23345889999999873   3489999999999999999999999998887777777766654322   246899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +||.+||+.||.+|||+.++++||||++..
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-44  Score=376.79  Aligned_cols=256  Identities=14%  Similarity=0.107  Sum_probs=190.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHH---HHHHhcCCCCceeeeeeecc---
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQE---ILLLSRFEHENIVQYFGTDK---  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~E---i~il~~l~HpnIv~l~~~~~---  348 (551)
                      ..+|.+++.||+|+||.||+|.+ .+|+.||||++......  .......+.+|   +.++.. +||||++++..+.   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~  137 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS  137 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--HHHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence            34699999999999999999987 58999999999765332  23344556677   455555 7999888653332   


Q ss_pred             ----CC-----------------CeEEEEEecccccchHHHHhhh--cCChHHH------HHHHHHHHHHHHHHHhCCee
Q 043852          349 ----DE-----------------NRLFIFLELVTKGSLANLYQKY--HLMDSQV------SAYTRQILNGLNYLHEQNVV  399 (551)
Q Consensus       349 ----~~-----------------~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i------~~i~~QI~~aL~yLH~~gIi  399 (551)
                          ..                 ..+|+|||||. ++|.+++...  .+....+      ..++.||+.||.|||++||+
T Consensus       138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv  216 (371)
T 3q60_A          138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV  216 (371)
T ss_dssp             EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence                11                 34899999998 7999998753  3555555      57779999999999999999


Q ss_pred             ecccccceEEEcCCCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 043852          400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH  479 (551)
Q Consensus       400 HrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~  479 (551)
                      ||||||+||||+.++.+||+|||+++....... ...+|+.|+|||++......++.++|||||||++|+|++|+.||..
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999999986543322 4457799999999843336789999999999999999999999976


Q ss_pred             chhHHH--HHH---hh--c-CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          480 LEGMQA--LFR---IG--K-GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       480 ~~~~~~--~~~---i~--~-~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ......  +..   ..  . .........++..+.+||.+||+.||++|||+.++++||||++..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            532110  000   00  0 111122247899999999999999999999999999999998654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.1e-44  Score=366.72  Aligned_cols=246  Identities=28%  Similarity=0.479  Sum_probs=204.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceE----EEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFF----AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~v----AVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|+++++||+|+||+||+|.+ .++..+    |+|.+..    .........+.+|+.++.+++||||+++++++.+..
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            4799999999999999999986 455554    6665532    222334567889999999999999999999998765


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                       .++++||+.+|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence             7899999999999998865  4588999999999999999999999999999999999999999999999999976543


Q ss_pred             CC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 ND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ..    .....+|+.|+|||++  .+..++.++|||||||++|||++ |..||.+.........+..+.....+..++..
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TCC-------CCCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             CcccccccCCCccccccChHHh--ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            22    2233468899999997  35678999999999999999999 99999887777777777777777778889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+|+.+||+.||.+|||+.+++++
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999976

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.5e-44  Score=368.78  Aligned_cols=246  Identities=29%  Similarity=0.453  Sum_probs=208.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCce----EEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFF----FAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~----vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|++++.||+|+||.||+|.+ .++..    ||+|.+.....    ......+.+|+.++.+++||||+++++++. ..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS----CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            4899999999999999999987 45665    66666543221    122234568999999999999999999886 55


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..++||||+.+|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            68999999999999998865  4689999999999999999999999999999999999999999999999999986543


Q ss_pred             CC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 ND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ..    .....||+.|+|||++  ....++.++|||||||++|+|++ |..||.+....+....+..+.....+..++..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESI--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID  245 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred             ccccccccCCCCcccccChHHh--ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence            32    2345578899999997  34568999999999999999999 99999988777777777777777778889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.9e-43  Score=363.01  Aligned_cols=252  Identities=26%  Similarity=0.466  Sum_probs=216.9

Q ss_pred             hhhcccCeeeeeEeccCCceEEEEEEe--------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceee
Q 043852          272 FRRRIMSWQKGELLGSGSFGTVYEGYT--------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQ  342 (551)
Q Consensus       272 ~~~~~~~y~~~~~LG~G~fG~VY~~~~--------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~  342 (551)
                      +....++|++++.||+|+||.||+|.+        .++..||||++...    ........+.+|+.++.++ +||||++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~  105 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIIN  105 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC----CcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence            333446899999999999999999975        35678999988532    2344566788999999999 8999999


Q ss_pred             eeeeccCCCeEEEEEecccccchHHHHhhhc-----------------CChHHHHHHHHHHHHHHHHHHhCCeeeccccc
Q 043852          343 YFGTDKDENRLFIFLELVTKGSLANLYQKYH-----------------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC  405 (551)
Q Consensus       343 l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~-----------------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP  405 (551)
                      +++++.+...+|+||||+.+++|.+++....                 +++..++.++.||+.||.|||++||+||||||
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            9999999999999999999999999987543                 78889999999999999999999999999999


Q ss_pred             ceEEEcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 043852          406 ANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHL  480 (551)
Q Consensus       406 ~NILl~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~  480 (551)
                      +|||++.++.+||+|||+++......    .....+|+.|+|||++.  ...++.++|||||||++|+|++ |..||.+.
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc--CCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            99999999999999999997654322    23345788999999973  4568999999999999999999 99999988


Q ss_pred             hhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          481 EGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       481 ~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...+....+..+.....+..++..+.+||.+||+.||.+|||+.+|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7777777777777777788899999999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.3e-43  Score=356.41  Aligned_cols=245  Identities=27%  Similarity=0.456  Sum_probs=204.2

Q ss_pred             cCeeeeeEeccCCceEEEEEE----e-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--
Q 043852          277 MSWQKGELLGSGSFGTVYEGY----T-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~----~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--  349 (551)
                      .+|++++.||+|+||.||+|.    + .++..||||++...     .......+.+|+.++.+++||||+++++++..  
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            489999999999999999997    3 47899999988632     34455678899999999999999999998754  


Q ss_pred             CCeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      ...+++|||||.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            35689999999999999998764  4899999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH----------------HHH
Q 043852          428 TMND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM----------------QAL  486 (551)
Q Consensus       428 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~----------------~~~  486 (551)
                      ....     .....+|..|+|||++  ....++.++|||||||++|+|++|..||......                ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -----------CTTCGGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHh--cCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            4322     2234467789999997  3557899999999999999999999998653321                223


Q ss_pred             HHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          487 FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       487 ~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..+..+.....+..++..+.+||.+||+.||.+|||+.+|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            344455566667889999999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=361.44  Aligned_cols=256  Identities=25%  Similarity=0.434  Sum_probs=204.0

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccc-hHHHHHHHHHHHHHhcC----CCCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQG-KQSILQLEQEILLLSRF----EHENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l----~HpnIv~l~~~~~~  349 (551)
                      .++|++++.||+|+||.||+|.+ .+++.||||++......... ......+.+|+.++.++    +|+||+++++++.+
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            34799999999999999999987 57899999998654322111 11223345788888888    89999999999999


Q ss_pred             CCeEEEEEec-ccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc-CCCcEEEEecCCccc
Q 043852          350 ENRLFIFLEL-VTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKA  426 (551)
Q Consensus       350 ~~~~~lV~Ey-~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~-~~g~vkL~DFGla~~  426 (551)
                      ....+++||| +.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~  189 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL  189 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence            9999999999 7899999988754 589999999999999999999999999999999999999 789999999999987


Q ss_pred             cccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          427 TTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       427 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                      ..........||+.|+|||++. ....++.++|||||||++|+|++|+.||......      ... ....+..++..+.
T Consensus       190 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~-~~~~~~~~~~~~~  261 (312)
T 2iwi_A          190 LHDEPYTDFDGTRVYSPPEWIS-RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------LEA-ELHFPAHVSPDCC  261 (312)
T ss_dssp             CCSSCBCCCCSCTTTSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHT-CCCCCTTSCHHHH
T ss_pred             cccCcccccCCcccccCceeee-cCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------hhh-ccCCcccCCHHHH
Confidence            7666666777999999999974 2333356899999999999999999999764321      111 2334567899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      +||.+||+.||++|||+.++++||||+......
T Consensus       262 ~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~  294 (312)
T 2iwi_A          262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV  294 (312)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred             HHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence            999999999999999999999999999765443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=356.74  Aligned_cols=262  Identities=31%  Similarity=0.522  Sum_probs=200.4

Q ss_pred             hhhhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          271 KFRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       271 ~~~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      .+...+++|++++.||+|+||.||+|.+ .+|..||||++.....   .......+..+..++..++||||+++++++.+
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            3445677999999999999999999988 5899999999875422   12223334455567888899999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ...+|+||||+ ++.+..+...  ..+++..++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999999 5566666653  5689999999999999999999995 999999999999999999999999999875


Q ss_pred             cccC-CcccCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHHhhcCCCCCCC--C
Q 043852          427 TTMN-DVKSCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHL-EGMQALFRIGKGEPPLVP--N  499 (551)
Q Consensus       427 ~~~~-~~~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~-~~~~~~~~i~~~~~~~~~--~  499 (551)
                      .... ......||+.|+|||++..   ....++.++|||||||++|+|++|+.||... .....+..+.....+..+  .
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred             ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence            5432 2334569999999999742   2456789999999999999999999999763 444555555555554444  3


Q ss_pred             cCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       500 ~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .++..+.+||.+||+.||.+|||+.+|++||||++..
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            5899999999999999999999999999999998543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-43  Score=359.23  Aligned_cols=250  Identities=25%  Similarity=0.415  Sum_probs=217.0

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD  347 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  347 (551)
                      ...++|++.+.||+|+||.||+|.+.      ++..||||++...    ........+.+|+.++++++|+||+++++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc----cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            33458999999999999999999753      4788999988532    2233455688999999999999999999999


Q ss_pred             cCCCeEEEEEecccccchHHHHhh-----------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcE
Q 043852          348 KDENRLFIFLELVTKGSLANLYQK-----------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV  416 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~-----------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~v  416 (551)
                      .+....|+||||+.+++|.+++..           ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence            999999999999999999998865           235888999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhc
Q 043852          417 KLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGK  491 (551)
Q Consensus       417 kL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~  491 (551)
                      ||+|||+++......    .....+|+.|+|||++  .+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhh--ccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            999999997553322    2233468899999997  35568999999999999999999 8999998888877777777


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.....+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            77777788899999999999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-43  Score=371.68  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=204.7

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CC-----ceeeeeeec
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HE-----NIVQYFGTD  347 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~  347 (551)
                      .+++|++++.||+|+||+||+|.+ .+++.||||++...      ......+..|+.++..+. |+     +|+++++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            356899999999999999999987 57899999998532      233445667887777764 44     499999999


Q ss_pred             cCCCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHH--hCCeeecccccceEEEc--CCCcEEEEe
Q 043852          348 KDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLH--EQNVVHRDIKCANILVD--ASGSVKLAD  420 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH--~~gIiHrDIKP~NILl~--~~g~vkL~D  420 (551)
                      .....+|+||||+.+ +|.+++...   .+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||+|
T Consensus       126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          126 MFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999999999965 898888654   4889999999999999999999  57999999999999995  477899999


Q ss_pred             cCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC----
Q 043852          421 FGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL----  496 (551)
Q Consensus       421 FGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~----  496 (551)
                      ||+++.... ......||+.|+|||++  .+..++.++|||||||++|||++|+.||.+....+.+..+.......    
T Consensus       205 FG~a~~~~~-~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLGQ-RIYQYIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETTC-CCCSSCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceeccc-ccccccCCccccChHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999976643 33456799999999997  34578999999999999999999999999877766665543311000    


Q ss_pred             -------------------------------CCCc----------------------------CCHHHHHHHHHhhhcCC
Q 043852          497 -------------------------------VPNS----------------------------LSRDARDFILKCLQVNP  517 (551)
Q Consensus       497 -------------------------------~~~~----------------------------~s~~l~~LI~~cL~~DP  517 (551)
                                                     .+..                            .+..+.+||.+||++||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                                           0000                            01378999999999999


Q ss_pred             CCCCCHHHHHhCcccCCcc
Q 043852          518 NDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       518 ~~RPS~~eILehpff~~~~  536 (551)
                      .+|||++|+|+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.1e-43  Score=347.38  Aligned_cols=247  Identities=19%  Similarity=0.366  Sum_probs=211.2

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--Ce
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--NR  352 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~  352 (551)
                      .+.+|++.+.||+|+||.||+|.+ ++..||||++.....   .......+.+|+.++.+++||||+++++++.+.  ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDW---STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTC---CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            356899999999999999999976 488899999875422   234456788999999999999999999998877  78


Q ss_pred             EEEEEecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          353 LFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      ++++|||+.+++|.+++....   +++..++.++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            899999999999999997653   899999999999999999999999  999999999999999999999999887543


Q ss_pred             ccCCcccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhh-cCCCCCCCCcCCHHH
Q 043852          428 TMNDVKSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIG-KGEPPLVPNSLSRDA  505 (551)
Q Consensus       428 ~~~~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l  505 (551)
                      .   .....||+.|+|||++... ...++.++|||||||++|+|++|+.||...........+. .+..+..+..++..+
T Consensus       164 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          164 Q---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             S---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred             c---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            2   2345689999999998432 2234558999999999999999999998877766655443 455566778899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||.+||+.||.+|||+.++++
T Consensus       241 ~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.8e-43  Score=352.74  Aligned_cols=248  Identities=26%  Similarity=0.442  Sum_probs=217.1

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .....+|++.+.||+|+||.||+|.+ .++..||+|++...      ......+.+|+.++.+++||||+++++++.+..
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            33456899999999999999999988 46899999998532      223456789999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      .+|+||||+.+++|.+++..   ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999999999999999875   348899999999999999999999999999999999999999999999999997654


Q ss_pred             cCCc---ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          429 MNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       429 ~~~~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ....   ....+|+.|+|||++  ....++.++|||||||++|+|++ |..||...........+........+..++..
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK  240 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCccccccCCccccCcCChhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHH
Confidence            3332   223467889999997  34578999999999999999999 99999887777777777777777778889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||.+||+.||.+|||+.++++
T Consensus       241 l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          241 VYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCChhhCcCHHHHHH
Confidence            999999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5e-43  Score=377.84  Aligned_cols=246  Identities=26%  Similarity=0.471  Sum_probs=216.2

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ....+|++.+.||+|+||.||+|.+.++..||||++.....      ....+.+|+.++++++||||+++++++. ...+
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            34458999999999999999999888888999999864321      2457889999999999999999999986 5678


Q ss_pred             EEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 FIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      |+|||||.+|+|.++++..   .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            9999999999999998743   5888899999999999999999999999999999999999999999999999765432


Q ss_pred             C---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          431 D---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       431 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                      .   .....+|+.|+|||++.  ...++.++|||||||++|||++ |+.||.+....+....+..+.....+..++..+.
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  415 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY  415 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred             ceeccCCCcccccccCHHHhc--cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2   23344678899999973  4578999999999999999999 9999999888888888888877777888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHh
Q 043852          507 DFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +||.+||+.||.+|||+.+|++
T Consensus       416 ~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          416 NIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHH
Confidence            9999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.2e-43  Score=349.17  Aligned_cols=244  Identities=28%  Similarity=0.493  Sum_probs=213.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .++|++++.||+|+||.||+|.+.++..||||++.....      ....+.+|+.++.+++||||+++++++.+ ...++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            458999999999999999999888888999999864321      13467899999999999999999999864 45899


Q ss_pred             EEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          356 FLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      ||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            99999999999998754   589999999999999999999999999999999999999999999999999976544332


Q ss_pred             ---ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          433 ---KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       433 ---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                         ....+|+.|+|||++.  ...++.++|||||||++|+|++ |..||.+....+....+..+.....+..++..+.+|
T Consensus       165 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  242 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL  242 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccCCCCccCccChhhhc--cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence               2344678899999973  4567999999999999999999 999999888877777777777777788899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh
Q 043852          509 ILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||+.||.+|||+.++++
T Consensus       243 i~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          243 MRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHH
Confidence            99999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2e-43  Score=362.42  Aligned_cols=268  Identities=28%  Similarity=0.494  Sum_probs=196.5

Q ss_pred             cCCCchhhhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHH-HHhcCCCCceeee
Q 043852          266 VSPNGKFRRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFEHENIVQY  343 (551)
Q Consensus       266 ~~p~~~~~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l  343 (551)
                      +.+...+....++|++++.||+|+||.||+|.+ .+|+.||||++....    ......++..|+. +++.++||||+++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~~~~h~niv~~   86 (327)
T 3aln_A           11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----DEKEQKQLLMDLDVVMRSSDCPYIVQF   86 (327)
T ss_dssp             CCCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----CHHHHHHHHHHHHHHHSSCCCTTBCCE
T ss_pred             CChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----CchHHHHHHHHHHHHHHcCCCCcEeee
Confidence            334444555567999999999999999999988 589999999987532    1223344555655 7888899999999


Q ss_pred             eeeccCCCeEEEEEecccccchHHHHh------hhcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEcCCCcE
Q 043852          344 FGTDKDENRLFIFLELVTKGSLANLYQ------KYHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVDASGSV  416 (551)
Q Consensus       344 ~~~~~~~~~~~lV~Ey~~ggsL~~ll~------~~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~~~g~v  416 (551)
                      ++++.+....|+||||+.+ +|.+++.      ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~  165 (327)
T 3aln_A           87 YGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI  165 (327)
T ss_dssp             EEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEE
T ss_pred             eeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCE
Confidence            9999999999999999986 7777665      35688999999999999999999999 99999999999999999999


Q ss_pred             EEEecCCccccccCC-cccCCCCCcccChhhhhc--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHhhcC
Q 043852          417 KLADFGLAKATTMND-VKSCKGTPFWMAPEVVNL--KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGKG  492 (551)
Q Consensus       417 kL~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~--~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-~~~~~~i~~~  492 (551)
                      ||+|||+++...... .....||+.|+|||++..  ....++.++|||||||++|+|++|+.||..... .+.+..+..+
T Consensus       166 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (327)
T 3aln_A          166 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG  245 (327)
T ss_dssp             EECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred             EEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence            999999997654332 233469999999999732  245689999999999999999999999976543 2333333444


Q ss_pred             CCCCCC----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          493 EPPLVP----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       493 ~~~~~~----~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      ..+..+    ..++..+.+||.+||+.||.+|||+.+|++||||.....+
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence            333332    3589999999999999999999999999999999865433

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.3e-43  Score=376.81  Aligned_cols=243  Identities=27%  Similarity=0.469  Sum_probs=211.7

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC-eE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN-RL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~  353 (551)
                      ...+|++++.||+|+||.||+|.+ .|..||||++....       ....+.+|+.++.+++||||+++++++.+.. .+
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            456899999999999999999976 47799999986432       2346789999999999999999999876554 79


Q ss_pred             EEEEecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 FIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      |+|||||.+|+|.+++++.+   ++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            99999999999999987643   688899999999999999999999999999999999999999999999999754332


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      . ....+|+.|+|||++  ....++.++|||||||++|||++ |..||......+....+..+.....+..++..+.+||
T Consensus       343 ~-~~~~~~~~y~aPE~~--~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          343 Q-DTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -----CCCTTTSCHHHH--HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             c-cCCCCCcceeCHHHh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            2 233578899999997  45678999999999999999998 9999998887777778888877788889999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 043852          510 LKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||+.||.+|||+.+|++
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-43  Score=367.40  Aligned_cols=255  Identities=27%  Similarity=0.395  Sum_probs=203.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-----------CCceeeee
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-----------HENIVQYF  344 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~  344 (551)
                      .+|++++.||+|+||.||+|.+ .+++.||||++...      ......+.+|+.++.++.           |+||++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            4899999999999999999987 68999999998532      233456678888888876           89999999


Q ss_pred             eeccCCC----eEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhC-CeeecccccceEEEc-----
Q 043852          345 GTDKDEN----RLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQ-NVVHRDIKCANILVD-----  411 (551)
Q Consensus       345 ~~~~~~~----~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~-gIiHrDIKP~NILl~-----  411 (551)
                      +++....    .++++|||+ +++|.+++..   ..+++..+..++.||+.||.|||++ ||+||||||+|||++     
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            9987544    789999999 8899998875   3488999999999999999999998 999999999999994     


Q ss_pred             -CCCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh------HH
Q 043852          412 -ASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG------MQ  484 (551)
Q Consensus       412 -~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~------~~  484 (551)
                       ..+.+||+|||+++..... .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.....      ..
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHH--HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cCcceEEEcccccccccCCC-CCCCCCCccccCcHHH--hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence             3448999999999765433 3445799999999997  355689999999999999999999999975431      11


Q ss_pred             HHHHhhc--CC---------------------------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCH
Q 043852          485 ALFRIGK--GE---------------------------------------PPLVPNSLSRDARDFILKCLQVNPNDRPTA  523 (551)
Q Consensus       485 ~~~~i~~--~~---------------------------------------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~  523 (551)
                      .+..+..  +.                                       ....+..++..+.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            1111111  00                                       011223456788999999999999999999


Q ss_pred             HHHHhCcccCCccccCCC
Q 043852          524 AQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       524 ~eILehpff~~~~~~~~~  541 (551)
                      +++++||||++.......
T Consensus       329 ~ell~hp~f~~~~~~~~~  346 (373)
T 1q8y_A          329 GGLVNHPWLKDTLGMEEI  346 (373)
T ss_dssp             HHHHTCGGGTTCTTCTTC
T ss_pred             HHHhhChhhhcccCcccc
Confidence            999999999987655443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-43  Score=363.12  Aligned_cols=254  Identities=28%  Similarity=0.482  Sum_probs=213.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccch-HHHHHHHHHHHHHhcCC--CCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGK-QSILQLEQEILLLSRFE--HENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~-~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~  351 (551)
                      ..+|++++.||+|+||.||+|.+ .+|..||||++.......... .....+.+|+.++.++.  |+||+++++++.+..
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            45899999999999999999987 689999999997654322110 11123457888899886  599999999999999


Q ss_pred             eEEEEEecccc-cchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc-CCCcEEEEecCCccccc
Q 043852          352 RLFIFLELVTK-GSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD-ASGSVKLADFGLAKATT  428 (551)
Q Consensus       352 ~~~lV~Ey~~g-gsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~-~~g~vkL~DFGla~~~~  428 (551)
                      .++++||++.+ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  201 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence            99999999976 899998865 4689999999999999999999999999999999999998 68899999999998776


Q ss_pred             cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       429 ~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                      ........||+.|+|||++. ....++.++|||||||++|+|++|+.||......      ... ....+..++..+.+|
T Consensus       202 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~-~~~~~~~~~~~~~~l  273 (320)
T 3a99_A          202 DTVYTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRG-QVFFRQRVSSECQHL  273 (320)
T ss_dssp             SSCBCCCCSCGGGSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHC-CCCCSSCCCHHHHHH
T ss_pred             cccccCCCCCccCCChHHhc-cCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------hcc-cccccccCCHHHHHH
Confidence            66566677999999999974 3333478899999999999999999999764321      112 233456789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      |.+||+.||.+|||+.+|++||||+....
T Consensus       274 i~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          274 IRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             HHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            99999999999999999999999997764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.4e-43  Score=350.89  Aligned_cols=249  Identities=25%  Similarity=0.447  Sum_probs=208.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccch--HHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGK--QSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ++|++.+.||+|+||.||+|.+ .++..||||++..........  .....+.+|+.++.+++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            4899999999999999999987 589999999986543322211  11257889999999999999999999997766  


Q ss_pred             EEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEcCCCc-----EEEEecCCc
Q 043852          354 FIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDASGS-----VKLADFGLA  424 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~~~g~-----vkL~DFGla  424 (551)
                      ++||||+.+++|.+++..  ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.     +||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            699999999999887743  35889999999999999999999999  999999999999988776     999999999


Q ss_pred             cccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH--HHH-hhcCCCCCCCCcC
Q 043852          425 KATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA--LFR-IGKGEPPLVPNSL  501 (551)
Q Consensus       425 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~--~~~-i~~~~~~~~~~~~  501 (551)
                      +.... ......||+.|+|||++......++.++|||||||++|+|++|+.||........  ... ......+..+..+
T Consensus       177 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 4f0f_A          177 QQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC  255 (287)
T ss_dssp             BCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTS
T ss_pred             ccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCccc
Confidence            75433 3445679999999999744455678999999999999999999999976543222  222 3345556677889


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +..+.+||.+||+.||.+|||+.++++
T Consensus       256 ~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          256 PPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-43  Score=351.50  Aligned_cols=248  Identities=26%  Similarity=0.431  Sum_probs=214.7

Q ss_pred             cCeeeee-EeccCCceEEEEEEe---cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGE-LLGSGSFGTVYEGYT---DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~-~LG~G~fG~VY~~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ++|.+.+ .||+|+||.||+|.+   .++..||||++...    ........+.+|+.++.+++||||+++++++ ....
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4677776 999999999999975   36888999998643    2344566788999999999999999999998 4556


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +++||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            8999999999999999853  45899999999999999999999999999999999999999999999999999765432


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      .     .....+|+.|+|||++.  ...++.++|||||||++|+|++ |..||......+....+..+.....+..++..
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  241 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cceeeccccccccccccCHHHhc--cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence            2     22334688999999973  4568999999999999999998 99999988877777778888777788899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      +.+||.+||+.||.+|||+.+++++.+
T Consensus       242 l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          242 LYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999999999999999999999998744

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-42  Score=354.95  Aligned_cols=255  Identities=24%  Similarity=0.456  Sum_probs=208.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC--CCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE--HENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~  354 (551)
                      .+|++++.||+|+||.||++.+.++..||||++.....   .......+.+|+.++.++.  |+||+++++++.+...+|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc---cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            37999999999999999999988899999999875432   2445667889999999997  599999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      ++|| +.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......  
T Consensus       105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred             EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence            9999 557799998865 4688899999999999999999999999999999999995 5899999999997654332  


Q ss_pred             --cccCCCCCcccChhhhhcc---------cCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHhhc-CCCCCCC
Q 043852          432 --VKSCKGTPFWMAPEVVNLK---------NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGK-GEPPLVP  498 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-~~~~~~i~~-~~~~~~~  498 (551)
                        .....||+.|+|||++...         ...++.++|||||||++|+|++|..||..... ...+..+.. ......+
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  262 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  262 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence              2345689999999997421         24689999999999999999999999976532 333333333 3334456


Q ss_pred             CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          499 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       499 ~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ..++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus       263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            67899999999999999999999999999999998654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.1e-43  Score=354.09  Aligned_cols=252  Identities=27%  Similarity=0.439  Sum_probs=212.6

Q ss_pred             hhhcccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeee
Q 043852          272 FRRRIMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYF  344 (551)
Q Consensus       272 ~~~~~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~  344 (551)
                      +....++|.+++.||+|+||.||+|.+      .++..||||++....    .......+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~   93 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNLL   93 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence            333445899999999999999999974      367899999986432    223456788999999999 999999999


Q ss_pred             eeccCCCeEEEEEecccccchHHHHhhh-------------------cCChHHHHHHHHHHHHHHHHHHhCCeeeccccc
Q 043852          345 GTDKDENRLFIFLELVTKGSLANLYQKY-------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC  405 (551)
Q Consensus       345 ~~~~~~~~~~lV~Ey~~ggsL~~ll~~~-------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP  405 (551)
                      +++.+....++||||+.+++|.+++...                   .+++..++.++.||+.||.|||++||+||||||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            9999999999999999999999998754                   288999999999999999999999999999999


Q ss_pred             ceEEEcCCCcEEEEecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 043852          406 ANILVDASGSVKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHL  480 (551)
Q Consensus       406 ~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~  480 (551)
                      +|||++.++.+||+|||++........    ....||+.|+|||++.  ...++.++|||||||++|+|++ |..||...
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc--CCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999999976544332    2344678899999973  4578999999999999999998 99999776


Q ss_pred             hhHHHHH-HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          481 EGMQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       481 ~~~~~~~-~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ....... .+..+.....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            5443333 334444555567899999999999999999999999999984

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=362.34  Aligned_cols=246  Identities=28%  Similarity=0.472  Sum_probs=205.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceE----EEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFF----AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~v----AVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|+++++||+|+||.||+|.+ .++..+    |+|.+...    ........+.+|+.++.+++||||+++++++.+..
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC----SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc----cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            4899999999999999999986 466655    55544322    22234556789999999999999999999988765


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                       .+++++|+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence             7899999999999998865  4588999999999999999999999999999999999999999999999999976533


Q ss_pred             CC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 ND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ..    .....+|+.|+|||++  .+..++.++|||||||++|+|++ |..||.+....+....+..+.....+..++..
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             ----------CCCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             ccccccccCCCccccccCHHHH--cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            22    2234468889999997  35678999999999999999999 99999988777777777777777778889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+||.+||+.||.+|||+.++++.
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999873

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.2e-43  Score=359.66  Aligned_cols=248  Identities=24%  Similarity=0.470  Sum_probs=212.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceE--EEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFF--AVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~v--AVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      +++|++.+.||+|+||.||+|.+ .+|..+  |+|.+....    .......+.+|+.++.++ +||||+++++++.+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            45899999999999999999987 466655  889886422    122345678999999999 8999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC
Q 043852          352 RLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG  414 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g  414 (551)
                      .+|+||||+.+++|.+++.+.                 .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            999999999999999998754                 488999999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcC
Q 043852          415 SVKLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG  492 (551)
Q Consensus       415 ~vkL~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~  492 (551)
                      .+||+|||+++..... ......+|+.|+|||++  ....++.++|||||||++|+|++ |..||.+....+....+..+
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhh--ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            9999999998744322 22334578899999997  34567999999999999999998 99999988888888888887


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       493 ~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7777778899999999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.7e-43  Score=366.27  Aligned_cols=255  Identities=28%  Similarity=0.432  Sum_probs=184.4

Q ss_pred             cccCeeeee-EeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC---
Q 043852          275 RIMSWQKGE-LLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD---  349 (551)
Q Consensus       275 ~~~~y~~~~-~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---  349 (551)
                      ..++|.+.+ +||+|+||.||+|.+ .+|+.||||++...      ....   ......+..+.|+||+++++++..   
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKAR---QEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHH---HHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            345899865 699999999999988 47999999998532      1111   122234667789999999998865   


Q ss_pred             -CCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CCcEEEEecC
Q 043852          350 -ENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SGSVKLADFG  422 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g~vkL~DFG  422 (551)
                       ...+|+|||||.+|+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             55689999999999999998764   4899999999999999999999999999999999999976   4559999999


Q ss_pred             CccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH----HHhhcC---CCC
Q 043852          423 LAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL----FRIGKG---EPP  495 (551)
Q Consensus       423 la~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~----~~i~~~---~~~  495 (551)
                      +++...........||+.|+|||++  ....++.++|||||||++|+|++|..||.........    ..+...   .+.
T Consensus       177 ~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          177 FAKETTQNALQTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             TCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             cceeccccccccCCCCcCccChhhh--CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            9987766656667799999999997  4556789999999999999999999999765443321    111111   122


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCC
Q 043852          496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSR  540 (551)
Q Consensus       496 ~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~  540 (551)
                      .....++..+.+||.+||+.||.+|||+.++++||||++......
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  299 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ  299 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence            223568999999999999999999999999999999998665443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.7e-43  Score=369.77  Aligned_cols=246  Identities=24%  Similarity=0.452  Sum_probs=204.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .+|.+.+.||+|+||.||+|++.    ++..||||++...    ........+.+|+.++.+++||||+++++++.+...
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            47999999999999999999764    5778999988542    123455678899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|+|||||.+++|.+++.+.  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999999764  5889999999999999999999999999999999999999999999999999765432


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      .     .....+|+.|+|||++  ....++.++|||||||++|||++ |+.||......+....+..+.....+..++..
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  278 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA  278 (373)
T ss_dssp             -------------CTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred             CccceeccCCCcCCCccChhhh--ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence            2     1122357789999997  35678999999999999999998 99999888877777777777666667789999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||.+||+.||.+|||+.+|++
T Consensus       279 l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCcChhhCcCHHHHHH
Confidence            999999999999999999999886

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-43  Score=361.40  Aligned_cols=250  Identities=24%  Similarity=0.417  Sum_probs=209.5

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeec
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTD  347 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  347 (551)
                      ...+|.+++.||+|+||.||+|.+      .++..||||++.....    ......+.+|+.++.++ .||||+++++++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC----HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345899999999999999999985      2466899999864321    22345678999999999 899999999999


Q ss_pred             cCCCeEEEEEecccccchHHHHhhhc------------------------CChHHHHHHHHHHHHHHHHHHhCCeeeccc
Q 043852          348 KDENRLFIFLELVTKGSLANLYQKYH------------------------LMDSQVSAYTRQILNGLNYLHEQNVVHRDI  403 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~~~------------------------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDI  403 (551)
                      .+...+|+|||||.+|+|.+++....                        +++..++.++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999987532                        688899999999999999999999999999


Q ss_pred             ccceEEEcCCCcEEEEecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 043852          404 KCANILVDASGSVKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYS  478 (551)
Q Consensus       404 KP~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~  478 (551)
                      ||+|||++.++.+||+|||++........    ....||+.|+|||++.  ...++.++|||||||++|+|+| |..||.
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc--cCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999976543321    2334688999999973  4578999999999999999998 999998


Q ss_pred             CchhHHHHH-HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 043852          479 HLEGMQALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  530 (551)
Q Consensus       479 ~~~~~~~~~-~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehp  530 (551)
                      +........ .+..+.....+..++..+.+||.+||+.||.+|||+.+|++|-
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            765444333 3444555566778999999999999999999999999999863

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.5e-43  Score=360.63  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=202.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCC-ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc------eeeeeeecc
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDG-FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN------IVQYFGTDK  348 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g-~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~  348 (551)
                      ++|++++.||+|+||.||+|.+ .++ ..||||++...      ......+.+|+.++..+.|++      |+.+++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            5899999999999999999987 344 78999998532      233456678888888887665      899999999


Q ss_pred             CCCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE---------------
Q 043852          349 DENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV---------------  410 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl---------------  410 (551)
                      ....+|+||||+.+ +|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||+               
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           93 FHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eCCeEEEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence            99999999999954 555555432   58999999999999999999999999999999999999               


Q ss_pred             ----cCCCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 043852          411 ----DASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL  486 (551)
Q Consensus       411 ----~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~  486 (551)
                          +.++.+||+|||+++.... ......||+.|+|||++  .+..++.++|||||||++|+|++|..||......+.+
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVI--LELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeee--ecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                5678999999999976433 23455799999999997  3567899999999999999999999999887665544


Q ss_pred             HHhhcCCCC-------------------------------------------CCCCcCCHHHHHHHHHhhhcCCCCCCCH
Q 043852          487 FRIGKGEPP-------------------------------------------LVPNSLSRDARDFILKCLQVNPNDRPTA  523 (551)
Q Consensus       487 ~~i~~~~~~-------------------------------------------~~~~~~s~~l~~LI~~cL~~DP~~RPS~  523 (551)
                      ..+.+...+                                           ......+..+.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            332221100                                           0011224578899999999999999999


Q ss_pred             HHHHhCcccCCccc
Q 043852          524 AQLMEHPFVKRPLQ  537 (551)
Q Consensus       524 ~eILehpff~~~~~  537 (551)
                      .++++||||++...
T Consensus       329 ~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          329 AEALLHPFFAGLTP  342 (355)
T ss_dssp             HHHTTSGGGGGCCH
T ss_pred             HHHhcChhhcCCCh
Confidence            99999999997654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.6e-43  Score=359.47  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=213.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      .+|++++.||+|+||.||+|.+      .++..||||++...    ........+.+|+.++.+++||||+++++++.+.
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc----cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            4899999999999999999973      46789999988532    2234456788999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC---CcEEEE
Q 043852          351 NRLFIFLELVTKGSLANLYQKY--------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS---GSVKLA  419 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~--------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~---g~vkL~  419 (551)
                      ...|+||||+.+++|.+++...        .+++..++.++.||+.||.|||++||+||||||+|||++.+   ..+||+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999998764        37888999999999999999999999999999999999844   469999


Q ss_pred             ecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC
Q 043852          420 DFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP  494 (551)
Q Consensus       420 DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~  494 (551)
                      |||++.......    .....||+.|+|||++.  ...++.++|||||||++|+|++ |..||...........+..+..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  263 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  263 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence            999987443222    22345789999999973  4578999999999999999998 9999998887777777777777


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       495 ~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      ...+..++..+.+||.+||+.||.+|||+.+|++|.|+-
T Consensus       264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            777888999999999999999999999999999998854

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.2e-43  Score=375.73  Aligned_cols=245  Identities=29%  Similarity=0.454  Sum_probs=211.2

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      ..++|++.+.||+|+||.||+|.+.++..||||++.....      ....+.+|+.++++++||||+++++++.+ ..+|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            3458999999999999999999888778899998864321      13467899999999999999999999876 6789


Q ss_pred             EEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          355 IFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +||||+.+|+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            99999999999999864   248899999999999999999999999999999999999999999999999997654332


Q ss_pred             c---ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHH
Q 043852          432 V---KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD  507 (551)
Q Consensus       432 ~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~  507 (551)
                      .   ....+|+.|+|||++.  ...++.++|||||||++|||++ |..||.+....+....+..+.....+..++..+.+
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  412 (452)
T ss_dssp             --------CCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             eecccCCcccccccCHhHHh--cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            2   2334678899999973  4578999999999999999999 99999998888888888888777778899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHh
Q 043852          508 FILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ||.+||+.||++|||+++|++
T Consensus       413 li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.6e-43  Score=359.70  Aligned_cols=241  Identities=21%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  354 (551)
                      .+|++++.||+|+||.||+|.+ .+|+.||||++......       ..+.+|+.++.++ +|+||+++++++.+....|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            4799999999999999999987 68999999998754322       1466899999999 9999999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc-----EEEEecCCcccc
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS-----VKLADFGLAKAT  427 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~-----vkL~DFGla~~~  427 (551)
                      +||||+ +++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++..
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999 8999999874  57999999999999999999999999999999999999998887     999999999865


Q ss_pred             ccCC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch---hHHHHHHhhcCCCC
Q 043852          428 TMND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGKGEPP  495 (551)
Q Consensus       428 ~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---~~~~~~~i~~~~~~  495 (551)
                      ....         .....||+.|+|||++  .+..++.++|||||||++|||++|+.||.+..   ..+.+..+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTH--LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHH--cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            3322         2456799999999997  45678999999999999999999999997643   23333333222111


Q ss_pred             C----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          496 L----VPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       496 ~----~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .    ....++ .+.+||.+||+.||.+||++.+|++
T Consensus       239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1    112345 9999999999999999999999877

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.1e-43  Score=360.70  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC---
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN---  351 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---  351 (551)
                      ...+|+++++||+|+||+||+|.+ .+..||||++...      .........|+.++.+++||||+++++++.+..   
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            345899999999999999999975 4789999998532      223345567999999999999999999987643   


Q ss_pred             -eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC----------CeeecccccceEEEcCCCcEEEEe
Q 043852          352 -RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ----------NVVHRDIKCANILVDASGSVKLAD  420 (551)
Q Consensus       352 -~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~----------gIiHrDIKP~NILl~~~g~vkL~D  420 (551)
                       .+|+|||||.+|+|.++++...+++..++.++.||+.||.|||+.          ||+||||||+|||++.++.+||+|
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             ceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence             479999999999999999988899999999999999999999999          999999999999999999999999


Q ss_pred             cCCccccccCC----cccCCCCCcccChhhhhcc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-----------
Q 043852          421 FGLAKATTMND----VKSCKGTPFWMAPEVVNLK---NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-----------  482 (551)
Q Consensus       421 FGla~~~~~~~----~~~~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-----------  482 (551)
                      ||+++......    .....||+.|+|||++...   ...++.++|||||||++|||+||+.||.+...           
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            99997543322    3345699999999998421   12456788999999999999999999964321           


Q ss_pred             ----HH-HHHHhhc-CCCCCCCC-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          483 ----MQ-ALFRIGK-GEPPLVPN-----SLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       483 ----~~-~~~~i~~-~~~~~~~~-----~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                          .. ....+.. ...+..+.     .++..+.+||.+||+.||++|||+.+|++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                11 1112222 22222222     23456999999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-42  Score=346.77  Aligned_cols=245  Identities=26%  Similarity=0.454  Sum_probs=209.6

Q ss_pred             CeeeeeEeccCCceEEEEEEec-C---CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD-D---GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~-~---g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .|...++||+|+||.||+|.+. +   +..+|+|.+..    .........+.+|+.++++++||||+++++++.+....
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR----ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc----cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            6888899999999999999852 3   33799998853    22334566788999999999999999999999776655


Q ss_pred             -EEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 -FIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 -~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                       +++|||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             999999999999999875  45888999999999999999999999999999999999999999999999999754322


Q ss_pred             ------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCH
Q 043852          431 ------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       431 ------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  503 (551)
                            ......+|+.|+|||++  ....++.++|||||||++|+|++ +.+||...........+..+.....+..++.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESL--QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD  255 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHH--TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             cccccccCcCCCCCccccChhhh--ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchH
Confidence                  23345578899999997  45678999999999999999999 5666777777777777777777777888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+.+||.+||+.||.+|||+.++++
T Consensus       256 ~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          256 SLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-42  Score=348.73  Aligned_cols=246  Identities=28%  Similarity=0.445  Sum_probs=210.9

Q ss_pred             cCeeeee-EeccCCceEEEEEEe---cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGE-LLGSGSFGTVYEGYT---DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~-~LG~G~fG~VY~~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .+|.+.+ .||+|+||.||+|.+   .++..||||++....   ........+.+|+.++..++||||+++++++ ....
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            4789888 999999999999954   357899999986432   2233456788999999999999999999998 5667


Q ss_pred             EEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          353 LFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      +|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence            89999999999999988764 48999999999999999999999999999999999999999999999999997654332


Q ss_pred             -----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          432 -----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       432 -----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                           .....+|+.|+|||++.  ...++.++|||||||++|+|++ |+.||......+....+..+.....+..++..+
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (291)
T 1xbb_A          172 NYYKAQTHGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM  249 (291)
T ss_dssp             SEEEC----CCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CcccccccCCCCceeeChHHhc--cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence                 12234678899999973  4567899999999999999999 999999888887777788887777888899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||.+||+.||.+|||+.++++
T Consensus       250 ~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          250 YDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-42  Score=347.39  Aligned_cols=248  Identities=27%  Similarity=0.462  Sum_probs=209.8

Q ss_pred             cccCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ..++|.+.+.||+|+||.||+|.+.    ++..||+|++....    .......+.+|+.++.+++||||+++++++.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence            3458999999999999999999753    23469999876431    234456788999999999999999999998754


Q ss_pred             CeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                       ..|+||||+.+++|.+++.+.  .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus        86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence             468999999999999998754  48899999999999999999999999999999999999999999999999987654


Q ss_pred             cCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          429 MND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       429 ~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ...   .....+|+.|+|||++  ....++.++|||||||++|+|++ |+.||...........+..+.....+..++..
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV  242 (281)
T ss_dssp             --------CCCCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred             cccccccccCCCCcceeCchhh--ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence            332   2334578899999997  35578999999999999999998 99999877666666666666666777889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-42  Score=347.03  Aligned_cols=243  Identities=26%  Similarity=0.454  Sum_probs=204.6

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-CCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-ENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~  353 (551)
                      ..++|++.+.||+|+||.||++.+ +|..||||++....       ....+.+|+.++.+++||||+++++++.+ ...+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            356899999999999999999965 58899999875321       23467899999999999999999998654 4578


Q ss_pred             EEEEecccccchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 FIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~---l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      |+||||+.+++|.+++....   +++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999999999887543   788999999999999999999999999999999999999999999999998754432


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                       .....+|+.|+|||++  ....++.++|||||||++|+|++ |..||......+....+..+.....+..++..+.+||
T Consensus       171 -~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  247 (278)
T 1byg_A          171 -QDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  247 (278)
T ss_dssp             ------CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             -ccCCCccccccCHHHh--CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence             2334578999999997  35678999999999999999998 9999988777777777777777777888999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHh
Q 043852          510 LKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||+.||.+|||+.++++
T Consensus       248 ~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          248 KNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCChhhCCCHHHHHH
Confidence            9999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.9e-44  Score=364.12  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=205.3

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ....++|++.+.||+|+||.||+|.+.+|..||||++....     ......+.+|+.++..++||||+++++++.+...
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            34556899999999999999999998889999999875432     2235578899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          353 LFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~-----~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      .|+||||+.+++|.+++...     .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999999988654     3888999999999999999999999999999999999999999999999999754


Q ss_pred             ccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-----HH--HHhhcCC---
Q 043852          428 TMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ-----AL--FRIGKGE---  493 (551)
Q Consensus       428 ~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~-----~~--~~i~~~~---  493 (551)
                      ....    .....||+.|+|||++.  ...++.++|||||||++|+|++|+.||.......     .+  .....+.   
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFI--KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHH--HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccCCCccccCHHHhc--CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            3221    23345899999999973  4568999999999999999999999996533211     00  0111111   


Q ss_pred             ------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 043852          494 ------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  530 (551)
Q Consensus       494 ------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehp  530 (551)
                            ....+..++..+.+|+.+||+.||++|||+.+++++-
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                  1112233556789999999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-42  Score=354.92  Aligned_cols=247  Identities=25%  Similarity=0.444  Sum_probs=209.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-C----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-D----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|.+.+.||+|+||.||+|.+. +    +..||||++....    .......+.+|+.++.+++||||+++++++.+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            37999999999999999999763 2    2359999986422    2344557889999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      .+++||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999999999999875  4589999999999999999999999999999999999999999999999999976543


Q ss_pred             CC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCH
Q 043852          430 ND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       430 ~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  503 (551)
                      ..     .....+|+.|+|||++  ....++.++|||||||++|+|++ |..||......+....+..+.....+..++.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  277 (333)
T ss_dssp             -----------CCCGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             ccccccccCCCCccccccCchhc--ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence            22     1223467889999997  45678999999999999999998 9999988887777777777766667778999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+.+||.+||+.||.+||++.+++++
T Consensus       278 ~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          278 AIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.7e-43  Score=380.83  Aligned_cols=254  Identities=25%  Similarity=0.426  Sum_probs=219.6

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEec-CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .....+|++.+.||+|+||.||+|.+. ++..||||++.....      ....+.+|+.++.+++||||+++++++.+..
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            334568999999999999999999884 589999998854321      2456889999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      .+|||||||.+|+|.+++.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999999999875   348889999999999999999999999999999999999999999999999998654


Q ss_pred             cCCc---ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          429 MNDV---KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       429 ~~~~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ....   ....+|+.|+|||++.  ...++.++|||||||+||||++ |..||.+.+..+....+..+.....+..++..
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  447 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK  447 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCceeecCCCcCCcceeCHhHHh--cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            3332   2334677899999973  4568999999999999999999 99999988877777777777777778899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +.+||.+||+.||.+|||+.+|++  .|+..+
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~--~L~~~~  477 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQ--AFETMF  477 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHTSC
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHH--HHHHHH
Confidence            999999999999999999999987  444433

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-42  Score=348.34  Aligned_cols=246  Identities=26%  Similarity=0.472  Sum_probs=209.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec-cCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD-KDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~  351 (551)
                      ..|++.+.||+|+||.||+|.+.    .+..+|+|.+..    .........+.+|+.++++++||||+++++++ ....
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT----CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc----CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            37999999999999999999852    233588888753    22344566788999999999999999999984 5567


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..|++|||+.+++|.+++..  ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            88999999999999999865  3488899999999999999999999999999999999999999999999999975533


Q ss_pred             CC------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCC
Q 043852          430 ND------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS  502 (551)
Q Consensus       430 ~~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  502 (551)
                      ..      .....+|+.|+|||++  ....++.++|||||||++|+|++ |.+||......+....+..+.....+..++
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  258 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred             cchhccccccCCCCCccccChHHh--cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence            22      2334578899999997  45578999999999999999999 777888777777777777777777788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..+.+||.+||+.||.+|||+.++++
T Consensus       259 ~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          259 DPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-42  Score=353.07  Aligned_cols=249  Identities=27%  Similarity=0.462  Sum_probs=209.9

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeec
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTD  347 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~  347 (551)
                      ..++|++++.||+|+||.||+|.+      .+++.||||++...    ........+.+|+.++.++ +||||+++++++
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC----CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            345899999999999999999974      35789999998643    2233455788999999999 789999999997


Q ss_pred             cCC-CeEEEEEecccccchHHHHhhhc-----------------CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEE
Q 043852          348 KDE-NRLFIFLELVTKGSLANLYQKYH-----------------LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL  409 (551)
Q Consensus       348 ~~~-~~~~lV~Ey~~ggsL~~ll~~~~-----------------l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NIL  409 (551)
                      ... ..+|++||||.+++|.+++....                 +++..++.++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            765 45899999999999999987543                 788899999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH-
Q 043852          410 VDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGM-  483 (551)
Q Consensus       410 l~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~-  483 (551)
                      ++.++.+||+|||+++......    .....||+.|+|||++  ....++.++|||||||++|+|++ |..||...... 
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh--ccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            9999999999999997654322    2234478899999997  35678999999999999999998 99999776533 


Q ss_pred             HHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          484 QALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       484 ~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .....+..+.....+..++..+.++|.+||+.||.+|||+.+|++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3334455555566677899999999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.1e-43  Score=350.16  Aligned_cols=252  Identities=19%  Similarity=0.344  Sum_probs=205.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec-CC-------ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeec
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD-DG-------FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTD  347 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~-~g-------~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  347 (551)
                      .++|++.+.||+|+||.||+|.+. ++       ..||+|++...     .......+.+|+.++.+++||||+++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----HRNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            358999999999999999999873 44       46999988532     223445788999999999999999999999


Q ss_pred             cCCCeEEEEEecccccchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc--------EE
Q 043852          348 KDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS--------VK  417 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~~~--l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~--------vk  417 (551)
                      .+....|+||||+.+++|.+++.+..  +++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999999987654  889999999999999999999999999999999999998887        99


Q ss_pred             EEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHhhcCCCCC
Q 043852          418 LADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPL  496 (551)
Q Consensus       418 L~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~  496 (551)
                      |+|||++......  ....||+.|+|||++. ....++.++|||||||++|+|++| .+||..............  ...
T Consensus       162 l~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~  236 (289)
T 4fvq_A          162 LSDPGISITVLPK--DILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RHQ  236 (289)
T ss_dssp             ECCCCSCTTTSCH--HHHHHTTTTSCHHHHH-CGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCC
T ss_pred             eccCcccccccCc--cccCCcCcccCHHHhC-CCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cCC
Confidence            9999998654322  2345789999999984 335689999999999999999995 556655554444333322  233


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       497 ~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      .+..++..+.+||.+||+.||.+|||+.++++  .+++.+...
T Consensus       237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~l~~p~  277 (289)
T 4fvq_A          237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIR--DLNSLFTPD  277 (289)
T ss_dssp             CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH--HHHTCC---
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhcCCC
Confidence            45567888999999999999999999999998  455444433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.4e-42  Score=347.05  Aligned_cols=242  Identities=21%  Similarity=0.292  Sum_probs=202.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  354 (551)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++......       ..+.+|+.++..+ +|+||+++++++.+....|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-------HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            4799999999999999999987 68999999998643322       1356889999998 7999999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc-----EEEEecCCcccc
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS-----VKLADFGLAKAT  427 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~-----vkL~DFGla~~~  427 (551)
                      +||||+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++..
T Consensus        83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999999 9999999875  35899999999999999999999999999999999999987776     999999999765


Q ss_pred             ccCC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch---hHHHHHHhhc----
Q 043852          428 TMND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE---GMQALFRIGK----  491 (551)
Q Consensus       428 ~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~---~~~~~~~i~~----  491 (551)
                      ....         .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+..   ....+..+..    
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccCccCCCCCcccCCchhh--cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            4322         2345699999999997  45678999999999999999999999997642   2333332222    


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .........++..+.+||.+||+.||.+|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1112223468999999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.8e-42  Score=351.41  Aligned_cols=249  Identities=25%  Similarity=0.438  Sum_probs=205.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      ..+|.+++.||+|+||.||+|...    ++..||||++....   ........+.+|+.++.+++||||+++++++.+..
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            348999999999999999999763    45589999886432   22345567889999999999999999999987654


Q ss_pred             -----eEEEEEecccccchHHHHhh-------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEE
Q 043852          352 -----RLFIFLELVTKGSLANLYQK-------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLA  419 (551)
Q Consensus       352 -----~~~lV~Ey~~ggsL~~ll~~-------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~  419 (551)
                           ..|++|||+.+++|.+++..       ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence                 45999999999999998832       348899999999999999999999999999999999999999999999


Q ss_pred             ecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCC
Q 043852          420 DFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEP  494 (551)
Q Consensus       420 DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~  494 (551)
                      |||+++......    .....+++.|+|||++  ....++.++|||||||++|+|++ |..||...........+..+..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHH--HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             ecCcceecccccccCcccccCCCccccCchhh--cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            999987654322    2234578899999997  45678999999999999999999 9999988877777777777777


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       495 ~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77788899999999999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.7e-42  Score=347.90  Aligned_cols=245  Identities=29%  Similarity=0.484  Sum_probs=204.8

Q ss_pred             CeeeeeEeccCCceEEEEEE----e-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC--
Q 043852          278 SWQKGELLGSGSFGTVYEGY----T-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE--  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~----~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--  350 (551)
                      .|++++.||+|+||.||+|.    + .+++.||||++.....    ......+.+|+.++.+++|+||+++++++.+.  
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            69999999999999999998    2 5799999999864332    22345678999999999999999999998776  


Q ss_pred             CeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ..+++||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            678999999999999999854  358999999999999999999999999999999999999999999999999997654


Q ss_pred             cCC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc---------------hhHHHHHH
Q 043852          429 MND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL---------------EGMQALFR  488 (551)
Q Consensus       429 ~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~---------------~~~~~~~~  488 (551)
                      ...     .....||..|+|||++  .+..++.++|||||||++|+|++|..|+...               ........
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeee--cCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            332     2345588889999997  3456789999999999999999999876332               12223344


Q ss_pred             hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       489 i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +..+.....+..++..+.+||.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            5556666677889999999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.5e-42  Score=351.37  Aligned_cols=250  Identities=30%  Similarity=0.459  Sum_probs=210.2

Q ss_pred             eeeeeEeccCCceEEEEEEe-----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--CC
Q 043852          279 WQKGELLGSGSFGTVYEGYT-----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--EN  351 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~  351 (551)
                      |++++.||+|+||+||++..     .+|+.||||++...    ........+.+|+.++.+++||||+++++++.+  ..
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            59999999999999988753     37899999998643    223456678899999999999999999999876  46


Q ss_pred             eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          352 RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      .+++||||+.+++|.+++.+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred             eEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence            78999999999999999998889999999999999999999999999999999999999999999999999997654332


Q ss_pred             -----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH---------------HHHHHhhc
Q 043852          432 -----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---------------QALFRIGK  491 (551)
Q Consensus       432 -----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~---------------~~~~~i~~  491 (551)
                           .....+|+.|+|||++.  ...++.++|||||||++|+|++|..||......               .....+..
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLK--EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             cccccccCCCCCceeeChHHhc--CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence                 23445888899999973  456789999999999999999999999654321               12233455


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +.....+..++..+.+||.+||+.||.+|||+.++++  +++...
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l~  309 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTVH  309 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHHH
Confidence            5566677889999999999999999999999999996  555433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.2e-42  Score=352.94  Aligned_cols=246  Identities=28%  Similarity=0.484  Sum_probs=208.7

Q ss_pred             cCeeeeeEeccCCceEEEEEE----e-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc--C
Q 043852          277 MSWQKGELLGSGSFGTVYEGY----T-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK--D  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~----~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~  349 (551)
                      .+|++++.||+|+||.||+|.    + .++..||||++...     .......+.+|+.++.+++|+||+++++++.  +
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            389999999999999999998    2 47899999998632     2344567889999999999999999999875  5


Q ss_pred             CCeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                      ...+|+||||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            6679999999999999999875  45899999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH---------------HHHH
Q 043852          428 TMND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---------------QALF  487 (551)
Q Consensus       428 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~---------------~~~~  487 (551)
                      ....     .....||+.|+|||++  .+..++.++|||||||++|+|++|..||......               ....
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHh--ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            4322     2334578889999997  3456799999999999999999999998654332               2333


Q ss_pred             HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          488 RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       488 ~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+..+.....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            445555666778899999999999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.9e-42  Score=345.83  Aligned_cols=246  Identities=27%  Similarity=0.547  Sum_probs=195.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      ++|++++.||+|+||.||+|.+..  .+|||++....   ........+.+|+.++++++|+||+++++++ ....+++|
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTA---PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccC---CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            379999999999999999997533  59999986543   2345566788999999999999999999965 45568999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc----C
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM----N  430 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~----~  430 (551)
                      ||||.+++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....    .
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred             EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence            999999999998853  4588999999999999999999999999999999999999999999999999875432    2


Q ss_pred             CcccCCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHh-hcCCC----CCCCCcCCHH
Q 043852          431 DVKSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI-GKGEP----PLVPNSLSRD  504 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i-~~~~~----~~~~~~~s~~  504 (551)
                      ......||+.|+|||++.. ....++.++|||||||++|+|++|+.||........+... ..+..    ......++..
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR  257 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred             cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence            2334569999999999742 2456789999999999999999999999876554444332 22222    2234568999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||.+||+.||.+|||+.++++
T Consensus       258 l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          258 MKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-42  Score=353.28  Aligned_cols=251  Identities=25%  Similarity=0.446  Sum_probs=209.9

Q ss_pred             hhhcccCeeeeeEeccCCceEEEEEEec-CC-----ceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeee
Q 043852          272 FRRRIMSWQKGELLGSGSFGTVYEGYTD-DG-----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYF  344 (551)
Q Consensus       272 ~~~~~~~y~~~~~LG~G~fG~VY~~~~~-~g-----~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~  344 (551)
                      +....++|.+++.||+|+||.||+|.+. ++     ..||+|.+....    .......+.+|+.++.++ +||||++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            3344568999999999999999999863 33     479999886432    234456788999999999 899999999


Q ss_pred             eeccCCCeEEEEEecccccchHHHHhhh---------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEE
Q 043852          345 GTDKDENRLFIFLELVTKGSLANLYQKY---------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL  409 (551)
Q Consensus       345 ~~~~~~~~~~lV~Ey~~ggsL~~ll~~~---------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NIL  409 (551)
                      +++.+...+|+||||+.+|+|.+++...               .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            9999999999999999999999988643               3688899999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHH
Q 043852          410 VDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQ  484 (551)
Q Consensus       410 l~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~  484 (551)
                      ++.++.+||+|||+++......    .....||+.|+|||++.  ...++.++|||||||++|+|++ |..||.+.....
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc--cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            9999999999999997554332    22344678899999973  4578999999999999999998 999998765444


Q ss_pred             HHHH-hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          485 ALFR-IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       485 ~~~~-i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .... +..+.....+..++..+.+||.+||+.||.+|||+.+|++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            3333 3344455566778999999999999999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.6e-42  Score=347.37  Aligned_cols=244  Identities=27%  Similarity=0.417  Sum_probs=193.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc--CCCCceeeeeeeccC----
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR--FEHENIVQYFGTDKD----  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~----  349 (551)
                      .++|++++.||+|+||+||+|.+ +|..||||++...        ....+..|..++..  ++||||+++++++.+    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            35899999999999999999976 7889999998532        12233445555554  899999999998543    


Q ss_pred             CCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHH--------hCCeeecccccceEEEcCCCcEEEEec
Q 043852          350 ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH--------EQNVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH--------~~gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                      ...+|+||||+.+|+|.++++...+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            456899999999999999999889999999999999999999999        999999999999999999999999999


Q ss_pred             CCccccccCC------cccCCCCCcccChhhhhcccC----CCCchhhHHHHHHHHHHHHcC----------CCCCCCch
Q 043852          422 GLAKATTMND------VKSCKGTPFWMAPEVVNLKNR----GYGLTADIWSLGCTVLEMLTR----------QPPYSHLE  481 (551)
Q Consensus       422 Gla~~~~~~~------~~~~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLG~iLyeLltG----------~~Pf~~~~  481 (551)
                      |+++......      .....||+.|+|||++.....    .++.++|||||||++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9997543322      233479999999999842211    345799999999999999999          88885432


Q ss_pred             ----hHHHHHHh--hcCCCCCCCC-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          482 ----GMQALFRI--GKGEPPLVPN-----SLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       482 ----~~~~~~~i--~~~~~~~~~~-----~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                          ........  .....+..+.     .++..+.+||.+||+.||.+|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                22222222  1222233332     25578999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-41  Score=345.99  Aligned_cols=263  Identities=29%  Similarity=0.521  Sum_probs=204.8

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+.+|++.+.||+|+||.||+|.+ .+|..||||++.....  ........+.+|+.++.+++|+||+++++++.+...+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            456899999999999999999987 6899999999865322  2344566788999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          354 FIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                      ++||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999998864     348899999999999999999999999999999999999999999999999987554


Q ss_pred             cCC--cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--hHHHHHHhhcCCCCC-CCCcCCH
Q 043852          429 MND--VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE--GMQALFRIGKGEPPL-VPNSLSR  503 (551)
Q Consensus       429 ~~~--~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--~~~~~~~i~~~~~~~-~~~~~s~  503 (551)
                      ...  .....||+.|+|||++  ....++.++|||||||++|+|++|..||.+..  .......+.....+. ....++.
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -----------CCSSCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCCccccccCCCeeEeChHHh--CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            322  2345689999999997  35678999999999999999999999996542  233334444443333 3367899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCCC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP  543 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~~  543 (551)
                      .+.+||.+||+.||.+|||+.+|++  .+++.......++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~--~l~~l~~~~~~~~  303 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYD--VAKRMHACTASSL  303 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHHHHC---
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH--HHHHHHHhhhhhh
Confidence            9999999999999999999999997  5555554444443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.4e-42  Score=349.50  Aligned_cols=252  Identities=27%  Similarity=0.368  Sum_probs=202.4

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      ...+++|++.+.||+|+||.||+|.+ .++..||||++.....  ........+.+|+.++.+++||||+++++++.+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            35577999999999999999999987 5799999998864322  22344567889999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+|++|||+.+++|.+++... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999999988764 5899999999999999999999999999999999999999999999999998765433


Q ss_pred             C---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC--CCCCCcCCHHH
Q 043852          431 D---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLVPNSLSRDA  505 (551)
Q Consensus       431 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l  505 (551)
                      .   .....||+.|+|||++  ....++.++|||||||++|+|++|+.||...........+....+  ...+..++..+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERF--SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF  265 (309)
T ss_dssp             ---------CCGGGCCGGGT--CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred             ccccccccCCCcCccCHHHH--cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence            2   2345689999999997  455778999999999999999999999988766544444433322  23456789999


Q ss_pred             HHHHHHhhhcCCCCCC-CHHHHHh
Q 043852          506 RDFILKCLQVNPNDRP-TAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RP-S~~eILe  528 (551)
                      .+||.+||+.||.+|| |++++++
T Consensus       266 ~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999999 8888875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.7e-42  Score=379.02  Aligned_cols=246  Identities=28%  Similarity=0.447  Sum_probs=216.0

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ...++|++.+.||+|+||.||+|.+.++..||||++.....      ....+.+|+.+|++++|+||+++++++.+ ..+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            34468999999999999999999988788899999864321      13467899999999999999999999876 678


Q ss_pred             EEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 FIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      |||||||.+|+|.++++.   ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999999999999999874   24889999999999999999999999999999999999999999999999999765432


Q ss_pred             C---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          431 D---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       431 ~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                      .   .....+|..|+|||++.  ...++.++|||||||+||||++ |..||.+....+.+..+..+.....+..++..+.
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  494 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAAL--YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH  494 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ceecccCCcCcccccCHHHhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2   22344678899999973  4578999999999999999999 9999999888888888888877777888999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHh
Q 043852          507 DFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +||.+||+.||++|||+.+|++
T Consensus       495 ~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          495 DLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=347.83  Aligned_cols=241  Identities=26%  Similarity=0.514  Sum_probs=199.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .++|++.+.||+|+||.||++.+ .+..||||.+...       .....+.+|+.++.+++||||+++++++.+.  .|+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-------SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-------THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEE
Confidence            35899999999999999999976 4788999987421       2345678999999999999999999998743  789


Q ss_pred             EEecccccchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHh---CCeeecccccceEEEcCCCc-EEEEecCCcccc
Q 043852          356 FLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNYLHE---QNVVHRDIKCANILVDASGS-VKLADFGLAKAT  427 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~----l~~~~i~~i~~QI~~aL~yLH~---~gIiHrDIKP~NILl~~~g~-vkL~DFGla~~~  427 (551)
                      ||||+.+++|.+++....    ++...+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999999987543    6788899999999999999999   89999999999999998886 799999998754


Q ss_pred             ccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCc--hhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          428 TMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHL--EGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       428 ~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                      ... .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||...  ........+..+..+..+..++..+
T Consensus       157 ~~~-~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          157 QTH-MTNNKGSAAWMAPEVF--EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI  233 (307)
T ss_dssp             ---------CCTTSSCHHHH--TCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred             ccc-cccCCCCCceEChhhh--CCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence            332 2344699999999997  4557899999999999999999999999754  2334444556666667778899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          506 RDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+||.+||+.||.+|||+.+++++
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-42  Score=343.74  Aligned_cols=243  Identities=28%  Similarity=0.511  Sum_probs=205.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC------
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD------  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------  349 (551)
                      .+|++++.||+|+||.||+|.+ .+|+.||+|++....         ..+.+|+.++.+++||||+++++++..      
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            4799999999999999999988 489999999987532         135589999999999999999998754      


Q ss_pred             ----------CCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcE
Q 043852          350 ----------ENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV  416 (551)
Q Consensus       350 ----------~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~v  416 (551)
                                ...+|+||||+.+++|.+++...   .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                      45589999999999999998643   58899999999999999999999999999999999999999999


Q ss_pred             EEEecCCccccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC
Q 043852          417 KLADFGLAKATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP  495 (551)
Q Consensus       417 kL~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~  495 (551)
                      ||+|||++...... ......||+.|+|||++  ....++.++|||||||++|+|++|..||....  .....+..+   
T Consensus       162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~---  234 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI--SSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG---  234 (284)
T ss_dssp             EECCCTTCEESSCCSCCCCCCSCCTTSCHHHH--HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTT---
T ss_pred             EECcchhheeccccccccccCCcccccChhhh--ccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhcc---
Confidence            99999998765433 23445699999999997  35678999999999999999999999875322  222233332   


Q ss_pred             CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          496 LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       496 ~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      .++..++..+.+||.+||+.||.+|||+.++++|.+.-+.
T Consensus       235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            2356689999999999999999999999999999875443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-42  Score=360.17  Aligned_cols=249  Identities=18%  Similarity=0.294  Sum_probs=194.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEecC------CceEEEEEEecCccCccch------HHHHHHHHHHHHHhcCCCCceeeee
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDD------GFFFAVKEVSLQDQGTQGK------QSILQLEQEILLLSRFEHENIVQYF  344 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~------g~~vAVK~i~~~~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~  344 (551)
                      ++|++++.||+|+||.||+|.+..      ++.||||++..........      .....+..|+..+..++|+||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            489999999999999999998743      5789999986543211110      0111233566678888999999999


Q ss_pred             eeccCC----CeEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc--CCCcE
Q 043852          345 GTDKDE----NRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD--ASGSV  416 (551)
Q Consensus       345 ~~~~~~----~~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~--~~g~v  416 (551)
                      +++.+.    ...||||||| +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++  .++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            998764    5689999999 9999999876  4589999999999999999999999999999999999999  88999


Q ss_pred             EEEecCCccccccCC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 043852          417 KLADFGLAKATTMND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF  487 (551)
Q Consensus       417 kL~DFGla~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~  487 (551)
                      ||+|||+++......         .....||+.|+|||++  .+..++.++|||||||++|||+||+.||.+........
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH--NGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHh--CCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            999999997543221         1334599999999997  45568999999999999999999999997532211111


Q ss_pred             H-hhcC---CC------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          488 R-IGKG---EP------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       488 ~-i~~~---~~------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      . ....   ..      ......++..+.+||..||+.||.+||++.+|++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1 0000   00      0112567999999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-42  Score=362.36  Aligned_cols=246  Identities=26%  Similarity=0.463  Sum_probs=201.8

Q ss_pred             CeeeeeEeccCCceEEEEEEec--C--CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc-CCCe
Q 043852          278 SWQKGELLGSGSFGTVYEGYTD--D--GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK-DENR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~--~--g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~  352 (551)
                      .|.+.+.||+|+||.||+|...  +  +..||||.+...    ........+.+|+.++.+++||||+++++++. ....
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            6889999999999999999863  2  246888877532    22345667889999999999999999999854 4567


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .|+||||+.+++|.++++..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            89999999999999999753  4788899999999999999999999999999999999999999999999999754332


Q ss_pred             C------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCH
Q 043852          431 D------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       431 ~------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  503 (551)
                      .      .....+|+.|+|||++  ....++.++|||||||++|||++ |.+||......+....+..+.....+..++.
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~  323 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD  323 (373)
T ss_dssp             ------------CCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCH
T ss_pred             ccccccccCCCCCcccccChHHh--cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            2      2234578889999997  35678999999999999999999 7889987776666667777777777888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+.+||.+||+.||.+|||+.+++++
T Consensus       324 ~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          324 PLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=356.47  Aligned_cols=249  Identities=20%  Similarity=0.284  Sum_probs=193.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccch------HHHHHHHHHHHHHhcCCCCceeeeeee
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGK------QSILQLEQEILLLSRFEHENIVQYFGT  346 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~  346 (551)
                      ++|.+++.||+|+||.||+|.+.    ++..+|||++..........      .....+.+|+.++..+.|+||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            47999999999999999999874    78899999987543211111      112235678889999999999999999


Q ss_pred             ccC----CCeEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC--cEEEE
Q 043852          347 DKD----ENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG--SVKLA  419 (551)
Q Consensus       347 ~~~----~~~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g--~vkL~  419 (551)
                      +.+    ...+|+||||| +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            877    78899999999 99999998754 689999999999999999999999999999999999998887  99999


Q ss_pred             ecCCccccccCC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHh
Q 043852          420 DFGLAKATTMND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLE-GMQALFRI  489 (551)
Q Consensus       420 DFGla~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~-~~~~~~~i  489 (551)
                      |||+++......         .....||+.|+|||++.  +..++.++|||||||++|||++|+.||.... ........
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK--GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH--TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhc--CCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            999997543221         24456999999999973  5578999999999999999999999995421 11111111


Q ss_pred             hcCCCCCC---------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          490 GKGEPPLV---------PNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       490 ~~~~~~~~---------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ........         ...++..+.+||.+||+.||.+|||+.+|++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            11111111         1268899999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.9e-42  Score=352.29  Aligned_cols=254  Identities=25%  Similarity=0.377  Sum_probs=203.1

Q ss_pred             hhhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          272 FRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       272 ~~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      +....++|.+.+.||+|+||.||+|.+.+|..||||++........    ...+.+|+.++..++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG----ELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C----CCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH----HHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            3344568999999999999999999877899999999864432211    125779999999999999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHhC---CeeecccccceEEEcCCCcEEEEecCC
Q 043852          352 RLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGLNYLHEQ---NVVHRDIKCANILVDASGSVKLADFGL  423 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-----~l~~~~i~~i~~QI~~aL~yLH~~---gIiHrDIKP~NILl~~~g~vkL~DFGl  423 (551)
                      ..++||||+.+++|.+++...     .+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            999999999999999998754     288899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh--------HHHHHHhhcC
Q 043852          424 AKATTMND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG--------MQALFRIGKG  492 (551)
Q Consensus       424 a~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~--------~~~~~~i~~~  492 (551)
                      ++......   .....||+.|+|||++.  ...++.++|||||||++|+|++|..||.....        ..........
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHH--HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccCcccccccccccCCcCccCHHHhc--cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            97654322   33445999999999973  45689999999999999999999999952110        0111111010


Q ss_pred             C----------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 043852          493 E----------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  531 (551)
Q Consensus       493 ~----------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpf  531 (551)
                      .          ....+...+..+.+|+.+||+.||.+|||+.+|++|-.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            0          01111223467999999999999999999999998754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.4e-42  Score=348.95  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=201.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc----CCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK----DEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~  351 (551)
                      ++|++++.||+|+||.||++.+ .+|+.||||++...     .......+.+|+.++..++||||+++++++.    ...
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            4799999999999999999987 68999999998642     2345567889999999999999999999886    455


Q ss_pred             eEEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          352 RLFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      ..|+||||+.+++|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            78999999999999998865     4589999999999999999999999999999999999999999999999999865


Q ss_pred             cccCC-----------cccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchh--HHHHHHhhcC
Q 043852          427 TTMND-----------VKSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG--MQALFRIGKG  492 (551)
Q Consensus       427 ~~~~~-----------~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~--~~~~~~i~~~  492 (551)
                      .....           .....||+.|+|||++... ...++.++|||||||++|+|++|+.||.....  ......+...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  263 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ  263 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence            43211           1223479999999987422 12368899999999999999999999953211  1111222333


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       493 ~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            3334456789999999999999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.7e-41  Score=340.23  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=201.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeee-ccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT-DKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~~~~  354 (551)
                      ++|++++.||+|+||.||+|.+ .+|+.||||++......       ..+.+|+.++..+.|++++..+.. +.+....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            4799999999999999999987 68999999998654322       146789999999998876665554 46677889


Q ss_pred             EEEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc---CCCcEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~---~~g~vkL~DFGla~~~~~  429 (551)
                      ++|||+ +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999999 889999987  44689999999999999999999999999999999999994   788999999999976543


Q ss_pred             CC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHhh----cCC
Q 043852          430 ND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIG----KGE  493 (551)
Q Consensus       430 ~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---~~~~~~i~----~~~  493 (551)
                      ..         .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.....   ...+..+.    ...
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccCChhhh--cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            32         2455699999999997  455689999999999999999999999976322   11222211    111


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       494 ~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      .......++..+.+||.+||+.||.+|||+.+|++  .|++.+.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~~~~  280 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFH  280 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH--HHHHHHH
Confidence            11223568999999999999999999999999987  4444443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-41  Score=363.59  Aligned_cols=247  Identities=30%  Similarity=0.438  Sum_probs=192.6

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|...+.||+|+||+||.+...+|..||||++...        ....+.+|+.++.++ +||||+++++++.+...+|+|
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            45667899999999998776678999999998642        123456899999876 899999999999999999999


Q ss_pred             EecccccchHHHHhhhcC--------ChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-------------Cc
Q 043852          357 LELVTKGSLANLYQKYHL--------MDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-------------GS  415 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l--------~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-------------g~  415 (551)
                      ||||. |+|.+++.....        .+..++.++.||+.||.|||++||+||||||+|||++.+             +.
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99996 599999876542        223456799999999999999999999999999999754             48


Q ss_pred             EEEEecCCccccccCC------cccCCCCCcccChhhhhc-----ccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH
Q 043852          416 VKLADFGLAKATTMND------VKSCKGTPFWMAPEVVNL-----KNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGM  483 (551)
Q Consensus       416 vkL~DFGla~~~~~~~------~~~~~GT~~Y~APEvl~~-----~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~  483 (551)
                      +||+|||+++......      .....||+.|+|||++..     ....++.++|||||||++|||++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998654332      234569999999999843     12568999999999999999999 99999765433


Q ss_pred             HHHHHhhcCCC--CCC----CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          484 QALFRIGKGEP--PLV----PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       484 ~~~~~i~~~~~--~~~----~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ..  .+..+..  ...    ...++..+.+||.+||+.||.+|||+.+|++||||...
T Consensus       247 ~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          247 ES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             HH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             HH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            32  1222211  111    12356789999999999999999999999999999753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-41  Score=341.16  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=199.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeee-ccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT-DKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~~~~~~~~  354 (551)
                      ++|++++.||+|+||.||+|.+ .+++.||||++.......       .+.+|+.++..+.|++++..+.. +.+....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-------CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-------HHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            4799999999999999999987 689999999876543322       35689999999998877666554 46677889


Q ss_pred             EEEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE---cCCCcEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl---~~~g~vkL~DFGla~~~~~  429 (551)
                      ++|||+ +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999999 889999987  4568999999999999999999999999999999999999   7889999999999976543


Q ss_pred             CC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH---HHHHHhh----cCC
Q 043852          430 ND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIG----KGE  493 (551)
Q Consensus       430 ~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~---~~~~~i~----~~~  493 (551)
                      ..         .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+....   ..+..+.    ...
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccCccCCCCcccccCCCccccchHHh--cCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            22         2345699999999997  4557899999999999999999999999764321   1111111    111


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       494 ~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                      .......++..+.+||.+||+.||.+|||+.+|++  .|++.+.+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~~~~~  281 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFHR  281 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH--HHHHHHHH
Confidence            11123567999999999999999999999999987  55544433

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-41  Score=340.51  Aligned_cols=251  Identities=31%  Similarity=0.506  Sum_probs=202.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEec--CCc--eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD--DGF--FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~--~g~--~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ++|++++.||+|+||+||+|.+.  ++.  .||||++.....  ........+.+|+.++.+++||||+++++++.+.. 
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            48999999999999999999752  333  689998864322  12345667889999999999999999999988765 


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+++|||+.+++|.+++..  ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            8899999999999998875  35899999999999999999999999999999999999999999999999998765433


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcC-CCCCCCCcCCH
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG-EPPLVPNSLSR  503 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~  503 (551)
                      .     .....+|+.|+|||++.  ...++.++|||||||++|+|++ |..||......+....+... .....+..++.
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             ccchhhhccCCCCceeeCchhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence            2     22345788899999973  4567899999999999999999 99999988777777666543 33445667999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                      .+.++|.+||+.||.+|||+.++++  ++++
T Consensus       253 ~l~~li~~~l~~~p~~Rps~~~l~~--~l~~  281 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRPTFVALRD--FLLE  281 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH--HHHH
Confidence            9999999999999999999999998  4443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-41  Score=347.63  Aligned_cols=243  Identities=28%  Similarity=0.400  Sum_probs=191.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc--CCCCceeeeeeeccCC---
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR--FEHENIVQYFGTDKDE---  350 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~---  350 (551)
                      .++|++++.||+|+||.||+|.+ .|..||||++....        ......|..++..  ++|+||+++++++.+.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE--------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             ccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            35899999999999999999976 48999999985321        1123344444444  5899999999998776   


Q ss_pred             -CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC--------CeeecccccceEEEcCCCcEEEEec
Q 043852          351 -NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ--------NVVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       351 -~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~--------gIiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                       ..+|+|||||.+++|.++++...+++..++.++.||+.||.|||++        ||+||||||+|||++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence             7899999999999999999988999999999999999999999998        9999999999999999999999999


Q ss_pred             CCccccccCCc------ccCCCCCcccChhhhhcccCCCCc------hhhHHHHHHHHHHHHcC----------CCCCCC
Q 043852          422 GLAKATTMNDV------KSCKGTPFWMAPEVVNLKNRGYGL------TADIWSLGCTVLEMLTR----------QPPYSH  479 (551)
Q Consensus       422 Gla~~~~~~~~------~~~~GT~~Y~APEvl~~~~~~~s~------ksDIwSLG~iLyeLltG----------~~Pf~~  479 (551)
                      |+++.......      ....||+.|+|||++.  ...+..      ++|||||||++|||++|          +.||..
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD--ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHT--TCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcc--cccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            99975433221      2457999999999974  222333      49999999999999999          777754


Q ss_pred             ch----hHHHHHHh--hcCCCCCCCC-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          480 LE----GMQALFRI--GKGEPPLVPN-----SLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       480 ~~----~~~~~~~i--~~~~~~~~~~-----~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ..    ........  .....+..+.     .++..+.+||.+||+.||.+|||+.+|++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            31    11222221  1222233332     466789999999999999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=349.17  Aligned_cols=254  Identities=25%  Similarity=0.359  Sum_probs=193.1

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeee-----ccC
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT-----DKD  349 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-----~~~  349 (551)
                      .+++|++++.||+|+||.||+|.. ++..||||++....      ........++..+..++|+||+++++.     +..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            456899999999999999999955 78999999986421      111122344555556899999999973     334


Q ss_pred             CCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhC---------CeeecccccceEEEcCCCcEEEEe
Q 043852          350 ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ---------NVVHRDIKCANILVDASGSVKLAD  420 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~---------gIiHrDIKP~NILl~~~g~vkL~D  420 (551)
                      ...+|+|||||.+|+|.+++.....++..++.++.||+.||.|||++         ||+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             CceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            45789999999999999999988889999999999999999999999         999999999999999999999999


Q ss_pred             cCCccccccC----------CcccCCCCCcccChhhhhcc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---
Q 043852          421 FGLAKATTMN----------DVKSCKGTPFWMAPEVVNLK-----NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---  482 (551)
Q Consensus       421 FGla~~~~~~----------~~~~~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---  482 (551)
                      ||+++.....          ......||+.|+|||++...     ...++.++|||||||++|||++|..||.....   
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            9999754322          12245699999999997421     13456789999999999999999766522111   


Q ss_pred             --------------HHHHH--HhhcCCCCCCCCc------CCHHHHHHHHHhhhcCCCCCCCHHHHHh------CcccCC
Q 043852          483 --------------MQALF--RIGKGEPPLVPNS------LSRDARDFILKCLQVNPNDRPTAAQLME------HPFVKR  534 (551)
Q Consensus       483 --------------~~~~~--~i~~~~~~~~~~~------~s~~l~~LI~~cL~~DP~~RPS~~eILe------hpff~~  534 (551)
                                    .....  .......+.++..      ++..+.+||.+||+.||++|||+.++++      ++|-++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence                          11111  1112222333332      4458999999999999999999999954      466554


Q ss_pred             c
Q 043852          535 P  535 (551)
Q Consensus       535 ~  535 (551)
                      .
T Consensus       324 ~  324 (336)
T 3g2f_A          324 K  324 (336)
T ss_dssp             -
T ss_pred             c
Confidence            4

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=362.77  Aligned_cols=249  Identities=25%  Similarity=0.436  Sum_probs=203.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC--eE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN--RL  353 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~  353 (551)
                      ++|.+.++||+|+||.||+|.+ .+|+.||||++......    .....+.+|+.++.+++||||+++++++.+..  ..
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            3799999999999999999988 57999999998643221    22445678999999999999999999987654  78


Q ss_pred             EEEEecccccchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE----cCCCcEEEEecCCcc
Q 043852          354 FIFLELVTKGSLANLYQKYH----LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV----DASGSVKLADFGLAK  425 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~----l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl----~~~g~vkL~DFGla~  425 (551)
                      |+|||||.+++|.+++....    +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999999987543    8999999999999999999999999999999999999    777889999999997


Q ss_pred             ccccC-CcccCCCCCcccChhhhhcc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCc----hhHHHHHHhhcCCC
Q 043852          426 ATTMN-DVKSCKGTPFWMAPEVVNLK------NRGYGLTADIWSLGCTVLEMLTRQPPYSHL----EGMQALFRIGKGEP  494 (551)
Q Consensus       426 ~~~~~-~~~~~~GT~~Y~APEvl~~~------~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~----~~~~~~~~i~~~~~  494 (551)
                      ..... ......||+.|+|||++...      ...++.++|||||||++|||++|+.||...    ...+.+.++..+.+
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            65433 23456799999999997421      145788999999999999999999999532    23445555555443


Q ss_pred             CCC------------------------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          495 PLV------------------------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       495 ~~~------------------------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...                        ...++..+.+||.+||+.||++|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            211                        12345678899999999999999999998654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5e-42  Score=349.64  Aligned_cols=260  Identities=23%  Similarity=0.482  Sum_probs=209.6

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ...++|++++.||+|+||.||+|.+..  .+|+|++........   ....+.+|+.++.+++|+||+++++++.+...+
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED---QLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC---CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH---HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            345689999999999999999997643  499998865432221   123456899999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--
Q 043852          354 FIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--  429 (551)
                      +++|||+.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....  
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999999999765  488999999999999999999999999999999999997 78999999999865421  


Q ss_pred             -----CCcccCCCCCcccChhhhhcc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC
Q 043852          430 -----NDVKSCKGTPFWMAPEVVNLK-------NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV  497 (551)
Q Consensus       430 -----~~~~~~~GT~~Y~APEvl~~~-------~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~  497 (551)
                           .......||+.|+|||++...       ...++.++|||||||++|+|++|..||...........+..+..+..
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL  263 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence                 122334589999999998431       34579999999999999999999999998877777777766655444


Q ss_pred             C-CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          498 P-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       498 ~-~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                      . ..++..+.+||.+||+.||.+|||+.++++  .+++...+...
T Consensus       264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~~  306 (319)
T 2y4i_B          264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRR  306 (319)
T ss_dssp             CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC------
T ss_pred             CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhcc
Confidence            3 368899999999999999999999999998  66655554433

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=377.63  Aligned_cols=244  Identities=26%  Similarity=0.441  Sum_probs=208.1

Q ss_pred             Ceeeee-EeccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          278 SWQKGE-LLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       278 ~y~~~~-~LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||++....    .......+.+|+.++.+++||||+++++++.+ ..+
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC----SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            455555 8999999999999763   56679999986432    12235578899999999999999999999876 568


Q ss_pred             EEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC
Q 043852          354 FIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND  431 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~  431 (551)
                      |+|||||.+|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999999999999998854  458999999999999999999999999999999999999999999999999998654322


Q ss_pred             -----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHH
Q 043852          432 -----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDA  505 (551)
Q Consensus       432 -----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l  505 (551)
                           .....+|+.|+|||++  ....++.++|||||||+||||++ |+.||.+....+....+..+.....+..++..+
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~--~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  568 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL  568 (613)
T ss_dssp             -----------CCTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ceeeeccCCCCccceeCHhhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence                 1122356889999997  35678999999999999999998 999999988888888888888888888999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHh
Q 043852          506 RDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       506 ~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+||.+||+.||.+|||+.+|++
T Consensus       569 ~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          569 YALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999854

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=345.71  Aligned_cols=244  Identities=26%  Similarity=0.430  Sum_probs=184.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeec--------
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTD--------  347 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~--------  347 (551)
                      +|++.++||+|+||.||+|.+ .+|+.||||++...     .......+.+|+.++.++. ||||+++++++        
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            799999999999999999987 58999999998543     2344556789999999996 99999999987        


Q ss_pred             cCCCeEEEEEecccccchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEcCCCcEEEEec
Q 043852          348 KDENRLFIFLELVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVDASGSVKLADF  421 (551)
Q Consensus       348 ~~~~~~~lV~Ey~~ggsL~~ll~~----~~l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~~~g~vkL~DF  421 (551)
                      .....++++|||+. |+|.+++..    ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            45566899999996 588777653    45899999999999999999999999  999999999999999999999999


Q ss_pred             CCccccccCCc--------------ccCCCCCcccChhhhhc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 043852          422 GLAKATTMNDV--------------KSCKGTPFWMAPEVVNL-KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQAL  486 (551)
Q Consensus       422 Gla~~~~~~~~--------------~~~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~  486 (551)
                      |+++.......              ....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.........
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  262 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV  262 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence            99976543221              13458999999999732 3456799999999999999999999999765544333


Q ss_pred             HHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 043852          487 FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  530 (551)
Q Consensus       487 ~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehp  530 (551)
                      ..   ......+..++..+.+||.+||+.||.+|||+.++++|-
T Consensus       263 ~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          263 NG---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cC---cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            22   222333456778899999999999999999999999874

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.3e-41  Score=341.45  Aligned_cols=237  Identities=26%  Similarity=0.420  Sum_probs=191.5

Q ss_pred             hcccCeeee-eEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHH-hcCCCCceeeeeeeccC-
Q 043852          274 RRIMSWQKG-ELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL-SRFEHENIVQYFGTDKD-  349 (551)
Q Consensus       274 ~~~~~y~~~-~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~-  349 (551)
                      ..+++|.+. ++||+|+||.||+|.+ .+++.||||++...          ..+.+|+.++ +.++||||+++++++.+ 
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            345688887 7899999999999987 68999999998531          1345777776 66789999999998876 


Q ss_pred             ---CCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CCcEEEEe
Q 043852          350 ---ENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SGSVKLAD  420 (551)
Q Consensus       350 ---~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g~vkL~D  420 (551)
                         ...+|+||||+.+++|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               77899999999999999998764   4899999999999999999999999999999999999998   78999999


Q ss_pred             cCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC---CCCCC
Q 043852          421 FGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG---EPPLV  497 (551)
Q Consensus       421 FGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~---~~~~~  497 (551)
                      ||++....                      ...++.++|||||||++|+|++|..||...........+...   .....
T Consensus       164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  221 (299)
T 3m2w_A          164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  221 (299)
T ss_dssp             CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred             cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence            99875432                      234678999999999999999999999775544332211111   11111


Q ss_pred             C----CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCCC
Q 043852          498 P----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP  542 (551)
Q Consensus       498 ~----~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~~  542 (551)
                      +    ..++..+.+||.+||+.||.+|||+.++++||||++.......+
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~  270 (299)
T 3m2w_A          222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  270 (299)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred             CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence            2    46899999999999999999999999999999999876554443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.7e-41  Score=344.19  Aligned_cols=246  Identities=29%  Similarity=0.435  Sum_probs=199.9

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      |..++.||+|+||.||+|.. ++..||||++..... .........+.+|+.++.+++||||+++++++.+....|++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTT-SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE-CCceEEEEEEecccC-cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44568999999999999975 688999999864322 1223445678899999999999999999999999999999999


Q ss_pred             cccccchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          359 LVTKGSLANLYQK----YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       359 y~~ggsL~~ll~~----~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      |+.+++|.+++..    ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++......   
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999998863    248899999999999999999999999999999999999999999999999987554322   


Q ss_pred             -cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH----HHHHhhc----------CCCCC
Q 043852          432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQ----ALFRIGK----------GEPPL  496 (551)
Q Consensus       432 -~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~----~~~~i~~----------~~~~~  496 (551)
                       .....||+.|+|||++.   ..++.++|||||||++|+|++|..||.......    ....+..          .....
T Consensus       191 ~~~~~~g~~~y~aPE~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHT---TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             cccccCCCcCcCChHHhc---CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence             23356899999999874   247899999999999999999999997643321    1111111          11122


Q ss_pred             CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          497 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       497 ~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+..++..+.+|+.+||+.||.+|||+.+|+++
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            233456789999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=344.51  Aligned_cols=245  Identities=27%  Similarity=0.453  Sum_probs=204.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|++++.||+|+||.||+|..     .+|..||||++...     .......+.+|+.++.+++|+||+++++++....
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            4799999999999999999972     47899999998642     2344567889999999999999999999876644


Q ss_pred             --eEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccc
Q 043852          352 --RLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       352 --~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~  427 (551)
                        .+++||||+.+++|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence              789999999999999998764  4889999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH----------------HHH
Q 043852          428 TMND-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM----------------QAL  486 (551)
Q Consensus       428 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~----------------~~~  486 (551)
                      ....     .....+|..|+|||++.  ...++.++|||||||++|+|++|..||......                ...
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhc--CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            4332     22345778899999974  456789999999999999999999998643211                112


Q ss_pred             HHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          487 FRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       487 ~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ..+..+.....+..++..+.+||.+||+.||.+|||+.+|++
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            233444445567789999999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=363.73  Aligned_cols=249  Identities=29%  Similarity=0.425  Sum_probs=196.2

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|.+.++||+|+||+||.....+|+.||||++......        .+.+|+.++.++ +||||+++++++.+...+|+|
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~--------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS--------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE--------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH--------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            69999999999999976655678999999998543211        234799999998 799999999999999999999


Q ss_pred             EecccccchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-----CcEEEEecCCcccccc
Q 043852          357 LELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-----GSVKLADFGLAKATTM  429 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~--l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-----g~vkL~DFGla~~~~~  429 (551)
                      ||||.+ +|.+++....  +.+..++.++.||+.||.|||++||+||||||+|||++.+     ..+||+|||+++....
T Consensus        97 ~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            999975 9998887643  5556778999999999999999999999999999999532     3588999999976543


Q ss_pred             C-----CcccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCC--CCCc
Q 043852          430 N-----DVKSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPL--VPNS  500 (551)
Q Consensus       430 ~-----~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~  500 (551)
                      .     ......||+.|+|||++... ...++.++|||||||++|||++ |..||...........+.......  ....
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH  255 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence            2     23446699999999997422 3567889999999999999999 999996654444333333222221  1233


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      .+..+.+||.+||+.||.+|||+.+|++||||...
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            45678999999999999999999999999999753

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=350.28  Aligned_cols=245  Identities=20%  Similarity=0.277  Sum_probs=197.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEec---------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceee-----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD---------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQ-----  342 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~---------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-----  342 (551)
                      ++|++++.||+|+||.||+|.+.         +++.||||++...          ..+.+|+.++.+++||||++     
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhhh
Confidence            58999999999999999999874         3889999998643          24668999999999999988     


Q ss_pred             ----------eeeeccC-CCeEEEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceE
Q 043852          343 ----------YFGTDKD-ENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANI  408 (551)
Q Consensus       343 ----------l~~~~~~-~~~~~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NI  408 (551)
                                +++++.. ...+|+||||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      4445443 67889999999 9999999976   4699999999999999999999999999999999999


Q ss_pred             EEcCCC--cEEEEecCCccccccCC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 043852          409 LVDASG--SVKLADFGLAKATTMND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY  477 (551)
Q Consensus       409 Ll~~~g--~vkL~DFGla~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf  477 (551)
                      |++.++  .+||+|||+++......         .....||+.|+|||++  .+..++.++|||||||++|+|++|+.||
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH--KGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999998  89999999997543221         1334699999999997  4557899999999999999999999999


Q ss_pred             CCch-hHHHHHHhh---cCCCCCCC------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          478 SHLE-GMQALFRIG---KGEPPLVP------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       478 ~~~~-~~~~~~~i~---~~~~~~~~------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .... ....+....   ........      ..++..+.+||.+||+.||.+|||+.+|++  .+++.+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~  335 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN--NLEALL  335 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHHHH
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH--HHHHHH
Confidence            7653 222222111   11112111      246899999999999999999999999987  444443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.4e-41  Score=375.55  Aligned_cols=241  Identities=28%  Similarity=0.455  Sum_probs=207.4

Q ss_pred             eeEeccCCceEEEEEEe---cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEe
Q 043852          282 GELLGSGSFGTVYEGYT---DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E  358 (551)
                      .+.||+|+||.||+|.+   .++..||||++....   ........+.+|+.++.+++|||||++++++.+ ..+++|||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG---GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence            35899999999999965   357889999886432   223345678899999999999999999999865 45889999


Q ss_pred             cccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-----c
Q 043852          359 LVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----V  432 (551)
Q Consensus       359 y~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-----~  432 (551)
                      ||.+|+|.++++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......     .
T Consensus       450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999999998754 58899999999999999999999999999999999999999999999999997654322     2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      ....+|+.|+|||++  ....++.++|||||||++|||++ |+.||.+....+....+..+.....+..++..+.+||.+
T Consensus       530 ~~~~~t~~y~APE~~--~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  607 (635)
T 4fl3_A          530 THGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL  607 (635)
T ss_dssp             -----CGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cCCCCceeeeChhhh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            233467889999997  45678999999999999999998 999999988888888888888888888999999999999


Q ss_pred             hhhcCCCCCCCHHHHHh
Q 043852          512 CLQVNPNDRPTAAQLME  528 (551)
Q Consensus       512 cL~~DP~~RPS~~eILe  528 (551)
                      ||+.||++|||+++|++
T Consensus       608 cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          608 CWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HTCSSTTTSCCHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHH
Confidence            99999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-40  Score=341.49  Aligned_cols=244  Identities=28%  Similarity=0.399  Sum_probs=198.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc--CCCCceeeeeeeccCCC---
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR--FEHENIVQYFGTDKDEN---  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~---  351 (551)
                      ++|++.+.||+|+||.||+|.+ +|+.||||++...        ....+.+|+.++..  ++||||+++++++....   
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            5899999999999999999976 6899999998532        12345677777776  78999999999988765   


Q ss_pred             -eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHH--------hCCeeecccccceEEEcCCCcEEEEecC
Q 043852          352 -RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH--------EQNVVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       352 -~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH--------~~gIiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                       .+|+||||+.+++|.+++.+..+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+|||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence             7999999999999999999889999999999999999999999        8999999999999999999999999999


Q ss_pred             CccccccCC------cccCCCCCcccChhhhhcccC----CCCchhhHHHHHHHHHHHHcC----------CCCCCCch-
Q 043852          423 LAKATTMND------VKSCKGTPFWMAPEVVNLKNR----GYGLTADIWSLGCTVLEMLTR----------QPPYSHLE-  481 (551)
Q Consensus       423 la~~~~~~~------~~~~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLG~iLyeLltG----------~~Pf~~~~-  481 (551)
                      ++.......      .....||+.|+|||++.....    .++.++|||||||++|+|++|          ..||.... 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            997654332      234569999999999742211    223789999999999999999          78886542 


Q ss_pred             ---hHHHHH-Hhh-cCCCCCCCC-----cCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          482 ---GMQALF-RIG-KGEPPLVPN-----SLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       482 ---~~~~~~-~i~-~~~~~~~~~-----~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                         ....+. .+. ....+.++.     .++..+.+||.+||+.||.+|||+.+|++|
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence               122222 222 222233332     344679999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=349.10  Aligned_cols=240  Identities=19%  Similarity=0.213  Sum_probs=192.3

Q ss_pred             hcccCeeeeeEeccCCceEEEEEE------ecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC---CCceeeee
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE---HENIVQYF  344 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~------~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~  344 (551)
                      ..-.+|.+.++||+|+||.||+|.      ..+++.||||++....        ...+..|+.++..++   |+||+.++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            334589999999999999999994      3579999999985321        224556777777776   99999999


Q ss_pred             eeccCCCeEEEEEecccccchHHHHhh------hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC------
Q 043852          345 GTDKDENRLFIFLELVTKGSLANLYQK------YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA------  412 (551)
Q Consensus       345 ~~~~~~~~~~lV~Ey~~ggsL~~ll~~------~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~------  412 (551)
                      +++......|+|||||.+|+|.+++..      ..+++..++.++.||+.||.|||++||+||||||+||||+.      
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999999863      45899999999999999999999999999999999999988      


Q ss_pred             -----CCcEEEEecCCccccc----cCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH
Q 043852          413 -----SGSVKLADFGLAKATT----MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM  483 (551)
Q Consensus       413 -----~g~vkL~DFGla~~~~----~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~  483 (551)
                           ++.+||+|||+++...    .......+||+.|+|||++  .+..|+.++|||||||++|||+||+.||......
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML--SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH--TTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh--cCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                 8999999999996543    1223456799999999997  3456899999999999999999999999543321


Q ss_pred             HHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          484 QALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       484 ~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .     ............++.+.+++..||+.+|.+|++..+.+.
T Consensus       292 ~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          292 E-----CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             E-----EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             c-----eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            0     000011111134678899999999999999965444433

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.5e-40  Score=370.95  Aligned_cols=251  Identities=28%  Similarity=0.471  Sum_probs=213.8

Q ss_pred             hhhhcccCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeee
Q 043852          271 KFRRRIMSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGT  346 (551)
Q Consensus       271 ~~~~~~~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  346 (551)
                      .+.....+|++++.||+|+||.||+|.+.    .+..||||++...    ........+.+|+.++.+++||||++++++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            33444568999999999999999999863    3567899976532    223445678899999999999999999999


Q ss_pred             ccCCCeEEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          347 DKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       347 ~~~~~~~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      +.+ +.+|+|||||.+|+|.++++..  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       460 ~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          460 ITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             ECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             Eec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence            854 5689999999999999998754  5888999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCc
Q 043852          425 KATTMND---VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNS  500 (551)
Q Consensus       425 ~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  500 (551)
                      +......   .....+|+.|+|||++.  ...++.++|||||||++|||++ |..||.+....+....+..+.....+..
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  616 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN  616 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhc--CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            7654332   22344778999999973  4578999999999999999997 9999999888888888888887778889


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          501 LSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ++..+.+||.+||+.||.+|||+.+|++
T Consensus       617 ~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          617 CPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.7e-40  Score=359.06  Aligned_cols=242  Identities=22%  Similarity=0.316  Sum_probs=199.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC-CceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH-ENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~  354 (551)
                      ++|+++++||+|+||.||+|.+ .+++.||||++.......       ++.+|+.++..+.| ++|..+..++.+....|
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-------CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-------HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            5899999999999999999987 689999999886543322       35689999999987 55666666777788899


Q ss_pred             EEEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEE---cCCCcEEEEecCCcccccc
Q 043852          355 IFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILV---DASGSVKLADFGLAKATTM  429 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl---~~~g~vkL~DFGla~~~~~  429 (551)
                      |||||+ +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++....
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999999 889999987  4569999999999999999999999999999999999999   5889999999999976543


Q ss_pred             CC---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHhhc----CC
Q 043852          430 ND---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGK----GE  493 (551)
Q Consensus       430 ~~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---~~~~~~i~~----~~  493 (551)
                      ..         .....||+.|+|||++  .+..++.++|||||||+||||++|+.||.+...   .+.+.++..    ..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTH--LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CccccccccccccccCCCccccCHHHh--cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            32         2256799999999997  456789999999999999999999999976432   222222211    11


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       494 ~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .......++.++.+||.+||+.||++||++.+|++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            11223568999999999999999999999998876

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.2e-42  Score=353.33  Aligned_cols=246  Identities=18%  Similarity=0.264  Sum_probs=190.8

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCc---cchHHHHHHHHHHHHHhcCC---------CCce---
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT---QGKQSILQLEQEILLLSRFE---------HENI---  340 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~---------HpnI---  340 (551)
                      .++|++++.||+|+||+||+|++ +|+.||||++.......   ........+.+|+.+++.++         |+||   
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35799999999999999999977 78999999998654321   12223456778888888876         5555   


Q ss_pred             --------------eeeeeeccC-------------CCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHH
Q 043852          341 --------------VQYFGTDKD-------------ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL  393 (551)
Q Consensus       341 --------------v~l~~~~~~-------------~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yL  393 (551)
                                    +++++++.+             ...+|+|||||.+|++.+.+.+..+++..++.++.||+.||.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence                          444554443             77899999999999777666667789999999999999999999


Q ss_pred             H-hCCeeecccccceEEEcCCC--------------------cEEEEecCCccccccCCcccCCCCCcccChhhhhcccC
Q 043852          394 H-EQNVVHRDIKCANILVDASG--------------------SVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNR  452 (551)
Q Consensus       394 H-~~gIiHrDIKP~NILl~~~g--------------------~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~  452 (551)
                      | ++||+||||||+|||++.++                    .+||+|||+++.....   ..+||+.|+|||++.  +.
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~--g~  252 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFT--GD  252 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGC--CC
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhc--CC
Confidence            9 99999999999999999887                    8999999999865432   347999999999984  22


Q ss_pred             CCCchhhHHHHHHH-HHHHHcCCCCCCCchhHH-HHHHhh---cCCCCC---CCCcCCHHHHHHHHHhhhcCCCCCCCHH
Q 043852          453 GYGLTADIWSLGCT-VLEMLTRQPPYSHLEGMQ-ALFRIG---KGEPPL---VPNSLSRDARDFILKCLQVNPNDRPTAA  524 (551)
Q Consensus       453 ~~s~ksDIwSLG~i-LyeLltG~~Pf~~~~~~~-~~~~i~---~~~~~~---~~~~~s~~l~~LI~~cL~~DP~~RPS~~  524 (551)
                      . +.++|||||+++ .+++++|..||....... ....+.   ......   .+..++.++.+||.+||+.|     |++
T Consensus       253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            3 889999998877 777888999986532211 111222   111111   12347889999999999976     999


Q ss_pred             HHH-hCcccC
Q 043852          525 QLM-EHPFVK  533 (551)
Q Consensus       525 eIL-ehpff~  533 (551)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999996

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-40  Score=354.04  Aligned_cols=249  Identities=20%  Similarity=0.228  Sum_probs=192.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC-Cceee------------
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH-ENIVQ------------  342 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~------------  342 (551)
                      ..|..+++||+|+||.||+|.+ .+|+.||||++......  .......+.+|+.++..+.| .|+..            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc--cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            4688999999999999999997 68999999988633222  22335568899999999987 22111            


Q ss_pred             ---e------eeeccC-----CCeEEEEEecccccchHHHHh--------hhcCChHHHHHHHHHHHHHHHHHHhCCeee
Q 043852          343 ---Y------FGTDKD-----ENRLFIFLELVTKGSLANLYQ--------KYHLMDSQVSAYTRQILNGLNYLHEQNVVH  400 (551)
Q Consensus       343 ---l------~~~~~~-----~~~~~lV~Ey~~ggsL~~ll~--------~~~l~~~~i~~i~~QI~~aL~yLH~~gIiH  400 (551)
                         +      ...+..     ...++++|+++ +++|.++++        ...+++..+..++.||+.||.|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence               1      111111     22457777776 568988875        334777888899999999999999999999


Q ss_pred             cccccceEEEcCCCcEEEEecCCccccccCCcccCCCCCcccChhhhhc--------ccCCCCchhhHHHHHHHHHHHHc
Q 043852          401 RDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNL--------KNRGYGLTADIWSLGCTVLEMLT  472 (551)
Q Consensus       401 rDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~--------~~~~~s~ksDIwSLG~iLyeLlt  472 (551)
                      |||||+||||+.++.+||+|||+++..... ....+| +.|+|||++..        ....++.++|||||||++|||++
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999999999999999998765443 444567 99999999732        23357889999999999999999


Q ss_pred             CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          473 RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       473 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      |+.||...........+...     ...++..+.+||.+||+.||.+|||+.++++||||++.
T Consensus       313 g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             SSCCCCTTGGGSCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCCCcchhhhHHHHHhh-----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            99999876654433333222     23578999999999999999999999999999999764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.1e-40  Score=370.52  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=203.3

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC----
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD----  349 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----  349 (551)
                      .+++|++.+.||+|+||.||+|.+ .+|..||||++...    ........+.+|+.++.+++||||+++++++..    
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            356899999999999999999987 57999999987532    234456678899999999999999999998765    


Q ss_pred             --CCeEEEEEecccccchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCc---EEEEe
Q 043852          350 --ENRLFIFLELVTKGSLANLYQKY----HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGS---VKLAD  420 (551)
Q Consensus       350 --~~~~~lV~Ey~~ggsL~~ll~~~----~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~---vkL~D  420 (551)
                        ....|+|||||.+++|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              67789999999999999998763    4889999999999999999999999999999999999997765   99999


Q ss_pred             cCCccccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH---------h-
Q 043852          421 FGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR---------I-  489 (551)
Q Consensus       421 FGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~---------i-  489 (551)
                      ||++....... .....||+.|+|||++  .+..++.++|||||||++|+|++|..||........+..         + 
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELL--EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSS--CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccccccccCCcccCChHHh--ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            99998664433 3456799999999997  456789999999999999999999999976433222110         0 


Q ss_pred             ----hcCC---------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          490 ----GKGE---------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       490 ----~~~~---------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                          ..+.         +......++..+.+||.+||.+||.+|||+.++++||||+.
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence                0000         01122346788999999999999999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-38  Score=322.57  Aligned_cols=222  Identities=15%  Similarity=0.113  Sum_probs=185.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++.+.||+|+||.||+|.+ .+|+.||||++.....  ........+.+|+.++.+++|+||+++++++.+.+..|+
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV--LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC--SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc--cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            4799999999999999999988 4699999998864432  224456678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccC
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC  435 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  435 (551)
                      |||||.|++|.++++.. .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|             
T Consensus       109 v~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred             EEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence            99999999999999764 4566788999999999999999999999999999999999999998544             


Q ss_pred             CCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH---HhhcCCCC---CCCCcCCHHHHHHH
Q 043852          436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF---RIGKGEPP---LVPNSLSRDARDFI  509 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~---~i~~~~~~---~~~~~~s~~l~~LI  509 (551)
                           |++         .++.++|||||||++|+|+||+.||.+.+....+.   +...+...   .....++..+.+||
T Consensus       175 -----~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  240 (286)
T 3uqc_A          175 -----TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA  240 (286)
T ss_dssp             -----CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred             -----ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHH
Confidence                 333         35889999999999999999999998765432211   11112111   12356899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhC
Q 043852          510 LKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+||++||.+| |+.++++.
T Consensus       241 ~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          241 ARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHcccCCccC-CHHHHHHH
Confidence            99999999999 99999883

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.1e-39  Score=362.31  Aligned_cols=238  Identities=24%  Similarity=0.305  Sum_probs=196.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEec--CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe--
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD--DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR--  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~--~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--  352 (551)
                      ++|++++.||+|+||.||+|.+.  +|..||||++...    ........+.+|+.++.+++||||+++++++.+...  
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            58999999999999999999874  6899999987532    223445577899999999999999999999876655  


Q ss_pred             ---EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          353 ---LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       353 ---~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                         .||||||+.|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             CceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence               7999999999999988766 79999999999999999999999999999999999999874 999999999976543


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC-CCCcCCHHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPNSLSRDARDF  508 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~L  508 (551)
                      .  ....||+.|+|||++..   .++.++|||||||++|+|++|.+||.+...        ...+.. ....++..+.+|
T Consensus       234 ~--~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~l~~l  300 (681)
T 2pzi_A          234 F--GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYV--------DGLPEDDPVLKTYDSYGRL  300 (681)
T ss_dssp             C--SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEEC--------SSCCTTCHHHHHCHHHHHH
T ss_pred             C--CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccc--------ccccccccccccCHHHHHH
Confidence            3  45679999999999742   348999999999999999999999865321        011110 011246789999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      |.+||++||.+||+..+.+.|+|+.
T Consensus       301 i~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          301 LRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HhhhccCChhhCCCHHHHHHHHHHH
Confidence            9999999999999999999998864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.2e-31  Score=294.08  Aligned_cols=185  Identities=15%  Similarity=0.103  Sum_probs=132.3

Q ss_pred             EeccCCceEEEEEEe-cCCceEEEEEEecCccC-----ccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCCeEEEE
Q 043852          284 LLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQG-----TQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       284 ~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~-----~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .++.|++|.+..+.. -.|+.||+|++......     ........++.+|+.+|+++ .|+||++++++++++..+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            567788887776654 57999999999765321     22344567799999999999 699999999999999999999


Q ss_pred             EecccccchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Ccc
Q 043852          357 LELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVK  433 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~-l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~  433 (551)
                      ||||+|++|.+++++.+ ++.   ..++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....  ...
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             EecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            99999999999998754 443   358999999999999999999999999999999999999999999865433  244


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCC
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ  474 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~  474 (551)
                      +.+||+.|||||++.   ..+..++|+||+|+++++|.++.
T Consensus       398 t~vGTp~YmAPE~l~---g~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          398 NLVQSFFVFVNELFA---ENKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHHC--------------------CCCCTTH
T ss_pred             CceechhhccHHHhC---CCCCCcccccccccchhhhcccc
Confidence            567999999999974   24577899999999988776543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=8e-28  Score=265.27  Aligned_cols=188  Identities=18%  Similarity=0.237  Sum_probs=146.3

Q ss_pred             eeeeEeccCCceEEEEEEecCCceEEEEEEecCccCcc---chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQ---GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      ...++||+|+||.||+| ...+..+++|+...+.....   ......++.+|+.++.+++||||+++..++......|||
T Consensus       339 ~~~~~LG~G~fg~Vy~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD-SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEE-ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEE-EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            34578999999999999 55678899998765332221   122345688999999999999999555544456667999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-----
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-----  431 (551)
                      ||||++++|.+++..       +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++......     
T Consensus       418 mE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          418 MSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             EECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             EECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            999999999999876       5689999999999999999999999999999988  99999999998765432     


Q ss_pred             ----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 043852          432 ----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY  477 (551)
Q Consensus       432 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf  477 (551)
                          .....||+.|||||+++.....|+..+|+|+..+-..+.+.++.+|
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                1345699999999998654567888899999999888888776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=4.5e-24  Score=216.32  Aligned_cols=148  Identities=17%  Similarity=0.155  Sum_probs=117.8

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCcc-----c--------hHHHHHHHHHHHHHhcCCCCceeeee
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQ-----G--------KQSILQLEQEILLLSRFEHENIVQYF  344 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~-----~--------~~~~~~~~~Ei~il~~l~HpnIv~l~  344 (551)
                      -|.+++.||+|+||.||+|.+.+|..||||++........     .        ......+.+|+.++.+++  | ++++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            4667799999999999999887799999999864321111     0        024557889999999998  4 5555


Q ss_pred             eeccCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          345 GTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       345 ~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      +++. .+..|+|||||+|++|.+ +.     ......++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus       168 ~~~~-~~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          168 KVYA-WEGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             CEEE-EETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             eEEe-ccceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            5443 355699999999999988 32     234568999999999999999999999999999999 999999999998


Q ss_pred             cccccCCcccCCCCCcccChhhh
Q 043852          425 KATTMNDVKSCKGTPFWMAPEVV  447 (551)
Q Consensus       425 ~~~~~~~~~~~~GT~~Y~APEvl  447 (551)
                      +           .+..++|||++
T Consensus       240 ~-----------~~~~~~a~e~l  251 (282)
T 1zar_A          240 V-----------EVGEEGWREIL  251 (282)
T ss_dssp             E-----------ETTSTTHHHHH
T ss_pred             e-----------ECCCCCHHHHH
Confidence            5           34467899986

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=2.5e-20  Score=185.95  Aligned_cols=142  Identities=20%  Similarity=0.263  Sum_probs=108.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCce--EEEEEEecCccCcc-------------------chHHHHHHHHHHHHHhcC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFF--FAVKEVSLQDQGTQ-------------------GKQSILQLEQEILLLSRF  335 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~--vAVK~i~~~~~~~~-------------------~~~~~~~~~~Ei~il~~l  335 (551)
                      -|.+.+.||+|+||.||+|.+ .+|..  ||||++........                   .......+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            377889999999999999988 68989  99998754321100                   112234678899999999


Q ss_pred             CCCce--eeeeeeccCCCeEEEEEecccc-c----chHHHHhhhcCChHHHHHHHHHHHHHHHHHH-hCCeeecccccce
Q 043852          336 EHENI--VQYFGTDKDENRLFIFLELVTK-G----SLANLYQKYHLMDSQVSAYTRQILNGLNYLH-EQNVVHRDIKCAN  407 (551)
Q Consensus       336 ~HpnI--v~l~~~~~~~~~~~lV~Ey~~g-g----sL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH-~~gIiHrDIKP~N  407 (551)
                      .|++|  +.++..    ...+|||||+.+ |    +|.++...  .++..+..++.||+.+|.||| ++||+||||||+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            88754  344432    346899999943 3    66665432  335678899999999999999 9999999999999


Q ss_pred             EEEcCCCcEEEEecCCcccc
Q 043852          408 ILVDASGSVKLADFGLAKAT  427 (551)
Q Consensus       408 ILl~~~g~vkL~DFGla~~~  427 (551)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99987  9999999998643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.7e-18  Score=182.72  Aligned_cols=139  Identities=15%  Similarity=0.171  Sum_probs=99.0

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCc------------cchHH-----HHHHHHHHHHHhcCCCCcee
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGT------------QGKQS-----ILQLEQEILLLSRFEHENIV  341 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~------------~~~~~-----~~~~~~Ei~il~~l~HpnIv  341 (551)
                      |.+++.||+|+||.||+|.+.+|+.||||+++......            .....     .....+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            89999999999999999998899999999875432110            00000     11123455555555433321


Q ss_pred             --eeeeeccCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-----
Q 043852          342 --QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-----  414 (551)
Q Consensus       342 --~l~~~~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-----  414 (551)
                        ..++.    ...+|||||+.|++|..+..     ......++.||+.+|.|||++|||||||||.|||++.+|     
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence              12221    12379999999998865432     234567889999999999999999999999999998776     


Q ss_pred             -----cEEEEecCCccc
Q 043852          415 -----SVKLADFGLAKA  426 (551)
Q Consensus       415 -----~vkL~DFGla~~  426 (551)
                           .+.|+||+-+..
T Consensus       248 ~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECCCTTCEE
T ss_pred             cccccceEEEEeCCccc
Confidence                 389999997643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=4e-12  Score=125.55  Aligned_cols=142  Identities=13%  Similarity=0.135  Sum_probs=111.4

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDEN  351 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  351 (551)
                      +..+..|.+...+|.|+++.||++.. .+..+++|+........     ...+.+|+.+++.+. +..+.++++++.+.+
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            45667899999999999999999964 46789999876421111     114668888888774 667888998888888


Q ss_pred             eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHh------------------------------------
Q 043852          352 RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE------------------------------------  395 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~------------------------------------  395 (551)
                      ..|+||||++|.+|.....    +......++.+++.+|..||+                                    
T Consensus        84 ~~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             ceEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            8999999999999876531    223345788999999999998                                    


Q ss_pred             -----------------------CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 -----------------------QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 -----------------------~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                                             ..++|+|++|.|||++.++.+.|+||+.+
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                   45899999999999976555679999965

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=9.4e-12  Score=121.60  Aligned_cols=137  Identities=17%  Similarity=0.153  Sum_probs=99.9

Q ss_pred             hhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc--eeeeeeeccCC
Q 043852          273 RRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN--IVQYFGTDKDE  350 (551)
Q Consensus       273 ~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~  350 (551)
                      ...+..|.+..+.+.|..+.||++...+|..+++|..... .       ...+.+|+.+++.+.+.+  +.++++++.+.
T Consensus        16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-A-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-T-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-c-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            3445566665555577779999997667888999986532 1       123557888787775444  56688888777


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQN---------------------------------  397 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~g---------------------------------  397 (551)
                      +..++||||++|.+|.  ...     .....++.+++..|..||+..                                 
T Consensus        88 ~~~~~v~e~i~G~~l~--~~~-----~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--SSH-----LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             SCEEEEEECCSSEETT--TSC-----CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             CCCEEEEEecCCcccC--cCc-----CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            8899999999998884  211     122356777778888888643                                 


Q ss_pred             -------------------------eeecccccceEEEcCCCcEEEEecCCc
Q 043852          398 -------------------------VVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       398 -------------------------IiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                                               ++|+|++|.|||++.++.+.|+||+.+
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence                                     999999999999987666779999976

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=5.6e-10  Score=115.58  Aligned_cols=140  Identities=15%  Similarity=0.236  Sum_probs=102.0

Q ss_pred             eeeEeccCCceEEEEEEecCCceEEEEEEe--cCccCccchHHHHHHHHHHHHHhcCC--CCceeeeeeeccCC---CeE
Q 043852          281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVS--LQDQGTQGKQSILQLEQEILLLSRFE--HENIVQYFGTDKDE---NRL  353 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~--~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~  353 (551)
                      .++.|+.|.++.||++...+ ..+++|+..  ....    ......+.+|+.+++.+.  +..+++++.++.+.   +..
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL----LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            46789999999999986644 577888654  2111    111235668888888886  34578888887766   457


Q ss_pred             EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 043852          354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE--------------------------------------  395 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~--------------------------------------  395 (551)
                      |+||||++|..+.+.. ...++......++.+++..|..||+                                      
T Consensus       117 ~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999999998774311 1236677788899999999999997                                      


Q ss_pred             --------------------CCeeecccccceEEEcCCCc--EEEEecCCccc
Q 043852          396 --------------------QNVVHRDIKCANILVDASGS--VKLADFGLAKA  426 (551)
Q Consensus       396 --------------------~gIiHrDIKP~NILl~~~g~--vkL~DFGla~~  426 (551)
                                          ..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                36999999999999987753  68999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.03  E-value=4.8e-10  Score=113.48  Aligned_cols=184  Identities=19%  Similarity=0.173  Sum_probs=119.0

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCc--eeeeeeeccCCC---eEEE
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HEN--IVQYFGTDKDEN---RLFI  355 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~l  355 (551)
                      ++.++.|....||++    +..+++|....       ......+.+|+.++..+. +..  +.+.+.......   ..|+
T Consensus        25 i~~~~~G~~n~v~~v----~~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEI----NRDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEES----TTSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             eEecCCCCcceEEEE----CCEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            356999999999997    25688887531       133456778998887763 322  445555544333   3488


Q ss_pred             EEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 043852          356 FLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE----------------------------------------  395 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~----------------------------------------  395 (551)
                      ||++++|.+|..... ..++..+...++.|++..|..||+                                        
T Consensus        94 vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999999988865322 346677777888888888888885                                        


Q ss_pred             ------------------CCeeecccccceEEEcC--CCcEEEEecCCccccccCC-cccCCCCCcccChhhhhc---cc
Q 043852          396 ------------------QNVVHRDIKCANILVDA--SGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNL---KN  451 (551)
Q Consensus       396 ------------------~gIiHrDIKP~NILl~~--~g~vkL~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~---~~  451 (551)
                                        ..++|+|++|.||+++.  .+.+.|+||+.+....... .........-..|+....   ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                              13799999999999987  4568899999875432110 000000000022332110   00


Q ss_pred             C---------CCCchhhHHHHHHHHHHHHcCCCCC
Q 043852          452 R---------GYGLTADIWSLGCTVLEMLTRQPPY  477 (551)
Q Consensus       452 ~---------~~s~ksDIwSLG~iLyeLltG~~Pf  477 (551)
                      .         ......+.|+++.++|.+.+|..+|
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0         0122368999999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.44  E-value=2.8e-06  Score=86.17  Aligned_cols=133  Identities=23%  Similarity=0.175  Sum_probs=88.6

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC---ceeeeeeecc-CCCeEEEEE
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE---NIVQYFGTDK-DENRLFIFL  357 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~  357 (551)
                      ++.++.|....||+.    |..+++|+..       .......+.+|..+|..+.+.   .+.+.+.++. ..+..|++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~-------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK-------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES-------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC-------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence            456899999999998    5678888642       122345678999999988652   3455555552 455678999


Q ss_pred             ecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 043852          358 ELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE------------------------------------------  395 (551)
Q Consensus       358 Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~------------------------------------------  395 (551)
                      |+++|..|....- ..++......++.|+...|..||+                                          
T Consensus        93 e~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           93 RKVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             ECCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9999988865211 122333334444444444444442                                          


Q ss_pred             ------------------CCeeecccccceEEEcC---CCc-EEEEecCCccc
Q 043852          396 ------------------QNVVHRDIKCANILVDA---SGS-VKLADFGLAKA  426 (551)
Q Consensus       396 ------------------~gIiHrDIKP~NILl~~---~g~-vkL~DFGla~~  426 (551)
                                        ..++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                              24699999999999987   455 48999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=3.9e-06  Score=82.53  Aligned_cols=129  Identities=14%  Similarity=0.148  Sum_probs=89.2

Q ss_pred             eccCCc-eEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccCCCeEEEEEeccc
Q 043852          285 LGSGSF-GTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKDENRLFIFLELVT  361 (551)
Q Consensus       285 LG~G~f-G~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~  361 (551)
                      +..|.- +.||+... .++..+++|+-...        ....+.+|...|+.+. +--+.+++.++.+.+..|+|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            434444 46898766 45678889976421        2335667888877664 2336678888888888999999999


Q ss_pred             ccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 043852          362 KGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE----------------------------------------------  395 (551)
Q Consensus       362 ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~----------------------------------------------  395 (551)
                      |.++.+.....   ......+..++...|..||.                                              
T Consensus       104 G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          104 GKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             SEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             CccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            98887654321   12233455555555555553                                              


Q ss_pred             -----C-------CeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 -----Q-------NVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 -----~-------gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                           .       .++|+|+++.|||++.++.+-|+||+.+
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a  221 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV  221 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence                 0       2799999999999987777789999976

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.21  E-value=2e-06  Score=88.47  Aligned_cols=83  Identities=5%  Similarity=-0.026  Sum_probs=50.9

Q ss_pred             eeeeEe-ccCCceEEEEEEec-------CCceEEEEEEecCcc-CccchHHHHHHHHHHHHHhcCCC---Cceeeeeeec
Q 043852          280 QKGELL-GSGSFGTVYEGYTD-------DGFFFAVKEVSLQDQ-GTQGKQSILQLEQEILLLSRFEH---ENIVQYFGTD  347 (551)
Q Consensus       280 ~~~~~L-G~G~fG~VY~~~~~-------~g~~vAVK~i~~~~~-~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~  347 (551)
                      ...+.| +.|....+|+....       ++..+++|....... .....   ..+.+|+.+++.+..   -.+.+++.++
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~---~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT---YRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC---CCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch---hHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            345778 89999999988654       266788886532210 00000   134466666665532   3466677766


Q ss_pred             cCC---CeEEEEEecccccch
Q 043852          348 KDE---NRLFIFLELVTKGSL  365 (551)
Q Consensus       348 ~~~---~~~~lV~Ey~~ggsL  365 (551)
                      .+.   +..|+||||++|..+
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCC
T ss_pred             cCCCccCCceEEEEecCCCCh
Confidence            554   356899999988654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.17  E-value=4.3e-06  Score=87.53  Aligned_cols=80  Identities=16%  Similarity=0.166  Sum_probs=47.4

Q ss_pred             eeEeccCCceEEEEEEec-CCceEEEEEEecCcc--CccchHHHHHHHHHHHHHhcCCC---CceeeeeeeccCCCeEEE
Q 043852          282 GELLGSGSFGTVYEGYTD-DGFFFAVKEVSLQDQ--GTQGKQSILQLEQEILLLSRFEH---ENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~-~g~~vAVK~i~~~~~--~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~l  355 (551)
                      .+.||.|.++.||++... ++..++||.......  .........++..|..++..+..   ..+.+++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            578999999999999753 567899997643211  00000112234567777766532   2345566543  334589


Q ss_pred             EEeccccc
Q 043852          356 FLELVTKG  363 (551)
Q Consensus       356 V~Ey~~gg  363 (551)
                      |||++.+.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.11  E-value=1.6e-05  Score=80.38  Aligned_cols=29  Identities=21%  Similarity=0.362  Sum_probs=26.7

Q ss_pred             CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      ..+||+|+++.|||++.++.+.|+||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            57999999999999988889999999976

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.74  E-value=0.00014  Score=76.69  Aligned_cols=32  Identities=16%  Similarity=0.336  Sum_probs=27.5

Q ss_pred             HhCCeeecccccceEEEcCCCcEEEEecCCccc
Q 043852          394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA  426 (551)
Q Consensus       394 H~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~  426 (551)
                      +...++|+|++|.|||++.++ ++|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            356799999999999998776 99999998753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.71  E-value=0.00039  Score=67.15  Aligned_cols=134  Identities=21%  Similarity=0.107  Sum_probs=92.3

Q ss_pred             cchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCCcccCCCCC
Q 043852          363 GSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTP  439 (551)
Q Consensus       363 gsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~  439 (551)
                      -+|.++++.  .+++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|-+.+ +.+.          ....
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------~~~~  101 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------AGEP  101 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------cccc
Confidence            478888875  469999999999999999887722 1112333467999999999998764 2110          1233


Q ss_pred             cccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhc----
Q 043852          440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV----  515 (551)
Q Consensus       440 ~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~----  515 (551)
                      .+.+||..   ....+.+.=|||||+++|.-+--..|                  ...+..+|+.+.+||..|.+-    
T Consensus       102 ~~~~pe~~---~~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~  160 (229)
T 2yle_A          102 PPVAGKLG---YSQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEAD  160 (229)
T ss_dssp             -----CCS---SSSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred             CCCChhhc---cccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhccccc
Confidence            46788864   24557899999999999988854333                  223456899999999999866    


Q ss_pred             ---------------------CCCCCCCHHHHHh
Q 043852          516 ---------------------NPNDRPTAAQLME  528 (551)
Q Consensus       516 ---------------------DP~~RPS~~eILe  528 (551)
                                           .+..|.++++|++
T Consensus       161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ------------------CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccccccccccccccccCcCCHHHHHH
Confidence                                 2468899999985

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.56  E-value=0.0002  Score=71.86  Aligned_cols=130  Identities=10%  Similarity=0.109  Sum_probs=71.1

Q ss_pred             eeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEEEEEecc
Q 043852          282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~Ey~  360 (551)
                      .+.|+.|....+|++     ..+++|+.........      ...+|+.++..+...++ .++++.+.+.  -++++||+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~------~r~~E~~~l~~l~~~g~~P~~~~~~~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYI------NRANEAVAAREAAKAGVSPEVLHVDPAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CC------CHHHHHHHHHHHHHTTSSCCEEEECTTT--CCEEEECC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcccee------CHHHHHHHHHHHHHcCCCCceEEEECCC--CEEEEeec
Confidence            688999999999998     5688887653211111      12345555554432222 4566554433  36899999


Q ss_pred             -cccchHH--------H-------Hhh---hc--CC-----hHHHHHHHHH--------------HHHHHHHHH----h-
Q 043852          361 -TKGSLAN--------L-------YQK---YH--LM-----DSQVSAYTRQ--------------ILNGLNYLH----E-  395 (551)
Q Consensus       361 -~ggsL~~--------l-------l~~---~~--l~-----~~~i~~i~~Q--------------I~~aL~yLH----~-  395 (551)
                       .|.++..        +       +.+   .+  +.     ...+..+..+              +...+..|.    . 
T Consensus        90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~  169 (301)
T 3dxq_A           90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH  169 (301)
T ss_dssp             TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence             6655421        0       000   00  00     0111111111              111111111    1 


Q ss_pred             ---CCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          396 ---QNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       396 ---~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                         ..++|+|+.+.||+ ..++.+.|+||..+.
T Consensus       170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             CCCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence               24899999999999 567789999999764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.48  E-value=0.00036  Score=70.90  Aligned_cols=31  Identities=35%  Similarity=0.397  Sum_probs=26.8

Q ss_pred             CCeeecccccceEEEcCC----CcEEEEecCCccc
Q 043852          396 QNVVHRDIKCANILVDAS----GSVKLADFGLAKA  426 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~----g~vkL~DFGla~~  426 (551)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999874    6899999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.41  E-value=0.0014  Score=66.82  Aligned_cols=76  Identities=18%  Similarity=0.149  Sum_probs=56.4

Q ss_pred             eeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC---CCceeeeeeeccCCCeEEEEE
Q 043852          281 KGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE---HENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      ..+.|+.|....+|+... ++..+++|+....        ....+..|...|+.+.   ...+++.+.+....+..++||
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm  110 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL  110 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence            357799999999999865 5667888976521        1334567777776663   356778888877778899999


Q ss_pred             ecccccch
Q 043852          358 ELVTKGSL  365 (551)
Q Consensus       358 Ey~~ggsL  365 (551)
                      ||++|..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.39  E-value=0.0012  Score=66.28  Aligned_cols=138  Identities=13%  Similarity=0.092  Sum_probs=74.7

Q ss_pred             eeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc--eeeeeeec------cCCC
Q 043852          280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN--IVQYFGTD------KDEN  351 (551)
Q Consensus       280 ~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~------~~~~  351 (551)
                      ...+.|+.|....+|++...+| .+++|.......    .   ..+..|+.++..+...+  +.+++...      ...+
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~----~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g   96 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE----K---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG   96 (322)
T ss_dssp             EEEEEECC---EEEEEEEESSC-CEEEEEECC-------C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred             eEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC----H---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence            3456788899999999976555 678897753211    1   12334555555443212  33333221      1235


Q ss_pred             eEEEEEecccccchHH-----H------H---h----hhcCC------hHHHHH---------------HHHHHHHHHHH
Q 043852          352 RLFIFLELVTKGSLAN-----L------Y---Q----KYHLM------DSQVSA---------------YTRQILNGLNY  392 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~-----l------l---~----~~~l~------~~~i~~---------------i~~QI~~aL~y  392 (551)
                      ..+++|+|++|..+..     +      +   .    ....+      ......               +...+...+.+
T Consensus        97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~  176 (322)
T 2ppq_A           97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY  176 (322)
T ss_dssp             EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred             EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence            5789999998865310     0      1   0    10111      000000               00113344555


Q ss_pred             HHh-------CCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          393 LHE-------QNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       393 LH~-------~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      |+.       .++||+|+++.|||++.++.+.|+||+.+.
T Consensus       177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            552       369999999999999876666899999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.35  E-value=0.0035  Score=62.21  Aligned_cols=78  Identities=18%  Similarity=0.058  Sum_probs=51.9

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC---CceeeeeeeccCCCeEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH---ENIVQYFGTDKDENRLF  354 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~  354 (551)
                      +...++.+|.|..+.||+....+|+.|++|+........     ...+..|+..|+.|.-   --+++.+++..    -+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~   86 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-----DGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RT   86 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-----TTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-----hhHHHHHHHHHHHHHhhCCCCcceEEeccC----ce
Confidence            345578899999999999988899999999754222111     1135577777776632   23455555432    37


Q ss_pred             EEEecccccc
Q 043852          355 IFLELVTKGS  364 (551)
Q Consensus       355 lV~Ey~~ggs  364 (551)
                      ++|||+.++.
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            8999987754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.16  E-value=0.0012  Score=66.61  Aligned_cols=76  Identities=14%  Similarity=0.054  Sum_probs=45.4

Q ss_pred             eEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCC--ceeeeeee-----ccCCCeEEE
Q 043852          283 ELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE--NIVQYFGT-----DKDENRLFI  355 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~-----~~~~~~~~l  355 (551)
                      ..|+ |....||++...+|..+++|.......   .   ...+..|..++..+...  .+++++..     ....+..++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence            4566 888899998666777899998752211   1   12344566655555321  23444443     112345688


Q ss_pred             EEecccccch
Q 043852          356 FLELVTKGSL  365 (551)
Q Consensus       356 V~Ey~~ggsL  365 (551)
                      +|++++|..+
T Consensus       105 l~~~i~G~~~  114 (328)
T 1zyl_A          105 VFPSVGGRQF  114 (328)
T ss_dssp             EEECCCCEEC
T ss_pred             EEEecCCCCC
Confidence            9999988543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.11  E-value=0.0019  Score=68.65  Aligned_cols=74  Identities=8%  Similarity=0.052  Sum_probs=47.6

Q ss_pred             eeeEeccCCceEEEEEEecC--------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCC
Q 043852          281 KGELLGSGSFGTVYEGYTDD--------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDEN  351 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~--------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~  351 (551)
                      ..+.|+.|....||++...+        +..+++|+....    ..   ...+..|..++..+...++ +++++.+.+  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence            45778999999999997542        578888876321    11   1233367777776643333 567776543  


Q ss_pred             eEEEEEecccccch
Q 043852          352 RLFIFLELVTKGSL  365 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL  365 (551)
                        .+|+||++|.+|
T Consensus       148 --g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 --GRLEEYIPSRPL  159 (429)
T ss_dssp             --EEEECCCCEEEC
T ss_pred             --CEEEEEeCCccc
Confidence              389999987544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.90  E-value=0.0012  Score=68.14  Aligned_cols=74  Identities=11%  Similarity=-0.037  Sum_probs=40.4

Q ss_pred             eeEeccCCceEEEEEEecC---------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCC
Q 043852          282 GELLGSGSFGTVYEGYTDD---------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN-IVQYFGTDKDEN  351 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~---------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~  351 (551)
                      .+.|+.|..-.+|++...+         +..+++|+......      .......|..++..+...+ +.++++.+.   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD------ELYNTISEFEVYKTMSKYKIAPQLLNTFN---  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG------GTSCHHHHHHHHHHHHHTTSSCCEEEEET---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc------ceecHHHHHHHHHHHHhcCCCCceEEecC---
Confidence            4678888889999987543         26788886532111      0111235666666554223 345665542   


Q ss_pred             eEEEEEecccccch
Q 043852          352 RLFIFLELVTKGSL  365 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL  365 (551)
                       -++||||++|..+
T Consensus       109 -~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 -GGRIEEWLYGDPL  121 (369)
T ss_dssp             -TEEEEECCCSEEC
T ss_pred             -CcEEEEEecCCcC
Confidence             2689999988543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.87  E-value=0.0024  Score=66.82  Aligned_cols=134  Identities=16%  Similarity=0.157  Sum_probs=78.3

Q ss_pred             eeEeccCCceEEEEEEec--------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCc-eeeeeeeccCCCe
Q 043852          282 GELLGSGSFGTVYEGYTD--------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN-IVQYFGTDKDENR  352 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~--------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~  352 (551)
                      ++.|..|-...+|++...        ++..|++|+.-.   ...   ....+.+|..+++.+...+ ..++++.+.+   
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE---  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT---
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---
Confidence            366878888889998753        246788886421   111   1234457777776664222 3566776654   


Q ss_pred             EEEEEecccccchHH--------------HHhh---hc------C--ChHHHHHHHHHHHH-------------------
Q 043852          353 LFIFLELVTKGSLAN--------------LYQK---YH------L--MDSQVSAYTRQILN-------------------  388 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~--------------ll~~---~~------l--~~~~i~~i~~QI~~-------------------  388 (551)
                       .+||||++|..|..              .+.+   ..      .  -..++..|..|+..                   
T Consensus       126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence             29999999866521              1111   00      1  12455556655422                   


Q ss_pred             HHHHHH----h----CCeeecccccceEEEcCC----CcEEEEecCCcc
Q 043852          389 GLNYLH----E----QNVVHRDIKCANILVDAS----GSVKLADFGLAK  425 (551)
Q Consensus       389 aL~yLH----~----~gIiHrDIKP~NILl~~~----g~vkL~DFGla~  425 (551)
                      .+..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            233333    2    259999999999999876    789999999874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.85  E-value=0.0066  Score=65.06  Aligned_cols=75  Identities=9%  Similarity=0.034  Sum_probs=46.7

Q ss_pred             eeeEeccCCceEEEEEEecC-CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEEEEEe
Q 043852          281 KGELLGSGSFGTVYEGYTDD-GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLFIFLE  358 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~-g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E  358 (551)
                      ..+.|+.|-...+|++...+ +..|++|+........      ....+|..++..+...++ .++++.+..    .+|||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~------idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e  181 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI------INREREKKISCILYNKNIAKKIYVFFTN----GRIEE  181 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC------SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh------cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEE
Confidence            45778999999999997644 4778888763221111      112467777777765444 567777632    35999


Q ss_pred             cccccch
Q 043852          359 LVTKGSL  365 (551)
Q Consensus       359 y~~ggsL  365 (551)
                      |++|..|
T Consensus       182 ~I~G~~l  188 (458)
T 2qg7_A          182 FMDGYAL  188 (458)
T ss_dssp             CCCSEEC
T ss_pred             eeCCccC
Confidence            9987554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.85  E-value=0.0073  Score=61.75  Aligned_cols=30  Identities=27%  Similarity=0.414  Sum_probs=26.9

Q ss_pred             CCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          396 QNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            369999999999999888899999998764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.86  E-value=0.056  Score=57.23  Aligned_cols=28  Identities=18%  Similarity=0.490  Sum_probs=25.5

Q ss_pred             CeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          397 NVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       397 gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      .++|+|+.+.||+ +.++.+.|+||..+.
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCC
Confidence            4899999999999 788899999999875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.82  E-value=0.32  Score=50.65  Aligned_cols=28  Identities=29%  Similarity=0.453  Sum_probs=24.5

Q ss_pred             eeecccccceEEE------cCCCcEEEEecCCcc
Q 043852          398 VVHRDIKCANILV------DASGSVKLADFGLAK  425 (551)
Q Consensus       398 IiHrDIKP~NILl------~~~g~vkL~DFGla~  425 (551)
                      ++|+|+.+.|||+      +.++.+.|+||-.|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            7899999999999      446789999999875

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.83  E-value=4.1  Score=38.88  Aligned_cols=122  Identities=10%  Similarity=0.088  Sum_probs=78.7

Q ss_pred             HHHHHhcCCCCceeeeeeeccCCCeEEEEEeccccc-chHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccc
Q 043852          328 EILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKG-SLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCA  406 (551)
Q Consensus       328 Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg-sL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~  406 (551)
                      |+.+|.. .||+++.. .+..+.+.+.+.++.-..+ +... ++  .++....+.++.+|+....+++  .=+|--|+|+
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik--~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~  108 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK--SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPD  108 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG--GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGG
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH--hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecc
Confidence            4444444 68888866 3445556666665554422 3322 33  3667788899999988775544  3367789999


Q ss_pred             eEEEcCCCcEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 043852          407 NILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS  478 (551)
Q Consensus       407 NILl~~~g~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~  478 (551)
                      ||+++.++.++++=.|+-..               ++|.       .++...=.-.+=|++..+++++..|.
T Consensus       109 NL~f~~~~~p~i~~RGik~~---------------l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNV---------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTT---------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccC---------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999986664211               1221       22333344467788899999988873

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	551
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-82
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-82
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-80
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-79
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-76
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-76
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-75
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-73
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-72
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-72
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-72
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-72
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-71
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-69
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-67
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-67
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-66
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-65
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-65
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-64
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-64
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-64
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-63
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-62
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-62
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-61
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-60
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-60
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-59
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-56
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-56
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-56
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-55
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-54
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-53
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-51
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-51
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-51
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-48
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-47
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-26

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  256 bits (656), Expect = 2e-82
 Identities = 98/270 (36%), Positives = 148/270 (54%), Gaps = 15/270 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           W+    LG G+FG VY+    +     A K +  + +     + +     EI +L+  +H
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDH 68

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
            NIV+       EN L+I +E    G++  +  +    L +SQ+    +Q L+ LNYLH+
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAK--ATTMNDVKSCKGTPFWMAPEVV---NLK 450
             ++HRD+K  NIL    G +KLADFG++     T+    S  GTP+WMAPEVV     K
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARDF 508
           +R Y   AD+WSLG T++EM   +PP+  L  M+ L +I K EPP +  P+  S + +DF
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248

Query: 509 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
           + KCL+ N + R T +QL++HPFV     K
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNK 278

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (651), Expect = 4e-82
 Identities = 76/257 (29%), Positives = 131/257 (50%), Gaps = 7/257 (2%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++ G  LG G FG VY        F  A+K +        G +   QL +E+ + S   H
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSHLRH 65

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ 396
            NI++ +G   D  R+++ LE    G++    QK     + + + Y  ++ N L+Y H +
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
            V+HRDIK  N+L+ ++G +K+ADFG +     +   +  GT  ++ PE+  ++ R +  
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM--IEGRMHDE 183

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
             D+WSLG    E L  +PP+      +   RI + E    P+ ++  ARD I + L+ N
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-PDFVTEGARDLISRLLKHN 242

Query: 517 PNDRPTAAQLMEHPFVK 533
           P+ RP   +++EHP++ 
Sbjct: 243 PSQRPMLREVLEHPWIT 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  252 bits (644), Expect = 2e-80
 Identities = 95/285 (33%), Positives = 139/285 (48%), Gaps = 15/285 (5%)

Query: 259 IKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQ 317
           + E  +   P   F            +G GSFG VY      +    A+K++S   +  Q
Sbjct: 4   VAELFFKDDPEKLF-------SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--Q 54

Query: 318 GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMD 376
             +    + +E+  L +  H N +QY G    E+  ++ +E     +       K  L +
Sbjct: 55  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114

Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
            +++A T   L GL YLH  N++HRD+K  NIL+   G VKL DFG A    M    S  
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFV 172

Query: 437 GTPFWMAPEVVNLKNRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-P 494
           GTP+WMAPEV+   + G Y    D+WSLG T +E+  R+PP  ++  M AL+ I + E P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232

Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS 539
            L     S   R+F+  CLQ  P DRPT+  L++H FV R    +
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 1e-79
 Identities = 94/290 (32%), Positives = 151/290 (52%), Gaps = 15/290 (5%)

Query: 259 IKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQ 317
           I E + ++   G  +++   + + E +G G+ GTVY       G   A+++++LQ Q   
Sbjct: 5   ILEKLRSIVSVGDPKKK---YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--- 58

Query: 318 GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS 377
                  +  EIL++   ++ NIV Y  +    + L++ +E +  GSL ++  +  + + 
Sbjct: 59  --PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG 116

Query: 378 QVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SC 435
           Q++A  R+ L  L +LH   V+HRDIK  NIL+   GSVKL DFG     T    K  + 
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176

Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP 495
            GTP+WMAPE   +  + YG   DIWSLG   +EM+  +PPY +   ++AL+ I     P
Sbjct: 177 VGTPYWMAPE--VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234

Query: 496 --LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPP 543
               P  LS   RDF+ +CL ++   R +A +L++H F+K     S   P
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 1e-76
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 13/268 (4%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           W   + LG G++G V            AVK V ++    +       +++EI +     H
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPENIKKEICINKMLNH 62

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           EN+V+++G  ++ N  ++FLE  + G L + +     + +     +  Q++ G+ YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNR 452
            + HRDIK  N+L+D   ++K++DFGLA     N+    +    GT  ++APE++  +  
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RRE 181

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP--NSLSRDARDFIL 510
            +    D+WS G  +  ML  + P+         +   K +   +     +       + 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 511 KCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
           K L  NP+ R T   + +  +  +PL+K
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLKK 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 2e-76
 Identities = 75/269 (27%), Positives = 130/269 (48%), Gaps = 20/269 (7%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++    +G+GS+G   +     DG     KE+         KQ ++    E+ LL   +H
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS---EVNLLRELKH 62

Query: 338 ENIVQYF--GTDKDENRLFIFLELVTKGSLANLYQKY-----HLMDSQVSAYTRQILNGL 390
            NIV+Y+    D+    L+I +E    G LA++  K      +L +  V     Q+   L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 391 NYLHEQN-----VVHRDIKCANILVDASGSVKLADFGLAKATTMND--VKSCKGTPFWMA 443
              H ++     V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GTP++M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSR 503
           PE   +    Y   +DIWSLGC + E+    PP++     +   +I +G+   +P   S 
Sbjct: 183 PEQ--MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFV 532
           +  + I + L +    RP+  +++E+P +
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (605), Expect = 4e-75
 Identities = 79/279 (28%), Positives = 141/279 (50%), Gaps = 23/279 (8%)

Query: 266 VSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQ 324
           +S +G+F +          +G GSF TVY+G  T+     A  E+  +      +Q   +
Sbjct: 4   MSNDGRFLKF------DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---R 54

Query: 325 LEQEILLLSRFEHENIVQYFG----TDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQV 379
            ++E  +L   +H NIV+++     T K +  + +  EL+T G+L    +++ +M    +
Sbjct: 55  FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114

Query: 380 SAYTRQILNGLNYLHEQN--VVHRDIKCANILVDA-SGSVKLADFGLAKATTMNDVKSCK 436
            ++ RQIL GL +LH +   ++HRD+KC NI +   +GSVK+ D GLA     +  K+  
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 174

Query: 437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI--GKGEP 494
           GTP +MAPE+       Y  + D+++ G  +LEM T + PYS  +    ++R      +P
Sbjct: 175 GTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231

Query: 495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                    + ++ I  C++ N ++R +   L+ H F +
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  234 bits (599), Expect = 4e-73
 Identities = 81/317 (25%), Positives = 146/317 (46%), Gaps = 23/317 (7%)

Query: 246 DGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFF 304
           D D   +D+  + + +PV  V     +      +   E LGSG+FG V+       G  F
Sbjct: 3   DYDKFYEDIWKKYVPQPV-EVKQGSVYDY----YDILEELGSGAFGVVHRCVEKATGRVF 57

Query: 305 AVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGS 364
             K ++              ++ EI ++++  H  ++      +D+  + + LE ++ G 
Sbjct: 58  VAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112

Query: 365 LANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA--SGSVKLAD 420
           L +      Y + +++V  Y RQ   GL ++HE ++VH DIK  NI+ +   + SVK+ D
Sbjct: 113 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 172

Query: 421 FGLAKATTMNDVKSC-KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSH 479
           FGLA     +++      T  + APE+  +     G   D+W++G     +L+   P++ 
Sbjct: 173 FGLATKLNPDEIVKVTTATAEFAAPEI--VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230

Query: 480 LEGMQALFRIGKGE---PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
            + ++ L  + + +        +S+S +A+DFI   LQ  P  R T    +EHP++K   
Sbjct: 231 EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290

Query: 537 QK--SRGPPSYYNNMHS 551
               SR P S YN +  
Sbjct: 291 SNLTSRIPSSRYNKIRQ 307

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 1e-72
 Identities = 67/264 (25%), Positives = 125/264 (47%), Gaps = 18/264 (6%)

Query: 278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
               G+ +GSGSFGTVY+G        AVK +++     Q  Q     + E+ +L +  H
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQ---AFKNEVGVLRKTRH 63

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHE 395
            NI+ + G      +L I  +     SL +            ++    RQ   G++YLH 
Sbjct: 64  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKN 451
           ++++HRD+K  NI +    +VK+ DFGLA   +        +   G+  WMAPEV+ +++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 452 RG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-----EPPLVPNSLSRDA 505
           +  Y   +D+++ G  + E++T Q PYS++     +  +        +   V ++  +  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 506 RDFILKCLQVNPNDRPTAAQLMEH 529
           +  + +CL+   ++RP   Q++  
Sbjct: 243 KRLMAECLKKKRDERPLFPQILAS 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  233 bits (594), Expect = 2e-72
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 19/285 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +   E LG+G+FG V+       G  FA K V    +          + +EI  +S   H
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRH 82

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
             +V      +D+N + +  E ++ G L       H  + + +   Y RQ+  GL ++HE
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 396 QNVVHRDIKCANILV--DASGSVKLADFGLAK-ATTMNDVKSCKGTPFWMAPEVVNLKNR 452
            N VH D+K  NI+     S  +KL DFGL         VK   GT  + APEV   + +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV--AEGK 200

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARDFI 509
             G   D+WS+G     +L+   P+      + L  +   +        + +S D +DFI
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260

Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKR---PLQKSRGPPSYYNNMHS 551
            K L  +PN R T  Q +EHP++     P + S+ P S Y  +  
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 305

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 4e-72
 Identities = 67/268 (25%), Positives = 128/268 (47%), Gaps = 11/268 (4%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILL 331
           ++R   ++ G++LG GSF TV           +A+K +  +    + K   +  E++++ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM- 62

Query: 332 LSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGL 390
            SR +H   V+ + T +D+ +L+  L     G L    +K     ++    YT +I++ L
Sbjct: 63  -SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 391 NYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEV 446
            YLH + ++HRD+K  NIL++    +++ DFG AK  +         S  GT  +++PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 447 VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
             L  +    ++D+W+LGC + +++   PP+          +I K E    P      AR
Sbjct: 182 --LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF-PEKFFPKAR 238

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVKR 534
           D + K L ++   R    ++  +  +K 
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 5e-72
 Identities = 78/302 (25%), Positives = 136/302 (45%), Gaps = 52/302 (17%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++K   LG+G+ G V++      G   A K + L+ +         Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNS 63

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQ 396
             IV ++G    +  + I +E +  GSL  + +K   + +  +   +  ++ GL YL E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 397 N-VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           + ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE   L+   Y 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER--LQGTHYS 181

Query: 456 LTADIWSLGCTVLEMLTRQPPYSH------------------------------------ 479
           + +DIWS+G +++EM   + P                                       
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 480 ------LEGMQALFRIGKGEPPLVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 532
                 +   + L  I    PP +P+   S + +DF+ KCL  NP +R    QLM H F+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 533 KR 534
           KR
Sbjct: 302 KR 303

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  229 bits (584), Expect = 6e-72
 Identities = 77/271 (28%), Positives = 130/271 (47%), Gaps = 15/271 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQ----EILLLS 333
           ++  E+LG G    V           +AVK + +   G+   + + +L +    E+ +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 334 RF-EHENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLN 391
           +   H NI+Q   T +     F+  +L+ KG L + L +K  L + +     R +L  + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 392 YLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-VKSCKGTPFWMAPEVV--- 447
            LH+ N+VHRD+K  NIL+D   ++KL DFG +      + ++   GTP ++APE++   
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 448 -NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSR 503
            N  + GYG   D+WS G  +  +L   PP+ H + M  L  I  G         +  S 
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 504 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
             +D + + L V P  R TA + + HPF ++
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 1e-71
 Identities = 63/269 (23%), Positives = 117/269 (43%), Gaps = 17/269 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +   E LG G FG V+    T     +  K V ++            +++EI +L+   H
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARH 60

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHE 395
            NI+    + +    L +  E ++   +        + L + ++ +Y  Q+   L +LH 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 396 QNVVHRDIKCANILVDASGS--VKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNR 452
            N+ H DI+  NI+     S  +K+ +FG A+     D  +     P + APEV   ++ 
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV--HQHD 178

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARDFI 509
                 D+WSLG  V  +L+   P+      Q +  I   E          +S +A DF+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
            + L      R TA++ ++HP++K+ +++
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIER 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  222 bits (567), Expect = 5e-69
 Identities = 73/278 (26%), Positives = 130/278 (46%), Gaps = 15/278 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +   ++LG+G+F  V            A+K ++ +    +GK+    +E EI +L + +H
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKA--LEGKEG--SMENEIAVLHKIKH 66

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
            NIV      +    L++ ++LV+ G L + + +K    +   S    Q+L+ + YLH+ 
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 397 NVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDV-KSCKGTPFWMAPEVVNLKNR 452
            +VHRD+K  N+L    D    + ++DFGL+K      V  +  GTP ++APEV  L  +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV--LAQK 184

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDARDFI 509
            Y    D WS+G     +L   PP+      +   +I K E        + +S  A+DFI
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244

Query: 510 LKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYYN 547
              ++ +P  R T  Q ++HP++       +      +
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVS 282

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 3e-67
 Identities = 60/254 (23%), Positives = 105/254 (41%), Gaps = 14/254 (5%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + LG+G FG V  G     +  A+K +              +  +E  ++    HE +V
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEAKVMMNLSHEKLV 62

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANL--YQKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           Q +G    +  +FI  E +  G L N     ++     Q+    + +   + YL  +  +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDVKS---CKGTPFWMAPEVVNLKNRGYGL 456
           HRD+   N LV+  G VK++DFGL++    ++  S    K    W  PEV  L    +  
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMYSKFSS 180

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +DIW+ G  + E+ +  + PY      +    I +G     P+  S      +  C   
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240

Query: 516 NPNDRPTAAQLMEH 529
             ++RPT   L+ +
Sbjct: 241 KADERPTFKILLSN 254

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 5e-67
 Identities = 78/260 (30%), Positives = 127/260 (48%), Gaps = 9/260 (3%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +   ++LG GSFG V+   +     FFA+K +               +E+ +L L+ +EH
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEH 62

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQ 396
             +   F T + +  LF  +E +  G L    Q  H  D S+ + Y  +I+ GL +LH +
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK--SCKGTPFWMAPEVVNLKNRGY 454
            +V+RD+K  NIL+D  G +K+ADFG+ K   + D K  +  GTP ++APE+  L  + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI--LLGQKY 180

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
             + D WS G  + EML  Q P+   +  +    I    P   P  L ++A+D ++K   
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY-PRWLEKEAKDLLVKLFV 239

Query: 515 VNPNDRPTAA-QLMEHPFVK 533
             P  R      + +HP  +
Sbjct: 240 REPEKRLGVRGDIRQHPLFR 259

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 6e-67
 Identities = 56/254 (22%), Positives = 105/254 (41%), Gaps = 14/254 (5%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            + +GSG FG V+ GY  +    A+K +       +         +E  ++ +  H  +V
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE------DFIEEAEVMMKLSHPKLV 63

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS--QVSAYTRQILNGLNYLHEQNVV 399
           Q +G   ++  + +  E +  G L++  +    + +   +      +  G+ YL E  V+
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 400 HRDIKCANILVDASGSVKLADFGLAKA---TTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           HRD+   N LV  +  +K++DFG+ +             K    W +PEV       Y  
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV--FSFSRYSS 181

Query: 457 TADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQV 515
            +D+WS G  + E+ +  + PY +    + +  I  G     P   S      +  C + 
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241

Query: 516 NPNDRPTAAQLMEH 529
            P DRP  ++L+  
Sbjct: 242 RPEDRPAFSRLLRQ 255

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 1e-66
 Identities = 74/283 (26%), Positives = 133/283 (46%), Gaps = 18/283 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQ-LEQEILLLSRFE 336
           +  GE LGSG F  V +      G  +A K +  +   +  +    + +E+E+ +L   +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLANLY-QKYHLMDSQVSAYTRQILNGLNYLHE 395
           H N++      +++  + + LELV  G L +   +K  L + + + + +QILNG+ YLH 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 396 QNVVHRDIKCANILVDASGS----VKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLK 450
             + H D+K  NI++         +K+ DFGLA      +  K+  GTP ++APE+  + 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI--VN 189

Query: 451 NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRDARD 507
               GL AD+WS+G     +L+   P+      + L  +            ++ S  A+D
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249

Query: 508 FILKCLQVNPNDRPTAAQLMEHPFVK-----RPLQKSRGPPSY 545
           FI + L  +P  R T    ++HP++K     + L  +   P +
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 2e-65
 Identities = 70/262 (26%), Positives = 119/262 (45%), Gaps = 15/262 (5%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVS---LQDQGTQGKQSILQLEQEILLLSR 334
           +Q G LLGSG FG+VY G    D    A+K V    + D G     + + +E  +L    
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNY 392
                +++     +  +   + LE          +  ++  L +    ++  Q+L  + +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 393 LHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKN 451
            H   V+HRDIK  NIL+D + G +KL DFG              GT  +  PE +   +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR-YH 184

Query: 452 RGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
           R +G +A +WSLG  + +M+    P+ H E       I +G+       +S + +  I  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF-RQRVSSECQHLIRW 237

Query: 512 CLQVNPNDRPTAAQLMEHPFVK 533
           CL + P+DRPT  ++  HP+++
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQ 259

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 2e-65
 Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 16/255 (6%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           +  + +G G FG V  G    G   AVK +           +      E  ++++  H N
Sbjct: 10  KLLQTIGKGEFGDVMLG-DYRGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSN 61

Query: 340 IVQYFGTD-KDENRLFIFLELVTKGSLANLYQKYH---LMDSQVSAYTRQILNGLNYLHE 395
           +VQ  G   +++  L+I  E + KGSL +  +      L    +  ++  +   + YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
            N VHRD+   N+LV      K++DFGL K  + +   + K    W APE   L+ + + 
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEA--LREKKFS 178

Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
             +D+WS G  + E+ +  + PY  +     + R+ KG     P+       + +  C  
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238

Query: 515 VNPNDRPTAAQLMEH 529
           ++   RP+  QL E 
Sbjct: 239 LDAAMRPSFLQLREQ 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 2e-65
 Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 19/260 (7%)

Query: 285 LGSGSFGTVYEGY---TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           LGSG+FGTV +GY          AVK +  +      K  +L    E  ++ + ++  IV
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 71

Query: 342 QYFGTDKDENRLFIFLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
           +  G  + E+ + +  E+   G L   L Q  H+ D  +     Q+  G+ YL E N VH
Sbjct: 72  RMIGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 401 RDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           RD+   N+L+      K++DFGL+KA              K    W APE   +    + 
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC--INYYKFS 188

Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
             +D+WS G  + E  +  Q PY  ++G +    + KGE    P    R+  D +  C  
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248

Query: 515 VNPNDRPTAAQL---MEHPF 531
            +  +RP  A +   + + +
Sbjct: 249 YDVENRPGFAAVELRLRNYY 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  214 bits (547), Expect = 3e-65
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 11/265 (4%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL-LLSRFE 336
           +    ++G G FG VY     D G  +A+K +  +    +  +++   E+ +L L+S  +
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 337 HENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
              IV         ++L   L+L+  G L  +L Q     ++ +  Y  +I+ GL ++H 
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYG 455
           + VV+RD+K ANIL+D  G V+++D GLA   +     +  GT  +MAPEV+  K   Y 
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYD 184

Query: 456 LTADIWSLGCTVLEMLTRQPPYSH--LEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
            +AD +SLGC + ++L    P+     +    + R+       +P+S S + R  +   L
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244

Query: 514 QVNPNDRPT-----AAQLMEHPFVK 533
           Q + N R       A ++ E PF +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFR 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 3e-64
 Identities = 68/262 (25%), Positives = 119/262 (45%), Gaps = 19/262 (7%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
           +  E LG+G FG V+ GY +     AVK +                  E  L+ + +H+ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD------AFLAEANLMKQLQHQR 69

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQ 396
           +V+ +     E  ++I  E +  GSL +  +      L  +++     QI  G+ ++ E+
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAK---ATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           N +HRD++ ANILV  + S K+ADFGLA+          +  K    W APE   +    
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA--INYGT 186

Query: 454 YGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC 512
           + + +D+WS G  + E++T  + PY  +   + +  + +G   + P++   +    +  C
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246

Query: 513 LQVNPNDRPTAAQLM---EHPF 531
            +  P DRPT   L    E  F
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFF 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  210 bits (535), Expect = 4e-64
 Identities = 71/262 (27%), Positives = 129/262 (49%), Gaps = 13/262 (4%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +Q    LG+GSFG V+      +G ++A+K +  +       + +     E L+LS   H
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--VVRLKQVEHTNDERLMLSIVTH 63

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSA-YTRQILNGLNYLHEQ 396
             I++ +GT +D  ++F+ ++ +  G L +L +K     + V+  Y  ++   L YLH +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGL 456
           ++++RD+K  NIL+D +G +K+ DFG AK    +   +  GTP ++APEV  +  + Y  
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCGTPDYIAPEV--VSTKPYNK 180

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVN 516
           + D WS G  + EML    P+     M+   +I   E    P   + D +D + + +  +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-PPFFNEDVKDLLSRLITRD 239

Query: 517 PNDR-----PTAAQLMEHPFVK 533
            + R          +  HP+ K
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 4e-64
 Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 25/280 (8%)

Query: 285 LGSGSFGTVYEGY---TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           LG G+FG+V +G           A+K +    +    K    ++ +E  ++ + ++  IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIV 72

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLHEQNVV 399
           +  G  + E  L + +E+   G L      ++  +  S V+    Q+  G+ YL E+N V
Sbjct: 73  RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 400 HRDIKCANILVDASGSVKLADFGLAKATTMNDV-----KSCKGTPFWMAPEVVNLKNRGY 454
           HRD+   N+L+      K++DFGL+KA   +D       + K    W APE   +  R +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC--INFRKF 189

Query: 455 GLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
              +D+WS G T+ E L+  Q PY  ++G + +  I +G+    P     +    +  C 
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249

Query: 514 QVNPNDRPTAAQL---MEHPFVKRPLQKSRGPPSYYNNMH 550
                DRP    +   M   +       +     ++++ H
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYSL----ASKVEGHHHHHH 285

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 7e-64
 Identities = 73/282 (25%), Positives = 117/282 (41%), Gaps = 32/282 (11%)

Query: 283 ELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
           + LG G F TVY+    +     A+K++ L  +            +EI LL    H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVH 400
                   ++ + +  + +       +      L  S + AY    L GL YLH+  ++H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 401 RDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTA 458
           RD+K  N+L+D +G +KLADFGLAK+  +          T ++ APE++    R YG+  
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF-GARMYGVGV 182

Query: 459 DIWSLGCTVLEMLTRQPPYSHLEGMQALFRI--GKGEPPL-------------------- 496
           D+W++GC + E+L R P       +  L RI    G P                      
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242

Query: 497 -----VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                + ++   D  D I      NP  R TA Q ++  +  
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 3e-63
 Identities = 69/268 (25%), Positives = 118/268 (44%), Gaps = 18/268 (6%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
              LG G FG V+ G  +     A+K +       +         QE  ++ +  HE +V
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQEAQVMKKLRHEKLV 75

Query: 342 QYFGTDKDENRLFIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNV 398
           Q +    +E  ++I  E ++KGSL +  +     +L   Q+     QI +G+ Y+   N 
Sbjct: 76  QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDV---KSCKGTPFWMAPEVVNLKNRGYG 455
           VHRD++ ANILV  +   K+ADFGLA+    N+    +  K    W APE        + 
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA--ALYGRFT 192

Query: 456 LTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           + +D+WS G  + E+ T+ + PY  +   + L ++ +G     P        D + +C +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 252

Query: 515 VNPNDRPTAAQLME--HPFVKRPLQKSR 540
             P +RPT   L      +      + +
Sbjct: 253 KEPEERPTFEYLQAFLEDYFTSTEPQYQ 280

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 1e-62
 Identities = 78/264 (29%), Positives = 120/264 (45%), Gaps = 18/264 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
            +  E LG GSFG V  G     +      AVK   L+       +++    +E+  +  
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVNAMHS 67

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNY 392
            +H N+++ +G       + +  EL   GSL +  +K+  H +   +S Y  Q+  G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----VKSCKGTPFWMAPEVV 447
           L  +  +HRD+   N+L+     VK+ DFGL +A   ND      +  K    W APE  
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES- 185

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGK-GEPPLVPNSLSRDA 505
            LK R +   +D W  G T+ EM T  Q P+  L G Q L +I K GE    P    +D 
Sbjct: 186 -LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244

Query: 506 RDFILKCLQVNPNDRPTAAQLMEH 529
            + +++C    P DRPT   L + 
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-62
 Identities = 71/258 (27%), Positives = 112/258 (43%), Gaps = 17/258 (6%)

Query: 282 GELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           G  +G G FG V++G      +     A+K                +  QE L + +F+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS----DSVREKFLQEALTMRQFDH 67

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
            +IV+  G    EN ++I +EL T G L +  Q     L  + +  Y  Q+   L YL  
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK---SCKGTPFWMAPEVVNLKNR 452
           +  VHRDI   N+LV ++  VKL DFGL++    +        K    WMAPE   +  R
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES--INFR 184

Query: 453 GYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK 511
            +   +D+W  G  + E+L     P+  ++    + RI  GE   +P +        + K
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244

Query: 512 CLQVNPNDRPTAAQLMEH 529
           C   +P+ RP   +L   
Sbjct: 245 CWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (518), Expect = 6e-62
 Identities = 62/262 (23%), Positives = 111/262 (42%), Gaps = 20/262 (7%)

Query: 282 GELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
            +++G+G FG V  G+         F A+K +         ++       E  ++ +F+H
Sbjct: 31  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDH 86

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS--QVSAYTRQILNGLNYLHE 395
            N++   G       + I  E +  GSL +  ++     +  Q+    R I  G+ YL +
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKA-------TTMNDVKSCKGTPFWMAPEVVN 448
            N VHRD+   NILV+++   K++DFGL++         T       K    W APE   
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA-- 204

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           ++ R +   +D+WS G  + E+++  + PY  +     +  I +      P         
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264

Query: 508 FILKCLQVNPNDRPTAAQLMEH 529
            +L C Q + N RP   Q++  
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNT 286

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-61
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 19/279 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +   +LLG G+FG V        G ++A+K +  +      K  +     E  +L    H
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRH 64

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMD-SQVSAYTRQILNGLNYLHEQ 396
             +       +  +RL   +E    G L     +  +    +   Y  +I++ L YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGY 454
           +VV+RDIK  N+++D  G +K+ DFGL K    +        GTP ++APEV  L++  Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDY 182

Query: 455 GLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQ 514
           G   D W LG  + EM+  + P+ + +  +    I   E    P +LS +A+  +   L+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-PRTLSPEAKSLLAGLLK 241

Query: 515 VNPNDRP-----TAAQLMEHPFVK-----RPLQKSRGPP 543
            +P  R       A ++MEH F         +QK   PP
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 6e-61
 Identities = 66/262 (25%), Positives = 112/262 (42%), Gaps = 20/262 (7%)

Query: 282 GELLGSGSFGTVYEGYTDD----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
            E++G G FG VY G   D        AVK ++           + Q   E +++  F H
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----IGEVSQFLTEGIIMKDFSH 87

Query: 338 ENIVQYFGTD-KDENRLFIFLELVTKGSLANLY--QKYHLMDSQVSAYTRQILNGLNYLH 394
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+ +L 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 395 EQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS------CKGTPFWMAPEVVN 448
            +  VHRD+   N ++D   +VK+ADFGLA+     +  S       K    WMA E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES-- 205

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARD 507
           L+ + +   +D+WS G  + E++TR  PPY  +        + +G   L P        +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265

Query: 508 FILKCLQVNPNDRPTAAQLMEH 529
            +LKC       RP+ ++L+  
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSR 287

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 6e-61
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 32/281 (11%)

Query: 282 GELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHEN 339
            ++LG G  G V + +       FA+K +          Q   +  +E+ L  R  +  +
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRASQCPH 66

Query: 340 IVQYFGT----DKDENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNY 392
           IV+              L I +E +  G L +  Q        + + S   + I   + Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 393 LHEQNVVHRDIKCANILVDA---SGSVKLADFGLAK-ATTMNDVKSCKGTPFWMAPEVVN 448
           LH  N+ HRD+K  N+L  +   +  +KL DFG AK  T+ N + +   TP+++APEV  
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV-- 184

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPY------SHLEGMQALFRIGKGEPP-LVPNSL 501
           L    Y  + D+WSLG  +  +L   PP+      +   GM+   R+G+ E P    + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGP 542
           S + +  I   L+  P  R T  + M HP++ +  +  + P
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-60
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 38/291 (13%)

Query: 279 WQKGELLGSGSFGTVYEGY--TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE 336
           ++    +G G++G V++     + G F A+K V +Q        S ++    +  L  FE
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 337 HENIVQYFG-----TDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNG 389
           H N+V+ F          E +L +  E V +     L +     +    +     Q+L G
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 390 LNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA-TTMNDVKSCKGTPFWMAPEVVN 448
           L++LH   VVHRD+K  NILV +SG +KLADFGLA+  +    + S   T ++ APEV  
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV-- 186

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG---------------- 492
           L    Y    D+WS+GC   EM  R+P +     +  L +I                   
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 493 ----------EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                             +    +D +LKCL  NP  R +A   + HP+ +
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  199 bits (506), Expect = 2e-60
 Identities = 64/269 (23%), Positives = 117/269 (43%), Gaps = 18/269 (6%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++ GE+LG G    V+           AVK +       +     L+  +E    +   H
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNH 66

Query: 338 ENIVQYFGTDKDEN----RLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNY 392
             IV  + T + E       +I +E V   +L ++      +   +           LN+
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAK-----ATTMNDVKSCKGTPFWMAPEVV 447
            H+  ++HRD+K ANI++ A+ +VK+ DFG+A+       ++    +  GT  +++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ- 185

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE---PPLVPNSLSRD 504
             +       +D++SLGC + E+LT +PP++    +   ++  + +   P      LS D
Sbjct: 186 -ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244

Query: 505 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
               +LK L  NP +R   A  M    V+
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  198 bits (504), Expect = 4e-60
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 35/285 (12%)

Query: 280 QKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHEN 339
              E +G G++G VY+   + G  FA+K++ L+ +      + ++   EI +L   +H N
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSN 61

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANL-YQKYHLMDSQVSAYTRQILNGLNYLHEQNV 398
           IV+ +     + RL +  E + +     L   +  L      ++  Q+LNG+ Y H++ V
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 399 VHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK--GTPFWMAPEVVNLKNRGYGL 456
           +HRD+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V+ + ++ Y  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL-MGSKKYST 180

Query: 457 TADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG------------------------ 492
           T DIWS+GC   EM+   P +  +     L RI +                         
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 493 ----EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                       L     D + K L+++PN R TA Q +EH + K
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-59
 Identities = 80/288 (27%), Positives = 129/288 (44%), Gaps = 37/288 (12%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +QK E +G G++G VY+      G   A+K++ L  +      + ++   EI LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNH 60

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--LMDSQVSAYTRQILNGLNYLHE 395
            NIV+       EN+L++  E + +     +       +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKA--TTMNDVKSCKGTPFWMAPEVVNLKNRG 453
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE++ L  + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL-LGCKY 179

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL----------------- 496
           Y    DIWSLGC   EM+TR+  +     +  LFRI +                      
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 497 -----------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                      V   L  D R  + + L  +PN R +A   + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 4e-59
 Identities = 76/308 (24%), Positives = 133/308 (43%), Gaps = 24/308 (7%)

Query: 259 IKEPVYNVSPNGKFRRRIMS-WQKGELLGSGSFGTVYEGY----TDDGFFFAVKEVSLQD 313
           +K  +   +  G   +  +  ++  ++LG+G++G V+        D G  +A+K +    
Sbjct: 5   VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 64

Query: 314 QGTQGKQSILQLEQEILLLSRFEHE-NIVQYFGTDKDENRLFIFLELVTKGSLAN-LYQK 371
              Q  ++      E  +L        +V      + E +L + L+ +  G L   L Q+
Sbjct: 65  I-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123

Query: 372 YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA---KATT 428
               + +V  Y  +I+  L +LH+  +++RDIK  NIL+D++G V L DFGL+    A  
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183

Query: 429 MNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFR 488
                   GT  +MAP++V   + G+    D WSLG  + E+LT   P++      +   
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243

Query: 489 IGKG---EPPLVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVK-----RP 535
           I +      P  P  +S  A+D I + L  +P  R       A ++ EH F +       
Sbjct: 244 ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 303

Query: 536 LQKSRGPP 543
             K    P
Sbjct: 304 AAKKVPAP 311

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 4e-59
 Identities = 62/285 (21%), Positives = 107/285 (37%), Gaps = 43/285 (15%)

Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           G++LGSG+FG V          T      AVK +  +            L  E+ ++++ 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQL 97

Query: 336 E-HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH--------------------- 373
             HENIV   G       +++  E    G L N  +                        
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 374 ---LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN 430
              L    +  +  Q+  G+ +L  ++ VHRD+   N+LV     VK+ DFGLA+    +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 431 D----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQA 485
                  + +    WMAPE  +L    Y + +D+WS G  + E+ +    PY  +     
Sbjct: 218 SNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275

Query: 486 LFRIGK-GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
            +++ + G     P   + +    +  C   +   RP+   L   
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 2e-58
 Identities = 59/269 (21%), Positives = 118/269 (43%), Gaps = 25/269 (9%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HEN 339
            +++G G+FG V +     DG         +++  +  K        E+ +L +   H N
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPN 72

Query: 340 IVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS-----------------QVSAY 382
           I+   G  +    L++ +E    G+L +  +K  ++++                 Q+  +
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 383 TRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-SCKGTPFW 441
              +  G++YL ++  +HRD+   NILV  +   K+ADFGL++   +   K   +    W
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNS 500
           MA E   L    Y   +D+WS G  + E+++    PY  +   +   ++ +G     P +
Sbjct: 193 MAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250

Query: 501 LSRDARDFILKCLQVNPNDRPTAAQLMEH 529
              +  D + +C +  P +RP+ AQ++  
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 2e-58
 Identities = 65/259 (25%), Positives = 124/259 (47%), Gaps = 11/259 (4%)

Query: 279 WQKGELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++K ++LGSG+FGTVY+G +  +G    +     + +     ++  ++  E  +++  ++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDS--QVSAYTRQILNGLNYLHE 395
            ++ +  G       + +  +L+  G L +  +++        +  +  QI  G+NYL +
Sbjct: 71  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 396 QNVVHRDIKCANILVDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKN 451
           + +VHRD+   N+LV     VK+ DFGLAK     +     +  K    WMA E   + +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES--ILH 187

Query: 452 RGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL 510
           R Y   +D+WS G TV E++T    PY  +   +    + KGE    P   + D    ++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMV 247

Query: 511 KCLQVNPNDRPTAAQLMEH 529
           KC  ++ + RP   +L+  
Sbjct: 248 KCWMIDADSRPKFRELIIE 266

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 4e-58
 Identities = 72/309 (23%), Positives = 122/309 (39%), Gaps = 51/309 (16%)

Query: 272 FRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEIL 330
           F   +  ++K   +G G+FG V++      G   A+K+V ++++    +   +   +EI 
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIK 61

Query: 331 LLSRFEHENIVQYFGT--------DKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSA 381
           +L   +HEN+V             ++ +  +++  +                   S++  
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKA------TTMNDVKSC 435
             + +LNGL Y+H   ++HRD+K AN+L+   G +KLADFGLA+A      +  N   + 
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 436 KGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI--GKGE 493
             T ++  PE++ L  R YG   D+W  GC + EM TR P          L  I    G 
Sbjct: 182 VVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 494 PP-----------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAA 524
                                          L        A D I K L ++P  R  + 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 525 QLMEHPFVK 533
             + H F  
Sbjct: 301 DALNHDFFW 309

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (489), Expect = 1e-57
 Identities = 58/285 (20%), Positives = 106/285 (37%), Gaps = 42/285 (14%)

Query: 280 QKGELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           +    +G G+FG V++         +     AVK +  +             ++E  L++
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS----ADMQADFQREAALMA 71

Query: 334 RFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-------------------- 373
            F++ NIV+  G       + +  E +  G L    +                       
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 374 -----LMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT 428
                L  ++     RQ+  G+ YL E+  VHRD+   N LV  +  VK+ADFGL++   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 429 MNDVK----SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ-PPYSHLEGM 483
             D      +      WM PE   +    Y   +D+W+ G  + E+ +    PY  +   
Sbjct: 192 SADYYKADGNDAIPIRWMPPES--IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 484 QALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           + ++ +  G     P +   +  + +  C    P DRP+   +  
Sbjct: 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (485), Expect = 3e-57
 Identities = 66/255 (25%), Positives = 113/255 (44%), Gaps = 16/255 (6%)

Query: 282 GELLGSGSFGTVYEG-YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI 340
              LG G +G VYEG +       AVK +       +      +  +E  ++   +H N+
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------EFLKEAAVMKEIKHPNL 75

Query: 341 VQYFGTDKDENRLFIFLELVTKGSLANLYQ---KYHLMDSQVSAYTRQILNGLNYLHEQN 397
           VQ  G    E   +I  E +T G+L +  +   +  +    +     QI + + YL ++N
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135

Query: 398 VVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGT---PFWMAPEVVNLKNRGY 454
            +HRD+   N LV  +  VK+ADFGL++  T +   +  G      W APE   L    +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES--LAYNKF 193

Query: 455 GLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL 513
            + +D+W+ G  + E+ T    PY  ++  Q    + K      P        + +  C 
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253

Query: 514 QVNPNDRPTAAQLME 528
           Q NP+DRP+ A++ +
Sbjct: 254 QWNPSDRPSFAEIHQ 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-56
 Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 21/271 (7%)

Query: 280 QKGELLGSGSFGTVYEGYTDDG-----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR 334
            + +++G+G FG VY+G             A+K +         ++  +    E  ++ +
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT----EKQRVDFLGEAGIMGQ 65

Query: 335 FEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNY 392
           F H NI++  G       + I  E +  G+L    ++        Q+    R I  G+ Y
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 393 LHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS-----CKGTPFWMAPEVV 447
           L   N VHRD+   NILV+++   K++DFGL++    +   +      K    W APE  
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA- 184

Query: 448 NLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR 506
            +  R +   +D+WS G  + E++T  + PY  L   + +  I  G     P        
Sbjct: 185 -ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243

Query: 507 DFILKCLQVNPNDRPTAAQLME--HPFVKRP 535
             +++C Q     RP  A ++      ++ P
Sbjct: 244 QLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (481), Expect = 6e-56
 Identities = 70/304 (23%), Positives = 132/304 (43%), Gaps = 13/304 (4%)

Query: 237 GPSISVHDHDGDDDRKDLAVRLIKEPVYNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEG 296
           G + +       +  K+   +  ++ +       +   ++  + + + LG+GSFG V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60

Query: 297 Y-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI 355
              + G  +A+K +  Q       + I     E  +L       +V+   + KD + L++
Sbjct: 61  KHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118

Query: 356 FLELVTKGSLAN-LYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG 414
            +E V  G + + L +     +     Y  QI+    YLH  ++++RD+K  N+L+D  G
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178

Query: 415 SVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ 474
            +++ DFG AK        +  GTP  +APE+  + ++GY    D W+LG  + EM    
Sbjct: 179 YIQVTDFGFAKR-VKGRTWTLCGTPEALAPEI--ILSKGYNKAVDWWALGVLIYEMAAGY 235

Query: 475 PPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDR-----PTAAQLMEH 529
           PP+   + +Q   +I  G+    P+  S D +D +   LQV+   R          +  H
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRF-PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294

Query: 530 PFVK 533
            +  
Sbjct: 295 KWFA 298

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 8e-56
 Identities = 74/306 (24%), Positives = 131/306 (42%), Gaps = 45/306 (14%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +     +G G++G V   Y   +    A+K++S  +     +    +  +EI +L RF H
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH----QTYCQRTLREIKILLRFRH 65

Query: 338 ENIVQYFGTDKDEN----RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
           ENI+      +       +    +  +    L  L +  HL +  +  +  QIL GL Y+
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKA-----TTMNDVKSCKGTPFWMAPEVVN 448
           H  NV+HRD+K +N+L++ +  +K+ DFGLA+           +     T ++ APE++ 
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 449 LKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI--GKGEPPL---------- 496
             ++GY  + DIWS+GC + EML+ +P +     +  L  I    G P            
Sbjct: 186 -NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 497 ------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK 538
                             +  +    A D + K L  NP+ R    Q + HP++++    
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

Query: 539 SRGPPS 544
           S  P +
Sbjct: 305 SDEPIA 310

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 9e-56
 Identities = 71/290 (24%), Positives = 112/290 (38%), Gaps = 50/290 (17%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIV 341
            E +G G FG V+ G    G   AVK  S +++ +         E EI       HENI+
Sbjct: 8   QESIGKGRFGEVWRG-KWRGEEVAVKIFSSREERSW------FREAEIYQTVMLRHENIL 60

Query: 342 QYFGTDKDEN----RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQ- 396
            +   D  +N    +L++  +    GSL +   +Y +    +        +GL +LH + 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 397 -------NVVHRDIKCANILVDASGSVKLADFGL------AKATTMNDVKSCKGTPFWMA 443
                   + HRD+K  NILV  +G+  +AD GL      A  T         GT  +MA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 444 PEV----VNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF------------ 487
           PEV    +N+K+      ADI+++G    E+  R       E  Q  +            
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 488 ----RIGKGEPPLVPNSLS-----RDARDFILKCLQVNPNDRPTAAQLME 528
                  +   P +PN        R     + +C   N   R TA ++ +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-55
 Identities = 82/322 (25%), Positives = 127/322 (39%), Gaps = 57/322 (17%)

Query: 273 RRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILL 331
           R + +S+   +++G+GSFG VY+    D G   A+K+V          Q      +E+ +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQDKRFKNRELQI 66

Query: 332 LSRFEHENIVQYF------GTDKDENRLFIFLELVTKGSLANLYQ----KYHLMDSQVSA 381
           + + +H NIV+        G  KDE  L + L+ V +            K  L    V  
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126

Query: 382 YTRQILNGLNYLHEQNVVHRDIKCANILVDASGSV-KLADFGLAKATTMND-VKSCKGTP 439
           Y  Q+   L Y+H   + HRDIK  N+L+D   +V KL DFG AK     +   S   + 
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186

Query: 440 FWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK--GEPP-- 495
           ++ APE++      Y  + D+WS GC + E+L  QP +    G+  L  I K  G P   
Sbjct: 187 YYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245

Query: 496 ------------------------LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 531
                                   +       +A     + L+  P  R T  +   H F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

Query: 532 VKR------PLQKSRGPPSYYN 547
                     L   R  P+ +N
Sbjct: 306 FDELRDPNVKLPNGRDTPALFN 327

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 5e-55
 Identities = 67/287 (23%), Positives = 118/287 (41%), Gaps = 30/287 (10%)

Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
              LG GSFG VYEG        +     A+K V+         +  ++   E  ++  F
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS----MRERIEFLNEASVMKEF 80

Query: 336 EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-----------LMDSQVSAYTR 384
              ++V+  G         + +EL+T+G L +  +                 S++     
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 385 QILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC----KGTPF 440
           +I +G+ YL+    VHRD+   N +V    +VK+ DFG+ +     D             
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 441 WMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPN 499
           WM+PE   LK+  +   +D+WS G  + E+ T  + PY  L   Q L  + +G     P+
Sbjct: 201 WMSPES--LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258

Query: 500 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRGPPSYY 546
           +      + +  C Q NP  RP+  +++    +K  ++      S+Y
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISS--IKEEMEPGFREVSFY 303

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (466), Expect = 1e-54
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 35/287 (12%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++K E +G G++GTV++    +     A+K V L D       S L+   EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60

Query: 338 ENIVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHEQ 396
           +NIV+       + +L +  E   +            L    V ++  Q+L GL + H +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 397 NVVHRDIKCANILVDASGSVKLADFGLAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGYG 455
           NV+HRD+K  N+L++ +G +KLA+FGLA+A  +     S +    W  P  V    + Y 
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 456 LTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPL------------------ 496
            + D+WS GC   E+    +P +   +    L RI +                       
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 497 ----------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                     V   L+   RD +   L+ NP  R +A + ++HP+  
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-54
 Identities = 68/279 (24%), Positives = 111/279 (39%), Gaps = 38/279 (13%)

Query: 282 GELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF 335
           G+ LG+G+FG V E        +D     AVK +      T+ +     L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA----LMSELKVLSYL 83

Query: 336 E-HENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-------------------LM 375
             H NIV   G         +  E    G L N  ++                     L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 376 DSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKS- 434
              + +++ Q+  G+ +L  +N +HRD+   NIL+      K+ DFGLA+    +     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 435 ---CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIG 490
               +    WMAPE   + N  Y   +D+WS G  + E+ +    PY  +      +++ 
Sbjct: 204 KGNARLPVKWMAPES--IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 491 K-GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 528
           K G   L P     +  D +  C   +P  RPT  Q+++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-53
 Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 37/279 (13%)

Query: 282 GELLGSGSFGTVYEG--------YTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS 333
           G+ LG G+FG V             +     AVK +         ++ +  L  E+ ++ 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMK 73

Query: 334 RF-EHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKY-----------------HLM 375
              +H+NI+   G    +  L++ +E  +KG+L    Q                    L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 376 DSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK-- 433
              + +   Q+  G+ YL  +  +HRD+   N+LV     +K+ADFGLA+     D    
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 434 --SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIG 490
             + +    WMAPE   L +R Y   +D+WS G  + E+ T    PY  +   +    + 
Sbjct: 194 TTNGRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 491 KGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           +G     P++ + +    +  C    P+ RPT  QL+E 
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (456), Expect = 7e-53
 Identities = 51/284 (17%), Positives = 96/284 (33%), Gaps = 34/284 (11%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++ G  +GSGSFG +Y G     G   A+K   +       K    QL  E  +    + 
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIYKMMQG 61

Query: 338 EN-IVQYFGTDKDENRLFIFLELVTKGSLA-NLYQKYHLMDSQVSAYTRQILNGLNYLHE 395
              I        + +   + +EL+         +         V     Q+++ + Y+H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 396 QNVVHRDIKCANILV---DASGSVKLADFGLAKATTMNDVKSC---------KGTPFWMA 443
           +N +HRD+K  N L+        V + DFGLAK                    GT  + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 444 PEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-------PPL 496
                          D+ SLG  ++       P+  L+      +  +           +
Sbjct: 182 INT--HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 497 VPNSLSRDARDFILKCLQVNPNDRPTAA---QLMEHPFVKRPLQ 537
           +      +   ++  C  +  +D+P  +   QL  + F ++   
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  177 bits (449), Expect = 1e-51
 Identities = 64/298 (21%), Positives = 117/298 (39%), Gaps = 54/298 (18%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-E 336
           +Q    LG G +  V+E     +     VK +              ++++EI +L     
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88

Query: 337 HENIVQYFGT--DKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLH 394
             NI+       D       +  E V       LYQ   L D  +  Y  +IL  L+Y H
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 146

Query: 395 EQNVVHRDIKCANILVDASG-SVKLADFGLAKATTMNDVKSCK-GTPFWMAPEVVNLKNR 452
              ++HRD+K  N+++D     ++L D+GLA+        + +  + ++  PE + +  +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE-LLVDYQ 205

Query: 453 GYGLTADIWSLGCTVLEMLTRQPPY----SHLEGMQALFRIGKGE--------------- 493
            Y  + D+WSLGC +  M+ R+ P+     + + +  + ++   E               
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 494 ------------------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                                  + +S +A DF+ K L+ +   R TA + MEHP+  
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-51
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 35/281 (12%)

Query: 279 WQKGELLGSGSFGTVYEGY------TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLL 332
            + G+ LG G+FG V E        T      AVK   L++  T  +   L  E +IL+ 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIH 72

Query: 333 SRFEHENIVQYFG-TDKDENRLFIFLELVTKGSLANLYQKY-----------------HL 374
               H N+V   G   K    L + +E    G+L+   +                    L
Sbjct: 73  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 375 MDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--- 431
               +  Y+ Q+  G+ +L  +  +HRD+   NIL+     VK+ DFGLA+    +    
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 432 -VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFR- 488
                +    WMAPE   + +R Y + +D+WS G  + E+ +    PY  ++  +   R 
Sbjct: 192 RKGDARLPLKWMAPET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 489 IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 529
           + +G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 3e-51
 Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 41/290 (14%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           +  + +GSG++G V        G   A+K++    Q     +   +  +E+ LL    HE
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMRHE 77

Query: 339 NIVQYFGTDKDENRLFIFLELVT-----KGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
           N++        +  L  F +           L  L +   L + ++     Q+L GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           H   ++HRD+K  N+ V+    +K+ DFGLA+    +++     T ++ APEV+ L    
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVVTRWYRAPEVI-LNWMR 195

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI--GKGEPPL--------------- 496
           Y  T DIWS+GC + EM+T +  +   + +  L  I    G PP                
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 497 -------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 533
                        +  + S  A + + K L ++   R TA + + HP+ +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 4e-51
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 41/291 (14%)

Query: 280 QKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHE 338
           Q    +GSG++G+V   + T  G   AVK++S   Q     +   +  +E+ LL   +HE
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHE 77

Query: 339 NIVQYFG-----TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYL 393
           N++            +E      +  +    L N+ +   L D  V     QIL GL Y+
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 394 HEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRG 453
           H  +++HRD+K +N+ V+    +K+ DFGLA+ T          T ++ APE++ L    
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-TGYVATRWYRAPEIM-LNWMH 195

Query: 454 YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI--GKGEPPL--------------- 496
           Y  T DIWS+GC + E+LT +  +   + +  L  I    G P                 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 497 -------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 534
                        V    +  A D + K L ++ + R TAAQ + H +  +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  167 bits (423), Expect = 4e-48
 Identities = 48/274 (17%), Positives = 91/274 (33%), Gaps = 33/274 (12%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           ++ G  +G GSFG ++EG    +    A+K           +    QL  E         
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-------RSDAPQLRDEYRTYKLLAG 59

Query: 338 -ENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYH-LMDSQVSAYTRQILNGLNYLHE 395
              I   +   ++     + ++L+       L           V+   +Q+L  +  +HE
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 396 QNVVHRDIKCANILVDA-----SGSVKLADFGLAKA---------TTMNDVKSCKGTPFW 441
           +++V+RDIK  N L+       +  + + DFG+ K              + K+  GT  +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 442 MAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ---PPYSHLEGMQALFRIGKGEPPLVP 498
           M+        R      D+ +LG   +  L               Q   RIG+ +     
Sbjct: 180 MSINT--HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 499 NSL----SRDARDFILKCLQVNPNDRPTAAQLME 528
             L      +   ++     +  +  P    L  
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 1e-47
 Identities = 72/336 (21%), Positives = 141/336 (41%), Gaps = 59/336 (17%)

Query: 264 YNVSPNGKFRRRIMSWQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSI 322
           Y+V         +  +Q  + +GSG+ G V   Y        A+K++S   Q     +  
Sbjct: 4   YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-- 61

Query: 323 LQLEQEILLLSRFEHENIVQYFG------TDKDENRLFIFLELVTKGSLANLYQKYHLMD 376
            +  +E++L+    H+NI+          T ++   +++ +EL+       +  +     
Sbjct: 62  -RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--H 118

Query: 377 SQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCK 436
            ++S    Q+L G+ +LH   ++HRD+K +NI+V +  ++K+ DFGLA+    + + +  
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178

Query: 437 -GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE-- 493
             T ++ APE   +   GY    DIWS+GC + EM+  +  +   + +    ++ +    
Sbjct: 179 VVTRYYRAPE--VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 494 ----------------------------PPLVPNSL-----------SRDARDFILKCLQ 514
                                       P L P+SL           +  ARD + K L 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 515 VNPNDRPTAAQLMEHPFVKR---PLQKSRGPPSYYN 547
           ++P  R +    ++HP++     P +    PP  Y+
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYD 332

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 71/330 (21%), Positives = 118/330 (35%), Gaps = 81/330 (24%)

Query: 279 WQKGELLGSGSFGTVYEGY-TDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH 337
           +     LG G F TV+      +    A+K V      T+        E EI LL R   
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE------AAEDEIKLLQRVND 68

Query: 338 ENIVQ-------------YFGTDKDENRLFIFLELVTKG----SLANLYQKYHLMDSQVS 380
            +  +                  K  N + + +     G    +L   Y+   +    V 
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 381 AYTRQILNGLNYLH-EQNVVHRDIKCANILVDASG------SVKLADFGLAKATTMNDVK 433
             ++Q+L GL+Y+H    ++H DIK  N+L++          +K+AD G A     +   
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY------SHLEGMQALF 487
           S   T  + +PEV  L    +G  ADIWS  C + E++T    +      S+ +    + 
Sbjct: 189 SI-QTREYRSPEV--LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245

Query: 488 RIGK--GEPP---------------------------------------LVPNSLSRDAR 506
           +I +  GE P                                             +++  
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305

Query: 507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPL 536
           DF+   LQ++P  R  A  L+ HP++K  L
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  104 bits (259), Expect = 2e-26
 Identities = 33/204 (16%), Positives = 65/204 (31%), Gaps = 33/204 (16%)

Query: 282 GELLGSGSFGTVYEGYTDDGFFFAVKEVSL-------------QDQGTQGKQSILQLEQE 328
           G+L+G G    V+  Y++      VK   +                      +I     E
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 329 ILLLSRFEHENIVQYFGTDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILN 388
              L + +   + + +          + +EL+         + Y +           IL 
Sbjct: 65  FRALQKLQGLAVPKVY----AWEGNAVLMELIDAK------ELYRVRVENPDEVLDMILE 114

Query: 389 GLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVN 448
            +   + + +VH D+   N+LV   G + + DF  +                 +  +V N
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEG------WREILERDVRN 167

Query: 449 LK---NRGYGLTADIWSLGCTVLE 469
           +    +R Y    DI S    +L+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	551
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.18
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.1
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.81
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.63

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-57  Score=453.04  Aligned_cols=254  Identities=30%  Similarity=0.531  Sum_probs=227.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||+||+|++ .+|+.||||++......  .......+.+|+.++++++|||||++++++.+...+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc--ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            56899999999999999999998 57999999998743221  1223456789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      +|||||.+|+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            99999999999998875 46899999999999999999999999999999999999999999999999999877666667


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhh
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      ...||+.|+|||++.  +..|+.++|||||||++|+|++|+.||.+.+..+.+.++.+... .+|..+++++.+||.+||
T Consensus       163 ~~~Gt~~Y~APE~~~--~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L  239 (263)
T d2j4za1         163 TLCGTLDYLPPEMIE--GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISRLL  239 (263)
T ss_dssp             ETTEEGGGCCHHHHT--TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCCTTSCHHHHHHHHHHT
T ss_pred             ccCCCCcccCHHHHc--CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCccCCHHHHHHHHHHc
Confidence            778999999999984  56789999999999999999999999998888777777776654 456789999999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCC
Q 043852          514 QVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~  534 (551)
                      ++||.+|||++|+|+||||+.
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=455.56  Aligned_cols=258  Identities=25%  Similarity=0.439  Sum_probs=217.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||+||+|++ .+|+.||||++......    .....+.+|+.++++++|||||++++++.+...+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc----hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence            45899999999999999999998 57999999999754322    22346789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      ||||||.+|+|.+++++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......  
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999999998865 469999999999999999999999999999999999999999999999999998654322  


Q ss_pred             --cccCCCCCcccChhhhhcccCC-CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH-HhhcC-CCCCCCCcCCHHHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRG-YGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKG-EPPLVPNSLSRDAR  506 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~-~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~-~i~~~-~~~~~~~~~s~~l~  506 (551)
                        ....+||+.|+|||++.  +.. ++.++|||||||++|||+||++||.......... .+... ........++.++.
T Consensus       160 ~~~~~~~GT~~Y~APE~~~--~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  237 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  237 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHH--CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             ccccceeeCcCccCHhHhc--CCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence              34567999999999984  334 4688999999999999999999997654433322 22222 22233457899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      +||.+||+.||++|||++|+++||||++++.+.
T Consensus       238 ~li~~~L~~dP~~R~t~~eil~hpwf~~~l~kg  270 (271)
T d1nvra_         238 ALLHKILVENPSARITIPDIKKDRWYNKPLKKG  270 (271)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhCcCCCCC
Confidence            999999999999999999999999999988764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=455.69  Aligned_cols=252  Identities=35%  Similarity=0.628  Sum_probs=223.7

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      +|++++.||+|+||+||+|.+ .+|+.||||++......     ....+.+|+.++++++|||||++++++.+...+|||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            699999999999999999987 68999999998754322     134678999999999999999999999999999999


Q ss_pred             EecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cccc
Q 043852          357 LELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKS  434 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~  434 (551)
                      ||||.||+|.+++.+..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  ....
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999999999889999999999999999999999999999999999999999999999999999865433  3456


Q ss_pred             CCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC--CCCCCcCCHHHHHHHHHh
Q 043852          435 CKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP--PLVPNSLSRDARDFILKC  512 (551)
Q Consensus       435 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~LI~~c  512 (551)
                      .+||+.|+|||++  .+..|+.++|||||||++|+|++|+.||.+.+....+..+.....  ...+..++..+++||.+|
T Consensus       176 ~~gt~~Y~aPE~~--~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  253 (293)
T d1yhwa1         176 MVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (293)
T ss_dssp             CCSCGGGCCHHHH--SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred             cccCCCccChhhh--cCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence            6799999999998  456789999999999999999999999998887777766654433  234567999999999999


Q ss_pred             hhcCCCCCCCHHHHHhCcccCCcc
Q 043852          513 LQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       513 L~~DP~~RPS~~eILehpff~~~~  536 (551)
                      |++||.+|||++|+|+||||+...
T Consensus       254 L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         254 LDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             TCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ccCChhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999998543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-56  Score=446.78  Aligned_cols=252  Identities=29%  Similarity=0.512  Sum_probs=214.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC--CCe
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD--ENR  352 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~  352 (551)
                      .++|++++.||+|+||+||+|++ .+|+.||||++.....   .......+.+|+.++.+++|||||++++++.+  ...
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC---CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence            46899999999999999999987 5899999999875433   23445678899999999999999999998854  567


Q ss_pred             EEEEEecccccchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHhCC-----eeecccccceEEEcCCCcEEEEecC
Q 043852          353 LFIFLELVTKGSLANLYQK-----YHLMDSQVSAYTRQILNGLNYLHEQN-----VVHRDIKCANILVDASGSVKLADFG  422 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~-----~~l~~~~i~~i~~QI~~aL~yLH~~g-----IiHrDIKP~NILl~~~g~vkL~DFG  422 (551)
                      +|||||||++|+|.+++.+     ..+++..++.++.||+.||.|||++|     |+||||||+||||+.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            8999999999999998864     35899999999999999999999876     9999999999999999999999999


Q ss_pred             CccccccC--CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCc
Q 043852          423 LAKATTMN--DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNS  500 (551)
Q Consensus       423 la~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  500 (551)
                      +++.....  ......||+.|+|||++  ....|+.++|||||||++|||+||+.||.+.+..+...++..+....++..
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  237 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQM--NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  237 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             ceeecccCCCccccCCCCcccCCHHHH--cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            99866433  23456799999999997  456789999999999999999999999999888888888888888888889


Q ss_pred             CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 043852          501 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  532 (551)
Q Consensus       501 ~s~~l~~LI~~cL~~DP~~RPS~~eILehpff  532 (551)
                      +++++.+||.+||+.||.+|||++||++|||+
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=447.97  Aligned_cols=254  Identities=38%  Similarity=0.678  Sum_probs=223.3

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|++++.||+|+||+||+|++ .+|..||||++.....     .....+.+|+.++++++|||||++++++.+...+|||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence            589999999999999999998 5899999999875422     2244677999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          357 LELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      ||||.+|+|.+++.+  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....  ..
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence            999999999998754  35999999999999999999999999999999999999999999999999999754322  23


Q ss_pred             ccCCCCCcccChhhhhc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC--CCcCCHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNL---KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV--PNSLSRDARD  507 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~s~~l~~  507 (551)
                      ....||+.|+|||++..   ....|+.++|||||||++|||+||+.||.+.+..+.+.++.++.++..  +..++.++.+
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~  247 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD  247 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence            45679999999999742   245689999999999999999999999998888888888877765443  4578999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ||.+||++||.+|||++||++||||+...
T Consensus       248 li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         248 FLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999998543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-55  Score=444.38  Aligned_cols=255  Identities=26%  Similarity=0.454  Sum_probs=222.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++.......  ......+.+|+.++++++||||+++++++.+...+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC--HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            45899999999999999999988 589999999997532211  223456889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC---
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~---  430 (551)
                      +|||||.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....   
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999988765 56999999999999999999999999999999999999999999999999999865432   


Q ss_pred             -CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 -DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                       .....+||+.|+|||++  .+..|+.++|||||||++|||++|+.||.+.+..+...++.++.. .++..+++++.+||
T Consensus       165 ~~~~~~~GT~~Y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li  241 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLV  241 (288)
T ss_dssp             -----CCCCGGGCCHHHH--HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCTTCCHHHHHHH
T ss_pred             cccccccCCccccCceee--ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-CCCccCCHHHHHHH
Confidence             23456799999999997  456789999999999999999999999999888888888877654 45778999999999


Q ss_pred             HHhhhcCCCCCCCHHH------HHhCcccCCc
Q 043852          510 LKCLQVNPNDRPTAAQ------LMEHPFVKRP  535 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~e------ILehpff~~~  535 (551)
                      .+||++||.+|||++|      |++||||+..
T Consensus       242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            9999999999999987      6899999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.5e-55  Score=446.06  Aligned_cols=255  Identities=35%  Similarity=0.596  Sum_probs=224.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|+.++.||+|+||+||+|++ .+|+.||||++.....  ........+.+|+.++.+++|||||++++++.+...+|+|
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            489999999999999999987 6899999999875432  2244566788999999999999999999999999999999


Q ss_pred             EecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcccC
Q 043852          357 LELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVKSC  435 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  435 (551)
                      ||||.+|+|..++. +..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....  ....
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~~  171 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANSF  171 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCCC
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CCcc
Confidence            99999999977654 45799999999999999999999999999999999999999999999999999976543  3456


Q ss_pred             CCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC-CCCcCCHHHHHHHHHhh
Q 043852          436 KGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL-VPNSLSRDARDFILKCL  513 (551)
Q Consensus       436 ~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~LI~~cL  513 (551)
                      .||+.|+|||++... ...|+.++|||||||++|||++|..||.+....+.+.++..+..+. .+..++..+.+||.+||
T Consensus       172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L  251 (309)
T d1u5ra_         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL  251 (309)
T ss_dssp             CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred             ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence            799999999998533 3468999999999999999999999999888888887777665544 45568999999999999


Q ss_pred             hcCCCCCCCHHHHHhCcccCCcc
Q 043852          514 QVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       514 ~~DP~~RPS~~eILehpff~~~~  536 (551)
                      ++||.+|||++++|+||||++..
T Consensus       252 ~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         252 QKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             cCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=436.75  Aligned_cols=249  Identities=29%  Similarity=0.533  Sum_probs=214.0

Q ss_pred             eeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC----CCeE
Q 043852          279 WQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD----ENRL  353 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~  353 (551)
                      |+..+.||+|+||+||+|.+ .++..||+|++.....   .......+.+|+.+|++++|||||++++++.+    ...+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            45677899999999999988 5789999999875432   23445678899999999999999999998754    4568


Q ss_pred             EEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCC--eeecccccceEEEc-CCCcEEEEecCCcccccc
Q 043852          354 FIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQN--VVHRDIKCANILVD-ASGSVKLADFGLAKATTM  429 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~g--IiHrDIKP~NILl~-~~g~vkL~DFGla~~~~~  429 (551)
                      |+|||||++|+|.+++++. .+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++....
T Consensus        88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999999988764 6899999999999999999999998  99999999999996 578999999999987666


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH-HHHhhcCCC-CCCCCcCCHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA-LFRIGKGEP-PLVPNSLSRDARD  507 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~-~~~i~~~~~-~~~~~~~s~~l~~  507 (551)
                      ......+||+.|+|||+++   ..|+.++|||||||++|||++|+.||.+...... ...+..+.. ...+..+++++.+
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~---~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  244 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             CccCCcccCccccCHHHhC---CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence            6667788999999999874   3589999999999999999999999977655444 445555433 3345568999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          508 FILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       508 LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      ||.+||++||++|||++|||+|||||
T Consensus       245 li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         245 IIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999997

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=451.23  Aligned_cols=257  Identities=30%  Similarity=0.502  Sum_probs=216.2

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      ++|++++.||+|+||+||+|++ .+|+.||+|++.....    .....++.+|+.+|++++|||||++++++.+...+|+
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4799999999999999999997 5899999999875422    2334577899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      |||||.||+|.+++.+ ..+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+........
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  161 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  161 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence            9999999999998865 469999999999999999999997 59999999999999999999999999999876655566


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH----------------------------
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQA----------------------------  485 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~----------------------------  485 (551)
                      +.+||+.|+|||++  .+..|+.++|||||||++|||++|+.||.+.+....                            
T Consensus       162 ~~~GT~~Y~APEvl--~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         162 SFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             --CCSSCCCCHHHH--HCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccCCccccCchHH--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            77899999999998  456799999999999999999999999965432211                            


Q ss_pred             --------------HHHhhcCCCCCCC-CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          486 --------------LFRIGKGEPPLVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       486 --------------~~~i~~~~~~~~~-~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                                    ...+....++..+ ..++.++.+||.+||+.||.+|||++|+|+||||++.-.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~  308 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  308 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccc
Confidence                          1111222222222 34689999999999999999999999999999998755433

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=437.04  Aligned_cols=256  Identities=29%  Similarity=0.497  Sum_probs=225.0

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCcc-chHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQ-GKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .|++++.||+|+||+||+|++ .+|+.||||++........ .......+.+|+.+|++++|||||++++++.+...+||
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            699999999999999999998 6899999999976543322 22235678899999999999999999999999999999


Q ss_pred             EEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC----cEEEEecCCcccccc-
Q 043852          356 FLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG----SVKLADFGLAKATTM-  429 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g----~vkL~DFGla~~~~~-  429 (551)
                      |||||.+|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+++.... 
T Consensus        91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~  170 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG  170 (293)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS
T ss_pred             EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC
Confidence            9999999999998865 4699999999999999999999999999999999999998776    599999999987643 


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRDAR  506 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~l~  506 (551)
                      .......||+.|+|||++  .+..++.++|||||||++|||++|+.||.+.+..+.+..+..+.....   +..++..++
T Consensus       171 ~~~~~~~~t~~y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  248 (293)
T d1jksa_         171 NEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  248 (293)
T ss_dssp             CBCSCCCCCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             ccccccCCCCcccCHHHH--cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence            334566799999999998  356789999999999999999999999999888888888777654433   357899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      +||.+||++||.+|||++|+++||||+..
T Consensus       249 ~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         249 DFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999853

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-54  Score=442.83  Aligned_cols=252  Identities=27%  Similarity=0.455  Sum_probs=206.6

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      .|++++.||+|+||+||+|++ .+|+.||||++.......    ....+.+|+.++++++|||||++++++.+.+.+|||
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG----KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            599999999999999999988 579999999997543322    234577999999999999999999999999999999


Q ss_pred             EecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc---CCCcEEEEecCCccccccCC-
Q 043852          357 LELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD---ASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~---~~g~vkL~DFGla~~~~~~~-  431 (551)
                      ||||.||+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||+.   .++.+||+|||+++...... 
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            999999999998865 4699999999999999999999999999999999999995   47899999999998664433 


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---CCCcCCHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDARDF  508 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~~L  508 (551)
                      ....+||+.|+|||++  .+..|+.++|||||||++|+|++|+.||.+....+....+.++....   .+..+|+++.+|
T Consensus       166 ~~~~~GT~~y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  243 (307)
T d1a06a_         166 LSTACGTPGYVAPEVL--AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF  243 (307)
T ss_dssp             -------CTTSCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             eeeeeeCccccCcHHH--cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence            4456799999999998  45678999999999999999999999999888888777777765433   335789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          509 ILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      |.+||++||.+|||++|+++||||++.
T Consensus       244 i~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         244 IRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999854

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=445.96  Aligned_cols=256  Identities=28%  Similarity=0.449  Sum_probs=226.5

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      .+++|++++.||+|+||.||+|++ .+|+.||||++.+.....  .....++.+|+.+|++++||||+++++++.+...+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC--HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            467899999999999999999998 689999999997542211  22355678999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--C
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--N  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~  430 (551)
                      |+|||||.||+|..++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999999999988876 4688999999999999999999999999999999999999999999999999986543  2


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      .....+||+.|+|||++  .+..|+.++|||||||++|||++|++||.+.+..+....+..+. ..+|..++.++.+||.
T Consensus       161 ~~~~~~GT~~Y~aPE~~--~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~  237 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             CBCCCEECGGGCCGGGG--SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhc--cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHH
Confidence            34567799999999997  45688999999999999999999999999988877777777665 4567889999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          511 KCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       511 ~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      +||++||.+|++     +++|++||||++.
T Consensus       238 ~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             hhccCCchhhcccccccHHHHHcCcccccC
Confidence            999999999994     9999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.8e-54  Score=447.17  Aligned_cols=256  Identities=29%  Similarity=0.441  Sum_probs=224.7

Q ss_pred             hcccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          274 RRIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       274 ~~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ..+++|++++.||+|+||+||+|++ .+|..||||++....     ......+.+|+.+|.+++|||||++++++.+.+.
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3467899999999999999999987 589999999986432     2334577899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC--CCcEEEEecCCccccc
Q 043852          353 LFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA--SGSVKLADFGLAKATT  428 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~--~g~vkL~DFGla~~~~  428 (551)
                      +|||||||.||+|.+++.  ...+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            999999999999999884  346999999999999999999999999999999999999964  6789999999998764


Q ss_pred             cC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCC---CCcCCHH
Q 043852          429 MN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLV---PNSLSRD  504 (551)
Q Consensus       429 ~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~  504 (551)
                      .. ......||+.|||||++  .+..|+.++|||||||++|+|++|+.||.+.+..+.+..+........   ...++..
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~--~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  255 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  255 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHH--HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred             cccccceecCcccccCHHHH--cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            43 34457799999999997  456789999999999999999999999998888888887776654332   2468999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      +++||.+||++||.+|||++|+|+||||+...
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999998654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.8e-54  Score=446.52  Aligned_cols=255  Identities=28%  Similarity=0.469  Sum_probs=225.2

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      .+.|++++.||+|+||.||+|++ .+|+.||||++....     ......+.+|+.+|++++|||||++++++.+...+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45799999999999999999998 589999999987532     223456779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc--CCCcEEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD--ASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~--~~g~vkL~DFGla~~~~~~  430 (551)
                      ||||||.||+|.+++.+.  ++++..++.++.||+.||.|||++||+||||||+||||+  .++.+||+|||+|+.....
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999999998877543  589999999999999999999999999999999999997  5789999999999876544


Q ss_pred             C-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---CCCcCCHHHH
Q 043852          431 D-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLSRDAR  506 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~  506 (551)
                      . .....||+.|+|||++  .+..|+.++|||||||++|+|+||..||.+.+..+.+.++..+....   ....++.++.
T Consensus       183 ~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIV--DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             SCEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CceeeccCcccccCHHHH--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            3 4456799999999997  45678999999999999999999999999988888888887765433   3357899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +||.+||++||.+|||++|+|+||||+....
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            9999999999999999999999999987543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.6e-54  Score=439.81  Aligned_cols=254  Identities=28%  Similarity=0.485  Sum_probs=225.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +.+|++++.||+|+||+||+|++ .+|+.||||++......  .......+.+|+.++++++|||||++++++.+...+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV--RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc--CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            56899999999999999999998 67999999999753221  1223456789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      +|||||.||+|..++... .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..... ..
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-~~  159 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY  159 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BC
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-cc
Confidence            999999999998887654 5788888999999999999999999999999999999999999999999999876533 44


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhh
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      ..+||+.|+|||++  .+..|+.++|||||||++|+|+||+.||.+.+..+.+.++.++.. .++..++.++.++|.+||
T Consensus       160 ~~~Gt~~Y~APE~l--~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L  236 (316)
T d1fota_         160 TLCGTPDYIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLI  236 (316)
T ss_dssp             CCCSCTTTCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHT
T ss_pred             cccCcccccCHHHH--cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHh
Confidence            56799999999997  456789999999999999999999999999888888888877754 456789999999999999


Q ss_pred             hcCCCCCC-----CHHHHHhCcccCCc
Q 043852          514 QVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       514 ~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      ++||.+|+     |+++|++||||++.
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             hhCHHhccccchhhHHHHHcCcccccC
Confidence            99999996     99999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-53  Score=445.72  Aligned_cols=259  Identities=28%  Similarity=0.428  Sum_probs=222.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCc-cchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGT-QGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      +++|+++++||+|+||.||+|++ .+|+.||||++....... ...........++.+++.++|||||++++++.+...+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            56899999999999999999998 589999999987543211 2223344445668888999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCc
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDV  432 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~  432 (551)
                      |||||||.||+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~  162 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  162 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence            999999999999998865 4588899999999999999999999999999999999999999999999999988776667


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh--HHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG--MQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ....||+.|+|||++. .+..|+.++|||||||++|||+||+.||.+...  ...+.+.........+..+++++.+||.
T Consensus       163 ~~~~GT~~y~APE~~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (364)
T d1omwa3         163 HASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE  241 (364)
T ss_dssp             CSCCSCGGGCCHHHHS-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred             cccccccccchhHHhh-cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence            7778999999999983 455789999999999999999999999976432  3334444445556667889999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHhCcccCCc
Q 043852          511 KCLQVNPNDRPT-----AAQLMEHPFVKRP  535 (551)
Q Consensus       511 ~cL~~DP~~RPS-----~~eILehpff~~~  535 (551)
                      +||++||.+|||     +++|++||||+..
T Consensus       242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            999999999999     7999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.6e-53  Score=426.60  Aligned_cols=259  Identities=28%  Similarity=0.473  Sum_probs=226.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccc----hHHHHHHHHHHHHHhcCC-CCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQG----KQSILQLEQEILLLSRFE-HENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~----~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~  350 (551)
                      ++|++++.||+|+||+||+|++ .+|+.||||++.........    +.....+.+|+.++.++. ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5899999999999999999987 68999999999876544332    233456789999999997 99999999999999


Q ss_pred             CeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..+|||||||++|+|.++++. ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  162 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  162 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence            999999999999999998864 4689999999999999999999999999999999999999999999999999987653


Q ss_pred             C-CcccCCCCCcccChhhhhc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---CCCcC
Q 043852          430 N-DVKSCKGTPFWMAPEVVNL----KNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSL  501 (551)
Q Consensus       430 ~-~~~~~~GT~~Y~APEvl~~----~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~  501 (551)
                      . ......||+.|+|||++..    ....++.++|||||||++|+|++|+.||.+.+.......+..+....   ....+
T Consensus       163 ~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (277)
T d1phka_         163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY  242 (277)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGS
T ss_pred             CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence            3 3445679999999999853    23457899999999999999999999999988888777777665332   23479


Q ss_pred             CHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          502 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       502 s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      |+++++||.+||++||.+|||++|||+||||++.
T Consensus       243 s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            9999999999999999999999999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=432.99  Aligned_cols=253  Identities=29%  Similarity=0.451  Sum_probs=210.5

Q ss_pred             eeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEec
Q 043852          281 KGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLEL  359 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey  359 (551)
                      .+++||+|+||+||+|++ .+|+.||||++...............+.+|+.++++++|||||++++++.+...+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            468999999999999998 5799999999875543333333345678999999999999999999999999999999999


Q ss_pred             ccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--CcccCC
Q 043852          360 VTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DVKSCK  436 (551)
Q Consensus       360 ~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~~~~~  436 (551)
                      |.++++..+... ..+++..+..+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  .....+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            999888877764 45899999999999999999999999999999999999999999999999999765433  234567


Q ss_pred             CCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--CC-------------------
Q 043852          437 GTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--PP-------------------  495 (551)
Q Consensus       437 GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~-------------------  495 (551)
                      ||+.|+|||++. ....|+.++|||||||++|||+||.+||.+.+..+.+.++.+..  +.                   
T Consensus       162 gt~~y~aPE~~~-~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         162 VTRWYRAPELLF-GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCTTCCHHHHT-TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             cChhhccHHHHc-cCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            999999999973 45578999999999999999999999999888887776654310  00                   


Q ss_pred             -C-----CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          496 -L-----VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       496 -~-----~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                       .     ....++.++.+||.+||++||++|||++|+|+||||+.
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence             0     01246889999999999999999999999999999984

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-53  Score=441.82  Aligned_cols=254  Identities=26%  Similarity=0.431  Sum_probs=225.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||.||+|++ .+|+.||||++......  .......+.+|+.+|+.++|||||++++++.+...+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc--CHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            57899999999999999999988 58999999998643221  1223456789999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCCcc
Q 043852          355 IFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMNDVK  433 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~~~  433 (551)
                      +||||+.+|+|..++.+ ..+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... ..
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~  196 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW  196 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BC
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cc
Confidence            99999999999888765 46999999999999999999999999999999999999999999999999999876533 34


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhh
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKCL  513 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL  513 (551)
                      ...||+.|||||++  .+..|+.++|||||||++|||+||+.||.+.+....+.++..+.. ..+..++.++.+||.+||
T Consensus       197 ~~~Gt~~Y~APE~~--~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L  273 (350)
T d1rdqe_         197 TLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CCEECGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHS
T ss_pred             cccCccccCCHHHH--cCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHh
Confidence            56799999999998  456789999999999999999999999999888888888877764 446789999999999999


Q ss_pred             hcCCCCCC-----CHHHHHhCcccCCc
Q 043852          514 QVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       514 ~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      ++||.+|+     |+++|++||||+..
T Consensus       274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         274 QVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hhCHHhccccccccHHHHHcCccccCC
Confidence            99999994     99999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-53  Score=433.21  Aligned_cols=256  Identities=24%  Similarity=0.391  Sum_probs=224.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||+||+|.+ .+|+.||||++....      .....+.+|+.+|+.++|||||++++++.+...+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            56899999999999999999998 589999999996432      12335779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC--CcEEEEecCCccccccC
Q 043852          355 IFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS--GSVKLADFGLAKATTMN  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~--g~vkL~DFGla~~~~~~  430 (551)
                      ||||||.||+|.+++.+.  .+++..++.|+.||+.||.|||++||+||||||+|||++.+  +.+||+|||+++.....
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999999998754  58999999999999999999999999999999999999854  48999999999866543


Q ss_pred             C-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCC---CcCCHHHH
Q 043852          431 D-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVP---NSLSRDAR  506 (551)
Q Consensus       431 ~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~l~  506 (551)
                      . .....||+.|+|||.+  .+..|+.++|||||||++|+|++|..||.+.+..+.+.++.++......   ..++.++.
T Consensus       158 ~~~~~~~~t~~y~ape~~--~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVH--QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             CEEEEEESCGGGSCHHHH--TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             Ccccccccccccccchhc--cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            3 4456699999999997  4567899999999999999999999999998888888888776654332   46899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                      +||.+||++||.+|||++|+++||||++...+.
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~~  268 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERV  268 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccCcccc
Confidence            999999999999999999999999998765443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-53  Score=432.75  Aligned_cols=255  Identities=29%  Similarity=0.512  Sum_probs=221.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHh-cCCCCceeeeeeeccCCCeE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLS-RFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~  353 (551)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.+.....  ......+..|+.++. .++|||||++++++.+...+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~--~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC--hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence            46899999999999999999998 589999999997532111  122344556666554 68999999999999999999


Q ss_pred             EEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc--C
Q 043852          354 FIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM--N  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~--~  430 (551)
                      |||||||.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            999999999999998865 4689999999999999999999999999999999999999999999999999986543  2


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      ......||+.|+|||++  .+..|+.++|||||||++|+|++|+.||.+.+..+.+.++..+. +.+|..++..+.+||.
T Consensus       159 ~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~  235 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEIL--LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLV  235 (320)
T ss_dssp             CBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred             cccccCCCCCcCCHHHH--cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHH
Confidence            34456799999999998  45678999999999999999999999999988888887777765 4567789999999999


Q ss_pred             HhhhcCCCCCCCHH-HHHhCcccCCc
Q 043852          511 KCLQVNPNDRPTAA-QLMEHPFVKRP  535 (551)
Q Consensus       511 ~cL~~DP~~RPS~~-eILehpff~~~  535 (551)
                      +||++||.+|||+. +|++||||++.
T Consensus       236 ~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         236 KLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HhcccCCCCCcCHHHHHHhCchhccC
Confidence            99999999999995 89999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=420.76  Aligned_cols=252  Identities=29%  Similarity=0.494  Sum_probs=212.9

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccc-hHHHHHHHHHHHHHhcCC--CCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQG-KQSILQLEQEILLLSRFE--HENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~  352 (551)
                      ++|+++++||+|+||+||+|++ .+|+.||||++......... .....++.+|+.++++++  |||||++++++.+...
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            3799999999999999999998 58999999999754332211 111223558999999886  8999999999999999


Q ss_pred             EEEEEecccc-cchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCC-CcEEEEecCCcccccc
Q 043852          353 LFIFLELVTK-GSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDAS-GSVKLADFGLAKATTM  429 (551)
Q Consensus       353 ~~lV~Ey~~g-gsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~-g~vkL~DFGla~~~~~  429 (551)
                      +|+||||+.+ +++.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999976 57777765 4569999999999999999999999999999999999999854 7999999999987766


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                      .......||+.|+|||++. ....++.++|||||||++|||+||+.||...+.      +.++. ..++..+|.++.+||
T Consensus       164 ~~~~~~~GT~~y~aPE~~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~-~~~~~~~s~~~~~li  235 (273)
T d1xwsa_         164 TVYTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ-VFFRQRVSSECQHLI  235 (273)
T ss_dssp             SCBCCCCSCGGGSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC-CCCSSCCCHHHHHHH
T ss_pred             ccccccccCCCcCCHHHHc-CCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhcc-cCCCCCCCHHHHHHH
Confidence            6667788999999999984 333457889999999999999999999987432      22232 345678999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          510 LKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                      .+||++||.+|||++|+++||||++..
T Consensus       236 ~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         236 RWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=415.66  Aligned_cols=249  Identities=28%  Similarity=0.494  Sum_probs=217.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .++|++++.||+|+||+||+|.++++..||||++.....      ....+.+|+.++.+++|||||++++++.+ +.+|+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC------CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            358999999999999999999988888999999864322      23467899999999999999999998765 45799


Q ss_pred             EEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          356 FLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      |||||.+|+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... 
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            9999999999987653   258999999999999999999999999999999999999999999999999998764433 


Q ss_pred             --cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                        .....||+.|+|||++.  ...++.++|||||||++|||+| |.+||......+.+..+..+..+..+..++..+.+|
T Consensus       165 ~~~~~~~gt~~y~APE~~~--~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL  242 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHH--HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccCCcccccChHHHh--CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence              33456899999999974  4568999999999999999999 566677777777888888888888889999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh--CcccC
Q 043852          509 ILKCLQVNPNDRPTAAQLME--HPFVK  533 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe--hpff~  533 (551)
                      |.+||+.||++|||+.+|++  |+||.
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            99999999999999999998  78874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=414.87  Aligned_cols=244  Identities=23%  Similarity=0.415  Sum_probs=208.9

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFL  357 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~  357 (551)
                      +|++++.||+|+||+||+|.+.++..||||++.....      ...++.+|+.++.+++|||||++++++.+.+.+|+||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            7999999999999999999988888999999864222      2246789999999999999999999999999999999


Q ss_pred             ecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---c
Q 043852          358 ELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---V  432 (551)
Q Consensus       358 Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---~  432 (551)
                      |||.+|+|.+++..  ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......   .
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            99999999998765  457889999999999999999999999999999999999999999999999998654332   2


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHH
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILK  511 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~  511 (551)
                      ....||+.|+|||++  ....|+.++|||||||++|||+| |.+||......+.+..+..+.....|..++..+.+||.+
T Consensus       160 ~~~~gt~~y~aPE~l--~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         160 TGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             -----CTTSCCHHHH--TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             cceecCcccCChHHh--cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            345689999999998  35579999999999999999999 677788777777888888888888889999999999999


Q ss_pred             hhhcCCCCCCCHHHHHhC
Q 043852          512 CLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       512 cL~~DP~~RPS~~eILeh  529 (551)
                      ||+.||++|||+++|++|
T Consensus       238 cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHH
Confidence            999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=419.18  Aligned_cols=256  Identities=31%  Similarity=0.514  Sum_probs=212.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||+||+|.+ .+|+.||||++......   .....++.+|+.++++++|||||++++++.+...+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~   77 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   77 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence            46899999999999999999998 68999999999654322   223456779999999999999999999999999999


Q ss_pred             EEEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          355 IFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      +|||||.++.+..+..  ..++++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....  
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9999998765554443  346999999999999999999999999999999999999999999999999999765432  


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC--CC-------------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE--PP-------------  495 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~--~~-------------  495 (551)
                      ......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+..+.+.++.+..  +.             
T Consensus       158 ~~~~~~gt~~y~apE~~~-~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILL-GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cceeecccceeeehhhhc-cccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            344557999999999873 34456899999999999999999999999888777666543210  00             


Q ss_pred             --CC-----------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          496 --LV-----------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       496 --~~-----------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                        ..           ...++.++.+||.+||++||.+|||+.|||+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence              00           12467899999999999999999999999999999855

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-51  Score=415.42  Aligned_cols=255  Identities=30%  Similarity=0.518  Sum_probs=215.6

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      +++|++++.||+|+||+||+|++.+|+.||||++......   .....++.+|+.+|++++|||||++++++.+....|+
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence            4689999999999999999999889999999999654322   2234567899999999999999999999999999999


Q ss_pred             EEecccccchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--Cc
Q 043852          356 FLELVTKGSLANLYQ-KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--DV  432 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~-~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~~  432 (551)
                      +|||+.++.+..+.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  ..
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence            999999988888776 456999999999999999999999999999999999999999999999999999765433  23


Q ss_pred             ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--CC----------------
Q 043852          433 KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--EP----------------  494 (551)
Q Consensus       433 ~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~~----------------  494 (551)
                      ....||+.|+|||++. ....++.++|||||||++|||++|+.||.+....+.+.++...  .+                
T Consensus       158 ~~~~~~~~y~~pE~~~-~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLM-GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             ----CCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceecccchhhhHHHHh-CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            4456899999999983 4456799999999999999999999999888777666554321  00                


Q ss_pred             ----------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCC
Q 043852          495 ----------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  534 (551)
Q Consensus       495 ----------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~  534 (551)
                                ......++..+.+||.+||++||++|||+.|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                      1123457899999999999999999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-51  Score=418.58  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=216.2

Q ss_pred             cccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  353 (551)
                      ..++|++++.||+|+||+||+|.+ .+|..||||++.....      ...++.+|+.+|++++|||||++++++.+...+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            345899999999999999999987 5799999998753321      234688999999999999999999999999999


Q ss_pred             EEEEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 FIFLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      |++||||.+|+|.+++.+   ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            999999999999998865   35888999999999999999999999999999999999999999999999999876543


Q ss_pred             Cc---ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCC-CCCchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          431 DV---KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPP-YSHLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       431 ~~---~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                      ..   ....||+.|+|||++.  ...|+.++|||||||++|||++|..| |.+.+.......+..+..+..+..++..+.
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~--~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  246 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  246 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHH--HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CceeeccccccccccChHHHc--CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHH
Confidence            32   2334789999999973  56789999999999999999996655 555555555556667777788889999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      +||.+||+.||++|||+++|++  +|+..++
T Consensus       247 ~li~~cl~~dP~~Rps~~ei~~--~L~~~~~  275 (287)
T d1opja_         247 ELMRACWQWNPSDRPSFAEIHQ--AFETMFQ  275 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH--HHHHTTS
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH--HHHHHHH
Confidence            9999999999999999999976  4544433

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=408.59  Aligned_cols=245  Identities=24%  Similarity=0.431  Sum_probs=220.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIF  356 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV  356 (551)
                      ++|++++.||+|+||+||+|+++++..||||++......      ...+.+|+.++.+++||||+++++++.+...+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            378899999999999999999888889999998753221      24678999999999999999999999999999999


Q ss_pred             EecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC---
Q 043852          357 LELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND---  431 (551)
Q Consensus       357 ~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~---  431 (551)
                      |||+.+|+|..++.  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999999988864  3468889999999999999999999999999999999999999999999999997654332   


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHH
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFIL  510 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~  510 (551)
                      .....||+.|+|||++.  ...++.++|||||||++|||+| |+.||...+..+...++.++.....|..++..+.+||.
T Consensus       158 ~~~~~~t~~y~aPE~~~--~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCSCCCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhc--CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence            23456899999999974  5678999999999999999998 89999999988888889998888889999999999999


Q ss_pred             HhhhcCCCCCCCHHHHHhC
Q 043852          511 KCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       511 ~cL~~DP~~RPS~~eILeh  529 (551)
                      +||+.||++|||+++|++|
T Consensus       236 ~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=417.23  Aligned_cols=248  Identities=27%  Similarity=0.513  Sum_probs=205.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .++|++++.||+|+||+||+|+.+.  .||||++.....   .......+.+|+.++.+++|||||++++++.+ ..+|+
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSC---CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            3578999999999999999997543  599999864422   23456678899999999999999999998754 56899


Q ss_pred             EEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC---
Q 043852          356 FLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN---  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~---  430 (551)
                      |||||++|+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....   
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999998864  45899999999999999999999999999999999999999999999999999765432   


Q ss_pred             -CcccCCCCCcccChhhhhcc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH-HhhcCCCC----CCCCcCCH
Q 043852          431 -DVKSCKGTPFWMAPEVVNLK-NRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF-RIGKGEPP----LVPNSLSR  503 (551)
Q Consensus       431 -~~~~~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~-~i~~~~~~----~~~~~~s~  503 (551)
                       ......||+.|||||++... ...|+.++|||||||+||||+||+.||.+......+. .+.++...    ..+..+++
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  240 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK  240 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence             23456799999999998543 2458999999999999999999999998876554443 33333322    34567899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+.+||.+||+.||.+|||+++|+++
T Consensus       241 ~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         241 AMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=414.21  Aligned_cols=250  Identities=27%  Similarity=0.452  Sum_probs=217.4

Q ss_pred             cCeeeeeE-eccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGEL-LGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~-LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||++...    ........+.+|+.+|.+++|||||++++++.++ .
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e
Confidence            36788885 999999999999752   4567999998642    2344566789999999999999999999998654 5


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|||||||++|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            7999999999999998753  46899999999999999999999999999999999999999999999999999865433


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      .     .....||+.|+|||++.  ...++.++|||||||++|||+| |+.||.+....+....+.++..+..|..++.+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  240 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  240 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccccccCccccChHHHh--CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            2     23445899999999984  4578999999999999999998 99999988888888888888888889999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHH---HhCcccC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQL---MEHPFVK  533 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eI---Lehpff~  533 (551)
                      +.+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999998   5677763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-51  Score=415.42  Aligned_cols=247  Identities=25%  Similarity=0.455  Sum_probs=206.8

Q ss_pred             cCeeeeeEeccCCceEEEEEEec-CCc---eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD-DGF---FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~-~g~---~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      .+|++.++||+|+||+||+|.+. +|.   .||||.+...    ........+.+|+.+|++++|||||++++++.+...
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            47899999999999999999873 333   5777876432    223455678999999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|+|||||.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999999987653  5899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCC
Q 043852          431 D-------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLS  502 (551)
Q Consensus       431 ~-------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  502 (551)
                      .       .....||+.|+|||++  ....|+.++|||||||++|||+| |+.||.+....+....+..+.....+..++
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP  259 (299)
T ss_dssp             --------------CGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             CCcceeeecccccCCccccCHHHH--hcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence            2       1123478999999997  35678999999999999999998 899999988888888888888888888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ..+.+||.+||+.||.+|||+.+|+++
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=413.98  Aligned_cols=245  Identities=28%  Similarity=0.470  Sum_probs=209.6

Q ss_pred             eEeccCCceEEEEEEec---CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEEEEec
Q 043852          283 ELLGSGSFGTVYEGYTD---DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFIFLEL  359 (551)
Q Consensus       283 ~~LG~G~fG~VY~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~Ey  359 (551)
                      +.||+|+||+||+|.+.   +++.||||++....   ........+.+|+.+|.+++|||||++++++.++ ..||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEc
Confidence            57999999999999753   45789999986432   2233456788999999999999999999998654 57899999


Q ss_pred             ccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-----cc
Q 043852          360 VTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-----VK  433 (551)
Q Consensus       360 ~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-----~~  433 (551)
                      |++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......     ..
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            999999998876 459999999999999999999999999999999999999999999999999998654322     23


Q ss_pred             cCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHh
Q 043852          434 SCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFILKC  512 (551)
Q Consensus       434 ~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~c  512 (551)
                      ...||+.|+|||++.  ...++.++|||||||++|||+| |++||.+....+....+.++..+..|..++.++.+||.+|
T Consensus       169 ~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~c  246 (277)
T d1xbba_         169 HGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC  246 (277)
T ss_dssp             --CCCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccCCCceecCchhhc--CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence            356899999999974  4568999999999999999998 8999999888888888888888888999999999999999


Q ss_pred             hhcCCCCCCCHHHH---HhCcccC
Q 043852          513 LQVNPNDRPTAAQL---MEHPFVK  533 (551)
Q Consensus       513 L~~DP~~RPS~~eI---Lehpff~  533 (551)
                      |+.||.+|||+++|   |+|+|++
T Consensus       247 l~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         247 WTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999998   4566643

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=411.39  Aligned_cols=255  Identities=31%  Similarity=0.514  Sum_probs=208.5

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cC-CceEEEEEEecCccCccchHHHHHHHHHHHHH---hcCCCCceeeeeeecc---
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DD-GFFFAVKEVSLQDQGTQGKQSILQLEQEILLL---SRFEHENIVQYFGTDK---  348 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~-g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~---  348 (551)
                      ++|++++.||+|+||+||+|++ .+ ++.||||++............   +.+|+.++   +.++||||+++++++.   
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~---~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCT---HHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHH---HHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            5899999999999999999987 44 678999999765433322222   33555554   4458999999999874   


Q ss_pred             --CCCeEEEEEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          349 --DENRLFIFLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       349 --~~~~~~lV~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                        ....+|++||||.++.+.....  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence              3457899999999987755443  456899999999999999999999999999999999999999999999999998


Q ss_pred             ccccc-CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCC----------
Q 043852          425 KATTM-NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGE----------  493 (551)
Q Consensus       425 ~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~----------  493 (551)
                      +.... .......||+.|+|||++  .+..|+.++|||||||++|||++|++||.+.+..+.+.++....          
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~--~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhcccccCCCcccChhhcCcchh--cCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            76543 334567799999999997  45679999999999999999999999999888777766543210          


Q ss_pred             ----------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          494 ----------------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       494 ----------------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                      .......++..+.+||.+||++||.+|||++|+|+||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                            0112345789999999999999999999999999999998653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=424.75  Aligned_cols=251  Identities=28%  Similarity=0.443  Sum_probs=206.5

Q ss_pred             ccCeeeee-EeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhc-CCCCceeeeeeeccC---
Q 043852          276 IMSWQKGE-LLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSR-FEHENIVQYFGTDKD---  349 (551)
Q Consensus       276 ~~~y~~~~-~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~---  349 (551)
                      +++|.+.+ +||+|+||+||+|++ .+|+.||||++...          ..+.+|+.++.+ .+|||||++++++.+   
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            56898875 699999999999998 68999999998531          245688888654 589999999998865   


Q ss_pred             -CCeEEEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CCcEEEEecC
Q 043852          350 -ENRLFIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SGSVKLADFG  422 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g~vkL~DFG  422 (551)
                       ...+|||||||+||+|.+++.+.   .+++..++.|+.||+.||+|||++||+||||||+|||++.   .+.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence             56789999999999999998753   5899999999999999999999999999999999999985   4679999999


Q ss_pred             Ccccccc-CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH----HhhcCCCCCC
Q 043852          423 LAKATTM-NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALF----RIGKGEPPLV  497 (551)
Q Consensus       423 la~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~----~i~~~~~~~~  497 (551)
                      +++.... .......||+.|+|||++  .+..|+.++|||||||++|+|+||++||.+........    ++..+.....
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCCCCC--CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             eeeeccCCCccccccCCcccCCcHHH--cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            9986543 334566799999999997  45578999999999999999999999997655433322    2222222211


Q ss_pred             ---CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          498 ---PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       498 ---~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                         ...++.++.+||.+||++||.+|||+.|+++||||++....
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  281 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  281 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence               13589999999999999999999999999999999765443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=415.97  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=211.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----  351 (551)
                      .+|++++.||+|+||+||+|++ .+|+.||||++....   ........+.+|+.+|++++|||||++++++...+    
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            4799999999999999999997 579999999986432   23445667889999999999999999999987654    


Q ss_pred             --eEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 --RLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 --~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                        .+|+||||| +.+|..+.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence              579999999 66898888888999999999999999999999999999999999999999999999999999976643


Q ss_pred             CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC-----------------
Q 043852          430 NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG-----------------  492 (551)
Q Consensus       430 ~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~-----------------  492 (551)
                       ......||+.|+|||++. ....++.++|||||||++|+|++|++||.+.+....+..+...                 
T Consensus       174 -~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         174 -EMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             -SCCSSCSCGGGCCTHHHH-TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             -ccccccccccccCHHHHc-CCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence             345567999999999973 3456799999999999999999999999887766554432221                 


Q ss_pred             -------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          493 -------------EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       493 -------------~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                                   ........++..+.+||.+||..||.+|||++|||+||||+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                         001123467899999999999999999999999999999997653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=416.98  Aligned_cols=247  Identities=25%  Similarity=0.433  Sum_probs=208.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEecC-C-----ceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTDD-G-----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~~-g-----~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  349 (551)
                      ++|+++++||+|+||+||+|++.. +     ..||+|.+.....    ......+.+|+.++.++ +|||||++++++.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC----HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            589999999999999999998632 2     3689998754322    22344677899999988 89999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhhh------------------------cCChHHHHHHHHHHHHHHHHHHhCCeeeccccc
Q 043852          350 ENRLFIFLELVTKGSLANLYQKY------------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC  405 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~------------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP  405 (551)
                      ...+|+|||||++|+|.++++..                        .+++..++.++.||+.||+|||++||+||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence            99999999999999999998643                        378889999999999999999999999999999


Q ss_pred             ceEEEcCCCcEEEEecCCccccccCCc----ccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 043852          406 ANILVDASGSVKLADFGLAKATTMNDV----KSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHL  480 (551)
Q Consensus       406 ~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~  480 (551)
                      +|||++.++.+||+|||+|+.......    ....||+.|||||++.  ...|+.++|||||||++|||+| |.+||.+.
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--EGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc--CCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999986544332    2445799999999973  5678999999999999999997 89999887


Q ss_pred             hhHHHHHH-hhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          481 EGMQALFR-IGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       481 ~~~~~~~~-i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      .....+.+ +..+..+..|..+++.+.+||.+||+.||++|||+++|++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66555544 44555666778899999999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=413.21  Aligned_cols=251  Identities=28%  Similarity=0.413  Sum_probs=208.4

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeecc------CC
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDK------DE  350 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------~~  350 (551)
                      +|+.+++||+|+||+||+|++ .+|+.||||++......         ..+|+.+|++++|+||+++++++.      +.
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            799999999999999999998 58999999999754322         237999999999999999999873      34


Q ss_pred             CeEEEEEecccccchHHHHh----hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCcc
Q 043852          351 NRLFIFLELVTKGSLANLYQ----KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAK  425 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~----~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~  425 (551)
                      .++|||||||.++.+..+..    ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            46899999998875544432    33599999999999999999999999999999999999999775 89999999998


Q ss_pred             ccccC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC--C---------
Q 043852          426 ATTMN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG--E---------  493 (551)
Q Consensus       426 ~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~--~---------  493 (551)
                      ..... ......||+.|+|||++. ....|+.++|||||||++|||++|+.||...+..+.+..+.+.  .         
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIF-GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             hccCCcccccccccccccChHHhh-cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            66433 345567999999999873 4567899999999999999999999999887776666554320  0         


Q ss_pred             --------C---------CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcccc
Q 043852          494 --------P---------PLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQK  538 (551)
Q Consensus       494 --------~---------~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~  538 (551)
                              .         ......+++++.+||.+||++||.+|||+.|+|+||||+.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence                    0         01123578999999999999999999999999999999876443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.9e-50  Score=402.00  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=208.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----  351 (551)
                      ++|++++.||+|+||+||+|.+ .+|+.||||++.....  ........+.+|+.+++.++||||+++++++.+..    
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT--TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            4699999999999999999987 6899999999865432  23455667899999999999999999999876543    


Q ss_pred             eEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          352 RLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .+|||||||.|++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            489999999999999877654 6999999999999999999999999999999999999999999999999998654322


Q ss_pred             -----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCCC---CCCcCC
Q 043852          431 -----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPPL---VPNSLS  502 (551)
Q Consensus       431 -----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s  502 (551)
                           .....+||+.|+|||++  .+..|+.++|||||||++|||+||++||.+.+..+...++....+..   ....+|
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             --------------TTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             cccccccccccCcccccCHHHH--cCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence                 23456799999999997  45678999999999999999999999999888887777766654432   345789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHhCcccC
Q 043852          503 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK  533 (551)
Q Consensus       503 ~~l~~LI~~cL~~DP~~RPS~~eILehpff~  533 (551)
                      ..+.+||.+||++||.+||+..+.+.|+|++
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999999999999999544455567654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-50  Score=405.00  Aligned_cols=251  Identities=28%  Similarity=0.455  Sum_probs=212.5

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  355 (551)
                      .++|++++.||+|+||+||+|++.++..||||++.....      ....+.+|+.++.+++|+|||++++++.+ +.+|+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC------CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            458999999999999999999988888899999854322      12467899999999999999999999865 45789


Q ss_pred             EEecccccchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC-
Q 043852          356 FLELVTKGSLANLYQK---YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND-  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~---~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~-  431 (551)
                      |||||.+|+|..++..   ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... 
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            9999999999888753   358999999999999999999999999999999999999999999999999997654332 


Q ss_pred             --cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHH
Q 043852          432 --VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDF  508 (551)
Q Consensus       432 --~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~L  508 (551)
                        .....||+.|+|||++  ....++.++|||||||++|||+|| .+||......+.+..+.++.....+..++..+.+|
T Consensus       169 ~~~~~~~gt~~y~aPE~~--~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  246 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  246 (285)
T ss_dssp             -------CCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             eeeccccccccccChHHH--hCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence              2345689999999997  456789999999999999999995 55566666777777788887777889999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHh--CcccCCc
Q 043852          509 ILKCLQVNPNDRPTAAQLME--HPFVKRP  535 (551)
Q Consensus       509 I~~cL~~DP~~RPS~~eILe--hpff~~~  535 (551)
                      |.+||+.||++|||+.+|++  ++||...
T Consensus       247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         247 MCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999999999999999987  7788654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=400.04  Aligned_cols=245  Identities=25%  Similarity=0.453  Sum_probs=206.5

Q ss_pred             CeeeeeEeccCCceEEEEEEecC-C----ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDD-G----FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~-g----~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      +|+..++||+|+||.||+|...+ +    ..||||++...    ........+.+|+.++.+++|||||++++++.+...
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc----cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            78999999999999999998642 2    36999988532    223445578899999999999999999999999999


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      .++|||||.++++.+++..  ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.....
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999999887754  45889999999999999999999999999999999999999999999999999865432


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      .     .....||+.|+|||++  ....++.++|||||||++|||++| .+||......+....+..+..+..+..++..
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l--~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  241 (283)
T ss_dssp             ----------CCCGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             CccceEeccCCCCccccCHHHH--ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence            2     2234589999999997  456789999999999999999995 5556666666777778888888888899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      +.+||.+||+.||++|||+.+|++
T Consensus       242 l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         242 IYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHCcCCHhHCcCHHHHHH
Confidence            999999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=396.77  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=215.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCeEE
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENRLF  354 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  354 (551)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.....   ......++.+|+.++++++|+||+++++++.+...++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   77 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence            35899999999999999999998 6899999999975432   2345667889999999999999999999999999999


Q ss_pred             EEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--C
Q 043852          355 IFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--D  431 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--~  431 (551)
                      ++++++.+++|..+++.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.....  .
T Consensus        78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            999999999998887654 6888999999999999999999999999999999999999999999999999865433  2


Q ss_pred             cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCC-CCchhHHHHHHhhc--C----------------
Q 043852          432 VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPY-SHLEGMQALFRIGK--G----------------  492 (551)
Q Consensus       432 ~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf-~~~~~~~~~~~i~~--~----------------  492 (551)
                      .....+++.|+|||++. ....++.++|||||||++|||++|+.|| .+.+..+.+.++..  +                
T Consensus       158 ~~~~~~~~~~~~pe~~~-~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCSCCSCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             ceeeccccchhhhhHhc-cCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            33455788999999873 4445799999999999999999999886 44444444433221  0                


Q ss_pred             ----------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          493 ----------EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       493 ----------~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                ........++..+.+||.+||++||.+|||++|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                      11112345788999999999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=405.57  Aligned_cols=256  Identities=28%  Similarity=0.456  Sum_probs=207.3

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-----
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-----  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----  349 (551)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.......   ....++.+|+.+|++++|+||+++++++..     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            56899999999999999999998 689999999986554322   233456799999999999999999998754     


Q ss_pred             ---CCeEEEEEecccccchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          350 ---ENRLFIFLELVTKGSLANLYQK-YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       350 ---~~~~~lV~Ey~~ggsL~~ll~~-~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                         ...+|++||||.++.+..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence               4468999999998877655443 468889999999999999999999999999999999999999999999999997


Q ss_pred             cccc------CCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCC---CC
Q 043852          426 ATTM------NDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEP---PL  496 (551)
Q Consensus       426 ~~~~------~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~---~~  496 (551)
                      ....      ......+||+.|+|||++. ....|+.++|||||||++|||++|+.||.+.+.......+.....   ..
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLL-GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHc-CCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            5432      2234467999999999973 445789999999999999999999999988777665554332111   00


Q ss_pred             CC----------------------------CcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCc
Q 043852          497 VP----------------------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  535 (551)
Q Consensus       497 ~~----------------------------~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~  535 (551)
                      ..                            ...+..+.+||.+||++||++|||++|+|+||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            00                            0136778899999999999999999999999999853

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=409.55  Aligned_cols=257  Identities=28%  Similarity=0.483  Sum_probs=209.8

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----e
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----R  352 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~  352 (551)
                      +|++++.||+|+||+||+|.+ .+|+.||||++....    .......+.+|+.+|++++||||+++++++....    .
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            699999999999999999987 689999999986422    3445567889999999999999999999986543    2


Q ss_pred             EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC--
Q 043852          353 LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN--  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~--  430 (551)
                      .+++++|+.+|+|.++++..++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            344455666899999999889999999999999999999999999999999999999999999999999999754332  


Q ss_pred             ---CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcC---------------
Q 043852          431 ---DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKG---------------  492 (551)
Q Consensus       431 ---~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~---------------  492 (551)
                         .....+||+.|+|||++. ....++.++||||+||++|+|++|+.||.+.+..+........               
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTT-TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             cceeeccccccceechHHHhh-cCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence               234456999999999974 4567899999999999999999999999877655444332110               


Q ss_pred             --------CC--C-----CCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccC
Q 043852          493 --------EP--P-----LVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKS  539 (551)
Q Consensus       493 --------~~--~-----~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~  539 (551)
                              .+  .     .....++.++.+||.+||++||.+|||++++|+||||++.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence                    00  0     01235788999999999999999999999999999999665543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=408.53  Aligned_cols=246  Identities=28%  Similarity=0.475  Sum_probs=207.4

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCc----eEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGF----FFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN  351 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~----~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  351 (551)
                      .+|+++++||+|+||+||+|.+ .+|+    .||+|++...    ........+.+|+.++.+++|||||++++++.+. 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            3799999999999999999987 4555    4777776432    2223456788999999999999999999999865 


Q ss_pred             eEEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          352 RLFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..++++||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            46788899999999887754  3588999999999999999999999999999999999999999999999999986543


Q ss_pred             CC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHH
Q 043852          430 ND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRD  504 (551)
Q Consensus       430 ~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  504 (551)
                      ..    .....||+.|+|||++.  +..|+.++|||||||++|||+| |.+||.+.+..+....+.++..+..+..++..
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~  241 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  241 (317)
T ss_dssp             TCC--------CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred             ccccccccccccCccccChHHHh--cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            32    22345899999999974  4578999999999999999998 89999988777777778888888888899999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          505 ARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       505 l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +.+||.+||+.||.+|||+.+|++|
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=396.68  Aligned_cols=246  Identities=29%  Similarity=0.488  Sum_probs=205.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEec----CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD----DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ++|++++.||+|+||.||+|++.    .+..||||.+...    ........+.+|+.++++++|||||++++++.+ +.
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~   81 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP   81 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-Ce
Confidence            47999999999999999999863    2345777776422    223445678899999999999999999999864 67


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +|+|||||.+|+|..++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            8999999999999987654  35899999999999999999999999999999999999999999999999999865432


Q ss_pred             ---CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          431 ---DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       431 ---~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                         ......||+.|+|||++  ....|+.++|||||||++|||+| |.+||......+...++..+.....+..++..+.
T Consensus       162 ~~~~~~~~~gt~~y~apE~l--~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  239 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  239 (273)
T ss_dssp             ---------CCGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceeccceecCcccchhhHh--ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence               23345689999999997  45678999999999999999998 8999999888888888888888888999999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +||.+||+.||++|||+.+|++|
T Consensus       240 ~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         240 SLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=409.14  Aligned_cols=259  Identities=27%  Similarity=0.427  Sum_probs=214.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe----cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC-CceeeeeeeccCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT----DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH-ENIVQYFGTDKDE  350 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~  350 (551)
                      +.+|++++.||+|+||+||+|.+    .+|+.||||++........ ......+.+|+.++.+++| |||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            56899999999999999999975    2589999999865432111 1123346689999999976 8999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY-HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTM  429 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~-~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~  429 (551)
                      ..+|++|||+.+|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            9999999999999999988755 578899999999999999999999999999999999999999999999999976533


Q ss_pred             C---CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH---HHHHHhhcCCCCCCCCcCCH
Q 043852          430 N---DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM---QALFRIGKGEPPLVPNSLSR  503 (551)
Q Consensus       430 ~---~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~s~  503 (551)
                      .   ......||+.|++||.+......++.++|||||||+||+|++|+.||.+....   ..+.+......+.++..++.
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  261 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  261 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence            2   23456699999999998655556889999999999999999999999665432   33333333344556778999


Q ss_pred             HHHHHHHHhhhcCCCCCC-----CHHHHHhCcccCCc
Q 043852          504 DARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  535 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RP-----S~~eILehpff~~~  535 (551)
                      .+.+||.+||++||.+||     |++|+++||||++.
T Consensus       262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            999999999999999999     58999999999873

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=408.54  Aligned_cols=260  Identities=28%  Similarity=0.409  Sum_probs=213.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-----C
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-----E  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~  350 (551)
                      ++|++++.||+|+||+||+|++ .+|+.||||++....   .......++.+|+.+|++++|+|||++++++..     .
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh---cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            4799999999999999999997 689999999986432   233445678899999999999999999998753     2


Q ss_pred             CeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          351 NRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      ...+++|+|+.+|+|.++++..++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++..... 
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence            3346667778899999999988999999999999999999999999999999999999999999999999999865543 


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhcCCCC---------------
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGKGEPP---------------  495 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~~~~~---------------  495 (551)
                      ......||+.|+|||++. ....++.++|||||||++|+|++|++||.+.+.......+......               
T Consensus       174 ~~~~~~g~~~y~apE~~~-~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         174 EMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             GGSSSCHHHHTSCHHHHT-TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             ccccccccccccCchhhc-CCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence            344566899999999863 4456789999999999999999999999887766555444221100               


Q ss_pred             -------C--------CCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccccCCC
Q 043852          496 -------L--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQKSRG  541 (551)
Q Consensus       496 -------~--------~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~~~~~  541 (551)
                             .        ....++..+.+||.+||+.||.+|||++|+|+||||++....+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~  313 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  313 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC
Confidence                   0        013578999999999999999999999999999999987654443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-49  Score=393.38  Aligned_cols=244  Identities=25%  Similarity=0.449  Sum_probs=207.6

Q ss_pred             cccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-CCeE
Q 043852          275 RIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-ENRL  353 (551)
Q Consensus       275 ~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~  353 (551)
                      ..++|++++.||+|+||.||+|.. .|..||||++....       ..+.+.+|+.++++++||||+++++++.+ ...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            345899999999999999999976 57789999985321       23467899999999999999999998854 4668


Q ss_pred             EEEEecccccchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          354 FIFLELVTKGSLANLYQKY---HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~---~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      |+|||||++|+|.+++.+.   .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999999999998653   4899999999999999999999999999999999999999999999999999865433


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcCCCCCCCCcCCHHHHHHH
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKGEPPLVPNSLSRDARDFI  509 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~LI  509 (551)
                       .....+|+.|+|||++.  +..++.++|||||||++|||+| |.+||...+..+....+.++..+..+..++..+.+||
T Consensus       157 -~~~~~~~~~y~aPE~l~--~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             ------CCTTTSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             -CccccccccCCChHHHh--CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence             33456899999999974  4578999999999999999998 7999998888888888888888888999999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHhC
Q 043852          510 LKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       510 ~~cL~~DP~~RPS~~eILeh  529 (551)
                      .+||+.||.+|||+.+|+++
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999884

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-48  Score=397.75  Aligned_cols=246  Identities=23%  Similarity=0.415  Sum_probs=215.7

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDE  350 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  350 (551)
                      ++|++++.||+|+||+||+|+..      ++..||||++...    .......++.+|+.++++++||||+++++++.+.
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh----cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            47999999999999999999753      4578999987532    2234566789999999999999999999999999


Q ss_pred             CeEEEEEecccccchHHHHhhh-------------------------cCChHHHHHHHHHHHHHHHHHHhCCeeeccccc
Q 043852          351 NRLFIFLELVTKGSLANLYQKY-------------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKC  405 (551)
Q Consensus       351 ~~~~lV~Ey~~ggsL~~ll~~~-------------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP  405 (551)
                      ...+++|||+.+|+|.+++...                         .++...+..++.||+.||+|||+++|+||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            9999999999999999988542                         377888999999999999999999999999999


Q ss_pred             ceEEEcCCCcEEEEecCCccccccC----CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCC-CCCCCc
Q 043852          406 ANILVDASGSVKLADFGLAKATTMN----DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQ-PPYSHL  480 (551)
Q Consensus       406 ~NILl~~~g~vkL~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~-~Pf~~~  480 (551)
                      +||||+.++.+||+|||+++.....    ......||+.|+|||++.  ...|+.++|||||||++|||++|. +||.+.
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc--cCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999754322    223456889999999984  567999999999999999999985 789988


Q ss_pred             hhHHHHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          481 EGMQALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       481 ~~~~~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ...+....+..+..+..+..++.++.+||.+||+.||.+|||+.||++
T Consensus       247 ~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         247 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888888899999888889999999999999999999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3e-48  Score=398.72  Aligned_cols=249  Identities=28%  Similarity=0.456  Sum_probs=205.1

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccC--CCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKD--ENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~  352 (551)
                      ++|+++++||+|+||+||+|++ .+|+.||||++....        ..++.+|+.+|.++. ||||+++++++..  ...
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            5899999999999999999998 689999999985321        235678999999995 9999999999864  457


Q ss_pred             EEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC-cEEEEecCCcccccc-C
Q 043852          353 LFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG-SVKLADFGLAKATTM-N  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g-~vkL~DFGla~~~~~-~  430 (551)
                      +|+|||||.+++|..+.+  .+++..++.+++||+.||.|||++||+||||||+||||+.++ .+||+|||+|+.... .
T Consensus       107 ~~~v~e~~~~~~L~~~~~--~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEEECCCSCBGGGTTT--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eeEEEeecCCCcHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999999987654  589999999999999999999999999999999999998765 699999999986643 3


Q ss_pred             CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHhhc-------------C----
Q 043852          431 DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG-MQALFRIGK-------------G----  492 (551)
Q Consensus       431 ~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~-~~~~~~i~~-------------~----  492 (551)
                      ......||+.|+|||++. ....++.++|||||||++|+|++|..||..... ......+..             .    
T Consensus       185 ~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             cccccccCccccCccccc-CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            455667999999999973 445689999999999999999999999965432 222111100             0    


Q ss_pred             -------------------CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          493 -------------------EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       493 -------------------~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                                         ........++.++.+||.+||++||.+|||++|+|+||||+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                               00111234789999999999999999999999999999998643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=394.62  Aligned_cols=247  Identities=27%  Similarity=0.462  Sum_probs=199.3

Q ss_pred             cCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccC
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKD  349 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~  349 (551)
                      ++|++++.||+|+||.||+|.+.      +++.||||++....    .......+.+|..++.++ +|+||+.+++++.+
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            58999999999999999999852      35689999875322    233345666777777666 68999999998655


Q ss_pred             -CCeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEc
Q 043852          350 -ENRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVD  411 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~  411 (551)
                       ...+++|||||++|+|.+++...                 .+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence             45689999999999999998542                 378899999999999999999999999999999999999


Q ss_pred             CCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHH-H
Q 043852          412 ASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQ-A  485 (551)
Q Consensus       412 ~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~~~-~  485 (551)
                      .++.+||+|||+|+......    .....||+.|+|||++.  +..++.++|||||||++|||+|| .+||.+....+ .
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhh--cCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999997543322    33456999999999984  56789999999999999999986 56887665443 3


Q ss_pred             HHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          486 LFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       486 ~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ...+..+..+..+..+++++.+||.+||+.||++|||+++|++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44556677777888999999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=390.45  Aligned_cols=247  Identities=31%  Similarity=0.509  Sum_probs=201.6

Q ss_pred             cCeeeeeEeccCCceEEEEEEec--CC--ceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCCe
Q 043852          277 MSWQKGELLGSGSFGTVYEGYTD--DG--FFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDENR  352 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~~--~g--~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  352 (551)
                      ++|++++.||+|+||.||+|...  ++  ..||||++.....  ........+.+|+.++.+++||||+++++++.+. .
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence            47999999999999999999752  33  3689998764332  2234566789999999999999999999999764 6


Q ss_pred             EEEEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccC
Q 043852          353 LFIFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMN  430 (551)
Q Consensus       353 ~~lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~  430 (551)
                      +++|||||.+|+|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            7899999999999887654  45999999999999999999999999999999999999999999999999999865433


Q ss_pred             C-----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHhhcC-CCCCCCCcCCH
Q 043852          431 D-----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQALFRIGKG-EPPLVPNSLSR  503 (551)
Q Consensus       431 ~-----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~  503 (551)
                      .     .....||..|+|||++.  ...++.++|||||||++|||+| |++||.+.+..+...++.+. ..+..+..++.
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHH--HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCcceecCccccCcccCCHHHHh--CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            2     22345788999999984  4578999999999999999998 89999998888887777544 45566788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          504 DARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       504 ~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+.+||.+||+.||++|||+++|++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999975

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=394.63  Aligned_cols=248  Identities=25%  Similarity=0.463  Sum_probs=212.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCce--EEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeeccCCC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFF--FAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDKDEN  351 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~--vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~  351 (551)
                      +++|++.++||+|+||.||+|++ .+|..  ||||.+....    .......+.+|+.+|.++ +|||||++++++.+.+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            45899999999999999999987 45554  6667664322    122345688999999998 7999999999999999


Q ss_pred             eEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCC
Q 043852          352 RLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASG  414 (551)
Q Consensus       352 ~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g  414 (551)
                      .+|+|||||++|+|.+++++.                 .+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999998642                 478899999999999999999999999999999999999999


Q ss_pred             cEEEEecCCccccccCC-cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHhhcC
Q 043852          415 SVKLADFGLAKATTMND-VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKG  492 (551)
Q Consensus       415 ~vkL~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~~~~~~~i~~~  492 (551)
                      .+||+|||+++...... .....||..|+|||.+.  ...|+.++|||||||++|||++| .+||.+.+..+....+.++
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHH--HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhc--cCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            99999999997654332 33456899999999984  45789999999999999999996 5689888888888888888


Q ss_pred             CCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 043852          493 EPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       493 ~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      ..+..+..+++++.+||.+||+.||++|||+.+|++|
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8888889999999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=390.72  Aligned_cols=247  Identities=27%  Similarity=0.458  Sum_probs=210.9

Q ss_pred             ccCeeeeeEeccCCceEEEEEEecC--------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTDD--------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGT  346 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~~--------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  346 (551)
                      .++|++++.||+|+||.||+|+...        +..||||++....    ......++.+|...+.++ +|||||+++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            3589999999999999999997522        2479999885422    234456777888888887 79999999999


Q ss_pred             ccCCCeEEEEEecccccchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEE
Q 043852          347 DKDENRLFIFLELVTKGSLANLYQKY-----------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL  409 (551)
Q Consensus       347 ~~~~~~~~lV~Ey~~ggsL~~ll~~~-----------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NIL  409 (551)
                      +.++..+|+|||||.+|+|.+++...                 .+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            99999999999999999999998643                 3789999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHH
Q 043852          410 VDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQ  484 (551)
Q Consensus       410 l~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~  484 (551)
                      ++.++.+||+|||+++......    .....||+.|+|||++.  ...|+.++||||||||+|||++ |.+||.+.+..+
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~--~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc--CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999998654332    33456899999999984  4689999999999999999998 799999888888


Q ss_pred             HHHHhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          485 ALFRIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       485 ~~~~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ....+..+..+..+..++..+.+||.+||+.||.+|||+.+|++
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            87888888888888999999999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=402.64  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=200.4

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-----
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-----  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----  349 (551)
                      +++|+++++||+|+||+||+|++ .+|+.||||++.....   ......++.+|+.++++++||||+++++++..     
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence            45899999999999999999998 5799999999975432   24455678899999999999999999999853     


Q ss_pred             -CCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccc
Q 043852          350 -ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATT  428 (551)
Q Consensus       350 -~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~  428 (551)
                       ...+|+|||||.++.+..+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++...
T Consensus        93 ~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          93 EFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             TCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             cCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence             46889999999876665443  458899999999999999999999999999999999999999999999999987654


Q ss_pred             cC-CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHhhc----------------
Q 043852          429 MN-DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGK----------------  491 (551)
Q Consensus       429 ~~-~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i~~----------------  491 (551)
                      .. ......||+.|+|||++  .+..++.++||||+||++|+|++|++||.+.+......++..                
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l--~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ----------CCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cccccccccccccccChhhh--cCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            43 34455699999999997  456789999999999999999999999987765554443321                


Q ss_pred             ------CCCCCC-------------------CCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCcc
Q 043852          492 ------GEPPLV-------------------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  536 (551)
Q Consensus       492 ------~~~~~~-------------------~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~  536 (551)
                            ......                   ....+.++.+||.+||.+||++|||++|||+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                  110000                   012456789999999999999999999999999998754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-48  Score=393.18  Aligned_cols=247  Identities=26%  Similarity=0.425  Sum_probs=216.7

Q ss_pred             ccCeeeeeEeccCCceEEEEEEec------CCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYTD------DGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD  349 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  349 (551)
                      .++|++++.||+|+||.||+|.+.      ++..||||++...    ........+.+|+.++.+++||||+++++++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc----cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            358999999999999999999752      3678999988532    233445678899999999999999999999999


Q ss_pred             CCeEEEEEecccccchHHHHhhh-----------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEE
Q 043852          350 ENRLFIFLELVTKGSLANLYQKY-----------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKL  418 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~-----------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL  418 (551)
                      ....++|||||.+|+|.+++...           .++...+..++.||+.||.|||+++|+||||||+|||++.++++||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999999987532           2577889999999999999999999999999999999999999999


Q ss_pred             EecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHhhcCC
Q 043852          419 ADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTR-QPPYSHLEGMQALFRIGKGE  493 (551)
Q Consensus       419 ~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG-~~Pf~~~~~~~~~~~i~~~~  493 (551)
                      +|||+++......    .....||+.|+|||.+  ....++.++|||||||++|||+|| .+||.+.+..+.+..+.++.
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l--~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHH--ccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            9999997654332    2334589999999997  456789999999999999999997 68899988888888888888


Q ss_pred             CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          494 PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       494 ~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .+..+..++..+.+||.+||+.||++|||+.+|++
T Consensus       253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88888999999999999999999999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-47  Score=387.15  Aligned_cols=254  Identities=26%  Similarity=0.454  Sum_probs=215.1

Q ss_pred             ccCeeeeeEeccCCceEEEEEEe------cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcC-CCCceeeeeeecc
Q 043852          276 IMSWQKGELLGSGSFGTVYEGYT------DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRF-EHENIVQYFGTDK  348 (551)
Q Consensus       276 ~~~y~~~~~LG~G~fG~VY~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~  348 (551)
                      .++|+++++||+|+||.||+|+.      .++..||||++...    ........+.+|+.++.++ +|||||++++++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc----cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            46899999999999999999974      35678999998643    2234455788999999998 6999999999999


Q ss_pred             CCCeEEEEEecccccchHHHHhhh-------------------cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEE
Q 043852          349 DENRLFIFLELVTKGSLANLYQKY-------------------HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANIL  409 (551)
Q Consensus       349 ~~~~~~lV~Ey~~ggsL~~ll~~~-------------------~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NIL  409 (551)
                      +...+|++||||.+|+|.+++.+.                   .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            999999999999999999988653                   3788899999999999999999999999999999999


Q ss_pred             EcCCCcEEEEecCCccccccCC----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHH
Q 043852          410 VDASGSVKLADFGLAKATTMND----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLT-RQPPYSHLEGMQ  484 (551)
Q Consensus       410 l~~~g~vkL~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLlt-G~~Pf~~~~~~~  484 (551)
                      ++.++.+||+|||+++......    .....||+.|+|||++  ....++.++|||||||++|||+| |.+||.......
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh--cCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999998654332    2345689999999997  45678999999999999999998 677776665555


Q ss_pred             HHH-HhhcCCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccCCccc
Q 043852          485 ALF-RIGKGEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  537 (551)
Q Consensus       485 ~~~-~i~~~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILehpff~~~~~  537 (551)
                      .+. .+..+..+..+..++..+.+||.+||+.||.+|||+++|++  .+++.+.
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~--~L~~~i~  307 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ--LIEKQIS  307 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhhc
Confidence            444 34566777778889999999999999999999999999997  4444333

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=383.98  Aligned_cols=243  Identities=26%  Similarity=0.451  Sum_probs=203.4

Q ss_pred             eeeEeccCCceEEEEEEecC----CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccC-CCeEEE
Q 043852          281 KGELLGSGSFGTVYEGYTDD----GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKD-ENRLFI  355 (551)
Q Consensus       281 ~~~~LG~G~fG~VY~~~~~~----g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l  355 (551)
                      ..++||+|+||+||+|.+..    ...||||++..    ........++.+|+.++.+++||||+++++++.+ ++.+++
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECC----CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            35789999999999998632    23589998853    2235556789999999999999999999998764 568999


Q ss_pred             EEecccccchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCccccccCC--
Q 043852          356 FLELVTKGSLANLYQKY--HLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAKATTMND--  431 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~~~--~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~~~~~~~--  431 (551)
                      |||||.+|+|.+++...  .++...+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++......  
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999988754  36677889999999999999999999999999999999999999999999998654332  


Q ss_pred             ----cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCC-CchhHHHHHHhhcCCCCCCCCcCCHHHH
Q 043852          432 ----VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYS-HLEGMQALFRIGKGEPPLVPNSLSRDAR  506 (551)
Q Consensus       432 ----~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~s~~l~  506 (551)
                          .....||+.|+|||++.  ...++.++|||||||++|||+||..||. .....+....+..+..+..|..+++.+.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHH--HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceecccccccccccChHHHh--cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence                22356899999999973  4578999999999999999999776664 3444455666777888888889999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHhC
Q 043852          507 DFILKCLQVNPNDRPTAAQLMEH  529 (551)
Q Consensus       507 ~LI~~cL~~DP~~RPS~~eILeh  529 (551)
                      +||.+||+.||++|||+.||++|
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=372.30  Aligned_cols=244  Identities=27%  Similarity=0.381  Sum_probs=191.7

Q ss_pred             CeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCceeeeeeeccCCC----eE
Q 043852          278 SWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENIVQYFGTDKDEN----RL  353 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~  353 (551)
                      +|.+.+.||+|+||.||+|+. +|..||||++....      ......+.|+..+.+++|||||++++++.+..    .+
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            688999999999999999974 78899999885321      11222345666777889999999999987543    68


Q ss_pred             EEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHh--------CCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          354 FIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE--------QNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       354 ~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~--------~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      |+|||||.+|+|.+++++.++++..+..++.|++.||.|||+        +||+||||||+||||+.++.+||+|||+++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999999999899999999999999999999996        599999999999999999999999999998


Q ss_pred             ccccCC------cccCCCCCcccChhhhhcccC----CCCchhhHHHHHHHHHHHHcCCCCCCCch--------------
Q 043852          426 ATTMND------VKSCKGTPFWMAPEVVNLKNR----GYGLTADIWSLGCTVLEMLTRQPPYSHLE--------------  481 (551)
Q Consensus       426 ~~~~~~------~~~~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLG~iLyeLltG~~Pf~~~~--------------  481 (551)
                      ......      .....||+.|+|||++.....    .++.++|||||||+||||+||..||....              
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            654322      234679999999999743211    25788999999999999999988763211              


Q ss_pred             hHHHHHHh--hcCCCCCCCCc-----CCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          482 GMQALFRI--GKGEPPLVPNS-----LSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       482 ~~~~~~~i--~~~~~~~~~~~-----~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      ....+...  .....+.++..     ....+.+|+.+||+.||.+|||+.||++
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            11222222  22222333322     2346889999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-45  Score=369.38  Aligned_cols=249  Identities=21%  Similarity=0.302  Sum_probs=195.1

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCeEEE
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENRLFI  355 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l  355 (551)
                      +|++++.||+|+||.||+|++ .+|+.||||++.......       ++..|+.+++.++|+|+ +.++.++.+...+++
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC-------CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH-------HHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            699999999999999999987 679999999987543221       35689999999987765 555666677888999


Q ss_pred             EEecccccchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC---CCcEEEEecCCccccccC
Q 043852          356 FLELVTKGSLANLYQ--KYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA---SGSVKLADFGLAKATTMN  430 (551)
Q Consensus       356 V~Ey~~ggsL~~ll~--~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~---~g~vkL~DFGla~~~~~~  430 (551)
                      |||||.+ +|...+.  ...+++..+..++.||+.||+|||++||+||||||+|||++.   +..++|+|||+|+.....
T Consensus        81 vme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          81 VMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             EEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9999955 5554443  346999999999999999999999999999999999999864   457999999999865432


Q ss_pred             C---------cccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHh---h----cCCC
Q 043852          431 D---------VKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGMQALFRI---G----KGEP  494 (551)
Q Consensus       431 ~---------~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~~~~~~i---~----~~~~  494 (551)
                      .         .....||+.|+|||++  .+..++.++|||||||++|||+||+.||...........+   .    ....
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHH--TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccceeccccCCcCCCccccCHHHH--hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            2         2345799999999997  4567899999999999999999999999765443322211   1    1112


Q ss_pred             CCCCCcCCHHHHHHHHHhhhcCCCCCCCHHH---HHhCcccCCcc
Q 043852          495 PLVPNSLSRDARDFILKCLQVNPNDRPTAAQ---LMEHPFVKRPL  536 (551)
Q Consensus       495 ~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~e---ILehpff~~~~  536 (551)
                      +.....++.++.+||.+||+.||++||++.+   +|+|+|.+..+
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence            2234578999999999999999999999875   46777765433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.9e-44  Score=360.25  Aligned_cols=242  Identities=21%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             cCeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC-CceeeeeeeccCCCeEE
Q 043852          277 MSWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH-ENIVQYFGTDKDENRLF  354 (551)
Q Consensus       277 ~~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~  354 (551)
                      ++|++++.||+|+||+||+|++ .+|+.||||++.......       .+.+|++++..+.| +||+.+++++.+....|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH-------HHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            3799999999999999999997 579999999886543221       35578888888875 89999999999999999


Q ss_pred             EEEecccccchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcC-----CCcEEEEecCCcccc
Q 043852          355 IFLELVTKGSLANLYQK--YHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDA-----SGSVKLADFGLAKAT  427 (551)
Q Consensus       355 lV~Ey~~ggsL~~ll~~--~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~-----~g~vkL~DFGla~~~  427 (551)
                      +||||| +++|.++++.  ..++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+..
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999 6788888764  35889999999999999999999999999999999999964     578999999999764


Q ss_pred             ccC---------CcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHhhc----
Q 043852          428 TMN---------DVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEG---MQALFRIGK----  491 (551)
Q Consensus       428 ~~~---------~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~---~~~~~~i~~----  491 (551)
                      ...         .....+||+.|||||++  .+..++.++|||||||++|||+||..||.+...   .....++..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~--~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHh--cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            322         23355799999999997  456799999999999999999999999975432   222222221    


Q ss_pred             CCCCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 043852          492 GEPPLVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  528 (551)
Q Consensus       492 ~~~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~eILe  528 (551)
                      .........+++++.+++..|+..+|++||+++.+.+
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1112234568999999999999999999999888765

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.9e-42  Score=356.21  Aligned_cols=253  Identities=26%  Similarity=0.366  Sum_probs=190.2

Q ss_pred             CeeeeeEeccCCceEEEEEEe-cCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-----------CCceeeeee
Q 043852          278 SWQKGELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-----------HENIVQYFG  345 (551)
Q Consensus       278 ~y~~~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~  345 (551)
                      +|+++++||+|+||+||+|++ .+|+.||||++...      ......+.+|+.+++.++           |+||+++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            599999999999999999998 68999999998632      222345567888877765           578999998


Q ss_pred             eccC--CCeEEEEEecccccchHH-HH---hhhcCChHHHHHHHHHHHHHHHHHHh-CCeeecccccceEEEcCCC----
Q 043852          346 TDKD--ENRLFIFLELVTKGSLAN-LY---QKYHLMDSQVSAYTRQILNGLNYLHE-QNVVHRDIKCANILVDASG----  414 (551)
Q Consensus       346 ~~~~--~~~~~lV~Ey~~ggsL~~-ll---~~~~l~~~~i~~i~~QI~~aL~yLH~-~gIiHrDIKP~NILl~~~g----  414 (551)
                      ++..  ....+++|+++..+.... ..   ....+++..+..++.||+.||.|||+ .||+||||||+||||+.++    
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence            8754  345566666655543322 22   23468889999999999999999998 8999999999999998665    


Q ss_pred             --cEEEEecCCccccccCCcccCCCCCcccChhhhhcccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH------HHH
Q 043852          415 --SVKLADFGLAKATTMNDVKSCKGTPFWMAPEVVNLKNRGYGLTADIWSLGCTVLEMLTRQPPYSHLEGM------QAL  486 (551)
Q Consensus       415 --~vkL~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~s~ksDIwSLG~iLyeLltG~~Pf~~~~~~------~~~  486 (551)
                        .++|+|||.+..... ......||+.|+|||++  ....|+.++|||||||++++|++|+.||......      ..+
T Consensus       168 ~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHH--HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             cceeeEeeccccccccc-ccccccccccccChhhc--cccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence              399999999876543 33556799999999987  3567899999999999999999999999643321      111


Q ss_pred             HH---hhcC--------------------C------------------CCCCCCcCCHHHHHHHHHhhhcCCCCCCCHHH
Q 043852          487 FR---IGKG--------------------E------------------PPLVPNSLSRDARDFILKCLQVNPNDRPTAAQ  525 (551)
Q Consensus       487 ~~---i~~~--------------------~------------------~~~~~~~~s~~l~~LI~~cL~~DP~~RPS~~e  525 (551)
                      ..   +...                    .                  ........+..+.+||.+||++||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            11   0000                    0                  00011234677999999999999999999999


Q ss_pred             HHhCcccCCccccC
Q 043852          526 LMEHPFVKRPLQKS  539 (551)
Q Consensus       526 ILehpff~~~~~~~  539 (551)
                      +|+||||+......
T Consensus       325 ~L~Hp~f~~~~~~~  338 (362)
T d1q8ya_         325 LVNHPWLKDTLGME  338 (362)
T ss_dssp             HHTCGGGTTCTTCT
T ss_pred             HhcCcccCCCCCcc
Confidence            99999999665443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=2.2e-25  Score=210.25  Aligned_cols=173  Identities=18%  Similarity=0.205  Sum_probs=125.7

Q ss_pred             eeeeeEeccCCceEEEEEEecCCceEEEEEEecCccC-------------ccchHHHHHHHHHHHHHhcCCCCceeeeee
Q 043852          279 WQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQG-------------TQGKQSILQLEQEILLLSRFEHENIVQYFG  345 (551)
Q Consensus       279 y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~-------------~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  345 (551)
                      +.+++.||+|+||+||+|.+.+|+.||||++......             ............|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            3578999999999999999888999999987532111             001122344567888999999999999887


Q ss_pred             eccCCCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHhCCeeecccccceEEEcCCCcEEEEecCCcc
Q 043852          346 TDKDENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHEQNVVHRDIKCANILVDASGSVKLADFGLAK  425 (551)
Q Consensus       346 ~~~~~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~~gIiHrDIKP~NILl~~~g~vkL~DFGla~  425 (551)
                      +..    .+++|||+.+..+..      ++...+..++.||+.+|.|||++||+||||||+|||++. +.++|+|||+|.
T Consensus        82 ~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDFG~a~  150 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV  150 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCCTTCE
T ss_pred             ecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CCEEEEECCCcc
Confidence            643    279999999876533      556677889999999999999999999999999999985 458999999986


Q ss_pred             ccccCCcccCCCCCcccChhh---hhcccCCCCchhhHHHHHHHHH
Q 043852          426 ATTMNDVKSCKGTPFWMAPEV---VNLKNRGYGLTADIWSLGCTVL  468 (551)
Q Consensus       426 ~~~~~~~~~~~GT~~Y~APEv---l~~~~~~~s~ksDIwSLG~iLy  468 (551)
                      ........      .|....+   .......|+.++|+||+.--+.
T Consensus       151 ~~~~~~~~------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         151 EVGEEGWR------EILERDVRNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             ETTSTTHH------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             cCCCCCcH------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence            55422211      1222111   0112346788899999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=1.8e-07  Score=89.36  Aligned_cols=144  Identities=13%  Similarity=0.149  Sum_probs=92.7

Q ss_pred             hhhhcccCeeeeeEeccCCceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCC-CCceeeeeeeccC
Q 043852          271 KFRRRIMSWQKGELLGSGSFGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFE-HENIVQYFGTDKD  349 (551)
Q Consensus       271 ~~~~~~~~y~~~~~LG~G~fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~  349 (551)
                      .+++.+..|+..+..+-++.+.||+... ++..+++|.........     ...+.+|...+..+. +--+.+++.+..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~   81 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence            3456677888888776677789999854 55567788765332211     113456766665553 3335667777777


Q ss_pred             CCeEEEEEecccccchHHHHhhhcCChHHHHHHHHHHHHHHHHHHh----------------------------------
Q 043852          350 ENRLFIFLELVTKGSLANLYQKYHLMDSQVSAYTRQILNGLNYLHE----------------------------------  395 (551)
Q Consensus       350 ~~~~~lV~Ey~~ggsL~~ll~~~~l~~~~i~~i~~QI~~aL~yLH~----------------------------------  395 (551)
                      ++..|+||++++|.++......    ......++.++...+..||+                                  
T Consensus        82 ~~~~~lv~~~l~G~~~~~~~~~----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          82 DGWSNLLMSEADGVLCSEEYED----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHTTT----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             CCceEEEEEecccccccccccc----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            8889999999999887543321    11122233333333333332                                  


Q ss_pred             -------------------------CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 -------------------------QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 -------------------------~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                                               ..++|+|+.|.|||++.++.+.|+||+.+
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence                                     13899999999999987666779999976

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.18  E-value=3.2e-06  Score=79.98  Aligned_cols=133  Identities=16%  Similarity=0.093  Sum_probs=79.5

Q ss_pred             EeccCC-ceEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCC--CceeeeeeeccCCCeEEEEEecc
Q 043852          284 LLGSGS-FGTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEH--ENIVQYFGTDKDENRLFIFLELV  360 (551)
Q Consensus       284 ~LG~G~-fG~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~  360 (551)
                      .+..|. -+.||+....++..+++|........        .+..|...++.+..  -.+.+++.+..+.+..+++|+++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~--------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN--------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS--------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh--------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence            344444 47899998788888999975432211        23455555554432  33566787777888899999999


Q ss_pred             cccchHHH--------------Hhhh--------cCChH--HHHH-H---H----------------HHHHHHHHHHHhC
Q 043852          361 TKGSLANL--------------YQKY--------HLMDS--QVSA-Y---T----------------RQILNGLNYLHEQ  396 (551)
Q Consensus       361 ~ggsL~~l--------------l~~~--------~l~~~--~i~~-i---~----------------~QI~~aL~yLH~~  396 (551)
                      +|.++...              +.+-        ++...  .... .   .                ......+..+...
T Consensus        89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  168 (255)
T d1nd4a_          89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  168 (255)
T ss_dssp             SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence            88765321              1110        00000  0000 0   0                0112233334332


Q ss_pred             -------CeeecccccceEEEcCCCcEEEEecCCc
Q 043852          397 -------NVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       397 -------gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                             .++|+|+.|.|||++.++.+-|+||+.+
T Consensus       169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~  203 (255)
T d1nd4a_         169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  203 (255)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             CCccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence                   3899999999999987766789999965

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.74  E-value=5.6e-05  Score=76.92  Aligned_cols=82  Identities=16%  Similarity=0.163  Sum_probs=47.0

Q ss_pred             eeEeccCCceEEEEEEe-cCCceEEEEEEecCc--cCccchHHHHHHHHHHHHHhcCC---CCceeeeeeeccCCCeEEE
Q 043852          282 GELLGSGSFGTVYEGYT-DDGFFFAVKEVSLQD--QGTQGKQSILQLEQEILLLSRFE---HENIVQYFGTDKDENRLFI  355 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~-~~g~~vAVK~i~~~~--~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l  355 (551)
                      .+.||.|..-.||++.+ .+++.++||.-....  .+........+...|...|..+.   ...+++++.+..  ...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence            45789999999999986 457788888643211  11111111223345665555442   235666776543  34578


Q ss_pred             EEecccccch
Q 043852          356 FLELVTKGSL  365 (551)
Q Consensus       356 V~Ey~~ggsL  365 (551)
                      +||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.10  E-value=0.00037  Score=68.59  Aligned_cols=69  Identities=14%  Similarity=0.101  Sum_probs=41.5

Q ss_pred             eEEEEEEecCCceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce--eeeee-----eccCCCeEEEEEeccccc
Q 043852          291 GTVYEGYTDDGFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI--VQYFG-----TDKDENRLFIFLELVTKG  363 (551)
Q Consensus       291 G~VY~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~~-----~~~~~~~~~lV~Ey~~gg  363 (551)
                      =.||++...+|..|++|+.+....      ...++..|+..+..|...+|  +..+.     .+...+..+.+++++.|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            479999888999999998643211      12345567766666542222  11111     123355678899999875


Q ss_pred             ch
Q 043852          364 SL  365 (551)
Q Consensus       364 sL  365 (551)
                      .+
T Consensus       110 ~~  111 (325)
T d1zyla1         110 QF  111 (325)
T ss_dssp             EC
T ss_pred             CC
Confidence            43

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.81  E-value=0.004  Score=60.13  Aligned_cols=29  Identities=28%  Similarity=0.345  Sum_probs=26.3

Q ss_pred             CCeeecccccceEEEcCCCcEEEEecCCc
Q 043852          396 QNVVHRDIKCANILVDASGSVKLADFGLA  424 (551)
Q Consensus       396 ~gIiHrDIKP~NILl~~~g~vkL~DFGla  424 (551)
                      .|+||+|+.+.||+++.+...-|+||+.+
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccccceeEeccccc
Confidence            47999999999999998877799999976

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.63  E-value=0.004  Score=62.49  Aligned_cols=73  Identities=8%  Similarity=0.059  Sum_probs=46.7

Q ss_pred             eeEeccCCceEEEEEEecC--------CceEEEEEEecCccCccchHHHHHHHHHHHHHhcCCCCce-eeeeeeccCCCe
Q 043852          282 GELLGSGSFGTVYEGYTDD--------GFFFAVKEVSLQDQGTQGKQSILQLEQEILLLSRFEHENI-VQYFGTDKDENR  352 (551)
Q Consensus       282 ~~~LG~G~fG~VY~~~~~~--------g~~vAVK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~  352 (551)
                      ++.|+.|-.=.+|++...+        ...|.+++.- .   ...   .....+|..+++.+.-.++ .++++++.+   
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~---~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~---  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N---PET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S---CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C---cch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence            4788889999999987533        3456666543 1   111   1234567777776653344 567777754   


Q ss_pred             EEEEEecccccch
Q 043852          353 LFIFLELVTKGSL  365 (551)
Q Consensus       353 ~~lV~Ey~~ggsL  365 (551)
                       .+|+||+.|..|
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             589999988654